PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Kim, H; Kim, JH				Kim, Heejeong; Kim, Jee Hee			Evaluation of the Clinical Usefulness of Critical Patient Severity Classification System and Glasgow Coma Scale for Neurological Patients in Intensive Care Units	ASIAN NURSING RESEARCH			English	Article						critical illness; Glasgow Coma Scale; intensive care units; neurology	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; MORTALITY; PREDICTION; OUTCOMES	Purpose: The purpose of this study was to evaluate the clinical usefulness of the Critical Patient Severity Classification System (CPSCS) and Glasgow Coma Scale (GCS) for critically ill neurological patients and to determine the applicability of CPSCS and GCS in predicting their mortality. Methods: Data were collected from the medical records of 187 neurological patients who were admitted to the intensive care unit of C university hospital. The data were analyzed through chi-square test, t test, Mann-Whitney, Kruskal-Wallis, goodness-of-fit test, and receiver operating characteristic curve. Results: In accordance with patients' general and clinical characteristics, patient mortality turned out to be significantly different depending on intensive care unit stay, endotracheal intubation, central venous catheter, and severity by CPSCS. H1osmer-Lemeshow goodness-of-fit tests were applied to CPSCS and GCS. The results of the discrimination test using the receiver operating characteristic curve were CPSCS0, .743, GCS(0) .583, CPSCS24, .734, GCS(24) .612, CPSCS48, .591, GCS(48) .646, CPSCS72, .622, and GCS(72) .623. Logistic regression analysis showed that each point on the CPSCS score signifies a 1.034 higher likelihood of dying. Conclusion: Applied to neurologically ill patients, early CPSCS scores can be regarded as a useful tool. Copyright (C) 2013, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.	[Kim, Heejeong] Namseoul Univ, Dept Nursing, Chungcheongnam Do, South Korea; [Kim, Jee Hee] Kangwon Natl Univ, Dept Emergency Med Technol, Samcheok Si 245907, Gangwon Do, South Korea	Kim, JH (corresponding author), Kangwon Natl Univ, Dept Emergency Med Technol, Samcheok Si 245907, Gangwon Do, South Korea.	kjh1962@hanmail.net			Namseoul University	This work was supported by the research grant provided by Namseoul University.	Carayon Pascale, 2005, Intensive Crit Care Nurs, V21, P284, DOI 10.1016/j.iccn.2004.12.003; Cavanagh Stephen J, 2002, J Neurosci Nurs, V34, P288; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Goncalves Leilane Andrade, 2007, Intensive Crit Care Nurs, V23, P355, DOI 10.1016/j.iccn.2007.04.009; Hospital Nurses Association, 1994, STUD EST NUMB NURS R; Kiekkas Panagiotis, 2007, Nurs Crit Care, V12, P34, DOI 10.1111/j.1478-5153.2006.00193.x; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Lee S. H., 2006, THESIS KYUNGPOOK U D; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McNett Molly, 2007, J Neurosci Nurs, V39, P68; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Padilha KG, 2008, INTENS CRIT CARE NUR, V24, P197, DOI 10.1016/j.iccn.2007.09.004; Ross S., 1988, J TRAUMA, V45, P42; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Shin J. H., 2004, THESIS CHOSUN U GWAN; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; Siempos II, 2009, CRIT CARE MED, V37, P2283, DOI 10.1097/CCM.0b013e3181a02a67; Soo Oh， Hyun, 2009, [Korean Journal of Adult Nursing, 성인간호학회지], V21, P489; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; TAUNTON RL, 1994, J NURS ADMIN, V24, P48; TEASDALE G, 1974, LANCET, V2, P81; Vincent JL, 2000, INTENS CARE MED, V26, P1023, DOI 10.1007/s001340051313; Waterhouse C., 2005, NURSING STANDARD, V19, P56, DOI 10.7748/ns2005.04.19.33.56.c3857; Youn B. H., 2005, J KOREAN ACAD ADULT, V17, P464; 이동건, 2003, Infection and Chemotherapy, V35, P145	31	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1976-1317	2093-7482		ASIAN NURS RES	Asian Nurs. Res.	MAR	2013	7	1					8	15		10.1016/j.anr.2013.01.002			8	Nursing	Nursing	128VE	WOS:000317797000002	25031210	DOAJ Gold			2021-06-18	
J	Lapitskaya, N; Moerk, SK; Gosseries, O; Nielsen, JF; de Noordhout, AM				Lapitskaya, Natallia; Moerk, Sofie Kirial; Gosseries, Olivia; Nielsen, Joergen Feldbaek; de Noordhout, Alain Maertens			Corticospinal excitability in patients with anoxic, traumatic, and non-traumatic diffuse brain injury	BRAIN STIMULATION			English	Article						Brain injury; Motor evoked potential; Transcranial magnetic stimulation; Short latency afferent inhibition	TRANSCRANIAL MAGNETIC STIMULATION; LATENCY AFFERENT INHIBITION; MOTOR EVOKED-POTENTIALS; INTRACORTICAL INHIBITION; UNAFFECTED HEMISPHERE; CHRONIC STROKE; HEAD-INJURY; CORTICAL EXCITABILITY; CORTEX DISINHIBITION; VISUAL-CORTEX	Background: Transcranial magnetic stimulation (TMS) have been frequently used to explore changes in motor cortex excitability in stroke and traumatic brain injury, while the extent of motor cortex reorganization in patients with diffuse non-traumatic brain injury remains largely unknown. Objective/Hypothesis: It was hypothesized that the motor cortex excitability would be decreased and would correlate to the severity of brain injury and level of functioning in patients with anoxic, traumatic, and non-traumatic diffuse brain injury. Methods: TMS was applied to primary motor cortices of 19 patients with brain injury (5 traumatic and 14 non-traumatic causes; on average four months after insult), and 9 healthy controls. The test parameters included resting motor threshold (RMT), short intracortical inhibition (SICI), intracortical facilitation (ICF), and short latency afferent inhibition (SAD. Excitability parameters were correlated to the severity of brain injury measured with Glasgow Coma Scale and the level of functioning assessed using the Ranchos Los Amigos Levels of Cognitive Functioning Assessment Scale and Functional Independence Measure. Results: The patient group revealed a significantly decreased SICI and SAI compared to healthy controls with the amount of SICI correlated significantly to the severity of brain injury. Other electrophysiological parameters did not differ between the groups and did not exhibit any significant relationship with clinical functional scores. Conclusions: The present study demonstrated the impairment of the cortical inhibitory circuits in patients with brain injury of traumatic and non-traumatic aetiology. Moreover, the significant correlation was found between the amount of SICI and the severity of brain injury. (C) 2013 Elsevier Inc. All rights reserved.	[Lapitskaya, Natallia; Moerk, Sofie Kirial; Nielsen, Joergen Feldbaek] Hammel Neurorehabil & Res Ctr, Res Dept, DK-8450 Hammel, Denmark; [Gosseries, Olivia] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, B-4000 Liege, Belgium; [de Noordhout, Alain Maertens] Univ Liege, Dept Neurol, Ctr Hosp Reg Citadelle, B-4000 Liege, Belgium	Lapitskaya, N (corresponding author), Hammel Neurorehabil & Res Ctr, Res Dept, Voldbyvej 15, DK-8450 Hammel, Denmark.	natlap@rm.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Gosseries, Olivia/AAB-6469-2020	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Gosseries, Olivia/0000-0001-9011-7496	European Neurological Society; Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Belgian National Funds for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS	NL is supported by the European Neurological Society Fellowship and Danish Medical Research Council. OG is supported by the Belgian National Funds for Scientific Research (FNRS).	Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Butefisch CM, 2003, BRAIN, V126, P470, DOI 10.1093/brain/awg044; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Celnik P, 2007, ARCH PHYS MED REHAB, V88, P1369, DOI 10.1016/j.apmr.2007.08.001; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1998, ACTA NEUROCHIR, V140, P467, DOI 10.1007/s007010050126; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Cicinelli P, 2003, STROKE, V34, P2653, DOI 10.1161/01.STR.0000092122.96722.72; DENOORDHOUT AM, 1992, J PHYSIOL-LONDON, V447, P535, DOI 10.1113/jphysiol.1992.sp019016; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Di Lazzaro V, 2006, NEUROLOGY, V66, P1111, DOI 10.1212/01.wnl.0000204183.26231.23; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P2494, DOI 10.1016/j.clinph.2008.08.010; Di Lazzaro V, 1998, ELECTROMYOGR MOTOR C, V109, P397, DOI 10.1016/S0924-980X(98)00038-1; Di Lazzaro V, 2000, EXP BRAIN RES, V135, P455, DOI 10.1007/s002210000543; Di Lazzaro V, 1999, CLIN NEUROPHYSIOL, V110, P1297, DOI 10.1016/S1388-2457(99)00060-7; Di Lazzaro V, 2010, CEREB CORTEX, V20, P1523, DOI 10.1093/cercor/bhp216; DOMANN R, 1993, NEUROSCI LETT, V155, P69, DOI 10.1016/0304-3940(93)90675-B; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fujiki M, 2006, NEUROSCI LETT, V405, P226, DOI 10.1016/j.neulet.2006.07.005; Hagen C, 1987, PROFESSIONAL STAFF A; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; HOMBERG V, 1991, ELECTROEN CLIN NEURO, V81, P377, DOI 10.1016/0168-5597(91)90027-U; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Koski L, 2004, NEUROREHAB NEURAL RE, V18, P230, DOI 10.1177/1545968304269210; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lapitskaya N, 2009, PROG BRAIN RES, V177, P191, DOI 10.1016/S0079-6123(09)17713-0; Liepert J, 2001, NEUROSCI LETT, V300, P149, DOI 10.1016/S0304-3940(01)01572-5; Liepert J, 2000, CLIN NEUROPHYSIOL, V111, P671, DOI 10.1016/S1388-2457(99)00312-0; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Magistris MR, 1999, BRAIN, V122, P265, DOI 10.1093/brain/122.2.265; Manganelli F, 2008, CLIN NEUROPHYSIOL, V119, P351, DOI 10.1016/j.clinph.2007.10.011; Manganotti P, 2002, CLIN NEUROPHYSIOL, V113, P936, DOI 10.1016/S1388-2457(02)00062-7; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; METHERATE R, 1995, EXP BRAIN RES, V107, P59; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Nardone R, 2008, J NEURAL TRANSM, V115, P1557, DOI 10.1007/s00702-008-0129-1; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Oliviero A, 2005, CLIN NEUROPHYSIOL, V116, P2592, DOI 10.1016/j.clinph.2005.07.015; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Puksa L, 2003, CLIN NEUROPHYSIOL, V114, P1079, DOI 10.1016/S1388-2457(03)00028-2; REID AE, 2002, HDB TRANSCRANIAL MAG, P97; Roricht S, 1998, J NEUROL, V245, P280, DOI 10.1007/s004150050219; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Sakuma K, 2007, CLIN NEUROPHYSIOL, V118, P1460, DOI 10.1016/j.clinph.2007.03.018; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Talelli P, 2006, CLIN NEUROPHYSIOL, V117, P1641, DOI 10.1016/j.clinph.2006.01.016; Taverni JP, 1998, BRAIN INJURY, V12, P77; TEASDALE G, 1974, LANCET, V2, P81; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Young GB, 2004, J CLIN NEUROPHYSIOL, V21, P379	66	11	13	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	MAR	2013	6	2					130	137		10.1016/j.brs.2012.03.010			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	115VM	WOS:000316840000006	22542389	Green Published			2021-06-18	
J	Sabuncuoglu, O				Sabuncuoglu, Osman			Understanding the relationships between breastfeeding, malocclusion, ADHD, sleep-disordered breathing and traumatic dental injuries	MEDICAL HYPOTHESES			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; NONNUTRITIVE SUCKING HABITS; IRON-DEFICIENCY; RISK-FACTORS; CHILDREN; APNEA; PREVALENCE; DIAGNOSIS; SYMPTOMS	Attention-deficit/hyperactivity disorder (ADHD), one of the most common neuropsychiatric disorders that present at young age, may occasionally be associated with physical problems and disorders. Among them exists a group of oral-pharyngeal conditions with considerable clinical morbidity. Previous research that identified absence or short duration of breastfeeding in ADHD children has been reviewed. Essential nutritional factors in breast milk can affect brain development and regulate the manifestation of ADHD symptoms. Low ferritin levels caused by insufficient breastfeeding may contribute to ADHD susceptibility because of the role of iron in dopaminergic activity. Insufficient breast feeding and subsequently excessive bottle-feeding may lead to increased rates of non-nutritive sucking habits, such as pacifier use and thumb-sucking, all of which are associated with the risk of development of malocclusions. Malocclusion refers to an unacceptable deviation from the ideal relationship of the upper and lower teeth and necessitates orthodontic treatment. Sleep-disordered breathing in children may present with neurocognitive symptoms that resemble ADHD and abnormal craniofacial developments, as well as malocclusions, have been cited as part of the syndrome. Obesity, which is an outcome of insufficient breastfeeding, is a shared comorbidity of ADHD and sleep-disordered breathing. The risk of traumatic dental injury is higher in children with ADHD and presence of malocclusions further increases the likelihood of dental injuries. In this review, certain oral-pharyngeal conditions relating to ADHD have been reviewed and links among them have been highlighted in a tentative explanatory model. More research that will provide increased awareness and clinical implications is needed. (C) 2012 Elsevier Ltd. All rights reserved.	[Sabuncuoglu, Osman] Marmara Univ, Sch Med, Dept Child & Adolescent Psychiat, Istanbul, Turkey	Sabuncuoglu, O (corresponding author), Halk Cad Emin Ongan Sok 11-15, TR-34672 Istanbul, Turkey.	sabuncuoglu2004@yahoo.com					Alonge OK, 2001, DENT TRAUMATOL, V17, P218; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Assis AMO, 2004, REV SAUDE PUBL, V38, P543, DOI 10.1590/s0034-89102004000400010; Atmetlla Gabriela, 2006, J Clin Pediatr Dent, V30, P183; Baker RD, 2010, PEDIATRICS, V126, P1040, DOI 10.1542/peds.2010-2576; Banabilh SM, 2010, ANGLE ORTHOD, V80, P37, DOI 10.2319/011509-26.1; Schutza TCB, 2011, ANGLE ORTHOD, V81, P222, DOI 10.2319/052710-233.1; Bimstein E, 2008, SPEC CARE DENT, V28, P107, DOI 10.1111/j.1754-4505.2008.00021.x; Borum M K, 2001, Int J Paediatr Dent, V11, P249; Brooks LJ, 2008, ANN ACAD MED SINGAP, V37, P701; Brotanek JM, 2005, ARCH PEDIAT ADOL MED, V159, P1038, DOI 10.1001/archpedi.159.11.1038; Calarge C, 2010, J CHILD ADOL PSYCHOP, V20, P495, DOI 10.1089/cap.2010.0053; Callen Jennifer, 2005, Adv Neonatal Care, V5, P72, DOI 10.1016/j.adnc.2004.12.003; Camurdan AD, 2008, PUBLIC HEALTH NUTR, V11, P1173, DOI 10.1017/S1368980008001742; Carrascoza Karina Camillo, 2006, J. Pediatr. (Rio J.), V82, P395, DOI [10.1590/S0021-75572006000600015, 10.2223/JPED.1536]; Cazzolla AP, 2010, EUR J PAEDIATR DENT, V11, P189; Chaparro CM, 2008, J NUTR, V138, P2529; Chervin RD, 2005, SLEEP, V28, P885, DOI 10.1093/sleep/28.7.885; Chervin RD, 2002, PEDIATRICS, V109, P449, DOI 10.1542/peds.109.3.449; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Cortese S, 2007, J PSYCHOSOM RES, V63, P587, DOI 10.1016/j.jpsychores.2007.08.005; Cortese S, 2009, J AM ACAD CHILD PSY, V48, P894, DOI 10.1097/CHI.0b013e3181ac09c9; Daley D, 2009, CHILD CARE HLTH DEV, V35, P754, DOI 10.1111/j.1365-2214.2009.00938.x; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; Davis C, 2010, CURR PSYCHIAT REP, V12, P389, DOI 10.1007/s11920-010-0133-7; de Oliveira AS, 2010, CAD SAUDE PUBLICA, V26, P409, DOI 10.1590/S0102-311X2010000200020; Diouf JS, 2010, INT ORTHOD, V8, P372, DOI 10.1016/j.ortho.2010.10.001; Fewtrell MS, 2011, P NUTR SOC, V70, P472, DOI 10.1017/S0029665111000589; Floet AMW, 2010, PEDIATR REV, V31, P56, DOI 10.1542/pir.31-2-56; FRIED I, 1995, J DENT CHILD, V62, P256; Gelgor Ibrahim Erhan, 2007, Eur J Dent, V1, P125; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Gozal D, 2008, CURR OPIN PEDIATR, V20, P654, DOI 10.1097/MOP.0b013e328316ec2d; Guilleminault C, 2005, ARCH PEDIAT ADOL MED, V159, P775, DOI 10.1001/archpedi.159.8.775; Heasman P, 2003, MASTER DENT RESTORAT; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Huang YS, 2007, SLEEP MED, V8, P18, DOI 10.1016/j.sleep.2006.05.016; Hultcrantz E, 2009, INT J PEDIATR OTORHI, V73, P1234, DOI 10.1016/j.ijporl.2009.05.012; Julvez J, 2007, ACTA PAEDIATR, V96, P842, DOI 10.1111/j.1651-2227.2007.00273.x; Kadziela-Olech H, 2005, Rocz Akad Med Bialymst, V50, P302; Katz-Sagi H, 2010, J CLIN PEDIATR DENT, V34, P287, DOI 10.17796/jcpd.34.4.p6714ln2g658322u; Kikuchi Makoto, 2005, Sleep Breath, V9, P146, DOI 10.1007/s11325-005-0028-8; Kim HW, 2009, PSYCHIAT INVEST, V6, P278, DOI 10.4306/pi.2009.6.4.278; Konofal E, 2008, PEDIATR NEUROL, V38, P20, DOI 10.1016/j.pediatrneurol.2007.08.014; Lalloo R, 2003, DENT TRAUMATOL, V19, P12, DOI 10.1034/j.1600-9657.2003.00139.x; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Li SH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-144; Medeiros Ana Paula Magalhães, 2009, Pró-Fono R. Atual. Cient., V21, P315, DOI 10.1590/S0104-56872009000400009; Miano S, 2011, CLIN NEUROPHYSIOL, V122, P311, DOI 10.1016/j.clinph.2010.06.019; Miyao E, 2008, INTERNAL MED, V47, P1573, DOI 10.2169/internalmedicine.47.0717; Montaldo L, 2011, INT J PAEDIATR DENT, V21, P68, DOI 10.1111/j.1365-263X.2010.01092.x; Montgomery-Downs HE, 2007, PEDIATRICS, V120, P1030, DOI 10.1542/peds.2007-0722; O'Brien LM, 2003, PEDIATRICS, V111, P554, DOI 10.1542/peds.111.3.554; Oddy Wendy H, 2012, Breastfeed Rev, V20, P7; Oliveira Maria A. A., 2005, J. Pediatr. (Rio J.), V81, P361, DOI 10.1590/S0021-75572005000600004; Oner P, 2008, CHILD PSYCHIAT HUM D, V39, P323, DOI 10.1007/s10578-007-0095-0; Owens JA, 2009, PEDIATR PULM, V44, P417, DOI 10.1002/ppul.20981; Perinetti G, 2008, ORAL HLTH PREV DENT, V6, P119; Pessah Stephanie, 2009, Orthod Fr, V80, P331, DOI 10.1051/orthodfr/2009024; Ray R Mark, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P360, DOI 10.1097/01.moo.0000186076.53986.71; Rizwanulla T, 2009, THESIS R GANDHI U HL; Sabuncuoglu O, 2005, DENT TRAUMATOL, V21, P249, DOI 10.1111/j.1600-9657.2005.00317.x; Sabuncuoglu O, 2007, DENT TRAUMATOL, V23, P137, DOI 10.1111/j.1600-9657.2005.00431.x; Sanchez-Molins M, 2010, EUR J PAEDIATR DENT, V11, P87; Schmied K, 2009, ZWR, V118, P26; Sever Y, 1997, NEUROPSYCHOBIOLOGY, V35, P178, DOI 10.1159/000119341; Sidlauskas A, 2009, MEDICINA-LITHUANIA, V45, P147, DOI 10.3390/medicina45020019; Stettler N, 2011, NESTLE NUTR WORKS SE, V68, P215, DOI 10.1159/000325884; STEVENS LJ, 1995, AM J CLIN NUTR, V62, P761; Surman Craig B H, 2006, J Atten Disord, V9, P550, DOI 10.1177/1087054705282121; Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482; Trawitzki Luciana Vitaliano Voi, 2005, Braz J Otorhinolaryngol, V71, P747; TurgeonOBrien H, 1996, J DENT CHILD, V63, P321; Viggiano D, 2004, ARCH DIS CHILD, V89, P1121, DOI 10.1136/adc.2003.029728; Vlastos IM, 2010, EUR J PEDIATR, V169, P261, DOI 10.1007/s00431-009-1019-8; Weber Silke Anna Thereza, 2006, Braz J Otorhinolaryngol, V72, P124; Wei JL, 2007, ARCH OTOLARYNGOL, V133, P974, DOI 10.1001/archotol.133.10.974; World Health Organization (WHO), 2009, INF YOUNG CHILD FEED; Yoon SYR, 2012, SLEEP MED REV, V16, P371, DOI 10.1016/j.smrv.2011.07.001; Yorbik O, 2003, COCUK GENCLIK RUH SA, V10, P115	81	11	12	2	40	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	MAR	2013	80	3					315	320		10.1016/j.mehy.2012.12.017			6	Medicine, Research & Experimental	Research & Experimental Medicine	102GZ	WOS:000315834400023	23306004				2021-06-18	
J	Blomster, LV; Cowin, GJ; Kurniawan, ND; Ruitenberg, MJ				Blomster, Linda V.; Cowin, Gary J.; Kurniawan, Nyoman D.; Ruitenberg, Marc J.			Detection of endogenous iron deposits in the injured mouse spinal cord through high-resolution ex vivo and in vivo MRI	NMR IN BIOMEDICINE			English	Article						neurotrauma; secondary injury; astrogliosis; neural scar; neurodegeneration; haemorrhage; oxidative stress	MAGNETIC-RESONANCE; QUANTITATIVE MRI; NERVOUS-SYSTEM; WHITE-MATTER; DEGENERATION; CELLS; RAT; TRANSPLANTATION; HISTOLOGY; BRAIN	The main aim of this study was to employ high-resolution MRI to investigate the spatiotemporal development of pathological features associated with contusive spinal cord injury (SCI) in mice. Experimental mice were subjected to either sham surgery or moderate contusive SCI. A 16.4-T small-animal MR system was employed for nondestructive imaging of post-mortem, fixed spinal cord specimens at the subacute (7?days) and more chronic (2835 days) stages post-injury. Routine histological techniques were used for subsequent investigation of the observed neuropathology at the microscopic level. The central core of the lesion appeared as a dark hypo-intense area on MR images at all time points investigated. Small focal hypo-intense spots were also observed spreading through the dorsal funiculi proximal and distal to the site of impact, an area that is known to undergo gliosis and Wallerian degeneration in response to injury. Histological examination revealed these hypo-intense spots to be high in iron content as determined by Prussian blue staining. Quantitative image analysis confirmed the increased presence of iron deposits at all post-injury time points investigated (p < 0.05). Distant iron deposits were also detectable through live imaging without the use of contrast-enhancing agents, enabling the longitudinal investigation of this pathology in individual animals. Further immunohistochemical evaluation showed that intracellular iron deposits localised to macrophages/microglia, astrocytes and oligodendrocytes in the subacute phase of SCI, but predominantly to glial fibrillary acidic protein-positive, CC-1-positive astrocytes at later stages of recovery. Progressive, widespread intracellular iron accumulation is thus a normal feature of SCI in mice, and high-resolution MRI can be effectively used to detect and monitor these neuropathological changes with time. Copyright (c) 2012 John Wiley & Sons, Ltd.	[Blomster, Linda V.; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia; [Blomster, Linda V.] Univ Western Australia, Sch Anat & Human Biol, Crawley, WA, Australia; [Cowin, Gary J.; Kurniawan, Nyoman D.] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld 4072, Australia; [Ruitenberg, Marc J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia	Ruitenberg, MJ (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.	m.ruitenberg@uq.edu.au	Cowin, Gary J/E-6147-2011; Cowin, Gary/U-8721-2019; Blomster, Linda V./L-6368-2018; Kurniawan, Nyoman/D-9764-2011	Cowin, Gary J/0000-0002-3400-3109; Cowin, Gary/0000-0002-3400-3109; Blomster, Linda V./0000-0002-7611-9740; Kurniawan, Nyoman/0000-0001-6340-182X; Ruitenberg, Marc/0000-0002-6917-0708	School of Biomedical Sciences (The University of Queensland); office of the DVC(R) of The University of Queensland; International Postgraduate Research Scholarship of Australian Government; Australian National Imaging Facility; Queensland NMR network	This work was financially supported by the School of Biomedical Sciences (The University of Queensland) and an Enabling Grant from the office of the DVC(R) of The University of Queensland. LVB is supported by an International Postgraduate Research Scholarship of the Australian Government. Additional support was received through the Australian National Imaging Facility and the Queensland NMR network.	Ahrens ET, 2011, BIOTECHNIQUES, V50, P229, DOI 10.2144/000113652; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bilgen M, 2008, BIOMARK MED, V2, P113, DOI 10.2217/17520363.2.2.113; Blackwell ML, 2009, NEUROIMAGE, V46, P382, DOI 10.1016/j.neuroimage.2009.01.030; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; BUNGE RP, 1993, ADV NEUROL, V59, P75; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Cowin GJ, 2011, NEUROIMAGE, V58, P69, DOI 10.1016/j.neuroimage.2011.06.003; David BT, 2010, EXP NEUROL, V226, P128, DOI 10.1016/j.expneurol.2010.08.014; Do-Dai DD, 2010, CURR PROBL DIAGN RAD, V39, P160, DOI 10.1067/j.cpradiol.2009.05.004; Dunning MD, 2006, NEUROIMAGE, V31, P172, DOI 10.1016/j.neuroimage.2005.11.050; Dunning MD, 2004, J NEUROSCI, V24, P9799, DOI 10.1523/JNEUROSCI.3126-04.2004; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Gaviria M, 2006, NEUROBIOL DIS, V22, P694, DOI 10.1016/j.nbd.2006.01.011; Geffner LF, 2008, CELL TRANSPLANT, V17, P1277, DOI 10.3727/096368908787648074; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Gonzalez-Lara LE, 2011, MOL IMAGING BIOL, V13, P702, DOI 10.1007/s11307-010-0393-y; Gonzalez-Lara LE, 2009, J NEUROTRAUM, V26, P753, DOI 10.1089/neu.2008.0704; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; HEYE N, 1994, ARCH GERONTOL GERIAT, V18, P181, DOI 10.1016/0167-4943(94)90012-4; Hu SL, 2009, J CELL BIOCHEM, V108, P529, DOI 10.1002/jcb.22283; Izawa T, 2010, BRAIN RES, V1349, P105, DOI 10.1016/j.brainres.2010.06.030; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Koszyca B, 2002, J CLIN NEUROSCI, V9, P298, DOI 10.1054/jocn.2001.0969; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Liu Jin-bo, 2004, Chin J Traumatol, V7, P229; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Paterniti I, 2010, FREE RADICAL RES, V44, P694, DOI 10.3109/10715761003742993; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; Rathnasamy G, 2011, J NEUROSCI, V31, P17982, DOI 10.1523/JNEUROSCI.2250-11.2011; Rathore KI, 2008, J NEUROSCI, V28, P12736, DOI 10.1523/JNEUROSCI.3649-08.2008; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Schonberg DL, 2009, EXP NEUROL, V218, P64, DOI 10.1016/j.expneurol.2009.04.005; Schwab ME, 1996, PHYSIOL REV, V76, P319; Ullmann JFP, 2010, NMR BIOMED, V23, P341, DOI 10.1002/nbm.1465; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016	47	11	11	0	10	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480			NMR BIOMED	NMR Biomed.	FEB	2013	26	2					141	150		10.1002/nbm.2829			10	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	075LC	WOS:000313886500005	22730180				2021-06-18	
J	Leitgeb, J; Mauritz, W; Brazinova, A; Majdan, M; Wilbacher, I				Leitgeb, Johannes; Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Wilbacher, Ingrid			Outcome after severe brain trauma associated with epidural hematoma	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Traumatic brain injury, severe; Epidural hematoma, outcome; Prognostic scores	ACUTE SUBDURAL-HEMATOMA; EXTRADURAL HEMATOMA; PROGNOSTIC VALUE; HEAD-INJURIES; MORTALITY; IMPACT; COMA; EPIDEMIOLOGY; EXPERIENCE; MANAGEMENT	The aim of this study was to identify factors contributing to outcomes after severe traumatic brain injury (TBI) associated with epidural hematoma (EDH). Between 02/2002 and 4/2010 17 Austrian centers prospectively enrolled 863 patients with moderate and severe TBI into observational studies. Data on accident, treatment, and outcomes were collected. Data sets from patients who had severe TBI (=Glasgow Coma Scale score < 9) and EDH were selected. Six-month outcomes were classified as "favorable" if Glasgow Outcome Scale (GOS) scores were 5 or 4, and were classified as "unfavorable" if GOS scores were 3 or less. The Rotterdam score was used to classify computed tomography (CT) findings; the scores published by Hukkelhoven et al. (J Neurotrauma 22:1025-1039, 2005) were used to estimate predicted rates of death and of unfavorable outcomes. Univariate (Fisher's exact test, t test, Chi(2)-test) and multivariate (logistic regression) statistics were used to identify factors associated with hospital mortality and favorable outcome. Of the 738 patients with severe TBI 159 (21.5 %) had EDH. Of these, 49 (30.8 %) died in the hospital, 21 (13.2 %) survived with unfavorable outcome, 82 (51.6 %) with favorable outcome; long-term outcome was unknown in 7 survivors (4.4 %). Mortality rates predicted by the Rotterdam score showed good correlation with observed mortality rates. According to the Hukkelhoven scores, observed/predicted ratios for mortality and unfavorable outcome were 0.94 and 0.97, respectively. Age, severity of TBI, and neurological status were the main factors influencing outcomes after severe TBI associated with EDH. We were unable to demonstrate significant effects of treatment factors.	[Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Wilbacher, Ingrid] INRO, Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Dept Publ Hlth, Fac Hlth & Social Serv, Trnava, Slovakia	Leitgeb, J (corresponding author), Med Univ Vienna, Dept Traumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at	Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712			Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Gerlach R, 2009, PEDIATR EMERG CARE, V25, P164, DOI 10.1097/PEC.0b013e31819a8966; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; PARZHUBER A, 1994, UNFALLCHIRURG, V97, P615; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tallon JM, 2008, CAN J SURG, V51, P339; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	25	11	14	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	FEB	2013	133	2					199	207		10.1007/s00402-012-1652-y			9	Orthopedics; Surgery	Orthopedics; Surgery	075EK	WOS:000313866400008	23161150				2021-06-18	
J	Reznik, JE; Gordon, SJ; Barker, RN; Keren, O; Arama, Y; Galea, MP				Reznik, Jacqueline E.; Gordon, Susan J.; Barker, Ruth N.; Keren, Ofer; Arama, Yuval; Galea, Mary P.			Extracorporeal Shock Wave Therapy (ESWT) as a treatment for recurrent Neurogenic Heterotopic Ossification (NHO)	BRAIN INJURY			English	Article						Brain injury; traumatic brain injury (TBI); neurogenic heterotopic ossification (NHO); extracorporeal shock wave therapy (ESWT)	BRAIN-INJURY; CHRONIC PAIN; RELIEF	Primary objective: To describe the effects of extracorporeal shock wave therapy (ESWT) on neurogenic heterotopic ossification (NHO). Research design: A single case study was considered the most appropriate methodology in this situation. Methods and procedures: The subject was a 43 year old female 10 years post-traumatic brain injury with recurring NHO around the hip joint. Baseline assessments of pain using a 10-point VAS, range of motion of the hip using a goniometer and walking ability (number of steps over a standard distance) were conducted. Four applications of ESWT using a Minispec (TM) Extracorporeal Shock Wave Lithotripsy machine (Medispec Int. USA) administered over 6 weeks to the anterolateral aspect of the right hip. Follow-up assessments were conducted weekly over the period of intervention and then monthly for 5 months. Main outcomes and results: Immediately following treatment, pain was reduced to 0 on the VAS scale; hip range of motion increased and the number of steps over a standard distance reduced, indicating increased step length. At 5-month follow-up, without further ESWT intervention, these results were maintained. Conclusion: This case study suggests that ESWT may be a non-invasive, low risk intervention for the management of NHO.	[Reznik, Jacqueline E.; Gordon, Susan J.; Barker, Ruth N.; Galea, Mary P.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Keren, Ofer] Chaim Sheba Med Ctr, Head Injury Dept, Ramat Gan, Israel; [Arama, Yuval] Assaf Harofe Med Ctr, Dept Orthopaed, Zerifin, Israel; [Galea, Mary P.] Univ Melbourne, Rehabil Sci Res Ctr, Melbourne, Vic, Australia	Reznik, JE (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	jackie.reznik@jcu.edu.au	Galea, Mary/F-4242-2010	Galea, Mary/0000-0003-0045-7978; Gordon, Susan/0000-0002-4760-1212; Reznik, Jacqueline/0000-0002-7324-9531			Banovac K, 2000, J Spinal Cord Med, V23, P40; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Banovac K, 1997, J Spinal Cord Med, V20, P60; Banovac Kresimir, 2004, J Spinal Cord Med, V27, P376; Botte MJ, 1997, ORTHOPEDICS, V20, P335; Buselli P, 2010, ULTRASOUND MED BIOL, V36, P397, DOI 10.1016/j.ultrasmedbio.2009.11.007; Chauveau C, 2004, EXP MOL PATHOL, V76, P37, DOI 10.1016/j.yexmp.2003.10.001; Cipriano Cara, 2009, Orthopedics, V32, DOI 10.3928/01477447-20090728-33; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286; Daud O, 1993, Disabil Rehabil, V15, P114; Dejerine, 1919, REV NEUROL-FRANCE, V35, P399; GARLAND DE, 1983, CLIN ORTHOP RELAT R, P197; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Goldman J, 1980, Physiotherapy, V66, P219; Haake M, 2002, ARCH ORTHOP TRAUM SU, V122, P222, DOI 10.1007/s00402-001-0362-7; Haake Michael, 2002, J Orthop Sci, V7, P97, DOI 10.1007/s776-002-8429-0; Helbig K, 2001, CLIN ORTHOP RELAT R, P68; Linan E, 2001, AM J PHYS MED REHAB, V80, P614, DOI 10.1097/00002060-200108000-00013; Maier M, 2003, CLIN ORTHOP RELAT R, P237, DOI 10.1097/01.blo.0000030173.56585.8f; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Mustafa M, 2011, UROL RES, V39, P223, DOI 10.1007/s00240-010-0339-5; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Ogden JA, 2001, CLIN ORTHOP RELAT R, P47, DOI 10.1097/00003086-200106000-00007; Rompe JD, 1996, J BONE JOINT SURG BR, V78B, P233; Rompe JD, 2001, CLIN ORTHOP RELAT R, P102, DOI 10.1097/00003086-200106000-00014; Sator-Katzenschlager SM, 2003, ANESTH ANALG, V97, P791, DOI 10.1213/01.ANE.0000078584.03856.D3; Schaden W, 2001, CLIN ORTHOP RELAT R, P90; Silver J R, 1969, Paraplegia, V7, P220; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; Stover S L, 1976, Paraplegia, V14, P146; Takahashi N, 2003, AUTON NEUROSCI-BASIC, V107, P81, DOI 10.1016/S1566-0702(03)00134-6; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang C, 2005, AM J SPORTS MED, V34, P592; Wang CJ, 2008, ARCH ORTHOP TRAUM SU, V128, P901, DOI 10.1007/s00402-007-0530-5; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wess OJ, 2008, UROL RES, V36, P327, DOI 10.1007/s00240-008-0156-2	40	11	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					242	247		10.3109/02699052.2012.729293			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500012	23384220	Green Accepted			2021-06-18	
J	Solomon, GS; Haase, RF; Kuhn, A				Solomon, Gary S.; Haase, Richard F.; Kuhn, Andrew			The Relationship among Neurocognitive Performances and Biopsychosocial Characteristics of Elite National Football League Draft Picks: An Exploratory Investigation	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						National Football League; Neurocognitive testing; Biopsychosocial characteristics; Draft picks; ImPACT; Concussion	TEST-RETEST RELIABILITY; CHRONIC TRAUMATIC ENCEPHALOPATHY; PROFESSIONAL FOOTBALL; HIGH-SCHOOL; RECURRENT CONCUSSION; NCAA CONCUSSION; TEST BATTERY; PLAYERS; IMPACT; NFL	Sports neuropsychology has emerged as a specialty area within the field of clinical neuropsychology. The role of the sports neuropsychologist, rooted in baseline and post-concussion testing, has evolved to include other clinical domains, including the clinical assessment of potential draft picks. There is no published information on the neurocognitive characteristics of these draft picks. We sought to determine whether elite NFL draft picks differed from NFL roster athletes on neurocognitive (ImPACT) and biopsychosocial characteristics, and given that no published data exists for this population, adopted null hypotheses. Null hypotheses were rejected for two of the four ImPACT scores, as elite draft picks scored higher on measures of visual motor speed and reaction time than roster NFL athletes. Subtle but distinct neurocognitive differences are noted when comparing elite NFL draft picks with norms from a cumulative roster of a single NFL team.	[Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Haase, Richard F.] SUNY Albany, Albany, NY 12222 USA; [Kuhn, Andrew] Boston Univ, Boston, MA 02215 USA	Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA.	garysolomon17@yahoo.com	Kuhn, Andrew W/AAM-4820-2020; Solomon, Gary/K-9011-2019	Kuhn, Andrew W/0000-0003-1836-7575; 			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Broglio S., 2008, BRIT J SPORT MED, V40, P802; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Casson Ira R, 2006, Neurosurgery, V59, pE1152; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DUCKRO PN, 1989, CEPHALALGIA, V9, P199, DOI 10.1046/j.1468-2982.1989.0903199.x; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gill A, 2012, J SPORT ECON, V13, P642, DOI 10.1177/1527002511429575; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson G., 2004, NAT ASS SCH PSYCH DA; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Kuzmits FE, 2008, J STRENGTH COND RES, V22, P1721, DOI 10.1519/JSC.0b013e318185f09d; Lovell M, 2007, IMPACT 2007 6 0 CLIN; Lovell M., 2002, IMPACT CONCUSSION MA; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Lyons BD, 2009, HUM PERFORM, V22, P225, DOI 10.1080/08959280902970401; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; National Institute of Mental Health (NIMH), 2012, STATISTICS; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Reider B, 2012, AM J SPORT MED, V40, P2197, DOI 10.1177/0363546512462362; Rencher A. C., 2002, METHODS MULTIVARIATE; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2012, ARCH CLIN NEUROPSYCH, V27, P622; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Wilens E, 2004, JAMA-J AM MED ASSOC, V292, P619, DOI 10.1001/jama.292.5.619; *WOND PERS TEST IN, 1992, WOND PERS TEST SCHOL; Wonderlic EF, 1939, J APPL PSYCHOL, V23, P685, DOI 10.1037/h0056432	49	11	11	1	23	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2013	28	1					9	20		10.1093/arclin/acs108			12	Psychology, Clinical; Psychology	Psychology	073EP	WOS:000313726600002	23220623	Bronze			2021-06-18	
J	Zhang, YM; Zhang, YQ; Cheng, SB; Chen, SX; Chen, AL; Tang, CZ				Zhang Yi-min; Zhang Yu-qing; Cheng Shao-bing; Chen Sheng-xin; Chen Ai-lian; Tang Chun-zhi			Effect of acupuncture on proliferation and differentiation of neural stem cells in brain tissues of rats with traumatic brain injury	CHINESE JOURNAL OF INTEGRATIVE MEDICINE			English	Article						traumatic brain injury; acupuncture; neural stem cells; proliferation and differentiation; rats	PRECURSORS	To observe the effect of acupuncture on proliferation and differentiation of neural stem cells in brain tissues of rats with traumatic brain injuny. Thirty SD rats were randomly and equally allocated to the sham-operated, the model and the acupuncture groups. The traumatic brain injury model was established by the free drop method. For the rats in the acupuncture group, acupuncture was applied once a day for 7 days. Brain histotomy was carried out when treatments were completed. Immunohistochemical techniques were adopted to detect the cells that express nestin, neurofilament proteins (NF)-200 and glial fibrillary acidic proteins (GFAP), the markers of neural stem cells, neurons, astrocytes respectively. Compared to the sham-operated group, the number of nestin-positive cells and NF-200-positive cells in brain tissues was decreased significantly in the model group (P < 0.01), whereas the number of GFAP-positive cells was significantly increased P < 0.01). Compared to the model group, the positive cells of nestin, NF-200, GFAP in brain tissues in the acupuncture group were increased obviously (P < 0.01). Acupuncture can significantly increase the number of nestin-positive cells, NF-200-positive cells and GFAP-positive cells, indicating the significant increase of neural stem cells, neurons and astrocytes in number. Acupuncture can improve neuranagenesis by promoting the proliferation and differentiation of neural stem cells in brain tissues. This might be one of the mechanisms for acupuncture to treat traumatic brain injury and to promote the repair of nervous function.	[Zhang Yi-min; Zhang Yu-qing; Cheng Shao-bing; Chen Sheng-xin; Chen Ai-lian] Jinan Univ, Guangzhou 510632, Guangdong, Peoples R China; [Tang Chun-zhi] Guangzhou Univ Tradit Chinese Med, Guangzhou 510405, Guangdong, Peoples R China	Zhang, YM (corresponding author), Jinan Univ, Guangzhou 510632, Guangdong, Peoples R China.	jane-107@163.com			Natural Science Foundation of GuangdongNational Natural Science Foundation of Guangdong Province [9151063201000028]; Project of Science and Technology of Guangdong [2011B031800284]	Supported by Project of Natural Science Foundation of Guangdong (No. 9151063201000028) and Project of Science and Technology of Guangdong (No. 2011B031800284)	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Chen T, 2009, CHIN ORG ENG RES CLI, V13, P5367; Chen Y, 2007, BRAIN RES, V1166, P9, DOI 10.1016/j.brainres.2007.06.043; Ding Y, 2009, CHIN MAGAZINE MODERN, V11, P138; Li MJ, 2008, CHIN ORGAN ENG RES C, V12, P5709; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Tang Q, 2009, CHIN MAGAZINE REHABI, V24, P676; [田贵华 TIAN Guihua], 2011, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V26, P1197; Tu XH, 2011, WORLD J ACUPUNCT MOX, V21, P6; [邬巍 Wu Wei], 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P238; Zhang XN, 2008, CHIN REHABIL THEORY, V14, P101; Zhang YM, 2006, CHIN CLIN REHABIL CH, V10, P135; Zhang YM, 2010, CHIN MED J CHIN, V51, P528; 黄艳君, 2007, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V22, P380	14	11	14	0	23	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0415			CHIN J INTEGR MED	Chin. J. Integr. Med.	FEB	2013	19	2					132	136		10.1007/s11655-013-1353-6			5	Integrative & Complementary Medicine	Integrative & Complementary Medicine	080WY	WOS:000314276000009	23371461				2021-06-18	
J	Zou, FH; Xu, J; Fu, HR; Cao, JH; Mao, H; Gong, MJ; Cui, G; Zhang, Y; Shi, W; Chen, J				Zou, Feihui; Xu, Jian; Fu, Hongran; Cao, Jianhua; Mao, Hui; Gong, Mingjie; Cui, Gang; Zhang, Yang; Shi, Wei; Chen, Jian			Different Functions of HIPK2 and CtBP2 in Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						HIPK2; CtBP2; Traumatic brain injury; Apoptosis; Proliferation; Rat	INTERACTING PROTEIN KINASE-2; TERMINAL BINDING-PROTEIN; SEVERE HEAD-INJURY; TRANSCRIPTIONAL COREPRESSOR; GROWTH-FACTOR; CELL-CYCLE; P53-INDEPENDENT APOPTOSIS; NEGATIVE MODULATION; GENE-EXPRESSION; CO-REPRESSORS	Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that lead to neuronal dysfunction and over-reactive astrocytes. In our study, homeodomain interacting protein kinase 2 (HIPK2) can interact with C-terminal binding protein 2 (CtBP2) in rat brain, which is a component of Wnt-regulated transcription. Up to now, the functions of HIPK2 and CtBP2 in CNS are still with limited acquaintance. In our study, we found that the interaction between HIPK2 and CtBP2 was involved in central nervous system (CNS) injury and repair. We performed an acute TBI model in adult rats. Western blot and immunohistochemistry analysis revealed that both HIPK2 and CtBP2 significantly increased in the peritrauma brain cortex in comparison to contralateral cerebral cortex. And immunofluorescence double-labeling revealed that HIPK2 was mainly co-expressed with NeuN but less GFAP. Meanwhile, we also examined that the expression profiles of active-caspase-3 was correlated with the expression of HIPK2 and the expression profiles of the proliferating cell nuclear antigen (PCNA) was correlated with the expression of CtBP2. HIPK2 participated in apoptosis of neurons, but CtBP2 was associated with the activation and proliferation of astrocytes. Immunoprecipitation further showed that they enhanced the interaction with each other in the pathophysiology process. In conclusion, this was the first description that HIPK2 interacted with CtBP2 in traumatic brains. Our data suggest that HIPK2 and CtBP2 might play important roles in CNS pathophysiology after TBI, and might provide a basis for the further study on their roles in regulating the prognosis after TBI.	[Zou, Feihui; Fu, Hongran; Mao, Hui; Gong, Mingjie; Cui, Gang; Zhang, Yang; Shi, Wei; Chen, Jian] Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Jian; Cao, Jianhua] Nantong Univ, Affiliated Hosp, Mental Hlth Ctr, Dept Psychiat, Nantong 226001, Jiangsu, Peoples R China	Shi, W (corresponding author), Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Dept Neurol, 19 Qi Xiu Rd, Nantong 226001, Jiangsu, Peoples R China.	ws740104@hotmail.com; chenjian9079@gmail.com					Al-Beiti MAM, 2008, AUST NZ J OBSTET GYN, V48, P329, DOI 10.1111/j.1479-828X.2008.00874.x; Birts CN, 2011, ONCOGENE, V30, P1272, DOI 10.1038/onc.2010.507; Bitomsky N, 2009, FEBS J, V276, P6074, DOI 10.1111/j.1742-4658.2009.07331.x; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Engelhardt OG, 2003, EXP CELL RES, V283, P36, DOI 10.1016/S0014-4827(02)00025-3; Erhardt L, 1996, EUR HEART J, V17, P1781; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Hamada F, 2004, DEV CELL, V7, P677, DOI 10.1016/j.devcel.2004.08.022; Hofmann TG, 2003, CANCER RES, V63, P8271; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kondo S, 2003, P NATL ACAD SCI USA, V100, P5431, DOI 10.1073/pnas.0530308100; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Kovi RC, 2010, CELL DEATH DIFFER, V17, P513, DOI 10.1038/cdd.2009.140; Lavra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020665; Lee W, 2009, DEVELOPMENT, V136, P241, DOI 10.1242/dev.025460; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Lin X, 2003, MOL CELL BIOL, V23, P9081, DOI 10.1128/MCB.23.24.9081-9093.2003; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Moller A, 2003, CANCER RES, V63, P4310; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Paliwal S, 2006, MOL CELL BIOL, V26, P2360, DOI 10.1128/MCB.26.6.2360-2372.2006; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SUBRAMANIAN T, 1989, ONCOGENE, V4, P415; Sung KS, 2005, FEBS LETT, V579, P3001, DOI 10.1016/j.febslet.2005.04.053; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; Wang SY, 2006, J BIOL CHEM, V281, P34810, DOI 10.1074/jbc.M607484200; Wang Y, 2001, BMC Mol Biol, V2, P8, DOI 10.1186/1471-2199-2-8; Wang Y, 2002, BIOCHEM BIOPH RES CO, V297, P148, DOI 10.1016/S0006-291X(02)02020-X; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang LP, 2005, BIOCHEM BIOPH RES CO, V330, P293, DOI 10.1016/j.bbrc.2005.02.156; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	57	11	12	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					395	408		10.1007/s12031-012-9906-2			14	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900018	23076816				2021-06-18	
J	Zou, XT; Wu, N; Tian, Y; Niezrecki, C; Chen, JL; Wang, XW				Zou, Xiaotian; Wu, Nan; Tian, Ye; Niezrecki, Christopher; Chen, Julie; Wang, Xingwei			Rapid miniature fiber optic pressure sensors for blast wave measurements	OPTICS AND LASERS IN ENGINEERING			English	Article						Fiber optic sensor; Fabry-Perot; Blast wave; Pressure sensor; Traumatic brain injury	INJURIES; BRAIN; DIAPHRAGM	Traumatic brain injury (TBI) is a serious potential threat to soldiers who are exposed to explosions. Since the pathophysiology of TBI associated with a blast wave is not clearly defined, it is crucial to have a sensing system to accurately quantify the blast wave dynamics. This paper presents an ultra-fast fiber optic pressure sensor based on Fabry-Perot (FP) interferometric principle that is capable of measuring the rapid pressure changes in a blast event. The blast event in the experiment was generated by a starter pistol blank firing at close range, which produced a more realistic wave profile compared to using compressed air driven shock tubes. To the authors' knowledge, it is also the first study to utilize fiber optic pressure sensors to measure the ballistics shock wave of a pistol firing. The results illustrated that the fiber optic pressure sensor has a rise time of 200 ns which demonstrated that the sensor has ability to capture the dynamic pressure transient during a blast event. Moreover, the resonant frequency of the sensor was determined to be 4.11 MHz, which agrees well with the specific designed value. Published by Elsevier Ltd.	[Zou, Xiaotian; Wang, Xingwei] Univ Massachusetts, Dept Biomed Engn & Biotechnol, Lowell, MA 01584 USA; [Wu, Nan; Tian, Ye; Wang, Xingwei] Univ Massachusetts, Dept Elect & Comp Engn, Lowell, MA 01584 USA; [Niezrecki, Christopher; Chen, Julie] Univ Massachusetts, Dept Mech Engn, Lowell, MA 01584 USA	Wang, XW (corresponding author), Univ Massachusetts, Dept Biomed Engn & Biotechnol, Lowell, MA 01584 USA.	xingwei_wang@uml.edu	Tian, Ye/A-1090-2014; Zou, Xiaotian/J-8657-2013; Tian, Ye/C-4662-2013	Tian, Ye/0000-0002-0785-1145; Tian, Ye/0000-0002-0785-1145	Army Research Laboratory (Nanomanufacturing of Multifunctional Sensors) [W911NF-07-2-0081]	The authors are grateful for the collaboration with Nanomanufacturing Center at University of Massachusetts Lowell. The authors also appreciate Army Research Laboratory for sponsoring this work (Nanomanufacturing of Multifunctional Sensors Ref. Award Number: W911NF-07-2-0081).	Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Eaton WP, 1997, SMART MATER STRUCT, V6, P530, DOI 10.1088/0964-1726/6/5/004; MacPherson WN, 2000, MEAS SCI TECHNOL, V11, P95, DOI 10.1088/0957-0233/11/2/302; Neff M, 1999, PROC GRAPH INTERF, P193; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parkes W, 2007, J MICROMECH MICROENG, V17, P1334, DOI 10.1088/0960-1317/17/7/016; Tian Y, 2011, SENSORS-BASEL, V11, P1078, DOI 10.3390/s110101078; Totsu K, 2003, 12 INT C TRANSD SOL, V1, P931; Wang WH, 2012, OPT COMMUN, V285, P3466, DOI 10.1016/j.optcom.2012.04.001; Wang WH, 2010, OPT EXPRESS, V18, P9006, DOI 10.1364/OE.18.009006; Wang WH, 2009, OPT EXPRESS, V17, P16613, DOI 10.1364/OE.17.016613; Watson S, 2006, MEAS SCI TECHNOL, V17, P1337, DOI 10.1088/0957-0233/17/6/008; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wu N, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/5/055102; Wu N, 2011, OPT EXPRESS, V19, P10797, DOI 10.1364/OE.19.010797; Xu J, 2005, P SOC PHOTO-OPT INS, P5998; Xu JC, 2005, OPT LETT, V30, P3269, DOI 10.1364/OL.30.003269; Zou X, 2011, STUDY BLAST EVENT PR, P802809; Zou XT, 2012, MEASUREMENT, V45, P1077, DOI 10.1016/j.measurement.2012.01.034	21	11	13	2	52	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-8166			OPT LASER ENG	Opt. Lasers Eng.	FEB	2013	51	2					134	139		10.1016/j.optlaseng.2012.09.001			6	Optics	Optics	038OG	WOS:000311183400007					2021-06-18	
J	Phillips, KF; Deshpande, LS; DeLorenzo, RJ				Phillips, Kristin F.; Deshpande, Laxmikant S.; DeLorenzo, Robert J.			Hypothermia reduces calcium entry via the N-methyl-D-aspartate and ryanodine receptors in cultured hippocampal neurons	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Calcium; Hypothermia; Ryanodine receptor; NMDA receptor	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; RECURRENT EPILEPTIFORM DISCHARGES; GLUTAMATE NEUROTOXICITY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; HOMEOSTATIC MECHANISMS; CLINICAL-TRIALS; CARDIAC-ARREST; AMINO-ACIDS	Hypothermia is a powerful neuroprotective method when induced following cardiac arrest, stroke, and traumatic brain injury. The physiological effects of hypothermia are multifaceted and therefore a better knowledge of its therapeutic targets will be central to developing innovative combination therapies to augment the protective benefits of hypothermia. Altered neuronal calcium dynamics have been implicated following stroke, status epilepticus and traumatic brain injury. This study was therefore initiated to evaluate the effect of hypothermia on various modes of calcium entry into a neuron. Here, we utilized various pharmacological agents to stimulate major routes of calcium entry in primary cultured hippocampal neurons. Fluorescent calcium indicator Fura-2AM was used to compare calcium ratio under normothermic (37 degrees C) and hypothermic (31 degrees C) conditions. The results of this study indicate that hypothermia preferentially reduces calcium entry through N-methyl-D-aspartate receptors and ryanodine receptors. Hypothermia, on the other hand, did not have a significant effect on calcium entry through the voltage-dependent calcium channels or the inositol tri-phosphate receptors. The ability of hypothermia to selectively affect both N-methyl-D-aspartate receptors and ryanodine receptors-mediated calcium systems makes it an attractive intervention for alleviating calcium elevations that are present following many neurological injuries. (C) 2012 Elsevier B.V. All rights reserved.	[Phillips, Kristin F.; Deshpande, Laxmikant S.; DeLorenzo, Robert J.] Virginia Commonwealth Univ, Sch Med, Dept Neurol, Richmond, VA 23298 USA; [DeLorenzo, Robert J.] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	DeLorenzo, RJ (corresponding author), Virginia Commonwealth Univ, Sch Med, POB 980599, Richmond, VA 23298 USA.	rdeloren@vcu.edu	Deshpande, Laxmikant S./B-7679-2013	Deshpande, Laxmikant S./0000-0003-1491-1561	CounterACT Program, National Institutes of Health Office of the Director (NIH OD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2U01NS058213-06, 1R21NS072061-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS058213, R21NS072061] Funding Source: NIH RePORTER	This research is supported by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD), and the National Institute of Neurological Disorders and Stroke (NINDS), Grant Number 2U01NS058213-06 and 1R21NS072061-01A1 to RJD.	Adachi M, 2001, PEDIATR RES, V50, P590, DOI 10.1203/00006450-200111000-00010; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Angehagen M, 2003, NEUROREPORT, V14, P471, DOI 10.1097/01.wnr.0000059774.23521.b7; Asai S, 2000, BRAIN RES, V864, P60, DOI 10.1016/S0006-8993(00)02151-X; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, J NEUROSCI, V8, P185; deLorenzo RJ, 1998, P NATL ACAD SCI USA, V95, P14482, DOI 10.1073/pnas.95.24.14482; Deshpande LS, 2008, EUR J PHARMACOL, V583, P73, DOI 10.1016/j.ejphar.2008.01.025; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; ENDO M, 1977, PHYSIOL REV, V57, P71; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; GREENE RW, 1985, BRIT J PHARMACOL, V85, P163, DOI 10.1111/j.1476-5381.1985.tb08843.x; Hrabetova S, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-12-j0002.2000; Hua Y, 2010, J ANESTH, V24, P726, DOI 10.1007/s00540-010-0999-x; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; Jacobs SE, 2011, ARCH PEDIAT ADOL MED, V165, P692, DOI 10.1001/archpediatrics.2011.43; JENDEN DJ, 1969, PHARMACOL REV, V21, P1; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Koulen P, 2001, MOL NEUROBIOL, V24, P65, DOI 10.1385/MN:24:1-3:065; Kvrivishvili G, 2002, NEUROREPORT, V13, P1995, DOI 10.1097/00001756-200211150-00001; LEI SHZ, 1992, BRAIN RES, V598, P196, DOI 10.1016/0006-8993(92)90183-A; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MICHAELS RL, 1990, J NEUROSCI, V10, P283; MOUDY AM, 1994, NEUROPHARMACOLOGY, V33, P953, DOI 10.1016/0028-3908(94)90153-8; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Nagarkatti N, 2010, EUR J NEUROSCI, V32, P80, DOI 10.1111/j.1460-9568.2010.07262.x; Niebauer M, 1999, NEUROPHARMACOLOGY, V38, P1343, DOI 10.1016/S0028-3908(99)00059-3; Ning XH, 2002, J APPL PHYSIOL, V92, P2200, DOI 10.1152/japplphysiol.01035.2001; OKUDA C, 1986, PHARMACOL BIOCHEM BE, V24, P79; Ooboshi H, 2000, BRAIN RES, V884, P23, DOI 10.1016/S0006-8993(00)02861-4; OSUGI T, 1986, BRAIN RES, V379, P84, DOI 10.1016/0006-8993(86)90258-1; Pal S, 2001, CELL CALCIUM, V30, P285, DOI 10.1054/ceca.2001.0236; Pal S, 1999, BRAIN RES, V851, P20, DOI 10.1016/S0006-8993(99)02035-1; Polderman KH, 2008, EUR J ANAESTH, V25, P23, DOI 10.1017/S026502150700333X; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rauck RL, 2006, J PAIN SYMPTOM MANAG, V31, P393, DOI 10.1016/j.jpainsymman.2005.10.003; Raza M, 2004, P NATL ACAD SCI USA, V101, P17522, DOI 10.1073/pnas.0408155101; Raza M, 2001, BRAIN RES, V903, P1, DOI 10.1016/S0006-8993(01)02127-8; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; Sanz-Clemente A., 2012, NEUROSCIENTIST; Shorvon S, 2011, EPILEPSIA, V52, P53, DOI 10.1111/j.1528-1167.2011.03238.x; SOMBATI S, 1995, J NEUROPHYSIOL, V73, P1706; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Sun DA, 2004, CELL CALCIUM, V35, P155, DOI 10.1016/j.ceca.2003.09.003; Sun DA, 2002, EPILEPSIA, V43, P1296, DOI 10.1046/j.1528-1157.2002.09702.x; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; UNEYAMA H, 1993, BRAIN RES, V604, P24, DOI 10.1016/0006-8993(93)90348-Q; Wenzel A, 1997, J NEUROCHEM, V68, P469; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; WUIS EW, 1989, PHARMACOL TOXICOL, V64, P156, DOI 10.1111/j.1600-0773.1989.tb00621.x; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371; Yoon KW, 1996, STROKE, V27, P122, DOI 10.1161/01.STR.27.1.122; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86; ZHANG L, 1993, NEUROSCI LETT, V158, P105, DOI 10.1016/0304-3940(93)90623-S	67	11	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JAN 5	2013	698	1-3					186	192		10.1016/j.ejphar.2012.10.010			7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	085LL	WOS:000314616200022	23085028	Green Accepted			2021-06-18	
J	Pereira, JLB; de Albuquerque, LAF; Dellaretti, M; Teles, G; de Carvalho, C; Vieira, G; Brochado, VM; Drummond, AV; de Morais, JE; Ferreira, LM; Miranda, PAC; de Sousa, AA				Barbosa Pereira, Julio Leonardo; Freitas de Albuquerque, Lucas Alverne; Dellaretti, Marcos; Teles, Gervasio; de Carvalho, Cardoso; Vieira, Gerival, Jr.; Brochado, Vitor Michelstaedter; Drummond, Austen Venancio; de Morais, Joyce Espeschit; Ferreira, Leticia Maia; Carvalho Miranda, Paulo Augusto; de Sousa, Atos Alves			Pituitary deficiency after aneurysmal subarachnoid hemorrhage	CLINICS			English	Article						Subarachnoid Hemorrhage; Endocrine Dysfunction; Aneurysm	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROENDOCRINE DYSFUNCTION; HYPOPITUITARISM	OBJECTIVE: Aneurysmal subarachnoid hemorrhage puts patients at high risk for the development of pituitary insufficiency. We evaluated the incidence of pituitary dysfunction in these patients and its correlation with clinical outcome. METHODS: Pituitary function was tested in 66 consecutive patients in the first 15 days after aneurysmal subarachnoid hemorrhage. The following were measured in all patients: thyroid-stimulating hormone, free thyroxine, triiodothyronine, luteinizing hormone, follicle-stimulating hormone, total testosterone (in males), estradiol (in females), prolactin, serum cortisol, plasma adrenocorticotropic hormone, growth hormone and insulin growth factor. RESULTS: The endocrine assessment was made at a mean of 7.4 days (standard deviation +/- 6.6) after subarachnoid hemorrhage. Forty-four (66.7%) female and 22 (33.3%) male patients were evaluated. Thirty-nine patients (59.1%) had some type of pituitary dysfunction. Follicle-stimulating hormone/luteinizing hormone deficiency was the most frequent disorder (34.8%), followed by growth hormone/insulin growth factor (28.7%), adrenocorticotropic hormone (18.1%) and thyroid-stimulating hormone (9%). Seventeen (25.7%) patients showed deficiencies in more than one axis. A greater incidence of hormone deficiency was observed in patients with a Glasgow Coma Scale score <= 13 (t test, p = 0.008), Hunt-Hess grade >= 4 (t test, p<0.001), or Fisher grade 4 (t test, p = 0.039). Hormone deficiency was not significantly associated (p>0.05) with increased hospitalization or clinical outcome. CONCLUSION: Pituitary dysfunction was identified in a substantial portion of patients with previous aneurysmal subarachnoid hemorrhage, but no association was found between this dysfunction and poor clinical outcome.	[Barbosa Pereira, Julio Leonardo; Freitas de Albuquerque, Lucas Alverne; Dellaretti, Marcos; Teles, Gervasio; de Carvalho, Cardoso; Vieira, Gerival, Jr.; Brochado, Vitor Michelstaedter; Drummond, Austen Venancio; de Morais, Joyce Espeschit; Ferreira, Leticia Maia; Carvalho Miranda, Paulo Augusto; de Sousa, Atos Alves] Santa Casa Belo Horizonte, Dept Neurosurg, Belo Horizonte, MG, Brazil	Pereira, JLB (corresponding author), Santa Casa Belo Horizonte, Dept Neurosurg, Belo Horizonte, MG, Brazil.	lucasalverne@yahoo.com.br	Dellaretti, Marcos/G-4664-2012; Pereira, Julio/H-3324-2011	Pereira, Julio/0000-0003-0303-7506			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Darzy K H, 2005, J Endocrinol Invest, V28, P78; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Inagawa T, 1997, SURG NEUROL, V47, P47, DOI 10.1016/S0090-3019(96)00370-9; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Mangieri P, 2003, ARQ NEURO-PSIQUIAT, V61, P14, DOI 10.1590/S0004-282X2003000100003; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sharshar T, 2011, CRIT CARE, V15, DOI 10.1186/cc10010; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732	19	11	12	0	0	HOSPITAL CLINICAS, UNIV SAO PAULO	SAO PAULO	FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL	1807-5932			CLINICS	Clinics		2013	68	6					745	749		10.6061/clinics/2013(06)04			5	Medicine, General & Internal	General & Internal Medicine	165DS	WOS:000320463800004	23778478	DOAJ Gold, Green Published			2021-06-18	
J	Ciuffreda, KJ; Yadav, NK; Ludlam, DP				Ciuffreda, Kenneth J.; Yadav, Naveen K.; Ludlam, Diana P.			Effect of binasal occlusion (BNO) on the visual-evoked potential (VEP) in mild traumatic brain injury (mTBI)	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); binasal occlusion; visual-evoked potential amplitude; visual-evoked potential latency; visual motion sensitivity; disinhibition	POPULATION; CONCUSSION; PROTOCOL; TBI	Primary objective: The purpose of the experiment was to assess the effect of binasal occlusion (BNO) on the visually-evoked potential (VEP) in visually-normal (VN) individuals and in those with mild traumatic brain injury (mTBI) for whom BNO frequently reduces their primary symptoms related to abnormally-increased visual motion sensitivity (VMS). Design and methods: Subjects were comprised of asymptomatic VN adults (n = 10) and individuals with mTBI (n = 10) having the symptom of VMS. Conventional full-field VEP testing was employed under two conditions: without BNO and with opaque BNO which blocked regions on either side of the VEP test stimulus. Subjective impressions were also assessed. Results: In VN, the mean VEP amplitude decreased significantly with BNO in all subjects. In contrast, in mTBI, the mean VEP amplitude increased significantly with BNO in all subjects. Latency was normal and unaffected in all cases. Repeat VEP testing in three subjects from each group revealed similar test-re-test findings. Visuomotor activities improved, with reduced symptoms, with BNO in the mTBI group. Conclusions: It is speculated that individuals with mTBI habitually attempt to suppress visual information in the near retinal periphery to reduce their abnormal VMS, with addition of the BNO negating the suppressive influence and thus producing a widespread disinhibition effect and resultant increase in VEP amplitude.	[Ciuffreda, Kenneth J.; Yadav, Naveen K.; Ludlam, Diana P.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA	Ciuffreda, KJ (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu					Ciuffreda K. J., 2012, VISUAL DIAGNOSIS CAR, P95; Ciuffreda K. J., 2011, J BEHAV OPTOMETRY, V22, P10; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Ciuffreda KJ, 2009, OPTOM VIS DEV, V40, P16; Ciuffreda KJ, 1999, CLIN EYE VIS CARE, V11, P41, DOI DOI 10.1016/S0953-4431(99)00010-7; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Gallop S, 1998, J BEHAV OPTOM, V9, P31; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Helvie R, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P45, DOI 10.1201/b10524-4; JAMPOLSKY A, 1955, ARCH OPHTHALMOL-CHIC, V54, P683; KAUFMAN LLOYD, 1963, VISION RES, V3, P401, DOI 10.1016/0042-6989(63)90092-0; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Proctor A, 1974, OPTOMETRY VISION DEV, V40, P45; Semrud-Clikeman M., 2001, TRAUMATIC BRAIN INJU, P28; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Winkler PA, 2009, OPTOMETRY, V80, P502, DOI 10.1016/j.optm.2009.01.014	20	11	11	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2013	27	1					41	47		10.3109/02699052.2012.700088			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300005	22900490				2021-06-18	
J	Drag, L; Renninger, C; King, R; Hoblyn, J				Drag, Lauren; Renninger, Christopher; King, Robert; Hoblyn, Jennifer			Predictors of Inpatient and Outpatient Healthcare Utilization in Veterans With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare; hospitalization; outpatients; traumatic brain injury; utilization; veterans	ILLNESS; HOSPITALIZATION; DIAGNOSES; SERVICES; COSTS; IRAQ	Objective: Traumatic brain injury (TBI) can place a significant financial and resource burden on healthcare systems. This study examined predictors of outpatient and inpatient healthcare utilization in veterans with a history of TBI. Methods: A secondary analysis was conducted on data from 1565 veterans with TBI and 1565 veterans without TBI seen for healthcare services at the VA Palo Alto Health Care System between 2000 and 2010. Patterns and predictors of outpatient and inpatient medical and psychiatric care were examined. Results: Veterans with TBI utilized significantly more services compared with the control group. The TBI group was seen for more than 160 000 outpatient services and was almost 9 times more likely to be hospitalized than the control group. Although psychiatric disorders were more prevalent in the TBI group and associated with increased medical and mental health utilization within the TBI group, they did not account fully for the significant group differences. Conclusions: Veterans with a history of TBI have much greater healthcare needs than veterans without TBI, likely because of non-TBI-related factors. Increased monitoring and early intervention treatments may be warranted for certain at-risk veterans with the goal of minimizing their need for long-term or extensive healthcare services in the future.	[Drag, Lauren] Palo Alto Univ, Palo Alto, CA USA; [Drag, Lauren] VA Palo Alto Hlth Care Syst, Res Serv, Palo Alto, CA 94304 USA; [King, Robert] VA Palo Alto Hlth Care Syst, Adm Serv, Palo Alto, CA 94304 USA; [Hoblyn, Jennifer] VA Palo Alto Hlth Care Syst, Psychiat Serv, Palo Alto, CA 94304 USA; [Renninger, Christopher; Hoblyn, Jennifer] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Drag, L (corresponding author), VA Palo Alto Hlth Care Syst, Res Serv, 3801 Miranda Ave 118J, Palo Alto, CA 94304 USA.	laurenldrag@gmail.com		Hoblyn MD, Jennifer/0000-0002-9393-4763			Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Angelo C, 2011, EARLY INTERV PSYCHIA, V5, P203, DOI 10.1111/j.1751-7893.2011.00261.x; Armed Forces Health Surveillance Center, 2011, MMSR, V18, P8; Bauer MS, 1997, J AFFECT DISORDERS, V44, P159, DOI 10.1016/S0165-0327(97)00046-3; Brenner LA, 2008, J HEAD TRAUMA REHAB, V23, P401, DOI 10.1097/01.HTR.0000341436.59627.a5; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Congressional Budget Office, 2010, POT COSTS VET HLTH C; Congressional Budget Office, 2009, EFF PROP INCR COST S; Defense and Veterans Brain Injury Center, FREQ ASK QUEST; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Ghose SS, 2005, MED CARE, V43, P1259, DOI 10.1097/01.mlr.0000185711.50480.13; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Hoofien D, 2000, J CLIN EXP NEUROPSYC, V22, P305, DOI 10.1076/1380-3395(200006)22:3;1-V;FT305; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sokal J, 2004, J NERV MENT DIS, V192, P421, DOI 10.1097/01.nmd.0000130135.78017.96; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Worley MJ, 2010, J SUBST ABUSE TREAT, V39, P124, DOI 10.1016/j.jsat.2010.05.009	27	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2013	28	1					39	47		10.1097/HTR.0b013e318263bb61			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	070ZW	WOS:000313555400005	22935573				2021-06-18	
J	Fife, GP; O'Sullivan, D; Pieter, W				Fife, G. P.; O'Sullivan, D.; Pieter, W.			BIOMECHNAICS OF HEAD INJURY IN OLYMPIC TAEKWONDO AND BOXING	BIOLOGY OF SPORT			English	Article						taelmondo; boxing injuries; head injury; biomechanics	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; IMPACTS; CONCUSSION; BIOMECHANICS	Objective: The purpose was to examine differences between taekwondo kicks and boxing punches in resultant linear head acceleration (RLA), head injury criterion (HIC15), peak head velocity, and peak foot and fist velocities. Data from two existing publications on boxing punches and taekwondo kicks were compared. Methods: For taekwondo head impacts a Hybrid II Crash Dummy (Hybrid II) head was instrumented with a tri-axial accelerometer mounted inside the Hybrid II head. The Hybrid II was fixed to a height-adjustable frame and fitted with a protective taekwondo helmet. For boxing testing, a Hybrid III Crash Dummy head was instrumented with an array of tri-axial accelerometers mounted at the head centre of gravity. Results: Differences in RLA between the roundhouse kick (130.11 +/- 51.67 g) and hook punch (71.23 +/- 32.19 g, d=1.39) and in HIC15 (clench axe kick: 162.63 +/- 104.10; uppercut: 24.10 +/- 12.54, d=2.29) were observed. Conclusions: Taekwondo kicks demonstrated significantly larger magnitudes than boxing punches for both RLA and HIC.	[Fife, G. P.] Yonsei Univ, Dept Phys Educ, Seoul 120749, South Korea; [Fife, G. P.; O'Sullivan, D.; Pieter, W.] Chung Ang Univ, Dept Phys Educ, Anseong 456756, Gyeonggido, South Korea; [Pieter, W.] Keimyung Univ, Dept Taekwondo, Taegu, South Korea	O'Sullivan, D (corresponding author), Chung Ang Univ, Coll Sport Sci, Dept Phys Educ, 72-1 Naeri Daedeokmyeon, Anseong 456756, Gyeonggido, South Korea.	tkd4@cau.ac.kr					Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cohen JE, 2010, ISR MED ASSOC J, V12, P509; Dun SC, 2007, J BIOMECH, V40, P265, DOI 10.1016/j.jbiomech.2006.01.008; El Ashker S, 2011, INT J PERF ANAL SPOR, V11, P356; Fife GP, 2012, ARCH BUDO, V8; Fife GP, 2013, INT SPORTMED J, V14, P53; Fife GP, 2011, BRIT J SPORT MED, V45, P318; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hanson O, 2011, P 3 INT S TAEKW STUD, P108; Hopkins GW, NEW VIEW STAT; Kazemi Mohsen, 2009, J Can Chiropr Assoc, V53, P144; Koh JO, 2011, P 3 INT S TAEKW STUD, P202; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Narvaez MA, 2011, THESIS MICHIGAN STAT; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; OLER M, 1991, J TRAUMA, V31, P251, DOI 10.1097/00005373-199131020-00017; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pieter W, 1998, JAMA-J AM MED ASSOC, V7, P10; PIETER W, 1998, KINESIOLOGY, V30, P22, DOI DOI 10.1589/JPTS.28.231; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; World Bank and International Finance Corporation, 2012, DUR CONT, P16; Young W, 2004, J SCI MED SPORT, V7, P23, DOI 10.1016/S1440-2440(04)80040-9; Zemper ED, 1989, BRIT J SPORT MED, V23, P161	31	11	11	1	25	INST SPORT	WARSAW 45	TRYLOGII 2, POB 30,, 01-892 WARSAW 45, POLAND	0860-021X	2083-1862		BIOL SPORT	Biol. Sport		2013	30	4					263	268		10.5604/20831862.1077551			6	Sport Sciences	Sport Sciences	AB8OF	WOS:000332049200005	24744497	DOAJ Gold			2021-06-18	
J	Hannold, EM; Classen, S; Winter, S; Lanford, DN; Levy, CE				Hannold, Elizabeth Lisa M.; Classen, Sherrilene; Winter, Sandra; Lanford, Desiree N.; Levy, Charles E.			Exploratory pilot study of driving perceptions among OIF/OEF Veterans with mTBI and PTSD	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Afghanistan; automobile driving; blast injuries; brain injuries; combat disorders; Iraq; occupational therapy; qualitative research methods; stress disorders/posttraumatic; Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COMBAT VETERANS; PERFORMANCE; IRAQ	Veterans of Iraq and Afghanistan may experience driving-related challenges postdeployment, including more at-fault crashes. Causes may include defensive driving tactics learned for combat zones and consequences of traumatic brain injuries (TBIs) and posttraumatic stress disorder (PTSD). Tailoring driver interventions to meet Veterans' needs requires an understanding of their driving perceptions. We explored the driving perceptions of five combat Veterans (4 men, I woman) with mild TBI and PTSD using grounded theory methods. Veterans participated in single, semistructured interviews during a comprehensive driving evaluation. Interviews were digitally recorded, transcribed verbatim, verified, and imported into NVivo 8 software for coding and analysis. Veterans were insightful about driving and identified specific environmental triggers for anxious driving, speeding, and road rage. Veterans used strategies to moderate driving behaviors, but continued to drive aggressively. Themes were used to develop a conceptual framework of driving postdeployment, laying the foundation for intervention studies.	[Hannold, Elizabeth Lisa M.; Winter, Sandra; Levy, Charles E.] North Florida South Georgia NFSG Dept Vet Affairs, Res Enhancement Award Program, Rehabil Outcomes Res Ctr, Gainesville, FL USA; [Classen, Sherrilene; Winter, Sandra; Lanford, Desiree N.; Levy, Charles E.] Univ Florida, Coll Publ Hlth & Hlth Profess, Inst Mobil Act & Participat, Gainesville, FL USA; [Classen, Sherrilene; Winter, Sandra; Lanford, Desiree N.; Levy, Charles E.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Occupat Therapy, Gainesville, FL USA; [Levy, Charles E.] NF SG VAHS, Phys Med & Rehabil Serv, Gainesville, FL 32608 USA	Hannold, EM (corresponding author), NF SG VAHS, RORC REAP, 151-B,1601 SW Archer Rd, Gainesville, FL 32608 USA.	lisa.hannold@va.gov			NF/SG Malcom Randall VA Medical Center [VA 00066678]	This material was based on work supported by the NF/SG Malcom Randall VA Medical Center (project VA 00066678; PI: Classen). The Institute for Mobility, Activity, and Participation at University of Florida's College of Public Health and Health Profession is also gratefully acknowledged for providing infrastructure.	Adler AB, 2009, J CONSULT CLIN PSYCH, V77, P928, DOI 10.1037/a0016877; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P2; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brookhuis K A, 2001, ASSESSMENT DRIVERS W; Charmaz K, 2006, CONSTRUCTING GROUNDE; Classen S, 2013, AM J OCCUP THER, V67, P108, DOI 10.5014/ajot.2013.005116; Classen S, 2011, AM J OCCUP THER, V65, P419, DOI 10.5014/ajot.2011.000893; Collins C., 2014, PTSD TBI WE ARE NOW; Florida Institute on Disability and Rehabilitation and Florida Trauma Rehabilitation Center for Returning Military Personnel, 2014, EFF DRIV INT PROGR S; GAGE M, 1992, AM J OCCUP THER, V46, P353, DOI 10.5014/ajot.46.4.353; Glaser B. G., 1967, DISCOVERY GROUNDED T; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kashdan TB, 2006, BEHAV RES THER, V44, P457, DOI 10.1016/j.brat.2005.03.001; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Knapik JJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-231; Kraft M, 2010, AM J PHYS MED REHAB, V89, P336, DOI 10.1097/PHM.0b013e3181d3eb5f; Kuhn E, 2010, J TRAUMA STRESS, V23, P399, DOI 10.1002/jts.20536; Lazarus, 2006, STRESS EMOTION NEW S; Lazarus R.S., 1984, STRESS APPRAISAL COP; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Lew HL, 2011, J REHABIL RES DEV, V48, P913, DOI 10.1682/JRRD.2010.08.0140; Lew HL, 2010, NEUROREHABILITATION, V26, P271, DOI 10.3233/NRE-2010-0562; Lew HL, 2009, J HEAD TRAUMA REHAB, V24, P51, DOI 10.1097/HTR.0b013e3181956fe3; Michon J.A., 1985, HUMAN BEHAV TRAFFIC; Miles Huberman, 1994, QUALITATIVE DATA ANA; Military Health System Office of Strategic Communications, 2012, DOD NUMB TRAUM BRAIN; National Center for PTSD, 2013, DSM CRIT PTSD; National Research Council: Committee on Gulf War and Health, 2008, GULF WAR HLTH, V7; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; SMART RG, 2002, TRAFFIC INJ PREV, V3, P183; Stern E., 2011, OT PRACTICE, V16, P6; Strauss A., 1998, BASICS QUALITATIVE R; Tanielian T, 2008, INVISIBLE WOUNDS WAR; The American Occupational Therapy Association, 2010, AM J OCCUPATIONAL S, V64, P112, DOI DOI 10.5014/AJOT.2010.64S112; United States Automobile Association, 2012, RET WARR DRIV SAF RE; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zamorski MA, 2012, PSYCHOL ASPECTS DEPL	44	11	11	0	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	10					1315	1330		10.1682/JRRD.2013.04.0084			16	Rehabilitation	Rehabilitation	AE0LR	WOS:000333658300004	24699968	Bronze			2021-06-18	
J	Hou, YM; Huang, Q; Prakash, R; Chaudhury, S				Hou, Yongmei; Huang, Qin; Prakash, Ravi; Chaudhury, Suprakash			Infrequent near death experiences in severe brain injury survivors - A quantitative and qualitative study	ANNALS OF INDIAN ACADEMY OF NEUROLOGY			English	Article						Near- death experiences; post- traumatic coma; qualitative analysis	CARDIAC-ARREST SURVIVORS; OF-BODY EXPERIENCES; POSTTRAUMATIC COMA; PERSPECTIVE; STATE	Background: Near death experiences (NDE) are receiving increasing attention by the scientific community because not only do they provide a glimpse of the complexity of the mind-brain interactions in 'near-death' circumstances but also because they have significant and long lasting effects on various psychological aspects of the survivors. The over-all incidence-reports of NDEs in literature have varied widely from a modest Figure of 10% to around 35%, even up to an incredible Figure of 72% in persons who have faced close brush with death. Somewhat similar to this range of difference in incidences are the differences prevalent in the opinions that theorists and researchers harbor around the world for explaining this phenomena. None the less, objective evidences have supported physiological theories the most. A wide range of physiological processes have been targeted for explaining NDEs. These include cerebral anoxia, chemical alterations like hypercapnia, presence of endorphins, ketamine, and serotonin, or abnormal activity of the temporal lobe or the limbic system. In spite of the fact that the physiological theories of NDEs have revolved around the derangements in brain, no study till date has taken up the task of evaluating the experiences of near-death in patients where specific injury has been to brain. Most of them have evaluated NDEs in cardiac-arrest patients. Post-traumatic coma is one such state regarding which the literature seriously lacks any information related to NDEs. Patients recollecting any memory of their post-traumatic coma are valuable assets for NDE researchers and needs special attention. Materials and Methods: Our present study was aimed at collecting this valuable information from survivors of severe head injury after a prolonged coma. The study was conducted in the head injury department of Guangdong 999 Brain hospital, Guangzhou, China. Patients included in the study were the ones Recovered from the posttraumatic coma following a severe head injury. A total of 86 patients were chosen. Near death experience scale (NDES) score of 7 or more was used as the criteria of screening NDE experiences. After identifying such individuals, the Prakash-modification of the Interpretative Phenomenological Analysis (IPA) was used to interview and record the data for qualitative analysis. Results: We found that contrary to earlier incidence reports, NDEs in post head injury patients were markedly low. Only 3 out of 86 of the patients recruited had a clear and confident experience of NDE. We conducted a qualitative study to explore further into these experiences. IPA of these 3 patients revealed four master themes: 1. Unique light visions 2. Intense feelings of astonishment, pleasure, and fear 3. The sense of helplessness 4. Supernatural but rationality of experience. Conclusion: NDE is uncommon in head-injury cases as compared to other near-death conditions. But the persons experiencing it have immense impacts on their belief systems and emotions. This experience should be further explored by studies of larger samples.	[Hou, Yongmei] Guangdong Med Coll, Dept Psychol, Zhanjiang, Guangdong, Peoples R China; [Huang, Qin] Guangdong 999 Brain Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Prakash, Ravi; Chaudhury, Suprakash] Ranchi Inst Neuropsychiat & Allied Sci, Ranchi 834006, Bihar, India	Prakash, R (corresponding author), Ranchi Inst Neuropsychiat & Allied Sci, Ranchi 834006, Bihar, India.	drravi2121@gmail.com	Chaudhury, Suprakash/H-2904-2019	Chaudhury, Suprakash/0000-0002-0115-1703			Arzy S, 2005, MED HYPOTHESES, V65, P841, DOI 10.1016/j.mehy.2005.04.044; Atwater P. M., 1988, COMING BACK LIFE AFT; Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Belanti J, 2008, TRANSCULT PSYCHIATRY, V45, P121, DOI 10.1177/1363461507088001; Bhaskar R., 1978, REALIST THEORY SCI; Blackmore SJ, 1996, J ROY SOC MED, V89, P73; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BMJ-BRIT MED J, V329, P1414, DOI 10.1136/bmj.329.7480.1414; Britton WB, 2004, PSYCHOL SCI, V15, P254, DOI 10.1111/j.0956-7976.2004.00661.x; Brooks N., 1984, CLOSED HEAD INJURY P; Carr D., 1982, ANABIOSIS, V2, P75; Carter Ch, 2010, SCI NEAR DEATH EXPER, p[150, 235]; De Ridder D, 2007, NEW ENGL J MED, V357, P1829, DOI 10.1056/NEJMoa070010; Fenwick P., 1995, TRUTH LIGHT; Fiske ST, 1991, SOC COGNITION, P94; French CC, 2005, PROG BRAIN RES, V150, P351, DOI 10.1016/S0079-6123(05)50025-6; French CC, 2001, LANCET, V358, P2010, DOI 10.1016/S0140-6736(01)07133-1; Greyson B, 2003, PSYCHIAT SERV, V54, P1649, DOI 10.1176/appi.ps.54.12.1649; Greyson B, 2003, GEN HOSP PSYCHIAT, V25, P269, DOI 10.1016/S0163-8343(03)00042-2; GREYSON B, 1993, PSYCHIATRY, V56, P390; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B., 2009, HDB NEAR DEATH EXPER, P213; Griffith Linda J, 2009, Psychiatry (Edgmont), V6, P35; Groth-Marnat G, 1998, J HUMANIST PSYCHOL, V38, P110, DOI 10.1177/00221678980383005; Husserl E., 1970, CRISIS EUROPEAN SCI; Jansen KL, 1997, J NEAR DEATH STUD, V16, P79; JUDSON IR, 1983, LANCET, V2, P561; Kenneth R, 1993, J NEAR DEATH STUD, V11, P223; LEMPERT T, 1994, LANCET, V344, P829, DOI 10.1016/S0140-6736(94)92389-2; Michael M, 1998, LIGHT DEATH ONE DOCT; Moody R., 1975, LIFE LIFE; Morse M., 1989, J NEAR DEATH STUDIES, V8, P45, DOI [DOI 10.1007/BF01076138, 10.1007/BF01076138]; Murray M, HLTH PSYCHOL, P218; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Pasricha A, 1993, J SCI EXPLOR, V7, P161; PAZZAGLIA P, 1975, J NEUROL NEUROSUR PS, V38, P149, DOI 10.1136/jnnp.38.2.149; Prakash R, 2009, P IASTED INT C COMP; Ravi P, 2009, J CONSCIOUSNESS STUD, V16, P2; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; RODIN EA, 1980, J NERV MENT DIS, V168, P259, DOI 10.1097/00005053-198005000-00001; Shevchenko KN, 2008, 3 INT C COGN SCI MOS, V2, P497; Smith J., 2003, QUALITATIVE PSYCHOL; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8; Van Lommel P, 2010, CONSCIOUSNESS LIFE S, p[105, 135]; Yamamura H, 1998, Nihon Ronen Igakkai Zasshi, V35, P103; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	47	11	12	0	23	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0972-2327	1998-3549		ANN INDIAN ACAD NEUR	Ann. Indian Acad. Neurol.	JAN-MAR	2013	16	1					75	81		10.4103/0972-2327.107715			7	Clinical Neurology	Neurosciences & Neurology	116TY	WOS:000316907100014	23661968	DOAJ Gold, Green Published			2021-06-18	
J	Lei-Rivera, L; Sutera, J; Galatioto, JA; Hujsak, BD; Gurley, JM				Lei-Rivera, Laura; Sutera, John; Galatioto, Jessica A.; Hujsak, Bryan D.; Gurley, James M.			Special tools for the assessment of balance and dizziness in individuals with mild traumatic brain injury	NEUROREHABILITATION			English	Article						Vestibular rehabilitation; traumatic brain injury; concussion; outcomes measures	ERROR SCORING SYSTEM; DWELLING OLDER-ADULTS; PAROXYSMAL POSITIONAL VERTIGO; FUNCTIONAL GAIT ASSESSMENT; SENSORY INTERACTION; POSTURAL STABILITY; FALL RISK; CLINICAL-TEST; FOLLOW-UP; CONCUSSION	INTRODUCTION: Although a majority of patients following minor traumatic brain injury recover to their pre-morbid functional level, persistent activity and participation limitations can occur in the refractory patient. These long-term consequences of brain injury may only become apparent months to years after the injury. In order to quantify these long-term sequella, laboratory, clinical and functional outcome measures may not only identify needed areas of treatment, but may also assist in determining the impact of the treatment on the individuals function. PURPOSE: The aim of this manuscript is to review the clinical utility of vestibular laboratory testing and the bedside vestibular examination in patients following mild traumatic brain injury. In addition, the validity and inter-observer reliability of functional outcome measures commonly used in individuals with mTBI will also be reviewed. SUMMARY: Because of the diffuse pathology seen with mTBI, multiple tests are needed to determine the resultant impairment and their impact on the patient's activity level and participation level. Laboratory test and bedside tests of vestibular impairment are reviewed. Functional outcome measures including the Dynamic Gait Index, the Functional Gait Assessment, the Balance Error Scoring System, and Dual Task Performance are reviewed for their appropriateness in quantifying the effect of mTBI at activity level and participation level of the individual. CONCLUSION: TBI rehabilitation services are increasingly exemplified by the needs of patients, rather than by the underlying pathology or diagnosis. Basing treatment decisions and treatment timing on laboratory, clinical, and functional testing can optimize the rehabilitation outcome.	[Lei-Rivera, Laura; Sutera, John; Hujsak, Bryan D.] New York Eye & Ear Infirm, Vestibular Rehabil Dept, New York, NY USA; [Galatioto, Jessica A.] New York Eye & Ear Infirm, Ctr Hearing & Balance Disorders, New York, NY USA; [Gurley, James M.] Mercy Coll, Phys Therapy Program, Dobbs Ferry, NY 10522 USA; [Gurley, James M.] James J Peters VAMC, Dept Otololaryngol, Bronx, NY USA	Gurley, JM (corresponding author), Mercy Coll, Phys Therapy Program, 555 Broadway, Dobbs Ferry, NY 10522 USA.	jgurley@mercy.edu					Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Ble A, 2005, J AM GERIATR SOC, V53, P410, DOI 10.1111/j.1532-5415.2005.53157.x; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DIETERICH M, 1993, ANN NEUROL, V33, P292, DOI 10.1002/ana.410330311; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Foley JA, 2010, BRAIN INJURY, V24, P851, DOI 10.3109/02699051003789278; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Guidetti G, 2002, CLIN OTOLARYNGOL, V27, P124, DOI 10.1046/j.1365-2273.2002.00545.x; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Jacobson G. P., 2008, BALANCE FUNCTION ASS, V179, p[148, 339]; Kisilevski V., 2001, INT TINNITUS J, V7; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKinnon B. J., NEUROOTOLOGIC TEST C; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Medley A, 2006, BRAIN INJURY, V20, P1403, DOI 10.1080/02699050601082057; Meltzer I., 2004, J AM GERIATR SOC, V52, P1255; Minor LB, 1999, NEUROLOGY, V53, P2158, DOI 10.1212/WNL.53.9.2158; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Nuti D, 2005, Acta Otorhinolaryngol Ital, V25, P271; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pickett T. C., 2007, J REHABILITATION RES, V44; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross LM, 2011, J SPORT REHABIL, V20, P296, DOI 10.1123/jsr.20.3.296; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Schrodt LA, 2004, GAIT POSTURE, V19, P279, DOI 10.1016/S0966-6362(03)00067-5; Schubert M., 2008, BALANCE FUNCTION ASS, p[148, 179, 339]; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; Schubert MC, 2006, JARO-J ASSOC RES OTO, V7, P329, DOI 10.1007/s10162-006-0047-6; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; ShumwayCook A, 1997, PHYS THER, V77, P46, DOI 10.1093/ptj/77.1.46; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Susco TM, 2004, J ATHL TRAINING, V39, P241; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Walker MF, 1999, NEUROLOGY, V53, P1576, DOI 10.1212/WNL.53.7.1576; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; *WHO, 1997, ICIDH 2 INT CLASS IM; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wrisley DM, 2004, ARCH PHYS MED REHAB, V85, P335, DOI 10.1016/j.apmr.2003.03.005; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336; Zwergal A, 2009, NEUROLOGY, V72, P1689, DOI 10.1212/WNL.0b013e3181a55ecf	61	11	12	0	29	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	3					463	472		10.3233/NRE-130869			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200005	23648601				2021-06-18	
J	Martin, M; Conlon, LW				Martin, Matthew; Conlon, Lauren Weinberger			Does Platelet Transfusion Improve Outcomes in Patients With Spontaneous or Traumatic Intracerebral Hemorrhage?	ANNALS OF EMERGENCY MEDICINE			English	Article							PRIOR ANTIPLATELET THERAPY; CONTROLLED-TRIAL; BRAIN-INJURY; HEAD-INJURY; ANTICOAGULATION; REVERSAL; ASPIRIN; GROWTH; AGENTS; ADULTS	[Ann Emerg Med. 2013;61:58-61.] Editor's Note: Emergency physicians must often make decisions about patient management without clear-cut data of sufficient quality to support clinical guidelines or evidence-based reviews. Topics in the Best Available Evidence section must be relevant to emergency physicians, are formally peer reviewed, and must have a sufficient literature base to draw a reasonable conclusion but not such a large literature base that a traditional "evidence-based" review, meta-analysis, or systematic review can be performed.	[Martin, Matthew; Conlon, Lauren Weinberger] Univ Penn, Dept Emergency Med, Hosp Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Conlon, LW (corresponding author), Univ Penn, Dept Emergency Med, Hosp Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	lauren.conlon@uphs.upenn.edu					Ajani UA, 2006, AM J PREV MED, V30, P74, DOI 10.1016/j.amepre.2005.08.042; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Beshay JE, 2010, J NEUROSURG, V112, P307, DOI 10.3171/2009.7.JNS0982; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Downey DM, 2009, AM SURGEON, V75, P1100; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; HARTWIGOTTO H, 1983, AM J MED, V75, P30, DOI 10.1016/0002-9343(83)90230-9; Karni A, 2001, AM SURGEON, V67, P1098; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e	24	11	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JAN	2013	61	1					58	61		10.1016/j.annemergmed.2012.03.025			4	Emergency Medicine	Emergency Medicine	069WY	WOS:000313469000012	22841709				2021-06-18	
J	Miyamoto, K; Ohtaki, H; Dohi, K; Tsumuraya, T; Song, DD; Kiriyama, K; Satoh, K; Shimizu, A; Aruga, T; Shioda, S				Miyamoto, Kazuyuki; Ohtaki, Hirokazu; Dohi, Kenji; Tsumuraya, Tomomi; Song, Dandan; Kiriyama, Keisuke; Satoh, Kazue; Shimizu, Ai; Aruga, Tohru; Shioda, Seiji			Therapeutic Time Window for Edaravone Treatment of Traumatic Brain Injury in Mice	BIOMED RESEARCH INTERNATIONAL			English	Article							FREE-RADICAL SCAVENGER; NEURONAL CELL-DEATH; UNITED-STATES; ANTIOXIDANT; INFARCTION; ISCHEMIA; OUTCOMES; MCI-186; NEUROPROTECTION; PROTECTS	Traumatic brain injury (TBI) is a major cause of death and disability in young people. No effective therapy is available to ameliorate its damaging effects. Our aim was to investigate the optimal therapeutic time window of edaravone, a free radical scavenger which is currently used in Japan. We also determined the temporal profile of reactive oxygen species (ROS) production, oxidative stress, and neuronal death. Male C57Bl/6 mice were subjected to a controlled cortical impact (CCI). Edaravone (3.0 mg/kg), or vehicle, was administered intravenously at 0, 3, or 6 hours following CCI. The production of superoxide radicals (O-2(center dot-)) as a marker of ROS, of nitrotyrosine (NT) as an indicator of oxidative stress, and neuronal death were measured for 24 hours following CCI. Superoxide radical production was clearly evident 3 hours after CCI, with oxidative stress and neuronal cell death becoming apparent after 6 hours. Edaravone administration after CCI resulted in a significant reduction in the injury volume and oxidative stress, particularly at the 3-hour time point. Moreover, the greatest decrease in O-2(center dot-) levels was observed when edaravone was administered 3 hours following CCI. These findings suggest that edaravone could prove clinically useful to ameliorate the devastating effects of TBI.	[Miyamoto, Kazuyuki; Ohtaki, Hirokazu; Tsumuraya, Tomomi; Song, Dandan; Kiriyama, Keisuke; Satoh, Kazue; Shimizu, Ai; Shioda, Seiji] Showa Univ Sch Med, Dept Anat, Shinagawa Ku, Tokyo 1428555, Japan; [Miyamoto, Kazuyuki; Dohi, Kenji; Aruga, Tohru] Showa Univ Sch Med, Dept Emergency & Crit Care Med, Shinagawa Ku, Tokyo 1428555, Japan	Shioda, S (corresponding author), Showa Univ Sch Med, Dept Anat, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	shioda@med.showa-u.ac.jp		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23592683]; MEXTMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23592683, 25670767] Funding Source: KAKEN	The project was supported by a Grant-in-Aid for Young Scientists B from the Japanese Ministry of Education, Culture, Sports, Science and Technology (Kazuyuki Miyamoto), JSPS KAKENHI (23592683) Grant-in-Aid for Scientific Research (C). This work was also supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012.	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; Dawson J, 2009, CEREBROVASC DIS, V28, P202, DOI 10.1159/000226580; Dohi K, 2007, ANTIOXID REDOX SIGN, V9, P281, DOI 10.1089/ars.2007.9.281; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Dohi K, 2010, ACTA NEUROCHIR SUPPL, V106, P315, DOI 10.1007/978-3-211-98811-4_59; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Inokuchi Y, 2009, J PHARMACOL EXP THER, V329, P687, DOI 10.1124/jpet.108.148676; Inoue H, 2007, J NEUROSCI RES, V85, P1427, DOI 10.1002/jnr.21279; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Koizumi T, 2006, ARCH SURG-CHICAGO, V141, P992, DOI 10.1001/archsurg.141.10.992; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Manno EM, 2008, CRIT CARE, V12, DOI 10.1186/cc7112; Miyamoto K., ACTA NEUROC IN PRESS; Mizushima H, 2002, J COMP NEUROL, V448, P203, DOI 10.1002/cne.10262; Munakata A, 2009, NEUROSURGERY, V64, P423, DOI 10.1227/01.NEU.0000338067.83059.EB; Nakase T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-39; Ohta S, 2005, SPINE, V30, P1154, DOI 10.1097/01.brs.0000162402.79482.fd; Ohtaki H, 2003, ACT NEUR S, V86, P191; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Ohtaki H, 2007, NEUROSCI RES, V58, P349, DOI 10.1016/j.neures.2007.04.005; Otomo E, 2003, CEREBROVASC DIS, V15, P222, DOI 10.1159/000069318; Oyama JI, 2010, HEART VESSELS, V25, P379, DOI 10.1007/s00380-009-1221-7; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sano Y, 2010, CHEM PHARM BULL, V58, P1020, DOI 10.1248/cpb.58.1020; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sharma P, 2011, ANN INDIAN ACAD NEUR, V14, P103, DOI 10.4103/0972-2327.82794; Sonoda A, 2009, BRIT J RADIOL, V82, P711, DOI 10.1259/bjr/13797020; Tabrizchi R, 2000, Curr Opin Investig Drugs, V1, P347; Utsumi H, 2006, P NATL ACAD SCI USA, V103, P1463, DOI 10.1073/pnas.0510670103; Vandelle E, 2011, PLANT SCI, V181, P534, DOI 10.1016/j.plantsci.2011.05.002; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Yamaguchi S, 2011, TOHOKU J EXP MED, V223, P235, DOI 10.1620/tjem.223.235; Yoshida H, 2006, CNS DRUG REV, V12, P9, DOI 10.1111/j.1527-3458.2006.00009.x; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	41	11	12	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2013	2013								379206	10.1155/2013/379206			13	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	128JP	WOS:000317765600001	23710445	DOAJ Gold, Green Published			2021-06-18	
J	Oddy, M; Ramos, SD				Oddy, Michael; Ramos, Sara da Silva			Cost effective ways of facilitating home based rehabilitation and support	NEUROREHABILITATION			English	Article						Traumatic brain injury; neurobehavioural disorder; community based rehabilitation; cost-effectiveness; technology; review	TRAUMATIC BRAIN-INJURY; ASSISTIVE-TECHNOLOGY; CAREGIVER BURDEN; SELF-ESTEEM; DEFICITS; PEOPLE; MEMORY; INTERVENTION; INTEGRATION; ASSISTANCE	BACKGROUND: The long term support of people with neurobehavioural disorders following a severe traumatic brain injury (TBI) can amount to a lifetime cost of several million dollars. Such costs are often obtained from personal injury compensation. However, those not eligible for such awards often depend on their families to provide support and care at no direct financial cost, but with indirect financial and human costs in terms of loss of productivity, and increased stress and health problems. OBJECTIVES: The aim of this paper is to examine the role of support workers in the long-term care of those with neurobehavioural deficits following severe TBI and to discuss the feasibility of meeting some aspects of their role with technological solutions. METHODS: This critical review uses observational and cost-analysis methodologies to establish the roles and costs associated with staff supporting people with neurobehavioural disorders resulting from severe TBI. RESULTS: The role of support workers is varied and includes prompting to initiate and guide simple or complex activities, promoting social behaviour and managing emotional reactions. Some of these roles can be fulfilled by existing technology. CONCLUSIONS: Cost effective care of those with long-term neurobehavioural disorders can be provided by a combination of human support and existing technology.	[Oddy, Michael; Ramos, Sara da Silva] Brain Injury Rehabil Trust, Slinfold RH13 0TP, W Sussex, England	Oddy, M (corresponding author), Brain Injury Rehabil Trust, 5 Oaks Rd, Slinfold RH13 0TP, W Sussex, England.	michael.oddy@thedtgroup.org					Agree EM, 2005, J GERONTOL B-PSYCHOL, V60, pS272, DOI 10.1093/geronb/60.5.S272; Andlin-Sobocki P, 2005, EUR J NEUROL, V12, P1, DOI 10.1111/j.1468-1331.2005.01202.x; Antonucci T C, 1983, Fam Community Health, V6, P1; Au-Yeung KY, 2011, AM J MANAG CARE, V17, pE277; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Boger J, 2011, NEUROREHABILITATION, V28, P271, DOI 10.3233/NRE-2011-0655; Brandt A, 2011, DISABIL REHABIL-ASSI, V6, P189, DOI 10.3109/17483107.2010.532286; Brown P., 2012, BRAIN IMPAIR, V13, P123, DOI [10.1017/BrImp.2012.12, DOI 10.1017/BRIMP.2012.12]; Craig A, 2005, MED SCI MONITOR, V11, pRA32; Croser R., 2001, AUSTR OCCUPATIONAL T, V48, P35; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; el Kaliouby R., 2005, Universal Access in the Information Society, V4, P121, DOI 10.1007/s10209-005-0119-0; Evans N, 2011, BRIT J OCCUP THER, V74, P249, DOI 10.4276/030802211X13046730116614; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Hamill M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-26; Hayes TL, 2009, TELEMED J E-HEALTH, V15, P770, DOI 10.1089/tmj.2009.0033; Higginson IJ, 2010, J CLIN EPIDEMIOL, V63, P535, DOI 10.1016/j.jclinepi.2009.06.014; Hoey J, 2010, COMPUT VIS IMAGE UND, V114, P503, DOI 10.1016/j.cviu.2009.06.008; Jackson H, 2001, NEUROREHABILITATION, V16, P27; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Jutai J, 2000, ASSIST TECHNOL, V12, P123, DOI 10.1080/10400435.2000.10132018; Kirsch NL, 2004, J HEAD TRAUMA REHAB, V19, P366, DOI 10.1097/00001199-200409000-00002; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lamontagne ME, 2009, BRAIN INJURY, V23, P693, DOI 10.1080/02699050902970760; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Lopresti EF, 2008, IEEE ENG MED BIOL, V27, P29, DOI 10.1109/EMB.2007.907396; Marmot M, 2003, BRIT MED J, V327, P574, DOI 10.1136/bmj.327.7415.574; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; McColl MA, 1999, BRAIN INJURY, V13, P311, DOI 10.1080/026990599121511; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McCrea J. D., 2009, REHABILITATION EXECU; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Mihailidis A, 2001, ASSIST TECHNOL, V13, P23, DOI 10.1080/10400435.2001.10132031; O'Neill B, 2010, NEUROPSYCHOL REHABIL, V20, P509, DOI 10.1080/09602010903519652; O'Neill B, 2008, J ASSIST TECHNOL, V2, P22, DOI 10.1108/17549450200800015; Orpwood R, 2008, J ASSIST TECHNOL, V2, P13, DOI 10.1108/17549450200800014; Redhead R., 2010, SOCIAL CARE NEURODIS, V1; Scherer MJ, 2005, DISABIL REHABIL, V27, P1321, DOI 10.1080/09638280500164800; Stinson DA, 2008, J PERS SOC PSYCHOL, V94, P412, DOI 10.1037/0022-3514.94.3.412; Svoboda E, 2010, NEUROPSYCHOL REHABIL, V20, P562, DOI 10.1080/09602011003669918; van Heugten CM, 2011, J REHABIL MED, V43, P647, DOI 10.2340/16501977-0818; Weddell RA, 2010, ARCH PHYS MED REHAB, V91, P897, DOI 10.1016/j.apmr.2010.01.020; Whitlatch CJ, 1997, J AGING HEALTH, V9, P222; Wignall B., 2009, RAATE 2009 C COV UK; Wood RL, 1999, NEUROPSYCHOL REHABIL, V9, P505, DOI 10.1080/096020199389554	49	11	12	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	4					781	790		10.3233/NRE-130902			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	184QF	WOS:000321907100009	23867404				2021-06-18	
J	Yeo, SS; Kim, SH; Jang, SH				Yeo, Sang Seok; Kim, Seong Ho; Jang, Sung Ho			Proximal weakness due to injury of the corticoreticular pathway in a patient with traumatic brain injury	NEUROREHABILITATION			English	Article						Diffusion tensor imaging; corticoreticulospinal tract; corticoreticular pathway; corticospinal tract; stroke	DIFFUSE AXONAL INJURY; PREMOTOR CORTEX; CORTICOSPINAL TRACT; MAGNETIC STIMULATION; STROKE PATIENTS; MOTOR RECOVERY; GAIT; WALKING; CAT	BACKGROUND: The corticoreticular pathway (CRP) innervates the proximal muscles of extremities and axial muscles; therefore, it is involved in postural control and gait. We report on a patient who exhibited proximal weakness due to a CRP injury, which was evaluated using diffusion tensor tractography (DTT). METHODS: A 62-year-old male patient who had been injured in a traffic accident underwent conservative management for a contusional hemorrhage in the right frontotemporal lobes, and a subdural and epidural hematoma in the right temporoparietal lobes. The patient exhibited right proximal weakness (shoulder: 3(+), hip: 3(+)) at two weeks after onset. Findings on brain MRI revealed encephalomalactic lesions in both frontal lobes. RESULTS: Findings on DTT of the left CRP showed discontinuation at the midbrain level; in contrast, the integrities of the corticospinal tract in both hemispheres were maintained from the cerebral cortex to the medulla along the known pathway of the corticospinal tract. CONCLUSION: The proximal weakness of the right shoulder and hip observed in this patient appeared to be attributed to injury of the left CRP.	[Yeo, Sang Seok; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea(NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A0 1001873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A0 1001873).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang WH, 2010, GAIT POSTURE, V32, P487, DOI 10.1016/j.gaitpost.2010.07.007; DAVIDOFF RA, 1990, NEUROLOGY, V40, P332; FREUND HJ, 1985, BRAIN, V108, P697, DOI 10.1093/brain/108.3.697; FREUND HJ, 1985, BEHAV BRAIN RES, V18, P187, DOI 10.1016/0166-4328(85)90074-9; FREUND HJ, 1984, EXP BRAIN RES, V53, P479; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2011, YONSEI MED J, V52, P553, DOI 10.3349/ymj.2011.52.4.553; Jang SH, 2010, INT J REHABIL RES, V33, P285, DOI 10.1097/MRR.0b013e32833f0500; Jang SH, 2009, NEUROREHABILITATION, V24, P285, DOI 10.3233/NRE-2009-0480; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Kably B, 1998, J NEUROPHYSIOL, V80, P389; Kably B, 1998, J NEUROPHYSIOL, V80, P406; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Medical Research Council (Great Britain), 1976, AIDS EX PER NERV SYS, Vvi, P62; Mendoza J, 2007, CLIN NEUROANATOMY NE; Miyai I, 1999, STROKE, V30, P1380, DOI 10.1161/01.STR.30.7.1380; Miyai I, 2002, ANN NEUROL, V52, P188, DOI 10.1002/ana.10274; Miyai I, 2003, STROKE, V34, P2866, DOI 10.1161/01.STR.0000100166.81077.8A; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Smania N, 2007, STROKE, V38, P1088, DOI 10.1161/01.STR.0000258077.88064.a3; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Suzuki M, 2008, NEUROIMAGE, V39, P600, DOI 10.1016/j.neuroimage.2007.08.044; Yeo SS, 2013, NEUROREHABILITATION, V32, P305, DOI 10.3233/NRE-130848; Yeo SS, 2012, NEUROSCI LETT, V508, P9, DOI 10.1016/j.neulet.2011.11.030	31	11	11	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2013	32	3					665	669		10.3233/NRE-130889			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	135DM	WOS:000318266200025	23648621				2021-06-18	
J	Bin, J; Wang, Q; Zhuo, YY; Xu, JP; Zhang, HT				Bin, Juan; Wang, Qian; Zhuo, Ye-Ye; Xu, Jiang-Ping; Zhang, Han-Ting			Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity	METABOLIC BRAIN DISEASE			English	Article						Piperphentonamine hydrochloride (PPTA); Cerebral ischemia; Memory; Apoptosis; PC12 cells; Rats	DELAYED NEURONAL DEATH; GLOBAL BRAIN ISCHEMIA; ACETYL-L-CARNITINE; IN-VITRO MODEL; CALCIUM; INJURY; DAMAGE; MITOCHONDRIAL; LEVOSIMENDAN; MECHANISMS	The calcium sensitizers levosimendan and piperphentonamine hydrochloride (PPTA) are used as cardiovascular drugs for treatment of heart failure. Given that levosimendan has been reported to exhibit a neuroprotective profile in a model of traumatic brain injury, it was interesting to know whether PPTA, a new calcium sensitizer recently developed in China, exerts a similar effect. The objective of this study was to determine whether PPTA exhibited neuroprotective effects and whether these properties were associated with memory. Four-vessel occlusion (4-VO) was used to induce global cerebral ischemia/reperfusion injury in rats treated with or without PPTA (5, 10 mg/kg, i.p., 2 h after the onset of reperfusion and then once a day for 15 consecutive days). Memory was measured using the step-through passive avoidance test. Neurochemical changes were examined in rat PC12 cells treated with oxygen-glucose deprivation (OGD) for 4 h followed by reoxygenation (OGD-R) for 24 h, in the absence or presence of PPTA. In vehicle-treated animals, 4-VO for 10 min produced memory deficits, as demonstrated by decreased retention in step-through passive avoidance, and massive neuron loss in the hippocampal CA1 subregion. These effects were attenuated by PPTA. The results were consistent with those observed in PC12 cells. PPTA treatment increased cell viability, as indicated by MTT assay, inhibited apoptosis, and decreased extracellular lactate dehydrogenase levels in Na2S2O4-treated PC12 cells. These results provide novel demonstration for the ability of PPTA to attenuate cerebral ischemia-induced memory deficits via neuroprotection in the hippocampus. The neuroprotective effect of PPTA appears to be associated with its anti-apoptotic activity. PPTA has the therapeutic potential for ischemic stroke.	[Bin, Juan; Wang, Qian; Zhuo, Ye-Ye; Xu, Jiang-Ping; Zhang, Han-Ting] So Med Univ, Dept Pharmacol, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Han-Ting] W Virginia Univ, Dept Behav Med & Psychiat, Hlth Sci Ctr, Morgantown, WV 26506 USA; [Zhang, Han-Ting] W Virginia Univ, Dept Physiol & Pharmacol, Hlth Sci Ctr, Morgantown, WV 26506 USA	Xu, JP (corresponding author), So Med Univ, Dept Pharmacol, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China.	jpx@smu.edu.com; Hzhang@hsc.wvu.edu	Xu, Jiangping/D-1456-2012		National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2011ZX09101-002-03]	This work was supported by the National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (No. 2011ZX09101-002-03 to JPX).	Anderson CA, 2010, NEUROREHABILITATION, V26, P47, DOI 10.3233/NRE-2010-0535; Annunziato L, 2007, ANN NY ACAD SCI, V1099, P413, DOI 10.1196/annals.1387.050; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Bartl J, 2010, ADHD-ATTEND DEFICIT, V2, P225, DOI 10.1007/s12402-010-0039-6; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Block F, 1997, PHARMACOL BIOCHEM BE, V56, P755, DOI 10.1016/S0091-3057(96)00484-4; Block F, 1997, BRAIN RES, V754, P279, DOI 10.1016/S0006-8993(97)00096-6; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Burda J, 2005, NEUROCHEM RES, V30, P1397, DOI 10.1007/s11064-005-8510-z; Cao BY, 2010, J ETHNOPHARMACOL, V131, P122, DOI 10.1016/j.jep.2010.06.009; Chen J, 1998, J NEUROSCI, V18, P4914; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Gao YA, 2010, BRAIN RES, V1358, P239, DOI 10.1016/j.brainres.2010.08.043; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Gong LW, 2002, EUR J NEUROSCI, V15, P779, DOI 10.1046/j.1460-9568.2002.01908.x; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Hamada N, 2009, J NEURAL TRANSM, V116, P841, DOI 10.1007/s00702-009-0250-9; Hartman RE, 2005, BRAIN RES, V1043, P48, DOI 10.1016/j.brainres.2005.02.030; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Hickenbottom SL, 2000, NEUROL CLIN, V18, P379, DOI 10.1016/S0733-8619(05)70198-5; Honisch A, 2010, BASIC RES CARDIOL, V105, P155, DOI 10.1007/s00395-009-0064-9; Iqbal S, 2002, BRAIN RES, V946, P162, DOI 10.1016/S0006-8993(02)02871-8; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Langdon KD, 2008, EUR J NEUROSCI, V28, P2310, DOI 10.1111/j.1460-9568.2008.06513.x; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li RB, 2012, CHINA PHARM, V15, P219; McCranor BJ, 2012, J BIOENERG BIOMEMBR, V44, P253, DOI 10.1007/s10863-012-9427-2; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Miao YF, 2010, INT J MOL SCI, V11, P140, DOI 10.3390/ijms11010140; Nanri M, 1998, JPN J PHARMACOL, V76, P23, DOI 10.1254/jjp.76.23; Ottani A, 2004, EUR J PHARMACOL, V485, P183, DOI 10.1016/j.ejphar.2003.11.072; Ozturk T, 2010, J CARDIOTHOR VASC AN, V24, P624, DOI 10.1053/j.jvca.2009.08.003; Phan TG, 2002, CLIN EXP PHARMACOL P, V29, P1, DOI 10.1046/j.1440-1681.2002.03609.x; Pisani A, 2004, CELL CALCIUM, V36, P277, DOI 10.1016/j.ceca.2004.02.010; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Roberts GG, 2007, ANTIOXID REDOX SIGN, V9, P2265, DOI 10.1089/ars.2007.1786; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Seta KA, 2004, CELL CALCIUM, V36, P331, DOI 10.1016/j.ceca.2004.02.006; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Virmani A, 2011, CURR NEUROPHARMACOL, V9, P195, DOI 10.2174/157015911795017182; Wang C, 2012, INT J NEUROPSYCHOPH, V15, P749, DOI 10.1017/S1461145711000836; Xu Bing, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1041; Yang XF, 2011, CELL MOL NEUROBIOL, V31, P303, DOI 10.1007/s10571-010-9622-9; [杨小龙 Yang Xiaolong], 2010, [湖南大学学报. 自然科学版, Journal of Hunan University. Natural Sciences], V37, P32; Yasa H, 2008, J SURG RES, V147, P138, DOI 10.1016/j.jss.2007.08.002; Zapater P, 1997, BRAIN RES, V772, P57, DOI 10.1016/S0006-8993(97)00838-X; Zeiger SLH, 2010, BBA-MOL BASIS DIS, V1802, P1095, DOI 10.1016/j.bbadis.2010.07.013; Zhang H, 2010, J BIOCHEM, V148, P413, DOI 10.1093/jb/mvq074; Zhang HT, 2000, NEUROPSYCHOPHARMACOL, V23, P198, DOI 10.1016/S0893-133X(00)00108-1; Zhang R, 2012, INT J MOL SCI, V13, P2078, DOI 10.3390/ijms13022078; Zhu Han-yi, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1858; [朱汉祎 ZHU Hanyi], 2011, [军事医学, Military Medical Sciences], V35, P286; Zhu JR, 2010, ACTA PHARMACOL SIN, V31, P273, DOI 10.1038/aps.2010.9	64	11	13	0	15	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	DEC	2012	27	4					495	505		10.1007/s11011-012-9330-x			11	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	040CT	WOS:000311298300011	22843383				2021-06-18	
J	Sturiale, CL; De Bonis, P; Rigante, L; Calandrelli, R; D'Arrigo, S; Pompucci, A; Mangiola, A; D'Apolito, G; Colosimo, C; Anile, C				Sturiale, Carmelo Lucio; De Bonis, Pasquale; Rigante, Luigi; Calandrelli, Rosalinda; D'Arrigo, Sonia; Pompucci, Angelo; Mangiola, Annunziato; D'Apolito, Gabriella; Colosimo, Cesare; Anile, Carmelo			Do Traumatic Brain Contusions Increase in Size after Decompressive Craniectomy?	JOURNAL OF NEUROTRAUMA			English	Article						brain contusions; decompressive craniectomy; hemorrhagic contusion; traumatic brain injury	HEAD-INJURY; INTRACEREBRAL HEMATOMA; HEMORRHAGE; PROGRESSION; CRANIOTOMY; LESIONS; EDEMA	Hemorrhagic contusions (HC) represent a common consequence of traumatic brain injury (TBI) and usually evolve during the first 12 h after trauma. The relationship between decompressive craniectomy (DC) and evolution of the post-traumatic HC is still unclear. The aim of the present study was to evaluate the impact of DC on HC evolution. Fifty-seven patients with the evidence of at least one HC at admission CT scan were analyzed. Twenty-five patients (Group 1) underwent DC and 32 patients underwent medical therapy alone (Group 2). Fisher's exact test was used to compare categorical variables. Logistic regression model was used to assess the independent contribution of predictive factors (age, <= 50 years; treatment received, DC vs. medical; anticoagulant/antiplatelet drugs intake; Rotterdam CT score, 1-3 vs. 4-6) to the evolution/new appearance of an HC. A significant increase (>= 2 cc) of any HC during the observation period was detected in 8 patients (14%): 4/25 patients (16%) of Group 1 and 4/32 patients (12.5%) of Group 2 (Fisher exact test two-sided p = 0.72). Univariate and multivariate analyses showed that none of the analyzed factors was associated with increased or de novo appearance of any HC. DC does not seem to constitute a risk factor for the evolution of HC.	[Sturiale, Carmelo Lucio; De Bonis, Pasquale; Rigante, Luigi; Pompucci, Angelo; Mangiola, Annunziato; Anile, Carmelo] Catholic Univ, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Calandrelli, Rosalinda; D'Apolito, Gabriella; Colosimo, Cesare] Catholic Univ, Sch Med, Dept Bio Imaging, I-00168 Rome, Italy; [D'Arrigo, Sonia] Catholic Univ, Sch Med, Dept Anaesthesiol & Intens Care, I-00168 Rome, Italy	De Bonis, P (corresponding author), Catholic Univ, Sch Med, Inst Neurosurg, Lgo F Vito 1, I-00168 Rome, Italy.	debonisvox@gmail.com	de bonis, pasquale/K-8200-2016; D'Arrigo, Sonia/K-8792-2018; Sturiale, Carmelo Lucio/K-6412-2016	de bonis, pasquale/0000-0002-9879-8940; D'Arrigo, Sonia/0000-0001-6740-3195; Sturiale, Carmelo Lucio/0000-0002-4080-2492; Calandrelli, Rosalinda/0000-0003-4517-3477; Rigante, Luigi/0000-0003-0539-526X; Colosimo, Cesare/0000-0003-3800-3648			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Csokay A, 2001, NEUROSURG REV, V24, P209, DOI 10.1007/s101430100158; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; Doughty R.G., 1938, SOUTH MED J, V31, P254; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; JAIMOVICH R, 1992, PEDIATR NEUROSURG, V17, P25, DOI 10.1159/000120562; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MERTOL T, 1991, British Journal of Neurosurgery, V5, P491, DOI 10.3109/02688699108998478; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Savers S, 2000, J NEUROTRAUM, V17, P507; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	27	11	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2723	2726		10.1089/neu.2012.2556			4	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800001	22873699				2021-06-18	
J	Forbes, CE; Cameron, KA; Grafman, J; Barbey, A; Solomon, J; Ritter, W; Ruchkin, DS				Forbes, Chad E.; Cameron, Katherine A.; Grafman, Jordan; Barbey, Aron; Solomon, Jeffrey; Ritter, Walter; Ruchkin, Daniel S.			Identifying temporal and causal contributions of neural processes underlying the Implicit Association Test (IAT)	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						event-related brain potentials; traumatic brain injuries; EEG coherence; implicit association test; automaticity; gender stereotypes; extra-striate visual cortex; prefrontal cortex	SOCIAL COGNITIVE NEUROSCIENCE; EVENT-RELATED-POTENTIALS; FRONTOTEMPORAL DEMENTIA; ATTITUDES; BRAIN; RACE; STEREOTYPES; LESIONS; CORTEX; MALLEABILITY	The Implicit Association Test (IAT) is a popular behavioral measure that assesses the associative strength between outgroup members and stereotypical and counterstereotypical traits. Less is known, however, about the degree to which the IAT reflects automatic processing. Two studies examined automatic processing contributions to a gender-IAT using a data driven, social neuroscience approach. Performance on congruent (e.g., categorizing male names with synonyms of strength) and incongruent (e.g., categorizing female names with synonyms of strength) IAT blocks were separately analyzed using EEG (event-related potentials, or ERPs, and coherence; Study 1) and lesion (Study 2) methodologies. Compared to incongruent blocks, performance on congruent IAT blocks was associated with more positive ERPs that manifested in frontal and occipital regions at automatic processing speeds, occipital regions at more controlled processing speeds and was compromised by volume loss in the anterior temporal lobe (ATL), insula and medial PFC. Performance on incongruent blocks was associated with volume loss in supplementary motor areas, cingulate gyrus and a region in medial PFC similar to that found for congruent blocks. Greater coherence was found between frontal and occipital regions to the extent individuals exhibited more bias. This suggests there are separable neural contributions to congruent and incongruent blocks of the IAT but there is also a surprising amount of overlap. Given the temporal and regional neural distinctions, these results provide converging evidence that stereotypic associative strength assessed by the IAT indexes automatic processing to a degree.	[Forbes, Chad E.] Univ Delaware, Dept Psychol, Social Neurosci Lab, Newark, DE 19716 USA; [Cameron, Katherine A.] Coppin State Univ, Dept Appl Psychol & Rehabil Counseling, Baltimore, MD USA; [Grafman, Jordan] Kessler Fdn, Traumat Brain Injury Res Lab, Res Ctr, W Orange, NJ USA; [Barbey, Aron] Univ Illinois, Beckman Inst Adv Sci & Technol, Decis Neurosci Lab, Champaign, IL USA; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; [Ritter, Walter] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ruchkin, Daniel S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	Forbes, CE (corresponding author), Univ Delaware, Dept Psychol, Social Neurosci Lab, 222 Wolf Hall, Newark, DE 19716 USA.	cforbes@psych.udel.edu			Support of Mentors and their Students (SOMAS) [1205]; National Science FoundationNational Science Foundation (NSF) [DUE-0426266]; National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	This research was supported in part by a Support of Mentors and their Students (SOMAS) Grant # 1205 awarded to Katherine A. Cameron, funded through the National Science Foundation (Grant No. DUE-0426266). Drs. Grafman and Ruchkin were supported through the National Institute of Neurological Disorders and Stroke Intramural Research Program. We thank Jonathan M. Fallica and Jessica L. Hobbs for their assistance and Fei'i L. Atualevao for her important contributions to the project during the SOMAS summer research program. We thank Dr. Marta Gozzi for making available data from her investigation of the effects of cortical lesions on stereotypical gender associations. We also thank Dr. William Gehring for his helpful comments on an earlier version of this manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ardid S, 2010, J NEUROSCI, V30, P2856, DOI 10.1523/JNEUROSCI.4222-09.2010; Banfield JF, 2006, NEUROIMAGE, V31, P1841, DOI 10.1016/j.neuroimage.2006.02.017; BARGH JA, 1997, ADV SOCIAL COGNITION, P1; Barnes Holmes D., 2004, INT J PSYCHOL PSYCHO, V4, P215; Barnes-Holmes D, 2008, PSYCHOL REC, V58, P497, DOI 10.1007/BF03395634; Baron AS, 2006, PSYCHOL SCI, V17, P53, DOI 10.1111/j.1467-9280.2005.01664.x; Bartholow B.D., 2007, SOCIAL NEUROSCIENCE, P376; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Blair IV, 1996, J PERS SOC PSYCHOL, V70, P1142, DOI 10.1037/0022-3514.70.6.1142; Bluemke M, 2006, J EXP SOC PSYCHOL, V42, P163, DOI 10.1016/j.jesp.2005.03.004; Brazier M. A. B., 1977, ELECT ACTIVITY NERVO; Coates M. A., 2011, EVENT RELATED POTENT; Cunningham W.A., 2007, SOC NEUROSCI-UK, P227; Cunningham WA, 2004, PSYCHOL SCI, V15, P806, DOI 10.1111/j.0956-7976.2004.00760.x; Cunningham WA, 2007, TRENDS COGN SCI, V11, P97, DOI 10.1016/j.tics.2006.12.005; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; Dasgupta N, 2001, J PERS SOC PSYCHOL, V81, P800, DOI 10.1037/0022-3514.81.5.800; De Houwer J, 2007, J EXP SOC PSYCHOL, V43, P972, DOI 10.1016/j.jesp.2006.10.007; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Devine P. G., 2009, HDB PREJUDICE STEREO, P61; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; EdwardsLee T, 1997, BRAIN, V120, P1027, DOI 10.1093/brain/120.6.1027; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Forbes CE, 2012, SOC COGN AFFECT NEUR, V7, P771, DOI 10.1093/scan/nsr052; Forbes CE, 2010, J PERS SOC PSYCHOL, V99, P740, DOI 10.1037/a0020971; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Gregg AP, 2006, J PERS SOC PSYCHOL, V90, P1, DOI 10.1037/0022-3514.90.1.1; He Y, 2009, SOC NEUROSCI-UK, V4, P426, DOI 10.1080/17470910902949184; Kim DY, 2003, SOC PSYCHOL QUART, V66, P83, DOI 10.2307/3090143; KLEIST K, 1922, GEISTES NERVENKRANKH; Knutson KM, 2007, HUM BRAIN MAPP, V28, P915, DOI 10.1002/hbm.20320; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lane Kristin A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Lins Otavio G., 1993, Brain Topography, V6, P51, DOI 10.1007/BF01234127; Luo Q, 2010, J NEUROSCI, V30, P5825, DOI 10.1523/JNEUROSCI.BC-5668-09.2010; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Mitchell JP, 2003, J EXP PSYCHOL GEN, V132, P455, DOI 10.1037/0096-3445.132.3.455; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; O'Toole C, 2009, PSYCHOL REC, V59, P207, DOI 10.1007/BF03395659; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Posner M., 1975, ATTENTION PERFORMANC, P669; Posner M.I., 1975, INFORM PROCESSING CO, P55; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Regan D., 1989, HUMAN BRAIN ELECTROP; Rothermund K, 2004, J EXP PSYCHOL GEN, V133, P139, DOI 10.1037/0096-3445.133.2.139; Rothermund K, 2001, Z EXP PSYCHOL, V48, P94, DOI 10.1026//0949-3946.48.2.94; Ruchkin DS, 1997, COGNITIVE BRAIN RES, V6, P95, DOI 10.1016/S0926-6410(97)00021-9; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Shi CJ, 1999, J NEUROSCI, V19, P420; Siegel M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00021; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Steffens MC, 2001, Z EXP PSYCHOL, V48, P123; Williams JK, 2011, SOC COGN AFFECT NEUR, V6, P468, DOI 10.1093/scan/nsq065; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zahn R, 2009, CEREB CORTEX, V19, P276, DOI 10.1093/cercor/bhn080	74	11	12	1	40	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 30	2012	6								320	10.3389/fnhum.2012.00320			18	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	045TF	WOS:000311719000001	23226123	DOAJ Gold, Green Published			2021-06-18	
J	Franschman, G; Greuters, S; Jansen, WH; Posthuma, LM; Peerdeman, SM; Wattjes, MP; Loer, SA; Boer, C				Franschman, Gaby; Greuters, Sjoerd; Jansen, Wim H.; Posthuma, Linda M.; Peerdeman, Saskia M.; Wattjes, Mike P.; Loer, Stephan A.; Boer, Christa			Haemostatic and cranial computed tomography characteristics in patients with acute and delayed coagulopathy after isolated traumatic brain injury	BRAIN INJURY			English	Article						Neurotrauma; cranial computed tomography; haemostasis; coagulation disorder; outcome	HEAD-INJURY; CLASSIFICATION; COAGULATION; DIAGNOSIS; AGE; PREDICTION	Primary objective: To investigate whether the development of coagulopathy at different stages after isolated traumatic brain injury (TBI) is associated with distinct cranial computed tomography characteristics. Research design: Retrospective cohort study in 226 patients with moderate-to-severe isolated TBI who were categorized as subjects without coagulopathy or with acute temporary, acute sustained or delayed coagulopathy. Methods and procedures: Coagulopathy was defined as an activated partial thromboplastin time >40 seconds and/or prothrombin time (PT) >1.2 and/or platelet count <120*109l(-1). Cranial CT scans were assigned to the six-point Traumatic Coma Data Bank (TCDB) CT-classification. Main outcomes and results: Coagulopathy occurred in 44% of patients in the first 24-hours post-trauma. Patients with acute, sustained coagulopathy showed a prolonged PT (1.64 +/- 0.89) when compared to patients without (1.03 +/- 0.07), acute temporary (1.27 +/- 0.22) or delayed coagulopathy (1.08 +/- 0.06; p<0.05). Patients with acute temporary or delayed coagulopathy had the worst TCDB CT classification scores, while mortality rates were the highest in patients with sustained or delayed coagulopathy. Conclusions: Not only the mere presence of coagulopathy, but also the course of haemostatic alterations following neurotrauma may hold predictive value for patient outcome, irrespective of the severity level of cerebral injury.	[Franschman, Gaby; Greuters, Sjoerd; Jansen, Wim H.; Posthuma, Linda M.; Loer, Stephan A.; Boer, Christa] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, NL-1081 HV Amsterdam, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Neurosurg, NL-1081 HV Amsterdam, Netherlands; [Wattjes, Mike P.] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Radiol, NL-1081 HV Amsterdam, Netherlands	Franschman, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	g.franschman@vumc.nl		Boer, Christa/0000-0002-7781-6951			Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Levrat A, 2008, BRIT J ANAESTH, V100, P792, DOI 10.1093/bja/aen083; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Yuan S, 2007, THROMB RES, V120, P29, DOI 10.1016/j.thromres.2006.07.002; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	33	11	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1464	1471		10.3109/02699052.2012.694566			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400007	22721350				2021-06-18	
J	Hoarau, X; Richer, E; Dehail, P; Cuny, E				Hoarau, Xavier; Richer, Edwidge; Dehail, Patrick; Cuny, Emmanuel			Comparison of long-term outcomes of patients with severe traumatic or hypoxic brain injuries treated with intrathecal baclofen therapy for dysautonomia	BRAIN INJURY			English	Article						Severe traumatic brain injury; hypoxia; dysautonomia; spasticity; hypertonia; intrathecal baclofen therapy; outcome	ALLEVIATES AUTONOMIC DYSFUNCTION; SUPRASPINAL SPASTICITY; VEGETATIVE STATE; DIENCEPHALIC SEIZURES; FUNCTIONAL OUTCOMES; HEAD-INJURY; INFUSION; RECOVERY; HYPERTONIA; SCALE	Primary objective: To compare the long-term outcome of patients with severe traumatic brain injury and patients with hypoxic brain injury with dysautonomia and hypertonia treated with intrathecal baclofen therapy. Methods and procedures: Fifty-three patients with severe traumatic (n = 43/53) or hypoxic (n = 10/53) brain injuries treated by intrathecal baclofen therapy were included to be evaluated with the Coma Recovery Scale-Revised, the Barthel Index, the Glasgow Outcome Scale, the Ashworth scale, the scores of hypertonic attacks, of sweating episode and of voluntary motor responses. A retrospective analysis highlighted patients' characteristics at admission and before surgery and their complications. Main outcomes and results: After a mean follow-up time of 9.6 years, 13/53 (24.5%) patients had died. Alive patients with traumatic brain injury had a higher level of consciousness recovery (p<0.02) and more abilities in activities of daily living (p<0.008) in the long-term. Their dysautonomia and limb hypertonia also significantly improved, contrary to patients with hypoxic brain injury who needed higher doses of baclofen (p<0.03). Conclusions: At long-term follow-up, patients with hypoxic brain injury had a poorer functional outcome than patients with traumatic brain injury with persistent symptoms of dysautonomia associated with uncontrolled hypertonia, despite the use of intrathecal baclofen.	[Hoarau, Xavier; Cuny, Emmanuel] Hop Pellegrin, Serv Neurochirurg, F-33076 Bordeaux, France; [Hoarau, Xavier; Dehail, Patrick; Cuny, Emmanuel] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Richer, Edwidge] Ctr Reeduc, Chateau Rauze, Cenac, France; [Dehail, Patrick] Hop Pellegrin, Serv Reeduc Fonct, F-33076 Bordeaux, France	Cuny, E (corresponding author), Univ Bordeaux Segalen, Hop Pellegrin, CHU Bordeaux, Serv Neurochirurg B, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	emmanuel.cuny@chu-bordeaux.fr	Dehail, Patrick/T-5081-2019				Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; COHADON F, 1993, NEUROCHIRURGIE, V39, P281; Condouret JPM, 1988, HEMIPLEGIE VASCULAIR, P45; Corral L, 2009, BRAIN INJURY, V23, P403, DOI 10.1080/02699050902788477; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; FitzGerald A, 2010, BRAIN INJURY, V24, P1311, DOI 10.3109/02699052.2010.506864; Francisco GE, 2005, BRAIN INJURY, V19, P359, DOI 10.1080/02699050400003999; Francois B, 2001, J TRAUMA, V50, P158, DOI 10.1097/00005373-200101000-00035; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MAHONEY F I, 1965, Md State Med J, V14, P61; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; PARKIN AJ, 1987, CORTEX, V23, P655, DOI 10.1016/S0010-9452(87)80055-2; PENN RD, 1995, MOVEMENT DISORD, V10, P675, DOI 10.1002/mds.870100524; PENN RD, 1984, LANCET, V1, P1078; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rawicki B, 1999, J NEUROSURG, V91, P733, DOI 10.3171/jns.1999.91.5.0733; Richard I, 2007, ACTA NEUROCHIR SUPPL, V97, P213; Rifici C, 1994, Funct Neurol, V9, P29; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188	45	11	13	1	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1451	1463		10.3109/02699052.2012.694564			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400006	22725634				2021-06-18	
J	Kholodenko, IV; Yarygin, KN; Gubsky, LV; Konieva, AA; Tairova, RT; Povarova, OV; Kholodenko, RV; Burunova, VV; Yarygin, VN; Skvortsova, VI				Kholodenko, I. V.; Yarygin, K. N.; Gubsky, L. V.; Konieva, A. A.; Tairova, R. T.; Povarova, O. V.; Kholodenko, R. V.; Burunova, V. V.; Yarygin, V. N.; Skvortsova, V. I.			Intravenous Xenotransplantation of Human Placental Mesenchymal Stem Cells to Rats: Comparative Analysis of Homing in Rat Brain in Two Models of Experimental Ischemic Stroke	BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						placental mesenchymal stem cells; ischemic stroke; middle cerebral artery occlusion; migration; homing		Mesenchymal stem cells from human placenta obtained after term natural delivery were cultured and labeled with vital dye Dil of magnetic fluorescing microparticles. The labeled cells were transplanted intravenously to rats with occlusion of the median cerebral artery. Penetration of cells through the brain-blood barrier and their distribution in the brain of experimental animals were studied on serial cryostat sections. Two models of cerebral artery occlusion associated with different traumatic consequences were used. The efficiency of crossing the blood-brain barrier by transplanted cells, the number of mesenchymal cells attaining the ischemic focus and neurogenic zones, and the time of death of transplanted cells largely depended on the degree and nature of injury to the central nervous system, which should be taken into account when planning the experiments for evaluation of the effects of cell therapy on the models of neurological diseases and in clinical studies in the field of regenerative neurology.	[Kholodenko, I. V.; Yarygin, K. N.; Burunova, V. V.] Russian Acad Med Sci, VN Orekhovich Res Inst Biomed Chem, Moscow, Russia; [Gubsky, L. V.; Konieva, A. A.; Tairova, R. T.; Povarova, O. V.; Yarygin, V. N.; Skvortsova, V. I.] NI Pirogov Russian State Med Univ, Moscow, Russia; [Konieva, A. A.] Minist Hlth & Social Dev, N Ossetian State Med Acad, Vladikavkaz, Russia; [Kholodenko, R. V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia	Yarygin, KN (corresponding author), Russian Acad Med Sci, VN Orekhovich Res Inst Biomed Chem, Moscow, Russia.	kyarygin@yandex.ru	Yarygin, Konstantin N/C-4047-2009; Povarova, O. V./R-3090-2016; Kholodenko, Irina V/F-7313-2017; Kholodenko, Roman/S-8412-2017; Kovrazhkina, Elena/AAR-2425-2021	Yarygin, Konstantin N/0000-0002-2261-851X; Kholodenko, Irina V/0000-0002-4079-5210; Kholodenko, Roman/0000-0001-6083-6588; Povarova, Oxana/0000-0003-1820-299X			Burunova V. V., 2010, KLETOCH TEKHNOL BIOL, P63; Cheglakov I. B., 2008, KLETOCH TEKHNOL BIOL, P73; Konieva A. A., 2010, KLETOCH TEKHNOL BIOL, P147; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Skvortsova VI, 2009, ZH NEVROL PSIKHIATR, V109, P62; SKVORTSOVA VI, 2008, KLETOCH TEKHNOL BIOL, P14; Stocum D. L, 2006, REGENERATIVE BIOL ME, P448; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Yarygin KN, 2012, ZH NEVROL PSIKHIATR, V112, P4; Yarygin KN, 2009, B EXP BIOL MED+, V148, P862, DOI 10.1007/s10517-010-0837-z	10	11	12	0	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4888	1573-8221		B EXP BIOL MED+	Bull. Exp. Biol. Med.	NOV	2012	154	1					118	123		10.1007/s10517-012-1890-6			6	Medicine, Research & Experimental	Research & Experimental Medicine	050QW	WOS:000312070100032	23330106				2021-06-18	
J	Moriarity, JM; Pietrzak, RH; Kutcher, JS; Clausen, MH; McAward, K; Darby, DG				Moriarity, James M.; Pietrzak, Robert H.; Kutcher, Jeffrey S.; Clausen, Margaretha Helen; McAward, Kevin; Darby, David G.			Unrecognised ringside concussive injury in amateur boxers	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Objectives Concussion is common in contact sports such as boxing. Diagnosis of concussion depends on symptom report or recognition of clinical features, and true incidence may be underestimated. Persistent morbidity is a possible risk of repeated or unrecognised concussion. This study aimed to evaluate pre and postbout cognitive performance in motivated amateur boxers in order to detect objective evidence of unrecognised cognitive impairment suggestive of concussive injury. Methods The study employed a prospective and observational design. Participants were amateur boxers who won at least one bout in a single elimination competition. Optimal preparticipation performance using a computerised cognitive assessment tool (CCAT, Axon Sports) and no significant deterioration in cognitive performance within 24 h postbout were required to compete. All boxers were screened for clinical evidence of concussion by a ringside physician. Results Of approximately 200 competing boxers, 96 were eligible having won at least one of the total 160 bouts. Mean age was 21.3 (SD 1.9) years (range 18.5-29.7). Of these, 17 (10.6%) failed their first postbout CCAT, with 12 (71%) passing a repeat test. Of the five remaining boxers, there were two boxers (1.3% of bouts) not suspected of a concussion after their bouts, who showed evolving slowing in cognitive performance typical of a concussion. Conclusions Cognitive impairment, as detected by subtle deterioration in reaction time measures, can occur in amateur boxers postbout that is not recognised at ringside. Although the vast majority of bouts were conducted safely, unrecognised injury may occur and be detectable using objective computerised cognitive assessment.	[Darby, David G.] Univ Melbourne, Mental Hlth Res Inst, Natl Neurosci Facil, Parkville, Vic 3010, Australia; [Moriarity, James M.; McAward, Kevin] Univ Notre Dame, Athlet Dept, Notre Dame, IN 46556 USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Kutcher, Jeffrey S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Clausen, Margaretha Helen] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia	Darby, DG (corresponding author), Univ Melbourne, Mental Hlth Res Inst, Natl Neurosci Facil, Level 3,Alan Gilbert Bldg, Parkville, Vic 3010, Australia.	ddarby@unimelb.edu.au			Cogstate Ltd.	Dr Darby is a shareholder and consultant for CogState Ltd, and neurologist employed in academic and private practice. Dr Moriarity is a sports physician employed at the University of Notre Dame, and consultant for Axon Sports. Dr McCrory is a neurologist, and received research and educational funding from Cogstate Ltd. Dr Pietrzak is a neuropsychologist and consultant for CogState Ltd. Dr Kutcher is Sports Section Chair for the American Academy of Neurology. Dr Clausen is a neuropsychologist. Dr McAward is a sports physician employed at the University of Notre Dame.		0	11	11	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	NOV	2012	46	14					1011	1015		10.1136/bjsports-2011-090893			5	Sport Sciences	Sport Sciences	027MX	WOS:000310357900011	22547563				2021-06-18	
J	Schonenberger, A; Billeter, AT; Seifert, B; Neuhaus, V; Trentz, O; Turina, M				Schoenenberger, Amadea; Billeter, Adrian T.; Seifert, Burkhardt; Neuhaus, Valentin; Trentz, Otmar; Turina, Matthias			Opportunities for improved trauma care of the elderly - A single center analysis of 2090 severely injured patients	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Trauma; Injury; Mortality; Elderly; Age; Brain	MULTIPLE-ORGAN FAILURE; BRAIN-INJURY; OLDER-ADULTS; AGE; OUTCOMES; PREDICTORS; MORTALITY; SCORE	Purpose: Western trauma centers are increasingly confronted with elderly trauma patients in parallel to an increase of the elderly population. The purpose of this study was to identify shortcomings and opportunities for improvement in the treatment of elderly trauma patients. Materials and methods: Retrospective analysis of a prospectively collected single-center trauma database. Patients were grouped according to age and analyzed using univariate and multivariate analysis. Results: 158 patients (7.6%) were older than 75 years, and 604 patients (28.9%) were between 50 and 75 years. Although comparable with respect to injury severity (injury severity score (ISS) 29-33) and age-adjusted Acute Physiologic and Chronic Health Evaluation (APACHE) score, there was a significant increase in mortality beyond the age of 50 (>75 years: 63.9%), with age being an independent predictor of mortality. Despite a similar rate and severity of head injuries (affecting 71% of all patients), mortality of head injuries was highest in patients >75 years (70.2%), accounting for the increased mortality in this group. Patients >75 years old were less likely to undergo craniotomy, and withdrawal of medical support occurred five times more frequently. Surviving patients >50 years required shorter ICU care than patients below 50 years (7.8 vs. 12.4 days). Conclusions: With increasing life expectancy and sustained independence, elderly trauma patients have become a regular occurrence in trauma services. Despite comparable injury severity and physiologic status upon admission, these patients suffer from disproportionately high mortality rates. Closed head injuries account for the majority of fatalities, regardless of the extent of therapeutic measures applied. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Turina, Matthias] Cleveland Clin, Dept Colorectal Surg, Inst Digest Dis, Cleveland, OH 44195 USA; [Schoenenberger, Amadea; Billeter, Adrian T.; Neuhaus, Valentin; Trentz, Otmar; Turina, Matthias] Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland; [Billeter, Adrian T.] Univ Louisville Hosp, Price Inst Surg Res, Louisville, KY 40201 USA; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, Div Biostat, CH-8001 Zurich, Switzerland; [Neuhaus, Valentin] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA	Turina, M (corresponding author), Cleveland Clin, Dept Colorectal Surg, Inst Digest Dis, Main Campus,Mail Code A-30,9500 Euclid Ave, Cleveland, OH 44195 USA.	mturina73@hotmail.com	Billeter, Adrian/O-2185-2019	Seifert, Burkhardt/0000-0002-5829-2478; Neuhaus, Valentin/0000-0003-4012-5628; Billeter, Adrian/0000-0001-8724-4793			Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Bennett KM, 2010, J SURG RES, V163, P127, DOI 10.1016/j.jss.2010.04.031; Billeter A, 2009, WORLD J SURG, V33, P558, DOI 10.1007/s00268-008-9896-y; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; FOGELHOLM R, 1975, J NEUROSURG, V42, P43, DOI 10.3171/jns.1975.42.1.0043; Gennarelli T., 2001, ABBREVIATED INJURY S; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; Haub C., 2011, 2010 WORLD POPULATIO; JOHNSON CL, 1994, AM SURGEON, V60, P899; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McGwin G, 2004, J TRAUMA, V56, P1291, DOI 10.1097/01.TA.0000089354.02065.D0; Meldon SW, 2000, ACAD EMERG MED, V7, P1166; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7	26	11	11	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943			ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	NOV-DEC	2012	55	3					660	666		10.1016/j.archger.2012.02.013			7	Geriatrics & Gerontology	Geriatrics & Gerontology	004GC	WOS:000308667900022	22465302				2021-06-18	
J	Wu, C; Orringer, DA; Lau, D; Fletcher, JJ				Wu, Chris; Orringer, Daniel A.; Lau, Darryl; Fletcher, Jeffrey J.			Cumulative incidence and predictors of neurosurgical interventions following nonsevere traumatic brain injury with mildly abnormal head imaging findings	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Mild traumatic brain injury; moderate traumatic brain injury; neurosurgical intervention	NATIONAL-SURVEY; MANAGEMENT; GUIDELINES; CENTERS	BACKGROUND: Incidence and predictors of neurosurgical interventions following nonsevere traumatic brain injury (TBI) with mildly abnormal head computed tomographic (CT) findings are poorly defined. Despite this, neurosurgical consultation is routinely requested in this patient population. Our objective was to determine incidence of neurosurgical intervention in this patient population and identify clinical and radiographic features predicting the subsequent need for these interventions. METHODS: We identified all consecutive adult patients with nonsevere TBI admitted from January 1, 2001, through December 31, 2010. The definitions of "mildly abnormal initial head CT findings'' and "neurosurgical interventions'' were determined a priori by author consensus. Cumulative incidence of neurosurgical interventions was determined, and multivariate logistic regression was used to identify independent predictors of neurosurgical intervention. RESULTS: Of 677 patients, 51 underwent neurosurgical intervention for a cumulative incidence of 7.5%. Only 1.6% required an intracranial procedure. In adjusted analysis, presence of coagulopathy (odds ratio [OR], 2.21; 95% confidence interval [CI], 1.13-4.3; p = 0.02), suspected cerebrospinal fluid leak (OR, 11.36; 95% CI, 2.83-45.58; p = 0.001), any basal cistern or sylvian fissure subarachnoid hemorrhage (OR, 2.94; 95% CI, 1.56-5.57; p = 0.001), depressed skull fracture (OR, 2.84; 95% CI, 1.29-6.28; p = 0.01), or unstable repeated head CT findings (OR, 2.81; 95% CI, 1.52-5.2; p = 0.001) remained an independent predictor of the need for subsequent neurosurgical intervention. CONCLUSION: Among patients with nonsevere TBI and mildly abnormal head imaging findings in which routine neurosurgical consultation is obtained, there is a low incidence of neurosurgical interventions. Our findings suggest that routine early neurosurgical consultation in this patient population may not be necessary; however, this should be tested in a prospective, comparative study. (J Trauma Acute Care Surg. 2012;73:1247-1253. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Wu, Chris; Orringer, Daniel A.; Lau, Darryl; Fletcher, Jeffrey J.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA	Fletcher, JJ (corresponding author), Univ Michigan Hlth Syst, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 Taubman Ctr, Ann Arbor, MI 48109 USA.	jeffletc@med.umich.edu		Orringer, Daniel/0000-0001-6427-8376	Michigan Institute for Clinical and Health Research [CTSA: UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986] Funding Source: NIH RePORTER	The authors have no conflicts of interest to report pertaining to the materials or methods used in this study or the findings specified in this article. This project was supported in part by a grant from the Michigan Institute for Clinical and Health Research (CTSA: UL1RR024986).	[Anonymous], 2009, VA DOD CLIN PRACTICE; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Manessiez O, 2007, J RADIOL, V88, P567, DOI 10.1016/S0221-0363(07)89856-8; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Stein SC, 1996, NEUROSURG QUART, V6, P108, DOI 10.1097/00013414-199606000-00004	14	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2012	73	5					1247	1253		10.1097/TA.0b013e318265d24e			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	043VF	WOS:000311577100038	23064607				2021-06-18	
J	Alam, HB; Pusateri, AE; Kindzelski, A; Egan, D; Hoots, K; Andrews, MT; Rhee, P; Tisherman, S; Mann, K; Vostal, J; Kochanek, PM; Scalea, T; Deal, V; Sheppard, F; Sopko, G				Alam, Hasan B.; Pusateri, Anthony E.; Kindzelski, Andrei; Egan, Debra; Hoots, Keith; Andrews, Matthew T.; Rhee, Peter; Tisherman, Samuel; Mann, Kenneth; Vostal, Jaroslav; Kochanek, Patrick M.; Scalea, Thomas; Deal, Virgil; Sheppard, Forest; Sopko, George		HYPOSTAT Workshop Participants	Hypothermia and hemostasis in severe trauma: A new crossroads workshop report	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Hypothermia; trauma; coagulopathy; injury; protection	SWINE MODEL; PROFOUND HYPOTHERMIA; CARDIAC-ARREST; HEMORRHAGIC-SHOCK; CIRCULATORY ARREST; BRAIN-INJURY; EMERGENCY PRESERVATION; CARDIOPULMONARY BYPASS; BETA-HYDROXYBUTYRATE; FLUID RESUSCITATION	OBJECTIVE: The hypothermia and hemostasis in severe trauma (HYPOSTAT): a new crossroads workshop was convened to evaluate the interplay among hypothermia, hemostasis, and severe trauma/hemorrhage. Trauma is the major cause of death in young individuals in the United States, with uncontrolled hemorrhage representing the major cause of preventable deaths. DATA SOURCES: This workshop organized by the National Heart, Lung, and Blood Institute and the US Army Medical Research and Material Command as a forum for exchange of ideas among experts from diverse fields. The specific workshop goals were to (1) identify state-of-the-art and needs in knowledge of biology of hypothermia and hemostasis in the setting of significant traumatic injury; (2) provide an interdisciplinary forum to enhance knowledge regarding early detection of traumatic shock and monitoring of the level and effect of controlled hypothermia in severe trauma settings; and (3) identify future research directions of the role of therapeutic-oriented hypothermia and hemostasis in trauma with severe blood loss. STUDY SELECTION: Not applicable. DATA EXTRACTION: Expert opinion and literature review. CONCLUSION: This document provides a summary of the expert opinion and highlights the recommendations that came out of the discussions at this workshop to guide scientific efforts in basic, translational, and clinical research in this area. (J Trauma Acute Care Surg. 2012;73:809-817. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02114 USA; [Alam, Hasan B.] Harvard Univ, Sch Med, Boston, MA USA; [Pusateri, Anthony E.; Deal, Virgil; Sheppard, Forest] US Dept Def, Washington, DC 20305 USA; [Kindzelski, Andrei; Egan, Debra; Hoots, Keith; Sopko, George] NIH, Bethesda, MD 20892 USA; [Vostal, Jaroslav] US FDA, Silver Spring, MD USA; [Scalea, Thomas] Univ Maryland, College Pk, MD 20742 USA; [Andrews, Matthew T.] Univ Minnesota, Duluth, MN 55812 USA; [Rhee, Peter] Univ Arizona, Tucson, AZ USA; [Tisherman, Samuel; Kochanek, Patrick M.] Univ Pittsburgh, Pittsburgh, PA USA; [Mann, Kenneth] Univ Vermont, Burlington, VT USA	Alam, HB (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care, 165 Cambridge St,Suite 810, Boston, MA 02114 USA.	hbalam@partners.org	Kochanek, Patrick M/D-2371-2015; Tisherman, Samuel A./AAK-9377-2020	Kochanek, Patrick M/0000-0002-2627-913X; Tisherman, Samuel A./0000-0003-3810-3729			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alam HB, 2012, BRIT J SURG, V99, P29, DOI 10.1002/bjs.7756; Alam HB, 2008, J TRAUMA, V64, P912, DOI 10.1097/TA.0b013e3181659e7f; Alam HB, 2006, SURGERY, V140, P307, DOI 10.1016/j.surg.2006.03.015; Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Alam HB, 2006, J TRAUMA, V60, P134, DOI 10.1097/01.ta.0000198469.95292.ec; Alam HB, 2005, J SURG RES, V126, P172, DOI 10.1016/j.jss.2005.01.019; Alam HB, 2004, J TRAUMA, V57, P961, DOI 10.1097/01.TA.0000149549.72389.3F; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Behringer W, 2003, CRIT CARE MED, V31, P1523, DOI 10.1097/01.CCM.0000063450.73967.40; Behringer W, 2000, ANESTHESIOLOGY, V93, P1491, DOI 10.1097/00000542-200012000-00022; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; Capone A, 1996, J TRAUMA, V40, P388, DOI 10.1097/00005373-199603000-00011; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chen Z, 2005, RESUSCITATION, V66, P209, DOI 10.1016/j.resuscitation.2005.01.021; COLE SL, 1956, JAMA-J AM MED ASSOC, V161, P1454, DOI 10.1001/jama.1956.02970150022005; Conrad MF, 2007, ANN THORAC SURG, V83, pS856, DOI 10.1016/j.athoracsur.2006.10.096; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; deMeis L, 1997, FEBS LETT, V406, P201, DOI 10.1016/S0014-5793(97)00244-5; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; EHRLICH M, 1995, TEX HEART I J, V22, P250; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Haman F, 2006, J APPL PHYSIOL, V100, P1702, DOI 10.1152/japplphysiol.01088.2005; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Henry PG, 2007, J NEUROCHEM, V101, P1505, DOI 10.1111/j.1471-4159.2007.04514.x; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; JENNINGS RB, 1988, CRIT CARE MED, V16, P988, DOI 10.1097/00003246-198810000-00010; Jonas Richard A, 2002, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V5, P76, DOI 10.1053/pcsu.2002.31493; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KADAR D, 1982, CAN ANAESTH SOC J, V29, P16, DOI 10.1007/BF03007942; Kheirbek T, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-65; Klein AH, 2010, SHOCK, V34, P565, DOI 10.1097/SHK.0b013e3181e15063; Kurtz CC, 2006, AM J PHYSIOL-GASTR L, V291, pG895, DOI 10.1152/ajpgi.00155.2006; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lindell SL, 2005, AM J PHYSIOL-GASTR L, V288, pG473, DOI 10.1152/ajpgi.00223.2004; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MATTOX KL, 1982, J TRAUMA, V22, P934, DOI 10.1097/00005373-198211000-00008; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Mulier KE, 2012, RESUSCITATION, V83, P253, DOI 10.1016/j.resuscitation.2011.08.003; PUIG MM, 1987, BRIT J ANAESTH, V59, P1459, DOI 10.1093/bja/59.11.1459; RADOVSKY A, 1995, STROKE, V26, P2127, DOI 10.1161/01.STR.26.11.2127; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Rothoerl Ralf Dirk, 2006, Neurosurg Focus, V20, pE5; Sailhamer EA, 2007, J AM COLL SURGEONS, V204, P642, DOI 10.1016/j.jamcollsurg.2007.01.017; Santry HP, 2010, SHOCK, V33, P229, DOI 10.1097/SHK.0b013e3181c30f0c; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scribner DM, 2010, J SURG RES, V164, pE131, DOI 10.1016/j.jss.2010.07.046; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Shuja F, 2009, J AM COLL SURGEONS, V209, P89, DOI 10.1016/j.jamcollsurg.2009.03.010; TAYLOR MJ, 1995, CIRCULATION, V91, P431, DOI 10.1161/01.CIR.91.2.431; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; Tisherman SA, 2004, CRIT CARE MED, V32, pS46, DOI 10.1097/01.CCM.0000110736.31246.C5; TISHERMAN SA, 1990, J TRAUMA, V30, P836, DOI 10.1097/00005373-199007000-00014; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; WONG KC, 1983, WESTERN J MED, V138, P227; Wu XR, 2008, J CEREBR BLOOD F MET, V28, P302, DOI 10.1038/sj.jcbfm.9600524; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540	87	11	12	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73	4					809	817		10.1097/TA.0b013e318265d1b8			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	029OL	WOS:000310505100003	23026915				2021-06-18	
J	Carlson, GA				Carlson, Gabrielle A.			Differential diagnosis of bipolar disorder in children and adolescents	WORLD PSYCHIATRY			English	Article						Bipolar disorder; mania; irritability; children; adolescents	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN INJURY; MANIC SYMPTOMS; LONGITUDINAL COURSE; MOOD DYSREGULATION; SPECTRUM DISORDERS; MENTAL-DISORDERS; STEP-BD; YOUTH; IRRITABILITY	Issues complicating the differential diagnosis of bipolar disorder in young people are discussed. They include: a) the subtype of bipolar disorder being considered; b) the person's age and stage of development; c) whether one views bipolar disorder more conservatively, requiring clear episodes that mark a distinct change from premorbid levels of function, or more liberally, focusing for instance on severe irritability/explosive outbursts as the mood change; d) who is reporting manic symptoms, and whether symptoms are past and must be recalled or current and more likely to be observed; e) impact of family history. The diagnosis of mania/bipolar I disorder may not become clear for a number of years. This is an impairing disorder, but so are the conditions from which it must be distinguished. Family history may increase the odds that certain symptoms/behaviors are manifestations of bipolar disorder but it does not make the diagnosis. Until there are biomarkers that can confirm the diagnosis, and treatments unique to the condition, it is wise to make a diagnosis of bipolar disorder in children and adolescents provisionally and keep an open mind to the likelihood that revisions may be necessary.	SUNY Stony Brook, Sch Med, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	Carlson, GA (corresponding author), SUNY Stony Brook, Sch Med, Dept Psychiat & Behav Sci, Putnam Hall,South Campus, Stony Brook, NY 11794 USA.						AKISKAL HS, 1979, PSYCHIAT CLIN N AM, V2, P527; Arnold LE, 2011, BIPOLAR DISORD, V13, P509, DOI 10.1111/j.1399-5618.2011.00948.x; Barkley RA, 2010, J AM ACAD CHILD PSY, V49, P503, DOI 10.1016/j.jaac.2010.01.019; Benazzi F, 2004, EUR PSYCHIAT, V19, P85, DOI 10.1016/j.eurpsy.2003.09.008; Biederman J, 2009, BIPOLAR DISORD, V11, P298, DOI 10.1111/j.1399-5618.2009.00671.x; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Bromet EJ, 2011, AM J PSYCHIAT, V168, P1186, DOI 10.1176/appi.ajp.2011.11010048; Brotman MA, 2006, BIOL PSYCHIAT, V60, P991, DOI 10.1016/j.biopsych.2006.08.042; Carlson G, 2005, JUVENILE-ONSET SCHIZOPHRENIA: ASSESSMENT, NEUROBIOLOGY, AND TREATMENT, P1; Carlson GA, 2003, J CHILD ADOL PSYCHOP, V13, P13, DOI 10.1089/104454603321666162; Carlson GA, 1999, J CHILD ADOL PSYCHOP, V9, P221, DOI 10.1089/cap.1999.9.221; Carlson GA, 1998, J AFFECT DISORDERS, V51, P113, DOI 10.1016/S0165-0327(98)00210-9; CARLSON GA, 1988, J AFFECT DISORDERS, V15, P219, DOI 10.1016/0165-0327(88)90019-5; Carlson GA, 1998, J AFFECT DISORDERS, V51, P177, DOI 10.1016/S0165-0327(98)00179-7; Carlson GA, 2006, DEV PSYCHOPATHOL, V18, P939, DOI 10.1017/S0954579406060470; Carlson GA, 2012, BIPOLAR DISORD, V14, P19, DOI 10.1111/j.1399-5618.2012.00982.x; Carlson GA, 2011, J AM ACAD CHILD PSY, V50, P1202, DOI 10.1016/j.jaac.2010.07.008; Carlson GA, 2011, J CHILD ADOL PSYCHOP, V21, P399, DOI 10.1089/cap.2011.0007; Carlson GA, 2011, WORLD PSYCHIATRY, V10, P195; Carlson GA, 2009, J CHILD ADOL PSYCHOP, V19, P281, DOI 10.1089/cap.2008.0108; Cicero DC, 2009, J ABNORM PSYCHOL, V118, P431, DOI 10.1037/a0015919; DELONG GR, 1988, J AUTISM DEV DISORD, V18, P593; Dubicka G, 2007, EUR J CHILD ADOLESC, V17, P153; Duffy A, 2011, AM AC CHILD AD PSYCH; Findling RL, 2010, J CLIN PSYCHIAT, V71, P1664, DOI 10.4088/JCP.09m05859yel; Galanter CA, 2008, CHILD ADOL PSYCH CL, V17, P325, DOI 10.1016/j.chc.2007.11.001; Gottesman II, 2010, ARCH GEN PSYCHIAT, V67, P252, DOI 10.1001/archgenpsychiatry.2010.1; Grof P, 2009, ACTA PSYCHIAT SCAND, V120, P378, DOI 10.1111/j.1600-0447.2009.01454.x; Hillegers MH, 2005, BIPOLAR DISORD, V7, P344, DOI 10.1111/j.1399-5618.2005.00215.x; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Lapalme M, 1997, CAN J PSYCHIAT, V42, P623, DOI 10.1177/070674379704200609; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Lewinsohn PM, 2002, CHILD ADOL PSYCH CL, V11, P461, DOI 10.1016/S1056-4993(02)00005-6; Margulies DM, 2012, BIPOLAR DISORD, V14, P488, DOI 10.1111/j.1399-5618.2012.01029.x; Martel MM, 2009, J CHILD PSYCHOL PSYC, V50, P1042, DOI 10.1111/j.1469-7610.2009.02105.x; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Meyer SE, 2009, J AFFECT DISORDERS, V113, P227, DOI 10.1016/j.jad.2008.05.024; Mick E, 2005, BIOL PSYCHIAT, V58, P576, DOI 10.1016/j.biopsych.2005.05.037; MILBERGER S, 1995, AM J PSYCHIAT, V152, P1793; Nierenberg AA, 2009, DEPRESS ANXIETY, V26, P106, DOI 10.1002/da.20547; Parens E, 2010, NEW ENGL J MED, V362, P1853, DOI 10.1056/NEJMp1003175; Pavuluri MN, 2006, J AM ACAD CHILD PSY, V45, P550, DOI 10.1097/01.chi.0000205700.40700.50; Post RM, 2010, J CLIN PSYCHIAT, V71, P864, DOI 10.4088/JCP.08m04994yel; Potegal M, 2009, CHILD PSYCHIAT HUM D, V40, P621, DOI 10.1007/s10578-009-0148-7; Sala R, 2010, J CLIN PSYCHIAT, V71, P1344, DOI 10.4088/JCP.09m05845gre; Serrano E, J ATTEN DIS IN PRESS; Simon NM, 2004, AM J PSYCHIAT, V161, P2222, DOI 10.1176/appi.ajp.161.12.2222; Stringaris A, 2009, PSYCHOL MED, V39, P1237, DOI 10.1017/S0033291708004662; Stringaris A, 2012, AM J PSYCHIAT, V169, P47, DOI 10.1176/appi.ajp.2011.10101549; Stringaris A, 2011, J ABNORM CHILD PSYCH, V39, P925, DOI 10.1007/s10802-011-9520-8; Stringaris A, 2009, AM J PSYCHIAT, V166, P1048, DOI 10.1176/appi.ajp.2009.08121849; Tillman R, 2004, AM J PSYCHIAT, V161, P1278, DOI 10.1176/appi.ajp.161.7.1278; Towbin KE, 2005, J CHILD ADOL PSYCHOP, V15, P452, DOI 10.1089/cap.2005.15.452; Wilens TE, 1999, J AM ACAD CHILD PSY, V38, P680, DOI 10.1097/00004583-199906000-00014; Youngstrom EA, 2004, J AFFECT DISORDERS, V82, pS5, DOI 10.1016/j.jad.2004.05.016; Youngstrom EA, 2008, J CLIN PSYCHIAT, V69, P831, DOI 10.4088/JCP.v69n0517	58	11	11	0	7	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1723-8617			WORLD PSYCHIATRY	World Psychiatry	OCT	2012	11	3					146	152					7	Psychiatry	Psychiatry	018XF	WOS:000309699800003	23024665				2021-06-18	
J	Lynch, KM; Brett, F				Lynch, Karen M.; Brett, Francesca			Headaches that kill: A retrospective study of incidence, etiology and clinical features in cases of sudden death	CEPHALALGIA			English	Article						Fatal headache; death; autopsy; red flag features		Objective: The study objective was to analyze cases of sudden death that presented to the National Deptartment of Clinical Neurosciences, Ireland, over a 10-year period (1997-2006) where headache was the presenting symptom. Background: Headache is a common yet challenging presentation in clinical neurology. In the vast majority of cases, the cause is trivial and reversible-however, in a few patients it may be indicative of a more sinister intracranial process. Recognizing associated "red flag'' features and identifying possible life-threatening causes are crucial in ensuring prompt and appropriate intervention. Design/methods: A retrospective study/database of all autopsy cases presenting to the Neuropathology Department in Beaumont Hospital, Dublin, was carried out for the period 1997-2006. Cases were selected with headache as the presenting clinical feature. Traumatic head injuries or known central nervous system (CNS) disorders were excluded. Autopsy and medical reports were reviewed to identify associated red flag features at initial presentation according to the International Classification of Headache Diseases, second edition (ICHD-II) criteria. Results: Fifty-five autopsy cases out of a total of 499 complying with selection criteria were reviewed. Over the 10-year-study period, the number of cases of fatal headaches over time were negatively correlated. The most commonly associated red flag symptoms included age over 50: loss of consciousness and collapse, and worst/thunderclap character of headache. Cause of death at autopsy comprised vascular events 60.4% (N = 29), primary brain tumours/cysts 16.7% (N = 8) and meningitis 6.25% (N = 3). Aneurysms accounted for the majority of vascular cases 22.9% (N = 11), with loss of consciousness, occipital headache, neck pain and a focal neurological deficit seen more commonly in this subset of cases. Conclusions: Sudden-onset headache is a common and often alarming presentation. The majority of cases are of a benign nature; however, a small proportion may be indicative of a catastrophic etiology. Documenting "red flags'' on initial presentation is crucial to acutely identify and treat those at highest risk. The results demonstrate an improving trend among clinicians in recognizing and initiating appropriate interventions in these patients, and highlights particular red flag features common in cases of fatal headaches.	[Lynch, Karen M.] Tufts Univ, Tufts Med Ctr, Dept Neurol, Boston, MA 02111 USA; [Brett, Francesca] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland	Lynch, KM (corresponding author), Tufts Univ, Tufts Med Ctr, Dept Neurol, 800 Washington St, Boston, MA 02111 USA.	klynch1@tuftsmedicalcenter.org		Brett, Francesca/0000-0002-7453-4027			Dodick D, 1997, POSTGRAD MED, V101, P46, DOI 10.3810/pgm.1997.05.217; DUMAS MD, 1994, CAN MED ASSOC J, V151, P1447; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Locker T, 2004, EMERG MED J, V21, P327, DOI 10.1136/emj.2003.012351; Marks DR, 1997, SEMIN NEUROL, V17, P307, DOI 10.1055/s-2008-1040943; Medina LS, 2003, NEUROIMAG CLIN N AM, V13, P225, DOI 10.1016/S1052-5149(03)00026-1; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sobri M, 2003, BRIT J RADIOL, V76, P532, DOI 10.1259/bjr/89012738; Spears Roderick C, 2004, Curr Pain Headache Rep, V8, P297, DOI 10.1007/s11916-004-0011-2; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354	10	11	11	0	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	OCT	2012	32	13					972	978		10.1177/0333102412455706			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	013CQ	WOS:000309283700005	22875877				2021-06-18	
J	Resnik, L; Borgia, M; Ni, PS; Pirraglia, PA; Jette, A				Resnik, Linda; Borgia, Matthew; Ni, Pensheng; Pirraglia, Paul A.; Jette, Alan			Reliability, validity and administrative burden of the community reintegration of injured service members computer adaptive test (CRIS-CAT)"	BMC MEDICAL RESEARCH METHODOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; AGGRESSIVE-BEHAVIOR; IRAQ	Background: The Computer Adaptive Test version of the Community Reintegration of Injured Service Members measure (CRIS-CAT) consists of three scales measuring Extent of, Perceived Limitations in, and Satisfaction with community integration. The CRIS-CAT was developed using item response theory methods. The purposes of this study were to assess the reliability, concurrent, known group and predictive validity and respondent burden of the CRIS-CAT. Methods: This was a three-part study that included a 1) a cross-sectional field study of 517 homeless, employed, and Operation Enduring Freedom / Operation Iraqi Freedom (OEF/OIF) Veterans; who completed all items in the CRIS item set, 2) a cohort study with one year follow-up study of 135 OEF/OIF Veterans, and 3) a 50-person study of CRIS-CAT administration. Conditional reliability of simulated CAT scores was calculated from the field study data, and concurrent validity and known group validity were examined using Pearson product correlations and ANOVAs. Data from the cohort were used to examine the ability of the CRIS-CAT to predict key one year outcomes. Data from the CRIS-CAT administration study were used to calculate ICC (2,1) minimum detectable change (MDC), and average number of items used during CAT administration. Results: Reliability scores for all scales were above 0.75, but decreased at both ends of the score continuum. CRIS-CAT scores were correlated with concurrent validity indicators and differed significantly between the three Veteran groups (P < .001). The odds of having any Emergency Room visits were reduced for Veterans with better CRIS-CAT scores (Extent, Perceived Satisfaction respectively: OR = 0.94, 0.93, 0.95; P < .05). CRIS-CAT scores were predictive of SF-12 physical and mental health related quality of life scores at the 1 year follow-up. Scales had ICCs >0.9. MDCs were 5.9, 6.2, and 3.6, respectively for Extent, Perceived and Satisfaction subscales. Number of items (mn, SD) administered at Visit 1 were 14.6 (3.8) 10.9 (2.7) and 10.4 (1.7) respectively for Extent, Perceived and Satisfaction subscales. Conclusion: The CRIS-CAT demonstrated sound measurement properties including reliability, construct, known group and predictive validity, and it was administered with minimal respondent burden. These findings support the use of this measure in assessing community reintegration.	[Resnik, Linda; Borgia, Matthew; Pirraglia, Paul A.] Providence VA Med Ctr, Providence, RI 02908 USA; [Resnik, Linda] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02903 USA; [Jette, Alan] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Dept Hlth Policy & Management, Boston, MA 02118 USA	Resnik, L (corresponding author), Providence VA Med Ctr, 830 Chalkstone Ave, Providence, RI 02908 USA.	Linda.Resnik@va.gov		Jette, Alan/0000-0002-2117-9973	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development HSRDUS Department of Veterans Affairs [DHI-07-144]; NIH-NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1 R42HD065688-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065688] Funding Source: NIH RePORTER	This research was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development HSR&D DHI-07-144. The Administration Study reported in this paper was supported by NIH-NICHD 1 R42HD065688-01. The information in this manuscript does not necessarily reflect the position or policy of the government; no official endorsement should be inferred.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anastasi A, 1997, PSYCHOL TESTING, V7th; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bock R., 1997, HDB MODERN ITEM RESP, P101, DOI DOI 10.1007/978-1-4757-2691-6_6; Brooks CA, 1992, CRAIG HAND ASS REP T; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; Cotton R, 2011, CLEAR HOLD BUILD STR; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Institute of Medicine, 2010, RET HOM IR AFGH PREL; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P70; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Resnik L, 2012, J REHABIL RES DEV, V49, P557, DOI 10.1682/JRRD.2011.04.0081; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; U.S. Department of Defense, 2011, US MIL CAS; Wainer H, 2000, COMPUTERIZED ADAPTIV; Walter OB, 2007, QUAL LIFE RES, V16, P143, DOI 10.1007/s11136-007-9191-7; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE., 1993, SF 36 HLTH SURVEY MA; WARM TA, 1989, PSYCHOMETRIKA, V54, P427, DOI 10.1007/BF02294627; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 2001, INT CLASS FUNCT DIS; Wounded Soldiers Get Help in Transition to VA, 2004, WOUND SOLD GET HELP; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	34	11	11	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2288			BMC MED RES METHODOL	BMC Med. Res. Methodol.	SEP 17	2012	12								145	10.1186/1471-2288-12-145			17	Health Care Sciences & Services	Health Care Sciences & Services	060TL	WOS:000312800900002	22984850	DOAJ Gold, Green Published			2021-06-18	
J	Bilgin, S; Guclu-Gunduz, A; Oruckaptan, H; Kose, N; Celik, B				Bilgin, Sevil; Guclu-Gunduz, Arzu; Oruckaptan, Hakan; Kose, Nezire; Celik, Bulent			Gait and Glasgow Coma Scale scores can predict functional recovery in patients with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						brain injury; traumatic brain injury; rehabilitation; early rehabilitation; function; prognosis; Glasgow Coma Scale; Glasgow Outcome Scale; functional level; neural regeneration	LENGTH-OF-STAY; INDEPENDENCE MEASURE; STROKE PATIENTS; REHABILITATION; CONSCIOUSNESS	Fifty-one patients with mild (n = 14), moderate (n = 10) and severe traumatic brain injury (n = 27) received early rehabilitation. Level of consciousness was evaluated using the Glasgow Coma Score. Functional level was determined using the Glasgow Outcome Score, whilst mobility was evaluated using the Mobility Scale for Acute Stroke. Activities of daily living were assessed using the Barthel Index. Following Bobath neurodevelopmental therapy, the level of consciousness was significantly improved in patients with moderate and severe traumatic brain injury, but was not greatly influenced in patients with mild traumatic brain injury. Mobility and functional level were significantly improved in patients with mild, moderate and severe traumatic brain injury. Gait recovery was more obvious in patients with mild traumatic brain injury than in patients with moderate and severe traumatic brain injury. Activities of daily living showed an improvement but this was insignificant except for patients with severe traumatic brain injury. Nevertheless, complete recovery was not acquired at discharge. Multiple regression analysis showed that gait and Glasgow Coma Scale scores can be considered predictors of functional outcomes following traumatic brain injury.	[Bilgin, Sevil; Kose, Nezire] Hacettepe Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, Ankara, Turkey; [Guclu-Gunduz, Arzu] Gazi Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, Ankara, Turkey; [Oruckaptan, Hakan] Hacettepe Univ, Fac Med, Dept Neurosurg, TR-06100 Ankara, Turkey; [Celik, Bulent] Gazi Univ, Dept Biostat, Fac Hlth Sci, Ankara, Turkey	Bilgin, S (corresponding author), Hacettepe Univ, Dept Physiotherapy & Rehabil, Fac Hlth Sci, TR-06100 Samanpazan Ankara, Turkey.	sevilcuvalci@yahoo.com	Celik, Bulent/A-7793-2017	Celik, Bulent/0000-0002-0481-4808			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 1995, NEW ENGL J MED, V333, P1581; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Aygencel Gulbin, 2008, J Forensic Leg Med, V15, P1, DOI 10.1016/j.jflm.2007.05.005; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dombovy Mary L, 2011, Continuum (Minneap Minn), V17, P584, DOI 10.1212/01.CON.0000399074.07686.76; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gupta A, 2012, ANN INDIAN ACAD NEUR, V15, P120, DOI 10.4103/0972-2327.94995; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Ilet PA, 2010, ARCH PHYS MED REHAB, V91, P788, DOI 10.1016/j.apmr.2009.11.028; JENNETT B, 1975, LANCET, V1, P480; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Lippert-Gruner M, 2010, NEUROL NEUROCHIR POL, V44, P475; Majdan M, EUR J PUBLI IN PRESS; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Navarrete-Navarro P, 2003, INTENS CARE MED, V29, P1237, DOI 10.1007/s00134-003-1755-6; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Simondson JA, 2003, CLIN REHABIL, V17, P558, DOI 10.1191/0269215503cr650oa; Wall G, NEUROCASE IN PRESS; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	31	11	11	0	11	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	SEP 5	2012	7	25					1978	1984		10.3969/j.issn.1673-5374.2012.25.009			7	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	018BT	WOS:000309635700009	25624828	DOAJ Gold			2021-06-18	
J	Desai, A; Bekelis, K; Zhao, WY; Ball, PA				Desai, Atman; Bekelis, Kimon; Zhao, Wenyan; Ball, Perry A.			Increased population density of neurosurgeons associated with decreased risk of death from motor vehicle accidents in the United States Clinical article	JOURNAL OF NEUROSURGERY			English	Article						motor vehicle crash; area resource file; trauma neurosurgeon population density	TRAUMA SYSTEMS; MORTALITY; CRASHES; INJURY	Object. Motor vehicle accidents (MVAs) are a leading cause of death and disability in young people. Given that a major cause of death from MVAs is traumatic brain injury, and neurosurgeons hold special expertise in this area relative to other members of a trauma team, the authors hypothesized that neurosurgeon population density would be related to reduced mortality from MVAs across US counties. Methods. The Area Resource File (2009-2010), a national health resource information database, was retrospectively analyzed. The primary outcome variable was the 3-year (2004-2006) average in MVA deaths per million population for each county. The primary independent variable was the density of neurosurgeons per million population in the year 2006. Multiple regression analysis was performed, adjusting for population density of general practitioners, urbanicity of the county, and socioeconomic status of the county. Results. The median number of annual MVA deaths per million population, in the 3141 counties analyzed, was 226 (interquartile range [IQR] 151-323). The median number of neurosurgeons per million population was 0 (IQR 0-0), while the median number of general practitioners per million population was 274 (IQR 175-410). Using an unadjusted analysis, each increase of I neurosurgeon per million population was associated with 1.90 fewer MVA deaths per million population (p < 0.001). On multivariate adjusted analysis, each increase of 1 neurosurgeon per million population was associated with 1.01 fewer MVA deaths per million population (p < 0.001), with a respective decrease in MVA deaths of 0.03 per million population for an increase in I general practitioner (p = 0.007). Rural location, persistent poverty, and low educational level were all associated with significant increases in the rate of MVA deaths. Conclusions. A higher population density of neurosurgeons is associated with a significant reduction in deaths from MVAs, a major cause of death nationally. This suggests that the availability of local neurosurgeons is an important factor in the overall likelihood of survival from an MVA, and therefore indicates the importance of promoting neurosurgical education and practice throughout the country. (http://thejns.org/doi/abs/10.3171/2012.6.JNS111281)	[Desai, Atman; Bekelis, Kimon; Ball, Perry A.] Dartmouth Hitchcock Med Ctr, Sect Neurosurg, Lebanon, NH 03756 USA; [Zhao, Wenyan] Dartmouth Hitchcock Med Ctr, Dept Orthopaed, Lebanon, NH 03756 USA	Desai, A (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	atman.desai@hitchcock.org	Bekelis, Kimon/Y-3402-2019				Adekoya N., 2009, Morbidity and Mortality Weekly Report, V58, P161; BAKER SP, 1988, J TRAUMA, V28, P741, DOI 10.1097/00005373-198806000-00003; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; Center for the Evaluative Clinical Sciences, 2006, SPIN SURG REP DARTM; Chang DC, 2011, J AM COLL SURGEONS, V212, P862, DOI 10.1016/j.jamcollsurg.2011.01.057; Clark DE, 1999, ACAD EMERG MED, V6, P125, DOI 10.1111/j.1553-2712.1999.tb01050.x; Committee on Trauma Research, 1985, INJ AM CONT PUBL HLT; Crompton JG, 2010, AM J SURG, V200, P191, DOI 10.1016/j.amjsurg.2009.07.047; *DARTM ATL WORK GR, 2000, DARTM ATL MUSC HLTH; Donaldson AE, 2006, ACCIDENT ANAL PREV, V38, P723, DOI 10.1016/j.aap.2006.01.002; Fingerhut LA., 1997, INJURY CHARTBOOK HLT; Gardner R, 2007, ARCH PEDIAT ADOL MED, V161, P889, DOI 10.1001/archpedi.161.9.889; Gonzalez RP, 2006, J TRAUMA, V61, P404, DOI 10.1097/01.ta.0000229816.16305.94; Gonzalez RP, 2009, AM J SURG, V197, P30, DOI 10.1016/j.amjsurg.2007.11.018; Li MD, 2008, J SAFETY RES, V39, P623, DOI 10.1016/j.jsr.2008.10.008; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; Marson AC, 2001, J TRAUMA, V50, P917; Melton SM, 2003, J TRAUMA, V54, P273, DOI 10.1097/01.TA.0000038506.54819.11; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Rice DP, 1989, COST INJURY US REPOR; Shafi S, 2006, J TRAUMA, V61, P1374, DOI 10.1097/01.ta.0000246698.07125.c0; Yoganandan N, 2010, ACCIDENT ANAL PREV, V42, P1370, DOI 10.1016/j.aap.2010.02.017	25	11	11	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2012	117	3					599	603		10.3171/2012.6.JNS111281			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	990JP	WOS:000307627100028	22827590	Bronze			2021-06-18	
J	Kendrick, D; Silverberg, ND; Barlow, S; Miller, WC; Moffat, J				Kendrick, Denise; Silverberg, Noah D.; Barlow, Susan; Miller, William C.; Moffat, Jacqui			Acquired brain injury self-management programme: A pilot study	BRAIN INJURY			English	Article						Mild traumatic brain injury; concussion; rehabilitation; self-efficacy; occupational performance	OCCUPATIONAL PERFORMANCE-MEASURE; COGNITIVE-BEHAVIORAL THERAPY; CHRONIC DISEASE; REHABILITATION; OUTCOMES; EDUCATION; SYMPTOMS; ILLNESS; ADULTS; CARE	Primary objective: Traditional rehabilitation is not well suited to individuals with chronic mild symptoms following an acquired brain injury. To address this, this study adapted a supported self-management programme (SMP) for this population. The aim of this study was to evaluate the potential effectiveness of this novel SMP. Research design: Retrospective case series with repeated measures. Methods and procedures: Fifty-three participants with chronic mild symptoms following an acquired brain injury (primarily mild traumatic brain injury) completed an SMP. The intervention involved eight coaching sessions with each an occupational therapist and psychologist, carried out in the community and based on SMP principles. The Canadian Occupational Performance Measure was administered at baseline, discharge and 3- and 9-month follow-up. This measure yielded scores for performance and satisfaction with daily functioning, covering the domains of self-care, productivity and leisure. Main outcomes and results: A complete case analysis of programme completers revealed that participants' ratings of their occupational performance and satisfaction improved markedly between baseline and discharge from the SMP. This set of outcome measures remained stable between discharge and the two follow-up points. Conclusions: This pilot study suggests that SMPs may improve daily functioning in individuals with chronic mild ABI symptoms. More methodologically robust clinical trials are warranted.	[Barlow, Susan] GF Strong Rehabil Ctr, Vancouver, BC V5Z 2G9, Canada; [Kendrick, Denise] Vancouver Gen Hosp, Vancouver, BC, Canada; [Silverberg, Noah D.] Univ British Columbia, Fac Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Moffat, Jacqui] Ridge Meadows Child Dev Ctr, Vancouver, BC, Canada	Barlow, S (corresponding author), GF Strong Rehabil Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	susan.barlow@vch.ca	Miller, William/S-7407-2019	Kendrick, Denise/0000-0003-3603-6542			Bandura A., 1986, SOCIAL FDN THOUGHT A; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodiam C., 1999, BR J OCCUP THER, V62, P123, DOI DOI 10.1177/030802269906200310; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cadilhac DA, 2011, STROKE, V42, P1673, DOI 10.1161/STROKEAHA.110.601997; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dedding C, 2004, CLIN REHABIL, V18, P660, DOI 10.1191/0269215504cr746oa; Dixon G, 2007, CLIN REHABIL, V21, P230, DOI 10.1177/0269215506071784; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Law M, 1990, Can J Occup Ther, V57, P82; Law M, 1994, Can J Occup Ther, V61, P191; Law M, 1998, CANADIAN OCCUPATIONA; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; McColl M A, 2000, Can J Occup Ther, V67, P22; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Muenchberger H, 2011, BRAIN INJURY, V25, P23, DOI 10.3109/02699052.2010.531689; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; Nolte S, 2007, PATIENT EDUC COUNS, V65, P351, DOI 10.1016/j.pec.2006.08.016; Phipps S, 2007, AM J OCCUP THER, V61, P328, DOI 10.5014/ajot.61.3.328; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Wressle E, 2002, J REHABIL MED, V34, P5, DOI 10.1080/165019702317242640	33	11	11	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1243	1249		10.3109/02699052.2012.672787			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600009	22658076				2021-06-18	
J	Li, YL; Li, LT; Yu, M; Wang, YZ; Ge, HY; Song, CQ				Li, Y. L.; Li, L. T.; Yu, M.; Wang, Y. Z.; Ge, H. Y.; Song, C. Q.			Beneficial Effects of the Herbal Medicine Di Huang Yin Zi in Patients with Spinal Cord Injury: a Randomized, Placebo-controlled Clinical Study	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Dr HUANG YIN ZI (DHYZ); CHINESE MEDICINE; COMPLEMENTARY MEDICINE; ALTERNATIVE MEDICINE; SPINAL CORD INJURY; FUNCTIONAL RECOVERY	GLYCYRRHIZAE-RADIX EXTRACT; NEUROLOGICAL FUNCTION; TIRILAZAD MESYLATE; GINSENG-RADIX; NITRIC-OXIDE; METHYLPREDNISOLONE; ANTIOXIDANT; APOPTOSIS; BRAIN; NALOXONE	OBJECTIVE: This study investigated the safety and therapeutic efficacy of Di Huang Yin Zi (DHYZ), a traditional Chinese decoction used to treat neurological disorders, in spinal cord injury (SCI). METHODS: In this double-blind, placebo-controlled study, patients with traumatic SCI and American Spinal Injury Association (ASIA) impairment grades B - D were randomized to receive DHYZ (n = 30) or placebo (n = 30) for 12 weeks. Both groups also received rehabilitation therapy during the study period. Motor and sensory function and activities of daily living (ADL) were assessed before treatment and at 4-week intervals. RESULTS: Significantly more patients in the DHYZ group showed an improved ASIA impairment grade during the treatment period (32.1%) compared with the placebo group (10.3%), and scores for sensory and motor function and ADL at the end of the treatment period were significantly higher in the DHYZ group than in the placebo group. No serious side-effects were reported. CONCLUSIONS: DHYZ was found to improve neurological function in patients with SCI and may be an effective adjuvant therapy to enhance functional recovery.	[Li, Y. L.; Wang, Y. Z.] Shandong Univ, Affiliated Hosp 2, Jinan 250100, Peoples R China; [Li, L. T.; Yu, M.; Song, C. Q.] Shandong Med Coll, Jinan, Peoples R China; [Ge, H. Y.] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Lab Expt Pain Res, Aalborg, Denmark	Li, YL (corresponding author), Shandong Univ, Affiliated Hosp 2, 247 Bei Yuan St, Jinan 250100, Peoples R China.	lyl.pro@163.com			Natural Science Foundation of Shandong Province, People's Republic of ChinaNatural Science Foundation of Shandong Province [30772695]	This study was supported by the Natural Science Foundation of Shandong Province, People's Republic of China (30772695). We thank Dr Shu-hua Wang for the randomization and coding procedures of the two groups. We also thank Dr Qing-Qiang Yu and nurses Xia-Yang and Lin Wang, who were responsible for distributing the medication and recording the times and doses of medication used each day in the study.	Ao Q, 2006, SPINAL CORD, V44, P662, DOI 10.1038/sj.sc.3101900; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Botterell E H, 1975, Can J Neurol Sci, V2, P361; Bracken M B, 1991, J Neurotrauma, V8 Suppl 1, pS47; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.251.1.45; BRACKEN MB, 1985, J NEUROSURG, V63, P704, DOI 10.3171/jns.1985.63.5.0704; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; CHEN HC, 1990, AM J CHINESE MED, V18, P25, DOI 10.1142/S0192415X90000058; Chen HY, 2005, ANN NY ACAD SCI, V1042, P396, DOI 10.1196/annals.1338.062; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dallmeijer AJ, 1999, MED SCI SPORT EXER, V31, P1330, DOI 10.1097/00005768-199909000-00015; DEJONG G, 1984, ARCH PHYS MED REHAB, V65, P66; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; Donovan WH, 1997, SPINAL CORD, V35, P275, DOI 10.1038/sj.sc.3100449; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Harkema SJ, 2001, NEUROSCIENTIST, V7, P455, DOI 10.1177/107385840100700514; Jian ZH, 2001, AM J CHINESE MED, V29, P509, DOI 10.1142/S0192415X01000538; Kim EH, 2003, BIOL PHARM BULL, V26, P1668, DOI 10.1248/bpb.26.1668; Kim SC, 2008, EVID-BASED COMPL ALT, V5, P165, DOI 10.1093/ecam/nem014; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Koo BS, 2004, PHYTOTHER RES, V18, P488, DOI 10.1002/ptr.1457; Kraus J.F., 1996, PRINCIPLES SPINE SUR, P41; KUBO M, 1994, BIOL PHARM BULL, V17, P1282, DOI 10.1248/bpb.17.1282; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li H, 2004, ANAL BIOANAL CHEM, V378, P1801, DOI 10.1007/s00216-004-2509-1; Li TJ, 2007, J PHARMACOL SCI, V105, P34, DOI 10.1254/jphs.FP0070450; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Lin ZH, 2005, J ETHNOPHARMACOL, V97, P477, DOI 10.1016/j.jep.2004.12.001; Nakajima S, 1998, AM J CHINESE MED, V26, P365, DOI 10.1142/S0192415X98000403; Park YH, 2009, PHARMAZIE, V64, P760, DOI 10.1691/ph.2009.9614; Peng QL, 1998, GEN PHARMACOL, V31, P221, DOI 10.1016/S0306-3623(97)00459-X; Peng QL, 1998, AM J CHINESE MED, V26, P291, DOI 10.1142/S0192415X98000336; Seo TB, 2006, ACTA PHARMACOL SIN, V27, P50, DOI 10.1111/j.1745-7254.2006.00252.x; Shimada Y, 2004, PHYTOMEDICINE, V11, P404, DOI 10.1016/j.phymed.2003.04.002; Shin HY, 2009, IMMUNOPHARM IMMUNOT, V31, P370, DOI 10.1080/08923970802698820; Staas W, 1998, REHABILITATION MED P, P1259; *STAT PHARM COMM P, 2000, PHARM PEOPL REP CHIN; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Toda S, 2001, PHYTOTHER RES, V15, P541, DOI 10.1002/ptr.848; Tsai CC, 2003, AM J CHINESE MED, V31, P665, DOI 10.1142/S0192415X03001387; Wong AMK, 2003, AM J PHYS MED REHAB, V82, P21, DOI 10.1097/00002060-200301000-00004; Wong M K, 1981, Taiwan Yi Xue Hui Za Zhi, V80, P433; Wu SJ, 2004, PHYTOTHER RES, V18, P1008, DOI 10.1002/ptr.1617; Xia WJ, 2005, PEDIATR RES, V58, P784, DOI 10.1203/01.PDR.0000180550.99162.BC; Yanaga A, 2006, BIOL PHARM BULL, V29, P2415, DOI 10.1248/bpb.29.2415; Yokozawa T, 2000, PHYTOMEDICINE, V6, P439, DOI 10.1016/S0944-7113(00)80072-0; Yokozawa T, 2000, PHYTOMEDICINE, V6, P453, DOI 10.1016/S0944-7113(00)80074-4; Yu Y, 2008, EXP BRAIN RES, V184, P307, DOI 10.1007/s00221-007-1100-3; Yun YJ, 2007, BIOL PHARM BULL, V30, P337, DOI 10.1248/bpb.30.337; Zhang ZJ, 2007, J PSYCHIATR RES, V41, P360, DOI 10.1016/j.jpsychires.2005.06.002; Zheng SY, 2004, AM J CHINESE MED, V32, P209, DOI 10.1142/S0192415X04001874	59	11	11	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	SEP-OCT	2012	40	5					1715	1724		10.1177/030006051204000510			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	046JV	WOS:000311762200010	23206453	DOAJ Gold			2021-06-18	
J	Mehan, ND; Strauss, KI				Mehan, Neal D.; Strauss, Kenneth I.			Combined age- and trauma-related proteomic changes in rat neocortex: a basis for brain vulnerability	NEUROBIOLOGY OF AGING			English	Article						Age; Geriatric brain injury; Adult brain injury; Pediatric brain injury; Proteomics	RESPONSE MEDIATOR PROTEIN-2; HEAT-SHOCK-PROTEIN; DIHYDROPYRIMIDINASE-RELATED PROTEIN-2; CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE BRAIN; CAT VISUAL-CORTEX; APOLIPOPROTEIN-E; NERVOUS-SYSTEM; C-FOS; MITOCHONDRIAL DYSFUNCTION	This proteomic study investigates the widely observed clinical phenomenon, that after comparable brain injuries, geriatric patients fare worse and recover less cognitive and neurologic function than younger victims. Utilizing a rat traumatic brain injury model, sham surgery or a neocortical contusion was induced in 3 age groups. Geriatric (21 months) rats performed worse on behavioral measures than young adults (12-16 weeks) and juveniles (5-6 weeks). Motor coordination and certain cognitive deficits showed age-dependence both before and after injury. Brain proteins were analyzed using silver-stained two-dimensional electrophoresis gels. Spot volume changes (>2-fold change, p<0.01) were identified between age and injury groups using computer-assisted densitometry. Sequences were determined by mass spectrometry of tryptic peptides. The 19 spots identified represented 13 different genes that fell into 4 general age-and injury-dependent expression patterns. Fifteen isoforms changed differentially with respect to both age and injury (p<0.05). Further investigations into the nature and function of these isoforms may yield insights into the vulnerability of older patients and resilience of younger patients in recovery after brain injuries. (C) 2012 Elsevier Inc. All rights reserved.	[Mehan, Neal D.; Strauss, Kenneth I.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA	Strauss, KI (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA.	kenneth.strauss@hc.msu.edu			Greater Cincinnati Foundation; Elizabeth P. Lips Memorial Award; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS054890, R01-NS038654]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038654, R01NS054890] Funding Source: NIH RePORTER	This work was supported in part by the Greater Cincinnati Foundation, Elizabeth P. Lips Memorial Award and NINDS R01-NS054890, NINDS R01-NS038654. The authors wish to acknowledge the excellent technical assistance of Michael Wyder, Shawn Lewis, Aixiang Xue, Raquel Moore, Mingfu Zhou, Jason Dudley and Nathan Kuhn. Thanks also to Detlef Schumann and Kenneth Greis for valuable discussions on experimental design, and to Jack Lipton for suggestions on the manuscript.	Allen GV, 2001, NEUROSCIENCE, V102, P603, DOI 10.1016/S0306-4522(00)00519-4; Alvarez-Dolado M, 1999, J NEUROCHEM, V73, P2240, DOI 10.1046/j.1471-4159.1999.0732240.x; Arnaud P, 2002, DIABETES-METAB RES, V18, P311, DOI 10.1002/dmrr.315; BLUMENFELD KS, 1992, J CEREBR BLOOD F MET, V12, P987, DOI 10.1038/jcbfm.1992.136; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brown I R, 1991, Results Probl Cell Differ, V17, P217; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; BROWN WM, 1992, CELL, V68, P7, DOI 10.1016/0092-8674(92)90200-V; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Carrette O, 2006, J CHROMATOGR B, V840, P1, DOI 10.1016/j.jchromb.2006.05.019; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; Cnops L, 2004, EUR J NEUROSCI, V19, P2345, DOI 10.1111/j.0953-816X.2004.03330.x; Cnops L, 2006, BRAIN RES, V1088, P109, DOI 10.1016/j.brainres.2006.03.028; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Eismann T, 2009, AM J PHYSIOL-GASTR L, V296, pG266, DOI 10.1152/ajpgi.90583.2008; Elwan O, 2003, J NEUROL SCI, V211, P15, DOI 10.1016/S0022-510X(03)00032-7; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Fountoulakis M, 2000, ELECTROPHORESIS, V21, P673, DOI 10.1002/(SICI)1522-2683(20000201)21:3<673::AID-ELPS673>3.0.CO;2-Y; Fujisawa H, 2008, PROTEOMICS, V8, P1706, DOI 10.1002/pmic.200700928; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; FURUTOKATO S, 1985, J BIOL CHEM, V260, P2054; Gemma C, 2007, REV NEUROSCIENCE, V18, P137; Gennaro G, 2003, CIRCULATION, V107, P230, DOI 10.1161/01.CIR.0000050652.47145.4C; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; GOLDMAN H, 1992, NEUROBIOL AGING, V13, P57, DOI 10.1016/0197-4580(92)90009-M; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Greenbaum L M, 1992, Agents Actions Suppl, V36, P215; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hattori N, 2003, J NUCL MED, V44, P1709; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Horvath AJ, 2004, J MOL EVOL, V59, P488, DOI 10.1007/s00239-004-2640-9; Iwazaki T, 2007, PROTEOMICS, V7, P1131, DOI 10.1002/pmic.200600595; KAGEYAMA R, 1985, J BIOL CHEM, V260, P2060; Kalabay L, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-15; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; KNOX CA, 1980, ACTA NEUROPATHOL, V51, P1, DOI 10.1007/BF00688844; Krueger-Naug A M R, 2002, Prog Mol Subcell Biol, V28, P235; Kuhla B, 2007, PROTEOMICS, V7, P3602, DOI 10.1002/pmic.200700248; Lanterna LAL, 2009, J STROKE CEREBROVASC, V18, P116, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.006; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Lin YL, 2008, BIOCHEM BIOPH RES CO, V369, P747, DOI 10.1016/j.bbrc.2008.02.095; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Masseguin C, 2005, NEUROBIOL AGING, V26, P917, DOI 10.1016/j.neurobiolaging.2004.07.013; MAYHAN WG, 1990, AM J PHYSIOL, V258, pH1735; Mayhan WG, 2001, MICROCIRCULATION, V8, P89, DOI 10.1038/sj.mn.7300154; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Molvarec A, 2009, HYPERTENS RES, V32, P665, DOI 10.1038/hr.2009.79; Monaco C, 1997, GENOMICS, V46, P217, DOI 10.1006/geno.1997.5036; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Ni MH, 2008, J CELL BIOCHEM, V103, P1833, DOI 10.1002/jcb.21575; OHKUBO K, 1991, J BIOCHEM-TOKYO, V109, P243; PAGES G, 1990, EUR J BIOCHEM, V190, P385, DOI 10.1111/j.1432-1033.1990.tb15587.x; Peeters RP, 2008, HORM-INT J ENDOCRINO, V7, P28, DOI 10.14310/horm.2002.1111035; Peila R, 2006, ACTA NEUROL SCAND, V114, P102, DOI 10.1111/j.1600-0404.2006.00693.x; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peters T., 1995, ALL ALBUMIN BIOCH GE, DOI 10.1016/B978-012552110-9/50008-8http://www.sciencedirect.com/science/article/pii/B9780125521109500088.; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Plumier JCL, 1997, J COMP NEUROL, V384, P409; Pola R, 2004, NEUROBIOL AGING, V25, P1361, DOI 10.1016/j.neurobiolaging.2004.02.028; Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006; Poon HF, 2004, NEUROSCIENCE, V126, P915, DOI 10.1016/j.neuroscience.2004.04.046; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI [10.1089/neu.2008.0769, 10.1089/neu.2008-0769]; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Putman CWMM, 1997, NEUROPEDIATRICS, V28, P106, DOI 10.1055/s-2007-973681; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; SANKAR R, 1983, NEUROBIOL AGING, V4, P65, DOI 10.1016/0197-4580(83)90056-8; Sironi L, 2001, STROKE, V32, P753, DOI 10.1161/01.STR.32.3.753; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith RG, 2005, ENDOCR REV, V26, P203, DOI 10.1210/er.2002-0017; Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021; Sun XC, 2008, CHIN J TRAUMATOL, V11, P247, DOI 10.1016/S1008-1275(08)60051-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Swift ME, 1999, LAB INVEST, V79, P1479; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Vaishnav RA, 2007, J NEUROSCI RES, V85, P373, DOI 10.1002/jnr.21130; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Vuaillat C, 2008, J NEUROIMMUNOL, V193, P38, DOI 10.1016/j.jneuroim.2007.09.033; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P95; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshida K, 1999, BIOL CHEM, V380, P95, DOI 10.1515/BC.1999.013; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhao XZ, 2006, INT J NEUROPSYCHOPH, V9, P705, DOI 10.1017/S1461145705006267	109	11	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	SEP	2012	33	9					1857	1873		10.1016/j.neurobiolaging.2011.09.029			17	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	981TW	WOS:000306994600001	22088680	Green Accepted			2021-06-18	
J	Meunier, JM; Chang, WTW; Bluett, B; Wenker, E; Lindsell, CJ; Shaw, GJ				Meunier, Jason M.; Chang, Wan-Tsu W.; Bluett, Brent; Wenker, Evan; Lindsell, Christopher J.; Shaw, George J.			Temperature Affects Thrombolytic Efficacy Using rt-PA and Eptifibatide, an In Vitro Study	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN-ACTIVATOR; ULTRASOUND ENHANCED THROMBOLYSIS; TRAUMATIC BRAIN-INJURY; MILD HYPOTHERMIA; CLOT DISSOLUTION; SHORT-TERM; DEPENDENCE; THERAPY; LYSIS	The potential for hypothermia as a neuroprotectant during stroke has led to its increase in clinical use. At the same time, combination pharmaceutical therapies for ischemic stroke using recombinant tissue plasminogen activator (rt-PA), and GP IIb-IIIa inhibitors, such as Eptifibatide (Epf ), are under study. However, there is little data on how the reactions triggered by these agents are impacted by temperature. Here, clot lysis during exposure to the combination of rt-PA and Epf is measured in an in vitro human clot model at hypothermic temperatures. The hypothesis is that lytic efficacy of rt-PA and Epf decreases with decreasing temperature. Whole blood clots from 31 volunteers were exposed to rt-PA (0.5 mu g/mL) and Epf (0.63 mu g/mL) in human fresh-frozen plasma (rt-PA+Epf ), rt-PA alone in plasma (rt-PA Alone), or to plasma alone (Control), at temperatures from 30 degrees C to 37 degrees C, for 30 minutes. Clot lysis was measured using a microscopic imaging technique; the mean fractional clot loss (FCL) at 30 minutes was used to determine lytic efficacy. Temperature had a significant impact on FCL in clots exposed to rt-PA+Epf, with the FCL being lower at 30 degrees C to 36 degrees C than at 37 degrees C. The FCL remained significantly higher for rt-PA+Epf-treated clots than Controls regardless of temperature, with the exception of measurements made at 30 degrees C when no significant differences in the FCL were observed between groups. The use of hypothermia as a neuroprotectant may negatively impact the therapeutic benefit of thrombolytic agents.	[Meunier, Jason M.; Chang, Wan-Tsu W.; Wenker, Evan; Lindsell, Christopher J.; Shaw, George J.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Bluett, Brent] Univ Texas Southwestern Austin, Austin, TX USA	Meunier, JM (corresponding author), Univ Cincinnati, Dept Emergency Med, ML 0769, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	meuniejn@ucmail.uc.edu		Lindsell, Christopher/0000-0002-3297-2811	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K02-NS056253, 3P50-NS044283-06S1]	This work was supported by NIH/NINDS through K02-NS056253 and 3P50-NS044283-06S1. The authors gratefully acknowledge useful conversations with Dr. Arthur Pancioli, Dr. Opeolu Adeoye, and Dr. William Knight of The Department of Emergency Medicine at The University of Cincinnati.	Abdullah JM, 2011, ACTA NEUROCHIR SUPPL, V111, P421, DOI 10.1007/978-3-7091-0693-8_72; Adams HP, 2008, STROKE, V39, P87, DOI 10.1161/STROKEAHA.106.476648; Adams HP, 1996, STROKE, V27, P1711; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Atar S, 2001, J THROMB THROMBOLYS, V11, P223, DOI 10.1023/A:1011912920777; Brekenfeld C, 2005, NEUROL RES, V27, pS29, DOI 10.1179/016164105X35549; Cannon CP, 2006, AM J CARDIOL, V98, p10Q, DOI 10.1016/j.amjcard.2006.09.026; Cheng J, 2005, ACOUST RES LETT ONL, V6, P25, DOI 10.1121/1.1815039; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cohen JE, 2012, J CLIN NEUROSCI, V19, P39, DOI 10.1016/j.jocn.2011.06.015; Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095; Connors John J 3rd, 2002, Rev Cardiovasc Med, V3 Suppl 2, pS92; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Di Lazzaro V, 2012, NEUROL SCI, V33, P661, DOI 10.1007/s10072-011-0824-9; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Donnan GA, 2011, NAT REV NEUROL, V7, P400, DOI 10.1038/nrneurol.2011.89; FRANCIS CW, 1995, THROMB HAEMOSTASIS, V73, P386; Granberg P O, 1991, Arctic Med Res, V50 Suppl 6, P23; Groysman LI, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.4.FOCUS1154; Hankey GJ, 2003, MED J AUSTRALIA, V178, P568, DOI 10.5694/j.1326-5377.2003.tb05361.x; Hardig BM, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-19; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Hitchcock KE, 2011, ULTRASOUND MED BIOL, V37, P1240, DOI 10.1016/j.ultrasmedbio.2011.05.011; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; JAFFE GJ, 1989, AM J OPHTHALMOL, V108, P90, DOI 10.1016/S0002-9394(14)73272-6; Jahan Reza, 2009, Expert Rev Cardiovasc Ther, V7, P375, DOI 10.1586/erc.09.13; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kollmar R, 2007, STROKE, V38, P1585, DOI 10.1161/STROKEAHA.106.475897; Lebiedz P, 2012, RESUSCITATION, V83, P602, DOI 10.1016/j.resuscitation.2011.11.016; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; LOREN M, 1989, THROMB RES, V56, P67, DOI 10.1016/0049-3848(89)90009-1; Maas A, 2011, LANCET NEUROL, V10, P111, DOI 10.1016/S1474-4422(10)70312-4; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; MARINKOVIC SV, 1958, STROKE, V15, P1022; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martin-Schild S, 2009, J STROKE CEREBROVASC, V18, P86, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.015; MEDEN P, 1994, ACTA NEUROL SCAND, V90, P91; Meunier JM, 2007, ULTRASOUND MED BIOL, V33, P576, DOI 10.1016/j.ultrasmedbio.2006.10.010; Meunier JM, 2011, CURR NEUROVASC RES, V8, P305; Meunier JM, 2009, THROMB RES, V123, P528, DOI 10.1016/j.thromres.2008.05.011; Nedelmann M, 2005, CEREBROVASC DIS, V20, P18, DOI 10.1159/000086122; Nielsen VG, 2011, BLOOD COAGUL FIBRIN, V22, P67, DOI 10.1097/MBC.0b013e3283423534; Pancioli AM, 2008, STROKE, V39, P3268, DOI 10.1161/STROKEAHA.108.517656; Patel SC, 1999, PROG CARDIOVASC DIS, V42, P217, DOI 10.1016/S0033-0620(99)70004-6; Polak JF, 2004, NEW ENGL J MED, V351, P2154, DOI 10.1056/NEJMp048249; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qureshi AI, 2006, NEUROSURGERY, V59, P789, DOI 10.1227/01.NEU.0000232862.06246.3D; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Shaw GJ, 2008, ULTRASOUND MED BIOL, V34, P1783, DOI 10.1016/j.ultrasmedbio.2008.03.020; Shaw GJ, 2007, PHYS MED BIOL, V52, P2953, DOI 10.1088/0031-9155/52/11/002; Shaw GJ, 2010, THROMB RES, V126, pE305, DOI 10.1016/j.thromres.2010.07.020; Shaw George J, 2009, BMC Res Notes, V2, P117, DOI 10.1186/1756-0500-2-117; Shaw GJ, 2006, THROMB RES, V117, P603, DOI 10.1016/j.thromres.2005.05.005; Takeuchi S, 2011, LANCET NEUROL, V10, P404, DOI 10.1016/S1474-4422(11)70083-7; Tanne D, 1999, NEUROLOGY, V53, P424, DOI 10.1212/WNL.53.2.424; Tao X, 2006, SURG NEUROL, V65, P155, DOI 10.1016/j.surneu.2005.05.027; van der Pals J, 2011, J THROMB THROMBOLYS, V32, P72, DOI 10.1007/s11239-010-0541-x; Winter Patrick M, 2005, Acad Radiol, V12 Suppl 1, pS9, DOI 10.1016/j.acra.2005.02.016; WONG KC, 1983, WESTERN J MED, V138, P227; YENARI MA, 1995, THROMB RES, V77, P475, DOI 10.1016/0049-3848(95)93883-2; Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P; Zgavc T, 2011, STROKE RES TREATMENT, V2011, P1; Zhao H, 2011, STROKE RES TREATMENT, V2011, P1; Zygun D, 2007, J CRIT CARE, V22, P235, DOI 10.1016/j.jcrc.2006.10.037	64	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	SEP 1	2012	2	3					112	118		10.1089/ther.2012.0007			7	Critical Care Medicine	General & Internal Medicine	V38PH	WOS:000209354800004	23667777	Green Published			2021-06-18	
J	Olivecrona, M; Koskinen, LOD				Olivecrona, Magnus; Koskinen, Lars-Owe D.			The IMPACT prognosis calculator used in patients with severe traumatic brain injury treated with an ICP-targeted therapy	ACTA NEUROCHIRURGICA			English	Article						Prognosis; Severe traumatic brain injury; ICP-targeted therapy; IMPACT	SEVERE HEAD-INJURY; GLASGOW OUTCOME SCALE; ADMISSION CHARACTERISTICS; MULTICENTER TRIAL; VALIDATION; EFFICACY; DESIGN	The prognosis of severe traumatic brain injury (sTBI) is important. The International Mission on Prognosis in Traumatic Brain Injury (IMPACT) study group has developed a prediction calculator for the outcome of patients with sTBI, and this has been made available on the World Wide Web. We have studied the use of the IMPACT calculator on sTBI patients treated with an ICP-targeted therapy based on the Lund concept. The individual clinical data of patients in a prospective sTBI protocol-driven trial of the treatment of sTBI using the Lund concept were entered into the prognosis calculator, and the individual prognosis for each patient was calculated and compared with the actual outcome at 6 months. The use of the IMPACT calculator led to an overestimation of mortality and of an unfavourable outcome. Compared with the IMPACT database, the absolute risk reduction (ARR) for mortality was 13.6 %. There is a statistically significant probability for the prediction of mortality and unfavourable outcome. A ROC curve analysis shows an area under the curve (AUC) in the Core model for mortality of 0.744 and of unfavourable outcome of 0.731, in the Extended model of 0.751 and 0.721 respectively, and in the Lab model of 0.779 and 0.810 respectively. The IMPACT prognosis calculator should be used with caution for the prediction of outcome for an individual patient with sTBI treated with an ICP-targeted therapy based on the Lund concept. We conclude that we have to initiate treatment in all patients with blunt sTBI and an initial ICP > 10 mmHg. It seems that the outcome in sTBI patients treated in this fashion is better than would have been expected from the IMPACT prognosis.	[Olivecrona, Magnus] Umea Univ, Dept Neurosurg, SE-90185 Umea, Sweden; [Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden	Olivecrona, M (corresponding author), Umea Univ, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@neuro.umu.se; lars-owe.koskinen@neuro.umu.se	Koskinen, Lars-Owe/AAQ-8957-2020	Koskinen, Lars-Owe/0000-0003-3528-8502	Foundation for Clinical Neurosciences at Umea University; Umea University Hospital; Tore Nilsson Foundation; Kempe Foundation; Capio Research Foundation	This study was financially supported by the Foundation for Clinical Neurosciences at Umea University, Umea University Hospital, Tore Nilsson Foundation, the Kempe Foundation, and Capio Research Foundation.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Hippocrates, 1928, SURG FRACTURES JOINT, VIII, P7; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; The European Study Group on Nimodipine in Severe Head Injury, 1994, J NEUROSURG, V80, P797; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	18	11	11	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	SEP	2012	154	9					1567	1573		10.1007/s00701-012-1351-z			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	994UF	WOS:000307957500005	22543506				2021-06-18	
J	Turner, RC; Seminerio, MJ; Naser, ZJ; Ford, JN; Martin, SJ; Matsumoto, RR; Rosen, CL; Huber, JD				Turner, Ryan C.; Seminerio, Michael J.; Naser, Zachary J.; Ford, J. Neal; Martin, Samantha J.; Matsumoto, Rae R.; Rosen, Charles L.; Huber, Jason D.			Effects of aging on behavioral assessment performance: implications for clinically relevant models of neurological disease Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						aging; behavior; neurological injury; stroke	TRAUMATIC BRAIN INJURY; RISK-FACTORS; STROKE; MOTOR; RATS; AGE; ISCHEMIA; DEFICITS; RECOMMENDATIONS	Object. Despite the role of aging in development of neurological and neurodegenerative diseases, the effects of age are often disregarded in experimental design of preclinical studies. Functional assessment increases the clinical relevance of animal models of neurological disease and adds value beyond traditional histological measures. However, the relationship between age and functional impairment has not been systematically assessed through a battery of functional tests. Methods. In this study, various sensorimotor and behavioral tests were used to evaluate effects of aging on functional performance in naive animals. Sensorimotor measures included locomotor activity; Rotarod, inclined plane, and grip-strength testing; and modified Neurological Severity Score. The Morris water maze was used to examine differences in learning and memory, and the elevated plus maze and forced swim test were used to assess anxiety-like and depressive-like behaviors, respectively. Results. Older Sprague-Dawley rats (18-20 months) were found to perform significantly worse on the inclined plane tests, and they exhibited alterations in elevated-plus maze and forced swim test compared with young adult rats (3-4 months). Specifically, older rats exhibited reduced exploration of open arms in elevated plus maze and higher immobility time in forced swim test. Spatial acquisition and reference memory were diminished in older rats compared with those in young adult rats. Conclusions. This study demonstrates clear differences between naive young adult and older animals, which may have implications in functional assessment for preclinical models of neurological disease. (http://thejns.org/doi/abs/10.3171/2012.5.JNS112224)	[Rosen, Charles L.] W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Turner, Ryan C.; Seminerio, Michael J.; Matsumoto, Rae R.; Rosen, Charles L.; Huber, Jason D.] W Virginia Univ, Ctr Neurosci, Sch Med, Morgantown, WV 26506 USA; [Seminerio, Michael J.; Ford, J. Neal; Martin, Samantha J.; Matsumoto, Rae R.; Huber, Jason D.] W Virginia Univ, Dept Basic Pharmaceut Sci, Sch Med, Morgantown, WV 26506 USA	Rosen, CL (corresponding author), W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, 1 Med Ctr Dr,POB 9183, Morgantown, WV 26506 USA.	crosen@hsc.wvu.edu		Turner, Ryan/0000-0001-5523-0645	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01-NS061954, 5T32GM08174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [S06GM008174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061954] Funding Source: NIH RePORTER	This work would not have been possible without NIH support provided to J.D.H. (NIH Grant No. 5R01-NS061954), and R.C.T. and M.J.S. (NIH Grant No. 5T32GM08174).	[Anonymous], 1999, STROKE, V30, P2752; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Cenci MA, 2002, NAT REV NEUROSCI, V3, P574, DOI 10.1038/nrn877; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hunter AJ, 1998, TRENDS PHARMACOL SCI, V19, P59, DOI 10.1016/S0165-6147(97)01157-7; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Mehan N. D., 2011, NEUROBIOL AGING; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Pan WH, 2006, EXP NEUROL, V198, P222, DOI 10.1016/j.expneurol.2005.11.020; PITSIKAS N, 1990, NEUROBIOL AGING, V11, P417, DOI 10.1016/0197-4580(90)90008-N; Popa-Wagner A, 2009, ROM J MORPHOL EMBRYO, V50, P155; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Porsolt R. D., 2001, CURR PROTOC NEUROSCI, V14, p10A1; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rosen CL, 2005, J NEUROSURG, V103, P687, DOI 10.3171/jns.2005.103.4.0687; Sacco RL, 1997, NEUROLOGY, V49, pS39, DOI 10.1212/WNL.49.5_Suppl_4.S39; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Watanabe T, 2004, J CEREBR BLOOD F MET, V24, P1205, DOI 10.1097/01.WCB.0000136525.75839.41	24	11	12	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2012	117	3					629	637		10.3171/2012.5.JNS112224			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	990JP	WOS:000307627100032	22746378				2021-06-18	
J	Green, SE; Bosch, M; McKenzie, JE; O'Connor, DA; Tavender, EJ; Bragge, P; Chau, M; Pitt, V; Rosenfeld, JV; Gruen, RL				Green, Sally E.; Bosch, Marije; McKenzie, Joanne E.; O'Connor, Denise A.; Tavender, Emma J.; Bragge, Peter; Chau, Marisa; Pitt, Veronica; Rosenfeld, Jeffrey V.; Gruen, Russell L.			Improving the care of people with traumatic brain injury through the Neurotrauma Evidence Translation (NET) program: protocol for a program of research	IMPLEMENTATION SCIENCE			English	Article						Knowledge translation research; Study protocol; Neurotrauma; Traumatic brain injury	QUALITY IMPROVEMENT INTERVENTIONS; RANDOMIZED CONTROLLED-TRIAL; LOW-BACK-PAIN; HEALTH-CARE; HEAD-INJURIES; UNITED-STATES; MANAGEMENT; GUIDELINE; BEHAVIOR; REHABILITATION	The Neurotrauma Evidence Translation (NET) program was funded in 2009 to increase the uptake of research evidence in the clinical care of patients who have sustained traumatic brain injury. This paper reports the rationale and plan for this five-year knowledge translation research program. The overarching aims of the program are threefold: to improve outcomes for people with traumatic brain injury; to create a network of neurotrauma clinicians and researchers with expertise in knowledge translation and evidence-based practice; and to contribute knowledge to the field of knowledge translation research. The program comprises a series of interlinked projects spanning varying clinical environments and disciplines relevant to neurotrauma, anchored within four themes representing core knowledge translation activities: reviewing research evidence; understanding practice; developing and testing interventions for practice change; and building capacity for knowledge translation in neurotrauma. The program uses a range of different methods and study designs, including: an evidence fellowship program; conduct of and training in systematic reviews; mixed method study designs to describe and understand factors that influence current practices (e. g., semi-structured interviews and surveys); theory-based methods to develop targeted interventions aiming to change practice; a cluster randomised trial to test the effectiveness of a targeted theory-informed intervention; stakeholder involvement activities; and knowledge translation events such as consensus conferences.	[Green, Sally E.; McKenzie, Joanne E.; O'Connor, Denise A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Bosch, Marije; Tavender, Emma J.; Bragge, Peter; Chau, Marisa; Pitt, Veronica] Monash Univ, Natl Trauma Res Inst, Dept Surg, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst,Dept Neurosurg, Dept Surg, Melbourne, Vic 3181, Australia; [Gruen, Russell L.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst,Dept Trauma, Dept Surg, Melbourne, Vic 3181, Australia	Green, SE (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia.	sally.green@monash.edu	McKenzie, Joanne E/I-2925-2014; O'Connor, Denise/ABC-6655-2020; Rosenfeld, Jeffrey V/B-7249-2011	McKenzie, Joanne E/0000-0003-3534-1641; O'Connor, Denise/0000-0002-6836-122X; Tavender, Emma/0000-0002-7230-712X; Bragge, Peter/0000-0003-0745-5131; Green, Sally Elizabeth/0000-0002-9564-9050	Victorian Transport Accident Commission, Australia	This protocol is based on the grant titled 'Improving evidence-based care and the outcomes of patients with traumatic brain injury and spinal cord injury through a program to facilitate knowledge transfer and exchange.' This study was funded by the Victorian Transport Accident Commission, Australia. We thank Ms Kate Phillips and the wider investigator team: Dr Mark Bayley; Dr Heather Buchan; Professor Peter Cameron; Professor Jamie Cooper; Dr David Cooksley; Professor Niki Ellis; Associate Professor Mark Fitzgerald; Professor Jill Francis; Professor Jeremy Grimshaw; Dr Sophie Hill; Ms Sue Huckson; Dr Tony Joseph; Dr Fary Khan; Dr Jonathan Knott; Professor John Lavis; Associate Professor Shawn Marshall; Professor Susan Michie; Associate Professor Peter Morley; Dr Andrew Pearce; Professor Jennie Ponsford; Mr Nick Rushworth; Dr Elisabeth (Lisa) Sherry.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; [Anonymous], 1999, JAMA, V282, P974; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bellner J, 1999, ACTA NEUROL SCAND, V100, P355; Bosch M, 2007, J EVAL CLIN PRACT, V13, P161, DOI 10.1111/j.1365-2753.2006.00660.x; Bosch M, 2013, J EVAL CLIN PRACT, V19, P763, DOI 10.1111/j.1365-2753.2012.01835.x; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Bruns JJ, 2009, MT SINAI J MED, V76, P129, DOI 10.1002/msj.20101; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chau M, 2011, COCHRANE DATABASE S3; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Foy R, 2011, BMJ QUAL SAF, V20, P453, DOI 10.1136/bmjqs.2010.047993; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gauden AJ, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009661, DOI 10.1002/14651858.CD009661]; Glaser B. G., 1967, DISCOVERY GROUNDED T; Glynn RJ, 2007, MED CARE, V45, pS38, DOI 10.1097/MLR.0b013e318070c0a0; Graham Ian D, 2007, Healthc Q, V10, P20; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grimshaw JM, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-38; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Gururaj G, 2005, NATL I MENTAL HLTH N, P61; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kitson A, 2010, CAN MED ASSOC J, V182, pE73, DOI 10.1503/cmaj.081231; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall MN, 2003, QUAL SAF HEALTH CARE, V12, P8, DOI 10.1136/qhc.12.1.8; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; McKenzie JE, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-86; McKenzie JE, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-11; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Miller L, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-7; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; O'Callaghan AM, 2009, AUST J RURAL HEALTH, V17, P119, DOI 10.1111/j.1440-1584.2009.01054.x; O'Connor CM, 2011, J AM COLL CARDIOL, V58, P915, DOI 10.1016/j.jacc.2011.03.057; Phillips K, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008929, DOI 10.1002/14651858.CD008929]; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Potter C, 2004, HEALTH POLICY PLANN, V19, P336, DOI 10.1093/heapol/czh038; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Short J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-37; Shortell SM, 2008, JAMA-J AM MED ASSOC, V299, P445, DOI 10.1001/jama.299.4.445; Shravat BP, 2006, EMERG MED J, V23, P109, DOI 10.1136/emj.2004.022327; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Sitzia John, 2002, Intensive Crit Care Nurs, V18, P230, DOI 10.1016/S0964339702000125; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Straus SE, 2009, KNOWLEDGE TRANSLATIO; Straus SE, 2009, CAN MED ASSOC J, V181, P165, DOI 10.1503/cmaj.081229; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Trevena L, 2011, AUST FAM PHYSICIAN, V40, P956; Walker AE, 2000, J EVAL CLIN PRACT, V6, P185, DOI 10.1046/j.1365-2753.2000.00235.x; Wensing M, 2010, CAN MED ASSOC J, V182, pE85, DOI 10.1503/cmaj.081233; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	61	11	11	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	AUG 7	2012	7								74	10.1186/1748-5908-7-74			7	Health Care Sciences & Services; Health Policy & Services	Health Care Sciences & Services	104AL	WOS:000315961200001	22866892	DOAJ Gold, Green Published			2021-06-18	
J	Godoy, DA; Rabinstein, AA; Biestro, A; Ainslie, PN; Di Napoli, M				Godoy, Daniel A.; Rabinstein, Alejandro A.; Biestro, Alberto; Ainslie, Philip N.; Di Napoli, Mario			Effects of Indomethacin Test on Intracranial Pressure and Cerebral Hemodynamics in Patients With Refractory Intracranial Hypertension: A Feasibility Study	NEUROSURGERY			English	Article						Cerebral perfusion pressure; Indomethacin; Intracerebral hemorrhage; Intracranial hypertension; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; BLOOD-FLOW-VELOCITY; HEAD-INJURY; ACUTE MANAGEMENT; METABOLISM; PERFUSION; OXYGEN; HYPERVENTILATION; CYCLOOXYGENASE; EXTRACTION	BACKGROUND: Intracranial hypertension is the final pathway of many neurocritical entities, such as spontaneous intracerebral hemorrhage (sICH) and severe traumatic brain injury (sTBI). OBJECTIVE: This study aimed to (1) determine alterations in intracranial pressure (ICP) and cerebral hemodynamics after an indomethacin (INDO) infusion test and the related association with survival in patients with refractory intracranial hypertension (RICH) secondary to sICH or sTBI and (2) assess the safety profile after INDO. METHODS: INDO was administered in a loading dose (0.8 mg/kg/15 min), followed by a 2-hour continuous infusion (0.5 mg/kg/h) in RICH patients with ICP greater than 20 mm Hg who did not respond to first-line therapies. Changes in ICP, cerebral perfusion pressure (CPP), and cerebrovascular variables (assessed by transcranial Doppler and jugular bulb saturation) were observed. Clinical outcome was assessed at 1 and 6 months according to the Glasgow Outcome Scale and correlated with INDO infusion test response. Analysis of INDO safety profile was conducted. RESULTS: Thirteen sICH and 10 sTBI patients were studied. The median GCS score at admission was 6. Within 30 minutes of INDO infusion, ICP decreased (42.0 +/- 13.5 vs 27.70 +/- 12.7mm Hg; Delta%: -48.4%; P < .001), and both CPP (57.7 +/- 4.8 vs 71.9 +/- 7.0 mm Hg; Delta%: +26.0%; P < .001) and middle cerebral artery velocity (35.2 +/- 5.6 vs 42.0 +/- 5.1 cm.s(-1); Delta%: +26.1%; P < .001) increased. The CPP response to a 2-hour INDO infusion test was correlated (R-2 = 0.72, P < .001) with survival. No adverse events were observed after INDO. CONCLUSION: Our findings support the effectiveness and feasibility of an INDO test in decreasing ICP and improving cerebral hemodynamics in surviving RICH patients. Future studies to evaluate different doses, lengths of infusion, and longer term effects are needed.	[Godoy, Daniel A.] Sanatorio Pasteur, Neurocrit Care Unit, Catamarca, Argentina; [Rabinstein, Alejandro A.] Mayo Clin, Neurosci Intens Care Unit, Rochester, MN USA; [Biestro, Alberto] Hosp Clin Montevideo, Intens Treatment Ctr, Montevideo, Uruguay; [Ainslie, Philip N.] Univ British Columbia Okanagan, Fac Hlth & Social Dev, Dept Human Kinet, Kelowna, BC, Canada; [Di Napoli, Mario] San Camillo de Lellis Gen Hosp, Neurol Serv, Rieti, Italy; [Di Napoli, Mario] SMDN Ctr Cardiovasc Med & Cerebrovasc Dis Prevent, Neurol Sect, Laquila, Italy	Godoy, DA (corresponding author), Chacabuco 675, RA-4700 San Fernando Valle Catam, Argentina.	dagodoytorres@yahoo.com.ar; mariodinapoli@katamail.com	Di Napoli, Mario/J-6418-2014	Di Napoli, Mario/0000-0001-9609-4926	Sanatorio Pasteur, Catamarca, Argentina	This work was supported by grants from the Sanatorio Pasteur, Catamarca, Argentina. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess KR, 2010, CHEST, V137, P707, DOI 10.1378/chest.09-1329; Clemmesen JO, 1997, HEPATOLOGY, V26, P1423; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cruz J, 1996, CRIT CARE MED, V24, P953, DOI 10.1097/00003246-199606000-00013; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Dahl B, 1996, ACTA NEUROCHIR, V138, P265, DOI 10.1007/BF01411736; ERIKSSON S, 1983, ACTA PHYSIOL SCAND, V117, P203, DOI 10.1111/j.1748-1716.1983.tb07198.x; Fox JL, 2010, CAN J EMERG MED, V12, P355; Godoy DA, 2005, ACTA ANAESTH SCAND, V49, P1577, DOI 10.1111/j.1399-6576.2005.00885_49_10.x; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Imberti R, 2005, J NEUROSURG, V102, P455, DOI 10.3171/jns.2005.102.3.0455; Jensen K, 1996, J NEUROSURG ANESTH, V8, P111, DOI 10.1097/00008506-199604000-00002; JENSEN K, 1993, ACTA NEUROCHIR, V124, P114, DOI 10.1007/BF01401132; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Marion DW, 2006, NEUROSURGERY, V58, P655; MARKUS HS, 1994, STROKE, V25, P1760, DOI 10.1161/01.STR.25.9.1760; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Minassian AT, 1998, J NEUROSURG, V88, P996, DOI 10.3171/jns.1998.88.6.0996; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PICKARD J, 1980, BRAIN RES, V197, P425, DOI 10.1016/0006-8993(80)91127-0; PICKARD JD, 1977, EUR J PHARMACOL, V43, P343, DOI 10.1016/0014-2999(77)90040-1; Poca MA, 2007, J NEUROSURG, V106, P530, DOI 10.3171/jns.2007.106.4.530; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; QUINTANA A, 1988, EUR J PHARMACOL, V149, P385, DOI 10.1016/0014-2999(88)90674-7; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rasmussen M, 2005, ACTA ANAESTH SCAND, V49, P341, DOI 10.1111/j.1399-6576.2005.00647.x; Rasmussen M, 2004, ANESTHESIOLOGY, V101, P872, DOI 10.1097/00000542-200410000-00011; Rasmussen M, 2004, ANAESTHESIA, V59, P229, DOI 10.1111/j.1365-2044.2004.03604.x; Roberts R G, 2002, Crit Care Resusc, V4, P271; Schumann P, 1996, NEUROSCI LETT, V220, P137, DOI 10.1016/S0304-3940(96)13210-9; Slavik RS, 1999, NEUROL RES, V21, P491; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; TEASDALE G, 1974, LANCET, V2, P81; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; Upton RN, 2008, CLIN EXP PHARMACOL P, V35, P317, DOI 10.1111/j.1440-1681.2007.04818.x; Valadka A B, 2000, Neurosurg Focus, V9, pe3; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; Weigert G, 2008, INVEST OPHTH VIS SCI, V49, P1065, DOI 10.1167/iovs.07-0824; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	54	11	11	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2012	71	2					245	257		10.1227/NEU.0b013e318256b9f5			13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	983HB	WOS:000307109301004	22531711				2021-06-18	
J	Marshall, SA; Riechers, RG				Marshall, Scott A.; Riechers, Ronald G., II			Diagnosis and Management of Moderate and Severe Traumatic Brain Injury Sustained in Combat	MILITARY MEDICINE			English	Article							CEREBRAL PERFUSION-PRESSURE; CLOSED-HEAD INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; HYPOTHERMIA; HERNIATION; THERAPY; CARE; LEVETIRACETAM; PROGESTERONE	Traumatic brain injury exists in a spectrum of severity among wounded personnel. The evaluation and clinical presentation, initial management, and treatment interventions to prevent secondary injury processes for combat-associated moderate and severe traumatic brain injury are reviewed. Promising therapies are discussed, and a current review of the literature is provided.	[Marshall, Scott A.] San Antonio Mil Med Ctr, Dept Neurol, Div Crit Care Med, Ft Sam Houston, TX 78234 USA; [Marshall, Scott A.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Riechers, Ronald G., II] Cleveland VA Med Ctr, Polytrauma Team, Cleveland, OH 44106 USA; [Riechers, Ronald G., II] Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44106 USA	Marshall, SA (corresponding author), San Antonio Mil Med Ctr, Dept Neurol, Div Crit Care Med, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.						Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; American College of Surgeons, 2004, ADV TRAUM LIF SUPP P; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, pS21; Brain Trauma Foundation, 2011, ONL TBI GUID; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Fletcher JJ, 2010, NEUROCRIT CARE, V13, P47, DOI 10.1007/s12028-010-9345-2; Geocadin R., 2004, HDB NEURO CRITICAL C, P73; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Habashi Nader M, 2005, Crit Care Med, V33, pS228, DOI 10.1097/01.CCM.0000155920.11893.37; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Juhasz M, 2010, DIGESTION, V81, P10, DOI 10.1159/000243717; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion D W, 1995, New Horiz, V3, P439; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; Marko NF, 2012, AM J RESP CRIT CARE, V185, P467, DOI 10.1164/rccm.201109-1698ED; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; Mossad EB, 2007, SEMIN CARDIOTHORAC V, V11, P34, DOI 10.1177/1089253206297413; Muehlschlegel S, 2009, ARCH NEUROL-CHICAGO, V66, P670, DOI 10.1001/archneurol.2009.33; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qureshi AI, 2008, NEUROLOGY, V70, P990, DOI 10.1212/01.wnl.0000311290.86780.78; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Ropper AH, 2004, NEUROLOGICAL NEUROSU; Schlifka B, 2010, J TRAUMA, V62, pS103; Schlifka B, 2007, J TRAUMA, V62, pS103, DOI 10.1097/TA.0b013e318065b4e5; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Seinfeld Joshua, 2007, Neurosurgery, V61, pE175; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEASDALE G, 1974, LANCET, V2, P81; Temkin N R, 1995, New Horiz, V3, P518; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Vilela MD, 2008, SURG NEUROL, V69, P293, DOI 10.1016/j.surneu.2007.01.027; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017	71	11	11	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2012	177	8		S	SI		76	85		10.7205/MILMED-D-12-00142			10	Medicine, General & Internal	General & Internal Medicine	V33OB	WOS:000209027000011	22953444	Bronze			2021-06-18	
J	McFadden, KL; Healy, KM; Hoversten, KP; Ito, TA; Hernandez, TD				McFadden, Kristina L.; Healy, Kyle M.; Hoversten, Kate P.; Ito, Tiffany A.; Hernandez, Theresa D.			Efficacy of acupressure for non-pharmacological stress reduction in college students	COMPLEMENTARY THERAPIES IN MEDICINE			English	Article						Placebo-controlled; Randomised; Blinded; Skin conductance; Heart rate variability	HEART-RATE-VARIABILITY; BISPECTRAL INDEX; MENTAL STRESS; HABITUATION; ANXIETY; REACTIVITY; NEUROENDOCRINE; RESPONSES; THERAPY	Objectives: Identifying a non-pharmacological intervention to reduce the stress response could be particularly beneficial to college students, a group prone to considerable stress. Acupressure has shown some efficacy in reducing stress in adults following stroke or traumatic brain injury (TBI), but multiple treatments were required. Results from single treatments in healthy populations have been mixed. Design: The current study used a randomised, placebo-controlled, single-blind design to investigate the use of a single acupressure treatment for stress reduction in healthy college students (n= 109) during a stressor. Interventions: Participants were randomly assigned to one of three single, 40-min interventions: active acupressure, placebo acupressure, or a relaxation CD control. A math task stressor administered before and after the intervention assessed intervention effects on stressor responsivity. Main outcome measures: Stress responses were measured by physiological (heart rate (HR), heart rate variability (HRV), skin conductance response (SCR)) and subjective measures (State Anxiety Inventory, nine-item Psychological Stress Measure) of anxiety and stress. Results: All interventions were associated with the following changes during the post-intervention stressor compared to the pre-intervention stressor: reduced HR (p < 0.001), increased HRV (p < 0.024), reduced SCR (p < 0.001), reduced subjective stress scores (p < 0.001), and increased correct answers (p < 0.001). Although all groups demonstrated stress reduction, there were no significant group differences after a single treatment. Conclusions: All interventions significantly reduced the stress response, although not differently. The lack of active acupressure-associated treatment effects appears to be due to insufficient dosing. (c) 2012 Elsevier Ltd. All rights reserved.	[McFadden, Kristina L.; Healy, Kyle M.; Hoversten, Kate P.; Ito, Tiffany A.; Hernandez, Theresa D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, UCB 345,1905 Colorado Ave, Boulder, CO 80309 USA.	Theresa.Hernandez@colorado.edu	Legget, Kristina/AAU-8563-2020	Legget, Kristina/0000-0002-2948-506X	Graduate School at the University of Colorado	Study funding was made available from the Innovative Grant Program from the Graduate School at the University of Colorado.; With appreciation to Jin Shin (acupressure) practitioner Christine Palafox, B.A., C.M.T., N.C.T.M.B. and to all study participants. We also thank undergraduate research assistants Samantha Kile, B.A. and Amanda Stahl, B.A. for help with data acquisition/entry, undergraduate research assistants D. Frank Distel and Nathan Faes for help with data entry, and James A. Kole, Ph.D. for statistical support. Study funding was made available from the Innovative Grant Program from the Graduate School at the University of Colorado.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Agarwal A, 2005, ANAESTHESIA, V60, P978, DOI 10.1111/j.1365-2044.2005.04332.x; ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Burleson MH, 2003, PSYCHOPHYSIOLOGY, V40, P358, DOI 10.1111/1469-8986.00039; Burmeister A, 1997, JIN SHIN JYUTSU TOUC; CACIOPPO JT, 1995, PSYCHOSOM MED, V57, P154, DOI 10.1097/00006842-199503000-00008; Castro MN, 2008, SCHIZOPHR RES, V99, P294, DOI 10.1016/j.schres.2007.08.025; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; Fassoulaki A, 2003, ANESTH ANALG, V96, P885, DOI 10.1213/01.ANE.0000048713.41657.D3; Fassoulaki A, 2007, ANESTH ANALG, V104, P312, DOI 10.1213/01.ane.0000250911.43942.4e; Felhendler D, 1999, Complement Ther Med, V7, P231, DOI 10.1016/S0965-2299(99)80007-7; Hamer M, 2006, BRAIN BEHAV IMMUN, V20, P456, DOI 10.1016/j.bbi.2006.01.001; Ice GH, 2007, CAM S BIO EVOL ANTHR, V49, P3; Jonsson P, 2010, PSYCHONEUROENDOCRINO, V35, P1397, DOI 10.1016/j.psyneuen.2010.04.003; KELSEY RM, 1993, CARDIOVASCULAR REACTIVITY TO PSYCHOLOGICAL STRESS & DISEASE, P135, DOI 10.1037/10125-006; Kober A, 2003, ANESTHESIOLOGY, V98, P1328, DOI 10.1097/00000542-200306000-00005; Lemyre Louise, 2009, Physiotherapy Theory and Practice, V25, P453, DOI 10.1080/09593980902886321; LYKKEN DT, 1988, PSYCHOPHYSIOLOGY, V25, P4, DOI 10.1111/j.1469-8986.1988.tb00949.x; Vanderlei LCM, 2009, REV BRAS CIR CARDIOV, V24, P205, DOI 10.1590/S0102-76382009000200018; McFadden KL, 2011, J NEUROTRAUM, V28, P21, DOI 10.1089/neu.2010.1515; McFadden KL, 2010, EXPLORE-NY, V6, P380, DOI 10.1016/j.explore.2010.08.004; McFadden KL, 2010, COMPLEMENT THER MED, V18, P42, DOI 10.1016/j.ctim.2010.01.001; Mines S., 1982, WELLSPRING, V11, P16; Munck A, 2010, STRESS SCI NEUROENDO, P162; Myers SS, 2008, J GEN INTERN MED, V23, P148, DOI 10.1007/s11606-007-0460-5; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SHAPIRO DA, 1981, BRIT J CLIN PSYCHOL, V20, P111, DOI 10.1111/j.2044-8260.1981.tb00504.x; Spielberger C.D., 1970, STATE TRAIT ANXIETY; Sugiura Toshifumi, 2007, Journal of Physiological Anthropology, V26, P257, DOI 10.2114/jpa2.26.257; SZABO A, 1992, PHYSIOL BEHAV, V51, P501, DOI 10.1016/0031-9384(92)90171-W; Tosevski DL, 2010, CURR OPIN PSYCHIATR, V23, P48, DOI 10.1097/YCO.0b013e328333d625; Tsay SL, 2005, J ADV NURS, V52, P142, DOI 10.1111/j.1365-2648.2005.03576.x; von Kanel R, 2006, BRAIN BEHAV IMMUN, V20, P40, DOI 10.1016/j.bbi.2005.03.013; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; Wang SM, 2005, ANESTH ANALG, V101, P666, DOI 10.1213/01.ANE.0000175212.17642.45; WATTS JMJ, 1975, PSYCHOPHYSIOLOGY, V12, P596, DOI 10.1111/j.1469-8986.1975.tb00053.x	38	11	11	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0965-2299	1873-6963		COMPLEMENT THER MED	Complement. Ther. Med.	AUG	2012	20	4					175	182		10.1016/j.ctim.2011.12.003			8	Integrative & Complementary Medicine	Integrative & Complementary Medicine	951NF	WOS:000304726600002	22579428				2021-06-18	
J	Moein, H; Sanati, MA; Fard, SA; Moein, P; Hasheminasab, SM				Moein, Hooshang; Sanati, Mohammad Ali; Fard, Salman Abbasi; Moein, Payam; Hasheminasab, Seyed Mohammad			Outcome of Decompressive Craniectomy in Patients With Severe Head Injury: A Pilot Randomized Clinical Trial	NEUROSURGERY QUARTERLY			English	Article						decompressive craniectomy; GCS; brain injury	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; SURGICAL DECOMPRESSION; MANAGEMENT; SECONDARY; CHILDREN; IMPACT; DAMAGE	Background: Head injury is the most important cause of death caused by trauma. Decompressive craniectomy is the best-known way to reduce otherwise intractable intracranial pressure and its complications in traumatic brain injury. Aim: This aim of this study was to evaluate the outcome of patients with decompressive craniectomy after severe traumatic brain injury and compare with a control group. Setting: Al-Zahra and Kashani hospital in Isfahan. Design: Pilot randomized clinical trial. Methods: Twenty patients were entered in this study. Patients were randomly divided into group A and group B. Group A received surgical and conservative treatment and group B underwent conservative treatment alone. Both groups were then followed for 6 months. Both groups' presentation Glasgow Coma Scale and Glasgow Outcome Scale (GOS) were compared. Results: A favorable GOS was achieved in 6 cases (60%) of patients in group A and in 2 cases (20%) in group B. However, the difference was not statistically significant. The death rate was higher in group B, with 3 cases (30%), and only 1 patient (10%) died in group A, but the difference was not significant. Conclusions: Decompressive craniectomy seems to be helpful and may lead to a better GOS achievement and improve the mortality rate among traumatic brain injury patients; however, further investigation will be needed to confirm the results.	[Moein, Hooshang] Al Zahra Hosp, Dept Neurosurg, Esfahan, Iran; [Sanati, Mohammad Ali; Fard, Salman Abbasi; Moein, Payam] Isfahan Univ Med Sci, Dept Neurosurg, Tehran, Iran; [Hasheminasab, Seyed Mohammad] Univ Tehran Med Sci, Fac Med, Tehran, Iran	Fard, SA (corresponding author), Al Zahra Hosp, Dept Neurosurg, Esfahan, Iran.	Dr_abbasi_s@yahoo.com					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Chen Chun-Chung, 2007, J Chin Med Assoc, V70, P56; DiValvasone S, 2010, CRITICAL CARE S1, V14, P298; Fukai J, 2009, NEUROL MED-CHIR, V49, P22, DOI 10.2176/nmc.49.22; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson Peter, 2007, Neurosurg Focus, V22, pE14; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; JENNETT B, 1975, LANCET, V1, P480; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Munch E, 2000, NEUROSURGERY, V47, P315; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Toussaint CP, 2008, NEUROSURG QUART, V18, P45, DOI 10.1097/WNQ.0b013e3181642924; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zhao Z, 2007, NEUROCRIT CARE, V7, P263, DOI 10.1007/s12028-007-0074-0; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	27	11	11	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	AUG	2012	22	3					149	152		10.1097/WNQ.0b013e318240f1e0			4	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	985IN	WOS:000307256700002					2021-06-18	
J	Sullivan, KA; Edmed, SL				Sullivan, Karen A.; Edmed, Shannon L.			The good-old-days bias and post-concussion syndrome symptom reporting in a non-clinical sample	BRAIN INJURY			English	Article						Mild traumatic brain injury; post-concussion syndrome; good-old-days bias; assessment	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION-LIKE SYMPTOMS; MILD HEAD-INJURY; CHRONIC PAIN; BASE RATES; ETIOLOGY; EXPECTATION; DEPRESSION	Primary objective: To investigate the good-old-days bias, a psychosocial factor associated with post-concussion syndrome (PCS). Study design: Repeated measures comparison of PCS symptoms reported 6 months prior (retrospectively) and currently. A non-clinical sample was used to determine if this bias is a general recall bias. Methods and procedures: Fifty-seven university students with no history of brain injury or neurological disease completed the British Columbia Post-concussion Symptom Inventory. Symptoms were reported on two occasions, spaced 1 week apart, commencing with current symptoms. Main outcomes and results: Using PCS symptom frequency by severity product scores, there was no significant difference in the 13 PCS symptoms reported across occasions, nor the relevant summary score (p = 0.199). These data do not support the presence of a general recall bias. However, significant differences emerged when analysed using a simple count of the total number of endorsed symptoms (p = 0.002, d = 0.39, small-to-medium effect) or the sample percentage that endorsed each symptom (four symptoms were endorsed by fewer participants retrospectively than currently). Conclusions: There is only weak evidence of a general recall bias in this non-clinical sample. Further consideration of the methods used to study this bias and its role clinically is needed.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, O Block B Wing Room 523,Kelvin Grove Campus,Victo, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counselling, Queensland University of Technology	The authors report no conflicts of interest. This work was conducted and written by the authors. This research was funded by the School of Psychology and Counselling, Queensland University of Technology.	Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Cohen J., 1988, STAT POWER ANAL OFR; Edmed S.L., APPL NEUROP IN PRESS; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Lovibond P.F., 1995, MANUAL DESPRESSION A; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Panayiotou A, AUSTR PSYCH IN PRESS; Panayiotou A, 2011, AUST PSYCHOL, V46, P210, DOI 10.1111/j.1742-9544.2010.00018.x; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Steinber WJ., 2011, STAT ALIVE; Sullivan KA, 2010, J HEAD TRAUMA REHAB, V17, P1; Tabachnick BG, 2007, USING MULTIVARIATE S; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006	29	11	11	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1098	1104		10.3109/02699052.2012.666367			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400006	22624800				2021-06-18	
J	Kane, MJ; Angoa-Perez, M; Francescutti, DM; Sykes, CE; Briggs, DI; Leung, LY; VandeVord, PJ; Kuhn, DM				Kane, Michael J.; Angoa-Perez, Mariana; Francescutti, Dina M.; Sykes, Catherine E.; Briggs, Denise I.; Leung, Lai Yee; VandeVord, Pamela J.; Kuhn, Donald M.			Altered gene expression in cultured microglia in response to simulated blast overpressure: Possible role of pulse duration	NEUROSCIENCE LETTERS			English	Article						Microglia; Gene expression; Blast; Overpressure; Barochamber; Primary trauma	TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; RATS; EXPOSURE; NEUROTOXICITY; ACTIVATION; MECHANISMS; RELEVANCE; STRIATUM; DISEASES	Blast overpressure has long been known to cause barotrauma to air-filled organs such as lung and middle ear. However, experience in Iraq and Afghanistan is revealing that individuals exposed to explosive munitions can also suffer traumatic brain injury (TBI) even in the absence of obvious external injury. The interaction of a blast shock wave with the brain in the intact cranial vault is extremely complex making it difficult to conclude that a blast wave interacts in a direct manner with the brain to cause injury. In an attempt to "isolate" the shock wave and test its primary effects on cells, we exposed cultured microglia to simulated blast overpressure in a barochamber. Overpressures ranging from 15 to 45 psi did not change microglial Cox-2 levels or TNF-alpha secretion nor did they cause cell damage. Microarray analysis revealed increases in expression of a number of microglial genes relating to immune function and inflammatory responses to include Saa3, Irg1, Fas and CxCl10. All changes in gene expression were dependent on pulse duration and were independent of pressure. These results indicate that microglia are mildly activated by blast overpressure and uncover a heretofore undocumented role for pulse duration in this process. Published by Elsevier Ireland Ltd.	[Kane, Michael J.; Angoa-Perez, Mariana; Francescutti, Dina M.; Sykes, Catherine E.; Briggs, Denise I.; Leung, Lai Yee; VandeVord, Pamela J.; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA; [Kane, Michael J.; Angoa-Perez, Mariana; Francescutti, Dina M.; Sykes, Catherine E.; Briggs, Denise I.; Kuhn, Donald M.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Leung, Lai Yee; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI USA	Kuhn, DM (corresponding author), John D Dingell VAMC, R&D Serv 11R, 4646 John R, Detroit, MI 48201 USA.	donald.kuhn@wayne.edu	Leung, Lai Yee/H-8204-2013	Briggs, Denise/0000-0002-4824-3947	Department of Veterans AffairsUS Department of Veterans Affairs; VA Career Development Award; VA Merit AwardUS Department of Veterans Affairs; VA Research Career Scientist Award; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA017327] Funding Source: NIH RePORTER	This work was supported by funding from the Department of Veterans Affairs, a VA Career Development Award (P.J.V.) and by VA Merit and Research Career Scientist Awards (D.M.K.).	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Kaur C, 1997, NEUROSCI RES, V27, P317, DOI 10.1016/S0168-0102(97)01164-4; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Lee KYK, 2011, NEUROIMAGE, V54, pS30, DOI 10.1016/j.neuroimage.2010.05.042; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas D.M., 2005, FASEB J; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906	40	11	11	0	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUL 26	2012	522	1					47	51		10.1016/j.neulet.2012.06.012			5	Neurosciences	Neurosciences & Neurology	982IF	WOS:000307035700010	22698585	Green Accepted			2021-06-18	
J	Bay, E; Kalpakjian, C; Giordani, B				Bay, Esther; Kalpakjian, Claire; Giordani, Bruno			Determinants of subjective memory complaints in community-dwelling adults with mild-to-moderate traumatic brain injury	BRAIN INJURY			English	Article						Chronic stress; brain injury; rehabilitation; depression; memory	COGNITIVE COMPLAINTS; NATURAL-HISTORY; STRESS; DEPRESSION; IMPACT; SYMPTOMS; CORTISOL; RECOVERY; OUTCOMES; TERM	Primary objective: This study sought to determine to what extent chronic stress, depression and neurobehavioural consequences explained post-TBI subjective memory complaints (SMC). Research design: An observational, cross-sectional design was used. Methods and procedures: One hundred and fifty-nine persons who were 1-36 months post-injury provided data using interviews, chart reviews and surveys. Predictor variables included the Center for Epidemiological Studies-Depression Scale (CES-D), Perceived Stress Scale (PSS-14) and sub-scales of the NFI. Main outcomes and results: SMC, according to the Neurobehavioural Functioning Inventory (NFI), was the main outcome variable. SMC could best be explained by increased age, months-since-injury, chronic situational stress and the frequency of somatic and communication difficulties, not depression (R-2 = 0.780, F = 97.39, [8, 152], p < 0.001). These findings suggest that, for persons in the chronic phase of recovery from their TBI, specific determinants other than general adjustment issues may apply. These include: increased chronic stress, age, somatic symptoms and communication difficulties. Conclusion: Self-reported chronic situational stress is positively associated with self-reported memory complaints, as well as somatic and communication difficulties. The causal ordering of these relationships would be best understood with prospective designs using biological correlates of chronic stress to advance understanding of post-TBI depression in older adults.	[Bay, Esther] Univ MI, Sch Nursing, Ann Arbor, MI 48109 USA; [Kalpakjian, Claire] Univ MI, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Giordani, Bruno] Univ MI, Dept Psychiat, Ann Arbor, MI 48109 USA; [Giordani, Bruno] Univ MI, Dept Psychol, Neuropsychol Sect, Ann Arbor, MI 48109 USA	Bay, E (corresponding author), Univ MI, Sch Nursing, 400 N Ingalls Bldg Div 1, Ann Arbor, MI 48109 USA.	pdq@med.umich.edu	Giordani, Bruno/AAR-1910-2021	Kalpakjian, Claire/0000-0001-6652-1245	Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007422] Funding Source: NIH RePORTER	The project described was supported by Award Number T32HD007422 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E, 2009, RES THEORY NURSING P, V23, P43; Bay E, 2012, NEUROCOGNITIVE UNPUB; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/088971804780957108; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S. C. R., 1995, MEASURING STRESS GUI, P1; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Donovan NJ, 2011, BRAIN INJURY, V25, P348, DOI 10.3109/02699052.2011.556105; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Garrett DD, 2010, PSYCHOL AGING, V25, P74, DOI 10.1037/a0017726; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Herbert J, 2006, J NEUROENDOCRINOL, V18, P393, DOI 10.1111/j.1365-2826.2006.01429.x; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hook JN, 2007, J INT NEUROPSYCH SOC, V13, P21, DOI 10.1017/S1355617707070051; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2009, MILD TRAUMATIC BRAIN, P285; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kreutzer J, 1999, NEUROBEHAVIORAL FUNC, P1; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lavretsky H, 2010, AM J PSYCHIAT, V167, P589, DOI 10.1176/appi.ajp.2009.09020280; Lee BK, 2007, ARCH GEN PSYCHIAT, V64, P810, DOI 10.1001/archpsyc.64.7.810; Lupien SJ, 2005, PSYCHONEUROENDOCRINO, V30, P225, DOI 10.1016/j.psyneuen.2004.08.003; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McEwen BS, 2000, NEUROCHEM RES, V25, P1219, DOI 10.1023/A:1007687911139; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Radley JJ, 2008, J COMP NEUROL, V507, P1141, DOI 10.1002/cne.21588; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yehuda Rachel, 2004, Psychoneuroendocrinology, V29, P1212, DOI 10.1016/j.psyneuen.2004.01.006	52	11	11	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					941	949		10.3109/02699052.2012.666365			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100005	22571456				2021-06-18	
J	Pachalska, M; Manko, G; Chantsoulis, M; Knapik, H; Mirski, A; Mirska, N				Pachalska, Maria; Manko, Grzegorz; Chantsoulis, Marzena; Knapik, Henryk; Mirski, Andrzej; Mirska, Natalia			The quality of life of persons with TBI in the process of a Comprehensive Rehabilitation Program	MEDICAL SCIENCE MONITOR			English	Article						treatment plan; individual needs; effectiveness of rehabilitation	SPINAL-CORD-INJURY; SHORT-TERM; BEHAVIOR; OUTCOMES; CHILDREN	Background: The aim of the research was to evaluate the effectiveness of the phased rehabilitation program in patients after traumatic brain injury, one developed by the authors and controlled by the strategic plan, pertaining to their quality of life compared to patients treated according to a standard, phased rehabilitation program. Material/Methods: The study included 40 patients of post traumatic brain injury treated at the Rehabilitation Clinic of the L. Rydygier Academy of Medical Sciences in Bydgoszcz and the Department of Medical Rehabilitation of the Cracow Rehabilitation Centre. An experimental group included 20 patients rehabilitated by a strategic approach and a control group consisted of 20 patients treated before the introduction of this approach. In assessing the effectiveness of rehabilitation, a structured interview was used with clinical observation and the Battery of Quality of Life Assessment. The study was conducted twice: before and after eight weeks of rehabilitation. Results: The quality of life of people after brain injury is affected by self-service difficulties, difficulties in meeting the physiological needs and loss of psychophysical comfort, decreased mobility, impaired cognitive functions and executive and social functions. There is no consistency between the stated (subjective) level of quality of life of the patient, and the depth of objectively measured disability resulting from the injury sustained. Conclusions: A rehabilitation program controlled by a strategic plan, in collaboration with the patient treated subjectively is more effective in improving the quality of life, since the cooperating patient is more motivated to carry out individually designed goals. A rehabilitation program based on a strategic plan is worthy of recommendation for the treatment and improvement of patients after cranio-cerebral trauma.	[Pachalska, Maria; Mirski, Andrzej; Mirska, Natalia] Andrzej Frycz Modrzewski Cracow Univ, Krakow, Poland; [Pachalska, Maria] Ctr Cognit & Commun, New York, NY USA; [Manko, Grzegorz] Jagiellonian Univ, Dept Ergon & Exercise Physiol, Fac Hlth Sci, Coll Med, Krakow, Poland; [Manko, Grzegorz] Elblag Univ Humanities & Econ, Dept Hlth Sci, Elblag, Poland; [Chantsoulis, Marzena] Acad Phys Educ, Dept Physiotherapy, Wroclaw, Poland; [Chantsoulis, Marzena] Mil Hosp 4, Dept Neurosurg, Wroclaw, Poland; [Knapik, Henryk] Acad Phys Educ, Fac Physiotherapy, Katowice, Poland	Pachalska, M (corresponding author), Andrzej Frycz Modrzewski Cracow Univ, Herlinga Grudzinskiego 1 St, Krakow, Poland.	neuropsychologia23@o2.pl	Knapik, Henryk/X-5978-2018; manko, grzegorz/I-5102-2012	Knapik, Henryk/0000-0003-2009-3788; 			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Baranowski P, 2000, Ortop Traumatol Rehabil, V2, P31; Bulinski L, 2010, MED SCI MONITOR, V16, pPH14; Bulpitt CJ, 1997, POSTGRAD MED J, V73, P613, DOI 10.1136/pgmj.73.864.613; CLAYTON KS, 1994, ARCH PHYS MED REHAB, V75, P633, DOI 10.1016/0003-9993(94)90184-8; Craig A, 1999, SPINAL CORD, V37, P345, DOI 10.1038/sj.sc.3100829; CURCOLL ML, 1992, PARAPLEGIA, V30, P425, DOI 10.1038/sc.1992.93; DENNIS RE, 1993, EXCEPT CHILDREN, V59, P499, DOI 10.1177/001440299305900603; Firsching R, 1998, SPINAL CORD, V36, P741, DOI 10.1038/sj.sc.3100713; Grady CL, 2002, CAN J PSYCHIAT, V47, P327, DOI 10.1177/070674370204700403; Grochmal-Bach B, 1996, SZTUKA LECZENIA, V2, P95; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; JUDD FK, 1986, PARAPLEGIA, V24, P6, DOI 10.1038/sc.1986.3; Kannisto M, 1998, SPINAL CORD, V36, P193, DOI 10.1038/sj.sc.3100543; Kennedy P, 1999, SPINAL CORD, V37, P136, DOI 10.1038/sj.sc.3100745; MacQueen BD, 2003, ORTOPEDIA TRAUMATOLO, V5, P797; MacQueen BD, 2003, NEUROPSYCHOLOGICZNE, P99; MacQueen BD, 2002, URAZY PNIA MOZGU KOM, P328; Manko G, 2004, OCENA SKUTECZNOSCI S; Pachalska M, 2000, Ortop Traumatol Rehabil, V2, P44; Pachalska M, 2001, Ortop Traumatol Rehabil, V3, P89; Pachalska M, 1998, SKALA OCENY JAKOSCI; Pachalska M, 2008, REHABILITACJA NEUROP; Pachalska M, 1997, VID PRES SESS 28 C I; Pachalska M, 2000, ORTOPEDIA TRAUMATOLO, V3, P34; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M, 2001, ORTOPEDIA TRAUMATOLO, V2, P182; Pruitt SD, 1998, SPINAL CORD, V36, P724, DOI 10.1038/sj.sc.3100649; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rubin K. H., 2006, SOCIAL EMOTIONAL PER, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Sapountzi-Krepia D, 1998, SPINAL CORD, V36, P432, DOI 10.1038/sj.sc.3100641; SINTONEN H, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P185; Snowdy Jr HA, 1992, CRITICAL CARE CLIN, V3, P449; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; STENSMAN R, 1994, PARAPLEGIA, V32, P416, DOI 10.1038/sc.1994.68; Talar J, 2002, URAZY PNIA MOZGU KOM, P207; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor-Sarno M, 1997, APHASIOLOGY, V11, P665; Vaidyananthan S, 1998, SPINAL CORD, V36, P409, DOI 10.1038/sj.sc.3100573; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	40	11	12	0	12	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUL	2012	18	7					CR432	CR442					11	Medicine, Research & Experimental	Research & Experimental Medicine	980HD	WOS:000306883300013	22739733	Green Published			2021-06-18	
J	Richards, D; Carroll, J				Richards, David; Carroll, Jolyon			Relationship between types of head injury and age of pedestrian	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Road safety; Pedestrian; Traumatic brain injury; Risk; Age; Traffic accident		This paper explores the relationship between age and the different types of head injury received by pedestrians in traffic accidents with cars. The analysis is based on information collected by hospitals in England, and is supported by in-depth case examples. The principle result is that the risk of intracranial injury increases with age, whilst the risk of fracture to the head or facial bones remains relatively constant. This agrees with previous findings for other groups of casualties, which have reported that that the decrease in brain size leads to an increase in the relative motion of the skull and brain in an impact, with a corresponding increase in the risk of traumatic brain injury. Intracranial injuries have also been found to place the greatest burden on hospitals, which may have implications on automotive design if prevention of these injuries is to be prioritised over fractures of the skull. (C) 2012 Jolyon Carroll. Published by Elsevier Ltd. All rights reserved.	[Richards, David; Carroll, Jolyon] TRL, Wokingham RG40 3GA, Berks, England	Carroll, J (corresponding author), TRL, Crowthorne House, Wokingham RG40 3GA, Berks, England.	jcarroll@trl.co.uk					Anderson T., 2010, NATL TRAVEL SURVEY 2; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Claessans M., 1997, P 41 STAPP CAR CRASH, P315, DOI DOI 10.4271/973338; Connecting for Health, 2011, DAT DICT ATTR PRIM D; Cuerden R., 2008, 73 DEP TRANSP; Dawodu S.T., 2003, TRAUMATIC BRAIN INJU; Department for Transport, 2010, NAT TRAV SURV 2009 N; Department for Transport, 2007, ROAD CAS GREAT BRIT; Department for Transport, 2006, ROAD ACC CAS COMP ST; Department for Transport, 2009, ROAD CAS GREAT BRIT; Department of Health, 2005, NHS REF COSTS 2004 A; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Hardy B.J., 2009, APSP33024R APROSYS E; Hardy B.J., 2008, APSP33018R APROSYS E; Hodgson V.R., 1979, P 23 STAPP CAR CRASH; Hodgson V.R., 1969, P 13 STAPP CAR CRASH, P18; Holbourn AHS, 1943, LANCET, V2, P438; Jennet W.B., 1989, P REC 1 FEBR 1989 RO; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Office for National Statistics, 2010, MID POP EST 2008; Office for National Statistics, 2011, CONS PRIC IND; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Richards D., 2009, P INT RES COUNC BIOM; Richards D.C., 2009, ENHANCED MED ENG LIN; Sarkar SN, 2009, TRAUMA, V11, P157, DOI 10.1177/1460408609335937; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; World Health Organization, 2009, GLOB STAT REP ROAD S; Zhang J., 2006, 50 ANN P ASS ADV AUT	31	11	11	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2012	47						16	23		10.1016/j.aap.2012.01.009			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	921WJ	WOS:000302508500003	22405234				2021-06-18	
J	Walcott, BP; Nahed, BV; Sheth, SA; Yanamadala, V; Caracci, JR; Asaad, WF				Walcott, Brian P.; Nahed, Brian V.; Sheth, Sameer A.; Yanamadala, Vijay; Caracci, James R.; Asaad, Wael F.			Bilateral Hemicraniectomy in Non-Penetrating Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bilateral; craniectomy; brain injury; intensive care unit; trauma	ACUTE SUBDURAL-HEMATOMA; TRANSORBITAL VENTRICULAR PUNCTURE; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; TRANSTENTORIAL HERNIATION; COMPUTERIZED-TOMOGRAPHY; COMATOSE PATIENTS; DURET HEMORRHAGE; MORTALITY; EVACUATION	Traumatic brain injury is a heterogeneous entity that encompasses both surgical and non-surgical conditions. Surgery may be indicated with traumatic lesions such as hemorrhage, fractures, or malignant cerebral edema. However, the neurological exam may be clouded by the effects of medications administered in the field, systemic injuries, and inaccuracies in hyperacute prognostication. Typically, neurological injury is considered irreversible if diffuse loss of grey/white matter differentiation or if brainstem hemorrhage (Duret hemorrhage) exists. We aim to characterize a cohort of patients undergoing bilateral hemicraniectomy for severe traumatic brain injury. A retrospective consecutive cohort of adult patients undergoing craniectomy for trauma was established between the dates of January 2008 and November 2011. The primary outcome of the study was in-hospital mortality. Secondary outcomes were ICU length of stay, surgical complications, and Glasgow Outcome Score at most recent follow-up. During the study period, 210 patients undergoing craniectomy for traumatic mass-occupying lesion (epidural hematoma, subdural hematoma, or parenchymal contusion) were analyzed. Of those, 9 met study criteria. In-hospital mortality was 67% (6 of 9 patients). The average ICU length of stay was 12 days. The GOS score was 3 in surviving patients. Bilateral hemicraniectomy is a heroic intervention for patients with severe TBI, but can be a life-saving procedure.	[Walcott, Brian P.; Nahed, Brian V.; Sheth, Sameer A.; Yanamadala, Vijay; Caracci, James R.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Walcott, Brian P.; Nahed, Brian V.; Sheth, Sameer A.; Yanamadala, Vijay; Caracci, James R.] Harvard Univ, Sch Med, Boston, MA USA; [Asaad, Wael F.] Brown Univ, Sch Med, Dept Neurosurg, Providence, RI 02912 USA	Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,White Bldg,Room 502, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Asaad, Wael/I-8485-2012; Nahed, Brian/E-4239-2014	Asaad, Wael/0000-0003-4406-9096; Nahed, Brian/0000-0001-8537-106X			Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Domenicucci M, 1998, NEUROSURGERY, V42, P51, DOI 10.1097/00006123-199801000-00010; Duhaime AC, 2007, PROG BRAIN RES, V161, P293, DOI 10.1016/S0079-6123(06)61020-0; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; FELL DA, 1975, J NEUROSURG, V42, P37, DOI 10.3171/jns.1975.42.1.0037; Gabl M, 1989, Unfallchirurgie, V15, P273; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Karasu A, 2010, ULUS TRAVMA ACIL CER, V16, P233; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lau D, 2012, J NEUROSURG, V116, P234, DOI 10.3171/2011.7.JNS11396; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Marion DW, 2006, NEUROSURGERY, V58, P655; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; NAVARRO IM, 1981, J NEUROSURG, V54, P273, DOI 10.3171/jns.1981.54.2.0273; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Tubbs RS, 2009, J NEUROSURG, V111, P1191, DOI 10.3171/2009.3.JNS081651; Wan WH, 2008, J CLIN NEUROSCI, V15, P223, DOI 10.1016/j.jocn.2007.05.025; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	36	11	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1879	1885		10.1089/neu.2012.2382			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400392	22452418				2021-06-18	
J	Bechi, A; Nucera, MP; Olivotto, I; Manetti, R; Fabbri, LP				Bechi, A.; Nucera, M. P.; Olivotto, I.; Manetti, R.; Fabbri, L. P.			Complete neurological recovery after systemic air embolism during endoscopic retrograde cholangiopancreatography	MINERVA ANESTESIOLOGICA			English	Article						Endoscopy Embolism, complications; Pancreas, surgery	DIAGNOSIS; PATIENT	Systemic air embolisms are a rare but often a fatal complication of endoscopic retrograde cholangiopancreatography (ERCP). Only few cases have been reported in scientific studies. This paper concerns a case of a systemic air embolism that occurred during endoscopic sphincterotomy for gallstone removal in a 79-year-old-woman and discusses possible mechanisms. The basic vital and neurologic signs of the woman deteriorated abruptly towards the end of the procedure. It was believed to be an air embolism and an urgent transthoracic echocardiography was ordered which confirmed the etiological diagnosis. Supportive measures were initiated: she was administered 100% oxygen, she was placed head down, left lateral position and fluid resuscitation was started to increase venous pressure. We considered hyperbaric oxygen therapy for neurological injury but, despite the severe initial presentation, she had a complete clinical recovery with only conservative treatment. Present experience stresses the importance of the awareness of this uncommon complication: a close vigilance of the anesthetists during ERCP is critical to ensure early diagnosis and a timely intervention. (Minerva Anestesiol 2012;78:622-5)	[Bechi, A.; Nucera, M. P.; Fabbri, L. P.] Careggi Hosp, Dept Anesthesia & Intens Care, Florence, Italy; [Olivotto, I.] Careggi Hosp, Dept Cardiol, Florence, Italy; [Manetti, R.] Careggi Hosp, Dept Gen Surg, Florence, Italy	Bechi, A (corresponding author), Careggi Hosp, Dept Anesthesia & Intens Care, Via Oblate 1, Florence, Italy.	annalisabechi@libero.it					Garcia BA, 2009, GASTROENTEROL HEPATO, V32, P614, DOI 10.1016/j.gastrohep.2009.06.001; Bisceglia M, 2009, ADV ANAT PATHOL, V16, P255, DOI 10.1097/PAP.0b013e3181aab793; Cha ST, 2010, YONSEI MED J, V51, P287, DOI 10.3349/ymj.2010.51.2.287; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Di Pisa M, 2011, MINERVA ANESTESIOL, V77, P90; Finsterer J, 2010, EUR J GASTROEN HEPAT, V22, P1157, DOI 10.1097/MEG.0b013e32833c5459; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Mohammedi I, 2002, J TRAUMA, V53, P1170, DOI 10.1097/00005373-200212000-00023; Natal BL., VENOUS AIR EMBOLISM; Nayagam J, 2004, ANAESTH INTENS CARE, V32, P260, DOI 10.1177/0310057X0403200217; Nesher E, 2002, Eur J Emerg Med, V9, P163, DOI 10.1097/00063110-200206000-00012; Siddiqui J, 2005, GASTROINTEST ENDOSC, V61, P153, DOI 10.1016/S0016-5107(04)02448-4; Sviri S, 2004, Crit Care Resusc, V6, P271; Tan BK, 2008, ANN FR ANESTH, V27, P240, DOI 10.1016/j.annfar.2007.12.015	14	11	13	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393			MINERVA ANESTESIOL	Minerva Anestesiol.	MAY	2012	78	5					622	625					4	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	941KL	WOS:000303962000014	22240610				2021-06-18	
J	Charland-Verville, V; Lassonde, M; Frasnelli, J				Charland-Verville, Vanessa; Lassonde, Maryse; Frasnelli, Johannes			Olfaction in athletes with concussion	AMERICAN JOURNAL OF RHINOLOGY & ALLERGY			English	Article							MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; OF-PENNSYLVANIA SMELL; ODOR IDENTIFICATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; POSTTRAUMATIC ANOSMIA; RECURRENT CONCUSSION; SPORTS CONCUSSION	Background: Moderate to severe traumatic brain injuries (TBIs) commonly lead to olfactory dysfunction; it is, however, unclear whether and to what degree mild TBI such as concussions, which are common sports injuries, affect olfactory function. We therefore aimed to evaluate smell function in athletes who sustained one or more sport concussions in a cross-sectional design. Methods: Twenty-two University-level football players with one or multiple concussions and 13 control athletes without a history of concussion participated. We measured olfactory function by using the Sniffin' Sticks test to assess subjects' ability to discriminate and identify odors as well as their detection thresholds. In addition, we assessed odor intensity and pleasantness. Results: We used number of concussions and time since the last concussion as independent variables and measure of olfactory function as dependent variables. Although we did not observe any significant effect of the number of concussions, athletes with a longer delay from time of concussion scored significantly weaker than more recently concussed subjects on the odor identification test and on an aggregate olfactory score. Accordingly, we observed a significant negative linear correlation between the odor identification score and the time elapsed since the last concussion. Conclusion: These findings suggest a possible degenerative effect of concussions on olfactory function. (Am J Rhinol Allergy 26, 222-226, 2012; doi: 10.2500/ajra.2012.26.3769)	[Frasnelli, Johannes] Univ Montreal, Dept Psychol, Ctr Rech Neuropsycholgie & Cognit, Montreal, PQ H2V 2S9, Canada; [Charland-Verville, Vanessa] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, Liege, Belgium; [Charland-Verville, Vanessa] Univ Liege, Dept Neurol, Liege, Belgium; [Charland-Verville, Vanessa] Univ Hosp Liege, Liege, Belgium	Frasnelli, J (corresponding author), Univ Montreal, Dept Psychol, Ctr Rech Neuropsycholgie & Cognit, Salle F-475,Pavillon Marie Victorin,90 Ave, Montreal, PQ H2V 2S9, Canada.	frasnelli@yahoo.com		Frasnelli, Johannes/0000-0002-8863-3982	NSERCNatural Sciences and Engineering Research Council of Canada (NSERC); CIHRCanadian Institutes of Health Research (CIHR)	Funded by the NSERC and CIHR	Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; DOTY RL, 1987, BRAIN RES BULL, V18, P597, DOI 10.1016/0361-9230(87)90129-8; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Eibenstein A, 2005, NEUROL SCI, V26, P156, DOI 10.1007/s10072-005-0453-2; Eslinger P J, 1982, Brain Cogn, V1, P259, DOI 10.1016/0278-2626(82)90028-8; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Fusetti M, 2010, J OTOLARYNGOL-HEAD N, V39, P175, DOI 10.2310/7070.2009.090046; Gaines AD, 2010, ALLERGY ASTHMA PROC, V31, P185, DOI 10.2500/aap.2010.31.3357; Graves AB, 1999, NEUROLOGY, V53, P1480, DOI 10.1212/WNL.53.7.1480; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Haehner A, 2009, CHEM SENSES, V34, P705, DOI 10.1093/chemse/bjp057; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jiang RS, 2009, AM J RHINOL ALLERGY, V23, P582, DOI 10.2500/ajra.2009.23.3370; Kelly JP, 1997, NEUROLOGY, V48, P581; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Lehrner J, 2009, CLIN NEUROPSYCHOL, V23, P818, DOI 10.1080/13854040802585030; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Makdissi M, 2010, AUST FAM PHYSICIAN, V39, P12; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Royall DR, 2002, NEUROEPIDEMIOLOGY, V21, P68, DOI 10.1159/000048619; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sela L, 2009, J NEUROSCI, V29, P12059, DOI 10.1523/JNEUROSCI.2114-09.2009; Sobel N, 2001, P NATL ACAD SCI USA, V98, P4154, DOI 10.1073/pnas.071061598; Sommer U, 2004, MOVEMENT DISORD, V19, P1196, DOI 10.1002/mds.20141; Tabert MH, 2006, ARCH GEN PSYCHIAT, V63, P916, DOI 10.1001/archpsyc.63.8.916; Varney N. R., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI DOI 10.1097/00001199-199303000-00005; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P802, DOI 10.1001/archpsyc.64.7.802; Wilson RS, 2009, ANN NY ACAD SCI, V1170, P730, DOI 10.1111/j.1749-6632.2009.04013.x	53	11	11	0	22	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1945-8924			AM J RHINOL ALLERGY	Am. J. Rhinol. Allergy	MAY-JUN	2012	26	3					222	226		10.2500/ajra.2012.26.3769			5	Otorhinolaryngology	Otorhinolaryngology	955AF	WOS:000304988800019	22643951				2021-06-18	
J	Howard, CJ				Howard, Christopher J.			Neurobiological Correlates of Partner Abusive Men: Equifinality in Perpetrators of Intimate Partner Violence	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						intimate partner violence; neurophysiology; neurobiology; childhood physical abuse	POSTTRAUMATIC-STRESS-DISORDER; COMPUTERIZED COGNITIVE REHABILITATION; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTERGENERATIONAL TRANSMISSION; DOMESTIC VIOLENCE; SELECT GROUP; NEUROFEEDBACK; CHILDREN; BEHAVIOR	This theoretical review integrates findings from functional imaging, counseling effectiveness program evaluation, and childhood physical abuse to inform current assessment and intervention practices with partner abusive men. Understanding how to adequately assess traumatic brain injury, trauma symptomatology, and concomitant deficits in conflict regulation strategies will be elucidated. Particular emphasis on executive functioning, verbal deficits, impulsivity and an integrative biopsychosocial model including the roles of quantitative electroencephalography, the hypothalamus-pituitary-adrenal axis, sympathetic nervous system, and serotonergic system will be presented, enriching current conceptualization and treatment of partner abusive men.	Antioch Univ, Dept Clin Psychol, Santa Barbara, CA 93101 USA	Howard, CJ (corresponding author), Antioch Univ, Dept Clin Psychol, 801 Garden St, Santa Barbara, CA 93101 USA.	choward@antioch.edu					Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Babcock JC, 2005, J ABNORM PSYCHOL, V114, P444, DOI 10.1037/0021-843X.114.3.444; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bangirana P, 2009, J DEV BEHAV PEDIATR, V30, P310, DOI 10.1097/DBP.0b013e3181b0f01b; Barlow D. H., 2001, CLIN HDB PSYCHOL DIS; Beach SRH, 2010, J FAM PSYCHOL, V24, P12, DOI 10.1037/a0018074; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Beutler L. E, REV INT PSI IN PRESS; BLACK DA, 1999, PARTNER CHILD ABUSE; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Briere J., 1995, TRAUMA SYMPTOM INVEN; Cicchetti D, 2002, J CONSULT CLIN PSYCH, V70, P6, DOI 10.1037//0022-006X.70.1.6; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cohen R A, 1999, Violence Vict, V14, P397; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Ehrensaft MK, 2003, J CONSULT CLIN PSYCH, V71, P741, DOI 10.1037/0022-006X.71.4.741; Fallon J. H, OHIO STATE J CRIMINA, V3, P341; Fang XM, 2008, J FAM VIOLENCE, V23, P303, DOI 10.1007/s10896-008-9152-0; Foa E. B., 2000, J TRAUMA STRESS, V13, P4; George DT, 2000, BIOL PSYCHIAT, V47, P804, DOI 10.1016/S0006-3223(99)00300-5; George DT, 2004, PSYCHIAT RES-NEUROIM, V130, P11, DOI 10.1016/S0925-4927(03)00105-7; Hammond DC, 2005, CHILD ADOL PSYCH CL, V14, P105, DOI 10.1016/j.chc.2004.07.008; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; HEBBEN N, 2002, ESSENTIALS NEUROPSYC; Hibbeln JR, 2004, BIOL PSYCHIAT, V56, P895, DOI 10.1016/j.biopsych.2004.08.021; Huang-Storms L., 2007, J NEUROTHERAPY, V10, P3; Ibric V.L., 2009, J NEUROTHER, V13, P156, DOI [https://doi.org/10.1080/10874200903118378, DOI 10.1080/10874200903118378]; ISNR Comprehensive Neurofeedback Bibliography compiled by Harold Burke at EEG, ISNR COMPREHENSIVE N; KALAT JW, 2007, BIOL PSYCHOL; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kendall-Tackett K. E., 2010, PSYCHONEUROIMMUNOLOG; Kendall-Tackett K, 2009, PSYCHOL TRAUMA-US, V1, P35, DOI 10.1037/a0015128; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kropotov J.D, 2009, QUANTITATIVE EEG EVE; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Leppamaki S, 2002, J AFFECT DISORDERS, V72, P139, DOI 10.1016/S0165-0327(01)00417-7; Lucas JA, 2006, CLIN NEUROPSYCHOLOGY, P351; Magdol L, 1998, J ABNORM PSYCHOL, V107, P375, DOI 10.1037/0021-843X.107.3.375; Manchester D, 2001, BRAIN DAM B, P157; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Marsh NV, 2006, BRAIN INJURY, V20, P61, DOI 10.1080/02699050500110645; Masterpasqua F, 2003, PROF PSYCHOL-RES PR, V34, P652, DOI 10.1037/0735-7028.34.6.652; McGrath J, 1997, NEUROPSYCHOL REHABIL, V7, P231, DOI 10.1080/713755532; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; MCMILLAN TM, 1991, BRIT J PSYCHIAT, V159, P431, DOI 10.1192/bjp.159.3.431; McNeil J E, 1996, Cogn Neuropsychiatry, V1, P239, DOI 10.1080/135468096396532; Metzger LJ, 2004, J ABNORM PSYCHOL, V113, P324, DOI 10.1037/0021-843X.113.2.324; Middelboe T., 1992, European Psychiatry, V7, P183; Moore TM, 2002, AGGRESSIVE BEHAV, V28, P299, DOI 10.1002/ab.90027; Mulvihill D, 2005, Compr Child Adoles N, V28, P115, DOI 10.1080/01460860590950890; Orr S.P., 2004, ASSESSING PSYCHOL TR; Paul RH, 2005, INT J NEUROSCI, V115, P1549, DOI 10.1080/00207450590957890; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Resick P. A., 2001, STRESS AND TRAUMA; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Snyder PJ., 2006, CLIN NEUROPSYCHOLOGY; Sokhadze Tato M., 2007, Journal of Neurotherapy, V11, P13, DOI 10.1300/J184v11n02_03; Southwick S. M., 2003, PTSD RES Q, V14, P1; Stith SM, 2000, J MARRIAGE FAM, V62, P640, DOI 10.1111/j.1741-3737.2000.00640.x; STRAUS MA, 1995, REVISED CONFLICT TAC; Susman EJ, 2006, NEUROSCI BIOBEHAV R, V30, P376, DOI 10.1016/j.neubiorev.2005.08.002; Thatcher R. W., 2010, J NEUROTHERAPY, V14, P122, DOI [10.1080/10874201003773500], DOI 10.1080/10874201003773500]; Thompson M, 2003, NEUROFEEDBACK BOOK I; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Tombaugh TN, 1996, TEST MEMORY MALINGER; U.S. Department of Health and Human Services Administration for Children and Families, 2005, CHILD MALTR 2003; US Department of Veterans Affairs, PTSD CHILDR AD; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Watts-English T, 2006, J SOC ISSUES, V62, P717, DOI 10.1111/j.1540-4560.2006.00484.x; Weathers F.W., 1991, PTSD CHECKLIST CIVIL; Wechsler D., 1995, WECHSLER ADULT INTEL; Yucha C., 2008, EVIDENCE BASED PRACT	80	11	12	0	26	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681	1942-969X		PSYCHOL TRAUMA-US	Psychol. Trauma	MAY	2012	4	3					330	337		10.1037/a0024229			8	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	941JI	WOS:000303959100011					2021-06-18	
J	Fischer, CM; Burkhardt, JK; Sarnthein, J; Bernays, RL; Bozinov, O				Fischer, Claudia M.; Burkhardt, Jan-Karl; Sarnthein, Johannes; Bernays, Rene Ludwig; Bozinov, Oliver			Aesthetic outcome in patients after polymethyl-methacrylate (PMMA) cranioplasty - a questionnaire-based single-centre study	NEUROLOGICAL RESEARCH			English	Article						Bone deformity; Cranioplasty; Polymethyl-methacrylate; PMMA; Aesthetic outcome; Questionnaire	TRAUMATIC BRAIN-INJURY; LARGE SKULL DEFECTS; POLYMETHYLMETHACRYLATE; RECONSTRUCTION; PROSTHESES; INFECTION; DESIGN; RATES	Objectives: Acquired skull deformities are common and most likely treated surgically by cranioplasty. Since data on patient aesthetic outcome after cranioplasty are rare in literature, we aimed to assess patient satisfaction after polymethyl-methacrylate (PMMA) cranioplasty in this study using a questionnaire. Methods: A patient questionnaire was developed to evaluate the grade of satisfaction after surgery. After approval by the institutional ethical review board, we were allowed to send to all 115 patients, who received a cranioplasty from 2001 to 2008 at the University Hospital of Zurich, our questionnaire once to retrospectively analyze the patient response together with the patient hospital records. Results: Out of 115 patients, 36 patients were lost to follow-up and our questionnaire was sent out once to 79 patients. Sixty-three of 79 patients replied to the questionnaire (79.7%) and 16 did not reply. Seventeen declined to participate in this study and out of the remaining 46 patients (58.2%, 18 women, mean age 54 years, range 20-83 years), who agreed to participate in this study, 22 (47.8%) judged their cranioplasty to be aesthetically 'excellent', 16 (34.8%) 'favorable' and 4 (8.7%) 'poor'. Another four patients (8.7%) were not satisfied, asking for a surgical revision. Patient age and gender was not related to the assessment of the aesthetic result. A higher satisfaction grade was found in patients with primary PMMA cranioplasty compared to PMMA cranioplasty implanted during a second surgery (Fisher's exact test, P=0.031). A dent was strongly associated with absence of satisfaction (P < 0.01, Fisher's exact test). Conclusion: Our questionnaire was suitable to assess patient satisfaction after cranioplasty. Localization of cranioplasty showed to be an important factor of aesthetic outcome, especially in the fronto-temporal region where a carefully planned reconstruction should be performed to guarantee an excellent grade of satisfaction after surgery.	[Fischer, Claudia M.; Burkhardt, Jan-Karl; Sarnthein, Johannes; Bernays, Rene Ludwig; Bozinov, Oliver] Univ Zurich, Univ Hosp, Dept Neurosurg, CH-8006 Zurich, Switzerland; [Burkhardt, Jan-Karl] Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA	Burkhardt, JK (corresponding author), Univ Zurich Hosp, Dept Neurosurg, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	JanKarl.Burkhardt@gmail.com	Sarnthein, Johannes/E-7959-2010	Sarnthein, Johannes/0000-0001-9141-381X; Bozinov, Oliver/0000-0002-4620-3992			Balossier A, 2011, NEUROCHIRURGIE, V57, P21, DOI 10.1016/j.neuchi.2010.08.003; Baumeister S, 2008, PLAST RECONSTR SURG, V122, p195E, DOI 10.1097/PRS.0b013e3181858eee; Bhargava D, 2010, ACTA NEUROCHIR, V152, P173, DOI 10.1007/s00701-009-0394-2; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bowles AP, 1999, SURG NEUROL, V52, P524, DOI 10.1016/S0090-3019(99)00112-3; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; Fathi AR, 2008, J CRANIOFAC SURG, V19, P777, DOI 10.1097/SCS.0b013e31816b1b2a; GLADSTONE HB, 1995, OTOLARYNG CLIN N AM, V28, P381; Jackson IT, 2000, BRIT J PLAST SURG, V53, P24, DOI 10.1054/bjps.1999.3236; Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088; Kelly BJ, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-65; Kongsved SM, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.3.e25; Kriegel RJ, 2007, ZBL NEUROCHIR, V68, P182, DOI 10.1055/s-2007-985857; LEE C, 1995, J CRANIO MAXILL SURG, V23, P133, DOI 10.1016/S1010-5182(05)80001-0; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Luparello D, 1998, Minerva Chir, V53, P575; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Oblu N, 1969, Rev Med Chir Soc Med Nat Iasi, V73, P911; Raza SM, 2008, NEUROSURGERY, V63, P262, DOI [10.1227/01.NEU.0000297011.27846.62, 10.1227/01.neu.0000317402.46583.c7]; Reichenberger MA, 2007, AESTHET PLAST SURG, V31, P397, DOI 10.1007/s00266-007-0009-3; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Trelle S, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-15; 홍기선, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P96	28	11	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2012	34	3					281	285		10.1179/1743132812Y.0000000007			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	922XR	WOS:000302582500009	22449405	Green Accepted			2021-06-18	
J	Furutani, R; Kibayashi, K				Furutani, Rui; Kibayashi, Kazuhiko			Morphological Alteration and Reduction of MAP2-Immunoreactivity in Pyramidal Neurons of Cerebral Cortex in a Rat Model of Focal Cortical Compression	JOURNAL OF NEUROTRAUMA			English	Article						apical and basilar dendrites; dendritic spine; focal cortical compression; microtubule-associated protein 2; pyramidal neuron	TRAUMATIC BRAIN-INJURY; ACUTE SUBDURAL-HEMATOMA; EXCITATORY AMINO-ACIDS; VISUAL-CORTEX; PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; DENDRITIC BUNDLES; NMDA RECEPTORS; PROTEIN; MAP2	Subdural hematoma causes cortical damage including brain tissue disruption, often resulting in neuronal dysfunction and neurological impairment. The aim of the present study was to identify the relationship between cerebral compression and neuronal injury. In this report, we investigated time-dependent morphological alterations within layers II, III, and V pyramidal neurons in the cerebral cortex, using Golgi-Cox staining and immunohistochemistry for microtubule-associated protein 2 (MAP2) in a rat model of focal cortical compression. An acryl pole was used to experimentally induce chronic cerebral compression by continuous pressure on the cortical surface. Changes in cellular morphology were examined at five survival time periods: 12 h and 1, 2, 3, and 4 weeks. The Golgi-Cox method revealed time-dependent alterations in dendritic length of apical and basilar dendrites of pyramidal neurons. The number of dendritic branch segments and spines of basilar dendrites were decreased in cells in layers II, III, and V. Immunohistochemical staining for MAP2 revealed changes in the intracellular distribution of immunoreactive materials. A significant reduction in MAP2 immunostaining was found in nerve cell bodies and apical dendrites of ipsilateral cortical neurons. The number of MAP2-immunoreactive neurons was significantly decreased at 12 h compared with the contralateral cerebral cortex in the same animal. Dendritic changes in layers II, III, and V pyramidal neurons were accompanied by reductions in intracellular MAP2-immunoreactive materials. The present results suggest that cortical compression causes alteration of cellular morphology as a consequence of injury, and that these morphological changes may be related to reductions in MAP2-immunoreactive materials.	[Furutani, Rui] Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan	Furutani, R (corresponding author), Tokyo Womens Med Univ, Dept Legal Med, Sch Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	furutani@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215			Akulinin VA, 2003, NEUROCHEM RES, V28, P373, DOI 10.1023/A:1022401922669; Audesirk G, 1997, DEV BRAIN RES, V102, P247, DOI 10.1016/S0165-3806(97)00100-4; Camilli P.D., 1984, NEUROSCIENCE, V11, P819; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Curtetti R, 2002, MECH AGEING DEV, V123, P473, DOI 10.1016/S0047-6374(01)00357-8; Dawson DA, 1996, J CEREBR BLOOD F MET, V16, P170, DOI 10.1097/00004647-199601000-00020; DERYCK M, 1992, BRAIN RES, V573, P44; Eijkenboom M, 2004, NEUROSCIENCE, V124, P523, DOI 10.1016/j.neuroscience.2003.11.019; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GABBOTT PLA, 1987, J COMP NEUROL, V259, P364, DOI 10.1002/cne.902590305; GHOSH S, 1987, J COMP NEUROL, V259, P424, DOI 10.1002/cne.902590309; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; GLASER EM, 1981, J NEUROSCI METH, V4, P117, DOI 10.1016/0165-0270(81)90045-5; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; HALPAIN S, 1990, NEURON, V5, P237, DOI 10.1016/0896-6273(90)90161-8; Hoskison MM, 2006, EXP NEUROL, V202, P302, DOI 10.1016/j.expneurol.2006.06.010; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Ichinohe N, 2003, EUR J NEUROSCI, V18, P1764, DOI 10.1046/j.1460-9568.2003.02900.x; KISVARDAY ZF, 1992, NEUROSCIENCE, V46, P275, DOI 10.1016/0306-4522(92)90050-C; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; LaBerge D, 2007, NEURAL NETWORKS, V20, P1004, DOI 10.1016/j.neunet.2007.09.006; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li GL, 2000, APMIS, V108, P98; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Perez-Cruz C, 2009, EUR J NEUROSCI, V29, P738, DOI 10.1111/j.1460-9568.2009.06622.x; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Sekino Y, 2006, MOL CELL NEUROSCI, V31, P493, DOI 10.1016/j.mcn.2005.11.003; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Takahashi H, 2003, J NEUROSCI, V23, P6586; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; Vercelli AE, 2004, EUR J NEUROSCI, V20, P495, DOI 10.1111/j.1460-9568.2004.03483.x; Vespa P., 2003, NEUROSURG FOCUS, V15, pA4; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858	45	11	12	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1266	1276		10.1089/neu.2010.1630			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100027	21401443				2021-06-18	
J	Gunther, M; Al Nimer, F; Gahm, C; Piehl, F; Mathiesen, T				Guenther, Mattias; Al Nimer, Faiez; Gahm, Caroline; Piehl, Fredrik; Mathiesen, Tiit			iNOS-mediated secondary inflammatory response differs between rat strains following experimental brain contusion	ACTA NEUROCHIRURGICA			English	Article						Neurotrauma; Neuroinflammation; TBI; Nitric oxide synthase; Peroxynitrite; Manganese superoxide dismutase; Dark Agouti; Piebald Virol Glaxo	NITRIC-OXIDE SYNTHASE; SPINAL-CORD INJURY; NON-MHC GENES; OXIDATIVE STRESS; PEROXYNITRITE; EXPRESSION; NEURODEGENERATION; NEUROPROTECTION; DEGENERATION; ACTIVATION	Nitric oxide is a key mediator of post-traumatic inflammation in the brain. We examined the expressions of iNOS, nNOS, and eNOS in inbred DA and PVGa rat strains where DA is susceptible to autoimmune neuroinflammation and PVGa-resistant. Parietal contusions using a weight drop model were produced in five rats per genotype. After 24 h, the brains were removed and analyzed using a range of immunohistochemical methods. PVGa presented significantly increased iNOS expression in infiltrating inflammatory cells in the perilesional area compared to DA (p < 0.05). The amount of w3/13-positive infiltrating inflammatory cells did not differ between strains. eNOS and nNOS expression did not differ between strains. iNOS-positive cells coexpressed neuronal (NeuN), macrophage (ED-1), and leucocyte (w3/13) markers. MnSOD was significantly increased in PVGa (p < 0.05). 3-Nitrotyrosine, a measure of peroxynitrite levels, and fluoro-jade stained neuronal degeneration, did not differ between strains. Two inbred rat strains with genetically determined differences in susceptibility to develop autoimmune disease displayed different levels of the inflammatory and anti-inflammatory mediators iNOS and MnSOD, indicating genetic regulation. Interestingly, the increased levels of iNOS did not lead to elevated expression of the neuronal cell-death marker fluoro-jade. The increased iNOS expression was correlated with increased expression of superoxide scavenger MnSOD. Excessive peroxynitrite formation was probably prevented by limitation of available superoxide. Subsequently, the higher expression of potentially deleterious iNOS in PVGa did not result in increased neuronal death.	[Guenther, Mattias; Al Nimer, Faiez; Gahm, Caroline; Piehl, Fredrik; Mathiesen, Tiit] Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg & Neuroimmunol, SE-17176 Stockholm, Sweden	Gunther, M (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg & Neuroimmunol, SE-17176 Stockholm, Sweden.	mattias.gunther@ki.se	Piehl, Fredrik/E-3451-2013; Nimer, Faiez Al/ABB-9465-2020; , Mattias/A-4442-2013	, Mattias/0000-0003-2372-6114; Mathiesen, Tiit/0000-0001-9463-1919; Al Nimer, Faiez/0000-0003-0937-5995; Piehl, Fredrik/0000-0001-8329-5219			Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Arteel GE, 1999, FEBS LETT, V445, P226, DOI 10.1016/S0014-5793(99)00073-3; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; BRADEN AWH, 1958, FERTIL STERIL, V9, P243; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Hooper DC, 2000, FASEB J, V14, P691; Inman D, 2002, J COMP NEUROL, V451, P225, DOI 10.1002/cne.10340; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Keller JN, 1998, J NEUROSCI, V18, P687; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Lorentzen JC, 1997, J NEUROIMMUNOL, V80, P31, DOI 10.1016/S0165-5728(97)00131-8; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Lundberg C, 2001, J COMP NEUROL, V431, P75; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Miljkovic D, 2004, CYTOKINE GROWTH F R, V15, P21, DOI 10.1016/j.cytogfr.2003.10.003; Noack H, 1998, GLIA, V23, P285, DOI 10.1002/(SICI)1098-1136(199808)23:4<285::AID-GLIA1>3.0.CO;2-2; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Ste-Marie L, 2001, BRAIN RES, V918, P10, DOI 10.1016/S0006-8993(01)02903-1; Steward O, 1999, EXP NEUROL, V157, P19, DOI 10.1006/exnr.1999.7040; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; WILSON DB, 1965, J EXP MED, V122, P143, DOI 10.1084/jem.122.1.143	47	11	11	0	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2012	154	4					689	697		10.1007/s00701-012-1297-1			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	912IA	WOS:000301788900019	22362050				2021-06-18	
J	John, CA; Day, MW				John, Cynthia (Cindi) A.; Day, Michael W.			Central Neurogenic Diabetes Insipidus, Syndrome of Inappropriate Secretion of Antidiuretic Hormone, and Cerebral Salt-Wasting Syndrome in Traumatic Brain Injury	CRITICAL CARE NURSE			English	Article								Central neurogenic diabetes insipidus, syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome are secondary events that affect patients with traumatic brain injury. All 3 syndromes affect both sodium and water balance; however, they have differences in pathophysiology, diagnosis, and treatment. Differentiating between hypernatremia (central neurogenic diabetes insipidus) and the 2 hyponatremia syndromes (syndrome of inappropriate secretion of antidiuretic hormone, and cerebral salt-wasting syndrome) is critical for preventing worsening neurological outcomes in patients with head injuries. (Critical Care Nurse. 2012;32[2]:e1-e8)	[John, Cynthia (Cindi) A.; Day, Michael W.] Providence Sacred Heart Med Ctr, Spokane, WA USA; [John, Cynthia (Cindi) A.; Day, Michael W.] Childrens Hosp, Spokane, WA USA	Day, MW (corresponding author), 12915 E Main Ave, Spokane Valley, WA 99216 USA.	cnsd_ccrn@yahoo.com					Boughey JC, 2004, AM SURGEON, V70, P500; Byrum D, 2009, AACN ADV CRITICAL CA, P939; Cooperman M, DIABETES INSIPIDUS; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Hickey J, 2009, CLIN PRACTICE NEUROL, P195; Klein MJ, POSTHEAD INJURY ENDO; Momi Jasminder, 2010, Perm J, V14, P62; Mortimer Diane Schretzman, 2006, J Neurosci Nurs, V38, P142; Palmer BF, 2003, TRENDS ENDOCRIN MET, V14, P182, DOI 10.1016/S1043-2760(03)00048-1; Pangilinan PH, CLASSIFICATION COMPL; Urdan L, 2006, THELANS CRITICAL CAR, P918; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; Zhang WC, 2010, J EMERG MED, V39, P151, DOI 10.1016/j.jemermed.2008.01.027	14	11	14	0	8	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	0279-5442	1940-8250		CRIT CARE NURSE	Crit. Care Nurse	APR	2012	32	2					E1	E8		10.4037/ccn2012904			8	Critical Care Medicine; Nursing	General & Internal Medicine; Nursing	025OV	WOS:000310201700001	22467619	Bronze			2021-06-18	
J	Meng, X; Browne, K; Huang, SM; Cullen, DK; Tofighi, MR; Rosen, A				Meng, X.; Browne, K.; Huang, S. M.; Cullen, D. K.; Tofighi, M. R.; Rosen, A.			Dynamic study of wireless intracranial pressure monitoring of rotational head injury in swine model	ELECTRONICS LETTERS			English	Article							SCALP	For what is believed to be for the first time, the dynamic study of wireless intracranial pressure measurements in a swine model of traumatic brain injury is described. This achieves an extremely important milestone, since the measurements demonstrate the system's robustness, and the feasibility of acquiring wireless readings of the intracranial pressure resulting from non-impact rotational head injury in swine. The fully implanted device uses a capacitive pressure sensor modulating an RF oscillator, coupled to a planar inverted-F antenna. The results match well those obtained from a standard fibre-optic based (tethered) commercial intracranial pressure monitor, as well as published literature data, and may enable a future trend in the use of implantable wireless systems for research or clinical diagnoses.	[Meng, X.; Huang, S. M.; Rosen, A.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Browne, K.; Cullen, D. K.] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Tofighi, M. R.] Penn State Univ, Capital Coll, Middletown, PA 17057 USA	Meng, X (corresponding author), Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.	xm26@drexel.edu	Huang, Shimin/X-6369-2019				Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Tofighi MR, 2006, ELECTRON LETT, V42, P148, DOI 10.1049/el:20063658	3	11	11	0	8	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	0013-5194			ELECTRON LETT	Electron. Lett.	MAR 29	2012	48	7					363	U92		10.1049/el.2012.0281			2	Engineering, Electrical & Electronic	Engineering	917NB	WOS:000302183300010					2021-06-18	
J	Mala, H; Castro, MR; Pearce, H; Kingod, SC; Nedergaard, SK; Scharff, Z; Zandersen, M; Mogensen, J				Mala, Hana; Castro, Maria Rodriguez; Pearce, Hadley; Kingod, Siff Camilla; Nedergaard, Signe Kjoer; Scharff, Zakaryiah; Zandersen, Maja; Mogensen, Jesper			Delayed intensive acquisition training alleviates the lesion-induced place learning deficits after fimbria-fornix transection in the rat	BRAIN RESEARCH			English	Article						Neurotrauma; Functional recovery; Place learning; Intensive training; Fimbria-fornix; Rat	INDUCED MOVEMENT THERAPY; PRIMARY MOTOR CORTEX; LONG-TERM-MEMORY; ALLOCENTRIC SPATIAL MEMORY; CONSTRAINT-INDUCED APHASIA; USE-DEPENDENT EXAGGERATION; BRAIN-INJURY; WATER-MAZE; BEHAVIORAL RECOVERY; STRATEGY SELECTION	This study evaluates the effects of two learning paradigms, intensive vs. baseline, on the posttraumatic acquisition of a water maze based place learning task. Rats were subjected either to a control operation (Sham) or to a fimbria-fornix (FF) transection, which renders the hippocampus dysfunctional and disrupts the acquisition of allocentric place learning. All animals were administered 30 post-lesion acquisition sessions, which spanned either 10 or 30 days. The acquisition period was followed by a 7 day pause after which a retention probe was administered. The lesioned animals were divided into 3 groups: i) Baseline Acquisition Paradigm (BAP) once daily for 30 days starting 1 week post-surgery; ii) Early Intensive Acquisition Paradigm (EIAP) 3 times daily for 10 days starting 1 week post-surgery; and Late Intensive Acquisition Paradigm (LIAP) 3 times daily for 10 days starting 3 weeks post-surgery. Within the control animals, one group followed the schedule of BAP, and one group followed the schedule of Intensive Acquisition Paradigm (IAP). All lesioned animals showed an impaired task acquisition. LIAP was beneficial in FF animals, in that it led to a better acquisition of the place learning task than the two other acquisition paradigms. The FF/EIAP group did not show improved acquisition compared to the FF/BAP group. The control animals were not differentially affected by the two learning schedules. The findings have implications for cognitive rehabilitation after brain injury and support the assumption that intensive treatment can lead to an improved learning, even when the neural structures underlying such a process are compromised. However, the timing of intensive treatment needs to be considered further. (C) 2012 Elsevier B.V. All rights reserved.	[Mala, Hana; Castro, Maria Rodriguez; Pearce, Hadley; Kingod, Siff Camilla; Nedergaard, Signe Kjoer; Scharff, Zakaryiah; Zandersen, Maja; Mogensen, Jesper] Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, DK-1353 Copenhagen K, Denmark	Mogensen, J (corresponding author), Univ Copenhagen, Unit Cognit Neurosci, Dept Psychol, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	jesper.mogensen@psy.ku.dk		Rytter, Hana Mala/0000-0002-2910-372X; Mogensen, Jesper/0000-0003-1959-581X	Danish Research CouncilDet Frie Forskningsrad (DFF)	The present study was supported by a grant from the Danish Research Council.	Alaei H, 2006, EUR J PHARMACOL, V536, P138, DOI 10.1016/j.ejphar.2006.02.025; Allred RP, 2008, EXP NEUROL, V210, P172, DOI 10.1016/j.expneurol.2007.10.010; Barbay S, 2006, EXP BRAIN RES, V169, P106, DOI 10.1007/s00221-005-0129-4; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bland ST, 2001, BEHAV BRAIN RES, V126, P33, DOI 10.1016/S0166-4328(01)00243-1; Boake C, 2007, NEUROREHAB NEURAL RE, V21, P14, DOI 10.1177/1545968306291858; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brasted PJ, 2003, BRAIN, V126, P1202, DOI 10.1093/brain/awg103; Briones TL, 2004, BRAIN RES, V997, P137, DOI 10.1016/j.brainres.2003.10.030; BUCHAN AM, 1990, BRAIN RES, V512, P7, DOI 10.1016/0006-8993(90)91163-B; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cain CK, 2003, J EXP PSYCHOL ANIM B, V29, P323, DOI 10.1037/0097-7403.29.4.323; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Comeau WL, 2010, BEHAV BRAIN RES, V214, P91, DOI 10.1016/j.bbr.2010.04.033; Commins S, 2003, BEHAV BRAIN RES, V139, P215, DOI 10.1016/S0166-4328(02)00270-X; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; de Araujo FLB, 2008, NEUROSCI LETT, V431, P179, DOI 10.1016/j.neulet.2007.11.038; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; DeBow SB, 2003, STROKE, V34, P1021, DOI 10.1161/01.STR.0000063374.89732.9F; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Farah CA, 2009, J NEUROSCI, V29, P10281, DOI 10.1523/JNEUROSCI.1533-09.2009; Friel KM, 2000, NEUROREHAB NEURAL RE, V14, P187, DOI 10.1177/154596830001400304; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; Gobbo OL, 2005, BEHAV BRAIN RES, V159, P21, DOI 10.1016/j.bbr.2004.09.021; GOODRICK CL, 1973, J EXP PSYCHOL, V98, P344, DOI 10.1037/h0034421; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hasselmo ME, 2010, BEHAV BRAIN RES, V215, P261, DOI 10.1016/j.bbr.2009.12.010; Herrera-Morales W, 2007, EUR J NEUROSCI, V25, P1581, DOI 10.1111/j.1460-9568.2007.05391.x; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Humm JL, 1998, BRAIN RES, V783, P286, DOI 10.1016/S0006-8993(97)01356-5; Janis LS, 1998, BEHAV BRAIN RES, V90, P23; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Kolb B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00204; Kornell N, 2008, PSYCHOL SCI, V19, P585, DOI 10.1111/j.1467-9280.2008.02127.x; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; LAHTINEN H, 1993, BRAIN RES BULL, V31, P311, DOI 10.1016/0361-9230(93)90223-X; Lavenex P, 2011, HIPPOCAMPUS, V21, P142, DOI 10.1002/hipo.20730; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; MacLellan CL, 2005, BRAIN RES, V1063, P40, DOI 10.1016/j.brainres.2005.09.027; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Mark VW, 2004, RESTOR NEUROL NEUROS, V22, P317; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; Meinzer M, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-28; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Meinzer M, 2010, NEUROIMAGE, V53, P283, DOI 10.1016/j.neuroimage.2010.06.004; Meinzer M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-20; Menke R, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-118; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Mogensen J, 2002, NEUROBIOL LEARN MEM, V78, P139, DOI 10.1006/nlme.2001.4055; Mogensen J, 2011, J CONSCIOUSNESS STUD, V18, P13; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Mogensen J, 2009, SCAND J PSYCHOL, V50, P561, DOI 10.1111/j.1467-9450.2009.00781.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murata Y, 2008, J NEUROPHYSIOL, V99, P773, DOI 10.1152/jn.01001.2007; Musicco M, 2003, ARCH PHYS MED REHAB, V84, P551, DOI 10.1053/apmr.2003.50084; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Nadeau SE, 2006, NEUROREHABILITATION, V21, P107; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Parslow DM, 2005, ACTA PSYCHOL, V118, P123, DOI 10.1016/j.actpsy.2004.10.006; Parslow DM, 2004, NEUROPSYCHOLOGY, V18, P450, DOI 10.1037/0894-4105.18.3.450; Philips GT, 2007, J NEUROSCI, V27, P13701, DOI 10.1523/JNEUROSCI.4262-07.2007; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; Ploughman M, 2007, BRAIN RES, V1150, P207, DOI 10.1016/j.brainres.2007.02.065; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Rogers JL, 2006, BEHAV NEUROSCI, V120, P852, DOI 10.1037/0735-7044.120.4.852; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; Seo HG, 2010, J KOREAN MED SCI, V25, P1638, DOI 10.3346/jkms.2010.25.11.1638; Shapiro ML, 2006, P NATL ACAD SCI USA, V103, P4287, DOI 10.1073/pnas.0508688103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Smith DM, 2006, HIPPOCAMPUS, V16, P716, DOI 10.1002/hipo.20208; Spreng M, 2002, BEHAV BRAIN RES, V128, P103, DOI 10.1016/S0166-4328(01)00266-2; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Sziklas V, 2002, HIPPOCAMPUS, V12, P543, DOI 10.1002/hipo.10030; Taub E, 2006, STROKE, V37, P1045, DOI 10.1161/01.STR.0000206463.66461.97; Taub E, 2003, J REHABIL MED, V35, P34, DOI 10.1080/16501960310010124; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Taub E, 1999, J REHABIL RES DEV, V36, P237; Taub E, 2006, NEUROREHABILITATION, V21, P93; Taub Edward, 2003, Phys Med Rehabil Clin N Am, V14, pS77, DOI 10.1016/S1047-9651(02)00052-9; Toppino TC, 2010, J EXP PSYCHOL LEARN, V36, P1480, DOI 10.1037/a0020949; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van der Lee JH, 2001, CURR OPIN NEUROL, V14, P741, DOI 10.1097/00019052-200112000-00010; Wais PE, 2011, HIPPOCAMPUS, V21, P9, DOI 10.1002/hipo.20716; WHISHAW IQ, 1988, BEHAV NEUROSCI, V102, P662, DOI 10.1037/0735-7044.102.5.662; Wilson BA, 2002, NEUROREHAB NEURAL RE, V16, P207, DOI 10.1177/0888439002016002003; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Yamaguchi Yoko, 2004, Journal of Integrative Neuroscience, V3, P143, DOI 10.1142/S0219635204000488; Zhao CS, 2009, TOHOKU J EXP MED, V218, P301, DOI 10.1620/tjem.218.301	113	11	11	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 22	2012	1445						40	51		10.1016/j.brainres.2012.01.035			12	Neurosciences	Neurosciences & Neurology	926KV	WOS:000302830800005	22322151				2021-06-18	
J	Yang, DM; Han, YX; Zhang, JF; Seyda, A; Chopp, M; Seyfried, DM				Yang, Dongmei; Han, Yuxia; Zhang, Jianfeng; Seyda, Agnieszka; Chopp, Michael; Seyfried, Donald M.			Therapeutic effect of human umbilical tissue-derived cell treatment in Rats with experimental intracerebral hemorrhage	BRAIN RESEARCH			English	Article						Intracerebral hemorrhage; Stem cells; Neurogenesis; Synaptogenesis	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; RODENT MODEL; BLOOD-CELLS; STROKE; CORD; RECOVERY; BENEFIT	Background and purpose: The present study examines whether human umbilical tissue-derived cells (hUTC) have a neuro-restorative effect and improve functional recovery after intracerebral hemorrhage (ICH) in rats. Methods: Primary ICH was induced in male Wistar rats by stereotactic injection of 100 mu L of autologous blood into the striatal region adjacent to the subventricular zone. Briefly, the rats were randomly divided into six groups, each group was intravenously injected either with 2 mL phosphate-buffered saline (PBS) or 3 million hUTC in PBS at 1, 3 or 7 days after ICH (n=8/group). To evaluate neurological functional outcome, each animal was subjected to the modified neurological severity score (mNSS) and corner turn tests at different time points after ICH. At four weeks post treatment, each group was anesthetized intraperitoneally, sacrificed, and brain tissues were processed histologically. Immunohistochemistry was employed to measure vascularity (vWF), neurogenesis (BrdU TUJ1, DCX and NeuN), synaptogenesis (synaptophysin) and apoptosis (TUNEL). Results: The hUTC-treated animals showed significantly improved neurological functional outcomes as assessed by mNSS and corner turn tests at 14, 21 and 28 days post-injection in each treatment group (P<0.05) as compared to the PBS controls. Animals treated with hUTC were seen to have significantly increased cell proliferation, vascularity and synaptogenesis, as well as reduced apoptosis in the hematoma rim compared to the corresponding control group (P<0.05). Conclusions: Intravenously infused hUTC have a beneficial effect after experimental ICH by functional and histochemical measurements of neural cell proliferation and synaptogenesis in the ICH border zone. This brain region also shows correlative evidence of neuronal recovery with increased vascularity. (C) 2012 Elsevier B.V. All rights reserved.	[Yang, Dongmei; Han, Yuxia; Zhang, Jianfeng; Seyfried, Donald M.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48202 USA; [Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Seyda, Agnieszka] Adv Technol & Regenerat Med LLC, Somerville, NJ 08876 USA	Seyfried, DM (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsdos@neuro.hfh.edu			Advanced Technologies and Regenerative Medicine, LLC	The research presented here was funded by Advanced Technologies and Regenerative Medicine, LLC, a Johnson & Johnson Affiliate.	Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Cheung RTF, 2007, REV RECENT CLIN TRIA, V2, P174, DOI 10.2174/157488707781662751; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Christensen MC, 2009, STROKE, V40, P1677, DOI 10.1161/STROKEAHA.108.538967; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Gomicka-Pawlak el B., ACTA NEUROBIOL EXP W, V71, P46; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Gorski JA, 2003, J NEUROSCI, V23, P6856; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Liao WB, 2009, CELL PHYSIOL BIOCHEM, V24, P307, DOI 10.1159/000233255; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Matsuoka N, 2003, STROKE, V34, P1519, DOI 10.1161/01.STR.0000070840.56414.3B; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Seyfried DM, 2009, INT J STROKE, V4, P250, DOI 10.1111/j.1747-4949.2009.00292.x; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Seyfried DM, 2010, J NEUROSURG, V112, P329, DOI 10.3171/2009.2.JNS08907; Skidmore CT, 2002, NEUROSURG CLIN N AM, V13, P281, DOI 10.1016/S1042-3680(02)00019-0; Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	38	11	12	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAR 20	2012	1444						1	10		10.1016/j.brainres.2012.01.024			10	Neurosciences	Neurosciences & Neurology	914PD	WOS:000301962600001	22341873				2021-06-18	
J	Kostka, T; Furgal, W; Gawronski, W; Bugajski, A; Czamara, A; Klukowski, K; Krysztofiak, H; Lewicki, R; Szygula, Z; Tomaszewski, W; Trzaska, T; Widuchowski, J; Ziemba, A; Jegier, A				Kostka, Tomasz; Furgal, Witold; Gawronski, Wojciech; Bugajski, Andrzej; Czamara, Andrzej; Klukowski, Krzysztof; Krysztofiak, Hubert; Lewicki, Romuald; Szygula, Zbigniew; Tomaszewski, Wieslaw; Trzaska, Tadeusz; Widuchowski, Jerzy; Ziemba, Andrzej; Jegier, Anna		Polish Soc Sports Med	Recommendations of the Polish Society of Sports Medicine on age criteria while qualifying children and youth for participation in various sports	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; RISK-FACTORS; INJURY RATES; BRAIN-INJURY; CONCUSSION; HEAD; EPIDEMIOLOGY; BOXERS		[Kostka, Tomasz] Med Univ Lodz, Fac Hlth Sci, Polish Soc Sports Med, PL-90647 Lodz, Poland; [Furgal, Witold] MEDIVITSPORT Hlth Ctr, Tarnobrzeg, Poland; [Gawronski, Wojciech; Szygula, Zbigniew] Univ Sch Phys Educ, Dept Sports Med, Krakow, Poland; [Bugajski, Andrzej; Czamara, Andrzej; Tomaszewski, Wieslaw] Coll Physiotherapy, Wroclaw, Poland; [Klukowski, Krzysztof] Univ Phys Educ, Chair Physiotherapy, Warsaw, Poland; [Krysztofiak, Hubert] Natl Ctr Sports Med, Warsaw, Poland; [Lewicki, Romuald] Inst Med Educ, Kielce, Poland; [Trzaska, Tadeusz] Univ Phys Educ, Dept Traumatol Sports, Poznan, Poland; [Widuchowski, Jerzy] Ctr Arthroscopy & Knee Surg, Piekary Slaskie, Poland; [Ziemba, Andrzej] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Appl Physiol, Warsaw, Poland; [Jegier, Anna] Med Univ Lodz, Dept Sports Med, Lodz, Poland	Kostka, T (corresponding author), Med Univ Lodz, Fac Hlth Sci, Polish Soc Sports Med, Pl Hallera 1, PL-90647 Lodz, Poland.	tomaszkostka@wp.pl	Czamara, Andrzej/N-2597-2018; Krysztofiak, Hubert/L-8083-2019; Gawronski, Wojciech/AAM-4585-2020	Czamara, Andrzej/0000-0002-2713-5090; Krysztofiak, Hubert/0000-0003-4567-1433; Szygula, Zbigniew/0000-0002-6685-6579; Ziemba, Andrzej/0000-0002-1987-3050			Adesunkanmi ARK, 1998, J TRAUMA, V44, P506, DOI 10.1097/00005373-199803000-00015; Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Anderson SJ, 2000, PEDIATRICS, V106, P154, DOI 10.1542/peds.106.1.154; [Anonymous], 2009, SPR ZAKR KON BAD LEK; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Blanpain R, 2002, LEGAL STATUS SPORTSM; Caine D, 2008, CLIN SPORT MED, V27, P19, DOI 10.1016/j.csm.2007.10.008; Caine D, 2006, CLIN J SPORT MED, V16, P500, DOI 10.1097/01.jsm.0000251181.36582.a0; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; David P., 2005, HUMAN RIGHTS YOUTH S; European Commission, 2007, STUD TRAIN YOUNG SPO; European Commission, 2009, WHIT PAP SPORT; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Frisch A, 2009, BRIT MED BULL, V92, P95, DOI 10.1093/bmb/ldp034; Furgal W, 2005, MEDYCYNA SPORTOWA, P747; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Knowles SB, 2010, BRIT J SPORT MED, V44, P38, DOI 10.1136/bjsm.2009.065763; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Maffulli N, 2010, BRIT J SPORT MED, V44, P21, DOI 10.1136/bjsm.2009.069526; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McGuine T, 2006, CLIN J SPORT MED, V16, P488, DOI 10.1097/01.jsm.0000248848.62368.43; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michell LJ, 1998, B WORLD HEALTH ORGAN, V76, P445; Morrison AB, 2007, BRIT J SPORT MED, V41, P852, DOI [10.1136/bjsm.2007.034827, 10.1136/bjsm.2006.034827]; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Steffen K, 2010, BRIT J SPORT MED, V44, P485, DOI 10.1136/bjsm.2010.073833; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Washington RL, 2001, PEDIATRICS, V107, P1459; Wingfield K, 2004, CLIN J SPORT MED, V14, P109, DOI 10.1097/00042752-200405000-00002; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn TR, 2008, NEUROL CLIN, V26, P257, DOI 10.1016/j.ncl.2007.11.004; Zazryn T, 2007, SPORTS MED, V37, P467; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	40	11	11	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2012	46	3					159	162		10.1136/bjsports-2011-090043			4	Sport Sciences	Sport Sciences	894WL	WOS:000300458100003	21948125	Green Published, Bronze			2021-06-18	
J	Nelson, DV; Esty, ML				Nelson, David V.; Esty, Mary Lee			Neurotherapy of Traumatic Brain Injury/Posttraumatic Stress Symptoms in OEF/OIF Veterans	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							INJURY; IRAQ; DISORDER; OUTCOMES	The Flexyx Neurotherapy System (FNS), a novel variant of EEG biofeedback, was adapted for intervention with seven treatment-refractory Afghanistan/Iraq war veterans, and brought about significant decreases in bothersome neurobehavioral and posttraumatic stress symptoms. FNS may help ameliorate mixed trauma spectrum syndromes. (The Journal of Neuropsychiatry and Clinical Neurosciences 2012; 24:237-240)	[Nelson, David V.; Esty, Mary Lee] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77341 USA; [Nelson, David V.; Esty, Mary Lee] Brain Wellness & Biofeedback Ctr Washington, Bethesda, MD USA	Nelson, DV (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, Box 2447, Huntsville, TX 77341 USA.	nelsondv@shsu.edu					Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; Mueller HH, 2001, J CLIN PSYCHOL, V57, P933, DOI 10.1002/jclp.1060; Ochs L, 2006, J NEUROTHER, V10, P5, DOI DOI 10.1300/J184V10N02_02; Ochs L, 1930, FLEXYX NEUROTHERAPY, P1997; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8	15	11	12	0	8	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2012	24	2					237	240		10.1176/appi.neuropsych.11020041			4	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	972MN	WOS:000306281300112	22772672				2021-06-18	
J	Shi, W; Gong, PP; Fan, J; Yan, YH; Ni, LC; Wu, XH; Cui, G; Wu, XM; Gu, XX; Chen, J				Shi, Wei; Gong, Peipei; Fan, Jian; Yan, Yao Hua; Ni, Lanchun; Wu, Xiaohong; Cui, Gang; Wu, Xinmin; Gu, Xingxing; Chen, Jian			The expression pattern of ADP-ribosyltransferase 3 in rat traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						ART3; Traumatic brain injury; Apoptosis; GAP43; Neurons; Rat	DIFFUSE AXONAL INJURY; GLIAL PROLIFERATION; RIBOSYLATION; NEUROGENESIS; SUBSTRATE; APOPTOSIS; TOXIN; NEUROPROTECTION; MECHANISMS; INHIBITION	Mammalian ecto ADP-ribosyltransferases (ARTs) can regulate the biological functions of various types of cells by catalyzing the transfer of single ADP-ribose moiety from NAD(+) to a specific amino acid in a target protein. ART3 is a member of the known ART family which is involved in cell division, DNA-repair and the regulation of the inflammatory response. To elucidate the expression, cellular localization and possible functions of ART3 in central nervous system (CNS) lesion and repair, we performed an acute traumatic brain injury model in adult rats. Western blot analysis showed that the expression of ART3 in ipsilateral brain cortex increased, then reached a peak at day 3 after traumatic brain injury (TBI), and gradually declined during the following days. But in the contralateral brain cortex, no obvious alterations were observed. Immunohistochemistry revealed the highly significant accumulation of ART3 at the ipsilateral brain in comparison to contralateral cerebral cortex. Double immunofluorescence labeling suggested that ART3 was localized mainly in the plasmalemma of neurons, but not in astrocytes or microglias within 3 mm from the lesion site at day 3 post-injury. In addition, we detected the expression profiles of caspase-3 and growth associated protein 43 (GAP-43) whose changes were correlated with the expression profiles of ART3 in this TBI model. Besides, co-localization of ART3/active caspase-3 and ART3/GAP43 were detected in NeuN-positive cells, respectively. Moreover, Pheochromocytoma (PC12) cells were treated with H2O2 to establish an apoptosis model. The results showed that the expression of ART3 was increased in the concentration and time dependence way. To further examine the involvement of ART3 in apoptosis of PC12, 3-Methoxybenzamide was used in flow cytometry analysis of apoptotic cells stained with Annexin V and PI. The experimental group in which 3-Methoxybenzamide used had a relative low level of apoptotic index compared with the untreated group. Together with previous reports, we hypothesize that ART3 may play important roles in CNS pathophysiology after TBI and further research is needed to have a good understanding of its function and mechanism.	[Shi, Wei; Gong, Peipei; Yan, Yao Hua; Ni, Lanchun; Wu, Xiaohong; Cui, Gang; Wu, Xinmin; Gu, Xingxing; Chen, Jian] Nantong Univ, Dept Neurosurg, Surg Comprehens Lab, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China; [Fan, Jian] Nantong Univ, Dept Neurosurg, Affiliated Qidong People Hosp, Nantong 226200, Jiangsu, Peoples R China	Chen, J (corresponding author), Nantong Univ, Dept Neurosurg, Surg Comprehens Lab, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.	chenjian1107@126.com	Yu, Hongwei/L-3754-2017	Yu, Hongwei/0000-0002-5607-0628	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870320, 31070723, 81070275, 81171139, 81172879]; Natural Science Foundation of Jiangsu provinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009161, BK2010169]; Nature Science Foundation of China Ministry of Health [2010-2-025]; Key Project Nature Science Foundation of Jiangsu Colleges and Universities [11KJA310002]; Nature Science Foundation of Jiangsu Colleges and Universities [09KJB320011]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 30870320, No. 31070723, No. 81070275, No. 81171139 and No. 81172879); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009161 and No. BK2010169); Nature Science Foundation of China Ministry of Health (2010-2-025); Key Project Nature Science Foundation of Jiangsu Colleges and Universities (No. 11KJA310002); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adriouch S, 2001, J IMMUNOL, V167, P196, DOI 10.4049/jimmunol.167.1.196; Balducci E, 2007, FEBS LETT, V581, P4199, DOI 10.1016/j.febslet.2007.07.061; BENOWITZ LI, 1991, PROG BRAIN RES, V89, P69; Braren R, 1998, BIOCHEM J, V336, P561, DOI 10.1042/bj3360561; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; COGGINS PJ, 1993, FEBS LETT, V335, P109, DOI 10.1016/0014-5793(93)80450-9; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; DELOULME JC, 1990, J CELL BIOL, V111, P1559, DOI 10.1083/jcb.111.4.1559; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DUMAN RS, 1991, J NEUROCHEM, V57, P2124, DOI 10.1111/j.1471-4159.1991.tb06431.x; Emery DL, 2000, J COMP NEUROL, V424, P521; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Friednich M, 2006, BBA-GENE STRUCT EXPR, V1759, P270, DOI 10.1016/j.bbaexp.2006.06.004; Friedrich M, 2006, ASIAN J ANDROL, V8, P281, DOI 10.1111/j.1745-7262.2006.00125.x; Grahnert A, 2002, BIOCHEM J, V362, P717, DOI 10.1042/0264-6021:3620717; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hong SY, 2009, PURINERG SIGNAL, V5, P369, DOI 10.1007/s11302-009-9162-2; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Koch-Nolte F, 1997, GENOMICS, V55, P130; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Levy I, 1996, FEBS LETT, V382, P276, DOI 10.1016/0014-5793(96)00183-4; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; Lodhi IJ, 2001, ARCH BIOCHEM BIOPHYS, V387, P66, DOI 10.1006/abbi.2000.2215; LOGAN A, 1992, J NEUROSCI, V12, P3828; LUDDEN PW, 1994, MOL CELL BIOCHEM, V138, P123, DOI 10.1007/BF00928453; Moss J, 1990, SCIENCE, V250, P841; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	45	11	12	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	FEB	2012	43	1					37	47		10.1007/s10735-011-9366-y			11	Cell Biology	Cell Biology	880AL	WOS:000299376400005	22037978				2021-06-18	
J	Amato, S; Resan, M; Mion, L				Amato, Shelly; Resan, Marian; Mion, Lorraine			The Feasibility, Reliability, and Clinical Utility of the Agitated Behavior Scale in Brain-Injured Rehabilitation Patients	REHABILITATION NURSING			English	Article						brain injury; research: quantitative; safety issues	PHYSICAL RESTRAINT USE; PREVALENCE	Patients with traumatic brain injury often experience physical and cognitive impairments as well as agitation requiring additional care to maintain a safe and therapeutic environment. Purpose: The aim of this study was to determine the feasibility, reliability and clinical utility of the Agitated Behavior Scale (ABS) as part of routine rehabilitation nursing assessment. Method: A prospective descriptive study was conducted on a brain injury rehabilitation unit consisting of a sample of 51 patients who were consecutively admitted over 4 months to a rehabilitation unit. Findings: Results showed that the tool was completed on the majority of nursing shifts, had high interrater agreement, and distinguished patients who were on constant observation or physically restrained. Conclusion and Clinical Relevance: The ABS can be used as an objective measure for nurses to guide the initiation and evaluate the effectiveness of various care strategies.	[Amato, Shelly] MetroHlth Rehabil Inst Ohio, Brain Injury & Stroke Rehabil Unit, Cleveland, OH USA; [Resan, Marian] MetroHlth Med Ctr Rehabil Nursing, Traumat Brain Injury Unit, Cleveland, OH USA; [Mion, Lorraine] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA	Amato, S (corresponding author), MetroHlth Rehabil Inst Ohio, Brain Injury & Stroke Rehabil Unit, Cleveland, OH USA.	samato@metrohealth.org					Bailey M, 2009, REHABIL NURS, V34, P11, DOI 10.1002/j.2048-7940.2009.tb00242.x; Beaulieu C, 2008, J HEAD TRAUMA REHAB, V23, P304, DOI 10.1097/01.HTR.0000336843.60961.b7; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Flanagan SR, 2009, PM&R, V1, P76, DOI 10.1016/j.pmrj.2008.10.013; Gordon V, 1999, Outcomes Manag Nurs Pract, V3, P153; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Levy M, 2005, NEUROREHABILITATION, V20, P279; Minnick AF, 1998, J NURS ADMIN, V28, P19, DOI 10.1097/00005110-199811000-00007; Minnick AF, 2007, J NURS SCHOLARSHIP, V39, P30, DOI 10.1111/j.1547-5069.2007.00140.x; Montgomery P, 1997, Rehabil Nurs, V22, P20; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114	17	11	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	JAN-FEB	2012	37	1					19	24		10.1002/RNJ.00001			6	Nursing; Rehabilitation	Nursing; Rehabilitation	998GG	WOS:000308224900004	22271217				2021-06-18	
J	Brown, CVR; Sowery, L; Curry, E; Valadka, AB; Glover, CS; Grabarkewitz, K; Green, T; Hail, S; Admire, J				Brown, Carlos V. R.; Sowery, Lauren; Curry, Eardie; Valadka, Alex B.; Glover, Cynthia S.; Grabarkewitz, Kim; Green, Terry; Hail, Steve; Admire, John			Recombinant Factor VIIa to Correct Coagulopathy in Patients with Traumatic Brain Injury Presenting to Outlying Facilities Before Transfer to the Regional Trauma Center	AMERICAN SURGEON			English	Article								Timely correction of coagulopathy in patients with traumatic brain injury (TBI) improves mortality. Recombinant, activated factor VII (VIIa) has been identified as an effective method to correct coagulopathy in patients with TBI. We performed a retrospective study (January 1, 2008-December 31, 2009) of all patients with TBI and coagulopathy (international normalized ratio (INR) > 1.5) transferred to our Level I trauma center. Twenty-three patients with coagulopathy and TBI were transferred to our trauma center, 100 per cent sustained a fall, and 100 per cent were taking warfarin at the time of injury. Ten patients received VIIa to correct coagulopathy before transfer, whereas 13 did not. The purpose of this study was to compare outcomes in patients who received VIIa with those who did not. When comparing the VIIa group with the no-VIIa group there was no difference in age, gender, Glasgow Coma Scale score, injury severity score, transfer time, or INR at outlying facility. Both groups received one unit of plasma before arrival at our trauma center; patients in the VIIa group received a single 1.2 mg dose of VIIa at the outlying facility. Upon arrival to our trauma center the VIIa group had a lower INR (1.0 vs 3.0, P = 0.02) and lower mortality (0% vs 39%, P = 0.03). In coagulopathic patients with TBI presenting to outlying institutions with limited resources to quickly provide plasma, VIIa efficiently corrects coagulopathy before transfer to definitive care at the regional trauma center. More rapid correction of coagulopathy with VIIa in this patient population may improve mortality.	[Brown, Carlos V. R.; Sowery, Lauren; Curry, Eardie; Valadka, Alex B.; Admire, John] Univ Texas Southwestern Austin, Univ Med Ctr Brackenridge, Austin, TX USA; [Glover, Cynthia S.] Seton Highland Lakes Med Ctr, Burnet, TX USA; [Grabarkewitz, Kim] Seton Edgar B Davis Hosp, Luling, TX USA; [Green, Terry] Seton Southwest Healthcare Ctr, Austin, TX USA; [Hail, Steve] Seton Med Ctr Williamson, Round Rock, TX USA	Brown, CVR (corresponding author), Univ Med Ctr Brackenridge, Trauma Serv, 601 East 15th St, Austin, TX 78701 USA.	CVRBrown@seton.org					Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; MEYER J, 2001, AGE 2000 CENSUS 2000; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a	9	11	12	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JAN	2012	78	1					57	60					4	Surgery	Surgery	V32LQ	WOS:000208953100035	22273315				2021-06-18	
J	Drebing, CE; Bell, M; Campinell, EA; Fraser, R; Malec, J; Penk, W; Pruitt-Stephens, L				Drebing, Charles E.; Bell, Morris; Campinell, E. Anthony; Fraser, Robert; Malec, James; Penk, Walter; Pruitt-Stephens, Laura			Vocational services research: Recommendations for next stage of work	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						design; employment; measurement; methodology outcomes; rehabilitation; research; vocational rehabilitation; vocational services work	TRAUMATIC BRAIN-INJURY; SEVERE MENTAL-ILLNESS; RANDOMIZED CONTROLLED-TRIAL; NEUROCOGNITIVE ENHANCEMENT THERAPY; COGNITIVE-BEHAVIORAL THERAPY; SUPPORTED EMPLOYMENT; FIDELITY SCALE; JOB PLACEMENT; OUTCOMES; REHABILITATION	As the field of vocational services (VS) research matures, it is necessary to review its progress and identify any important gaps in measurement and methodology that may hamper future efforts. To encourage progress, we have identified (1) ways to increase consistency in measuring employment outcomes, (2) emerging patterns and lingering gaps in the range of variables and measures commonly used in VS research, (3) broader methodological patterns and needs in the area of study design and sampling, (4) interventions that warrant additional study, and (5) broad strategies to increase the overall amount and quality of VS research. The goal of this article is to assist the field in achieving clearer coherence in shared expectations and standards for research so that the field can consolidate its gains as it helps people successfully return to rewarding jobs in the community.	[Drebing, Charles E.] Bedford Dept Vet Affairs Med Ctr, Psychol Serv, Bedford, MA USA; [Bell, Morris] Yale Univ, Dept Psychiat, West Haven, CT USA; [Campinell, E. Anthony] Vet Hlth Adm, Off Mental Hlth Serv, Lowell, MA USA; [Fraser, Robert] Univ Washington, Dept Neurol Neurol Surg & Rehabil Med, Seattle, WA 98195 USA; [Malec, James] Indiana Univ Sch Med, Indianapolis, IN USA; [Malec, James] Rehabil Hosp Indiana, Indianapolis, IN USA; [Penk, Walter] Texas A&M Univ Hlth Sci Ctr, Coll Med, Bryan, TX USA; [Pruitt-Stephens, Laura] Texas A&M Univ, College Stn, TX USA	Drebing, CE (corresponding author), Bedford VAMC, 200 Springs Rd 116B, Bedford, MA 01730 USA.	charles.drebing@va.gov			VHA Office of Research and Development; New England Mental Illness Research Education and Clinical Center	This material is based on work supported by the VHA Office of Research and Development and the New England Mental Illness Research Education and Clinical Center.	[Anonymous], 2001, INT CLASS FUNCT DIS; [Anonymous], 2002, DIAGN STAT MAN MENT; [Anonymous], 2002, PRES NEW FREED COMM; Becker DR., 1993, WORKING LIFE INDIVID; Bedell JR, 1998, PSYCHIATR REHABIL J, V21, P279, DOI 10.1037/h0095301; BELL M, 2003, J VOCATIONAL REHABIL, V18, P43; Bell MD, 2007, J NORWEGIAN PSYCHOL, V44, P606; Bell MD, 2008, SCHIZOPHR RES, V105, P18, DOI 10.1016/j.schres.2008.06.026; Bell MD, 2005, J REHABIL RES DEV, V42, P829, DOI 10.1682/JRRD.2005.03.0061; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; Black W, 2004, BR J OCCUP THER, V67, P526, DOI DOI 10.1177/030802260406701202; Bond, 2003, J VOCATIONAL REHABIL, V18, P59; Bond GR, 2007, J CONSULT CLIN PSYCH, V75, P968, DOI 10.1037/0022-006X.75.6.968; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Bond GR, 2010, RES SOCIAL WORK PRAC, V20, P493, DOI 10.1177/1049731509358085; Bond GR, 1997, REHABIL COUNS BULL, V40, P265; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Bruyere SM, 2006, REHABIL COUNS BULL, V50, P46, DOI 10.1177/00343552060500010601; Bush PW, 2009, PSYCHIAT SERV, V60, P1024, DOI 10.1176/appi.ps.60.8.1024; Campbell K, 2007, J VOCAT REHABIL, V27, P3; Chalamat M, 2005, AUST NZ J PSYCHIAT, V39, P693, DOI 10.1080/j.1440-1614.2005.01653.x; Chan ASM, 2009, AM J OCCUP THER, V63, P238, DOI 10.5014/ajot.63.3.238; Chandler D, 1999, PSYCHIATR REHABIL J, V23, P24, DOI 10.1037/h0095198; Cimera RE, 2009, J APPL REHABILITATIO, V40, P28; Conley R, 2009, J VOCAT REHABIL, V31, P19, DOI 10.3233/JVR-2009-0468; Connors SH, 2001, RESOURCE FACILITATIO; Cook JA, 2006, J VOCAT REHABIL, V25, P71; Cook JA, 2008, PSYCHIATR REHABIL J, V31, P291, DOI 10.2975/31.4.2008.291.295; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corthell DW, 1990, TRAUMATIC BRAIN INJU; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; CURL RM, 1993, J VOCATIONAL REHABIL, V3, P72; Drebing C.E., 2006, PSYCHOL SERV, V3, P181, DOI DOI 10.1037/1541-1559.3.3.181; Drebing CE, 2005, J APPL BEHAV ANAL, V38, P359, DOI 10.1901/jaba.2005.100-03; Drebing CE, 2004, REHABIL COUNS BULL, V47, P162, DOI 10.1177/00343552040470030501; Drebing CE, 2005, P ANN CONV AM PSYCH; Drebing CE, 2007, J REHABIL RES DEV, V44, P851, DOI 10.1682/JRRD.2006.09.0123; Evans R W, 1991, J Insur Med, V23, P192; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Fraser VV, 2008, PSYCHIATR REHABIL J, V31, P332, DOI 10.2975/31.4.2008.332.339; Gowdy EA, 2004, PSYCHIATR REHABIL J, V28, P150, DOI 10.2975/28.2004.150.156; Greenberg GA, 2007, MIL MED, V172, P162, DOI 10.7205/MILMED.172.2.162; Griffin C, 2008, J VOCAT REHABIL, V28, P135; Gutman SA, 2009, AM J OCCUP THER, V63, P245, DOI 10.5014/ajot.63.3.245; Hagner D, 2000, REHABIL COUNS BULL, V44, P22, DOI 10.1177/003435520004400104; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hser YI, 2004, PSYCHIAT SERV, V55, P767, DOI 10.1176/appi.ps.55.7.767; Humphreys K, 1997, J STUD ALCOHOL, V58, P231, DOI 10.15288/jsa.1997.58.231; Koop JI, 2004, PSYCHIATR REHABIL J, V28, P16, DOI 10.2975/28.2004.16.24; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lawer L, 2009, J AUTISM DEV DISORD, V39, P487, DOI 10.1007/s10803-008-0649-4; Liberman R., 2008, RECOVERY DISABILITY; Lysaker PH, 2009, SCHIZOPHR RES, V107, P186, DOI 10.1016/j.schres.2008.10.018; Lysaker PH, 2005, J REHABIL RES DEV, V42, P673, DOI 10.1682/JRRD.2004.12.0157; Macias C, 2009, ADM POLICY MENT HLTH, V36, P331, DOI 10.1007/s10488-009-0224-0; Magura S, 2007, SUBST USE MISUSE, V42, P811, DOI 10.1080/10826080701202403; Malec J, 2005, REHABILITATION TRAUM; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; McKay C, 2005, PSYCHIATR REHABIL J, V29, P25, DOI 10.2975/29.2005.25.33; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; Mueller L, 2008, P 117 ANN M AM PSYCH; Mueser KT, 1997, J NERV MENT DIS, V185, P419, DOI 10.1097/00005053-199707000-00001; Noone W, 2002, COMMUNITY BASED EMPL; Ouellet MC, 2009, J HEAD TRAUMA REHAB, V24, P262, DOI 10.1097/HTR.0b013e3181a68b73; Penk W, 2009, PSYCHIATR REHABIL J, V33, P297, DOI 10.2975/33.4.2010.297.307; Pinsk J, 2008, P VA C TRANSF MENT H; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; Prochaska J.O., 1986, TREATING ADDICTIVE B; Resnick S. G., 2006, PSYCHOL SERV, V3, P239, DOI DOI 10.1037/1541-1559.3.4.239; Rudnick A, 2009, PSYCHIAT SERV, V60, P1690, DOI 10.1176/ps.2009.60.12.1690; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schneider J, 2009, HEALTH SOC CARE COMM, V17, P151, DOI 10.1111/j.1365-2524.2008.00810.x; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shankar J, 2008, SOC WORK MENT HEALTH, V7, P271, DOI 10.1080/15332980802072603; Silverman K, 2007, J APPL BEHAV ANAL, V40, P387, DOI 10.1901/jaba.2007.40-387; Siu PSK, 2010, J VOCAT REHABIL, V32, P15, DOI 10.3233/JVR-2010-0491; Stewart M, 2000, J FAM PRACTICE, V49, P796; THOMAS DF, 1993, COMMUNITY BASED EMPL; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Warburton J, 2008, EUR J AGEING, V5, P129, DOI 10.1007/s10433-008-0081-9; Warner R, 2006, PSYCHIAT SERV, V57, P1488, DOI 10.1176/appi.ps.57.10.1488; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WEHMAN P, 1993, COMMUNITY BASED EMPL; Wong CJ, 2004, EXP CLIN PSYCHOPHARM, V12, P39, DOI 10.1037/1064-1297.12.1.39; Wong CJ, 2007, SUBST USE MISUSE, V42, P1127, DOI 10.1080/10826080701407952; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946	92	11	11	0	17	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	1					101	119		10.1682/JRRD.2010.06.0105			19	Rehabilitation	Rehabilitation	149ES	WOS:000319302400011	22492342	Bronze			2021-06-18	
J	Edmed, SL; Sullivan, KA				Edmed, Shannon L.; Sullivan, Karen A.			Base Rates of Postconcussion Syndrome by Method of Symptom Report	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						assessment; base rates; mild traumatic brain injury; postconcussion syndrome	POST-CONCUSSION SYMPTOMS; TRAUMATIC BRAIN-INJURY; PEOPLE; INTERVIEW; CRITERIA	This study compared the base rate of postconcussion syndrome (PCS) symptoms using three different assessment methods in a nonclinical sample. Seventy-three university students with no history of brain injury or neurological disease reported symptoms experienced during the previous 2 weeks in response to an open-ended question, a structured interview (simulated), and the British Columbia Postconcussion Symptom Inventory (BC-PSI). Statistically significant differences (all p < .001, d = 1.80-3.93, large effect sizes) were found between the number of symptoms reported on all assessment methods, such that participants reported the most PCS symptoms on the BC-PSI (M = 9.45, SD = 2.52), followed by the structured interview (M = 5.58, SD = 2.02), and the open-ended question (M = 1.86, SD = 1.00). Further, 100%, 92.1%, and 25.4% of the sample reported three or more ICD-10 Category C PCS symptoms on the BC-PSI, structured interview, and open-ended question, respectively. Findings suggest that method of assessment influences PCS base rates, such that symptom elicitation decreases relative to the reduction in prompting associated with each assessment method. Therefore, different diagnostic conclusions may be drawn depending on method of assessment used. Clinicians need to consider how their chosen assessment method may be influencing the symptoms reported by their patients.	[Edmed, Shannon L.; Sullivan, Karen A.] Queensland Univ Technol, Sch Psychol & Counseling, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Sullivan, Karen A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia	Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counseling, Clin Neuropsychol Res Grp, Victoria Pk Rd,O Block,B Wing,Room 523, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au			School of Psychology and Counseling, Queensland University of Technology	This study was supported in part by a research funding allocation to Miss Shannon Edmed, and allocation to support manuscript completion to Associate Professor Karen Sullivan by the School of Psychology and Counseling, Queensland University of Technology. The research protocol was assessed and approved by The Queensland University of Technology Human Research Ethics Committee (QUT Ref no: 1000000311) and by occupational workplace health and safety officers.	Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Gouvier WD, 1998, CRIT ISS NE, P55; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Lovibond P.F., 1995, MANUAL DESPRESSION A; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stapleton E, 2008, J LARYNGOL OTOL, V122, P139, DOI 10.1017/S0022215107009073; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tabachnick BG, 2007, USING MULTIVARIATE S; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3	25	11	11	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2012	19	3					164	170		10.1080/09084282.2011.643961			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	994RU	WOS:000307949900002	23373602				2021-06-18	
J	Gonen-Yaacovi, G; Burgess, PW				Gonen-Yaacovi, Gil; Burgess, Paul W.			PROSPECTIVE MEMORY: THE FUTURE FOR FUTURE INTENTIONS	PSYCHOLOGICA BELGICA			English	Article							TRAUMATIC BRAIN-INJURY; AGE-RELATED DIFFERENCES; RETROSPECTIVE-MEMORY; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; COMPLEX INTENTIONS; MULTIPLE PROCESSES; ONGOING ACTIVITIES; YOUNG-ADULTS; EVENT	Prospective memory is the ability to remember to execute future intentions and thoughts. It is probably the newest established field of memory research. We provide a selective review of work conducted in the last two decades with respect to the following issues: (1) the different types and characteristics of prospective tasks, (2) the theoretical models of the cognitive processes supporting prospective memory, (3) prospective memory performance in younger and older adults and (4) the findings from neuropsychological and neuroimaging studies. The findings indicate an extraordinarily fast progress in our understanding of the behaviour and the brain regions that are involved in this important ability, and suggest at least two possible emerging areas of enquiry for future research: a link with the closely related field of prospection (i.e., thinking about the future), and "expectation prospective memory" (triggering of behaviour in the absence of awareness depending on contingencies learnt from the environment).	[Gonen-Yaacovi, Gil; Burgess, Paul W.] UCL, Inst Cognit Neurosci, London WC1N 3AR, England	Burgess, PW (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.bur-gess@ucl.ac.uk	Burgess, Paul W/A-1811-2010				Aberle I, 2010, DEV PSYCHOL, V46, P1444, DOI 10.1037/a0020718; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Altgassen M, 2008, J CLIN EXP NEUROPSYC, V30, P777, DOI 10.1080/13803390701779552; Altgassen M, 2007, J INT NEUROPSYCH SOC, V13, P888, DOI 10.1017/S1355617707071068; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Baddeley A. D., 1984, EVERYDAY MEMORY ACTI, P1; Bailey PE, 2010, Q J EXP PSYCHOL, V63, P646, DOI 10.1080/17470210903521797; Benoit R.G., 2011, CEREBRAL CORTEX; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Blais C, 2012, Q J EXP PSYCHOL, V65, P268, DOI 10.1080/17470211003775234; Block RA, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P25, DOI 10.1142/9789812707123_0002; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Brandimonte M., 1996, PROSPECTIVE MEMORY T; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Brewer GA, 2010, MEM COGNITION, V38, P304, DOI 10.3758/MC.38.3.304; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess P.W., 2011, NEUROPSYCHOLOGIA, V49, P2185; Burgess P. W., 1996, BEHAV ASSESSMENT DYS; Burgess P. W., 2008, PROSPECTIVE MEMORY C, P233; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Cherry KE, 1999, PSYCHOL AGING, V14, P60, DOI 10.1037/0882-7974.14.1.60; Cherry KE, 2001, MEMORY, V9, P177, DOI 10.1080/09658210143000092; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cook GI, 2007, PSYCHON B REV, V14, P101, DOI 10.3758/BF03194035; Cook GI, 2005, APPL COGNITIVE PSYCH, V19, P345, DOI 10.1002/acp.1082; Costa A, 2008, NEUROPSYCHOLOGY, V22, P283, DOI 10.1037/0894-4105.22.3.283; Craik F.I.M., 1986, HUMAN MEMORY COGNITI, P409; d'Ydewalle G, 2001, AM J PSYCHOL, V114, P411, DOI 10.2307/1423688; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; EINSTEIN GO, 1992, PSYCHOL AGING, V7, P471, DOI 10.1037/0882-7974.7.3.471; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ellis J, 1999, BRIT J PSYCHOL, V90, P9, DOI 10.1348/000712699161233; Ellis J., 1998, ADHERENCE TREATMENT, P113; Eschen A, 2007, INT J PSYCHOPHYSIOL, V64, P259, DOI 10.1016/j.ijpsycho.2006.09.005; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Graf P, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P1, DOI 10.1142/9789812707123_0001; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guynn MJ, 2007, PSYCHON B REV, V14, P484, DOI 10.3758/BF03194094; Guynn MJ, 1998, MEM COGNITION, V26, P287, DOI 10.3758/BF03201140; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hashimoto T, 2011, NEUROIMAGE, V54, P645, DOI 10.1016/j.neuroimage.2010.07.047; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Henry JD, 2007, SCHIZOPHR RES, V95, P179, DOI 10.1016/j.schres.2007.06.003; Hicks JL, 2000, J EXP PSYCHOL LEARN, V26, P1160, DOI 10.1037/0278-7393.26.5.1160; Jones CRG, 2011, J AUTISM DEV DISORD, V41, P455, DOI 10.1007/s10803-010-1067-y; Katai S, 2003, J NEUROL NEUROSUR PS, V74, P704, DOI 10.1136/jnnp.74.6.704; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2005, J NEUROL NEUROSUR PS, V76, P1501, DOI 10.1136/jnnp.2004.051268; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Koechlin E, 1999, NATURE, V399, P148; Kondel TK, 2002, BRAIN COGNITION, V48, P405, DOI 10.1006/brcg.2001.1387; Kumar D, 2005, J CLIN EXP NEUROPSYC, V27, P867, DOI 10.1080/13803390490919100; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 1996, PROSPECTIVE MEMORY T; Kvavilashvili L, 2009, MEMORY, V17, P180, DOI 10.1080/09658210802194366; Lee E, 2010, ARCH CLIN NEUROPSYCH, V25, P640, DOI 10.1093/arclin/acq061; Levy R. L., 1984, EVERYDAY MEMORY ACTI, P93; Leynes PA, 2003, CONSCIOUS COGN, V12, P1, DOI 10.1016/S1053-8100(02)00002-8; LINTON M, 1978, PRACTICAL ASPECTS ME; Loft S, 2007, MEM COGNITION, V35, P263, DOI 10.3758/BF03193447; LOFTUS EF, 1971, PSYCHON SCI, V23, P315, DOI 10.3758/BF03336128; Mantyla T, 1993, Memory, V1, P203, DOI 10.1080/09658219308258233; Marsh R.L., 2006, MEM COGNITION, V29, P861; Marsh RL, 2007, AGING NEUROPSYCHOL C, V14, P168, DOI 10.1080/138255891007074; Marsh RL, 2005, J EXP PSYCHOL LEARN, V31, P68, DOI 10.1037/0278-7393.31.1.68; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2002, PSYCHON B REV, V9, P604, DOI 10.3758/BF03196319; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Maylor E.A., 1996, PROSPECTIVE MEMORY T, P173; Maylor E. A., 1993, ADULT INFORMATION PR, P529; Maylor EA, 1998, AGING NEUROPSYCHOL C, V5, P107, DOI 10.1076/anec.5.2.107.599; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McCauley S.R., 2011, J CLIN EXPT NEUROPSY; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M. A., 2007, PROSPECTIVE MEMORY O; McDaniel M. A., 2008, PUZZLE INCONSISTENT, P141; McDaniel MA, 1998, MEM COGNITION, V26, P121, DOI 10.3758/BF03211375; McDaniel MA, 2004, J EXP PSYCHOL LEARN, V30, P605, DOI 10.1037/0278-7393.30.3.605; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; Meacham J. A., 1982, MEMORY OBSERVED REME, P327; MEACHAM JA, 1977, J PSYCHOL, V97, P191, DOI 10.1080/00223980.1977.9923962; Meacham JA, 1975, MEMORY OBSERVED, P327; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Moscovitch M, 1982, AGING COGNITIVE PROC, P55; Moscovitch Morris, 1994, P269; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Okuda J, 2011, NEUROPSYCHOLOGIA, V49, P2258, DOI 10.1016/j.neuropsychologia.2011.02.005; Palmer HM, 2000, BRAIN COGNITION, V44, P103; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; PATTON GW, 1993, EXP AGING RES, V19, P165, DOI 10.1080/03610739308253929; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Potvin MJ, 2011, BRAIN INJURY, V25, P192, DOI 10.3109/02699052.2010.541896; Racsmany M, 2011, J CLIN EXP NEUROPSYC, V33, P85, DOI 10.1080/13803395.2010.493147; Rajendran G., 2010, J AUTISM DEV DISORDE; Reese CM, 2002, AGING NEUROPSYCHOL C, V9, P98, DOI 10.1076/anec.9.2.98.9546; Rendell P. G., 1993, AUSTR J AGEING, V12, P11, DOI [10.1111/j.1741-6612.1993.tb00578.x, DOI 10.1111/J.1741-6612.1993.TB00578.X]; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Rendell PG, 1999, J GERONTOL B-PSYCHOL, V54, pP256, DOI 10.1093/geronb/54B.4.P256; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2008, ANN NY ACAD SCI, V1124, P39, DOI 10.1196/annals.1440.001; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P736, DOI 10.1037/a0018971; Scullin MK, 2010, J EXP PSYCHOL LEARN, V36, P190, DOI 10.1037/a0017732; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith R.E, 2008, PROSPECTIVE MEMORY C, P42; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Smith RE, 2006, J EXP PSYCHOL LEARN, V32, P623, DOI 10.1037/0278-7393.32.3.623; Smith RE, 2010, J EXP PSYCHOL LEARN, V36, P1089, DOI 10.1037/a0019183; Smith RE, 2010, DEV PSYCHOL, V46, P230, DOI 10.1037/a0017100; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Umeda S, 2011, NEUROPSYCHOLOGIA, V49, P2178, DOI 10.1016/j.neuropsychologia.2011.03.036; Vogels WWA, 2002, BRAIN COGNITION, V49, P341, DOI 10.1006/brcg.2001.1504; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Weiler JA, 2010, BEHAV BRAIN RES, V212, P196, DOI 10.1016/j.bbr.2010.04.013; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 1999, PSYCHOL AGING, V14, P264, DOI 10.1037/0882-7974.14.2.264; West R, 2005, PSYCHON B REV, V12, P502, DOI 10.3758/BF03193795; West R, 2003, PSYCHOL AGING, V18, P461, DOI 10.1037/0882-7974.18.3.461; West R, 2003, PSYCHOPHYSIOLOGY, V40, P260, DOI 10.1111/1469-8986.00028; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; West R, 2001, PSYCHOL AGING, V16, P682, DOI 10.1037//0882-7974.16.4.682; WEST RL, 1988, PRACTICAL ASPECTS ME, V2, P119; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; West R, 2007, INT J PSYCHOPHYSIOL, V64, P269, DOI 10.1016/j.ijpsycho.2006.09.006; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2004, COGN AFFECT BEHAV NE, V4, P354, DOI 10.3758/CABN.4.3.354; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; West R, 2002, COGN AFFECT BEHAV NE, V2, P162, DOI 10.3758/CABN.2.2.162; Wilkins A. J., 1978, PRACTICAL ASPECTS ME, V1, P27; Williams JMG, 1996, MEM COGNITION, V24, P116, DOI 10.3758/BF03197278; Zimmermann TD, 2006, Q J EXP PSYCHOL, V59, P2040, DOI 10.1080/17470210600917835; Zinke K, 2010, CHILD NEUROPSYCHOL, V16, P338, DOI 10.1080/09297041003631451; Zollig J, 2010, CORTEX, V46, P575, DOI 10.1016/j.cortex.2009.09.010	169	11	11	0	36	UBIQUITY PRESS LTD	LONDON	2N, 6 OSBORNE ST, LONDON, E1 6TD, ENGLAND	0033-2879			PSYCHOL BELG	Psychol. Belg.		2012	52	2-3			SI		173	204					32	Psychology, Multidisciplinary	Psychology	004XN	WOS:000308714900006		DOAJ Gold			2021-06-18	
J	Haar, CV; Emery, MA; Hoane, MR				Haar, Cole Vonder; Emery, Michael A.; Hoane, Michael R.			Chronic folic acid administration confers no treatment effects in either a high or low dose following unilateral controlled cortical impact injury in the rat	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Vitamin-therapy; traumatic brain injury; neurotoxicity; therapeutic; recovery of function	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; FLUID PERCUSSION INJURY; NICOTINAMIDE TREATMENT; CONTUSION INJURY; SUPPLEMENTATION; EXPRESSION; FOLATE; DAMAGE; NEUROPROTECTION	Purpose: Traumatic brain injury (TBI) is a major health concern today and effective treatments must be developed in order to combat the numerous TBIs that occur each year. Multiple b-vitamins have been shown to have neuroprotective effects, however, folic acid (B-9) has not been widely studied. The current study examined two different doses in a rodent model of controlled cortical impact (CCI) TBI. Methods: Sham procedures or a unilateral parietal controlled cortical impact injury was induced. Rats were administered either vehicle or folic acid in an 80 mu g/kg or 800 mu g/kg dose. Rats were tested on the bilateral tactile adhesive removal task, rotarod task and the Morris water maze. Brains were examined to determine lesion size and neuronal loss. Results: Neither of the folic acid-treated groups showed improvement on any behavioral task or anatomical measure post-CCI and the high dose group had increased neuronal loss compared to the vehicle. Administration of the high dose in sham animals resulted in some behavioral dysfunction and significant neuronal loss. Conclusions: The results from this study suggest that folic acid may not represent an effective avenue for treatment and that higher doses may actually be detrimental following TBI.	[Haar, Cole Vonder; Emery, Michael A.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA	Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrated Res Cognit & Neural Sci, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Emery, Michael/0000-0002-8587-4115; Hoane, Michael/0000-0001-7779-2657; Vonder Haar, Cole/0000-0001-7949-2068	ARRA from NINDS [NS045647]; Southern Illinois University's Center for Integrated Research in Cognitive and Neural Sciences; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS045647]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	Thanks to Derrick Haan for his assistance with behavioral tasks and to Lynn Moore for her help with histological analyses. This project was funded by ARRA funds from NINDS NS045647 and Southern Illinois University's Center for Integrated Research in Cognitive and Neural Sciences. Funded by NINDS NS045647.	Achon M, 2000, BRIT J NUTR, V83, P177, DOI 10.1017/S0007114500000222; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Centers for Disease Control, 2010, INJ PREV CONTR TRAUM; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fenech M, 2001, MUTAT RES-FUND MOL M, V475, P57, DOI 10.1016/S0027-5107(01)00079-3; Fioravanti M, 1997, ARCH GERONTOL GERIAT, V26, P1, DOI 10.1016/S0167-4943(97)00028-9; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Iskandar BJ, 2004, ANN NEUROL, V56, P221, DOI 10.1002/ana.20174; Kelly PJ, 2003, STROKE, V34, pE51, DOI 10.1161/01.STR.0000071109.23410.AB; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MOSER E, 1993, J NEUROSCI, V13, P3916; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sommer BR, 2003, J GERIATR PSYCH NEUR, V16, P156, DOI 10.1177/0891988703256052; Sunder-Plassmann G, 2000, J AM SOC NEPHROL, V11, P1106, DOI 10.1681/ASN.V1161106; Vogel T, 2009, INT J CLIN PRACT, V63, P1061, DOI 10.1111/j.1742-1241.2009.02026.x	36	11	11	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2012	30	4					291	302		10.3233/RNN-2012-110196			12	Neurosciences	Neurosciences & Neurology	973OA	WOS:000306368300003	22572023				2021-06-18	
J	Stiers, W; Carlozzi, N; Cernich, A; Velozo, C; Pape, T; Hart, T; Gulliver, S; Rogers, M; Villarreal, E; Gordon, S; Gordon, W; Whiteneck, G				Stiers, William; Carlozzi, Noelle; Cernich, Alison; Velozo, Craig; Pape, Theresa; Hart, Tessa; Gulliver, Suzy; Rogers, Margaret; Villarreal, Edgar; Gordon, Shalanda; Gordon, Wayne; Whiteneck, Gale			Measurement of social participation outcomes in rehabilitation of veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						clinical practice; measurement; outcomes; participation; rehabilitation; research; social participation; traumatic brain injury; VA; veterans	COMMUNITY INTEGRATION QUESTIONNAIRE; PORTLAND ADAPTABILITY INVENTORY; QUALITY-OF-LIFE; POSTCONCUSSION SYNDROME; PSYCHOMETRIC EVALUATION; SOCIETAL PARTICIPATION; SYMPTOMS; DISABILITY; INDIVIDUALS; AWARENESS	Traumatic brain injury (TBI) is a significant concern in the veteran population, and the Department of Veteran Affairs (VA) has devoted substantial healthcare resources to the rehabilitation of veterans with TBI. Evaluating the outcomes of these rehabilitation activities requires measuring whether they meaningfully improve veterans' lives, especially with regard to community and vocational participation, which are strongly linked to perceived quality of life. In January 2010, the VA Rehabilitation Research and Development Service convened an invitational conference focused on outcome measurement in rehabilitation with a specific focus on veterans' community and vocational participation. This article reports on the working group, addressing the issues of conceptualizing and operationalizing such participation outcome measures for veterans with TBI; we discuss conceptual models of participation, review participation subdomains and their instruments of measurement, and identify current research issues and needs. Two avenues are identified for advancing participation measurement in veterans with TBI. First, we describe suggestions to facilitate the immediate implementation of participation measurement into TBI clinical practice and rehabilitation (cont) research within the VA healthcare system. Second, we describe recommendations for future VA research funding initiatives specific to improving the measurement of participatiOn in veterans with TBI.	[Stiers, William] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD 21239 USA; [Carlozzi, Noelle] Kessler Fdn, Res Ctr, W Orange, NJ USA; [Carlozzi, Noelle] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Cernich, Alison] Dept Vet Affairs VA Maryland Hlth Care Syst, Baltimore, MD USA; [Cernich, Alison] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Cernich, Alison] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; [Velozo, Craig] North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA; [Velozo, Craig] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Pape, Theresa] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Pape, Theresa] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Hart, Tessa] Einstein Healthcare Network, Dept Psychiat, Einstein Med Ctr, Philadelphia, PA USA; [Gulliver, Suzy] Cent Texas Vet Hlth Care Syst, Waco VA Med Ctr, Ctr Excellence Res Returning War Vet, Waco, TX USA; [Gulliver, Suzy] Texas A&M Hlth Sci Ctr, Coll Med, Bryan, TX USA; [Rogers, Margaret] Amer Speech Language Hearing Assoc, Rockville, MD USA; [Villarreal, Edgar] VA Eastern Colorado Hlth Care Syst, Denver, CO USA; [Gordon, Shalanda] Cent Texas Vet Hlth Care Syst, Austin Outpatient Clin, Austin, TX USA; [Gordon, Shalanda] St Phillips Coll, San Antonio, TX USA; [Gordon, Wayne] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Whiteneck, Gale] Craig Hosp, Englewood, CO USA	Stiers, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, 5601 Loch Raven Blvd,Suite 406, Baltimore, MD 21239 USA.	wstiers1@jhmi.edu	Gulliver, Suzy/X-9776-2019	Bender Pape, Theresa/0000-0001-7738-5963; Gulliver, Suzy Bird/0000-0002-6476-9447; Stiers, William/0000-0002-1826-8350	State of the Art Conference on Outcome Measures in Rehabilitation; VA Office of Research and Development	This material was based on work supported by the State of the Art Conference on Outcome Measures in Rehabilitation, VA Office of Research and Development.	[Anonymous], 1980, INT CLASS IMP DIS HA; Bode RK, 2010, ARCH PHYS MED REHAB, V91, pS60, DOI 10.1016/j.apmr.2009.10.035; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Bond T. G., 2001, APPL RASCH MODEL; Brandt E. N., 1997, ENABLING AM ASSESSIN; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Campbell A., 1976, QUALITY AM LIFE PERC; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D F, 1995, Oncology (Williston Park), V9, P47; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; *DOD, 2009, DOD WORLDW NUMB TRAU; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; Gandek B, 2007, AM J PHYS MED REHAB, V86, P57, DOI 10.1097/01.PHM.0000233200.43822.21; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Golding H, 2009, J REHABIL RES DEV, V46, pVII, DOI 10.1682/JRRD.2009.06.0081; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; *INST MED, 2009, GULF WAR HLTH, V7; International Classification of Functioning, 2001, INT CLASS FUNCT DIS; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; JAFFEE M, 2010, P 8 WORLD C BRAIN IN; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC27; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MALEC J, 2005, MAYOPORTLAND ADAPTAB; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Malec JF., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; *NAT CTR INJ PREV, TRAUM BRAIN INJ; Park N, 2009, CYBERPSYCHOL BEHAV, V12, P729, DOI 10.1089/cpb.2009.0003; PATRICK DL, 1988, TGO-TIJDSCHR THER GE, V13, P152; Pope AM, 1991, DISABILITY AM NATL A; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; SCHMIDT MF, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199508000-00003; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; SCHWARTZ S, 1996, ANSWERING QUESTIONS; Schwarz, 1999, WELL BEING FDN HEDON; Seekins T, 2007, REHABIL PSYCHOL, V52, P319, DOI 10.1037/0090-5550.52.3.319; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; *US DEP EDUC, 2007, NIDRR LONG RANG PLAN; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; *WHO, 1997, ICIDH 2 INT CLASS IM; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002; 2010, SYLL DET; 2009, DOD WORLDW NUMB TRAU	76	11	12	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	1					139	153		10.1682/JRRD.2010.07.0131			15	Rehabilitation	Rehabilitation	149ES	WOS:000319302400013	22492344	Bronze			2021-06-18	
J	Viano, DC; Hamberger, A; Bolouri, H; Saljo, A				Viano, David C.; Hamberger, Anders; Bolouri, Hayde; Saljo, Annette			Evaluation of Three Animal Models for Concussion and Serious Brain Injury	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Head impact; Traumatic brain injury; Animal models	EXPERIMENTAL HEAD-INJURY; CONTROLLED CORTICAL IMPACT; PROFESSIONAL FOOTBALL; CEREBRAL CIRCULATION; AXONAL INJURY; ROTATIONAL ACCELERATION; PERCUSSION CONCUSSION; RAT-BRAIN; TRAUMA; MORPHOLOGY	Three animal models were evaluated in this study involving head impacts of the rat, including the Marmarou drop-weight and two momentum-exchange techniques. In series 1, 36 Wistar rats were hit on the side of the free-moving head using Marmarou's 450 g impact mass at 4.4, 5.4, and 6.3 m/s. Head acceleration was measured and injuries were observed. The 6.3-m/s side impact resulted in no deaths, no skull fractures, infrequent contusions, and some injuries consistent with diffuse axonal injury. In series 2, 57 Marmarou drop-weight tests were conducted to study head biomechanical responses. Marmarou's technique involves a head impact followed by prolonged loading into a foam pad under the animal. Based on the literature, the 2 m (6.3 m/s) Marmarou drop causes death, skull fracture, brain and spinal cord contusions, and diffuse axonal injury. These injuries are more severe than that occurring with impact of similar mass and velocity to the free-moving head. Impacts to the free-moving head provide more realistic animal models to study concussion and severe brain injury.	[Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI 48304 USA; [Hamberger, Anders; Bolouri, Hayde; Saljo, Annette] Univ Gothenburg, Dept Anat & Cell Biol, S-40530 Gothenburg, Sweden	Viano, DC (corresponding author), ProBiomechanics LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net			National Football League; NFL Charities; NFL Players Association; League	Funding for this research was provided by the National Football League and NFL Charities, which is funded by the NFL Players Association and the League. The authors gratefully appreciate their support.	Allen A.R., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Chou CC, 1974, SAE T, P398; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ellingson Benjamin M., 2005, V41, P86; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Gurdjian ES, 1975, IMPACT HEAD INJURY M; Gurgjian E. S., 1954, NEUROLOGY, V4, P674; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LINDGREN S, 1967, J TRAUM, V7, P493, DOI 10.1097/00005373-196707000-00001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P511, DOI 10.1016/0013-4694(55)90077-8; MEYER JS, 1956, ELECTROEN CLIN NEURO, V8, P107, DOI 10.1016/0013-4694(56)90037-2; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; NILSSON B, 1977, J NEUROSURG, V47, P274, DOI 10.3171/jns.1977.47.2.0274; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tornheim P A, 1976, Surg Neurol, V5, P171; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; VIANO DC, 1988, J BIOMECH, V21, P387, DOI 10.1016/0021-9290(88)90145-5; VIANO DC, 1999, CRASH PREV INJ CONTR, V1, P35; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	53	11	12	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		213	226		10.1007/s10439-011-0386-2			14	Engineering, Biomedical	Engineering	895HJ	WOS:000300486700019	22012080				2021-06-18	
J	Wilde, EA; Hunter, JV; Bigler, ED				Wilde, Elisabeth A.; Hunter, Jill V.; Bigler, Erin D.			A primer of neuroimaging analysis in neurorehabilitation outcome research	NEUROREHABILITATION			English	Article						Neuroimaging primer and analysis; neurorehabilitation; diffusion tensor imaging (DTI); magnetic resonance imaging (MRI); computed tomography (CT)	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; COMMON DATA ELEMENTS; COGNITIVE IMPAIRMENT; CEREBRAL ATROPHY; CHILDREN; TOMOGRAPHY; MORPHOLOGY; RECOVERY; STROKE	Although most neurological patients that enter a rehabilitation treatment program have had either a computed tomography (CT) or magnetic resonance imaging (MRI) scan, the utilization of neuroimaging in rehabilitation has been limited. However, a number of new MRI methods for image analysis hold great promise to better inform the neurorehabilitation clinician. The current review provides a foundation in neuroimaging fundamentals for neurorehabilitation specialists and examines the progress in using such techniques as quantitative MRI analyses, diffusion tensor imaging (DTI) and functional MRI to better understand the neurologically impaired patient.	[Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Wilde, Elisabeth A.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA	Wilde, EA (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	ewilde@bcm.edu					Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Atlas SW., 2002, MAGNETIC RESONANCE I; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P441, DOI 10.1037/10361-021; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bigler ED, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00228; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Ciumas C, 2008, CURR OPIN NEUROL, V21, P431, DOI 10.1097/WCO.0b013e3283056a3c; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Finger S., 1994, OOF NEUROSCIENCE; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Gauthier LV, 2012, STROKE, V43, P453, DOI 10.1161/STROKEAHA.111.633255; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haller Sven, 2009, Top Magn Reson Imaging, V20, P301, DOI 10.1097/RMR.0b013e318207a5a9; Hong JH, 2010, J REHABIL MED, V42, P979, DOI 10.2340/16501977-0603; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Jang SH, 2011, NEUROREHABILITATION, V28, P345, DOI 10.3233/NRE-2011-0662; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kononen M, 2012, EUR J NEUROL, V19, P578, DOI 10.1111/j.1468-1331.2011.03572.x; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Lee SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025930; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lotze M, 2012, NEUROREHAB NEURAL RE, V26, P594, DOI 10.1177/1545968311427706; Luccichenti G, 2010, FUNCT NEUROL, V25, P109; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reed BR, 2004, ARCH NEUROL-CHICAGO, V61, P1545, DOI 10.1001/archneur.61.10.1545; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Robinson RJ, 2011, J NEUROIMAGING, V21, pE189, DOI 10.1111/j.1552-6569.2010.00516.x; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Seitz RJ, 2010, J MAGN RESON IMAGING, V32, P756, DOI 10.1002/jmri.22315; Sherer M, 2006, BRAIN INJURY, V20, P997, DOI 10.1080/02699050600677055; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Stroman PW, 2012, CLIN NEUROL NEUROSUR, V114, P460, DOI 10.1016/j.clineuro.2012.01.003; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Takao H, 2010, NEURORADIOLOGY, V52, P691, DOI 10.1007/s00234-010-0715-4; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Vannorsdall TD, 2010, J NEUROPSYCH CLIN N, V22, P173, DOI 10.1176/appi.neuropsych.22.2.173; Vogel AC, 2010, NEUROPSYCHOL REV, V20, P362, DOI 10.1007/s11065-010-9145-7; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	62	11	11	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	3					227	243		10.3233/NRE-2012-0793			17	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	028QC	WOS:000310436200002	23093452				2021-06-18	
J	Yeo, SS; Chang, MC; Kim, SH; Son, S; Jang, SH				Yeo, Sang Seok; Chang, Min Cheol; Kim, Seong Ho; Son, Sumin; Jang, Sung Ho			Neural connection between injured cingulum and pedunculopontine nucleus in a patient with traumatic brain injury	NEUROREHABILITATION			English	Article						Cingulum; axonal injury; head trauma; diffusion tensor imaging; brain plasticity	DIFFUSION-TENSOR; CHOLINERGIC PATHWAYS; MILD; TRACTOGRAPHY; RAT	We report on a patient with traumatic brain injury who showed neural connection between injured cingulum and pedunculopontine nucleus on diffusion tensor tractography (DTT). A 74-year-old male who had suffered a traffic accident underwent conservative management for subarachnoid haemorrhage. Brain MRI which was performed 6 months after onset showed no specific lesions. On 6-month DTTs for cingulum of the patient, we observed discontinuations of both cingulums above the genu of corpus callosum. However, the left cingulum was connected to the left PPN via a neural tract that passed through the anterior corona radiata and thalamus. The neural connection between the injured cingulum and PPN seems to be a compensatory phenomenon for the destruction of cholinergic pathways from basal forebrain. We believe that this result might suggest one of recovery mechanisms of injured cingulum following brain injury.	[Yeo, Sang Seok; Chang, Min Cheol; Son, Sumin; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2012R1A1A4A0100 1873]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A4A0100 1873).	Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BUTCHER LL, 2004, RAT NERVOUS SYSTEM, P1257, DOI DOI 10.1016/B978-012547638-6/50036-5; Concha L, 2005, AM J NEURORADIOL, V26, P2267; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hong J. H., 2011, J HEAD TRAU IN PRESS; Hong JH, 2010, BRAIN RES, V1346, P190, DOI 10.1016/j.brainres.2010.05.088; Huijzen Cv, 2008, HUMAN CENTRAL NERVOU, Vxiv, P967; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee WT, 2008, MED NEUROANATOMY; Malykhin N, 2008, PSYCHIAT RES-NEUROIM, V164, P132, DOI 10.1016/j.pscychresns.2007.11.007; Mendoza JE, 2007, CLIN NEUROANATOMY NE, pix; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Nestler E. J., 2001, MOL NEUROPHARMACOLOG, Vxvi, P539; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Paxinos G., 1990, HUMAN NERVOUS SYSTEM, Vxi, P1195; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WOOLF NJ, 1986, BRAIN RES BULL, V16, P603, DOI 10.1016/0361-9230(86)90134-6; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	21	11	11	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	2					143	146		10.3233/NRE-2012-0783			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	003IN	WOS:000308604700006	22951708				2021-06-18	
J	Zahid, M; Bin Sabir, A; Asif, N; Julfiqar, M; Khan, AQ; Ahmad, S; Siddiqui, YS				Zahid, Mohammad; Bin Sabir, Aamir; Asif, Naiyer; Julfiqar, Mohammad; Khan, A. Q.; Ahmad, Sohail; Siddiqui, Yasir S.			Fixation using cannulated screws and fibular strut grafts for fresh femoral neck fractures with posterior comminution	JOURNAL OF ORTHOPAEDIC SURGERY			English	Article						bone screws; bone transplantation; femoral neck fractures; fibula		Purpose. To evaluate the use of fibular grafting for fresh femoral neck fractures with posterior comminution. Methods. 18 women and 15 men aged 20 to 60 years underwent osteosynthesis and fibular strut grafting supplemented with 7.0-mm cannulated hip screws for Garden grades III (n=21) and IV (n=12) femoral neck fractures associated with posterior comminution. All fractures were reduced by closed methods, and no hip was aspirated. Clinical and radiological outcomes were evaluated. Results. The mean delay in presentation after injury was 3.2 (range, 1-12) days. The mean delay in operation was 8.8 (range, 5-21) days. The mean follow-up period was 2 (range, 1-4) years. According to the Harris hip score, outcome was good to excellent in 20 patients, fair in 7, and poor in 6. 27 of the 33 patients achieved bone union after a mean of 4.7 (range, 4.2-7) months. In 5 patients, the bone was united with a mean of 10 degrees of varus collapse and a mean of 1 cm of shortening. Six patients had nonunion. Other complications included screw migration in the joint space (n=1), graft migration into the joint space (n=3), and screw pullout (n=5). No patient had avascular necrosis of the femoral head. Conclusion. Osteosynthesis and fibular grafting for freshly displaced femoral neck fractures with posterior comminution is an inexpensive and technically less demanding procedure for retaining a stable, painless, mobile, and functional hip.	[Zahid, Mohammad; Bin Sabir, Aamir; Asif, Naiyer; Julfiqar, Mohammad; Khan, A. Q.; Ahmad, Sohail; Siddiqui, Yasir S.] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Orthopaed Surg, Aligarh 202002, Uttar Pradesh, India	Julfiqar, M (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Orthopaed Surg, Aligarh 202002, Uttar Pradesh, India.	drzulfiqar1983@rediffmail.com					BARNES R, 1976, J BONE JOINT SURG BR, V58, P2; Cho MR, 2007, J ORTHOP TRAUMA, V21, P158, DOI 10.1097/BOT.0b013e31803773ae; DOOLEY BJ, 1982, AUST NZ J SURG, V52, P134, DOI 10.1111/j.1445-2197.1982.tb06087.x; Estrada LS, 2002, CLIN ORTHOP RELAT R, P110; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630; GARDEN RS, 1974, ORTHOP CLIN N AM, V5, P683; HARGADON EJ, 1963, J BONE JOINT SURG BR, V45, P305; Hirata T, 2001, CLIN ORTHOP RELAT R, P294; Krastman P, 2006, ARCH ORTHOP TRAUM SU, V126, P297, DOI 10.1007/s00402-006-0143-4; LUYAO GL, 1994, J BONE JOINT SURG AM, V76A, P15, DOI 10.2106/00004623-199401000-00003; Mathews V, 2004, CLIN ORTHOP RELAT R, P57, DOI 10.1097/01.blo.0000118700.22681.50; MEYERS MH, 1973, J BONE JOINT SURG AM, VA 55, P257, DOI 10.2106/00004623-197355020-00002; MEYERS MH, 1975, J BONE JOINT SURG AM, V57, P718, DOI 10.2106/00004623-197557050-00034; Mishra D, 1998, INDIAN J ORTHOP, V32, P32; Nagi ON, 1998, J BONE JOINT SURG BR, V80B, P798, DOI 10.1302/0301-620X.80B5.8703; NAGI ON, 1986, J BONE JOINT SURG BR, V68, P387; PARKER MJ, 1993, HIP FRACTURE MANAGEM, P273; Roshan A, 2006, CLIN ORTHOP RELAT R, P152, DOI 10.1097/01.blo.0000203483.13583.c8; SCHECK M, 1980, CLIN ORTHOP RELAT R, P138; STEWART MJ, 1956, J BONE JOINT SURG AM, V38, P33, DOI 10.2106/00004623-195638010-00004; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P837, DOI 10.2106/00004623-198466060-00003	21	11	18	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2309-4990			J ORTHOP SURG-HONG K	J. Orthop. Surg.		2012	20	2					191	195		10.1177/230949901202000211			5	Orthopedics; Surgery	Orthopedics; Surgery	V35TN	WOS:000209171100011	22933677	DOAJ Gold			2021-06-18	
J	Maeir, A; Krauss, S; Katz, N				Maeir, Adina; Krauss, Shim; Katz, Noomi			Ecological Validity of the Multiple Errands Test (MET) on Discharge From Neurorehabilitation Hospital	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article						executive functions; multitasking; community participation	PORTLAND ADAPTABILITY INVENTORY; FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; SIMPLIFIED VERSION; REHABILITATION; PARTICIPATION; RELIABILITY; AWARENESS; PEOPLE	The purpose of this prospective study was to examine the predictive and ecological validity of the Multiple Errands Test (MET) on discharge from neurorehabilitation hospital to the community. The specific objective was to examine the relationships between discharge MET scores and follow-up scores on the Participation Index (M2PI). The study sample included 30 participants with acquired brain injury who were independent in basic activities of daily living 1 week prior to discharge from a neurorehabilitation unit. The MET Hospital-Version was administered at discharge and the M2PI was administered to participants and their caregivers during a home visit 3 months after discharge. Moderate significant correlations were found between the MET and the M2PI scores (self and caregiver MET total error score with total M2PI r = .403, r = .510), with a greater correlation coefficient for caregiver ratings than for self ratings. Partial correlation analysis demonstrated the stability of this relationship while controlling for basic cognitive status scores. The results provide supporting evidence for the ecological validity of the MET at discharge from neurorehabilitation. In addition, the findings highlight the need for community-based rehabilitation that will reduce the impact of executive function deficits on participation in daily life.	[Maeir, Adina; Krauss, Shim; Katz, Noomi] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; [Katz, Noomi] Ono Acad Coll, Res Inst Hlth & Med Profess, Jerusalem, Israel		amaeir@mscc.huji.ac.il					Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Anderson V., 2008, EXECUTIVE FUNCTIONS; Baum C. M., 2003, EXECUTIVE FUNCTION P; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Dawson D. R., 2005, AM C REH MED CHIC IL; Dawson D. R., 2005, M INT NEUR SOC ST LO; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; FLEMING J, 2009, INT ENCY REHABILITAT; Gioia G., 2008, EXECUTIVE FUNCTION F, P179; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; Granger CV, 2009, AM J PHYS MED REHAB, V88, P961, DOI [10.1097/PHM.0b013e3181c1ec38, 10.1097/PHM.0b013e3181clec38]; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; KATZ N, 2005, COGNITION OCCUPATION, pR13; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; LEVAV M, 2005, WORLD FED OCC THER S; LEZAK MD, 2004, NEUROPSYCHOL ASSESSM; MALEC J, 2005, MAYOPORTLAND ADAPTAB; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ones Kadriye, 2005, J Stroke Cerebrovasc Dis, V14, P261, DOI 10.1016/j.jstrokecerebrovasdis.2005.07.003; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Roth R. M., 2005, PSYCHOL ASSESSMENT R; Schwartz M. F., 2003, NATURALISTIC ACTION; Schwartz MF, 2002, NEUROPSYCHOL REHABIL, V12, P311, DOI 10.1080/09602010244000084; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SOHLBERG MM, 2001, COGNITIVE REHABILITA, P230; Tranel D, 2007, J CLIN EXP NEUROPSYC, V29, P319, DOI 10.1080/13803390600701376; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wilson BA, 2010, STUD NEUROPSYCHOL NE, P385; World Health Organization, 2001, INT CLASS FUNCT DIS; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	47	11	11	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	WIN	2011	31	1		S	SI		S38	S46		10.3928/15394492-20101108-07			9	Rehabilitation	Rehabilitation	707ME	WOS:000286289900007	24650263				2021-06-18	
J	McDonald, S; Rosenfeld, J; Henry, JD; Togher, L; Tate, R; Bornhofen, C				McDonald, Skye; Rosenfeld, Julia; Henry, Julie D.; Togher, Leanne; Tate, Robyn; Bornhofen, Cristina			Emotion Perception and Alexithymia in People With Severe Traumatic Brain Injury: One Disorder or Two? A Preliminary Investigation	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; emotion perception; alexithymia	POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; HEAD-INJURY; SOCIAL-PERCEPTION; FACIAL EMOTION; ORGANIC ALEXITHYMIA; GENERAL-POPULATION; EATING-DISORDERS; FRONTAL-LOBE; SELF-REPORT	Primary objective: Recent research studies attest to the presence of deficits in emotion perception following severe traumatic brain injury (TBI). Additionally, a growing number of studies report significant levels of alexithymia (disorder of emotional cognition) following TBI. This research aimed to examine the relation between the two, while assessing the influence of posttraumatic stress disorder (PTSD). Design: Cross-sectional study examining levels of alexithymia, emotion perception disorders and PTSD and their association, in 20 people with severe, chronic TBI and 20 adults without brain injuries. Methods: Participants were assessed on the Toronto Alexithymia - 20 Scale, the Posttraumatic Diagnostic Scale and on two emotion perception tasks: matching and labelling of photos depicting the 6 basic emotions. Results:The group with TBI were impaired relative to controls when matching facial expressions. Their performance on 'fear' was especially poor. Performance on labelling was similar in pattern, although failed to reach significance. There was no association between poor performance on fear, or other negative expressions, and either PTSD or alexithymia symptoms in the TBI group. Conclusions: Alexithymia, as assessed by the TAS-20, taps a constellation of difficulties that do not appear to include difficulties with emotion perception in people with traumatic brain injuries.	[McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Univ Sydney, Sydney, NSW 2006, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014; Togher, Leanne/AAC-7083-2019	McDonald, Skye/0000-0003-0723-6094; Togher, Leanne/0000-0002-4518-6748; Henry, Julie/0000-0002-2081-3717	Australian Research CouncilAustralian Research Council; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by grants from the Australian Research Council and the National Health and Medical Research Council. We would like to thank the Royal Rehabilitation Centre, Sydney, for assisting with participant recruitment. We are indebted to the people with traumatic brain injuries and other members of the community who gave their time freely to assist with this research.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Allerdings MD, 2001, BRAIN COGNITION, V47, P304; Badura AS, 2003, J ANXIETY DISORD, V17, P349, DOI 10.1016/S0887-6185(02)00201-3; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; BERENBAUM H, 1994, COGNITION EMOTION, V8, P231, DOI 10.1080/02699939408408939; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BIRD K, 2001, PSY PROGRAM CONTRAST; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Connelly M, 2007, J PSYCHOSOM RES, V62, P649, DOI 10.1016/j.jpsychores.2006.12.008; Courville CB, 1945, PATHOLOGY NERVOUS SY; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Eizaguirre AE, 2004, PERS INDIV DIFFER, V36, P321, DOI 10.1016/S0191-8869(03)00099-0; Ekman P., 1976, PICTURES FACIAL AFFE; Felmingham KL, 2003, NEUROREPORT, V14, P777, DOI 10.1097/00001756-200304150-00024; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Frewen PA, 2008, J ABNORM PSYCHOL, V117, P171, DOI 10.1037/0021-843X.117.1.171; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; GUR RC, 1992, PSYCHIAT RES, V42, P241, DOI 10.1016/0165-1781(92)90116-K; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Hale WW, 1998, J AFFECT DISORDERS, V47, P63, DOI 10.1016/S0165-0327(97)00112-2; HARRIS RJ, 1994, ANOVA ANAL VARIANCE; Haviland MG, 1996, J PSYCHOSOM RES, V41, P597, DOI 10.1016/S0022-3999(96)00223-1; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hintikka J, 2001, COMPR PSYCHIAT, V42, P234, DOI 10.1053/comp.2001.23147; Honkalampi K, 2001, PSYCHOTHER PSYCHOSOM, V70, P247, DOI 10.1159/000056262; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lane RD, 2000, PSYCHOSOM MED, V62, P492, DOI 10.1097/00006842-200007000-00007; Lane RD, 1997, BIOL PSYCHIAT, V42, P834, DOI 10.1016/S0006-3223(97)00050-4; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; Lorenzo, 2002, THESIS; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V61, P13, DOI 10.2466/pms.1985.61.1.13; MAYER JD, 1990, J PERS ASSESS, V54, P772, DOI 10.1207/s15327752jpa5403&4_29; MCDONALD PW, 1990, PSYCHOSOM MED, V52, P199, DOI 10.1097/00006842-199003000-00007; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S., 2011, INT J PSYCHOPHYSIOLO; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Monson CM, 2004, J TRAUMA STRESS, V17, P275, DOI 10.1023/B:JOTS.0000029271.58494.05; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P1390, DOI 10.1176/appi.ajp.161.8.1390; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rastam M, 1997, ACTA PSYCHIAT SCAND, V95, P385, DOI 10.1111/j.1600-0447.1997.tb09650.x; Rosenthal R, 2000, CONTRASTS EFFECT SIZ; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Sheeran T, 2002, J CONSULT CLIN PSYCH, V70, P961, DOI 10.1037//0022-006X.70.4.000; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spitzer RL, 1990, STRUCTURED CLIN INTE; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Surguladze SA, 2004, NEUROPSYCHOLOGY, V18, P212, DOI 10.1037/0894-4105.18.2.212; Taylor G. J., 1997, DISORDERS AFFECT REG; Taylor GJ, 1996, J PSYCHOSOM RES, V41, P561, DOI 10.1016/S0022-3999(96)00224-3; Taylor GJ, 2004, PSYCHOTHER PSYCHOSOM, V73, P68, DOI 10.1159/000075537; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Wood RLL, 2010, J INT NEUROPSYCH SOC, V16, P1108, DOI 10.1017/S1355617710001013; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Zech E, 1999, EUR J PERSONALITY, V13, P511; Zeitlin S.B., 1993, AM J PSYCHIAT, V60, P150; Zlotnick C, 2001, J TRAUMA STRESS, V14, P177, DOI 10.1023/A:1007899918410	88	11	11	1	29	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2011	12	3					165	178					14	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	887FJ	WOS:000299912000001					2021-06-18	
J	Sifri, ZC; Nyak, N; Homnick, AT; Mohr, AA; Yonclas, P; Livingston, DH				Sifri, Ziad C.; Nyak, Natasha; Homnick, Adena T.; Mohr, Alicia A.; Yonclas, Peter; Livingston, David H.			Utility of Repeat Head Computed Tomography in Patients With an Abnormal Neurologic Examination After Minimal Head Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Minimal head injury; Repeat head computed tomography; Neurosurgical intervention; Intracranial bleed; Neurological deterioration	TRAUMATIC BRAIN-INJURY; CT; ADMISSION; MODERATE; MILD; MANAGEMENT	Background: Previous studies proposed that repeat head computed tomography (RHCT) is of no value in patients with a minimal head injury (MHI) and normal neurologic examination (NE). The goal of our study was to investigate the value of RHCT in patients with MHI with an abnormal NE. Methods: A retrospective chart review of adult patients presenting to a Level I trauma center from July 2002 to December 2006 with MHI was performed. Demographics, injury severity, and HCT findings were collected. Patients with an abnormal NE at the time of RHCT were divided into three subgroups: acute deterioration NE (AD-NE), persistently abnormal NE (PANE), and unknown NE (U-NE). Changes in the management and outcomes after RHCT were compared. Results: One hundred seven patients had a MHI with an abnormal NE. Of those, seven (6.5%) had a change in management after RHCT. At the time of RHCT, 68 patients (63%) had a PA-NE, 21 AD-NE, and 18 U-NE. Six patients (29%) with AD-NE, 1 patient (6%) with an U-NE, and no patients with PA-NE required changes in management after RHCT. Compared with a RHCT, NE had higher positive and negative predictive values in determining the need for management changes. Conclusions: Of all patients with MHI with an abnormal NE at the time of RHCT, 63% had a PA-NE. Although a RHCT is beneficial to patients with an acutely deteriorating or U-NE, it appears to be of little value in patients with a PA-NE. Compared with RHCT, serial NE may be a stronger predictor for the need for intervention in patients with MHI.	[Sifri, Ziad C.] UMDNJ NJMS, Div Trauma & Crit Care, Dept Surg, New Jersey Trauma Ctr, Newark, NJ 07101 USA	Sifri, ZC (corresponding author), UMDNJ NJMS, Div Trauma & Crit Care, Dept Surg, New Jersey Trauma Ctr, 150 Bergen St,M232, Newark, NJ 07101 USA.	sifrizi@umdnj.edu	Mohr, Alicia M/E-3016-2015	Mohr, Alicia/0000-0003-1732-1313			Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Homnick AT, 2009, AAST ANN C PITTSB PA; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LeTarte P, 2000, TRAUMA, P397; Levin HS, 1996, NEUROTRAUMA, P749; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Shackford SR, 2004, J TRAUMA, V56, P480; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sinson G, 2001, J TRAUMA, V51, P875; Stearley H E, 1998, Am J Crit Care, V7, P282; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	24	11	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1605	1610		10.1097/TA.0b013e31822b3728			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	869RT	WOS:000298616400028	21857258				2021-06-18	
J	Maestas, KL; Benge, JF; Pastorek, NJ; LeMaire, A; Darrow, R				Maestas, Kacey Little; Benge, Jared F.; Pastorek, Nicholas J.; LeMaire, Ashley; Darrow, Rachel			Factor Structure of Posttraumatic Stress Disorder Symptoms in OEF/OIF Veterans Presenting to a Polytrauma Clinic	REHABILITATION PSYCHOLOGY			English	Article						factor analysis; posttraumatic stress; veterans; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONFIRMATORY FACTOR-ANALYSIS; PERSISTENT POSTCONCUSSIVE SYMPTOMS; MEASUREMENT INVARIANCE; WAR VETERANS; CHRONIC PAIN; CHECKLIST; COMBAT; IRAQ; AFGHANISTAN	Objective: A significant number of Operation Iraqi Freedom/Operation Enduring Freedom (OEF/OIF) veterans are returning from deployment and presenting to Veterans Health Administration (VHA) polytrauma clinics with elevated rates of posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Inherent to the accurate assessment and treatment of this diagnostically complex group of veterans is the assumption that the construct of PTSD is the same in this population as in other trauma groups. To our knowledge, no previous study has examined the structure of PTSD in this relevant and fast-growing population of treatment-seeking OEF/OIF veterans. Evidence suggests that the latent structure of PTSD symptoms is best represented by a four-factor model, rather than the three-factor model found in the current DSM-IV-TR. Thus, we examined the three and four-factor models using the PTSD Check List-Civilian (PCL-C) in a sample of treatment-seeking OEF/OIF veterans seen through a VHA polytrauma clinic. Method: A chart review was conducted for OEF/OIF veterans (N = 361) seen through a VHA outpatient polytrauma clinic from September 2007 through August 2008. Participants completed the PCL-C as part of a comprehensive polytrauma evaluation. Results: Confirmatory factor analyses showed that the DSM-IV-TR three-factor model did not fit the data well. A direct comparison showed that the four-factor model provided a superior fit relative to the three-factor model. Conclusion: Results extend the generalizability of the four-factor model to OEF/OIF veterans presenting to Veterans Health Administration (VHA) polytrauma clinics.	[Maestas, Kacey Little] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Maestas, Kacey Little; Pastorek, Nicholas J.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Benge, Jared F.; Pastorek, Nicholas J.] Jack C Montgomery VA Med Ctr, Rehabil Care Line, Muskogee, OK USA; [LeMaire, Ashley] Mem Hosp Gulfport, Dept Neurosci & Rehabil, Gulfport, MS USA; [Darrow, Rachel] Ralph H Johnson VA Med Ctr, Mental Hlth Care Line, Charleston, SC USA	Pastorek, NJ (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd,RCL 117, Houston, TX 77030 USA.	nicholas.pastorek@va.gov		Benge, Jared/0000-0001-6201-3278			Amdur RL, 2001, J ANXIETY DISORD, V15, P345, DOI 10.1016/S0887-6185(01)00068-8; American Psychiatric Association, 2001, DSM 5 DEV WEBS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arbuckle J, 2008, AMOS 17 USERS GUIDE; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Baschnagel JS, 2005, J TRAUMA STRESS, V18, P677, DOI 10.1002/jts.20076; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P1343, DOI 10.1001/archpsyc.62.12.1343; Browne M.W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Davidson JRT, 1997, PSYCHOL MED, V27, P153, DOI 10.1017/S0033291796004229; Department of Veterans Affairs and Department of Defense Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU; DuHamel KN, 2004, PSYCHOL ASSESSMENT, V16, P255, DOI 10.1037/1040-3590.16.3.255; Felmingham KL, 2002, PSYCHIAT RES, V109, P171, DOI 10.1016/S0165-1781(02)00003-3; FOA EB, 1992, PSYCHOL BULL, V112, P218, DOI 10.1037/0033-2909.112.2.218; Friedman MJ, 2011, DEPRESS ANXIETY, V28, P750, DOI 10.1002/da.20767; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P1044, DOI 10.1097/PHM.0b013e3181c1ef29; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Lintz B. T., 1992, CLIN PSYCHOL REV, V12, P417, DOI [10.1016/0272-7358(92)90125-R, DOI 10.1016/0272-7358(92)90125-R]; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mansfield AJ, 2010, J TRAUMA STRESS, V23, P91, DOI 10.1002/jts.20492; Marshall GN, 2004, J TRAUMA STRESS, V17, P223, DOI 10.1023/B:JOTS.0000029265.56982.86; McDonald SD, 2008, J TRAUMA STRESS, V21, P309, DOI 10.1002/jts.20344; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Miller MW, 2010, J TRAUMA STRESS, V23, P631, DOI 10.1002/jts.20559; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Palmieri PA, 2005, J TRAUMA STRESS, V18, P657, DOI 10.1002/jts.20074; Schinka JA, 2007, J TRAUMA STRESS, V20, P281, DOI 10.1002/jts.20202; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shevlin M, 2009, J ANXIETY DISORD, V23, P995, DOI 10.1016/j.janxdis.2009.07.001; Simms LJ, 2002, J ABNORM PSYCHOL, V111, P637, DOI 10.1037//0021-843X.111.4.637; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Taylor S, 1998, J ABNORM PSYCHOL, V107, P154, DOI 10.1037/0021-843X.107.1.154; Taylor S, 2003, J CONSULT CLIN PSYCH, V71, P330, DOI 10.1037/0022-006X.71.2.330; Taylor S, 2001, J CONSULT CLIN PSYCH, V69, P541, DOI 10.1037//0022-006X.69.3.541; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F. W., 1993, ANN M INT SOC TRAUM	51	11	10	0	6	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2011	56	4					366	373		10.1037/a0025447			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	862AQ	WOS:000298062600010	21928917				2021-06-18	
J	D'Onofrio, PM; Thayapararajah, M; Lysko, MD; Magharious, M; Spratt, SK; Lee, G; Ando, D; Surosky, R; Fehlings, MG; Koeberle, PD				D'Onofrio, Philippe M.; Thayapararajah, Mahinthan; Lysko, Meghan D.; Magharious, Mark; Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard; Fehlings, Michael G.; Koeberle, Paulo D.			Gene Therapy for Traumatic Central Nervous System Injury and Stroke Using an Engineered Zinc Finger Protein that Upregulates VEGF-A	JOURNAL OF NEUROTRAUMA			English	Article						CNS; ischemia; retinal ganglion cell; trauma; VEGF	ENDOTHELIAL GROWTH-FACTOR; RETINAL GANGLION-CELLS; PUPILLARY LIGHT REFLEX; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTION FACTOR; IN-VIVO; HINDLIMB ISCHEMIA; NITRIC-OXIDE; AXONAL REGENERATION; BRAIN-INJURY	Recent studies have identified anti-apoptotic functions for vascular endothelial growth factor (VEGF) in the central nervous system (CNS). However, VEGF therapy has been hampered by a tendency to promote vascular permeability, edema, and inflammation. Recently, engineered zinc finger proteins (ZFPs) that upregulate multiple forms of VEGF in their natural biological ratios, have been developed to overcome these negative side effects. We used retinal trauma and ischemia models, and a cortical pial strip ischemia model to determine if VEGF upregulating ZFPs are neuroprotective in the adult CNS. Optic nerve transection and ophthalmic artery ligation lead to the apoptotic degeneration of retinal ganglion cells (RGCs) and are, respectively, two highly reproducible models for CNS trauma or ischemia. Adeno-associated vectors (AAV) vectors encoding VEGF-ZFPs (AAV-VEGF-ZFP) significantly increased RGC survival by similar to twofold at 14 days after optic nerve transection or ophthalmic artery ligation. Furthermore, AAV-VEGF-ZFP enhanced recovery of the pupillary light reflex. RECA-1 immunostaining demonstrated no appreciable differences between retinas treated with AAV-VEGF-ZFP and controls, suggesting that AAV-VEGF-ZFP treatment did not affect retinal vasculature. Following pial strip of the forelimb motor cortex, brains treated with an adenovirus encoding VEGF ZFPs (AdV-ZFP) showed higher neuronal survival, accelerated wound contraction, and reduced lesion volume between 1 and 6 weeks after injury. Behavioral testing using the cylinder test for vertical exploration showed that AdV-VEGF-ZFP treatment enhanced contralateral forelimb function within the first 2 weeks after injury. Our results indicate that VEGF ZFP therapy is neuroprotective following traumatic injury or stroke in the adult mammalian CNS.	[Koeberle, Paulo D.] Univ Toronto, Div Anat, Dept Surg, Toronto, ON M5S 1A8, Canada; [Magharious, Mark; Koeberle, Paulo D.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5S 1A8, Canada; [Spratt, S. Kaye; Lee, Gary; Ando, Dale; Surosky, Richard] Sangamo Biosci, Dept Therapeut Dev, Port Richmond, CA USA	Koeberle, PD (corresponding author), Univ Toronto, Div Anat, Dept Surg, MSB 1186,1 Kings Coll, Toronto, ON M5S 1A8, Canada.	paulo.koeberle@utoronto.ca		Fehlings, Michael/0000-0002-5722-6364			Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Borlongan CV, 2006, CAN MED ASSOC J, V174, P954, DOI 10.1503/cmaj.060199; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Dai QS, 2004, CIRCULATION, V110, P2467, DOI 10.1161/01.CIR.0000145139.53840.49; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373, DOI 10.2174/1389203054546334; Fu CY, 2007, J HUAZHONG UNIV SCI, V27, P186, DOI 10.1007/s11596-007-0221-z; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Guy J, 1999, ARCH OPHTHALMOL-CHIC, V117, P929; Hata Y, 2008, BRIT J OPHTHALMOL, V92, P1540, DOI 10.1136/bjo.2008.141002; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaur C, 2009, INVEST OPHTH VIS SCI, V50, P5364, DOI 10.1167/iovs.09-3552; Kilic U, 2006, J NEUROSCI, V26, P12439, DOI 10.1523/JNEUROSCI.0434-06.2006; KLOOSTER J, 1995, BRAIN RES, V688, P34, DOI 10.1016/0006-8993(95)00497-E; Koeberle PD, 2008, CELL DEATH DIFFER, V15, P471, DOI 10.1038/sj.cdd.4402281; Koeberle PD, 2004, J NEUROBIOL, V59, P162, DOI 10.1002/neu.10345; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Li YJ, 2007, DIABETES, V56, P656, DOI 10.2337/db06-0999; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; McCarran WJ, 2007, J NEUROSCI, V27, P4220, DOI 10.1523/JNEUROSCI.5542-06.2007; Nakazawa T, 2002, INVEST OPHTH VIS SCI, V43, P3319; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Pernet V, 2005, J NEUROCHEM, V93, P72, DOI 10.1111/j.1471-4159.2005.03002.x; Price SA, 2006, DIABETES, V55, P1847, DOI 10.2337/db05-1060; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; RADEL JD, 1995, NEUROSCIENCE, V68, P893, DOI 10.1016/0306-4522(95)00191-K; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; Ramanathan MD, 2003, EXP BIOL MED, V228, P697; Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795; Sapieha PS, 2006, J NEUROSCI RES, V83, P985, DOI 10.1002/jnr.20803; Schreiber RC, 2002, J NEUROBIOL, V53, P68, DOI 10.1002/neu.10093; Sivakumar V, 2008, BRAIN PATHOL, V18, P71, DOI 10.1111/j.1750-3639.2007.00104.x; Skoff RP, 2007, NEUROCHEM RES, V32, P331, DOI 10.1007/s11064-006-9188-6; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Witmer AN, 2004, J HISTOCHEM CYTOCHEM, V52, P39, DOI 10.1177/002215540405200105; Witmer AN, 2002, INVEST OPHTH VIS SCI, V43, P849; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; Xie DH, 2006, J VASC SURG, V44, P166, DOI 10.1016/j.jvs.2006.03.024; Yang JJ, 2000, CURR EYE RES, V21, P981, DOI 10.1076/ceyr.21.6.981.6991; Young MJ, 1998, BRAIN RES, V787, P191, DOI 10.1016/S0006-8993(97)01473-X; YOUNG MJ, 1994, NEUROSCIENCE, V62, P481, DOI 10.1016/0306-4522(94)90381-6; Yu J, 2006, FASEB J, V20, P479, DOI 10.1096/fj.04-3670fje; Zhang L, 2000, J BIOL CHEM, V275, P33850, DOI 10.1074/jbc.M005341200; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	60	11	12	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1863	1879		10.1089/neu.2011.1896			17	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000017	21902538				2021-06-18	
J	Kangas, M; Williams, JR; Smee, RI				Kangas, Maria; Williams, Janet R.; Smee, Robert I.			Benefit Finding in Adults Treated for Benign Meningioma Brain Tumours: Relations with Psychosocial Wellbeing	BRAIN IMPAIRMENT			English	Article						brain tumour; meningioma; benefit finding; psychosocial wellbeing; intrusions; avoidance	POSTTRAUMATIC GROWTH; BREAST-CANCER; INJURY; DEPRESSION; ADJUSTMENT; WOMEN; HEAD	Introduction: Research has indicated that individuals may report benefit finding (BF) as a result of experiencing potentially life-threatening traumatic events, such as being diagnosed with cancer or sustaining an acquired brain injury (ABI). No study to date has examined the incidence and correlates of BF in adult brain tumour samples. The present study aimed to investigate the association between BF and demographic and psychosocial variables in adults treated for a benign meningioma. Method: Seventy participants aged 36 to 87 years completed questionnaires that assessed perceived BF resulting from one's meningioma experience, intrusion and avoidance symptoms, emotional wellbeing and perceived quality of social support. Results: 39% of the sample had been diagnosed with their tumour within a 2-year period prior to assessment ('early' meningioma subgroup), while the remaining 61% of participants had been diagnosed with their tumour for more than 2 years ('late' meningioma subgroup). Almost two thirds (63%) of the sample reported deriving a moderate amount of BF due to their meningioma experience; although different psychological variables were found to be associated with BF according to group status. Whereas greater BF was found to be significantly associated with elevated depressive symptoms in the 'early' subsample, elevated BF was significantly positively correlated with intrusions and avoidance symptoms in the 'late' subsample. Conclusions: The findings indicate that BF may co-occur in context of both adaptive and positive illusory processes, which is consistent with the Janus-Face model of growth following adversity. The findings also support the use of psychosocial interventions to facilitate psychosocial adjustment following health crises.	[Kangas, Maria] Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia; [Williams, Janet R.; Smee, Robert I.] Prince Wales Hosp, Prince Wales Canc Ctr, Sydney, NSW, Australia; [Smee, Robert I.] Prince Wales Private Hosp, Sydney, NSW, Australia	Kangas, M (corresponding author), Macquarie Univ, Ctr Emot Hlth, Dept Psychol, Sydney, NSW 2109, Australia.	maria.kangas@mq.edu.au	McLean, Emma/F-4616-2012	Kangas, Maria/0000-0001-8693-2949	Macquarie University	This study was partially supported by a research grant from Macquarie University awarded to Dr Kangas.	Andrykowski M.A., 2010, PSYCHO-ONCOLOGY, P348, DOI DOI 10.1093/MED/9780195367430.003.0047; Antoni MH, 2001, HEALTH PSYCHOL, V20, P20, DOI 10.1037/0278-6133.20.1.20; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Cahill S. P., 2007, HDB PTSD SCI PRACTIC, P55; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; Carver CS, 2004, HEALTH PSYCHOL, V23, P595, DOI 10.1037/0278-6133.23.6.595; De Monte F., 1995, BRAIN TUMOURS, P375; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Harrington S, 2008, J PSYCHOSOC ONCOL, V26, P43, DOI 10.1080/07347330802115848; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Helgeson VS, 1996, HEALTH PSYCHOL, V15, P135, DOI 10.1037/0278-6133.15.2.135; Horowitz M. J., 1986, STRESS RESPONSE SYND; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0; Kinsinger DP, 2006, PSYCHO-ONCOL, V15, P954, DOI 10.1002/pon.1028; Lechner SC, 2003, PSYCHO-ONCOL, V12, P491, DOI 10.1002/pon.671; Lechner SC., 2009, OXFORD HDB POSITIVE, P633; Lundgren T, 2008, J BEHAV MED, V31, P225, DOI 10.1007/s10865-008-9151-x; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; McNair D, 1971, MANUAL PROFILE MOOD; ORance L., 2007, DISABILITY AUSTR ACQ; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Pringle AM, 1999, BRIT J NEUROSURG, V13, P46, DOI 10.1080/02688699944177; Sawyer A, 2010, CLIN PSYCHOL REV, V30, P436, DOI 10.1016/j.cpr.2010.02.004; Schulz U, 2004, SOC SCI MED, V59, P653, DOI 10.1016/j.socscimed.2003.11.019; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; Tomich PL, 2004, HEALTH PSYCHOL, V23, P16, DOI 10.1037/0278-6133.23.1.16; Updegraff J.A., 2000, LOSS TRAUMA GEN CLOS, P3; Urcuyo KR, 2005, PSYCHOL HEALTH, V20, P175, DOI 10.1080/08870440512331317634; van Nieuwenhuizen D, 2007, J NEURO-ONCOL, V84, P271, DOI 10.1007/s11060-007-9366-7; Weiss D., 1997, ASSESSING PSYCHOL TR; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	39	11	12	1	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2011	12	2			SI		105	116					12	Clinical Neurology; Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	837BH	WOS:000296165600004					2021-06-18	
J	McLellan, TL; McKinlay, A				McLellan, Tracey L.; McKinlay, Audrey			Does the way concussion is portrayed affect public awareness of appropriate concussion management: the case of rugby league	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; ASSOCIATION; STATEMENT; COHORT	It is important to identify factors that might adversely affect appropriate medical consultation and management of concussion. One factor that might present a barrier to timely intervention is media portrayal of concussion in sporting events, such as professional rugby league. Accordingly, the current study employed a surveillance method of publicly available broadcast information to establish the incidence rate of probable concussion in the National Rugby League's Telstra Premiership 2010 season and examined how these injury events were shown to be managed with respect to return-to-play procedures. The incident rate for probable concussion was higher than previously reported: 11.10\1000 player hours (95% CI 5.78 to 16.40) and was likely underestimated. Importantly, most injured players were shown to continue playing or return to play despite being visibly concussed and described as such by the commentary team. Although 'return-to-play decisions' for professional players are guided by medical assessment, the authors discuss whether the way concussion is portrayed might affect public awareness of appropriate concussion management.	[McLellan, Tracey L.; McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia	McLellan, TL (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	tracey.mclellan@canterbury.ac.nz		McKinlay, Audrey/0000-0001-9846-8514	Department of Psychology, University of Canterbury, New Zealand	The current study was funded by the Department of Psychology, University of Canterbury, New Zealand.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x	16	11	11	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	SEP	2011	45	12					993	996		10.1136/bjsm.2011.083618			4	Sport Sciences	Sport Sciences	816PM	WOS:000294614600014	21540191				2021-06-18	
J	Takase, K; Mizuochi, J				Takase, Katsumi; Mizuochi, Jun			Irreducible dislocation of the radial head with undisplaced olecranon fracture in a child: a case report	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						annular ligament; irreducible reduction; Monteggia fracture; olecranon fracture; radial head	ANTERIOR DISLOCATION; MONTEGGIA FRACTURE; ELBOW; NECK	Irreducible isolated dislocation of the radial head is a rare injury. In this study, we describe a patient with irreducible dislocation of the radial head associated with an undisplaced fracture of the olecranon. A 6-year-old girl fell down while walking and suffered injury to the posterior aspect of the proximal ulnar shaft with the right elbow in a slightly flexed position. Plain radiographs of the elbow revealed an anterior-medial dislocation of the radial head and an undisplaced fracture of the olecranon. However, the attempted closed reduction was not successful. An open reduction was then performed through a lateral approach. The radial head was found to be protruding through a buttonhole tear of the anterior joint capsule, causing the joint to become interposed between the articular surfaces of the joint, precluding closed reduction. Once the interposed capsule was extricated from the joint, the radial head could be easily reduced. At this point, no tear of the annular ligament was observed. Six months after the surgery, the patient was able to use her elbow fully and without pain. The range of motion was 0-140 degrees for both extension and flexion and 90 degrees for pronation and supination. Plain radiographs revealed a united bone of the olecranon and good reduction of the radial head. The radial head pushed through the tear of the anterior joint capsule. This buttonhole effect on the radial head prevented closed reduction of the radial head. J Pediatr Orthop B 20:345-348 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Takase, Katsumi] Tokyo Med Univ, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1600023, Japan	Takase, K (corresponding author), Tokyo Med Univ, Dept Orthoped Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	k-takase@muf.biglobe.ne.jp					HAMILTON W, 1973, CLIN ORTHOP RELAT R, P94; HUME AC, 1957, J BONE JOINT SURG BR, V39, P508; KAMALI M, 1974, J BONE JOINT SURG AM, VA 56, P841, DOI 10.2106/00004623-197456040-00026; KONG KC, 1993, ARCH ORTHOP TRAUM SU, V112, P304, DOI 10.1007/BF00452972; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402; NEVIASER RJ, 1971, CLIN ORTHOP RELAT R, P72; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; Ruchelsman DE, 2005, J ORTHOP TRAUMA, V19, P425; TRIANTAFYLLOU SJ, 1992, CLIN ORTHOP RELAT R, P153; WATSON JAS, 1994, INJURY, V25, P325, DOI 10.1016/0020-1383(94)90246-1; WILEY JJ, 1974, J BONE JOINT SURG BR, VB 56, P501; Yoshihara Y, 2002, J TRAUMA, V53, P984, DOI 10.1097/00005373-200211000-00028	12	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1060-152X			J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SEP	2011	20	5					345	348		10.1097/BPB.0b013e32834534cb			4	Orthopedics; Pediatrics	Orthopedics; Pediatrics	803NP	WOS:000293588300015	21460738				2021-06-18	
J	Matsukawa, H; Shinoda, M; Fujii, M; Takahashi, O; Yamamoto, D; Murakata, A; Ishikawa, R				Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Takahashi, Osamu; Yamamoto, Daisuke; Murakata, Atsushi; Ishikawa, Ryoichi			Genu of corpus callosum in diffuse axonal injury induces a worse 1-year outcome in patients with traumatic brain injury	ACTA NEUROCHIRURGICA			English	Article						Corpus callosum; Diffuse axonal injury; Genu; Traumatic brain injury	HEAD-INJURY; COGNITIVE IMPAIRMENT; ATROPHY; LEUKOARAIOSIS; MILD; DIAGNOSIS; FEATURES; MODERATE; LESIONS; GAIT	Previous studies have shown a relationship between diffuse axonal injury (DAI) and unfavorable clinical outcome in patients with traumatic brain injury (TBI), but it remains unclear whether the type of DAI lesion influences outcome after TBI. The aim of the present study was to investigate whether 1-year outcome after TBI differed between patients with different types of lesions. A retrospective, single-institution study involving 261 patients with TBI was carried out between April 2003 and December 2009. Outcome was measured using the Glasgow Outcome Scale (GOS) 1 year after TBI. DAI lesions occurred in the lobar region, corpus callosum (CC), and brainstem. CC lesions were subdivided into three types: genu, body, and splenium. Univariate and multivariate logistic regression analyses were performed to evaluate the relationships between clinical characteristics and outcome for each type of DAI lesion and each type of CC lesion in patients with TBI. Sixty-nine patients had DAI lesions: 34 in the lobar region, 30 in the CC, and five in the brainstem. Of the 30 patients with CC lesions, ten each were found in the genu, body, and splenium. Each DAI, CC, and genu lesion was significantly associated with unfavorable outcome 1 year after TBI by multivariate analysis using variables that were significantly associated with unfavorable outcome as determined by univariate analysis after adjustment for age. CC lesions, especially those in the genu, were related to unfavorable 1-year outcome in patients with TBI.	[Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Yamamoto, Daisuke; Murakata, Atsushi; Ishikawa, Ryoichi] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Dept Clin Epidemiol, Chuo Ku, Tokyo 1048560, Japan	Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan	This study was supported by a medical research grant on traffic accident from The General Insurance Association of Japan 2010.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bhadelia RA, 2009, STROKE, V40, P3816, DOI 10.1161/STROKEAHA.109.564765; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Caille S, 2005, NEUROSURGERY, V57, P50, DOI 10.1227/01.NEU.0000163089.31657.08; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; GEFFEN GM, 1994, BEHAV BRAIN RES, V64, P131, DOI 10.1016/0166-4328(94)90125-2; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Hausdorff JM, 2005, EXP BRAIN RES, V164, P541, DOI 10.1007/s00221-005-2280-3; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V7905, P480; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moretti M, 2005, NEUROL SCI, V26, P61, DOI 10.1007/s10072-005-0437-2; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; PANDYA DN, 1971, BRAIN RES, V32, P31, DOI 10.1016/0006-8993(71)90153-3; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Ryberg C, 2007, NEUROBIOL AGING, V28, P955, DOI 10.1016/j.neurobiolaging.2006.04.008; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmahmann J, 2009, FIBER PATHWAYS BRAIN; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; YAMANOUCHI H, 1990, J NEUROL, V237, P39, DOI 10.1007/BF00319666; YAMAUCHI H, 1994, STROKE, V25, P1788, DOI 10.1161/01.STR.25.9.1788; Yamauchi H, 2000, STROKE, V31, P1515, DOI 10.1161/01.STR.31.7.1515	36	11	11	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	AUG	2011	153	8					1687	1694		10.1007/s00701-011-1002-9			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	794TU	WOS:000292925000020	21479582				2021-06-18	
J	Pecha, T; Sharma, D; Hoffman, NG; Sookplung, P; Curry, P; Vavilala, MS				Pecha, Travis; Sharma, Deepak; Hoffman, Noah G.; Sookplung, Pimwan; Curry, Parichat; Vavilala, Monica S.			Hyperglycemia During Craniotomy for Adult Traumatic Brain Injury	ANESTHESIA AND ANALGESIA			English	Article							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; RISK-FACTORS; HEAD-INJURY; GLUCOSE; IMPACT; MICRODIALYSIS	BACKGROUND: Hyperglycemia after traumatic brain injury (TBI) is associated with poor outcome, but previous studies have not addressed intraoperative hyperglycemia in adult TBI. In this study, we examined glucose value variability and risk factors for hyperglycemia during craniotomy in adults with TBI. METHODS: A retrospective cohort study of patients >= 18 years who underwent urgent or emergent craniotomy for TBI at Harborview Medical Center (level 1 adult and pediatric trauma center) between October 2007 and May 2010 was performed. Preoperative (within 24 hours of anesthesia start) and intraoperative (during anesthesia) glucose values for each patient were retrieved. The prevalence of intraoperative hyperglycemia (glucose >= 200 mg/dL), hypoglycemia (glucose <60 mg/dL), and glycemic trends was determined. Generalized Estimating Equations was used to determine the independent predictors of intraoperative hyperglycemia. Data are presented as adjusted odds ratio (AOR) (95% confidence interval [CI]), and P < 0.05 reflects significance. RESULTS: Intraoperative hyperglycemia was common (26 [15%]) and intraoperative hypoglycemia was not observed. Independent risk factors of intraoperative hyperglycemia were age >= 65 years (AOR 3.9 [95% CI: 1.4-10.3]; P = 0.007), Glasgow Coma Scale score <9 (AOR 4.9 [95% CI: 1.6-15.1]; P = 0.006), preoperative hyperglycemia (AOR 4.4 [95% CI: 1.7-11.6]; P = 0.003), and subdural hematoma (AOR 5.6 [95% CI: 1.4-22.2]; P = 0.02). Mean intraoperative glucose was highest in severe TBI patients (P = 0.02). There was both between-patient (79.5% variance; P < 0.001) and within-patient (20.5% variance; P < 0.001) intraoperative glucose value variability. Patients with intraoperative hyperglycemia had higher in-hospital mortality (8 [31%] vs 20 [13%]; P < 0.02). CONCLUSION: Intraoperative hyperglycemia was common in adults undergoing urgent/emergent craniotomy for TBI and was predicted by severe TBI, the presence of subdural hematoma, preoperative hyperglycemia, and age >= 65 years. However, there was significant variability in intraoperative glucose values. (Anesth Analg 2011;113:336-42)	[Pecha, Travis; Sharma, Deepak; Sookplung, Pimwan; Curry, Parichat; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Sch Med, Seattle, WA 98104 USA	Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@uw.edu			University of WashingtonUniversity of Washington; University of Washington Department of Anesthesiology and Pain MedicineUniversity of Washington	Supported by the University of Washington Medical Student Research Training Program, and University of Washington Department of Anesthesiology and Pain Medicine departmental sources.	Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bower WF, 2010, AM J SURG, V199, P240, DOI 10.1016/j.amjsurg.2009.04.010; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Krinsley JS, 2007, CRIT CARE MED, V35, P2262, DOI 10.1097/01.CCM.0000282073.98414.4B; Lipshutz AKM, 2009, ANESTHESIOLOGY, V110, P408, DOI 10.1097/ALN.0b013e3181948a80; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2009, AM SURGEON, V75, P25; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SIEBER F, 1986, ANESTHESIOLOGY, V64, P453, DOI 10.1097/00000542-198604000-00007; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	23	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	AUG	2011	113	2					336	342		10.1213/ANE.0b013e31821d3dde			7	Anesthesiology	Anesthesiology	796PQ	WOS:000293064500021	21596888				2021-06-18	
J	Stuart, RM; Claassen, J; Schmidt, M; Helbok, R; Kurtz, P; Fernandez, L; Lee, K; Badjatia, N; Mayer, SA; Lavine, S; Connolly, ES				Stuart, Robert Morgan; Claassen, Jan; Schmidt, Michael; Helbok, Raimund; Kurtz, Pedro; Fernandez, Luis; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.; Lavine, Sean; Connolly, E. Sander			Multimodality Neuromonitoring and Decompressive Hemicraniectomy After Subarachnoid Hemorrhage	NEUROCRITICAL CARE			English	Article						Intracranial monitoring; Multimodality brain monitoring; Decompressive craniectomy; Microdialysis; Brain oxygen	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; CRANIECTOMY; MICRODIALYSIS; INFARCTION; VASOSPASM; PRESSURE	We report the case of a young woman with delayed cerebral infarction and intracranial hypertension following subarachnoid hemorrhage requiring hemicraniectomy, who underwent multimodality neuromonitoring of the contralateral hemisphere before and after craniectomy. Intracranial hypertension was preceded by signs of ischemia and impaired brain metabolism diagnosed through cerebral microdialysis and PbtO2 monitoring, as well as a decrease in cerebral perfusion pressure (CPP) to < 40 mmHg despite increasing vasopressor requirements. We describe how a comprehensive multimodality neuromonitoring approach was utilized to inform the decision to perform an early decompressive hemicraniectomy. Post-operatively, CPP and intracranial pressure (ICP) normalized, and the patient was weaned off all pressors within hours. The modified Rankin score at 3 and 12 months was 5. Delayed rescue hemicraniectomy can be life-saving after poor grade SAH. The role of multimodality brain monitoring for determining the optimal timing of hemicraniectomy deserves further study.	[Stuart, Robert Morgan] Columbia Presbyterian Med Ctr, Neurol Inst New York, Dept Neurosurg, New York, NY 10032 USA; [Claassen, Jan; Schmidt, Michael; Helbok, Raimund; Kurtz, Pedro; Fernandez, Luis; Lee, Kiwon; Badjatia, Neeraj; Mayer, Stephan A.] Columbia Univ Coll Phys & Surg, Dept Neurol, Div Crit Care Neurol, New York, NY 10032 USA; [Stuart, Robert Morgan; Lavine, Sean; Connolly, E. Sander] Columbia Univ Coll Phys & Surg, Dept Neurol Surg, New York, NY 10032 USA	Stuart, RM (corresponding author), Columbia Presbyterian Med Ctr, Neurol Inst New York, Dept Neurosurg, 710 W 168th St, New York, NY 10032 USA.	rms2130@columbia.edu	Helbok, Raimund/AAA-8361-2021; Claassen, Jan/AAA-5451-2020		National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Wellcome TrustWellcome TrustEuropean Commission; Howard Hughes Medical Institute (HHMI)Howard Hughes Medical Institute	This work was not funded by the National Institute of Health (NIH), Wellcome Trust, Howard Hughes Medical Institute (HHMI) or any other institution requiring open access.	Bardt TF, 1998, ACT NEUR S, V71, P153; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Berger C, 1999, STROKE, V30, P460, DOI 10.1161/01.STR.30.2.460; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Kirkness CJ, 2009, CRIT CARE MED, V37, P371, DOI 10.1097/CCM.0b013e3181930eff; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; Munch E, 2000, NEUROSURGERY, V47, P315; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Shimoda M, 2001, NEUROSURGERY, V49, P1341, DOI 10.1097/00006123-200112000-00010; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; Ushewokunze S, 2009, CHILD NERV SYST, V25, P341, DOI 10.1007/s00381-008-0752-z; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	23	11	11	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2011	15	1					146	150		10.1007/s12028-009-9264-2			5	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	789XI	WOS:000292552100023	19669604				2021-06-18	
J	Deng, P; Xu, ZC				Deng, Ping; Xu, Zao C.			Contribution of I-h to Neuronal Damage in the Hippocampus after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						HCN channel; hilar cell; neuronal excitability; neuroprotection; trauma	CORTICAL IMPACT MODEL; PROTEIN-KINASE-C; STRIATAL CHOLINERGIC INTERNEURONS; TRANSIENT FOREBRAIN ISCHEMIA; ACTIVATED PACEMAKER CHANNELS; CA1 PYRAMIDAL NEURONS; CATION CHANNELS; DENDRITIC I(H); DENTATE GYRUS; UP-REGULATION	Traumatic brain injury (TBI) causes selective neuronal damage in the hippocampus; however, the underlying mechanisms are still unclear. Post-traumatic alterations of ion channel activity, which actively regulate neuronal excitability and thus impact on excitotoxicity, may be involved in TBI-induced neuronal injury. Here we report that hyperpolarization-activated cation current (I-h) contributes to the distinct vulnerability of hippocampal neurons in TBI. In a rat model of controlled cortical injury, moderate TBI produced neuronal death of both hippocampal CA3 neurons and mossy cells in the hilus, but not CA1 pyramidal cells. Treatment with lamotrigine, which enhances dendritic I-h, ameliorated TBI-induced neuronal damage to CA3 neurons and mossy cells. In contrast, intraventricular administration of I-h channel blocker caused cell death in the CA1 region after TBI. Whole-cell recordings revealed that, differently from CA3 neurons, CA1 pyramidal cells expressed larger Ih and exhibited a post-traumatic increase of I-h amplitude. Moreover, blocking I-h led to an increase of neuronal excitability, with greater effects seen in post-traumatic CA1 pyramidal cells than in CA3 neurons. In addition, the I-h in mossy cells was dramatically inhibited early after TBI. Our findings indicate that differential changes of I-h in hippocampal neurons may be one of the mechanisms of selective cell death, and that an enhancement of functional I-h may protect hippocampal neurons against TBI.	[Deng, Ping; Xu, Zao C.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Deng, P (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 507, Indianapolis, IN 46202 USA.	zcxu@iupui.edu; pideng@iupui.edu			Indiana Spinal Cord and Brain Injury Fund [ISDH/A70-0-079212]; American Heart AssociationAmerican Heart Association [0630172N]	This work was supported by the Indiana Spinal Cord and Brain Injury Fund (ISDH/A70-0-079212) and American Heart Association grant 0630172N to P.D.	Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Brauer AU, 2001, FASEB J, V15, P2689, DOI 10.1096/fj.01-0235com; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Deng P, 2005, NEUROSCIENCE, V131, P135, DOI 10.1016/j.neuroscience.2004.11.004; Deng P, 2008, J CEREBR BLOOD F MET, V28, P939, DOI 10.1038/sj.jcbfm.9600583; Deng P, 2007, J NEUROSCI, V27, P3148, DOI 10.1523/JNEUROSCI.5535-06.2007; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan Y, 2008, EXP NEUROL, V212, P415, DOI 10.1016/j.expneurol.2008.04.032; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Golarai G, 2001, J NEUROSCI, V21, P8523; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Howard AL, 2007, J NEUROPHYSIOL, V97, P2394, DOI 10.1152/jn.00509.2006; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189; Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/j.cell.2004.11.020; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Toth Z, 1997, J NEUROSCI, V17, P8106; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	59	11	11	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2011	28	7					1173	1183		10.1089/neu.2010.1683			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	794BL	WOS:000292869600006	21463147				2021-06-18	
J	Geary, EK; Kraus, MF; Rubin, LH; Pliskin, NH; Little, DM				Geary, Elizabeth K.; Kraus, Marilyn F.; Rubin, Leah H.; Pliskin, Neil H.; Little, Deborah M.			Verbal Learning Strategy Following Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Post-concussive syndrome; Concussion; Semantic; Cognition; Executive functions; Brain/behavior relationships	SCHIZOPHRENIA-SPECTRUM DISORDERS; FRONTAL LESIONS; FREE-RECALL; EXECUTIVE DYSFUNCTION; MEMORY REHABILITATION; COGNITIVE IMPAIRMENT; QUALITATIVE ASPECTS; MULTIPLE-SCLEROSIS; DIFFUSION-TENSOR; TEST-2ND EDITION	That learning and memory deficits persist many years following mild traumatic brain injury (mTBI) is controversial due to inconsistent objective evidence supporting subjective complaints. Our prior work demonstrated significant reductions in performance on the initial trial of a verbal learning task and overall slower rate of learning in well-motivated mTBI participants relative to demographically matched controls. In our previous work, we speculated that differences in strategy use could explain the differences in rate of learning. The current study serves to test this hypothesis by examining strategy use on the California Verbal Learning Test-Second Edition. Our present findings support the primary hypothesis that mTBI participants under-utilize semantic clustering strategies during list-learning relative to control participants. Despite achieving comparable total learning scores, we posit that the persisting learning and memory difficulties reported by some mTBI patients may be related to reduced usage of efficient internally driven strategies that facilitate learning. Given that strategy training has demonstrated improvements in learning and memory in educational and occupational settings, we offer that these findings have translational value in offering an additional approach in remediation of learning and memory complaints reported by some following mTBI. (JINS, 2011, 17, 709-719)	[Geary, Elizabeth K.; Kraus, Marilyn F.; Pliskin, Neil H.; Little, Deborah M.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL 60612 USA; [Geary, Elizabeth K.; Little, Deborah M.] Univ Illinois, Coll Med, Ctr Stroke Res, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Rubin, Leah H.; Pliskin, Neil H.] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL 60612 USA; [Kraus, Marilyn F.; Rubin, Leah H.; Pliskin, Neil H.] Univ Illinois, Coll Med, Ctr Cognit Med, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Coll Med, Dept Anat, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Coll Med, Dept Ophthalmol, Chicago, IL 60612 USA; [Little, Deborah M.] Univ Illinois, Coll Med, Dept Psychol, Chicago, IL 60612 USA	Little, DM (corresponding author), Univ Illinois, Coll Med, Dept Neurol, MC 796,912 S Wood St 855 N, Chicago, IL 60612 USA.	deborahmlittle@gmail.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 MH068787]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32-MH067631]; Marshall Goldberg Traumatic Brain Injury Fund; NICHD/ORWHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH Office of Research on Women's Health (ORWH) [K12HD055892]; Department of DefenseUnited States Department of Defense [PT 075675]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH067631, K23MH068787] Funding Source: NIH RePORTER	This work is supported in part by NIH grant K23 MH068787 (MFK) and T32-MH067631 (EKG) from the National Institute of Mental Health, the Marshall Goldberg Traumatic Brain Injury Fund, NICHD/ORWH grant K12HD055892 (LHR), and a grant from the Department of Defense/Congressionally Directed Medical Research Program grant PT 075675. The contents of this study are solely the responsibility of the authors and do not necessarily represent the official views of the University of Illinois at Chicago, Department of Defense, Congressionally Directed Medical Research Program, Department of the Army, National Institute of Child Health and Human Development, the National Institutes of Health, or the National Institute of Mental Health. Special thanks to Sarung Kashyap for his contribution in the preparation of the raw data for these analyses. The authors have no financial and/or relationship conflicts of interest to disclose.	Alexander M, 2006, J INT NEUROPSYCH SOC, V12, P192, DOI 10.1017/S1355617706060292; Alexander MP, 2009, J COGNITIVE NEUROSCI, V21, P1422, DOI 10.1162/jocn.2009.21094; Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Basso MR, 2006, J INT NEUROPSYCH SOC, V12, P640, DOI 10.1017/S1355617706060759; Becker S, 2003, J COGNITIVE NEUROSCI, V15, P821, DOI 10.1162/089892903322370744; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chan AS, 2000, SCHIZOPHR RES, V41, P431, DOI 10.1016/S0920-9964(99)00078-X; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; DeJong J, 2010, J CLIN EXP NEUROPSYC, V32, P953, DOI 10.1080/13803391003645640; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 2010, CLIN NEUROPSYCHOL, V24, P70, DOI 10.1080/13854040903002232; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DEROSA DV, 1970, J VERB LEARN VERB BE, V9, P269, DOI 10.1016/S0022-5371(70)80060-3; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ellis H. C., 1965, TRANSFER LEARNING; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Fiszdon JM, 2006, PSYCHIAT RES, V143, P159, DOI 10.1016/j.psychres.2005.09.012; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Gongvatana A, 2007, J NEUROPSYCH CLIN N, V19, P36, DOI 10.1176/appi.neuropsych.19.1.36; GSOTTSCHNEIDER A, 2010, J NEUROPSYCHOLOGY; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jefferies E, 2008, J MEM LANG, V58, P66, DOI 10.1016/j.jml.2007.06.004; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LUEK SP, 1976, MEM COGNITION, V4, P476, DOI 10.3758/BF03213207; Matsui M, 2008, PROG NEURO-PSYCHOPH, V32, P1854, DOI 10.1016/j.pnpbp.2008.08.018; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ranjith N, 2010, ANN INDIAN ACAD NEUR, V13, P117, DOI 10.4103/0972-2327.64639; Ribeiro F, 2007, J CLIN EXP NEUROPSYC, V29, P187, DOI 10.1080/13803390600629775; Roofeh D, 2006, SCHIZOPHR RES, V85, P201, DOI 10.1016/j.schres.2006.03.030; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Schefft BK, 2008, APPL NEUROPSYCHOL, V15, P61, DOI 10.1080/09084280801917806; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schweizer TA, 2010, BEHAV NEUROL, V23, P31, DOI [10.3233/BEN-2010-0269, 10.1155/2010/102421]; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; STERNBERG RJ, 1977, PSYCHOL BULL, V84, P539, DOI 10.1037/0033-2909.84.3.539; Strangman GE, 2008, ARCH PHYS MED REHAB, V89, P974, DOI 10.1016/j.apmr.2008.02.011; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Turner MS, 2007, NEUROPSYCHOLOGIA, V45, P1540, DOI 10.1016/j.neuropsychologia.2006.11.013; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.007; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; West L. K., 2010, J NEUROPSYCHOLOGY; YOUNG RK, 1965, J EXP PSYCHOL, V70, P338, DOI 10.1037/h0022257; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B	71	11	11	2	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2011	17	4					709	719		10.1017/S1355617711000646			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	781NL	WOS:000291939900015	21554788				2021-06-18	
J	Geeraerts, T; Coles, JP; Aigbirhio, FI; Pickard, JD; Menon, DK; Fryer, TD; Hong, YT				Geeraerts, Thomas; Coles, Jonathan P.; Aigbirhio, Franklin I.; Pickard, John D.; Menon, David K.; Fryer, Tim D.; Hong, Young T.			Validation of reference tissue modelling for [C-11]flumazenil positron emission tomography following head injury	ANNALS OF NUCLEAR MEDICINE			English	Article						[C-11]Flumazenil; Kinetic modelling; Positron emission tomography (PET); Reference tissue; Traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; ARTERIAL INPUT FUNCTION; C-11 FLUMAZENIL; DIFFUSION-TENSOR; CEREBRAL-ISCHEMIA; PET; RECEPTOR; BINDING; LIGAND; PARAMETERS	[C-11]Flumazenil ([C-11]FMZ) positron emission tomography (PET) can be used as a measure of neuronal loss. The purpose of this study was to validate reference tissue kinetic modelling of [C-11]FMZ PET within a group of patients with head injury. Following earlier studies, the pons was used as the reference region. PET scans were performed on 16 controls and 11 patients at least 6 months following injury, each of whom also had arterial blood sampling to provide whole blood and metabolite-corrected plasma input functions. Regional non-displaceable binding potentials (BPND) were calculated from five reference tissue models and compared to BPND from arterial input models. For the patients, the regions included a peri-lesional region of interest (ROI). Total distribution volume of the pons was not significantly different between control and patient groups (P = 0.24). BPND from all the reference tissue approaches correlated well with BPND from the plasma input models for both controls (r (2) = 0.98-1.00; P < 0.001) and patients (r (2) = 0.99-1.00; P < 0.001). For the peri-lesional regions (n = 11 ROI values), the correlation was also high (r (2) = 0.91). These results indicate that reference tissue modelling with the pons as the reference region is valid for [C-11]FMZ PET in head-injured patients at 6 months following injury within both normal appearing and peri-lesional brain regions.	[Coles, Jonathan P.] Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge CB2 2QQ, England; [Geeraerts, Thomas; Coles, Jonathan P.; Menon, David K.] Univ Cambridge, Univ Div Anaesthesia, Cambridge, England; [Coles, Jonathan P.; Aigbirhio, Franklin I.; Pickard, John D.; Menon, David K.; Fryer, Tim D.; Hong, Young T.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Pickard, John D.] Univ Cambridge, Acad Neurosurg Unit, Cambridge, England; [Geeraerts, Thomas] Univ Paris Sud, Ctr Hosp Univ Bicetre, AP HP, Dept Anesthesie Reanimat Chirurg, F-94275 Le Kremlin Bicetre, France	Coles, JP (corresponding author), Addenbrookes Hosp, Univ Dept Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	jpc44@wbic.cam.ac.uk			Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); UK Government; Royal College of Anaesthetists/British Journal of Anaesthesia; Cambridge National Institute for Health Research (NIHR) Biomedical Research CentreNational Institute for Health Research (NIHR); Societe Francaise d'Anesthesie et de Reanimation; Jounees d'enseignement post-universitaire; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	We wish to thank the Wolfson Brain Imaging Centre radiochemistry and scanning staff for their assistance with data acquisition. These studies were supported by the Medical Research Council (UK), a Technology Foresight from the UK Government, a Royal College of Anaesthetists/British Journal of Anaesthesia project grant and the Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre. Dr. Geeraerts was funded from the Societe Francaise d'Anesthesie et de Reanimation and from the Jounees d'enseignement post-universitaire. No potential conflicts of interest were disclosed.	Baron JC, 2001, BRAIN, V124, P2, DOI 10.1093/brain/124.1.2; Barre L, 1991, Int J Rad Appl Instrum A, V42, P435, DOI 10.1016/0883-2889(91)90102-7; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Cleij MC, 2007, J LABELLED COMPD RAD, V50, P19, DOI 10.1002/jlcr.1152; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; DELFORGE J, 1995, J CEREBR BLOOD F MET, V15, P284, DOI 10.1038/jcbfm.1995.34; Folkersma H, 2009, J NUCL MED, V50, P1975, DOI 10.2967/jnumed.109.067512; Guadagno JV, 2008, BRAIN, V131, P2666, DOI 10.1093/brain/awn175; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gunn RN, 1998, NEUROIMAGE, V8, P426, DOI 10.1006/nimg.1998.0379; Hammers A, 2008, J CEREBR BLOOD F MET, V28, P207, DOI 10.1038/sj.jcbfm.9600515; Heiss W.D., 1997, STROKE, V28, P2051; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1997, STROKE, V28, P2045, DOI 10.1161/01.STR.28.10.2045; Heiss WD, 2001, BRAIN, V124, P20, DOI 10.1093/brain/124.1.20; HUME SP, 1992, SYNAPSE, V12, P47, DOI 10.1002/syn.890120106; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Klumpers UMH, 2008, J CEREBR BLOOD F MET, V28, P579, DOI 10.1038/sj.jcbfm.9600554; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Miederer I, 2009, EUR J NUCL MED MOL I, V36, P659, DOI 10.1007/s00259-008-0990-z; Millet P, 2002, NEUROIMAGE, V17, P928, DOI 10.1006/nimg.2002.1233; Okazawa H, 2004, J COMPUT ASSIST TOMO, V28, P428, DOI 10.1097/00004728-200405000-00021; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; SETTE G, 1993, STROKE, V24, P2057; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; TEASDALE G, 1974, LANCET, V2, P81; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34	36	11	11	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0914-7187			ANN NUCL MED	Ann. Nucl. Med.	JUL	2011	25	6					396	405		10.1007/s12149-011-0480-4			10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	790RG	WOS:000292606300002	21461598				2021-06-18	
J	Honeybul, S; Ho, KM; Lind, CRP; Gillett, GR				Honeybul, Stephen; Ho, Kwok M.; Lind, Christopher R. P.; Gillett, Grant R.			Decompressive Craniectomy for Diffuse Cerebral Swelling After Trauma: Long-Term Outcome and Ethical Considerations	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Decompressive craniectomy; Outcome; Neurotrauma; Ethics	BRAIN-INJURY; SURGICAL DECOMPRESSION; ARTERY INFARCTION; MULTICENTER; SURGERY; VALIDATION; RECOVERY; TRIAL; SCALE	Background: There is currently much interest in the use of decompressive for the management of diffuse cerebral swelling after trauma. Although the use of the procedure may improve survival, some of those survivors may be left severely disabled. The aim of this study was to see whether severe disability can be predicted and discuss the difficult ethical issue that this raises. Methods: This was a retrospective cohort subgroup analysis of those patients with severe head injury in Western Australia between 2004 and 2008 who had had a decompressive craniectomy for intractably raised intracranial pressure despite maximal medical management. Results: Among a total of 1,786 adult neurotrauma patients admitted between 2004 and 2008, 74 patients required a bifrontal decompressive craniectomy for intractably raised intracranial pressure. After the application of Corticosteroid Randomization After Significant Head Injury (CRASH) trial collaborators' prediction model, predicted and observed outcomes were compared. The mean timing and median timing of surgery were 42 hours and 30 hours after hospital admission, respectively. The timing of decompressive craniectomy was inversely correlated to the severity of the head injury (Spearman's correlation coefficient = -0.251, p = 0.031). At 18-month follow-up, 16 patients were deceased, 3 were in a persistent vegetative state, and 10 were severely disabled. In contrast to these unfavorable outcomes, 35 patients had a good outcome and 10 were moderately disabled at 18 months. The discrimination of the CRASH prediction model was excellent (area under receiver-operating characteristic curve, 0.905; 95% confidence interval, 0.829-0.982; p = 0.001). Conclusion: Our data provide some evidence that the CRASH prediction model may help clinicians and families to make informed decision about the benefits and risks of decompressive craniectomy for diffuse cerebral swelling.	[Honeybul, Stephen; Lind, Christopher R. P.] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; Royal Perth Hosp, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher R. P.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand	Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; BLAKE R, 2007, DAY D HERBERT WOKE; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Fins JJ, 2009, ANN NY ACAD SCI, V1157, P131, DOI 10.1111/j.1749-6632.2009.04473.x; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gillett G, 2001, NEW ZEAL MED J, V114, P188; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hall K. M., 1992, NEUROREHABILITATION, V2, DOI [10.3233/NRE-1992-2410, DOI 10.3233/NRE-1992-2410]; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2009, J CLIN NEUROSCI, V16, P727, DOI 10.1016/j.jocn.2008.06.015; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2010, ACTA NEUROCHIR, V152, P959, DOI 10.1007/s00701-010-0626-5; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kobylarz E, 2004, ARCH NEUROL-CHICAGO, V61, P1357, DOI 10.1001/archneur.61.9.1357; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Meier U, 2005, ACT NEUR S, V95, P55; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; SCHIFF ND, 2003, CEREBRUM, V5, P7; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	37	11	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					128	132		10.1097/TA.0b013e3182117b6c			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	790RR	WOS:000292607400032	21460742				2021-06-18	
J	Mattio, M; Ceaglio, N; Oggero, M; Perotti, N; Amadeo, I; Orozco, G; Forno, G; Kratje, R; Etcheverrigaray, M				Mattio, Monica; Ceaglio, Natalia; Oggero, Marcos; Perotti, Norma; Amadeo, Ignacio; Orozco, Gustavo; Forno, Guillermina; Kratje, Ricardo; Etcheverrigaray, Marina			Isolation and Characterization of a Subset of Erythropoietin Glycoforms with Cytoprotective but Minimal Erythropoietic Activity	BIOTECHNOLOGY PROGRESS			English	Article						erythropoietin; isoforms; cytoprotection	RECOMBINANT-HUMAN-ERYTHROPOIETIN; MICE OVEREXPRESSING ERYTHROPOIETIN; BLOOD-BRAIN-BARRIER; CELL-DEATH; IN-VITRO; GM-CSF; RECEPTOR; GLYCOSYLATION; ESTABLISHMENT; CIRCULATION	Although historically used for the treatment of anemia, erythropoietin (EPO) has emerged as a neurotrophic and neuroprotective agent in different conditions of neuronal damage (traumatic brain injury, ischemia, spinal cord compression, peripheral neuropathy, retinal damage, epilepsy, Parkinson's Disease, among others). Nonetheless, EPO's therapeutic application is limited due to its hematological side-effects. With the aim of obtaining EPO derivatives resembling the hormone isolated from cells and tissues of neural origin, a novel combination of less acidic EPO glycoforms-designated as neuroepoetin (rhNEPO)- was purified to homogeneity from the supernatant of a CHO-producing cell line by a four-step chromatographic procedure. This simple and single process allowed us to prepare two EPO derivatives with distinct therapeutic expectations: the hematopoietic version and a minimally hematopoietic, but mainly in vitro cytoprotective, alternative. Further biological characterization showed that the in vivo erythropoietic activity of rhNEPO was 25-times lower than that of rhEPO. Interestingly, using different in vitro cytoprotective assays we found that this molecule exerts cytoprotection equivalent to, or better than, that of rhEPO in cells of neural phenotype. Furthermore, despite its shorter plasma half-life, rhNEPO was rapidly absorbed and promptly detected in the cerebrospinal fluid after intravenous administration in rats (5 min postinjection, in comparison with 30 min for rhEPO). Therefore, our results support the study of neuroepoetin as a potential drug for the treatment of neurological diseases, combining high cytoprotective activity with reduced hematological side-effects. (C) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 27: 1018-1028, 2011	[Oggero, Marcos] Univ Nacl Litoral, Cell Culture Lab, Fac Bioquim & Ciencias Biol, Sch Biochem & Biol Sci, Santa Fe, Argentina; [Amadeo, Ignacio; Orozco, Gustavo; Forno, Guillermina] Zelltek SA, RN PTLC 168, RA-3000 Paraje El Pozo, Santa Fe, Argentina	Oggero, M (corresponding author), Univ Nacl Litoral, Cell Culture Lab, Fac Bioquim & Ciencias Biol, Sch Biochem & Biol Sci, Ciudad Univ,CC 242,S3000ZAA, Santa Fe, Argentina.	moggero@fbcb.unl.edu.ar		Oggero, Marcos/0000-0002-9234-9511; Ceaglio, Natalia/0000-0003-2798-4532	Universidad Nacional del Litoral [5/38, 356.698]; Zelltek SA; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	The authors thank Alejandro Raimondi for his kind cooperation in CZE experiments, Francisco Godoy for his valuable help in artwork preparation and Gisela Leal for meticulously proofreading the manuscript. This work was supported by the following Argentine institutions: Universidad Nacional del Litoral (CAI+D 2006 No. 5/38; SAT No. 356.698), Zelltek SA and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; *COUNC EUR, 2008, EUR PHARM, P1813; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; Egrie JC, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_3.3; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fisher JW, 2003, EXP BIOL MED, V228, P1; FUKUDA MN, 1989, BLOOD, V73, P84; GOOCHE CF, 1992, BIOTECHNOLOGY, V9, P1347; Haviv R, 1997, J NEUROSCI RES, V50, P69, DOI 10.1002/(SICI)1097-4547(19971001)50:1<69::AID-JNR8>3.0.CO;2-J; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; KOMATSU N, 1993, BLOOD, V82, P456; Konstantinopoulos PA, 2007, BBA-REV CANCER, V1776, P1, DOI 10.1016/j.bbcan.2007.07.002; KRATJE RB, 1992, BIOTECHNOL BIOENG, V39, P233, DOI 10.1002/bit.260390216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li G, 2008, NEUROSCI LETT, V442, P143, DOI 10.1016/j.neulet.2008.07.007; LIM VS, 1991, AM J KIDNEY DIS, V18, P34; Llop E, 2008, ANAL BIOCHEM, V383, P243, DOI 10.1016/j.ab.2008.08.027; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Shargel L, 2005, APPL BIOPHARMACEUTIC; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; TAKEUCHI M, 1990, J BIOL CHEM, V265, P12127; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; Wagner KF, 2001, BLOOD, V97, P536, DOI 10.1182/blood.V97.2.536; WASLEY LC, 1991, BLOOD, V77, P2642; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Xenocostas A, 2005, EUR J CLIN PHARMACOL, V61, P189, DOI 10.1007/s00228-005-0896-7; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x	42	11	11	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	8756-7938			BIOTECHNOL PROGR	Biotechnol. Prog.	JUL-AUG	2011	27	4					1018	1028		10.1002/btpr.633			11	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	810EG	WOS:000294107600013	21608141				2021-06-18	
J	Tiemessen, CAM; Hoedemaekers, CWE; van Iersel, FM; Rosken, GHJ; van der Hoeven, J; Biessels, GJ; Slooter, AJC				Tiemessen, Charlotte A. M.; Hoedemaekers, Cornelia W. E.; van Iersel, Freya M.; Rosken, Gerrit H. J.; van der Hoeven, Johannes; Biessels, Geert-Jan; Slooter, Arjen J. C.			Intensive Insulin Therapy Increases the Risk of Hypoglycemia in Neurocritical Care Patients	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						intensive insulin therapy; effects; protocol; neurocritical care patients; intensive care; hypoglycemia	CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; GLUCOSE CONTROL; STRESS HYPERGLYCEMIA; STROKE; MICRODIALYSIS; MANAGEMENT; INFARCTION; BENEFITS	Background: Intensive insulin therapy protocols are widely used in intensive care medicine. A disadvantage of these protocols may be the occurrence of hypoglycemic episodes. Neurocritical care patients are particularly vulnerable to the effects of hypoglycemia. We aimed to study the risk of hypoglycemia in neurocritical care patients in relation to intensive insulin therapy. Methods: To determine the effects of 2 different intensive insulin therapy protocols on glucose levels and hypoglycemia incidence, we collected data before and after implementation of the protocols in 2 university hospitals. The risk of hypoglycemia (blood glucose level below 3.0 mmol/L) was studied retrospectively with logistic regression analyses. Results: In hospital A, data were obtained on 152 patients before implementation of the protocol and on 649 patients after implementation of the protocol. In hospital B, data were obtained on 111 patients before implementation of the protocol and on 118 patients thereafter. Implementation of intensive insulin therapy protocols increased the time spent in the desired blood glucose range of 4.6 to 6.0 mmol/L in both hospitals, but increased the risk of hypoglycemia: the absolute risk of hypoglycemia during intensive care unit admission increased in hospital A from 14.5% to 20.3% (adjusted odds ratio = 1.3; 95% confidence interval: 0.8-2.3) and in hospital B from 3.6% to 29.7% (adjusted odds ratio = 28.6; 95% confidence interval: 5.9-138.9). Conclusions: Implementation of intensive insulin therapy protocols in neurocritical care patients not only seems to increase the time spent in the desired blood glucose range, but also seems to increase the risk of hypoglycemia. The risk of hypoglycemia strongly depends on characteristics of the intensive insulin therapy protocol.	[Slooter, Arjen J. C.] Univ Med Ctr, Dept Intens Care Med, UMC Utrecht, NL-3508 GA Utrecht, Netherlands; [Biessels, Geert-Jan] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3508 GA Utrecht, Netherlands; [Tiemessen, Charlotte A. M.; Hoedemaekers, Cornelia W. E.; van Iersel, Freya M.; Rosken, Gerrit H. J.; van der Hoeven, Johannes] St Radboud Univ, Med Ctr, Dept Intens Care, Nijmegen, Netherlands	Slooter, AJC (corresponding author), Univ Med Ctr, Dept Intens Care Med, UMC Utrecht, POB 85500,Room F-06-149, NL-3508 GA Utrecht, Netherlands.	A.Slooter-3@umcutrecht.nl	van der Hoeven, J.G./H-8048-2014; Hoedemaekers, C.W.E./L-4375-2015				Badjatia N, 2005, CRIT CARE MED, V33, P1603, DOI 10.1097/01.CCM.0000168054.60538.2B; Bellomo R, 2009, MAYO CLIN PROC, V84, P400, DOI 10.1016/S0025-6196(11)60557-0; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2009, J NEUROSURG ANESTH, V21, P2, DOI 10.1097/ANA.0b013e31818f8a5c; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Claassen J, 2004, CRIT CARE MED, V32, P832, DOI 10.1097/01.CCM.0000114830.48833.8A; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Godoy DA, 2010, NEUROCRIT CARE, V13, P425, DOI 10.1007/s12028-010-9404-8; Green DM, 2010, NEUROCRIT CARE, V13, P299, DOI 10.1007/s12028-010-9417-3; Jacka MJ, 2009, CAN J NEUROL SCI, V36, P436, DOI 10.1017/S0317167100007757; Juvela S, 2005, J NEUROSURG, V102, P998, DOI 10.3171/jns.2005.102.6.0998; Kanji S, 2010, NEUROCRIT CARE, V12, P43, DOI 10.1007/s12028-009-9275-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Lewis KS, 2004, ANN PHARMACOTHER, V38, P1243, DOI 10.1345/aph.1D211; Li PA, 2001, BRAIN RES, V912, P203, DOI 10.1016/S0006-8993(01)02724-X; MELAMED E, 1976, J NEUROL SCI, V29, P267, DOI 10.1016/0022-510X(76)90176-3; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oksanen T, 2007, INTENS CARE MED, V33, P2093, DOI 10.1007/s00134-007-0876-8; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stead LG, 2009, NEUROCRIT CARE, V10, P181, DOI 10.1007/s12028-008-9080-0; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	28	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2011	23	3					206	214		10.1097/ANA.0b013e31821aa6f2			9	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	774YY	WOS:000291423900008	21593693				2021-06-18	
J	Avesani, R; Fedeli, M; Ferraro, C; Khansefid, M				Avesani, R.; Fedeli, M.; Ferraro, C.; Khansefid, M.			Use of early indicators in rehabilitation process to predict functional outcomes in subjects with acquired brain injury	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injuries; Rehabilitation; Outcomes; Evaluation studies	DISABILITY RATING-SCALE; TBI	Background. The use of Evaluation Scales in ABI is necessary for measure of outcome, but not always they are used as predictor factors for rehabilitation processes and organization. Aim. The aim of this study was to evaluate the effectiveness and efficiency of an inpatient rehabilitation program for patients with traumatic brain injury through the use of selected indicators and to identify predictive factors for functional outcome. Design. This was a retrospective database analysis. Setting. Patients admitted to an Intensive Rehabilitation Unit as inpatient (Sacro Cuore-Don Calabria Hospital, Negrar-Verona). Population. The population included patients with traumatic brain injury. Methods. The study enrolled 175 patients admitted to an Intensive Rehabilitation Unit between 2004 and 2007. Data collected included demographic characteristics, first 24-hours worst GCS, length of acute and rehabilitative stay at admission and discharge FIM, DRS, LCF and GOS. Results. There was a statistically significant recovery over the course of admission for all assessment tools (P < 0.000). When patients were subdivided on the basis of admission DRS categories a linear correlation among variables could be observed, with most disabled patients showing the longest acute and rehabilitation stays and the lowest functional gains. Within each DRS category age appeared to affect improvement (P < 0.005) while final outcome was influenced not only by age but also by initial functional status (P < 0.000) and time from injury to admission (P < 0.004). Conclusions and Clinical Rehabilitation Impact. Systematic data collection in intensive rehabilitation is of great importance to monitor recovery and plan appropriate programs on the basis of admission functional status.	[Avesani, R.; Khansefid, M.] Sacra Cuore Hosp, Dept Rehabil Med, I-37024 Verona, Italy; [Fedeli, M.; Ferraro, C.] Univ Padua, Dept Rehabil Med, Padua, Italy	Avesani, R (corresponding author), Sacra Cuore Hosp, Dept Rehabil Med, I-37024 Verona, Italy.	renato.avesani@sacrocuore.it					Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Novack TA, 2000, BRAIN INJURY, V14, P987; ntroduction to the Disability Rating Scale, 2000, CTR OUTCOME MEASUREM, P2000; Poon WS, 2005, ACT NEUR S, V93, P207; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stineman MG, 2001, ARCH PHYS MED REHAB, V82, P553, DOI 10.1053/apmr.2001.24088; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Wright J, CTR OUTCOME MEASUREM; WRIGHT J, GLASGOW OUTCOME SCAL; ZAFONTE RD, 1996, AM J PHYS REHABIL, V75, P346	21	11	11	0	1	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087			EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	JUN	2011	47	2					203	212					10	Rehabilitation	Rehabilitation	774TW	WOS:000291410500003	21364510				2021-06-18	
J	Brandstack, N; Kurki, T; Hiekkanen, H; Tenovuo, O				Brandstack, N.; Kurki, T.; Hiekkanen, H.; Tenovuo, O.			Diffusivity of Normal-Appearing Tissue in Acute Traumatic Brain Injury	CLINICAL NEURORADIOLOGY			English	Article						Traumatic brain injury; Diffusion weighted MRI; Magnetic resonance imaging; Glasgow coma scale; Glasgow outcome scale	CLOSED-HEAD INJURY; AXONAL INJURY; EDEMA; COEFFICIENT; MRI; SCALE	Apparent diffusion coefficient (ADC) values derived from diffusion-weighted magnetic resonance imaging (MRI) can provide information about traumatic changes not visible in conventional MRI. The ADC values in acute traumatic brain injury (TBI) were measured and correlated with initial severity and outcome scores. In this study 22 unselected patients were studied 1 week (mean 7 +/- 2 days) after TBI of variable severity. In conventional MRI 7 patients were without visible findings, 15 showed cortical contusions or traumatic axonal injury and 14 healthy subjects served as controls. The ADC values were measured from 46 brain regions away from the visible traumatic changes and compared between the groups. Regional ADC values and the number of abnormal regions were correlated with the Glasgow coma scale (GCS) on arrival in hospital and the Glasgow outcome scale (extended version, GOS-E) at 1 year after injury. The ADC values of TBI patients with and without visible lesions did not show any differences but both groups differed significantly from the controls in several cortical and deep brain regions. Increased ADC values were common in TBI groups but decreased ADC values were relatively uncommon. The regional ADC values and the number of abnormal regions did not correlate with either GCS or GOS-E scores. Increased diffusion in normal appearing brain tissue is a common finding 1 week after TBI in patients with and without visible lesions in conventional MRI. More investigations are needed to evaluate how these findings could be used for clinical applications.	[Brandstack, N.] Helsinki Univ Hosp, Dept Radiol, Helsinki 00029, Finland; [Kurki, T.] Turku Univ Hosp, Dept Radiol, Turku 20521, Finland; [Hiekkanen, H.; Tenovuo, O.] Turku Univ Hosp, Dept Neurol, Turku 20521, Finland	Brandstack, N (corresponding author), Helsinki Univ Hosp, Dept Radiol, POB 340, Helsinki 00029, Finland.	nimabr@utu.fi		Kurki, Timo/0000-0001-5532-3534			Ahlhelm F, 2004, MED SCI MONITOR, V10, pMT121; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Cellerini M, 1997, ACTA ANAT, V158, P215; CURNES JT, 1988, AM J NEURORADIOL, V9, P1061; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Engelter ST, 2000, AM J ROENTGENOL, V175, P425, DOI 10.2214/ajr.175.2.1750425; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou A, 2003, ACT NEUR S, V86, P7; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Schaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Tench CR, 2002, MAGN RESON MED, V47, P967, DOI 10.1002/mrm.10144	32	11	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1869-1439	1869-1447		CLIN NEURORADIOL	Clin. Neuroradiol.	JUN	2011	21	2					75	82		10.1007/s00062-011-0058-5			8	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	798UI	WOS:000293237300004	21394634				2021-06-18	
J	Carrera, E; Steiner, LA; Castellani, G; Smielewski, P; Zweifel, C; Haubrich, C; Pickard, JD; Menon, DK; Czosnyka, M				Carrera, Emmanuel; Steiner, Luzius A.; Castellani, Gianluca; Smielewski, Peter; Zweifel, Christian; Haubrich, Christina; Pickard, John D.; Menon, David K.; Czosnyka, Marek			Changes in Cerebral Compartmental Compliances during Mild Hypocapnia in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; brain trauma; cerebrospinal fluid; CBF autoregulation	BLOOD-FLOW VELOCITY; CEREBROSPINAL-FLUID SYSTEM; INTRACRANIAL-PRESSURE; HEAD-INJURY; MODERATE HYPERVENTILATION; DOPPLER ULTRASOUND; CARBON-DIOXIDE; PULSE PRESSURE; HUMANS; AUTOREGULATION	The benefit of induced hyperventilation for intracranial pressure (ICP) control after severe traumatic brain injury (TBI) is controversial. In this study, we investigated the impact of early and sustained hyperventilation on compliances of the cerebral arteries and of the cerebrospinal (CSF) compartment during mild hyperventilation in severe TBI patients. We included 27 severe TBI patients (mean 39.5 +/- 3.4 years, 6 women) in whom an increase in ventilation (20% increase in respiratory minute volume) was performed during 50 min as part of a standard clinical CO(2) reactivity test. Using a new mathematical model, cerebral arterial compliance (Ca) and CSF compartment compliance (Ci) were calculated based on the analysis of ICP, arterial blood pressure, and cerebral blood flow velocity waveforms. Hyperventilation initially induced a reduction in ICP (17.5 +/- 6.6 vs. 13.9 +/- 6.2 mmHg; p < 0.001), which correlated with an increase in Ci (r(2) = 0.213; p = 0.015). Concomitantly, the reduction in cerebral blood flow velocities (CBFV, 74.6 +/- 27.0 vs. 62.9 +/- 22.9 cm/sec; p < 0.001) marginally correlated with the reduction in Ca (r(2) = 0.209; p = 0.017). During sustained hyperventilation, ICP increased (13.9 +/- 6.2 vs. 15.3 +/- 6.4 mmHg; p < 0.001), which correlated with a reduction in Ci (r(2) = 0.297; p = 0.003), but no significant changes in Ca were found during that period. The early reduction in Ca persisted irrespective of the duration of hyperventilation, which may contribute to the lack of clinical benefit of hyperventilation after TBI. Further studies are needed to determine whether monitoring of arterial and CSF compartment compliances may detect and prevent an adverse ischemic event during hyperventilation.	[Carrera, Emmanuel; Castellani, Gianluca; Smielewski, Peter; Zweifel, Christian; Haubrich, Christina; Pickard, John D.; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Acad Neurosurg Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Cambridge CB2 2QQ, England; [Steiner, Luzius A.] Univ Hosp, Dept Anaesthesia, Lausanne, Switzerland	Carrera, E (corresponding author), Univ Cambridge, Dept Clin Neurosci, Acad Neurosurg Unit, Addenbrookes Hosp, Level 4,A Block, Cambridge CB2 2QQ, England.	emmanuel.carrera@chuv.ch	Steiner, Luzius/J-1987-2019; Steiner, Luzius/C-9836-2011	Smielewski, Peter/0000-0001-5096-3938; Carrera, Emmanuel/0000-0003-0045-5382	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PASSMP3-124262, PBBSP3-125550]; National Institute of Health Research, United KingdomNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986, G0001237] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	This work was supported by the Swiss National Science Foundation (PASSMP3-124262 to E. C., and PBBSP3-125550 to C.Z.) and the National Institute of Health Research, United Kingdom.	AASLID R, 1991, STROKE, V22, P1148, DOI 10.1161/01.STR.22.9.1148; Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; ATKINSON JLD, 1990, BRAIN RES, V517, P333, DOI 10.1016/0006-8993(90)91046-J; AVEZAAT CJ, 1984, CEREBROSPINAL FLUID, P57; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; BRADAC GB, 1976, NEURORADIOLOGY, V10, P257, DOI 10.1007/BF00327574; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; CARRERA E, 2010, J NEUROIMAG IN PRESS; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; COLD GE, 1981, ACTA ANAESTH SCAND, V25, P397, DOI 10.1111/j.1399-6576.1981.tb01673.x; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; ERIKSSON S, 1983, ACTA PHYSIOL SCAND, V117, P203, DOI 10.1111/j.1748-1716.1983.tb07198.x; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; PETRUK KC, 1974, STROKE, V5, P230, DOI 10.1161/01.STR.5.2.230; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Poulin MJ, 1996, STROKE, V27, P2244, DOI 10.1161/01.STR.27.12.2244; REIVICH M, 1964, AM J PHYSIOL, V206, P25; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Smielewski P, 2005, ACT NEUR S, V95, P43; Steiner LA, 2005, ACTA NEUROCHIR SUPPL, V95, P17; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Tain RW, 2009, IEEE T BIO-MED ENG, V56, P544, DOI 10.1109/TBME.2008.2006010; Valdueza JM, 1997, AM J NEURORADIOL, V18, P1929; Wilkinson IB, 2001, J PHYSIOL-LONDON, V530, P541, DOI 10.1111/j.1469-7793.2001.0541k.x; YURA T, 1995, NEPHRON, V71, P168, DOI 10.1159/000188707	35	11	11	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2011	28	6					889	896		10.1089/neu.2010.1377			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	788PT	WOS:000292457600004	21204704	Green Published			2021-06-18	
J	Kamp, MA; Slotty, P; Sarikaya-Seiwert, S; Steiger, HJ; Hanggi, D				Kamp, Marcel A.; Slotty, Philipp; Sarikaya-Seiwert, Sevgi; Steiger, Hans-Jakob; Haenggi, Daniel			Traumatic brain injuries in illustrated literature: experience from a series of over 700 head injuries in the Asterix comic books	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Illustrated literature risk factors; Ancient Roman Empire; Asterix		The goal of the present study was to analyze the epidemiology and specific risk factors of traumatic brain injury (TBI) in the Asterix illustrated comic books. Among the illustrated literature, TBI is a predominating injury pattern. A retrospective analysis of TBI in all 34 Asterix comic books was performed by examining the initial neurological status and signs of TBI. Clinical data were correlated to information regarding the trauma mechanism, the sociocultural background of victims and offenders, and the circumstances of the traumata, to identify specific risk factors. Seven hundred and four TBIs were identified. The majority of persons involved were adult and male. The major cause of trauma was assault (98.8%). Traumata were classified to be severe in over 50% (GCS 3-8). Different neurological deficits and signs of basal skull fractures were identified. Although over half of head-injury victims had a severe initial impairment of consciousness, no case of death or permanent neurological deficit was found. The largest group of head-injured characters was constituted by Romans (63.9%), while Gauls caused nearly 90% of the TBIs. A helmet had been worn by 70.5% of victims but had been lost in the vast majority of cases (87.7%). In 83% of cases, TBIs were caused under the influence of a doping agent called "the magic potion". Although over half of patients had an initially severe impairment of consciousness after TBI, no permanent deficit could be found. Roman nationality, hypoglossal paresis, lost helmet, and ingestion of the magic potion were significantly correlated with severe initial impairment of consciousness (p a parts per thousand currency signaEuro parts per thousand 0.05).	[Kamp, Marcel A.; Slotty, Philipp; Sarikaya-Seiwert, Sevgi; Steiger, Hans-Jakob; Haenggi, Daniel] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany	Kamp, MA (corresponding author), Univ Dusseldorf, Dept Neurosurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	marcelalexander.kamp@uni-duesseldorf.de	Sarikaya-Seiwert, Sevgi/AAH-4859-2020; Steiger, Hans-Jakob/AAN-8307-2021	Steiger, Hans-Jakob/0000-0002-8249-2998; Kamp, Marcel/0000-0002-1252-2944			Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Kanz F, 2006, FORENSIC SCI INT, V160, P207, DOI 10.1016/j.forsciint.2005.10.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenartz D, 2000, ANTICANCER RES, V20, P2073; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Rose F C, 1997, J Hist Neurosci, V6, P154; Sanchez Gonzalo Moreno, 2007, Neurosurg Focus, V23, pE5; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; WILKINS RH, 1964, J NEUROSURG, V21, P240, DOI 10.3171/jns.1964.21.3.0240	11	11	11	0	31	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2011	153	6					1351	1355		10.1007/s00701-011-0993-6			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	766OV	WOS:000290795700028	21472486				2021-06-18	
J	Katz-Leurer, M; Rotem, H; Keren, O; Meyer, S				Katz-Leurer, Michal; Rotem, Hemda; Keren, Ofer; Meyer, Shirley			Effect of concurrent cognitive tasks on gait features among children post-severe traumatic brain injury and typically-developed controls	BRAIN INJURY			English	Article						Concurrent tasks; gait characteristics; traumatic brain injury (TBI)	STABILITY FOLLOWING CONCUSSION; ALZHEIMERS-DISEASE; DIVIDED ATTENTION; STRIDE VELOCITY; OLDER-ADULTS; VARIABILITY; PERFORMANCE; WALKING; BALANCE	Aim: To investigate and compare the influence of concurrent cognitive tasks on gait characteristics in children post-traumatic brain injury (TBI) and typically-developed (TD) controls. Methods: Fifteen children post-TBI (aged 9.5 +/- 2.2 years) and 15 TD controls (aged 9.9 +/- 1.3 years) were included in the study. The children were asked to walk under three conditions: (1) walking at a self-selected speed, (2) walking at a self-selected speed while memorizing and recalling a series of three random numbers and (3) walking at a self-selected speed while listening and identifying commonly experienced sounds. Gait parameters include walking speed, step time and length and step time and length variability as measured with the GAITRite(R) system. Results: Introduction of a concurrent task led to decreased walking speed and step length and increased step time and step length variability in both groups, but with a significantly prominent effect in children post-TBI. The results also showed that the effect of a concurrent cognitive task on walking depended on the complexity level of the task. Conclusion: When children were asked to perform an additional task while they were walking, this had a negative effect on their gait. One may deduce from these results that control of the rhythmic stepping mechanism at a self-selected walking speed in children is dependant to an extent on their ability to focus attention on their gait. In children post-TBI who usually have an attention deficit anyway, this ability is severely disturbed.	[Katz-Leurer, Michal] Tel Aviv Univ, Phys Therapy Dept, Sch Hlth Profess, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Katz-Leurer, Michal; Rotem, Hemda; Meyer, Shirley] Alyn Childrens Orthoped Hosp & Rehabil Ctr, Jerusalem, Israel; [Keren, Ofer] Tel Aviv Univ, Chaim Sheba Med Ctr, Rehabil Dept, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Katz-Leurer, M (corresponding author), Tel Aviv Univ, Phys Therapy Dept, Sch Hlth Profess, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	michalkz@post.tau.ac.il					Beauchet Olivier, 2005, J Neuroeng Rehabil, V2, P26, DOI 10.1186/1743-0003-2-26; Beauchet Olivier, 2006, Psychol Neuropsychiatr Vieil, V4, P215; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cherng RJ, 2007, GAIT POSTURE, V26, P231, DOI 10.1016/j.gaitpost.2006.09.004; Cocchini G, 2004, REV NEUROL-FRANCE, V160, P74, DOI 10.1016/S0035-3787(04)70849-8; Dubost V, 2008, GAIT POSTURE, V27, P138, DOI 10.1016/j.gaitpost.2007.03.011; Dubost V, 2006, HUM MOVEMENT SCI, V25, P372, DOI 10.1016/j.humov.2006.03.004; Heiderscheit BC, 2000, J APPL BIOMECH, V16, P419, DOI 10.1123/jab.16.4.419; Huang Hsiang-Ju, 2003, Pediatr Phys Ther, V15, P105, DOI 10.1097/01.PEP.0000067886.96352.6B; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Logie RH, 2004, NEUROPSYCHOLOGY, V18, P504, DOI 10.1037/0894-4105.18.3.504; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; Sheridan PL, 2003, J AM GERIATR SOC, V51, P1633, DOI 10.1046/j.1532-5415.2003.51516.x; Silsupadol P, 2006, PHYS THER, V86, P269, DOI 10.1093/ptj/86.2.269; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Thorpe DE, 2005, ARCH PHYS MED REHAB, V86, P2342, DOI 10.1016/j.apmr.2005.07.301; WHITALL J, 1991, J EXP CHILD PSYCHOL, V51, P245, DOI 10.1016/0022-0965(91)90035-Q; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x	25	11	11	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					581	586		10.3109/02699052.2011.572943			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300004	21534735				2021-06-18	
J	Wang, XH; Xu, MH; Liang, H; Xu, LS				Wang, Xuhui; Xu, Minhui; Liang, Hong; Xu, Lunshan			Comparison of CT and MRI in diagnosis of cerebrospinal leak induced by multiple fractures of skull base	RADIOLOGY AND ONCOLOGY			English	Article						MRI; diagnosis; multiple basilar skull fracture; cerebrospinal leak	HIGH-RESOLUTION CT; FLUID LEAKS; CSF LEAKS; CISTERNOGRAPHY	Background. Multiple basilar skull fracture and cerebrospinal leak are common complications of traumatic brain injury, which required a surgical repair. But due to the complexity of basilar skull fracture after severe trauma, preoperatively an exact radiological location is always difficult. Multi-row spiral CT and MRI are currently widely applied in the clinical diagnosis. The present study was performed to compare the accuracy of cisternography by multi-row spiral CT and MRI in the diagnosis of cerebrospinal leak. Methods. A total of 23 patients with multiple basilar skull fracture after traumatic brain injury were included. The radiological and surgical data were retrospectively analyzed. 64-row CT (mm/row) scan and three-dimensional reconstruction were performed in 12 patients, while MR plain scan and cisternography were performed in another 11 patients. The location of cerebrospinal leak was diagnosed by 2 experienced physicians majoring neurological radiology. Surgery was performed in all patients. The cerebrospinal leak location was confirmed and repaired during surgery. The result was considered as accurate when cerebrospinal leak was absent after surgery. Results. According to the surgical exploration, the preoperative diagnosis of the active cerebrospinal leak location was accurate in 9 out of 12 patients with CT scan. The location could not be confirmed by CT because of multiple fractures in 2 patients and the missed diagnosis occurred in 1 patient. The preoperative diagnosis was accurate in 10 out of 11 patients with MRI examination. Conclusions. MRI cisternography is more advanced than multi-row CT scan in multiple basilar skull fracture. The combination of the two examinations may increase the diagnostic ratio of active cerebrospinal leak.	[Xu, Lunshan] Third Mil Med Univ, Dept Neurosurg, Daping Hosp, Chongqing 400042, Peoples R China; Third Mil Med Univ, Dept Neurosurg, Inst Surg Res, Chongqing 400042, Peoples R China	Xu, LS (corresponding author), Third Mil Med Univ, Dept Neurosurg, Daping Hosp, Chongqing 400042, Peoples R China.	david0608@yeah.net					Arbelaez A, 2007, AM J ROENTGENOL, V188, pW560, DOI 10.2214/AJR.05.1280; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Hilinski JM, 2001, OTOL NEUROTOL, V22, P701, DOI 10.1097/00129492-200109000-00025; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; La Fata V, 2008, AM J NEURORADIOL, V29, P536, DOI 10.3174/ajnr.A0885; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; McMains KC, 2004, LARYNGOSCOPE, V114, P1833, DOI 10.1097/00005537-200410000-00029; Prokop M, 2003, EUR J RADIOL, V45, pS4, DOI 10.1016/S0720-048X(02)00358-3; Rajer M, 2008, RADIOL ONCOL, V42, P23, DOI 10.2478/v10019-007-0035-4; Schlosser RJ, 2004, LARYNGOSCOPE, V114, P255, DOI 10.1097/00005537-200402000-00015; Selcuk H, 2010, AM J NEURORADIOL, V31, P71, DOI 10.3174/ajnr.A1788; Shetty PG, 1998, AM J NEURORADIOL, V19, P633; Stanic K, 2010, RADIOL ONCOL, V44, P180, DOI 10.2478/v10019-010-0038-4; Stone JA, 1999, AM J NEURORADIOL, V20, P706	14	11	11	1	2	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1318-2099	1581-3207		RADIOL ONCOL	Radiol. Oncol.	JUN	2011	45	2					91	96		10.2478/v10019-011-0007-6			6	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	772XJ	WOS:000291271200003	22933941	DOAJ Gold, Green Published			2021-06-18	
J	Gabbe, BJ; Lyons, RA; Lecky, FE; Bouamra, O; Woodford, M; Coats, TJ; Cameron, PA				Gabbe, Belinda J.; Lyons, Ronan A.; Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.; Cameron, Peter A.			Comparison of Mortality Following Hospitalisation for Isolated Head Injury in England and Wales, and Victoria, Australia	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; SYSTEM; CARE; REGISTRY; QUALITY; MANAGEMENT; SURVIVAL; OUTCOMES; TRENDS	Background: Traumatic brain injury (TBI) remains a leading cause of death and disability. The National Institute for Health and Clinical Excellence (NICE) guidelines recommend transfer of severe TBI cases to neurosurgical centres, irrespective of the need for neurosurgery. This observational study investigated the risk-adjusted mortality of isolated TBI admissions in England/Wales, and Victoria, Australia, and the impact of neurosurgical centre management on outcomes. Methods: Isolated TBI admissions (> 15 years, July 2005-June 2006) were extracted from the hospital discharge datasets for both jurisdictions. Severe isolated TBI (AIS severity >3) admissions were provided by the Trauma Audit and Research Network (TARN) and Victorian State Trauma Registry (VSTR) for England/Wales, and Victoria, respectively. Multivariable logistic regression was used to compare risk-adjusted mortality between jurisdictions. Findings: Mortality was 12% (749/6256) in England/Wales and 9% (91/1048) in Victoria for isolated TBI admissions. Adjusted odds of death in England/Wales were higher compared to Victoria overall (OR 2.0, 95% CI: 1.6, 2.5), and for cases <65 years (OR 2.36, 95% CI: 1.51, 3.69). For severe TBI, mortality was 23% (133/575) for TARN and 20% (68/346) for VSTR, with 72% of TARN and 86% of VSTR cases managed at a neurosurgical centre. The adjusted mortality odds for severe TBI cases in TARN were higher compared to the VSTR (OR 1.45, 95% CI: 0.96, 2.19), but particularly for cases <65 years (OR 2.04, 95% CI: 1.07, 3.90). Neurosurgical centre management modified the effect overall (OR 1.12, 95% CI: 0.73, 1.74) and for cases <65 years (OR 1.53, 95% CI: 0.77, 3.03). Conclusion: The risk-adjusted odds of mortality for all isolated TBI admissions, and severe TBI cases, were higher in England/Wales when compared to Victoria. The lower percentage of cases managed at neurosurgical centres in England and Wales was an explanatory factor, supporting the changes made to the NICE guidelines.	[Gabbe, Belinda J.; Cameron, Peter A.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia; [Gabbe, Belinda J.; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Lyons, Ronan A.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.] Univ Manchester, Salford Royal Hosp, Manchester Acad Hlth Sci Ctr,Sch Community Based, Trauma Audit & Res Network,Hlth Sci Res Grp, Salford, Lancs, England; [Lecky, Fiona E.] Salford Royal Hosp, Dept Emergency Med, Salford, Lancs, England; [Coats, Timothy J.] Leicester Royal Infirm, Dept Accid & Emergency, Leicester, Leics, England; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia	Gabbe, BJ (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia.	belinda.gabbe@monash.edu	Lyons, Ronan/G-7741-2012	Lyons, Ronan/0000-0001-5225-000X; Cameron, Peter/0000-0002-1443-557X; Gabbe, Belinda/0000-0001-7096-7688; Coats, Timothy/0000-0003-2736-2784	Department of Human Services (Victoria); Transport Accident Commission (TAC) Health Research; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	The VSTR is a Department of Human Services (Victoria) and Transport Accident Commission (TAC) Health Research funded and approved initiative. Dr. Belinda Gabbe and Prof. Peter Cameron were supported by a Career Development Award and a Practitioner Fellowship, respectively, from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Coats TJ, 1999, J ACCID EMERG MED, V16, P182; Esposito Thomas J, 2006, Adv Surg, V40, P213, DOI 10.1016/j.yasu.2006.06.002; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; MacLeod JBA, 2004, AM SURGEON, V70, P805; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; O'Reilly GM, 2010, ACAD EMERG MED, V17, P1122, DOI 10.1111/j.1553-2712.2010.00887.x; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20545	10.1371/journal.pone.0020545			8	Multidisciplinary Sciences	Science & Technology - Other Topics	770OP	WOS:000291097600093	21655237	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Rickels, E; von Wild, K; Wenzlaff, P				Rickels, E.; von Wild, K.; Wenzlaff, P.			Treatment of traumatic brain injury in Germany	UNFALLCHIRURG			German	Article						Traumatic brain Injury (TBI); Epidemiology; Clinical pathway; Quality management; Subjective sequelae	MINOR HEAD-INJURY; EPIDEMIOLOGY; POPULATION; RULE; US	The relationship between severe, moderate and mild traumatic brain injury (TBI) as well as the course of treatment and quality management, were studied in a 1-year prospective study in regions of Hannover and Munster Germany. A total of 6,783 patients were documented at the initial examination (58.4% male, 28.1% children < 16 years old) and 63.5% participated in the follow-up survey 1 year after the accident. Of these TBI patients 5,220 (73%) were admitted to hospital for clinical treatment but only 258 (< 4%) received inpatient rehabilitation. The incidence of TBI was 332/100,000 inhabitants and according to the Glasgow Coma Scale (GCS) brain injury was mild in 90.9%, severe in 5.2% and moderate in 3.9%. The main cause of injury was a fall (52.5%) followed by a traffic accident (26.3%). In-hospital mortality was 1%. Only 56% of TBI patients were neurological examined and 63% were examined in hospital within the first hour after the accident. An immediate x-ray of the skull with a doubtful evidential value was made in 82%. Of the participants 35.9% were still receiving medical treatment 1 year after the accident although the majority only suffered mild TBI. An overabundance of severe socioeconomic consequences, e.g. loss of job, accommodation, family, were also found following only mild TBI.	[Rickels, E.] Allgemeines Krankenhaus Celle, Bereich Neurochirurg, D-29223 Celle, Germany; [von Wild, K.] Univ Munster, Fak Med, Cerebprotect Forderverein eV, Munster, Germany; [Wenzlaff, P.] Arztekammer Niedersachsen, Zentrum Qualitat & Management Gesundheitswesen, Hannover, Germany	Rickels, E (corresponding author), Allgemeines Krankenhaus Celle, Bereich Neurochirurg, Siemenspl 4, D-29223 Celle, Germany.	emrickels@t-online.de					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; *CDC, 2003, TRAUM BRAIN INJ US R; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; RICKELS E, 2006, SCHADEL HIRNVERLETZU; SARWADEI F, 2002, J NEUROSURG SCI, V46, P111; Schootman M, 2000, BRAIN INJURY, V14, P373; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; WEIMAR C, 2003, DTSCH ARZTEBL, V100	17	11	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAY	2011	114	5					417	423		10.1007/s00113-010-1872-y			7	Emergency Medicine; Surgery	Emergency Medicine; Surgery	762OZ	WOS:000290490600010	21461785				2021-06-18	
J	Harr, ME; Heskestad, B; Ingebrigtsen, T; Romner, B; Ronning, P; Helseth, E				Harr, Marianne Efskind; Heskestad, Ben; Ingebrigtsen, Tor; Romner, Bertil; Ronning, Pal; Helseth, Eirik			Alcohol consumption, blood alcohol concentration level and guideline compliance in hospital referred patients with minimal, mild and moderate head injuries	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; EPIDEMIOLOGY; MANAGEMENT; SEVERITY	Background: In 2000 the Scandinavian Neurotrauma Committee published guidelines for safe and cost-effective management of minimal, mild and moderate head injured patients. The aims of this study were to investigate to what extent the head injury population is under the influence of alcohol, and to evaluate whether the physicians' compliance to the guidelines is affected when patients are influenced by alcohol. Methods: This study included adult patients (>= 15 years) referred to a Norwegian University Hospital with minimal, mild and moderate head injuries classified according to the Head Injury Severity Scale (HISS). Information on alcohol consumption was recorded, and in most of these patients blood alcohol concentration (BAC) was measured. Compliance with the abovementioned guidelines was registered. Results: The study includes 860 patients. 35.8% of the patients had consumed alcohol, and 92.1% of these patients had a BAC >= 1.00 parts per thousand. Young age, male gender, trauma occurring during the weekends, mild and moderate head injuries were independent factors significantly associated with being under the influence of alcohol. Guideline compliance was 60.5%, and over-triage was the main violation. The guideline compliance showed no significant correlation to alcohol consumption or to BAC-level. Conclusions: This study confirms that alcohol consumption is common among patients with head injuries. The physicians' guideline compliance was not affected by the patients' alcohol consumption, and alcohol influence could therefore not explain the low guideline compliance.	[Harr, Marianne Efskind; Heskestad, Ben; Ronning, Pal; Helseth, Eirik] Oslo Univ Hosp Ulleval, Dept Neurosurg, N-0424 Oslo, Norway; [Harr, Marianne Efskind; Heskestad, Ben; Helseth, Eirik] Univ Oslo, Fac Med, N-0315 Oslo, Norway; [Heskestad, Ben] Stavanger Univ Hosp, Dept Neurosurg, N-4068 Stavanger, Norway; [Ingebrigtsen, Tor; Romner, Bertil] Univ Tromso, Dept Neurosurg, Fac Hlth Sci, Inst Clin Med, N-9038 Tromso, Norway; [Ingebrigtsen, Tor; Romner, Bertil] Univ Hosp N Norway, N-9038 Tromso, Norway; [Romner, Bertil] Rigshosp, Dept Neurosurg, DK-2100 Copenhagen O, Denmark	Harr, ME (corresponding author), Oslo Univ Hosp Ulleval, Dept Neurosurg, POB 4950 Nydalen, N-0424 Oslo, Norway.	marianne.efskind@gmail.com	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Gururaj G., 2004, J INDIAN MED ASSOC, V102, P163; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; MACLEOD JBA, 2010, INJURY, V41, P847, DOI DOI 10.1016/J.INJURY.2010.01.098; Moskowitz H., 2000, REV LIT EFFECTS LOW; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; R Development Core Team, 2010, R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP R LANG ENV STAT COMP; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033; WHO, 2007, ALC INJ EM DEP SUMM	27	11	11	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 17	2011	19								25	10.1186/1757-7241-19-25			5	Emergency Medicine	Emergency Medicine	767QH	WOS:000290870600001	21496318	DOAJ Gold, Green Published			2021-06-18	
J	Rekha, J; Veena, LR; Prem, N; Kalaivani, P; Choudhury, R; Alladi, PA; Agrahari, M; Raju, TR; Kutty, BM				Rekha, J.; Veena, L. R.; Prem, Neethi; Kalaivani, P.; Choudhury, Rupam; Alladi, Phalguni Anand; Agrahari, Maulishree; Raju, T. R.; Kutty, Bindu M.			NIH-3T3 fibroblast transplants enhance host regeneration and improve spatial learning in ventral subicular lesioned rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						CNS insult; Cognitive impairment; Fibroblast transplants; Trophic support; Host regeneration; Behavioural recovery	NERVE GROWTH-FACTOR; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; RADIAL MAZE PERFORMANCE; CA1 PYRAMIDAL CELLS; SPINAL-CORD-INJURY; ENTORHINAL CORTEX; ENRICHED ENVIRONMENT; ADULT-RATS; CHOLINE-ACETYLTRANSFERASE	Transplants, besides providing neural replacement, also stimulate host regeneration, which could serve as a powerful means to establish functional recovery in CNS insults. Earlier, we have reported the H3-GFP transplant mediated recovery of cognitive functions in the ventral subicular lesioned rats. In the present study, we demonstrate the efficacy of a non-neural fibroblast transplants in mediating host regeneration and functional recovery in ventral subicular lesioned rats. Adult male Wistar rats were lesioned with ibotenic acid in the ventral subiculum (VSL) and were transplanted with NIH-3T3 fibroblast cells into CA1 region of the hippocampus. Ventral subicular lesioning impaired the spatial task performances in rats and produced considerable degree of dendritic atrophy of the hippocampal pyramidal neurons. Two months following transplantation, the transplants were seen in the dentate gyrus and expressed BDNF and bFGF. Further, the VSL rats with fibroblast transplants showed enhanced expression of BDNF in the hippocampus and enhanced dendritic branching and increased spine density in the CA1 hippocampal pyramidal neurons. Transplantation of fibroblast cells also helped to establish functional recovery and the rats with transplants showed enhanced spatial learning performances. We attribute the recovery of cognitive functions to the graft mediated host regeneration, although the mechanisms of functional recovery remain to be elucidated. (C) 2010 Elsevier B.V. All rights reserved.	[Rekha, J.; Veena, L. R.; Prem, Neethi; Kalaivani, P.; Alladi, Phalguni Anand; Raju, T. R.; Kutty, Bindu M.] NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neuro Sci, Dept Neurophysiol, Bangalore 560029, Karnataka, India; [Agrahari, Maulishree] PES Inst Technol, Dept Biotechnol, Bangalore 560085, Karnataka, India; [Choudhury, Rupam] TIFR, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Kutty, BM (corresponding author), NIMHANS Deemed Univ, Natl Inst Mental Hlth & Neuro Sci, Dept Neurophysiol, Bangalore 560029, Karnataka, India.	bindu.nimhans@gmail.com	Alladi, Phalguni/AAY-6912-2020	Alladi, Phalguni/0000-0002-2876-3478	Department of Biotechnology (DBT), New DelhiDepartment of Biotechnology (DBT) India [BT/PR 6567/Med/14/849/2005]	The study was funded by the Department of Biotechnology (DBT), New Delhi, (project No. BT/PR 6567/Med/14/849/2005). We acknowledge with thanks the support provided by Dr. M.M. Panicker, Associate Professor, NCBS-TIFR, GKVK Campus, Bangalore 560065, during the study and also for suggesting the use of NIH-3T3 fibroblast cell lines.	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Barde YA, 1987, PROG BRAIN RES <D>, V71, P185; BERGER TW, 1980, BRAIN RES, V183, P265, DOI 10.1016/0006-8993(80)90463-1; Bindu B, 2007, NEUROSCIENCE, V144, P412, DOI 10.1016/j.neuroscience.2006.09.057; Bindu B, 2005, BRAIN RES, V1063, P121, DOI 10.1016/j.brainres.2005.09.044; Bonde C, 2000, NEUROREPORT, V11, P4069, DOI 10.1097/00001756-200012180-00032; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; CHO YH, 1995, NEUROBIOL LEARN MEM, V64, P285, DOI 10.1006/nlme.1995.0011; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; DAVIES DC, 1992, ACTA NEUROPATHOL, V83, P510, DOI 10.1007/BF00310028; DEKKER AJ, 1994, NEUROSCIENCE, V60, P299, DOI 10.1016/0306-4522(94)90244-5; Devi L, 2003, BRAIN RES, V960, P9, DOI 10.1016/S0006-8993(02)03699-5; Dhanushkodi A, 2007, BEHAV NEUROSCI, V121, P491, DOI 10.1037/0735-7044.121.3.491; Dickinson-Anson H, 2003, MOL THER, V8, P51, DOI 10.1016/S1525-0016(03)00145-X; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FISHER LJ, 1993, J NEUROCHEM, V61, P1323, DOI 10.1111/j.1471-4159.1993.tb13625.x; Floresco SB, 1996, BEHAV BRAIN RES, V81, P163, DOI 10.1016/S0166-4328(96)00058-7; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GOODLETT CR, 1989, BEHAV BRAIN RES, V32, P63, DOI 10.1016/S0166-4328(89)80072-5; Govindaiah, 1997, BRAIN RES, V745, P121, DOI 10.1016/S0006-8993(96)01135-3; Herzog CD, 2002, NEUROSCIENCE, V113, P569, DOI 10.1016/S0306-4522(02)00203-8; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hodges H, 2000, NEUROSCIENCE, V101, P945, DOI 10.1016/S0306-4522(00)00408-5; JARRARD LE, 1978, J COMP PHYSIOL PSYCH, V92, P1119, DOI 10.1037/h0077516; JARRARD LE, 1984, PHARMACOL BIOCHEM BE, V21, P273, DOI 10.1016/0091-3057(84)90226-0; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Kerr DA, 2003, J NEUROSCI, V23, P5131; Kim D, 2001, NEUROREHAB NEURAL RE, V15, P141, DOI 10.1177/154596830101500207; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; Laxmi TR, 1999, BRAIN RES, V816, P245, DOI 10.1016/S0006-8993(98)01187-1; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; LeviMontalcini R, 1996, TRENDS NEUROSCI, V19, P514, DOI 10.1016/S0166-2236(96)10058-8; Li N, 2007, BIOCHEM BIOPH RES CO, V356, P561, DOI 10.1016/j.bbrc.2007.03.013; LINDSAY RM, 1984, NEUROSCIENCE, V12, P45, DOI 10.1016/0306-4522(84)90136-2; Liu W G, 1999, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V13, P291; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Modo M, 2002, STROKE, V33, P2270, DOI 10.1161/01.STR.0000027693.50675.C5; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nutan K S, 1998, Indian J Physiol Pharmacol, V42, P460; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Oswald CJP, 2000, BEHAV NEUROSCI, V114, P211, DOI 10.1037/0735-7044.114.1.211; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; Pizzo DP, 2004, MOL BRAIN RES, V126, P1, DOI 10.1016/j.molbrainres.2004.03.006; Rampon C, 2000, NAT NEUROSCI, V3, P238; Rao BSS, 2001, NEUROSCIENCE, V102, P319, DOI 10.1016/S0306-4522(00)00462-0; Rao MS, 2006, NEUROBIOL DIS, V21, P276, DOI 10.1016/j.nbd.2005.07.009; Rekha J, 2009, BEHAV NEUROSCI, V123, P1197, DOI 10.1037/a0017655; Scholl DA, 1956, ORG CEREBRAL CORTEX; SEGAL RA, 1995, J NEUROSCI, V15, P4970; SHARP PE, 1990, J NEUROSCI, V10, P3093; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; SUNANDA RMS, 1995, BRAIN RES, V694, P312, DOI DOI 10.1016/0006-8993(95)00822-8.PUBMED:8974660; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; Tobias CA, 2001, J NEUROTRAUM, V18, P287, DOI 10.1089/08977150151070937; Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; TUSZYNSKI MH, 1994, EXP NEUROL, V126, P1, DOI 10.1006/exnr.1994.1037; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; VOLPE BT, 1989, STROKE, V20, P1700, DOI 10.1161/01.STR.20.12.1700; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; YEE BK, 1994, J NEUROSCI, V14, P3766; Yuan QJ, 2000, NEUROREPORT, V11, P2237, DOI 10.1097/00001756-200007140-00035; Yuen EC, 1996, ANN NEUROL, V40, P346, DOI 10.1002/ana.410400304; Zaman V, 2003, HIPPOCAMPUS, V13, P618, DOI 10.1002/hipo.10091	82	11	13	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR 15	2011	218	2					315	324		10.1016/j.bbr.2010.11.020			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	730OF	WOS:000288042600008	21074573				2021-06-18	
J	Berry, C; Ley, EJ; Mirocha, J; Margulies, DR; Tillou, A; Salim, A				Berry, Cherisse; Ley, Eric J.; Mirocha, James; Margulies, Daniel R.; Tillou, Areti; Salim, Ali			Do pregnant women have improved outcomes after traumatic brain injury?	AMERICAN JOURNAL OF SURGERY			English	Article						Traumatic brain injury; Sex; Pregnant; Outcome; Mortality	GENDER-DIFFERENCE; DIMORPHISM; OBESITY; IMPACT	BACKGROUND: Pregnant women, who have significantly elevated levels of estrogen and progesterone, might benefit from the neuroprotective effect of steroid hormones. METHODS: Pregnant patients were identified and compared with their nonpregnant counterparts with respect to demographics and outcome. \ RESULTS: Of the 18,800 female, moderate to severe TBI patients, 71 were pregnant. Similar mortalities were noted in pregnant and nonpregnant TBI patients (9.9% vs 9.3%, P = .84). Adjusting for confounding variables, pregnant TBI patients had a trend toward increased mortality (adjusted odds ratio [AOR] = 2.2; 95% confidence interval [CI], .9-5.1; P = .07). In patients aged 15 to 47 years (n = 8,854), similar mortalities were noted in pregnant and nonpregnant TBI patients (9.9% vs 6.8%, P = .34). After adjusting for risk factors, again there was a trend toward increased mortality in the pregnant TBI group (AOR = 2.0; 95% CI, .8-4.6; P = .12). CONCLUSIONS: Pregnant patients with moderate to severe TBI show no statistically significant difference in mortality compared with their nonpregnant counterparts. (C) 2011 Elsevier Inc. All rights reserved.	[Berry, Cherisse; Ley, Eric J.; Mirocha, James; Margulies, Daniel R.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Tillou, Areti] Univ Calif Los Angeles, Div Trauma, Los Angeles, CA USA	Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215NT, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Bernasconi D, 1996, METABOLISM, V45, P72, DOI 10.1016/S0026-0495(96)90202-4; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.041483198; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; KIRSCHNER MA, 1990, J CLIN ENDOCR METAB, V70, P473, DOI 10.1210/jcem-70-2-473; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; SAMOJLIK E, 1984, J CLIN ENDOCR METAB, V59, P949, DOI 10.1210/jcem-59-5-949; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10	18	11	11	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2011	201	4					429	432		10.1016/j.amjsurg.2010.10.008			4	Surgery	Surgery	747HU	WOS:000289311700002	21421094				2021-06-18	
J	Scherwath, A; Sommerfeldt, DW; Bindt, C; Nolte, A; Boiger, A; Koch, U; Petersen-Ewert, C				Scherwath, Angela; Sommerfeldt, Dirk W.; Bindt, Carola; Nolte, Achim; Boiger, Annette; Koch, Uwe; Petersen-Ewert, Corinna			Identifying children and adolescents with cognitive dysfunction following mild traumatic brain injury-Preliminary findings on abbreviated neuropsychological testing	BRAIN INJURY			English	Article						Abbreviated neuropsychological testing; cognitive function; mild traumatic brain injury; children; adolescents	CLOSED-HEAD-INJURY; POPULATION; MANAGEMENT; RECOVERY; CONCUSSION; TBI	Objective: Studies on cognitive function in paediatric patients suffering head trauma suggest neuropsychological impairment even after mild traumatic brain injury (MTBI). The present study examined the feasibility of abbreviated neuropsychological testing in different settings in children and adolescents following MTBI. Methods: Within the scope of two prospective studies on psychosocial and cognitive outcome, 71 school-aged children with mild, moderate or severe TBI were assessed. In addition, 15 healthy children were included in the study. The abbreviated instrument comprises three standardized tests measuring attention and memory functions (Digit Symbol, Digit Span, learning trials of the German Auditory Verbal Learning Test). Impairment rates were calculated according to a defined cut-off score for clinically significant cognitive impairment. Results: Abbreviated testing could easily be implemented both in the acute and post-acute clinical setting. Out of the children with MTBI, 12% (shortly after injury) and 30% (2 months after injury), respectively, were classified as cognitively impaired. Following moderate or severe TBI, impairment occurred in 50% of the patients. Healthy children showed the best performance, while children with severe TBI performed worst. Conclusion: Results suggest that abbreviated testing allows detection of MTBI-related cognitive dysfunction. Identified children should be referred to a clinical neuropsychologist for comprehensive assessment.	[Scherwath, Angela] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, D-20246 Hamburg, Germany; [Sommerfeldt, Dirk W.; Boiger, Annette] Altona Childrens Hosp, Hamburg, Germany; [Nolte, Achim] HELIOS Clin Geesthacht, Geesthacht, Germany; [Petersen-Ewert, Corinna] Hamburg Univ Appl Sci, Hamburg, Germany	Scherwath, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Martinistr 52-W26, D-20246 Hamburg, Germany.	a.scherwath@uke.uni-hamburg.de	Koch, Uwe/A-5825-2009; Scherwath, Angela/Q-4197-2016		ZNS-Hannelore Kohl Stiftung; Stiftung Wohlfahrtspflege Nordrhein-Westfalen; Hamburg macht Kinder gesund e.V	This study was supported by funding from the 'ZNS-Hannelore Kohl Stiftung', the 'Stiftung Wohlfahrtspflege Nordrhein-Westfalen' and the 'Hamburg macht Kinder gesund e.V.'.	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Dahl E, 2006, INJURY, V37, P402, DOI 10.1016/j.injury.2005.09.008; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Gordon Kevin E, 2006, Semin Pediatr Neurol, V13, P243, DOI 10.1016/j.spen.2006.09.005; Gruters A, 2007, HORM RES, V68, P107, DOI 10.1159/000110591; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Helmstaedter C., 2001, VERBALER LERN MERKFA; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hotz G, 2001, J HEAD TRAUMA REHAB, V16, P426, DOI 10.1097/00001199-200110000-00003; Kahl H, 2007, BUNDESGESUNDHEITSBLA, V50, P718, DOI 10.1007/s00103-007-0233-7; Kamerling SN, 2003, PEDIATR EMERG CARE, V19, P431, DOI 10.1097/01.pec.0000092590.40174.1f; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; McCrea M., 2000, STANDARDIZED ASSESSM; Petersen C, 2006, BRAIN INJURY, V20, P321, DOI 10.1080/02699050500488108; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Savitsky EA, 2000, AM J EMERG MED, V18, P96, DOI 10.1016/S0735-6757(00)90060-3; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; TEWES U, 2001, HAMBURGWECHSLER INTE; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Von Aster M., 2006, WECHSLER INTELLIGENZ; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017	36	11	11	0	24	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2011	25	4					401	408		10.3109/02699052.2011.557351			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	739RL	WOS:000288735600010	21355673				2021-06-18	
J	Wani, AA; Ramzan, AU; Malik, NK; Qayoom, A; Nizami, FA; Kirmani, AR; Wan, MA				Wani, Abrar A.; Ramzan, Altaf U.; Malik, Nayil K.; Qayoom, Abdul; Nizami, Furqan A.; Kirmani, Altaf R.; Wan, M. Afzal			Missile injury to the pediatric brain in conflict zones Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						penetrating missile injury; pediatric brain injury; conflict	SEVERE HEAD-INJURY; CRANIOCEREBRAL GUNSHOT WOUNDS; TRAUMATIC EXTRADURAL HEMATOMAS; OPERATION-IRAQI-FREEDOM; GLASGOW-COMA-SCALE; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; BLAST INJURIES; EXPERIENCE; CHILDREN	Object. This study was conducted both prospectively and retrospectively at one center over a period of 8 years. The population consisted of all patients with both an age 18 years or younger and a diagnosed penetrating missile injury (PMI) during the study interval. The authors analyzed factors determining outcome and demographic trends in this population, and they compared them with those in the more developed world Methods. Fifty-one patients were the victims of armed conflict, although no one was directly a party to any battle. This mechanism of injury is in strong opposition to data in the literature from developed countries, in which most missile injuries are the result of suicide or homicide or are even sports related. Moreover, all previous studies on the pediatric population have considered only injuries from gunshots, but authors of the current study have included injuries from other penetrating missiles as well. Results. On cross tabulation analysis using the chi-square test, the factors shown to correlate with outcome included the Glasgow Coma Scale (GCS) score, pupillary abnormalities, patient age, hemodynamic status, and bi-hemispheric damage. On multinomial regression analysis, the two strongest predictors of death were GCS score and pupillary abnormalities. The GCS score and hemodynamic status were the strongest predictors of disability. Conclusions. There was no difference in the prognostic factors for PMI between developing or more developed countries. Glasgow Coma Scale score, pupillary abnormalities, and hemodynamic status were the strongest predictors of outcome. In conflict zones in developing countries the victims were mostly innocent bystanders, whereas in the more developed countries homicides and suicides were the leading etiological factors. (DOI: 10.317112010.12.PEDSIO241 )	[Wani, Abrar A.; Ramzan, Altaf U.; Malik, Nayil K.; Qayoom, Abdul; Nizami, Furqan A.; Kirmani, Altaf R.; Wan, M. Afzal] Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, JK, India	Wani, AA (corresponding author), Sherikashmir Inst Med Sci, Dept Neurosurg, Srinagar, JK, India.	abrarwani@rediffmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARLOW B, 1982, J PEDIATR SURG, V17, P927, DOI 10.1016/S0022-3468(82)80469-7; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chambers LW, 2005, ARCH SURG-CHICAGO, V140, P26, DOI 10.1001/archsurg.140.1.26; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Comninos S C, 1979, Acta Neurochir Suppl (Wien), V28, P144; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DHELLEMMES P, 1985, J NEUROSURG, V62, P861, DOI 10.3171/jns.1985.62.6.0861; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gutierrez FA, 1981, CONCEPTS PEDIAT NEUR, P188; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; Humphreys RP, 1983, CONCEPTS PEDIATRIC N, V3, P191; Jagannathan J, 2007, J NEUROSURG, V106, pA761; Jandial R, 2008, NEUROSURGERY, V62, P472, DOI 10.1227/01.neu.0000316015.05550.7a; JENNETT B, 1976, LANCET, V1, P1031; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; KRIEGER D, 1993, CRIT CARE MED, V21, P1944, DOI 10.1097/00003246-199312000-00024; Kunze E, 1998, ACT NEUR S, V71, P16; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; Levy M L, 2000, Neurosurg Focus, V8, pe2, DOI 10.3171/foc.2000.8.1.153; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Liebenberg WA, 2005, NEUROSURGERY, V57, P293, DOI 10.1227/01.NEU.0000166662.77797.EC; LILLARD PL, 1978, SURG NEUROL, V9, P79; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAYER T, 1982, CLIN PEDIATR, V21, P391, DOI 10.1177/000992288202100701; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MINER ME, 1986, NEUROSURGERY, V19, P952, DOI 10.1227/00006123-198612000-00009; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RAIMONDI AJ, 1970, J NEUROSURG, V32, P647, DOI 10.3171/jns.1970.32.6.0647; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rodoplu Ulkumen, 2004, Prehosp Disaster Med, V19, P133; ROPPER AH, 1990, NEUROLOGY, V40, P1707; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SHERMAN WD, 1980, WESTERN J MED, V132, P99; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P161; ZUCCARELLO M, 1985, CHILD NERV SYST, V1, P158, DOI 10.1007/BF00735731	54	11	11	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2011	7	3					276	281		10.3171/2010.12.PEDS10241			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	725WE	WOS:000287676800013	21361767				2021-06-18	
J	Edmonds, RD; Cuschieri, J; Minei, JP; Rosengart, MR; Maier, RV; Harbrecht, BG; Billiar, TR; Peitzman, AB; Moore, EE; Sperry, JL				Edmonds, Rebecca D.; Cuschieri, Joseph; Minei, Joseph P.; Rosengart, Matthew R.; Maier, Ronald V.; Harbrecht, Brian G.; Billiar, Timothy R.; Peitzman, Andrew B.; Moore, Ernest E.; Sperry, Jason L.		Inflammation Host Response Injury	Body Adipose Content is Independently Associated With a Higher Risk of Organ Failure and Nosocomial Infection in the Nonobese Patient Postinjury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	40th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 07, 2010	Telluride, CO	Western Trauma Assoc			STANDARD OPERATING PROCEDURES; SCALE COLLABORATIVE PROJECT; ORIENTED RESEARCH CORE; NECROSIS-FACTOR-ALPHA; CLINICAL CARE; HOST RESPONSE; BLUNT TRAUMA; MASS-INDEX; OBESITY; INJURY	Objective: Obesity defined by a body mass index (BMI) > 30 kg/m(2) is associated with increased morbidity and mortality following trauma. Evidence suggests that obesity represents a state of chronic inflammation and that the adipose tissue content may affect the intensity and resolution of inflammatory response. We sought to avoid the confounding effects attributable to obesity and determine the association of BMI and outcomes following injury in nonobese patients. Methods: Data were obtained from a multicenter prospective cohort study evaluating outcomes in blunt-injured adults with hemorrhagic shock. Only patients with a BMI >= 18.5 and <30 were analyzed. Those with isolated traumatic brain injury and cervical cord injury and those who survived <24 hours were excluded. Logistic regression was used to evaluate the effects of BMI on mortality, multiple organ failure (MOF, multiple organs dysfunction score [MODS] <5), and nosocomial infection (NI) after adjusting for differences in demographics, injury severity, early resuscitation needs, shock parameters, and comorbidities. Results: Overall mortality, MOF, and NI rates for the study cohort (n = 820) were 13%, 37%, and 46%, respectively. Median Injury Severity Score was 33 (interquartile range, 22-41). Median BMI for the study cohort was 25 (interquartile range, 23-27). As BMI increased, maximum organ dysfunction scores also significantly increased for cardiac, respiratory, and renal systems. Logistic regression revealed no significant association with mortality (odds ratio [OR] = 0.95; 95% confidence interval [CI], 0.9-1.0); however, BMI was independently associated with a higher risk of MOF (OR = 1.09; 95% CI, 1.02-1.06) and NI (OR = 1.07; 95% CI, 1.01-1.13). For every single-point increase in BMI, the risk of MOF and NI increase by 9% and 7%, respectively. Conclusion: The risk of MOF and NI increases as BMI increases in the nonobese injured patient. These results suggest that body adipose content may be associated with the magnitude of or extent of the inflammatory response postinjury. Further studies are needed to elucidate the mechanism responsible for this association.	[Edmonds, Rebecca D.; Rosengart, Matthew R.; Billiar, Timothy R.; Peitzman, Andrew B.; Sperry, Jason L.] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15213 USA; [Cuschieri, Joseph; Maier, Ronald V.] Harborview Med Ctr, Div Gen Surg & Trauma, Washington, DC USA; [Cuschieri, Joseph; Maier, Ronald V.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Minei, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Burn, Dallas, TX 75390 USA; [Harbrecht, Brian G.] Univ Louisville, Dept Surg, Div Gen Surg & Trauma, Louisville, KY 40292 USA; [Moore, Ernest E.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Moore, Ernest E.] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA	Sperry, JL (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, 200 Lothrop St, Pittsburgh, PA 15213 USA.	sperryjl@upmc.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM062119] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024154] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM062119-1] Funding Source: Medline		Alban RF, 2006, AM SURGEON, V72, P966; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; Bochicchio GV, 2006, J AM COLL SURGEONS, V203, P533, DOI 10.1016/j.jamcollsurg.2006.07.001; Brandt C A, 2003, AMIA Annu Symp Proc, P794; Brown CVR, 2005, J TRAUMA, V59, P1048, DOI 10.1097/01.ta.0000189047.65630.c5; Byrnes MC, 2005, J TRAUMA, V58, P232, DOI 10.1097/01.TA.0000152081.67588.10; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; CHOBAN PS, 1991, J TRAUMA, V31, P1253, DOI 10.1097/00005373-199109000-00009; Ciesla DJ, 2006, J AM COLL SURGEONS, V203, P539, DOI 10.1016/j.jamcollsurg.2006.06.029; Davenport DL, 2009, J VASC SURG, V49, P140, DOI 10.1016/j.jvs.2008.08.052; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Duane TM, 2006, J TRAUMA, V61, P1218, DOI 10.1097/01.ta.0000241022.43088.e1; Falagas ME, 2009, OBES REV, V10, P280, DOI 10.1111/j.1467-789X.2008.00546.x; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Harbrecht BG, 2007, J TRAUMA, V63, P703, DOI 10.1097/TA.0b013e31811eadea; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Maier RV, 2005, J TRAUMA, V59, P762, DOI 10.1097/01.ta.0000177656.85206.cd; MANSHIP L, 1984, AM SURGEON, V50, P94; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Marshall JC, 1999, EUR J SURG, V163, P62; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; Mullen JT, 2009, ANN SURG, V250, P166, DOI 10.1097/SLA.0b013e3181ad8935; Nathens AB, 2005, J TRAUMA, V59, P764, DOI 10.1097/01.ta.0000177759.17704.35; Nathens AB, 1996, WORLD J SURG, V20, P386, DOI 10.1007/s002689900061; Neville AL, 2004, ARCH SURG-CHICAGO, V139, P983, DOI 10.1001/archsurg.139.9.983; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; West MA, 2006, J TRAUMA, V61, P436, DOI 10.1097/01.ta.0000232517.83039.c4; Winfield RD, 2010, CRIT CARE MED, V38, P51, DOI 10.1097/CCM.0b013e3181b08089	38	11	11	1	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2011	70	2					292	298		10.1097/TA.0b013e31820b5f69			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	719FV	WOS:000287187700009	21307724				2021-06-18	
J	Huh, JW; Widing, AG; Raghupathi, R				Huh, Jimmy W.; Widing, Ashley G.; Raghupathi, Ramesh			Differential Effects of Injury Severity on Cognition and Cellular Pathology after Contusive Brain Trauma in the Immature Rat	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; caspases; children; cognition; contusion; infants; neurodegeneration; traumatic axonal injury; traumatic brain injury	CONTROLLED CORTICAL IMPACT; LATERAL FLUID PERCUSSION; MORRIS WATER MAZE; AXONAL INJURY; HEAD-INJURY; SPINAL-CORD; COMA SCALE; MEMORY DEFICITS; YOUNG-CHILDREN; NEURONAL LOSS	Although diffuse brain damage has been suggested to be the predominant predictor of neurological morbidity following closed head injury in infants and children, the presence of contusions also predicts long-term neurobehavioral dysfunction. Contusive brain trauma in the 17-day-old rat resulted in neurodegeneration and caspase activation in the cortex at 1 day, and in the thalamus at 3 days post-injury, and to a greater extent following a deeper impact. Cortical tissue loss in the 4-mm impact group was significantly greater than that in the 3-mm impact group (p<0.05), and exhibited a time-dependent increase over the first 3 weeks post-injury. Traumatic axonal injury was observed in the white matter tracts below the site of impact at 1 day, and in the corpus callosum at 3 days, to a greater extent following 4-mm impact. In contrast, cellular caspase-3 activation in these white matter tracts was only observed at 24 h post-injury and was not affected by impact depth. Similarly, neurodegeneration and caspase activation in the hippocampus was restricted to the dentate gyrus and occurred to a similar extent in both injured groups. Only the 4-mm impact group exhibited learning deficits in the first week (p<0.0001) that was sustained until the third week post-injury (p<0.0001), while deficits in the 3-mm impact group were seen only at 3 weeks post-injury (p<0.02). These observations demonstrate that increasing severity of injury in immature animals does not uniformly increase the extent of cellular damage, and that the progression of tissue damage and behavioral deficits varies as a function of injury severity.	[Widing, Ashley G.; Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	rramesh@drexelmed.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS053651, R01-HD061963]; VA merit review grantUS Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS053651] Funding Source: NIH RePORTER	These studies were supported in part by National Institute of Neurological Disorders and Stroke grants K08-NS053651 and R01-HD061963, and a VA merit review grant.	Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2000, BRAIN INJURY, V14, P679; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durham SR, 2000, J NEUROTRAUM, V17, P729, DOI 10.1089/neu.2000.17.729; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Hannay HJ, 1999, J NEUROTRAUM, V16, P1103, DOI 10.1089/neu.1999.16.1103; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Nottingham SA, 2003, J COMP NEUROL, V464, P463, DOI 10.1002/cne.10806; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rasband WS, 2007, IMAGE J; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.3.CO;2-#; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TEASDALE G, 1974, LANCET, V2, P81; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	66	11	14	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2011	28	2					245	257		10.1089/neu.2010.1639			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	719UE	WOS:000287234700008	21091272	Green Published			2021-06-18	
J	Keightley, M; Kendall, V; Jang, SH; Parker, C; Agnihotri, S; Colantonio, A; Minore, B; Katt, M; Cameron, A; White, R; Longboat-White, C; Bellavance, A				Keightley, Michelle; Kendall, Victoria; Jang, Shu-Hyun; Parker, Cindy; Agnihotri, Sabrina; Colantonio, Angela; Minore, Bruce; Katt, Mae; Cameron, Anita; White, Randy; Longboat-White, Claudine; Bellavance, Alice			From health care to home community: An Aboriginal community-based ABI transition strategy	BRAIN INJURY			English	Article						Acquired brain injury; Aboriginal health; transition; framework analysis	TRAUMATIC BRAIN-INJURY; ETHNIC DISPARITIES; REHABILITATION; OUTCOMES	Primary objective: To explore the barriers and enablers surrounding the transition from health care to home community settings for Aboriginal clients recovering from acquired brain injuries (ABI) in northwestern Ontario. Research design: Participatory research design using qualitative methods. Methods: Focus groups conducted with clients with ABI, their caregivers and hospital and community health-care workers. The Framework Method of analysis was used to uncover emerging themes. Findings: Six main categories emerged: ABI diagnosis accuracy, acute service delivery and hospital care, transition from hospital to homecare services, transition from hospital to community services, participant suggestions to improve service delivery and transition, and views on traditional healing methods during recovery. Discussion: A lack of awareness, education and resources were acknowledged as key challenges to successful transitioning by clients and healthcare providers. Geographical isolation of the communities was highlighted as a barrier to accessibility of services and programmes, but the community was also regarded as an important source of social support. The development of educational and screening tools and needs assessments of remote communities were identified to be strategies that may improve transitions. Conclusions: Findings demonstrate that the structure of rehabilitation and discharge processes for Aboriginal clients living on reserves or in remote communities are of great concern and warrants further research.	[Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle; Agnihotri, Sabrina; Colantonio, Angela] Univ Toronto, Dept Psychol, Toronto, ON M5G 1V7, Canada; [Keightley, Michelle; Colantonio, Angela] Toronto Rehabil Inst, Toronto, ON, Canada; [Keightley, Michelle] Bloorview Kids Rehab, Toronto, ON, Canada; [Minore, Bruce; Katt, Mae] Lakehead Univ, Ctr Rural & No Hlth Res, Thunder Bay, ON P7B 5E1, Canada; [Cameron, Anita; White, Randy; Longboat-White, Claudine] Washagamis Bay First Nation, Wassay Gezhig Na Nahn Dah We Igamig, Keewatin, ON, Canada; [Bellavance, Alice] Brain Injury Serv No Ontario, Thunder Bay, ON, Canada	Keightley, M (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Grad Dept Rehabil Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	michelle.keightley@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Ontario Neurotrauma Foundation; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	The authors gratefully acknowledge the Ontario Neurotrauma Foundation who provided financial support for the research project. We recognize the support of the University of Toronto, Toronto Rehabilitation Institute Foundation and a grant from the Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute.	Blackmer J, 1999, BRAIN INJURY, V13, P627; Bolch Denise, 2005, Aust J Rural Health, V13, P91, DOI 10.1111/j.1440-1854.2005.00660.x; CLOSSON T, 2005, INTEGRATED SERVICE P; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; Dickson G, 2001, Health Care Women Int, V22, P471, DOI 10.1080/073993301317094290; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; GAGE M, 1996, AM J OCCUPATIONAL TH, V51, P96; Green L, 1995, STUDY PARTICIPATORY; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; *N W MENT HLTH IMP, 2002, REG MENT HLTH SYST N; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; *ONT BRAIN INJ ASS, 2010, WHAT IS BRAIN INJ; Patton M.Q., 2002, QUALITATIVE RES EVAL; *QSR, 2002, QSR N6 SOFTW VERS 6; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; Ritchie J., 2002, ANAL QUALITATIVE DAT, P187, DOI DOI 10.4324/9780203413081_CHAPTER_9; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; *STAND SEN COMM SO, 2006, OUT SHAD LAST HIGHL; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Swallow V, 2003, J CLIN NURS, V12, P610, DOI 10.1046/j.1365-2702.2003.00728.x; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; TURNER BJ, 2008, DISABILITY REHABILIT, V23, P250; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Young TK, 2003, BRIT MED J, V327, P419, DOI 10.1136/bmj.327.7412.419	30	11	12	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2011	25	2					142	152		10.3109/02699052.2010.541898			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800002	21219087				2021-06-18	
J	Ono, MY; Ownsworth, T; Walters, B				Ono, Miyuki; Ownsworth, Tamara; Walters, Benjamin			Preliminary investigation of misconceptions and expectations of the effects of traumatic brain injury and symptom reporting	BRAIN INJURY			English	Article						Brain injury; TBI; misconceptions; expectations; symptom reporting	PERSISTENT POSTCONCUSSION SYNDROME; HEAD-INJURY; SUBJECTIVE COMPLAINTS; EMOTIONAL ADJUSTMENT; SELF-AWARENESS; ETIOLOGY; DEFICITS	Objective: This study aimed, first, to introduce a new measure for examining misconceptions of the effects of traumatic brain injury (TBI) and, secondly, to conduct a preliminary investigation of the impact of misconceptions and expectations on level of symptom reporting. Methods: The Head Injury Knowledge Scale (HIKS) was piloted for its utility in this study using a sample (n = 13) of individuals with brain injury. A sample of 99 uninjured participants was randomly allocated into either TBI simulation (n = 59) or control (n = 40) groups using a 3:2 allocation ratio. All participants initially completed the HIKS and then controls completed the Symptom Expectancy Checklist (SEC). The TBI simulation group was presented with a simulation scenario concerning severe TBI and then completed the SEC. Retrospective data on the SEC for individuals with a severe TBI (n = 38) were used for comparison purposes. Results: The HIKS was deemed suitable for use in the present study based on pilot data and internal consistency analysis of the two sub-scales (alpha > 0.60). The uninjured participants displayed a greater tendency to over-generalize than minimize the effects of TBI (p < 0.001). The TBI simulation group reported a higher level of symptoms on the SEC than controls and those with severe TBI (p < 0.001). However, level of symptom reporting on the SEC in the simulation group was not significantly related to misconceptions of the effects of TBI (p > 0.05). Conclusions: Based on these preliminary findings, the HIKS may provide a useful measure of the relative tendency to over-generalize or minimize the effects of TBI. However, further research is needed to investigate the reliability and validity of the HIKS prior to clinical use.	Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Griffith Inst Hlth & Med Res, Brisbane, Qld 4111, Australia	Ono, MY (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt Campus, Nathan, Qld 4111, Australia.	m.ono@griffith.edu.au		Ownsworth, Tamara/0000-0003-1835-7094			Babin PR, 2002, J REHABIL, V68, P4; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CULLUM CM, 1990, TRAUMATIC BRAIN INJU, P129; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gouvier D. W., 1988, ARCH CLIN NEUROPSYCH, V3, P331; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; HABERMAN SJ, 1973, BIOMETRICS, V29, P205, DOI 10.2307/2529686; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kirmayer L. J., 1997, ADULT PSYCHOPATHOLOG, P333; Kolb B., 1996, FUNDAMENTALS HUMAN N; Kolb B., 2003, FUNDAMENTALS HUMAN N; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LISHMAN WA, 1998, ORGANIC PSYCHIAT CON; Mitchell M.L., 2004, RES DESIGN EXPLAINED; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nunnally J.C., 1967, PSYCHOMETRIC THEORY, V226; OWNSWORTH T, 2006, BRAIN IMPAIR, V7, P95; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Pallant J., 2013, SPSS SURVIVAL MANUAL; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P299; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Sherer M., 2004, The Awareness Questionnaire. The center for outcome measurement in brain injury; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tabachnick BG, 2007, USING MULTIVARIATE S; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; WILSON K, 1993, ASSERTION ITS SOCIAL; Zasler ND, 2003, NEUROPSYCHOL REHABIL, V13, P31, DOI 10.1080/09602010	45	11	11	0	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2011	25	2					237	249		10.3109/02699052.2010.541893			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800010	21219094				2021-06-18	
J	Piebes, SK; Snyder, AR; Bay, RC; McLeod, TCV				Piebes, Sarah K.; Snyder, Alison R.; Bay, R. Curtis; McLeod, Tamara C. Valovich			Measurement Properties of Headache-Specific Outcomes Scales in Adolescent Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						concussion; patient report; reliability	QUALITY-OF-LIFE; SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; IMPACT; QUESTIONNAIRE; DISABILITY; COLLEGIATE; CHILDREN; IDENTIFICATION; MANAGEMENT	Context: Recurrent headaches significantly affect health-related quality of life (HRQOL) in adults; the impact of headache on HRQOL among adolescents is unknown, and the psychometric properties of headache-specific outcomes instruments have not been adequately studied in this population. Objective: To evaluate the psychometric properties of the Headache Impact Test (HIT-6) and Pediatric Migraine Disability Assessment (PedMIDAS) in healthy adolescent athletes. Design: Descriptive survey. Setting: High school athletic training facilities during the fall sports season. Participants: 177 high school athletes (89 males and 88 females). Interventions: A survey consisting of a demographic and concussion-history questionnaire, a graded symptom scale, the HIT-6, and the PedMIDAS. Internal consistency (alpha), test retest reliability (r(s)), Bland-Altman analyses, and the Mann-Whitney U test were used to evaluate psychometric properties and age and gender differences. Main Outcome Measures: The HIT-6 and PedMIDAS item and total scores. Results: Test-retest reliability for the HIT-6 total score was r(s)=.72, and reliability of individual items ranged from r(s)=.52 to .67. The test-retest reliability for the PedMIDAS total score was r(s)=.61, and reliability of individual items ranged from r(s)=.23 to .62. Both scales demonstrated acceptable internal consistency: HIT-6 alpha=.89-.90 and PedMIDAS alpha=.71-.75. Conclusions: The authors found moderate test-retest reliability for the HIT-6 and the PedMIDAS in a healthy adolescent athlete population. Research on the applicability and utility of the HIT-6 and PedMIDAS in concussed adolescents is warranted.	[Piebes, Sarah K.; Snyder, Alison R.; Bay, R. Curtis; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA	Piebes, SK (corresponding author), AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA.		McLeod, Tamara/AAU-9435-2020	Bay, Ralph/0000-0003-3525-9269			Aliprandi A, 2004, NEUROL SCI, V25, pS274, DOI 10.1007/s10072-004-0307-3; Bayliss MS, 2002, HIT 6 USERS GUIDE; Bjorner JB, 2003, QUAL LIFE RES, V12, P981, DOI 10.1023/A:1026123400242; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; D'Amico D, 2003, NEUROL SCI, V24, pS97; Egger HL, 1998, J AM ACAD CHILD PSY, V37, P951, DOI 10.1097/00004583-199809000-00015; Evans RW, 2004, NEUROL CLIN, V22, pXI, DOI 10.1016/S0733-8619(03)00103-8; Fichtel A, 2002, HEADACHE, V42, P766, DOI 10.1046/j.1526-4610.2002.02178.x; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hershey AD, 2004, CEPHALALGIA, V24, P844, DOI 10.1111/j.1468-2982.2004.00757.x; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Landgraf JM, 1998, QUAL LIFE RES, V7, P433, DOI 10.1023/A:1008810004694; LANGLOIS J, 2007, PHYS TOOL KIT; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Marcus DA, 2003, HEADACHE, V43, P117, DOI 10.1046/j.1526-4610.2003.03028.x; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; Patrick DL, 2002, J ADOLESCENCE, V25, P287, DOI 10.1006/jado.2002.0471; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rhee Hyekyun, 2005, Pediatr Nurs, V31, P314; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Snyder A, 2007, ATHL TRAIN ED J, V2, P31; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Vitulano LA, 2003, CHILD ADOL PSYCH CL, V12, pXIII, DOI 10.1016/S1056-4993(03)00032-4	35	11	11	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716			J SPORT REHABIL	J. Sport Rehabil.	FEB	2011	20	1			SI		129	142		10.1123/jsr.20.1.129			14	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	719AX	WOS:000287172700012	21411828				2021-06-18	
J	Clark, IA; Atwood, CS				Clark, Ian A.; Atwood, Craig S.			Is TNF a Link between Aging-Related Reproductive Endocrine Dyscrasia and Alzheimer's Disease?	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; anxiety; cell cycle; dyotic signaling; endocrine dyscrasia; etanercept; inflammation; oxytocin; sex hormones; tumor necrosis factor (TNF)	TUMOR-NECROSIS-FACTOR; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; FOLLICLE-STIMULATING-HORMONE; FACTOR-ALPHA; LUTEINIZING-HORMONE; RHEUMATOID-ARTHRITIS; POSTMENOPAUSAL WOMEN; CELL-PROLIFERATION; COGNITIVE DECLINE	This commentary addresses a novel mechanism by which aging-related changes in reproductive hormones could mediate their action in the brain. It presents the evidence that dyotic endocrine signals modulate the expression of tumor necrosis factor (TNF) and related cytokines, and that these cytokines are a functionally important downstream link mediating neurodegeneration and dysfunction. This convergence of dyotic signaling on TNF-mediated degeneration and dysfunction has important implications for understanding the pathophysiology of AD, stroke, and traumatic brain disease, and also for the treatment of these diseases.	[Clark, Ian A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Atwood, Craig S.] Vet Adm Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Atwood, Craig S.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Atwood, Craig S.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA, Australia	Clark, IA (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia.	ian.clark@anu.edu.au; csa@medicine.wisc.edu	Clark, Ian A./K-2069-2012		NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG033514] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG033514] Funding Source: Medline		Akiyama H, 1996, NEUROSCI LETT, V219, P115, DOI 10.1016/S0304-3940(96)13197-9; ANDREWS H, 1987, GUT, V28, P1600, DOI 10.1136/gut.28.12.1600; Arendt T, 1998, J NEURAL TRANSM-SUPP, P147; Asthana S, 1999, PSYCHONEUROENDOCRINO, V24, P657, DOI 10.1016/S0306-4530(99)00020-7; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; Atwood CS, 2011, EXP GERONTOL, V46, P100, DOI 10.1016/j.exger.2010.09.007; Atwood CS, 2005, J NEUROPATH EXP NEUR, V64, P93, DOI 10.1093/jnen/64.2.93; Atwood CS, 2010, FUNCTIONAL AMYLOID A, P115; Barron AM, 2010, ENDOCRINOLOGY, V151, P5380, DOI 10.1210/en.2009-1168; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Berry A, 2008, HORM BEHAV, V54, P143, DOI 10.1016/j.yhbeh.2008.02.006; Bishop GM, 2002, NATURE, V416, P677, DOI 10.1038/416677d; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Bowen RL, 2004, GERONTOLOGY, V50, P265, DOI 10.1159/000079125; Bowen RL, 2000, J NEUROENDOCRINOL, V12, P351; Bowen RL, 2004, J BIOL CHEM, V279, P20539, DOI 10.1074/jbc.M311993200; BOWEN RL, 2004, 9 INT C ALZH DIS 17; BRENNAN FM, 1989, LANCET, V2, P244; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; Bryan KJ, 2010, J NEUROCHEM, V112, P870, DOI 10.1111/j.1471-4159.2009.06502.x; Buchhave P, 2009, NEUROSCI LETT, V450, P56, DOI 10.1016/j.neulet.2008.10.091; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carter CJ, 2008, NEUROCHEM INT, V52, P920, DOI 10.1016/j.neuint.2007.11.003; Casadesus G, 2006, BBA-MOL BASIS DIS, V1762, P447, DOI 10.1016/j.bbadis.2006.01.008; Casadesus G, 2007, MOL CELL ENDOCRINOL, V269, P107, DOI 10.1016/j.mce.2006.06.013; Chang D, 1997, ADV EXP MED BIOL, V429, P261; Charles P, 1999, J IMMUNOL, V163, P1521; Cherrier MM, 2005, NEUROLOGY, V64, P2063, DOI 10.1212/01.WNL.0000165995.98986.F1; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Clodi M, 2008, AM J PHYSIOL-ENDOC M, V295, pE686, DOI 10.1152/ajpendo.90263.2008; D'Amico AV, 2010, ALZ DIS ASSOC DIS, V24, P85, DOI 10.1097/WAD.0b013e31819cb8f4; Di Bona D, 2009, BRAIN RES REV, V61, P60, DOI 10.1016/j.brainresrev.2009.05.001; Dinomais M, 2009, J REHABIL MED, V41, P286, DOI 10.2340/16501977-0329; Ferreira RA, 2010, CONTRACEPTION, V81, P117, DOI 10.1016/j.contraception.2009.08.003; Ficicioglu C, 2010, GYNECOL ENDOCRINOL, V26, P181, DOI [10.1080/09513590903215557, 10.3109/09513590903215557]; FILLIT H, 1986, PSYCHONEUROENDOCRINO, V11, P337, DOI 10.1016/0306-4530(86)90019-3; Frye CA, 2007, NEUROBIOL LEARN MEM, V88, P208, DOI 10.1016/j.nlm.2007.04.003; Ge YW, 2002, ANN NY ACAD SCI, V973, P463, DOI 10.1111/j.1749-6632.2002.tb04684.x; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Gouras GK, 2000, P NATL ACAD SCI USA, V97, P1202, DOI 10.1073/pnas.97.3.1202; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Haider S, 2009, PLACENTA, V30, P111, DOI 10.1016/j.placenta.2008.10.012; HARDARDOTTIR I, 1994, J CLIN INVEST, V94, P1304, DOI 10.1172/JCI117449; Hawken PAR, 2009, BIOL REPROD, V80, P1146, DOI 10.1095/biolreprod.108.075341; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Hogervorst E, 2004, EXP GERONTOL, V39, P1633, DOI 10.1016/j.exger.2004.06.019; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hsu SM, 2000, BIOCHEM BIOPH RES CO, V279, P47, DOI 10.1006/bbrc.2000.3891; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; JAFFE K, 1994, PHARMACOL BIOCHEM BE, V47, P493, DOI 10.1016/0091-3057(94)90149-X; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; Karelina K, 2009, P NATL ACAD SCI USA, V106, P5895, DOI 10.1073/pnas.0810737106; Kass AS, 2010, SCAND J RHEUMATOL, V39, P109, DOI 10.3109/03009740903270607; Khan KN, 2010, HUM REPROD, V25, P642, DOI 10.1093/humrep/dep437; Kipp M, 2007, J NEUROENDOCRINOL, V19, P819, DOI 10.1111/j.1365-2826.2007.01588.x; Laurin D, 2009, NEUROBIOL AGING, V30, P1724, DOI 10.1016/j.neurobiolaging.2008.01.008; Lee HG, 2009, NEUROCHEM INT, V54, P84, DOI 10.1016/j.neuint.2008.10.013; Lee R, 2009, PSYCHONEUROENDOCRINO, V34, P1567, DOI 10.1016/j.psyneuen.2009.06.002; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Lin J, 2010, J NEUROPATH EXP NEUR, V69, P253, DOI 10.1097/NEN.0b013e3181d072cf; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Manly JJ, 2000, NEUROLOGY, V54, P833, DOI 10.1212/WNL.54.4.833; Manthey D, 2001, EUR J BIOCHEM, V268, P4285, DOI 10.1046/j.1432-1327.2001.02346.x; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Medeiros R, 2010, BEHAV BRAIN RES, V209, P165, DOI 10.1016/j.bbr.2010.01.040; Meethal SV, 2005, ENDOCRINE, V26, P317, DOI 10.1385/ENDO:26:3:317; Meresman GF, 2003, HUM REPROD, V18, P1767, DOI 10.1093/humrep/deg356; Missig G, 2010, NEUROPSYCHOPHARMACOL, V35, P2607, DOI 10.1038/npp.2010.155; Mueller L, 2010, BIOCHEM BIOPH RES CO, V397, P586, DOI 10.1016/j.bbrc.2010.05.163; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Norman GJ, 2010, PSYCHOSOM MED, V72, P519, DOI 10.1097/PSY.0b013e3181de8678; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Patel A, 2010, BRAIN BEHAV IMMUN, V24, P1276, DOI 10.1016/j.bbi.2010.05.005; Petanceska SS, 2000, EXP GERONTOL, V35, P1317, DOI 10.1016/S0531-5565(00)00157-1; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Raina AK, 2000, J NEUROSCI RES, V61, P128, DOI 10.1002/1097-4547(20000715)61:2<128::AID-JNR2>3.0.CO;2-H; Raina AK, 1999, INT J EXP PATHOL, V80, P71, DOI 10.1046/j.1365-2613.1999.00106.x; RALSTON SH, 1990, J BONE MINER RES, V5, P983; REDL H, 1996, AM J PHYSIOL, V40, pR1193; RODRIGUEZSIERRA JF, 1986, LIFE SCI, V38, P1841, DOI 10.1016/0024-3205(86)90139-6; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Schuitemaker A, 2009, NEUROBIOL AGING, V30, P1885, DOI 10.1016/j.neurobiolaging.2008.01.014; SHALABY MR, 1989, CLIN IMMUNOL IMMUNOP, V53, P488, DOI 10.1016/0090-1229(89)90010-X; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Short RA, 2001, MAYO CLIN PROC, V76, P906; Slattery DA, 2010, NEUROPHARMACOLOGY, V58, P56, DOI 10.1016/j.neuropharm.2009.06.038; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Smith MA, 2002, LANCET, V359, P1864, DOI 10.1016/S0140-6736(02)08695-6; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Srivastava S, 1999, J CLIN INVEST, V104, P503, DOI 10.1172/JCI7094; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Tobinick Edward L, 2009, BMC Res Notes, V2, P28; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Uguz F, 2009, PSYCHIAT CLIN NEUROS, V63, P50, DOI 10.1111/j.1440-1819.2008.01905.x; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vieira MMM, 2010, J NEUROIMMUNOL, V229, P212, DOI 10.1016/j.jneuroim.2010.07.018; WHARTON W, 2011, J ALZHEIMERS DIS; Wilson AC, 2008, BBA-MOL BASIS DIS, V1782, P401, DOI 10.1016/j.bbadis.2008.02.011; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Yang SH, 2003, ANN NY ACAD SCI, V1007, P101, DOI 10.1196/annals.1286.010; Yi KD, 2011, BRAIN RES, V1379, P61, DOI 10.1016/j.brainres.2010.11.058; Zheng H, 2002, J NEUROCHEM, V80, P191, DOI 10.1046/j.0022-3042.2001.00690.x	127	11	13	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2011	27	4					691	699		10.3233/JAD-2011-110887			9	Neurosciences	Neurosciences & Neurology	866GI	WOS:000298368100002	21891866	Green Accepted			2021-06-18	
J	de Guise, E; Gosselin, N; LeBlanc, J; Champoux, MC; Couturier, C; Lamoureux, J; Dagher, J; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; Gosselin, Nadia; LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Dagher, Jehane; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Clock Drawing and Mini-Mental State Examination in Patients with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						clock drawing; level 1 trauma center; Mini-Mental State Examination; outcome; traumatic brain injury	SEVERE HEAD-INJURY; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PREDICTIVE-VALUE; DEMENTIA; PERFORMANCE; COMA; CARE	The aim of this study was to compare the performances of patients with mild, moderate, and severe traumatic brain injury (TBI) on the Clock Drawing Test (CDT), the Mini-Mental State Examination (MMSE), and neuropsychological measures as well as to correlate these measures with outcome assessed by the Extended Glasgow Outcome Score. This study was conducted in an acute care early rehabilitation setting on 102 patients with mild, 30 with moderate, and 30 with severe TBI. Patients with moderate and severe TBI showed more impairment on the CDT compared with those with mild TBI. Similar results were obtained for the MMSE, F-(2,F-159df)= 3.789, p = .025. Finally, a receiver-operating characteristic analysis showed that the CDT and the Trail-Making Test-Part B (TMT-B) in combination have the potential for prediction of outcome in a TBI population. In conclusion, this combination of the CDT and the TMT-B seems to be useful for early assessment of TBI patients.	[de Guise, Elaine] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; [Gosselin, Nadia] Montreal Neurol Hosp & Inst, Cognit Neurosci Unit, Montreal, PQ, Canada; [LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Dagher, Jehane] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Rehabil Med, Montreal, PQ H3G 1A4, Canada; [Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Neurosurg, Montreal, PQ H3G 1A4, Canada	de Guise, E (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.	elaine.deguise@muhc.mcgill.ca		Lamoureux, Julie/0000-0002-4986-2504			Adunsky A, 2002, CLIN REHABIL, V16, P414, DOI 10.1191/0269215502cr514oa; Canadian Institute for Health Information, 2006, HEAD INJ CAN DEC CHA; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Delis DC., 1994, CLOCK DRAWING NEUROP; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Esteban-Santillan C, 1998, J AM GERIATR SOC, V46, P1266, DOI 10.1111/j.1532-5415.1998.tb04543.x; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FISHER BW, 1995, J AM GERIATR SOC, V43, P175, DOI 10.1111/j.1532-5415.1995.tb06385.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Goodglass H., 1972, ASSESSMENT APHASIA R; Hagen C, 1972, RANCHO LOS AMIGOS SC; HAMILTON BB, 1987, REHABILITATION OUTCO, P135; Hawkins ML, 2003, AM SURGEON, V69, P497; Hubbard EJ, 2008, ARCH CLIN NEUROPSYCH, V23, P295, DOI 10.1016/j.acn.2007.12.003; HUNTZINGER JA, 1992, GEN HOSP PSYCHIAT, V14, P142, DOI 10.1016/0163-8343(92)90040-H; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LIBON DJ, 1993, ARCH CLIN NEUROPSYCH, V8, P405, DOI 10.1016/0887-6177(93)90004-K; Lieberman D, 1999, INT J GERIATR PSYCH, V14, P325, DOI 10.1002/(SICI)1099-1166(199905)14:5<325::AID-GPS904>3.0.CO;2-Q; Long CJ, 1992, HDB HEAD TRAUMA ACUT, P107; Milne A, 2008, INT PSYCHOGERIATR, V20, P911, DOI 10.1017/S1041610208007394; Paganini-Hill A, 2001, J AM GERIATR SOC, V49, P941, DOI 10.1046/j.1532-5415.2001.49185.x; Peters R, 2008, DEMENT GERIATR COGN, V26, P351, DOI 10.1159/000162261; REICHMAN WE, 1993, PERCEPT MOTOR SKILL, V76, P793, DOI 10.2466/pms.1993.76.3.793; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; ROYALL DR, 1994, J NEUROPSYCH CLIN N, V6, P62; Ruchinskas RA, 2001, ARCH PHYS MED REHAB, V82, P920, DOI 10.1053/apmr.2001.23993; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.3.CO;2-L; SIGNORET JL, 1989, EVALUATION TROUBLES; Suhr JA, 1999, ARCH PHYS MED REHAB, V80, P773, DOI 10.1016/S0003-9993(99)90226-5; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Tranel D, 2008, NEUROPSYCHOLOGY, V22, P553, DOI 10.1037/0894-4105.22.5.553; von Gunten A, 2008, EUR NEUROL, V60, P73, DOI 10.1159/000131895; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x; Zhou AH, 2008, INT J GERIATR PSYCH, V23, P422, DOI 10.1002/gps.1897	40	11	11	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	3					179	190		10.1080/09084282.2011.595444			12	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	884YJ	WOS:000299744500004	21846217				2021-06-18	
J	Gonzalez-Mao, MC; Reparaz-Andrade, A; Del Campo-Perez, V; Alvarez-Garcia, E; Vara-Perez, C; Andrade-Olivie, MA				Gonzalez-Mao, M. C.; Reparaz-Andrade, A.; Del Campo-Perez, V.; Alvarez-Garcia, E.; Vara-Perez, C.; Andrade-Olivie, M. A.			Model Predicting Survival/Exitus After Traumatic Brain Injury: Biomarker S100B 24H	CLINICAL LABORATORY			English	Article						Traumatic Brain Injury (TBI); biomarkers; S100B; GOS; GCS; model predicting; positive prediction value (PPV); negative prediction value (NPV)	SEVERE HEAD-INJURY; SERUM S100B; METHODOLOGICAL FEATURES; OUTCOME PREDICTION; S-100B PROTEIN; MARKER; VALIDATION; DIAGNOSIS; AMNESIA; DAMAGE	Background: The enigma of Traumatic Brain Injury (TBI), reflected in recent scientific literature, is its uncertain consequences, variability of the final prognosis with apparently similar TBI, necessity for peripheral biomarkers, and more specific predictive models. Objectives: To study the relationship between serum S100B and survival in TBI patients in various serious situations; the S100B level in patients without traumatic pathology or associated tumour, subjected to stressful situations such as neurological intensive care unit (NICU) stay; the possible overestimation caused by extracerebral liberation in TBI patients and associated polytraumatism; the predictive cutoffs to determine the most sensitive and specific chronology; and achieve a predictive prognostic model. Methods: Patients admitted to the NICU within 6 hours after TBI were selected. We measured: a) clinical: exitus yes/no; age and gender, traumatic mechanism, polytraumatism yes/no, GCS score, unconsciousness duration, amnesia duration, neurological focality, and surgical interventions; b) radiological: CT scan for radiological lesions; c) biochemical: serum SB100B at 6, 24, 48 and 72 hours after TBI and drug abuse detected in the urine; d) COS on hospital discharge. Results: N: 149 TBI patients, independent of polytraumatism, mean serum S100B at 6, 24, 48, and 72 hours: 2.1, 1.3, 1.2, and 0.6 mu g/L, respectively; N: 124 without associated polytraumatism, S100B at 6, 24, 48, and 72 hours: 2.0, 1.4, 1.3, and 0.6 mu g/L; N: 50 control I S100B 24 hours: 0.17 mu g/L (0.04 - 0.56) and 25 healthy subjects S100B 0.057 mu g/L (0.02-0.094). Conclusions: Significantly higher S100B levels are observed on exitus, with excellent TBI prognosis and evolution performance. Hospital stay in the NICU produces significant increases in S100B compared to healthy subjects, without invalidating it as a biomarker. Polytraumatism associated to TBI does not significantly alter S100B levels. S100B at 24 hours >= 0.90 mu g/L appears to predict unfavourable TBI evolution with a NPV: 94.2 % and PPV: 54.9 %. We propose a predictive model when we associate S100B at 24 hours with amnesia duration over 30 minutes with a NPV of 85.5 % and a PPV of 83.3 %. (Clin. Lab. 2011;57:587-597)	[Gonzalez-Mao, M. C.; Reparaz-Andrade, A.; Alvarez-Garcia, E.; Andrade-Olivie, M. A.] Univ Hosp Complex Vigo CHUVI, Dept Clin Chem, Vigo, Spain; [Vara-Perez, C.] Univ Hosp Complex Vigo CHUVI, Intens Care Unit, Vigo, Spain	Gonzalez-Mao, MC (corresponding author), Argazada 25 Samil Vigo, Vigo, Spain.	Maria.carmen.gonzalez.mao@sergas.es	Reparaz-Andrade, Alfredo/AAB-7976-2021; Gonzalez Mao, Maria Carmen/T-5403-2017; Badia, M. Amelia Cibeira/C-4308-2015	Reparaz-Andrade, Alfredo/0000-0001-5682-9457; Gonzalez Mao, Maria Carmen/0000-0003-3890-6118; Badia, M. Amelia Cibeira/0000-0001-6016-5374	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; European Regional Development Fund (FEDER)European Commission; Health Research Fund (FIS)Instituto de Salud Carlos III [PI08/90342]	This article has been financed by Instituto de Salud Carlos III, Health Research Fund (FIS) code PI08/90342 and cofinanced by the European Regional Development Fund (FEDER).	Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI [10.1089/neu.2008.0738, 10.1089/neu.2008-0738]; Boto GR, 2006, NEUROCIRUGIA, V17, P215; Boto GR, 2004, NEUROCIRUGIA, V15, P233; BRAAKMAN R, 1992, ACTA NEUROCHIR, V116, P161, DOI 10.1007/BF01540870; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gazzolo D, 2010, CLIN CHEM LAB MED, V48, P1363, DOI 10.1515/CCLM.2010.262; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hayes RL, 2009, METHODS MOL BIOL, V566, P303, DOI 10.1007/978-1-59745-562-6_20; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hu Dian-lei, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P221; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Leite MC, 2008, J NEUROSCI METH, V169, P93, DOI 10.1016/j.jneumeth.2007.11.021; MAO MCG, 2009, CLIN CHEM S, V55, pA200; Margis R, 2004, BRAIN RES, V1028, P213, DOI 10.1016/j.brainres.2004.09.013; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martenson ED, 2001, J CLIN ONCOL, V19, P824, DOI 10.1200/JCO.2001.19.3.824; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Routsi C, 2006, SHOCK, V26, P20, DOI 10.1097/01.shk.0000209546.06801.d7; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Snyder-Ramos SA, 2003, RESTOR NEUROL NEUROS, V21, P123; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	35	11	12	0	5	CLIN LAB PUBL	HEIDELBERG	IM BREITSPIEL 15, HEIDELBERG, D-69126, GERMANY	1433-6510			CLIN LAB	Clin. Lab.		2011	57	7-8					587	597					11	Medical Laboratory Technology	Medical Laboratory Technology	825DL	WOS:000295251000016	21888023				2021-06-18	
J	Lancioni, GE; O'Reilly, MF; Singh, NN; Oliva, D				Lancioni, Giulio E.; O'Reilly, Mark F.; Singh, Nirbhay N.; Oliva, Doretta			Enabling two women with blindness and additional disabilities to make phone calls independently via a computer-aided telephone system	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Blindness; computer-aided telephone; microswitches; motor disabilities	TRAUMATIC BRAIN-INJURY; INTELLECTUAL DISABILITIES; MULTIPLE DISABILITIES; VOCATIONAL-REHABILITATION; PHYSICAL-DISABILITIES; VISUAL IMPAIRMENTS; LEISURE ACTIVITIES; SOCIAL VALIDATION; PEOPLE; INDIVIDUALS	Objective: To assess whether two women with blindness and additional disabilities could make independent phone calls through a computer-aided telephone system. Method: For each participant, the study involved an ABAB design, in which the A represented baseline phases and the B represented intervention phases with the special telephone system (involving among others a net-book computer with specific software, a global system for mobile communication modem and a microswitch). Results: Both participants learned to use the system and made phone calls independently to a variety of partners such as family members, friends and staff personnel. Conclusion: The system assessed in this study might represent a useful means for enabling persons with blindness and additional disabilities to manage phone calls on their own.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Singh, Nirbhay N.] Amer Hlth & Wellness Inst, Verona, VA USA; [Oliva, Doretta] Lega F DOro Res Ctr, Osimo, Italy	Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Lancioni, Giulio/0000-0002-6515-5690			Bache J, 2008, NEUROREHABILITATION, V23, P343; Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Cavenaugh BS, 2006, J VISUAL IMPAIR BLIN, V100, P425; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Durando J, 2008, J VISUAL IMPAIR BLIN, V102, P40, DOI 10.1177/0145482X0810200105; Fichten CS, 2009, J VISUAL IMPAIR BLIN, V103, P543, DOI 10.1177/0145482X0910300905; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Hersen M., 2009, SINGLE CASE EXPT DES; Huo XL, 2008, IEEE T NEUR SYS REH, V16, P497, DOI 10.1109/TNSRE.2008.2003375; Jessup GM, 2010, J VISUAL IMPAIR BLIN, V104, P419, DOI 10.1177/0145482X1010400705; Johnson KL, 2009, DISABIL REHABIL-ASSI, V4, P1, DOI 10.1080/17483100802239648; Kim J, 2010, IEEE ENG MED BIO, P5250, DOI 10.1109/IEMBS.2010.5626294; Lancioni G.E., 2011, CLIN CASE STUDIES, V10, P79, DOI DOI 10.1177/1534650110395380; Lancioni G, 2011, DEV NEUROREHABIL, V14, P8, DOI 10.3109/17518423.2010.519760; Lancioni GE, 2006, J DEV PHYS DISABIL, V18, P383, DOI 10.1007/s10882-006-9024-6; Lim L., 2000, INT J DISABIL DEV ED, V47, P77; Madar T, 2007, ADV MENTAL HLTH INTE, V1, P29; Manley K, 2008, J BEHAV EDUC, V17, P221, DOI 10.1007/s10864-008-9065-2; Mesterman R, 2010, J CHILD NEUROL, V25, P36, DOI 10.1177/0883073809336677; Miltenberger R.G., 2007, BEHAV MODIFICATION P; Bryen DN, 2007, INTELLECT DEV DISAB, V45, P1, DOI 10.1352/1934-9556(2007)45[1:CPUBAW]2.0.CO;2; Nguyen T, 2008, TECHNOLOGY DISABILIT, V20, P225; Nguyen T, 2007, ASSIST TECHNOL, V19, P78, DOI 10.1080/10400435.2007.10131867; Patterson I, 2009, LEISURE STUD, V28, P387, DOI 10.1080/02614360903071688; Peterson JJ, 2009, J APPL RES INTELLECT, V22, P487, DOI 10.1111/j.1468-3148.2009.00500.x; Sesto Mary E, 2008, Universal Access in the Information Society, V7, P25, DOI 10.1007/s10209-007-0099-3; Sohlberg MM, 2005, APHASIOLOGY, V19, P651, DOI 10.1080/02687030544000100; Solish A, 2010, J APPL RES INTELLECT, V23, P226, DOI 10.1111/j.1468-3148.2009.00525.x; Stock SE, 2008, J INTELL DISABIL RES, V52, P1155, DOI 10.1111/j.1365-2788.2008.01099.x; Su CY, 2008, J INTELL DISABIL RES, V52, P18, DOI 10.1111/j.1365-2788.2007.00969.x; Sundqvist A, 2010, AUGMENT ALTERN COMM, V26, P255, DOI 10.3109/07434618.2010.528796; Sung YT, 2010, J COMPUT ASSIST LEAR, V26, P106, DOI [10.1111/J.1365-2729.2010.00345.x, 10.1111/j.1365-2729.2010.00345.x]; Tomasik M, 2007, J VISUAL IMPAIR BLIN, V101, P657, DOI 10.1177/0145482X0710101012; Trelease RB, 2008, ANAT SCI EDUC, V1, P233, DOI 10.1002/ase.58; Trief E, 2010, J VISUAL IMPAIR BLIN, V104, P499, DOI 10.1177/0145482X1010400806; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105; Yang CH, 2008, MATH COMPUT MODEL, V47, P318, DOI 10.1016/j.mcm.2007.01.012	38	11	11	2	7	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423			DEV NEUROREHABIL	Dev. Neurorehabil.		2011	14	5					283	289		10.3109/17518423.2011.586372			7	Clinical Neurology; Pediatrics; Rehabilitation	Neurosciences & Neurology; Pediatrics; Rehabilitation	827XY	WOS:000295464800004	21870952				2021-06-18	
J	Medaglia, JD; Ramanathan, DM; Venkatesan, UM; Hillary, FG				Medaglia, John D.; Ramanathan, Deepa M.; Venkatesan, Umesh M.; Hillary, Frank G.			The challenge of non-ergodicity in network neuroscience	NETWORK-COMPUTATION IN NEURAL SYSTEMS			English	Article						functional neuroimaging; traumatic brain injury; network modeling; neuroscience		Ergodicity can be assumed when the structure of data is consistent across individuals and time. Neural network approaches do not frequently test for ergodicity in data which holds important consequences for data integration and intepretation. To demonstrate this problem, we present several network models in healthy and clinical samples where there exists considerable heterogeneity across individuals. We offer suggestions for the analysis, interpretation, and reporting of neural network data. The goal is to arrive at an understanding of the sources of non-ergodicity and approaches for valid network modeling in neuroscience.	[Medaglia, John D.; Ramanathan, Deepa M.; Venkatesan, Umesh M.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, Frank G.] Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 223 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Ramanathan-Elion, Deepa/0000-0001-7723-7346			Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Gates KM, 2011, NEUROIMAGE, V54, P1151, DOI 10.1016/j.neuroimage.2010.08.051; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Lamiell JT, 1998, THEOR PSYCHOL, V8, P23, DOI 10.1177/0959354398081002; Molenaar P.C.M., 2004, MEAS INTERDISCIP RES, V2, P201, DOI [10.1207/s15366359mea0204_1., DOI 10.1207/S15366359MEA0204_1]; Molenaar PCM, 2009, CURR DIR PSYCHOL SCI, V18, P112, DOI 10.1111/j.1467-8721.2009.01619.x; Rypma B, 2002, J COGNITIVE NEUROSCI, V14, P721, DOI 10.1162/08989290260138627; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 2001, PSYCHOL AGING, V16, P371, DOI 10.1037//0882-7974.16.3.371; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163	15	11	11	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0954-898X	1361-6536		NETWORK-COMP NEURAL	Netw.-Comput. Neural Syst.		2011	22	1-4					148	153		10.3109/09638237.2011.639604			6	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Neurosciences	Computer Science; Engineering; Neurosciences & Neurology	857XF	WOS:000297757300009	22149675				2021-06-18	
J	Pastore, V; Colombo, K; Liscio, M; Galbiati, S; Adduci, A; Villa, F; Strazzer, S				Pastore, Valentina; Colombo, Katia; Liscio, Mariarosaria; Galbiati, Susanna; Adduci, Anna; Villa, Federica; Strazzer, Sandra			Efficacy of cognitive behavioural therapy for children and adolescents with traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; cognitive behavioural therapy; psychological intervention	PSYCHIATRIC-DISORDERS; PRACTICAL SCALE; SEQUELAE; INDIVIDUALS; CHILDHOOD; ANXIETY; OUTCOMES; TBI; AGE	Purpose. Behavioural and psychological disorders after traumatic brain injury (TBI) are very common. The purposes of this study were to estimate the frequency of these problems in our sample, to evaluate the effectiveness of cognitive behavioural therapy (CBT) and to assess the predictive value of important clinical variables for the treatment outcome. Method. Forty patients aged 4-18 years were included in this study. Twenty-eight patients received CBT at our Institute (clinical group), while 12 patients did not receive any treatment at all (control group). The CBCL/4-18 and the VABS were administered to parents at the beginning of the study and after 12 months. Results. A high frequency of psychological and behavioural problems was found in both groups of patients. After CBT, the clinical group showed a significant advantage on several CBCL scales and a greater increase in adaptive behaviour on the VABS Socialisation domain. The Glasgow Coma Scale score, days of unconsciousness and age at injury were not predictors of the severity of psychological problems at the follow-up for the patients of the clinical group. Conclusions. Our results suggest that CBT is an effective intervention for young patients with psychological problems after TBI.	[Pastore, Valentina; Colombo, Katia; Liscio, Mariarosaria; Galbiati, Susanna; Adduci, Anna; Villa, Federica; Strazzer, Sandra] IRCCS Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy	Pastore, V (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, Lecco, Italy.	valentina.pastore@bp.lnf.it	Galbiati, Susanna/AAH-6883-2019; Pastore, Valentina/AAH-6831-2019; Strazzer, Sandra/AAH-5712-2019; Colombo, Katia/ABE-5754-2020	Galbiati, Susanna/0000-0001-7209-4251; Pastore, Valentina/0000-0002-3170-3070; Strazzer, Sandra/0000-0001-8414-6565; Colombo, Katia/0000-0002-5390-106X			Achenbach T.M., 1983, CHILD BEHAV CHECKLIS; Balboni G, 2001, AM J MENT RETARD, V106, P162, DOI 10.1352/0895-8017(2001)106<0162:DVOTVS>2.0.CO;2; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burns B J, 1999, Clin Child Fam Psychol Rev, V2, P199, DOI 10.1023/A:1021826216025; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Compton SN, 2004, J AM ACAD CHILD PSY, V43, P930, DOI 10.1097/01.chi.0000127589.57468.bf; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gualtieri CT, 1999, NEUROREHABILITATION, V13, P103; JENNETT B, 1975, LANCET, V1, P480; Kazdin AE, 1998, J CONSULT CLIN PSYCH, V66, P19, DOI 10.1037/0022-006X.66.1.19; Kendall PC, 1998, J CONSULT CLIN PSYCH, V66, P3, DOI 10.1037/0022-006X.66.1.3; Liscio M, 2008, DISABIL REHABIL, V30, P275, DOI 10.1080/09638280701257023; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Monga S, 2009, DEPRESS ANXIETY, V26, P243, DOI 10.1002/da.20551; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nybo T, 1999, BRAIN INJURY, V13, P759; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Poggi G, 2009, DISABIL REHABIL, V31, P1066, DOI 10.1080/09638280802509546; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; Sparrow S., 1984, VINELAND ADAPTIVE BE; Suveg C, 2009, J ANXIETY DISORD, V23, P341, DOI 10.1016/j.janxdis.2009.01.003; Tavano A, 2009, BRAIN INJURY, V23, P167, DOI 10.1080/02699050802657012; TEASDALE G, 1974, LANCET, V2, P81; Warner CM, 2009, J CLIN PSYCHOL MED S, V16, P169, DOI 10.1007/s10880-008-9143-6; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Ylvisaker M, 2007, PHYS MED REH CLIN N, V18, pvii; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	37	11	11	0	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	8					675	683		10.3109/09638288.2010.506239			9	Rehabilitation	Rehabilitation	746UG	WOS:000289272600006	20695794				2021-06-18	
J	Sahin, B; Albayrak, BS; Ismailoglu, O; Gorgulu, A				Sahin, Berkant; Albayrak, Baki S.; Ismailoglu, Ozgur; Gorgulu, Askin			The effects of medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the spinal cord injury	NEUROLOGICAL RESEARCH			English	Article						Medroxy progesterone acetate; TNF-alpha; IL-1beta; Spinal cord injury	TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; NERVOUS-SYSTEM; BLOOD-FLOW; METHYLPREDNISOLONE; EXPRESSION; RATS; INTERLEUKIN-1-BETA; RECEPTORS; RECOVERY	Objectives: Spinal cord injuries (SCIs) have high morbidity and mortality rates and currently the definitive treatment of complete SCIs are still not possible. We investigated the effects of the medroxy progesterone acetate on the pro-inflammatory cytokines, TNF-alpha and IL-1beta in the early phase of the SCI. Methods: Forty-eight Wistar albino male rats were divided equally into four groups each consisting of 12 rats. All animals underwent T10-T12 laminectomy. We administered placebo, and 8 mg/kg medroxy progesterone acetate (MPA) intra-peritoneally into control and progesterone group at 30 minutes after the clip-compression trauma in spinal cord. We performed only T10-T12 laminectomy and clip-compression trauma in laminectomy and trauma group, respectively. Half of the rats from each group were killed at 1 hour and the other half were killed at 6 hours after the trauma. Spinal cord segments were then removed and stored at -80 degrees C in phosphate buffer. TNF-alpha and IL-1beta levels were determined using ELISA kit. Results: We have found that there was an increase only in the TNF-alpha level at 6 hours after the trauma comparing to control group. MPA appeared to lower the TNF-alpha level significantly in the trauma group. Discussion: This experimentally proven anti-inflammatory effect of MPA via acting upon TNF-alpha may offer new therapeutic options in human subjects with SCIs.	[Sahin, Berkant; Albayrak, Baki S.; Ismailoglu, Ozgur; Gorgulu, Askin] Suleyman Demirel Univ, Dept Neurosurg, TR-32200 Isparta, Turkey	Albayrak, BS (corresponding author), Suleyman Demirel Univ, Dept Neurosurg, TR-32200 Isparta, Turkey.	serdarbaki@gmail.com					ALOISI F, 1992, J IMMUNOL, V149, P2358; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Banik N L, 1985, Cent Nerv Syst Trauma, V2, P99; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; Braughler RW, 1985, CENT NERV SYST TRAUM, V2, P269; Coirini H, 2002, NEUROSCIENCE, V113, P883, DOI 10.1016/S0306-4522(02)00224-5; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; DELATORRE JC, 1981, SPINE, V6, P315, DOI 10.1097/00007632-198107000-00001; DEMEDIUK P, 1985, PROG BRAIN RES, V63, P211; Dohrmann GJ, 1972, ARCH NEUROL-CHICAGO, V7, P468; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; FADEN AI, 1985, NEUROLOGY, V35, P1331, DOI 10.1212/WNL.35.9.1331; Hall E D, 1987, Cent Nerv Syst Trauma, V4, P15; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Katoh S, 1997, INJURY, V28, P215, DOI 10.1016/S0020-1383(96)00184-2; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Koyanagi I, 1997, NEUROL RES, V19, P289, DOI 10.1080/01616412.1997.11740815; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Marketos SG, 1999, SPINE, V24, P2358, DOI 10.1097/00007632-199911150-00012; MARX JL, 1987, SCIENCE, V235, P529, DOI 10.1126/science.3810154; Naderi S, 2002, SPINE SPINAL CORD SU, P1; OSTERHOLM JL, 1974, J NEUROSURG, V40, P5, DOI 10.3171/jns.1974.40.1.0003; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Sanon A, 1996, NEUROSURGERY, V39, P657; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; SMITH SS, 1989, BRAIN RES, V476, P307, DOI 10.1016/0006-8993(89)91251-1; TATOR CH, 1984, CAN J SURG, V27, P289; Thind KK, 1997, NEUROENDOCRINOLOGY, V65, P314, DOI 10.1159/000127190; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004	40	11	14	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2011	33	1					63	67		10.1179/016164110X12807570510095			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	704JN	WOS:000286048500009	21208533				2021-06-18	
J	Wang, HP; Yu, XJ; Xu, GH; Xu, GT; Gao, GS; Xu, XH				Wang, Haipeng; Yu, Xiaojun; Xu, Guohui; Xu, Guangtao; Gao, Guishan; Xu, Xiaohu			Alcoholism and Traumatic Subarachnoid Hemorrhage: An Experimental Study on Vascular Morphology and Biomechanics	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic subarachnoid hemorrhage (TSAH); Vascular biomechanics; Rat model of alcoholism; Strike model; Forensic pathology	PERCUSSION BRAIN-INJURY; RAT AORTA; VERTEBRAL ARTERY; CONSUMPTION; MECHANISMS; COLLAGEN; ELASTIN; TISSUE; DEATH	Background: Traumatic subarachnoid hemorrhage (TSAH) related to alcohol abuse is a notable risk factor. Here, we investigated the vascular morphology and biomechanics of TSAH in rat models of acute alcoholic intoxication and chronic alcoholism rats to explore the possible mechanisms of TSAH. Methods: Sixty male Sprague-Dawley rats were divided into acute alcoholic intoxication and chronic alcoholism groups. Edible spirituous liquor (56% vol/vol) was intragastrically given (15 mL/kg) once to the rats in the acute group, and given twice daily (8 mL/kg for 2 weeks and 12 mL/kg for another 2 weeks) to rats in the chronic group. A self-made instrument was used to inflict head injury. Whole brain, arterial blood, and thoracic aorta of rats were sampled for morphologic and biomechanical examination. Results: Compared with the acute alcoholic rats, the chronic alcoholic rats showed significant morphologic and biomechanical changes: (1) decreased body weight (p < 0.05), (2) higher morbidity and mortality from TSAH (p < 0.01), (3) greater mean thickness of vascular wall of subarachnoid small arteries and each layer thickness of thoracic aorta (p < 0.05), (4) decreased failure load and corresponding extensibility (60 kPa and limit load) of thoracic aorta, and (5) increased elastic modulus (30 kPa, range in physiologic stress) (p < 0.05). Conclusions: Chronic alcoholism can induce the morphologic and biomechanical changes in cerebral vessels and thoracic aorta. The synergistic effect of alcohol abuse and minor blow may be one of the mechanisms of TSAH. High blood pressure from long-term alcohol abuse is also a notable factor.	[Wang, Haipeng; Yu, Xiaojun; Xu, Guohui; Xu, Guangtao; Gao, Guishan; Xu, Xiaohu] Shantou Univ, Coll Med, Dept Forens Med, Shantou City, Guangdong, Peoples R China; [Wang, Haipeng] Beihua Univ, Basic Med Coll, Dept Forens Med, Jilin, Jilin Prov, Peoples R China	Yu, XJ (corresponding author), Shantou Univ, Coll Med, Dept Forens Med, Shantou City, Guangdong, Peoples R China.	cnxjyu@yahoo.com.cn	Xu, Guangtao/L-8929-2017	Xu, Guangtao/0000-0001-5846-9280	National Natural Science Foundation Council of ChinaNational Natural Science Foundation of China (NSFC) [30772458]	Source of support: National Natural Science Foundation Council of China (No. 30772458).	ANDREASSEN TT, 1987, ACTA ENDOCRINOL-COP, V115, P338, DOI 10.1530/acta.0.1150338; Assoul N, 2008, J BIOMECH, V41, P2227, DOI 10.1016/j.jbiomech.2008.04.017; Baglietto L, 2006, ALCOHOL ALCOHOLISM, V41, P664, DOI 10.1093/alcalc/agl087; BARBOUR RL, 1993, ALCOHOL CLIN EXP RES, V17, P1319, DOI 10.1111/j.1530-0277.1993.tb05248.x; BRUEL A, 1991, ACTA ENDOCRINOL-COP, V125, P49, DOI 10.1530/acta.0.1250049; Cerqueira Nereide Freire, 2005, Acta Cir. Bras., V20, P213, DOI 10.1590/S0102-86502005000300004; CHAN TCK, 1985, HYPERTENSION, V7, P519, DOI 10.1161/01.HYP.7.4.519; Daula M, 2006, AM J FOREN MED PATH, V27, P355, DOI 10.1097/01.paf.0000233554.79665.0c; DECK JHN, 1986, ARCH PATHOL LAB MED, V110, P489; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; FACTOR M, 1976, AM HEART J, V92, P561; FARAG AM, 1988, FORENSIC SCI INT, V38, P275, DOI 10.1016/0379-0738(88)90173-9; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gdovinova Z, 2001, ALCOHOL ALCOHOLISM, V36, P346, DOI 10.1093/alcalc/36.4.346; Gray JT, 1999, FORENSIC SCI INT, V105, P13, DOI 10.1016/S0379-0738(99)00113-9; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; Hillbom M, 1998, NOVART FDN SYMP, V216, P193; JOHN JH, 2004, BIOCHEM BIOPH RES CO, V323, P361; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V370, P44, DOI 10.1016/j.bbrc.2008.03.005; Liu Z. R., 1996, NEW ADV BIOMECHANICS, P188; Mayhan WG, 1996, ALCOHOL CLIN EXP RES, V20, P538, DOI 10.1111/j.1530-0277.1996.tb01089.x; Mizutani K, 1999, J HYPERTENS, V17, P481, DOI 10.1097/00004872-199917040-00005; OXLUND H, 1980, ACTA ENDOCRINOL-COP, V94, P132, DOI 10.1530/acta.0.0940132; Partridge CR, 1999, LIFE SCI, V65, P1395, DOI 10.1016/S0024-3205(99)00381-1; PLANT JR, 1993, AM J FOREN MED PATH, V14, P61, DOI 10.1097/00000433-199303000-00015; Sampei K, 1996, NEURORADIOLOGY, V38, P291; SANTI FP, 1993, STUDY THORACIC AORTA; Sarphie TG, 1996, ALCOHOL CLIN EXP RES, V20, P973, DOI 10.1111/j.1530-0277.1996.tb01933.x; SIMONSEN J, 1963, J Forensic Sci, V8, P97; SIMONSEN J, 1984, FORENSIC SCI INT, V24, P57, DOI 10.1016/0379-0738(84)90152-X; Simonsen J, 1967, J Forensic Med, V14, P146; SOHAL RS, 1969, CARDIOVASC RES, V3, P369, DOI 10.1093/cvr/3.3.369; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; WILSON JS, 1982, ALCOHOL CLIN EXP RES, V6, P117, DOI 10.1111/j.1530-0277.1982.tb05389.x	35	11	14	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2011	70	1					E6	E12		10.1097/TA.0b013e3181cda3b9			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	707WD	WOS:000286320300002	21217473				2021-06-18	
J	Zhou, H; Chen, Q; Kong, DL; Guo, JA; Wang, QA; Yu, SY				Zhou, Hao; Chen, Qing; Kong, Dan Li; Guo, Jiang; Wang, Qian; Yu, Shou Yi			Effect of Resveratrol on Gliotransmitter Levels and p38 Activities in Cultured Astrocytes	NEUROCHEMICAL RESEARCH			English	Article						Resveratrol; Amino acid; p38 MAPK; Astrocyte; Stretch injury	D-SERINE; GLUTAMATE TRANSPORTERS; NMDA RECEPTORS; GLIAL-CELLS; BRAIN; RELEASE; NEURONS; NEUROTOXICITY; ACTIVATION; GLYCINE	Accumulating evidence suggests that resveratrol may have beneficial effects against traumatic brain injury. However, its effect on the regulation of extracellular levels of gliotransmitter and on the activation of p38 MAPK in astrocytes is still unknown. We have examined whether resveratrol regulates extracellular levels of gliotransmitter as well as the activation of p38 MAPK in cultured astrocytes before and after stretch injury. The extracellular levels of glutamate, D-/L-serine and D-serine were apparently reduced by 100 mu M resveratrol in control astrocyte cultures. The dramatic increase of glutamate and D-serine release induced by stretch injury was also clearly inhibited by resveratrol. Resveratrol mediates this response by reduction of release through inhibition of extracellular calcium influx and increment of gliotransmitter uptake through enhancement of amino acid transporter expressed in the membrane of astrocyte. In addition, resveratrol definitely reduced the activation of p38 MAPK in cultured astrocytes following stretch injury. AMPA receptor is involved in the activation of p38 following injury. Conversely, the levels of glutamine and glycine were not obviously affected by resveratrol before and after injury. Intracellular levels of glutamate and D-serine are not apparently changed by stretch injury. Collectively, our data suggest that resveratrol might play an important role in protection of the nervous system after injury by decreasing the extracellular levels of gliotransmitter and inhibiting activation of p38 MAPK following injury.	[Chen, Qing; Kong, Dan Li; Guo, Jiang; Yu, Shou Yi] So Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Hao; Wang, Qian] So Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Yu, SY (corresponding author), So Med Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	zw7980@fimmu.com			Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University	We would like to thank Zhiye Zhuang for manuscript review and technical support in cell cultures. This work was supported by Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University.	Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Ban JY, 2008, J PHARMACOL SCI, V106, P68, DOI 10.1254/jphs.FP0071206; Brown DR, 1999, MOL CELL NEUROSCI, V13, P379, DOI 10.1006/mcne.1999.0751; CHAPARRO HV, 2008, INT J DEV NEUROSCI, V26, P487; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Eaton MJ, 2007, J PAIN, V8, P33, DOI 10.1016/j.jpain.2006.05.013; FABRICIO MB, 2007, PHYTOCHEMISTRY, V68, P1992; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Jakab M, 2008, CELL PHYSIOL BIOCHEM, V22, P567, DOI 10.1159/000185541; JIONG C, 2004, J BIOL CHEM, V279, P35903; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; MARCO V, 2000, NEUROSCI LETT, V281, P123; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; Montal M, 1998, BBA-BIOENERGETICS, V1366, P113, DOI 10.1016/S0005-2728(98)00124-8; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; OLIET SH, 2008, NEUROSCIENCE, V19; Ou HC, 2006, CLIN CHIM ACTA, V364, P196, DOI 10.1016/j.cccn.2005.06.018; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Verleysdonk S, 1999, GLIA, V27, P239, DOI 10.1002/(SICI)1098-1136(199909)27:3<239::AID-GLIA5>3.0.CO;2-K; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	32	11	13	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JAN	2011	36	1					17	26		10.1007/s11064-010-0254-8			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	711KA	WOS:000286589000003	20842424				2021-06-18	
J	de Liano, BGG; Umilta, C; Stablum, F; Tebaldi, F; Cantagallo, A				Gil-Gomez de Liano, Beatriz; Umilta, Carlo; Stablum, Franca; Tebaldi, Francesca; Cantagallo, Anna			Attentional distractor interference may be diminished by concurrent working memory load in normal participants and traumatic brain injury patients	BRAIN AND COGNITION			English	Article						Selective attention; Working memory load; Distractor processing; Traumatic brain injury patients	CLOSED-HEAD INJURY; SELECTIVE ATTENTION; VISUAL-SEARCH; COGNITIVE CONTROL; TASK; DEFICITS; REHABILITATION; INHIBITION; PARADIGM	A reduction in congruency effects under working memory (WM) load has been previously described using different attentional paradigms (e.g., Kim, Kim, & Chun, 2005; Smilek, Enns, Eastwood, & Merikle, 2006). One hypothesis is that different types of WM load have different effects on attentional selection, depending on whether a specific memory load demands resources in common with target or distractor processing. In particular, if information in WM is related to the distractors in the selective attention task, there is a reduction in distraction (Kim et al., 2005). However, although previous results seem to point to a decrease in interference under high WM load conditions (Kim et al., 2005), the lack of a neutral baseline for the congruency effects makes it difficult to differentiate between a decrease in interference or in facilitation. In the present work we included neutral trials in the task introduced by Kim et al. (2005) and tested normal participants and traumatic brain injury patients. Results support a reduction in the processing of distractors under WM load, at least for incongruent trials in both groups. Theoretical as well as applied implications are discussed. (C) 2010 Elsevier Inc. All rights reserved.	[Gil-Gomez de Liano, Beatriz] Autonomous Univ Madrid, Fac Psicol, Dept Social Psychol & Methodol, E-28049 Madrid, Spain; [Umilta, Carlo; Stablum, Franca] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy; [Tebaldi, Francesca; Cantagallo, Anna] Hosp Ferrara, Dept Neurosci Rehabil, Ferrara, Italy; [Tebaldi, Francesca; Cantagallo, Anna] Univ Ferrara, I-44100 Ferrara, Italy	de Liano, BGG (corresponding author), Autonomous Univ Madrid, Fac Psicol, Dept Social Psychol & Methodol, C Ivan Pavlov,6 Carretera Colmenar,Km 15,Campus C, E-28049 Madrid, Spain.	bgil.gomezdelianno@uam.es	de Liano, Beatriz Gil-Gomez/L-1715-2014	de Liano, Beatriz Gil-Gomez/0000-0002-7823-4486; Stablum, Franca/0000-0003-0123-5090			Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Dell'Acqua R, 2003, EXP BRAIN RES, V152, P29, DOI 10.1007/s00221-003-1512-7; de Liano BGG, 2011, PSICOLOGICA, V32, P13; de Liano BGG, 2010, PSICOTHEMA, V22, P725; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; HOLZMAN PS, 1994, ARCH GEN PSYCHIAT, V51, P952; JENNETT B, 1975, LANCET, V1, P480; KIM MS, 2006, J VISION, V6, pA125; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Park S, 2007, J EXP PSYCHOL HUMAN, V33, P1062, DOI 10.1037/0096-1523.33.5.1062; Perlstein WM, 1998, NEUROPSYCHOLOGY, V12, P414, DOI 10.1037/0894-4105.12.3.414; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PERSLTEIN WM, 2006, NEUROPSYCHOLOGIA, V44, P260; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD JL, 2000, NEUROPSYCHOLOGICAL A, P355; Posner M I, 1989, J Cogn Neurosci, V1, P50, DOI 10.1162/jocn.1989.1.1.50; Posner M.I., 1994, IMAGES MIND; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1982, PHILOS T ROY SOC B, V298, P187, DOI 10.1098/rstb.1982.0081; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RABBITT PM, 1997, METHODOLOGY FRONTAL, P81; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Rissman J, 2009, NEUROPSYCHOLOGIA, V47, P1637, DOI 10.1016/j.neuropsychologia.2009.01.036; Sandson J, 1988, COGNITIVE APPROACHES; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Smilek D, 2006, VIS COGN, V14, P543, DOI 10.1080/13506280500193487; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE JD, 1993, EUR J COGN PSYCHOL, V5, P417, DOI 10.1080/09541449308520128; Townsend J.T., 1983, STOCHASTIC MODELLING; Umilta C, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P37; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Woodman GF, 2001, PSYCHOL SCI, V12, P219, DOI 10.1111/1467-9280.00339	48	11	11	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626	1090-2147		BRAIN COGNITION	Brain Cogn.	DEC	2010	74	3					298	305		10.1016/j.bandc.2010.08.009			8	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	679SY	WOS:000284182300015	20846773				2021-06-18	
J	Balik, V; Lehto, H; Hoza, D; Sulla, I; Hernesniemi, J				Balik, V.; Lehto, H.; Hoza, D.; Sulla, I.; Hernesniemi, J.			Posterior Fossa Extradural Haematomas	CENTRAL EUROPEAN NEUROSURGERY			English	Article						extradural haematoma; posterior cranial fossa; occipital extension	TRAUMATIC EPIDURAL HEMATOMAS; CRANIAL FOSSA; CHILDREN; VERTEX; CT; PROGNOSIS; SURVIVAL	Background: Posttraumatic epidural haematoma (EDH) of the temporal region is the most common site of supratentorial extradural bleeding; other locations are considered atypical. We reviewed 24 patients with EDH located in the posterior cranial fossa (PFEDH) treated at two neurosurgical centres between January 2000 and November 2006. Material and Methods: In the retrospective study we analysed gender and age distribution, type of injury, clinical presentation, Glasgow Coma Scale (GCS) score on admission, radiological images, interval between trauma and surgery, and outcome. Results: 24 patients with PFEDH constituted 11.5 % of 209 surgically treated individuals with EDH. The best outcomes were obtained by patients with GCS scores of 15-14 on admission. Patients in the fourth to seventh decade of life had less favourable outcomes than younger ones. More than half of the patients with PFEDH had associated intradural lesions. Only patients with concomitant brain contusion had a more favourable recovery. The 3 worst levels on the Glasgow Outcome Scale (GOS) were observed in patients suffering from subdural or intracerebral haematoma, or both, associated with the PFEDHs. The majority of patients with concurrent lesions and supratentorial extension of the haemorrhage were in the subgroup undergoing craniotomy between 24 and 72 h after injury. Patients treated in this time interval also had the most unfavourable outcomes. A classical lucid interval was observed only in one patient. The mortality rate in the series was 4.2 %. Conclusion: The most significant factors influencing outcome in our patients were GCS on admission, age, and associated intradural lesions.	[Sulla, I.] Safarik Univ, Fac Med, AD Ctr, Dept Neurosurg, Kosice 04011, Slovakia; [Lehto, H.; Hernesniemi, J.] Helsinki Univ Hosp, Dept Neurosurg, Helsinki, Finland; [Hoza, D.] Charles Univ Prague, Univ Hosp Motol, Fac Med, Dept Neurosurg, Prague, Czech Republic	Sulla, I (corresponding author), Safarik Univ, Fac Med, AD Ctr, Dept Neurosurg, Kosice Trieda SNP 1, Kosice 04011, Slovakia.	isulla@upjs.sk					AGBI CB, 1987, SURG NEUROL, V28, P123, DOI 10.1016/0090-3019(87)90085-1; ARKINS TJ, 1977, AM J DIS CHILD, V131, P690, DOI 10.1001/archpedi.1977.02120190084019; Asanin B, 2009, ACTA CLIN CROAT, V48, P27; Balik V, 2007, BRATISL MED J, V108, P409; BESSON G, 1978, NEUROCHIRURGIE, V24, P53; BOITEN J, 1989, J NEUROL NEUROSUR PS, V52, P914, DOI 10.1136/jnnp.52.7.914-a; BORZONE M, 1988, ACTA NEUROCHIR, V93, P55, DOI 10.1007/BF01409903; BORZONE M, 1991, J NEUROSURG SCI, V35, P260; Bozbuga M, 1999, NEUROSURG REV, V22, P34, DOI 10.1007/s101430050006; BRAMBILLA G, 1986, ACTA NEUROCHIR, V80, P24, DOI 10.1007/BF01809553; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; CAMPBELL E, 1953, ANN SURG, V138, P509, DOI 10.1097/00000658-195310000-00003; CERVANTES LA, 1983, J NEUROSURG, V59, P351, DOI 10.3171/jns.1983.59.2.0351; CHOUX M, 1975, CHILD BRAIN, V1, P337; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; CORDOBES F, 1980, ACTA NEUROCHIR, V53, P275, DOI 10.1007/BF02074800; Dorizzi A, 1968, Sist Nerv, V20, P63; GARZAMERCADO R, 1983, J NEUROSURG, V59, P664, DOI 10.3171/jns.1983.59.4.0664; Gdovinova Z, 2009, TXB GEN NEUROLOGY, P152; Gelabert M, 1997, BRIT J NEUROSURG, V11, P573; Gruskiewicz J, 1976, Surg Neurol, V5, P122; GUTHKELCH AN, 1949, J NEUROSURG, V6, P180, DOI 10.3171/jns.1949.6.2.0180; HARWOODNASH DC, 1971, RADIOLOGY, V101, P151, DOI 10.1148/101.1.151; Holzschuh M, 1989, Br J Neurosurg, V3, P171, DOI 10.3109/02688698909002792; HOOPER RS, 1954, BRIT J SURG, V42, P19, DOI 10.1002/bjs.18004217103; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JAMIESON KG, 1972, J NEUROSURG, V36, P644, DOI 10.3171/jns.1972.36.5.0644; JENNETT B, 1975, LANCET, V1, P480; KALYANARAMAN S, 1972, P I NEUROL MADRAS, V2, P22; Karasawa H, 1997, J NEUROSURG, V86, P629, DOI 10.3171/jns.1997.86.4.0629; Karasu A, 2008, SURG NEUROL, V69, P247, DOI 10.1016/j.surneu.2007.02.024; KINOMOTO T, 1985, NEUROTRAUMATOLOGY, V8, P77; Li TD, 2007, ACTA CRYSTALLOGR E, V63, pM1870, DOI 10.1107/S1600536807027237; LUI TN, 1993, J TRAUMA, V34, P211, DOI 10.1097/00005373-199302000-00005; Maggi G, 1998, J Neurosurg Sci, V42, P95; Mahajan R. K., 1993, Annals Academy of Medicine Singapore, V22, P410; Malik NK, 2007, SURG NEUROL, V68, P155, DOI 10.1016/j.surneu.2006.10.051; MCCULLOCH GAJ, 1976, MED J AUSTRALIA, V2, P303, DOI 10.5694/j.1326-5377.1976.tb130189.x; Mckenzie KG, 1938, BRIT J SURG, V26, P346, DOI 10.1002/bjs.18002610215; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Mracek Z, 1999, CESK SLOV NEUROL N, V62, P336; NAGAMINE Y, 1979, NO SHINKEI GEKA, V9, P357; NEUBAUER UJ, 1987, ACTA NEUROCHIR, V87, P105, DOI 10.1007/BF01476060; ONUMA T, 1990, SHINKEUI GAISHO, V13, P57; OTSUKA S-I, 1990, Neurologia Medico-Chirurgica, V30, P24, DOI 10.2176/nmc.30.24; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; Pereira CU, 2004, J BRAS NEUROCIRURG, V15, P18; POZZATI E, 1989, SURG NEUROL, V32, P300, DOI 10.1016/0090-3019(89)90234-6; RIVANO C, 1991, Zentralblatt fuer Neurochirurgie, V52, P77; RIVANO C, 1992, NEUROCHIRURGIA, V35, P43; RIVAS JJ, 1988, NEUROSURGERY, V23, P44, DOI 10.1227/00006123-198807000-00010; RODA JM, 1983, SURG NEUROL, V19, P419, DOI 10.1016/0090-3019(83)90138-6; SCHIEFER W, 1964, BEITR NEUROCHIR, V8, P39; Sinha AK, 2009, CENT EUR NEUROSURG, V70, P52, DOI 10.1055/s-2008-0042; Steno J, 1990, Rozhl Chir, V69, P358; STJOHN JN, 1986, SURG NEUROL, V25, P457, DOI 10.1016/0090-3019(86)90085-6; STONE JL, 1979, SURG NEUROL, V11, P419; SUBRAHMANIAN MV, 1975, BRIT J SURG, V62, P397, DOI 10.1002/bjs.1800620517; Sulla I., 2003, Folia Veterinaria, V47, P95; Wang E. C. M., 1998, SMJ, V39, P107; WONG CW, 1994, ACTA NEUROCHIR, V126, P124, DOI 10.1007/BF01476421; WRIGHT RL, 1966, J NEUROSURG, V25, P402, DOI 10.3171/jns.1966.25.4.0402; ZUCCARELLO M, 1981, NEUROSURGERY, V8, P434, DOI 10.1227/00006123-198104000-00005	63	11	11	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	1868-4904	1868-4912		CENT EUR NEUROSURG	Cent. Eur. Neurosurg.	NOV	2010	71	4					167	172		10.1055/s-0030-1249046			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	681WW	WOS:000284355500002	20422510				2021-06-18	
J	Morrow, SE; Pearson, M				Morrow, Stephen E.; Pearson, Matthew			Management Strategies for Severe Closed Head Injuries in Children	SEMINARS IN PEDIATRIC SURGERY			English	Article						Severe brain injury; Pediatric; Head trauma; Intracranial pressure; Hypertonic saline; Decompressive craniectomy; Hypothermia	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL HYPERTENSION; THERAPEUTIC HYPOTHERMIA; COMPUTED-TOMOGRAPHY; CONTROLLED-TRIAL; MODERATE; CRANIOPLASTY; OXYGENATION	Brain injuries represent the most common cause of mortality and long-term morbidity from trauma in children. The management of closed head injuries focuses on prevention of secondary injury by optimizing the delivery of oxygen and nutrients to the injured brain while minimizing neuronal metabolic demand. Despite the known differences between the immature and mature brain, treatments used in head-injured children are mainly extrapolated from those employed in adults due to the paucity of class one and two studies focused on the pediatric age group. Therapies intended to minimize secondary brain injury, such as cerebrospinal fluid drainage, hypertonic saline infusion, barbiturate coma induction, brain cooling, and decompressive craniectomy, vary widely in their clinical application among practitioners and trauma centers and have unclear indications, benefits, and long-term consequences. Prospective studies on brain injury management in children are needed to develop treatment strategies that optimize outcomes. (C) 2010 Elsevier Inc. All rights reserved.	[Morrow, Stephen E.] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Dept Pediat Surg, Nashville, TN USA; [Pearson, Matthew] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Dept Neurosurg, Nashville, TN USA	Morrow, SE (corresponding author), 2200 Childrens Way,Suite 7100, Nashville, TN 37232 USA.	stephen.morrow@vanderbilt.edu	Pearson, Matthew/AAR-7763-2020				Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carney NA, 2003, PEDIATR CRIT CARE ME, V4, P1; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; EISENBERG HM, 1980, NEUROSURGERY, V7, P598; FANCONI S, 1988, INTENS CARE MED, V14, P163; Figaji AA, 2008, ACTA NEUROCHIR SUPPL, V102, P77, DOI 10.1007/978-3-211-85578-2_15; Fortune PM, 2010, PEDIATR CRIT CARE ME, V11, P339, DOI 10.1097/PCC.0b013e3181c014ab; GERIACH R, 2009, PEDIATR EMERG CARE, V25, P164; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; GRANDE PO, 2004, YB INTENSIVE CARE EM, P215; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; HENDRICK EB, 1959, ARCH SURG-CHICAGO, V79, P362; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVY DI, 1995, J NEUROSURG, V83, P453, DOI 10.3171/jns.1995.83.3.0453; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; NODBY HK, 1984, NEUROCHIRURGIA, V72, P157; Philip S, 2009, CRIT CARE MED, V37, P2973, DOI 10.1097/CCM.0b013e3181a963f6; PLATT JH, 1984, NEUROSURGERY, V15, P427; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Young KD, 2004, ANN EMERG MED, V43, P435, DOI 10.1016/j.annemergmed.2003.09.016; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	43	11	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1055-8586	1532-9453		SEMIN PEDIATR SURG	Semin. Pediatr. Surg.	NOV	2010	19	4					279	285		10.1053/j.sempedsurg.2010.07.001			7	Pediatrics; Surgery	Pediatrics; Surgery	665IL	WOS:000283028500007	20889084				2021-06-18	
J	Portaccio, E; Goretti, B; Zipoli, V; Hakiki, B; Giannini, M; Pasto, L; Razzolini, L; Amato, MP				Portaccio, Emilio; Goretti, Benedetta; Zipoli, Valentina; Hakiki, Bahia; Giannini, Marta; Pasto, Luisa; Razzolini, Lorenzo; Amato, Maria Pia			Cognitive rehabilitation in children and adolescents with multiple sclerosis	NEUROLOGICAL SCIENCES			English	Article						Multiple sclerosis; Cognitive impairment; Cognitive rehabilitation	TRAUMATIC BRAIN-INJURY; REMEDIATION; CHILDHOOD; PROGRAM; MEMORY; TRIAL	Cognitive impairment can be detected in a sizeable proportion of pediatric multiple sclerosis (MS) patients. It involves memory, complex attention, information processing speed, executive functions, linguistic abilities, and intelligent quotient. It has a great impact on school, everyday and social activities, and significantly progresses overtime in the great majority of the subjects. These findings highlight the importance of a comprehensive and systematic assessment of MS-related cognitive difficulties in pediatric cases. Moreover, despite the acknowledged relevance of cognitive impairment in this age range, specific interventions for pediatric MS are lacking. As for rehabilitative strategies, there is some evidence of efficacy in other diseases, in particular brain trauma, tumor, and stroke. The development of effective rehabilitative strategies tailored to the needs of young MS patients is a priority for future research in the field.	[Portaccio, Emilio; Goretti, Benedetta; Zipoli, Valentina; Hakiki, Bahia; Giannini, Marta; Pasto, Luisa; Razzolini, Lorenzo; Amato, Maria Pia] Univ Florence, Dept Neurol, I-50134 Florence, Italy	Portaccio, E (corresponding author), Univ Florence, Dept Neurol, Viale Morgagni 85, I-50134 Florence, Italy.	portilio@tin.it	amato, Maria Pia/AAL-5998-2020	amato, Maria Pia/0000-0003-3325-3760; Hakiki, Bahia/0000-0001-8540-7405			Amato MP, 2008, NEUROLOGY, V70, P1891, DOI 10.1212/01.wnl.0000312276.23177.fa; Amato Maria Pia, 2008, Expert Rev Neurother, V8, P1585, DOI 10.1586/14737175.8.10.1585; AMATO MP, 2010, NEUROLOGY IN PRESS; Baddeley A. D., 1986, WORKING MEMORY; Banwell B, 2007, LANCET NEUROL, V6, P887, DOI 10.1016/S1474-4422(07)70242-9; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Franzen KM, 1996, CHILD NEUROPSYCHOL, V2, P176, DOI 10.1080/09297049608402250; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Portaccio E, 2009, MULT SCLER J, V15, P620, DOI 10.1177/1352458508101950; RAOSM, 1986, J CLIN EXP NEUROPSYC, V8, P503; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Yerys BE, 2003, J PEDIAT HEMATOL ONC, V25, P495, DOI 10.1097/00043426-200306000-00014	18	11	12	2	9	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	NOV	2010	31			2			275	278		10.1007/s10072-010-0377-3			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	687LA	WOS:000284778800015	20635109				2021-06-18	
J	Xiao, FR; Liao, CC; Huang, KC; Chiang, IJ; Wong, JM				Xiao, Furen; Liao, Chun-Chih; Huang, Ke-Chun; Chiang, I. -Jen; Wong, Jau-Min			Automated assessment of midline shift in head injury patients	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						CT scanning; Head trauma; Midline shift; Computer-aided assessment; Outcome; Other tools of modern imaging	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; OUTCOME PREDICTION; TOMOGRAPHY; CLASSIFICATION; CT	Objectives: Midline shift (MLS) is an important quantitative feature for evaluating severity of brain compression by various pathologies, including traumatic intracranial hematomas. In this study, we sought to determine the accuracy and the prognostic value of our computer algorithm that automatically measures the MLS of the brain on computed tomography (CT) images in patients with head injury. Patients and methods: Modelling the deformed midline into three segments, we had designed an algorithm to estimate the MLS automatically. We retrospectively applied our algorithm to the initial CT images of 53 patients with head injury to determine the automated MLS (aMLS) and validated it against that measured by human (hMLS). Both measurements were separately used to predict the neurological outcome of the patients. Results: The hMLS ranged from 0 to 30 mm. It was greater than 5 mm in images of 17 patients (32%). In 49 images (92%), the difference between hMLS and aMLS was <1 mm. To detect MLS >5 mm, our algorithm achieved sensitivity of 94% and specificity of 100%. For mortality prediction, aMLS was no worse than hMLS. Conclusion: In summary. automated MLS was accurate and predicted outcome as well as that measured manually. This approach might be useful in constructing a fully automated computer-assisted diagnosis system. (C) 2010 Elsevier B.V. All rights reserved.	[Xiao, Furen; Liao, Chun-Chih; Huang, Ke-Chun; Chiang, I. -Jen; Wong, Jau-Min] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Xiao, Furen] Natl Taiwan Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Liao, Chun-Chih] Taipei Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, I. -Jen] Taipei Med Univ, Grad Inst Med Informat, Taipei, Taiwan	Liao, CC (corresponding author), Dept Neurosurg, 127 Su Yuan Rd, Hsinchuang 242, Taipei County, Taiwan.	d95548001@ntu.edu.tw		Xiao, Furen/0000-0001-9683-3979; Liao, Chun-Chih/0000-0001-9398-8617			Bardera A, 2009, COMPUT MED IMAG GRAP, V33, P304, DOI 10.1016/j.compmedimag.2009.02.001; Bullock RM, 2000, J NEUROTRAUM, V17, P449; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Development Core Team, 2008, R LANG ENV STAT COMP; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Hilden J, 1996, STAT MED, V15, P969, DOI 10.1002/(SICI)1097-0258(19960530)15:10<969::AID-SIM211>3.0.CO;2-9; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; LIAO CC, 2006, 6 IEEE INT C DAT MIN, P463; Liao CC, 2010, COMPUT BIOL MED, V40, P331, DOI 10.1016/j.compbiomed.2010.01.004; Liu BQ, 2008, IEEE ENG MED BIO, P1214, DOI 10.1109/IEMBS.2008.4649381; Lu W, 2005, ULTRASOUND MED BIOL, V31, P929, DOI 10.1016/j.ultrasmedbio.2005.04.002; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590	20	11	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2010	112	9					785	790		10.1016/j.clineuro.2010.06.020			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	676MR	WOS:000283916500009	20663606				2021-06-18	
J	Davenport, A				Davenport, Andrew			Management of acute kidney injury in neurotrauma	HEMODIALYSIS INTERNATIONAL			English	Article						Hemodialysis; cerebral edema; dialyzer membranes; acute kidney injury; hemofiltration	ACUTE-RENAL-FAILURE; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; PERITONEAL-DIALYSIS; REPLACEMENT THERAPY; ILL PATIENTS; HEAD-INJURY; HEMODIALYSIS; COMPLICATIONS; PATIENT	Fortunately, the incidence of acute kidney injury (AKI) in neurotrauma is low and decreasing. Whereas the majority of AKI occurs in older patients with pre-existing chronic kidney disease, neurotrauma typically occurs in children and young adults with normal renal function. The development of outreach trauma teams has improved initial resuscitation, reducing both volume responsive and volume unresponsive cases of AKI. Most cases occur in the setting of multiple organ trauma with muscle injury, or patients who subsequently develop multiple organ failure. Once AKI has developed and renal replacement therapy is required, continuous modalities of renal replacement therapy offer an advantage to the patient with compromised cerebral perfusion and intracranial hypertension, by reducing the rate of change in serum urea, compared with standard intermittent therapies of hemodialysis and hemofiltration, thus minimizing abrupt changes in serum osmolality. Continuous hemodialysis and hemofiltration are better suited to maintain a normal or high serum sodium and thermal losses through the extracorporeal circuit, than peritoneal dialysis. Dialyzers should preferably be minimally bioincompatible and of a small surface area. In patients at risk of intracranial hemorrhage and those with invasive intracranial monitoring, systemic anticoagulants should either be avoided or regional anticoagulants should be used.	UCL, Sch Med, UCL Ctr Nephrol, London NW3 2PF, England	Davenport, A (corresponding author), UCL, Sch Med, UCL Ctr Nephrol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk					ARIEFF AI, 1973, KIDNEY INT, V4, P177, DOI 10.1038/ki.1973.100; Basile C, 2009, G Ital Nefrol, V26, P22; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P561; DAVENPORT A, 1989, AM J KIDNEY DIS, V14, P516, DOI 10.1016/S0272-6386(89)80153-2; Davenport A, 2008, PERITON DIALYSIS INT, V28, P423; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; DAVENPORT A, 1989, INT J ARTIF ORGANS, V12, P703, DOI 10.1177/039139888901201107; DAVENPORT A, 1991, NEPHRON, V59, P449, DOI 10.1159/000186607; DAVENPORT A, 2008, NEPHROL DIAL TRANSPL, V1, P41; Davenport A, 2008, HEMODIAL INT, V12, P307, DOI 10.1111/j.1542-4758.2008.00271.x; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; Davenport Andrew, 2006, Hemodial Int, V10, P162; Davenport A, 2009, CLIN KIDNEY J, V2, P439, DOI 10.1093/ndtplus/sfp136; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; DORMAN HR, 1990, MEDICINE, V69, P153, DOI 10.1097/00005792-199005000-00003; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Gabriel DP, 2009, PERITON DIALYSIS INT, V29, pS62; Gondo G, 1989, Neurol Med Chir (Tokyo), V29, P1125, DOI 10.2176/nmc.29.1125; Iunovidov I M, 1977, Zh Nevropatol Psikhiatr Im S S Korsakova, V77, P1656; Ivarsen P, 2007, NEPHROL DIAL TRANSPL, V22, P2999, DOI 10.1093/ndt/gfm284; JONES JG, 1992, NEPHROL DIAL TRANSPL, V7, P110, DOI 10.1093/oxfordjournals.ndt.a092078; Kielar ML, 2002, CURR OPIN NEPHROL HY, V11, P451, DOI 10.1097/00041552-200207000-00013; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Probst C, 2009, INJURY, V40, P77, DOI 10.1016/j.injury.2008.10.004; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Sabsovich I, 2007, AM J CRIT CARE, V16, P82, DOI 10.4037/ajcc2007.16.1.82; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Stevens RD, 2008, NEUROL CLIN, V26, P543, DOI 10.1016/j.ncl.2008.03.014; Stoves J, 2001, ARTIF ORGANS, V25, P1009, DOI 10.1046/j.1525-1594.2001.06703.x; TAYLOR WH, 1957, LANCET, V2, P703; TAYLOR WH, 1958, BRIT J SURG, V46, P136, DOI 10.1002/bjs.18004619611; Trinh-Trang-Tan MM, 2005, NEPHROL DIAL TRANSPL, V20, P1984, DOI 10.1093/ndt/gfh877	35	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1492-7535	1542-4758		HEMODIAL INT	Hemodial. Int.	OCT	2010	14			1			S27	S31		10.1111/j.1542-4758.2010.00487.x			5	Urology & Nephrology	Urology & Nephrology	660IW	WOS:000282634800006	21040416				2021-06-18	
J	De Wolf, A; Lane-Brown, A; Tate, RL; Middleton, J; Cameron, ID				De Wolf, Annelies; Lane-Brown, Amanda; Tate, Robyn L.; Middleton, James; Cameron, Ian D.			Measuring community integration after spinal cord injury: validation of the Sydney psychosocial reintegration scale and community integration measure	QUALITY OF LIFE RESEARCH			English	Article						Sydney psychosocial reintegration scale-SPRS; Community integration measure-CIM; Outcomes measurement; Community integration; Participation	PSYCHOMETRIC PROPERTIES; OUTCOMES RESEARCH; BRAIN-INJURY; HANDICAP; DIFFERENCE; RECOVERY; HEALTH	To evaluate the reliability, validity, sensitivity to change, and clinical usefulness of the Sydney Psychosocial Reintegration Scale (SPRS) and Community Integration Measure (CIM) for people with spinal cord injury (SCI). A sample of 58 people with recent traumatic SCI was followed up at 12 months post-discharge from inpatient rehabilitation. The SPRS, CIM, Craig Handicap Assessment and Reporting Technique (CHART) and SF-6D Health Utility Scale (SF-6D) were administered. The SPRS and CIM were internally consistent (alpha = .80 and .78, respectively). The SPRS showed greatest sensitivity to change as measured by percentage of participants meeting minimum difference in score change over time (21%). CIM and CHART had comparable sensitivity to change (14% minimum difference). SPRS correlated significantly with CHART (r = .72, P < .001), unlike CIM. Neither SPRS nor CIM discriminated between high and low impairment, unlike CHART. Correlations with CHART and SF-6D domains supported convergent and divergent validity of the SPRS domains. Research should continue to develop conceptually and psychometrically valid instruments to capture the multidimensionality of community integration. The SPRS and CIM show potential to extend measurement of community reintegration following SCI.	[De Wolf, Annelies; Lane-Brown, Amanda; Tate, Robyn L.; Middleton, James; Cameron, Ian D.] Univ Sydney, Rehabil Studies Unit, Ryde, NSW 2112, Australia; [De Wolf, Annelies; Lane-Brown, Amanda; Tate, Robyn L.; Middleton, James; Cameron, Ian D.] Royal Rehabil Ctr Sydney, Ryde, NSW 2112, Australia	De Wolf, A (corresponding author), Univ Sydney, Rehabil Studies Unit, 59 Charles St, Ryde, NSW 2112, Australia.	anneliesd@med.usyd.edu.au		Middleton, James/0000-0002-2777-8619			Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Betz N., 2000, PSYCHOL RES HDB GUID, P239; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Cardol M, 1999, DISABIL REHABIL, V21, P97, DOI 10.1080/096382899297819; CARR AJ, 1994, BRIT J RHEUMATOL, V33, P378; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; De Wolf A., 2008, J REHABILITATION S47, V40, P106; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dijkers M., 1991, J AM PARAPLEGIA SOC, V14, P85; Dijkers M. P., 2000, ARCH PHYS MED REH S2, V81, P63; Dijkers Marcel., 1998, TOP SPINAL CORD INJ, V4, P1, DOI [10.1310/BJJA-2018-45KL-0VTL, DOI 10.1310/BJJA-2018-45KL-0VTL]; Field A.P., 2005, DISCOVERING STAT USI; Gray DB, 2000, ARCH PHYS MED REHAB, V81, pS10, DOI 10.1053/apmr.2000.20616; Hall KM, 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lee BB, 2008, VALUE HEALTH, V11, P680, DOI 10.1111/j.1524-4733.2007.00311.x; Ley P., 1972, QUANTITATIVE ASPECTS; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; Noreau Luc, 2005, J Neurol Phys Ther, V29, P147; Perdices M, 2005, BRAIN IMPAIR, V6, DOI [10.1375/brim.2005.6.3.219, DOI 10.1375/brim.2005.6.3.219]; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Schuck P, 2003, INT J REHABIL RES, V26, P85, DOI 10.1097/00004356-200306000-00002; Streiner DL, 2003, J PERS ASSESS, V80, P99, DOI 10.1207/S15327752JPA8001_18; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 1998, CLIN NEUROPSYCHOL, V12, P348, DOI 10.1076/clin.12.3.348.1988; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Ware JE., 1993, SF 36 HLTH SURVEY MA; Whiteneck G, 1999, ARCH PHYS MED REHAB, V80, P1485, DOI 10.1016/S0003-9993(99)90262-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 2001, INT CLASS FUNCT DIS	35	11	11	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343			QUAL LIFE RES	Qual. Life Res.	OCT	2010	19	8					1185	1193		10.1007/s11136-010-9685-6			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	651CS	WOS:000281902800012	20582722				2021-06-18	
J	Gobbel, GT; Kondziolka, D; Fellows-Mayle, W; Uram, M				Gobbel, Glenn T.; Kondziolka, Douglas; Fellows-Mayle, Wendy; Uram, Martin			Cellular transplantation for the nervous system: impact of time after preparation on cell viability and survival Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						cell transplantation; brain; stroke; Parkinson disease	MARROW STROMAL CELLS; NEURAL STEM-CELLS; TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; HUNTINGTONS-DISEASE; FUNCTIONAL RECOVERY; DOPAMINE NEURONS; RAT MODEL; STROKE; THERAPY	Object. Cell transplantation has shown promise for the treatment of various neurological disorders, but the factors that influence cell survival and integration following transplantation are poorly understood. In fact, little is known regarding how simple but potentially critical variables, including the method of cellular preparation and administration, might affect transplant success. The goal of the present study was to determine the impact of time between tissue preparation and implantation on cellular viability. Time can vary with cell preparation, delivery to the operating room, and surgical technique. This study was also designed to evaluate the sensitivity of various methods of assessing implant viability. Methods. Cell lines of neural progenitor cells and bone marrow stromal cells were generated from healthy adult mice. On the day of experimentation, the cells were collected, suspended in a balanced salt solution, and sequentially assessed for viability for up to 3.5 hours based on their appearance under phase-contrast microscopy, their ability to retain a fluorescent dye, and their attachment to a cultivation surface for 24 hours. Results. When viability was measured based on the ability of cells to retain a fluorescent dye, there was a decrease in viability of 10-15% each hour. Based on the ability of the cells to attach to a culture surface and grow for 24 hours, viability decreased more rapidly at approximately 20% per hour. In addition, only about one-third of the cells judged viable based on phase-contrast microscopy or acute dye retention were found to be viable based on plating, and only 10% of the cells initially judged as viable were still capable of survival after 3 hours in suspension. Conclusions. The authors' results indicate that that there can be significant losses in viability between preparation and implantation and that more sophisticated methods of evaluation, such as the ability of cells to attach to a substrate and grow, may be required to detect decreases in viability. The time between preparation and implantation will be an important factor in clinical trial design. (DOI: 10.3171/2009.10.JNS09252)	[Gobbel, Glenn T.] Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, Pittsburgh, PA 15213 USA; [Gobbel, Glenn T.; Kondziolka, Douglas] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Uram, Martin] MEDRAD Inc, Indianola, PA USA	Gobbel, GT (corresponding author), Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	gobbelg@upmc.edu			MEDRAD, Inc.; NASANational Aeronautics & Space Administration (NASA) [NNJ06HE87G]	The work in this study was supported by a grant from MEDRAD, Inc., to Glenn T. Gobbel based on work supported by NASA under award No. NNJ06HE87G.	Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Behrstock S, 2006, GENE THER, V13, P379, DOI 10.1038/sj.gt.3302679; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Braak H, 2008, NAT MED, V14, P483, DOI 10.1038/nm0508-483; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; Franklin RJM, 1997, J ANAT, V190, P23, DOI 10.1046/j.1469-7580.1997.19010023.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; Freshney R, 1994, CULTURE ANIMAL CELLS, P71; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; MADRAZO I, 1995, NEUROL RES, V17, P312, DOI 10.1080/01616412.1995.11740334; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; Marchionini DM, 2004, CELL TRANSPLANT, V13, P273, DOI 10.3727/000000004783983972; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; Niranjan A, 2007, J NEUROSURG, V107, P383, DOI 10.3171/JNS-07/08/0383; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Stilley CS, 2004, NEUROLOGY, V63, P1320, DOI 10.1212/01.WNL.0000140700.44904.53; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Terpstra BT, 2007, J NEUROSCI METH, V166, P13, DOI 10.1016/j.jneumeth.2007.06.022; Thompson TP, 1999, NEUROSURGERY, V45, P741, DOI 10.1097/00006123-199910000-00001; VIDAIR CA, 1993, INT J RADIAT BIOL, V63, P589, DOI 10.1080/09553009314450771; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146	36	11	11	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	2010	113	3					666	672		10.3171/2009.10.JNS09252			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	641FV	WOS:000281111100034	19911893				2021-06-18	
J	Howell, CA; Nelson, NG; McKenzie, LB				Howell, Candace A.; Nelson, Nicolas G.; McKenzie, Lara B.			Pediatric and Adolescent Sledding-Related Injuries Treated in US Emergency Departments in 1997-2007	PEDIATRICS			English	Article						National Electronic Injury Surveillance System; injury; sledding; emergency department; traumatic brain injury	TRAUMATIC BRAIN-INJURY; UNITED-STATES; CHILDREN	OBJECTIVES: The objectives were to examine comprehensively the patterns and to estimate the rates of sledding-related injuries among children and adolescents treated in US emergency departments between 1997 and 2007. METHODS: Through the use of the National Electronic Injury Surveillance System database, cases of sledding-related injuries were selected by using diagnosis codes for sleds. Sample weights were used to calculate national estimates. US Census Bureau data were used to calculate injury rates per 100 000 individuals <= 19 years of age. Computation of odds ratios with 95% confidence intervals was performed. RESULTS: From 1997 through 2007 an estimated 229 023 patients <= 19 years of age were treated for sledding-related injuries in US emergency departments, with an average of 20 820 cases per year. Children 10 to 14 years of age sustained 42.5% of sledding-related injuries, and boys represented 59.8% of all cases. The most frequent injury diagnoses were fractures (26.3%), followed by contusions and abrasions (25.0%). The head was the most commonly injured body part (34.1%), and injuries to the head were twice as likely to occur during collisions as through other mechanisms. Traumatic brain injuries were more likely to occur with snow tubes than with other sled types. A total of 4.1% of all cases required hospitalization. CONCLUSIONS: More research on the prevention of sledding-related injuries is warranted, particularly regarding the impact of helmets in reducing injury rates. The use of sledding products that may reduce visibility (such as snow tubes) should be discouraged. Pediatrics 2010; 126: 517-524	[Howell, Candace A.; Nelson, Nicolas G.; McKenzie, Lara B.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [McKenzie, Lara B.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	lara.mckenzie@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			Barton BK, 2007, J PEDIATR PSYCHOL, V32, P517, DOI 10.1093/jpepsy/jsm014; Bernardo L M, 1998, J Trauma Nurs, V5, P34; *CONS PROD SAF COM, 2000, NAT EL INJ SURV SYST; *CONS PROD SAF COM, 2007, NAT EL INJ SURV SYST; *CONS PROD SAF COM, 1999, SKI HELM EV POT RED; DERSHEWITZ R, 1990, AM J DIS CHILD, V144, P1071; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; Landsman I S, 1987, Pediatr Emerg Care, V3, P277, DOI 10.1097/00006565-198712000-00015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee F, 1999, Inj Prev, V5, P198; LEWIS LM, 1994, SOUTHERN MED J, V87, P174, DOI 10.1097/00007611-199402000-00004; Major CP, 1999, SOUTHERN MED J, V92, P193, DOI 10.1097/00007611-199902000-00006; MANARY MJ, 1993, PEDIATR EMERG CARE, V9, P155, DOI 10.1097/00006565-199306000-00011; Noffsinger Dana, 2008, J Trauma Nurs, V15, P58, DOI 10.1097/01.JTN.0000327328.60405.f9; OBRIEN K, 2009, BOSTON GLOBE    0309; Ortega HW, 2005, PEDIATR EMERG CARE, V21, P839, DOI 10.1097/01.pec.0000190233.27857.6a; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schroeder T., 2001, NEISS SAMPLE DESIGN; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; SHUGERMAN RP, 1992, PEDIATR EMERG CARE, V8, P283, DOI 10.1097/00006565-199210000-00009; Skarbek-Borowska S, 2006, ACAD EMERG MED, V13, P181, DOI [10.1111/j.1553-2712.2006.tb01669.x, 10.1197/j.aem.2005.09.009]; *SLEDS COM, HIST SLEDS TOB; *US BUR CENS, INT EST US POP AG SE; *US BUR CENS, NAT POP EST 2000S; Voaklander DC, 2001, ACAD EMERG MED, V8, P629, DOI 10.1111/j.1553-2712.2001.tb00176.x; Wagner Christopher, 2005, Air Med J, V24, P10, DOI 10.1016/j.amj.2004.10.007; Whitebread D, 2000, BRIT J EDUC PSYCHOL, V70, P539, DOI 10.1348/000709900158290; WYNNE AD, 1994, J TRAUMA, V37, P820, DOI 10.1097/00005373-199411000-00019; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	29	11	11	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2010	126	3					517	524		10.1542/peds.2009-1499			8	Pediatrics	Pediatrics	646JK	WOS:000281535700014	20732939				2021-06-18	
J	Noonan, VK; Kopec, JA; Noreau, L; Singer, J; Masse, LC; Zhang, HB; Dvorak, MF				Noonan, Vanessa K.; Kopec, Jacek A.; Noreau, Luc; Singer, Joel; Masse, Louise C.; Zhang, Hongbin; Dvorak, Marcel F.			COMPARING THE VALIDITY OF FIVE PARTICIPATION INSTRUMENTS IN PERSONS WITH SPINAL CONDITIONS	JOURNAL OF REHABILITATION MEDICINE			English	Article						consumer participation; World Health Organization; rehabilitation; questionnaires; disability evaluation	TRAUMATIC BRAIN-INJURY; CORD-INJURY; DISABILITY; QUALITY; IMPACT; RELIABILITY; VALIDATION; AUTONOMY; CRITERIA; INDEX	Objective: To evaluate and compare the construct validity of 5 participation instruments developed using the International Classification of Functioning, Disability and Health (ICF). Methods: A total of 545 subjects diagnosed and treated for a spinal condition at an acute hospital were followed-up and consented to complete a questionnaire. Subjects completed 5 participation instruments (Impact on Participation and Autonomy (IPA), Keele Assessment of,Participation (KAP), Participation Measure-Post Acute Care (PM-PAC), Participation Objective Participation Subjective (POPS), World Health Organization Disability Assessment Schedule II (WHODAS II)). In addition, each subject completed a health status instrument and a quality of life instrument. The dimensionality, convergent/discriminant validity and known-group validity of the participation instruments were assessed. Results: A confirmatory factor analysis of the facture structure for the IPA and PM-PAC demonstrated adequate model fit. For convergent/discriminant validity, correlations were generally higher among similar domains of the WHODAS II, IPA, KAP and PM-PAC, and as expected the lowest correlations were observed with the objective domains of the POPS. Most instruments demonstrated known-group validity. Conclusion: Differences in the construct validity evidence of the POPS compared with the other 4 instruments were noted. To date, there is no gold standard for measuring participation, and clinicians and researchers should consider the type of information required prior to selecting an instrument.	[Noonan, Vanessa K.; Zhang, Hongbin; Dvorak, Marcel F.] Univ British Columbia, Dept Orthopaed, Div Spine, Vancouver, BC V5Z 1M9, Canada; [Noonan, Vanessa K.; Kopec, Jacek A.; Singer, Joel] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Kopec, Jacek A.] Arthrit Res Ctr Canada, Vancouver, BC, Canada; [Noreau, Luc] Univ Laval, Rehabil Dept, Quebec City, PQ, Canada; [Noreau, Luc] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Singer, Joel] Univ British Columbia, Canadian HIV Trials Network, Vancouver, BC V5Z 1M9, Canada; [Masse, Louise C.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	Noonan, VK (corresponding author), Univ British Columbia, Dept Orthopaed, Div Spine, Vancouver, BC V5Z 1M9, Canada.	Vanessa.Noonan@vch.ca		Masse, Louise/0000-0003-2483-8791	Paetzold Chair in Spinal Cord Injury Clinical Research; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	We would like to thank the staff at the Vancouver Spine Research Office for their assistance with this study. Also, we would like to acknowledge the funding we received from the Paetzold Chair in Spinal Cord Injury Clinical Research. VKN's research is supported by a Fellowship from the Canadian Institutes of Health Research.	Aaronson N, 2002, QUAL LIFE RES, V11, P193; Anderson KD, 2007, SPINAL CORD, V45, P328, DOI 10.1038/sj.sc.3101977; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Brown T.A, 2006, CONFIRMATORY FACTOR, V3rd; Browne M.W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cardol M, 2001, ARCH PHYS MED REHAB, V82, P210, DOI 10.1053/apmr.2001.18218; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fayers P, 2000, QUALITY LIFE ASSESSM; FEINSTEIN AR, 1987, J CHRON DIS, V40, P635, DOI 10.1016/0021-9681(87)90027-0; FERRANS CE, 1985, ADV NURS SCI, V8, P15, DOI 10.1097/00012272-198510000-00005; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Gandek B, 2007, AM J PHYS MED REHAB, V86, P57, DOI 10.1097/01.PHM.0000233200.43822.21; Hoenig H, 1999, SPINE, V24, P539, DOI 10.1097/00007632-199903150-00007; Hoenig H, 1998, ARCH PHYS MED REHAB, V79, P378, DOI 10.1016/S0003-9993(98)90137-X; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joreskog KG., 1993, SAGE FOCUS EDITIONS, V154, P294; Marino RJ., 2003, J SPINAL CORD MED, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x; Noonan VK, 2010, J REHABIL MED, V42, P735, DOI 10.2340/16501977-0583; Noonan VK, 2009, DISABIL REHABIL, V31, P1883, DOI 10.1080/09638280902846947; Rochette A, 2006, DISABIL REHABIL, V28, P1231, DOI 10.1080/09638280600554827; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Sibley A, 2006, CLIN REHABIL, V20, P793, DOI 10.1177/0269215506070808; Statistics Canada, 2007, 2006 CENS DICT; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; *WHO, WHODAS 2; Wilkie R, 2005, QUAL LIFE RES, V14, P1889, DOI 10.1007/s11136-005-4325-2; World Health Organization, 2001, INT CLASS FUNCT DIS	35	11	11	0	10	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2010	42	8					724	734		10.2340/16501977-0584			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	651KQ	WOS:000281927000005	20809054	DOAJ Gold, Green Published			2021-06-18	
J	Hilbert, P; Lefering, R; Stuttmann, R				Hilbert, P.; Lefering, R.; Stuttmann, R.			Different case fatality rates at German trauma centres	ANAESTHESIST			German	Article						Multiple trauma; Revised injury severity classification; Case fatality rate; Standardized mortality ratio; Injury severity score	EMERGENCY-ROOM MANAGEMENT; COMPUTED-TOMOGRAPHY; INJURED PATIENTS; MULTIPLE TRAUMA; RESUSCITATION; ALGORITHM	The level of trauma care in Germany belongs to one of the best worldwide. Nevertheless, previous studies have shown significant differences in the case fatality rates of multiple trauma patients in German trauma centres. The objective of this study was to indentify the reasons for the different outcomes based on data of the trauma registry of the German Society of Orthopaedic Surgery and Traumatology. Due to the inadequacy of comparing only the case fataltiy rates in the different trauma centres, the data recorded in the trauma registry were analyzed in a retrospective, multicentre study to calculate the probability of survival, revised injury severity classification (RISC) and, additionally, the standardized mortality ratio (SMR) for ranking of the participating trauma centres. As a criterion for inclusion in the study, a minimum of 100 trauma patients admitted directly from the scene within a 4 year period was set. The ranking was carried out using the SMR (observed mortality divided by probability of survival). With the help of data from the trauma registry an attempt was made to find the differences in trauma management between the top 10 centres (lowest SMR), the 10 middle and the last 10 centres (highest SMR) in the ranking. The data of 6,522 patients were included in the study. There were significant differences in the pre-hospital time, the time spent in the emergency room (ER) and time until a CT scan had been performed. Pre-hospital time was longer in patients admitted to the top centres, whereas time in the ER was longer in the last centres of the ranking. Comparing the sum of pre-hospital time and time in the ER, there were no differences between the top and the last centres. At the scene of accident overall intubation rate and intubation rate in patients with traumatic brain injury were higher in patients admitted to the top centres. Regarding the transport modality, significantly more patients were transported by helicopter in the group of the top centres. In top centres CT scans, in particular whole-body CTs, were initiated sooner and used much more frequently so that the rate of missed injuries was much lower. The amount of fluid given at the scene of accident did not differ between the centres but the amount of fluid given in ER and the operating room until admission to the intensive care unit was significantly higher in the top centres. There are significant differences in the pre-hospital and clinical care of patients admitted to German trauma centres. Under clinical conditions a tight time management, an immediate and complete diagnostic approach, particularly by means of whole-body CT and a liberal fluid resuscitation seem to be favorable factors.	[Hilbert, P.; Stuttmann, R.] BG Kliniken Bergmannstrost, Klin Anaesthesiol Intens & Notfallmed, D-06112 Halle, Saale, Germany; [Lefering, R.] Univ Witten Herdecke, IFOM, Cologne, Germany	Hilbert, P (corresponding author), BG Kliniken Bergmannstrost, Klin Anaesthesiol Intens & Notfallmed, Merseburgerstr 165, D-06112 Halle, Saale, Germany.	Peter.Hilbert@bergmannstrost.com		Hilbert-Carius, Peter/0000-0002-4704-2377			Bogner V, 2009, UNFALLCHIRURG, V112, P838, DOI 10.1007/s00113-009-1606-1; Boldt J, 2004, CAN J ANAESTH, V51, P500, DOI 10.1007/BF03018316; Chiara O, 2008, MINERVA ANESTESIOL, V74, P303; COWLEY RA, 1976, CLIN MED/US, V83, P16; Exadaktylos AK, 2008, INJURY, V39, P525, DOI 10.1016/j.injury.2007.10.019; Hilbert P, 2007, INJURY, V38, P552, DOI 10.1016/j.injury.2006.12.023; Hilbert P, 2005, ANASTH INTENSIV NOTF, V40, P720, DOI 10.1055/s-2005-921036; Hoffstetter P, 2008, ROFO-FORTSCHR RONTG, V180, P120, DOI 10.1055/s-2007-963594; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Kanz KG, 2004, UNFALLCHIRURG, V107, P937, DOI 10.1007/s00113-004-0845-4; Maury P, 2007, EUROPACE, V9, P212, DOI 10.1093/europace/eum016; Nast-Kolb D, 2005, UNFALLCHIRURG, V108, P804, DOI 10.1007/s00113-005-1004-2; Nast-Kolb D, 2005, UNFALLCHIRURG, V108, P792, DOI 10.1007/s00113-005-1022-0	13	11	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-2417			ANAESTHESIST	Anaesthesist	AUG	2010	59	8					700	+		10.1007/s00101-010-1742-6			7	Anesthesiology	Anesthesiology	640HI	WOS:000281040100003	20532470				2021-06-18	
J	Forbes, JA; Reig, AS; Tomycz, LD; Tulipan, N				Forbes, Jonathan A.; Reig, Adam S.; Tomycz, Luke D.; Tulipan, Noel			Intracranial hypertension caused by a depressed skull fracture resulting in superior sagittal sinus thrombosis in a pediatric patient: treatment with ventriculoperitoneal shunt insertion Case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						sagittal sinus thrombosis; depressed skull fracture; ventriculoperitoneal shunt	OF-THE-LITERATURE; CRANIAL FRACTURE; VENOUS SINUS; OCCLUSION; PRESSURE; STENOSIS; INJURY	Object. Intracranial hypertension resulting from compression of the superior sagittal sinus (SSS) by an overlying depressed calvarial fracture is a rare condition. Primary surgical treatment for the symptomatic patient in this setting traditionally involves elevation of the fracture, which often carries significant associated morbidity. Methods. The authors report a case involving a 6-year-old boy who suffered a closed, depressed, parietooccipital fracture as the result of an unhelmeted all-terrain vehicle accident. This fracture caused compression and subsequent thrombosis of the SSS, which resulted in CSF malabsorption and progressive intracranial hypertension. Initially headache free following the injury, he had developed severe and unremitting headaches by postinjury Day 7. A CT angiography study of the head obtained at this time exhibited thrombosis of the SSS underlying the depressed calvarial fracture. Subsequent lumbar puncture demonstrated markedly elevated intrathecal pressures. Large volumes of CSF were removed, with temporary improvement in symptoms. After medical management with anticoagulation failed, the decision was made to proceed with image-guided ventriculoperitoneal shunt insertion. Results. The patient's headaches resolved immediately following the procedure, and anticoagulation therapy was reinstituted. Follow-up images obtained 4 months after the injury demonstrated evidence of resolution of the depressed fracture, with recanalization of the SSS. The anticoagulation therapy was then discontinued. To the authors' knowledge, this report is the first description of ventriculoperitoneal shunt insertion as the primary treatment of this infrequent condition. Conclusions. This report demonstrates that select patients with this presentation can undergo CSF diversion in lieu of elevation of the depressed skull fracture a surgical procedure shown to be associated with increased risks when the depressed fracture overlies the posterior SSS. The literature on this topic is reviewed and management of this condition is discussed. (DOI: 10.3171/2010.3.PEDS09441)	[Forbes, Jonathan A.; Reig, Adam S.; Tomycz, Luke D.; Tulipan, Noel] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37232 USA	Tulipan, N (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, 9226 Doctors Off Tower, Nashville, TN 37232 USA.	noel.tulipan@vanderbilt.edu					Binder DK, 2004, NEUROSURGERY, V55, P986, DOI 10.1227/01.NEU.0000137329.13981.01; Bishop FS, 2009, J NEUROSURG, V111, P17, DOI 10.3171/2009.2.JNS08491; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Donovan DJ, 2005, SURG NEUROL, V63, P380, DOI 10.1016/j.surneu.2004.06.020; Drake JM, 2009, CHILD NERV SYST, V25, P467, DOI 10.1007/s00381-008-0761-y; DUPLESSIS JJ, 1993, J TRAUMA, V34, P290, DOI 10.1097/00005373-199302000-00021; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MEIER U, 1992, ACTA NEUROCHIR, V119, P91, DOI 10.1007/BF01541788; Meltzer H, 2000, J TRAUMA, V49, P981, DOI 10.1097/00005373-200011000-00035; Ozer FD, 2005, J EMERG MED, V29, P137, DOI 10.1016/j.jemermed.2005.03.006; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Uzan M, 1998, J NEUROSURG, V88, P598, DOI 10.3171/jns.1998.88.3.0598; vandenBrink WA, 1996, NEUROSURGERY, V38, P1044, DOI 10.1097/00006123-199605000-00039; Vender JR, 2005, J NEUROSURG, V103, P458, DOI 10.3171/ped.2005.103.5.0458; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849	16	11	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2010	6	1					23	28		10.3171/2010.3.PEDS09441			6	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	615BV	WOS:000279107100004	20593983				2021-06-18	
J	Xin, ZL; Wu, XK; Xu, JR; Li, X				Xin, Zhao-liang; Wu, Xiao-kang; Xu, Jian-rong; Li, Xi			Arachnoid cell involvement in the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage	JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B			English	Article						Arachnoid cells; Cell culture; Human leukocyte antigen-DR (HLA-DR); Soluble interleukin-2 receptor (sIL-2r)	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; DENDRITIC CELLS; MONOCLONAL-ANTIBODY; CHOROID-PLEXUS; TISSUE FACTOR; MACROPHAGES; ARTERY; MODEL	To assess if arachnoid cells have the capability to present antigen and activate T-lymphocytes after stimulation by bloody cerebrospinal fluid (CSF), and to illuminate the mechanism of coagulation-initiated inflammation in the subarachnoid space after subarachnoid hemorrhage (SAH). Arachnoid cells were cultured, characterized, and examined by immunofluorescence for the basal expression of human leukocyte antigen-DR (HLA-DR). Expression of HLA-DR, after co-culturing arachnoid cells in vitro with bloody CSF, was investigated by immunofluorescence and flow cytometry (FCM). The variation of arachnoid cells' ultrastructure was observed by transmission electron microscope (TEM). Arachnoid cells were co-cultured with peripheral blood mononuclear cells (PBMCs). The content of soluble interleukin-2 receptor (sIL-2r) in culture medium was detected by enzyme-linked immunosorbent assay (ELISA). (1) Arachnoid cells were successfully cultured for many passages. The immunofluorescent staining was positive for HLA-DR in over 95% of the human arachnoid cells. The punctate HLA-DR was distributed in cytoplasm and not in the karyon. (2) After co-culturing arachnoid cells in vitro with bloody CSF, numerous particles with strong fluorescence appeared in the cytoplasm on Day 6. On Day 8, the quantity of particles and fluorescent intensity were maximal. FCM showed that the percentage of HLA-DR expressing cells was (2.5 +/- 0.4)% at the first 5 d, increasing to (60.8 +/- 3.6)% on Day 7. (3) After co-culturing arachnoid cells in vitro with bloody CSF, many lysosome and secondary lysosome particles were present in the cytoplasm. Hyperplasia of rough endoplasmic reticulum and enlarged cysts were observed, with numerous phagocytizing vesicles also observed at the edge of the arachnoid cells. (4) Arachnoid cells stimulated by bloody CSF were co-cultured in vitro with PBMCs. The content of sIL-2r in the culture medium, having been maintained at around 1.30 ng/ml during the first 3 d, had increased by Day 4. The content of sIL-2r peaked 7.53 ng/ml on Day 7 and then reduced gradually. (1) Basic HLA-DR expression is present in arachnoid cells. (2) After stimulation by bloody CSF, arachnoid cells have the potential to serve as antigen presenting cells (APCs) and the ability to activate T-lymphocytes, indicating that arachnoid cells are involved in the mechanism of coagulation-initiated inflammation in the subarachnoid space after SAH.	[Xin, Zhao-liang; Li, Xi] Zhejiang Med Coll, Dept Neurosurg, Hangzhou 310053, Zhejiang, Peoples R China; [Wu, Xiao-kang] Shanghai Tenth Peoples Hosp, Dept Neurosurg, Shanghai 200072, Peoples R China; [Xu, Jian-rong] Yiwu Cent Hosp, Dept Neurosurg, Yiwu 322000, Peoples R China	Xin, ZL (corresponding author), Zhejiang Med Coll, Dept Neurosurg, Hangzhou 310053, Zhejiang, Peoples R China.	wxk555@sohu.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30370497]; Science and Technology Research Program of Zhejiang Province, China [2007-C-33039]	Project supported by the National Natural Science Foundation of China (No. 30370497) and the Science and Technology Research Program of Zhejiang Province, China (No. 2007-C-33039)	Ahn YM, 2002, NEUROSURGERY, V50, P843, DOI 10.1097/00006123-200204000-00029; AKOPOV SE, 1992, EXPERIENTIA, V48, P34, DOI 10.1007/BF01923601; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Aydin MD, 2005, INT J NEUROSCI, V115, P1595, DOI 10.1080/00207450590958079; Bernstein JJ, 1996, INT J DEV NEUROSCI, V14, P681, DOI 10.1016/0736-5748(95)00096-8; Chrapusta SJ, 2000, SCAND J IMMUNOL, V51, P400; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Clatterbuck RE, 2002, J NEUROSURG, V97, P676, DOI 10.3171/jns.2002.97.3.0676; Cunningham MA, 1999, BLOOD, V94, P3413, DOI 10.1182/blood.V94.10.3413.422k24_3413_3420; Eddleman CS, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2008.11.FOCUS08278; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; FRANK E, 1995, SPINE, V20, P2093, DOI 10.1097/00007632-199510000-00004; FRANK EH, 1983, EXP CELL RES, V146, P371, DOI 10.1016/0014-4827(83)90138-6; Gomis P, 2005, J NEUROSURG, V102, P715, DOI 10.3171/jns.2005.102.4.0715; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; Hendryk S, 2004, NEUROENDOCRINOL LETT, V25, P141; Iuliano BA, 2004, J NEUROSURG, V100, P287, DOI 10.3171/jns.2004.100.2.0287; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; Jin HL, 2006, INT IMMUNOL, V18, P565, DOI 10.1093/intimm/dxh398; Kim KY, 2002, NEUROREPORT, V13, P849, DOI 10.1097/00001756-200205070-00022; KUBOTA T, 1993, STROKE, V24, P1993, DOI 10.1161/01.STR.24.12.1993; Kwon KY, 2001, J KOREAN MED SCI, V16, P774, DOI 10.3346/jkms.2001.16.6.774; Lan W, 2005, ANESTH ANALG, V100, P409, DOI 10.1213/01.ANE.0000142113.39092.87; Massicotte EM, 1999, J NEUROSURG, V91, P80, DOI 10.3171/jns.1999.91.1.0080; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Mathiesen T, 1996, BRIT J NEUROSURG, V10, P89, DOI 10.1080/02688699650040584; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; McMenamin PG, 2003, CELL TISSUE RES, V313, P259, DOI 10.1007/s00441-003-0779-0; MOTOHASHI O, 1995, NEUROSCI LETT, V190, P105, DOI 10.1016/0304-3940(95)11513-V; MOTOHASHI O, 1995, ACTA NEUROCHIR, V136, P88, DOI 10.1007/BF01411441; MURPHY M, 1991, J NEUROSCI RES, V30, P475, DOI 10.1002/jnr.490300304; Muth H, 2005, THROMB HAEMOSTASIS, V94, P1028, DOI 10.1160/TH05-01-0002; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Ogihara K, 2001, BRAIN RES, V889, P89, DOI 10.1016/S0006-8993(00)03120-6; Pradilla G, 2004, J NEUROSURG, V101, P88, DOI 10.3171/jns.2004.101.1.0088; Prignano F, 1998, INT J DERMATOL, V37, P116, DOI 10.1046/j.1365-4362.1998.00116.x; Raymackers J, 2000, ELECTROPHORESIS, V21, P2266, DOI 10.1002/1522-2683(20000601)21:11<2266::AID-ELPS2266>3.0.CO;2-Z; Recinos PF, 2006, SURG NEUROL, V66, P463, DOI 10.1016/j.surneu.2006.04.010; Sanchez CM, 2004, NEUROLOGIA, V19, P44; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Todo K, 2008, STROKE, V39, P1875, DOI 10.1161/STROKEAHA.107.503433; Wada Hiromi, 2002, J Atheroscler Thromb, V9, P224; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Zubkov AY, 2002, NEUROSCI LETT, V326, P137, DOI 10.1016/S0304-3940(02)00188-X	45	11	12	0	6	ZHEJIANG UNIV	HANGZHOU	EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA	1673-1581	1862-1783		J ZHEJIANG UNIV-SC B	J. Zhejiang Univ.-SCI. B	JUL	2010	11	7					516	523		10.1631/jzus.B1000099			8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Research & Experimental Medicine	620NB	WOS:000279505500007	20593517	Green Published			2021-06-18	
J	Conner, KA; Williams, LE; McKenzie, LB; Shields, BJ; Fernandez, SA; Smith, GA				Conner, Kristen A.; Williams, Lindsay E.; McKenzie, Lara B.; Shields, Brenda J.; Fernandez, Soledad A.; Smith, Gary A.			Pediatric Pedestrian Injuries and Associated Hospital Resource Utilization in the United States, 2003	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Pedestrian; Injuries; Hospital charges; Length of stay; Pediatrics	POSTTRAUMATIC-STRESS-DISORDER; TRAFFIC ACCIDENTS; CHILDREN; PREVENTION; AGE; EPIDEMIOLOGY; VEHICLES; PATTERNS; TRAUMA; RISK	Background: The objective was to calculate national estimates of pedestrian-related hospitalizations and associated use of healthcare resources among children <= 19 years of age and to explore the effects of sociodemographic, hospital-related factors, and injury severity on total charges and lengths of stay (LOS) in the United States. Methods: Data from the 2003 Healthcare Cost and Utilization Project Kids' Inpatient Database were used. The sample included patients <= 19 years hospitalized with pedestrian-related injuries, from 3,438 hospitals in 36 states. National estimates of pedestrian-associated hospitalizations, rates, resource use, injury severity, and demographics were calculated. Potentially significant covariate associations were studied using hospital charges and LOS. Results: In 2003, 9,172 pedestrian-associated hospitalizations occurred among children <= 19 years in the United States, resulting in $290.8 million (standard deviation [SD] = $23.6 million) in inpatient charges and 44,895 (SD = 2,964) days of hospitalization. Mean (SD) hospital charges and LOS were $32,059 ($74,778) days and 4.9 (10.9) days, respectively. Thirty-six percent of patients suffered a traumatic brain injury, and 21% sustained severe injury with an injury severity scale score >= 16. A traffic-related event was the cause of 92.7% of hospitalizations. Older age, higher injury severity, urban and Western hospital location, children's hospital type, and longer LOS were significantly associated with higher total hospital charges. Older age and higher injury severity were significantly associated with longer LOS. Conclusion: Pediatric pedestrian injuries contribute substantially to the healthcare resource burden in the United States, accounting for similar to 45,000 days of hospitalization and >$290 million in inpatient charges annually.	[Conner, Kristen A.; Williams, Lindsay E.; McKenzie, Lara B.; Shields, Brenda J.; Smith, Gary A.] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Williams, Lindsay E.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Fernandez, Soledad A.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA	Smith, GA (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	McKenzie, Lara/C-5122-2012	McKenzie, Lara/0000-0003-2889-0001			AGRAN P, 1991, PEDIATRICS, V87, P70; Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; BRISON RJ, 1988, AM J PUBLIC HEALTH, V78, P793, DOI 10.2105/AJPH.78.7.793; Calhoun AD, 1998, ACAD EMERG MED, V5, P685, DOI 10.1111/j.1553-2712.1998.tb02486.x; *CDCP, UN PED NONF INJ RAT; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P144; Centers for Disease Control and Prevention NCfIPaC, 2005, WEB BAS INJ STAT QUE; Chakravarthy B, 2007, PEDIATR EMERG CARE, V23, P738, DOI 10.1097/PEC.0b013e318156acea; Crandall JR, 2002, BRIT MED J, V324, P1145, DOI 10.1136/bmj.324.7346.1145; de Vries APJ, 1999, PEDIATRICS, V104, P1293, DOI 10.1542/peds.104.6.1293; Demetriades D, 2004, J AM COLL SURGEONS, V199, P382, DOI 10.1016/j.jamcollsurg.2004.03.027; DERLET R W, 1989, Journal of Emergency Medicine, V7, P5; Di Scala C, 2001, Annu Proc Assoc Adv Automot Med, V45, P241; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; DiMaggio C, 2002, ACAD EMERG MED, V9, P54; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; Elvik R, 2001, ACCIDENT ANAL PREV, V33, P327, DOI 10.1016/S0001-4575(00)00046-4; GARDNER R, 2007, ARCH PEDIAT ADOLESC, V161, P1; *HEALTHC COST UT P, 2003, DESCR DAT EL KIDS IN; Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality, 2003, HEALTHC COST UT PROJ; Henary Basem Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P105; Ivarsson B Johan, 2006, Traffic Inj Prev, V7, P290, DOI 10.1080/15389580600652283; *J HOPK U TRI AN I, 2002, ICDMAP90 J HOPK U TR; JOLY MF, 1991, SOC SCI MED, V33, P765, DOI 10.1016/0277-9536(91)90375-M; KING WD, 1992, PEDIATR EMERG CARE, V8, P221, DOI 10.1097/00006565-199208000-00013; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; MACKAY M, 1994, INJURY, V25, P615, DOI 10.1016/0020-1383(94)90037-X; MALEK M, 1990, ACCIDENT ANAL PREV, V22, P301, DOI 10.1016/0001-4575(90)90046-N; Miller Ted R, 2004, Annu Proc Assoc Adv Automot Med, V48, P265; Nadler EP, 2001, PEDIATRICS, V108, P326, DOI 10.1542/peds.108.2.326; Nance ML, 2004, PEDIATR EMERG CARE, V20, P569, DOI 10.1097/01.pec.0000139736.00850.da; *NAT ASS CHILDR HO, MEMBERSH CRIT; *NAT CTR INJ PREV, 2002, CDC INJ RES AG; *NAT HIGHW TRAFF A, 2006, 801818 DOT HS NAT HI; Posner JC, 2002, INJURY PREV, V8, P231, DOI 10.1136/ip.8.3.231; RIVARA FP, 1985, PEDIATRICS, V76, P375; RIVARA FP, 1990, AM J DIS CHILD, V144, P692, DOI 10.1001/archpedi.1990.02150300090023; RIVARA FP, 1991, PEDIATRICS, V88, P770; *SAS I INC, 2004, SAS SYST WIND COMP P; Silen ML, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e7; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; *STATACORP LP, 2003, STAT STAT SOFTW COMP; Turner Cathy, 2004, Inj Control Saf Promot, V11, P231, DOI 10.1080/156609704/233/289751; *US BUR CENS, 2000 CENS TOT POP SE; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Wazana A, 1997, Inj Prev, V3, P295, DOI 10.1136/ip.3.4.295; WINN DG, 1991, PEDIATRICS, V88, P776; RECOMMENDED FRAMEWOR; BEST PRACTICES SKILL	51	11	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2010	68	6					1406	1412		10.1097/TA.0b013e3181b28b05			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	610ES	WOS:000278714600026	20093987				2021-06-18	
J	McCauley, SR; Wilde, EA; Kelly, TM; Weyand, AM; Yallampalli, R; Waldron, EJ; Pedroza, C; Schnelle, KP; Boake, C; Levin, HS; Moretti, P				McCauley, Stephen R.; Wilde, Elisabeth A.; Kelly, Tara M.; Weyand, Annie M.; Yallampalli, Ragini; Waldron, Eric J.; Pedroza, Claudia; Schnelle, Kathleen P.; Boake, Corwin; Levin, Harvey S.; Moretti, Paolo			The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): II. Reliability and Convergent Validity	JOURNAL OF NEUROTRAUMA			English	Article						convergent validity; Neurological Outcome Scale for Traumatic Brain Injury; outcome; reliability; traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; DISABILITY RATING-SCALE; NIH STROKE SCALE; CLOSED-HEAD INJURY; INTERRATER RELIABILITY; RECOVERY; PREDICTOR	A standardized measure of neurological dysfunction specifically designed for TBI currently does not exist and the lack of assessment of this domain represents a substantial gap. To address this, the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) was developed for TBI outcomes research through the addition to and modification of items specifically relevant to patients with TBI, based on the National Institutes of Health Stroke Scale. In a sample of 50 participants (mean age = 33.3 years, SD = 12.9) <= 18 months (mean = 3.1, SD = 3.2) following moderate (n = 8) to severe (n = 42) TBI, internal consistency of the NOS-TBI was high (Cronbach's alpha = 0.942). Test-retest reliability also was high (rho = 0.97, p < 0.0001), and individual item kappas between independent raters were excellent, ranging from 0.83 to 1.0. Overall inter-rater agreement between independent raters (Kendall's coefficient of concordance) for the NOS-TBI total score was excellent (W = 0.995). Convergent validity was demonstrated through significant Spearman rank-order correlations between the NOS-TBI and the concurrently administered Disability Rating Scale (rho = 0.75, p < 0.0001), Rancho Los Amigos Scale (rho = -0.60, p < 0.0001), Supervision Rating Scale (rho = 0.59, p < 0.0001), and the FIM (TM) (rho = -0.68, p < 0.0001). These results suggest that the NOS-TBI is a reliable and valid measure of neurological functioning in patients with moderate to severe TBI.	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Kelly, Tara M.; Schnelle, Kathleen P.; Boake, Corwin; Levin, Harvey S.] Univ Texas Houston Med Sch, Houston, TX USA; [Wilde, Elisabeth A.; Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Yallampalli, Ragini; Waldron, Eric J.] Univ Houston Univ Pk, Houston, TX USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Moretti, Paolo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Institutes of Health/National Institute of Neurological Disease and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 43353]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	We would like to extend our gratitude to the participants and their families, whose cooperation and patience helped make this study possible. This study was supported in part by grant NS 43353 from the National Institutes of Health/National Institute of Neurological Disease and Stroke, to Guy L. Clifton, Principal Investigator. The information in this article and the article itself has never previously been published either electronically or in print. None of the authors have any financial or other relationships that could be construed as a conflict of interest with respect to the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	American Educational Research Association American Psychological Association National Council of Measurement in Education Joint Committee on Standards for Educational Psychological Testing (US), 1999, STAND ED PSYCH TEST; Anastasi A, 1997, PSYCHOL TESTING, V7th; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hagen C, 1979, REHABILITATION HEAD; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Josephson SA, 2006, CEREBROVASC DIS, V22, P389, DOI 10.1159/000094857; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kendall M. G., 1962, RANK CORRELATION MET; LANDIS JR, 1977, BIOMETRICS, V33, P174; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Powers D W, 2001, Emerg Med Serv, V30, P52; PULLICINO P, 1992, STROKE, V23, P919, DOI 10.1161/str.23.6.919a; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RASCH G, 1966, BRIT J MATH STAT PSY, V19, P49, DOI 10.1111/j.2044-8317.1966.tb00354.x; *SAS I INC, 2008, STAT AN SOFTW WIND; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; Spilker J, 1997, J Neurosci Nurs, V29, P384; Sun TK, 2006, INT J NURS STUD, V43, P457, DOI 10.1016/j.ijnurstu.2005.07.004; TEASDALE G, 1974, LANCET, V2, P81; von Eye A., 2005, ANAL RATER AGREEMENT; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilde EA, 2010, J NEUROTRAUM, V27, P983, DOI 10.1089/neu.2009.1194; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wright B.D., 1982, RATING SCALE ANAL	37	11	11	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					991	997		10.1089/neu.2009.1195			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300003	20210595	Green Published			2021-06-18	
J	Olson, DM; Bader, MK; Dennis, C; Mahanes, D; Riemen, K				Olson, DaiWai M.; Bader, Mary Kay; Dennis, Christina; Mahanes, Dea; Riemen, Kristina			Multicenter Pilot Study: Safety of Automated Chest Percussion in Patients at Risk for Intracranial Hypertension	JOURNAL OF NEUROSCIENCE NURSING			English	Article							TRAUMATIC BRAIN-INJURY; PRESSURE; MANAGEMENT; PREVENTION	In the critical care setting, the focus of care during the first few weeks following acute brain injury is prevention of secondary brain injury by optimizing cerebral perfusion. Ensuring adequate oxygenation and perfusion of cerebral tissues requires attention to all of the body systems. Chest percussion therapy (CPT) promotes pulmonary hygiene and optimizes gas exchange by opening the alveoli. However, many patients with brain injury have intracranial pressure (ICP) monitoring, and conventional wisdom supports limiting activities such as CPT that may stimulate the patient and increase ICP. The purpose of this study was to explore the effects of CPT on ICP. Thirty participants were enrolled over a 6-month period. Data were collected at 1-minute intervals for 1 hour. Each patient was randomized to receive automated CPT (using specialty beds) for 10 minutes, starting at 10, 20, 30, or 40 minutes into the hour. There were no differences in mean ICP values before, during, or after CPT. This study provides evidence that it is safe to perform CPT in patients with ICP monitoring in situ.	[Olson, DaiWai M.; Riemen, Kristina] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Bader, Mary Kay] Mission Hosp, Mission Viejo, CA USA; [Dennis, Christina] WakeMed Hlth & Hosp, Raleigh, NC USA; [Mahanes, Dea] Univ Virginia Hlth Syst, Charlottesville, VA USA	Olson, DM (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.	Olson006@mc.duke.edu		Olson, DaiWai/0000-0002-9280-078X			AANN, 2004, AANN COR CURR NEUR N; Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Bader MK, 2003, CRIT CARE NURSE, V23, P40; Bader MK, 2003, CRIT CARE NURSE, V23, P29; *BRAIN INJ ASS AM, 2005, BRAIN INJ; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Branson RD, 2007, RESP CARE, V52, P1328; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS; *CDC, 2009, CTR DIS CONTR PREV F; Dennis L J, 2001, Neurol India, V49 Suppl 1, pS37; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Grap Mary Jo, 2004, Crit Care Nurs Clin North Am, V16, P349, DOI 10.1016/j.ccell.2004.03.005; Greenberg MS, 2001, HDB NEUROSURGERY; HAMMON WE, 1993, CHEST, V103, P1409, DOI 10.1378/chest.103.5.1409; Hess D R, 2001, Respir Care, V46, P1276; Hickey JV, 2009, BIOL RES NURS, V11, P174, DOI 10.1177/1099800409332902; Hickey JV, 2009, CLIN PRACTICE NEUROL, P270; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kaynar AM, 2007, RESP CARE, V52, P1687; Littell RC, 1998, J ANIM SCI, V76, P1216; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; Littlejohns LR, 2003, CRIT CARE NURSE, V23, P6; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; March K, 2000, Crit Care Nurs Clin North Am, V12, P429; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marino PL, 2007, ICU BOOK; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; Olson DM, 2007, NEUROCRIT CARE, V6, P100, DOI 10.1007/s12028-007-0015-y; Olson DaiWai M, 2003, Crit Care Nurse, V23, P45; Olson DM, 2009, AM J CRIT CARE, V18, P330, DOI 10.4037/ajcc2009523; Olson DM., 2007, CRITICAL CARE NURSIN, P359; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Strbian D, 2008, NEUROSCIENCE, V153, P175, DOI 10.1016/j.neuroscience.2008.02.012; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Yanko J R, 2001, Crit Care Nurs Q, V23, P1; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	50	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2010	42	3					119	127		10.1097/JNN.0b013e3181d4a3aa			9	Clinical Neurology; Nursing	Neurosciences & Neurology; Nursing	602OV	WOS:000278149600002	20550071				2021-06-18	
J	Agarwalla, PK; Dunn, GP; Laws, ER				Agarwalla, Pankaj K.; Dunn, Gavin P.; Laws, Edward R.			An historical context of modern principles in the management of intracranial injury from projectiles	NEUROSURGICAL FOCUS			English	Article						military; traumatic brain injury; neurosurgical history; projectile injury	PENETRATING CRANIOCEREBRAL INJURIES; GUNSHOT WOUNDS; BONE FRAGMENTS; MISSILE WOUNDS; HEAD WOUNDS; FOLLOW-UP; BRAIN; VIETNAM; WAR; NEUROSURGERY	The contemporary management of projectile head injuries owes much to the lessons neurosurgeons have distilled from their experiences in war. Through early investigation and an increasingly detailed account of wartime clinical experience, neurosurgeons-including the field's early giants-began to gain a greater understanding not only of intracranial missile pathophysiology but also of appropriate management. In this paper, the authors trace the development of the principles of managing intracranial projectile injury from the Crimean War in the 19th century through the Vietnam War to provide a context that frames a summary of today's core management principles. (DOI: 10.3171/2010.2.FOCUS1038)	[Laws, Edward R.] Harvard Univ, Sch Med, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Agarwalla, Pankaj K.; Dunn, Gavin P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA	Laws, ER (corresponding author), Harvard Univ, Sch Med, Dept Neurosurg, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	elaws@partners.org					ABBOTT K H, 1946, Mil Surg, V98, P469; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; Ascroft PB, 1943, LANCET, V2, P211; Ascroft Peter B., 1944, ARCH NEUROL AND PSYCHIAT, V51, P295; BARNETT JC, 1955, J NEUROSURG, V12, P34, DOI 10.3171/jns.1955.12.1.0034; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bliss M., 2005, HARVEY CUSHING LIFE; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; Cairns H, 1944, BMJ-BRIT MED J, V1944, P33; Cairns H, 1944, BRIT J SURG, V32, P199, DOI 10.1002/bjs.18003212539; CAIRNS H, 1947, BRIT J SURG        S, V1, P9; CAIRNS H, 1947, BR J SURG WAR SURG S, V1, P198; CAMPBELL EH, 1945, ANN SURG, V122, P375, DOI 10.1097/00000658-194509000-00004; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1982, ACTA CHIR SCAND, P351; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CAREY ME, 2004, YOUMANS NEUROLOGICAL, V4, P5523; Cushing H, 1918, BRIT J SURG, V5, P558; Cushing H, 1918, Br Med J, V1, P221; Cybulski GR, 2008, NEUROSURGERY, V63, P808, DOI 10.1227/01.NEU.0000325732.58528.86; DAGI TF, 1997, HIST NEUROSURGERY; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; ECKER AD, 1945, J NEUROSURG, V2, P384, DOI 10.3171/jns.1945.2.5.0384; Eden K, 1943, LANCET, V2, P689; ERICKSON TC, 1946, JAMA-J AM MED ASSOC, V132, P561, DOI 10.1001/jama.1946.02870450015004; FACKLER ML, 1988, JAMA-J AM MED ASSOC, V259, P2730, DOI 10.1001/jama.259.18.2730; FINLAYSON AI, 1945, B US ARMY MED DEP, V87, P61; FORMENTO F, 1990, NOTES OBSERVATIONS A; Fulton JF, 1946, HARVEY CUSHING BIOGR; GAYNOR WC, 1945, ANN SURG, V122, P12; Gray HMW, 1916, BRIT MED J, V1916, P261, DOI 10.1136/bmj.1.2877.261; GROFF RA, 1946, AM J SURG, V72, P434, DOI 10.1016/0002-9610(46)90333-9; GRUNNAGLE JF, 1945, WAR MED, V8, P376; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HANIGAN WC, 1994, BRIT J NEUROSURG, V8, P279, DOI 10.3109/02688699409029615; Hanigan WC, 2003, NEUROSURGERY, V53, P713, DOI 10.1227/01.NEU.0000079626.37622.6A; HANIGAN WC, 1988, NEUROSURGERY, V23, P283, DOI 10.1227/00006123-198809000-00001; HAYNES WG, 1945, J NEUROSURG, V2, P463, DOI 10.3171/jns.1945.2.6.0463; HAYNES WG, 1945, J NEUROSURG, V2, P365, DOI 10.3171/jns.1945.2.5.0365; HAYNES WG, 1945, J NEUROSURG, V2, P469, DOI 10.3171/jns.1945.2.6.0469; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Horrax G, 1919, BRIT J SURG, V7, P10, DOI 10.1002/bjs.1800072504; Horsley V., 1894, NATURE, V50, P104; HORSLEY V, 1915, BRIT MED J, V20, P321; KAUFMAN HH, 1991, SURG NEUROL, V36, P370, DOI 10.1016/0090-3019(91)90026-6; Kelly PJ, 2003, NEUROSURGERY, V52, P927, DOI 10.1227/01.NEU.0000053179.51319.D0; KRAMER SP, 1897, PHILOS T ROY SOC LON, V188, P223; LEWIN W, 1956, BRIT J SURG, V43, P628, DOI 10.1002/bjs.18004318216; MACLEOD GHB, 1858, NOTES SURG WAR CRIME; MALTBY GL, 1946, J NEUROSURG, V3, P239, DOI 10.3171/jns.1946.3.3.0239; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MATSON DD, 1946, J NEUROSURG, V3, P46, DOI 10.3171/jns.1946.3.1.0046; MEIROWSKY AM, 1953, J NEUROSURG, V10, P496, DOI 10.3171/jns.1953.10.5.0496; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MEIROWSKY AM, 1953, ANN SURG, V138, P178, DOI 10.1097/00000658-195308000-00003; MEIROWSKY AM, 1953, J NEUROSURG, V10, P373, DOI 10.3171/jns.1953.10.4.0373; Mitchell SW., 1872, INJURIES NERVES THEI; MITCHELL SW, 1864, GUNSHOT WOUNDS OTHER; POPP AJ, 1995, J NEUROSURG, V83, P174, DOI 10.3171/jns.1995.83.1.0174; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; RISH BL, 1980, J NEUROSURG, V53, P772, DOI 10.3171/jns.1980.53.6.0772; ROWE SN, 1945, J NEUROSURG, V2, P391, DOI 10.3171/jns.1945.2.5.0391; RUSSELL WR, 1952, J NEUROL NEUROSUR PS, V15, P93, DOI 10.1136/jnnp.15.2.93; RUSSELL WR, 1947, BRIT J SURG S, V1, P252; Schurr PH, 2005, J ROY SOC MED, V98, P423, DOI 10.1258/jrsm.98.9.423; SCHWARTZ HG, 1945, ANN SURG, V121, P129; SHEARBURN EW, 1946, AM J SURG, V72, P441, DOI 10.1016/0002-9610(46)90334-0; SLEMON HV, 1945, J NEUROSURG, V2, P332, DOI 10.3171/jns.1945.2.4.0332; SMALL JM, 1947, BR J SURG S, V1, P6274; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Stromeyer GFL, 1862, GUNSHOT FRACTURES; *USA, 1965, NEUR SURG TRAUM; WALKER AE, 1959, J NEUROSURG, V16, P600, DOI 10.3171/jns.1959.16.6.0600; WALKER AE, 1946, SCIENCE, V103, P116, DOI 10.1126/science.103.2665.116; WALLACE PB, 1960, ANN SURG, V151, P174, DOI 10.1097/00000658-196002000-00004; WANNAMAKER GT, 1958, J NEUROSURG, V15, P512, DOI 10.3171/jns.1958.15.5.0512; WANNAMAKER GT, 1954, J NEUROSURG, V11, P151, DOI 10.3171/jns.1954.11.2.0151; 1944, J NEUROSURG, V1, P1	80	11	11	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E23	10.3171/2010.2.FOCUS1038			13	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600023	20568940				2021-06-18	
J	Bergman, K; Bay, E				Bergman, Karen; Bay, Esther			MILD TRAUMATIC BRAIN INJURY/CONCUSSION: A REVIEW FOR ED NURSES	JOURNAL OF EMERGENCY NURSING			English	Article							POST-CONCUSSION SYMPTOMS; RANDOMIZED-TRIAL; EARLY PREDICTORS; FOLLOW-UP; INJURY; REHABILITATION; INTERVENTION; COMPLAINTS; IDENTIFICATION; ASSOCIATION		[Bergman, Karen] Bronson Hosp, Kalamazoo, MI USA; [Bergman, Karen; Bay, Esther] Michigan State Univ, E Lansing, MI 48824 USA	Bergman, K (corresponding author), 601 John St, Kalamazoo, MI 49007 USA.	bergmank@bronsonhg.org					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Armes J, 2007, CANCER-AM CANCER SOC, V110, P1385, DOI 10.1002/cncr.22923; BAY E, W J NURS RE IN PRESS; BAY E, 2006, CARE MANAGE J, V7, P9; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/088971804780957108; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Bronfort G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001878.PUB2; Centers for Disease Control and Prevention, TRAUM BRAIN INJ; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Gioia G, ACUTE CONCUSSION EVA; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; JAGODA A, 2008, J EMERG NURS, V35, pE5; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Nicholson K, 2004, J HEAD TRAUMA REHAB, V19, P2, DOI 10.1097/00001199-200401000-00002; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sikorskii A, 2006, J PAIN SYMPTOM MANAG, V32, P129, DOI 10.1016/j.jpainsymman.2006.02.013; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	57	11	11	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	MAY	2010	36	3					221	230		10.1016/j.jen.2009.07.001			10	Emergency Medicine; Nursing	Emergency Medicine; Nursing	605KF	WOS:000278345800010	20457317				2021-06-18	
J	Crandall, M; Sridharan, L; Schermer, C				Crandall, Marie; Sridharan, Lakshmi; Schermer, Carol			Injury and Health Among Toddlers in Vulnerable Families	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	22nd Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 13-17, 2009	Lake Buena Vista, FL	Eastern Assoc Surg Trauma		Injury; Pediatrics; Disparities	TRAUMATIC BRAIN-INJURY; INTIMATE PARTNER VIOLENCE; CHILDHOOD INJURY; YOUNG-CHILDREN; RISK-FACTORS; ALCOHOL-USE; CARE; DISPARITIES; PREVENTION; MORTALITY	Background: Injury is consistently a leading cause of death for young children, and social stressors can increase injury risk. We investigated the incidence of injury and developmental and health outcomes among children up to 3 years of age in a cohort of vulnerable families. Methods: The Fragile Families and Child Wellbeing Study is a longitudinal cohort of similar to 5,000 families across the United States, which deliberately oversamples unwed couples and lower income families. Data from interviews with mothers conducted shortly after birth and follow-up surveys at 1 year and 3 years were used for this analysis. Multivariate regression analysis was used to identify independent risk factors for injury. Results: Three-year follow-up data on injury were complete for 3,153 families. Three hundred nineteen children (10.2%) were injured in the first year and 386 (12.4%) in the third year. Eighty-one children suffered injuries noted in both survey periods. Children injured in the first year were twice as likely to have been reinjured in the third year, and previous injury was the strongest predictor of subsequent injury (OR, 1.96; 95% confidence interval, 1.41-2.71; p < 0.01). Injured children who were healthy as infants were nearly twice as likely to have "poor" or "fair" health as uninjured children in their third year (p < 0.01). Conclusions: Children in vulnerable families are at high risk for injury. In particular, children injured within the first year of life are at high risk for recurrent injury and poor health outcomes. Increased support and targeted interventions may improve outcomes and decrease childhood injury burden among at-risk families.	[Crandall, Marie] Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Trauma & Crit Care, Chicago, IL 60611 USA; [Schermer, Carol] Loyola Univ, Med Ctr, Dept Surg, Maywood, IL 60153 USA	Crandall, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Trauma & Crit Care, 676 N St Clair,Suite 650, Chicago, IL 60611 USA.	mcrandall@northwestern.edu	Crandall, Marie/L-9066-2019	Crandall, Marie/0000-0002-6536-3123			Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; Bair-Merritt MH, 2008, PEDIATRICS, V121, pE473, DOI 10.1542/peds.2007-1671; BASS JL, 1995, PEDIATRICS, V95, P274; BIJUR PE, 1992, JAMA-J AM MED ASSOC, V267, P3166, DOI 10.1001/jama.267.23.3166; Braun PA, 2005, INJURY PREV, V11, P251, DOI 10.1136/ip.2004.006510; Cousins Judy, 2005, Community Pract, V78, P276; Crandall M, 2006, J SURG RES, V133, P7, DOI 10.1016/j.jss.2006.02.027; Damashek A, 2009, J PEDIATR PSYCHOL, V34, P344, DOI 10.1093/jpepsy/jsn097; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Dunn L. M., 1997, PPVT 3 PEABODY PICTU; Friedlaender EY, 2005, PEDIATRICS, V116, P1303, DOI 10.1542/peds.2004-1988; Hayes JR, 2005, J NATL MED ASSOC, V97, P362; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keenan HT, 2006, PEDIATRICS, V117, P1291, DOI 10.1542/peds.2005-1883; Kendrick D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006020.pub2; Kendrick D, 2009, HEALTH EDUC RES, V24, P32, DOI 10.1093/her/cym083; KING WD, 1992, PEDIATR EMERG CARE, V8, P221, DOI 10.1097/00006565-199208000-00013; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; LARAQUE D, 1994, AM J PUBLIC HEALTH, V84, P1691; MCCAIG LF, 2006, ADV DATA VITAL HLTH, V372; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Peden M., 2008, WORLD REPORT CHILD I; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Qi CHQ, 2006, LANG SPEECH HEAR SER, V37, P5, DOI 10.1044/0161-1461(2006/002); Rivara FP, 2007, PEDIATRICS, V120, P1270, DOI 10.1542/peds.2007-1148; Scholer SJ, 1997, PEDIATRICS, V100, P342, DOI 10.1542/peds.100.3.342; Simon TD, 2008, INT J INJ CONTROL SA, V15, P141, DOI 10.1080/17457300802404430; Singh GK, 2007, AM J PUBLIC HEALTH, V97, P1658, DOI 10.2105/AJPH.2006.087320; Tamburro RF, 2002, INJURY PREV, V8, P242, DOI 10.1136/ip.8.3.242; Watt Kerrianne, 2006, Emerg Med Australas, V18, P108, DOI 10.1111/j.1742-6723.2006.00817.x; *WISQARS, 2008, NAT CTR INJ PREV CON; 2003, CHILD TRENDS DATA BA	34	11	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2010	68	5					1128	1133		10.1097/TA.0b013e3181d89403			6	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	595MQ	WOS:000277615200018	20453768				2021-06-18	
J	Ibrahim, NG; Natesh, R; Szczesny, SE; Ryall, K; Eucker, SA; Coats, B; Margulies, SS				Ibrahim, Nicole G.; Natesh, Rahul; Szczesny, Spencer E.; Ryall, Karen; Eucker, Stephanie A.; Coats, Brittany; Margulies, Susan S.			In Situ Deformations in the Immature Brain During Rapid Rotations	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						brain tissue strains; finite element model validation; brain deformation; pediatric head injury	TRAUMATIC AXONAL INJURY; SIMPLE ELONGATION; SKULL; MODEL; HEAD	Head trauma is the leading cause of death and debilitating injury in children. Computational models are important tools used to understand head injury mechanisms but they must be validated with experimental data. In this communication we present in situ measurements of brain deformation during rapid, nonimpact head rotation in juvenile pigs of different ages. These data will he used to validate computational models identifying age-dependent thresholds of axonal injury. Fresh 5 days (n = 3) and 4 weeks (n = 2) old piglet heads were transected horizontally and secured in a container The cut sulface of each brain was marked and covered with a transparent, lubricated plate that allowed the brain to move freely in the plane of rotation. For each brain, a rapid (20-28 ms) 65 deg rotation was applied sequentially at 50 rad/s, 75 rad/s, and 75 rad/s. Each rotation was digitally captured at 2500 frames/s (480 X 320 pixels) and mark locations were tracked and used to compute strain using an in-house program in MATLAB. Peak values of principal strain (E(peak)) were significantly larger during deceleration than during acceleration of the head rotation (p<0.05), and doubled with a 50% increase in velocity. Epeak was also significantly higher during the second 75 rad/s rotation than during the first 75 rad/s rotation (p<0.0001), suggesting structural alteration at 75 racily and the possibility that similar changes may have occurred at 50 rad/s. Analyzing only lower velocity (50 rad/s) rotations, E peak significantly increased with age (16.5% versus 12.4%, p<0.003), which was likely due to the larger brain mass and smaller viscoelastic modulus of the 4 weeks old pig brain compared with those of the 5 days old. Strain measurement error for the overall methodology was estimated to be 1%. Brain tissue strain during rapid, nonimpact head rotation in the juvenile pig varies significantly with age. The empirical data presented will be used to validate computational model predictions of brain motion under similar loading conditions and to assist in the development of age-specific thresholds for axonal injury Future studies will examine the brain-skull displacement and will be used to validate brain-skull interactions in computational models. [DOI: 10.1115/1.4000956]	[Ibrahim, Nicole G.; Natesh, Rahul; Szczesny, Spencer E.; Ryall, Karen; Eucker, Stephanie A.; Coats, Brittany; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Ibrahim, NG (corresponding author), Univ Penn, Dept Bioengn, 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.	margulie@seas.upenn.edu	Eucker, Stephanie/AAL-1828-2021	Eucker, Stephanie/0000-0001-9986-5773; Szczesny, Spencer/0000-0002-7691-949X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS039679]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER	The authors would like to thank Jill Ralston for her technical expertise throughout the study. Support provided by NIH Grant No. R01 NS039679.	Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; GOSCH H H, 1969, Surgical Forum (Chicago), V20, P425; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; HARDY WN, 1997, CRASHWORTHINESS OCCU, V225, P241; HODGSON VR, 1966, J NEUROSURG, V25, P549, DOI 10.3171/jns.1966.25.5.0549; IBRAHIM NG, 1992, J NEUROSURG PE UNPUB; IBRAHIM NG, 2009, HEAD INJURY BIOMECHA; LJUNG C, 1975, J BIOMECH, V8, P263, DOI 10.1016/0021-9290(75)90078-0; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MILLER RT, 1998, P 42 STAPP CAR CRASH, P155; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH, P41; PRANGE M, 2002, BIOMECHANICS TRAUMAT; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; PUDENZ RH, 1946, J NEUROSURG, V3, P87; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; SHATSKY SA, 1973, P 17 STAPP CAR CRASH, P361; 2006, DEATHS INJURIES 2001	24	11	11	0	2	ASME-AMER SOC MECHANICAL ENG	NEW YORK	THREE PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731			J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	APR	2010	132	4							044501	10.1115/1.4000956			4	Biophysics; Engineering, Biomedical	Biophysics; Engineering	585FN	WOS:000276810000011	20387974				2021-06-18	
J	Lancioni, GE; O'Reilly, MF; Singh, NN; Buonocunto, F; Sacco, V; Colonna, F; Navarro, J; Lanzilotti, C; Megna, G				Lancioni, Giulio E.; O'Reilly, Mark F.; Singh, Nirbhay N.; Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa; Megna, Gianfranco			Post-coma Persons with Minimal Consciousness and Motor Disabilities Learn to Use Assistive Communication Technology to Seek Environmental Stimulation	JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES			English	Article						Post-coma; Assistive technology; Microswitches; Minimally conscious state; Motor disabilities	PROFOUND MULTIPLE DISABILITIES; PERSISTENT VEGETATIVE STATE; TRAUMATIC BRAIN-INJURY; RECOVERY SCALE; REHABILITATION; DISORDERS; MICROSWITCH; CONSENSUS; PEOPLE; ADULTS	This study assessed whether two post-coma persons with minimally conscious state and extensive motor disabilities would learn to use assistive communication technology, namely microswitches, to gain access to preferred environmental stimuli. Each of the participants (adults) was provided with two microswitches that could be activated with small motor responses (e.g., finger movements and eyelid raising). The microswitches were introduced in succession according to a multiple probe design across microswitches/responses and allowed access to different sets of stimuli (i.e., recordings of songs and video-clips). Eventually, the use of the two microswitches was alternated within and across days. Each participant learned to use both microswitches successfully and maintained high levels of responding when the microswitches were alternated. The importance of assistive communication technology within programs for post-coma persons with disorders of consciousness and extensive motor disabilities is discussed.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Singh, Nirbhay N.] ONE Res Inst, Midlothian, VA USA; [Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Lanzilotti, Crocifissa] S Raffaele Rehabil Ctr, Ceglie Messapica, BR, Italy; [Megna, Gianfranco] Univ Bari, Dept Neurorehabil, I-70100 Bari, Italy	Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Navarro solano, Jorge/0000-0003-1508-6727; Lancioni, Giulio/0000-0002-6515-5690			Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Bernat JL, 2007, NEUROLOGY, V68, P885, DOI 10.1212/01.wnl.0000258973.95355.68; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Catania A. C., 2007, LEARNING; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Coleman MR, 2005, NEUROPSYCHOL REHABIL, V15, P161, DOI 10.1080/09602010443000669; Davis Alice E, 2003, J Neurosci Nurs, V35, P202; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Giacino JT, 2007, CURR OPIN NEUROL, V20, P614, DOI 10.1097/WCO.0b013e3282f189ef; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; Hersen M., 2009, SINGLE CASE EXPT DES; Holburn S, 2004, BEHAV INTERVENT, V19, P25, DOI 10.1002/bin.147; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kazdin AE, 2001, BEHAV MODIFICATION A; Kennedy K, 2005, SINGLE CASE DESIGNS; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Lancioni GE, 2008, EUR J PHYS REHAB MED, V44, P449; Lancioni G E, 2006, Pediatr Rehabil, V9, P137, DOI 10.1080/13638490500235466; Lancioni GE, 2005, BEHAV INTERVENT, V20, P147, DOI 10.1002/bin.185; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P379, DOI 10.1007/s10882-008-9104-x; Lancioni GE, 2008, PERCEPT MOTOR SKILL, V106, P355, DOI 10.2466/PMS.106.2.355-370; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P209, DOI 10.1007/s10882-008-9105-9; Lancioni GE, 2009, DISABIL REHABIL-ASSI, V4, P367, DOI 10.1080/17483100903038584; Lancioni GE, 2009, DEV NEUROREHABIL, V12, P24, DOI 10.1080/17518420902776995; Leong B, 2002, BRAIN INJURY, V16, P217, DOI 10.1080/02699050110103283; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Mcnaughton D, 2007, AUGMENT ALTERN COMM, V23, P217, DOI 10.1080/07434610701573856; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Noda R, 2004, BRAIN INJURY, V18, P509, DOI 10.1080/02699050310001645810; Petry K, 2005, J APPL RES INTELLECT, V18, P35, DOI 10.1111/j.1468-3148.2004.00209.x; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Siegel S., 1988, NONPARAMETRIC STAT; SIMPSON DM, 2009, NEUROSURGERY PSYCHIA, V80, P380; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Wales L., 2005, BRIT J OCCUPATIONAL, V68, P486; Wilson FC, 2007, DISABIL REHABIL, V29, P1751, DOI 10.1080/09638280601118432	41	11	11	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1056-263X			J DEV PHYS DISABIL	J. Dev. Phys. Disabil.	APR	2010	22	2					119	129		10.1007/s10882-009-9163-7			11	Education, Special; Psychology, Developmental; Rehabilitation	Education & Educational Research; Psychology; Rehabilitation	568RM	WOS:000275540200003					2021-06-18	
J	Sabini, RC; Reddy, CC				Sabini, Rosanna C.; Reddy, Cara Camiolo			Concussion Management and Treatment Considerations in the Adolescent Population	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; adolescents; sports; diagnosis; management; traumatic brain injury	SPORTS-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; BASE-LINE; COLLEGIATE; SYMPTOMS; EPIDEMIOLOGY	Over the past decade, significant advances have been made in understanding concussions. Information regarding proper identification, pathophysiology, risks, outcomes, and management protocols has shifted the treatment paradigm from a generalized grading system to an individualized approach. Early identification and timely management of a concussion is necessary to ensure that patients minimize persistent post-concussive symptoms affecting the physical, behavioral, emotional, and cognitive domains. Adolescents are particularly vulnerable to concussions, having greater susceptibility and more prolonged recovery aft er sustaining an injury. This article aims to inform clinicians on how to improve symptom relief and functional outcomes for adolescent patients with concussion via immediate intervention, neuropsychological management, and pharmacological treatment.	[Sabini, Rosanna C.; Reddy, Cara Camiolo] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15219 USA	Sabini, RC (corresponding author), Univ Pittsburgh, Med Ctr, 1400 Locust St,Suite 7203, Pittsburgh, PA 15219 USA.	dr.sabini@gmail.com		Sabini, Rosanna/0000-0002-9273-3855			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Bruce JM, 2004, NEUROLOGY, V63, P1516; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; ELLEMBERG D, J NEUROTRAUMA; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maroon Joseph C, 2002, Clin Neurosurg, V49, P319; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Swartz EE, 2009, PHYSICIAN SPORTSMED, V37, P20, DOI 10.3810/psm.2009.12.1738; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; YARNELL PR, 1970, LANCET, V1, P863; 2009, REPORT TRENDS PARTIC	56	11	11	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR	2010	38	1					139	146		10.3810/psm.2010.04.1771			8	Primary Health Care; Orthopedics; Sport Sciences	General & Internal Medicine; Orthopedics; Sport Sciences	766SO	WOS:000290807000015	20424411				2021-06-18	
J	Docherty, E; Hassan, A; Burke, D				Docherty, Elizabeth; Hassan, Abu; Burke, Derek			Things that go bump ... bump ... bump: an analysis of injuries from falling down stairs in children based at Sheffield Children's Hospital	EMERGENCY MEDICINE JOURNAL			English	Article								Background Falls down stairs are a common presentation to the paediatric emergency department. The pattern of injury associated with this mechanism of injury has not been described for the UK population. A retrospective analysis of attendances to the Emergency Department of Sheffield Children's Hospital was carried out. Results Overall 90% (216/239) of patients sustained one or more injuries; 69% (165/239) sustained minor head and facial injuries; 12% (29/239) sustained minor soft tissue injuries of other regions; 10% (23/239) had limb fractures, of which 60% (14/23) were of the upper limb (nine clavicle fractures, one supracondylar fracture of the elbow and four wrist fractures) and 40% (9/23) were of the lower limb (four femoral fractures and five tibial fractures). Two per cent (5/239) had skull fractures (all were in the group of children dropped while being carried on the stairs). Injuries to more than one body part occurred in only 3% (8/239) of cases. Discussion The results suggest that children who fall down the stairs are mainly toddlers and in general sustain only minor injuries, the commonest being a minor head injury. Severe truncal and extremity injuries or injuries involving multiple body regions should provoke further questioning looking for evidence of non-accidental injury. There is no correlation between the number of stairs fallen down and the likelihood or severity of injury. Conclusion Infants who fall down stairs with their carer or are dropped while being carried down stairs require an especially close evaluation.	[Docherty, Elizabeth] Sheffield Childrens Hosp, Emergency Dept, Sheffield S10 2TH, S Yorkshire, England; [Docherty, Elizabeth; Hassan, Abu] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England	Docherty, E (corresponding author), Sheffield Childrens Hosp, Emergency Dept, Sheffield S10 2TH, S Yorkshire, England.	ebdocherty@gmail.com					BARLOW B, 1983, J PEDIATR SURG, V18, P509, DOI 10.1016/S0022-3468(83)80210-3; CASEY R, 1986, PEDIATRICS, V78, P497; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; JOFFE M, 1988, PEDIATRICS, V82, P457	4	11	11	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	MAR	2010	27	3					207	208		10.1136/emj.2008.069179			2	Emergency Medicine	Emergency Medicine	571VA	WOS:000275782800018	20304888				2021-06-18	
J	Guitton, TG; Ring, D				Guitton, Thierry G.; Ring, David			Nonsurgically Treated Terrible Triad Injuries of the Elbow: Report of Four Cases	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Dislocations; elbow; nonsurgical; terrible triad	RADIAL HEAD; FRACTURES; DISLOCATIONS	This case series describes 4 patients with terrible triad injury of the elbow (dislocation with fractures of the radial head and coronoid) who were treated nonsurgically. Following nonsurgical treatment in this select group of patients, the elbow was well aligned, and the patients regained good elbow function. Three of these 4 patients had good results. One patient had surgery for residual stiffness, ulnar neuropathy, and a radial head deformity. We conclude that, in selected terrible triad cases, when the elbow is well aligned and the radial head and coronoid fractures are relatively small and minimally displaced after closed reduction and there is no mechanical block to motion, patients might regain good elbow function without surgery. (J Hand Surg 2010;35A:464-467.(C) 2010 Published by Elsevier Inc. on behalf of the American Society for Surgery of the Hand.)	[Ring, David] Harvard Univ, Massachusetts Gen Hosp, Yawkey Ctr, Orthopaed Hand & Upper Extrem Serv,Med Sch, Boston, MA 02114 USA	Ring, D (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Yawkey Ctr, Orthopaed Hand & Upper Extrem Serv,Med Sch, Suite 2100,55 Fruit St, Boston, MA 02114 USA.	dring@partners.org		Guitton, Thierry/0000-0002-2599-1985	Small Bone Innovations; Wright Medical; Stichting Anna FondsFWO; Stichting Wetenschappelijk Ondernek Orthopaedisch Chirurgie; VSB Fonds; Smith and Nephew; Acumed; Tornier	Funding was received from Small Bone Innovations (DR.), Wright Medical (DR.), Stichting Anna Fonds (T.G.G.),Stichting Wetenschappelijk Ondernek Orthopaedisch Chirurgie (T.G.G.), VSB Fonds (T.G.G.), Smith and Nephew (D.R.), Acumed (DA.), and Tornier (DA.).	BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; Closkey RF, 2000, J BONE JOINT SURG AM, V82A, P1749, DOI 10.2106/00004623-200012000-00009; Doornberg JN, 2006, J HAND SURG-AM, V31A, P794, DOI 10.1016/j.jhsa.2006.01.004; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; Hotchkiss Robert N., 1996, P929; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JOSEFSSON PO, 1989, CLIN ORTHOP RELAT R, P126; Jupiter JB, 1993, ELBOW ITS DISORDERS, P328; King GJW, 1999, J SHOULDER ELB SURG, V8, P351; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; O'Driscoll Shawn W, 2003, Instr Course Lect, V52, P113; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006	13	11	18	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023	1531-6564		J HAND SURG-AM	J. Hand Surg.-Am. Vol.	MAR	2010	35A	3					464	467		10.1016/j.jhsa.2009.12.015			4	Orthopedics; Surgery	Orthopedics; Surgery	588SB	WOS:000277092800017	20193862				2021-06-18	
J	Martin, CA; Care, M; Rangel, EL; Brown, RL; Garcia, VF; Falcone, RA				Martin, Colin A.; Care, Marguerite; Rangel, Erika L.; Brown, Rebeccah L.; Garcia, Victor F.; Falcone, Richard A., Jr.			Severity of head computed tomography scan findings fail to explain racial differences in mortality following child abuse	AMERICAN JOURNAL OF SURGERY			English	Article						Non-accidental trauma; Traumatic brain injury; Computed tomography; Outcomes disparities	TRAUMATIC BRAIN-INJURY; HEALTH-INSURANCE PROGRAM; GLASGOW COMA SCALE; EMERGENCY-DEPARTMENT; PEDIATRIC TRAUMA; DIRECT TRANSPORT; CARE; DISPARITIES; SYSTEM; PREDICTORS	INTRODUCTION: Differences in head injury severity may not be fully appreciated in child abuse victims. The purpose of this study was to determine if differential findings on initial head computed tomography (CT) scan could explain observed differential outcome by race. METHODS: We identified 164 abuse patients from our trauma registry with an Injury Severity Score (ISS) >= 15. Their initial head CT scan was graded from I to 4 (normal to severe). Statistical analysis was performed to asses the correlation between race, head CT grade, Glascow Coma Scale (GCS) score, and mortality. RESULTS: Overall mortality was 17%: 11% for white children, 32% for African-American children (P < .05). In review of the head CT scans there was no difference by race in types of injuries or head CT grade. Using a multivariate regression model, African-American race remained an independent risk factor for mortality with an odd ratio of 4.3 (95% confidence interval [CI] 1.6-11.5). CONCLUSION: African-American children had a significantly higher mortality rate despite similar findings on initial head CT scans. Factors other than injury severity may explain these disparate outcomes. (C) 2010 Elsevier Inc. All rights reserved.	[Martin, Colin A.; Rangel, Erika L.; Brown, Rebeccah L.; Garcia, Victor F.; Falcone, Richard A., Jr.] Univ Cincinnati, Div Pediat & Thorac Surg, Dept Surg, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH 45229 USA; [Care, Marguerite] Univ Cincinnati, Cincinnati Childrens Hosp, Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA	Falcone, RA (corresponding author), Univ Cincinnati, Div Pediat & Thorac Surg, Dept Surg, Cincinnati Childrens Hosp,Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Richard.Falcone@cchmc.org					Al West T, 2000, J TRAUMA, V49, P530, DOI 10.1097/00005373-200009000-00022; BALL WS, 1989, RADIOLOGY, V173, P609, DOI 10.1148/radiology.173.3.2813759; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Byck GR, 2000, PEDIATRICS, V106, P14, DOI 10.1542/peds.106.1.14; Cantais E, 2001, INTENS CARE MED, V27, P1511, DOI 10.1007/s001340101039; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chung CY, 2006, PEDIATR NEUROL, V34, P379, DOI 10.1016/j.pediatrneurol.2005.10.012; Teruel GC, 2007, J PEDIATR SURG, V42, P1903, DOI 10.1016/j.jpedsurg.2007.07.020; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Epstein AM, 2001, NEW ENGL J MED, V344, P1471, DOI 10.1056/NEJM200105103441911; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Federico SG, 2007, PEDIATRICS, V120, pe1009, DOI 10.1542/peds.2006-3094; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hannan EL, 2005, J TRAUMA, V58, P244, DOI 10.1097/01.TA.0000141995.44721.44; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hymel KP, 1997, PEDIATR RADIOL, V27, P743, DOI 10.1007/s002470050215; JENNETT B, 1976, LANCET, V1, P1031; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; KRIEGER N, 1962, AM J PUBLIC HEALTH, V98, pS20; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Lindberg DM, 2008, PEDIATRICS, V121, pE945, DOI 10.1542/peds.2007-2485; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; RANGEL E, PEDIATRICS IN PRESS; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Shone LP, 2003, PEDIATRICS, V112, pE521; Smedley BD, 2008, HEALTH AFFAIR, V27, P447, DOI 10.1377/hlthaff.27.2.447; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zimmerman R A, 1994, Neuroimaging Clin N Am, V4, P349; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P39, DOI 10.1007/BF00395197; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	48	11	11	0	2	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	FEB	2010	199	2					210	215		10.1016/j.amjsurg.2009.05.001			6	Surgery	Surgery	587AU	WOS:000276959700012	19892316				2021-06-18	
J	Smith, KD; Zhu, L				Smith, Katisha D.; Zhu, Liang			Theoretical evaluation of a simple cooling pad for inducing hypothermia in the spinal cord following traumatic injury	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Spinal cord injury; Cerebrospinal fluid; Hypothermia; Temperature; Heat transfer	CEREBROSPINAL-FLUID CIRCULATION; HEAT-TRANSFER ENHANCEMENT; OSCILLATING-FLOW; BLOOD-FLOW; SYSTEMIC HYPOTHERMIA; LOCAL HYPOTHERMIA; BRAIN; ISCHEMIA; RAT; PATHOPHYSIOLOGY	The Pennes bioheat equation and finite element method (FEM) are used to solve for the temperature distributions in the spinal cord and cerebrospinal fluid (CSF) during 30 min of cooling for spinal cord injury (SCI) patients. The average CSF and spinal cord temperatures are reduced by 3.48 and 2.72A degrees C, respectively. The 100-mm wide pad provides the desired cooling and uses the least amount of material. The presence of zero-average CSF oscillation under normal conditions decreases the cooling extent in the spinal cord due to the introduction of warm CSF surrounding the spinal cord. The temperature decrease in the spinal cord is more than doubled when the temperature at the back of the torso is lowered from 20 to 0A degrees C. Spinal cord ischemia, often observed after traumatic spinal cord injury, promotes cooling penetration. The proposed technique can reduce the spinal cord temperature by 2A degrees C within 30 min and may be a feasible treatment for traumatic SCI.	[Smith, Katisha D.; Zhu, Liang] Univ Maryland, Dept Mech Engn, Baltimore, MD 21250 USA	Zhu, L (corresponding author), Univ Maryland, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	zliang@umbc.edu			State of Maryland TEDCO fund; LSAMP Bridge to the Doctorate Program; NIGMS Initiative for Minority Student DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25-GM55036]; Procter and Gamble; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM055036] Funding Source: NIH RePORTER	This research was supported in part by the State of Maryland TEDCO fund, the LSAMP Bridge to the Doctorate Program, an NIGMS Initiative for Minority Student Development Grant (R25-GM55036), and Procter and Gamble. This research was performed by Katisha D. Smith in partial fulfillment of the requirements for the Ph.D. degree from the University of Maryland, Baltimore County.	Acosta-Rua G J, 1970, J Iowa Med Soc, V60, P326; ALBIN M, 1968, J NEUROSURG, V28, P113; Albin M S, 1968, Surg Forum, V19, P423; Albin M S, 1965, Surg Forum, V16, P423; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; BLACK PR, 1976, J SURG RES, V20, P49, DOI 10.1016/0022-4804(76)90083-4; Bricolo A, 1976, Surg Neurol, V6, P101; Casas CE, 2005, J NEUROSURG-SPINE, V2, P308, DOI 10.3171/spi.2005.2.3.0308; Chandrupatla TR., 2002, INTRO FINITE ELEMENT; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; FEINBERG DA, 1987, RADIOLOGY, V163, P793, DOI 10.1148/radiology.163.3.3575734; GOETZ T, 1988, Journal of Neurotrauma, V5, P139, DOI 10.1089/neu.1988.5.139; GRAY H, 2001, GRAYS ANATOMY FACSIM; Gul H, 2007, EXP HEAT TRANSFER, V20, P73, DOI 10.1080/08916150600977523; Hansebout R R, 1975, Surg Neurol, V4, P531; HANSEBOUT RR, 1984, SPINE, V9, P508, DOI 10.1097/00007632-198407000-00020; HANSEBOUT RR, 1985, CAN J NEUROL SCI, V12, P83, DOI 10.1017/S0317167100046758; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hemida HN, 2002, INT J HEAT MASS TRAN, V45, P1767, DOI 10.1016/S0017-9310(01)00274-5; Hirsch C., 1988, NUMERICAL COMPUTATIO, VVolume I; Huang PC, 2005, J THERMOPHYS HEAT TR, V19, P460, DOI 10.2514/1.10348; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Inamasu J, 2003, J NEUROL SCI, V209, P55, DOI 10.1016/S0022-510X(02)00463-X; Incropera F., 1996, FUNDAMENTALS HEAT MA; Isaka M, 2006, J VASC SURG, V43, P1257, DOI 10.1016/j.jvs.2006.02.017; Iwai H, 2004, INT J HEAT MASS TRAN, V47, P4659, DOI 10.1016/j.ijheatmasstransfer.2003.08.03; Kwun BD, 1995, J SURG RES, V59, P780, DOI 10.1006/jsre.1995.1239; Leong KC, 2005, INT J HEAT MASS TRAN, V48, P243, DOI 10.1016/j.ijheatmasstransfer.2004.08.025; Li P, 2000, INT J HEAT MASS TRAN, V43, P3551, DOI 10.1016/S0017-9310(99)00390-7; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; MAGANAES B, 1989, BRIT J NEUROSURG, V3, P659; Marsala M, 1997, J NEUROSCI METH, V74, P97, DOI 10.1016/S0165-0270(97)02270-X; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; MINKOWYCZ W, 1997, ADV NUMERICAL HEAT T; Mori A, 2005, ANN THORAC SURG, V80, P1829, DOI 10.1016/j.athoracsur.2005.04.031; O'Connell JEA, 1943, BRAIN, V66, P204, DOI 10.1093/brain/66.3.204; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; PRYTHERCH DR, 1979, PHYS MED BIOL, V24, P1196, DOI 10.1088/0031-9155/24/6/010; Reyes Onix, 2003, P R Health Sci J, V22, P277; RUBINI L, 1981, SPINE, V6, P417, DOI 10.1097/00007632-198107000-00013; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; SCHELLINGER D, 1992, AM J NEURORADIOL, V13, P1393; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; TATOR CH, 1972, CAN MED ASSOC J, V107, P143; THIENPRASIT P, 1975, J NEUROSURG, V42, P150, DOI 10.3171/jns.1975.42.2.0150; Tsutsumi Koji, 2004, Jpn J Thorac Cardiovasc Surg, V52, P411; Wang LM, 2005, CELL RES, V15, P387, DOI 10.1038/sj.cr.7290306; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; WELLS JD, 1978, SURG NEUROL, V10, P200; Westergren H, 2001, SPINAL CORD, V39, P74, DOI 10.1038/sj.sc.3101127; Xian HZ, 2007, DRY TECHNOL, V25, P723, DOI 10.1080/07373930701291173; Xu XJ, 1999, J APPL PHYSIOL, V86, P265; YASHON D, 1973, J NEUROSURG, V39, P742, DOI 10.3171/jns.1973.39.6.0742; Zhang XR, 2004, INT J HEAT MASS TRAN, V47, P4439, DOI 10.1016/j.ijheatmasstransfer.2004.03.030; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; ZHU L, 2002, STANDARD HDB BIOMEDI, pCH2	58	11	11	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	FEB	2010	48	2					167	175		10.1007/s11517-009-0543-z			9	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	544UL	WOS:000273684700008	19890670				2021-06-18	
J	Yang, YM; Lai, H; Tao, CY; Yang, H				Yang, Yuming; Lai, Hua; Tao, Chunyan; Yang, Hua			Correlation of luminescent properties of ZnO and Eu doped ZnO nanorods	JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS			English	Article							ZINC-OXIDE NANOWIRES; HYDROTHERMAL GROWTH; NANOSTRUCTURES; PHOTOLUMINESCENCE; PERFORMANCE; MORPHOLOGY; ARRAYS	ZnO and ZnO:Eu nanorods were originally synthesized by concussion method. The nanorods present a wurtzite nanostructure with dispersive distribution morphology. The average diameter and length of the nanorods are about 80 nm and 2 mu m, respectively. The best concussion time, concussion frequency, the function of HMT and the growth mechanism are presented in this paper. This method is simple, economical, and environmentally mild. We believe other kinds of ZnO nanostructures could be obtained by this method when appropriate agents are added. However, because of the different chemical properties between trivalent RE ions and the cations of ZnO, it is rather difficult to incorporate RE ions into the lattice of semiconductors effectively via a wet chemical method. Based on our experiments, the sample of ZnO : Eu-1%(3+) is single-phase and its PL signal is stronger than other single-phase ZnO : Eu-X(3+) samples. So 1% content of Eu3+ was chosen as the best doping concentration.	[Yang, Yuming; Lai, Hua; Yang, Hua] Jilin Univ, Coll Chem, Changchun 130012, Peoples R China; [Tao, Chunyan] Jilin Univ, Key Lab Supramol Struct & Mat, Minist Educ, Changchun 130012, Peoples R China	Yang, H (corresponding author), Jilin Univ, Coll Chem, Changchun 130012, Peoples R China.	huayang86@sina.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC)	This work is supported by National Natural Science Foundation of China (NSFC).	AHUJA IS, 1982, J MOL STRUCT, V81, P229, DOI 10.1016/0022-2860(82)85335-0; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Chang YC, 2007, J PHYS CHEM C, V111, P1268, DOI 10.1021/jp066786q; Destaillats H, 2001, IND ENG CHEM RES, V40, P3855, DOI 10.1021/ie010110u; Fan Z., 2004, ADV MATER, V15, P838; Geng J, 2006, J PHYS CHEM B, V110, P13777, DOI 10.1021/jp057562v; Gou XL, 2008, J MATER CHEM, V18, P965, DOI 10.1039/b716745h; Guo M, 2005, J SOLID STATE CHEM, V178, P3210, DOI 10.1016/j.jssc.2005.07.013; Guo M, 2005, J SOLID STATE CHEM, V178, P1864, DOI 10.1016/j.jssc.2005.03.031; Hartanto AB, 2004, APPL PHYS A-MATER, V78, P299, DOI 10.1007/s00339-003-2286-2; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H; JIE J, 2005, SYNTHESIS OPTICAL PR, DOI DOI 10.1063/1.1854737; Johnson JC, 2003, J PHYS CHEM B, V107, P8816, DOI 10.1021/jp034482n; Kind H, 2002, ADV MATER, V14, P158, DOI 10.1002/1521-4095(20020116)14:2<158::AID-ADMA158>3.0.CO;2-W; Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p; Kong YC, 2001, APPL PHYS LETT, V78, P407, DOI 10.1063/1.1342050; Lao JY, 2002, NANO LETT, V2, P1287, DOI 10.1021/nl025753t; Lao JY, 2003, NANO LETT, V3, P235, DOI 10.1021/nl025884u; Law M, 2005, NAT MATER, V4, P455, DOI 10.1038/nmat1387; Li SY, 2004, J APPL PHYS, V95, P3711, DOI 10.1063/1.1655685; Li YB, 2002, APPL PHYS LETT, V81, P144, DOI 10.1063/1.1492008; Liu B, 2003, J AM CHEM SOC, V125, P4430, DOI 10.1021/ja0299452; MASON TJ, 1999, SONOCHEMISTRY, P16; PAN ZW, 1947, SCIENCE, V291, P2001; Park JY, 2004, J MICROBIOL BIOTECHN, V14, P35, DOI 10.1039/b312821k; Park WI, 2003, APPL PHYS LETT, V82, P964, DOI 10.1063/1.1544437; Pol VG, 2002, CHEM MATER, V14, P3920, DOI 10.1021/cm0203464; SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055; Wang Z, 2004, LANGMUIR, V20, P3441, DOI 10.1021/la036098n; Williams TM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236211; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Xing YJ, 2004, SOLID STATE COMMUN, V129, P671, DOI 10.1016/j.ssc.2003.11.049; Xu LF, 2007, J PHYS CHEM C, V111, P11560, DOI 10.1021/jp071536a; Yan HQ, 2003, ADV MATER, V15, P402, DOI 10.1002/adma.200390091; Yan HQ, 2003, ADV MATER, V15, P1907, DOI 10.1002/adma.200305490; Yang J, 2006, J NANOSCI NANOTECHNO, V6, P2196, DOI 10.1166/jnn.2006.363; Yao BD, 2002, APPL PHYS LETT, V81, P757, DOI 10.1063/1.1495878; Yu WD, 2004, APPL PHYS LETT, V84, P2658, DOI 10.1063/1.1695097; Zhang J, 2002, CHEM MATER, V14, P4172, DOI 10.1021/cm020077h	40	11	11	1	15	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0957-4522	1573-482X		J MATER SCI-MATER EL	J. Mater. Sci.-Mater. Electron.	FEB	2010	21	2					173	178		10.1007/s10854-009-9889-0			6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Engineering; Materials Science; Physics	545RE	WOS:000273753300012					2021-06-18	
J	Anderson, TM; Knight, RG				Anderson, Tracy M.; Knight, Robert G.			The long-term effects of traumatic brain injury on the coordinative function of the central executive	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Dual task; Dual-task test; Divided attention; Traumatic brain injury; Dysexecutive syndrome; Digit span; Tracing task	DUAL-TASK COORDINATION; WORKING-MEMORY; DIVIDED ATTENTION; DEFICIT; SCALE	The objective of this study was to compare the coordinative function of the central executive of working memory in matched groups of controls and persons with traumatic brain injury (TBI) with long-term impairments in functioning, using a dual-task paradigm. The dual-task procedure required participants to complete digit span and tracing tasks separately and then together to produce a change index that reflects loss of productivity on the dual trial. A TBI group and a matched group of controls were compared on this task and on ratings of social competency and neuropsychological tests. The two groups were found to differ in social competence, in the number of dysexecutive symptoms, and on dual-task performance, but not on any other measures of cognitive ability. Poor performance on the dual task was found only in persons with initial very severe TBI. There was no evidence that the group difference on the dual task was the consequence of increased task difficulty level, distribution of attention, or other within-task biases. Performance on the dual task was correlated with dysexecutive symptoms and social competency (in particular interpersonal and cognitive competence), but not with other tests of executive functioning. The findings suggest that deficits in the coordinative function persist in long-term survivors of TBI after other deficits in executive functioning may have resolved and are associated with lower ratings of current interpersonal competence.	[Knight, Robert G.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Anderson, Tracy M.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Anderson, Tracy M.] St Vincents Hosp, Clin Res Unit Anxiety & Depress, Sydney, NSW 2010, Australia	Knight, RG (corresponding author), Univ Otago, Dept Psychol, Box 56, Dunedin, New Zealand.	rknight@psy.otago.ac.nz			Neurological Foundation of New Zealand	The authors are grateful to Alan Baddeley and Sergio Della Sala for supplying the materials for the dual-task test used in this paper. Copies of this material may be accessed at www.psy.ed.ac.uk/people/sdsala/tests/sdsdualtask. The authors acknowledge the late Hamish Godfrey for his assistance with this project and are grateful to the Head Injury Society (Invercargill) for their assistance in recruiting participants for this study. This research was supported by a PhD scholarship awarded to Tracy Anderson from the Neurological Foundation of New Zealand.	Alderman N, 1996, NEUROPSYCHOL REHABIL, V6, P161, DOI 10.1080/713755505; Asloun S, 2008, J CLIN EXP NEUROPSYC, V30, P481, DOI 10.1080/13803390701550144; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A., 1974, PSYCHOL LEARN MOTIV, P47, DOI [10.1016/s0079-7421(08)60452-1, DOI 10.1016/S0079-7421(08)60452-1]; Baddeley A. D., 2002, PRINCIPLES FRONTAL L, P246, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0016; Baddeley A. D., 1997, METHODOLOGY FRONTAL; Baddeley A. D., 1986, WORKING MEMORY; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; DALRYMPLEALFORD JC, 1994, J NEUROL NEUROSUR PS, V57, P360, DOI 10.1136/jnnp.57.3.360; DELLASALA S, 1999, PAPER PENCIL DUAL TA; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; HARTMAN A, 1992, CLIN REHABIL, V6, P133; Heaton R., 1993, WISCONSIN CARD SORTI; Hegarty M, 2000, MEM COGNITION, V28, P376, DOI 10.3758/BF03198553; International Labor Office, 1988, INT STAND CLASS OCC; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Logie RH, 2004, NEUROPSYCHOLOGY, V18, P504, DOI 10.1037/0894-4105.18.3.504; Miyake A., 1999, MODELS WORKING MEMOR; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Rosin FM, 1999, BRAZ J MED BIOL RES, V32, P1249, DOI 10.1590/S0100-879X1999001000012; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Sala SD, 1995, ANN NY ACAD SCI, V769, P161, DOI 10.1111/j.1749-6632.1995.tb38137.x; Spreen O., 1998, COMPENDIUM NEUROPSYC; Sylwan RP, 1999, BRAZ J MED BIOL RES, V32, P1263, DOI 10.1590/S0100-879X1999001000013; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wilson, 1991, NATL ADULT READING T; Wilson BA, 1996, BEHAV ASSESSMENT DYS; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	35	11	11	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	10					1074	1082	PII 922305187	10.1080/13803391003733560			9	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	692JV	WOS:000285150000005	20486007				2021-06-18	
J	Bentz, K; Molcanyi, M; Schneider, A; Riess, P; Maegele, M; Bosche, B; Hampl, JA; Hescheler, J; Patz, S; Schafer, U				Bentz, Kristine; Molcanyi, Marek; Schneider, Annette; Riess, Peter; Maegele, Marc; Bosche, Bert; Hampl, Juergen A.; Hescheler, Juergen; Patz, Silke; Schaefer, Ute			Extract Derived from Rat Brains in the Acute Phase Following Traumatic Brain Injury Impairs Survival of Undifferentiated Stem Cells and Induces Rapid Differentiation of Surviving Cells	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						TBI; Stem cell; Differentiation; Inhibition; Oct-4; Nestin; Fgf5	FLUID-PERCUSSION MODEL; NEURONAL DIFFERENTIATION; INFLAMMATORY RESPONSE; INHIBITING ACTIVITY; COGNITIVE FUNCTION; TRANSPLANTATION; TISSUE; PROGENITORS; MIGRATE	Dramatic cerebral responses following brain injury (TBI) comprise inflammation, cell death, and modulation of trophic factor release. These cerebral modulations might induce and /or attenuate acute neuronal damage. Here, we investigated the effect of tissue extract derived from healthy (HBE) or injured rat brain (TBE) on the differentiation of cultured embryonic stem cells in vitro. Rats were sacrificed at t = 45 minutes following lateral fluid-percussion injury and extracts of cerebral tissue were prepared from 4-6 healthy or injured rat brain hemispheres. Murine embryonic stem cells (CGR8) cultured in serum-free medium were then conditioned for a week with HBE or TBE. Omission of serum from the culture medium induced neural differentiation of CGR8 stem cells, as indicated by a significant time dependent down-regulation of oct-4 with a concomitant upregulation of nestin after 7 days. In parallel cell loss was observed that seemed to be largely due to apoptotic cell death. In TBE treated cells, on the other hand, a significant amplification of apoptotic cell death, enhancement of nestin and MAP2 expression and marked morphological changes such as axonal-like outgrowth was observed within 3 days of conditioning. Treatment of stem cells with HBE resulted in less pronounced neuronal differentiation processes. Axonal-like outgrowth was not observed. Our data suggest that during the early acute phase of traumatic injury the cerebral environment is disposed to detrimental as well as potent protective signals that seem to rapidly induce neurogenic processes. Copyright (C) 2010 S. Karger AG, Basel	[Patz, Silke; Schaefer, Ute] Med Univ Graz, Res Unit Expt Neurotraumatol, A-8036 Graz, Austria; [Bentz, Kristine] Syddanskuniv, Bonn, Germany; [Molcanyi, Marek; Bosche, Bert; Hampl, Juergen A.] Univ Cologne, Clin Neurosurg, Bonn, Germany; [Schneider, Annette] Univ Witten Herdecke, Inst Res Operat Med, Bonn, Germany; [Riess, Peter] Waldklin, Dept Trauma & Orthopaed Surg, Bonn, Germany; [Maegele, Marc] Univ Witten Herdecke, Clin Trauma & Orthopaed Surg, Bonn, Germany; [Hescheler, Juergen] Univ Cologne, Dept Neurophysiol, Fac Med, Bonn, Germany	Schafer, U (corresponding author), Med Univ Graz, Res Unit Expt Neurotraumatol, Auenbrugger Pl 2, A-8036 Graz, Austria.	ute.schaefer@medunigraz.at	Bosche, Bert/AAB-7150-2020	Bosche, Bert/0000-0002-5313-3195			Bentz K, 2007, J NEUROSCI RES, V85, P1057, DOI 10.1002/jnr.21219; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; HEATH JK, 1988, J CELL SCI, P257; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Potts Mathew B, 2006, NeuroRx, V3, P143; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Tseng HC, 2006, NEUROBIOL DIS, V22, P88, DOI 10.1016/j.nbd.2005.10.007; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	27	11	11	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2010	26	6					821	830		10.1159/000323991			10	Cell Biology; Physiology	Cell Biology; Physiology	702FY	WOS:000285881200003	21220913	Bronze			2021-06-18	
J	Bjorkdahl, A				Bjorkdahl, Ann			The return to work after a neuropsychological programme and prognostic factors for success	BRAIN INJURY			English	Article						Brain injury; longitudinal; awareness; cognition; pre-morbid occupation	TRAUMATIC BRAIN-INJURY; MILIEU-BASED NEUROREHABILITATION; ACUTE PREDICTORS; SELF-AWARENESS; REHABILITATION; STROKE; EMPLOYMENT; OUTCOMES; INTERVENTION; PERSPECTIVES	Introduction: Several factors influence the return to work (RTW) after brain injury (BI). The aims of the study were to follow-up the RTW after a vocational neuropsychological programme for individuals with a brain injury and to explore factors predicting RTW. The hypothesis was that as self-awareness was already addressed in the programme, severity of injury would have a greater impact on RTW. Method: Sixty-five of 72 persons (median age 27) who had attended the programme 1998-2003 were interviewed about their occupation at 1, 2, 3 and 5 years after the programme. A logistic regression was made with the variables concerning process skill, somatic problems and irritability, the digit symbol coding and pre-morbid occupation to explore predictors of RTW. Results: The main cause was TBI (44.6%). Before injury 77% were employed or studied and after the injury 80% did not have any occupation. After 5 years 40% had returned to work. The only significant variable in the regression was the pre-morbid occupation. Discussion: The study stresses the difficulty to know the key elements involved in RTW which confirms the need for rehabilitation to focus on several factors in different contexts in order to affect the outcome.	[Bjorkdahl, Ann] Bracke Diakoni Fdn, Res Unit, S-41804 Gothenburg, Sweden; [Bjorkdahl, Ann] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Bjorkdahl, A (corresponding author), Bracke Diakoni Fdn, Res Unit, Box 210 62, S-41804 Gothenburg, Sweden.	ann.bjorkdahl@brackediakoni.se					Benton A, 1989, MULTILINGUAL APHASIA; Bernstein JH., 1996, DEV SCORING SYSTEM R; BERNTORP E, 1995, HAEMOPHILIA, V1, P3, DOI 10.1111/j.1365-2516.1995.tb00103.x; Bjorkdahl Ann, 2004, J Stroke Cerebrovasc Dis, V13, P122, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.004; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN EC, 1958, J CONSULT PSYCHOL, V22, P469, DOI 10.1037/h0039980; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Daniel K, 2009, STROKE, V40, pE431, DOI [10.1161/STROKEAHA.108.534487, 10.1161/STROKEAHA.108.535088]; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; Fleming J, 1999, BRAIN INJURY, V13, P417; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P161, DOI 10.1053/apmr.2003.50098; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Leung K L, 2005, Work, V25, P333; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Possl O, 2001, BRAIN INJURY, V15, P15; Saeki S, 2000, DISABIL REHABIL, V22, P578, DOI 10.1080/09638280050138241; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Treger I, 2007, DISABIL REHABIL, V29, P1397, DOI 10.1080/09638280701314923; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Watanabe TK, 2003, ARCH PHYS MED REHAB, V84, pS23, DOI 10.1053/apmr.2003.50054; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wolfenden B, 2009, INT J REHABIL RES, V32, P93, DOI 10.1097/MRR.0b013e328325a358; World Health Organization, 2001, INT CLASS FUNCT DIS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	49	11	14	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1061	1069		10.3109/02699052.2010.494588			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700002	20597634				2021-06-18	
J	Huebinger, RM; Gomez, R; Mcgee, D; Chang, LY; Bender, JE; O'Keeffe, T; Burris, AM; Friese, SM; Purdue, GF; Hunt, JL; Arnoldo, BD; Horton, JW; Barber, RC				Huebinger, Ryan M.; Gomez, Ruben; McGee, Daphne; Chang, Ling-Yu; Bender, Jessica E.; O'Keeffe, Terence; Burris, Agnes M.; Friese, Susan M.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Horton, Jureta W.; Barber, Robert C.			ASSOCIATION OF MITOCHONDRIAL ALLELE 4216C WITH INCREASED RISK FOR SEPSIS-RELATED ORGAN DYSFUNCTION AND SHOCK AFTER BURN INJURY	SHOCK			English	Article						Mitochondrial electron transport chain; mitochondrial DNA polymorphism; genetic association; complex I	HUMAN GENOME EPIDEMIOLOGY; PARKINSONS-DISEASE; SEPTIC SHOCK; MORTALITY; TRAUMA; POLYMORPHISMS; NETWORKS; VARIANT; DEATH	Impaired mitochondrial activity has been linked to increased risk for clinical complications after injury. Furthermore, variant mitochondrial alleles have been identified and are thought to result in decreased mitochondrial activity. These include a nonsynonymous mitochondrial polymorphism (T4216C) in the nicotinamide adenine dinucleotide dehydrogenase 1 gene (ND1), encoding a key member of complex I within the electron transport chain, which is found almost exclusively among Caucasians. We hypothesized that burn patients carrying ND1 4216C are less able to generate the cellular energy necessary for an effective immune response and are at increased risk for infectious complications. The association between 4216C and outcome after burn injury was evaluated in a cohort of 175 Caucasian patients admitted to the Parkland Hospital with burns covering greater than or equal to 15% of their total body surface area or greater than or equal to 5% full-thickness burns under an institutional review board-approved protocol. To remove confounding unrelated to burn injury, individuals were excluded if they presented with significant non-burn-related trauma (Injury Severity Score >= 16), traumatic or anoxic brain injury, spinal cord injury, were HIV/AIDS positive, had active malignancy, or survived less than 48 h postadmission. Within this cohort of patients, carriage of the 4216C allele was significantly associated by unadjusted analysis with increased risk for sepsis-related organ dysfunction or septic shock (P = 0.011). After adjustment for full-thickness burn size, inhalation injury, age, and sex, carriage of the 4216C allele was associated with complicated sepsis (adjusted odds ratio = 3.7; 95% confidence interval, 1.5-9.1; P = 0.005), relative to carriers of the T allele.	[Huebinger, Ryan M.; Chang, Ling-Yu; Burris, Agnes M.; Purdue, Gary F.; Hunt, John L.; Arnoldo, Brett D.; Horton, Jureta W.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Gomez, Ruben] Detroit Med Ctr, Dept Surg, Detroit, MI USA; [McGee, Daphne] Baylor Univ, Waco, TX 76798 USA; [Bender, Jessica E.; O'Keeffe, Terence; Friese, Susan M.] Arizona Hlth Sci Ctr, Dept Surg, Tucson, AZ 85724 USA	Barber, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.barber@utsouthwestern.edu			National Institutes of Health/US National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM057054-09, 5P50 GM21681-42, 5T32 GM00859313]; UT Southwestern Medical Center Department of Surgery Critical Care Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM057054, P50GM021681] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health/US National Institute of General Medical Sciences (grant no. R01-GM057054-09 to J.W.H. and grant nos. 5P50 GM21681-42 and 5T32 GM00859313) and the UT Southwestern Medical Center Department of Surgery Critical Care Fellowship.	Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barber RC, 2007, J BURN CARE RES, V28, P205, DOI 10.1097/BCR.0B013E318031A1BF; Bloemsma GC, 2008, BURNS, V34, P1103, DOI 10.1016/j.burns.2008.02.010; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Canter JA, 2007, ANN SURG, V246, P406, DOI 10.1097/SLA.0b013e3181469955; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Gomez R, 2009, J TRAUMA, V66, P850, DOI 10.1097/TA.0b013e3181991ac8; Hofmann S, 1997, AM J HUM GENET, V60, P1539; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Karter Michael., 2008, FIRE LOSS US 2007; Kudsk K A, 1994, Nutr Clin Pract, V9, P165, DOI 10.1177/0115426594009005165; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; McDaniel DO, 2007, J TRAUMA, V63, P147, DOI 10.1097/TA.0b013e31806bf0ab; MERRELL SW, 1989, J TRAUMA, V29, P1362, DOI 10.1097/00005373-198910000-00012; Militsa B, 2001, Neurol India, V49 Suppl 1, pS75; Miller SF, 2006, J BURN CARE RES, V27, P411, DOI 10.1097/01.BCR.0000226260.17523.22; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Seminara D, 2007, EPIDEMIOLOGY, V18, P1, DOI 10.1097/01.ede.0000249540.17855.b7; Sigalet DL, 2004, CAN J SURG, V47, P109; Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Velez DR, 2008, MITOCHONDRION, V8, P130, DOI 10.1016/j.mito.2007.10.007	31	11	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2010	33	1					19	23		10.1097/SHK.0b013e3181a99508			5	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	535LQ	WOS:000272970200005	19487983				2021-06-18	
J	Makdissi, M				Makdissi, Michael			Sports related concussion Management in general practice	AUSTRALIAN FAMILY PHYSICIAN			English	Article						wounds and injuries; athletic injuries; brain concussion	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; HEAD-INJURY; AGREEMENT STATEMENT; ENCEPHALOPATHY; EPIDEMIOLOGY; IMPAIRMENT; SYMPTOMS; RECOVERY; SEQUELAE	Background Concussive injuries are common in many sports and recreational activities, especially those involving body contact, collisions or high speed. Over the past 8 years, international experts met on three occasions to address key issues in the understanding and management of concussion in sport; most recently in Zurich in November 2008. The consensus statement produced from this meeting provides an outline of up-to-date knowledge and best practice management guidelines on concussion in sport. Objective The aim of this article is to provide an overview of the key concepts from the Zurich consensus statement, including an understanding of concussion and an outline of potential risks and recommended management as applicable to the general practice setting. Discussion Concussion is thought to reflect a functional injury to the brain. Clinical features are typically short lived and resolve spontaneously, with the majority of affected individuals recovering within 10-14 days. However, complications can occur including prolonged symptoms or cognitive deficit, depression, and cumulative deterioration in brain function. The potential for adverse outcomes and the absence of direct measures of recovery following a concussive injury, make decisions regarding return to play a challenge. Clinical management includes confirming the diagnosis, differentiating concussion from structural head injury, estimating the severity of injury, and determining when the patient can return safely to competition. Players should return to play in a graded fashion after clinical features have resolved and cognitive function has returned to 'normal' on neuropsychological testing.	[Makdissi, Michael] Australasian Coll Sports Phys, Melbourne, Vic, Australia; [Makdissi, Michael] Olymp Pk Sports Med Ctr, Melbourne, Vic, Australia	Makdissi, M (corresponding author), Australasian Coll Sports Phys, Melbourne, Vic, Australia.	makdissi@unimelb.edu.au					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chadwick D, 1997, BRIT MED J, V314, P1283; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hinton-Bayre AD, 2004, J SCI MED SPORT, V7, P400, DOI 10.1016/S1440-2440(04)80035-5; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Makdissi M, 2009, BRIT J SPORT MED, V43, pI23, DOI 10.1136/bjsm.2009.058206; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; WESCHLER D, 1981, WESCHLER ADULT INTEL; WRIGHTSON P, 1983, PAT MANAGEMENT, V3, P79	52	11	11	0	3	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	JAN-FEB	2010	39	1-2					12	17					6	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	552KW	WOS:000274289900005	20369128				2021-06-18	
J	Theobald, P; Whitelegg, L; Nokes, LDM; Jones, MD				Theobald, Peter; Whitelegg, Liam; Nokes, Leonard D. M.; Jones, Michael D.			The predicted risk of head injury from fall-related impacts on to third-generation artificial turf and grass soccer surfaces: A comparative biomechanical analysis	SPORTS BIOMECHANICS			English	Article						Artificial; head; injury; soccer; turf	CONCUSSION; SYSTEM	The risk of soccer players sustaining mild traumatic brain injury (MTBI) following head impact with a playing surface is unclear. This study investigates MTBI by performing headform impact tests from varying heights onto a range of third-generation artificial turf surfaces. Each turf was prepared as per manufacturers specifications within a laboratory, before being tested immediately following installation and then again after a bedding-in period. Each turf was tested dry and when wetted to saturation. Data from the laboratory tests were compared to an in situ third-generation surface and a professional grass surface. The surface performance threshold was set at a head impact criterion (HIC)=400, which equates to a 10% risk of the head impact causing MTBI. All six third-generation surfaces had a 10% risk of MTBI from a fall 0.77m; the inferior surfaces required a fall from just 0.46m to have a 10% MTBI risk. Wetting the artificial turf did not produce a statistically significant improvement (P 0.01). The in situ third-generation playing surface produced HIC values within the range of bedded-in experimental values. However, the natural turf pitch was the superior performer - necessitating fall heights exceeding those achievable during games to achieve HIC=400.	[Theobald, Peter; Whitelegg, Liam; Nokes, Leonard D. M.; Jones, Michael D.] Cardiff Univ, Inst Med Engn & Med Phys, Trauma Biomech Res Grp, Cardiff CF24 3AA, S Glam, Wales	Jones, MD (corresponding author), Cardiff Univ, Inst Med Engn & Med Phys, Trauma Biomech Res Grp, Cardiff CF24 3AA, S Glam, Wales.	JonesMD1@Cardiff.ac.uk	Theobald, Peter S/C-2490-2013	Theobald, Peter S/0000-0002-3227-7130			Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; BJORNEBOE J, 2008, BRIT J SPORT MED, V42, P494; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; *BSI, 1998, 71881998 BSI; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; *FIFA, 2008, QUAL CONC FOOTB TURF; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hrysomallis C, 2004, J SCI MED SPORT, V7, P156, DOI 10.1016/S1440-2440(04)80005-7; KING AI, 2003, INT C BIOM IMP LISB; Mahieu NN, 2006, AM J SPORT MED, V34, P226, DOI 10.1177/0363546505279918; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; Naunheim R, 2002, J TRAUMA, V53, P691, DOI 10.1097/00005373-200210000-00012; PRASAD P, 1985, 851246 SAE; Shorten MR, 2003, SPORTS SURFACES; SOLIGARD T, 2008, BRIT J SPORT MED, V42, P494; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; STOJSIH S, 2008, BRIT J SPORTS MED	20	11	11	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.		2010	9	1					29	37	PII 920020742	10.1080/14763141003690245			9	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	597IR	WOS:000277750800003	20446637				2021-06-18	
J	Czeiter, E; Buki, A; Bukovics, P; Farkas, O; Pai, J; Kovesdi, E; Doczi, T; Sandor, J				Czeiter, Endre; Buki, Andras; Bukovics, Peter; Farkas, Orsolya; Pai, Jozsef; Kovesdi, Erzsebet; Doczi, Tamas; Sandor, Janos			Calpain Inhibition Reduces Axolemmal Leakage in Traumatic Axonal Injury	MOLECULES			English	Article						calpain; MDL-28170; traumatic axonal injury; traumatic brain injury	SPECTRIN BREAKDOWN PRODUCTS; FOCAL CEREBRAL-ISCHEMIA; BRAIN-INJURY; CEREBROSPINAL-FLUID; SPINAL-CORD; HEAD-INJURY; PERMEABILITY; PROTEOLYSIS; RAT; ACTIVATION	Calcium-induced, calpain- mediated proteolysis (CMSP) has recently been implicated to the pathogenesis of diffuse (traumatic) axonal injury (TAI). Some studies suggested that subaxolemmal CMSP may contribute to axolemmal permeability (AP) alterations observed in TAI. Seeking direct evidence for this premise we investigated whether subaxolemmal CMSP may contribute to axolemmal permeability alterations (APA) and pre-injury calpain- inhibition could reduce AP in a rat model of TAI. Horseradish peroxidase (HRP, a tracer that accumulates in axons with APA) was administered one hour prior to injury into the lateral ventricle; 30 min preinjury a single tail vein bolus injection of 30 mg/kg MDL-28170 (a calpain inhibitor) or its vehicle was applied in Wistar rats exposed to impact acceleration brain injury. Histological detection of traumatically injured axonal segments accumulating HRP and statistical analysis revealed that pre-injury administration of the calpain inhibitor MDL-28170 significantly reduced the average length of HRP-labeled axonal segments. The axono-protective effect of pre-injury calpain inhibition recently demonstrated with classical immunohistochemical markers of TAI was further corroborated in this experiment; significant reduction of the length of labeled axons in the drug-treated rats implicate CMSP in the progression of altered AP in TAI.	[Czeiter, Endre; Buki, Andras; Bukovics, Peter; Farkas, Orsolya; Pai, Jozsef; Kovesdi, Erzsebet; Doczi, Tamas] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Sandor, Janos] Univ Pecs, Inst Appl Hlth Sci, Dept Publ Hlth, Pecs, Hungary	Buki, A (corresponding author), Univ Pecs, Dept Neurosurg, Pecs, Hungary.	endre.czeiter@aok.pte.hu; 2saturn@gmail.com; janos.sandor@etk.pte.hu	Bukovics, Peter/A-6019-2009; Czeiter, Endre/B-1404-2009; Buki, Andras/B-1960-2010; Doczi, Tamas/C-5750-2009	Pal, Jozsef/0000-0001-6468-6409	Aventis Pharmaceuticals [MDL-28170]; Hungarian Science Founds [OTKA T048724, OTKA PD 72240]; Bekesy Scholarship of the Hungarian Academy of Sciences	The authors thank the Aventis Pharmaceuticals for the kind donation of the MDL-28170 and Csabane Andok, Andrasne Nodor and Jozsef Nyiradi for their technical assistance. This study was supported by the Hungarian Science Founds (OTKA T048724; OTKA PD 72240) and the Bekesy Scholarship of the Hungarian Academy of Sciences.	Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cardali S, 2006, J Neurosurg Sci, V50, P25; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Couto LA, 2004, J NEUROSCI RES, V77, P410, DOI 10.1002/jnr.20170; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Lee KS, 1997, ANN NY ACAD SCI, V825, P95, DOI 10.1111/j.1749-6632.1997.tb48419.x; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Povlishock JT, 2001, HEAD TRAUMA, P281; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182	28	11	12	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2009	14	12					5115	5123		10.3390/molecules14125115			9	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	536KL	WOS:000273043200020	20032879	DOAJ Gold, Green Published			2021-06-18	
J	Fietzek, UM; Kossmehl, P; Barthels, A; Ebersbach, G; Zynda, B; Wissel, J				Fietzek, U. M.; Kossmehl, P.; Barthels, A.; Ebersbach, G.; Zynda, B.; Wissel, J.			Botulinum toxin B increases mouth opening in patients with spastic trismus	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						botulinumtoxin; bruxism; movement disorders; neurorehabilitation; spasticity; trismus	ANTIBODY-FORMATION; CERVICAL DYSTONIA; DOUBLE-BLIND; NEUROTOXIN; MANAGEMENT; DISORDERS; EFFICACY; SPREAD; SAFETY	Background: Severe generalized spastic movement disorders of various aetiologies often involve the jaw muscles and lead to a spastic trismus with masseter muscle hypertonia. We report a placebo-controlled randomized study on patients with spastic trismus. Methods: Eleven patients with masseter hypertonia because of stroke, hypoxic encephalopathy or traumatic brain injury were allocated to either botulinum toxin serotype B (BoNT/B) injections into the masseter muscles or placebo treatment. The dental gap, the amount of saliva, salivation scales, and a clinical goal attainment were evaluated. Results: Three weeks after injection the BoNT/B group showed a significantly increased mouth opening compared with placebo treatment (P < 0.05). In addition to the muscle paralysing effect, a goal attainment scale demonstrated a clinical benefit for the BoNT/B group (P < 0.01). Conclusions: Botulinum toxin serotype B injections into the masseter muscles effectively reduce hypertonia and provide for better mouth opening, thereby contributing to a positive and desired clinical goal.	[Fietzek, U. M.; Kossmehl, P.; Wissel, J.] Kliniken Beelitz GmbH, Neurol Rehabil Klin, D-14547 Beelitz, Germany; [Fietzek, U. M.] Neurol Krankenhaus Munchen, Ctr Parkinsons Dis & Movement Disorders, D-80804 Munich, Germany; [Barthels, A.; Zynda, B.] MEDIAN Klin Grunheide, Rehabil Klin Neurol, D-15537 Grunheide, Germany; [Ebersbach, G.] Kliniken Beelitz GmbH, Movement Disorder Clin, D-14547 Beelitz, Germany	Wissel, J (corresponding author), Kliniken Beelitz GmbH, Neurol Rehabil Klin, Paracelsusring 6A, D-14547 Beelitz, Germany.	wissel@rehaklinik-beelitz.de		Fietzek, Urban/0000-0002-4323-9930; Ebersbach, Georg/0000-0003-3403-6987			Andrade L A, 1994, Arq Neuropsiquiatr, V52, P410; Aoki KR, 2002, TOXICON, V40, P923, DOI 10.1016/S0041-0101(02)00086-7; Berweck S, 2007, DEV MED CHILD NEUROL, V49, P62, DOI 10.1017/S0012162207000151; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brashear A, 1999, NEUROLOGY, V53, P1439, DOI 10.1212/WNL.53.7.1439; Brin MF, 1997, MUSCLE NERVE, pS208; BRINKE MAD, 2003, NEUROL REHABIL, V9, P153; BUCHBINDER D, 1993, J ORAL MAXIL SURG, V51, P863, DOI 10.1016/S0278-2391(10)80104-1; de Paiva A, 1999, P NATL ACAD SCI USA, V96, P3200, DOI 10.1073/pnas.96.6.3200; Dijkstra PU, 2004, ORAL ONCOL, V40, P879, DOI 10.1016/j.oraloncology.2004.04.003; Dodd SL, 1998, EUR J NEUROL, V5, P181, DOI 10.1046/j.1468-1331.1998.520181.x; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dressler D, 2003, EUR NEUROL, V49, P34, DOI 10.1159/000067023; Dressler D, 2006, NEUROTOX RES, V9, P121, DOI 10.1007/BF03033929; Herrmann J, 2004, ANN NEUROL, V55, P732, DOI 10.1002/ana.20098; JANKOVIC J, 1987, NEUROLOGY, V37, P616, DOI 10.1212/WNL.37.4.616; Kadyan V, 2005, ARCH PHYS MED REHAB, V86, P594, DOI 10.1016/j.apmr.2004.06.061; Kim HJ, 2000, ARCH NEUROL-CHICAGO, V57, P576, DOI 10.1001/archneur.57.4.576; Lew MF, 1997, NEUROLOGY, V49, P701, DOI 10.1212/WNL.49.3.701; LOU JS, 1995, MOVEMENT DISORD, V10, P680, DOI 10.1002/mds.870100527; Marien Manuel Jr., 1997, General Dentistry, V45, P350; Pal PK, 2000, NEUROLOGY, V54, P244, DOI 10.1212/WNL.54.1.244; Pathak MS, 2006, EUR J NEUROL, V13, P42, DOI 10.1111/j.1468-1331.2006.01444.x; Porta M, 2001, J NEUROL NEUROSUR PS, V70, P538, DOI 10.1136/jnnp.70.4.538; Restivo DA, 2005, NEUROLOGY, V64, P2152, DOI 10.1212/01.WNL.0000167410.39109.1C; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schwartz M, 2002, CLIN J PAIN, V18, pS198, DOI 10.1097/00002508-200211001-00013; Schwerin A, 2004, PEDIATR NEUROL, V31, P109, DOI 10.1016/j.pediatrneurol.2003.12.016; SHAARI CM, 1991, LARYNGOSCOPE, V101, P960; SIMPSON DM, 1997, MUSCLE NERVE       S, V6, P169; Spillane KS, 2003, AM J PHYS MED REHAB, V82, P485, DOI 10.1097/01.PHM.0000070110.26037.86; Tan EK, 2000, J AM DENT ASSOC, V131, P211, DOI 10.14219/jada.archive.2000.0149; TVETERAS K, 1986, CLIN OTOLARYNGOL, V11, P383, DOI 10.1111/j.1365-2273.1986.tb00141.x; VITA GM, 1995, ANESTHESIOLOGY, V82, P1097, DOI 10.1097/00000542-199505000-00002; Winterholler MGM, 2002, NEUROLOGY, V58, P502, DOI 10.1212/WNL.58.3.502; Wissel J, 2000, J PAIN SYMPTOM MANAG, V20, P44, DOI 10.1016/S0885-3924(00)00146-9	36	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	DEC	2009	16	12					1299	1304		10.1111/j.1468-1331.2009.02723.x			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	522BT	WOS:000271973400008	19566902				2021-06-18	
J	Lewandowski, L; Rieger, B; Smyth, J; Perry, L; Gathje, R				Lewandowski, Lawrence; Rieger, Brian; Smyth, Joshua; Perry, Lorraine; Gathje, Rebecca			Measuring Post-concussion Symptoms in Adolescents: Feasibility of Ecological Momentary Assessment	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Symptoms; Assessment; Adolescents	POSTCONCUSSION SYNDROME; MILD; INJURY	Although there is a large literature examining head trauma in general, several areas remain understudied. Notably, little is known about symptom expression over the course of a day for adolescents recovering from concussion. Furthermore, intra-individual symptom variability has not been well characterized. This pilot study examined the feasibility of a momentary data-gathering method, as well as the sensitivity of the assessment to the subtle and dynamic changes in symptoms of concussion. Six adolescents, three of whom suffered a concussion and three non-injured controls, provided symptom ratings five times per day for 5 days. This ecological momentary assessment (EMA) was conducted on a personal digital assistant to capture variability in symptom reports while in the natural environment. Preliminary results indicated that the EMA method showed great promise as a research tool in natural settings (e. g., school and home). Adolescents were able to comply with all tasks with little interference in their daily activities. Students with concussion showed generally higher symptom ratings across physical, cognitive, and affective domains, and temporal and diurnal patterns for symptoms emerged. Implications for future research and patient care are discussed.	[Lewandowski, Lawrence; Smyth, Joshua; Perry, Lorraine; Gathje, Rebecca] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Rieger, Brian] SUNY Upstate Med Univ, Rehabil Psychol Dept, Syracuse, NY USA	Lewandowski, L (corresponding author), Syracuse Univ, Dept Psychol, 472 Huntington Hall, Syracuse, NY 13244 USA.	ljlewand@syr.edu		Smyth, Joshua/0000-0002-0904-5390			Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smyth J. M., 2003, J HAPPINESS STUD, V4, P35, DOI [10.1023/A:1023657221954, DOI 10.1023/A:1023657221954]; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5	12	11	11	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2009	24	8					791	796		10.1093/arclin/acp087			6	Psychology, Clinical; Psychology	Psychology	524VO	WOS:000272172700008	19892712	Bronze			2021-06-18	
J	Ylioja, SG; Baird, AD; Podell, K				Ylioja, Shelley G.; Baird, Anne D.; Podell, Kenneth			Developing a Spatial Analogue of the Reliable Digit Span	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Traumatic brain injury; Forensic neuropsychology	MALINGERED NEUROCOGNITIVE DYSFUNCTION; ADULT INTELLIGENCE SCALE; SYMPTOM VALIDITY TEST; NEUROPSYCHOLOGICAL TESTS; CLASSIFICATION ACCURACY; III DIGIT; MEMORY; PERFORMANCE; SPECIFICITY; SENSITIVITY	It is recommended that performance validity be assessed in all neuropsychological cases involving external incentive. The present study sought to develop an embedded performance validity measure based on the Spatial Span task of the Wechsler Memory Scale-III in a sample of litigating persistent postconcussion complainants. The Reliable Spatial Span (RSS) calculation had specificity, sensitivity, and predictive power values within the range of other embedded measures. This finding suggests that RSS is able to distinguish between persistent postconcussion complainants demonstrating valid and invalid performance. Other calculations involving Spatial Span scores had lower classification accuracy. Reliable Digit Span (RDS) classification accuracy within the present sample was lower than that of previous research, as well as of RSS. Potential reasons for lack of RDS replication are discussed, along with the potential use of RSS as an embedded validity performance indicator.	[Baird, Anne D.; Podell, Kenneth] Henry Ford Hlth Syst, Div Neuropsychol, Detroit, MI 48202 USA; [Ylioja, Shelley G.; Baird, Anne D.; Podell, Kenneth] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada	Podell, K (corresponding author), Henry Ford Hlth Syst, Div Neuropsychol, 1 Ford Pl 1E, Detroit, MI 48202 USA.	kpodell1@hfhs.org			National Sciences and Engineering Research Council of Canada.Natural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by a Canada Graduate Scholarship Master's awarded to the first author by the National Sciences and Engineering Research Council of Canada.	Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; Darke S., 1988, COGN EMOT, V2, P145, DOI DOI 10.1080/02699938808408071; Delis DC, 2000, CALIFORNIA VERBAL LE; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 1996, WORD MEMORY TEST USE; GREENE RL, 1998, MMPI 2 ADULT INTERPR; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Heaton R., 1993, WISCONSIN CARD SORTI; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hester RL, 2004, J INT NEUROPSYCH SOC, V10, P475, DOI 10.1017/S1355617704104037; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Mammarella IC, 2005, COGN NEUROPSYCHOL, V22, P1055, DOI 10.1080/02643290442000509; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Matthews C, 1964, INSTRUCTION MANUAL A; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; MOREY LC, 1996, PERSONALITY ASSESSME; Reitan RM., 1985, HALSTEAD REITAN NEUR; Ruff R.M., 1996, RUFF 2 7 SELECTIVE A; Ruff R. M., 1988, RUFF FIGURAL FLUENCY; SLICK D, 2006, COMPENDIUM NEUROPSYC, P1; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smyth MM, 1996, Q J EXP PSYCHOL-A, V49, P159; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Szmalec A, 2005, MEM COGNITION, V33, P531, DOI 10.3758/BF03193069; The Psychological Corporation, 1999, WECHSL ABBR SCAL INT; The Psychological Corporation, 1997, WAIS III WMS III TEC; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Vandierendonck A, 1998, EUR J COGN PSYCHOL, V10, P413, DOI 10.1080/713752284; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wilde N, 2002, CLIN NEUROPSYCHOL, V16, P322, DOI 10.1076/clin.16.3.322.13858; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME, V3; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]	57	11	11	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2009	24	8					729	739		10.1093/arclin/acp078			11	Psychology, Clinical; Psychology	Psychology	524VO	WOS:000272172700002	19854719	Bronze			2021-06-18	
J	Jones, HA				Jones, Helen A.			Arterial transducer placement and cerebral perfusion pressure monitoring: a discussion	NURSING IN CRITICAL CARE			English	Article						Head injuries; Intensive care nursing; Monitoring	CRITICAL CLOSING PRESSURE; INTRACRANIAL-PRESSURE; HEAD-INJURY; HYPERTENSION; CIRCULATION; REACTIVITY; FLOW	Aim: To discuss existing disparity of practice and clinical implications of measuring cerebral perfusion pressure (CPP) from differing reference points thus highlighting the need for standardized benchmarks. Background: When managing traumatic brain injury (TBI), the arterial transducer level is a key to an accurate CPP reading; however, there is a lack of national standards about where to zero arterial transducers when monitoring CPP. Methods: A systematized search using the Cochrane library database, Pubmed database, Medline, British Library on line, CINAHL and PROQUEST using key search terms was used to identify articles that could form a basis for a discussion. Papers published between 2000 and 2008 were included. Papers that did not discuss arterial transducer level placement and CPP were excluded. The Brian Trauma Guidelines 2007 were scrutinized for recommendations. Results: Of 57 empirical studies accessed, none reported or explored the placement of the arterial transducer during CPP measurement. Conflicting opinions were identified within the literature and there were no recommendations made for practice within the Brain Trauma Foundation Guidelines 2007. Discussion: At the present time, there is insufficient evidence for recommending standard placement for mean arterial pressure (MAP) measurements for patients with TBI. There are implications to consider as the treatment prescribed will differ depending on where the arterial transducer is placed because the MAP and CPP displayed will fall by 15 mm Hg at a head elevation of 30 degrees. This poses a number of questions: is the CPP underestimated with the arterial transducer placed at head level? Is the CPP overestimated if the transducer is placed at mid axilla level? Recommendations: Further research is recommended. However, studies would be difficult to power as head-injured patients constitute a heterogeneous population. Professional consensus should be applied and standardized benchmarks agreed.	[Jones, Helen A.] Walton Ctr Neurol & Neurosurg NHS Trust, Liverpool 97AL, Merseyside, England	Jones, HA (corresponding author), Walton Ctr Neurol & Neurosurg NHS Trust, Lower Lane, Liverpool 97AL, Merseyside, England.	helen.jones@thewaltoncentre.nhs.uk					BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, DOI DOI 10.1089/NEU.9987; *BRAINIT GROUP, 2008, HYDR PRESS CALC CPP; Buhre W, 2003, BRIT J ANAESTH, V90, P291, DOI 10.1093/bja/aeg073; BULLOCK J, 2001, PHYSIOLOGY; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Farrar JK, 1973, STROKE, V4, P795, DOI 10.1161/01.STR.4.5.795; Hicks JW, 2005, AM J PHYSIOL-REG I, V289, pR629, DOI 10.1152/ajpregu.00810.2004; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; INGRAM M, 2006, CRITICAL CARE PHI S1, V10, P450; JONES H, 2008, BACCN C JUN 2008; LOBATO EB, 2007, COMPLICATIONS ANAEST, P849; MATTA BF, 2000, TXB NEUROANAESTHESIA, P101; McCann YG, 2001, CHEST, V120, P1322, DOI 10.1378/chest.120.4.1322; MUNIS J, 2008, APSF NEWSL, V22, P82; Munis JR, 2000, J NEUROSURG ANESTH, V12, P290, DOI 10.1097/00008506-200007000-00029; NORDSTROM CH, 2003, NEUROSURG FOCUS, V15; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; PRANEVICIUS M, 2008, ANESTHESIA PATIENT S, V23, P21; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Thees C, 2002, ANESTHESIOLOGY, V96, P595, DOI 10.1097/00000542-200203000-00014; Tortora GJ, 2000, PRINCIPLES ANATOMY P; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002	23	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1362-1017	1478-5153		NURS CRIT CARE	Nurs. Crit. Care	NOV-DEC	2009	14	6					303	310		10.1111/j.1478-5153.2009.00352.x			8	Nursing	Nursing	V18IH	WOS:000207998000005	19840277				2021-06-18	
J	Mazzola, RF; Mazzola, IC				Mazzola, Riccardo F.; Mazzola, Isabella C.			Treatise on Skull Fractures by Berengario Da Carpi (1460-1530)	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						History; skull fractures; history of surgical instruments; history of plastic surgery		Jacopo Berengario was born in Carpi, a medieval city close to Modena (northern Italy), circa 1460. He Studied medicine at Bologna University and, in 1489, graduated in philosophy and medicine. He was appointed lecturer in anatomy and surgery at the same University, a position that lie maintained for 24 years. Between 1514 and 1523, Berengario published some important anatomic and surgical works, which gave considerable fame to him. Commentaria... supra Anatomiam Mundini (Commentary... on the Anatomy of Mondino), published in 1521, constitutes the first example of an illustrated anatomic textbook ever printed. The anatomic illustrations were intended for explaining the text. Artistically speaking, the plates are typical examples of the Renaissance period and worthy of the greatest consideration. De Fractura Calvae sive Cranei (On Fracture of the Calvaria or Cranium), published in Bologna in 15 18, is the first treatise devoted to head injuries ever printed. It is a landmark in the development of cranial surgery that went through numerous editions. The text was prepared in 2 months and dedicated to Lorenzo de' Medici, Duke of Urbino, who experienced a skull injury in the occipital region. Berengario wanted to demonstrate to other physicians his knowledge of anatomy and his expertise on the brain and head traumas. The book includes the illustration of an entire surgical kit or a corpus instrumentorum for performing cranial operations, which appeared for the first time in a printed book. However, Berengario's highly commendable aim was to indicate to the reader the step-by-step procedure of craniotomy for management of skull fractures along with the sequential use of the previously presented instruments.	[Mazzola, Riccardo F.] Univ Milan, Fdn Osped Maggiore Policlin Regina Elena & Mangia, Dipartimento Sci Chirurg Specialist, IRCCS, I-20122 Milan, Italy; [Mazzola, Isabella C.] Rhein Westfal TH Aachen, Univ Hosp, Dept Plast Surg, Aachen, Germany	Mazzola, RF (corresponding author), Univ Milan, Via Marchiondi 7, I-20122 Milan, Italy.	riccardo.mazzola@fastwebnet.it					CELLINI B, 1728, VITA LUI MEDESIMO SC, P32; CHOULANT L, 1920, HIST BIBLIO ANATOMIC, P136; DECARPI JB, 1990, FRACTURES SKULL CRAN, pR21; FORNI GC, 1948, INSEGNAMENTO CHIRURG, P62; FRENCH R, 1999, DISSECTION VIVISECTI, P91; GURLT E, 1898, GESCH CHIRURG IHRER, V1, P961; MAJNO G, 1975, HEALING HAND MAN WOU, V94, P166; MEDICI M, 1857, COMPENDIO STORICO SC, P54; Putti Vittoro, 1937, BERENGARIO CARPI SAG; VASARI G, 1568, VITE PIU ECCELLENT 3, V1, P83	10	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	NOV	2009	20	6					1981	1984		10.1097/SCS.0b013e3181bd2ddc			4	Surgery	Surgery	526SL	WOS:000272313600007	19881381				2021-06-18	
J	Balaratnasingam, C; Pham, D; Morgan, WH; Bass, L; Cringle, SJ; Yu, DY				Balaratnasingam, Chandrakumar; Pham, Duy; Morgan, William H.; Bass, Louise; Cringle, Stephen J.; Yu, Dao-Yi			Mitochondrial Cytochrome C Oxidase Expression in the Central Nervous System Is Elevated at Sites of Pressure Gradient Elevation but Not Absolute Pressure Increase	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						axon; CNS; cytochrome c oxidase; mitochondria; optic nerve; pressure	CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE; INTRAOCULAR-PRESSURE; AXOPLASMIC-TRANSPORT; AXONAL-TRANSPORT; TISSUE PRESSURE; LAMINA-CRIBROSA; BRAIN-INJURY; ULTRASTRUCTURE; HISTOCHEMISTRY	The paucity of suitable experimental models has made it difficult to isolate the pathogenic role of mitochondria in central nervous system diseases associated with absolute pressure elevation and increased pressure gradients. Experimental models of traumatic brain injury (TBI) and hydrocephalus have been useful for examining the mitochondrial response following pressure increase in the central nervous system; however, the presence of multiple pathogenic factors acting on the brain in these previous studies has made it difficult to determine whether the induced changes were a result of mechanical damage, intracranial pressure elevation, or other pathogenic factors. By direct monitoring and control of pressures in the intraocular, intracranial, and vascular compartments, we use the pig optic nerve, a typical central white matter tract, to compare the temporal sequence of cytochrome c oxidase (CcO) levels between regions of absolute pressure elevation and pressure gradient increase. We demonstrate that a rise in pressure gradient without traumatic injury up-regulates CcO levels across the site of the gradient, in a manner similar to what has been previously reported for hydrocephalus. We also demonstrate that CcO changes do not occur following an absolute pressure rise. These findings taken together with our recent reports suggest that mitochondria initiate an early compensatory response to axonal damage following pressure gradient increase. Extrapolation of our results also suggests that decreased CcO levels in TBI may be secondary to mechanical damage. This study emphasises the importance of pressure gradients in regulating mitochondrial function in the central nervous system. (C) 2009 Wiley-Liss, Inc.	[Balaratnasingam, Chandrakumar; Pham, Duy; Morgan, William H.; Cringle, Stephen J.; Yu, Dao-Yi] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Balaratnasingam, Chandrakumar; Pham, Duy; Morgan, William H.; Cringle, Stephen J.; Yu, Dao-Yi] Univ Western Australia, ARC Ctr Excellence Vis Sci, Perth, WA 6009, Australia; [Bass, Louise] Murdoch Univ, Vet Hosp, Dept Anesthesia, Perth, WA, Australia	Yu, DY (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia.			Cringle, Stephen/0000-0002-5427-554X; Yu, Dao-Yi/0000-0002-9490-534X			ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P800; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; ANDERSON DR, 1969, ARCH OPHTHALMOL-CHIC, V82, P659, DOI 10.1001/archopht.1969.00990020653015; Balaratnasingam C, 2008, INVEST OPHTH VIS SCI, V49, P986, DOI 10.1167/iovs.07-1090; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; BAZZY AR, 1992, J APPL PHYSIOL, V72, P266; Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791; Brooks Dennis E., 1998, Veterinary Ophthalmology, V1, P129, DOI 10.1046/j.1463-5224.1998.00029.x; Buki A, 2000, J NEUROSCI, V20, P2825; CURTI D, 1990, MECH AGEING DEV, V55, P171, DOI 10.1016/0047-6374(90)90024-A; Ding Y, 2001, NEUROSCIENCE, V106, P659, DOI 10.1016/S0306-4522(01)00166-X; GORDON SR, 1988, J HISTOCHEM CYTOCHEM, V36, P701, DOI 10.1177/36.6.3367053; HAHNENBERGER RW, 1980, ACTA PHYSIOL SCAND, V109, P117, DOI 10.1111/j.1748-1716.1980.tb06575.x; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Morgan WH, 1998, INVEST OPHTH VIS SCI, V39, P1419; OCHS S, 1974, FED PROC, V33, P1049; PEROTTI ME, 1983, J HISTOCHEM CYTOCHEM, V31, P351, DOI 10.1177/31.3.6186730; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; POCETA JS, 1981, ANAT RECORD, V200, P349, DOI 10.1002/ar.1092000315; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; WehbyGrant MC, 1996, PEDIATR NEUROSURG, V24, P79, DOI 10.1159/000121021; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5	23	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2009	87	13					2973	2982		10.1002/jnr.22120			10	Neurosciences	Neurosciences & Neurology	492SB	WOS:000269678600016	19437548				2021-06-18	
J	Flohe, S; Nast-Kolb, D				Flohe, S.; Nast-Kolb, D.			Surgical management of life-threatening injuries	UNFALLCHIRURG			German	Article						Emergency room management; Advanced trauma life support (ATLS (R)); Emergency interventions; Fatal trias	EMERGENCY-DEPARTMENT THORACOTOMY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; ABDOMINAL EXSANGUINATION; STILL USEFUL; COAGULOPATHY; CRANIOTOMY; SURVIVAL; PACKING	Life-threatening situations after multiple trauma which then require interruption of the diagnostic algorithm and immediate surgical treatment after admission are a challenge for the multidisciplinary trauma team. Emergency surgery after trauma may be necessary for the abdomen, the pelvis, the chest as well as the head. Therefore, several disciplines may be involved. Damage control surgery is the leading surgical strategy in emergency surgery in unstable trauma patients. The main aspects of damage control surgery are outlined in this article. The goal of damage control surgery is to gain control of bleeding as soon as possible without additional surgical trauma. Packing plays a central role in damage control surgery of the abdomen and the pelvis. Surgical decision-making occurs under unfavorable circumstances and extreme time pressure. However, surgical interventions in the shock room rarely occur in the German health system. Therefore, indications and decision-making processes of these challenging situations have to be practiced with standardized algorithms. The "Definitive Surgical Trauma Care" (DSTC)courses may contribute to a straightforward performance in an emergency operation.	[Flohe, S.] Univ Klinikum Dusseldorf, Klin Unfall & Handchirurg, D-40225 Dusseldorf, Germany; [Nast-Kolb, D.] Univ Klinikum Essen, Unfallchirurg Klin, Essen, Germany	Flohe, S (corresponding author), Univ Klinikum Dusseldorf, Klin Unfall & Handchirurg, Moorenstr 5, D-40225 Dusseldorf, Germany.	Sascha.Flohe@med.uni-duesseldorf.de		Flohe, Sascha/0000-0002-8033-1242; Shahid, Sana/0000-0002-7492-1537			Ali J, 2008, CAN J SURG, V51, P185; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Bulinski P, 2003, J TRAUMA, V54, P161, DOI 10.1097/00005373-200301000-00020; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Degiannis E, 2006, WORLD J SURG, V30, P1258, DOI 10.1007/s00268-005-0463-5; Doll D, 2006, UNFALLCHIRURG, V109, P898, DOI 10.1007/s00113-006-1096-3; FELICIANO DV, 1981, J TRAUMA, V21, P285, DOI 10.1097/00005373-198104000-00005; Hall BL, 2005, J TRAUMA, V59, P773, DOI 10.1097/01.ta.0000177457.45246.8e; Heinzelmann M, 2004, UNFALLCHIRURG, V107, P871, DOI 10.1007/s00113-004-0846-3; Ivatury RR, 2008, J TRAUMA, V64, P7; Jacobs L M, 2001, Conn Med, V65, P265; Matthes G, 2006, UNFALLCHIRURG, V109, P437, DOI 10.1007/s00113-006-1065-x; Moore EE, 1996, AM J SURG, V172, P405, DOI 10.1016/S0002-9610(96)00216-4; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Osborn PM, 2009, INJURY, V40, P54, DOI 10.1016/j.injury.2008.08.038; Pitts LH, 1998, J TRAUMA, V44, P989; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; SCHEIN M, 1986, BRIT J SURG, V73, P369, DOI 10.1002/bjs.1800730514; Seamon MJ, 2008, J TRAUMA, V64, P1, DOI 10.1097/TA.0b013e3181606125; Soreide K, 2007, INJURY, V38, P34, DOI 10.1016/j.injury.2006.06.125; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TOMINAGA GT, 1993, AM SURGEON, V59, P834	24	11	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	OCT	2009	112	10					854	859		10.1007/s00113-009-1680-4			6	Emergency Medicine; Surgery	Emergency Medicine; Surgery	505DG	WOS:000270668300004	19756452				2021-06-18	
J	Marinaro, J; Smith, J; Tawil, I; Billstrand, M; Crookston, KP				Marinaro, Jonathan; Smith, Jessica; Tawil, Isaac; Billstrand, Mary; Crookston, Kendall P.			HBOC-201 use in traumatic brain injury: case report and review of literature	TRANSFUSION			English	Article							JEHOVAH-WITNESS; OXYGEN CARRIER; BLOOD SUBSTITUTES; HEMORRHAGIC-SHOCK; HEMOGLOBIN; RESUSCITATION; INFARCTION; EFFICACY; SAFETY; MODEL	BACKGROUND: The first use of HBOC-201 in severe traumatic brain injury (TBI) is presented. The use of noninvasive cerebral oximetric devices to follow clinical progress in a patient infused with HBOC-201 is reported and the literature of hemoglobin-based oxygen carriers (HBOCs) in brain injury is reported. CASE REPORT: A 21-year-old Jehovah's Witness who was hit and dragged by a motor vehicle was admitted to the University of New Mexico Hospital Level 1 Trauma Center Trauma Surgical Intensive Care Unit with severe TBI and extensive soft tissue loss resulting in profound anemia. The patient received infusion of HBOC-201 with regional and global oximetric monitoring. RESULTS: Chart abstraction was performed to identify clinically relevant physiologic markers of patient progress. We observed a marked increase in brain tissue oxygen saturations, central venous oxygen saturation, and hemodynamic variables after administration of HBOC-201. The patient subsequently suffered massive cerebral edema and died. CONCLUSIONS: Major HBOC trials to date have excluded severe TBI. We report the first use of an HBOC in severe TBI to correct profound anemia. The HBOC-201 rapidly corrected cerebral venous and central venous oxygen saturations. The patient's death may have been due to massive reperfusion injury from delayed repayment of cerebral oxygen debt in a severely ischemic brain.	[Marinaro, Jonathan] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Anesthesiol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA	Marinaro, J (corresponding author), Univ New Mexico, Dept Surg, MSC10-5610,1 Univ New Mexico, Albuquerque, NM 87131 USA.	jmarinaro@salud.unm.edu					Agrawal YP, 2005, TRANSFUSION, V45, P1735, DOI 10.1111/j.1537-2995.2005.00599.x; Allison G, 2004, SOUTH MED J, V97, P1257, DOI 10.1097/01.SMJ.0000140857.11967.2D; *BIOP CORP, 2008, OX SOL; Carson JL, 2002, TRANSFUSION, V42, P812, DOI 10.1046/j.1537-2995.2002.00123.x; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Cothren C, 2002, NEW ENGL J MED, V346, P1097, DOI 10.1056/NEJM200204043461420; Creteur J, 2003, CRIT CARE MED, V31, pS698, DOI 10.1097/01.CCM.0000098037.40520.81; Gannon CJ, 2002, CRIT CARE MED, V30, P1893, DOI 10.1097/00003246-200208000-00036; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Greenburg AG, 2004, CRIT CARE, V8, pS61, DOI 10.1186/cc2455; GUYTON A, 2002, GOLDFRANKS TOXICOLOG, P1438; Hare GMT, 2004, ANESTH ANALG, V99, P528, DOI 10.1213/01.ANE.0000136769.65960.D1; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; Hughes GS, 1996, CRIT CARE MED, V24, P756; Kerby JD, 2007, SHOCK, V27, P652, DOI 10.1097/01.shk.0000248584.10400.dc; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; Lurie F, 2003, ANESTH ANALG, V96, P46, DOI 10.1097/00000539-200301000-00010; Margulies DR, 2002, J TRAUMA, V52, P796, DOI 10.1097/00005373-200204000-00037; Mokhlesi B, 2003, CHEST, V123, P897, DOI 10.1378/chest.123.3.897; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Pan J, 2007, NEURORADIOLOGY, V49, P93, DOI 10.1007/s00234-006-0183-z; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Saxena R, 1999, STROKE, V30, P993, DOI 10.1161/01.STR.30.5.993; Schalte G, 2005, BRIT J ANAESTH, V94, P442, DOI 10.1093/bja/aei068; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Winslow RM, 2000, BRIT J HAEMATOL, V111, P387, DOI 10.1046/j.1365-2141.2000.02326.x	28	11	11	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	OCT	2009	49	10					2054	2059		10.1111/j.1537-2995.2009.02235.x			6	Hematology	Hematology	502BW	WOS:000270430100010	19497051				2021-06-18	
J	Caeyenberghs, K; van Roon, D; van Aken, K; De Cock, P; Linden, CV; Swinnen, SP; Smits-Engelsman, BCM				Caeyenberghs, Karen; van Roon, Dominique; van Aken, Katrijn; De Cock, Paul; Linden, Catharine Vander; Swinnen, Stephan P.; Smits-Engelsman, Bouwien C. M.			Static and Dynamic Visuomotor Task Performance in Children With Acquired Brain Injury: Predictive Control Deficits Under Increased Temporal Pressure	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; anticipation; brain damage; children; eye-hand coordination; manual pursuit; motor control	MOVEMENT ASSESSMENT BATTERY; CLOSED-HEAD INJURY; MOTOR-PERFORMANCE; MANUAL TRACKING; RELIABILITY; RECOVERY; DISORDERS; VALIDITY; MODERATE; IMAGERY	Objective: To compare performance of children with acquired brain injury (AB I) on static versus dynamic visuornotor tasks with that of control children. Participants: Twenty-eight children with ABI and 28 normal age- and gender-matched controls (aged 6-16 years). Main Measures: Two visuornotor tasks on a digitizing tablet: (1) a static motor task requiring tracing of a flower figure and (2) a dynamic task consisting of tracking an accelerating dot presented on a monitor. Results: Children with ABI performed worse than the control group only during the dynamic tracking task; the duration within the target was shorter, the distance between the centers of cursor and target was larger, and the number of velocity peaks per centimeter and the number of stops (ie, the number of submovements) were higher than those of the control group. Rather than resulting from movement execution problems, this might be due to less adequate processing of fast incoming sensory information, resulting in a decreased ability to anticipate the movement of the target (predictive control). Conclusion: Deficits in eye-hand coordination require careful attention, even in the postinjury chronic phase.	[Caeyenberghs, Karen; Smits-Engelsman, Bouwien C. M.] Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Dept Biomed Kinesiol, B-3001 Louvain, Belgium; [van Aken, Katrijn] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, B-3001 Louvain, Belgium; [De Cock, Paul] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Paediat, B-3001 Louvain, Belgium; [Linden, Catharine Vander] Ghent Univ Hosp, Child Rehabil Ctr, Dept Phys Med & Rehabil, B-9000 Ghent, Belgium; [Smits-Engelsman, Bouwien C. M.] Univ Profess, Breda, Netherlands	Smits-Engelsman, BCM (corresponding author), Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Dept Biomed Kinesiol, Tervuursevest 101, B-3001 Louvain, Belgium.	bouwiensmits@hotmail.com		Caeyenberghs, Karen/0000-0001-7009-6843	Research Foundation-FlandersFWO [7.0004.05, GP.026.06N]; Katholieke Universiteit LeuvenKU Leuven [F/06/024]	The support for this study was provided through a grant from the Research Program of the Research Foundation-Flanders (FWO, Levenslijn # 7.0004.05). D. van Roon was funded by a visiting postdoctoral fellowship of the Research Foundation-Flanders (FWO, GP.026.06N) and the Research Fund of Katholieke Universiteit Leuven (F/06/024). K. Caeyenbergbs was funded by a PhD fellowsbip of the Research Foundation-Flanders (FWO).	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Caeyenberghs K, 2009, BRAIN COGNITION, V69, P154, DOI 10.1016/j.bandc.2008.07.001; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; CAIRNEY J, 2008, HUM MOVEMENT SCI, P15; Carey JR, 1998, ARCH PHYS MED REHAB, V79, P435, DOI 10.1016/S0003-9993(98)90146-0; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Croce RV, 2001, PERCEPT MOTOR SKILL, V93, P275, DOI 10.2466/pms.2001.93.1.275; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; DeJong WP, 1996, HANDWRITING AND DRAWING RESEARCH, P429; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Foulder-Hughes L., 2003, BRIT J OCCUPATIONAL, V66, P9; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Henderson S. E., 1992, MOVEMENT ASSESSMENT; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; MOUNOUD P, 1985, J EXP CHILD PSYCHOL, V40, P115, DOI 10.1016/0022-0965(85)90068-2; Smits-Engelsman BC, 1998, MOVEMENT ASSESSMENT; Smits-Engelsman BCM, 1998, HUM MOVEMENT SCI, V17, P699, DOI 10.1016/S0167-9457(98)00019-0; Smits-Engelsman BCM, 2001, HUM MOVEMENT SCI, V20, P161, DOI 10.1016/S0167-9457(01)00033-1; Smits-Engelsman BCM, 2008, PHYS THER, V88, P286, DOI 10.2522/ptj.20070068; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; van Hartingsveldt Margo J, 2005, Occup Ther Int, V12, P1, DOI 10.1002/oti.11; van Roon D, 2008, CHILD DEV, V79, P852, DOI 10.1111/j.1467-8624.2008.01163.x; Van Waelvelde H, 2007, CLIN REHABIL, V21, P465, DOI 10.1177/0269215507074052; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilson BN, 2000, AM J OCCUP THER, V54, P484, DOI 10.5014/ajot.54.5.484; Wilson PH, 2002, J CHILD NEUROL, V17, P491, DOI 10.1177/088307380201700704; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	41	11	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2009	24	5					363	373		10.1097/HTR.0b013e3181af0810			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	509WG	WOS:000271049300007	19858970				2021-06-18	
J	Medina, AC				Carolina Medina, Aida			Functional Appliance Treatment for Bilateral Condylar Fracture in a Pediatric Patient	PEDIATRIC DENTISTRY			English	Article						CONDYLAR FRACTURE; MANDIBULAR FRACTURE; CONSERVATIVE TREATMENT; FUNCTIONAL ORTHODONTIC APPLIANCE; HEAD TRAUMA	FOLLOW-UP; MAXILLOFACIAL FRACTURES; OPEN REDUCTION; CHILDREN; INJURIES	Trauma to the mandible may cause condylar fracture (CF). The prevalence of CF in children is low and treatment must focus on possible long-term effects on the growing facial skeleton and soft tissues. Consequences may include functional disturbances, facial asymmetry, mandibular retrusion, temporomandibular joint dysfunction and ankylosis. Conservative treatment, including close observation, soft diet, physiotherapy, and functional appliances, is advised in most cases. The purpose of this report was to describe the case of a pediatric female patient with bilateral condylar fracture. Treatment consisted of physiotherapy and hybrid functional appliances. Satisfactory remodeling of both condyles occurred and normal occlusion and jaw movements were obtained. Close monitoring will continue throughout the 6-year follow-up period and completion of growth. The conservative treatment approach proved successful in this case. (Pediatr Dent 2009;31:432-7) Received June 8, 2008 / Last Revision August 23, 2008 / Revision Accepted August 27 2008	Cent Univ Venezuela, Dept Pediat Dent, Caracas, Venezuela	Medina, AC (corresponding author), Cent Univ Venezuela, Dept Pediat Dent, Caracas, Venezuela.	caromemo@gmail.com	Medina, Aida Carolina/AAN-9227-2020	Medina, Aida Carolina/0000-0002-0465-4410	CDCH-UCV (Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela) [ICC 10-056-2007]	Presentation of preliminary results of this case at the 21<SUP>st</SUP> IAPD Congress, Hong Kong 2007, was made possible by the CDCH-UCV (Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela) grant no. ICC 10-056-2007.	AMARATUNGA NADA, 1992, J DENT CHILD, V59, P111; Chacon GE, 2003, J ORAL MAXIL SURG, V61, P668, DOI 10.1053/joms.2003.50134; Chatzistavrou Evangelia K, 2007, World J Orthod, V8, P241; Choi J, 2005, INT J ORAL MAX SURG, V34, P851, DOI 10.1016/j.ijom.2005.04.005; Crean S T, 2000, Int J Paediatr Dent, V10, P229, DOI 10.1046/j.1365-263x.2000.00196.x; DeFabianis P, 2001, J Clin Pediatr Dent, V26, P29; DeFabianis P, 2001, J Clin Pediatr Dent, V25, P203; Defabianis P, 2004, J OROFAC PAIN, V18, P253; Defabianis Patrizia, 2003, J Clin Pediatr Dent, V27, P191; Defabianis Patrizia, 2003, J Clin Pediatr Dent, V27, P297; Defabianis Patrizia, 2002, J Clin Pediatr Dent, V26, P243; Deleyiannis FWB, 2006, ANN PLAS SURG, V57, P495, DOI 10.1097/01.sap.0000226943.79337.bf; Dimitroulis G, 1997, AUST DENT J, V42, P367, DOI 10.1111/j.1834-7819.1997.tb06079.x; Ellis E, 2005, J ORAL MAXIL SURG, V63, P115, DOI 10.1016/j.joms.2004.02.019; Gerhard S, 2007, INT J ORAL MAX SURG, V36, P214, DOI 10.1016/j.ijom.2006.09.013; GIRTHOFER C, 2002, J OROFAC ORTHOP, V63, P429; Guven O, 2001, J CRANIO MAXILL SURG, V29, P232, DOI 10.1054/jcms.2001.0228; HOTZ RP, 1978, AM J ORTHOD DENTOFAC, V73, P365, DOI 10.1016/0002-9416(78)90169-0; Iida S, 2002, J CRANIO MAXILL SURG, V30, P237, DOI 10.1054/jcms.2002.0295; KAHL B, 1995, DENTOMAXILLOFAC RAD, V24, P37, DOI 10.1259/dmfr.24.1.8593906; Kahl-Nieke B, 1999, J Orofac Orthop, V60, P24, DOI 10.1007/BF01358713; Kahl-Nieke B, 1998, J Orofac Orthop, V59, P150, DOI 10.1007/BF01317176; KLAMMT G, 1969, Fortschritte der Kieferorthopaedie, V30, P305, DOI 10.1007/BF02286281; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P153, DOI 10.1016/S0300-9785(77)80048-3; NORHOLT SE, 1993, J ORAL MAXIL SURG, V51, P1302, DOI 10.1016/S0278-2391(10)80132-6; Ogunlewe MO, 2006, INT J PAEDIATR DENT, V16, P358, DOI 10.1111/j.1365-263X.2006.00757.x; PROFFIT WR, 1980, AM J ORTHOD DENTOFAC, V78, P1, DOI 10.1016/0002-9416(80)90037-8; Ramirez Yanez GO, 2002, WORLD J ORTHOD, V3, P349; Schoen R, 2005, BRIT J ORAL MAX SURG, V43, P258, DOI 10.1016/j.bjoms.2004.11.005; Strobl H, 1999, INT J ORAL MAX SURG, V28, P95; Thoren H, 2001, J ORAL MAXIL SURG, V59, P768, DOI 10.1053/joms.2001.23369; VIG PS, 1986, AM J ORTHOD DENTOFAC, V90, P273, DOI 10.1016/0889-5406(86)90084-3; Yamashiro T, 1998, ANGLE ORTHOD, V68, P85	34	11	13	0	6	AMER ACAD PEDIATRIC DENTISTRY	CHICAGO	211 E CHICAGO AVENUE SUITE 1036, CHICAGO, IL 60611-2616 USA	0164-1263	1942-5473		PEDIATR DENT	Pediatr. Dent.	SEP-OCT	2009	31	5					432	437					6	Dentistry, Oral Surgery & Medicine; Pediatrics	Dentistry, Oral Surgery & Medicine; Pediatrics	668SI	WOS:000283289700012	19947140				2021-06-18	
J	de Groot, V; Beckerman, H; Uitdehaag, BM; Hintzen, RQ; Minneboo, A; Heymans, MW; Lankhorst, GJ; Polman, CH; Bouter, LM				de Groot, Vincent; Beckerman, Heleen; Uitdehaag, Bernard M.; Hintzen, Rogier Q.; Minneboo, Arjan; Heymans, Martijn W.; Lankhorst, Gustaaf J.; Polman, Chris H.; Bouter, Lex M.		Functional Prognostication Disabil	Physical and Cognitive Functioning After 3 Years Can Be Predicted Using Information From the Diagnostic Process in Recently Diagnosed Multiple Sclerosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cohort studies; Disability evaluation; Multiple sclerosis; Prognosis; Rehabilitation	LOGISTIC-REGRESSION ANALYSIS; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SMALL DATA SETS; PROGNOSTIC MODELS; NATURAL-HISTORY; FOLLOW-UP; EXTERNAL VALIDATION; DISABILITY; COHORT	Objective: To predict functioning after 3 years in patients with recently diagnosed multiple sclerosis (MS). Design: Inception cohort with 3 years of follow-up. At baseline, predictors were obtained from medical history taking, neurologic examination, and magnetic resonance imaging (MRI). Setting: Neurology outpatient clinic. Participants: Patients with MS (N=156); 146 with complete follow-up. Interventions: Not applicable. Main Outcome Measures: Inability to walk at least 500m, impaired dexterity, cognitive impairments, incontinence, in ability to drive a car or use public transportation, social dysfunction, and reliance on a disability pension. Results: Clinical prediction rules were constructed for the models that were well calibrated (sufficient agreement between predicted and observed outcomes, based on Visual inspection of calibration curves) and that showed sufficient discrimination (area under the receiver operation characteristic curve >.70) after internal bootstrap validation. The models for the inability to walk at least 500m, impaired dexterity, and cognitive impairments were well calibrated. Discrimination was sufficient for all 7 models, except the one predicting social dysfunction (.67). The inability to walk at least 500m was predicted by the perceived ability to walk, impairment of the cerebellar tract, and the number of MRI lesions in the spinal cord. Impaired dexterity was predicted by the perceived ability to use the hands, impairments of the pyramidal, cerebellar, and sensory tracts, and the T2-weighted infratentorial lesion load. Cognitive impairment was predicted by age, gender, the perceived ability to concentrate, and the T2-weighted supratentorial lesion load. Conclusions: Inability to walk at least 500m, impaired dexterity, and cognitive impairments can be predicted with predictors that are derived from medical history taking, neurologic examination, and MRI shortly after a definite diagnosis of MS has been made.	[de Groot, Vincent; Beckerman, Heleen; Lankhorst, Gustaaf J.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, NL-1007 MB Amsterdam, Netherlands; [Uitdehaag, Bernard M.] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; [Uitdehaag, Bernard M.; Polman, Chris H.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Minneboo, Arjan] Vrije Univ Amsterdam Med Ctr, Dept Radiol, NL-1007 MB Amsterdam, Netherlands; [de Groot, Vincent; Beckerman, Heleen; Heymans, Martijn W.; Lankhorst, Gustaaf J.; Bouter, Lex M.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, NL-1007 MB Amsterdam, Netherlands; [Hintzen, Rogier Q.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands	de Groot, V (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	v.degroot@vumc.nl	De Groot, Vincent/S-3482-2019; de Groot, Vincent/J-8977-2013; de Groot, I.J.M./L-4339-2015; Bouter, Lex/X-1003-2019	de Groot, Vincent/0000-0002-6073-6250; Bouter, Lex/0000-0002-2659-5482; Beckerman, Heleen/0000-0002-8421-3630; Heymans, Martijn/0000-0002-3889-0921	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [NWO 940-33-009]	Supported by The Netherlands Organization for Scientific Research (grant no. NWO 940-33-009).	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Amato M. P., 2000, Neurological Sciences, V21, pS831, DOI 10.1007/s100720070021; Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Bot JCJ, 2004, NEUROLOGY, V62, P226, DOI 10.1212/WNL.62.2.226; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; de Groot V, 2005, MULT SCLER, V11, P713, DOI 10.1191/1352458505ms1238oa; de Groot V, 2008, J REHABIL MED, V40, P151, DOI 10.2340/16501977-0145; Dent A, 2000, BRIT J CLIN PSYCHOL, V39, P311, DOI 10.1348/014466500163329; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Janssens ACJW, 2004, J CLIN EPIDEMIOL, V57, P180, DOI 10.1016/S0895-4356(03)00260-9; Janssens ACJW, 2003, EUR J NEUROL, V10, P287, DOI 10.1046/j.1468-1331.2003.00583.x; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kalkers NF, 2001, NEUROLOGY, V56, P215, DOI 10.1212/WNL.56.2.215; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LAMAN H, 1994, DISABIL REHABIL, V16, P198, DOI 10.3109/09638289409166613; Lankhorst GJ, 1996, J NEUROL, V243, P469, DOI 10.1007/BF00900502; Matheny ME, 2005, J BIOMED INFORM, V38, P367, DOI 10.1016/j.jbi.2005.02.007; NORM, 1999, MULT IMP INC MULT DA; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pittock SJ, 2004, NEUROLOGY, V62, P51, DOI 10.1212/01.WNL.0000101724.93433.00; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Righini M, 2004, CURR OPIN PULM MED, V10, P345, DOI 10.1097/01.mcp.0000130329.21799.7b; RUNMARKER B, 1994, J NEUROL, V241, P597, DOI 10.1007/BF00920623; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Solari A, 2002, MULT SCLER, V8, P169, DOI 10.1191/1352458502ms780oa; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Uitdehaag BMJ, 2002, MULT SCLER, V8, P366, DOI 10.1191/1352458502ms835oa; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; VANBENNEKOM CAM, 1995, ARCH PHYS MED REHAB, V76, P501, DOI 10.1016/S0003-9993(95)80502-8; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; WEINSHENKER BG, 1991, BRAIN, V114, P1045, DOI 10.1093/brain/114.2.1045	46	11	11	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2009	90	9					1478	1488		10.1016/j.apmr.2009.03.018			11	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	496AA	WOS:000269938100004	19735774	Green Published			2021-06-18	
J	Fletcher, JJ; Bergman, K; Feucht, EC; Blostein, P				Fletcher, Jeffrey J.; Bergman, Karen; Feucht, Eric C.; Blostein, Paul			Continuous Renal Replacement Therapy for Refractory Intracranial Hypertension	NEUROCRITICAL CARE			English	Article						Continuous renal replacement therapy; Traumatic brain injury; Hemofiltration; Hypervolemia; Intracranial hypertension	CONTINUOUS VENOVENOUS HEMOFILTRATION; CEREBRAL EDEMA; BRAIN WATER; PRESSURE; HEMODIALYSIS; FLUID; MANAGEMENT; DIALYSIS; FAILURE; UREMIA	Little is known about the effects of hemodialysis on the injured brain, however; concern exists over the use of intermittent hemodialysis in patients with acute brain injury (ABI) due to its hemodynamic effects and increased intracranial pressure (ICP) associated with therapy. Continuous renal replacement therapy (CRRT) has become the preferred method of renal support in these patients though there is limited data to support its safety. Furthermore, exacerbations of cerebral edema have been reported. CRRT is an option for the treatment of hypervolemia and in theory may improve intracranial compliance. We report the case of a poly-trauma patient with severe traumatic brain injury (TBI) in which CRRT was implemented solely for refractory intracranial hypertension. A 28-year-old male was involved in a high-speed motor vehicle collision suffering a severe TBI and polytrauma. He required significant volume resuscitation. Intensive care unit course was complicated by shock, acute respiratory distress syndrome, ventilator associated pneumonia, and development of intracranial hypertension (IH). Data were collected by retrospective chart review. Continuous hemofiltration was initiated for IH refractory to medical therapy. Within hours of initiation increase, ICP improved and normalized. Hemofiltration was safely discontinued after 48 h. Modified Rankin Score was 2 at 90 days. Though unproven, CRRT may be beneficial in patients with IH due to gentle removal of fluid, solutes, and inflammatory cytokines. Given the limited data on safety of CRRT in patients with ABI, we encourage further reports.	[Fletcher, Jeffrey J.; Bergman, Karen; Feucht, Eric C.; Blostein, Paul] Bronson Methodist Hosp, Dept Neurol Neurocrit Care, Kalamazoo, MI 49007 USA; [Fletcher, Jeffrey J.; Bergman, Karen; Feucht, Eric C.; Blostein, Paul] Bronson Methodist Hosp, Dept Crit Care Med & Trauma Crit Care, Kalamazoo, MI 49007 USA	Fletcher, JJ (corresponding author), Bronson Methodist Hosp, Dept Neurol Neurocrit Care, 601 John St,Suite M-124, Kalamazoo, MI 49007 USA.	fletchej@bronsonhg.org					ARIEFF AI, 1973, KIDNEY INT, V4, P177, DOI 10.1038/ki.1973.100; ARIEFF AI, 1976, J CLIN INVEST, V58, P306, DOI 10.1172/JCI108473; BELLOMO R, 1993, CRIT CARE MED, V21, P522, DOI 10.1097/00003246-199304000-00011; BERTRAND YM, 1983, INTENS CARE MED, V9, P321, DOI 10.1007/BF01692550; Caruso DM, 1998, J NEUROSURG, V89, P649, DOI 10.3171/jns.1998.89.4.0649; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; DAVENPORT A, 1989, AM J KIDNEY DIS, V14, P516, DOI 10.1016/S0272-6386(89)80153-2; Davenport A, 1999, KIDNEY INT, V56, pS62, DOI 10.1046/j.1523-1755.56.s.72.3.x; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; DAVENPORT A, 1990, NEPHROL DIAL TRANSPL, V5, P192, DOI 10.1093/ndt/5.3.192; DAVENPORT A, 1991, CONTRIB NEPHROL, V93, P225; DAVENPORT A, 1987, BRIT MED J, V295, P1098; Davenport A, 2007, CONTRIB NEPHROL, V156, P333, DOI 10.1159/000102124; Galons JP, 1996, J CLIN INVEST, V98, P750, DOI 10.1172/JCI118847; Ghahramani N, 2008, NEPHROLOGY, V13, P570, DOI 10.1111/j.1440-1797.2008.00966.x; Goldsmith DJA, 1997, CLIN SCI, V93, P593, DOI 10.1042/cs0930593; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Rabindranath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003773.pub3; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; SCHETZ M, 1997, CURR OPIN CRIT CARE, V3, P434; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; SHENKIN HA, 1968, J NEUROSURG, V28, P417, DOI 10.3171/jns.1968.28.5.0417; SHENKIN HA, 1976, J NEUROSURG, V45, P432, DOI 10.3171/jns.1976.45.4.0432; Silver SM, 1996, AM J KIDNEY DIS, V28, P1, DOI 10.1016/S0272-6386(96)90124-9; Silver SM, 1995, J AM SOC NEPHROL, V6, P1600; TRACHTMAN H, 1993, J AM SOC NEPHROL, V3, P1913	28	11	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2009	11	1					101	105		10.1007/s12028-009-9197-9			5	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	468AU	WOS:000267786400019	19267223				2021-06-18	
J	van Hensbroek, PB; Mulder, S; Luitse, JSK; van Ooijen, MR; Goslings, JC				van Hensbroek, P. Boele; Mulder, S.; Luitse, J. S. K.; van Ooijen, M. R.; Goslings, J. C.			Staircase falls: High-risk groups and injury characteristics in 464 patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Staircase falls; Injury characteristics; High-risk groups; Young children; Senior citizens	CHILDREN; ACCIDENTS; SLIP; TRIP; AGE	Introduction: Few data are available about the epidemiology and injury characteristics in staircase falls. The available literature mainly concerns children and autopsy studies. Objective: To describe the epidemiology and injury characteristics of staircase falls, and to identify high-risk groups for these falls. Methods: All patients who reported to an academic Accident & Emergency (A&E) department in 2005 after a staircase fall were selected in the Dutch Injury Surveillance System These data were linked to the hospital Trauma Registry database. Results: Four hundred and sixty-four patients (42% male, p = 0.001), with a median age of 35 years were included. Children under five suffered significantly more head injuries. Male patients showed significantly more thoracic injuries than female patients. Spinal column fractures were only seen in patients over 25 years of age. Older patients tended to accumulate more rib fractures and lower extremity fractures and were admitted more frequently than the younger patients. Sixty-one patients (13%) required admission. Two patients, both with severe traumatic brain injury TBI), died. National data on staircase falls were comparable with our hospital data. However, in comparison to the national population data, senior citizens in this study had an incidence that was markedly higher than in the younger patients. Conclusion: Injuries due to staircase falls occur in all age groups, however, children under five years are relatively over-represented with higher rates of head injury. Senior citizens showed a markedly higher incidence than younger patients. Most injuries occur to the distal extremities and are relatively mild. (C) 2009 Elsevier Ltd. All rights reserved.	[van Hensbroek, P. Boele; Luitse, J. S. K.; van Ooijen, M. R.; Goslings, J. C.] Acad Med Ctr, Trauma Unit, Dept Surg, NL-1100 DD Amsterdam, Netherlands; [Mulder, S.] Consumer Safety Inst, Amsterdam, Netherlands	van Hensbroek, PB (corresponding author), Acad Med Ctr, Trauma Unit, Dept Surg, G4-134,Meibergdreef 9,POB 22660, NL-1100 DD Amsterdam, Netherlands.	p.boelevanhensbroek@amc.nl					Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Albrecht-Anoschenko J, 2005, ZBL NEUROCHIR, V66, P59, DOI 10.1055/s-2005-836487; Cayless SM, 2001, APPL ERGON, V32, P155, DOI 10.1016/S0003-6870(00)00052-1; Chang LT, 2007, J TRAUMA, V63, P70, DOI 10.1097/01.ta.0000219142.15584.b8; CHIAVIELLO CT, 1994, PEDIATRICS, V94, P679; DAWODU ST, 2007, TRAUMATIC BRAIN INJU; *DEP TRAD IND METR, 2007, AV SLIPS TRIPS BROK; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Hamel KA, 2004, J AM GERIATR SOC, V52, P563, DOI 10.1111/j.1532-5415.2004.52162.x; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; JOFFE M, 1988, PEDIATRICS, V82, P457; McGeehan J, 2006, PEDIATRICS, V118, pE279, DOI 10.1542/peds.2005-1822; MOSENTHAL AC, 1995, J TRAUMA, V38, P753, DOI 10.1097/00005373-199505000-00013; *STAT NETH, 2008, POP BAS FIG; Trokel M, 2006, PEDIATR EMERG CARE, V22, P700, DOI 10.1097/01.pec.0000238734.76413.d0; Wyatt JP, 1999, INJURY, V30, P31, DOI 10.1016/S0020-1383(98)00191-0	16	11	11	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	AUG	2009	40	8					884	889		10.1016/j.injury.2009.01.105			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	483FU	WOS:000268948800020	19486973				2021-06-18	
J	Hashimoto, K; Abo, M				Hashimoto, Keiji; Abo, Masahiro			ABNORMAL REGIONAL BENZODIAZEPINE RECEPTOR UPTAKE IN THE PREFRONTAL CORTEX IN PATIENTS WITH MILD TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						mild traumatic brain injury; MTBI; single photon emission tomography; SPECT; neuropsychological dysfunction	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; POSTCONCUSSION SYNDROME; SPECT; PERFUSION; CT	Objective: The diagnosis and management of mild traumatic brain injury continues to he a subject of debate, with varying opinions regarding the extent to which organically based impairments vs the impact of other stressors cause ongoing disability. The aim of this stud), was to elucidate the possible abnormalities in benzodiazepine receptor uptake in the brains of patients with mild traumatic brain injury. Nine unmedicated patients with mild traumatic brain injury were investigated using (123)I-iomazenil single photon emission computerized tomography (SPECT). Design: A descriptive study comparing patients after mild traumatic brain injury with matched control subjects. Subjects: Nine patients with mild traumatic brain injury and 5 controls. Methods: The SPECT scan was taken 180 min after injection of tracer. Results and conclusion: All 9 patients had a significant increase (> 2 standard deviations higher than the mean of controls) in benzodiazepine receptor uptake in the prefrontal cortex and significantly higher frontal association cortex-to-average global brain activity ratios than in controls. This SPECT study demonstrated focally altered benzodiazepine receptor uptake in the prefrontal cortices in patients with mild traumatic brain injury.	[Hashimoto, Keiji] Jikei Univ, Div Rehabil Med, Natl Ctr Child Hlth & Dev, Sch Med, Tokyo 1578535, Japan; [Abo, Masahiro] Jikei Univ, Dept Rehabil Med, Sch Med, Tokyo 1578535, Japan	Hashimoto, K (corresponding author), Jikei Univ, Div Rehabil Med, Natl Ctr Child Hlth & Dev, Sch Med, 2-10-1 Okura, Tokyo 1578535, Japan.	hashimoto-k@ncchd.go.jp		Hashimoto, Keiji/0000-0003-2412-860X; Abo, Masahiro/0000-0001-6701-4974			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; JACOBS A, 1994, J NUCL MED, V35, P942; KUIKKA JT, 1995, NUCL MED COMMUN, V16, P273, DOI 10.1097/00006231-199504000-00159; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MINOSHIMA S, 1995, J NUCL MED, V36, P1238; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; TIKOFSKY RS, 1994, J NUCL MED, V35, P947	17	11	12	0	0	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUL	2009	41	8					661	665		10.2340/16501977-0388			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	474WY	WOS:000268316700010	19565161	DOAJ Gold			2021-06-18	
J	Hill, PS; Ngo, AD; Khuong, TA; Dao, HL; Hoang, HM; Trinh, HT; Nguyen, LTN; Nguyen, PH				Hill, Peter S.; Ngo, Anh D.; Khuong, Tuan A.; Dao, Huong L.; Hoang, Hanh M.; Trinh, Hang T.; Nguyen, Lien T. N.; Nguyen, Phong H.			Mandatory helmet legislation and the print media in Viet Nam	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Viet Nam; Motorcycles; Helmets; Print media; Policy; Prevention	MASS-MEDIA; HEALTH; POLICY	With motorcycle ownership high and rising in Viet Nam, and motorcycle riders vulnerable to both fatal and non-fatal injury, the re-introduction of mandatory helmet legislation in 2007 has been a priority for the Vietnamese government. The paper uses a qualitative analysis of web-based versions of the eight most popular newspapers in Viet Nam to track reporting over four phases of the implementation of the legislation, identifying codes and constructing the dominant themes of the media coverage. The study documents the justification and promotion of the legislation, and the mechanisms for preparing for its implementation at a national and local level, developing solutions and encouraging the replication of successful strategies. It records opposition and obstacles to helmet use, and concerns raised around the quality of helmets purchased. In return, the press notes the response of the market in innovative solutions to these problems. With the successful implementation of the legislation, the functions of the print media in promulgating and promoting the legislation, together with the reporting of ongoing resistance to the process, serve to enable a dialogue between the State and population around expressed concerns. In highlighting quality control of helmets as a key issue, the media have identified a potential ongoing role in monitoring the state's initiative in reducing the road toll from traumatic brain injury in motorcyclists. (C) 2009 Elsevier Ltd. All rights reserved.	[Hill, Peter S.; Ngo, Anh D.; Khuong, Tuan A.] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia; [Hoang, Hanh M.; Trinh, Hang T.; Nguyen, Lien T. N.; Nguyen, Phong H.] Hlth Strategy & Policy Inst, Hanoi, Vietnam; [Dao, Huong L.] Viet Nam Off, World Bank, Hanoi, Vietnam	Hill, PS (corresponding author), Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia.	peter.hill@sph.uq.edu.au; n.anh@sph.uq.edu.au; khuonganhtuan@hspi.org.vn; hdao1@worldbank.org; hoangmyhanh@hspi.org.vn; namedmoon@yahoo.com; namlien71@yahoo.com; phong_the_great@yahoo.com	Hill, Peter Stewart/AAL-8053-2020; Hill, Peter/F-2768-2010	Hill, Peter Stewart/0000-0001-7091-5108; Hill, Peter/0000-0001-7091-5108			*A FFORD ASS, 2008, VIET NAM 2007 RETR C; *AQDAS, ATL QUAL DAT AN SOFT; *AS INJ PREV FDN, 2008, CEL UN GET WORD OUT; Blows S, 2005, INJURY PREV, V11, P304, DOI 10.1136/ip.2005.0086680; BUSE K, 2005, MAKING HLTH POLICY, P75; Chapman S, 1994, FIGHT PUBLIC HLTH PR; CHAPMAN S, 1998, HDB PUBLIC HLTH METH, P483; CHINH ND, 2008, ABSTR REP 2 AS PAC C, P97; CONWAY T, 2004, 241 OVERS DEV I; CRAFT G, 2008, LESSONS HELMET WEARI; DAN CAN, 2007, CHRISTMAS GOD FATHER; DAN CAN, 2008, WHEN HEAD PROTECTOR; DAN CAN, 2007, NO EXCEPTION THOSE W; DAN N, 2007, SAFETY HELMETS WHICH; DAN N, 2007, HO CHI MINH CITY; DAN N, 2007, DECEMBER 15 THERE WI; DAN N, 2007, HANOI DA NANG ENCOUR; DAN N, 2007, STRICTLY PUNISH MOTO; DAN N, 2007, MANAGEMENT SAFETY HE; DAN N, 2007, WEAR SAFETY HELMET M; DAN N, 2007, MOBILIZE RESOURCES F; *DHYTCC, 2003, BAO CAO KET QUA NGHI; DONG L, 2007, VIETNAM LABOUR UNION; DONG L, 2007, TPHCM PRESENTING 200; DONG L, 2007, HEAT HELMETS; DONG L, 2007, POLICE ROAD REMIND P; Elder RW, 2004, AM J PREV MED, V27, P57, DOI 10.1016/j.amepre.2004.03.002; *GOV VIET NAM, 2007, 322007NQCP GOV VIET; HANH HTM, 2008, VIETNAM COST EFFECT, V6, P17; Harrabin R, 2003, HLTH NEWS RISK REPOR; Heng R. H.-K., 2001, SOJOURN, V16, P213; Hung DV, 2006, INJURY PREV, V12, P409, DOI 10.1136/ip.2006.012724; Hung DV, 2008, ACCIDENT ANAL PREV, V40, P1627, DOI 10.1016/j.aap.2008.05.002; HUYEN NTT, 2008, MINISTRY HLTH NEWSLE, P20; Kerkvliet B. J. T., 2001, SOJURN: Journal of Social Issues in Southeast Asia, V16, P238, DOI 10.1355/SJ16-2D; Khan H, 2008, EJC SUPPL, V6, P137, DOI 10.1016/S1359-6349(08)71702-6; LIU BC, 2008, HELMETS PREVENTING I, P4333, DOI DOI 10.1002/14651858.CD004333.PUB3; MART D, 1998, MASS MEDIA VIETNAM P, V25, P20; MCDONNELL MB, 2008, INJURY PREVENTION RO; McKay MP, 2004, ANN EMERG MED, V44, P155, DOI 10.1016/jannemergmed.2004.05.009; *MIN TRANSP, 2001, 082001TTBGTVT MIN TR; *MIN TRANSP, 2000, 3122000TTBGTVT MIN T; *MIN TRANSP, 2003, 012003TTBGTVT MIN TR; NIEN T, 2007, 1 DAY IMPLEMENTING H; NIEN T, 2007, 1 DAY IMPLEMENTING D; NIEN T, 2007, 3 DAY FOLLOWING ENFO; NIEN T, 2007, HCM CITY STEPS INSPE; NIEN T, 2008, DONT JUST BECAUSE WE; NIEN T, 2007, COLLABORATION CONTRO; NIEN T, 2007, UNIQUE CHRISTMAS TRE; NIEN T, 2007, HANOI FULL HELMETS A; Nolen Sixten, 2002, Inj Control Saf Promot, V9, P89, DOI 10.1076/icsp.9.2.89.8695; OTTEN AL, 1992, HEALTH AFFAIR, V11, P111, DOI 10.1377/hlthaff.11.4.111; Paalman M, 1997, HEALTH POLICY PLANN, V12, P86, DOI 10.1093/heapol/12.1.86; Peden M., 2004, WORLD REPORT ROAD TR; PHONG SG, 2007, 2 DAY LAW COMES INTO; PHONG SG, 2007, G CRAFT WEARS SAFETY; PHONG SG, 2007, MOTOR RIDERS VOLUNTA; PHONG SG, 2007, SURVIVED THANKS WEAR; PHONG SG, 2007, MORE THAN 60 SAMPLES; PHONG SG, 2007, SAFETY MARKET HCM CI; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; SHELOV SP, 1995, PEDIATR ANN, V24, P419, DOI 10.3928/0090-4481-19950801-09; Stead M, 2005, HEALTH EDUC RES, V20, P36, DOI 10.1093/her/cyg093; THAI NT, 2008, MINISTRY HLTH NEWSLE, P18; TRE T, 2007, 10000 HELMETS GIVEN; TRE T, 2007, SOME WEAR SOME DONT; TRE T, 2007, ANNOUNCEMENT LIST SA; TRE T, 2007, MORE FREE HELMETS XE; TRE T, 2007, GENUINE FAKE HELMETS; TRE T, 2007, BOOMING LIVE OFF SER; TRE T, 2007, THOUGHTS HELMET; TRE T, 2007, HELMETS MUST CONTAIN; TRE T, 2007, HANOI POLICE ROLE MO; TRE T, 2007, G CRAFT WEARS SAFETY; TRE T, 2007, INSIDER; TRE T, 2007, FAKE HELMET FELL GRO; TRE T, 2007, DONT LET CASE SPEND; TRE T, 2007, PROBLEMS ARISING HEL; TRE T, 2007, HANOI MORE THAN 80 H; Truitt A, 2008, AM ETHNOL, V35, P3, DOI 10.1111/j.1548-1425.2008.00002.x; *VIETN, 2007, INC WEAR HELM MAN AD; *VIETN, 2007, AG HELM AG STRAIGHT; *VIETN, 2007, WEAR HELM LOOK IT EC; *VNEXPRESS, 2007, YOUNG GIRLS SAF HELM; *VNEXPRESS, 2007, BOOM SERV HELM; *VNEXPRESS, 2007, DISC WEAR HELM; *VNEXPRESS, 2007, 20 HELM SAMPLE DO NO; *VNEXPRESS, 2007, HAN SIGN COMM; *VNEXPRESS, 2007, SAF HELM AR DANG CHI; WALLACK L, 1994, J PUBLIC HEALTH POL, V15, P420, DOI 10.2307/3343024; WILSON BJ, 2007, J NUTR EDUC BEHAV, V8, P201; Witter S, 1996, INT J HEALTH PLAN M, V11, P159; 2008, GLOBAL ROAD SAFETY P	94	11	12	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2009	41	4					789	797		10.1016/j.aap.2009.04.001			9	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	471QC	WOS:000268072200016	19540968				2021-06-18	
J	Knight, RG; O'Hagan, K				Knight, Robert G.; O'Hagan, Kimberley			Autobiographical memory in long-term survivors of severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Remote memory; Retrograde amnesia; Autobiographical memory; Social deficits; Semantic memory	CLOSED-HEAD INJURY; EPISODIC MEMORY; COGNITIVE NEUROSCIENCE; SEMANTIC MEMORY; RETROGRADE; REMOTE; RECOLLECTION; SENSE; SELF	The aim of this study was to examine the ability of persons who had sustained a severe traumatic brain injury (TBI) at least 6 years previously to recall memories associated with famous names. Each of 19 persons with TBI was matched with a healthy control of the same age, gender, and occupational-educational background. A list of 115 names of famous people was compiled, 25 of whom came to prominence in each decade from 1960 to 1999, and 15 in the period 2000 to 2005. Participants were first asked whether they recognized each name as being of a famous person and to state the reason for the individual's fame. For those names they correctly identified, they were asked to recall a memory associated with the person; each memory produced was categorized as a context-specific memory or a general memory. The ability to recognize and identify famous names was well preserved in the TBI group; however, they showed a consistent impairment in the ability to recall specific episodic memories acquired before and after the date of the TBI. This inability to generate personal and specific information is likely to have an impact on the ability of the person with TBI to participate in interpersonal interactions and problem solve in complex social situations.	[Knight, Robert G.; O'Hagan, Kimberley] Univ Otago, Dept Psychol, Dunedin 9013, New Zealand	Knight, RG (corresponding author), Univ Otago, Dept Psychol, Box 56, Dunedin 9013, New Zealand.	rknight@psy.otago.ac.nz			University of Otago	This study was supported by a University of Otago research grant.	ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fujii T., 2000, HDB NEUROPSYCHOLOGY, V4, P23; Gilboa A, 2006, HIPPOCAMPUS, V16, P966, DOI 10.1002/hipo.20226; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Jennett B, 1981, MANAGEMENT HEAD INJU; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KNOWLTON BJ, 1995, J EXP PSYCHOL LEARN, V21, P699, DOI 10.1037/0278-7393.21.3.699; Knowlton BJ, 1998, ACTA PSYCHOL, V98, P253, DOI 10.1016/S0001-6918(97)00045-0; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Piolino P, 2005, COGN NEUROPSYCHOL, V22, P1005, DOI 10.1080/02643290442000428; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; RENDLE V, 2005, BRAIN IMPAIRMENT, V6, P90; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1975, J EXP PSYCHOL-HUM L, V104, P50; Steinvorth S, 2005, NEUROPSYCHOLOGIA, V43, P479, DOI 10.1016/j.neuropsychologia.2005.01.001; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Westmacott R, 2004, COGN NEUROPSYCHOL, V21, P353, DOI 10.1080/02643290342000375; Westmacott R, 2004, NEUROPSYCHOLOGIA, V42, P25, DOI 10.1016/S0028-3932(03)00147-7; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	33	11	11	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2009	31	5					575	583		10.1080/13803390802363710			9	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	473YT	WOS:000268249200007	18972310				2021-06-18	
J	Yang, YG; Jiang, DM; Quan, ZX; Ou, YS				Yang, Y-G; Jiang, D-M; Quan, Z-X; Ou, Y-S			Insulin with Chondroitinase ABC Treats the Rat Model of Acute Spinal Cord Injury	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						INSULIN; CHONDROITINASE ABC; ACUTE SPINAL CORD INJURY; RAT MODEL; AXON REGROWTH; GROWTH ASSOCIATED PROTEIN 43	AXONAL REGENERATION; GROWTH; RECOVERY; PROTEOGLYCANS; HEMISECTION; EXPRESSION; PREVENTION; OUTGROWTH; NEURONS; CNS	Traumatic brain injury is often associated with acute spinal cord injury (ASCI). Insulin and chondroitinase ABC (ChABC) are both therapeutically effective, but the combined therapeutic effect of insulin and ChABC is still not clear. A combination of insulin and ChABC were used to treat a rat model of ASCI. This combination therapy prevented neuronal cell death by improving motor function, increasing cell growth and inhibiting cell apoptosis in ASCI rats. Expression of growth-associated protein 43, a marker of axonal re-growth, increased after combined treatment with insulin and ChABC. These results may provide a basis for a future method of treating ASCI.	[Yang, Y-G; Jiang, D-M; Quan, Z-X; Ou, Y-S] Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing 400016, Peoples R China	Jiang, DM (corresponding author), Chongqing Med Univ, Dept Orthopaed, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	dmjiang2009@yahoo.cn					Aarts LHJ, 1998, ADV EXP MED BIOL, V446, P85; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brange J, 1993, Pharm Biotechnol, V5, P315; Caggiano AO, 2005, J NEUROTRAUM, V22, P226, DOI 10.1089/neu.2005.22.226; Chen CH, 2005, J CELL BIOCHEM, V94, P684, DOI 10.1002/jcb.20341; Chen HY, 2005, J NEUROCYTOL, V34, P37, DOI 10.1007/s11068-005-5046-8; Colberg SR, 2007, CURR DIABETES REV, V3, P176; Costacou T, 2003, ANNU REV NUTR, V23, P147, DOI 10.1146/annurev.nutr.23.011702.073027; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Filbin MT, 2000, CURR BIOL, V10, pR100, DOI 10.1016/S0960-9822(00)00302-X; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Li GL, 1996, ACTA NEUROPATHOL, V92, P19, DOI 10.1007/s004010050484; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nihal M, 2005, INT J CANCER, V114, P513, DOI 10.1002/ijc.20785; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rouleau P, 2007, J NEUROTRAUM, V24, P367, DOI 10.1089/neu.2006.0117; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; TENCER AF, 1985, SPINE, V10, P586, DOI 10.1097/00007632-198507000-00014; Tom VJ, 2008, EXP NEUROL, V211, P315, DOI 10.1016/j.expneurol.2008.01.021; Wenner P, 1999, J NEUROSCI, V19, P7557, DOI 10.1523/JNEUROSCI.19-17-07557.1999; Wu XH, 2007, J NEUROTRAUM, V24, P1502, DOI 10.1089/neu.2006.0228; Yick LW, 2003, EXP NEUROL, V182, P160, DOI 10.1016/S0014-4886(02)00052-3; Zhao YH, 2007, NEUROSCI LETT, V429, P49, DOI 10.1016/j.neulet.2007.09.076	32	11	11	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	JUL-AUG	2009	37	4					1097	1107		10.1177/147323000903700414			11	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	509RQ	WOS:000271036300014	19761692	Green Published, Bronze			2021-06-18	
J	Zetterling, M; Hillered, L; Samuelsson, C; Karlsson, T; Enblad, P; Ronne-Engstrom, E				Zetterling, Maria; Hillered, Lars; Samuelsson, Carolina; Karlsson, Torbjorn; Enblad, Per; Ronne-Engstrom, Elisabeth			Temporal patterns of interstitial pyruvate and amino acids after subarachnoid haemorrhage are related to the level of consciousness-a clinical microdialysis study	ACTA NEUROCHIRURGICA			English	Article						Amino acids; Microdialysis; Pyruvate; Subarachnoid haemorrhage	TRAUMATIC BRAIN-INJURY; NEUROINTENSIVE CARE; INTRACEREBRAL MICRODIALYSIS; GLUCOSE PHOSPHORYLATION; CEREBRAL MICRODIALYSIS; NEUROLOGICAL DEFICITS; CEREBROSPINAL-FLUID; METABOLISM; ISCHEMIA; MECHANISMS	Temporal patterns of brain interstitial amino acids after subarachnoid haemorrhage (SAH) were studied in relation to energy metabolite levels and to the severity of the initial global ischaemia as reflected by the level of consciousness at admission. Intracerebral microdialysis was used to measure brain interstitial amino acids and the energy metabolites glucose, lactate, and pyruvate during five days in 19 patients. Patients who were conscious (n = 11) were compared to those who were unconscious on admission (n = 8). Eight non-transmitter amino acids (alanine, aspargine, glutamine, isoleucine, leucine, phenylalanine, serine and tyrosine), as well as glycine and pyruvate showed a pattern of increasing concentrations starting at 60-70 h after the onset of SAH. The conscious patients showed more pronounced elevations of non-transmitter amino acids, glycine, taurine and pyruvate compared to the unconscious patient group. Pyruvate levels were initially critically low for all patients, then normalised in the conscious patients but remained low in the unconscious group. There was an increase of the cerebral interstitial levels of non-transmitter amino acids and glycine which correlated temporally to pyruvate levels, more pronounced in patients conscious on admission. Pyruvate levels in these patients normalised, but remained reduced in the unconscious patients. The increase of the non-transmitter amino acids and glycine could reflect an increased amino acid turnover in an attempt at repairing the injured brain, which could have been hampered by the lower pyruvate levels. Interstitial pyruvate may be a useful marker of the energy metabolic situation in the acutely injured brain.	[Zetterling, Maria; Hillered, Lars; Samuelsson, Carolina; Enblad, Per; Ronne-Engstrom, Elisabeth] Univ Uppsala Hosp, Dept Neurosci Neurosurg, S-75185 Uppsala, Sweden; [Karlsson, Torbjorn] Univ Uppsala Hosp, Dept Surg Anaesthesia & Intens Care, S-75185 Uppsala, Sweden	Zetterling, M (corresponding author), Univ Uppsala Hosp, Dept Neurosci Neurosurg, S-75185 Uppsala, Sweden.	maria.zetterling@telia.com		Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Selander Foundation; Uppsala University Hospital	The Swedish Research Council, the Selander Foundation and Uppsala University Hospital supported the study financially.	Bartnik BL, 2007, J NEUROTRAUM, V24, P1079, DOI 10.1089/neu.2006.0210; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BIELICKI L, 1976, N-S ARCH PHARMACOL, V293, P25, DOI 10.1007/BF00498867; Bosche B, 2003, STROKE, V34, P2908, DOI 10.1161/01.STR.0000100158.51986.EB; Cesarini KG, 1999, J NEUROSURG, V90, P664, DOI 10.3171/jns.1999.90.4.0664; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Dahlbacka S, 2006, HEART SURG FORUM, V9, pE710, DOI 10.1532/HSF98.20061022; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; EDVINSSON K, 2002, CEREBRAL BLOOD FLOW, P162; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Engstrom ER, 2005, NEUROSCI LETT, V384, P7, DOI [10.1016/j.neurlet.2005.04.030, 10.1016/j.neulet.2005.04.030]; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GOLDSMITH JD, 1995, HEARING RES, V83, P80, DOI 10.1016/0378-5955(94)00193-T; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; JENNETT B, 1975, LANCET, V1, P480; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; LEHMANN A, 1991, J NEUROCHEM, V56, P690, DOI 10.1111/j.1471-4159.1991.tb08204.x; LEHMANN A, 1990, TAURINE FUNCTIONAL N, V351, P337; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; NAGELHUS EA, 1994, ADV EXP MED BIOL, V359, P325; O'Kane RL, 2004, AM J PHYSIOL-ENDOC M, V287, pE622, DOI 10.1152/ajpendo.00187.2004; O'Kane RL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1167, DOI 10.1152/ajpendo.00193.2003; Ori C, 1997, LIFE SCI, V60, P1349, DOI 10.1016/S0024-3205(97)00080-5; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; RONNEENGSTROM E, 1992, J CEREBR BLOOD F MET, V12, P873, DOI 10.1038/jcbfm.1992.119; Runnerstam M, 1997, NEUROL RES, V19, P361, DOI 10.1080/01616412.1997.11740826; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; SAMUELSSON C, 2007, J CEREB; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; VONHOLST H, 1985, ACTA NEUROCHIR, V78, P46, DOI 10.1007/BF01809241	47	11	11	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUL	2009	151	7					771	780		10.1007/s00701-009-0384-4			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	462WL	WOS:000267388600007	19430719				2021-06-18	
J	Ferguson, SD; Coccaro, EF				Ferguson, Sherise D.; Coccaro, Emil F.			HISTORY OF MILD TO MODERATE TRAUMATIC BRAIN INJURY AND AGGRESSION IN PHYSICALLY HEALTHY PARTICIPANTS WITH AND WITHOUT PERSONALITY DISORDER	JOURNAL OF PERSONALITY DISORDERS			English	Article							BLUNT HEAD-INJURY; BEHAVIOR; AGITATION; RELATIVES; CHILDREN; SCALE	We tested the hypothesis that history of mild to moderate traumatic brain injury (TBI) is associated with higher scores on psychometrically valid measures of aggression and impulsivity in both normal control (NC), and personality disordered (PD), participants. Participants were 458 research volunteers in whom history of mild TBI and measures of both aggression and impulsivity were collected. Aggression, but not impulsivity, scores were elevated as a function of TBI and PD status; there was no interaction between mild TBI and subject group. These data suggest that lifetime history of mild TBI is associated with history of aggression regardless of history of psychiatric disorder.	[Coccaro, Emil F.] Univ Chicago, Clin Neurosci & Psychopharmacol Res Unit, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	Coccaro, EF (corresponding author), Univ Chicago, Clin Neurosci & Psychopharmacol Res Unit, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ecoccaro@yoda.bsd.uchicago.edu			NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH46948, K02MH00951] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K02MH000951, R01MH046948] Funding Source: NIH RePORTER		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Bunce SC, 2005, J PSYCHIATR RES, V39, P421, DOI 10.1016/j.jpsychires.2004.09.005; Coccaro E. F., 2003, AGGRESSION PSYCHIAT, P149; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; Coccaro EF, 1996, ARCH GEN PSYCHIAT, V53, P531; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; *DEP DEF VET HEAD, 1999, BRAIN INJ YOU; Diaz F G, 1995, Med Law, V14, P131; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Eysenck H. J, 1975, MANUAL EYSENCK PERSO; First MB., 1997, STRUCTURED CLIN INTE; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Kim E, 2002, NEUROREHABILITATION, V17, P297; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfohl B., 1995, STRUCTURED CLIN INTE; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; The Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; VIRKKUNEN M, 1977, DIS NERV SYST, V38, P907; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	30	11	11	0	4	GUILFORD PUBLICATIONS INC	NEW YORK	370 SEVENTH AVE, SUITE 1200, NEW YORK, NY 10001-1020 USA	0885-579X	1943-2763		J PERS DISORD	J. Pers. Disord.	JUN	2009	23	3					230	239		10.1521/pedi.2009.23.3.230			10	Psychiatry	Psychiatry	459NC	WOS:000267108600002	19538079				2021-06-18	
J	Moriello, G; Frear, M; Seaburg, K				Moriello, Gabriele; Frear, Matthew; Seaburg, Kristin			The Recovery of Running Ability in an Adolescent Male After Traumatic Brain Injury: A Case Study	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						treadmill training; body weight support; rehabilitation program; traumatic brain injury; running	BODY-WEIGHT SUPPORT; ASSESSMENT-TOOL HIMAT; TREADMILL WALKING; MENTAL PRACTICE; GAIT; RELIABILITY; SPEED; LOCOMOTION; STROKE; LEVEL	Background and Purpose: The purpose of this case study was to document outcomes after a rehabilitation program in an adolescent male after traumatic brain injury. Three years after sustaining an injury in a skiing accident, a 17-year-old boy participated in a rehabilitation program with the goal of acquiring the ability to run one mile with his peers. On initial evaluation, the individual had significant left lower extremity weakness, impaired standing balance, limited endurance, and running limitations. He was able to run 10 m wearing a plastic ankle-foot orthosis on the left side but required supervision for safety. Methods: The intervention included strength training once weekly for 17 weeks, body weight-supported, treadmill-based locomotor training once weekly for 15 weeks followed by a combination of overground locomotor training and strengthening exercise once weekly for six weeks. Outcomes: After the intervention, muscle strength of the lower extremities increased and the individual was able to run one mile independently. The quality of his running improved, with better mechanics to absorb forces at impact during the absorption phase and increased lower extremity extension during the propulsion phase. Discussion: A rehabilitation program consisting of strengthening and locomotor training improved running speed, quality, and endurance in an adolescent male after traumatic brain injury. He was able to progress to a less restrictive carbon fiber brace as a result of gains in lower extremity strength. This change in ability allowed him to participate in physical education by running on a track and playing softball with his peers.	[Moriello, Gabriele; Frear, Matthew; Seaburg, Kristin] Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA	Moriello, G (corresponding author), Sage Coll, Dept Phys Therapy, Troy, NY 12180 USA.	morieg@sage.edu					American Physical Therapy Association, 2005, EX PHYS ACT GUID STR; American Physical Therapy Association, 2001, GUID PHYS THER PRACT; [Anonymous], 2008, 7 DYNAMIC STRETCHES; [Anonymous], 1998, REH PERS TRAUM BRAIN; Arnetz JE., 2004, ADV PHYSIOTHER, V6, P50, DOI DOI 10.1080/14038190310017147; ARNHEIM DD, 1997, PRINCIPLES ATHLETIC; Balogun JA, 1998, EUR J PHYS MED REHAB, V8, P48; Bocchinfuso C., 1994, J SPORT REHABIL, V3, P125, DOI [10.1123/jsr.3.2.125., DOI 10.1123/JSR.3.2.125]; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Brown L. E., 2005, TRAINING SPEED AGILI; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Colby SM, 1999, GAIT POSTURE, V10, P200, DOI 10.1016/S0966-6362(99)00035-1; DELECLUSE C, 1995, MED SCI SPORT EXER, V27, P1203; Dugan Sheila A, 2005, Phys Med Rehabil Clin N Am, V16, P603, DOI 10.1016/j.pmr.2005.02.007; Farley CT, 1998, EXERCISE SPORT SCI R, V26, P253; Fisk J., 2008, AAOS ATLAS ORTHOSES; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Green J, 2002, CLIN REHABIL, V16, P306, DOI 10.1191/0269215502cr495oa; HALL C, 1999, THERAPEUTIC EXERCISE; Hasegawa H, 2002, PERIODIZED TRAINING, P69; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Hesse S, 1997, J NEUROL REHABIL, V11, P15; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; Hesse S, 1999, ARCH PHYS MED REHAB, V80, P421, DOI 10.1016/S0003-9993(99)90279-4; Jung AP, 2003, SPORTS MED, V33, P539, DOI 10.2165/00007256-200333070-00005; Kolber MJ, 2005, PHYS THER REV, V10, P99, DOI 10.1179/108331905X55730; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; MACPHERSON K, 1995, J ORTHOP SPORT PHYS, V21, P147, DOI 10.2519/jospt.1995.21.3.147; Milgrom C, 2003, BRIT J SPORT MED, V37, P160, DOI 10.1136/bjsm.37.2.160; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Miller MG, 2006, J SPORT SCI MED, V5, P459; Mossberg KA, 2008, PHYS THER, V88, P77, DOI 10.2522/ptj.20070022; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Motl RW, 2007, ADAPT PHYS ACT Q, V24, P245, DOI 10.1123/apaq.24.3.245; Myer GD, 2007, J STRENGTH COND RES, V21, P831; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Paris D L, 1992, J Athl Train, V27, P253; Polit F. D., 2004, NURSING RES PRINCIPL; Ranchos Los Amigos Hospital, 1979, REH HEAD INJ AD; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Scherer M, 2007, BRAIN INJURY, V21, P93, DOI 10.1080/02699050601149104; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4, 89-122; Schmitz, 2007, PHYS REHABILITATION; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; Shepherd R, 1999, NEUROREHAB NEURAL RE, V13, P171, DOI 10.1177/154596839901300303; Shumway-Cook A, 2007, MOTOR CONTROL TRANSL; Sidaway B, 2005, PHYS THER, V85, P1053, DOI 10.1093/ptj/85.10.1053; The Ohio State University Medical Center, STAND LEG THER EX; Thordarson DB, 1997, CLIN SPORT MED, V16, P239, DOI 10.1016/S0278-5919(05)70019-3; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2001, BRAIN INJURY, V15, P831; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922; Woolley S M, 2001, Top Stroke Rehabil, V7, P1; Zafeiridis A, 2005, J SPORT MED PHYS FIT, V45, P284	63	11	11	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUN	2009	33	2					111	120		10.1097/NPT.0b013e3181a6ab6b			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	V23BN	WOS:000208318400006	19556920				2021-06-18	
J	Petrov, T				Petrov, Theodor			Amelioration of hypoperfusion after traumatic brain injury by in vivo endothelin-1 knockout	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						microcirculation; laser Doppler flowmetry; morphometry; immunocytochemistry	VASCULAR SMOOTH-MUSCLE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; RECEPTOR ANTAGONIST; GENE-EXPRESSION; BLOOD-FLOW; SIGNALING PATHWAYS; CEREBRAL-ISCHEMIA; CARDIAC-ARREST; RAT MODEL; CELLS	Endothelin 1 (ET-1) is one of the most powerful vasoconstrictors in the brain. Its expression is upregulated after traumatic brain injury (TBI) and is a major factor in the ensuing hypoperfusion. Attenuation of ET-1 effects has been mainly achieved by blockade of its receptors. The result of a direct blockade of ET-1 mRNA synthesis is not known. We used the Marmarou's model to inflict injury to male Sprague-Dawley rats injected with antisense ET-1 oligodeoxynucleotides (ODNs) before injury. Laser Doppler flowmetry in noninjured rats (2 groups, i.e., untreated and animals that received cODNs) revealed a constant cerebral blood flow of approximately 14 mL.min(-1).100 g(-1), whereas the values from injured animals pretreated with control ODNs (cODNs) or from animals subjected to TBI alone were approximately 8.0 mL.min(-1).100 g(-1) during the 18-48 h time period post-TBI. After antisense ET-1 ODNs pretreatment, however, cerebral blood flow in injured animals was approximately 17 mL.min(-1).100 g(-1) during the 6-48 h time period. Antisense ET-1 ODNs-treated animals also had 19%-29% larger microvessel cross-sectional area and approximately one-third less ET-1 immunoreactivity in the 50-75% range after injury than did cODNs-treated animals after TBI. The results indicate that this direct in vivo approach is an effective therapeutic intervention for the restoration of cerebral blood flow after TBI.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS39860]; Department of Neurological Surgery, Wayne State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grant NS39860 awarded to T. P. The author thanks Dr. H. K. Park, Department of Neurological Surgery, Wayne State University, for contributing to this study by providing technical assistance in the LDF recordings.	Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Barman SA, 2005, LUNG, V183, P425, DOI 10.1007/s00408-005-2554-3; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Chen P, 2001, J NEUROIMMUNOL, V116, P62, DOI 10.1016/S0165-5728(01)00280-6; Chen Y, 2003, AM J PHYSIOL-CELL PH, V284, pC243, DOI 10.1152/ajpcell.00305.2002; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; FLORY CM, 1993, LAB INVEST, V69, P396; FRANK HJL, 1993, ENDOCRINOLOGY, V133, P1092, DOI 10.1210/en.133.3.1092; FUXE K, 1992, EXP BRAIN RES, V88, P131, DOI 10.1007/BF02259134; Greenwood K, 2000, PEDIATR RES, V48, P346, DOI 10.1203/00006450-200009000-00014; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hickey RW, 2003, CRIT CARE MED, V31, P531, DOI 10.1097/01.CCM.0000050323.84293.11; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Kawaguchi Chikako, 2002, Pathophysiology, V8, P249, DOI 10.1016/S0928-4680(02)00014-7; Kreipke CW, 2007, NEUROL RES, V29, P604, DOI 10.1179/016164107X166317; Krep H, 2000, CRIT CARE MED, V28, P2873, DOI 10.1097/00003246-200008000-00031; Kwok CF, 2007, AM J PHYSIOL-ENDOC M, V292, pE648, DOI 10.1152/ajpendo.00084.2006; MACRAE IM, 1993, J CEREBR BLOOD F MET, V13, P276, DOI 10.1038/jcbfm.1993.34; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Milan J, 2006, AM J PHYSIOL-CELL PH, V291, pC155, DOI 10.1152/ajpcell.00239.2005; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; ODONNELL ME, 1995, AM J PHYSIOL-CELL PH, V268, pC747; PARK HK, 1999, J MENTAL HLTH, V3, P32; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Shin TK, 2001, NEUROREPORT, V12, P1465, DOI 10.1097/00001756-200105250-00034; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; SZYMKOWSKI DE, 2002, DRUG DISCOV TODAY, V7, P107, DOI DOI 10.1016/S1359-6446(01)02123-7; Takahashi A, 1997, ACTA NEUROPATHOL, V93, P354, DOI 10.1007/s004010050627; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Touzani O, 1997, J CEREBR BLOOD F MET, V17, P1157, DOI 10.1097/00004647-199711000-00004; Yunoki M, 2003, SURG NEUROL, V59, P156, DOI 10.1016/S0090-3019(02)01040-6	41	11	11	0	0	NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS	OTTAWA	BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA	0008-4212			CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	MAY	2009	87	5					379	386		10.1139/Y09-022			8	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	450ZX	WOS:000266441600007	19448736				2021-06-18	
J	Pastuszko, P; Pirzadeh, A; Reade, E; Kubin, J; Mendoza, A; Schears, GJ; Greeley, WJ; Pastuszko, A				Pastuszko, Peter; Pirzadeh, Afsaneh; Reade, Erin; Kubin, Joanna; Mendoza, Alberto; Schears, Gregory J.; Greeley, William J.; Pastuszko, Anna			The effect of hypothermia on neuronal viability following cardiopulmonary bypass and circulatory arrest in newborn piglets	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	22nd Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	SEP 14-17, 2008	Lisbon, PORTUGAL	European Assoc Cardio Thorac Surg		Newborn; Brain; Cardiopulmonary bypass; Circulatory arrest; Hypothermia; Apoptosis	ASPHYXIAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; PROTEIN EXPRESSION; GLOBAL-ISCHEMIA; DOPAMINE; RAT; REPERFUSION; APOPTOSIS; NEUROPROTECTION	Objective: To determine the effect of recovery with mild hypothermia after cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) on the activity of selected key proteins involved in initiation (Bax, Caspase-3) or inhibition of apoptotic injury (Bcl-2, increased ratio Bcl-2/Bax) in the brain of newborn piglets. Methods: The piglets were placed on CPB, cooled with pH-stat management to 18 degrees C, subjected to 30 min of DHCA followed by 1 h of tow flow at 20 ml/kg/min, rewarmed to 37 degrees C (normothermia) or to 33 degrees C (hypothermia), separated from CPB, and monitored for 6 h. Expression of above proteins was measured in striatum, hippocampus and frontal cortex by Western blots. The results are mean for six experiments +/- SEM. Results: There were no significant differences in Bcl-2 level between normothermic and hypothermic groups. The Bax levels in normothermic group in cortex, hippocampus and striatum were 94 +/- 9, 136 +/- 22 and 125 +/- 34 and decreased in the hypothermic group to 59 +/- 17 (p = 0.028), 70 +/- 6 (p = 0.002) and 48 +/- 8 (p = 0.01). In cortex, hippocampus and striatum Bcl-2/Bax ratio increased from 1.23, 0.79 and 0.88 in normothermia to 1.96, 1.28 and 2.92 in hypothermia. Expression of Caspase-3 was 245 +/- 39, 202 +/- 74 and 244 +/- 31 in cortex, hippocampus and striatum in the normothermic group and this decreased to 146 +/- 24 (p = 0.018), 44 +/- 16 (p = 7 x 10(-7)) and 81 +/- 16 (p = 0.01) in the hypothermic group. Conclusion: In neonatal piglet model of cardiopulmonary bypass with circulatory arrest, mild hypothermia during post bypass recovery provides significant protection from cellular apoptosis, as indicated by lower expression of Bax and Caspase-3 and an increased Bcl-2/Bax ratio. The biggest protection was observed in striatum probably by decreasing of neurotoxicity of striatal dopamine. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.	[Pastuszko, Peter] Univ Calif San Diego, Dept Surg, San Diego, CA 92123 USA; [Pirzadeh, Afsaneh; Reade, Erin; Greeley, William J.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Kubin, Joanna; Mendoza, Alberto; Pastuszko, Anna] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Schears, Gregory J.] Mayo Clin, Dept Anesthesiol & Crit Care, Rochester, MN USA	Pastuszko, P (corresponding author), Univ Calif San Diego, Rady Childrens Hosp, 3030 Childrens Way,Suite 202, San Diego, CA 92123 USA.	ppastuszko@rchsd.org	pirzadeh, Akbar/R-7722-2017	pirzadeh, Akbar/0000-0001-9168-2147	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD041484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL058669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031465] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL058669, HL058669, R01 HL058669-08] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD041484-04, R01 HD041484] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS031465, R01 NS031465-14, NS031465] Funding Source: Medline		BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; Corbett D, 1997, STROKE, V28, P2238, DOI 10.1161/01.STR.28.11.2238; Eberspacher E, 2003, J NEUROSURG ANESTH, V15, P200, DOI 10.1097/00008506-200307000-00007; Fritz KI, 2003, NEUROSCI LETT, V352, P211, DOI 10.1016/j.neulet.2003.08.049; Hicks SD, 2000, NEUROSCIENCE, V98, P677, DOI 10.1016/S0306-4522(00)00169-X; Hicks SD, 2000, J CEREBR BLOOD F MET, V20, P520, DOI 10.1097/00004647-200003000-00011; Horiguchi T, 2002, BRAIN RES, V952, P222, DOI 10.1016/S0006-8993(02)03242-0; Hoyt KR, 1997, EXP NEUROL, V143, P269, DOI 10.1006/exnr.1996.6374; HUANG CC, 1995, J NEUROCHEM, V65, pS97; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; Kochanek PM, 2001, PEDIATR CLIN N AM, V48, P661, DOI 10.1016/S0031-3955(05)70333-3; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 1996, CRIT CARE MED, V24, pS81; Noh JS, 1999, EXP NEUROL, V159, P217, DOI 10.1006/exnr.1999.7144; Nussmeier NA, 2005, TEX HEART I J, V32, P472; OLANO M, 1995, J NEUROCHEM, V65, P1205; Pastuszko P, 2007, EUR J CARDIO-THORAC, V31, P899, DOI 10.1016/j.ejcts.2007.01.049; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Porat S, 1999, ANN NY ACAD SCI, V893, P372, DOI 10.1111/j.1749-6632.1999.tb07858.x; Schleien CL, 2001, ANN EMERG MED, V37, pS182, DOI 10.1067/mem.2001.114170; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Yue X, 1997, NEUROPATH APPL NEURO, V23, P16; Zhao H, 1997, NEUROREPORT, V8, P2389, DOI 10.1097/00001756-199707070-00057	25	11	12	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	APR	2009	35	4					577	581		10.1016/j.ejcts.2009.01.001			5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	438RO	WOS:000265573300005	19217795	Green Accepted, Bronze			2021-06-18	
J	Rando, K; Zunini, G; Negroto, A				Rando, K.; Zunini, G.; Negroto, A.			Intraoperative hyponatremia during craniofacial surgery	PEDIATRIC ANESTHESIA			English	Article						craniofacial surgery; hyponatremia; mannitol; complications	SALT-WASTING SYNDROME; ANTIDIURETIC-HORMONE SECRETION; TRAUMATIC BRAIN-INJURY; HOSPITALIZED CHILDREN; NATRIURETIC-PEPTIDE; MANAGEMENT; PATIENT; WATER	Hyponatremia is an important cause of morbidity in some groups of hospitalized children. Our aim is to describe the incidence and severity of intraoperative hyponatremia in children undergoing craniofacial surgery, and determine the associated risk factors. A descriptive retrospective study of children who underwent primary craniofacial surgery between March 1994 and February 2008 was performed. All administered fluids contained a minimum sodium concentration of 140 mmol.l(-1). Hyponatremia was classified as follows: severe <= 125 mmol.l(-1); moderate 126-130 mmol.l(-1); and, mild 131-134 mmol.l(-1). Hundred and seven cases are reported. Severe, moderate and mild intraoperative hyponatremia occurred in 14 (13%), 21 (19%) and 23 (22%) children respectively. Mannitol was given to 31 (29%) children, but was not associated with the development of hyponatremia. Neither the type nor duration of surgery, type of fluid replacement nor hourly urinary output, was associated with development of hyponatremia. Most episodes of significant intraoperative hyponatremia (44%) were detected between the 2nd and the 4th hour of surgery. There were no identified neurological sequelae (e.g. coma, neurological deficit) attributable to the hyponatremia. Despite strict avoidance of low sodium solutions (< 140 mmol.l(-1)), hyponatremia occurs frequently in children undergoing craniofacial surgery in our practice; and is unrelated to the administration of mannitol. Although the mechanisms are yet to be determined, anesthesiologists should be aware of this issue and be prepared to monitor and treat this potentially serious complication.	Univ Hosp, Natl Craniofacial Surg Unit, Montevideo, Uruguay; Univ Hosp, Dept Anesthesia, Montevideo, Uruguay	Rando, K (corresponding author), Guadalupe 1578, Montevideo 11800, Uruguay.	karina.rando@gmail.com					Adrogue HJ, 2005, AM J NEPHROL, V25, P240, DOI 10.1159/000086019; Ausman JI, 2008, SURG NEUROL, V69, P221, DOI 10.1016/j.surneu.2007.12.013; Bohn D, 2005, QJM-INT J MED, V98, P691, DOI 10.1093/qjmed/hci101; Byeon JH, 2005, J KOREAN MED SCI, V20, P866, DOI 10.3346/jkms.2005.20.5.866; Guerrero R, 2007, EUR J ENDOCRINOL, V156, P611, DOI 10.1530/EJE-06-0659; Halperin ML, 1998, FLUID ELECTROLYTE AC; HOLLIDAY MA, 1957, PEDIATRICS, V19, P823; Hoorn EJ, 2004, PEDIATRICS, V113, P1279, DOI 10.1542/peds.113.5.1279; Jimenez R, 2006, PEDIATR NEUROL, V35, P261, DOI 10.1016/j.pediatrneurol.2006.05.004; Kirchhoff C, 2006, J NEUROTRAUM, V23, P943, DOI 10.1089/neu.2006.23.943; Levine JP, 2001, PLAST RECONSTR SURG, V108, P1501, DOI 10.1097/00006534-200111000-00009; Lieh-Lai MW, 1999, CRIT CARE MED, V27, P622, DOI 10.1097/00003246-199903000-00046; Lu DC, 2008, SURG NEUROL, V69, P226, DOI 10.1016/j.surneu.2007.02.051; MILLER R, 2005, MILLER ANESTHESIA, P1104; Nakajima K, 2005, INT J CARDIOL, V104, P332, DOI 10.1016/j.ijcard.2004.12.020; Palmer BF, 2000, NEPHROL DIAL TRANSPL, V15, P262, DOI 10.1093/ndt/15.2.262; Porzio P, 2000, CRIT CARE MED, V28, P1905, DOI 10.1097/00003246-200006000-00037; Sata A, 2006, NEUROENDOCRINOLOGY, V83, P117, DOI 10.1159/000094725; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Singh S, 2002, CRIT CARE MED, V30, P2575, DOI 10.1097/00003246-200211000-00028; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; WATTAD A, 1992, CLIN PEDIATR, V31, P153, DOI 10.1177/000992289203100305; Yun JJ, 2008, INTERN MED J, V38, P74, DOI 10.1111/j.1445-5994.2007.01561.x	23	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	APR	2009	19	4					358	363		10.1111/j.1460-9592.2009.02928.x			6	Anesthesiology; Pediatrics	Anesthesiology; Pediatrics	418RK	WOS:000264165900010	19236596				2021-06-18	
J	Tango, HK; Schmidt, AP; Mizumoto, N; Lacava, M; Auler, JOC				Tango, Humberto K.; Schmidt, Andre P.; Mizumoto, Nelson; Lacava, Marcelo; Auler, Jose O. C., Jr.			Low Hematocrit Levels Increase Intracranial Pressure in an Animal Model of Cryogenic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Normovolemic hemodilution; Traumatic brain injury; Cerebral perfusion pressure; Intracranial pressure	ACUTE NORMOVOLEMIC HEMODILUTION; EXPERIMENTAL CEREBRAL EDEMA; ACUTE ISCHEMIC STROKE; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; BLOOD-FLOW; REPLACEMENT; THERAPY; RABBITS; VOLUME	Background: Brain injury is responsible for significant morbidity and mortality in trauma patients, but controversy still exists over optimal fluid management for these patients. This study aimed to investigate the effects of acute hemodilution with hydroxyethyl starch (HES) or lactated Ringer's solution (LR) in intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in dogs submitted to a cryogenic brain injury model. Methods: Design-Prospective laboratory animal study. Setting-Research laboratory in a teaching hospital. Subjects-Thirty-five male mongrel dogs. Interventions-Animals were enrolled to five groups: control, hemodilution with LR or HES 6% to an hematocrit target of 27% or 35%. Results: ICP and CPP levels were measured after cryogenic brain injury. Hemodilution promotes an increment of ICP levels, which decreases CPP when hematocrit target was estimated in 27.% after hemodilution. However, no differences were observed regarding crystalloid or colloid solution used for hemodilution in ICP and CPP levels. Conclusions: Hemodilution to a low hematocrit level increases ICP and decreases CPP scores in dogs submitted to a cryogenic brain injury. These results suggest that excessive hemodilution to a hematocrit below 30% should be avoided in traumatic brain injury patients.	[Tango, Humberto K.; Schmidt, Andre P.; Mizumoto, Nelson; Lacava, Marcelo; Auler, Jose O. C., Jr.] Univ Sao Paulo, Sch Med, Dept Anesthesia, Lab Med Invest LIM Anestesiol 08, Sao Paulo, Brazil	Auler, JOC (corresponding author), Av Dr Eneas Carvalho Aguiar,44,2 Andar,Bloco 1, BR-05403000 Sao Paulo, Brazil.	auler@incor.usp.br	Junior, Jose Otavio Costa Auler/C-4492-2017; Schmidt, Andre P/E-4652-2012	Junior, Jose Otavio Costa Auler/0000-0002-3919-1743; 	FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Supported by the Brazilian funding agency FAPESP.	ALBRIGHT AL, 1982, ACTA NEUROCHIR, V60, P257, DOI 10.1007/BF01406311; Asplund K., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000103; Bak Z, 2000, ANESTHESIOLOGY, V92, P1250, DOI 10.1097/00000542-200005000-00012; Bendo A A, 1993, Acta Anaesthesiol Belg, V44, P103; Biboulet P, 1996, BRIT J ANAESTH, V76, P81; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; Ginsberg MD, 2006, STROKE, V37, P2100, DOI 10.1161/01.STR.0000231388.72646.05; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; GRANDE PO, 1997, ACTA ANAESTH SCAND, V42, pS23; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Hlatky R., 2003, NEUROSURG FOCUS, V14, P1; Homi HM, 2004, ANESTH ANALG, V99, P974, DOI 10.1213/01.ane.0000131504.90754.d0; James HE, 2006, ACT NEUR S, V96, P125; Jones SB, 2004, J CLIN ANESTH, V16, P11, DOI 10.1016/j.jclinane.2003.03.003; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; KOROSUE K, 1992, STROKE, V23, P1487, DOI 10.1161/01.STR.23.10.1487; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Otsuki DA, 2006, ARTIF ORGANS, V30, P458, DOI 10.1111/j.1525-1594.2006.00242.x; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Reasoner DK, 1996, ANESTH ANALG, V82, P61, DOI 10.1097/00000539-199601000-00011; Rudolf J, 2002, CEREBROVASC DIS, V14, P33, DOI 10.1159/000063721; TODD MM, 1994, AM J PHYSIOL-HEART C, V267, pH2025; TU YK, 2002, AM J PHYSIOL-HEART C, V282, pH832; York J, 2000, J TRAUMA, V48, P376, DOI 10.1097/00005373-200003000-00002; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023	31	11	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2009	66	3					720	726		10.1097/TA.0b013e3181719b35			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	419ZU	WOS:000264259000022	19276744				2021-06-18	
J	Allen, DN; Haderlie, M; Kazakov, D; Mayfield, J				Allen, Daniel N.; Haderlie, Michael; Kazakov, Dmitriy; Mayfield, Joan			CONSTRUCT AND CRITERION VALIDITY OF THE COMPREHENSIVE TRAIL MAKING TEST IN CHILDREN AND ADOLESCENTS WITH TRAUMATIC BRAIN INJURY	CHILD NEUROPSYCHOLOGY			English	Article						Children; Adolescents; Trail Making Test; Traumatic brain injury; Validity	SERIAL ASSESSMENT; CATEGORY TEST; MAKING TEST; WAIS-R; SCHIZOPHRENIA; VARIANTS; DAMAGE	The current study examined the construct and criterion validity of the Comprehensive Trail Making Test (CTMT) when used to evaluate children and adolescents with traumatic brain injury (TBI). Participants included 100 children and adolescents, 50 who had sustained TBI and 50 normal comparisons (NC). Analyses indicated that the CTMT factor scores were significantly correlated with tests of perceptual organizational ability, processing speed, and motor function and provided support for its construct validity. Additionally, correlations between the various CTMT scores suggested that a different pattern of associations was present in the TBI group compared to the NC group. Finally, the TBI group performed significantly worse (p < .001) on all of the CTMT scores, including each of the five CTMT trails as well as the factor and composite index scores. Results support the construct and criterion validity of the CTMT when used to assess children and adolescents with TBI.	[Allen, Daniel N.; Haderlie, Michael; Kazakov, Dmitriy] Univ Nevada Las Vegas, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA	Allen, DN (corresponding author), Univ Nevada Las Vegas, 4505 Maryland Pkwy,Box 455030, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 1998, SCHIZOPHR RES, V34, P87, DOI 10.1016/S0920-9964(98)00090-5; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Army Individual Test Battery, 1944, MAN DIR SCOR; Atkinson TM, 2008, J PSYCHOEDUC ASSESS, V26, P42, DOI 10.1177/0734282907301592; Buck KK, 2008, J CLIN EXP NEUROPSYC, V30, P312, DOI 10.1080/13803390701390483; Burton D. B., 1994, PSYCHOL ASSESSMENT, V6, P380; Conners CK, 2000, CONTINUOUS PERFORMAN; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; GASS CS, 1990, PSYCHOL REP, V67, P569; GOLDSTEIN G, 1966, PERCEPT MOTOR SKILL, V22, P347, DOI 10.2466/pms.1966.22.2.347; LEITER RG, 1949, PSYCHOL SERVICE CTR, V1, P139; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; Partington J, 1949, PSYCHOL SERVICE CTR, V1, P46; Partington JE., 1949, PSYCHOL SERV CTR J, V1, P11; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; REITAN RM, 1992, HALSTEADREITAN NEURO; Reynolds C, 2002, DEV TEST VISUAL PERC; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Smith SR, 2008, CLIN NEUROPSYCHOL, V22, P507, DOI 10.1080/13854040701399269; TEASDALE G, 1974, LANCET, V2, P81; Ward LC, 2000, ASSESSMENT, V7, P79, DOI 10.1177/107319110000700107; WATSON N, 1949, PSYCHOL SERVICE CTR, V1, P49; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WAIS 3 ADM SCORING M; Woodcock R. W., 2001, EXAMINERS MANUAL WOO	31	11	11	0	10	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.		2009	15	6					543	553		10.1080/09297040902748234			11	Clinical Neurology	Neurosciences & Neurology	520IE	WOS:000271836400003	19319747				2021-06-18	
J	Beretta, E; Cimolin, V; Piccinini, L; Turconi, A; Galbiati, S; Crivellini, M; Galli, M; Strazzer, S				Beretta, Elena; Cimolin, Veronica; Piccinini, Luigi; Turconi, Anna Carla; Galbiati, Sara; Crivellini, Marcello; Galli, Manuela; Strazzer, Sandra			Assessment of gait recovery in children after traumatic brain injury	BRAIN INJURY			English	Article						Children; traumatic brain injury; gait analysis; kinematics; kinetics	MOTOR FUNCTION MEASURE; GROSS MOTOR; ADOLESCENTS; REHABILITATION; PERFORMANCE; PREVALENCE; DISABILITY; SCORES	Objective: The aims were: (1) to quantify the functional limitation of children at the beginning of recovery of independent ambulation after Traumatic Brain Injury (TBI), using clinical-functional scales; (2) to evaluate the changes in gait pattern during rehabilitation (about 5 months later), using 3D Gait Analysis (GA) in post-acute phase; (3) to investigate the presence of correlation among parameters obtained by 3DGA, clinical assessment and measures connected with the trauma. Methods: Fourteen children with hemiplegia after severe TBI were evaluated at independent gait recovery (S0) and 5.5 months later (S1) by clinical assessment (GOS, DRS, WeeFIM and GMFM) and 3D GA (spatio-temporal parameters, kinematics and kinetics). Results: At S1 all clinical measures had improved. Regarding spatio-temporal parameters, velocity and step length improved. Significant progress was evident at the ankle joint, while an unchanged condition appeared at pelvis and hip in sagittal plane with a worsening of hip rotation which increased its internal rotation. Significant correlations were found between motor performance, clinical assessment and trauma-related measures. Conclusions: Repeated GA and clinical evaluations were useful in quantifying the motor recovery of children with TBI during rehabilitation underpinning the role of GA in quantifying these modifications in an objective and non-invasive way.	[Beretta, Elena; Piccinini, Luigi; Turconi, Anna Carla; Galbiati, Sara; Strazzer, Sandra] IRCCS E Medea Nostra Famiglia, I-23842 Bosisio Parini, LC, Italy; [Cimolin, Veronica; Crivellini, Marcello; Galli, Manuela] Politecn Milan, Dipartimento Bioingn, I-20133 Milan, Italy; [Galli, Manuela] IRCCS San Raffaele Pisana San Raffaele SPA, Rome, Italy	Beretta, E (corresponding author), IRCCS E Medea Nostra Famiglia, Via don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	elena.beretta@bp.lnf.it	Turconi, Anna Carla/AAX-6521-2020; Strazzer, Sandra/AAH-5712-2019; Galli, Manuela/AAH-8783-2019; Beretta, Elena/AAH-5369-2019; Galbiati, Sara/AAA-7115-2020; Turconi, Anna Carla/ABE-6747-2020; piccinini, luigi/AAH-5470-2019; Cimolin, Veronica/AAA-3326-2021	Strazzer, Sandra/0000-0001-8414-6565; Beretta, Elena/0000-0002-8036-7624; Galbiati, Sara/0000-0001-6810-359X; Turconi, Anna Carla/0000-0002-5482-924X; piccinini, luigi/0000-0001-7027-6676; Cimolin, Veronica/0000-0001-6299-7254; Galli, Manuela/0000-0003-2772-4837			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Drouin LM, 1996, DEV MED CHILD NEUROL, V38, P1007; Emanuelson IM, 1997, DEV MED CHILD NEUROL, V39, P502; ESQUENAZI A, 2006, J HEAD TRAUMA REHAB, V87, P437; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Linder-Lucht M, 2007, PEDIATRICS, V120, P880, DOI 10.1542/peds.2006-2258; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Poggi G, 2000, BRAIN INJURY, V14, P833, DOI 10.1080/026990500421930; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wechsler D., 1974, MANUAL WECHSLER INTE; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	31	11	11	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	9					751	759	PII 913451840	10.1080/02699050903133988			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	475UR	WOS:000268387600006	19637000				2021-06-18	
J	Catroppa, C; Anderson, V; Muscara, F				Catroppa, Cathy; Anderson, Vicki; Muscara, Frank			Rehabilitation of executive skills post-childhood traumatic brain injury (TBI): A pilot intervention study	DEVELOPMENTAL NEUROREHABILITATION			English	Article						intervention; childhood; executive skills; brain injury	HEAD-INJURY; RECOVERY; CHILDREN; REMEDIATION; ADOLESCENCE; KNOWLEDGE; DEFICITS; ABILITY; IMPACT	Background: Following TBI in childhood it is common for deficits to be seen in higher order skills, such as executive functions, both in the acute and longer-term post-injury. Despite this, very little evaluative research has been conducted with children post-TBI, particularly in the area of EF. Methods: The current study aimed to develop and implement a pilot intervention programme for adolescent/young adults (n = 3), in the chronic phase of recovery, when EF skills are no longer in a rapid state of development. Results and conclusions: Study results highlight the importance and need for accurate and relevant outcome measures that capture subtle as well as more obvious changes following intervention.	[Catroppa, Cathy; Anderson, Vicki; Muscara, Frank] Murdoch Childrens Res Inst, Australian Ctr Child Neuropsychol Studies, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki; Muscara, Frank] Univ Melbourne, Melbourne, Vic 3010, Australia	Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au					Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Beardmore S, 1999, NEUROPSYCHOL REHABIL, V9, P45, DOI 10.1080/713755588; Cannon WB., 1949, SUPERSENSITIVITY DEN; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; CHALMERS D, 1993, INT J BEHAV DEV, V16, P191, DOI 10.1177/016502549301600206; CICERONE K, 1990, NEUROPSYCHOLOGY EVER, P71; Cronin AF, 2001, AM J OCCUP THER, V55, P377, DOI 10.5014/ajot.55.4.377; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; DAVIS MJ, 2005, J DENT CHILDREN, V62, P93; Delis DC, 2001, DELISKAPLAN EXECUTIV; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1989, CLIN NEUROPSYCHOLOGY, P495; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Garth J, 1997, Pediatr Rehabil, V1, P99; Gioia G.A., 2000, BEHAV RATING INVENTO; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Kazdin A. E, 1984, BEHAV MODIFICATION A; Kelly T., 2000, CLIN NEUROPSYCHOL, V1, P38; Kolb B., 1996, FUNDAMENTALS HUMAN N; KOLB B, 1999, COGNITIVE NEUROREHAB; Lashley Karl S., 1929, BRAIN MECH INTELLIGE; Laurence S., 1978, RECOVERY BRAIN DAMAG, P369; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Luria A. R., 1963, RESTORATION FUNCTION; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; Mottram Lisa, 2004, Pediatr Rehabil, V7, P133, DOI 10.1080/1363849042000202286; NEIMEIER P, 2005, NEUROPSYCHOL REHABIL, V15, P129; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J., 1995, TRAUMATIC BRAIN INJU; Rey A, 1964, EXAMEN CLIN PSYCHOL; ROTHI LJ, 1983, J CLIN NEUROPSYCHOL, V5, P73, DOI 10.1080/01688638308401152; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; Selznick L, 2000, BEHAV INTERVENT, V15, P243, DOI 10.1002/1099-078X(200007/09)15:3<243::AID-BIN59>3.0.CO;2-1; STERLING L, 1994, STUDENTS AC IN PRESS; Stuss D. T., 1994, BRAIN INJURY REHABIL, P212; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THOMPSON J, 1995, J INT NEUROPSYCH SOC, P1; THOMSON JB, 2000, NEUROPSYCHOLOGICAL M, P233; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; WALSH K, 1978, NEUROPSYCHOLOGY CLIN; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	56	11	11	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2009	12	5					361	369		10.3109/17518420903087335			9	Clinical Neurology; Pediatrics; Rehabilitation	Neurosciences & Neurology; Pediatrics; Rehabilitation	V15FS	WOS:000207788500011	20477565				2021-06-18	
J	Galvin, J; Mandalis, A				Galvin, Jane; Mandalis, Anna			Executive skills and their functional implications: Approaches to rehabilitation after childhood TBI	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Rehabilitation; brain injury; paediatric; outcomes	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL SUPPORTS; SCHOOL-AGE-CHILDREN; YOUNG-CHILDREN; SHORT-TERM; SOCIAL-PARTICIPATION; ACADEMIC PLACEMENT; NEEDS SCALE; OUTCOMES; ADOLESCENTS	Background: It is widely acknowledged that children recover differently from adults following traumatic brain injury. The impact of neurological injury in the context of developing skills and changing expectations of behaviour requires a developmental approach to rehabilitation that considers children's abilities across home, school and community environments. Methods: This article aims to provide an overview of the impact of executive deficits on everyday functioning and to review information about intervention strategies that support long term development of skills. Results and conclusions: While individual disciplines are not directly referred to in this paper, input from a comprehensive and co-ordinated interdisciplinary team is crucial to understanding and reducing the impact of executive deficits on functional performance.	[Galvin, Jane] Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Melbourne, Vic, Australia; [Galvin, Jane; Mandalis, Anna] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Galvin, Jane] La Trobe Univ, Sch Occupat Therapy, Bundoora, Vic, Australia; [Mandalis, Anna] Sydney Childrens Hosp, Dept Psychol, Randwick, NSW, Australia	Galvin, J (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	jane.galvin@mcri.edu.au					Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANDERSON VA, 2007, DEV NEUROREHABIL, V10, P269; *AUSTR I HLTH WELF, 2003, AUSTR US GUID VERS 1; Bates G, 2006, DEV MED CHILD NEUROL, V48, P697, DOI 10.1017/S0012162206001472; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; BLOSSER JL, 1994, ED DIMENSIONS ACQUIR, P413; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Carlson PM, 2006, BRAIN INJURY, V20, P1111, DOI 10.1080/02699050600955337; CATROPPA C, 2008, J PEDIATR PSYCHOL, V33, P1; De Luca CR, 2010, STUD NEUROPSYCHOL NE, P23; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; DUNN W, 1994, AM J OCCUP THER, V48, P595, DOI 10.5014/ajot.48.7.595; Eslinger P. J., 1996, ATTENTION MEMORY EXE, P367; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Garth J, 1997, Pediatr Rehabil, V1, P99; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; King Gillian A., 1999, Physical and Occupational Therapy in Pediatrics, V19, P5; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Law M., 2005, CANADIAN OCCUPATIONA, V4th ed; Law Mary, 1998, Physical and Occupational Therapy in Pediatrics, V18, P83, DOI 10.1300/J006v18n01_06; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Murphy NA, 2008, PEDIATRICS, V121, P1057, DOI 10.1542/peds.2008-0566; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Polatajko Helene J., 2001, Physical and Occupational Therapy in Pediatrics, V20, P107, DOI 10.1300/J006v20n02_07; Rosenbaum P., 1998, PHYS OCCUP THER PEDI, V18, P1, DOI DOI 10.1080/J006V18N01; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sohlberg MM, 1998, APHASIOLOGY, V12, P1047, DOI 10.1080/02687039808249469; Soo C, 2007, J HEAD TRAUMA REHAB, V22, P288, DOI 10.1097/01.HTR.0000290973.01872.4c; Soo C, 2008, DEV NEUROREHABIL, V11, P204, DOI 10.1080/17518420802259498; Steenbeek D, 2008, CHILD CARE HLTH DEV, V34, P521, DOI 10.1111/j.1365-2214.2008.00841.x; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR, P121; Ylvisaker M., 1993, STAFF DEV CLIN INTER, P57; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	59	11	11	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2009	12	5					352	360		10.3109/17518420903087293			9	Clinical Neurology; Pediatrics; Rehabilitation	Neurosciences & Neurology; Pediatrics; Rehabilitation	V15FS	WOS:000207788500010	20477564				2021-06-18	
J	Homaifar, BY; Harwood, JE; Wagner, TH; Brenner, LA				Homaifar, Beeta Y.; Harwood, Jeri E.; Wagner, Todd H.; Brenner, Lisa A.			Description of outpatient utilization and costs in group of veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						aging; costs; Department of Veterans Affairs; healthcare; nonacute care; outpatient services; rehabilitation; traumatic brain injury; utilization; veterans	MULTICENTER ANALYSIS; CARE; REHABILITATION; HEALTH; MANAGEMENT; MILITARY; MEDICINE; OUTCOMES; SYSTEMS; CHARGES	In an attempt to increase Understanding regarding the nonacute healthcare needs of veterans with traumatic brain injury (TBI), we examined the outpatient utilization and cost patterns of 72 patients with TBI who were at least 4 years postinjury. We selected participants from a clinical database of veterans receiving care at a western Department of Veterans Affairs (VA) medical center. We extracted data from national utilization databases maintained by the VA and examined data from primary care and internal medicine, psychiatry and substance use, rehabilitation, and other services (e.g., ancillary, diagnostic, prosthetic, dental, nursing home, and home care). We extracted data For fiscal years 2002 to 2007. In addition to descriptive statistics, we modeled visits per year as a function of time since injury. The data show that this sample of patients with TBI consistently used a wide array Of Outpatient services over time with considerable variation in cost. Further study regarding economic aspects of care for patients with TBI is warranted.	[Homaifar, Beeta Y.; Brenner, Lisa A.] Dept Vet Affairs Vet Integrated Serv Network 19, Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Homaifar, Beeta Y.; Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Harwood, Jeri E.] Univ Colorado Denver, Sch Med, Dept Pediat, Aurora, CO USA; [Harwood, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Wagner, Todd H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wagner, Todd H.] Stanford Univ, Stanford, CA 94305 USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA	Homaifar, BY (corresponding author), VA VISN 19, Mental Illness Res Educ & Clin Ctr, 1055 Clermont St, Denver, CO 80220 USA.	beeta.homaifar1@va.gov	Brenner, Lisa A./AAG-2442-2019	Wagner, Todd/0000-0001-7625-3504	VA Veterans Integrated Service Network 19 Mental Illness Research, Education and Clinical Center	This work was supported by the VA Veterans Integrated Service Network 19 Mental Illness Research, Education and Clinical Center.	Bureau of Labor Statistics, CONS PRIC IND; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cote Murray J, 2007, Health Care Manag Sci, V10, P253, DOI 10.1007/s10729-007-9018-7; *DEP VET AFF, 2004, VETEESA138 SP DEP VE; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Felicetti T, 2005, PROF CASE MANAG, V10, P264; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Liang H, 2003, BIOSTATISTICS, V4, P297, DOI 10.1093/biostatistics/4.2.297; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; SAYWELL RM, 1989, J AM GERIATR SOC, V37, P625, DOI 10.1111/j.1532-5415.1989.tb01253.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000; Yu W, 2003, MED CARE RES REV, V60, p40S, DOI 10.1177/1077558703256724	23	11	12	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	8					1003	1010		10.1682/JRRD.2008.12.0166			8	Rehabilitation	Rehabilitation	550YO	WOS:000274171000003	20157857	Bronze			2021-06-18	
J	Hoshida, S; Hatano, M; Furukawa, M; Ito, M				Hoshida, Shigeru; Hatano, Miyako; Furukawa, Mitsuru; Ito, Makoto			Neuroprotective effects of vitamin E on adult rat motor neurones following facial nerve avulsion	ACTA OTO-LARYNGOLOGICA			English	Article						Facial nerve avulsion; -tocopherol nicotinate; retrograde degeneration; facial motor nucleus (FMN); 4-hydroxynonenal	CEREBRAL-ISCHEMIA; NITRIC-OXIDE; DOUBLE-BLIND; CELL-DEATH; MOTONEURONS; INJURY; EXPRESSION; APOPTOSIS; BRAIN; TJ-23	Conclusion. The present study demonstrates the neuroprotective effect of vitamin E after peripheral facial nerve injury. Antioxidants may have therapeutic potential in traumatic facial nerve dysfunction resulting from traumatic temporal bone injury and ear surgery. Objective. We investigated the possible neuroprotective effect of vitamin E on the facial motor nucleus (FMN) motor neurones after peripheral nerve avulsion. Methods. In 36 adult rats, the right facial nerve was avulsed from the stylomastoid foramen. Following nerve avulsion, immunohistochemistry was used to investigate the effects of vitamin E on 4-hydroxynonenal (HNE) activity. FMN motor neurones and glial cells were counted bilaterally in sections stained with cresyl violet. Results. Rats administered vitamin E exhibited clear suppression of injury-induced neuronal HNE expression in the ipsilateral FMN as compared to non-treated controls. Following nerve avulsion, the number of surviving motor neurones in the ipsilateral FMN was significantly greater among vitamin E-treated rats than non-treated controls.	[Hoshida, Shigeru; Hatano, Miyako; Furukawa, Mitsuru; Ito, Makoto] Kanazawa Univ, Grad Sch Med Sci, Div Neurosci, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan	Ito, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Div Neurosci, Dept Otolaryngol Head & Neck Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	makoto@med.kanazawa-u.ac.jp			Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19591961]	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (#19591961).	Bartels M, 2004, CLIN NUTR, V23, P1360, DOI 10.1016/j.clnu.2004.05.003; Chaudhary G, 2003, FUND CLIN PHARMACOL, V17, P703, DOI 10.1046/j.0767-3981.2003.00209.x; Hayden KM, 2007, AM J MED, V120, P180, DOI 10.1016/j.amjmed.2006.03.039; Hottinger AF, 2000, J NEUROSCI, V20, P5587; Ikeda T, 2002, NEUROSCI LETT, V329, P33, DOI 10.1016/S0304-3940(02)00573-6; Ito M, 2007, OTOLARYNG HEAD NECK, V136, P225, DOI 10.1016/j.otohns.2006.08.012; Itoh T, 1996, AM J CHINESE MED, V24, P205, DOI 10.1142/S0192415X9600027X; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Maclusky NJ, 2003, NEUROSCIENCE, V118, P741, DOI 10.1016/S0306-4522(02)00940-5; Mattsson P, 1999, BRAIN RES BULL, V49, P333, DOI 10.1016/S0361-9230(98)00178-6; Pilger E, 2007, J INTERN MED, V261, P276, DOI 10.1111/j.1365-2796.2006.01763.x; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P1827, DOI 10.1016/j.freeradbiomed.2006.01.019; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Rossiter JP, 1996, EXP NEUROL, V138, P33, DOI 10.1006/exnr.1996.0044; RUAN RS, 1995, BRAIN RES, V698, P163, DOI 10.1016/0006-8993(95)00887-V; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006; Uchiyama K, 2004, CLIN EXP PHARMACOL P, V31, P226, DOI 10.1111/j.1440-1681.2004.03981.x; Ueda Y, 1996, NEUROCHEM RES, V21, P909, DOI 10.1007/BF02532340; WU WT, 1993, EXP NEUROL, V120, P153, DOI 10.1006/exnr.1993.1050	19	11	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.		2009	129	3					330	336	PII 901462640	10.1080/00016480802210431			7	Otorhinolaryngology	Otorhinolaryngology	410CH	WOS:000263553200016	18720077				2021-06-18	
J	Jonsson, CA; Smedler, AC; Ljungmark, ML; Emanuelson, I				Jonsson, Catherine Aaro; Smedler, Ann-Charlotte; Ljungmark, Mia Leis; Emanuelson, Ingrid			Long-term cognitive outcome after neurosurgically treated childhood traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; paediatric; long-term; outcome; cognitive	HEAD-INJURY; NORMATIVE DATA; INTRACRANIAL-PRESSURE; MEMORY FUNCTION; WORKING-MEMORY; PEDIATRIC TBI; YOUNG-ADULTS; LUND CONCEPT; CHILDREN; RECOVERY	Objective: To explore the cognitive long-term outcome of two cohorts of patients neurosurgically treated for childhood traumatic brain injury (CTBI), either in 1987-1991 according to an older concept or 1997-2001 with a stronger emphasis on volume targeted interventions. Research design and methods: Participants in the two cohorts were subject to an extensive neuropsychological assessment, 13.2 and 6.1 years post-injury, respectively. In a between-group design, assessment results of the two cohorts, n = 18 and n = 23, were compared to each other and to controls. Data were analysed with multivariate analyses of variance. Results: Long-term cognitive deficits for both groups of similar magnitude and character were observed in both groups. Abilities were especially low regarding executive and memory function and verbal IQ. The cognitive results are discussed in terms of vulnerability of verbal functions and decreased executive control over memory-functions. Conclusions: There is a definite need for long-term follow-up of cognitive deficits after neurosurgically treated CTBI, also with the newer neurosurgical concept. Verbal learning and the executive control over memory functions should be addressed with interventions aimed at restoration, coping and compensation.	[Jonsson, Catherine Aaro] Stockholm Univ, Dept Psychol, Jamtland Cty Council, Res & Dev Unit, S-10691 Stockholm, Sweden; [Ljungmark, Mia Leis; Emanuelson, Ingrid] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden	Jonsson, CA (corresponding author), Stockholm Univ, Dept Psychol, Jamtland Cty Council, Res & Dev Unit, S-10691 Stockholm, Sweden.	catherine.aaro.jonsson@jll.se			Research and Development Unit, Jamtland County Council, Department of Psychology, Stockholm University; Cancer and Traffic Injury Fund, Stockholm	This research was supported by The Research and Development Unit, Jamtland County Council, Department of Psychology, Stockholm University and The Cancer and Traffic Injury Fund, Stockholm. We thank the persons that generously contributed their time to this research and Goran Horneman and Per Folkesson who made their assembled data available for this study. We are also grateful to Bertil Rydenhag, Sahlgrenska Academy, Institute of Neuroscience and Physiology, for helpful information and important feed-back about the neurosurgical background.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Birkenkamp R., 1998, D2 TEST ATTENTION; BOLL T, 1993, CHILDRENS CATEGORY T; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Eker C, 2000, BRAIN INJURY, V14, P605; EMANUELSON I, TRAUMATIC BRAI UNPUB; Emanuelson I, 1998, PEDIAT REHABILITATIO, V65, P70; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FINLAYSON MAJ, 1976, PERCEPT MOTOR SKILL, V43, P475, DOI 10.2466/pms.1976.43.2.475; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI DOI 10.1080/13854049108404102; GADDES WH, 1975, BRAIN LANG, V2, P257, DOI 10.1016/S0093-934X(75)80070-8; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GILLETT J, 2004, NEUROREHABILITATION, V207, P218; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; JENNETT B, 1975, LANCET, V1, P480; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P449; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Meyers J., 1995, REY COMPLEX FIGURE T; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Pressley M., 1997, MEMORY DEV 2 20; *PSYK, 1996, MAN WAIS R; *PSYK AB, 1999, WISC 3 MAN; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Spreen O., 1998, COMPENDIUM NEUROPSYC; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Van Heugten CM, 2006, BRAIN INJURY, V20, P895, DOI 10.1080/02699050600832015; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618; YEATES KO, 2005, J AM ACAD CHILD PSY, V44, P6; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	52	11	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	13-14					1008	1016		10.3109/02699050903379354			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	529YR	WOS:000272556000003	19909050				2021-06-18	
J	McDonald, S; Bornhofen, C; Hunt, C				McDonald, Skye; Bornhofen, Cristina; Hunt, Christopher			Addressing deficits in emotion recognition after severe traumatic brain injury: The role of focused attention and mimicry	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Rehabilitation; Emotion; Social perception; Attention	FACIAL AFFECT RECOGNITION; CLOSED-HEAD INJURY; PERCEPTION DEFICITS; SOCIAL-PERCEPTION; SELECTIVE ATTENTION; EXPRESSION; SCHIZOPHRENIA; BEHAVIOR; INTELLIGENCE; PLASTICITY	Deficits in emotion perception are prevalent in people with severe traumatic brain injury (TBI) and are an important target for remediation. Preliminary work has indicated that emotion perception can improve with treatment but there is a dearth of studies examining the efficacy of specific techniques. In this study we examined two remediation strategies: (1) focusing attention on relevant aspects of the facial expression, and (2) mimicking the facial expression. Twenty-two people with chronic, severe brain injuries and 32 people matched on basic demographic variables were asked to label six basic emotions spontaneously followed by either a Focus or Mimic instructional strategy. Contrary to expectations, the TBI group was not poorer than the control group in the Spontaneous condition. Consequently, the effects of Focus vs. Mimic were examined for participants who had average scores or less in the Spontaneous condition (n = 14 and 20, respectively). The poorer performing control group was found to benefit from repeated exposure regardless of remediation strategy. The TBI group did not. Over and above repeated exposure, the Focus instruction assisted control participants but lead to poorer performance in those with TBI. The Mimic strategy resulted in little improvement for either group. Those who benefited least from the Focus strategies in the TBI group were those with poor abstract reasoning and flexibility. There was no such association in the control group and no associations between cognitive abilities and changes in scores using the Mimic strategy in either group.	[McDonald, Skye; Bornhofen, Cristina; Hunt, Christopher] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Hunt, Christopher/0000-0001-5648-1139	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC); University of New South Wales	This project was funded by the National Health and Medical Research Council of Australia and the University of New South Wales. We would like to thank Zoe Hill, Broke Adams and Corrine Restuccio for their assistance with data collection. We are indebted to the people with traumatic brain injury and others from the community who volunteered to take part in this study.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Adolphs R, 1996, J NEUROSCI, V16, P7678; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Benton A., 1994, MULTILINGUAL APHASIA; BENTON AL, 1978, FACIAL RECOGNITION T; BOICE R, 1983, PSYCHOL BULL, V93, P3, DOI 10.1037/0033-2909.93.1.3; Bolte S, 2006, BEHAV NEUROSCI, V120, P211, DOI 10.1037/0735-7044.120.1.211; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BURGESS PW, 1997, HAYLINGS BRIXTON TES; Combs DR, 2006, SCHIZOPHR RES, V87, P340, DOI 10.1016/j.schres.2006.05.003; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davies M, 1998, J PERS SOC PSYCHOL, V75, P989, DOI 10.1037/0022-3514.75.4.989; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Ekman P., 1976, PICTURES FACIAL AFFE; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hess U, 1998, COGNITION EMOTION, V12, P509, DOI 10.1080/026999398379547; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Martin RA, 1996, J RES PERS, V30, P290, DOI 10.1006/jrpe.1996.0019; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2005, BRAIN IMPAIR, V6, P56, DOI DOI 10.1375/BRIM.6.1.56.65481; McHugo GJ, 1996, MOTIV EMOTION, V20, P85, DOI 10.1007/BF02253867; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Penn DL, 2000, SCHIZOPHR RES, V46, P217, DOI 10.1016/S0920-9964(00)00005-0; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pleger B, 2003, NEUROSCI LETT, V335, P192, DOI 10.1016/S0304-3940(02)01153-9; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Reitan R. M, 1992, TRAIL MAKING TEST; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Roberts RD, 2006, EMOTION, V6, P663, DOI 10.1037/1528-3542.6.4.663; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Silver H, 2004, PSYCHIAT RES, V128, P147, DOI 10.1016/j.psychres.2004.06.002; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D., 2001, WECHSLER TEST ADULT; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Weiss EM, 2006, AGGRESSIVE BEHAV, V32, P187, DOI 10.1002/ab.20120	59	11	12	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2009	19	3					321	339	PII 909314286	10.1080/09602010802193989			19	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	435UO	WOS:000265369000001	19274576				2021-06-18	
J	Meyers, JE; Rohling, ML				Meyers, John E.; Rohling, Martin L.			CT and MRI Correlations with Neuropsychological Tests	APPLIED NEUROPSYCHOLOGY			English	Article						MNB; MRI; Meyers Neuropsychological Battery; neuropsychology	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SHORT BATTERY; INTELLIGENCE; PERFORMANCE; WAIS; VALIDATION; LOCALIZATION; DEFICITS; APHASIA	This study consisted of 124 brain-injured participants who were administered the Meyers Neuropsychological Battery (MNB) and (Meyers, 2003); the MNB contains commonly used neuropsychological instruments. These individuals had defined lesions on CT/MRI studies. The current study examined the performance of more modern versions of older tests and some newer neuropsychological tests to determine their sensitivity to lesion location as identified in the brain scans. The results showed 84% concordance with previously hypothesized localization results. Tables of sensitivity to various localizations were constructed along with functional maps for the various tests. These data will assist the clinician in assessing consistency ill cognitive impairment across test performance. Newer versions of tests seem to perform as well or better than their previous versions for localization; although localization is not the main purpose of modern neuropsychological assessment, the current data do indicate that the modern versions of neuropsychological tests do perform generally as expected. Memory tests were found to be the most sensitive to injury regardless of the location of injury.	[Meyers, John E.] Meyers Neuropsychol Serv, Mililani, HI 96789 USA; [Rohling, Martin L.] Univ S Alabama, Dept Psychol, Mobile, AL 36688 USA	Meyers, JE (corresponding author), Meyers Neuropsychol Serv, 94-553 Alapoai St 162, Mililani, HI 96789 USA.	jmeyersneuro@yahoo.com					BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A, 1989, MULTILINGUAL APHASIA; Benton A., 1959, RIGHT LEFT DISCRIMIN; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BLACK FW, 1986, J CLIN PSYCHOL, V42, P770, DOI 10.1002/1097-4679(198609)42:5<770::AID-JCLP2270420516>3.0.CO;2-P; BLACK FW, 1976, CORTEX, V12, P212, DOI 10.1016/S0010-9452(76)80002-0; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Brandt J., 1985, ANN NY ACAD SCI, V44, P502; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CHASE TN, 1984, ARCH NEUROL-CHICAGO, V41, P1244, DOI 10.1001/archneur.1984.04050230026012; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DeFilippis NA, 1997, BOOKLET CATEGORY TES; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GOLDBERG E, 1994, J COGNITIVE NEUROSCI, V6, P276, DOI 10.1162/jocn.1994.6.3.276; GOLDSTEIN G, 1983, REHABILITATION BRAIN; Goodglass H., 1983, ASSESSMENT APHASIA R; GREENLIEF CL, 1985, J INT NEUROPSYCH SOC, V4, P595; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; Halstead WC, 1947, BRAIN INTELLIGENCE; Hardcastle VG, 2002, PHILOS SCI, V69, pS72, DOI 10.1086/341769; Heaton RK, 2004, REVISED COMPREHENSIV; HOM J, 1984, J CLIN NEUROPSYCHOL, V6, P309, DOI 10.1080/01688638408401221; Howieson DB, 2004, NEUROPSYCHOLOGICAL A, P286; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kaplan E., 1983, BOSTON NAMING TEST; Kertesz A, 1994, LOCALIZATION NEUROIM, P1; KING MC, 1981, J CLIN PSYCHOL, V37, P400, DOI 10.1002/1097-4679(198104)37:2<400::AID-JCLP2270370233>3.0.CO;2-B; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Leonberger F. T., 1992, NEUROPSYCHOLOGY, V6, P239, DOI DOI 10.1037/0894-4105.6.3.239; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; MARGOLIN DI, 1990, J CLIN EXP NEUROPSYC, V12, P597, DOI 10.1080/01688639008401004; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; MCFIE J, 1975, ASSESSMENT ORGANIC I; Meyers J, 1995, REY COMPLEX FIGURE R; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; MEYERS JE, 2003, MEYERS NEUROPSYCHOLO; MICELI G, 1981, Journal of Clinical Neuropsychology, V3, P53, DOI 10.1080/01688638108403113; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Newcombe F., 1969, MISSILE WOUNDS BRAIN; PHILLIPS CG, 1984, BRAIN, V107, P328, DOI 10.1093/brain/107.1.328; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; RAMIER AM, 1970, REV NEUROL, V123, P17; REITAN R, 1986, TRAUMATIC BRAIN INJU, V2; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; Reitan RM., 1985, HALSTEAD REITAN NEUR; REY A, 1964, EXAMIN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Rothi L J, 1991, Clin Commun Disord, V1, P7; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; RUSSELL EW, 1987, NEUROPSYCHOLOGY, V1, P2; Scheres A, 2004, ARCH CLIN NEUROPSYCH, V19, P569, DOI 10.1016/j.acn.2003.08.005; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; SKLAR M, 1963, J SPEECH HEAR RES, V6, P84, DOI 10.1044/jshr.0601.84; Spreen O., 1998, COMPENDIUM NEUROPSYC; STORANDT M, 1986, HDB CLIN MEMORY ASSE; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Tulsky D.S., 2003, CLIN INTERPRETATION; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; WANG PL, 1987, FRONTAL LOBES REVISI; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler, 1981, WAIS R MANUAL; Wechsler D, 1997, WAIS 3 ADM SCORING M	80	11	11	0	11	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2009	16	4					237	253		10.1080/09084280903098752			17	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	539ZD	WOS:000273298100001	20183179				2021-06-18	
B	Owen, AM; Schiff, ND; Laureys, S		Laureys, S; Tononi, G		Owen, Adrian M.; Schiff, Nicholas D.; Laureys, Steven			The Assessment of Conscious Awareness in the Vegetative State	NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY			English	Article; Book Chapter							CEREBRAL-BLOOD-FLOW; EMISSION TOMOGRAPHY DATA; TRAUMATIC BRAIN INJURY; GLUCOSE-METABOLISM; NEURONAL-ACTIVITY; PERSISTENT; RECOVERY; PET; CONNECTIVITY; DIAGNOSIS	The assessment of patients in the vegetative state is extremely complex and depends frequently on subjective interpretations of the observed spontaneous and volitional behaviour. In recent years, a number of studies have demonstrated an important role for functional neuroimaging in the identification of residual cognitive function, and even conscious awareness, in some patients fulfilling the clinical criteria for vegetative state. Such studies, when successful, may be particularly useful where there is concern about the accuracy of the diagnosis and the possibility that residual cognitive function has remained undetected. However, use of these techniques in severely brain-injured persons is methodologically complex and requires careful quantitative analysis and interpretation. In addition, ethical frameworks to guide research in these patients urgently need to be developed to accommodate these emerging technologies.	[Owen, Adrian M.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England; [Owen, Adrian M.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Schiff, Nicholas D.] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; [Laureys, Steven] Univ Hosp CHU, Dept Neurol, Liege, Belgium; [Laureys, Steven] Univ Liege, Cyclotron Res Ctr, Belgian Natl Funds Sci Res, Liege, Belgium	Owen, AM (corresponding author), Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England.	adrian.owen@mrc-cbu.cam.ac.uk; nds2001@med.cornell.edu; steven.laureys@ulg.ac.be	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807			AGARDH CD, 1983, ANN NEUROL, V14, P482, DOI 10.1002/ana.410140414; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; Bates D, 2005, NEUROPSYCHOL REHABIL, V15, P175, DOI 10.1080/09602010443000399; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; deJong BM, 1997, CLIN NEUROL NEUROSUR, V99, P213, DOI 10.1016/S0303-8467(97)00024-3; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Edgren E, 2003, RESUSCITATION, V57, P161, DOI 10.1016/S0300-9572(03)00004-2; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gsell W, 2000, J CHEM NEUROANAT, V20, P215, DOI 10.1016/S0891-0618(00)00095-8; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; Hamzei F, 2003, NEUROIMAGE, V20, P1393, DOI 10.1016/S1053-8119(03)00384-7; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HERSCOVITCH P, 1986, J CEREBR BLOOD F MET, V6, P120, DOI 10.1038/jcbfm.1986.14; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; JENNETT B, 1972, LANCET, V1, P734; Jennett B., 2002, VEGETATIVE STATE MED; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2000, PHYSL IMAGING BRAIN, P329; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Momose T, 1989, Radiat Med, V7, P243; Owen AM, 2007, SCIENCE, V315, DOI 10.1126/science.1135583; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Owen AM, 2005, PROG BRAIN RES, V150, P457, DOI 10.1016/S0079-6123(05)50032-3; Owen AM, 2002, NEUROCASE, V8, P394, DOI 10.1076/neur.8.4.394.16184; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; Rudolf J, 2002, EUR J NEUROL, V9, P671, DOI 10.1046/j.1468-1331.2002.00468.x; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Rudolf J, 1999, J NEUROSURG ANESTH, V11, P17, DOI 10.1097/00008506-199901000-00004; Sakatani K, 2003, ACT NEUR S, V87, P59; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; The Royal College of Physicians, 2003, VEG STAT GUID DIAGN; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; TURKSTRA LS, 1995, BRAIN INJURY, V9, P61, DOI 10.3109/02699059509004573; VIDEEN TO, 1988, J CEREBR BLOOD F MET, V8, P662, DOI 10.1038/jcbfm.1988.113; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841; Wilson BA, 2001, BRAIN INJURY, V15, P1083, DOI 10.1080/02699050110082197; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613	54	11	12	0	0	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-092102-0; 978-0-12-374168-4				2009							163	172		10.1016/B978-0-12-374168-4.00013-7			10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	BEI12	WOS:000316668600015					2021-06-18	
J	Yang, XY; Yang, SY; Wang, J; Zhang, XM; Wang, C; Hong, GL				Yang, Xinyu; Yang, Shuyuan; Wang, Jie; Zhang, Xuemin; Wang, Chen; Hong, Guoliang			Expressive proteomics profile changes of injured human brain cortex due to acute brain trauma	BRAIN INJURY			English	Article						Traumatic brain injury; proteomics; human; cortex	INTEGRIN-LINKED KINASE; CONTROLLED CORTICAL IMPACT; ALZHEIMERS-DISEASE BRAIN; GROWTH-FACTOR; 2-DIMENSIONAL ELECTROPHORESIS; MASS-SPECTROMETRY; NEURONAL INJURY; CEREBRAL-CORTEX; PROTEINS; CELLS	Objective: To find the expressive proteomics changes in damaged human brain cortex after traumatic brain injury (TBI). Method: By rapid high-throughput and precise proteomic techniques, the traumatic injured human frontal cortexes were compared with non-trauma controls. Results: On 2-DE PAGE, 138 protein spots were found significantly different on expressive level of quantitative mature. Most of these proteins expressed in a fluctuant fashion within 18 hours after trauma, with mean levels lower than control. Eighty-two protein spots were identified by MALDI-MS TOF, which were products of 71 proteins and could be grouped into 10 categories based on possible functions: cytoskeleton (n = 10), metabolism (n = 13), electron transport (n = 8), signalling transduction (n = 4), stress response (n = 6), protein synthesis and turnover (n = 8), transporter (n = 5), cell cycle (n = 1), other (n = 8) and unknown (n = 9). Conclusion: After traumatic brain injury, there are significant proteins expressing changes in damaged brain tissue. These proteins may play a critical role in TBI. Although some of these proteins functions are not fully understood, they may become novel biomarkers and novel therapy targets in the future.	[Yang, Xinyu; Yang, Shuyuan; Wang, Chen; Hong, Guoliang] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Wang, Jie; Zhang, Xuemin] Acad Mil Med Sci, Natl Ctr Biomed Anal, Beijing, Peoples R China	Yang, SY (corresponding author), Tianjin Med Univ, Dept Neurosurg, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	paradiseyang@gmail.com			National Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [30271331]	This work was supported by the National Science Foundation of China (NSFC), ( No. 30271331).	Abdullaev Y, 2005, NAT NEUROSCI, V8, P1424, DOI 10.1038/nn1105-1424; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Bajo M, 2002, PROTEOMICS, V2, P1539, DOI 10.1002/1615-9861(200211)2:11<1539::AID-PROT1539>3.0.CO;2-C; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; BERNANOVAGIORGI.S, 2002, PROTEOMICS, V2, P534; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buono P, 1997, BIOCHEM J, V323, P245, DOI 10.1042/bj3230245; Butterfield DA, 2004, BRAIN RES, V1000, P1, DOI 10.1016/j.brainres.2003.12.012; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Chen W, 2002, NEUROCHEM RES, V27, P871, DOI 10.1023/A:1020383313177; Chin LS, 1999, MOL BRAIN RES, V67, P239, DOI 10.1016/S0169-328X(99)00066-2; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Davidsson P, 2002, MOL BRAIN RES, V109, P128, DOI 10.1016/S0169-328X(02)00549-1; Davidsson P, 2001, PROTEOMICS, V1, P444; Ekegren T, 2006, J PROTEOME RES, V5, P2364, DOI 10.1021/pr060237f; Eun JP, 2004, EXP MOL MED, V36, P185, DOI 10.1038/emm.2004.26; Fei Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-96; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Fountoulakis M, 2002, PROTEOMICS, V2, P1547, DOI 10.1002/1615-9861(200211)2:11<1547::AID-PROT1547>3.0.CO;2-M; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hoffrogge R, 2006, NEURODEGENER DIS, V3, P112, DOI 10.1159/000092102; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kaneko Y, 2004, J CELL SCI, V117, P407, DOI 10.1242/jcs.00871; Kartmann B, 2001, J CELL SCI, V114, P839; Kim SI, 2004, NEUROCHEM RES, V29, P1317, DOI 10.1023/B:NERE.0000023618.35579.7c; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; LEE JM, 2005, J NEUROSCI, V25, P6449; Leypoldt F, 2002, NEUROSCI LETT, V324, P37, DOI 10.1016/S0304-3940(02)00170-2; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Loan T, 1999, NUTRITION, V15, P809; Lubec G, 2003, PROG NEUROBIOL, V69, P193, DOI 10.1016/S0301-0082(03)00036-4; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marion Donald W, 2006, Prog Neurol Surg, V19, P171, DOI 10.1159/000095191; Maurer Martin H, 2003, Proteome Sci, V1, P4, DOI 10.1186/1477-5956-1-4; Mills J, 2003, J NEUROSCI, V23, P1638; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Patel K, 2002, PROTEOMICS, V2, P1464, DOI 10.1002/1615-9861(200210)2:10<1464::AID-PROT1464>3.0.CO;2-9; Peyrl A, 2003, PROTEOMICS, V3, P1781, DOI 10.1002/pmic.200300460; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Poona HF, 2005, NEUROCHEM INT, V46, P159, DOI 10.1016/j.neuint.2004.07.008; Renault F, 2003, BIOCHEM PHARMACOL, V66, P1581, DOI 10.1016/S0006-2952(03)00514-8; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; Vanrobaeys F, 2005, J PROTEOME RES, V4, P2283, DOI 10.1021/pr050205c; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Yamaji R, 2004, ARCH BIOCHEM BIOPHYS, V423, P332, DOI 10.1016/j.abb.2004.01.003; Yang JW, 2005, J PROTEOME RES, V4, P768, DOI 10.1021/pr049774v; Yoganathan N, 2002, PHARMACOL THERAPEUT, V93, P233, DOI 10.1016/S0163-7258(02)00192-4	57	11	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	10					830	840	PII 914074702	10.1080/02699050903196670			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	485SP	WOS:000269144600007	19697172				2021-06-18	
J	Yard, EE; Comstock, RD				Yard, Ellen E.; Comstock, R. Dawn			Effects of Field Location, Time in Competition, and Phase of Play on Injury Severity in High School Football	RESEARCH IN SPORTS MEDICINE			English	Article						epidemiology; competition intensity; concussion; kickoff; punt	AMERICAN FOOTBALL; RISK-FACTORS; LIFE STRESS; PROFESSIONAL FOOTBALL; CONCUSSION; SPORTS; ANXIETY; LEVEL; RATES; ANKLE	This study evaluated the effects of competitive intensity, represented by the variables time in competition, phase of play, and field location, on injury severity in U.S. high school football. The injury rate was higher in competition than practice (RR = 4.75, 95% CI: 4.34-5.20). Mild and moderate injuries were frequently lower leg/foot/ankle sprains/strains and concussions. Severe injuries were frequently knee Sprains/strains and arm fractures. Severe injuries composed a greater proportion of injuries sustained during the beginning and middle of competition compared with injuries sustained during the end/overtime (IPR = 1.83, 95% CI: 1.25-2.69). Compared with injuries sustained during general play, a greater proportion of kickoff/punt injuries were severe (IPR = 1.69, 95% CI: 1.07-2.68) or were concussions (IPR = 1.86, 95% CI: 1.05-3.30). Identifying factors contributing to severe injury is a crucial first step toward developing targeted evidence-based interventions aimed at reducing the incidence of severe injuries among the millions of high school football players.	[Yard, Ellen E.; Comstock, R. Dawn] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH 43205 USA; [Comstock, R. Dawn] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Comstock, R. Dawn] Coll Publ Hlth, Div Epidemiol, Columbus, OH USA	Yard, EE (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	Yard@NationwideChildrens.org			Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000674] Funding Source: NIH RePORTER	This report was funded by the Centers for Disease Control and Prevention (CDC) grant #R49/CE000674-01.	Alsop J C, 2000, J Sci Med Sport, V3, P97, DOI 10.1016/S1440-2440(00)80072-9; *AM FOOTB MONTHL, 2006, LONG RED LIN     JUN; Beynnon BD, 2005, AM J SPORT MED, V33, P1485, DOI 10.1177/0363546505275490; Bishop PJ, 1996, AM J SPORT MED, V24, P235, DOI 10.1177/036354659602400222; BLACKWELL B, 1990, Athletic Training, V25, P25; CANALE ST, 1981, AM J SPORT MED, V9, P384, DOI 10.1177/036354658100900608; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; CODDINGTON RD, 1980, J HUM STRESS, V6, P3, DOI 10.1080/0097840X.1980.9936100; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Gabbett TJ, 2004, J SPORT SCI, V22, P409, DOI 10.1080/02640410310001641638; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gomez JE, 1998, CLIN J SPORT MED, V8, P115, DOI 10.1097/00042752-199804000-00010; HANSON SJ, 1992, J SPORT EXERCISE PSY, V14, P262, DOI 10.1123/jsep.14.3.262; Junge A, 2000, AM J SPORT MED, V28, pS10; Kaplan LD, 2005, AM J SPORT MED, V33, P1142, DOI 10.1177/0363546505274718; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; KOLT GS, 1994, PERCEPT MOTOR SKILL, V78, P955, DOI 10.2466/pms.1994.78.3.955; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; *NAT FED STAT HIGH, 2005, 2004 05 NFHS HIGH SC; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; PARGMAN D, 1989, SPORTS TRAINING MED, V1, P203; PASSER MW, 1983, J HUM STRESS, V9, P11, DOI 10.1080/0097840X.1983.9935025; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Peterson L, 2000, AM J SPORT MED, V28, pS51; PETRIE TA, 1993, J SPORT EXERCISE PSY, V15, P261, DOI 10.1123/jsep.15.3.261; Powell JW, 1999, J ATHL TRAINING, V34, P277; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Stuart Michael J, 2005, Med Sport Sci, V49, P62, DOI 10.1159/000085392; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Tyler TF, 2006, AM J SPORT MED, V34, P471, DOI 10.1177/0363546505280429; *US BUR CENS, 2007, CENS REG DIV US; *US FOOTB, 2006, COACH GUID SPEC TEAM	40	11	11	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2009	17	1					35	49		10.1080/15438620802678495			15	Sport Sciences	Sport Sciences	451RW	WOS:000266488800004	19266392				2021-06-18	
J	Brenner, LA; Harwood, JEE; Homaifar, BY; Cawthra, E; Waldman, J; Adler, LE				Brenner, Lisa A.; Harwood, Jeri E. E.; Homaifar, Beeta Y.; Cawthra, Ellen; Waldman, Jeffrey; Adler, Lawrence E.			Psychiatric Hospitalization and Veterans With Traumatic Brain Injury: A Retrospective Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; drug; psychiatric hospitalization; substance abuse; traumatic brain injury	MULTICENTER ANALYSIS; DRUG-USE; PREVALENCE; SUICIDE; ALCOHOL; POPULATION; DISORDERS	To determine risk factors for psychiatric hospitalization after traumatic brain injury (TBI) in veterans. Subjects and procedures: Medical records of 96 veteran, with histories of TBI (17 mild, 33 moderate, and 46 severe) were reviewed for information concerning psychiatric history, including hospitalization and substance misuse. Results: Subjects with a history of problematic drug and alcohol use had a significantly higher probability of psychiatric hospitalization than those without such a history. Gender, age, problematic alcohol use without problematic drug use, injury severity, time since injury, years of follow-up, and a history of psychiatric symptoms (including those attributed to general medical conditions) were not identified as significant risk factors. Ninety-one veterans (95%) had a history of psychiatric difficulty. In addition, the probability of post-TBI problematic drug and alcohol use, given a pre-TBI history of such use, was significantly higher than the probability given no history. Conclusions: Veterans with problematic drug and alcohol use are at increased risk for psychiatric hospitalization after TBI. In addition, the likelihood of problematic post-TBI drug and alcohol use was significantly greater for those with a preinjury history. Ninety-five percent of veterans in the current sample endorsed lifetime histories of psychiatric difficulty. These findings highlight the need for evidence-based means of psychiatric and/or substance abuse treatment of those with a history of TBI.	[Brenner, Lisa A.; Harwood, Jeri E. E.; Homaifar, Beeta Y.; Cawthra, Ellen; Waldman, Jeffrey; Adler, Lawrence E.] UCD, Sch Med, VA VISN 19 Mental Illness Res Educ & Clin Ctr, Aurora, CO USA; [Brenner, Lisa A.; Homaifar, Beeta Y.; Adler, Lawrence E.] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Denver, Dept Phys Med & Rehabil, Aurora, CO USA; [Harwood, Jeri E. E.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Adler, LE (corresponding author), VA VISN 19 MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	Lisa.Brenner@va.gov	Brenner, Lisa A./AAG-2442-2019		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [50878-09] Funding Source: Medline		Ahmed II, 1998, SEMIN CLIN NEUROPSYC, V3, P23; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Brenner LA, 2007, J HEAD TRAUMA REHAB, V22, P56, DOI 10.1097/00001199-200701000-00007; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; *DEP VET AFF, 2004, VETEESA138 DEP VET A; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI [10.1111/j.1553-2712.2004.tb01434.x, 10.1197/j.aem.2003.09.014]; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Institute of Medicine, 1990, BROAD BAS TREATM ALC; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Schnyder U, 1997, GEN HOSP PSYCHIAT, V19, P119, DOI 10.1016/S0163-8343(96)00169-7; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thurman DJ., 1995, GUIDELINES SURVEILLA; Way BB, 2001, PSYCHIATR SERV, V52, P214, DOI 10.1176/appi.ps.52.2.214; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	23	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					401	406		10.1097/01.HTR.0000341436.59627.a5			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300006	19033833				2021-06-18	
J	Cox, CD; West, EJ; Liu, MC; Wang, KKW; Hayes, RL; Lyeth, BG				Cox, Christopher D.; West, Eric J.; Liu, Ming Cheng; Wang, Kevin K. W.; Hayes, Ronald L.; Lyeth, Bruce G.			Dicyclomine, an M1 Muscarinic Antagonist, Reduces Biomarker Levels, But Not Neuronal Degeneration, in Fluid Percussion Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						CSF; dicyclomine; immunohistochemistry; spectrin; TBI	LONG-TERM POTENTIATION; ALPHA-II-SPECTRIN; CHOLINERGIC RECEPTOR-BINDING; SIGNAL-TRANSDUCTION PATHWAY; PHOSPHATIDYLINOSITOL BISPHOSPHATE; BEHAVIORAL DEFICITS; BREAKDOWN PRODUCTS; PHOSPHOINOSITIDE TURNOVER; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE	Recent studies indicate that alpha II-spectrin breakdown products (SBDPs) have utility as biological markers of traumatic brain injury (TBI). However, the utility of SBDP biomarkers for detecting effects of therapeutic interventions has not been explored. Acetylcholine plays a role in pathological neuronal excitation and TBI-induced muscarinic cholinergic receptor activation may contribute to excitotoxic processes. In experiment I, regional and temporal changes in calpain-mediated alpha-spectrin degradation were evaluated at 3, 12, 24, and 48 h using immunostaining for 145-kDa SBDP. Immunostaining of SBDP-145 was only evident in the hemisphere ipsilateral to TBI and was generally limited to the cortex except at 24 h when immunostaining was also prominent in the dentate gyrus and striatum. In Experiment II, cerebral spinal fluid (CSF) samples were analyzed for various SBDPs 24 h after moderate lateral fluid percussion TBI. Rats were administered either dicyclomine (5 mg/kg i.p.) or saline vehicle (n=8 per group) 5 min prior to injury. Injury produced significant increases (p< 0.001) of 300%, 230%, and >1000% in SBDP-150, -145, and -120, respectively in vehicle-treated rats compared to sham. Dicyclomine treatment produced decreases of 38% (p=0.077), 37% (p=0.028), and 63% (p=0.051) in SBDP-150, -145, and -120, respectively, compared to vehicle-treated injury. Following CSF extraction, coronal brain sections were processed for detecting degenerating neurons using Fluoro-Jade histofluorescence. Stereological techniques were used to quantify neuronal degeneration in the dorsal hippocampus CA2/3 region and in the parietal cortex. No significant differences were detected in numbers of degenerating neurons in the dorsal CA2/3 hippocampus or the parietal cortex between saline and dicyclomine treatment groups. The percent weight loss following TBI was significantly reduced by dicyclomine treatment. These data provide additional evidence that, as TBI biomarkers, SBDPs are able to detect a therapeutic intervention even in the absence of changes in neuronal cell degeneration measured by Fluoro-jade.	[Cox, Christopher D.; West, Eric J.; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Liu, Ming Cheng; Wang, Kevin K. W.; Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA; [Wang, Kevin K. W.; Hayes, Ronald L.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Wang, Kevin K. W.; Hayes, Ronald L.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA	Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474; Wang, Kevin/0000-0002-9343-6473	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS29995, NS45136, NS051431, NS049175]; DoDUnited States Department of Defense [DAMD17-03-1-0772, DAMD17-03-1-0066]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045136, R01NS051431, R01NS049175, R01NS029995] Funding Source: NIH RePORTER	This research was supported by NIH NS29995, NS45136 (to B.G.L.); DoD DAMD17-03-1-0772, DAMD17-03-1-0066, NIH NS051431 (to R.L.H.); and NIH NS049175 (to K.K.W.W.).	Amaral David G., 1995, P443; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349; BURGARD EC, 1990, NEUROSCI LETT, V116, P34, DOI 10.1016/0304-3940(90)90382-J; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P405; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GALLO MP, 1993, J PHYSIOL-LONDON, V471, P41, DOI 10.1113/jphysiol.1993.sp019890; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; HABER B, 1980, NEUROBIOLOGY CEREBRO, V1, P345; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; Jenkner FL, 1954, NERVENARZT, V25, P77; JENKNER FL, 1955, ELECTROEN CLIN NEURO, V7, P303, DOI 10.1016/0013-4694(55)90044-4; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Jiang ZW, 2000, BRAIN RES, V852, P37, DOI 10.1016/S0006-8993(99)02230-1; JOHNSON GVW, 1989, BIOCHEM BIOPH RES CO, V163, P1505, DOI 10.1016/0006-291X(89)91150-9; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KUMAGAE Y, 1991, J NEUROCHEM, V56, P1169, DOI 10.1111/j.1471-4159.1991.tb11407.x; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; OLNEY JW, 1983, NATURE, V301, P520, DOI 10.1038/301520a0; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; PRASAD MR, 1994, J NEUROCHEM, V63, P773; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; REEVES TM, 1995, EXP BRAIN RES, V106, P248; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIDO TC, 1994, FASEB J, V8, P814; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Sharma VK, 1996, CIRC RES, V79, P86, DOI 10.1161/01.RES.79.1.86; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; TURSKI WA, 1983, EXPERIENTIA, V39, P1408, DOI 10.1007/BF01990130; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 2002, METH NE FRO NEUROSCI, P181; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	73	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2008	25	11					1355	1365		10.1089/neu.2008.0671			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	384BP	WOS:000261718900008	19061379	Green Published, Green Accepted			2021-06-18	
J	Lee, HO; Koh, EJ; Oh, YM; Park, SS; Kwon, KH; Choi, HY				Lee, Hai-Ong; Koh, Eun-Jeong; Oh, Young-Min; Park, Seung-Soo; Kwon, Ki-Hun; Choi, Ha-Young			Effect of Vagus Nerve Stimulation in Post-Traumatic Epilepsy and Failed Epilepsy Surgery : Preliminary Report	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Vagus nerve; Electric stimulation; Epilepsy; Post-traumatic	TERM-FOLLOW-UP; LONG-TERM; REFRACTORY EPILEPSY; DEVICE PARAMETERS; PARTIAL SEIZURES; THERAPY	Objective : Vagus nerve stimulation (VNS) has been used in epilepsy patients refractory to standard medical treatments and unsuitable candidates for resective or disconnective surgery. In this study, we investigated the efficacy of VNS to patients who had refractory result to epilepsy surgery and patients with post-traumatic epilepsy. Methods : We analyzed the effect of VNS in 11 patients who had undergone previous epilepsy surgery and patients with intractable post-traumatic epilepsy associated with brain injury. All patients underwent VNS implantation between October 2005 and December 2006. Results : We evaluated seizure frequency before and after implantation of VNS and maximum follow up period was 24 months. In the first 6 months, 11 patients showed an average of 74.3% seizure reduction. After 12 months, 10 patients showed 85.2% seizure reduction. Eighteen months after implantation, 9 patients showed 92.4% seizure reduction and 7 patients showed 97.2% seizure reduction after 24 months. Six patients were seizure-free at this time. Conclusion : We conclude that the VNS is a helpful treatment modality in patients with surgically refractory epilepsy and in patients with post-traumatic epilepsy due to severe brain injury.	[Lee, Hai-Ong; Koh, Eun-Jeong; Oh, Young-Min; Park, Seung-Soo; Kwon, Ki-Hun; Choi, Ha-Young] Chonbuk Natl Univ, Med Sch Hosp, Dept Neurosurg, Res Inst Clin Med, Jeonju 561712, South Korea	Koh, EJ (corresponding author), Chonbuk Natl Univ, Med Sch Hosp, Dept Neurosurg, Res Inst Clin Med, 634-18 Geumam Dong, Jeonju 561712, South Korea.	kohejns@chonbuk.ac.kr					Ardesch JJ, 2007, SEIZURE-EUR J EPILEP, V16, P579, DOI 10.1016/j.seizure.2007.04.005; Ben Renfroe J, 2002, NEUROLOGY, V59, pS26, DOI 10.1212/WNL.59.6_suppl_4.S26; DeGiorgio CM, 2001, EPILEPSIA, V42, P1017, DOI 10.1046/j.1528-1157.2001.0420081017.x; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; GEORGE R, 1994, EPILEPSIA, V35, P637, DOI 10.1111/j.1528-1157.1994.tb02484.x; Heck C, 2002, NEUROLOGY, V59, pS31, DOI 10.1212/WNL.59.6_suppl_4.S31; HOLDER LK, 1992, PACE, V15, P1557, DOI 10.1111/j.1540-8159.1992.tb02934.x; Morris GL, 1999, NEUROLOGY, V53, P1731, DOI 10.1212/WNL.53.8.1731; Morrow JI, 2000, SEIZURE-EUR J EPILEP, V9, P442, DOI 10.1053/seiz.2000.0417; Schachter SC, 2002, NEUROLOGY, V59, pS15, DOI 10.1212/WNL.59.6_suppl_4.S15; Spanaki MV, 2004, SEIZURE-EUR J EPILEP, V13, P587, DOI 10.1016/j.seizure.2004.01.009; Uthman BM, 2004, NEUROLOGY, V63, P1124, DOI 10.1212/01.WNL.0000138499.87068.C0; You SJ, 2007, J KOREAN MED SCI, V22, P442, DOI 10.3346/jkms.2007.22.3.442	13	11	11	0	0	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2008	44	4					196	198		10.3340/jkns.2008.44.4.196			3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	367OO	WOS:000260561500003	19096676	DOAJ Gold, Green Published			2021-06-18	
J	Luukinen, H; Jokelainen, J; Kervinen, K; Kesaniemi, YA; Winqvist, S; Hillbom, M				Luukinen, H.; Jokelainen, J.; Kervinen, K.; Kesaniemi, Y. A.; Winqvist, S.; Hillbom, M.			Risk of dementia associated with the ApoE epsilon 4 allele and falls causing head injury without explicit traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						ageing; ApoE epsilon 4; dementia; fall accident; head injury	APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; OLDER-ADULTS; POPULATION; PEOPLE; AGE	Objectives - Severe head injury (HI) and the apolipoprotein E (ApoE) epsilon 4 allele are risk factors for dementia. The corresponding effect of falls causing HI without explicit traumatic brain injury (TBI) in association with the ApoE epsilon 4 is not known. Materials and methods - Altogether 134 persons aged 70 years or older constituted a retrospective population sample, who scored >= 26 in the MiniMental State Examination (MMSE) test at baseline and were clinically examined for dementia 9 years afterward. Fall-related HI causing superficial laceration or bruises or wounds that require suturing were prospectively recorded during the 9-year follow-up. We used Cox regression with age at the diagnosis of dementia as a dependent variable. Results - Twenty-eight (21%) subjects had falls causing HI without explicit TBI, the ApoE epsilon 4 allele was seen in 44 (33%), and clinical dementia was diagnosed in 25 (19%). Adjusted for the baseline MMSE score, sex and educational status, the hazard ratio for subsequent dementia in subjects having falls with HI without explicit TBI and the ApoE epsilon 4 allele as compared with those who do not possess these characteristics was 2.70 (95% confidence interval, 1.02-7.16). Conclusions - According to the results of this small retrospective study, falls with HI without explicit TBI in connection with the ApoE epsilon 4 allele is associated with subsequent dementia among older adults.	[Luukinen, H.; Jokelainen, J.] Univ Oulu, Oulu Univ Hosp, Unit Gen Practice, Dept Publ Hlth Sci & Gen Practice, FIN-90014 Oulu, Finland; [Kervinen, K.; Kesaniemi, Y. A.] Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland; [Kervinen, K.; Kesaniemi, Y. A.] Univ Oulu, Bioctr, FIN-90014 Oulu, Finland; [Winqvist, S.; Hillbom, M.] Univ Hosp Oulu, Dept Neurol, Oulu, Finland	Luukinen, H (corresponding author), Univ Oulu, Oulu Univ Hosp, Unit Gen Practice, Dept Publ Hlth Sci & Gen Practice, PB 5000, FIN-90014 Oulu, Finland.	heikki.luukinen@oulu.fi		Jokelainen, Jari/0000-0003-4629-0560			Aevarsson O, 1997, Int Psychogeriatr, V9, P11; *AM PSYCH ASS, 1994, DSM4 AM PSCYH ASS; Commenges D, 1998, STAT MED, V17, P1973, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; EHNHOLM C, 1986, J LIPID RES, V27, P227; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Juva K, 2000, INT PSYCHOGERIATR, V12, P379, DOI 10.1017/S1041610200006487; Katzman R, 1996, NEUROLOGY, V46, P889; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; LUUKINEN H, 1994, J CLIN EPIDEMIOL, V47, P843, DOI 10.1016/0895-4356(94)90187-2; Luukinen H, 1999, J AM GERIATR SOC, V47, P1451, DOI 10.1111/j.1532-5415.1999.tb01566.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAZZUCCHI A, 1992, J NEUROL, V239, P256; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; van Doorn C, 2003, J AM GERIATR SOC, V51, P1213, DOI 10.1046/j.1532-5415.2003.51404.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	31	11	11	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	SEP	2008	118	3					153	158		10.1111/j.1600-0404.2008.00994.x			6	Clinical Neurology	Neurosciences & Neurology	336PC	WOS:000258376100003	18307571				2021-06-18	
J	Siddharthan, K; Scott, S; Bass, E; Nelson, A				Siddharthan, Kris; Scott, Steven; Bass, Elizabeth; Nelson, Audrey			Rehabilitation outcomes for veterans with polytrauma treated at the Tampa VA	REHABILITATION NURSING			English	Article						combat polytrauma; health outcomes; rehabilitation; Veterans Administration	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; IDENTIFICATION; DEPRESSION; SURVIVAL	Returning soldiers from Iraq and Afghanistan who have sustained polytrauma have a combination of complex physical and mental morbidities that require extensive therapy and rehabilitation. This study examined the effect of rehabilitation on 116 polytrauma patients with service-connected injuries treated at the Tampa VA; improvements in functional and cognitive abilities were measured using the Functional Independence Measure (FIM (TM)) scores and healthcare costs for rehabilitation treatment were also assessed. Intensive rehabilitation therapy increased functional ability in this cohort with an average improvement in total FIM scores of 23 points, Total inpatient costs for these patients exceeded $4 million in approximately 3 years. Rehabilitation nurses face challenges providing quality care to this target patient population, including characterizing war-related polytrauma, providing surveillance, coordinating care, synchronizing care for patients with multiple injuries, and conducting evidence-based pain management.	[Siddharthan, Kris] James A Haley Vet Adm Med Ctr, Patient Safety Ctr Inquiry VISN8, Tampa, FL 33612 USA; [Scott, Steven] James A Haley Vet Adm Med Ctr, Level Polytrauma Ctr 1, Tampa, FL 33612 USA; [Bass, Elizabeth; Nelson, Audrey] James A Haley Vet Adm Med Ctr, Patient Safety Ctr Inquiry, Tampa, FL 33612 USA; [Bass, Elizabeth] Univ S Florida, Sch Aging Studies, Tampa, FL 33620 USA; [Nelson, Audrey] Univ S Florida, Coll Nursing, Tampa, FL 33620 USA	Siddharthan, K (corresponding author), James A Haley Vet Adm Med Ctr, Patient Safety Ctr Inquiry VISN8, Tampa, FL 33612 USA.	kris.siddharthan@med.va.gov					Aziz Mohamed A, 2004, J Psychiatr Pract, V10, P307, DOI 10.1097/00131746-200409000-00004; BINGHAM RL, 1990, J GEN INTERN MED, V5, P342, DOI 10.1007/BF02600403; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cambron JA, 2004, J MANIP PHYSIOL THER, V27, P299, DOI 10.1016/j.jmpt.2004.04.003; CDC, 1986, COMPR PLAN EP SURV; Corson K, 2004, AM J MANAG CARE, V10, P839; *DEF VET BRAIN INJ, BLAST INJ; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; GIBBS N, 2005, TIME, V167, P50; GRANGER CV, 1996, PHYSICAL MED REHABIL, P247; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Kennedy BM, 2005, ETHNIC DIS, V15, P373; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Pobereskin LH, 2001, J NEUROSURG, V95, P555, DOI 10.3171/jns.2001.95.4.0555; Powell S, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-11; Scott SG, 2005, FEDERAL PRACTITIONER, V22, P67; Sheeran T, 2002, J CONSULT CLIN PSYCH, V70, P961, DOI 10.1037//0022-006X.70.4.000; Sheeran T, 2002, PSYCHIAT RES, V109, P51, DOI 10.1016/S0165-1781(01)00364-X; Starr AJ, 2004, J BONE JOINT SURG AM, V86A, P1115, DOI 10.2106/00004623-200406000-00001; *US DEP DEF, 2008, OP IR FREED OP END; vanderFeltzCornelis CM, 1997, INT J PSYCHIAT MED, V27, P1; ZITTER M, 1997, DIS MANAGEMENT SYSTE, P1	25	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0278-4807	2048-7940		REHABIL NURS	Rehabil. Nurs.	SEP-OCT	2008	33	5					221	225		10.1002/j.2048-7940.2008.tb00231.x			5	Nursing; Rehabilitation	Nursing; Rehabilitation	343JK	WOS:000258849200007	18767404				2021-06-18	
J	Garcia-Molina, A; Rajo, PR; Gomez, PV; Plaja, CJI; Roig-Rovira, T				Garcia-Molina, Alberto; Rodriguez Rajo, Pablo; Vendrell Gomez, Pere; Junque i Plaja, Carme; Roig-Rovira, Teresa			Orbitofrontal dysfunction in multiple sclerosis: Iowa Gambling Task	PSICOTHEMA			Spanish	Article; Proceedings Paper	18th Technical Congress of the Institute-Guttmann	2006	Barcelona, SPAIN	Inst Guttmann			SOMATIC MARKER HYPOTHESIS; DECISION-MAKING PROCESSES; HUMAN PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE DAMAGE; COGNITIVE DYSFUNCTION; NEUROPSYCHOLOGY; PERFORMANCE; IMPAIRMENT	Cognitive dysfunction has been widely studied in multiple sclerosis (MS), however decision-making has been less investigated. The current study examined the decision-making processes of patients with multiple sclerosis (MS) using a computerized version of the Iowa Gambling Task (IGT). This task was applied to 18 patients with clinically diagnosed MS and 18 healthy control subjects matched for age, sex, and years of education. The results showed that IGT scores differ significantly between patients with MS and the healthy control subjects: the patients with MS made significantly less advantageous decisions than the controls in the IGT. Possible causes of impaired decision-making in multiple sclerosis are discussed.	[Garcia-Molina, Alberto; Rodriguez Rajo, Pablo; Roig-Rovira, Teresa] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Vendrell Gomez, Pere; Junque i Plaja, Carme] Univ Barcelona, E-08007 Barcelona, Spain	Plaja, CJI (corresponding author), Inst Univ Neurorehabil Guttmann, Badalona 08916, Spain.	agarciam.investigacio@guttmann.com	Vendrell, Pere/B-4392-2011	Vendrell, Pere/0000-0001-8918-5440			Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Arango-Lasprilla JC, 2007, PSICOTHEMA, V19, P1; Beatty W W, 1996, J Int Neuropsychol Soc, V2, P134; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Birnboim S, 2004, MULT SCLER J, V10, P67, DOI 10.1191/1352458504ms980oa; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Calabrese P, 2006, J NEUROL, V253, P10, DOI 10.1007/s00415-006-1103-1; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clark L, 2004, NEUROCASE, V10, P398, DOI 10.1080/13554790490882799; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio A., 1994, DESCARTESERROR EMOTI; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Garcia-Molina A, 2007, NEUROLOGIA, V22, P206; GRIGSBY J, 1993, ARCH PHYS MED REHAB, V74, P1350, DOI 10.1016/0003-9993(93)90091-N; Kleeberg J, 2004, ANN NEUROL, V56, P787, DOI 10.1002/ana.20277; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Nagy H, 2006, J INT NEUROPSYCH SOC, V12, P559, DOI 10.1017/S1355617706060644; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; Rolania OS, 2006, PSICOTHEMA, V18, P84; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Simon VM, 1997, PSICOTHEMA, V9, P365; Stablum F, 2004, BRAIN COGNITION, V56, P328, DOI 10.1016/j.bandc.2004.08.048	32	11	12	0	3	COLEGIO OFICIAL DE PSICOLOGOS DE ASTURIAS	OVIEDO	ILDEFONSO S. DEL RIO, 4-1 B, 33001 OVIEDO, SPAIN	0214-9915	1886-144X		PSICOTHEMA	Psicothema	AUG	2008	20	3					445	449					5	Psychology, Multidisciplinary	Psychology	326NG	WOS:000257665600017	18674441	DOAJ Gold			2021-06-18	
J	Mathioudakis, N; Salvatori, R				Mathioudakis, Nestoras; Salvatori, Roberto			Adult-onset growth hormone deficiency: causes, complications and treatment options	CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY			English	Article						adult-onset growth hormone deficiency; growth hormone deficiency in adults; growth hormone replacement therapy	TRAUMATIC BRAIN-INJURY; GH REPLACEMENT THERAPY; QUALITY-OF-LIFE; RADIOLOGICAL SPINAL DEFORMITIES; AMYOTROPHIC-LATERAL-SCLEROSIS; BONE-MINERAL DENSITY; CARDIOVASCULAR RISK; FACTOR-I; HYPOPITUITARY PATIENTS; SUBSTITUTION THERAPY	Purpose of review Description of the progresses related to the complications and treatment of adult-onset growth hormone deficiency. Recent findings Growth hormone deficiency in adults has gained attention as a clinical syndrome associated with increased morbidity and possibly mortality. Many studies have been conducted on the consequences of growth hormone deficiency and of its replacement, supporting its use in appropriate patients. Early studies were characterized by a high incidence of side effects due to a lack of pilot data to guide appropriate dosing. Given the wide variability in individual responsiveness to growth hormone therapy based on age, sex, and body composition, recent work has been dedicated to understanding which patients derive benefit from therapy, minimizing side effects, and ensuring cost-effectiveness. Summary Long-term prospective trials have shown that growth hormone replacement therapy results in improvements in body composition, dyslipidemia, bone mineral density, and quality of life. The effects on endpoints such as cardiovascular morbidity and mortality and fractures are, however, not fully proven. Randomized trials that compare homogenous groups of growth hormone deficiency patients are still needed. Given the high cost of treatment, dynamic testing for growth hormone deficiency should only be performed in patients in whom there is high clinical suspicion, and therapy should be limited to those with biochemically proven growth hormone deficiency.	[Mathioudakis, Nestoras; Salvatori, Roberto] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD USA	Salvatori, R (corresponding author), Johns Hopkins Sch Med, Div Endocrinol & Metab, 1830 E Monument St,Suite 333, Baltimore, MD 21287 USA.	salvator@jhmi.edu	Mathioudakis, Nestoras/AAP-4595-2020	Mathioudakis, Nestoras/0000-0002-0210-655X			Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Andreassen M, 2007, CLIN ENDOCRINOL, V67, P909, DOI 10.1111/j.1365-2265.2007.02986.x; Arwert LI, 2006, NEUROENDOCRINOLOGY, V83, P12, DOI 10.1159/000093337; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; Behan LA, 2007, HORM RES, V68, P18, DOI 10.1159/000110466; Bidlingmaier M, 2006, J CLIN ENDOCR METAB, V91, P2926, DOI 10.1210/jc.2006-0514; Blackman MR, 2007, NEW ENGL J MED, V357, P2397, DOI 10.1056/NEJMe0707201; Bollerslev J, 2006, EUR J ENDOCRINOL, V154, P537, DOI 10.1530/eje.1.02125; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Buchfelder M, 2007, EUR J ENDOCRINOL, V157, P149, DOI 10.1530/EJE-07-0164; Burger Albert G, 2006, Endocr Pract, V12, P682; Chihara K, 2006, CURR MED RES OPIN, V22, P1973, DOI 10.1185/030079906X132460; Climent V, 2007, CURR MED CHEM, V14, P1399, DOI 10.2174/092986707780831195; Devin JK, 2007, J CLIN ENDOCR METAB, V92, P3633, DOI 10.1210/jc.2007-0609; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Gelato M, 2007, CLIN THER, V29, P2269, DOI 10.1016/j.clinthera.2007.11.004; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Gilchrist FJ, 2002, CLIN ENDOCRINOL, V57, P363, DOI 10.1046/j.1365-2265.2002.01608.x; Gomez JM, 2006, CLIN ENDOCRINOL, V64, P632, DOI 10.1111/j.1365-2265.2006.02518.x; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; Hartman ML, 2008, J CLIN ENDOCR METAB, V93, P125, DOI 10.1210/jc.2007-1430; Higham CE, 2007, PITUITARY, V10, P159, DOI 10.1007/s11102-007-0027-9; Hitz MF, 2006, CLIN ENDOCRINOL, V65, P783, DOI 10.1111/j.1365-2265.2006.02667.x; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Holmer H, 2007, J BONE MINER RES, V22, P1842, DOI 10.1359/JBMR.070811; Holmer H, 2007, J CLIN ENDOCR METAB, V92, P3560, DOI 10.1210/jc.2007-0458; Khosla S, 2007, NEW ENGL J MED, V356, P2293, DOI 10.1056/NEJMcp070341; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Koranyi J, 2001, J CLIN ENDOCR METAB, V86, P4693, DOI 10.1210/jc.86.10.4693; Leonsson M, 2003, CLIN ENDOCRINOL, V59, P242, DOI 10.1046/j.1365-2265.2003.01832.x; Li GL, 2008, J CLIN ENDOCR METAB, V93, P1379, DOI 10.1210/jc.2007-2021; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; Maison P, 2007, DIABETIC MED, V24, P1012, DOI 10.1111/j.1464-5491.2007.02195.x; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; Gomez JM, 2007, CURR NEUROVASC RES, V4, P55; Mazziotti G, 2006, J BONE MINER RES, V21, P520, DOI 10.1359/JBMR.060112; Mazziotti G, 2008, PITUITARY, V11, P55, DOI 10.1007/s11102-007-0069-z; McMillan CV, 2003, CLIN ENDOCRINOL, V59, P467, DOI 10.1046/j.1365-2265.2003.01870.x; Mesa J, 2003, MED CLIN-BARCELONA, V120, P41, DOI 10.1157/13042257; Miljic Dragana, 2006, Hormones (Athens), V5, P187; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Monson JP, 2007, CLIN ENDOCRINOL, V67, P623, DOI 10.1111/j.1365-2265.2007.02935.x; Morselli LL, 2007, J ENDOCRINOL INVEST, V30, P767, DOI 10.1007/BF03350815; Morselli LL, 2006, CLIN ENDOCRINOL, V65, P385, DOI 10.1111/j.1365-2265.2006.02609.x; Nilsson AG, 2007, GROWTH HORM IGF RES, V17, P441, DOI 10.1016/j.ghir.2007.05.005; Oflaz H, 2007, CLIN ENDOCRINOL, V66, P524, DOI 10.1111/j.1365-2265.2007.02767.x; Oliveira JLM, 2007, J CLIN ENDOCR METAB, V92, P4664, DOI 10.1210/jc.2007-1636; Randeva HS, 2004, CIRCULATION, V109, P2405, DOI 10.1161/01.CIR.0000129763.51060.77; Rizzo M, 2007, INT J CLIN PRACT, V61, P1949, DOI 10.1111/j.1742-1241.2007.01596.x; Rizzo M, 2008, GROWTH HORM IGF RES, V18, P264, DOI 10.1016/j.ghir.2007.10.003; Rizzo M, 2007, EUR J ENDOCRINOL, V156, P361, DOI 10.1530/EJE-06-0652; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sathiavageeswaran M, 2007, EUR J ENDOCRINOL, V156, P439, DOI 10.1530/eje.1.02346; SCACCHI M, 2008, CLIN ENDOCRINOL OXF; Scacchi M, 2007, CLIN ENDOCRINOL, V67, P790, DOI 10.1111/j.1365-2265.2007.02965.x; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Sesmilo G, 2000, ANN INTERN MED, V133, P111, DOI 10.7326/0003-4819-133-2-200007180-00010; Shechter M, 2007, GROWTH HORM IGF RES, V17, P165, DOI 10.1016/j.ghir.2007.01.009; Snyder PJ, 2007, J BONE MINER RES, V22, P762, DOI 10.1359/JBMR.070205; STANLEY TL, 2008, PITUITARY; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Stochholm K, 2007, HORM RES, V68, P173, DOI 10.1159/000110618; Stochholm K, 2006, EUR J ENDOCRINOL, V155, P61, DOI 10.1530/eje.1.02191; Svensson J, 2007, GROWTH HORM IGF RES, V17, P67, DOI 10.1016/j.ghir.2006.11.002; Takahashi Y, 2007, GASTROENTEROLOGY, V132, P938, DOI 10.1053/j.gastro.2006.12.024; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Urushihara H, 2007, EUR J ENDOCRINOL, V156, P637, DOI 10.1530/EJE-07-0016; van der Klaauw AA, 2007, EUR J ENDOCRINOL, V156, P455, DOI 10.1530/EJE-06-0699	72	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1752-296X	1752-2978		CURR OPIN ENDOCRINOL	Curr. Opin. Endocrinol. Diabetes Obes.	AUG	2008	15	4					352	358		10.1097/MED.0b013e3282ffd97d			7	Endocrinology & Metabolism	Endocrinology & Metabolism	V14SV	WOS:000207755000008	18594276				2021-06-18	
J	Ding, MC; Lo, EH; Stanley, GB				Ding, M. C.; Lo, E. H.; Stanley, G. B.			Sustained focal cortical compression reduces electrically-induced seizure threshold	NEUROSCIENCE			English	Article						traumatic brain injury; spreading depression; excitation and inhibition	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; IN-VITRO; RAT; IMPACT; MODEL; ISCHEMIA; INSULTS; NEURONS; VULNERABILITY	Brain injury can often result in the subsequent appearance of seizures, suggesting an alteration in neural excitability associated with the balance between neuronal excitation and inhibition. The process by which this occurs has yet to be fully elucidated. The specific nature of the changes in excitation and inhibition is still unclear, as is the process by which the seizures appear following injury. In this study, we investigated the effects of focal cortical compression on electrically-induced localized seizure threshold in rats. Male Long Evans rats were implanted with stimulating screw electrodes in their motor cortices above the regions controlling forelimb movement. Initial seizure threshold was determined in the animals using a ramped electrical stimulation procedure prior to any compression. Following initial threshold determination, animals underwent sustained cortical compression and then following a 24 h recovery period had their seizure thresholds tested again with electrical stimulation. Reliability of threshold measurements was confirmed through repeated measurements of seizure threshold. Localized seizure threshold was significantly lowered following sustained cortical compression as compared with control cases. Taken together, the results here suggest a change in global brain excitability following localized, focal compression. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.	[Stanley, G. B.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ding, M. C.; Stanley, G. B.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ding, M. C.; Stanley, G. B.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lo, E. H.] Harvard Univ, Sch Med, Neuroprotect Res Lab, Charlestown, MA 02129 USA; [Stanley, G. B.] Emory Univ, Atlanta, GA 30332 USA	Stanley, GB (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Ding, Ming-Chieh/0000-0002-2278-5326	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048285] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS048285-04, R01 NS048285, R01NS48285] Funding Source: Medline		Adamo PF, 2005, J AM ANIM HOSP ASSOC, V41, P400, DOI 10.5326/0410400; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bough KJ, 2003, EPILEPSIA, V44, P752, DOI 10.1046/j.1528-1157.2003.55502.x; Chen JR, 2004, J NEUROTRAUM, V21, P1640, DOI 10.1089/0897715042441729; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Glass TF, 2004, NEUROBIOL DIS, V17, P378, DOI 10.1016/j.nbd.2004.07.017; Krupp E, 1998, J PHARMACOL EXP THER, V285, P1137; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; LOSCHER W, 1985, J PHARMACOL EXP THER, V233, P204; Luszczki JJ, 2007, NEUROSCI LETT, V421, P87, DOI 10.1016/j.neulet.2007.05.028; Maeda M, 1998, ACT NEUR S, V71, P293; Marino R, 2006, NEUROLOGY, V67, P1165, DOI 10.1212/01.wnl.0000238081.35281.b5; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Nguyen SM, 2007, J NEUROSCI METH, V161, P281, DOI 10.1016/j.jneumeth.2006.10.026; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Reinert M, 2000, Neurosurg Focus, V8, pe10; Salci K, 2006, NEUROSURGERY, V59, P367, DOI 10.1227/01.NEU.0000222648.61065.38; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; VOSKUYL RA, 1989, EPILEPSY RES, V3, P120, DOI 10.1016/0920-1211(89)90039-9; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Yang HY, 2006, BEHAV BRAIN RES, V172, P80, DOI 10.1016/j.bbr.2006.04.023	26	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JUN 23	2008	154	2					551	555		10.1016/j.neuroscience.2008.03.088			5	Neurosciences	Neurosciences & Neurology	319OB	WOS:000257172200015	18495350	Green Accepted			2021-06-18	
J	Whiting, MD; Hamm, RJ				Whiting, Mark D.; Hamm, Robert J.			Mechanisms of anterograde and retrograde memory impairment following experimental traumatic brain injury	BRAIN RESEARCH			English	Article						brain injury; amnesia; retrieval; memory impairment; rat	MEDIAL TEMPORAL-LOBE; LONG-TERM-MEMORY; DEFICITS; CONSOLIDATION; AMNESIA; RETRIEVAL; RATS; HIPPOCAMPUS; MODEL	Memory impairment is common following traumatic brain injury. However, the specific processes underlying the impairments remain unknown. Traumatic brain injury may interfere with several of the stages of the learning and memory process. In two separate experiments, we examined the specific nature of both anterograde and retrograde memory dysfunction following fluid percussion brain injury in rats. In Experiment 1, we examined the retention of spatial memory in the MWM after equating initial learning between sham and injured animals. Animals were trained to criterion and then tested for retention 4, 8, or 24 h post-training. Although injured animals displayed deficits in task acquisition, retention performance was not significantly different between groups. In Experiment 2, we examined the effects of injury on the retention of retrograde spatial memories in the MWM. Animals were injured either 1 or 14 days post-training and then received retention probe trials followed by a reminding procedure and second probe trial 14 days post-injury. All injured animals displayed retention deficits in the probe trials 14 days post-injury. However, after the reminding procedure, injured animals displayed sham-level performance during the second probe trial. The results of these experiments suggest that with anterograde memory impairment induced by traumatic brain injury, the primary deficit lies in task acquisition, not the retention of information within long-term memory. Retrograde memory impairment following injury appears to be mediated primarily by deficits in memory retrieval. (c) 2008 Elsevier B.V. All rights reserved.	[Whiting, Mark D.] Quinnipiac Univ, Dept Psychol, Hamden, CT 06518 USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23221 USA	Whiting, MD (corresponding author), Quinnipiac Univ, Dept Psychol, LW LIB,275 Mt Carmel Ave, Hamden, CT 06518 USA.	mark.whiting@quinnipiac.edu					ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCKEE RD, 1992, J NEUROSCI, V12, P3765; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Riedel G, 1999, NAT NEUROSCI, V2, P898; Sellal FO, 2002, CORTEX, V38, P499, DOI 10.1016/S0010-9452(08)70019-4; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; ZHOU YL, 1995, PHYSIOL BEHAV, V57, P1107, DOI 10.1016/0031-9384(95)00019-F	20	11	11	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 5	2008	1213						69	77		10.1016/j.brainres.2008.01.107			9	Neurosciences	Neurosciences & Neurology	319TD	WOS:000257186000008	18455704				2021-06-18	
J	Prigatano, GP; Gray, JA				Prigatano, George P.; Gray, Jennifer A.			Predictors of performance on three developmentally sensitive neuropsychological tests in children with and without traumatic brain injury	BRAIN INJURY			English	Article						normal functioning school age children; traumatic brain injury; developmentally sensitive neuropsychological tests; predictors of performance	ACADEMIC-ACHIEVEMENT; COGNITIVE RESERVE; RECOVERY; SEVERITY; SKILLS; AGE	Objective: To determine the effect of age and vocabulary as predictors of performance on neuropsychological tests in children with and without traumatic brain injury (TBI). Setting and participants: In the first study, 213 school-age children were evaluated in their public school environment. In the second study, 65 children with a history of TBI were examined in a medical centre. Major outcome measures: Age of the child and two estimates of intellectual functioning (Vocabulary and Block Design) were used to predict performance on the Barrow Neurological Institute Screen for Higher Cerebral Functions in School-Age Children (BNIS-C), a verbal fluency task and the Halstead Finger Tapping Test (HFTT). Results: In study 1, the exact age of the child was the strongest predictor of performance (e.g. 47.5% of the variability on the BNIS-C) in normal school-age children. Vocabulary level accounted for less than 10% of the variability across the three measures. In children with TBI (study 2; n = 65) age effects remained strong, but a greater vocabulary effect was observed on two of the three measures (i.e. 29.2% on the BNIS-C and 18.8% on verbal fluency). Conclusions: While age is an important predictor of neuropsychological test performance in children, post-injury vocabulary level appears to be an important moderator variable.	[Prigatano, George P.; Gray, Jennifer A.] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA	Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 222 W Thomas Rd,Suite 315, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Baron I., 2004, NEUROPSYCHOLOGICAL E; Belsky J, 2004, HARVARD EDUC REV, V74, P1; Biemiller A, 2006, J EDUC PSYCHOL, V98, P44, DOI 10.1037/0022-0663.98.1.44; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DONDERS J, 1994, J SCHOOL PSYCHOL, V32, P53, DOI 10.1016/0022-4405(94)90028-0; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fuld P. A., 1981, FULD OBJECT MEMORY E; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Keppel G., 1989, DATA ANAL RES DESIGN; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Miller AL, 2005, SOC DEV, V14, P637, DOI 10.1111/j.1467-9507.2005.00321.x; Prigatano GP, 2008, J INT NEUROPSYCH SOC, V14, P143, DOI 10.1017/S1355617708080089; Prigatano GP, 2007, DEV NEUROPSYCHOL, V32, P757, DOI 10.1080/87565640701539469; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; PRIGATANO GP, CHILD NEURO IN PRESS; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 2005, BNI SCREEN HIGHER CE; PRIGATANO GP, 2005, BNI Q, V21, P4; PRIGATANO GP, 2004, COMMUNITY SCH REINTE, P151; Reitan RM, 1955, MANUAL ADM NEUROPSYC; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RIVARA JMB, 1994, 4 C INT ASS STUD TRA; *SPSS INC, 1998, SPSS BAS 8 0 WIND US; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; TEASDALE G, 1981, MANAGEMENT HEAD INJU; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 2003, WISC 4 WECHSLER INTE; Wechsler D., 1991, WISC 3 WECHSLER INTE; YEATES KO, 2000, CLOSED HEAD INJURY P, P92	39	11	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2008	22	6					491	500		10.1080/02699050802084902			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	316TW	WOS:000256973600006	18465390				2021-06-18	
J	Tanriverdi, F; Alp, E; Demiraslan, H; Dokmetas, HS; Unluhizarci, K; Doganay, M; Casanueva, FF; Kelestimur, F				Tanriverdi, F.; Alp, E.; Demiraslan, H.; Dokmetas, H. S.; Unluhizarci, K.; Doganay, M.; Casanueva, F. F.; Kelestimur, F.			Investigation of pituitary functions in patients with acute meningitis: A pilot study	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						GH deficiency; GHRH plus arginine; hypopituitarism; meningitis; pituitary	TRAUMATIC BRAIN-INJURY; TUBERCULOUS MENINGITIS; HYPOPITUITARISM; INSUFFICIENCY; MENINGOENCEPHALITIS; COMPLICATION; MASS	Objective: Although long-term pituitary consequences of tuberculous meningitis are well documented in the literature, there have been few case reports of pituitary dysfunction after acute bacteria[ or viral meningitis. In this preliminary study, we have assessed the pituitary functions in adult patients who had acute bacterial or viral meningitis. Design and methods: Fourteen patients (8 men, 6 women; mean age 35.3 +/- 13.3) were included in the study. The diagnosis of bacterial and viral meningitis was proven by clinical findings, cerebrospinal fluid (CSF) examination, gram staining, and blood and CSF cultures. Pituitary functions were evaluated ranging from 6 to 48 months (mean 20 months) after acute meningitis. GH deficiency was investigated by the GHRH+arginine stimulation test. Results: Four of 14 patients (28.6%) had isolated GH deficiency. In GH-deficient patients, the earliest duration was 6 months and the latest duration was 48 months after the diagnosis of acute meningitis. Three of the GH-deficient patients had acute bacterial meningitis and I patient had acute viral meningitis. Pituitary magnetic resonance imaging revealed normal pituitary gland in the patients with GH deficiency. Conclusions: This is the first systematic study evaluating the anterior pituitary function long term after the diagnosis of acute meningitis. Based on the present study, it is tempting to speculate that pituitary dysfunction is a more common sequel of acute bacterial or viral meningitis than hitherto reported. Studies with high numbers of patients are warranted to ascertain the prevalence of meningitis-induced hypopituitarism.	[Tanriverdi, F.; Unluhizarci, K.; Kelestimur, F.] Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; [Alp, E.; Demiraslan, H.; Doganay, M.] Erciyes Univ, Sch Med, Dept Infect Dis, TR-38039 Kayseri, Turkey; [Dokmetas, H. S.] Cumhuriyet Univ, Sch Med, Dept Endocrinol, Sivas, Turkey; [Casanueva, F. F.] Univ Santiago de Compostela, Sch Med, Dept Med, Santiago De Compostela, Spain; [Casanueva, F. F.] Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Santiago De Compostela, Spain	Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	Doganay, Mehmet/G-4250-2019	Doganay, Mehmet/0000-0003-3922-4901			BURKE CW, 1992, CLIN ENDOCRINOL, V36, P133, DOI 10.1111/j.1365-2265.1992.tb00946.x; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; DELATORRE JC, 1992, P NATL ACAD SCI USA, V89, P9939, DOI 10.1073/pnas.89.20.9939; DRURY MI, 1968, BRIT MED J, V1, P842, DOI 10.1136/bmj.1.5595.842; GARG SK, 1987, TROP GEOGR MED, V39, P296; HAGG E, 1978, ACTA MED SCAND, V203, P231; HALL R, 1980, FUNDAMENTALS CLIN EN; JEW K, 1984, NEUROSURGERY, V14, P567, DOI 10.1227/00006123-198405000-00008; Katsuno Makoto, 2003, No To Shinkei, V55, P967; KUPARI M, 1980, ACTA ENDOCRINOL-COP, V94, P433, DOI 10.1530/acta.0.0940433; LAM KSL, 1993, ANN INTERN MED, V118, P701, DOI 10.7326/0003-4819-118-9-199305010-00007; Lamberts SWJ, 1998, LANCET, V352, P127; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LICHTENSTEIN MJ, 1982, J ENDOCRINOL INVEST, V5, P111, DOI 10.1007/BF03350501; Lynch C, 2007, BRIT J HOSP MED, V68, P272, DOI 10.12968/hmed.2007.68.5.23336; Muraoka A, 1989, Nihon Naika Gakkai Zasshi, V78, P684; PAI KG, 1976, J PEDIATR-US, V88, P289, DOI 10.1016/S0022-3476(76)81002-5; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; TUNKEL AR, 2005, PRINCIPLES PRACTICE, P1083	19	11	11	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	JUN	2008	31	6					489	491		10.1007/BF03346395			3	Endocrinology & Metabolism	Endocrinology & Metabolism	327HP	WOS:000257720500001	18591878				2021-06-18	
J	Kokiko-Cochran, ON; Michaels, MP; Hamm, RJ				Kokiko-Cochran, Olga N.; Michaels, Maria P.; Hamm, Robert J.			Delayed glucose treatment improves cognitive function following fluid-percussion injury	NEUROSCIENCE LETTERS			English	Article						traumatic brain injury; brain injury; cognitive recovery; glucose; rat	TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; METABOLIC DEPRESSION; CEREBRAL CONCUSSION; CONTUSION VOLUME; BLOOD-GLUCOSE; RATS; MEMORY; HYPERGLYCEMIA; INCREASES	Experimental traumatic brain injury (TBI) results in marked neurochemical and metabolic changes. Research has demonstrated that after the initial insult the brain undergoes an immediate state of hypermetabolism followed by a sustained period of hypometabolism. The altered extra- and intracellular environment can compromise neuronal performance and limit functional recovery. If brain metabolism is depressed chronically after TBI, then interventions that are designed to increase metabolism may be beneficial to outcome. Glucose treatment has been shown to improve cognition in many populations, particularly those with cognitive deficits. The following experiments examined the effects of delayed postinjury glucose supplementation on cognitive function following TBI. Male Sprague-Dawley rats received either sham or lateral fluid-percussion (LFP) injury. Cognitive functioning was assessed with the Morris water maze (MWM) on postinjury days 11-15. In the first experiment, saline or 100 mg/kg glucose was administered 10 min before cognition assessment. Injured animals treated with glucose displayed significantly shorter latencies to reach the goal platform compared to injured saline-treated animals. Glucose had no effect on sham-injured rats. In the second experiment, injured rats were given daily injections of saline of 100 mg/kg glucose for 10 days beginning 24 h after injury. Rats were then tested in he MWM on days 11 -15 without glucose or saline treatment. In this experiment, glucose treatment did not affect MWM performance. These data provide evidence that the chronic energy supplementation after TBI improves outcome when administered shortly before cognitive assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.	[Kokiko-Cochran, Olga N.; Michaels, Maria P.; Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA	Kokiko-Cochran, ON (corresponding author), Virginia Commonwealth Univ, Dept Psychol, Box 842018,808 W Franklin St, Richmond, VA 23284 USA.	kokikoon@vcu.edu					Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bergui M, 1997, J NEUROSURG, V87, P803; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; CRAFT S, 1994, PSYCHOBIOLOGY, V22, P95; CRAFT S, 1992, J CLIN EXP NEUROPSYC, V14, P253, DOI 10.1080/01688639208402827; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; FERNSTROM JD, 1971, SCIENCE, V174, P414; Flint RW, 1997, DEV PSYCHOBIOL, V31, P207, DOI 10.1002/(SICI)1098-2302(199711)31:3<207::AID-DEV5>3.0.CO;2-W; Fucetola R, 1999, PSYCHIAT RES, V88, P1, DOI 10.1016/S0165-1781(99)00063-3; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; GOLD PE, 1995, AM J CLIN NUTR, V61, p987S, DOI 10.1093/ajcn/61.4.987S; GOLD PE, 1991, NEUR CONT B, V6, P391; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; Korol DL, 1998, AM J CLIN NUTR, V67, p764S; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Manning CA, 1997, PSYCHOBIOLOGY, V25, P103; Manning CA, 1998, NEUROPSYCHOLOGY, V12, P479, DOI 10.1037/0894-4105.12.3.479; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; Messier C, 1996, BEHAV BRAIN RES, V75, P1, DOI 10.1016/0166-4328(95)00153-0; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; SARA SJ, 1988, NEUROBIOL AGING, V9, P31; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STONE WS, 1990, PSYCHOBIOLOGY, V18, P227; STONE WS, 1988, BEHAV NEURAL BIOL, V50, P325, DOI 10.1016/S0163-1047(88)91018-7; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; WHITE NM, 1991, NEUR CONT B, V6, P421; WHITE NM, 1986, LIFE SCI, V38, P2255, DOI 10.1016/0024-3205(86)90578-3; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	47	11	11	1	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 2	2008	436	1					27	30		10.1016/j.neulet.2008.02.046			4	Neurosciences	Neurosciences & Neurology	298OG	WOS:000255696400006	18355962				2021-06-18	
J	Espinosa-Aguilar, A; Reyes-Morales, H; Huerta-Posada, CE; de Leon, ILP; Lopez-Lopez, F; Mejia-Hernandez, M; Mondragon-Martinez, MA; Calderon-Tellez, LM; Amezcua-Cuevas, RL; Rebollar-Gonzalez, JA				Espinosa-Aguilar, Amilcar; Reyes-Morales, Hortensia; Huerta-Posada, Carlos E.; Limon-Perez de Leon, Itzcoatl; Lopez-Lopez, Fernando; Mejia-Hernandez, Margarita; Mondragon-Martinez, Maria A.; Calderon-Tellez, Ligia M.; Amezcua-Cuevas, Rosa L.; Rebollar-Gonzalez, Jorge A.			Design and validation of a critical pathway for hospital management of patients with severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						severe traumatic brain injury; critical pathways; health care process; nosocomial infections	CEREBRAL PERFUSION-PRESSURE; COMA SCALE SCORE; BLOOD-FLOW; HYPERVENTILATION; HYPOTHERMIA; STAY; CARE	Background: Critical pathways for the management of patients with severe traumatic brain injury (STBI) may contribute to reducing the incidence of hospital complications, length of hospitalization stay, and cost of care. Such pathways have previously been developed for departments with significant resource availability. In Mexico, STBI is the most important cause of complications and length of stay in neurotrauma services at public hospitals. Although current treatment is designed basically in accordance with the Brain Trauma Foundation guidelines, shortfalls in the availability of local resources make it difficult to comply with these standards, and no critical pathway is available that accords with the resources of public hospitals. The purpose of the present study was to design and to validate a critical pathway for managing STBI patients that would be suitable for implementation in neurotrauma departments of middle-income level countries. Methods: The study comprised two phases: design (through literature review and design plan) and validation (content, construct, and appearance) of the critical pathway. Results: The validated critical pathway for managing STBI patients entails four sequential subprocesses summarizing the hospital's care procedures, and includes three components: (1) nodes and criteria (in some cases, indicators are also included); (2) health team members in charge of the patient; (3) maximum estimated time for compliance with recommendations. Conclusions: This validated critical pathway is based on the current scientific evidence and accords with the availability of resources of middle-income countries.	[Reyes-Morales, Hortensia] Mexican Inst Social Secur, Natl Med Ctr Century 21, Epidemiol & Hlth Serv Res Unity, Mexico City, DF, Mexico; [Reyes-Morales, Hortensia] Mexican Inst Social Secur, Natl Med Ctr Century 21, Epidemiol & Hlth Serv Res Unity, Mexico City, DF, Mexico	Espinosa-Aguilar, A (corresponding author), Mollendo 617, Mexico City 07300, DF, Mexico.	amilcar.espinosa@imss.gob.mx					Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; ALDERSON P, 2006, COCHRANE DB SYST REV, P4; ALDERSON P, 2000, COCHRANE DB SYST REV, V2; *AM COLL SURG, 2004, ADV TRAUM LIF SUPP, P157; Andrews PJD, 2005, BRIT J ANAESTH, V94, P330, DOI 10.1093/bja/aei025; Barbaccia J J, 2001, Curr Opin Anaesthesiol, V14, P227, DOI 10.1097/00001503-200104000-00016; BECKER D, 1989, TXB HEAD INJURY; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Chesnut RM, 1997, J TRAUMA, V42, pS19, DOI 10.1097/00005373-199705001-00004; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; ESPINOSAAGUILAR A, 2001, BOOK MEM 12 WORLD C; Gastmeier P, 2002, INFECT CONT HOSP EP, V23, P91, DOI 10.1086/502013; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hoff JT, 1996, J TRAUMA, V40, P1048, DOI 10.1097/00005373-199606000-00037; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Kavanagh RJ, 2001, BRIT J ANAESTH, V86, P110, DOI 10.1093/bja/86.1.110; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MASS A, 2002, INT C REC ADV NEUR I; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; NARAYAN R, 1996, J NEUROTRAUMA; National Health and Medical Research Council, 1999, GUID DEV IMPL EV CLI; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; NUNNALLY J, 1991, PSYCHOMETRIC THEORY, P99; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; PEARSON SD, 1995, ANN INTERN MED, V123, P941, DOI 10.7326/0003-4819-123-12-199512150-00008; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; Sprouse M W, 1995, J Healthc Qual, V17, P40; Stricker KH, 2005, ACTA ANAESTH SCAND, V49, P975, DOI 10.1111/j.1399-6576.2005.00702.x; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TER A, 2002, CRIT CARE MED VOLUME, V30, P1616; Thal SC, 2005, CURR OPIN ANESTHESIO, V18, P490, DOI 10.1097/01.aco.0000182561.32680.30; THOMAS S, 2001, ANN EMERG MED, V38, pS4; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; World Bank, 2006, WORLD BANK ANN REP 2; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906	45	11	11	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2008	64	5					1327	1341		10.1097/TA.0b013e3181469ebe			15	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	301SH	WOS:000255915400032	18469658				2021-06-18	
J	Yetiser, S; Kahraman, E				Yetiser, Sertac; Kahraman, Erkan			An analysis of time-dependent changes of neurotrophic factors (BDNF, CNTF) in traumatic facial nerve injury of a nerve-cut and nerve-crush model in rats	OTOLOGY & NEUROTOLOGY			English	Article; Proceedings Paper	26th Politzer-Society Meeting	OCT 13-16, 2007	Cleveland, OH	Politzer Soc		brain-derived neurotrophic factor; ciliary neurotrophic factor; traumatic facial injury	MESSENGER-RNA; FACTOR PREVENTS; SCIATIC-NERVE; MOTOR NEURONS; ADULT-RAT; MOTONEURONS; REGENERATION; BRAIN; EXPRESSION; AXOTOMY	Hypothesis: To investigate neurotrophic changes in the injured facial nerve in rats. Background: Time-dependent follow-up of brain-derived neurotropbic factor (BDNF) and ciliary neurotrophic factor (CNTF) concentrations in a standardized nerve-cut and nerve-crush trauma model could present valuable information about estimation of the extent of the injury. Methods: Ninety Wistar rats were grouped into permanent (transection: nerve-cut) and transient (compression: nerve-crush) nerve injury and analyzed for neurotrophic changes at Week I and after 1, 3, and 6 months. Ten undissected rats served as controls. Permanent injury was accomplished with a 5-mm transection. To model transient injury, the facial nerve was pressed by vascular clamps for 40 minutes. Rat BDNF and CNTF enzyme-linked immunosorbent assay kits were used to perform histochemical analysis of blood samples. Measurements were compared with variance analysis and Student's t tests. Results: BDNF levels in nerve-injured preparations from both groups at consecutive intervals were not significant from those of controls, except for transient increases in the first week. When BDNF levels in nerve-cut and nerve-crush groups were compared at each interval separately, differences were insignificant (p > 0.05). CNTF levels at consecutive intervals were significant from that of control rats in both groups. When CN0054F levels in nerve-cut and nerve-crush groups were compared at each interval separately, differences were significant (p = 0.023, p = 0.001, p = 0.043, and p = 0.023). Conclusion: Elevated levels of BDNF in the first week after nerve injury do not differentiate the severity of the facial nerve injury. However, diminished CNTF levels in the nerve-crush group were significant when compared with that of nerve-cut group. This finding suggests the possibility that CNTF levels can distinguish whether the facial nerve is interrupted after trauma. Further experimental studies should investigate the indicative role of CNTF levels as a marker of nerve disruption in the clinical setting.	[Yetiser, Sertac; Kahraman, Erkan] Gulhane Mil Med Acad, Dept ORL & HNS, TR-06018 Ankara, Turkey	Yetiser, S (corresponding author), Gulhane Mil Med Acad, Dept ORL & HNS, TR-06018 Ankara, Turkey.	syetiser@yahoo.com					Ambron RT, 1996, MOL NEUROBIOL, V13, P61, DOI 10.1007/BF02740752; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; KIEFER R, 1995, INT J DEV NEUROSCI, V13, P331; Kobayashi NR, 1996, EUR J NEUROSCI, V8, P1018, DOI 10.1111/j.1460-9568.1996.tb01588.x; KOLIATSOS VE, 1993, NEURON, V10, P359, DOI 10.1016/0896-6273(93)90326-M; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LOWRIE MB, 1992, TRENDS NEUROSCI, V15, P80, DOI 10.1016/0166-2236(92)90014-Y; MANTHORPE M, 1986, BRAIN RES, V367, P282, DOI 10.1016/0006-8993(86)91603-3; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; SAIKA T, 1991, MOL BRAIN RES, V9, P157, DOI 10.1016/0169-328X(91)90142-K; Sendtner M, 1997, J NEUROSCI, V17, P6999; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Serpe CJ, 2005, BRAIN BEHAV IMMUN, V19, P173, DOI 10.1016/j.bbi.2004.07.005; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Tong JXX, 1997, J NEUROCYTOL, V26, P339, DOI 10.1023/A:1018508819191; ULENKATE HJLM, 1994, ACTA NEUROPATHOL, V88, P558; Walter M A, 1993, Facial Plast Surg, V9, P68, DOI 10.1055/s-2008-1064597; Watabe K, 2005, NEUROPATHOLOGY, V25, P371, DOI 10.1111/j.1440-1789.2005.00609.x; Watabe K, 2001, Hum Cell, V14, P7; WU W, 1993, DEV BIOL, V158, P456, DOI 10.1006/dbio.1993.1203	24	11	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1531-7129			OTOL NEUROTOL	Otol. Neurotol.	APR	2008	29	3					392	396		10.1097/MAO.0b013e318161ab3e			5	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	288IW	WOS:000254980800023	18494143				2021-06-18	
J	Hoizey, G; Canas, F; Binet, L; Kaltenbach, ML; Jeunehomme, G; Bernard, MH; Lamiable, D				Hoizey, Guillaume; Canas, Frederic; Binet, Laurent; Kaltenbach, Matthieu L.; Jeunehomme, Gerard; Bernard, Marie-Helene; Lamiable, Denis			Thiodicarb and methomyl tissue distribution in a fatal multiple compounds poisoning	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; thiodicarb; methomyl; fatal poisoning; tissue distribution; liquid chromatography ion trap mass spectrometry	CARBAMATE	Thiodicarb is a nonsystemic carbamate insecticide whose acetylcholinesterase activity is related to its main methomyl degradation product. A 40-year-old woman was found dead in her car. Empty packages of medicines and an open bottle of Larvin(R) containing thiodicarb were found near her body. No signs of violence nor traumatic injuries were noticed upon autopsy, and police investigations strongly suggested a suicide. Systematic toxicological analysis performed on postmortem specimens revealed the presence of various sedatives, hypnotics, and antipsychotic drugs in blood, urine, and gastric content. Some of the compounds identified were determined at blood concentrations well above the known therapeutic concentrations: zolpidem (2.87 mg/L), bromazepam (2.39 mg/L), nordazepam (4.21 mg/L), and levopremazine (0.64 mg/L). Specific analysis of thiodicarb and of its methomyl metabolite was then performed on all fluids and tissues collected during autopsy by liquid chromatography ion trap tandem mass spectrometry (LC-MS-MS). The anticholinesterase capacity of blood, urine, and gastric content collected at autopsy was 83%, 82%, and 32%, respectively (normal value: 0%). The presence of thiodicarb in the bottle found near the body corroborates the hypothesis of an intake of that compound. Although thiodicarb was only detected in gastric content (24.3 mg/L), its methomyl metabolite was quantified in most postmortem tissues and fluids: gastric content (19.9 mg/L), peripheral blood (0.7 mg/L), urine (8.5 mg/L), bile (2.7 mg/L), liver (0.7 mg/kg), kidney (1.7 mg/kg), lung (1.5 mg/kg), brain (9.3 mg/kg), and heart (3.6 mg/kg).	[Hoizey, Guillaume; Binet, Laurent; Lamiable, Denis] CHU Reims, Hosp Maison Blanche, Lab Pharmacol & Toxicol, F-51092 Reims, France; [Kaltenbach, Matthieu L.] UFR Pharm, Lab Pharmacol & Pharmacocinet, Reims, France	Hoizey, G (corresponding author), CHU Reims, Hosp Maison Blanche, Lab Pharmacol & Toxicol, 45 Rue Cognacq Jay, F-51092 Reims, France.	ghoizey@chu-reims.fr					ALAWADI AH, 2001, B INT ASS FORENSIC T, V31, P6; BISMUTH C, 2000, TOXICOLOGIE CLIN, P516; DRUMMER OH, 1997, 35 ANN M PAD IT 24 2; *INT ASS FOR TOX, 2006, TIAFT REF BLOOD LIST; MAHIEU P, 1982, J TOXICOL-CLIN TOXIC, V19, P425, DOI 10.3109/15563658208992497; MIYAZAKI T, 1989, FORENSIC SCI INT, V42, P263, DOI 10.1016/0379-0738(89)90094-7; Moriya F, 2005, FORENSIC SCI INT, V149, P167, DOI 10.1016/j.forsciint.2004.06.013; Moriya F, 1999, J FORENSIC SCI, V44, P1131; Peters FT, 2007, FORENSIC SCI INT, V165, P216, DOI 10.1016/j.forsciint.2006.05.021; Tsatsakis AM, 1998, SCI JUSTICE, V38, P282; Tsatsakis AM, 1996, SCI JUSTICE, V36, P41, DOI 10.1016/S1355-0306(96)72553-4	11	11	12	0	10	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-1198			J FORENSIC SCI	J. Forensic Sci.	MAR	2008	53	2					499	502		10.1111/j.1556-4029.2008.00676.x			4	Medicine, Legal	Legal Medicine	278SF	WOS:000254305900041	18366586				2021-06-18	
J	Morais, DF; Spotti, AR; Tognola, WA; Gaia, FFP; Andrade, AF				Morais, Dionei F.; Spotti, Antonio R.; Tognola, Waldir A.; Gaia, Felipe F. P.; Andrade, Almir F.			Clinical application of magnetic resonance in acute traumatic brain injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						magnetic resonance imaging; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; IMAGING FINDINGS; CORPUS-CALLOSUM; MR; CT; TOMOGRAPHY; FEATURES; LESIONS	Purpose: To evaluate the clinical applications of magnetic resonance imaging (MRI) in patients with acute traumatic brain injury (TBI): to identify the type, quantity, severity; and improvement clinical-radiological correlation. Method: Assessment of 55 patients who were imaged using CT and MRI, 34 (61.8%) males and 21 (38.2%) females, with acute (0 to 5 days) and closed TBI. Results: Statistical significant differences (McNemar test): ocurred fractures were detected by CT in 29.1% and by MRI in 3.6% of the patients; subdural hematoma by CT in 10.9% and MRI in 36.4%; diffuse axonal injury (DAI) by CT in 1.8% and MRI in 50.9%; cortical contusions by CT in 9.1% and MRI in 41.8%; subarachnoid hemorrhage by CT in 18.2% and MRI in 41.8%. Conclusion: MRI was superior to the CT in the identification of DAI, subarachnoid hemorrhage, cortical contusions, and acute subdural hematoma; however it was inferior in diagnosing fractures. The detection of DAI was associated with the severity of acute TBI.	Fac Med Sao Jose do Rio Preto, Dept Ciencias Neurol, Sao Jose Do Rio Preto, SP, Brazil; [Morais, Dionei F.; Gaia, Felipe F. P.] Hosp Base, Serv Neurocirurg, Sao Jose Do Rio Preto, SP, Brazil; [Spotti, Antonio R.; Tognola, Waldir A.] FAMERP, Dept Ciencias Neurol, Sao Jose Do Rio Preto, SP, Brazil; [Andrade, Almir F.] HC FMUSP, Dept Neurocirurg Emergencia, Sao Paulo, Brazil	Morais, DF (corresponding author), Avenida Jose Munia 4850, BR-15090500 Sao Jose Dos Campos, Brazil.	centro@cerebroecoluna.com.br		Gaia, Felipe/0000-0003-3457-3053			ANDRADE AF, 2006, SURG NEUROL, V65, P10; ANDRADE AF, 2004, THESIS SAO PAULO; Braga FT, 2003, AM J NEURORADIOL, V24, P1863; *COM TRAUM COL AM, 1997, SUP AV VID TRAUM SAV; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; GEAN AD, TRAUMATIC BRAIN LESI; Gennarelli TA, 1993, HEAD INJURY, P137; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; GENTRY LR, 2002, MAGNETIC RESONANCE I, P1059; Gentry LR, 1991, NEUROIMAG CLIN N AM, V1, P411; GUSMAO SN, 2000, NEUROTRAUMATOLOGIA, P170; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KRAUS JF, 1996, NEUROTRAUMA, P13; Lee Bruce, 2005, NeuroRx, V2, P372; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MACPHERSON BCM, 1990, CLIN RADIOL, V42, P321, DOI 10.1016/S0009-9260(05)82145-2; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Osborn AG, 2004, DIAGNOSTIC IMAGING B; OSBORN AG, 1999, DIAGNOSTICO NEURORRA, P199; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; ROCHA AJ, 2006, J COMPUT ASSIST TOMO, V2, P295; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; TEASDALE G, 1974, LANCET, V2, P81; Tokutomi T, 1997, ACT NEUR S, V70, P80; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; ZAR Jh, 2009, BIOSTATISTICAL ANAL; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	36	11	12	0	7	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2008	66	1					53	58		10.1590/S0004-282X2008000100013			6	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	282PQ	WOS:000254580100013	18392415	DOAJ Gold			2021-06-18	
J	Nakstad, PH; Gjertsen, O; Pedersen, HK				Nakstad, P. Hj.; Gjertsen, O.; Pedersen, H. Kr.			Correlation of Head Trauma and Traumatic Aneurysms	INTERVENTIONAL NEURORADIOLOGY			English	Article						trauma; skull; fracture; aneurysm; endovascular treatment	SUPERIOR CEREBELLAR ARTERY; INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; PERICALLOSAL ANEURYSM; INJURY; ANGIOGRAPHY; DIAGNOSIS; SECONDARY; BRAIN	Subarachnoid hemorrhage following severe trauma to the head is relatively common. In most cases the bleed originates front superficial veins and occasionally from arteries. Following the replacement of cerebral angiography with CT in the diagnostic evaluation of head traumas fewer traumatic aneurysms have been observed. This may indicate that some traumatic aneurysms are missed if angiographic procedures are not performed in patients with severe head injury. Trauma patients admitted to our institution are submitted to CT including a bone algorithm. In case of subarachnoid hemorrhage, especially in the basal cisterns, CT- angiography is performed. Digital subtraction angiography is performed as well in cases with uncertain interpretations. During one year 81 patients were admitted with subarachnoid hemorrhage following head trauma. Thirteen (16%) of them underwent CT-angiography and in five (6.2%) with SAH in the basal cistern traumatic aneurysms were found. Four of these cases had a skull base fracture including fractures through the clivus. Four cases were embolized and one very small extradural aneurysm is still not treated. One small pericallosal aneurysm was operated. A traumatic aneurysm should always be suspected n patients with skull base fractures and subarachnoid hemorrhage in the basal cisterns.	[Nakstad, P. Hj.] Univ Oslo, Ulleval Univ Hosp, Dept Neuroradiol, Div Med Serv, N-0407 Oslo, Norway	Nakstad, PH (corresponding author), Univ Oslo, Ulleval Univ Hosp, Dept Neuroradiol, Div Med Serv, N-0407 Oslo, Norway.						Chambers N, 2002, PAEDIATR ANAESTH, V12, P356, DOI 10.1046/j.1460-9592.2002.00831.x; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GIANNOTTA SL, 1982, CLIN NEUR, V29, P288; Gjertsen O, 2007, INTERV NEURORADIOL, V13, P167, DOI 10.1177/159101990701300207; HALBACH VV, 1987, AM J NEURORADIOL, V8, P627; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Marx MV, 2005, J VASC INTERV RADIOL, V16, P631, DOI 10.1016/S1051-0443(07)60643-5; MCDONALD EJ, 1976, AM J RADIOL, V16, P792; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MIRVIS SE, 1990, AJNR, V11, P335; NAKSTAD P, 1987, NEURORADIOLOGY, V29, P312, DOI 10.1007/BF00451778; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NAKSTAD PH, 1992, ACTA RADIOL, V33, P145; Pedersen HK, 2001, ACTA RADIOL, V42, P43, DOI 10.1034/j.1600-0455.2001.042001043.x; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; SCHWARTZ RB, 1994, RADIOLOGY, V192, P717, DOI 10.1148/radiology.192.3.8058939; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SONG JK, 1999, AM J RADIOL, V173, P111; TAVERAS JM, 1976, CEREBRAL ANGIOGRAPHY, V2, P543; Tsubokawa T, 1975, No Shinkei Geka, V3, P663; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294	26	11	11	0	1	EDIZIONI CENTAURO	BOLOGNA	VIA DEL PRATELLO, 8, 40122 BOLOGNA, ITALY	1123-9344			INTERV NEURORADIOL	Interv. Neuroradiol.	MAR	2008	14	1					33	38		10.1177/159101990801400104			6	Clinical Neurology; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	407NF	WOS:000263370900004	20557783	Green Published			2021-06-18	
J	Youngblut, JM; Brooten, D				Youngblut, JoAnne M.; Brooten, Dorothy			Mother's mental health, mother-child relationship, and family functioning 3 months after a preschooler's head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; family functioning; parent mental health; preschool children	TRAUMATIC BRAIN-INJURY; PREDICTORS; ATTENTION; RECOVERY; DISTRESS; BURDEN	Objective: Investigate mothers' mental health, mother-child relationship, and family functioning 3 months after preschool children's head trauma and hospital discharge. Design: Prospective survey. Setting: Seven hospitals; families' homes. Participants: Eighty mothers of children (ages 3-6) with head trauma. Measures: Perceived injury severity, Mental Health Inventory, Parental Stressor Scale taken in pediatric intensive care unit 24 to 48 hours after admission; Mental Health Inventory, Parenting Stress Index, FACES II, Multidimensional Scale of Perceived Social Support taken at 3 months postdischarge. Results: Injury severity had negative effects on mothers' mental health at 3 months after discharge, but not on the mother-child relationship and the family's functioning. Mothers' baseline mental health and ongoing support had positive effects on mother-child relationship and family adaptability. Conclusions: Mothers with greater stress and poorer mental health during their child's hospitalization may be at risk for negative mother-child and family outcomes. Interventions that decrease parents' stress during hospitalization and promote ongoing social support after discharge may diminish this risk.	[Youngblut, JoAnne M.; Brooten, Dorothy] Florida Int Univ, Coll Nursing & Hlth Sci, Miami, FL 33199 USA	Youngblut, JM (corresponding author), Florida Int Univ, Coll Nursing & Hlth Sci, 11200 SW 8th St,Room 485, Miami, FL 33199 USA.	youngblu@fiu.edu; drjmy3@aolcom.com			NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR004430-06, R01 NR04430, R01 NR004430] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004430] Funding Source: NIH RePORTER		Abidin R.R., 1990, PARENTING STRESS IND; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; *ASS ADV AUT MED, 1990, ABBR INJ SCAL; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; BERENBAUM J, 1992, J PEDIATR PSYCHOL, V17, P359, DOI 10.1093/jpepsy/17.3.359; BOARD RM, 1994, PARENTAL CARE THEIR; Carter M C, 1989, Matern Child Nurs J, V18, P187; CARTER MC, 1983, PARENTAL STRESSOR SC; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; GREEN M, 1964, PEDIATRICS, V34, P58; Guerra H L, 1997, Rev Panam Salud Publica, V2, P115, DOI 10.1590/S1020-49891997000800004; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; MAX J, 1998, CHILD ADOL PSYCH CL, V37, P83; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCubbin M. A., 1993, FAMILIES HLTH ILLNES, P20; MCKINNEY B, 1984, TEST CRITIQUES, P504; Melnyk BM, 1997, RES NURS HEALTH, V20, P3; OLSON D. H., 1989, CIRCUMPLEX MODEL SYS, P7; Olson DH, 1983, MARRIAGE FAMILY ASSE, P299; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; STRUSS D, 2004, BRAIN COGNITION, V55, P69; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; VEIT CT, 1983, J CONSULT CLIN PSYCH, V51, P730, DOI 10.1037/0022-006X.51.5.730; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Youngblut J M, 1995, Issues Compr Pediatr Nurs, V18, P11, DOI 10.3109/01460869509080954; Youngblut J M, 1991, AACN Clin Issues Crit Care Nurs, V2, P329; Youngblut JM, 2006, J PEDIATR PSYCHOL, V31, P608, DOI 10.1093/jpepsy/jsj066; Youngblut JoAnne M, 2005, Pediatr Crit Care Med, V6, P550, DOI 10.1097/01.PCC.0000163283.27419.E9; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	34	11	11	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2008	23	2					92	102		10.1097/01.HTR.0000314528.85758.30			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	280KW	WOS:000254426700004	18362763	Green Accepted			2021-06-18	
J	Zhang, ZR; Fauser, U; Schluesener, HJ				Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.			Dexamethasone suppresses infiltration of RhoA(+) cells into early lesions of rat traumatic brain injury	ACTA NEUROPATHOLOGICA			English	Article						RhoA; dexamethasone; traumatic brain injury; microglia; macrophages; weight-drop model	CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; RHO-GTPASES; LEUKOCYTE RECRUITMENT; CLOSTRIDIUM-BOTULINUM; ACTIN CYTOSKELETON; AXON REGENERATION; ADP-RIBOSYLATION	Inflammatory cell infiltration is a major part of secondary tissue damage in traumatic brain injury (TBI). RhoA is an important member of Rho GTPases and is involved in leukocyte migration. Inhibition of RhoA and its downstream target, Rho-associated coiled kinase (ROCK), has been proven to promote axon regeneration and function recovery following injury in the central nervous system (CNS). Previously, we showed that dexamethasone, an immunosuppressive corticosteroid, attenuated early expression of three molecules associated with microglia/macrophages activation following TBI in rats. Here, the effects of dexamethasone on the early expression of RhoA have been investigated in brains of TBI rats by immunohistochemistry. In brains of rats treated with TBI alone, significant RhoA(+) cell accumulation was observed at 18 h post-injury and continuously increased during our observed time period. The accumulated RhoA(+) cells were distributed to the areas of pannecrosis and selective neuronal loss. Most accumulated RhoA(+) cells were identified as active microglia/macrophages by double-labelling. Dexamethasone (1 mg/kg body weight) was intraperitoneally injected on day 0 and 2 immediately following brain injury. Numbers of RhoA(+) cells were significantly reduced on day 1 and 2 following administration of dexamethasone but returned to vehicle control level on day 4. However, dexamethasone treatment did not change the proportion of RhoA(+) cells. These observations suggest that dexamethasone has only a transient effect on early leukocyte recruitment.	[Zhang, Zhiren; Fauser, Uwe; Schluesener, Hermann J.] Univ Tubingen, Brain Res Inst, D-72076 Tubingen, Germany	Zhang, ZR (corresponding author), Univ Tubingen, Brain Res Inst, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	Zhang, Zhiren/O-1012-2019; zhang, zhiren/I-1046-2014	Zhang, Zhiren/0000-0002-5238-2835; zhang, zhiren/0000-0002-5238-2835			Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Angkachatchai V, 1999, J IMMUNOL, V163, P3819; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; Dergham P, 2002, J NEUROSCI, V22, P6570; Donovan FM, 1997, J NEUROSCI, V17, P5316; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Fournier AE, 2003, J NEUROSCI, V23, P1416; Gaab M R, 1994, Zentralbl Neurochir, V55, P135; Gahm C, 2005, ACTA NEUROCHIR, V147, P1071, DOI 10.1007/s00701-005-0590-7; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Greenwood J, 2003, FASEB J, V17, P905, DOI 10.1096/fj.02-1014fje; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; Hendricks JJA, 2004, J EXP MED, V200, P1667, DOI 10.1084/jem.20040819; Holmin, 1996, ACTA NEUROCHIR, V138, P418, DOI 10.1007/BF01420304; Irazuzta J, 2005, INTENS CARE MED, V31, P146, DOI 10.1007/s00134-004-2462-7; Kim JS, 2005, EXP MOL MED, V37, P575, DOI 10.1038/emm.2005.71; Knaus UG, 2000, IMMUNOL RES, V21, P103, DOI 10.1385/IR:21:2-3:103; Kubes P, 2000, BRAIN PATHOL, V10, P127; LANG P, 1992, J BIOL CHEM, V267, P11677; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maderna P, 2002, AM J PATHOL, V160, P2275, DOI 10.1016/S0002-9440(10)61175-3; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; O'Kane EM, 2003, MOL BRAIN RES, V114, P1, DOI 10.1016/S0169-328X(03)00121-9; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pixley FJ, 2005, J CELL SCI, V118, P1873, DOI 10.1242/jcs.02314; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Skaper SD, 2001, PROG NEUROBIOL, V65, P593, DOI 10.1016/S0301-0082(01)00017-X; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Walters CE, 2002, J IMMUNOL, V168, P4087, DOI 10.4049/jimmunol.168.8.4087; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Yang JT, 2005, EXP NEUROL, V192, P437, DOI 10.1016/j.expneurol.2004.12.023; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhang ZR, 2006, EXP NEUROL, V197, P252, DOI 10.1016/j.expneurol.2005.09.015	56	11	12	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	MAR	2008	115	3					335	343		10.1007/s00401-007-0301-y			9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	265GB	WOS:000253346000007	17929039				2021-06-18	
J	Hachiya, NS; Kozuka, Y; Kaneko, K				Hachiya, Naomi S.; Kozuka, Yoshimichi; Kaneko, Kiyotoshi			Mechanical stress and formation of protein aggregates in neurodegenerative disorders	MEDICAL HYPOTHESES			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRINUCLEOTIDE CAG REPEAT; TRAUMATIC BRAIN-INJURY; HUNTINGTONS-DISEASE; PROFESSIONAL FOOTBALL; ALZHEIMERS-DISEASE; RISK; AGE; EXPANSION; SYNUCLEIN	Misfolded protein aggregates and inclusion bodies have been associated with various protein conformation disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and prion diseases including bovine spongiform encephalopathy (BSE). Models have been proposed as plausible explanations for the extension and progression of protein aggregates; however, little is known about the initiation process of protein aggregation, particularly in sporadic neurodegenerative diseases. Epidemiological data have suggested a tight association between sporadic neurodegenerative diseases and history of mechanical stresses such as trauma, head injury, and occupational exposures, including professional soccer and boxer's brain that carries histological hallmarks of AD/PD. Here, we propose that mechanical stress is an environmental factor that provokes a disturbance in cellular quality control systems and molecular chaperones that target misfolded proteins. This subsequently initiates protein aggregation and results in sporadic neurodegenerative disorders. Further, continuous and repetitive exposure to environmental mechanical stress, mostly in an unrecognized manner, is inevitable in daily life and thus, it functions as a potential driving force for protein aggregation. In this regard, a recent identification of the fact that an intracellular mechanosensor actually exists may support our notion. Reduction in the mechanical stress in combination with other conventional aspects should facilitate the development of rational therapeutics for these neurodegenerative disorders. (C) 2007 Elsevier Ltd. All rights reserved.	[Hachiya, Naomi S.; Kozuka, Yoshimichi; Kaneko, Kiyotoshi] Tokyo Med Univ, Dept Neurophysiol, Tokyo 1608402, Japan	Kaneko, K (corresponding author), Tokyo Med Univ, Dept Neurophysiol, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	k-kaneko@tokyo-med.ac.jp					ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; DAVANIPOUR Z, 1985, NEUROLOGY, V35, P1483, DOI 10.1212/WNL.35.10.1483; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Goodwin Linda, 2006, J Insur Med, V38, P300; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Lutz Richard E, 2007, Semin Pediatr Neurol, V14, P26, DOI 10.1016/j.spen.2006.11.006; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Piazza O, 2004, CURR MED RES OPIN, V20, P505, DOI 10.1185/030079904125003296; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Squitieri F, 2006, EUR J NEUROL, V13, P408, DOI 10.1111/j.1468-1331.2006.01264.x; Strong MJ, 2005, J NEUROPATH EXP NEUR, V64, P649, DOI 10.1097/01.jnen.0000173889.71434.ea; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; UITTI RJ, 1993, EUR NEUROL, V33, P6, DOI 10.1159/000118533; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9	29	11	11	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses		2008	70	5					1034	1037		10.1016/j.mehy.2007.06.043			4	Medicine, Research & Experimental	Research & Experimental Medicine	295BU	WOS:000255450800026	17910993				2021-06-18	
J	Jacobs, ML; Donders, J				Jacobs, Monica L.; Donders, Jacobus			Performance discrepancies on the California Verbal Learning Test - Second Edition (CVLT-II) after traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						learning; memory; traumatic brain injury	RECALL DISCRIMINABILITY; MEMORY; INDEXES; UTILITY	One hundred fourteen patients with traumatic brain injury (TBI), selected from a 5-year series of consecutive rehabilitation referrals, completed the California Verbal Learning Test-Second Edition (CVLT-II) within 1 year after injury. Various performance contrasts (i.e., proactive interference, retroactive interference, rapid forgetting, and retrieval problems) were evaluated. Initial analyses revealed higher rates of rapid forgetting in the TBI group as compared to the standardization sample. Follow-up analyses between those patients with and without unusual degrees of rapid forgetting did not reveal any significant differences between these groups on demographic or neurological variables (p>0.10 for all variables). It is concluded that performance discrepancies on the CVLT-II should never be used in isolation to determine the presence or absence of acquired cerebral or memory impairment. However, regardless of the cause, such discrepancies may still be relevant for clinical treatment recommendations. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Jacobs, Monica L.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy S E, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CVLT 2 COMPREHENSIVE; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Donders J, 2006, PSYCHOL ASSESSMENT, V18, P458, DOI 10.1037/1040-3590.18.4.458; Fiszdon JM, 2006, PSYCHIAT RES, V143, P159, DOI 10.1016/j.psychres.2005.09.012; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; McDonald CR, 2001, ARCH CLIN NEUROPSYCH, V16, P571, DOI 10.1016/S0887-6177(00)00068-8; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Smith RM, 2006, COGN BEHAV NEUROL, V19, P157, DOI 10.1097/01.wnn.0000213909.41901.cc; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	19	11	11	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2008	23	1					113	118		10.1016/j.acn.2007.09.003			6	Psychology, Clinical; Psychology	Psychology	259ET	WOS:000252922600009	17959354	Bronze			2021-06-18	
J	Leon-Carrion, J; Martin-Rodriguez, JF; Damas-Lopez, J; Martin, JMBY; Dominguez-Morales, MDR				Leon-Carrion, Jose; Martin-Rodriguez, Juan Francisco; Damas-Lopez, Jesus; Martin, Juan Manuel Barroso Y.; Dominguez-Morales, Maria Del Rosario			A QEEG index of level of functional dependence for people sustaining acquired brain injury: The Seville Independence Index (SINDI)	BRAIN INJURY			English	Article; Proceedings Paper	Annual Meeting Society-of-Applied-Neuroscience	SEP 13-19, 2006	Swansea, WALES	Soc Appl Neurosci		traumatic brain injury; stroke; functional independence; QEEG; neuropsychological assessment; forensic assessment	EEG COHERENCE; MRI; ELECTROENCEPHALOGRAPHY; RELIABILITY; STABILITY; MODEL; SCALE; POWER	Primary objective: To find an easy-to-use, valid and reliable tool for evaluating the level of functional dependence of an individual with brain damage who seeks a diagnosis of his/her functional dependence in daily activities. Methods: Eighty-one patients with acquired brain injury (ABI) in post-acute phase, 40 traumatic brain injury (TBI) and 41 cerebral vascular accident (CVA), were assessed using quantitative electroencephalography (QEEG) and grouped according to the FIM + FAM scale. Discriminant analysis was performed on QEEG variables to obtain a discriminant function with the best discriminative capacity between functionality groups. Results: Discriminant analysis showed classification accuracy of 100% in the training set sample and 75% in an external cross-validation sample; 100% sensitivity and 100% specificity were reached. Coherence measures were the most numerous variables in the function. Conclusions: These results point out that the discriminant function may be a useful tool in objective evaluations of patients seeking a diagnosis of their level of dependence and that it could be included in current functionality assessment protocols.	[Leon-Carrion, Jose; Martin-Rodriguez, Juan Francisco; Martin, Juan Manuel Barroso Y.] Univ Seville, Sch Psychol, Dept Expt Psychol, Human Neuropsychol Lab, Seville 41018, Spain; [Leon-Carrion, Jose; Martin-Rodriguez, Juan Francisco; Damas-Lopez, Jesus; Dominguez-Morales, Maria Del Rosario] Ctr Brain Injury Rehabil CRECER, Seville, Spain	Leon-Carrion, J (corresponding author), Univ Seville, Sch Psychol, Dept Expt Psychol, Human Neuropsychol Lab, C Camilo Jose Cela S-N, Seville 41018, Spain.	leoncarrion@us.es	Barroso y Martin, Juan Manuel/AAB-9758-2020	Martin Rodriguez, Juan Francisco/0000-0003-1392-8775			Arruda JE, 1996, INT J PSYCHOPHYSIOL, V23, P63, DOI 10.1016/0167-8760(96)00032-3; Broicolo A, 1973, J NEUROSURG SCI, V17, P278; CorsiCabrera M, 1997, ELECTROEN CLIN NEURO, V102, P248, DOI 10.1016/S0013-4694(96)95179-6; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DOODS TA, 1993, ARCH PHYS MED REHAB, V74, P531; Finnigan SP, 2004, STROKE, V35, P899, DOI 10.1161/01.STR.0000122622.73916.d2; Fuster JM, 2006, INT J PSYCHOPHYSIOL, V60, P125, DOI 10.1016/j.ijpsycho.2005.12.015; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hebb Donald O., 1949, ORG BEHAV, p[63, 70]; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; JENNETT B, 1975, LANCET, V1, P480; JOHN ER, 1977, SCIENCE, V196, P1393, DOI 10.1126/science.867036; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LEONCARRION J, CLIN NEUROPHYSIOLOGY; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lubar JF, 1997, APPL PSYCHOPHYS BIOF, V22, P111, DOI 10.1023/A:1026276228832; LUND TR, 1995, PSYCHOPHYSIOLOGY, V32, P66, DOI 10.1111/j.1469-8986.1995.tb03407.x; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Neumann N, 2004, BRAIN RES PROTOC, V14, P25, DOI 10.1016/j.brainresprot.2004.09.001; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; Srivastava G, 2005, NEUROIMAGE, V24, P50, DOI 10.1016/j.neuroimage.2004.09.041; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thornton K, 2003, ARCH CLIN NEUROPSYCH, V18, P363, DOI 10.1016/S0887-6177(02)00139-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	11	12	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	1					61	74		10.1080/02699050701824143			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400008	18183510				2021-06-18	
J	Morris, SL; Dodd, KJ; Morris, ME				Morris, Susan L.; Dodd, Karen J.; Morris, Meg E.			Reliability of dynamometry to quantify isometric strength following traumatic brain injury	BRAIN INJURY			English	Article						Reliability and validity; traumatic brain injury	HAND-HELD DYNAMOMETRY; TREADMILL WALKING; MUSCLE STRENGTH; STROKE PATIENTS; DISABILITY	Objective: To investigate the within-session reliability and test-re-test reliability of hand-held dynamometry (HHD) to quantify strength in hip flexors, quadriceps, plantarflexors and triceps brachii following traumatic brain injury (TBI). Design: Within-session reliability was examined across six consecutive trials of HHD. Test-re-test reliability was examined between two sessions separated by 7 days. Setting: Private physical therapy practice, Melbourne, Australia. Participants: Ten adults with TBI with a mean age of 32.5 years (range = 19-63, SD = 12.8) and mean time after injury of 12.2 years (range = 2.3-26, SD = 8.6). Main outcome measures: Isometric strength measured by HHD. Results: Test-re-test reliability of HHD following TBI was good when repeated tests occurred within a single session. Within a session, the first trial was the most variable out of the six examined. Of the four muscles examined, re-test measures of strength for the quadriceps, plantarflexors and triceps were the most reliable. For the hip flexors an increase greater than 3.1 kg (28%) was needed before real change could be detected. Test-re-test reliability was higher for muscles tested on the more affected side (ICC(2,1) = 0.55-0.93) than muscles tested on the less affected side (ICC(2,1) = 0.09-0.86). Conclusions: To gain a representative measure of isometric strength using HHD in a single session, three trials are recommended. The first is for familiarization and trials 2 and 3 are averaged to provide a typical measure of isometric muscle strength. Further research needs to occur but alternative methods to quantify muscle strength might be needed if repeated measures are to be performed over a 7-day interval.	[Morris, Susan L.] Private Neurol Physiotherapy Practice, Melbourne, Vic, Australia; [Morris, Susan L.; Dodd, Karen J.] La Trobe Univ, Musculoskeletal Res Ctr, Melbourne, Vic, Australia; [Morris, Susan L.; Dodd, Karen J.] La Trobe Univ, Sch Physiotherapy, Melbourne, Vic, Australia; [Morris, Meg E.] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic 3010, Australia	Morris, SL (corresponding author), POB 308, Warrandyte, Vic 3113, Australia.	sjaj@people.net.au		Morris, Meg/0000-0002-0114-4175	La Trobe University	This research was partially supported by a Faculty Research Grant, Faculty of Health Sciences, La Trobe University.; I certify that all financial and material support for this research and work are clearly identified in the title page attached to the manuscript.	*ACSM, 2000, ACSM GUID EX TEST PR; AGRE JC, 1987, ARCH PHYS MED REHAB, V68, P454; Altman D, 1991, PRACTICAL STAT MED R; ANDREWS AW, 1991, J HUM MUSCLE PERFORM, V1, P35; Badics E, 2002, NEUROREHABILITATION, V17, P211; Bohannon RW, 1997, J NEUROL REHABIL, V11, P115; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; BOHANNON RW, 1987, CLIN BIOMECH, V2, P74, DOI 10.1016/0268-0033(87)90131-8; BOHANNON RW, 1990, CLIN PHYS PHYSIOL M, V11, P217, DOI 10.1088/0143-0815/11/3/004; Bohannon RW, 1987, CLIN REHABIL, V1, P5; Canning CG, 2004, CLIN REHABIL, V18, P300, DOI 10.1191/0269215504cr715oa; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P322, DOI 10.1053/apmr.2002.29622; GIULIANI C, 1995, NEUROLOGY REPORT, V19, P29; GOLDIE PA, 1990, PHYS THER, V70, P234, DOI 10.1093/ptj/70.4.234; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Matsas A, 2000, GAIT POSTURE, V11, P46, DOI 10.1016/S0966-6362(99)00048-X; Mercier C, 2004, CLIN REHABIL, V18, P215, DOI 10.1191/0269215504cr724oa; Merlini L, 2002, MUSCLE NERVE, V26, P64, DOI 10.1002/mus.10166; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; OLNEY SJ, 1991, ARCH PHYS MED REHAB, V72, P309; Pallant J., 2001, SPSS SURVIVAL MANUAL; Portney LG., 1993, FDN CLIN RES APPL PR, V3rd; RICHARDSON J, 1997, PHYSIOTHERAPY THEORY, V79, P369; Richardson Julie, 1998, Physiotherapy Theory and Practice, V14, P49, DOI 10.3109/09593989809070043; RIDDLE DL, 1989, PHYS THER, V69, P182, DOI 10.1093/ptj/69.3.182; Shepherd Roberta B., 2001, Neural Plasticity, V8, P121, DOI 10.1155/NP.2001.121; STRATFORD P W, 1992, Physiotherapy Canada, V44, P14; STUBERG WA, 1988, PHYS THER, V68, P977, DOI 10.1093/ptj/68.6.977; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Wass E, 2005, GAIT POSTURE, V21, P72, DOI 10.1016/j.gaitpost.2004.01.003; Weiss A, 2000, AM J PHYS MED REHAB, V79, P369, DOI 10.1097/00002060-200007000-00009; WHITELY J, 1962, RES QUART, V34, P248; WIKHOLM J B, 1991, Journal of Orthopaedic and Sports Physical Therapy, V13, P191; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	35	11	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	13-14					1030	1037	PII 907311794	10.1080/02699050802533775			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	389ZM	WOS:000262134100007	19117182				2021-06-18	
J	Payette, DJ; Xie, J; Shirwany, N; Guo, Q				Payette, Daniel J.; Xie, Jun; Shirwany, Najeeb; Guo, Qing			Exacerbation of Apoptosis of Cortical Neurons Following Traumatic Brain Injury in Par-4 Transgenic Mice	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Traumatic brain injury; cerebral cortex; apoptosis; prostate apoptosis response-4; cell culture	AMYLOID-BETA-PEPTIDE; MITOCHONDRIAL PERMEABILITY TRANSITION; ZIPPER PROTEIN PAR-4; CELL-DEATH; ISCHEMIA-REPERFUSION; HIPPOCAMPAL-NEURONS; CASPASE ACTIVATION; OXIDATIVE DAMAGE; NERVOUS-SYSTEM; EXPRESSION	Traumatic brain injury (TBI) is a significant clinical problem, yet few effective strategies for treating it have emerged. People that sustain and survive a TBI are left with significant cognitive, behavioral, and communicative disabilities. Apoptotic neuronal death occurs following TBI. Prostate apoptosis response-4 (Par-4) is a death domain-containing protein initially characterized as a critical regulator of apoptosis in prostate cancer cells. We have recently generated and characterized Par-4 transgenic mice in which the expression of the par-4 transgene was limited to cells of neuronal lineage. We now provide evidence that, in cortical neurons from these mice, Par-4 drastically increases apoptotic neuronal death in both in vitro and in vivo models of TBI. In vitro experiments were performed in 7-day-old primary cultures of cortical neurons using a previously published, scratch-induced mechanical trauma model. Neurons that overexpress Par-4 showed not only a significant decrease in overall neuron survival after TBI compared to wild-type cells, but also exhibited a sharper decrease in mitochondrial transmembrane potential, a higher degree of free radical accumulation, and earlier activation of caspase-3 than wild-type cells did. In vivo experiments were performed utilizing a weight drop TBI model. A significantly increased volume of cortical injury and exacerbated activation of caspase-3 were observed in Par-4 transgenic mice when compared to those in wild-type mice. These data suggests that aberrant Par-4 expression exacerbates neuronal cell death following TBI by altering mitochondrial function, enhancing oxidative damage, and execution of apoptosis via caspase activation.	[Payette, Daniel J.; Xie, Jun; Shirwany, Najeeb; Guo, Qing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	Guo, Q (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.	qing-guo@ouhsc.edu			University of Oklahoma Health Sciences Center (OUHSC)	We thank Paul Tompkins in the Department of Neurosurgery at the University of Oklahoma Health Sciences Center for his excellent technical assistance in establishing the mouse cortical impact models. This work was supported by a research startup fund to Q.G. from The University of Oklahoma Health Sciences Center (OUHSC).	Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Chung H, 2007, J ENDOCRINOL, V194, P77, DOI 10.1677/JOE-07-0073; Cole K, 2004, INT J DEV NEUROSCI, V22, P485, DOI 10.1016/j.ijdevneu.2004.07.015; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Dhillon HS, 2001, EXP NEUROL, V170, P140, DOI 10.1006/exnr.2001.7685; DRESSLER J, 2006, INT J LEGAL MED; El-Guendy N, 2003, MOL CELL BIOL, V23, P5516, DOI 10.1128/MCB.23.16.5516-5525.2003; El-Guendy N, 2003, EXP CELL RES, V283, P51, DOI 10.1016/S0014-4827(02)00016-2; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo Q, 2004, J BIOL CHEM, V279, P4596, DOI 10.1074/jbc.M309811200; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; Guo Q, 1999, P NATL ACAD SCI USA, V96, P4125, DOI 10.1073/pnas.96.7.4125; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hutchins JB, 1998, ANAT REC, V253, P79, DOI 10.1002/(SICI)1097-0185(199806)253:3<79::AID-AR4>3.0.CO;2-9; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Khodorov B I, 2002, Neurosci Behav Physiol, V32, P541, DOI 10.1023/A:1019819925257; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Mattson MP, 1999, J MOL NEUROSCI, V13, P17, DOI 10.1385/JMN:13:1-2:17; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Qiu GF, 1999, ONCOGENE, V18, P623, DOI 10.1038/sj.onc.1202344; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rangnekar VM, 1998, APOPTOSIS, V3, P61, DOI 10.1023/A:1009666705875; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sells SF, 1997, MOL CELL BIOL, V17, P3823, DOI 10.1128/MCB.17.7.3823; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 1999, J NEUROSCI, V19, P6248; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Xie J, 2005, J NEUROCHEM, V92, P59, DOI 10.1111/j.1471-4159.2004.02834.x; Xie J, 2004, J BIOL CHEM, V279, P28266, DOI 10.1074/jbc.M401495200; Xie J, 2004, NEUROBIOL DIS, V16, P150, DOI 10.1016/j.nbd.2004.02.003; Xie J, 2001, BRAIN RES, V915, P1, DOI 10.1016/S0006-8993(01)02803-7; Xie J, 2007, AM J PHYSIOL-RENAL, V292, pF107, DOI 10.1152/ajprenal.00083.2006; Xie J, 2006, J AM SOC NEPHROL, V17, P3336, DOI 10.1681/ASN.2006040311; Yildirim Erkan, 2006, Heart Lung Circ, V15, P124, DOI 10.1016/j.hlc.2005.10.001; Zhu HY, 2000, J NEUROCHEM, V75, P117, DOI 10.1046/j.1471-4159.2000.0750117.x	49	11	14	0	0	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2008	1	1					44	56					13	Oncology; Pathology	Oncology; Pathology	V18RE	WOS:000208021100006	18784822				2021-06-18	
J	Satish, U; Streufert, S; Eslinger, PJ				Satish, Usha; Streufert, Siegfried; Eslinger, Paul J.			Simulation-based executive cognitive assessment and rehabilitation after traumatic frontal lobe injury: A case report	DISABILITY AND REHABILITATION			English	Article						cognitive simulation assessment; cognitive rehabilitation; traumatic brain injury; executive functions	CLOSED-HEAD-INJURY; BRAIN-INJURY; DEFICITS; MANAGEMENT; COMPLEXITY; DAMAGE	Purpose.To investigate whether identifying specific deficits after brain injury can lead to a more focused and potentially effective cognitive rehabilitation technology. Method.Cognitive simulation assessment was undertaken in a 47-year-old man with trauma-related prefrontal damage and persisting occupational and cognitive-behavioral difficulties at 15 months post brain injury. Results.Results revealed significant difficulties in measured levels of activity, initiative, information utilization, response flexibility, and effective decision-making strategies which accorded well with his real-life complaints despite normal neuropsychological test scores. This profile of findings was then used to design a two-stage intervention program. The first stage focused on participant education and awareness about his simulation-based problem solving difficulties. In the second stage specific goals were formulated to improve problem solving impairments that were then the target of weekly training sessions using pertinent decision-making and problem-solving vignettes. A parallel version of the cognitive simulation assessment was undertaken post-cognitive training (3 months after initial assessment) and revealed significant improvements in targeted executive cognitive-behavioral areas. Conclusion.Results of this cognitive rehabilitation probe supported the feasibility and validity of undertaking a cognitive simulation approach to identify residual executive function deficits after traumatic brain injury, even with a normal neuropsychological test profile. Further studies are needed to establish the reliability, generalizability and maintenance of such gains.	[Eslinger, Paul J.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Neural & Behav Sci,Univ Hosp Rehabil Ctr, Hershey, PA 17033 USA; [Eslinger, Paul J.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Radiol,Univ Hosp Rehabil Ctr, Hershey, PA 17033 USA; [Eslinger, Paul J.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Neurol,Univ Hosp Rehabil Ctr, Hershey, PA 17033 USA; [Satish, Usha; Streufert, Siegfried] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Hershey, PA USA	Eslinger, PJ (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol H037, POB 50, Hershey, PA 17033 USA.	peslinger@psu.edu					BREUER K, 1996, CORPORATE TRAINING E; BREUILLE D, 1996, CLIN NUTR, V15, P21; Cicerone KD, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P246; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Eslinger Paul J., 1996, P415; ESLINGER PJ, IN PRESS NEUROREHABI; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Levine B, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P80; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RIZZO M, 1996, HEAD INJURY POSTCONC; Robertson IH, 1996, GOAL MANAGEMENT TRAI; Satish U, 2006, PSYCHOL REC, V56, P181, DOI 10.1007/BF03395543; Satish U, 1999, NEUROCASE, V5, P355, DOI 10.1093/neucas/5.4.355; Satish U, 1997, J APPL SOC PSYCHOL, V27, P2047, DOI 10.1111/j.1559-1816.1997.tb01640.x; STREUFERT S, 1988, PERS PSYCHOL, V41, P537, DOI 10.1111/j.1744-6570.1988.tb00643.x; Streufert S, 1997, J APPL SOC PSYCHOL, V27, P2068, DOI 10.1111/j.1559-1816.1997.tb01641.x; Streufert S., 1988, Computers in Human Behaviour, V4, P77, DOI 10.1016/0747-5632(88)90034-9; Streufert S., 1986, COMPLEXITY MANAGERS; Streufert S., 1978, BEHAV COMPLEX ENV; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; *WHO, 2000, 1C1DH2 WHO	32	11	11	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2008	30	6					468	478		10.1080/09638280701625401			11	Rehabilitation	Rehabilitation	267LX	WOS:000253511600006	18297501				2021-06-18	
J	Toung, TJ; Nyquist, P; Mirski, MA				Toung, Thomas J.; Nyquist, Paul; Mirski, Marek A.			Effect of hypertonic saline concentration on cerebral and visceral organ water in an uninjured rodent model	CRITICAL CARE MEDICINE			English	Article						hypertonic saline; osmotic therapy; intravascular volume; sodium; diuresis; blood-brain barrier; intracranial pressure	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; HEMORRHAGIC-SHOCK; FLUID MANAGEMENT; HEAD-INJURY; BLOOD-FLOW; RESUSCITATION; HYPERTENSION; OSMOTHERAPY; MANNITOL	Objective: Hypertonic saline has been shown to be an effective osmotic agent to reduce brain water and hence brain volume and intracranial pressure. A direct correlation between dose and effect has been demonstrated, but no studies have compared the effects of different concentrations of the same osmotic load of hypertonic saline over time. We compared the effects of different tonicity of infused hypertonic saline on cerebral, lung, and small bowel water extraction over time under controlled conditions. Design: Laboratory study. Setting. Medical school. Subjects. Male Wistar rats (280-450 g). Interventions. Anesthetized rats were randomized to a 15-min intravenous bolus infusion of 0.9% NaCl or five equisodium but different concentrations of hypertonic saline: 4.2%, 7.5%, 10%, 23.4%, and 30%. Following infusion, animals remained anesthetized for 60, 180, or 300 mins without additional fluids given (n >= 6 per group). Blood was sampled, total urine output was measured, and the animal was then killed under deep anesthesia. Cerebral, lung, and small bowel water contents were derived by wet/dry weight measures. Measurements and Main Results. After 60 mins, hypertonic saline administered at 50 mosm/kg resulted in an increase in serum osmolarity in all hypertonic saline groups (p < .05 vs. normal saline), with a significantly greater increase measured using 23.4% or 30% hypertonic saline (23.4%, 365.0 +/- 8.8 mosm/L, p <.05 vs. other lesser hypertonic saline doses). The durable effect was present throughout the 300-min period by all but the lowest hypertonic saline (4.2% NaCl). Lung but not small bowel organ water was diminished by hypertonic saline. Brain water content (79.1 +/- 0.2% in normal saline controls) was, however, significantly reduced. Conclusions: Hypertonic saline is effective in reducing organ water content in a setting of preserved blood-brain barrier but is not as effective in visceral organs. At equiosmotic doses of hypertonic saline, concentration plays no substantial role in altering serum osmolarity but appears to benefit duration of action. At very high concentrations, such as 23.4% NaCl, additional water extraction is also manifested. At such high concentration of NaCl, tonicity, indeed, matters, especially in water shifts across the blood-brain barrier.	[Toung, Thomas J.; Nyquist, Paul; Mirski, Marek A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Nyquist, Paul; Mirski, Marek A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Mirski, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.	mmirski@jhmi.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38684] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038684] Funding Source: NIH RePORTER		Al-Rawi PG, 2005, ACTA NEUROCHIR SUPPL, V95, P123; Angle N, 1998, SHOCK, V9, P164, DOI 10.1097/00024382-199803000-00002; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Bender R, 2007, RESUSCITATION, V72, P74, DOI 10.1016/j.resuscitation.2006.05.019; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; Bhardwaj, 1999, Curr Treat Options Neurol, V1, P179, DOI 10.1007/s11940-999-0002-z; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Harukuni Izumi, 2002, J Anesth, V16, P229, DOI 10.1007/s005400200030; HEBESTREIT A, 2007, EUR J APPL PHYS 0223; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KOENIG MA, IN PRESS CRIT CARE M; Levin MH, 2006, J BIOL CHEM, V281, P25803, DOI 10.1074/jbc.M604332200; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Noppens RR, 2006, CRIT CARE MED, V34, P2194, DOI 10.1097/01.CCM.0000228915.94169.B1; Ogden AT, 2005, NEUROSURGERY, V57, P207, DOI 10.1227/01.NEU.0000166533.79031.D8; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; SEELINGER E, 2001, J PHYSL, V15, P941; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Toung TJK, 2007, CRIT CARE MED, V35, P526, DOI 10.1097/01.CCM.0000253309.44567.A6; Tseng MY, 2003, STROKE, V34, P1389, DOI 10.1161/01.STR.0000071526.45277.44; ULATOWSKI JA, 2004, CUR OPIN CRIT CARE, V10, P126; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56	36	11	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2008	36	1					256	261		10.1097/01.CCM.0000295306.52783.1E			6	Critical Care Medicine	General & Internal Medicine	291YA	WOS:000255232100036	18090381				2021-06-18	
J	van de Nes, JAP; Bajanowski, T; Trubner, K				van de Nes, J. A. P.; Bajanowski, T.; Truebner, K.			Fibromuscular dysplasia of the basilar artery: An unusual case with medico-legal implications	FORENSIC SCIENCE INTERNATIONAL			English	Article						fibromuscular dysplasia; histopathology; occipital condyle fracture; traffic accident; traumatic subarachnoid hemorrhage	TRAUMATIC SUBARACHNOID HEMORRHAGE; SUDDEN NATURAL DEATH; OF-THE-LITERATURE; AUTOPSY VERIFICATION; DISEASE; INJURIES; BRAIN; WHEEL	A 28-year-old male car driver was reported to suddenly loose the control over his vehicle, to hit the right and middle crash barrier, and to be unconscious as the car came to a halt in a position at right angles to the road. The car was hit in its left side by an automobile with high velocity, and the 28-year-old driver died. Examination of the brain revealed a massive isolated basal subarachnoid hemorrhage and a complete tearing of the basilar artery. A macroscopically detectable aneurysm was not found. However, histological examination of the large arteries at the base of the brain showed (i) fibromuscular dysplasia (FMD) mostly involving the basilar artery (ii) with a ruptured micro-aneurysm in its upper third part. The observations of the eye witnesses that the driver initially lost control over his car were judged in favour of the accused to be due to that rupture of the micro-aneurysm, while complete transverse tearing of the basilar artery occurred during the car crash due to hyperextension and rotation of his neck. Intracranial FMD is a rare cause in the differential diagnosis of isolated basal subarachnoid hemorrhage. The medico-legal implications of this entity are described in the presented case. (C) 2007 Elsevier Ireland Ltd. All rights reserved.	Univ Hosp Essen, Dept Pathol & Neuropathol, D-45122 Essen, Germany; Univ Hosp Essen, Dept Legal Med, Essen, Germany	van de Nes, JAP (corresponding author), Univ Hosp Essen, Dept Pathol & Neuropathol, Hufelandstr 55, D-45122 Essen, Germany.	johannes.van.de.nes@uni-essen.de					ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; Arunodaya GR, 1997, NEUROLOGY, V48, P1605, DOI 10.1212/WNL.48.6.1605; Aulino JM, 2005, EMERG RADIOL, V11, P342, DOI 10.1007/s10140-005-0425-0; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Bunai Y, 2000, AM J FOREN MED PATH, V21, P343, DOI 10.1097/00000433-200012000-00009; Buttner A, 1999, FORENSIC SCI INT, V103, P101, DOI 10.1016/S0379-0738(99)00063-8; CONTOSTAVLOS DL, 1995, FORENSIC SCI INT, V73, P61, DOI 10.1016/0379-0738(95)01700-3; DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; Eachempati SR, 1998, J TRAUMA, V44, P406, DOI 10.1097/00005373-199802000-00035; FURIE DM, 1995, AM J ROENTGENOL, V164, P1205; Gray JT, 1999, FORENSIC SCI INT, V105, P13, DOI 10.1016/S0379-0738(99)00113-9; HARRISON EG, 1971, MAYO CLIN PROC, V46, P161; HEGEDUS K, 1984, ARCH NEUROL-CHICAGO, V41, P440, DOI 10.1001/archneur.1984.04050160106024; HILL LD, 1965, ARCH SURG-CHICAGO, V90, P585; Hiraiwa K, 2005, NEUROL MED-CHIR, V45, P549, DOI 10.2176/nmc.45.549; HIRSCH CS, 1975, HUM PATHOL, V6, P749, DOI 10.1016/S0046-8177(75)80084-0; HOUSER OW, 1971, RADIOLOGY, V101, P606; KRAULAND W, 1981, Z RECHTSMED, V87, P1; LUSCHER TF, 1987, MAYO CLIN PROC, V62, P931; LUSCHER TF, 1986, NEPHRON, V44, P109, DOI 10.1159/000184059; METTINGER KL, 1982, STROKE, V13, P53, DOI 10.1161/01.STR.13.1.53; METTINGER KL, 1982, STROKE, V13, P46, DOI 10.1161/01.STR.13.1.46; OSTROM M, 1987, J FORENSIC SCI, V32, P988; RINALDI I, 1976, STROKE, V7, P511, DOI 10.1161/01.STR.7.5.511; Sato Y, 1997, AM J FOREN MED PATH, V18, P129, DOI 10.1097/00000433-199706000-00004; SCHMIDT P, 1990, FORENSIC SCI INT, V48, P155, DOI 10.1016/0379-0738(90)90108-B; SIMONSEN J, 1984, FORENSIC SCI INT, V24, P57, DOI 10.1016/0379-0738(84)90152-X; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P561; TATSUNO Y, 1974, ARCH PATHOL, V97, P211	30	11	12	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	DEC 20	2007	173	2-3					188	192		10.1016/j.forsciint.2007.02.016			5	Medicine, Legal	Legal Medicine	233FO	WOS:000251076000018	17383130				2021-06-18	
J	Brinar, VV; Habek, M; Ozretic, D; Djakovic, V; Matijevic, V				Brinar, Vesna V.; Habek, Mario; Ozretic, David; Djakovic, Visnja; Matijevic, Vesna			Isolated nontraumatic abducens nerve palsy	ACTA NEUROLOGICA BELGICA			English	Article						abducens nerve; palsy; traumatic; nontraumatic	NASOPHARYNGEAL CARCINOMA; PETROUS APICITIS; PARALYSIS; PROGNOSIS	Introduction : Abducens nerve palsy (ANP) is the most common isolated palsy. The injury of the abducens nerve can occur anywhere along its long course, so differential diagnosis of ANP occasionally demands thorough investigation to find the proper cause. Patients : Ten patients with isolated ANP are presented. The causes included nasopharyngeal carcinoma, diabetes, cholesteatoma of the inner ear, carotid-cavernous fistula, subarachnoid bleeding, hydrocephalus, toxic ANP, multiple sclerosis, clinically isolated syndrome suggestive of multiple sclerosis, and Tolosa-Hunt syndrome. Discussion : Based on the cases presented and review of the literature, we argue that every patient with isolated nontraumatic ANP requires brain MRI as an initial diagnostic tool. If this finding remains inconclusive, additional tests including angiography and CSF examination should be performed.	Univ Zagreb, Zagreb Univ Hosp Ctr, Univ Dept Neurol, HR-10000 Zagreb, Croatia; [Ozretic, David] Univ Zagreb, Zagreb Sch Med, Dept Radiol, Zagreb, Croatia; [Ozretic, David] Univ Zagreb, Univ Hosp Ctr, Zagreb, Croatia; [Brinar, Vesna V.; Habek, Mario; Djakovic, Visnja; Matijevic, Vesna] Univ Zagreb, Zagreb Sch Med, Univ Dept Neurol, Referral Ctr Demyelinating Dis Cent Nervous Syst, Zagreb, Croatia	Habek, M (corresponding author), Univ Zagreb, Zagreb Univ Hosp Ctr, Univ Dept Neurol, Kispaticeva 12, HR-10000 Zagreb, Croatia.	mhabek@mef.hr					Alioglu Z, 1999, J NEURORADIOLOGY, V26, P68; Atilla H, 2000, ACTA NEUROL BELG, V100, P246; Barr D, 2000, J NEUROL, V247, P701, DOI 10.1007/s004150070114; Bendszus M, 2001, NEURORADIOLOGY, V43, P742, DOI 10.1007/s002340100572; Chan JW, 2003, NEUROLOGY, V61, P1417, DOI 10.1212/01.WNL.0000090567.33686.A3; CHOLE RA, 1983, ANN OTO RHINOL LARYN, V92, P544, DOI 10.1177/000348948309200603; Durkin SR, 2006, OPHTHALMOLOGY, V113, P2108, DOI 10.1016/j.ophtha.2006.06.026; Holmes J M, 1998, J AAPOS, V2, P265, DOI 10.1016/S1091-8531(98)90081-7; Holmes JM, 2001, OPHTHALMOLOGY, V108, P1457, DOI 10.1016/S0161-6420(01)00633-9; Ilhan O, 2002, EUR J OPHTHALMOL, V12, P55; Iwasaki M, 2006, SURG NEUROL, V65, P516, DOI 10.1016/j.surneu.2005.06.044; Kawase Takeshi, 1996, Neurologia Medico-Chirurgica, V36, P1, DOI 10.2176/nmc.36.1; KEANE JR, 1976, ARCH NEUROL-CHICAGO, V33, P681, DOI 10.1001/archneur.1976.00500100015007; Lee MS, 1999, PEDIATR NEUROL, V20, P49, DOI 10.1016/S0887-8994(98)00090-3; Mak W, 1999, CLIN NEUROL NEUROSUR, V101, P111, DOI 10.1016/S0303-8467(99)00006-2; Malloy Kelly A, 2007, Optometry, V78, P55, DOI 10.1016/j.optm.2006.08.015; Marzo S J, 2001, Ear Nose Throat J, V80, P869; Paik JW, 2004, EUR NEUROL, V52, P254, DOI 10.1159/000082373; Patel SV, 2004, OPHTHALMOLOGY, V111, P369, DOI 10.1016/j.ophtha.2003.05.024; Peters GB, 2002, OPHTHALMOLOGY, V109, P1925, DOI 10.1016/S0161-6420(02)01226-5; Price T, 2002, J LARYNGOL OTOL, V116, P726, DOI 10.1258/002221502760238055; RICHARDS BW, 1992, AM J OPHTHALMOL, V113, P489, DOI 10.1016/S0002-9394(14)74718-X	22	11	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2007	107	4					126	130					5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	281RL	WOS:000254516300008	18416288				2021-06-18	
J	Fernandez-Duque, D; Black, SE				Fernandez-Duque, Diego; Black, Sandra E.			Metacognitive judgment and denial of deficit: Evidence from frontotemporal dementia	JUDGMENT AND DECISION MAKING JOURNAL			English	Article						frontotemporal dementia; metacognition; overconfidence; generality	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; SELF-AWARENESS; WORK GROUP; ANOSOGNOSIA; DIAGNOSIS; UNAWARE; AD	Patients suffering from the behavioral variant of Frontotemporal Dementia (FTD-b) often exaggerate their abilities. Are those errors in judgment limited to domains in which patients under-perform, or do FTD-b patients overestimate their abilities in other domains? Is overconfidence in FTD-b patients domain-specific or domain-general? To address this question, we asked patients at early stages of FTD-b to judge their performance in two domains (attention, perception) in which they exhibit relatively spared abilities. In both domains, FTD-b patients overestimated their performance relative to patients with Dementia of Alzheimer Type (DAT) and healthy elderly subjects. Results are consistent with a domain-general deficit in metacognitive judgment. We discuss these findings in relation to "regression to the mean" accounts of overconfidence and the role of emotions in metacognitive judgments.	[Fernandez-Duque, Diego] Villanova Univ, Dept Psychol, Villanova, PA 19085 USA; [Black, Sandra E.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada	Fernandez-Duque, D (corresponding author), Villanova Univ, Dept Psychol, 800 Lancaster Ave, Villanova, PA 19085 USA.	diego.fernandezduque@villanova.edu	Black, Sandra E./C-7294-2011				Alicke M.D., 2005, STUDIES SELF IDENTIT, P85; ALLISON ST, 1989, SOC COGNITION, V7, P275, DOI 10.1521/soco.1989.7.3.275; Barrett AM, 2005, NEUROLOGY, V64, P693, DOI 10.1212/01.WNL.0000151959.64379.1B; Beck MR, 2007, CONSCIOUS COGN, V16, P31, DOI 10.1016/j.concog.2006.01.003; Benton A. L., 1983, CONTRIBUTIONS TO NEU, P30; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burson KA, 2006, J PERS SOC PSYCHOL, V90, P60, DOI 10.1037/0022-3514.90.1.60; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callen DJA, 2001, NEUROLOGY, V57, P1669, DOI 10.1212/WNL.57.9.1669; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; DELIS D, 1987, CALIFORNIA VERBAL LE; Eslinger PJ, 2005, J NEUROL NEUROSUR PS, V76, P1630, DOI 10.1136/jnnp.2004.053157; FISCHHOFF B, 1977, J EXP PSYCHOL HUMAN, V3, P552, DOI 10.1037/0096-1523.3.4.552; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P185, DOI DOI 10.1016/0022-3956(75)90026-6; GILOVICH T, 2002, HEURISTICS JUDGMENT; Grossman M, 2002, J INT NEUROPSYCH SOC, V8, P566, DOI 10.1017/S1355617702814357; Kaplan E.F., 1982, BOSTON NAMING TEST; Kertesz A, 2000, J INT NEUROPSYCH SOC, V6, P460, DOI 10.1017/S1355617700644041; Kertesz A., 1982, W APHASIA BATTERY; Krueger J, 2002, J PERS SOC PSYCHOL, V82, P180, DOI 10.1037//0022-3514.82.2.180; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; LICHTENSTEIN S, 1977, ORGAN BEHAV HUM PERF, V20, P159, DOI 10.1016/0030-5073(77)90001-0; Malle BF, 2001, J PERS SOC PSYCHOL, V81, P278, DOI 10.1037//0022-3514.81.2.278; Marcel AJ, 2004, CORTEX, V40, P19, DOI 10.1016/S0010-9452(08)70919-5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Mendez ME, 2005, J NEUROPSYCH CLIN N, V17, P413, DOI 10.1176/appi.neuropsych.17.3.413; MICHON A, 1994, J NEUROL NEUROSUR PS, V57, P805, DOI 10.1136/jnnp.57.7.805; Moulin CJA, 2000, NEUROPSYCHOLOGIA, V38, P1242, DOI 10.1016/S0028-3932(00)00037-3; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nelson T. O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI DOI 10.1016/S0079-7421(08)60053-5; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rankin KP, 2005, J NEUROL NEUROSUR PS, V76, P632, DOI 10.1136/jnnp.2004.042879; Salmon E, 2006, HUM BRAIN MAPP, V27, P588, DOI 10.1002/hbm.20203; Simmond M, 2003, BRAIN INJURY, V17, P325, DOI 10.1080/0269905021000013219; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Souchay C, 2003, NEUROCASE, V9, P482, DOI 10.1076/neur.9.6.482.29376; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P719, DOI 10.1136/jnnp.2005.085373; Starkstein SE, 1996, J NEUROL NEUROSUR PS, V61, P485, DOI 10.1136/jnnp.61.5.485; Vuilleumier P, 2004, CORTEX, V40, P9, DOI 10.1016/S0010-9452(08)70918-3; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Weschler D., 1987, WESCHLER MEMORY SCAL	45	11	11	0	4	SOC JUDGMENT & DECISION MAKING	TALLAHASSEE	FLORIDA STATE UNIV, TALLAHASSEE, FL 32306-1110 USA	1930-2975			JUDGM DECIS MAK	Judgm. Decis. Mak.	DEC	2007	2	6					359	370					12	Psychology, Multidisciplinary	Psychology	348SK	WOS:000259230000004		DOAJ Gold			2021-06-18	
J	Fins, JJ; Shapiro, ZE				Fins, Joseph J.; Shapiro, Zachary E.			Neuroimaging and neuroethics: clinical and policy considerations	CURRENT OPINION IN NEUROLOGY			English	Article						anoxic brain injury; diffusion tensor imaging; functional MRI; minimally conscious state; traumatic brain injury; vegetative state	MINIMALLY CONSCIOUS STATE; PERSISTENT VEGETATIVE STATE; LATE RECOVERY; DISORDERS; DIAGNOSIS	Purpose of review Neuroimaging is providing a window on severe brain injury and mechanisms of recovery in patients with consciousness disorders. This brief essay will consider the ethical implications of these developments for clinical diagnosis, emerging therapeutics and health policy. Recent findings Over the past year, functional imaging has led to two dramatic findings with the potential to alter how clinicians categorize severe brain injury and understand mechanisms of recovery. One paper reported a neuroimaging response in a patient who was behaviorally in the vegetative state. Another described structural changes in a patient with late emergence from the minimally conscious state. Summary Research into functional imaging and disorders of consciousness have the potential to elucidate mechanisms of brain recovery and refine their diagnostic nosology. These distinctions are becoming increasingly important given the potential of emerging therapeutic approaches to the minimally conscious state. Despite this promise the refinement of descriptive categories such as the vegetative and minimally conscious states is not without some degree of peril. Investigators and clinicians need to appreciate the uncertainty that will be engendered as diagnostic categories are redrawn and resist the premature dissemination of neuroimaging technology before its ethical implications for clinical practice are well understood.	New York Prebyterian Weill Cornell Med Ctr, Profess Med & Profeess Publ Hlth, Div Med Eth, New York, NY 10021 USA; Brown Univ, Providence, RI 02912 USA	Fins, JJ (corresponding author), New York Prebyterian Weill Cornell Med Ctr, Profess Med & Profeess Publ Hlth, Div Med Eth, 435 E 70th Str, Suite 4-J, New York, NY 10021 USA.	jjfins@med.cornell.edu					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Annas George J, 1996, Duquesne Law Rev, V34, P875; [Anonymous], 1968, JAMA, V205, P337; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Berube J, 2006, MOHONK REPORT REPORT; Cantor NL, 2001, J LAW MED ETHICS, V29, P182; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; CRANFORD RE, 1994, J AM GERIATR SOC, V42, P894, DOI 10.1111/j.1532-5415.1994.tb06567.x; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Fins JJ, 2005, PROG BRAIN RES, V150, P565, DOI 10.1016/S0079-6123(05)50040-2; Fins JJ, 2005, AM J BIOETHICS, V5, P56, DOI 10.1080/15265160590960951; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2005, HASTINGS CENT REP, V35, P22, DOI 10.1353/hcr.2005.0020; FINS JJ, 2006, PALLATIVE ETHICS CAR; FINS JJ, 2004, SUPPORT PALL CARE, V4, P169; Fins JJ, 2006, HASTINGS CENT REP, V36, P8, DOI 10.1353/hcr.2006.0094; Fins JJ, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601064231; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hirsch J, 2005, PROG BRAIN RES, V150, P25, DOI 10.1016/S0079-61239(05)50003-7; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 2002, VEG STAT; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Menon DK, 1998, LANCET, V352, P1148, DOI 10.1016/S0140-6736(05)79795-6; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1981, DEF DEATH MED LEG ET; Schiff N, 1999, J COGNITIVE NEUROSCI, V11, P650, DOI 10.1162/089892999563715; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; SCHIFF ND, 2003, CEREBRUM, V5, P7; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wilson FC, 2002, NEUROREHABILITATION, V17, P231	39	11	11	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2007	20	6					650	654		10.1097/WCO.0b013e3282f11f6d			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	235BU	WOS:000251209300008	17992084				2021-06-18	
J	Galanaud, D; Naccache, L; Puybasset, L				Galanaud, Damien; Naccache, Lionel; Puybasset, Louis			Exploring impaired consciousness: the MRI approach	CURRENT OPINION IN NEUROLOGY			English	Article						brain; functional MRI; imaging-traumatic; injury-anoxia; spectroscopy-diffusion; tensor	MAGNETIC-RESONANCE; OWN NAME; ARCHITECTURE; AWARENESS; RECOVERY; PATIENT	Purpose of review To summarize the application of advanced MRI sequences such as magnetic resonance spectroscopy, diffusion tensor imaging and functional MRI for the evaluation of patients with altered consciousness. Recent findings Magnetic resonance spectroscopy, volumetry and diffusion tensor imaging have shown promising results in the evaluation of traumatic or anoxo-ischaemic brain lesions and can detect damage of the brainstem, basal ganglia and white matter tracts not visible on conventional sequences. A diffusion tensor imaging study has raised the possibility of detecting ongoing axonal regrowth many years after the initial injury in minimally conscious patients. Functional MRI studies have shown that a high level of brain activities, such as recognizing one's own name or imagining playing tennis, can be preserved in vegetative patients. Summary The development of quantitative imaging could lead to a more objective evaluation of the extent of destruction or preservation of critical brain areas at the acute phase of brain injury, which could be integrated in multi-parametric decisional strategies for these patients. Functional imaging could help define borders between the various levels of altered consciousness and detect the presence of cryptic residual functions in vegetative or minimally conscious patients. This approach could eventually help determine the neurological outcome and make individual blueprints of the preserved brain activities in severely brain injured patients.	Univ Paris 06, Pitie Salpetriere Hosp, Dept Neuroradiol, Paris, France; Univ Paris 06, Pitie Salpetriere Hosp, Dept Clin Neurophysiol, Paris, France; Univ Paris 06, Pitie Salpetriere Hosp, Dept Neurosurg Intens Care Unit, Paris, France	Galanaud, D (corresponding author), Univ Paris 06, Pitie Salpetriere Hosp, APHP, Dept Neuroradiol, 47 Blvd Hop, F-75013 Paris, France.	galanaud@dat.org		naccache, lionel/0000-0002-2874-1009			Ammermann H, 2007, J NEUROL SCI, V260, P65, DOI 10.1016/j.jns.2007.03.026; Bernat JL, 2007, NEUROLOGY, V68, P885, DOI 10.1212/01.wnl.0000258973.95355.68; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Gasser T, 2005, NEUROSURGERY, V57, P94, DOI 10.1227/01.NEU.0000163488.91335.C5; Hopkin M, 2006, NATURE, V443, P132, DOI 10.1038/443132b; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Laureys S, 2006, J CLIN INVEST, V116, P1823, DOI 10.1172/JCI29172; Marcar VL, 2006, AM J NEURORADIOL, V27, P799; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Plourde G, 2006, ANESTHESIOLOGY, V104, P448, DOI 10.1097/00000542-200603000-00011; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Siva N, 2006, LANCET NEUROL, V5, P906, DOI 10.1016/S1474-4422(06)70592-0; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wang SM, 2007, ANESTH ANALG, V105, P499, DOI 10.1213/01.ane.0000270216.71234.f5; 2006, NATURE, V443, P121	24	11	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1350-7540	1473-6551		CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2007	20	6					627	631		10.1097/WCO.0b013e3282f169ec			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	235BU	WOS:000251209300004	17992080				2021-06-18	
J	Is, M; Coskun, A; Sanus, GZ; Tanriverdi, T; Kafadar, AM; Hanimoglu, H; Tanriover, N; Gezen, F; Uzan, M				Is, Merih; Coskun, Abdurrahman; Sanus, Galip Zihni; Tanriverdi, Taner; Kafadar, Ali Metin; Hanimoglu, Hakan; Tanriover, Necmettin; Gezen, Ferruh; Uzan, Mustafa			High-sensitivity C-reactive protein levels in cerebrospinal fluid and serum in severe head injury: Relationship to tumor necrosis factor-alpha and interleukin-6	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						hsCRP; IL-6; inflammation; severe head injury; TNF-alpha	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CENTRAL-NERVOUS-SYSTEM; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK MARKER; TNF-ALPHA; CYTOKINES; MEDIATOR; IL-6	Recent studies have demonstrated the role of high-sensitivity C-reactive protein (hsCRP) in inflammatory diseases; however, it is unclear whether this molecule has a role after severe head injury (SHI). Our aim was to evaluate the levels of hsCRP in both cerebrospinal fluid (CSF) and serum from patients after SHI. The study focused on 11 patients with SHI and evaluated CSF and serum levels of hsCRP, tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in a 10-day period following the head trauma. The values were compared with those from nine control patients, who had normal pressure hydrocephalus. In the CSF and serum of the patients after SHI HsCRP was found to be significantly higher, at all times, than in the controls; TNF-alpha and IL-6 levels were also higher in these patients. However, hsCRP levels did not correlate with either TNF-alpha or IL-6. TNF-alpha and IL-6 increased during the period immediately following the SHI and intrathecal levels were always higher than those of the serum. This study demonstrates for the first time that hsCRP reaches high levels in both CSF and serum in patients with SHI, and it may therefore be used as an inflammatory index. This finding suggests a need for further studies in this area, which are larger in scope than the present study. (c) 2007 Elsevier Ltd. All rights reserved.	[Is, Merih; Gezen, Ferruh] Abant Izzet Baysal Univ, Duzce Med Fac, Dept Neurosurg, Duzce, Turkey; [Coskun, Abdurrahman] Abant Izzet Baysal Univ, Duzce Med Fac, Dept Clin Biochem, Duzce, Turkey; [Sanus, Galip Zihni; Tanriverdi, Taner; Kafadar, Ali Metin; Hanimoglu, Hakan; Tanriover, Necmettin; Uzan, Mustafa] Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey	Tanriverdi, T (corresponding author), PK 5 Cerrahpasa, TR-34301 Istanbul, Turkey.	tanerato2000@yahoo.com	Coskun, Abdurrahman/C-3906-2015; Kafadar, Ali/AAH-9387-2019; Uzan, Mustafa/D-6571-2019; Tanriverdi, Taner/C-9003-2019; Sanus, Galip Zihni/D-6715-2019; Ulu, Mustafa Onur/D-6484-2019; Tanriover, Necmettin/AAD-3212-2020	Coskun, Abdurrahman/0000-0002-1273-0604; Kafadar, Ali/0000-0002-3312-3192; Ulu, Mustafa Onur/0000-0002-6256-0869; Tanriover, Necmettin/0000-0001-7628-9443; Uzan, Mustafa/0000-0001-7214-380X; Sanus, Galip Zihni/0000-0001-6539-7254			Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Bickel C, 2002, AM J CARDIOL, V89, P901, DOI 10.1016/S0002-9149(02)02236-1; Blake GJ, 2003, AM J PHYSIOL-REG I, V285, pR1250, DOI 10.1152/ajpregu.00227.2003; Byl Baudouin, 1997, Clin Microbiol Infect, V3, P306, DOI 10.1111/j.1469-0691.1997.tb00618.x; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Chang CY, 2005, NUTRITION, V21, P987, DOI 10.1016/j.nut.2005.02.010; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; Gerdes LU, 1998, SCAND J CLIN LAB INV, V58, P383, DOI 10.1080/00365519850186364; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; JENNETT B, 1993, J NEUROL NEUROSUR PS, V60, P5; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Jialal I, 2001, Am J Clin Pathol, V116 Suppl, pS108; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Libby Peter, 2004, Am J Med, V116 Suppl 6A, p9S; MACKIEWICZ A, 1991, J IMMUNOL, V146, P3032; Marquardt L, 2005, J NEUROL SCI, V236, P65, DOI 10.1016/j.jns.2005.05.006; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; POBER JS, 1990, PHYSIOL REV, V70, P427; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Tamam Y, 2005, TOHOKU J EXP MED, V206, P91, DOI 10.1620/tjem.206.91; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Vainas T, 2005, J VASC SURG, V42, P243, DOI 10.1016/j.jvs.2005.03.060; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	37	11	12	1	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2007	14	12					1163	1171		10.1016/j.jocn.2006.05.020			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	241HK	WOS:000251647300005	17884503				2021-06-18	
J	Lok, J; Wang, H; Murata, Y; Zhu, HH; Qin, T; Whalen, MJ; Lo, EH				Lok, Josephine; Wang, Hui; Murata, Yoshihiro; Zhu, Hai Hao; Qin, Tao; Whalen, Michael J.; Lo, Eng H.			Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; neuregulin; neuroprotection; probe; spatial memory; traumatic brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; CEREBRAL-ISCHEMIA; TISSUE-DAMAGE; RATS; DEATH; RECOVERY; SURVIVAL; DEFICITS; STROKE	Neuregulin-1 is a pleiotropic endogenous growth factor that is neuroprotective in experimental models of cerebral ischemia. We tested the hypothesis that pretreatment with neuregulin-1 would be similarly protective after traumatic brain injury in mice. Mice were administered neuregulin-1 or equal amounts of vehicle intravenously immediately before controlled cortical impact. Injured mice were subjected to motor and cognitive testing, and brain tissue loss was quantitated at 4 weeks. Compared to vehicle, pretreatment with neuregulin-1 had no effect on brain tissue loss, motor function, or acquisition of a spatial learning task. However, neuregulin-1 treated mice showed improved retention of spatial memory versus vehicle-treated mice in subsequent probe trials (p < 0.05). These proof-of-principle data suggest that neuregulin-1 may improve some functional outcomes after brain trauma. Further studies are therefore warranted to more carefully explore molecular mechanisms, dose-responses, and relationships between morphological outcome and long-term recovery.	[Lok, Josephine; Murata, Yoshihiro; Zhu, Hai Hao; Lo, Eng H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol & Neurol,Neuroprotect Res Lab, Boston, MA USA; [Lok, Josephine; Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat Crit Care Med, Boston, MA 02114 USA; [Wang, Hui] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA USA; [Qin, Tao] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci, Boston, MA USA	Lok, J (corresponding author), Neuroprotect Res Lab, MGH E 149-2401, Charlestown, MA 02129 USA.	jlok1@partners.org			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS048422, P01NS055104, R01NS037074, R01NS053560, R01NS047447] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS47447, R01-NS48422, R01-NS53560, R01-NS37074, P01-NS55104] Funding Source: Medline		Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; BANNERMAN DM, 1994, J NEUROSCI, V14, P7404; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Di Segni A, 2005, J MOL NEUROSCI, V26, P57, DOI 10.1385/JMN:26:1:057; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flores AI, 2000, J NEUROSCI, V20, P7622; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; Guo WP, 2006, BRAIN RES, V1087, P180, DOI 10.1016/j.brainres.2006.03.007; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; Shyu WC, 2004, NEUROBIOL AGING, V25, P935, DOI 10.1016/j.neurobiolaging.2003.10.012; SINSON G, 1995, J NEUROCHEM, V65, P2209; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Tonegawa S, 2003, PHILOS T R SOC B, V358, P787, DOI 10.1098/rstb.2002.1243; Vaynman S, 2007, NEUROSCIENCE, V144, P825, DOI 10.1016/j.neuroscience.2006.10.005; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497	23	11	11	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2007	24	12					1817	1822		10.1089/neu.2007.0372			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	245BR	WOS:000251910000004	18159993				2021-06-18	
J	Mueller, CA; Schluesener, HJ; Fauser, U; Conrad, S; Schwab, JM				Mueller, C. A.; Schluesener, H. J.; Fauser, U.; Conrad, S.; Schwab, J. M.			Lesional expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following traumatic brain injury (TBI)	EXPERIMENTAL NEUROLOGY			English	Article						CNS injury; vascular remodelling; antiangiogenesis	ENDOTHELIAL GROWTH-FACTOR; SPINAL-CORD-INJURY; INFLAMMATORY RESPONSE; MICROGLIAL CELLS; RAT-BRAIN; VASCULAR ARCHITECTURE; CEREBRAL-ISCHEMIA; BARRIER BREAKDOWN; COLLAGEN-XVIII; ALPHA-1 CHAIN	We have analysed the expression of the endogenous angiogenesis inhibitor endostatin/collagen XVIII following stab wound injury and observed a highly significant (p < 0.0001) lesional accumulation confined to areas of pan-necrotic injury and developing secondary damage. Maximal cell numbers were detected at Day 14, declining until Day 21 after injury. Further, endostatin/collagen XVIII+ monocytic cells accumulated in Virchow-Robin spaces where they formed cell clusters. Besides being prevailingly localised to ED1(+) activated microglia/macrophages, endostatin/collagen XVIII expression was also detected by subendothelial surrounding vessels in the lesioned area. Late and prolonged accumulation of endostatin/collagen XVIII+ microglia/macrophages and increased numbers of endostatin/collagen XVIII+ subendothelial cells/vessels in areas of vascular pruning and regression, point to a role in the termination of the transient angiogenic response, linked to a "late" inflammatory milieu. (c) 2007 Elsevier Inc. All rights reserved.	[Mueller, C. A.] Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; [Mueller, C. A.; Schluesener, H. J.; Fauser, U.; Conrad, S.; Schwab, J. M.] Univ Tubingen, Sch Med, Inst Brain Res, D-72076 Tubingen, Germany; [Conrad, S.] Univ Tubingen, Sch Med, Div Tissue Engn, Inst Anat, Tubingen, Germany; [Schwab, J. M.] Humboldt Univ, Charite Med Sch, Dept Neurol & Experimental Neurol, D-10117 Berlin, Germany	Mueller, CA (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	Christian-Andreas.Mueller@ukb.uni-bonn.de		Schwab, Jan/0000-0001-6784-4919			BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Berger AC, 2000, J SURG RES, V91, P26, DOI 10.1006/jsre.2000.5890; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bloch W, 2000, FASEB J, V14, P2373; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; Deininger MH, 2006, J NEUROTRAUM, V23, P1103, DOI 10.1089/neu.2006.23.1103; Dong SC, 2003, J BIOL CHEM, V278, P1700, DOI 10.1074/jbc.M209276200; DSOUZA S, 1995, J NEUROSCI, V15, P7293; Ferreras M, 2000, FEBS LETT, V486, P247, DOI 10.1016/S0014-5793(00)02249-3; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gerlach C, 1997, LAB INVEST, V77, P697; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hirji N, 1998, J IMMUNOL, V160, P6004; Hsu CY, 1996, NEUROTRAUMA, P1433; ImperatoKalmar EL, 1997, EXP NEUROL, V145, P322, DOI 10.1006/exnr.1997.6449; Jander S, 1998, EUR J NEUROSCI, V10, P680, DOI 10.1046/j.1460-9568.1998.00078.x; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kato H, 2000, BRAIN PATHOL, V10, P137; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Ma L, 2002, P NATL ACAD SCI USA, V99, P13243, DOI 10.1073/pnas.202392199; MAMEROS AG, 2001, MATRIX BIOL, V20, P337; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh TK, 1996, LAB INVEST, V74, P315; MonteroMenei CN, 1996, BRAIN RES, V724, P55, DOI 10.1016/0006-8993(96)00268-5; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2005, LAB INVEST, V85, P1189, DOI 10.1038/labinvest.3700325; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; OH SP, 1994, GENOMICS, V19, P494, DOI 10.1006/geno.1994.1098; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Popovich PG, 2003, EXP NEUROL, V182, P275, DOI 10.1016/S0014-4886(03)00120-1; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; Rehn M, 1996, GENOMICS, V32, P436, DOI 10.1006/geno.1996.0139; REHN M, 1994, J BIOL CHEM, V269, P13929; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Schluesener HJ, 1996, J NEUROSCI RES, V44, P606; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Strik HM, 2001, CANCER, V91, P1013, DOI 10.1002/1097-0142(20010301)91:5<1013::AID-CNCR1092>3.3.CO;2-H; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Takahashi K, 2003, FASEB J, V17, P896, DOI 10.1096/fj.02-0824fje; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed	67	11	13	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2007	208	2					228	237		10.1016/j.expneurol.2007.07.020			10	Neurosciences	Neurosciences & Neurology	241OP	WOS:000251666000007	17942095				2021-06-18	
J	Venetsanou, K; Vlachos, K; Moles, A; Fragakis, G; Fildissis, G; Baltopoulos, G				Venetsanou, Kyriaki; Vlachos, Konstantinos; Moles, Athanassios; Fragakis, Gerassimos; Fildissis, George; Baltopoulos, George			Hypolipoproteinemia and hyperinflammatory cytokines in serum of severe and moderate traumatic brain injury (TBI) patients	EUROPEAN CYTOKINE NETWORK			English	Article						low-density lipoprotein cholesterol; traumatic brain injury; cytokines	CEREBROSPINAL-FLUID; TNF-ALPHA; INTERLEUKIN-8; SEPSIS; IL-6	Traumatic brain injury (TBI) acts as an inducer of the inflammatory reaction expressed by the release of pro-inflammatory cytokines (interieukin-1 beta [IL-1 beta], interleukin-6 [IL-6] and interleukin-8 [IL-8]), and causes metabolic alterations in the early, post-traumatic state, either in the brain or/and the systemic circulation. The metabolic changes involve carbohydrates, proteins and lipids. We focused on the serum lipid profile, the impact of trauma on lipoproteins, and their subsequent effects, on inflammation. We investigated the role of cytokines and serum lipids, in patient outcome, reviewing 30-day mortality and the Glasgow Coma Scale (GCS). total of 75 patients with severe or moderate TBI (GCS <= 13) were allocated to two groups (group 1 non-survivors and group 2 survivors). One blood sample was collected from each patient within 24h of admission. Cytokines were measured in serum by ELISA and serum lipids using an enzymatic method. We found significantly decreased serum lipid levels and increased cytokines levels for all patients compared with healthy volunteers. Comparing the two groups, IL-6 and IL-8 levels were higher (p < 0.0001) and LDL levels lower (p = 0.003) in non-survivors than in survivors. We observed a significant inverse correlation between IL-8 and LDL (p = 0.04) in patients with an unfavorable outcome. Our results suggest that LDL alone, or in combination with IL-6 and IL-8, could be a possible prognostic factor for outcome in patients with TBI, as regards 30-day mortality.	[Venetsanou, Kyriaki; Moles, Athanassios; Fildissis, George; Baltopoulos, George] Univ Athens, KAT Gen Hosp, Sch Nursing, ICU,Res Unit, Athens 14561, Greece; [Vlachos, Konstantinos; Fragakis, Gerassimos] KAT Gen Hosp, Neurosurg Clin, Athens 14561, Greece	Venetsanou, K (corresponding author), Univ Athens, KAT Gen Hosp, Sch Nursing, ICU,Res Unit, Nikis 2, Athens 14561, Greece.	icuru@nurs.uoa.gr					BENVENISTE EN, 1995, HUMAN CYTOKINES THEI, P159; CHIARETTI A, 2007, EUR J PAEDIAT NEUROL; CHIHKANG C, 2005, BLOOD PURIFICAT, V23, P134; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kilpatrick RD, 2007, J AM SOC NEPHROL, V18, P293, DOI 10.1681/ASN.2006070795; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; MAIER B, 2007, SHOCK; Nicholson G, 2005, ANAEST INTENS CARE M, V6, P313, DOI 10.1383/anes.2005.6.9.313; NOFLER JR, 2002, ATHEROSCLEROSIS, V161, P1; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Wilson RF, 2003, CRIT CARE, V7, P413, DOI 10.1186/cc2390; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82	14	11	12	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE		1952-4005		EUR CYTOKINE NETW	Eur. Cytokine Netw.	DEC	2007	18	4					206	209		10.1684/ecn.2007.0112			4	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	246IP	WOS:000252001000006	17993453				2021-06-18	
J	Dettmer, JL; Daunhauer, L; Detmar-Hanna, D; Sample, PL				Dettmer, Judy L.; Daunhauer, Lisa; Detmar-Hanna, Donna; Sample, Pat L.			Putting brain injury on the radar: Exploratory reliability and validity analyses of the Screening Tool for Identification of Acquired Brain Injury in School-Aged Children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; identification; screening tool; special education; tool validity and reliability; traumatic brain injury	HEAD-INJURY; SYMPTOMS; CARE	Purpose: This study explored the reliability and validity of the Screening Tool for the Identification of Acquired Brain Injury in School-Aged Children (STI). Methods: Parents and teachers of students (K-12) from 3 different groups (students with known acquired brain injuries, students with special education needs, and typical students) rated their students' behaviors, symptoms, and injuries using the STI. Results: Test-retest and internal consistency analyses indicated acceptable reliability. Additionally, the 3 activities used to determine test validity all yielded positive results. Discussion: The STI indicates sensitivity to learning challenges; however, further research is needed to develop instrument specificity. We also introduce the idea of using tools, such as the STI for the purpose of an "educational identification" for students who are in need of immediate support, and for whom no formal medical diagnosis yet exists.	Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Colorado State Univ, Ctr Community Partnerships, Ft Collins, CO 80523 USA	Sample, PL (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	psample@cahs.colostate.edu					Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Dise-Lewis J. E., 2002, BRAIN STARS BRAIN IN; Glang A, 2004, NEUROREHABILITATION, V19, P219; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; GORDON WS, 2006, TBI RES REV POLICY P, V2, P1; HIBBARD M, 2001, STUDENTS TRAUMATIC B; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Keyser-Marcus L, 2002, TEACH EXCEPT CHILD, V34, P62; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LASH M, 2002, BRAIN INJ SOURCE, V6, P20; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1017/S0021963001006667; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Portney L., 2015, FDN CLIN RES APPL PR, V3rd ed.; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Savage RC, 2001, NEUROREHABILITATION, V16, P49; SAVAGE RC, 2007, CHILDREN ADOLESCENTS; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; *US DEP ED, IND DIS ED ACT IDE B; *US DEP HHS CDCP N, 1999, TRAUM BRAIN INJ US R; 2006, FED REG 2, V71, P46539	23	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					339	349		10.1097/01.HTR.0000300229.13490.c7			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500004	18025966				2021-06-18	
J	Reichard, AA; Langlois, JA; Sample, PL; Wald, MM; Pickelsimer, EE				Reichard, Audrey A.; Langlois, Jean A.; Sample, Pat L.; Wald, Marlena M.; Pickelsimer, E. Elisabeth			Violence, abuse, and neglect among people with traumatic brain injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						abuse; disability; neglect; prevention; qualitative research; traumatic brain injury; violence; victimization	PERSONAL ASSISTANCE PROVIDERS; SEXUAL-ABUSE; DEVELOPMENTAL-DISABILITIES; PHYSICAL-DISABILITIES; LEARNING-DISABILITIES; WOMEN; ADULTS	Background: Violence, abuse, and neglect (VAN) among people with physical and other disabilities has been reported; however, little is known about VAN experiences among people with traumatic brain injuries (TBI). Methods: Nine people who reported experiencing VAN post-TBI were interviewed for this phenomenological study. The data were analyzed to understand VAN as experienced by those with TBI. Results: Participants detailed many VAN experiences along with contributing factors, barriers in obtaining help, and recommendations for improving preventive and assistance services. Conclusions: Greater efforts are needed to identify and prevent VAN among people with TBI. Services following VAN must be improved.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Injury Response, Atlanta, GA USA; Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Lockheed Martin Corp, Atlanta, GA USA; Med Univ S Carolina, Div Epidemiol, Charleston, SC 29425 USA	Reichard, AA (corresponding author), NIOSH, Ctr Dis Control & Prevent, Div Safety Res, 1095 Willowdale Rd,MS H1808, Morgantown, WV 26505 USA.	AReichard@cdc.gov					ANDREWS AB, 1993, J SOCIAL WORK HUMAN, V8, P137, DOI DOI 10.1300/J291V08N02_; BEAIL N, 1995, J INTELL DISABIL RES, V39, P382, DOI 10.1111/j.1365-2788.1995.tb00542.x; Brown H., 1994, CHILD ABUSE REV, V3, P26, DOI [10.1002/car.2380030106, DOI 10.1002/CAR.2380030106]; Chang JC, 2003, J WOMENS HEALTH, V12, P699, DOI 10.1089/154099903322404348; Christoffel T, 2006, INJURY PREVENTION PU; Cramer E. P., 2003, J HUMAN BEHAV SOCIAL, V7, P183, DOI DOI 10.1300/J137V07N03_11; Curry MA, 2001, VIOLENCE AGAINST WOM, V7, P60, DOI 10.1177/10778010122182307; CURRY MA, 2003, J AGGRESS MALTREAT T, V8, P123, DOI DOI 10.1300/J146v08n07_06; FUREY EM, 1994, SEX DISABIL, V12, P285, DOI 10.1007/BF02575320; KEATING KA, 1998, ADV SPECIAL ED, P279; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Marley JA, 2001, SOC WORK, V46, P115, DOI 10.1093/sw/46.2.115; McFarlane J, 2001, J WOMEN HEALTH GEN-B, V10, P861, DOI 10.1089/152460901753285750; Milberger Sharon, 2003, Violence Vict, V18, P581, DOI 10.1891/vivi.2003.18.5.581; Moustakas C., 1994, PHENOMENOLOGICAL RES; Nosek MA, 2004, FAM COMMUNITY HEALTH, V27, P6, DOI 10.1097/00003727-200401000-00003; Nosek MA, 2003, SOC SCI MED, V56, P1737, DOI 10.1016/S0277-9536(02)00169-7; Nosek MA, 2001, VIOLENCE AGAINST WOM, V7, P477, DOI 10.1177/10778010122182569; NOSEK MA, 2002, PREV INT VIOL CHILDR; NOSEK MA, 1997, J DISABIL POLICY STU, V8, P157, DOI DOI 10.1177/104420739700800208; Oktay JS, 2004, HEALTH SOC WORK, V29, P177, DOI 10.1093/hsw/29.3.177; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Patton M.Q., 2002, QUALITATIVE RES EVAL; Petersilia JR, 2001, CRIM JUSTICE BEHAV, V28, P655, DOI 10.1177/009385480102800601; Rizzo Matthew, 1996, P1; Rosenberg M., 1991, VIOLENCE AM PUBLIC H, P14; Saxton M, 2001, VIOLENCE AGAINST WOM, V7, P393, DOI 10.1177/10778010122182523; *SCI SOFTW DEV, 1997, ATL TI COMP PROGR VE; Seidman I., 1998, INTERVIEWING QUALITA; Sequeira H, 2003, BRIT J PSYCHIAT, V183, P451, DOI 10.1192/bjp.183.5.451; Sequeira H, 2001, VIOLENCE AGAINST WOM, V7, P462, DOI 10.1177/10778010122182550; Sobsey D., 1991, SEX DISABIL, V9, P243, DOI DOI 10.1007/BF01102395; Sobsey D.D., 1994, VIOLENCE ABUSE LIVES; *STAT U NEW YORK U, 2002, CALL ACT END CRIM VI; Stromsness M. M., 1993, WOMEN THER, V14, P139, DOI DOI 10.1300/J015V14N03_14; Swedlund NP, 2000, J REHABIL, V66, P57; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR; TURK V, 1993, MENT HANDICAP RES, V6, P193, DOI DOI 10.1111/J.1468-3148.1993.TB00053.X; *US DEP COMM EC ST, 2003, DIS STAT 2000; *US DEP HHS, 1999, NIH CONS STAT REH PE, P5; *US DEP HHS CDCP N, 2005, FACTS TRAUM BRAIN IN; *US DEP JUST OFF J, 1998, WORK VICT CRIM DIS; Van Manen M., 1990, RES LIVED EXPERIENCE; Verdugo MA, 1997, AGGRESS VIOLENT BEH, V2, P143, DOI 10.1016/S1359-1789(96)00020-1; Watson-Armstrong L. A., 1994, J APPL REHABILITATIO, V25, P36; Welner SL, 2000, SEX TRANSM DIS, V27, P272, DOI 10.1097/00007435-200005000-00007; World Health Organization, 2002, WORLD REP VIOL HLTH; Young ME, 1997, ARCH PHYS MED REHAB, V78, pS34, DOI 10.1016/S0003-9993(97)90219-7	48	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					390	402		10.1097/01.HTR.0000300234.36361.b1			13	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500009	18025971				2021-06-18	
J	Reid-Arndt, SA; Schopp, L; Brenneke, L; Johnstone, B; Poole, AD				Reid-Arndt, Stephanie A.; Schopp, Laura; Brenneke, Lori; Johnstone, Brick; Poole, A. Diane			Evaluation of the traumatic brain injury early referral programme in Missouri	BRAIN INJURY			English	Article						traumatic brain injury; community integration; outcome; functional status; employment; case management	FAMILY; NEEDS	Purpose: Missouri's traumatic brain injury (TBI) early referral programme connects individuals with TBI to state services in the acute stages of recovery. This study evaluated the impact of this programme on service utilization and functional outcomes. Method: Sixty-seven individuals in the Early Referral (ER) programme were compared with 31 individuals who received services later in their recovery (controls) in terms of their functioning upon programme enrollment and programme services received. Telephone surveys were then completed with 29 ER and 22 later-referred controls assessing social/emotional and vocational functioning, as well as satisfaction with programme services. Results: The ER group had greater functional limitations than controls upon enrollment. Despite this, at follow-up the ER group evidenced significantly better social integration, emotional well-being and vocational functioning than the control group. Individuals in the ER group did not require/receive more programme resources to achieve these better outcomes. Across both groups, 91% reported feeling the programme is valuable for individuals with TBI. Conclusions: Missouri's TBI early referral programme provides efficacious and cost-effective targeted support for individuals with TBI. Contact with clients and their families during or shortly after acute rehabilitation appears to be associated with better functional outcomes without an increase in the level of services rendered.	[Reid-Arndt, Stephanie A.; Schopp, Laura; Johnstone, Brick] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA; [Brenneke, Lori; Poole, A. Diane] Missouri Dept Hlth & Senior Serv, Div Community & Publ Hlth Special Hlth Care Needs, Jefferson, AR USA	Reid-Arndt, SA (corresponding author), Univ Missouri, Dept Hlth Psychol, 1 Hosp Dr,DC 116-88, Columbia, MO 65212 USA.	reidarndts@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Cusick CP, 2003, BRAIN INJURY, V17, P931, DOI 10.1080/0269905031000110391; ENGLANDER J, 1999, REHABILITATION ADULT, P354; Finkelstein EA., 2006, INCIDENCE EC BURDEN; Fitzsimmons RD, 2003, BRAIN INJURY, V17, P947, DOI 10.1080/0269905031000110409; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; McNeny R., 1999, REHABILITATION ADULT, P242; MICHAUD LJ, 1999, REHABILITATION ADULT, P345; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	17	11	11	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1295	1302		10.1080/02699050701721802			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200008	17963093				2021-06-18	
J	Becker, F; Reinvang, I				Becker, Frank; Reinvang, Ivar			Event-related potentials indicate bi-hemispherical changes in speech sound processing during aphasia rehabilitation	JOURNAL OF REHABILITATION MEDICINE			English	Article						aphasia; rehabilitation; event-related potentials; mismatch negativity; MMN; N1; N2; P3; plasticity	MISMATCH NEGATIVITY; LANGUAGE; REORGANIZATION; STROKE	Objective: To investigate changes in brain activation related to tone and speech sound processing during aphasia rehabilitation. Design: Longitudinal study investigating patients with stroke, subarachnoid hemorrhage and traumatic brain injury 3 and 7 months post-injury. Subjects: Eight patients with aphasia, reflecting a wide range of auditory comprehension impairment. Methods: Token test and Norwegian Basic Aphasia Assessment were used to measure auditory comprehension function. Brain event-related potentials were recorded in passive paradigms with harmonically rich tones and syllables in order to obtain the mismatch negativity component that reflects automatic stimulus discrimination. In an active syllable discrimination paradigm, stimulus feature integration (N1), attended stimulus discrimination and classification (N2), and target detection (P3) were studied. Results: Auditory comprehension scores improved approximately 10% during the observation period. Ipsilesional frontal P3- and N2-amplitude increased significantly. A significant shift in topographical distribution from the contralesional to the ipsilesional hemisphere was observed for the N2 component. The study of individual waveforms indicates inter-individual differences in reorganization after brain injury. Conclusion: Hemispherical distribution of brain activation correlating with speech sound processing in aphasia can change during the first months after brain injury. Eventrelated potentials are a potentially useful method for detecting individual activation patterns relevant to recovery in aphasia rehabilitation.	Univ Oslo, Fac Div Ulleval Hosp, Sunnaas Rehabil Hosp, Oslo, Norway; Sunnaas Rehabil Hosp, NO-1450 Nesoddtangen, Norway; Univ Oslo, Dept Psychol, Oslo, Norway	Becker, F (corresponding author), Sunnaas Rehabil Hosp, NO-1450 Nesoddtangen, Norway.	frank.becker@sunnaas.no		Becker, Frank/0000-0002-0857-0628			Becker F, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-6; Becker F, 2007, BRAIN LANG, V100, P69, DOI 10.1016/j.bandl.2006.09.004; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Giaquinto S, 2004, FUNCT NEUROL, V19, P219; Hyde M, 1997, AUDIOL NEURO-OTOL, V2, P281, DOI 10.1159/000259253; Ilvonen TM, 2001, PSYCHOPHYSIOLOGY, V38, P622, DOI 10.1017/S0048577201000117; Knecht S, 2002, NAT NEUROSCI, V5, P695, DOI 10.1038/nn868; Mazzini Letizia, 2004, Phys Med Rehabil Clin N Am, V15, P163, DOI 10.1016/S1047-9651(03)00101-3; Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Pulvermuller F, 2005, NEUROIMAGE, V28, P481, DOI 10.1016/j.neuroimage.2005.06.038; Reinvang I., 1985, APHASIA BRAIN ORG; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090	14	11	16	1	14	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	OCT	2007	39	8					658	661		10.2340/16501977-0112			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	225UK	WOS:000250543400012	17896059	DOAJ Gold			2021-06-18	
J	Ibrahim, MI; Abdullah, M; Naing, L; Abdullah, JM; Idris, Z; Aljunid, SM				Ibrahim, Mohd Ismail; Abdullah, Mazlan; Naing, Lin; Abdullah, Jafri Malin; Idris, Zamzuri; Aljunid, Syed Mohamed			Cost effectiveness analysis of using multiple neuromodalities in treating severe traumatic brain injury in a developing country like Malaysia	ASIAN JOURNAL OF SURGERY			English	Article						cost-effectiveness; economic evaluation; multiple neuromonitoring; severe traumatic brain injury		OBJECTIVE: The aim of this study was to determine the cost-effectiveness of using baseline neuromonitoring (BNM) compared with multimodality monitoring (M3) for severe traumatic brain injury (TBI). METHODS: Sixty-two patients with severe TBI underwent a prospective observational study where they were divided into two groups of patients receiving treatment with M3 (32 patients) and BNM (30 patients). The macro and micro costings were performed on each patient. The Barthel Index score after 1 year was used as an outcome measurement tool for both groups. The cost-effectiveness (CE) ratio was calculated using the Poisson regression model. RESULTS: The costs of equipment and consumables between the groups was statistically significant (p < 0.001) after correcting for age and severity of injury. Other cost categories were not significantly different. The crude CE ratios were 168.66 (95% CI: 168.32, 169.03) and 144.16 (95% CI: 143.87, 144.45) for BNM and M3 respectively. The two crude CE ratios were significantly different (p < 0.001). It was calculated by controlling or adjusting age, gender, Glasgow Coma Score, Marshall's classification at admission and type of injury. The adjusted CE ratios were 171.32 (95% CI: 170.97,171.68) and 141.50 (95% CI: 141.26, 141.79) for BNM and M3, respectively. The two adjusted CE ratios were significantly different (p < 0.001). CONCLUSION: The application of M3 for severe TBI was more cost-effective than BNM. All calculations were made at 3.8 Malaysian Ringgit (MYR) to the United States dollar (USD).	Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia; Univ Sains Malaysia, Sch Med Sci, Dept Community Med, Kubang Kerian 16150, Kelantan, Malaysia; Natl Univ, Fac Med, Dept Community Hlth, Bangi, Malaysia	Abdullah, JM (corresponding author), Univ Sains Malaysia, Hosp Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Univ Sains Malaysia Hlth Campus, Kubang Kerian 16150, Kelantan, Malaysia.	deptneurosciencesppspusm@yahoo.com	Abdullah, Mazlan/AAD-9128-2019; Aljunid, Syed/J-6009-2014; Ibrahim, Mohd Ismail/C-8347-2016; Abdullah, J/C-2828-2011	Aljunid, Syed/0000-0002-0380-1335; Ibrahim, Mohd Ismail/0000-0002-5470-4180; Abdullah, J/0000-0002-0258-7410			AHMAD TJ, 2002, NCD MALAYSIA, V2, P29; ASHELY MJ, 1990, J INSURANCE MED, V22, P230; ASHLEY MJ, 1990, J INSURANCE MED, V22, P156; CHAN KH, 1993, NEUROSURGERY, V32, P547; Cormio M, 2001, J NEUROSURG ANESTH, V13, P250, DOI 10.1097/00008506-200107000-00014; Hlatky Roman, 2002, Curr Opin Anaesthesiol, V15, P489, DOI 10.1097/00001503-200210000-00003; KELVIN KWY, 2002, ACCIDENT ANAL PREV, V4, P12; Kirkpatrick PJ, 1996, NEUROSURGERY, V39, P714, DOI 10.1097/00006123-199610000-00013; LOEWEN SC, 1989, PHYS THER, V69, P780; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; MAHONEY F I, 1965, Md State Med J, V14, P61; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; Merican M I, 2004, Med J Malaysia, V59, P84; Miller J D, 1994, Neurosurg Clin N Am, V5, P661; Miller JI, 1998, ACT NEUR S, V71, P82; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Murray A, 1998, ACCIDENT ANAL PREV, V30, P169, DOI 10.1016/S0001-4575(97)00088-2; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; MURRAY CJL, 1999, GLOBAL BURDEN DIS IN, V1, P29; Neter John., 2004, APPL LINEAR STAT MOD; NEWLON PG, 1984, J TRAUMA, V24, P61, DOI 10.1097/00005373-198401000-00010; RUWAIDA I, 2003, NEUROSURG FOCUS, V15, P1; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Tan H, 2001, Chin J Traumatol, V4, P156; Vigue B, 1999, INTENS CARE MED, V25, P1477, DOI 10.1007/s001340051107; Waran V, 2000, BRIT J NEUROSURG, V14, P469; White H, 2002, CAN J ANAESTH, V49, P623, DOI 10.1007/BF03017393	29	11	11	0	0	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1015-9584	0219-3108		ASIAN J SURG	Asian J. Surg.	OCT	2007	30	4					261	266		10.1016/S1015-9584(08)60036-6			6	Surgery	Surgery	227WX	WOS:000250689600006	17962129				2021-06-18	
J	Morgan, AT; Liegeois, F; Occomore, L				Morgan, A. T.; Liegeois, F.; Occomore, L.			Electropalatography treatment for articulation impairment in children with dysarthria post-traumatic brain injury	BRAIN INJURY			English	Article						speech; brain injury; paediatric; dysarthria; electropalatography; intervention	PALATE CONTACT; EPG; REMEDIATION; ADOLESCENTS; CHILDHOOD; SPEAKERS	Primary objective: Dysarthria with severe articulatory impairment is a common and debilitating sequelae following severe traumatic brain injury ( TBI). Eectropalatography ( EPG) is an instrumental treatment technique allowing visual feedback of tongue to palate movement during real time articulation. The present study investigated the effectiveness of EPG in treating the articulatory component of dysarthria post-TBI. Study design/ methods: The articulatory component of dysarthria post-TBI was treated once per week with EPG over a 10-week period in three adolescents ( aged 14 years 10 months-15 years 1 month). A multiple case series ABA treatment design was used. Perceptual ( articulation, intelligibility) and EPG ( spatial, durational) assessments were conducted pre- and post-treatment to determine outcome. Results/ discussion: Perceptual improvement was noted for phoneme precision and length. Spatial EPG measures confirmed increased precision of phoneme production. No clear pattern of change for phoneme duration occurred. Intelligibility increased at word and sentence level, with little change reported in everyday speech intelligibility. Conclusion: This preliminary study indicates that EPG treatment may be effective for improving speech at the isolated phoneme, word or sentence level of articulation. These preliminary results are encouraging, being the first study to report speech changes post-treatment in participants with severe TBI and persistent dysarthria. Further research is required, however, in order to understand the regenerative capacity of articulatory function post-brain injury and to determine optimal treatment parameters for achieving generalization of therapy to everyday connected speech.	UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London, England; Childrens Trust Paediat Rehabil Ctr, Surrey, England	Morgan, AT (corresponding author), Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.	angela.morgan@mcri.edu.au	Occomore-Kent, Louise/AAI-9298-2021; Liegeois, Frederique/A-6351-2009; Morgan, Angela/J-5235-2017	Occomore-Kent, Louise/0000-0002-6212-5461; Morgan, Angela/0000-0003-1147-7405; Liegeois, Frederique/0000-0002-8640-6217			BARRY RM, 1989, CLIN LINGUIST PHONET, V3, P81, DOI 10.3109/02699208908985273; BYRD D, 1995, J SPEECH HEAR RES, V38, P821, DOI 10.1044/jshr.3804.821; Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; CAHILL LM, 2002, J MED SPEECH-LANG PA, V8, P347; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Cheng HY, 2007, J SPEECH LANG HEAR R, V50, P375, DOI 10.1044/1092-4388(2007/027); COSTEFF H, 1985, SCAND J REHABIL MED, P10; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; DAGENAIS PA, 1995, J COMMUN DISORD, V28, P303, DOI 10.1016/0021-9924(95)00059-1; DAGENAIS PA, 1994, AM J SPEECH-LANG PAT, V3, P67, DOI DOI 10.1044/1058-0360.0303.67; Darley F., 1975, MOTOR SPEECH DISORDE; DENT H, 1995, EUR J DISORDER COMM, V30, P264; DENT H, 1992, INTERDISCIPLINARY PE, P211; Duffy JR, 2019, MOTOR SPEECH DISORDE; FARNETANI E, 1991, QUADERNI CTR STUDIO, V10, P117; Gibbon FE, 2003, CLIN LINGUIST PHONET, V17, P365, DOI 10.1080/0269920031000079976; Goldman R., 2000, GOLDMAN FRISTOE TEST; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Goozee JV, 2003, J MED SPEECH-LANG PA, V11, P115; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; Hartelius L, 2005, J MED SPEECH-LANG PA, V13, P189; HOWARD S, 1995, EUR J DISORDER COMM, V30, P246; Ladefoged P., 2001, COURSE PHONETICS; McAuliffe M J, 2001, Logoped Phoniatr Vocol, V26, P165, DOI 10.1080/14015430127770; McAuliffe MJ, 2003, CLIN LINGUIST PHONET, V17, P43, DOI 10.1080/0269920021000066846; MORGANBARRY RA, 1995, EUR J DISORDER COMM, V30, P256; Rosenbeck JC, 1991, CLIN MANAGEMENT NEUR, P97; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Theodoros DG, 2001, TRAUMATIC BRAIN INJU, P155; TITZE IR, 1993, J SPEECH HEAR RES, V36, P1177, DOI 10.1044/jshr.3606.1177; van Mourik M, 1997, PEDIATR NEUROL, V17, P299; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; WELLS JC, 1997, WHAT ESTUARY ENGLISH, V3, P46; Weschler D., 1999, WESCHLER ABBREVIATED; Wilcox K. A., 1999, CHILDRENS SPEECH INT; WOOD S, 1999, ACQUIRED NEUROGENIC, P203; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston K. M., 1996, AM J SPEECH-LANG PAT, V5, P55, DOI [DOI 10.1044/1058-0360.0501.55, 10.1044/ 1058-0360.0501.55]; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; ZIEGLER W, 1989, APHASIOLOGY, V3, P449, DOI 10.1080/02687038908249006	44	11	11	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1183	1193		10.1080/02699050701649573			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900010	17896211				2021-06-18	
J	Tessier, C; Weill-Chounlamountry, A; Michelot, N; Pradat-Diehl, P				Tessier, Catherine; Weill-Chounlamountry, Agnes; Michelot, Nadine; Pradat-Diehl, Pascale			Rehabilitation of word deafness due to auditory analysis disorder	BRAIN INJURY			English	Article						aphasia; cognitive rehabilitation; traumatic brain injury; stroke; disability	SUBCORTICAL LESIONS; APHASIA; COMPREHENSION; RECOGNITION; MODULARITY; ERRORLESS; THERAPY; NEGLECT; PATIENT; STROKE	Background: Word deafness refers to an inability to understand spoken words despite intact hearing. In a cognitive approach, word deafness could be explained by a deficiency at the lower perceptive level of the auditory process. The impairment of the auditory analysis system would explain a disorder of identification of speech sounds. Only few studies addressed rehabilitation of central auditory processing and have described therapy focused on phoneme discrimination. Objective: To determine whether a specific auditory analysis rehabilitation addressing phoneme discrimination and phoneme recognition may improve oral comprehension and communication. Method: A single-case experimental design was used in a 65 year-old woman, with word deafness consecutive to a cerebral infarction which occurred 10 months before. Verbal naming, written expression and written comprehension were normal. Verbal comprehension, repetition and phoneme discrimination and recognition were impaired. In terms of cognitive model of auditory processing, the patient showed impairment of the auditory analysis system affecting verbal comprehension. A computerized rehabilitation of auditory analysis system was carried out in two consecutive tasks: phoneme discrimination and phoneme recognition. Errorless learning therapy was used, with a difficulty hierarchy practised from the easier to the most difficult phoneme and systematic visual cues which were progressively delayed and suppressed. This study tested the efficacy and the specificity of this therapy on the addressed tasks ( phoneme discrimination and recognition), related tasks ( oral comprehension and repetition), independent tasks ( recognition of environmental sounds) and daily life ( questionnaire). Results: The phoneme discrimination and recognition impairment was stable over 4 months before therapy. After therapy, phoneme discrimination ( p< 0.001) and phoneme recognition ( p< 0.0001) were improved. The improvement was specific to verbal sounds recognition, while non-verbal sounds recognition was unchanged. An improvement occurred for repetition ( p< 0.05) and oral comprehension ( p< 0.01). The communication disability decreased ( p< 0.05). Conclusion: In a case of word deafness, this study demonstrates not only the efficacy of a specific phoneme processing therapy but also its efficacy in the improvement of higher level of cognitive treatment such as oral comprehension and its transfer in daily life. The role of errorless therapy using systematic visual cues and difficulty hierarchy must be underlined.	Grp Hop Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; UPMC, INSERM, U731, F-75013 Paris, France	Pradat-Diehl, P (corresponding author), Pr Perrigot Hop Salpetriere, Serv Med Phys & Readaptat, 47-83 Blvd Hop, F-75651 Paris, France.	pascale.pradat@psl.aphp.fr	Weill-Chounlamountry, Agnes/D-2870-2011	Weill-Chounlamountry, Agnes/0000-0001-6844-5979			AUERBACH SH, 1982, BRAIN, V105, P271, DOI 10.1093/brain/105.2.271; BADDELEY A, 1993, NEUROPSYCHOL REHABIL, V3, P235, DOI 10.1080/09602019308401438; Baddeley A. D., 1986, WORKING MEMORY; BEHRMANN M, 1995, NEUROPSYCHOL REHABIL, V5, P149, DOI 10.1080/09602019508520179; BLUMSTEIN SE, 1977, NEUROPSYCHOLOGIA, V15, P19, DOI 10.1016/0028-3932(77)90111-7; CARAMAZZA A, 1993, NEUROPSYCHOL REHABIL, V3, P217, DOI 10.1080/09602019308401437; DARRIGRAND B, 2000, APHASIE REEDUCATION, P88; DARRIGRAND B, 2000, ECHELLE COMMUNICATIO; DUCARNE B, 1992, GLOSSA, V30, P10; DUCARNE B, 1989, EXAMEN APHASIE; DUCARNE B, 1986, REEDUCATION SEMIOLOG; ELLIS AW, 1994, COGNITIVE NEUROPSYCH, P287; EUSTACHE F, 1993, REV NEUROPSYCHOL, V3, P353; FILLINGHAM J, 2006, NEUROPSYCHOLGICAL RE, V16, P29; Fillingham JK, 2003, NEUROPSYCHOL REHABIL, V13, P337, DOI 10.1080/09602010343000020; FRANKLIN S, 1989, APHASIOLOGY, V3, P189, DOI 10.1080/02687038908248991; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; Griffiths TD, 1999, NEUROCASE, V5, P365, DOI 10.1080/13554799908402733; Griffiths TD, 2002, CURR OPIN NEUROL, V15, P31, DOI 10.1097/00019052-200202000-00006; Jacquemot C., 2002, CORTEX, V38, P869, DOI DOI 10.1016/S0010-9452(08)70059-5; Komatsu S, 2000, NEUROPSYCHOL REHABIL, V10, P113, DOI 10.1080/096020100389200; LADAVAS E, 1994, COGN NEUROPSYCHOL, V11, P75, DOI 10.1080/02643299408251967; LECOURS AR, 1979, REEDUCATION TROUBLES, P578; Maneta A, 2001, INT J LANG COMM DIS, V36, P91, DOI 10.1080/13682820150217581; Martin P, 2006, BRAIN LANG, V97, P214, DOI 10.1016/j.bandl.2005.10.009; Martin RC, 1999, BRAIN LANG, V70, P437, DOI 10.1006/brln.1999.2184; MITCHUM CC, 1995, NEUROPSYCHOL REHABIL, V5, P1, DOI 10.1080/09602019508520173; Morris J, 1996, APHASIOLOGY, V10, P137, DOI 10.1080/02687039608248402; Musiek Frank E, 2004, J Am Acad Audiol, V15, P133, DOI 10.3766/jaaa.15.2.4; Pedersen PM, 2004, CEREBROVASC DIS, V17, P35, DOI 10.1159/000073896; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Pinard M, 2002, NEUROCASE, V8, P40, DOI 10.1093/neucas/8.1.40; Polster MR, 1998, CORTEX, V34, P47, DOI 10.1016/S0010-9452(08)70736-6; PRAAMSTRA P, 1991, BRAIN, V114, P1197, DOI 10.1093/brain/114.3.1197; PRADATDIEHL P, 1998, SYNDROMES NEGLIGENCE, P235; Riley GA, 2000, NEUROPSYCHOL REHABIL, V10, P133, DOI 10.1080/096020100389219; ROBERTSON IH, 1990, ARCH PHYS MED REHAB, V71, P663; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P172, DOI 10.1044/jslhr.4101.172; SHINDO M, 1991, BRAIN LANG, V40, P301; Shivashankar N, 2001, CLIN NEUROL NEUROSUR, V103, P201, DOI 10.1016/S0303-8467(01)00136-6; Tanaka Y, 2002, CORTEX, V38, P69, DOI 10.1016/S0010-9452(08)70639-7; TESSIER C, 2000, ENTRETIENS ORTHOPHON, P39; Vitte E, 2002, NEUROLOGY, V58, P970, DOI 10.1212/WNL.58.6.970; Wee J, 1999, ARCH PHYS MED REHAB, V80, P1106, DOI 10.1016/S0003-9993(99)90069-2; WILSON BA, 1993, NEUROPSYCHOL REHABIL, V3, P1; Wirkowski E, 2006, J EMERG MED, V30, P53, DOI 10.1016/j.jemermed.2005.03.016	46	11	14	8	32	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2007	21	11					1165	1174		10.1080/02699050701559186			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	222WX	WOS:000250329900008	17852097				2021-06-18	
J	Aloni, R; Keren, O; Katz, S				Aloni, R.; Keren, O.; Katz, S.			Sex therapy surrogate partners for individuals with very limited functional ability following traumatic brain injury	SEXUALITY AND DISABILITY			English	Article						Traumatic brain injury; sex rehabilitation; sex therapy; surrogate partner	FAMILY; DAMAGE	The use of surrogate sex therapists for survivors after Traumatic Brain Injury (TBI) who have Very Limited Functional Ability (VLFA) is discussed. It includes the rationale of using surrogate therapy with this population as well as some of the professional and ethical issues that such therapy can evoke. It is suggested that surrogate therapy can provide satisfaction and positive experiences to the restricted lives of some of the VLFA-TBI survivors. The use of surrogate therapy is viewed as a part of the integral rehabilitation process aimed at improving the quality of life and the fulfillment of basic human intimacy needs. Often requiring help in this important area of life, they are not always able to initiate and control emotional behaviors to promote healthy sexual relationship and activity. Surrogate therapy is an activity that can help survivors with TBI monitor and initiate feelings, reactions and motivation in intimate relationships, as well as provide a certain amount of control over their lives. A case study is presented to illustrate the process of sex therapy with a surrogate partner for a VLFA-TBI survivor.	Sexual Private Clin, Tel Aviv, Israel; Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel	Keren, O (corresponding author), Rehabil Pediat Ctr, POB 9117, IL-91090 Jerusalem, Israel.	ofkeren@internet-zahav.net					ALONI R, 2003, SEXUALITY DIFFICULTI, P14; APFELBAUM B, 1977, J SEX RES, V13, P234; ARMSTRONG C, 1991, J REHABIL, V17, P15; COLE M, 1985, BRIT J PSYCHIAT, V147, P337, DOI 10.1192/bjp.147.4.337; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Griffith ER, 1993, SEXUALITY PERSON TRA; Groswasser Z, 1998, J HEAD TRAUMA REHAB, V13, P69, DOI 10.1097/00001199-199802000-00009; JOHNSON W, 1981, SEXUAL ED COUNSELING, P244; Katz DI, 2007, BRAIN INJURY MED PRI, P3; KEREN O, 2000, SISTEMA NERVOSO, V1, P23; Kothari S., 2007, BRAIN INJURY MED PRI, P169; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Masters WH, 1970, HUMAN SEXUAL INADEQU; Oksenberg A, 2000, SLEEP, V23, P953; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Ponsford J., 1995, TRAUMATIC BRAIN INJU; SANDEL ME, 2007, BRAIN INJURY MED, V37, P673; Strauss D, 1991, SEX DISABIL, V9, P49; TEASDALE G, 1974, LANCET, V2, P81; WRIGHT G, 1988, TOTAL REHABILITATION	22	11	11	1	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0146-1044			SEX DISABIL	Sex. Disabil.	SEP	2007	25	3					125	134		10.1007/s11195-007-9047-7			10	Rehabilitation	Rehabilitation	207SM	WOS:000249271400004					2021-06-18	
J	Bansal, V; Fortlage, D; Lee, JG; Hill, LL; Potenza, B; Coimbra, R				Bansal, Vishal; Fortlage, Dale; Lee, Jeanne G.; Hill, Linda L.; Potenza, Bruce; Coimbra, Raul			Significant injury in cruise ship passengers - A case series	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							EPIDEMIOLOGY; FALLS; RISK	Background: The attention placed on cruise ship infectious epidemics has helped create important preventive strategies in improving food handling, sanitation, and overall cruise ship medical care. However, the incidence of serious injury in cruise ship passengers has never been fully described. In 2006, there was an increase in the number of cruise ship passengers receiving medical care at a Level I trauma center. This report provides a case series analysis of eight patients identified as suffering from significant cruise ship-related injuries. Methods: A retrospective, descriptive study design was used. Data on trauma patients transported directly from cruise ships and admitted to a university Level I trauma center in 2003-2006 were reviewed. Results: A total of 2132 patients were admitted as major trauma resuscitations in 2006. Eight were identified as being injured on a major cruise ship compared to an average of 1.7 patients/year in the preceding 3 years. All but one patient was female. Three patients had significant medical comorbidities. All eight patients suffered injuries from falls, five of which were in stairwells. Concussions were the most common injury. Five patients were discharged to home, two to extended rehabilitation facilities, and one died. Conclusions: In this case series, falls were the sole cause of major injury among cruise ship passengers. Improved surveillance and characterization of injuries among cruise ship passengers is needed to inform safety policies and develop programs to prevent passenger injury.	Univ Calif San Diego, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Family & Preventat Med, La Jolla, CA 92093 USA	Coimbra, R (corresponding author), Univ Calif San Diego, Div Trauma Surg Crit Care & Burns, 200 W Arbor Dr 8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			American College of Emergency Physicians, 1996, ANN EMERG MED, V27, P846; Cramer EH, 2006, AM J PREV MED, V30, P252, DOI 10.1016/j.amepre.2005.10.027; DIGIOVANNA T, 1992, ANN EMERG MED, V21, P1476, DOI 10.1016/S0196-0644(05)80065-4; Kannus P, 2007, INJURY, V38, P81, DOI 10.1016/j.injury.2006.08.027; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Koo D, 1996, JAMA-J AM MED ASSOC, V275, P545, DOI 10.1001/jama.275.7.545; Marshall SW, 2005, AM J PREV MED, V28, P95, DOI 10.1016/j.amepre.2004.09.015; Peake DE, 1999, ANN EMERG MED, V33, P67, DOI 10.1016/S0196-0644(99)70419-1; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; SMOCK WS, 1995, J TRAUMA, V38, P489, DOI 10.1097/00005373-199504000-00004	10	11	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	SEP	2007	33	3					219	221		10.1016/j.amepre.2007.05.004			3	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	210JO	WOS:000249452700009	17826583				2021-06-18	
J	Silverberg, ND; Hanks, RA; Mckay, C				Silverberg, Noah D.; Hanks, Robin A.; Mckay, Cherisse			Cognitive estimation in traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						neuropsychological tests; neurobehavioral manifestations; head injuries; closed head injuries; penetrating; cognition; judgment	TESTS	The present study explores the construct and ecological validity of the Biber Cognitive Estimation Test (BCET) in a traumatic brain injury (TBI) sample. Participants completed the BCET in the course of a neuropsychological evaluation at 1-15 years after injury. BCET scores correlated moderately with other standard measures of executive functioning, and contrary to our hypotheses, at least as high with neuropsychological tests with minimal demands on executive functioning. Moreover, partialing out the portion of BCET variance not attributable to executive functioning markedly attenuated the former correlations. With respect to ecological validity, BCET scores did not predict concurrent functional status, as measured by the Disability Rating Scale. By comparison, standard measures of executive functioning strongly correlated with each other, correlated less strongly with nonexecutive functioning measures, and predicted functional status. In conclusion, unlike standard measures of executive functioning, the BCET demonstrated poor construct and ecological validity in TBI patients.	Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; Inst Rehabil, Dept Rehabil Psychol & Neuropsychol, Detroit, MI USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Silverberg, ND (corresponding author), Univ Windsor, Dept Psychol, 173 Chrysler Hall S,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	noahsilverberg@hotmail.com					Axelrod B. N., 1994, ASSESSMENT, V1, P269, DOI DOI 10.1177/107319119400100307; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Brand M, 2003, NEUROPSYCHOLOGIA, V41, P575, DOI 10.1016/S0028-3932(02)00183-5; Bullard SE, 2004, ARCH CLIN NEUROPSYCH, V19, P835, DOI 10.1016/j.acn.2003.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DELIS DC, 2000, CALIFORNIA VERBAL LE; Denckla MB, 1996, DEV NEUROPSYCHOL, V12, P5, DOI 10.1080/87565649609540637; Gillespie DC, 2002, J CLIN EXP NEUROPSYC, V24, P286, DOI 10.1076/jcen.24.3.286.988; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Heaton R., 1993, WISCONSIN CARD SORTI; JACKSON CT, 2002, VALIDATION BIBER COG; Liss M, 2000, J AUTISM DEV DISORD, V30, P613, DOI 10.1023/A:1005699713072; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; *PSYCH CORP, 1997, WECHSL AD INT SCAL; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM., 1985, HALSTEAD REITAN NEUR; SHALLICE T, 1978, CORTEX, V14, P293; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; SHRETLAN DJ, 1992, J CLIN EXP NEUROPSYC, V14, P77	20	11	11	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2007	13	5					898	902		10.1017/S1355617707071135			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	205UQ	WOS:000249140500018	17697421				2021-06-18	
J	Kocaaga, Z; Bal, S; Gurgan, A				Kocaaga, Zehra; Bal, Serpil; Gurgan, Alev			Hemiplegia and heterotopic ossification on the non-paretic extremity: A case report	JOURNAL OF REHABILITATION MEDICINE			English	Article						hemiplegia; stroke; heterotopic ossification	CORD-INJURED PATIENTS; MYOSITIS-OSSIFICANS; BONE-FORMATION	Heterotopic ossification is the formation of new bone in an abnormal location. It is usually seen following central nervous system disorders, including spinal cord injury, traumatic brain injury, encephalitis, and burn and trauma. Heterotopic ossification in post-stroke hemiplegia is rare; the reported incidence is 0.5-1.2%. It usually occurs on the paretic side of hemiplegic patients. We present here a case of post-stroke hemiplegia with heterotopic ossification in the non-paretic limb.	Ataturk Res & Educ Hosp, Dept Phys Med & Rehabil, Izmir, Turkey	Kocaaga, Z (corresponding author), Izmir Ataturk Egitim ve Arastirma Hastanesi, Fizik Tedavi ve Rehabil Klin 2, TR-35280 Izmir, Turkey.	zehrakocaaga@hotmail.com					ACKERMAN LV, 1958, J BONE JOINT SURG AM, V40, P279, DOI 10.2106/00004623-195840020-00004; Bosse A, 1997, Veroff Pathol, V146, P1; Chua KSG, 2003, BRAIN INJURY, V17, P535, DOI 10.1080/0269905021000010104; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P303; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1992, ORTHOPAEDIC REHABILI, P453; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; LAL S, 1989, ARCH PHYS MED REHAB, V70, P387; Lotta S, 2001, SPINAL CORD, V39, P595, DOI 10.1038/sj.sc.3101134; MICHELSSON JE, 1983, CLIN ORTHOP RELAT R, P265; MICHELSSON JE, 1980, J BONE JOINT SURG AM, V62, P811, DOI 10.2106/00004623-198062050-00017; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; Stover SL, 1986, MANAGEMENT SPINAL CO, P284; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407; Warren S B, 1990, Orthop Rev, V19, P603; WHARTON GW, 1970, J BONE JOINT SURG AM, VA 52, P105, DOI 10.2106/00004623-197052010-00010; WHYTE J, 2005, PHYS MED REHABILIATI, V2, P1677; Zeilig G, 2006, ARCH PHYS MED REHAB, V87, P92, DOI 10.1016/j.apmr.2005.07.308	21	11	11	0	0	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUL	2007	39	6					500	502		10.2340/16501977-0086			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	192TR	WOS:000248226400011	17624486	DOAJ Gold			2021-06-18	
J	Mehta, S				Mehta, Sanjay			Neuroimaging for paediatric minor closed head injuries	PAEDIATRICS & CHILD HEALTH			English	Article						clinical decision rules; computed tomography; minor head injuries; neuroimaging	DECISION RULE; COMPUTED-TOMOGRAPHY; CHILDREN; TRAUMA; RISK	It is clear that paediatric minor head injuries are common and that most cases may be observed without neuroimaging. However, with easier access to computed tomography scans, there has been an increase in its use. In the present article, clinical decision rules for neuroimaging of paediatric minor head injuries, such as the Child and Adolescent Trial for Cardiovascular Health (CATCH) study, will be discussed. Risk factors that should trigger concern are persistently low Glasgow coma scale, suspected open or basilar skull fracture, worsening headache, irritability, large and boggy scalp hematomas and dangerous mechanism of injury. An update on recent recommendations and evidence-based changes are provided.	Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, Toronto, ON M5G 2L3, Canada	Mehta, S (corresponding author), Hosp Sick Children, Dept Pediat, Div Pediat Emergency Med, 1220-525 Univ Ave, Toronto, ON M5G 2L3, Canada.	sanjay.mehta@sickkids.ca					Bergman DA, 1999, PEDIATRICS, V104, P1407; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; Dayan PS, 2007, ACAD EMERG MED, V14, P978, DOI 10.1197/j.aem.2007.06.033; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Greenes DS, 2003, ANN EMERG MED, V42, P515, DOI 10.1067/S0196-0644(03)00631-0; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; *PUBL HLTH AG CAN, CHIRRP CAN HOSP INJ; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Thomas KE, 2006, PEDIATR RADIOL, V36, P823, DOI 10.1007/s00247-006-0170-x	12	11	11	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1205-7088	1918-1485		PAED CHILD HEALT-CAN	Paediatr. Child Health	JUL-AUG	2007	12	6					482	484		10.1093/pch/12.6.482			3	Pediatrics	Pediatrics	281QC	WOS:000254512500011	19030413	Bronze, Green Published			2021-06-18	
J	Reiter, PD; Valuck, RJ; Taylor, RS				Reiter, Pamela D.; Valuck, Robert J.; Taylor, Rustorl S.			Evaluation of off-label recombinant activated factor VII for multiple indications in children	CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS			English	Article						NovoSeven; recombinant activated factor VII; bleeding; child	GLANZMANN THROMBASTHENIA; CARDIAC-SURGERY; COAGULOPATHY; TRANSFUSION; INFECTIONS; MANAGEMENT; HEMORRHAGE	Despite a paucity of safety and efficacy data, the use of recombinant activated factor VII in children for off-label indications has now surpassed its use in hemophilia. A retrospective chart review was conducted of 46 subjects (age, 6.7 +/- 6 years; weight, 26 20 kg) who received recombinant activated factor VII for nonhemophiliac indications between January 1, 2004, and September 1, 2005. Indications for use included prevention (n = 6) or treatment (n = 40) of bleeding due to general surgery, hepatic failure, gastrointestinal bleeding, severe traumatic brain injury, bone marrow transplant, cardiac, acetaminophen overdose, and multiorgan system failure. Decreases in prothrombin time, partial thromboplastin time, and international normalized ratio were observed. No inappropriate thrombotic events were noted. Administration of recombinant activated factor VII was associated with a reduction in coagulation markers without obvious adverse thrombotic events at cost of $4189 per dose. These findings should be confirmed in a prospective trial.	Childrens Hosp, Pediat ICU & Trauma, Denver, CO 80218 USA; Univ Colorado, Denver, CO 80262 USA; Sch Pharm, Hlth Sci Ctr, Denver, CO 80262 USA; Christus Santa Rosa Hosp, Dept Pharm, San Antonio, TX USA	Reiter, PD (corresponding author), Ctr Pediat Med, Dept Pharm, PharmD 1056 E 19th Ave,Campus Box 375, Denver, CO 80218 USA.	reiter.pam@tchden.org					Almeida AM, 2003, BRIT J HAEMATOL, V121, P477, DOI 10.1046/j.1365-2141.2003.04286.x; Blatt J, 2001, BONE MARROW TRANSPL, V28, P405, DOI 10.1038/sj.bmt.1703157; Brown JB, 2003, J PEDIATR GASTR NUTR, V37, P268, DOI 10.1097/00005176-200309000-00013; Cetin H, 2006, BLOOD COAGUL FIBRIN, V17, P213, DOI 10.1097/01.mbc.0000220245.20036.2d; Chuansumrit A, 2004, BLOOD COAGUL FIBRIN, V15, P335, DOI 10.1097/00001721-200406000-00008; CULIC S, 2006, PEDIATR BLOOD C 0302; Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138; Egan JR, 2004, INTENS CARE MED, V30, P682, DOI 10.1007/s00134-003-2108-1; Hennewig U, 2005, KLIN PADIATR, V217, P365, DOI 10.1055/s-2005-872523; Kalicinski P, 2005, PEDIATR TRANSPLANT, V9, P299, DOI 10.1111/j.1399-3046.2005.00309.x; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Pychynska-Pokorska Magdalena, 2004, Pediatr Crit Care Med, V5, P246, DOI 10.1097/01.PCC.0000123546.78900.67; Razon Y, 2005, PEDIATR ANESTH, V15, P235, DOI 10.1111/j.1460-9592.2005.01429.x; SHANDER A, 2005, PHARMACOL THERAPEUT, V30, P644; Stein DM, 2005, J TRAUMA, V59, P609, DOI 10.1097/01.ta.0000177655.67763.df; Tancabelic J, 2004, PEDIATR BLOOD CANCER, V43, P170, DOI 10.1002/pbc.20078; Taylor RW, 2006, CRIT CARE MED, V34, P2302, DOI 10.1097/01.CCM.0000234034.51040.7F; Tobias JD, 2003, SOUTH MED J, V96, P12, DOI 10.1097/01.SMJ.0000047629.79538.82; Tobias Joseph D, 2003, Pediatr Crit Care Med, V4, P49, DOI 10.1097/00130478-200301000-00009; Veldman A, 2002, INTENS CARE MED, V28, P1635, DOI 10.1007/s00134-002-1489-x; Yilmaz BT, 2005, PEDIATR CARDIOL, V26, P843, DOI 10.1007/s00246-004-0919-7	22	11	11	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1076-0296			CLIN APPL THROMB-HEM	Clin. Appl. Thromb.-Hemost.	JUL	2007	13	3					233	240		10.1177/1076029607302402			8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	184XG	WOS:000247675300001	17636185	Bronze			2021-06-18	
J	Yi, JH; Herrero, R; Chen, G; Hazell, AS				Yi, Jae-Hyuk; Herrero, Raquel; Chen, Gang; Hazell, Alan S.			Glutamate transporter EAAT4 is increased in hippocampal astrocytes following lateral fluid-percussion injury in the rat	BRAIN RESEARCH			English	Article						traumatic brain injury; glutamate transporter; EAAT4; excitotoxicity; astrocyte; fluid-percussion; brain trauma	PURKINJE-CELL VULNERABILITY; TRAUMATIC BRAIN-INJURY; GATED CHLORIDE CHANNEL; EXPRESSION; GLT-1; LOCALIZATION; CEREBELLUM; PROTEINS; GLAST; MILD	Functional impairment of glutamate transporters contributes to excitotoxic damage and exacerbation of injury in certain neurodegenerative disorders. Several high-affinity sodium-dependent glutamate transporters have been cloned thus far. Of these, EAAT4 is abundantly expressed in Purkinje cells of the cerebellum in rats. However, little is currently known regarding levels of EAAT4 following traumatic brain injury (TBI). In this study, EAAT4 changes were examined for up to 7 days after moderate fluid-percussion by immunoblotting and immunohistochemistry. TBI caused a 20% and 25% increase in EAAT4 levels in the injured hippocampus at day 3 and day 7 following the insult. Immunohistochemical analysis revealed this increase to be localized in cells exhibiting morphological characteristics of astrocytes. In addition, increased EAAT4 immunoreactivity was observed in astrocytes in the ipsilateral cortex and cerebellum at day 3 post-injury that persisted up to 7 days after the insult. Given the reported novel characteristics of chloride conductance displayed by this transporter, our findings of increased EAAT4 levels suggest this protein may play an important role in the pathophysiology of TBI. (C) 2007 Elsevier B.V. All rights reserved.	Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Hazell, AS (corresponding author), CHUM, Hop St Luc, NeuroRescu Lab, 1058 St Denis, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca		Herrero, Raquel/0000-0001-8789-0904			Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; Hu WH, 2003, GLIA, V44, P13, DOI 10.1002/glia.10268; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lin CLG, 1998, MOL BRAIN RES, V63, P174, DOI 10.1016/S0169-328X(98)00256-3; Nagao S, 1997, NEUROSCIENCE, V78, P929; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; PAXINOS G, 1998, RAT BRAIN STEREOTAXI; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Ward MM, 2004, CELL TISSUE RES, V315, P305, DOI 10.1007/s00441-003-0849-3; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099	23	11	12	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 18	2007	1154						200	205		10.1016/j.brainres.2007.04.011			6	Neurosciences	Neurosciences & Neurology	187OK	WOS:000247857400022	17490622				2021-06-18	
J	Corneli, G; Gasco, V; Prodam, F; Grottoli, S; Aimaretti, G; Ghigo, E				Corneli, Ginevra; Gasco, Valentina; Prodam, Flavia; Grottoli, Silvia; Aimaretti, Gianluca; Ghigo, Ezio			Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood	PITUITARY			English	Article						growth hormone deficiency; GHRH; ITT	GH-RELEASING HORMONE; TRAUMATIC BRAIN-INJURY; INSULIN TOLERANCE-TEST; BODY-MASS INDEX; GH/IGF-I AXIS; ANTERIOR-PITUITARY DYSFUNCTION; PLUS ARGININE TEST; IGF-I; (GH)-RELEASING HORMONE; STIMULATION TEST	Current guidelines for the diagnosis of adult growth hormone deficiency (GHD) state that the diagnosis must be proven biochemically by provocative testing that is done within the appropriate clinical context. The need for reliance on provocative testing is based on evidence that the evaluation of spontaneous growth hormone (GH) secretion over 24 h and the measurement of IGF-I and IGFBP-3 levels do not distinguish between normal and GHD subjects. Regarding IGF-I, it has been demonstrated that very low levels in patients highly suspected for GHD (i. e., patients with childhood-onset, severe GHD, or with multiple hypopituitarism acquired in adulthood) may be considered definitive evidence for severe GHD obviating the need for provocative tests. However, normal IGF-I levels do not rule out severe GHD and therefore adults suspected for GHD and with normal IGF-I levels must undergo a provocative test of GH secretion. The insulin tolerance test (ITT) is the test of choice, with severe GHD being defined by a GH peak less than 3 mu g/ l, the cut-off that distinguishes normal from GHD adults. The ITT is contraindicated in the presence of ischemic heart disease, seizure disorders, and in the elderly. Other tests are as reliable as the ITT, provided they are used with appropriate cut-off limits. Glucagon stimulation, a classical test, and especially new maximal tests such as GHRH in combination with arginine or GHS (i. e., GHRP-6) have welldefined cut-off limits, are reproducible, are independent of age and gender, and are able to distinguish between normal and GHD subjects. The confounding effect of overweight or obesity on the interpretation of the GH response to provocative tests needs to be considered as the somatotropic response to all stimuli is negatively correlated with body mass index. Appropriate cut-offs for lean, overweight, and obese subjects must be used in order to avoid false-positive diagnoses of severe GHD in obese adults.	[Corneli, Ginevra; Prodam, Flavia; Aimaretti, Gianluca] Amedeo Avogadro Univ, Dept Clin & Expt Med, I-28100 Novara, Italy; [Gasco, Valentina; Grottoli, Silvia; Ghigo, Ezio] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy	Aimaretti, G (corresponding author), Amedeo Avogadro Univ, Dept Clin & Expt Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it		Prodam, Flavia/0000-0001-9660-5335			Abs R, 2003, EUR J ENDOCRINOL, V148, pS3, DOI 10.1530/eje.0.148S003; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J ENDOCRINOL INVEST, V21, P506, DOI 10.1007/BF03347336; Aimaretti G, 2005, ENDOCRIN DEV, V9, P76, DOI 10.1159/000085758; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, HORM RES, V62, P26, DOI 10.1159/000080755; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P247, DOI 10.1007/BF03345381; Aimaretti G, 2001, Pituitary, V4, P129, DOI 10.1023/A:1015306705154; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Aimaretti G, 2002, CLIN ENDOCRINOL, V56, P765, DOI 10.1046/j.1365-2265.2002.01547.x; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; Aimaretti Gianluca, 2004, Pediatr Endocrinol Rev, V2 Suppl 1, P86; Arafah BM, 2001, ENDOCR-RELAT CANCER, V8, P287, DOI 10.1677/erc.0.0080287; Arvat E, 1997, ACTA PAEDIATR, V86, P92; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Baldelli R, 2001, ENDOCRINE, V14, P95, DOI 10.1385/ENDO:14:1:095; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bjork J, 2005, J CLIN ENDOCR METAB, V90, P6048, DOI 10.1210/jc.2005-0304; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Broglio F, 2006, FRONT HORM RES, V35, P102, DOI 10.1159/000094313; Camanni F, 2006, J ENDOCRINOL INVEST, V29, P190, DOI 10.1007/BF03344096; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; Casanueva FF, 1999, TRENDS ENDOCRIN MET, V10, P30, DOI 10.1016/S1043-2760(98)00116-7; Cianfarani S, 2005, J CLIN ENDOCR METAB, V90, P6028, DOI 10.1210/jc.2005-0721; Clasey JL, 2001, J CLIN ENDOCR METAB, V86, P3845, DOI 10.1210/jc.86.8.3845; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cook D M, 2000, Adv Intern Med, V45, P297; Cordido F, 2003, EUR J ENDOCRINOL, V149, P117, DOI 10.1530/eje.0.1490117; Cordido F, 1998, J CLIN ENDOCR METAB, V83, P4350, DOI 10.1210/jc.83.12.4350; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cornelia G, 2003, GROWTH HORM IGF RES, V13, P104, DOI 10.1016/S1096-6374(03)00010-8; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Gasperi M, 1999, J CLIN ENDOCR METAB, V84, P2633, DOI 10.1210/jc.84.8.2633; Gharib Hossein, 2003, Endocr Pract, V9, P64; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; GHIGO E, 1992, METABOLISM, V41, P560, DOI 10.1016/0026-0495(92)90220-5; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Gottero C, 2002, J Endocrinol Invest, V25, P42; Granada ML, 2000, EUR J ENDOCRINOL, V142, P243, DOI 10.1530/eje.0.1420243; Haijma SV, 2005, EUR J ENDOCRINOL, V152, P575, DOI 10.1530/eje.1.01887; Ham JN, 2005, CLIN ENDOCRINOL, V62, P628, DOI 10.1111/j.1365-2265.2005.02272.x; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; HOECK HC, 1995, EUR J ENDOCRINOL, V133, P305, DOI 10.1530/eje.0.1330305; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Iglesias P, 2001, THYROID, V11, P1043, DOI 10.1089/105072501753271734; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; KOPELMAN PG, 1985, CLIN ENDOCRINOL, V23, P87, DOI 10.1111/j.1365-2265.1985.tb00187.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Leal A, 2002, CLIN ENDOCRINOL, V57, P377, DOI 10.1046/j.1365-2265.2002.01623.x; Maccario M, 1999, J ENDOCRINOL INVEST, V22, P424, DOI 10.1007/BF03343585; Maccario M, 2002, ANN ENDOCRINOL-PARIS, V63, P140; Maccario M, 2000, INT J OBESITY, V24, pS96, DOI 10.1038/sj.ijo.0801289; Maccario M, 1997, INT J OBESITY, V21, P27, DOI 10.1038/sj.ijo.0800356; Maghnie M, 2002, J CLIN ENDOCR METAB, V87, P2740, DOI 10.1210/jc.87.6.2740; Maghnie M, 2001, J CLIN ENDOCR METAB, V86, P1574, DOI 10.1210/jc.86.4.1574; Mahajan T, 2000, J CLIN ENDOCR METAB, V85, P1473, DOI 10.1210/jc.85.4.1473; Marzullo P, 2001, J CLIN ENDOCR METAB, V86, P3001, DOI 10.1210/jc.86.7.3001; Masel Brent E, 2005, Pituitary, V8, P263, DOI 10.1007/s11102-006-6052-2; Merriam GR, 2003, ENDOCRINE, V22, P41, DOI 10.1385/ENDO:22:1:41; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Muller EE, 2002, NEUROBIOL AGING, V23, P907, DOI 10.1016/S0197-4580(02)00026-X; *NAT I CLIN EXC, 2006, HUM GROWTH HARM SOM, P64; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, CLIN ENDOCRINOL, V60, P185, DOI 10.1046/j.1365-2265.2003.01955.x; Popovic V, 2003, CLIN ENDOCRINOL, V59, P251, DOI 10.1046/j.1365-2265.2003.01835.x; Popovic V, 2002, J CLIN ENDOCR METAB, V87, P2095, DOI 10.1210/jc.87.5.2095; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Procopio M, 1995, CLIN ENDOCRINOL, V43, P665, DOI 10.1111/j.1365-2265.1995.tb00532.x; Qu XD, 2005, J CLIN ENDOCR METAB, V90, P1563, DOI 10.1210/jc.2004-1450; Ross RJM, 2000, INT J OBESITY, V24, pS92, DOI 10.1038/sj.ijo.0801288; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; THORNER MO, 1998, WILLIAMS TXB ENDOCRI, P165; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000	88	11	12	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	JUN	2007	10	2					141	149		10.1007/s11102-007-0031-0			9	Endocrinology & Metabolism	Endocrinology & Metabolism	250MI	WOS:000252303800006	17429591				2021-06-18	
J	DeGracia, DJ; Kreipke, CW; Kayali, FM; Rafols, JA				DeGracia, Donald J.; Kreipke, Christian W.; Kayali, Foaz M.; Rafols, Jose A.			Brain endothelial HSP-70 stress response coincides with endothelial and pericyte death after brain trauma	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; heat shock response; cell death	HEAT-SHOCK-PROTEIN; CEREBRAL-BLOOD-FLOW; GROWTH-FACTOR; INJURY; EXPRESSION; CELLS; INDUCTION; RATS; HEAT-SHOCK-PROTEIN-70; INHIBITION	Objectives: Our objective was to characterize the heat shock response (HSR) in a model of traumatic brain injury (TBI) and to determine the association of HSR to cell death. Methods: We used immunofluorescent detection of HSP-70 to characterize HSR and TUNEL labeling to determine the pattern of cell death. Results: HSP-70 immunofluorescence revealed a steady increase from 4 to 48 hours following TBI, culminating in a ubiquitous expression with the capillary bed 48 hours post-TBI. TUNEL labeling revealed a small subset of endothelial cell death and a most robust staining of putative pericyte cell death. Discussion: Our results show that while injury causes a detectable stress response, cell death is not a direct consequence of the HSR.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Rafols, JA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	jrafols@med.wayne.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS044100, R01NS039860] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS044100, NS039860] Funding Source: Medline		Armstead WM, 2005, AM J PHYSIOL-HEART C, V289, pH1184, DOI 10.1152/ajpheart.00276.2005; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Da Rocha AB, 2005, J NEUROTRAUM, V22, P966, DOI 10.1089/neu.2005.22.966; DeGracia DJ, 2007, J CEREBR BLOOD F MET, V27, P875, DOI 10.1038/sj.jcbfm.9600388; Dore-Duffy P, 1999, MICROVASC RES, V57, P75, DOI 10.1006/mvre.1998.2112; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Fraser HM, 2006, REPRODUCTION, V132, P589, DOI 10.1530/rep.1.01064; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; *I LAB AN RES COMM, 1996, NIH PUBL; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; KETIS NV, 1988, CANCER RES, V48, P2101; KREIPKE CW, 2007, NEUROL RES, V29; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; Lindsberg PJ, 1996, J CEREBR BLOOD F MET, V16, P82, DOI 10.1097/00004647-199601000-00010; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Pickard JD, 2005, ACT NEUR S, V95, P459; Planas AM, 1997, PROG NEUROBIOL, V51, P607, DOI 10.1016/S0301-0082(97)00004-X; Portig I, 1996, ELECTROPHORESIS, V17, P803, DOI 10.1002/elps.1150170431; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Soti C, 2006, HANDB EXP PHARM, V172, P417; Suzuki H, 1998, SURG NEUROL, V49, P67, DOI 10.1016/S0090-3019(97)98983-7; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wang JH, 1997, AM J PHYSIOL-CELL PH, V272, pC1543; Wong HR, 1996, AM J RESP CELL MOL, V15, P745, DOI 10.1165/ajrcmb.15.6.8969269; Xu LJ, 2006, NEUROBIOL AGING, V27, P562, DOI 10.1016/j.neurobiolaging.2005.09.032; ZHU W, 1994, BIOCHEM BIOPH RES CO, V200, P389, DOI 10.1006/bbrc.1994.1461	36	11	11	0	3	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	JUN	2007	29	4					356	361		10.1179/016164107X204666			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	192PM	WOS:000248214200004	17626730				2021-06-18	
J	Lupi, A; Bertagnoni, G; Salgarello, M; Orsolon, P; Malfatti, V; Zanco, P				Lupi, Andrea; Bertagnoni, Giannettore; Salgarello, Matteo; Orsolon, Piergiuseppe; Malfatti, Veronica; Zanco, Pierluigi			Cerebellar vermis relative hypermetabolism: An almost constant PET finding in an injured brain	CLINICAL NUCLEAR MEDICINE			English	Article						brain FDG metabolism; subcortical structures activation; brain trauma	COGNITIVE EVOKED-POTENTIALS; PERSISTENT VEGETATIVE STATE; HEAD-INJURY; COMA; METABOLISM; PERFUSION; RECOVERY; SPECT	Cortical alterations of brain metabolism, as seen in PET, obviously depend on the nature of the damage (either mechanical, toxic, anoxic, or other). However, some subcortical abnormalities seem to occur rather frequently regardless of the extension, position and cause of the damage. In particular, relative cerebellar vermis activation seems to be frequently encountered. The aim of this work was to determine the incidence of this pattern in a heterogeneous population of brain trauma, and to compare it on a quantitative basis with a group of age-sex matched controls. The case records of this study consist of 58 consecutive patients, 44 males, 14 females, age 14-69 (median 34) 44 traumatic, 8 anoxic, 4 vascular and 2 toxic injuries. In the trauma group, the visualization of the cerebellar vermis was readily appreciable as a consistent majority of cases. In particular, the mean vermis/cerebellum ratio (calculated by appropriate ROI positioning) was 1.26 +/- 0.17 SD (range 0.92-1.82); in the control group the same parameters showed much less dispersion: average 0.92 +/- 0.06, range 0.80-1.10 (P < 0.005). If, on the basis of the normal group data, a cut-off value of 1 is accepted for the v/c ratio, it is noted that 54/57 trauma patients (95%) showed a ratio above this value. In conclusion, a hypermetabolic cerebellar vermis is a common finding in a damaged brain, regardless of the nature of the trauma (probably due to the relative preservation compared with other structures of alternative metabolic pathways), and seems to be the hallmark of the injured brain.	Opsed S Bortolo, Div Nucl Med, I-36100 Vicenza, Italy; Opsed S Bortolo, Div Phys Med, I-36100 Vicenza, Italy	Lupi, A (corresponding author), Opsed S Bortolo, Div Nucl Med, Via M Rodolfi, I-36100 Vicenza, Italy.	andrea.lupi@ulssvicenza.it	Lupi, Andrea/AAI-8661-2020				Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Beuthien-Baumann B, 2003, NUCL MED COMMUN, V24, P643, DOI 10.1097/00006231-200306000-00005; Bonito V, 2002, NEUROL SCI, V23, P131, DOI 10.1007/s100720200040; Claeys KG, 2003, NEUROIMAGE, V20, P840, DOI 10.1016/S1053-8119(03)00366-5; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; Guerit JM, 1997, ACTA NEUROL BELG, V97, P214; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Hattori N, 2004, J NUCL MED, V45, P775; Hattori N, 2003, J NUCL MED, V44, P1709; Holguin JA, 2003, REV NEUROLOGIA, V37, P259; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Matsumura M, 2004, BRAIN RES BULL, V63, P471, DOI 10.1016/j.brainresbull.2004.04.008; McLean SAM, 1999, J CLIN PATHOL, V52, P490, DOI 10.1136/jcp.52.7.490; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Palma V, 1989, Acta Neurol (Napoli), V11, P259; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Plum F, 1975, Ciba Found Symp, P121; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Snedecor G.W., 1989, STAT METHODS, V8th; *SPSS INC STAFF, 1993, SPSS PC PLUS GUID DA; Van Mier HI, 2002, ANN NY ACAD SCI, V978, P334	30	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JUN	2007	32	6					445	451		10.1097/RLU.0b013e3180537621			7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	172FM	WOS:000246789500004	17515750				2021-06-18	
J	Garcia-Molina, A; Roig-Rovira, T; Ensenat-Cantallops, A; Sanchez-Carrion, R; Pico-Azanza, N; Pena-Casanova, J				Garcia-Molina, A.; Roig-Rovira, T.; Ensenat-Cantallops, A.; Sanchez-Carrion, R.; Pico-Azanza, N.; Pena-Casanova, J.			Examination of decision-making processes in patients with traumatic brain injury	NEUROLOGIA			Spanish	Article						traumatic brain injury; decision-making; gambling task; behaviour; knowledge	SOMATIC MARKER HYPOTHESIS; PREFRONTAL CORTEX; GAMBLING TASK; EMOTION; DAMAGE; EPIDEMIOLOGY; PERFORMANCE; DYSFUNCTION; DEFICIT	Introduction. Patients with. moderate or severe traumatic brain injury (TBI) may show impairment in decision-making processes. The Iowa Gambling Task (IGT) has become a widely used neuropsychological research tool to investigate decision-making by simulating real-life decision-making in terms of uncertainty, reward, and punishment. Objective. Investigate decision-making in patients with moderate or severe TBI during performance of the IGT, and study patient's conscious knowledge of the task's reinforcement contingencies (:reward/punishment schedule). Patients and methods. Forty patients with moderate or severe TBI and 30 healthy volunteers participated in the study. Decision-making was evaluated using a computerized version of the IGT. After completing the task, the participants' knowledge of the task was tested. Results. The TBI group had worse performance on the IGT than the control group. They chose more unfavorable cards of the deck than the favorable ones. IGT score differences were observed among TBI patients in relation to level of knowledge of the task. The patients with knowledge of the task's reinforcement contingencies showed better performance, while the patients with scarce knowledge presented worse performance. Conclusions. These results suggest that there is a direct relationship between the knowledge that patients with moderate and serious TBI have regarding the TBI reinforcement contingencies and their performance in the task.	Guttmann UAB, Inst Univ Neurorrehabil, E-08916 Badalona, Barcelona, Spain; Hosp del Mar, IMAS, Secc Neurol Conducta & Demencias, Barcelona, Spain	Roig-Rovira, T (corresponding author), Guttmann UAB, Inst Univ Neurorrehabil, Cami Can Rutin S-N, E-08916 Badalona, Barcelona, Spain.	troig@guttmann.com					Bark R, 2005, PSYCHIAT RES, V134, P131, DOI 10.1016/j.psychres.2004.04.013; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERNABEU M, 1999, REHABILITACION TRAUM; Bowman CH, 2005, BRAIN COGNITION, V57, P21, DOI 10.1016/j.bandc.2004.08.015; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Damasio A., 1994, DESCARTESERROR EMOTI; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Damasio AR, 2003, SER AFFECTIVE SCI, P66; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JUNQUE C, 1998, TRAUMATISMOS CRANEOE; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mesulam MM, 2000, PRINCIPLES BEHAV COG, P1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHOLBERG MM, 2001, COGNITIVE REHABILITA; Stuss D.T., 1986, FRONTAL LOBES; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wilson B. A, 1999, CASE STUDIES NEUROPS; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	38	11	12	0	7	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	MAY	2007	22	4					206	212					7	Clinical Neurology	Neurosciences & Neurology	179DJ	WOS:000247269200002	17492514				2021-06-18	
J	Cummings, JL				Cummings, Jeffrey L.			Involuntary emotional expression disorder: Definition, diagnosis, and measurement scales	CNS SPECTRUMS			English	Article							TRAUMATIC BRAIN-INJURY; PSEUDOBULBAR AFFECT; MULTIPLE-SCLEROSIS; PATHOLOGICAL LAUGHTER; AFFECTIVE LABILITY; NITROUS-OXIDE; PREVALENCE; STROKE; PALSY	Involuntary emotional expression disorder (IEED) is a syndrome in which emotional or affective motor control becomes dysregulated as a result of brain damage from neurological disease or as a result of brain injury. A debilitating disorder with persistent symptoms, IEED has a significant impact upon the lives of patients and caregivers, but is often overlooked or misdiagnosed. IEED is a clinically well-defined disorder, and specific criteria may be used when making a diagnosis. It must be distinguished from depression or other psychological and neurological conditions. Several assessment scales have been validated for use in IEED, in order to evaluate the baseline severity and to track the course of the disorder and response to treatment.	Univ Calif Los Angeles, Alzheimers Dis Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Deane F Johnson Ctr Neurotherapeut, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Cummings, JL (corresponding author), Univ Calif Los Angeles, Alzheimers Dis Ctr, 10911 Weyburn Ave, Los Angeles, CA 90095 USA.	jcummings@mednet.ucla.edu					Adams R. D., 1997, PRINCIPLES NEUROLOGY; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Arciniegas DB, 2005, CNS SPECTRUMS, V10, P1, DOI 10.1017/S1092852900026602; BERKOVIC SF, 1999, MOVEMENT DISORDERS N; BESSON G, 1991, ARCH NEUROL-CHICAGO, V48, P501, DOI 10.1001/archneur.1991.00530170061021; BLEULER E, 1950, DEMENTIA PRAECOX; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Darwin C, 1872, EXPRESSION EMOTIONS; DEFENDORF AR, 1904, CLIN PSYCHIAT TXB AB; DUCHOWNY MS, 1983, HDB HUMAN RES, V2; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; Finger S, 1998, ARCH NEUROL-CHICAGO, V55, P241, DOI 10.1001/archneur.55.2.241; GOPINATH SP, 1993, CLIN PEDIATR, V32, P126, DOI 10.1177/000992289303200215; GREEN RL, 1987, AM J PSYCHIAT, V144, P442; Green RL, 1998, SEMIN CLIN NEUROPSYC, V3, P195; HARRIS L, 1974, J PSYCHEDEL DRUG, V6, P29, DOI 10.1080/02791072.1974.10471502; HARVEY PD, 1989, J CLIN PSYCHOL, V45, P786, DOI 10.1002/1097-4679(198909)45:5<786::AID-JCLP2270450515>3.0.CO;2-P; Haupt M, 1996, Int Psychogeriatr, V8 Suppl 3, P409; James W., 1890, PRINCIPLES PSYCHOL; James W, 1882, MIND, V7, P186; JAY V, 1991, NEUROLOGY, V41, P416, DOI 10.1212/WNL.41.3.416; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; LADER M, 1987, TXB MED TREATMENT, P285; Langworthy OR, 1940, ARCH INTERN MED, V65, P106, DOI 10.1001/archinte.1940.00190070116008; Lauterbach EC, 1997, J NEUROPSYCH CLIN N, V9, P259; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; Mendez MF, 2005, J NEUROPSYCH CLIN N, V17, P429, DOI 10.1176/appi.neuropsych.17.3.429; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; Paus S, 2005, ARCH NEUROL-CHICAGO, V62, P1312, DOI 10.1001/archneur.62.8.1312; POECK K, 1969, DISORDERS EMOTION, P343; RAULIN JM, 1900, RIRE EXILARANTS; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; SETHI PK, 1976, J NEUROL NEUROSUR PS, V39, P823, DOI 10.1136/jnnp.39.9.823; SHAIBANI AT, 1994, NEUROPSY NEUROPSY BE, V7, P243; SIEGEL RK, 1985, J PSYCHOACTIVE DRUGS, V17, P87, DOI 10.1080/02791072.1985.10472327; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; Smith RA, 2004, AMYOTROPH LATERAL SC, V5, P99, DOI 10.1080/17434470410020058; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Stearns FR, 1972, LAUGHING PHYSL PATHO; STEINBERG H, 1956, BRIT J PSYCHOL, V47, P183, DOI 10.1111/j.2044-8295.1956.tb00581.x; Stoll WA, 1947, SCHWEIZ ARCH NEUROL, V60, P279; STRUB AL, 1988, NEUROBEHAVIOURAL DIS; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Tsai WC, 1998, SCAND J REHABIL MED, V30, P145; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; PSEUDOBULBAR AFFECT; LIVING IEED	56	11	12	0	2	M B L COMMUNICATIONS, INC	NEW YORK	333 HUDSON ST, 7TH FLOOR, NEW YORK, NY 10013 USA	1092-8529			CNS SPECTRUMS	CNS Spectr.	APR	2007	12	4		5			11	16					6	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	170WT	WOS:000246697600003	17426670				2021-06-18	
J	Driver, SJ				Driver, Simon J.			Psychometric properties and analysis of the physical activity social influence scale for adults with traumatic brain injuries	ADAPTED PHYSICAL ACTIVITY QUARTERLY			English	Article							MULTIDIMENSIONAL SCALE; CAREGIVER BURDEN; SUPPORT; INDIVIDUALS; EFFICACY; PEOPLE; PREDICTORS; BEHAVIORS; NETWORKS; AQUATICS	The study consisted of (a) assessing the validity and reliability of the Social Influence Scale (SIS) for adults with brain injuries and (b) examining the types and sources of social influence and demographic variables that affect participants' physical activity behaviors. Three confirmatory factor analyses, intraclass correlations, and a repeated measures MANOVA were completed on responses from 402 adults with brain injuries. Results provide evidence of the validity and reliability of the SIS, and post hoc analyses revealed that participants reported receiving different types of social influence from family, friends, and caregivers. Findings have implications for specialists and suggestions are provided on ways to enhance the physical activity participation of adults with brain injuries.	Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	Driver, SJ (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA.			driver, simon/0000-0003-2356-432X			Alcock JE, 1991, TXB SOCIAL PSYCHOL; ARMSTRONG C, 1991, J REHABIL, V57, P15; Bandura A., 1986, SOCIAL FDN THOUGHT A; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Berkhuysen MA, 1999, PATIENT EDUC COUNS, V38, P21, DOI 10.1016/S0738-3991(98)00115-3; BRUSTAD RJ, 2003, DEV SPORT EXERCISE P, P145; Chogahara M, 1998, J AGING PHYS ACTIV, V6, P1, DOI 10.1123/japa.6.1.1; Chogahara M, 1999, J GERONTOL B-PSYCHOL, V54, pS356, DOI 10.1093/geronb/54B.6.S356; Clarke D E, 1996, J Cardiopulm Rehabil, V16, P372, DOI 10.1097/00008483-199611000-00006; Coakley, 2001, SPORT SOC ISSUES CON; Cohen J, 1988, STAT ANAL BEHAV SCI; CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297; Cutrona C. E., 1990, SOCIAL SUPPORT INTER, P319, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Cutrona CE., 1987, ADV PERSONAL RELATIO, V1, P37; Driver S, 2006, ADAPT PHYS ACT Q, V23, P148, DOI 10.1123/apaq.23.2.148; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2006, ADAPT PHYS ACT Q, V23, P1; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; DRIVER S, 2003, J COGNITIVE REHABILI, V21, P26; DUNCAN TE, 1993, J APPL SOC PSYCHOL, V23, P1498, DOI 10.1111/j.1559-1816.1993.tb01045.x; DUNCAN TE, 1993, J BEHAV MED, V16, P199, DOI 10.1007/BF00844893; Eyler AA, 1999, SOC SCI MED, V49, P781, DOI 10.1016/S0277-9536(99)00137-9; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; HAGAN C, 1979, REHABILITATION HEAD; Harter S., 1987, CONT TOPICS DEV PSYC, P219; Holosko M, 1989, CANADIAN J REHABILIT, V2, P145; Howell DC, 2001, STAT METHODS PSYCHOL; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Joreskog KG, LISREL 8 STRUCTURAL; KAPLAN SP, 1990, REHABILITATION COUNS, V34, P17; KARPMAN T, 1985, J APPL REHABILITATIO, V17, P28; KENDALL E, 1998, NEUROPSYCHOL REHABIL, V6, P101; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KWAN W, 1995, J LEISURABILITY, V21, P26; Leathem J, 1996, BRAIN INJURY, V10, P27; Litwin H, 2003, J AGING PHYS ACTIV, V11, P389, DOI 10.1123/japa.11.3.389; Loehlin J.C., 1998, LATENT VARIABLE MODE; LOX CL, 2003, PSYCHOL EXERCISE THE; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McAuley E, 2000, PREV MED, V31, P608, DOI 10.1006/pmed.2000.0740; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; *NAT ENV PROT COUN, 1999, NAT ENV PROT MEAS AS, P1; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Potter J. S., 1994, Journal of Leisurability, V21, P34; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; Resnick Barbara, 2002, Clin Nurs Res, V11, P52, DOI 10.1177/1054773802011001005; Ruehlman L. S., 1991, PSYCHOL ASSESSMENT J, V3, P97; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Singer J.E., 1984, HDB PSYCHOL HLTH, P253; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Stuss D.T., 1986, FRONTAL LOBES; Tabachnick B., 2001, USING MULTIVARIATE S; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Udry E, 1997, J SPORT EXERCISE PSY, V19, P71, DOI 10.1123/jsep.19.1.71; *US DEP HHS, 2000, HEALTH PEOPL 2010 UN; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Yun J, 2002, ADAPT PHYS ACT Q, V19, P32, DOI 10.1123/apaq.19.1.32; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	63	11	11	1	6	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0736-5829	1543-2777		ADAPT PHYS ACT Q	Adapt. Phys. Act. Q.	APR	2007	24	2					160	177		10.1123/apaq.24.2.160			18	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	159OU	WOS:000245876500004	17916915				2021-06-18	
J	Edwards, P; Fernandes, J; Roberts, I; Kuppermann, N				Edwards, Phil; Fernandes, Janice; Roberts, Ian; Kuppermann, Nathan			Young men were at risk of becoming lost to follow-up in a cohort of head-injured adults	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Article						clinical trial; follow-up; traumatic brain injury; loss to follow-up; outcome assessment; risk factors	GLASGOW OUTCOME SCALE; CRASH TRIAL; MRC CRASH; QUESTIONNAIRES; ATTRITION	Objective: This study is to identify predictors of loss to follow-up among adults with head injury. Study Design and Setting: A prospective cohort of 1,857 adults enrolled in the Medical Research Council (MRC) CRASH trial known to be alive 2 weeks after head injury. Six-month follow-up was defined as "overdue" if over 6 months late. Patient information collected at enrollment and after 14 days was used to predict overdue follow-up. A random two-thirds of the cohort was analyzed using logistic regression and binary recursive partitioning. The regression model and decision rule derived by recursive partitioning were evaluated using the remaining third. Results: Overdue follow-up was more likely in patients aged 25-34 years (odds ratio, 1.76; 95% confidence interval [CI] = 1.18-2.62), victims of assault (1.63; 1.09-2.45), patients independent after 2 weeks (1.79; 1.18-2.72) and patients for whom postcodes (2.36; 1.65-3.39), telephone numbers (1.82; 1.19-2.79) or general practitioners (1.67; 1.16-2.39) were unknown. Binary recursive partitioning specifically identified males aged younger than 43 years to be at risk. Conclusion: Successful follow-up in head-injury studies requires patients' postcodes and telephone numbers to be available. Young men remain at risk of becoming lost to follow-up, presenting a challenge for researchers aiming for complete data. (C) 2007 Elsevier Inc. All rights reserved.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, CRASH Trials Coordinating Ctr, London WC1E 7HT, England; Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; Univ Calif Davis, Sch Med, Dept Paediat, Davis, CA 95616 USA	Edwards, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, CRASH Trials Coordinating Ctr, Keppel St, London WC1E 7HT, England.	phil.edwards@LSHTM.ac.uk		Edwards, Phil/0000-0003-4431-8822			Armstrong B, 1995, MONOGRAPHS EPIDEMIOL, P294; Braet V, 2002, EMERG MED J, V19, P510; BRIEMAN L, 1994, CLASSIFICATION REGRE; Coats TJ, 2005, EMERG MED J, V22, P683, DOI 10.1136/emj.2005.024588; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P213, DOI 10.1016/S0895-4356(01)00472-3; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Edwards P, 2005, J EPIDEMIOL COMMUN H, V59, P987, DOI 10.1136/jech.2005.034397; Edwards P, 2005, LANCET, V365, P1957; Murray CJL., 1996, GLOBAL HLTH STAT COM; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Rothman K., 1998, MODERN EPIDEMIOLOGY, P79; *STAT CORP, 1999, STATACORP STAT STAT; Steinberg D., 1997, CART CLASSIFICATION; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; Weinberger M, 2002, J CLIN EPIDEMIOL, V55, P230, DOI 10.1016/S0895-4356(01)00437-1; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yates D, 1999, J ACCID EMERG MED, V16, P83	18	11	11	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-4356			J CLIN EPIDEMIOL	J. Clin. Epidemiol.	APR	2007	60	4					417	424		10.1016/j.jclinepi.2006.06.021			8	Health Care Sciences & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	148SF	WOS:000245094200015	17346617				2021-06-18	
J	Handel, SF; Ovitt, L; Spiro, JR; Rao, V				Handel, Sharon F.; Ovitt, Linda; Spiro, Jennifer R.; Rao, Vani			Affective disorder and personality change in a patient with traumatic brain injury	PSYCHOSOMATICS			English	Article							PSYCHIATRIC ASPECTS; DEPRESSION; MANAGEMENT		Johns Hosp Sch Med, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD USA; Johns Hopkins Bayview Med Ctr, Brain Injury Clin, Dept Psychiat, Community Psychiat Program, Baltimore, MD USA	Rao, V (corresponding author), Johns Hopkins Univ Hosp, Dept Psychiat & Behav Sci, Div Geriatr Psychiat & Neuropsychiat, 550 N Broadway, Baltimore, MD 21205 USA.	vrao@jhmi.edu					Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Beresford TP, 2005, BRAIN INJURY, V19, P309, DOI 10.1080/02699050410001720121; Deb S, 1999, AM J PSYCHIAT, V156, P374; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kim E, 2002, J NEUROPSYCH CLIN N, V14, P202, DOI 10.1176/appi.neuropsych.14.2.202; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Mustafa B, 2005, J NEUROPSYCH CLIN N, V17, P122, DOI 10.1176/appi.neuropsych.17.1.122; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791	17	11	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	FEB	2007	48	1					67	70		10.1176/appi.psy.48.1.67			4	Psychiatry; Psychology	Psychiatry; Psychology	123RN	WOS:000243313300011	17209153				2021-06-18	
J	Koshinaga, M; Suma, T; Fukushima, M; Tsuboi, I; Aizawa, S; Katayama, Y				Koshinaga, M.; Suma, T.; Fukushima, M.; Tsuboi, I.; Aizawa, S.; Katayama, Y.			Rapid microglial activation induced by traumatic brain injury is independent of blood brain barrier disruption	HISTOLOGY AND HISTOPATHOLOGY			English	Article						microglia; blood brain barrier; brain injury; CR3	SPREADING DEPRESSION; RAT; CELLS; DAMAGE; ASTROCYTES; EXPRESSION; ISCHEMIA; RELEASE	Following CNS injury, microglia respond and transform into reactive species exhibiting characteristic morphological changes that have been termed "activated" or "ameboid" microglia. In an attempt to establish that microglial reactions induced immediately after injury are caused by intrinsic mechanisms rather than infiltration of blood and its constituents, oxygenized Ringer's solution was perfused into the cerebral circulation of rats so that the circulating blood could be eliminated prior to injury induction. Under artificial respiration, a catheter was inserted from the cardiac apex into the ascending aorta, and oxygenized Ringer's solution was immediately perfused with a pulsatile blood pump, resulting in wash out of the circulating blood from the brain within 1 min. Subsequently, a cortical contusion was induced in the unilateral parietal cortex using a controlled cortical impact (CCI) device. At 5 min following the injury, the brain was fixed by perfusion of fixative through the catheter and removed. Coronal vibratome sections were then processed for CR3 immunohistochemistry to examine the microglial activation. It appeared that microglial activation with both morphological transformation and an increase in CR3 immunoreactivity was induced throughout the hemisphere ipsilateral to the injury side exclusively, even in rats with elimination of circulating blood. The microglial reactions did not differ substantially from those observed in the control rats with extensive BBB disruption. The present results thus provide direct evidence that the microglial activation induced immediately after injury is independent of infiltration of circulating blood induced by concurrent BBB disruption.	Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo 1738610, Japan; Nihon Univ, Sch Med, Dept Anat, Tokyo 1738610, Japan	Koshinaga, M (corresponding author), Nihon Univ, Sch Med, Dept Anat & Neurol Surg, 30-1 Oyaguchi Kamimachi, Tokyo 1738610, Japan.	koshimo@med.nihon-u.ac.jp					AKIYAMA H, 1988, J NEUROSCI RES, V20, P147, DOI 10.1002/jnr.490200202; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Caggiano AO, 1996, J COMP NEUROL, V369, P93, DOI 10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Del Rio-Hortega R., 1965, CYTOLOGY CELLULAR PA, P483; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GEHRMANN J, 1992, J CEREBR BLOOD F MET, V12, P257, DOI 10.1038/jcbfm.1992.36; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; HOSSMANN KA, 1973, ARCH NEUROL-CHICAGO, V29, P375, DOI 10.1001/archneur.1973.00490300037004; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; KREUTZBERG GW, 1987, ENCY NEUROSCIENCE, P661; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Maeda T, 1998, J NEUROTRAUM, V15, P655, DOI 10.1089/neu.1998.15.655; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; SHIPLEY MT, 1994, SOC NEUR ABSTR, V365, P4; SUZUMURA A, 1990, J NEUROIMMUNOL, V30, P111, DOI 10.1016/0165-5728(90)90094-4; WALZ W, 1993, J NEUROSCI, V13, P4403	27	11	12	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	FEB	2007	22	2					129	135					7	Cell Biology; Pathology	Cell Biology; Pathology	113CY	WOS:000242576600002	17149685				2021-06-18	
J	Cordeiro, JR; Camelier, A; Oakley, F; Jardim, JR				Cordeiro, Junia R.; Camelier, Aquiles; Oakley, Frances; Jardim, Jose R.			Cross-cultural reproducibility of the Brazilian Portuguese version of the role checklist for persons with chronic obstructive pulmonary disease	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						chronic obstructive pulmonary disease (COPD); culture; role	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; OCCUPATIONAL-THERAPY; TRANSLATION; ADAPTATION; AGREEMENT; PATIENT	OBJECTIVE. This article presents the results of a cross-cultural reproducibility and test-retest reliability study of a Brazilian version of the Role Checklist, in a population with chronic obstructive pulmonary disease (COPD). METHODS. The English version was translated and culturally adapted into Brazilian Portuguese, then administered twice at a 2-week interval to a group of 25 clinically stable individuals with COPD. RESULTS. Cross-cultural adaptation led to adjustments in some terms used in the checklist. Values obtained for kappa suggested mode rate-to-substantial agreement for Part I and Part II. No statistically significant correlations were found between agreement and variables of gender, occupation, marital status, level of education, level of depression, or severity of bronchial obstruction. CONCLUSION. The Brazilian Portuguese version of the Role Checklist was found content valid and reliable for persons with COPD and probably for the Brazilian population in general.	Univ Fed Sao Paulo, Brazil Resp Div, Lar Escola Sao Francisco, BR-04023062 Sao Paulo, Brazil; Univ Fed Sao Paulo, Rehabil Pulm Ctr, Lar Escola Sao Francisco, BR-04023062 Sao Paulo, Brazil; Hosp Israelita Albert Einstein, Occupat Therapy Sect, Sao Paulo, Brazil; NIH, Occupat Therapy Sect, Bethesda, MD 20892 USA	Cordeiro, JR (corresponding author), Univ Fed Sao Paulo, Brazil Resp Div, Lar Escola Sao Francisco, Rua Botucatu 740,3o Andar, BR-04023062 Sao Paulo, Brazil.	juniacordeiro@terra.com.br; joserjardim@yahoo.com.br	Jardim, Jose R/E-3205-2016	Camelier, Aquiles/0000-0001-5410-5180			BAKER F, 1991, SOC SCI MED, V32, P697, DOI 10.1016/0277-9536(91)90149-7; BARRIS R, 1986, OCCUP THER J RES, V6, P301, DOI 10.1177/153944928600600504; BARRIS R, 1988, OCCUPATIONAL THERAPY, V8, P3; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; BAVARO SM, 1991, AM J OCCUP THER, V45, P456, DOI 10.5014/ajot.45.5.456; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Biaggio AMB., 1979, INVENTARIO ANSIEDADE; BRANHOLM IB, 1994, DISABIL REHABIL, V16, P205; Camelier A, 2005, RESP MED, V99, P602, DOI 10.1016/j.rmed.2004.09.022; Camelier Aquiles, 2003, J. Pneumologia, V29, P28, DOI 10.1590/S0102-35862003000100007; Chen S, 2003, PERS SOC PSYCHOL B, V29, P1285, DOI 10.1177/0146167203255226; Colon H, 2002, AM J OCCUP THER, V56, P586, DOI 10.5014/ajot.56.5.586; COPPOLA S, 2000, PULMONARY REHABILITA, P213; Crowe TK, 1997, AM J OCCUP THER, V51, P651, DOI 10.5014/ajot.51.8.651; DICKERSON AE, 1995, AM J OCCUP THER, V49, P221, DOI 10.5014/ajot.49.3.221; DUELLMAN MK, 1986, AM J OCCUP THER, V40, P618, DOI 10.5014/ajot.40.9.618; EBB E W, 1989, Occupational Therapy in Mental Health, V9, P53, DOI 10.1300/J004v09n02_03; EGAN M, 1992, OCCUP THER J RES, V12, P342, DOI 10.1177/153944929201200602; ELLIOTT MS, 1987, OCCUP THER J RES, V7, P215, DOI 10.1177/153944928700700403; Fabbri Leonardo, 2004, COPD, V1, P105; Falcao DD, 2003, J RHEUMATOL, V30, P379; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Fernandez-Castro J, 2002, PSYCHOL REP, V91, P431, DOI 10.2466/PR0.91.6.431-435; Frosch S, 1997, BRAIN INJURY, V11, P891; *GOLD, 2003, POCK GUID DIAGN TREA; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; GUSICH RL, 1984, OCCUPATIONAL THERAPY, V4, P59; Hachey R, 2001, Can J Occup Ther, V68, P112; Hachey R., 1995, OCCUPATIONAL THERAPY, V2, P190, DOI DOI 10.1002/0TI.V2.3; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Hulley SB., 2001, DESIGNING CLIN RES, V3rd; JACOWAY IS, 1987, OCCUPATIONAL THERAPY, V7, P17; Karpinski A, 2004, PERS SOC PSYCHOL B, V30, P22, DOI 10.1177/0146167203258835; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Kusznir A, 1996, CAN J OCCUP THER, V63, P313; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEDERER J M, 1985, Occupational Therapy in Mental Health, V5, P59, DOI 10.1300/J004v05n02_05; Morettin P. A., 2004, ESTATISTICA BASICA; OAKLEY F, 1986, OCCUP THER J RES, V6, P157, DOI 10.1177/153944928600600303; OAKLEY F, 1985, AM J OCCUP THER, V39, P147, DOI 10.5014/ajot.39.3.147; OAKLEY F, 1987, OCCUPATIONAL THERAPY, V7, P215; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; RUST KM, 1987, OCCUPATIONAL THERAPY, V7, P17; SEPIOL JM, 1990, AM J OCCUP THER, V44, P1008, DOI 10.5014/ajot.44.11.1008; SKELTON JA, 1991, MENTAL REPRESENTATIO; SMYNTEK L, 1985, Occupational Therapy in Mental Health, V5, P21, DOI 10.1300/J004v05n01_02; Sousa TC, 2000, J PNEUMOL, V26, P119, DOI DOI 10.1590/S0102-35862000000300004; SOUZA CB, 2003, PSICOL SAUDE DOENCAS, V4, P149; Velloso M, 2003, CHEST, V123, P1047, DOI 10.1378/chest.123.4.1047; WATSON MA, 1991, PHYS OCCUPATIONAL TH, V10, P27, DOI DOI 10.1080/J148V10N01_03; *WHO, 2004, CHRON OBSTR PULM DIS; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609	53	11	11	0	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2007	61	1					33	40		10.5014/ajot.61.1.33			8	Rehabilitation	Rehabilitation	130EM	WOS:000243782300004	17302103				2021-06-18	
B	Donders, J		Hunter, SJ; Donders, J		Donders, Jacobus			Traumatic brain injury	PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE			English	Article; Book Chapter							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; SEROTONIN REUPTAKE INHIBITORS; VERBAL-LEARNING-TEST; LONG-TERM OUTCOMES; EXECUTIVE FUNCTION; PSYCHIATRIC-DISORDERS; FAMILY INTERVENTION; PERSONALITY-CHANGE; CHILDRENS-VERSION									Adelson PD, 2003, CRIT CARE MED, V31, pS418, DOI 10.1097/00003246-200306006-00002; AGRAN PF, 1992, ACCIDENT ANAL PREV, V24, P349, DOI 10.1016/0001-4575(92)90047-M; *AM ED RES ASS, 1999, STAND ED PSYCH TESTS; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Baron I., 2004, NEUROPSYCHOLOGICAL E; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; BIGLER ED, 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Courtney DB, 2004, CAN J PSYCHIAT, V49, P557, DOI 10.1177/070674370404900807; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Delis D, 1994, CALIFORNIA VERBAL LE; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Donders J, 1999, DEV NEUROPSYCHOL, V15, P395, DOI 10.1080/87565649909540757; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Donders J, 2003, J HEAD TRAUMA REHAB, V18, P106, DOI 10.1097/00001199-200303000-00002; Donders J, 2001, CHILD NEUROPSYCHOL, V7, P99, DOI 10.1076/chin.7.2.99.3126; Donders J, 1997, Pediatr Rehabil, V1, P179; Donders J, 2000, J HEAD TRAUMA REHAB, V15, P792, DOI 10.1097/00001199-200004000-00004; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, V2, P166; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Farmer JE, 2002, DEV NEUROPSYCHOL, V22, P455, DOI 10.1207/S15326942DN2202_2; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gil AM, 2003, J SCHOOL PSYCHOL, V41, P337, DOI 10.1016/S0022-4405(03)00085-2; Gioia G.A., 2000, BEHAV RATING INVENTO; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Green LB, 2004, AM J PHYS MED REHAB, V83, P893, DOI 10.1097/01.PHM.0000143400.15346.C8; Hackbarth RM, 2002, CRIT CARE MED, V30, P1630, DOI 10.1097/00003246-200207000-00038; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Holmbeck GN, 2002, J PEDIATR PSYCHOL, V27, P87, DOI 10.1093/jpepsy/27.1.87; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Makaroff KL, 2003, DEV MED CHILD NEUROL, V45, P497, DOI 10.1017/S0012162203000926; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marshall KW, 1998, AM J NEURORADIOL, V19, P1599; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mottram L, 2005, PSYCHOL ASSESSMENT, V17, P212, DOI 10.1037/1040-3590.17.2.212; Nybo T, 2004, J INT NEUROPSYCH SOC, V10, P719, DOI 10.1017/S1355617704105109; Nybo T, 1999, BRAIN INJURY, V13, P759; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Poussaint TY, 2002, NEUROIMAG CLIN N AM, V12, P271, DOI 10.1016/S1052-5149(02)00005-9; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Swift EE, 2003, J DEV BEHAV PEDIATR, V24, P24, DOI 10.1097/00004703-200302000-00007; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Teplicky R, 2005, ARCH PHYS MED REHAB, V86, P924, DOI 10.1016/j.apmr.2004.07.355; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Verger K, 2001, BRAIN INJURY, V15, P211; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; WAALAND PK, 1993, BRAIN INJURY, V7, P135, DOI 10.3109/02699059309008167; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Waters RJ, 2005, CURR OPIN CRIT CARE, V11, P105, DOI 10.1097/01.ccx.0000155354.78617.91; Wechsler D., 2003, WECHSLER INTELLIGENC; Wechsler D., 1991, WECHSLER INTELLIGENC; Weller Elizabeth B, 2005, Curr Psychiatry Rep, V7, P87, DOI 10.1007/s11920-005-0003-x; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wong ICK, 2004, DRUG SAFETY, V27, P991, DOI 10.2165/00002018-200427130-00002; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Yeates KO., 2005, WISC 4 CLIN USE INTE, P415, DOI [10.1016/B978-012564931-5/50014-1, DOI 10.1016/B978-012564931-5/50014-1]; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	141	11	11	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-87550-9				2007							91	111					21	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	BXM34	WOS:000296371600006					2021-06-18	
J	Harvey, AR				Harvey, Alan R.			Combined therapies in the treatment of neurotrauma: Polymers, bridges and gene therapy in visual system repair	NEURODEGENERATIVE DISEASES			English	Article						transplantation; peripheral nerve; growth factors; viral vectors; retinal ganglion cells; ciliary neurotrophic factor; brain-derived neurotrophic factor; optic nerve; optic tract	ADENOASSOCIATED VIRAL VECTORS; GANGLION-CELL SURVIVAL; AXONAL REGENERATION; CNS REPAIR; CNTF; TRANSPLANTATION; RETINA	Background: The mature central nervous system (CNS) has limited capacity for self-renewal and repair after injury or neurodegeneration, and therapeutic strategies are needed to promote the viability of damaged neurons and the regrowth of their axons. The retina and optic nerve (ON) are part of the CNS, and the visual system is widely used in experimental studies on injury and repair. Objective: To test various cellular and molecular approaches in attempts to replace retinal ganglion cells (RGCs) in depleted retinas or, more usually, promote the survival of endogenous injured RGCs and stimulate axonal regeneration after ON or intracranial optic tract (OT) injury. Methods and Results: Intraocular injections of brain-derived neurotrophic factor and ciliary neurotrophic factor (CNTF) temporarily increase RGC survival after ON injury. More sustained neuroprotection is obtained using adeno-associated viral vectors to transfect RGCs with brain-derived neurotrophic factor or CNTF genes. After ON crush, intravitreal adeno-associated viral CNTF injections also increase RGC axonal regrowth. Additional protective and growth effects are obtained after intraocular elevation of cAMP and by manipulation of protein kinase signalling pathways in RGCs. Regeneration is increased by transplanting a segment of peripheral nerve onto the cut ON. Schwann cells in peripheral nerve grafts can be genetically modified using lentiviral vectors to over-express CNTF, resulting in increased regrowth of RGC axons. After OT lesions, hydrogels have been used to bridge the injury, sometimes with the incorporation of signalling peptides or cells genetically modified to express neurotrophic factors. Conclusions: There is now a general consensus that combinatorial approaches are needed to elicit sustained and effective regenerative responses in injured adult CNS neurons. Copyright (c) 2007 S. Karger AG, Basel.	Univ Western Australia, Sch Anat & Human Biol, Crawley, Australia	Harvey, AR (corresponding author), Univ Western Australia, Sch Anat & Human Biol, M309,35 Stirling Highway, Perth, WA 6009, Australia.	arharvey@anhb.uwa.edu.au	Harvey, Alan/A-4911-2008	, Alan/0000-0002-2590-831X			Chierzi S, 2001, RESTOR NEUROL NEUROS, V19, P109; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Cui Q, 2003, J NEUROTRAUM, V20, P17, DOI 10.1089/08977150360517155; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Gates M A, 2000, Prog Brain Res, V127, P115; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; Hu Y, 2005, MOL THER, V11, P906, DOI 10.1016/j.ymthe.2005.01.016; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; Lund RD, 2003, J LEUKOCYTE BIOL, V74, P151, DOI 10.1189/jlb.0103041; Mandel RJ, 2006, MOL THER, V13, P463, DOI 10.1016/j.ymthe.2005.11.009; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Mellough CB, 2004, EXP NEUROL, V186, P6, DOI 10.1016/j.expneurol.2003.10.021; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407; Shen S., 1989, NEURON, V23, P285; Surace EM, 2003, PROG RETIN EYE RES, V22, P705, DOI 10.1016/S1350-9462(03)00052-1; Thanos S, 1997, SURV OPHTHALMOL, V42, pS5, DOI 10.1016/S0039-6257(97)80024-0; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239	23	11	12	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1660-2854	1660-2862		NEURODEGENER DIS	Neurodegener. Dis.		2007	4	4					300	305		10.1159/000101886			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	193TZ	WOS:000248299200003	17627133				2021-06-18	
J	Oh, EJ; Kim, YM; Jegal, DW; Kahng, J; Park, YJ; Han, K				Oh, Eun-Jee; Kim, Young-Min; Jegal, Dong-Wook; Kahng, Jimin; Park, Yeon-Joon; Han, Kyungja			Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department	JOURNAL OF CLINICAL LABORATORY ANALYSIS			English	Article						elecsys S100; acute brain injury; emergency department; screening; serum marker	ELECSYS(R) S100 IMMUNOASSAY; SERUM S-100 PROTEIN; MINOR HEAD-INJURY; MULTICENTER; S100-BETA; DAMAGE; DISEASE; TRAUMA	The aim of this study was to evaluate the screening and diagnostic validity of the initial serum S100 levels by Elecsys S100 immunoassay in an emergency department. We measured serum S100 in 101 acute brain injury (ABI) patients, in 40 healthy subjects, and in 41 chronic brain injury (CBI) patients (the control group). The ABI patients were divided in several groups according to the Glasgow Coma Scale (GCS), injury type and findings of brain imaging. Of the 101 patients, the 66 cranial computed tomography (CCT) or brain magnetic resonance imaging (MRI)positive patients showed higher S100 levels than did the 35 CCT/MRI-negative patients (P= 0.028). At a cutoff of 0.105 mu g/L, the sensitivity was 84.8% and the specificity 74.3% for all of the ABI patients, and the sensitivity was increased to 96.9% for the traumatic ABI patients for detecting image-positive ABI. There was no significant difference of S100 levels among the groups on the CCT or MRI pathological findings (P = 0.478). In conclusion, serum S100 levels can be used in the emergency department as an additional screening tool to identify CCT- or MRI-positive ABI.	[Oh, Eun-Jee; Jegal, Dong-Wook; Kahng, Jimin; Park, Yeon-Joon; Han, Kyungja] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul 137040, South Korea; [Kim, Young-Min] Catholic Univ Korea, Coll Med, Dept Emergency Med, Seoul 137040, South Korea	Oh, EJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Lab Med, 505 Banpodong, Seoul 137040, South Korea.	ejoh@catholic.ackr		Oh, Eun-Jee/0000-0001-5870-915X			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P366, DOI 10.1177/000456329703400405; Alber B, 2005, CLIN CHEM LAB MED, V43, P557, DOI 10.1515/CCLM.2005.097; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; HAIMOTO H, 1987, LAB INVEST, V57, P489; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; KAHN HJ, 1991, MODERN PATHOL, V4, P698; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976	19	11	11	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0887-8013	1098-2825		J CLIN LAB ANAL	J. Clin. Lab. Anal.		2007	21	6					387	392		10.1002/jcla.20201			6	Medical Laboratory Technology	Medical Laboratory Technology	241KC	WOS:000251654300008	18022928	Green Published			2021-06-18	
J	Vorst, MV; Ono, K; Chan, P; Stuhmiller, J				Vander Vorst, Michael; Ono, Koshiro; Chan, Philemon; Stuhmiller, James			Correlates to traumatic brain injury in nonhuman primates	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury (TBI); concussion; subarachnoid hemorrhage (SAH); brain contusion; subdural hematoma (SDH); injury criteria; statistical analysis; risk factors; correlate; regression	CONCUSSION; FOOTBALL	Background: Traumatic brain injury (TBI) is a major health problem, both in terms of the economic cost to society and the survivor's quality of life. The development of devices to protect against TBI requires criteria that relate observed injury to measurements of head kinematics. The objective of this study is to find the best statistical correlates to impact-induced TBI in nonhuman primates using a qualified, self-consistent set of historical kinematic and TBI data from impact tests on nonhuman primates. Methods: A database was constructed and qualified from historical head impact tests on nonhuman primates. Multivariate logistic regression analysis with backwards stepwise elimination was performed. Variables considered are the peak rotational acceleration (Omega(max)), the peak linear acceleration (A(max)), and the number of impacts (N). Results: Bivariate combinations of angular acceleration and the number of impacts are the best correlates to all modes of TBI considered, i.e., concussion, subarachnoid hemorrhage, brain contusion, and subdural hematoma. For a nonhuman primate with 100-g brain mass, the criteria that the probability of TBI is less than 10% by injury mode are: Concussion: Omega N-max(0.84) < 70 krad/s/s SAH: Omega N-max(0.70) < 160 krad/s/s Contusion: Omega N-max(0.35) < 160 krad/s/s SDH: Omega N-max(0.60) < 280 krad/s/s Conclusions: Based on this dataset, the best statistically based risk factor for all modes of TBI in nonhuman primates is the bivariate combination of rotational acceleration and number of impacts.	Titan Corp, San Diego, CA 92121 USA	Vorst, MV (corresponding author), Titan Corp, 3394 Carmel Mt Rd, San Diego, CA 92121 USA.	mvandervorst@titan.com					Abel JM, 1978, P 22 STAPP CAR CRASH; Centers for Disease Control, 2004, TRAUM BRAIN INJ FACT; DUMA S, 2004, P AM SOC BIOM C; Gennarelli T.A., 1990, 34 ANN P ASS ADV AUT; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hodgson VR, 1970, P 14 STAPP CAR CRASH; Hosmer D, 1989, APPL LOGISTIC REGRES; KIKUCHI A, 1982, P 9 INT TECHN C EXPT; NEWMAN JA, 2000, P 2000 IRCOBI C; NUSHOLTZ GS, 1987, AVIAT SPACE ENVIR MD, V58, P9; Ommaya AK, 1967, P 11 STAPP CAR CRASH, P670906; OMMAYA AK, 1970, SOC AUTOMOTIVE ENG; Ono K., 1980, P 24 STAPP CAR CRASH; PATRICK LM, 1965, SOC AUTOMOTIVE ENG; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; STALNAKER RL, 1977, DOTHS802; STAPP JP, 1957, AM J SURG, V93, P374; Suresh S., 1991, FATIGUE MAT	18	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2007	62	1					199	206		10.1097/01.ta.0000238665.09611.4b			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	126CP	WOS:000243490100038	17215755				2021-06-18	
J	Mujuru, P; Singla, L; Helmkamp, J; Bell, J; Hu, W				Mujuru, Priscah; Singla, Lisa; Helmkamp, James; Bell, Jennifer; Hu, Wen			Evaluation of the burden of logging injuries using West Virginia Workers' Compensation claims data from 1996 to 2001	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						occupational injuries; logging injuries; indemnity costs; permanent disability; traumatic brain injuries; injury prevention; workers' compensation; ICD-9 codes	OCCUPATIONAL INJURY; UNITED-STATES; COSTS; ILLNESS; RISK	Background The risks associated with logging are well documented, however little work has been done on estimating the economic impact of injuries among loggers. Methods West Virginia Workers' Compensation claims data for the period 1996-2001 was used to assess the economic burden of logging injuries in the state. Results There were 1,371 claimants during this period with the highest number of claims (39%) in the 25-34 years age category. The total cost of injuries was over $14 million. The most severe injuries, traumatic brain injuries (TBI), thoracic, cervical, and lumbar, resulted in the highest medical costs, indemnity costs and permanent disability. The average medical cost for logging-related to TBI was $198,048 compared to $15,321 for other major industries. Conclusions The magnitude of the economic costs underscores the need for active research of injury prevention among loggers and for greater attention to occupational safety and health programs.	W Virginia Univ, Dept Community Med, Inst Occupat & Environm Hlth, Morgantown, WV 26506 USA; W Virginia Univ, Dept Injury Control, Res Ctr, Morgantown, WV 26506 USA; NIOSH, Div Safety Res, CDCt, Morgantown, WV USA	Mujuru, P (corresponding author), W Virginia Univ, Dept Community Med, Inst Occupat & Environm Hlth, Morgantown, WV 26506 USA.	pmujuru@hsc.wvu.edu			NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000345] Funding Source: NIH RePORTER; NCIPC CDC HHS [5 R49/CE000345-02] Funding Source: Medline		Bell JL, 2006, J SAFETY RES, V37, P53, DOI 10.1016/j.jsr.2005.10.019; Bell JL, 2003, AM J IND MED, V44, P502, DOI 10.1002/ajim.10307; Boden LI, 2001, AM J IND MED, V40, P398, DOI 10.1002/ajim.10013; *BUR LAB STAT, 2004, NAT CENS FAT OCC INJ; Childs R. A., 2005, W VIRGINIAS FORESTS; EWAN C, 1991, SOCIOL HLTH ILLN, V13, P169; Fischer V, 2005, AM J IND MED, V47, P246, DOI 10.1002/ajim.20133; Fosbroke DE, 1997, AM J IND MED, V31, P459, DOI 10.1002/(SICI)1097-0274(199704)31:4<459::AID-AJIM13>3.3.CO;2-E; GALIZZI M, 1998, WORKERS STORY RESULT; Glazner JE, 1998, AM J IND MED, V34, P105, DOI 10.1002/(SICI)1097-0274(199808)34:2<105::AID-AJIM2>3.0.CO;2-W; Johnson CM, 2002, AM SURGEON, V68, P573; Leigh JP, 1997, J OCCUP ENVIRON MED, V39, P1170; Leigh JP, 2004, SCAND J WORK ENV HEA, V30, P199, DOI 10.5271/sjweh.780; Leigh JP, 1997, ARCH INTERN MED, V157, P1557, DOI 10.1001/archinte.157.14.1557; Miller TR, 1995, ACCIDENT ANAL PREV, V27, P741, DOI 10.1016/0001-4575(95)00022-4; Morse T F, 1998, Int J Occup Environ Health, V4, P209; MYERS JR, 1994, J SAFETY RES, V25, P97, DOI 10.1016/0022-4375(94)90021-3; *NAT SAF COUNC, 2004, INJURY FACTS; PAULOZZI LJ, 1987, J OCCUP MED, V29, P105; Pransky G, 2000, AM J IND MED, V37, P400, DOI 10.1002/(SICI)1097-0274(200004)37:4<400::AID-AJIM10>3.0.CO;2-C; Schulte PA, 2005, J OCCUP ENVIRON MED, V47, P607, DOI 10.1097/01.jom.0000165086.25595.9d; STRUNIN L, 2000, HUMAN COSTS OCCUPATI; Sygnatur E.F, 1998, COMPENSATION WORKING, P3; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	24	11	11	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0271-3586			AM J IND MED	Am. J. Ind. Med.	DEC	2006	49	12					1039	1045		10.1002/ajim.20389			7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	108ZN	WOS:000242277800007	17096361				2021-06-18	
J	Kumar, V; Naik, RS; Hillert, M; Klein, J				Kumar, Vikas; Naik, Runa S.; Hillert, Markus; Klein, Jochen			Effects of chloride flux modulators in an in vitro model of brain edema formation	BRAIN RESEARCH			English	Article						edema; furosemide; DIDS; niflumic acid; NMDA receptor; oxygen-glucose deprivation	OXYGEN-GLUCOSE-DEPRIVATION; EXCITOTOXIC CELL-DEATH; K+-CL-COTRANSPORTER; HIPPOCAMPAL SLICE; INTRACELLULAR CHLORIDE; NA+; GLUTAMATE; HOMEOSTASIS; INHIBITION; ACTIVATION	Brain edema is a serious consequence of hemispheric stroke and traumatic brain injury and contributes significantly to patient mortality. In the present study, we measured water contents in hippocampal slices as an in vitro model of edema formation. Excitotoxic conditions induced by N-methyl-D-aspartate (NMDA, 300 mu M), as well as ischemia induced by oxygen-glucose deprivation (OGD), caused cellular edema formation as indicated by an increase of slice water contents. In the presence of furosemide, an inhibitor of the Na,K,Cl-cotransporter, NMDA-induced edema were reduced by 64% while OGD-induced edema were unaffected. The same observation, i.e., reduction of excitotoxic edema formation but no effect on ischemia-induced edema, was made with chloride transport inhibitors such as DIDS and niflumic acid. Under ischemic conditions, modulation of GABA(A) receptors by bicuculline, a GABA antagonist, or by diazepam, a CABAergic agonist, did not significantly affect edema formation. Further experiments demonstrated that low chloride conditions prevented NMDA-induced, but not OGD-induced, water influx. Omission of calcium ions had no effect. Our results show that NMDA-induced edema formation is highly dependent on chloride influx as it was prevented by low-chloride conditions and by various compounds that interfere with chloride influx. In contrast, OGD-induced edema observed in brain slices was not affected by modulators of chloride fluxes. The results are discussed with reference to ionic changes occurring during tissue ischemia. (c) 2006 Elsevier B.V. All rights reserved.	Texas Tech Univ, Sch Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	Klein, J (corresponding author), Texas Tech Univ, Sch Pharm, Hlth Sci Ctr, Dept Pharmaceut Sci, 1300 Coulter Dr, Amarillo, TX 79106 USA.	jochen.klein@ttuhsc.edu	Klein, Jochen/B-9730-2008	Klein, Jochen/0000-0001-6971-3381	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine [R21AT003399] Funding Source: NIH RePORTER		Abbruscato TJ, 2004, J PHARMACOL EXP THER, V310, P459, DOI 10.1124/jpet.104.066274; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Babot Z, 2005, EUR J NEUROSCI, V21, P103, DOI 10.1111/j.1460-9568.2004.03848.x; Beck J, 2003, J NEUROSCI, V23, P5061; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Breder J, 2000, NEUROPHARMACOLOGY, V39, P1779, DOI 10.1016/S0028-3908(00)00027-7; Chen Q, 1999, EXP NEUROL, V160, P215, DOI 10.1006/exnr.1999.7179; CHOI DW, 1987, J NEUROSCI, V7, P369; Czyz A, 2002, J NEUROCHEM, V81, P379, DOI 10.1046/j.1471-4159.2002.00851.x; ERDO SL, 1991, BRAIN RES, V542, P254, DOI 10.1016/0006-8993(91)91575-L; Foroutan S, 2005, AM J PHYSIOL-CELL PH, V289, pC1492, DOI 10.1152/ajpcell.00257.2005; Galeffi F, 2004, J NEUROSCI, V24, P4478, DOI 10.1523/JNEUROSCI.0755-04.2004; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grondahl TO, 1998, NEUROL RES, V20, P131; HANSEN AJ, 1985, PHYSIOL REV, V65, P101; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Inglefield JR, 1998, J NEUROCHEM, V71, P1396; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Klein J, 2003, PHARMACOPSYCHIATRY, V36, pS78; Lipton P, 1999, PHYSIOL REV, V79, P1431; Lodder J, 2006, CEREBROVASC DIS, V21, P120, DOI 10.1159/000090210; Lopachin RM, 2001, NEUROSCIENCE, V103, P971, DOI 10.1016/S0306-4522(01)00035-5; MacGregor DG, 2003, J NEUROCHEM, V85, P1402, DOI 10.1046/j.1471-4159.2003.01772.x; Martinez-Sanchez M, 2004, NEUROSCIENCE, V128, P729, DOI 10.1016/j.neuroscience.2004.06.074; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; OLNEY JW, 1986, NEUROSCI LETT, V65, P65, DOI 10.1016/0304-3940(86)90121-7; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Pond BB, 2006, J NEUROSCI, V26, P1396, DOI 10.1523/JNEUROSCI.1421-05.2006; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Siklos L, 1997, NEUROSCIENCE, V79, P1013, DOI 10.1016/S0306-4522(97)00031-6; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; STEMMER JE, 2004, EUR J NEUROSCI, V19, P2915; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772; TAKATA M, 1995, INTEGR COMPUT-AID E, V2, P249; UNTERBERGA W, 2004, NEUROSCIENCE, V129, P1019; Weichel O, 1999, N-S ARCH PHARMACOL, V360, P609, DOI 10.1007/s002109900131; Yan YP, 2001, J CEREBR BLOOD F MET, V21, P711, DOI 10.1097/00004647-200106000-00009	46	11	13	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 29	2006	1122						222	229		10.1016/j.brainres.2006.09.012			8	Neurosciences	Neurosciences & Neurology	114LU	WOS:000242668500027	17014830	Green Accepted			2021-06-18	
J	Demir, SO; Oktay, F; Uysal, H; Selcuk, B				Demir, Sibel Ozbudak; Oktay, Fuegen; Uysal, Hilmi; Selcuk, Baran			Upper extremity shortness in children with hemiplegic cerebral palsy	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						hemiplegic cerebral palsy; upper extremity shortness	TRAUMATIC BRAIN-INJURY; SPASTIC HEMIPLEGIA; SKELETAL; GROWTH; HANDS	Objective: To evaluate upper extremity shortness in patients with hemiplegic cerebral palsy (HCP) and to investigate the association between extremity shortness, motor level, and muscle tone. Design: Prospective, controlled study. Subjects: Forty-two children with HCP and 29 healthy children. Methods: Radiographs of the involved and the uninvolved humerus, forearm, and hands were obtained with a radiographic ruler placed adjacent to the extremity. The lengths and the diameters of both the diaphyses and metaphyses of the humerus, ulna, radius, and the second and the fifth metacarpal bones were measured in patients and the control group. The discrepancy was calculated as a percentage compared with the normal side. The Ashworth Scale was used in the evaluation of spasticity, and the Brunnstrom recovery staging was used in the motor evaluation. Results: Children with HCP had significant differences in bone lengths and diameters compared with control children. There was no significant correlation between the upper extremity Brunnstrom stagings and the differences of bone length and diameter. A significant correlation was observed between the hand Brunnstrom staging and percentage difference of the bone length and diameter. The spasticity level showed no relation to the differences in bone length and diameter. Conclusions: Children with HCP have significant side-to-side limb-length discrepancy when compared with control children. The discrepancy increases with age. The extent of shortening did not appear to be related to upper extremity function and spasticity. The extremity shortness showed a relation to hand function.	Minist Hlth, Ankara Phys Med Rehabil Educ & Res Hosp, Ankara, Turkey; Akdeniz Univ Fac Med, Antalya, Turkey	Demir, SO (corresponding author), Y Dikmen Mah Turan Gunes bulvari,12 Cadde 11-4,Ay, TR-06450 Ankara, Turkey.	sibiozbudak@hotmail.com	Uysal, Hilmi/C-3651-2016	Uysal, Hilmi/0000-0002-6063-377X			CARTER DR, 1987, J BIOMECH, V20, P1095, DOI 10.1016/0021-9290(87)90027-3; CARTER DR, 1987, CLIN ORTHOP RELAT R, P237; Chenu C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P132; Chung UI, 1998, P NATL ACAD SCI USA, V95, P13030, DOI 10.1073/pnas.95.22.13030; Flett P, 2003, J PAEDIATR CHILD H, V39, P6, DOI 10.1046/j.1440-1754.2003.00082.x; Goldstein Murray, 2001, Developmental Medicine and Child Neurology, V43, P563, DOI 10.1017/S0012162201001025; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kong CK, 1999, DEV MED CHILD NEUROL, V41, P758, DOI 10.1017/S0012162299001528; Lin PP, 1996, DEV MED CHILD NEUROL, V38, P782; McDaid PJ, 2002, J PEDIATR ORTHOPED, V22, P364; Pellegrino L, 1998, CARING FOR CHILDREN WITH CEREBRAL PALSY, P3; STEMPIEN LM, 1996, PHYS MED REHABILITAT, P1191; STEVENSON RD, 1995, DEV MED CHILD NEUROL, V37, P124; STRECKER TR, 1983, TERATOLOGY, V27, P159, DOI 10.1002/tera.1420270204; TACHDJIAN MO, 1958, J BONE JOINT SURG AM, V40, P85, DOI 10.2106/00004623-195840010-00008; TIZARD JPM, 1954, JAMA-J AM MED ASSOC, V155, P628, DOI 10.1001/jama.1954.03690250008003; Uvebrant P, 1988, Acta Paediatr Scand Suppl, V345, P1; VANHEEST AE, 1993, J HAND SURG-AM, V18A, P278, DOI 10.1016/0363-5023(93)90361-6; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620	20	11	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	NOV-DEC	2006	26	6					764	768		10.1097/01.bpo.0000235393.34289.82			5	Orthopedics; Pediatrics	Orthopedics; Pediatrics	157CB	WOS:000245695100014	17065942				2021-06-18	
J	Hummel, MC; Morse, BC; Hayes, LE				Hummel, Margaret C.; Morse, Bryan C.; Hayes, Lloyd E.			Reactive thrombocytosis associated with enoxaparin	PHARMACOTHERAPY			English	Article						thrombocytosis; platelets; low-molecular-weight heparin; enoxaparin	MOLECULAR-WEIGHT HEPARINS	A 42-year-old man was hospitalized for a closed head injury caused by a bicycle accident. On hospital day 8, he developed thrombocytosis. Eleven days later, his platelet count reached 1005 x 10(3)/mm(3). A review of his drug therapy indicated enoxaparin as a potential reversible cause of reactive thrombocytosis. Enoxaparin was discontinued, and the patient's platelet count declined, eventually normalizing 6 days later. At that time, enoxaparin was restarted; this resulted in an increase in his platelet count that peaked 8 days later at 920 x 10(3)/mm(3). After each occurrence of thrombocytosis, enoxaparin was switched to unfractionated heparin in combination with sequential compression devices for deep vein thrombosis prophylaxis. No complications secondary to thrombocytosis were noted. Our patient's experience suggests that unfractionated heparin may be substituted for enoxaparin if this adverse effect is suspected.	Greensville Hosp Syst Univ, Med Ctr, Dept Gen Surg, Greenville, SC 29605 USA; Greensville Hosp Syst Univ, Med Ctr, Dept Pharm, Clin Serv, Greenville, SC 29605 USA; Greensville Hosp Syst Univ, Med Ctr, Div Pulm Crit Care Med, Greenville, SC 29605 USA	Morse, BC (corresponding author), Greensville Hosp Syst Univ, Med Ctr, Dept Gen Surg, 701 Grove Rd, Greenville, SC 29605 USA.						[Anonymous], 2003, Prescrire Int, V12, P183; BRACE LD, 2002, HEMATOLOGY CLIN PRIN, P683; Cestac P, 2003, DRUG SAFETY, V26, P197, DOI 10.2165/00002018-200326030-00005; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; KLASCO RK, DRUGDEX SYSTEM; Liautard C, 2002, ANN PHARMACOTHER, V36, P1351; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Rizzieri DA, 1996, ANN INTERN MED, V125, P157, DOI 10.7326/0003-4819-125-2-199607150-00031; SHEN ZX, 1994, BRIT J HAEMATOL, V88, P608, DOI 10.1111/j.1365-2141.1994.tb05080.x; Williams E, 1997, ANN INTERN MED, V126, P742, DOI 10.7326/0003-4819-126-9-199705010-00024; Wyrick-Glatzel Janis, 1997, P509; Ziaja K, 1999, INT ANGIOL, V18, P65	12	11	13	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	NOV	2006	26	11					1667	1670		10.1592/phco.26.11.1667			4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	101ZG	WOS:000241779600018	17064215				2021-06-18	
J	Pryor, J; Shi, R				Pryor, J.; Shi, R.			Electrophysiological changes in isolated spinal cord white matter in response to oxygen deprivation	SPINAL CORD			English	Article						axons; spinal cord injury; in vitro; sucrose gap recording; membrane; neurotrauma; afterpotential	AORTIC-ANEURYSM REPAIR; RAT OPTIC-NERVE; MYELINATED AXONS; DEPOLARIZING AFTERPOTENTIALS; ISCHEMIC-INJURY; BRAIN INJURY; IN-VITRO; CALCIUM; CONDUCTION; GLUCOSE	Study design: In vitro studies using isolated guinea pig spinal cord white matter. Objectives: To determine whether lack of oxygen can cause irreversible impairment of electrical impulse conduction. Setting: Department of Basic Medical Sciences, Purdue University, West Lafayette, Indiana, USA. Methods: The hypoxic injury was induced by reducing the oxygen tension of the perfused solution by 80%. Compound action potentials (CAPs) were monitored before, during, and after oxygen deprivation. Results: We have found that 60 min of hypoxia reduced the conduction to 30% of preinjury level and recovered to approximately 60% of the preinjury level upon reoxygenation. Larger axons appeared to be more vulnerable to oxygen deprivation. We noted a significant decrease and recovery of the depolarizing afterpotential (DAP). Likewise, there was a delay and recovery of absolute and relative refractory period. Concomitantly, the ability of axons to follow repetitive stimuli was suppressed following oxygen deprivation but recovered upon reoxygenation. Conclusion: Following 60 min of oxygen deprivation and 30 min of reoxygenation, mammalian spinal cord white matter can partially recover electrical impulse conduction. However, within the same period, cords gained a complete recovery of other electrical properties, such as the depression of DAP, the delaying of refractory period, and the decreased ability to respond to repetitive stimuli. Compared to previous findings when both oxygen and glucose were deprived, we conclude that glucose plays a relatively minor role during the acute stage of oxygen deprivation in mammalian spinal cord white matter.	Purdue Univ, Dept Vet Med Sci, Ctr Paralysis Res, Inst Appl Neurol, W Lafayette, IN 47907 USA	Shi, R (corresponding author), Purdue Univ, Dept Vet Med Sci, Ctr Paralysis Res, Inst Appl Neurol, W Lafayette, IN 47907 USA.						Agrawal SK, 1996, J NEUROSCI, V16, P545; ALLEN BT, 1995, VASCULAR SURG THEORY, P1402; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BLIGHT AR, 1985, NEUROSCIENCE, V15, P1, DOI 10.1016/0306-4522(85)90118-6; BORGENS RB, 2003, ADV ANAT EMBRYOL CEL, V171, pR1; Coselli JS, 1997, ANN THORAC SURG, V63, P28, DOI 10.1016/S0003-4975(96)01029-6; FRIEDMAN A, 1992, NEUROSCI LETT, V135, P13, DOI 10.1016/0304-3940(92)90125-Q; GORDON TR, 1990, NEUROSCIENCE, V37, P829, DOI 10.1016/0306-4522(90)90112-H; GORDON TR, 1989, BRAIN RES, V502, P252, DOI 10.1016/0006-8993(89)90620-3; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; KAJI R, 1989, NEUROLOGY, V39, P1364, DOI 10.1212/WNL.39.10.1364; Kanellopoulos GK, 1997, STROKE, V28, P2532, DOI 10.1161/01.STR.28.12.2532; KOJIMA M, 1986, EUR J PHARMACOL, V122, P65, DOI 10.1016/0014-2999(86)90159-7; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; LasserRoss N, 1997, J NEUROPHYSIOL, V78, P825; LEBLANC MH, 1994, STROKE, V25, P1443, DOI 10.1161/01.STR.25.7.1443; Lemon N, 2000, J NEUROPHYSIOL, V84, P1519; LOPANTSEV VE, 1990, NEUROSCIENCE, V38, P137, DOI 10.1016/0306-4522(90)90380-M; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; Safi HJ, 1998, ANN THORAC SURG, V66, P1204, DOI 10.1016/S0003-4975(98)00781-4; Sala F, 1999, ANN NY ACAD SCI, V890, P133, DOI 10.1111/j.1749-6632.1999.tb07989.x; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SATRAN R, 1988, Stroke, V19, P529; Shi R, 1999, J NEUROPHYSIOL, V81, P2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 1996, J NEUROPHYSIOL, V76, P1572; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; Stys PK, 1998, NEUROSCIENCE, V82, P21; STYS PK, 1991, BRAIN RES, V546, P18, DOI 10.1016/0006-8993(91)91154-S; SUAREZKURTZ G, 1979, J PHYSIOL-LONDON, V286, P317, DOI 10.1113/jphysiol.1979.sp012621; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TEREK RM, 1987, AM J PHYSIOL, V252, pH645; Wass CT, 1996, MAYO CLIN PROC, V71, P801; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WITTE OW, 1994, EPILEPSY RES, V18, P43, DOI 10.1016/0920-1211(94)90032-9; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86; YOUNG W, 1985, CENTRAL NERVOUS SYST, P463; Young Wise, 1993, Journal of Emergency Medicine, V11, P13; Zareie M, 2003, NEPHROL DIAL TRANSPL, V18, P2629, DOI 10.1093/ndt/gfg356; ZHANG L, 1993, J NEUROPHYSIOL, V70, P223	44	11	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	NOV	2006	44	11					653	661		10.1038/sj.sc.3101901			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	103KS	WOS:000241884700002	16432530	Bronze			2021-06-18	
J	Heep, A; Bartmann, P; Stoffel-Wagner, B; Bos, A; Hoving, E; Brouwer, O; Teelken, A; Schaller, C; Sival, D				Heep, Axel; Bartmann, Peter; Stoffel-Wagner, Birgit; Bos, Arie; Hoving, Eelco; Brouwer, Oebele; Teelken, Albert; Schaller, Carlo; Sival, Deborah			Cerebrospinal fluid obstruction and malabsorption in human neonatal hydrocephaly	CHILDS NERVOUS SYSTEM			English	Article						congenital hydrocephalus; CSF; TGF beta-1; procollagen type 1 N propeptide; IL-6	TISSUE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PROCOLLAGEN PROPEPTIDES; LEPTOMENINGEAL CELLS; REACTIVE ASTROCYTES; PRETERM INFANTS; DEPOSITION	Introduction: The pathophysiology involved in human neonatal high-pressure hydrocephalus (HC) includes both cerebrospinal fluid (CSF) malabsorption and obstruction. Objective: The aim was to estimate the relative contribution between CSF malabsorption and obstruction in three different etiological groups of neonatal high-pressure HC by assessment of specific CSF biomarkers indicative of growth factor- and fibrosis-related CSF malabsorption (transforming growth factor beta-1 (TGF beta-1), aminoterminal propeptide of type 1 collagen (PC1NP)]. Materials and methods: Patients were subdivided into three groups. Group A: spina bifida HC (n=12); group B: non-haemorrhagic triventricular HC (n=4); and group C: posthaemorrhagic HC (n=6). To exclude for confounding differences in pro-inflammatory state between the three groups, interleukin-6 (IL-6) CSF concentrations were assessed. Consecutively, the CSF concentrations of TGF beta-1 and PC1NP were compared between the different groups. Results: Median CSF concentrations of IL-6 were low and did not differ between groups. Median CSF concentrations of PC1NP were significantly lower in group A (median: 180 ng/ml, range 90-808) than in group C (median: 1,060, range 396-1194; p=0.002). TGF beta-1 concentrations were significantly higher in group C (median 355 pg/ml, range 129-843) than in groups A (median 103, range 78-675 pg/ml) and B (median 120 pg/ml, range 91-188; p=0.01 and 0.03, respectively). Conclusion: In neonatal posthaemorrhagic HC, high concentrations of malabsorption-related biomarkers contrast with lower concentrations in SB and non-haemorrhagic triventricular HC. During the early development of high pressure HC in SB neonates, CSF biomarkers strongly indicate that CSF obstruction contributes more to the development of HC than malabsorption.	Univ Bonn, Dept Neonatol, D-53113 Bonn, Germany; Univ Bonn, Dept Clin Biochem, D-53105 Bonn, Germany; Univ Groningen, Med Ctr, Dept Pediat, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Neurosurg, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Neurol, NL-9700 RB Groningen, Netherlands; Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany	Heep, A (corresponding author), Univ Bonn, Dept Neonatol, Adenauerallee 119, D-53113 Bonn, Germany.	axel.heep@ukb.uni-bonn.de					Baumeister FAM, 2000, INFECTION, V28, P234, DOI 10.1007/s150100070043; Bell MJ, 1997, ACT NEUR S, V70, P96; BELL WO, 1995, PEDIATR NEUROSURG, V23, P42, DOI 10.1159/000120934; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boillat CA, 1997, EXP NEUROL, V147, P377, DOI 10.1006/exnr.1997.6617; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Cai X, 1999, EUR J PEDIATR SURG, V9, P35, DOI 10.1055/s-2008-1072312; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Del Bigio MR, 1998, EXP NEUROL, V154, P157, DOI 10.1006/exnr.1998.6922; Flood C, 2001, J CEREBR BLOOD F MET, V21, P157, DOI 10.1097/00004647-200102000-00007; FRIEDE RL, 1989, DEV NEUROPATHOLOGY, P220; Heep A., 2000, Biology of the Neonate, V78, P153; Heep A, 2004, PEDIATR RES, V56, P768, DOI 10.1203/01.PDR.0000141524.32142.53; Heep A, 2004, EUR J PEDIATR, V163, P44, DOI 10.1007/s00431-003-1333-5; Heep A, 2002, ARCH DIS CHILD-FETAL, V87, pF34, DOI 10.1136/fn.87.1.F34; Heep A, 2001, CHILD NERV SYST, V17, P47, DOI 10.1007/s003810000363; Johanson CE, 1999, AM J PHYSIOL-REG I, V277, pR263, DOI 10.1152/ajpregu.1999.277.1.R263; Johanson Conrad E., 2001, Trends in Neurosciences, V24, P631, DOI 10.1016/S0166-2236(00)02040-3; JOHNSON MD, 1992, LAB INVEST, V67, P360; KIM RC, 1989, NEUROSURGERY, V24, P771, DOI 10.1227/00006123-198905000-00022; KITAZAWA K, 1994, STROKE, V25, P1400, DOI 10.1161/01.STR.25.7.1400; Koch D, 2004, CHILD NERV SYST, V20, P405, DOI 10.1007/s00381-004-0958-7; LEVENE MI, 1981, ARCH DIS CHILD, V56, P900, DOI 10.1136/adc.56.12.900; Li XF, 2005, CHILD NERV SYST, V21, P32, DOI 10.1007/s00381-004-1034-z; Massicotte EM, 1999, J NEUROSURG, V91, P80, DOI 10.3171/jns.1999.91.1.0080; Moinuddin SM, 2000, NEUROL RES, V22, P215, DOI 10.1080/01616412.2000.11741064; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; MORI K, 1995, CHILD NERV SYST, V11, P523, DOI 10.1007/BF00822842; MOTOHASHI O, 1995, ACTA NEUROCHIR, V136, P88, DOI 10.1007/BF01411441; Nakazato F, 2002, NEUROL MED-CHIR, V42, P151, DOI 10.2176/nmc.42.151; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Paneth N, 1999, J PEDIATR-US, V134, P527, DOI 10.1016/S0022-3476(99)70231-3; PATTISAPU JV, 2003, EUR J SURG, V13, pS55; RISTELI J, 1995, J HEPATOL, V22, P77; RISTELI L, 1987, METHOD ENZYMOL, V145, P391; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Sajanti J, 1999, BBA-MOL BASIS DIS, V1454, P209, DOI 10.1016/S0925-4439(99)00016-2; Sajanti J, 2000, NEUROLOGY, V55, P359, DOI 10.1212/WNL.55.3.359; Sajanti J, 1999, J NEUROL NEUROSUR PS, V67, P185, DOI 10.1136/jnnp.67.2.185; Schwab JM, 2000, NEUROPATH APPL NEURO, V26, P434, DOI 10.1046/j.1365-2990.2000.00271.x; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; SUZUKI S, 1977, ACTA NEUROCHIR, V39, P1, DOI 10.1007/BF01405236; TADA T, 1994, J NEUROIMMUNOL, V50, P153, DOI 10.1016/0165-5728(94)90041-8; Takei F, 1995, PEDIATR NEUROSURG, V23, P246, DOI 10.1159/000120967; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Volpe JJ, 2001, NEUROLOGY NEWBORN, P428; Wang JF, 2004, WOUND REPAIR REGEN, V12, P205, DOI 10.1111/j.1067-1927.2004.012113.x; WYSSCORAY T, 1995, AM J PATHOL, V147, P53; Xia YX, 2000, NEUROSCI LETT, V280, P220, DOI 10.1016/S0304-3940(00)00782-5; XIAO L, 2002, HUNAN YI KE DA XUE, V28, P13	50	11	13	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2006	22	10					1249	1255		10.1007/s00381-006-0102-y			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	087CY	WOS:000240721300009	16699804				2021-06-18	
J	Rasmussen, IA; Antonsen, IK; Berntsen, EM; Xu, J; Lagopoulos, J; Haberg, AK				Rasmussen, Inge-Andre, Jr.; Antonsen, Ida Kristin; Berntsen, Erik Magnus; Xu, Jian; Lagopoulos, Jim; Haberg, Asta Kristine			Brain activation measured using functional magnetic resonance imaging during the Tower of London task	ACTA NEUROPSYCHIATRICA			English	Article						fMRI; TBI; Tower of London	DORSOLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; PARKINSONS-DISEASE; HEAD-INJURY; FMRI; PET; SEGMENTATION; INFORMATION; PERFORMANCE; IMPAIRMENT	Background: Individuals with traumatic brain injury (TBI) often suffer from a number of enduring cognitive impairments such as in attention, memory, speed of processing information and dual-task performance. Objective: The aim of this study was to assess the patterns of regional brain activation in response to the Tower of London (ToL) task in a group of patients suffering from chronic TBI using functional magnetic resonance imaging (fMRI). Methods: fMRI was performed during performance of the ToL planning task in 10 patients suffering from severe TBI and in 10 age- and sex-matched controls using a 3 T magnetic resonance scanner. Results: Performance data showed no difference in response accuracy between the TBI group and the healthy control group. Statistical parametric brain maps showed that the TBI group activates larger and additional areas of the cerebral cortex than the healthy control group both for tasks and for a subtraction contrast between the tasks. Conclusions: The results of this study are interpreted as a cortical reorganization inside the executive system of vigilance and working memory in patients with TBI. Both parietal and frontal areas are recruited to compensate for damaged brain tissue.	Norwegian Univ Sci & Technol, Dept Circulat & Imaging, Fac Med, N-7006 Trondheim, Norway; Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; Black Dog Inst, Neurosci Res Grp, Mood Disorders Unit, Sydney, NSW, Australia; Westmead Hosp, Dept Neurol, Sydney, NSW, Australia	Rasmussen, IA (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Imaging, Fac Med, N-7006 Trondheim, Norway.	inge.rasmussen@ntnu.no	Berntsen, Erik Magnus/AAM-7134-2020				ANZAI Y, 1979, PSYCHOL REV, V86, P124, DOI 10.1037/0033-295X.86.2.124; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BROUWER WH, 1994, INT NEUR SOC 1994 AN; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MORRIS RG, 1993, NEUROPSYCHOLOGIA, V31, P1367, DOI 10.1016/0028-3932(93)90104-8; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Petrides M, 2000, J NEUROSCI, V20, P7496; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rasser PE, 2005, NEUROIMAGE, V26, P941, DOI 10.1016/j.neuroimage.2004.11.054; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; Robertson EM, 2001, CEREB CORTEX, V11, P628, DOI 10.1093/cercor/11.7.628; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Schall U, 2003, NEUROIMAGE, V20, P1154, DOI 10.1016/S1053-8119(03)00338-0; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Seidman LJ, 1998, NEUROPSYCHOLOGY, V12, P505, DOI 10.1037/0894-4105.12.4.505; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Talairach J., 1988, COPLANAR STEREOTAXIC; van den Heuvel OA, 2003, NEUROIMAGE, V18, P367, DOI 10.1016/S1053-8119(02)00010-1; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Walsh K. W., 1985, UNDERSTANDING BRAIN	36	11	11	0	13	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0924-2708			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	OCT	2006	18	5					216	225		10.1111/j.1601-5215.2006.00145.x			10	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	107QW	WOS:000242187100005	26989921				2021-06-18	
J	Stubbe, HD; Greiner, C; Westphal, M; Rickert, CH; Van Aken, H; Eichel, V; Wassmann, H; Daudel, F; Hinder, F				Stubbe, Henning D.; Greiner, Christoph; Westphal, Martin; Rickert, Christian H.; Van Aken, Hugo; Eichel, Vera; Wassmann, Hansdetlef; Daudel, Fritz; Hinder, Frank			Cerebral response to norepinephrine compared with fluid resuscitation in ovine traumatic brain injury and systemic inflammation	CRITICAL CARE MEDICINE			English	Article						head injury; endotoxemia; intracranial pressure; cerebral blood flow; fluid resuscitation; vasopressor therapy; cerebral perfusion	INTERNAL CAROTID-ARTERY; BLOOD-FLOW; NITRIC-OXIDE; HEAD-INJURY; PERFUSION-PRESSURE; SEPTIC SHOCK; MANAGEMENT; SEPSIS; ENDOTOXEMIA; RATS	Objective. Traumatic brain injury is frequently accompanied by a systemic inflammatory response. Systemic inflammation was associated with cerebral hyperperfusion uncoupled to global oxygen metabolism in ovine head trauma. The present study investigated the cerebral effects of cerebral perfusion pressure (CPP) management performed by either fluid resuscitation or vasopressor treatment of low CPP induced by systemic inflammation. Design: Nonrandomized experimental study. Setting: University hospital laboratory. Subjects. A total of 12 adult sheep. Interventions, Measurements, and Main Results: Sheep were anesthetized and ventilated throughout the experimental period (13 hrs). After baseline measurements (hour 0), blunt head trauma was induced by a nonpenetrating stunner. After postinjury measurements (hour 2), all animals received continuous endotoxin infusion. At hour 10, one group (n = 6) was infused with hydroxyethyl starch until CPP reached 60-70 mm Hg. A second group (n = 6) received norepinephrine for CPP elevation. In the norepinephrine group, blood was isovolemically exchanged by hydroxyethyl starch to achieve comparable hematocrit levels. Head trauma increased intracranial pressure and decreased brain tissue oxygen tension. Endotoxemia induced a hyperdynamic cardiovascular response with increased internal carotid blood flow in the presence of systemic hypotension and decreased CPP. Hydroxyethyl starch infusion further increased internal carotid blood flow from (mean +/- SD) 247 +/- 26 (hour 10) to 342 +/- 42 mL/min (hour 13) and intracranial pressure from 20 +/- 4 (hour 10) to a maximum of 25 +/- 3 mm Hg (hour 12) but did not significantly affect brain tissue oxygen tension, sinus venous oxygen saturation and oxygen extraction fraction. Norepinephrine increased internal carotid blood flow from 268 +/- 19 to 342 +/- 58 mL/min and intracranial pressure from 22 +/- 11 to 24 +/- 11 mm Hg (hour 10 vs. hour 13) but significantly increased sinus venous oxygen saturation from 49 +/- 4 (hour 10) to a maximum of 59 +/- 6 mm Hg (hour 12) and decreased oxygen extraction fraction. The increase in brain tissue oxygen tension during norepinephrine treatment was not significant. Conclusion: We conclude that despite identical carotid blood flows, only CPP management with norepinephrine reduced the cerebral oxygen deficit in this model.	Univ Klinikum Munster, Klin & Poliklin Anasthesiol & Operat Intens Med, Munster, Germany; Univ Klinikum Munster, Klin & Poliklin Neurochirurg, Munster, Germany; Univ Klinikum Munster, Inst Neuropathol, Gerhard Domagk Inst Pathol, Munster, Germany; Inselspital Bern, Klin Intens Med, D-3010 Bern, Germany	Stubbe, HD (corresponding author), Univ Klinikum Munster, Klin & Poliklin Anasthesiol & Operat Intens Med, Munster, Germany.						Booke M, 1995, Prog Clin Biol Res, V392, P393; Booke M, 2003, ANESTH ANALG, V96, P1122, DOI 10.1213/01.ANE.0000052516.86497.B6; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Dal Nogare A R, 1991, Am J Med Sci, V302, P50; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hinder F, 2003, CRIT CARE MED, V31, P903, DOI 10.1097/01.CCM.0000050289.15988.67; Hinder F, 1999, AM J RESP CRIT CARE, V159, P252, DOI 10.1164/ajrccm.159.1.9806024; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Meadow W, 1999, PEDIATR RES, V45, P324, DOI 10.1203/00006450-199903000-00006; Muckart DJJ, 1997, CRIT CARE MED, V25, P1789, DOI 10.1097/00003246-199711000-00014; Myburgh JA, 1998, ACT NEUR S, V71, P19; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Stubbe HD, 2004, J CEREBR BLOOD F MET, V24, P1400, DOI 10.1097/01.WCB.0000141516.61418.82; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Tian J, 2004, ANESTH ANALG, V98, P768; TODD MM, 1993, ANESTHESIOLOGY, V78, P945, DOI 10.1097/00000542-199305000-00020; TRABER DL, 1988, AM J PHYSIOL, V254, pH833; York J, 2000, J TRAUMA, V48, P376, DOI 10.1097/00005373-200003000-00002	27	11	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	OCT	2006	34	10					2651	2657		10.1097/01.CCM.0000239196.17999.B7			7	Critical Care Medicine	General & Internal Medicine	088EZ	WOS:000240795700021	16932232				2021-06-18	
J	Brewer, BR; Klatzky, RL; Matsuoka, Y				Brewer, Bambi R.; Klatzky, Roberta L.; Matsuoka, Yoky			Visual-feedback distortion in a robotic rehabilitation environment	PROCEEDINGS OF THE IEEE			English	Article						feedback distortion; hand; rehabilitation robotics; stroke; traumatic brain injury	RESEARCH ARM TEST; HAPTIC DOMINANCE; ASSESSMENT SCALE; FORM PERCEPTION; VISION; MOVEMENT; STROKE; PROPRIOCEPTION; RELIABILITY; TOUCH	We create a robotic rehabilitation environment that distorts the visual feedback of a movement representation to restore lost movements. The use of visual-feedback distortion produces a perceptual gap between the perceived (visual) and actual somatosensory experiences, in which movements can be manipulated without patients' knowledge. Previously, we reported the smallest amount of distortion that is imperceptible by measuring just noticeable difference (JND), the distortion size that is tolerable without detection, and the invariance of perceived physical effort under visual-feedback distortion. In this paper, we report the performance changes under visual-feedback distortion in a robotic rehabilitation environment. By interleaving trials with no visual feedback, we showed that the internal somatosensory representation of the movement goal changed along with visual distortion for unimpaired and motor-impaired subjects. In addition, a gradual change of visual-feedback distortion within one experiment allowed movement changes significantly larger than the JND. These changes were robust under sudden lack of visual feedback and even when subjects were informed of possible distortion ahead of time. Finally, preliminary results of a six-week rehabilitation paradigm are reported. Improvements in the patient's hand condition were found, particularly in the range of motion of the index and middle fingers.	Inst Robot, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA	Brewer, BR (corresponding author), Inst Robot, Pittsburgh, PA 15213 USA.	bambi@andrew.cmu.edu; klatzky@cmu.edu; yoky@cs.cmu.edu					Atkinson J. W., 1964, INTRO MOTIVATION; BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P1017, DOI 10.1037/0022-3514.45.5.1017; BANDURA A, 1986, ORGAN BEHAV HUM DEC, V38, P92, DOI 10.1016/0749-5978(86)90028-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOCK O, 1990, BEHAV BRAIN RES, V41, P167, DOI 10.1016/0166-4328(90)90106-O; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Brewer BR, 2005, IEEE T NEUR SYS REH, V13, P1, DOI 10.1109/TNSRE.2005.843443; BREWER BR, P 2004 IEEE INT C RO, P2080; BREWER BR, 2003, P 8 INT C REH ROB DA, P258; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Fagan M, 2003, 11TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS - HAPTICS 2003, PROCEEDINGS, P159, DOI 10.1109/HAPTIC.2003.1191263; HELLER MA, 1983, PERCEPTION, V12, P607, DOI 10.1068/p120607; HELLER MA, 1992, PERCEPTION, V21, P655, DOI 10.1068/p210655; Heller MA, 1999, PERCEPT PSYCHOPHYS, V61, P1384, DOI 10.3758/BF03206188; JONES LA, 1989, PERCEPTION, V18, P681, DOI 10.1068/p180681; Kopp B, 1997, ARCH PHYS MED REHAB, V78, P615, DOI 10.1016/S0003-9993(97)90427-5; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; LEDERMAN SJ, IN PRESS HDB MULTISE; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Matsuoka Y, 2002, PHYSIOL BEHAV, V77, P651, DOI 10.1016/S0031-9384(02)00914-9; PATTON JL, 2005, IN PRESS EXP BRAIN R; Reinkensmeyer DJ, 2000, J REHABIL RES DEV, V37, P653; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457; Schrater PR, 2000, INT J COMPUT VISION, V40, P73; SINGER G, 1969, PERCEPT PSYCHOPHYS, V5, P315, DOI 10.3758/BF03209572; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Srinivasan M. A., 1996, Proceedings of the ASME Dynamic Systems and Control Division, P555; TAUB E, ARM MOTOR ABILITY TE; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van der Lee JH, 2001, J REHABIL MED, V33, P110; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; 2004, HEART DIS STROKE STA	37	11	11	0	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9219	1558-2256		P IEEE	Proc. IEEE	SEP	2006	94	9					1739	1751		10.1109/JPROC.2006.880715			13	Engineering, Electrical & Electronic	Engineering	101ZK	WOS:000241780000010					2021-06-18	
J	Kurtz, JE; Putnam, SH				Kurtz, John E.; Putnam, Steven H.			Patient-informant agreement on personality ratings and self-awareness after head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; SIGNIFICANT OTHERS; 5-FACTOR MODEL; BEHAVIORAL LIMITATIONS; IMPAIRED AWARENESS; SPOUSE RATINGS; REHABILITATION; SIMILARITY; RELATIVES; SCALE	To address concerns about self-awareness deficits and the validity of self-ratings by patients with head injury (HI), the current study examines mean differences and correlations between self-ratings from 52 patients with HI and ratings of the patient by informants using the revised NEO Personality Inventory (NEO-PI-R). Patient self-ratings were significantly lower than informant ratings on neuroticism and extraversion and significantly higher on conscientiousness. Patient-informant correlations ranged from .42 for conscientiousness to .67 for agreeableness, and these agreement correlations compare favorably with those obtained from normal adult samples. Hierarchical multiple regression equations for each of the five NEO-PI-R trait domains showed that more severe injuries were associated with higher agreement for extraversion. For all five traits, the strongest predictors of informant personality ratings were the patients' self-ratings. The implications of these findings for clinical assessment and improved research on self-awareness deficits after HI are discussed.	Villanova Univ, Dept Psychol, Villanova, PA 19085 USA; Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Kurtz, JE (corresponding author), Villanova Univ, Dept Psychol, 800 Lancaster Ave, Villanova, PA 19085 USA.	John.Kurtz@Villanova.edu	Kurtz, John/AAR-2598-2021		NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5T32 HD07421-04] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007421] Funding Source: NIH RePORTER		ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Allen MJ, 1979, INTRO MEASUREMENT TH; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; BORKENAU P, 1993, J PERS SOC PSYCHOL, V65, P546, DOI 10.1037/0022-3514.65.3.546; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Coetzer BR, 2001, J COGN REHABIL, V19, P8; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cohen J., 1983, APPL MULTIPLE REGRES; Costa P., 1992, REVISED NEO PERSONAL; Costa PT, 1992, PSYCHOLASSESS, V4, P5, DOI [10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, DOI 10.1037//1040-3590.4.1.5]; Damasio A., 1994, DESCARTESERROR EMOTI; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.ps.41.020190.002221; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; ELLIOTT TR, 1995, PSYCHOL ASSESSMENT M, P325, DOI DOI 10.1037/10175-008; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 2002, J COGNITIVE REHABILI, V20, P28; Foltz C, 1997, ASSESSMENT, V4, P287, DOI 10.1177/107319119700400308; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Funder D.C., 1997, HDB PERSONALITY PSYC, P617, DOI DOI 10.1016/B978-012134645-4/50025-1; FUNDER DC, 1995, J PERS SOC PSYCHOL, V69, P656, DOI 10.1037/0022-3514.69.4.656; Furnham AF, 1997, J PERS ASSESS, V69, P229, DOI 10.1207/s15327752jpa6901_14; JOHN OP, 1993, J PERS, V61, P521, DOI 10.1111/j.1467-6494.1993.tb00781.x; JOHN OP, 1994, J PERS SOC PSYCHOL, V66, P206, DOI 10.1037/0022-3514.66.1.206; John OP., 1999, HDB PERSONALITY THEO, P102; Kenny D. A., 1994, INTERPERSONAL PERCEP; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Klein SB, 1996, J EXP PSYCHOL GEN, V125, P250, DOI 10.1037/0096-3445.125.3.250; Kurtz JE, 2003, J PERS, V71, P21, DOI 10.1111/1467-6494.t01-1-00005; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; McCrae, 1994, Assessment, V1, P159, DOI 10.1177/1073191194001002006; McCrae RR, 1998, J PERS, V66, P285, DOI 10.1111/1467-6494.00013; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MUTEN E, 1991, J PERS ASSESS, V57, P449, DOI 10.1207/s15327752jpa5703_5; Newman AC, 2000, BRAIN INJURY, V14, P333; Nunnally J.C., 1978, PSYCHOMETRIC THEORY; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Ross SR, 1997, ASSESSMENT, V4, P395, DOI 10.1177/107319119700400410; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wallace CA, 2000, BRAIN INJURY, V14, P549; Watson D, 2000, J PERS SOC PSYCHOL, V78, P546, DOI 10.1037/0022-3514.78.3.546	58	11	11	0	20	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2006	20	3					453	468		10.1080/13854040590967090			16	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	071MT	WOS:000239607000007	16895858				2021-06-18	
J	Bates, G				Bates, Gordon			Medication in the treatment of the behavioural sequelae of traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							EPISODIC DYSCONTROL; CONDUCT DISORDER; HEAD-INJURIES; DOUBLE-BLIND; CHILDREN; METHYLPHENIDATE; ADOLESCENTS; SECONDARY	A significant proportion of children who sustain traumatic brain injury will go on to experience disturbance in their academic, emotional, and social functioning. There is a role for medication in the treatment of these late onset changes. This review will focus on the recognition and pharmacological treatment of the most common and most problematic presentations that may follow head injury, and supports the use of stimulant medication for secondary attention-deficit-hyperactivity disorder despite the small evidence base for use in children.	Birmingham Childrens Hosp, Parkview Clin, Birmingham B13 8QE, W Midlands, England	Bates, G (corresponding author), Birmingham Childrens Hosp, Parkview Clin, 60 Queensbridge Rd, Birmingham B13 8QE, W Midlands, England.	gordon.bates@bch.nhs.uk					Adams A, 2001, BCS CONF SERIES, P49; ALDRICH MS, 1992, NEUROLOGY, V42, P34; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arango C, 2002, J AM ACAD CHILD PSY, V41, P1147, DOI 10.1097/00004583-200210000-00004; BATES GDL, 1995, BEHAV NEUROL, V8, P103, DOI 10.3233/BEN-1995-8205; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Broughton RJ, 1997, NEUROLOGY, V49, P444, DOI 10.1212/WNL.49.2.444; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BROWN RT, 1991, J CLIN CHILD PSYCHOL, V20, P282, DOI 10.1207/s15374424jccp2003_7; CAMPBELL M, 1995, J AM ACAD CHILD PSY, V34, P445, DOI 10.1097/00004583-199504000-00011; Childs A, 1987, Brain Inj, V1, P49, DOI 10.3109/02699058709034444; CLARKE DJ, 1989, MED SCI LAW, V29, P136, DOI 10.1177/002580248902900209; Conners CK, 1997, MANUAL CONNERS RATIN; *DEP HLTH, 2004, HOSP EP STAT; DILLEY M, 2006, ADV PSYCHIAT TREAT, V12, P23; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GOLDSTEIN DJ, 1995, BRIT J PSYCHIAT, V166, P660, DOI 10.1192/bjp.166.5.660; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gordon N, 1999, DEV MED CHILD NEUROL, V41, P786, DOI 10.1017/S0012162299001565; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Gualtieri CT, 2002, BRAIN INJURY MENTAL; GUALTIERI CT, 2002, BRAIN INJURY MENTAL, P21; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Jin C, 2004, CNS SPECTRUMS, V9, P217, DOI 10.1017/S1092852900009019; LeBlanc JC, 2005, INT CLIN PSYCHOPHARM, V20, P275, DOI 10.1097/01.yic.0000166403.03732.72; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LEWIN J, 1992, BRIT J PSYCHIAT, V161, P261, DOI 10.1192/bjp.161.2.261; LIPPER S, 1977, J NERV MENT DIS, V5, P366; Lustig RH, 1999, J PEDIATR-US, V135, P162, DOI 10.1016/S0022-3476(99)70017-X; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1017/S0021963001006667; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; OSHANICK, 1998, TRAUMATIC BRAIN INJU, P53; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; Shapira NA, 2000, J CLIN PSYCHIAT, V61, P368, DOI 10.4088/JCP.v61n0508; STEWART JT, 1985, J CLIN PSYCHIAT, V46, P496; Stores G, 2001, CLIN DEV MED, P126; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86	43	11	11	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	AUG	2006	48	8					697	701		10.1017/S0012162206001472			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	068DY	WOS:000239353800016	16836786				2021-06-18	
J	Bathen, TF; Sjobakk, TE; Skranes, J; Brubakk, AM; Vik, T; Martinussen, M; Myhr, GE; Gribbestad, IS; Axelson, D				Bathen, Tone F.; Sjoebakk, Torill E.; Skranes, Jon; Brubakk, Ann-Mari; Vik, Torstein; Martinussen, Marit; Myhr, Gunnar E.; Gribbestad, Ingrid S.; Axelson, David			Cerebral metabolite differences in adolescents with low birth weight: assessment with in vivo proton MR spectroscopy	PEDIATRIC RADIOLOGY			English	Article						very low birth weight; in vivo proton MRS; probabilistic neural network; partial least squares regression discriminant analysis; adolescents; brain metabolites	MAGNETIC-RESONANCE-SPECTROSCOPY; FOR-GESTATIONAL-AGE; NEURAL-NETWORK ANALYSES; TRAUMATIC BRAIN-INJURY; PEAK ALIGNMENT; NMR SIGNALS; CHILDREN; INFANTS; DISEASE; H-1-MRS	Background: Children with very low birth weight (VLBW) have a significantly increased risk of later neurodevelopmental problems, while infants born small for gestational age (SGA) at term are also at some risk of developing neurological impairment. Objective: To investigate possible brain metabolite differences in adolescents with VLBW, SGA at term and controls by proton in vivo magnetic resonance spectroscopy (MRS) at 1.5 T. Materials and methods: MR spectra were acquired from volumes localized in the left frontal lobe, containing mainly white matter (54 subjects). Peak areas of N-acetyl aspartate (NAA), choline (Cho) and creatine (Cr) were determined, and the peak area ratio of NAA to Cr, total Cho to Cr, or NAA to Cho calculated. Probabilistic neural network (PNN) analysis was performed utilizing the chemical shift region containing resonances from NAA, Cho and Cr as inputs. Results: No significant difference in the peak area ratios could be found using the Kruskal-Wallis test. By application of PNN, a correct classification of 52 of the 54 adolescents with a sensitivity and specificity exceeding 93% for all groups was achieved. Conclusion: Small, yet systematic, differences in brain metabolite distribution among the groups were confirmed by PNN analysis.	Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, MTFS, N-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Neurosci, MTFS, N-7489 Trondheim, Norway; Norwegian Univ Sci & Technol, St Olavs Hosp HF, Dept Lab Med Childrens & Womens Hlth, N-7006 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practise, MTFS, N-7489 Trondheim, Norway; St Olavs Univ Hosp, Dept Radiol, N-7006 Trondheim, Norway; MRi Consulting, Kingston, ON, Canada	Bathen, TF (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, MTFS, N-7489 Trondheim, Norway.	tone.f.bathen@ntnu.no	Martinussen, Marit/AAE-8135-2021	Martinussen, Marit/0000-0002-7090-4326			ARNOLD DL, 2005, MR SPECTROSCOPY CLIN, P139; Axelson D, 2002, J MAGN RESON IMAGING, V16, P13, DOI 10.1002/jmri.10125; Bakken IJ, 1999, EPILEPSY RES, V35, P245, DOI 10.1016/S0920-1211(99)00019-4; Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1399; Cady EB, 1996, MAGN RESON MED, V36, P878, DOI 10.1002/mrm.1910360610; Despagne F, 1998, ANALYST, V123, p157R; Evensen KAI, 2004, ARCH DIS CHILD-FETAL, V89, pF451, DOI 10.1136/adc.2003.037788; Filippi CG, 2002, AM J NEURORADIOL, V23, P882; FORD CC, 1992, NEUROLOGY, V42, P1408, DOI 10.1212/WNL.42.7.1408; Forshed J, 2003, ANAL CHIM ACTA, V487, P189, DOI 10.1016/S0003-2670(03)00570-1; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Hollo O, 2002, ARCH PEDIAT ADOL MED, V156, P179, DOI 10.1001/archpedi.156.2.179; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Horska A, 2002, J MAGN RESON IMAGING, V15, P137, DOI 10.1002/jmri.10057; Imamura Keiko, 2003, Magn Reson Med Sci, V2, P117, DOI 10.2463/mrms.2.117; Indredavik MS, 2004, ARCH DIS CHILD-FETAL, V89, pF445, DOI 10.1136/adc.2003.038943; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Kemsley EK, 1996, CHEMOMETR INTELL LAB, V33, P47, DOI 10.1016/0169-7439(95)00090-9; KIMURA H, 1995, RADIOLOGY, V194, P483, DOI 10.1148/radiology.194.2.7529934; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Kutschera J, 2002, Z GEBURTSH NEONATOL, V206, P65, DOI 10.1055/s-2002-30139; Lee GC, 2004, ANAL CHIM ACTA, V513, P413, DOI 10.1016/j.aca.2004.02.068; LUCASIUS CB, 1993, CHEMOMETR INTELL LAB, V19, P1, DOI 10.1016/0169-7439(93)80079-W; MEYER B, 1991, SCIENCE, V251, P542, DOI 10.1126/science.1990429; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Moore GJ, 1998, PEDIATR RADIOL, V28, P805, DOI 10.1007/s002470050470; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Preul MC, 1996, NAT MED, V2, P323, DOI 10.1038/nm0396-323; Shu SK, 1997, PEDIATR NEUROL, V17, P309, DOI 10.1016/S0887-8994(97)00140-9; Skranes JS, 2005, PEDIATR RADIOL, V35, P758, DOI 10.1007/s00247-005-1446-2; Skranes JS, 1998, PEDIATR RADIOL, V28, P471, DOI 10.1007/s002470050387; SKRANES JS, 1993, NEUROPEDIATRICS, V24, P256, DOI 10.1055/s-2008-1071553; Smith LM, 2001, PEDIATRICS, V107, P227, DOI 10.1542/peds.107.2.227; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; TOFT PB, 1994, JMRI-J MAGN RESON IM, V4, P1, DOI 10.1002/jmri.1880040102; Usenius JP, 1996, NEUROREPORT, V7, P1597, DOI 10.1097/00001756-199607080-00013; Yeo RA, 2000, DEV NEUROPSYCHOL, V17, P143, DOI 10.1207/S15326942DN1702_01; Zimmerman RA, 1997, AM J NEURORADIOL, V18, P1872	40	11	11	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	AUG	2006	36	8					802	809		10.1007/s00247-006-0159-5			8	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	068GZ	WOS:000239362400007	16703344				2021-06-18	
J	Briassoulis, G; Mavrikiou, M; Margeli, A; Lazaropoulou, C; Natsi, L; Papassotiriou, I; Hatzis, T				Briassoulis, George; Mavrikiou, Maria; Margeli, Alexandra; Lazaropoulou, Christina; Natsi, Labrini; Papassotiriou, Ioannis; Hatzis, Tasos			Circulating levels of KL-6 in acute respiratory distress syndrome sepsis or traumatic brain injury in critically ill children	PEDIATRIC PULMONOLOGY			English	Article						acute respiratory distress syndrome; critically ill children; KL-6; sepsis; traumatic brain injury	ACUTE LUNG INJURY; PULMONARY ALVEOLAR PROTEINOSIS; HUMAN MUC1 MUCIN; SERUM KL-6; CONSENSUS CONFERENCE; CLINICAL-OUTCOMES; DISEASE-ACTIVITY; PLASMA; FLUID; DEFINITIONS	KL-6 is a high molecular weight glycoprotein that is expressed on the apical borders of normal secretary alveolar epithelial cells. The aim of our study was to elucidate the potential role of circulating levels of KL-6, related to C-reacting protein (CRP), disease severity (PRISM, TISS), length of stay (LOS) or mechanical ventilation (LOMV), and outcome, in children with acute respiratory distress syndrome (ARDS), sepsis, or traumatic brain injury (TBI). KL-6 concentrations were monitored using solid phase sandwich enzyme-linked immunosorbent assay in plasma of nine patients with ARDS and compared to nine patients with TBI, nine with sepsis, and nine ventilated patients with cancer of matched illness severity on days 1, 3, 5, 7, and 10. Initial respiratory/ventilatory parameters (oxygenation index, plateau pressures) were recorded for ARDS patients. Patients with ARDS had higher early plasma levels of KL-6 (956 +/- 400 U/ml), as compared to patients with TBI (169 +/- 9 U/ml), sepsis (282 +/- 81 U/ml), and ventilated controls (255 +/- 40 U/ml). Significant correlations were demonstrated between plasma KL-6 concentration and oxygenation index, PaO2: FiO(2) ratio, LOS and LOMV, but not with CRP or PRISM. Only in patients with ARDS, plasma KL-6 levels were higher in non-survivors than survivors (P< 0.03). Plasma KL-6 levels have possible prognostic significance and may provide a useful marker for ARDS in critically ill children.	Univ Hosp Heraklion, Pediat Intens Care Unit, Iraklion 71110, Crete, Greece; Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens, Greece	Briassoulis, G (corresponding author), Univ Hosp Heraklion, Pediat Intens Care Unit, POB 1352, Iraklion 71110, Crete, Greece.	ggbriass@otenet.gr					Agouridakis P, 2002, RESPIR RES, V3, DOI 10.1186/rr193; Ashida T, 2001, INT J HEMATOL, V74, P464, DOI 10.1007/BF02982094; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brower RG, 2004, NEW ENGL J MED, V351, P327; Curley MAQ, 2005, JAMA-J AM MED ASSOC, V294, P229, DOI 10.1001/jama.294.2.229; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Flori Heidi R, 2003, Pediatr Crit Care Med, V4, P315, DOI 10.1097/01.PCC.0000074583.27727.8E; Flori HR, 2005, AM J RESP CRIT CARE, V171, P995, DOI 10.1164/rccm.200404-544OC; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; HAMADA H, 1992, CHEST, V101, P858, DOI 10.1378/chest.101.3.858; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hirasawa Y, 1997, AM J RESP CELL MOL, V17, P501, DOI 10.1165/ajrcmb.17.4.2253; Inoue Y, 2006, RESPIROLOGY, V11, pS55, DOI 10.1111/j.1440-1843.2006.00810.x; Inoue Y, 1997, AM J RESP CRIT CARE, V156, P109, DOI 10.1164/ajrccm.156.1.9612043; Ishizaka A, 2004, AM J PHYSIOL-LUNG C, V286, pL1088, DOI 10.1152/ajplung.00420.2002; Kashiwabara K, 2006, CHEST, V129, P402, DOI 10.1378/chest.129.2.402; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; Kobayashi J, 1996, CHEST, V109, P1276, DOI 10.1378/chest.109.5.1276; KOBAYASHI J, 1995, CHEST, V108, P311, DOI 10.1378/chest.108.2.311; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; KOHNO N, 1993, AM REV RESPIR DIS, V148, P637, DOI 10.1164/ajrccm/148.3.637; Kuwano K, 2002, RESPIROLOGY, V7, P15, DOI 10.1046/j.1440-1843.2002.00369.x; Ohshimo S, 2005, BIOCHEM BIOPH RES CO, V338, P1845, DOI 10.1016/j.bbrc.2005.10.144; Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Sato H, 2004, EUR RESPIR J, V23, P142, DOI 10.1183/09031936.03.00070303; Selman M, 2003, AM J RESP CELL MOL, V29, pS93; Takahashi T, 1998, AM J RESP CRIT CARE, V158, P1294, DOI 10.1164/ajrccm.158.4.9712003; Thammasitboon Satid, 2005, Pediatr Crit Care Med, V6, P340; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115; Zhao X, 2005, LUNG, V183, P87, DOI 10.1007/s00408-004-2522-3	32	11	12	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	8755-6863	1099-0496		PEDIATR PULM	Pediatr. Pulmonol.	AUG	2006	41	8					790	795		10.1002/ppul.20465			6	Pediatrics; Respiratory System	Pediatrics; Respiratory System	067AF	WOS:000239271600014	16779848				2021-06-18	
J	Mazzeo, AT; Kunene, NK; Choi, S; Gilman, C; Bullock, RM				Mazzeo, Anna Teresa; Kunene, Niki K.; Choi, Sung; Gilman, Charlotte; Bullock, Ross M.			Quantitation of ischemic events after severe traumatic brain injury in humans: A simple scoring system	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						severe head injury; cerebral ischemia; outcome; microdialysis; scoring system	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; EXCITATORY AMINO-ACIDS; INTERSTITIAL GLYCEROL; INTRACEREBRAL MICRODIALYSIS; TISSUE OXYGENATION; LACTATE; METABOLISM; GLUCOSE; HYPOXIA	Background: Cerebral ischemia is recognized as one of the most important mechanisms responsible for secondary brain damage following severe traumatic brain injury (TBI), contributing to an increased mortality and a worse neurologic outcome. Method: A simple 5-item scoring system, taking into account the occurrence of specific potentially brain-damaging events (hypoxemia, hypotension, low cerebral blood flow, herniation, and low cerebral perfusion pressure) has been tested in a large population of severe TBI patients. Aims of this retrospective study were to validate the ability of the proposed ischemic score to predict neurologic outcome and to correlate the ischemic score with the results of microdialysis-based neurochemical monitoring and brain tissue oxygen monitoring. Findings: In a population of 172 severe TBI patients, a significant correlation was found between ischemic score and neurologic outcome, both at 3 months (r = -0.32; P < 0.01) and at 6 months (r = -0.31; P < 0.01). Significant correlations were also found with the most important neurochemical analytes. Conclusions: The ischemic score proposed here, may be determined during the acute intensive care unit period, and correlates closely with outcome, which can only be determined 3 to 6 months, after injury. It also shows a correlation with neurochemical analytes.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Div Neurosurg, Richmond, VA 23219 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Informat Syst, Richmond, VA 23219 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Richmond, VA 23219 USA; Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Messina, Italy	Bullock, RM (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Div Neurosurg, 417 N 11th St,ACC 6th Floor,Harold F Young Neuros, Richmond, VA 23219 USA.	robulloc@hsc.vcu.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		Alessandri B, 1999, ACT NEUR S, V75, P21; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BELL BA, 1985, J NEUROSURG, V62, P31, DOI 10.3171/jns.1985.62.1.0031; BOSE B, 1988, STROKE, V19, P28, DOI 10.1161/01.STR.19.1.28; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Cornford EM, 2002, EPILEPSIA, V43, P1360, DOI 10.1046/j.1528-1157.2002.01602.x; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hong SS, 2004, BRAIN RES, V1009, P195, DOI 10.1016/j.brainres.2004.03.004; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; JENNETT B, 1975, LANCET, V1, P480; Jones SC, 2002, ANESTHESIOLOGY, V97, P488, DOI 10.1097/00000542-200208000-00028; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koura SS, 1998, ACT NEUR S, V71, P244; LANGEMANN H, 1995, CLIN NEUROL NEUROSUR, V97, P149, DOI 10.1016/0303-8467(94)00067-G; Lewandowski K, 2003, ANAESTHESIST, V52, P965, DOI 10.1007/s00101-003-0550-7; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marrif H, 1999, J NEUROSCI RES, V57, P255; Mendelowitsch A, 2001, METHODS, V23, P73, DOI 10.1006/meth.2000.1107; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MORAWETZ RB, 1979, FED PROC, V38, P2493; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Ridley SA, 2002, ANAESTHESIA, V57, P761, DOI 10.1046/j.1365-2044.2002.02619.x; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; Schneweis S, 2001, STROKE, V32, P1863, DOI 10.1161/01.STR.32.8.1863; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Siddiqui MM, 2001, METHODS, V23, P83, DOI 10.1006/meth.2000.1108; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; SYMON L, 1976, STROKE, V7, P547, DOI 10.1161/01.STR.7.6.547; Symon L, 1977, Adv Exp Med Biol, V94, P775; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zauner A, 1996, ACT NEUR S, V67, P40; Zwienenberg M, 2001, HEAD TRAUMA, P303	63	11	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2006	18	3					170	178		10.1097/01.ana.0000210999.18033.f6			9	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	059FQ	WOS:000238719100002	16799343				2021-06-18	
J	Olasode, BJ; Komolafe, IE; Komolafe, M; Olasode, OA				Olasode, Babatunde J.; Komolafe, I. E.; Komolafe, M.; Olasode, Olayinka A.			Traumatic spinal cord injuries in Ile-Ife, Nigeria, and its environs	TROPICAL DOCTOR			English	Article							PATHOPHYSIOLOGY	In Ile-Ife, Nigeria, traumatic brain injuries are largely due to traffic accidents caused mainly by the bad maintenance of the roads and unsafe driving. Young men in the productive stage of their lives are those most affected. The resultant disabilities include quadriplegia (in more than half the patients) and paraplegia. The cost of treating and providing adequate facilities for these patients imposes a heavy economic burden upon developing countries.	Obafemi Awolowo Univ, Dept Morbid Anat, Ife, Osun State, Nigeria; Obafemi Awolowo Univ, Dept Neurosurg, Ife, Osun State, Nigeria; Obafemi Awolowo Univ, Dept Neurol, Ife, Osun State, Nigeria; Obafemi Awolowo Univ, Dept Dermatol, Ife, Osun State, Nigeria	Olasode, BJ (corresponding author), Obafemi Awolowo Univ, Dept Morbid Anat, PMB 5538, Ife, Osun State, Nigeria.	bjshalom428@yahoo.com	Olasode, Olayinka/AAL-6831-2020				Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HUGHES JT, 1997, BROCKS INJURIES BRAI, P668; LEESTMA JE, 1997, NEUROPATHOLOGY DIAGN, P475; TATOR CH, 1990, BRIT J SURG, V77, P485; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x	7	11	11	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0049-4755	1758-1133		TROP DOCT	Trop. Dr.	JUL	2006	36	3					181	182		10.1258/004947506777978136			2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	073FW	WOS:000239729400023	16884634				2021-06-18	
J	Zhao, WZ; Wu, CY; Yin, K; Young, TY; Ginsberg, MD				Zhao, Weizhao; Wu, Chunyan; Yin, Kai; Young, Tzay Y.; Ginsberg, Myron D.			Pixel-based statistical analysis by a 3D clustering approach: Application to autoradiographic images	COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE			English	Article						autoradiographic images; traumatic brain injury; statistical analysis; image processing	CEREBRAL-ARTERY OCCLUSION; GLUCOSE-UTILIZATION; BLOOD-FLOW; QUANTITATIVE AUTORADIOGRAPHY; PROBABILISTIC ATLAS; PARAMETRIC MAPS; BRAIN RESPONSES; PET IMAGES; ACTIVATION; RATS	Statistical analysis of medical images in experimental laboratories plays an important role in confirming scientific findings and in guiding potential clinical applications. In experimental neuroscience studies, autoradiographic images taken under differing physiological or pathological conditions from replicate animals are often compared in order to detect any significant change in glucose utilization or blood flow and to localize these changes. For these comparisons to be valid and informative, proper statistical procedures are in order. Conventional methods include statistic parametric mapping (SPM) analysis, non-parametric analysis and cluster- analysis. Each method of comparison has a specific purpose. This paper describes an approach that combines these conventional methods and presents a non-parametric statistical procedure based on cluster- analysis for localizing significant differences in autoradiographic data sets. By thresholding cluster sizes rather than pixel values to reject false positives, this approach enhances statistical power. By re-shuffling the data sets to produce the null distribution of a cluster size statistic, the test makes few assumptions as to the statistical properties of the SPM, and thus it is valid under a broad range of conditions. The designed method was tested on autoradiographic images of rats subjected to moderate traumatic brain injury (TBI). Different methods were also performed on the same data sets. Comparison among these methods shows that this method is suitable for the statistical analysis of autoradiographic images. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; Univ Miami, Dept Elect & Comp Engn, Coral Gables, FL 33124 USA; Univ Miami, Sch Med, Dept Neurol, Cerebral Vasc Dis Res Ctr, Miami, FL 33101 USA	Zhao, WZ (corresponding author), Univ Miami, Dept Biomed Engn, POB 248294, Coral Gables, FL 33124 USA.	w.zhao1@miami.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2P50NS05820] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS005820] Funding Source: NIH RePORTER		Back T, 1998, NEUROL RES, V20, P643; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BROWN LG, 1992, ACM COMPUT SURV, V24, P325, DOI DOI 10.1145/146370.146374; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Cheng RCH, 2001, WSC'01: PROCEEDINGS OF THE 2001 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P179, DOI 10.1109/WSC.2001.977264; Dinov ID, 2000, J COMPUT ASSIST TOMO, V24, P128, DOI 10.1097/00004728-200001000-00024; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; FOX PT, 1991, J CEREBR BLOOD F MET, V11, pA79, DOI 10.1038/jcbfm.1991.41; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; GHATAN PH, 1995, NEUROIMAGE, V2, P112, DOI 10.1006/nimg.1995.1014; Ginsberg MD, 2003, ANN NEUROL, V54, P330, DOI 10.1002/ana.10659; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Gonzalez R.C., 2002, DIGITAL IMAGE PROCES, V2nd; HIBBARD LS, 1984, AM J PHYSIOL, V247, pE412; HIBBARD LS, 1987, SCIENCE, V236, P1641, DOI 10.1126/science.3603004; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; Iwi G, 1999, PHYS MED BIOL, V44, pN55, DOI 10.1088/0031-9155/44/4/021; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; MATTHEWS DE, 1985, USING UNDERSTANDING; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McColl J H, 1994, Stat Methods Med Res, V3, P63, DOI 10.1177/096228029400300105; Paxinos G., 1982, RAT BRAIN STEREOTAXI; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Rangarajan A, 1997, Med Image Anal, V1, P379; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Royackkers N, 1999, NEUROIMAGE, V10, P625, DOI 10.1006/nimg.1999.0512; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; Siegel S., 1956, NONPARAMETRIC STAT B; SMITH CB, 1988, P NATL ACAD SCI USA, V85, P9341, DOI 10.1073/pnas.85.23.9341; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Thompson P M, 1997, Med Image Anal, V1, P271; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; VOTAW JR, 1995, J CEREBR BLOOD F MET, V15, P492, DOI 10.1038/jcbfm.1995.61; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552, DOI 10.1038/jcbfm.1995.69; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003; ZHAO WZ, 1993, IEEE T MED IMAGING, V12, P782, DOI 10.1109/42.251130; Zilles K., 1985, CORTEX RAT	46	11	11	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-2607	1872-7565		COMPUT METH PROG BIO	Comput. Meth. Programs Biomed.	JUL	2006	83	1					18	28		10.1016/j.cmpb.2006.05.005			11	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods; Engineering, Biomedical; Medical Informatics	Computer Science; Engineering; Medical Informatics	067ZY	WOS:000239342500003	16828919				2021-06-18	
J	Kennedy, JE; Lumpkin, RJ; Grissom, JR				Kennedy, JE; Lumpkin, RJ; Grissom, JR			A survey of mild traumatic brain injury treatment in the emergency room and primary care medical clinics	MILITARY MEDICINE			English	Article; Proceedings Paper	27th Annual Williamsburg Traumatic Brain Injury Rehabilitation Conference	JUN 06-08, 2003	Williamsburg, VA				HEAD-INJURY; RISK-FACTORS; MANAGEMENT; VALIDATION; DIAGNOSIS; PROPOSAL; US	This study surveyed health care providers about their evaluation and treatment of mild traumatic brain injury (TBI) in adults. We presented two vignettes describing mild TBI cases to staff in the emergency department (N = 22) and primary care clinics (N = 16) at Wilford Hall Air Force Medical Center and asked how they would evaluate and treat these patients. Most providers said they would assess visual changes, nausea[vomiting, headache, and neck pain. More emergency department personnel than primary care clinic providers would make referrals to different specialties, whereas more primary care clinic providers would schedule a follow-up appointment. Neither group of providers mentioned assessing common postconcussive symptoms of fatigue, emotional changes, and problems sleeping. Comparing findings to current literature suggest that added focus on emotional, cognitive and psychosocial factors, and education of the patient and family could improve early identification of mild TBI patients at risk for poor recovery.	Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX 78227 USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA	Kennedy, JE (corresponding author), Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, POB 27376, San Antonio, TX 78227 USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; *CDCP NAT CTR INJ, 2003, REP C MILD TRAUM BRA; *CTR DIS CONTR PRE, 2001, INJ FACT BOOK 2001 2; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; KAY T, 1992, PHYSICAL MED REHABIL, V6, P109; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schootman M, 2000, BRAIN INJURY, V14, P373; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609	23	11	11	0	2	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JUN	2006	171	6					516	521		10.7205/MILMED.171.6.516			6	Medicine, General & Internal	General & Internal Medicine	058IH	WOS:000238658200017	16808133	Bronze			2021-06-18	
J	Pape, TLB; Lundgren, S; Heinemann, AW; Guernon, A; Giobbie-Hurder, A; Wang, J; Roth, H; Blahnik, M; Williams, V				Pape, Theresa Louise-Bender; Lundgren, Sandra; Heinemann, Allen W.; Guernon, Ann; Giobbie-Hurder, Anita; Wang, Jia; Roth, Heidi; Blahnik, Melanie; Williams, Vanessa			Establishing a prognosis for functional outcome during coma recovery	BRAIN INJURY			English	Article						coma; unconsciousness; prognostication; functional outcomes	TRAUMATIC BRAIN-INJURY; CRAIG HANDICAP ASSESSMENT; EFFECTS REGRESSION-ANALYSIS; DISABILITY RATING-SCALE; COMMUNITY INTEGRATION; LIFE SATISFACTION; PATIENT HEALTH; REHABILITATION; VALIDITY; RELIABILITY	Primary objective: One of the most challenging tasks for clinicians caring for survivors of severe brain injury (BI) is establishing a prognosis, for long-term functional outcome, while the patient is unconscious. The objective of this article is to report findings regarding the prediction of functional outcomes 1-year after severe BI using data available when the patient is unconscious. Research design: Longitudinal prognostication study. Methods and procedures: Persons unconscious after severe BI who present to inpatient (IP) rehabilitation hospitals in the Midwestern US are enrolled in an ongoing study. Each subject is followed for 1-year and the final outcome interview includes similar to 70 questions; 32 of these questions are from the Craig Handicap Assessment and Reporting Technique (CHART). A sample of 63 persons was abstracted from the study database to examine the predictability of 42 independent variables and 16 dichotomous outcomes. Main outcomes and results: Twelve of the 16 dichotomous outcomes were found to be significantly predictable (p < 0.05). These involve activity, participation, environment and quality of life outcomes. Ten predictors were found to be significant (p < 0.05): aetiology (Closed Head Injury vs. Other BI), presence of urinary tract infection (UTI), seizure, hypertension during IP rehabilitation, veteran benefit eligibility, health insurance, marital status at injury, whether or not recovery of consciousness occurred within 1 year, the number of days between injury and admission to acute rehabilitation and the average length of IP rehabilitation stay. Eight of the 10 variables are available early after injury or when the patient is unconscious.	Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, Hines, IL 60141 USA; Marianjay Rehabil Hosp, Wheaton, IL USA; Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; VA Med Ctr, Mental & Behav Hlth Patient Serv Line MC 116 B, Minneapolis, MN USA; VA Med Ctr, Def & Vet Brain Injury Ctr, Minneapolis, MN USA; Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; Edward Hines Jr VA Hosp, VA Cooperat Studies Program Coordinating Ctr, Hines, IL USA; Rehabil Inst Chicago, Traumat Brain Injury Program, Chicago, IL 60611 USA	Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, POB 5000,M-C 15H, Hines, IL 60141 USA.	theresa.pape@va.gov	Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326; Bender Pape, Theresa/0000-0001-7738-5963			Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Anderson Caroline J, 2002, J Spinal Cord Med, V25, P184; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORWIN B, 1996, J PHYS MED REHABILIT, V75, P105; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GIACINO J, 1992, JFK COMA RECOVERY SC; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; Hahn EA, 2003, ARCH PHYS MED REHAB, V84, pS35, DOI 10.1053/apmr.2003.50245; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hanson CS, 2001, AM J OCCUP THER, V55, P332, DOI 10.5014/ajot.55.3.332; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hedeker D, 1996, COMPUT METH PROG BIO, V49, P229, DOI 10.1016/0169-2607(96)01723-3; Hedeker D, 2000, STAT METHODS MED RES, V9, P161, DOI 10.1191/096228000667253473; Henderson V W, 1987, Bull Clin Neurosci, V52, P47; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JENNETT B, 1975, LANCET, V1, P480; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; PAPE T, 1999, THESIS U ILLINOIS CH; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Pape TLB, 2004, J REHABIL RES DEV, V41, P155, DOI 10.1682/JRRD.2004.02.0155; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENTHAL M, 1999, FUNCTIONAL CONSEQUEN; ROTHMAN ML, 1991, MED CARE, V29, P115, DOI 10.1097/00005650-199102000-00004; SEGAL ME, 1995, AM J PHYS MED REHAB, V74, P276, DOI 10.1097/00002060-199507000-00004; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tyler EJ, 2002, ARCH PHYS MED REHAB, V83, P236, DOI 10.1053/apmr.2002.27466; Vogel LC, 1998, ARCH PHYS MED REHAB, V79, P1496, DOI 10.1016/S0003-9993(98)90409-9; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; World Health Organization ( WHO ), 2002, COMM LANG FUNCT DIS; Wright B.D., 1982, RATING SCALE ANAL; Zafonte RD, 1996, NEUROREHABILITATION, V6, P19, DOI 10.3233/NRE-1996-6104; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	49	11	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	7					743	758		10.1080/02699050600676933			16	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200009	16809207				2021-06-18	
J	Ringel, F; Baethmann, A; Plesnila, N				Ringel, F; Baethmann, A; Plesnila, N			Lactacidosis-induced glial cell swelling depends on extracellular Ca2+	NEUROSCIENCE LETTERS			English	Article						cell volume regulation; acidosis-induced cell swelling; cytotoxic brain edema; calcium; glial cells	C6 GLIOMA-CELLS; VOLUME REGULATION; INTRACELLULAR PH; INVITRO MODEL; BRAIN EDEMA; LACTIC-ACID; ACIDIFICATION; COTRANSPORT; ASTROCYTES; MECHANISMS	Cerebral tissue acidosis following ischemia or traumatic brain injury contributes to cytotoxic brain edema formation. In vitro lactacidosis induces swelling of glial cells by intracellular Na+- and Cl--accumulation by the Na+/H+-antiporter, Cl-/HCO3--antiporters and the Na+-K+-2Cl(-) cotransport. The present study aimed to elucidate whether mechanisms of lactacidosis-induced glial swelling are dependent on intra-or extracellular Ca2+-ions. Therefore, C6 glioma cells were exposed to a lactacidosis of pH 6.2 in standard or calcium-free medium and following intracellular calcium chelation. Cell volume and intracellular pH were assessed by flow cytometry. Lactacidosis of pH 6.2 induced a prompt and sustained swelling of suspended C6 glioma cells reaching a maximum of 128% within 60 min. Omission of Ca2+ from the suspension medium strongly attenuated cell swelling while chelation of intracellular Ca2+ had no effects. Intracellular acidosis was not affected by either treatment. The present data show a strong dependency of lactacidosis-induced glial swelling upon extracellular Ca2+ while intracellular acidosis is not affected by omission of [Ca2+](e). Therefore, our data suggest that the Na+-K+-2Cl(-)-cotransporter, the only so far known transporter involved in cell volume regulation but not in pH(i) regulation during lactacidosis, is activated in a [Ca2+](e)-dependent manner. (c) 2006 Elsevier Ireland Ltd. All rights reserved.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Ctr Med, Walter Brendel Ctr Expt Med, Lab Expt Neurosurg, Munich, Germany	Ringel, F (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	florian.ringel@ukb.uni-bonn.de	Ringel, Florian/E-4933-2014; Plesnila, Nikolaus/T-7522-2019				BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; CHASSANDE O, 1988, EUR J BIOCHEM, V171, P425, DOI 10.1111/j.1432-1033.1988.tb13807.x; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; GOLDMAN SA, 1989, J CEREBR BLOOD F MET, V9, P471, DOI 10.1038/jcbfm.1989.70; JAKUBOVICZ DE, 1987, BRAIN RES, V435, P138, DOI 10.1016/0006-8993(87)91594-0; JAKUBOVICZ DE, 1989, BRAIN RES, V485, P215, DOI 10.1016/0006-8993(89)90564-7; KACHEL V, 1976, J HISTOCHEM CYTOCHEM, V24, P211, DOI 10.1177/24.1.1254918; KEMPSKI O, 1987, STROKE, V18, P623, DOI 10.1161/01.STR.18.3.623; KEMPSKI O, 1988, STROKE, V19, P385, DOI 10.1161/01.STR.19.3.385; KEMPSKI O, 1983, BRAIN RES, V279, P217, DOI 10.1016/0006-8993(83)90180-4; KIMELBERG HK, 1987, J PHYSIOL-PARIS, V82, P294; MARMAROU A, 1992, J NEUROTRAUM, V9, P551; Mongin AA, 1996, BBA-BIOMEMBRANES, V1285, P229, DOI 10.1016/S0005-2736(96)00165-4; MONGIN AA, 1994, BRAIN RES, V655, P110, DOI 10.1016/0006-8993(94)91603-9; Morihata H, 2000, J NEUROSCI, V20, P7220; Nabekura T, 2003, GLIA, V41, P247, DOI 10.1002/glia.10190; Pasantes-Morales H, 2000, NEUROCHEM RES, V25, P1301, DOI 10.1023/A:1007652330703; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Pringle AK, 2004, CELL CALCIUM, V36, P235, DOI 10.1016/j.ceca.2004.02.014; Ringel F, 2000, J NEUROCHEM, V75, P125, DOI 10.1046/j.1471-4159.2000.0750125.x; SIESJO BK, 1988, NEUROCHEM PATHOL, V9, P31; STAUB F, 1993, J NEUROL SCI, V119, P79, DOI 10.1016/0022-510X(93)90194-4; STAUB F, 1994, J CEREBR BLOOD F MET, V14, P1030, DOI 10.1038/jcbfm.1994.135; STAUB F, 1990, J CEREBR BLOOD F MET, V10, P866, DOI 10.1038/jcbfm.1990.143; STRUPP M, 1993, GLIA, V9, P136, DOI 10.1002/glia.440090207; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012	26	11	12	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAY 8	2006	398	3					306	309		10.1016/j.neulet.2006.01.012			4	Neurosciences	Neurosciences & Neurology	041DQ	WOS:000237434000029	16469448				2021-06-18	
J	Radulovic, D; Janosevic, V; Djurovic, B; Slavik, E				Radulovic, D.; Janosevic, V.; Djurovic, B.; Slavik, E.			Traumatic delayed epidural hematoma	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						head injury; delayed epidural hematoma; neurological observation; computerized tomography	MILD HEAD-INJURY; EXTRADURAL HEMATOMA; ONSET	Object: Traumatic delayed epidural hematoma (DEH) can be defined as a hematoma that is insignificant or not present on the initial computerized tomography (CT) scan made after trauma but subsequent CT scan shows sizeable epidural bleeding. During a 3-year period we have treated a total of 96 epidural hematomas, eight (8.3%) of which had a delayed onset. Case Report: We present here an analysis of the eight patients with traumatic DEH which had a significant mass effect in all patients and required surgical evacuation. In three patients with mild head injury (GCS > 12) neurological deterioration indicated the necessity of repeating the CT scan and preceded the detection of DEH. In only one case of the five patients with moderate (8 < GCS < 13) and severe head injury (GCS < 9) was neurological deterioration the precursor of the DEH. All patients were immediately operated on after diagnosis. Postoperative outcome was favorable in all cases. Conclusions: DEHs are highly unpredictable and continue to cause diagnostic difficulty. Close observation for signs of clinical deterioration and repeat CT scan are the most important factors for early detection of DEH. Early diagnosis and prompt operation offers excellent results for DEHs.	Clin Ctr Serbia, Inst Neurosurg, Belgrade 11000, Serbia Monteneg	Radulovic, D (corresponding author), Clin Ctr Serbia, Inst Neurosurg, Visegradska 26, Belgrade 11000, Serbia Monteneg.	rd@yubc.net					Alappat JP, 2002, NEUROL INDIA, V50, P313; ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; BUCCI MN, 1986, NEUROSURGERY, V19, P65, DOI 10.1227/00006123-198607000-00009; DIROCCO A, 1991, NEURORADIOLOGY, V33, P253, DOI 10.1007/BF00588229; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; Ferrera PC, 1997, AM J EMERG MED, V15, P76, DOI 10.1016/S0735-6757(97)90055-3; FUKAMACHI A, 1984, COMPUT RADIOL, V8, P197, DOI 10.1016/0730-4862(84)90123-9; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; Inamasu J, 2001, AM J EMERG MED, V19, P324, DOI 10.1053/ajem.2001.24480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; POON WS, 1992, NEUROSURGERY, V30, P681; Riesgo P, 1997, SURG NEUROL, V48, P226, DOI 10.1016/S0090-3019(97)00194-8; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8	14	11	12	0	2	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.	MAY	2006	67	2					76	80		10.1055/s-2006-933359			5	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	042WL	WOS:000237561200003	16673239				2021-06-18	
J	Barus, D; Kozin, SH				Barus, Diane; Kozin, Scott H.			The evaluation and treatment of elbow dysfunction secondary to spasticity and paralysis	JOURNAL OF HAND THERAPY			English	Article							TO-TRICEPS TRANSFER; SPINAL-CORD INJURY; BOTULINUM TOXIN; TETRAPLEGIA; BICEPS	An integrated pharmaceutical, surgical, and therapeutic approach is described for the management of patients with spasticity and paralysis of the elbow due to central nervous system injury The patient populations considered in this article include those with cerebral palsy, traumatic brain injury, and spinal cord injuries. Therapy evaluations and techniques and pharmacologic interventions to prevent loss of elbow motion are presented. Surgical techniques such as tendon lengthening, joint releases, and/or tendon transfer and postoperative therapy guidelines to restore loss of elbow motion are reviewed. Outcomes of this team approach in one clinical setting are presented.	Shriners Hosp Children, Philadelphia, PA 19140 USA; Temple Univ, Dept Orthopaed Surg, Philadelphia, PA 19122 USA	Kozin, SH (corresponding author), Shriners Hosp Children, 3551 N Broad St, Philadelphia, PA 19140 USA.	skozin@shrinenet.org					APPLE DF, 1996, CHILD SPINAL CORD IN, P269; BLACKMORE SM, REHABILITATION HAND, P1779; Cup EHC, 2003, CLIN REHABIL, V17, P402, DOI 10.1191/0269215503cr635oa; Dunkerley AL, 2000, SPINAL CORD, V38, P435, DOI 10.1038/sj.sc.3101025; Flowers K R, 1994, J Hand Ther, V7, P150; GRIFFITH AJ, REHABILITATION HAND, P1245; HAMBLETON P, 1993, J MED MICROBIOL, V39, P243, DOI 10.1099/00222615-39-4-243; HANSON RW, 1976, ARCH PHYS MED REHAB, V57, P291; House J H, 1976, J Hand Surg Am, V1, P152; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KOZIN SH, 2002, J AM SOC SURG HAND, V3, P141; Kuz JE, 1999, J HAND SURG-AM, V24A, P161; Law M, 1990, Can J Occup Ther, V57, P82; Law M, 1994, Can J Occup Ther, V61, P191; MACDERMID JC, REHABILITATION HAND, P285; MCCLURE PW, 1994, PHYS THER, V74, P1101, DOI 10.1093/ptj/74.12.1101; MORREY BF, 1990, J BONE JOINT SURG AM, V72A, P601, DOI 10.2106/00004623-199072040-00019; Mulcahey MJ, 1999, J PEDIATR ORTHOPED, V19, P319, DOI 10.1097/00004694-199905000-00008; Mulcahey MJ, 2003, J HAND SURG-AM, V28A, P964, DOI 10.1016/S0363-5023(03)00485-4; PELJOVICH AE, REHABILITATION HAND, P854; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Revol M, 1999, J HAND SURG-BRIT EUR, V24B, P235, DOI 10.1054/jhsb.1998.0184; Sewell L, 2001, BR J OCCUP THER, V64, P305, DOI DOI 10.1177/030802260106400607; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; Vogel L, 1997, DEV MED CHILD NEUROL, V39, P202	25	11	11	0	1	HANLEY & BELFUS-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0894-1130			J HAND THER	J. Hand Ther.	APR-JUN	2006	19	2					192	205		10.1197/j.jht.2006.02.012			14	Orthopedics; Rehabilitation; Surgery	Orthopedics; Rehabilitation; Surgery	101RZ	WOS:000241759500012	16713867				2021-06-18	
J	Mukhida, K; Sharma, MR; Shilpakar, SK				Mukhida, K; Sharma, MR; Shilpakar, SK			Pediatric neurotrauma in Kathmandu, Nepal: implications for injury management and control	CHILDS NERVOUS SYSTEM			English	Article						brain injury; developing countries; epidemiology; Nepal; preventive measures; spinal cord injury	TRAUMATIC BRAIN-INJURY; LIFE-SUPPORT PROGRAM; LOW-INCOME COUNTRIES; CHILDHOOD INJURIES; MEDICAL-SERVICES; GLOBAL BURDEN; CHILDREN; HEALTH; CARE; NEUROSURGERY	There is a scarcity of data regarding childhood neurological injuries in developing countries such as Nepal. The epidemiology of acute pediatric neurotrauma in Kathmandu was studied to assess the implications of these data for injury prevention programs. The clinical records of patients <= 18 years who presented to Tribhuvan University Teaching Hospital between April 1, 2001 and April 1, 2004 with acute neurological trauma and were subsequently admitted to hospital were retrospectively reviewed. A standard proforma was used to collect information on patient demographics, the nature and etiology of the injuries, their acute management, and outcomes. Four hundred sixteen injured children were admitted to hospital, and the charts for 352 (85%) were available for review. Spinal injuries were relatively rare (4%) compared to head injuries (96%). Falls were the most common cause of injuries (61%). It took significantly longer (p < 0.001) for children injured in rural Nepal (62%) to obtain neurosurgical care (30.1 h) than those injured within Kathmandu (7.1 h). A Glasgow Outcome Score of 5 was obtained for 96%, 76%, and 22% of patients with mild, moderate, or severe head injuries, respectively. Besides efforts to improve prehospital transport and acute management of these injuries, preventive measures that are applicable to the Nepalese scenario are urgently needed. Interventions should focus on health education programs directed at parents and children and upgrading of road safety measures. Neurological injuries must also be viewed in the context of the broader social issues in Nepal that contribute to injury.	Dalhousie Univ, Cell Restorat Lab, Dept Anat & Neurobiol, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Cell Restorat Lab, Dept Surg, Halifax, NS B3H 4H7, Canada; Univ Toronto, Div Neurosurg, Toronto, ON, Canada; Tribhuvan Univ, Inst Med, Div Neurosurg, Kathmandu, Nepal	Mukhida, K (corresponding author), Dalhousie Univ, Cell Restorat Lab, Dept Anat & Neurobiol, 5850 Coll St,12th Floor,Sir Charles Tupper Med Bl, Halifax, NS B3H 4H7, Canada.	kmukhida@dal.ca	Sharma, Mohan/AAP-9322-2021				Abantanga FA, 1998, PEDIATR SURG INT, V13, P515, DOI 10.1007/s003830050387; Ad Hoc Committee on Health Research Relating to Future Intervention Options, 1996, INV HLTH RES DEV; ADELOYE A, 1986, CHILD NERV SYST, V2, P309, DOI 10.1007/BF00271945; Albright AL, 2004, J NEUROSURG, V101, P125, DOI 10.3171/ped.2004.101.2.0125; ALI J, 1994, J TRAUMA, V36, P391, DOI 10.1097/00005373-199403000-00020; ALI J, 1993, J TRAUMA, V34, P890, DOI 10.1097/00005373-199306000-00022; ALLHOUSE MJ, 1993, PEDIATR EMERG CARE, V9, P159; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; *B TRAUM FDN, 2000, GUID PREH MAN TRAUM; *B TRAUM TASK FORC, 2000, J NEUROTRAUM, V17, P451; Bagan M, 1997, SURG NEUROL, V47, P512, DOI 10.1016/S0090-3019(96)00546-0; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; BERGER LR, 1996, INJURY CONTROL GLOBA; Bernstein E, 1994, Acad Emerg Med, V1, P277; *BRIT BROADC CORP, 2004, NEP VIOL LEAV DEAD; *BRIT BROADC CORP, 2004, STRIK CONT CRIPPL NE; *BRIT BROADC CORP, 2004, CONC NEP REB THREAT; *BRIT BROADC CORP, 2004, REB CUT LINKS NEP CA; Devkota UP, 2001, BRIT J NEUROSURG, V15, P13, DOI 10.1080/02688690020024328; Faillace WJ, 2002, SURG CLIN N AM, V82, P349, DOI 10.1016/S0039-6109(02)00010-5; Forjouh S, 1999, PREHOSPITAL IMMEDIAT, V3, P66; GEDLU E, 1994, E AFR MED J, V71, P807; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hauswald M, 1997, AM J EMERG MED, V15, P600, DOI 10.1016/S0735-6757(97)90167-4; Husum H, 2003, J TRAUMA, V54, P1188, DOI 10.1097/01.TA.0000073609.12530.19; Ibbotson G, 2003, CAN MED ASSOC J, V169, P1301; Istre GR, 2003, INJURY PREV, V9, P349, DOI 10.1136/ip.9.4.349; JANSON S, 1994, J TROP PEDIATRICS, V40, P88, DOI 10.1093/tropej/40.2.88; Jimba M, 2001, LANCET, V358, P1017, DOI 10.1016/S0140-6736(01)06148-7; Johnson DL, 1996, PEDIATR NEUROSURG, V25, P309, DOI 10.1159/000121145; Joseph M, 2003, NEUROL INDIA, V51, P333; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MANCIAUX MRG, 1985, ACTA PAEDIATR SCAND, V74, P163, DOI 10.1111/j.1651-2227.1985.tb10944.x; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; MICHAUD C, 1994, B WORLD HEALTH ORGAN, V72, P639; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; Mock CN, 2002, J TRAUMA, V53, P90, DOI 10.1097/00005373-200207000-00018; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; Poudel-Tandukar K, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-a; Poudyal AK, 2003, TROP MED INT HEALTH, V8, P956, DOI 10.1046/j.1365-3156.2003.01094.x; Rajbhandari KC, 2004, CAN J NEUROL SCI, V31, P257, DOI 10.1017/S0317167100053919; Ramamurthi B, 2004, SURG NEUROL, V61, P109, DOI 10.1016/j.surneu.2003.08.034; Razzak JA, 2004, PUBLIC HEALTH, V118, P114, DOI 10.1016/S0033-3506(03)00147-1; REICHENHEIM ME, 1989, HEALTH POLICY PLANN, V4, P162; Roberts I, 1996, BRIT MED J, V313, P784; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Schwarz R, 2004, CLEFT PALATE-CRAN J, V41, P199, DOI 10.1597/03-016; SHILPAKAR SK, 2003, J SOC SURG NEPAL, V6, P33; Shokunbi T, 1994, West Afr J Med, V13, P38; Shrestha MK, 2004, BRIT J OPHTHALMOL, V88, P319, DOI 10.1136/bjo.2003.026260; Singh S, 2004, CAN MED ASSOC J, V171, P1499, DOI 10.1503/cmaj.1040777; SPIEGEL CN, 1977, AM J PUBLIC HEALTH, V67, P1143, DOI 10.2105/AJPH.67.12.1143; Stevenson PC, 2002, LANCET, V359, P1495, DOI 10.1016/S0140-6736(02)08472-6; Stevenson PC, 2001, LANCET, V358, P752, DOI 10.1016/S0140-6736(01)05844-5; STREEFLAND P, 1985, SOC SCI MED, V20, P1151, DOI 10.1016/0277-9536(85)90192-3; Tursz A, 1986, World Health Stat Q, V39, P257; *UNICEF, 2004, AT GLANC NEP; Waxweiler R J, 1994, Acad Emerg Med, V1, P204; *WORLD BANK, 2004, NEP DAT PROF; Yagmur Y, 2004, INJURY, V35, P425, DOI 10.1016/S0020-1383(03)00198-0; Zwi A B, 1996, Inj Prev, V2, P91, DOI 10.1136/ip.2.2.91	66	11	14	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2006	22	4					352	362		10.1007/s00381-005-1235-0			11	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	026YL	WOS:000236379300005	16170573				2021-06-18	
J	Du, CJ; Ma, HS; Ruo, M; Zhang, ZJ; Yu, XJ; Zeng, YJ				Du, CJ; Ma, HS; Ruo, M; Zhang, ZJ; Yu, XJ; Zeng, YJ			An experimental study on the biomechanical properties of the cancellous bones of distal femur	BIO-MEDICAL MATERIALS AND ENGINEERING			English	Article						mechanical properties; cancellous bones; distal femur; biomechanics	MECHANICAL-PROPERTIES; MODEL	Objectives: To study the comprehensive biomechanical properties of the cancellous bone of distal femur through a series of mechanical tests, and provide relevant subjects with the basic technical data. Backgrounds: The study on bone mechanics is a commonly used approach to evaluate the biomechanical competency of bone. The biomechanical properties of bone have come to be the precondition of the further research of these relevant clinical subjects. Methods: In this paper, comprehensive items of mechanical properties of the cancellous bones of distal femur were conducted, and many valuable test results were obtained through a series of mechanical tests, which comprised tensile test, compression test, torsion test, shear test, bending test and impact test. The specimens were extracted from the normal corpses of Chinese donors died from acute head injury. As another key problem in this kind of experiment, the sampling and fixing method of cancellous bones specimens was developed and optimized in this research. Results: A series of the experimental data of mechanical properties of cancellous bones were obtained in the tests, these experimental data include tensile strength, compression strength, yield tensile strength, modulus of elasticity, torsion strength, shear strength, torsion modulus, bending strength, yield shear limit and impact toughness, which can reflect the complex mechanical competency of bone, being of great value and practice in clinic and further research on cancellous bones. The mechanical properties of the cancellous bones of distal femur were analyzed and discussed. Conclusions: The biomechanical properties of the cancellous bones have a close relationship with individual difference. Comprehensive items of the mechanical properties of the bone can evaluate the mechanical performance of the bone better, and can provide more valuable data to relevant research.	Beijing Univ Technol, Biomech & Med Informat Inst, Beijing 100022, Peoples R China; Jilin Univ, Changchun 130022, Peoples R China; Shantou Univ, Coll Med, Shantou 515031, Peoples R China	Zeng, YJ (corresponding author), Beijing Univ Technol, Biomech & Med Informat Inst, Beijing 100022, Peoples R China.	yjzeng@bjpu.edu.cn					ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4; Bohatyrewicz A, 1999, FLUORIDE, V32, P47; BOYD SK, P N AM C BIOM 98; BROWN SJ, 2002, HLTH OSTEOARTHRITIS; Ding M, 2002, J BONE JOINT SURG BR, V84B, P900, DOI 10.1302/0301-620X.84B6.11994; Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6; GILSON J, 1985, J BIOMECH, V18, P317; GOLDSTEIN SA, 1993, CALCIFIED TISSUE INT, V53, pS127, DOI 10.1007/BF01673421; GUO Y, 1999, CHINESE J BIOMEDICAL, V18, P250; Hogan HA, 2000, J BONE MINER RES, V15, P284, DOI 10.1359/jbmr.2000.15.2.284; KEAVENY TM, 1993, J BIOMECH ENG-T ASME, V115, P534, DOI 10.1115/1.2895536; Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348; Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047; MARTENS M, 1983, J BIOMECH, V16, P971, DOI 10.1016/0021-9290(83)90098-2; Matter HP, 2001, J BIOMED MATER RES, V55, P40, DOI 10.1002/1097-4636(200104)55:1<40::AID-JBM60>3.0.CO;2-6; Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7; van der Linden JC, 2001, J BIOMECH, V34, P1573, DOI 10.1016/S0021-9290(01)00146-4; van der Linden JC, 2001, J BONE MINER RES, V16, P457, DOI 10.1359/jbmr.2001.16.3.457; van Loon C J, 1999, Acta Orthop Belg, V65, P154; VESTERBY A, 1993, BONE, V14, P193, DOI 10.1016/8756-3282(93)90140-6; Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5	21	11	13	0	20	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0959-2989	1878-3619		BIO-MED MATER ENG	Bio-Med. Mater. Eng.		2006	16	3					215	222					8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	016ZY	WOS:000235665100006	16518020				2021-06-18	
J	Mayzler, O; Leon, A; Eilig, I; Fuxman, Y; Benifla, M; Freixo, PC; Gurevich, B; Agassi, R; Artru, AA; Shapria, Y				Mayzler, O; Leon, A; Eilig, I; Fuxman, Y; Benifla, M; Freixo, PC; Gurevich, B; Agassi, R; Artru, AA; Shapria, Y			The effect of hypertonic (3%) saline with and without furosemide on plasma osmolality, sodium concentration, and brain water content after closed head trauma in rats	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral edema; diuretic; hyperosmolar therapy	ELEVATED INTRACRANIAL-PRESSURE; CEREBRAL BLOOD-FLOW; HEMORRHAGIC-SHOCK; CEREBROSPINAL-FLUID; INJURY; MANNITOL; RESUSCITATION; EDEMA; MODEL; HYPERTENSION	Adding furosemide (F) to mannitol causes a greater decrease of brain volume, intracranial pressure, and brain water content (BW) as compared with mannitol alone. We examined whether adding F to hypertonic saline (HS) causes less increase of BW early after closed head trauma (CHT) as compared with HS alone. With institutional approval, 125 rats underwent sham surgery or CHT and then immediately received no treatment, HS (1.2 g/kg, 3% solution), or HS + F (2 mg/kg), In groups 1-10 (n = 8/group), the percent BW content was determined at 30, 60, or 120 minutes. In groups 11-14 (n = 8/group), physiologic values were determined at 0, 30, 60, and 120 minutes. At 120 minutes, the increase of BW caused by CHT (sham = 78.9 +/- 0.6% and CHT = 81.5 +/- 2.2%, mean +/- SD) was prevented by HS + F (78.0 +/- 0.8%) but not by HS (80.7 +/- 2.2%). Both HS and HS + F similarly increased plasma osmotality and sodium concentration. Post-CHT hypotension and acidosis (30 and 60 minutes) and decrease of hemoglobin concentration (120 minutes) were less with HS + F than with HS. We conclude that adding F to HS decreases BW without causing more increase of osmolality and Na than that caused by HS alone.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Soroka Med Ctr, Dept Surg, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Soroka Med Ctr, Div Anesthesiol, IL-84101 Beer Sheva, Israel; Barzilay Med Ctr, Dept Surg, Askelon, Israel; Soroka Med Ctr, Dept Neurosurg, IL-84101 Beer Sheva, Israel	Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, 356540, Seattle, WA 98195 USA.	artruaa@u.washington.edu					BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BERGER S, 1994, ACTA NEUROCHIR, P494; DAUTERMANN C, 1992, ADV EXP MED BIOL, V317, P731; Dixon CE, 1996, NEUROTRAUMA, P1337; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; FOXWORTHY JC, 1990, J NEUROSURG ANESTH, V2, P256, DOI 10.1097/00008506-199012000-00002; GUNNAR W, 1988, SURGERY, V103, P398; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Ichai C, 1997, ANN FR ANESTH, V16, P435, DOI 10.1016/S0750-7658(97)81476-1; JACKSON EK, 2001, GOODMAN GILMANS PHAR, P757; LORENZO AV, 1986, Z KINDERCHIR, V41, P10; MELBY JM, 1982, CAN J PHYSIOL PHARM, V60, P405, DOI 10.1139/y82-059; MILHORAT TH, 2001, ANESTHESIA NEUROSURG, P115; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NELSON GIC, 1983, EUR HEART J, V4, P706, DOI 10.1093/oxfordjournals.eurheartj.a061382; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; POLLAY M, 1983, J NEUROSURG, V59, P945, DOI 10.3171/jns.1983.59.6.0945; Prandota Joseph, 2002, Am J Ther, V9, P317, DOI 10.1097/00045391-200207000-00009; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAGAISIS V, 2002, MEDICINA B AIRES, V39, P243; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Saltarini M, 2002, Eur J Emerg Med, V9, P262, DOI 10.1097/00063110-200209000-00011; SCHELLER MS, 1991, J NEUROSURG ANESTH, V3, P291, DOI 10.1097/00008506-199112000-00009; SCHETTINI A, 1982, J NEUROSURG, V56, P679, DOI 10.3171/jns.1982.56.5.0679; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; TOMITA H, 1994, ACTA NEUROCHIR, P547; TORNHEIM PA, 1979, NEUROSURGERY, V4, P48, DOI 10.1227/00006123-197901000-00009; Toung TJK, 2002, J NEUROSURG ANESTH, V14, P187, DOI 10.1097/00008506-200207000-00003; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; WILKINSON HA, 1983, NEUROSURGERY, V12, P405, DOI 10.1227/00006123-198304000-00006; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	39	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2006	18	1					24	31		10.1097/01.ana.0000188358.41284.cb			8	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	000YF	WOS:000234497700005	16369137				2021-06-18	
J	Westcott, MC; Alfano, DP				Westcott, MC; Alfano, DP			The symptom checklist-90-revised and mild traumatic brain injury	BRAIN INJURY			English	Article						neuropsychological assessment; mild traumatic brain injury; symptom checklist-90-revised	MINOR HEAD-INJURY; CHRONIC PAIN; SCL-90-R; WHIPLASH; PERSONALITY; DEPRESSION; DISABILITY; MMPI	Objective: Assessment of emotional functioning is a critical aspect of the clinical neuropsychological evaluation of individuals following mild traumatic brain injury (MTBI). The objective of this study was to examine the utility of the Symptom Checklist-90-Revised as a brief tool for assessing psychological and symptomatic distress following MTBI. Method: A contrasted groups approach, involving three clinical groups (MTBI, Whiplash Associated Disorder, Type I Diabetes) and a non-clinical control group, was used in this study. Results: The group with MTBI scored significantly higher on the majority of primary symptom dimensions and global distress indices of the SCL-90-R compared to both the diabetes and non-clinical control groups. Analysis of individual cases further revealed that 68.2% of the participants in the group with MTBI were classified as positive cases, a rate significantly higher than that of the diabetes and non-clinical control groups. The group with MTBI did not differ significantly from the group of individuals with whiplash associated disorder with respect to elevation of primary symptom dimensions or global distress indices, or the number of cases classified as positive. Conclusion: The results of this study suggest that the SCL-90-R has considerable utility as a general measure of psychological and symptomatic distress following MTBI.	Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada; Univ Calgary, Dept Appl Psychol, Calgary, AB, Canada	Alfano, DP (corresponding author), Univ Regina, Dept Psychol, Regina, SK S4S 0A2, Canada.	dennis.alfano@uregina.ca					Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; Alfano DP, 1999, ARCH CLIN NEUROPSYCH, V14, P780; ALFANO DP, IN PRESS BRAIN COGNI; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; CARPENTER KM, 1995, J CLIN PSYCHOL, V51, P383, DOI 10.1002/1097-4679(199505)51:3<383::AID-JCLP2270510310>3.0.CO;2-Q; Cripe LI, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P291; DEROGATIS LR, 1994, SCL90R ADM SCORING P; DICESARE A, 1990, COGNITIVE REHABILITA, V8, P14; Fabiano RJ, 1998, J REHABIL, V64, P9; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kellett SC, 1999, J APPL RES INTELLECT, V12, P323, DOI 10.1111/j.1468-3148.1999.tb00088.x; KINNEY RK, 1991, SPINE, V16, P940, DOI 10.1097/00007632-199108000-00013; MATEER CA, 1992, PHYSICAL MED REHABIL, V6, P143; Miller L, 1998, J COGNITIVE REHABILI, V16, P10; MOBAYED M, 1990, J AFFECT DISORDERS, V19, P237, DOI 10.1016/0165-0327(90)90100-M; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Morgan CD, 1998, ASSESSMENT, V5, P197, DOI 10.1177/107319119800500210; Nemeth AJ, 1996, ARCH CLIN NEUROPSYCH, V11, P677, DOI 10.1016/S0887-6177(96)80004-7; Peebles JE, 2001, SPINE, V26, P766, DOI 10.1097/00007632-200104010-00014; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Radloff LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306; Rauter UK, 1996, J CLIN PSYCHOL, V52, P625; REITAN RM, 2000, MILD HEAD INJURY INT; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHMIDTKE D, 1993, CANADIAN PSYCHOL, V33, P436; Schmitz N, 2000, PSYCHOL REP, V86, P263, DOI 10.2466/PR0.86.1.263-274; Stovner LJ, 1996, SPINE, V21, P2735, DOI 10.1097/00007632-199612010-00006; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Tabachnick B., 2001, USING MULTIVARIATE S; Vassend O, 1999, BEHAV RES THER, V37, P685, DOI 10.1016/S0005-7967(98)00182-X; Wallis BJ, 1996, SPINE, V21, P804, DOI 10.1097/00007632-199604010-00006; WILKINSON DG, 1981, BRIT J PSYCHIAT, V138, P1, DOI 10.1192/bjp.138.1.1	39	11	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1261	1267		10.1080/02699050500150104			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200010	16286342				2021-06-18	
J	[Anonymous]				[Anonymous]			Concussion (mild traumatic brain injury) and the team physician: A consensus statement	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article																*AM COLL SPORTS ME, 2001, MED SCI SPORTS EXERC, V33, P846; Herring SA, 2002, MED SCI SPORT EXER, V34, P1212	2	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2005	37	11					2012	2015		10.1249/01.mss.0000186726.18341.70			4	Sport Sciences	Sport Sciences	986LL	WOS:000233451000026	16286874				2021-06-18	
J	Davies, R; Mcmillan, TM				Davies, R; Mcmillan, TM			Opinion about post-concussion syndrome in health professionals	BRAIN INJURY			English	Article							HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; FOLLOW-UP; DISABILITY	Objective: To compare opinion about post-concussion syndrome (PCS) in accident and emergency doctors, clinical neuropsychologists and neurosurgeons. Method: A UK postal survey was sent to all accident and emergency doctors, neurosurgeons and clinical neuropsychologists listed by their professional bodies. Predictions of symptom complaint were made from a vignette about minor traumatic brain injury and a questionnaire about PCS-symptoms, cause, recovery and treatment. Results: All professional groups named headache, attention and memory difficulties as most common symptoms. Clinical neuropsychologists listed more symptoms at recall, more often achieved 'caseness' (Diagnostic and Statistical Manual-IV or International Classification of Diseases-10 criteria) and were more optimistic about treatment effectiveness. Neurosurgeons were more pessimistic about recovery. Organic factors were most frequently cited as the main cause of PCS, followed by emotional factors and then compensation factors. Conclusions: There was fair consistency between professional groups regarding PCS. Differences may reflect differing clinical roles between the professions, in terms of early care and late rehabilitation. The usefulness of the concept of PCS is discussed. All groups and particularly those working in acute settings may benefit from further information about minor brain injury including the effectiveness of psychological interventions.	Univ Glasgow, Gartnavel Royal Hosp, Glasgow G12 0XH, Lanark, Scotland	Mcmillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, 1055 Great Western Rd, Glasgow G12 0XH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; AUERBACH AH, 1967, DIS NERV SYST, V28, P110; Bazarian J, 2000, BRAIN INJURY, V14, P285; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; MACKENZIE JA, 2004, UNPUB KNOWLEDGE POST; McMillan T, 2003, STUD NEUROPSYCHOL DE, P271; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; *NAT I CLIN EXC, 2003, N0235 NICE; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; *ROYAL COLL SURG E, 1999, REP WORK PART MAN PE; *SCOTT INT GUID NE, 2001, EARL MAN PEOPL HEAD; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; World Health Organization, 1992, ICD 10 ICD 10 CLASS	31	11	12	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	2005	19	11					941	947		10.1080/02699050400000565			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	983YY	WOS:000233269500009	16299935				2021-06-18	
J	Steiner, ME; Quigley, DB; Wang, F; Balint, CR; Boland, AL				Steiner, ME; Quigley, DB; Wang, F; Balint, CR; Boland, AL			Team physicians in college athletics	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						team physician; intercollegiate athletics; athletic injuries; athletic medicine		Background: There has been little documentation of what constitutes the clinical work of intercollegiate team physicians. Team physicians could be recruited based on the needs of athletes. Hypothesis: A multidisciplinary team of physicians is necessary to treat college athletes. Most physician evaluations are for musculoskeletal injuries treated nonoperatively. Study Design: Descriptive epidemiology study. Methods: For a 2-year period, a database was created that recorded information on team physician encounters with intercollegiate athletes at a major university. Data on imaging studies, hospitalizations, and surgeries were also recorded. The diagnoses for physician encounters with all undergraduates through the university's health service were also recorded. Results: More initial athlete evaluations were for musculoskeletal diagnoses (73%) than for general medical diagnoses (27%) (P <.05). Four percent of musculoskeletal injuries required surgery. Most general medical evaluations were single visits for upper respiratory infections and dermatologic disorders, or multiple visits for concussions. Football accounted for 22% of all physician encounters, more than any other sport (P <.05). Per capita, men and women sought care at an equal rate. In contrast, 10% of physician encounters with the general pool of undergraduates were for musculoskeletal diagnoses. Student athletes did not require a greater number of physician encounters than did the general undergraduate pool of students on a per capita basis. Conclusion: Intercollegiate team physicians primarily treat musculoskeletal injuries that do not require surgery. General medical care is often single evaluations of common conditions and repeat evaluations for concussions.	Harvard Univ, Athlet Dept, Boston, MA USA; Harvard Univ, Sch Med, New England Baptist Hosp Sports Med Sect, Hlth Serv, Boston, MA USA	Steiner, ME (corresponding author), 830 Boylston St, Brookline, MA 02467 USA.	mesteinermd@cs.com					*AM BOARD MED SPEC, ANN REP REF HDB; *AM ORTH SOC SPORT, SPORTS MED SURV 1999; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; MAGEE J, 2002, SPORTS MED UPDATE, P4; Matheson GO, 2002, PHYSICIAN SPORTSMED, V30, P3, DOI [10.3810/psm.2002.02.149, 10.3810/psm.2002.04.240]; THORNDIKE A, 1956, ATHLETIC INJURIES PR; 2000, AM J SPORTS MED, V28, P440	7	11	11	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	OCT	2005	33	10					1545	1551		10.1177/0363546505275491			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	968BX	WOS:000232138000014	16009978				2021-06-18	
J	Dawson, DR; Markowitz, M; Stuss, DT				Dawson, DR; Markowitz, M; Stuss, DT			Community integration status 4 years after traumatic brain injury - Participant-proxy agreement	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community integration; Katz Adjustment Scale; level of agreement; measurement; traumatic brain injury	KATZ ADJUSTMENT SCALE; ACUTE PREDICTORS; SOCIAL-BEHAVIOR; RELIABILITY; CONCORDANCE; RECOVERY; VALIDITY; OUTCOMES; RATINGS; FAMILY	objectives: To measure the level of agreement on community integration outcomes 4 years after traumatic brain injury (TBI) in relation to injury severity, proxy-participant relationship, and type of question. Participants: Thirty-one survivors of TBI (14 with mild TBI and 17 with moderate-severe TBI) and 31 significant other proxies. Measures: General and leisure activity scales of the Katz Adjustment Scale (KAS). Results: Agreement was highest between proxies and participants with mild versus moderate-severe TBIs, between Spouse proxies and TBI participants compared to nonspouse proxies and on the more objective subscales (frequency of participation) compared to the expectation and satisfaction scales regardless of injury severity or proxy-participant relationship. Conclusions: For research purposes, proxy data are acceptable but clinicians should assess outcomes and set goals with input from both persons with TBIs and their proxies.	Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Occupat Therapy, Toronto, ON, Canada; Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Psychol, Toronto, ON, Canada	Dawson, DR (corresponding author), Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	ddawson@klaru-baycrest.on.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121			Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; BASSETT SS, 1990, PSYCHOL AGING, V5, P127, DOI 10.1037/0882-7974.5.1.127; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; FABIANO RJ, 1992, REHABIL PSYCHOL, V37, P75, DOI 10.1037/h0079096; Feinstein AR., 1987, CLINIMETRICS; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Law M, 1987, CANADIAN J OCCUPATIO, V54, P133, DOI DOI 10.1177/000841748705400308; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, pL1067; McDowell I, 1996, MEASURING HLTH GUIDE; Ocampo S, 1997, OCCUP THER INT, V4, P161; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Stuss DT, 2000, NEUROLOGY, V54, P1337, DOI 10.1212/WNL.54.6.1337; Tepper S, 1996, BRAIN INJURY, V10, P575, DOI 10.1080/026990596124142; World Health Organization, INT CLASS FUNCT DIS	28	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2005	20	5					426	435		10.1097/00001199-200509000-00004			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	965NO	WOS:000231957600005	16170251				2021-06-18	
J	Faraji, M; Ashrafzadeh, F				Faraji, M; Ashrafzadeh, F			Penetrating head injuries in children	NEUROSURGERY QUARTERLY			English	Article						air gun pellet; children; penetrating head injury	INTERNAL CAROTID-ARTERY; CRANIOCEREBRAL MISSILE WOUNDS; CIVILIAN GUNSHOT WOUNDS; GUN PELLET INJURIES; TRAUMATIC ANEURYSMS; LEBANESE CONFLICT; BRAIN; VIETNAM; MANAGEMENT; CHILDHOOD	Head trauma is exceedingly common in children but rarely presents as a penetrating injury to the skull. Early recognition and correct management of the possible complications of penetrating head injuries (PHIs) is important and may prevent a poor outcome. The authors' experience with 14 cases of PHIs in children referred to the Department of Neurosurgery during the last 20 years is presented. The characteristic findings on physical examination and imaging studies performed in these cases are described. All cases occurred in children in the first decade of life. There were 10 boys and 4 girls. A damaged globe that had to be exenterated was the earliest complication (1 case), followed by cerebrospinal fluid leakage (3 cases) and diabetes insipidus (1 case). Objects were removed in 11 cases. In addition to plain radiographs, computed tomography scanning and angiography were used as diagnostic procedures. The present series of patients is one of the largest collections of PHIs in children younger than 10 years of age reported in the literature. The need for prompt extrication of these objects and the possible complications of such injuries have been reviewed.	Mashhad Univ Med Sci, Dept Neurosurg, Mashhad 9176653347, Iran; Mashhad Univ Med Sci, Dept Neurol, Mashhad 9176653347, Iran	Faraji, M (corresponding author), Mashhad Univ Med Sci, Dept Neurosurg, 48 Mollasadra 4 Ave,Ahmadabad BLVD, Mashhad 9176653347, Iran.	Farajirad@yahoo.com					Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; ARABI B, 1988, NEUROSURGERY, V22, P1056; BISHOP EJ, 1967, NEUROSURGERY TRAUMA, P203; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CHAPMAN PH, 1985, CONCEPTS PEDIAT NEUR, V5, P1; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; EICHLER A, 1996, J NEUROSURG, V31, P72; FURLOW LT, 1974, J NEUROSURGY, V4, P380; GRAHAM TW, 1994, NEUROSURGERY, V27, P696; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; KOJIMA T, 1987, NEUROSURGERY, V20, P322, DOI 10.1227/00006123-198702000-00022; MALTBY GL, 1946, J NEUROSURG, V3, P239, DOI 10.3171/jns.1946.3.3.0239; Martinez-Lage JF, 2001, PEDIATR SURG INT, V17, P657, DOI 10.1007/s003830100018; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; PENCEK TL, 1986, J NEUROSURG, V64, P813, DOI 10.3171/jns.1986.64.5.0813; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RAHIMIZADEH A, 1987, ACTA NEUROCHIR, V84, P93, DOI 10.1007/BF01418831; RAHMAT H, 1984, J NEUROSURG, V60, P630, DOI 10.3171/jns.1984.60.3.0630; RAINMOND AJ, 1970, J NEUROSURG, V32, P647; RICH NM, 1980, AM J SURG, V139, P414, DOI 10.1016/0002-9610(80)90304-9; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; VAQUERO J, 1982, NEURORADIOLOGY, V23, P161; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	38	11	11	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-6438			NEUROSURG QUART	Neurosurg. Q.	SEP	2005	15	3					160	163		10.1097/01.wnq.0000176390.07352.4d			4	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	961VK	WOS:000231689700004					2021-06-18	
J	Swaine, BR; Desrosiers, J; Bourbonnais, D; Larochelle, JL				Swaine, BR; Desrosiers, J; Bourbonnais, D; Larochelle, JL			Norms for 15-to 34-year-olds for different versions of the finger-to-nose test	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	14th International World Congress of Physical Therapy (WCPT)	JUN 04-07, 2003	Barcelona, SPAIN			movement disorders; rehabilitation; time; upper extremity	TRAUMATIC BRAIN-INJURY; UPPER-LIMB; MOVEMENTS; COORDINATION; VISION; ADULTS	Swaine BR, Desrosiers J, Bourbonnais D, Larochelle J-L. Norms for 15- to 34-year-olds for different versions of the finger-to-nose test. Arch Phys Med Rehabil 2005;86:1665-9. Objectives: To develop norms for the time to execute different versions of the finger-to-nose test (FNT) and to determine the effects of different testing procedures on performance in people aged 15 to 34 years. Design: Cross-sectional. Setting: Research center. Participants: Healthy subjects (149 men, 148 women; age range, 15-34y) participated, and 36 men and 36 women were included in each of the 4 age categories studied (15-19y, 20-24y, 25-29y, 30-34y). Participants performed, in random order, 5 forms of the test in 2 positions (sitting, supine) with the right and left upper limbs (ULs). Interventions: Not applicable. Main Outcome Measure: Time (in seconds) to complete 5 cycles of movement. Results: Test version and side of UL were found to affect performances; right-sided performances were faster than left-sided. Performances did not vary significantly (P >.001) with sex or among age categories; therefore, the results are presented for the group. Mean performances varied from 3.44 to 4.29 seconds. Subsequent analysis of variance (with data for each UL) showed main effects for testing position (sitting > lying) and eye condition (eyes open > eyes closed). Versions were strongly interrelated (.85 < r <.98). Conclusions: Norms for the time to execute different FNT versions were developed for both ULs for healthy people ages 15 to 34 years.(c) 2005 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; Inst Readaptat Montreal, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; Univ Sherbrooke, Inst Geriatr, Ctr Rech Vieillissement, Sherbrooke, PQ J1K 2R1, Canada; Univ Sherbrooke, Fac Med, Dept Med Famille, Sherbrooke, PQ J1K 2R1, Canada	Swaine, BR (corresponding author), Univ Montreal, Fac Med, Ecole Readaptat, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca					Bourbonnais D, 1997, NEUROREHABILITATION, V9, P3, DOI 10.3233/NRE-1997-9102; Bruininks R. H., 1978, BRUININKS OSERETSKY; Day BL, 1998, BRAIN, V121, P357, DOI 10.1093/brain/121.2.357; DESROSIERS J, 1995, AGE AGEING, V24, P108, DOI 10.1093/ageing/24.2.108; DITTIGER M, 2001, J PHYS THER SCI, P1375; Feys PG, 2003, ARCH PHYS MED REHAB, V84, P79, DOI 10.1053/apmr.2003.50068; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; GRINKLER R, 1966, NEUROLOGY; HANSEN M, 1994, ACTA NEUROL SCAND, V90, P145; Helsen WF, 1998, CORTEX, V34, P513, DOI 10.1016/S0010-9452(08)70511-2; JOHNSTON K, 1998, CAN J NEUROL SCI, V25, pS98; KJERLAND R. N., 1953, PROC IOWA ACAD SCI, V60, P519; KRAUS JF, 1987, HEAD INJURY, P1; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OTT L, 1977, INTRO STAT METHODS D; POTVIN AR, 1980, J AM GERIATR SOC, V28, P1; Schmitz Thomas J., 1994, P97; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, IN PRESS PHYSIOTHER; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; VERKERK PH, 1990, CLIN NEUROL NEUROSUR, V92, P105, DOI 10.1016/0303-8467(90)90084-I	23	11	11	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2005	86	8					1665	1669		10.1016/j.apmr.2004.11.021			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	953LN	WOS:000231077900025	16084824				2021-06-18	
J	De Monte, VE; Geffen, GM; Kwapil, K				De Monte, VE; Geffen, GM; Kwapil, K			Test-retest reliability and practice effects of a rapid screen of mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							VERBAL-LEARNING TEST; HEAD-INJURY; SENSITIVITY; CONCUSSION; SPORTS; FORM	Test-retest reliabilities and practice affects of measures from the Rapid Screen of Concussion (RSC), in addition to the Digit Symbol Substitution Test (Digit Symbol), were examined. Twenty five male participants were tested three times; each testing session scheduled a week apart. The test-retest reliability estimates for most measures were reasonably good, ranging from .79 to .97. An exception was the delayed word recall test, which has had a reliability estimate of .66 for the first retest, and .59 for the second retest. Practice effects were evident from Times 1 to 2 on the sentence comprehension and delayed recall subtests of the RSC, Digit Symbol and a composite score. There was also a practice effect of the same magnitude found from Time 2 to Time 3 on Digit Symbol, delayed recall and the composite score. Statistics on measures for both the first and second retest intervals, with associated practice affects, are presented to enable the calculation of reliable change indices (RCI). The RCI may be used to assess any improvement in cognitive functioning after mild Traumatic Brain Injury.	Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Brisbane, Qld 4006, Australia	De Monte, VE (corresponding author), Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	comerf@psy.uq.edu.au					Baddeley A.D., 1992, SPEED CAPACITY LANGU; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Brandt J., 2001, HOPKINS VERBAL LEARN; Chelune GJ, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P123; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; De Monte VE, 2004, J CLIN EXP NEUROPSYC, V26, P628, DOI 10.1080/13803390490504443; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; GEFFEN GM, 1994, ARCH CLIN NEUROPSYCH, V9, P303, DOI 10.1016/0887-6177(94)90018-3; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Kwapil KJ., 2003, BRAIN IMPAIR, V4, P155; Mateer CA, 2000, NEUROPSYCHOLOGICAL M, P3; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RASMUSSON DX, 1995, ARCH CLIN NEUROPSYCH, V10, P21, DOI 10.1016/0887-6177(94)E0001-6; Sattler JM, 1988, ASSESSMENT CHILDREN; Sawrie S M, 1996, J Int Neuropsychol Soc, V2, P556; UCHIYAMA CL, 1995, ARCH CLIN NEUROPSYCH, V10, P133, DOI 10.1016/0887-6177(94)E0034-M; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; YOUNGJOHN JR, 1992, CLIN NEUROPSYCHOL, V0006, P00276, DOI DOI 10.1080/13854049208404129	26	11	11	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	2005	27	5					624	632		10.1080/13803390490918589			9	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	936WB	WOS:000229885000010	16019639				2021-06-18	
J	Schalamon, J; Singer, G; Kurschel, S; Hollwarth, M				Schalamon, J; Singer, G; Kurschel, S; Hollwarth, M			Somatosensory evoked potentials in children with severe head trauma	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						children; head trauma; prognosis; somatosensory evoked potentials	SEVERE BRAIN INJURY; COMATOSE CHILDREN; PREDICTION	We evaluated the predictive value of somatosensory evoked potentials (SEP) in a series of children with severe traumatic brain injury (TBI). The prospective clinical investigation was performed in a Level I paediatric trauma centre. We included 26 consecutive comatose paediatric patients aged from 1 month to 17 years (median age 11 years) following severe TBI (initial Glasgow Coma Score (GCS) 8 or below). Besides SEP recordings, the intracranial pressure and the results of an initial cranial CT scan were filed. The Glasgow Outcome Scale (GOS) was used to assess outcome at discharge. Thirteen children had normal SEP measurements, three patients had abnormal SEP recordings and a cortical response was bilaterally absent in ten children. Out of 26 children, 10 died whereas two remained in a persistent vegetative state. Only one child suffered from significant neurological deficits (GOS 3) at discharge. Seven patients survived with a GOS of 4 and six children survived without neurological impairment (GOS 5). Normal SEP indicated a favourable outcome in most children but did not rule out the occurrence of death, while absence of SEP was related to unfavourable outcome in all cases. Conclusion: Measurement of somatosensory evoked potentials provides valuable data for determining the prognosis at early coma stages. Our data show that an unfavourable outcome can be predicted with higher precision than a favourable outcome.	Med Univ Graz, Dept Paediat Surg, A-8036 Graz, Austria; Med Univ Graz, Dept Neurosurg, Graz, Austria	Schalamon, J (corresponding author), Med Univ Graz, Dept Paediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.	johannes.schalamon@meduni-graz.at		Singer, Georg/0000-0003-4770-3144			Airey CM, 2001, DISABIL REHABIL, V23, P509; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; DAWSON GD, 1954, ELECTROEN CLIN NEURO, V6, P65, DOI 10.1016/0013-4694(54)90007-3; Facco E, 2002, CLIN NEUROPHYSIOL, V113, P1855, DOI 10.1016/S1388-2457(02)00259-6; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; JENNETT B, 1975, LANCET, V2, P480; Lehmann U, 1997, UNFALLCHIRURG, V100, P705, DOI 10.1007/s001130050180; Maas A. I., 2000, CURR OPIN CRIT CARE, V6, P281; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; TEASDALE G, 1974, LANCET, V2, P81; Wohlrab G, 2001, NEUROPEDIATRICS, V32, P271, DOI 10.1055/s-2001-19123	15	11	11	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	JUL	2005	164	7					417	420		10.1007/s00431-005-1656-5			4	Pediatrics	Pediatrics	937AO	WOS:000229897100005	15812665				2021-06-18	
J	Dolberg, OT; Barkai, G; Gross, Y; Schreiber, S				Dolberg, OT; Barkai, G; Gross, Y; Schreiber, S			Differential effects of topiramate in patients with traumatic brain injury and obesity - a case series	PSYCHOPHARMACOLOGY			English	Article						binge eating disorder; obesity; PTSD; post traumatic stress disorder; topiramate; traumatic brain injury; TBI; weight gain; epilepsy; side effects	BINGE-EATING DISORDER; WEIGHT-GAIN; MOOD; MONOTHERAPY; MANAGEMENT	Topiramate is an antiepileptic drug known to have effects on weight. In order to use this as a tool to treat eating disorders, it is useful to examine whether these effects can be predicted in certain patients. To report the effects of topiramate, initiated for the treatment of epilepsy, on top of ongoing treatment, on eating patterns and weight of 17 patients with traumatic brain injury (TBI) with post-traumatic epilepsy and weight gain of various etiologies. Patients were followed up according to their usual treatment plan. Topiramate was added on top of current and stable treatment. Dose was titrated based on the patients' neurological status. Patients were asked to report side effects. No other changes were made. Of the 17 patients included, one patient dropped out. Six patients with binge eating disorder (BED) demonstrated the most pronounced effects, with marked attenuation of binges and normalizing body mass index. Less noticeable were the effects in patients with mood disorders. Topiramate was ineffective in patients whose overweight was a side effect of their medication. Side effects were rated as mild and included somnolence, paresthesias, mild cognitive disturbances and some gastrointestinal disturbances. In this report of the actual effects of topiramate in a clinical setting on weight and eating habits of 17 patients with TBI and obesity of various etiologies, topiramate seemed to be a safe intervention. Topiramate appeared to be differentially effective, with particular effects on primary pathological eating patterns.	Tel Aviv Univ, Sourasky Med Ctr, Dept Psychiat, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, Dept Psychiat, Tel Aviv, Israel; Neuropsychiat Unit Treatment & Rehabil, Tel Aviv, Israel; Bar Ilan Univ, Dept Psychol, Givat Shemuel, Israel	Dolberg, OT (corresponding author), Lundbeck Israel Ltd, POB 3088, IL-49130 Petah Tiqwa, Israel.	orna@lundbeck.com	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Appolinario JC, 2002, CAN J PSYCHIAT, V47, P271, DOI 10.1177/070674370204700309; Birt Julie, 2003, Ann Clin Psychiatry, V15, P49, DOI 10.3109/10401230309085669; Bray GA, 2003, OBES RES, V11, P722, DOI 10.1038/oby.2003.102; Calabrese JR, 2001, J CLIN PSYCHOPHARM, V21, P340, DOI 10.1097/00004714-200106000-00015; Carpenter LL, 2002, J AFFECT DISORDERS, V69, P251, DOI 10.1016/S0165-0327(01)00337-8; Chengappa KNR, 2001, EUR PSYCHIAT, V16, P186, DOI 10.1016/S0924-9338(01)00562-4; Chengappa KNR, 2001, BIPOLAR DISORD, V3, P215, DOI 10.1034/j.1399-5618.2001.030501.x; Colom F, 2001, J CLIN PSYCHIAT, V62, P475, DOI 10.4088/JCP.v62n0612c; Dursun SM, 2000, CAN J PSYCHIAT, V45, P198; Dursun SM, 2001, CAN J PSYCHIAT, V46, P287, DOI 10.1177/070674370104600316; Erfurth A, 2000, NEUROPSYCHOBIOLOGY, V42, P50, DOI 10.1159/000054854; Gordon A, 1999, AM J PSYCHIAT, V156, P968; Lessig MC, 2001, J AM ACAD CHILD PSY, V40, P1364, DOI 10.1097/00004583-200112000-00003; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Shapira NA, 2000, J CLIN PSYCHIAT, V61, P368, DOI 10.4088/JCP.v61n0508; Van Ameringen M, 2002, J CLIN PSYCHIAT, V63, P981, DOI 10.4088/JCP.v63n1104; Wallace SJ, 2001, BRAIN DEV-JPN, V23, P277, DOI 10.1016/S0387-7604(01)00230-3; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X; Werneke U, 2002, INT CLIN PSYCHOPHARM, V17, P145, DOI 10.1097/00004850-200207000-00001; Young WB, 2002, CEPHALALGIA, V22, P659, DOI 10.1046/j.1468-2982.2002.00380.x	20	11	11	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2005	179	4					838	845		10.1007/s00213-004-2117-y			8	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	924ZZ	WOS:000229022600013	15619108				2021-06-18	
J	Grill, E; Harder, M; Fischbacher, L; Boldt, C; Mittrach, R; Stucki, G				Grill, E; Harder, M; Fischbacher, L; Boldt, C; Mittrach, R; Stucki, G			Identification of relevant ICF categories by patients in early post-acute rehabilitation facilities	PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN			English	Article						rehabilitation; outcome assessment; cross sectional studies; post-acute rehabilitation; ICF; ICF core set	TRAUMATIC BRAIN INJURY; STROKE	Purpose: To describe functioning and health of patients in early post-acute rehabilitation facilities and to identify the most common problems using the International Classification of Functioning, Disability and Health (ICF). Material and method: Crosssectional survey in a convenience sample of patients requiring rehabilitation in early post-acute rehabilitation facilities. The second level categories of the ICF were used to collect information on patients' problems. For the ICF components Body Functions, Body Structures and Activities and Participation absolute and relative frequencies of impairments or limitations in the study population were reported. For the component Environmental Factors absolute and relative frequencies of perceived barriers or facilitators were reported. Results: The mean age in the sample of 174 patients was 59.8 years. 37% of the patients were female. 85 categories (35%) had a prevalence of 30% and above. The 85 categories included 25 categories (32%) of Body Functions, 10 categories (33%) of Body Structures, 30 categories (41%) of Activities and Participation and 20 (39%) categories of Environmental Factors. The most common categories belonged to the chapters Movement related functions and Mobility. Conclusion: This study is a first step towards the development of ICF Core Sets for patients in early post-acute rehabilitation facilities.	Univ Munich, Dept Phys Med & Rehabil, D-81377 Munich, Germany; Univ Munich, Inst Hlth & Rehabil Sci, WHO FIC Collaborating Ctr DIMDI, ICF Res Branch, D-81377 Munich, Germany; Community Hosp Bogenhausen, Dept Phys Med & Rehabil, Munich, Germany	Stucki, G (corresponding author), Univ Munich, Dept Phys Med & Rehabil, Marchioninistr 15, D-81377 Munich, Germany.	gerold.stucki@med.uni-muenchen.de	Grill, Eva/D-1875-2010; Grill, Eva/AAF-8104-2020	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984			*ACCP AACVPR PULM, 1997, J CARDIOPULM REHABIL, V17, P371; BOLDT C, 2005, IN PRESS DISABIL REH; Collin C, 1988, Int Disabil Stud, V10, P61; GRESHAM GE, 1980, ARCH PHYS MED REHAB, V61, P355; GRILL E, 2005, IN PRESS DISABIL REH; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Grissom SP, 2001, AM J PHYS MED REHAB, V80, P798, DOI 10.1097/00002060-200111000-00002; Karner AM, 2004, J ADV NURS, V46, P204, DOI 10.1111/j.1365-2648.2003.02980.x; Kelly-Hayes M, 1998, STROKE, V29, P1274, DOI 10.1161/01.STR.29.6.1274; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; LOEWEN SC, 1990, STROKE, V21, P78, DOI 10.1161/01.STR.21.1.78; Mant J, 2000, LANCET, V356, P808, DOI 10.1016/S0140-6736(00)02655-6; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; Pashkow P, 1995, J Cardiopulm Rehabil, V15, P394, DOI 10.1097/00008483-199511000-00001; Prosiege lM, 1996, NEUROL REHABIL, V1, P7; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; STIERJARMER M, 2005, IN PRESS DISABIL REH; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, PHYS MED REHAB KUROR, V12, P146, DOI 10.1055/s-2002-32718; STUCKI G, 2005, IN PRESS DISABIL REH	22	11	11	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0940-6689	1439-085X		PHYS MED REHAB KUROR	Physik. Med. Rehabilitationsmed. Kurort.	JUN	2005	15	3					168	173		10.1055/s-2004-834778			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	942AE	WOS:000230254500003					2021-06-18	
J	Cheng, HY; Goozee, JV; Murdoch, BE				Cheng, HY; Goozee, JV; Murdoch, BE			Analysis of articulatory dynamics in dysarthria following brain injury in childhood using electromagnetic articulography and electropalatography	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							CLOSED-HEAD INJURY; SPEECH DISORDERS; CHILDREN; EPG; SPEAKERS; ALVEOLAR; CONTACT; VELAR; MOTOR	Two physiological assessments, electromagnetic articulography (EMA) and electropalatography (EPG), were used simultaneously to investigate the articulatory dynamics in an 18-year-old male with dysarthria 9 years following traumatic brain injury (TBI). Eight words consisting of /t, s, integral, k/ in word initial and word final positions were produced up to 10 times. A nonneurologically impaired male served as a control subject. Six parameters were analyzed using EMA: velocity, acceleration, deceleration, distance, duration, and motion path of tongue movements. Using EPG, the pattern and amount of tongue-to-palate contact and the duration of the closure/constriction phase of each consonant produced were assessed. Timing disturbances in the TBI speaker's speech were highlighted in perceptual assessments in the form of prolonged phonemes and a reduced speech rate. EMA analysis revealed that the approach and release phase durations of the consonant productions were within normal limits. Kinematic strategies such as decreased velocity and decreased distances traveled by the tongue, however, may have counterbalanced each other to produce these appropriate results. EPG examination revealed significantly longer closure/constriction phase periods, which may have contributed to the prolonged phonemes and reduced speech rate observed. The implications of these findings for the development of treatment programs for dysarthria subsequent to TBI will be highlighted.	Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia	Cheng, HY (corresponding author), Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia.	y.cheng@shrs.uq.edu.au	Murdoch, Bruce E/C-1397-2012				ADAMS SG, 1993, J SPEECH HEAR RES, V36, P41, DOI 10.1044/jshr.3601.41; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAHILL LM, 2001, TRAUMATIC BRAIN INJU, P121; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; DAGENAIS PA, 1994, J PHONETICS, V22, P225, DOI 10.1016/S0095-4470(19)30202-5; Darley F., 1975, MOTOR SPEECH DISORDE; Duffy J. R., 2020, MOTOR SPEECH DISORDE; Ellis L, 2002, J PHONETICS, V30, P373, DOI 10.1006/jpho.2001.0162; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; ENDERBY PM, 1983, FRENCHAY DYSARTHRIA; Fitzpatrick L, 2002, J PHONETICS, V30, P397, DOI 10.1006/jpho.2001.0158; GIBBON F, 1990, BRIT J DISORD COMMUN, V25, P329; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; HOOLE P, 1993, LANG SPEECH, V36, P235, DOI 10.1177/002383099303600307; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; Krakow RA, 1999, J PHONETICS, V27, P23, DOI 10.1006/jpho.1999.0089; Kuehn D. P., 1976, J PHONETICS, V4, P303; MANUEL SY, 2002, AM SPEECH LANG HEAR; MANUEL SY, 1998, J ACOUSTICAL SOC S1, V84, pS84; Marslen-Wilson William D., 1980, SPOKEN LANGUAGE GENE, P39, DOI 10.1007/978-94-009-9091-3_2; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; Murdoch B. E., 1987, AUSTR J HUMAN COMMUN, V15, P15; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; OSTRY DJ, 1985, J ACOUST SOC AM, V77, P640, DOI 10.1121/1.391882; SCOTT D, 2002, UNPUB EPGLAB MANUAL; Sosin DM, 1996, BRAIN INJURY, V10, P47; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, p[53, 75]; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; WEISMER G, 1991, DYSARTHRIA APRAXIA S; Yorkston K.M., 1981, ASSESSMENT INTELLIGI	39	11	11	0	12	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2005	13	1					15	35					21	Audiology & Speech-Language Pathology; Clinical Neurology	Audiology & Speech-Language Pathology; Neurosciences & Neurology	914WM	WOS:000228258700004					2021-06-18	
B	Elovic, EP; Dobrovic, NM; Fellus, JL		DeLuca, J		Elovic, Elie P.; Dobrovic, Nino M.; Fellus, Jonathan L.			Fatigue after Traumatic Brain Injury	FATIGUE AS A WINDOW TO THE BRAIN	Issues in Clinical and Cognitive Neuropsychology		English	Article; Book Chapter							GROWTH-HORMONE DEFICIENCY; ANTERIOR-PITUITARY DYSFUNCTION; PLACEBO-CONTROLLED TRIAL; HEAD-INJURY; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; POSTTRAUMATIC SEIZURES; SLEEP DISTURBANCE; HYPOPITUITARISM; PERFORMANCE		[Elovic, Elie P.] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA; [Elovic, Elie P.] Kessler Med Rehabil Res & Educ Corp, Traumat Brain Injury Res, W Orange, NJ USA; [Fellus, Jonathan L.] Kessler Inst Rehabil, Brain Injury Serv, W Orange, NJ USA	Elovic, EP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, 185 S Orange Ave, Newark, NJ 07103 USA.						Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Blomstrand E, 2001, AMINO ACIDS, V20, P25, DOI 10.1007/s007260170063; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; BLOMSTRAND E, 1991, ACTA PHYSIOL SCAND, V143, P225, DOI 10.1111/j.1748-1716.1991.tb09225.x; Breitbart W, 2001, ARCH INTERN MED, V161, P411, DOI 10.1001/archinte.161.3.411; BURMAN P, 1995, J CLIN ENDOCR METAB, V80, P3585, DOI 10.1210/jc.80.12.3585; Busek P, 2000, Sb Lek, V101, P233; Carpenter M.B., 1985, CORE TEXT NEUROANATO; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; COHEN RA, 1989, ARCH NEUROL-CHICAGO, V46, P676, DOI 10.1001/archneur.1989.00520420096030; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Dwyer D, 2000, ACTA PHYSIOL SCAND, V170, P211, DOI 10.1046/j.1365-201x.2000.00774.x; EDWARDS OM, 1986, MEDICINE, V65, P281; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P184, DOI 10.1097/00001199-200403000-00010; Elovic EP, 2003, J HEAD TRAUMA REHAB, V18, P541, DOI 10.1097/00001199-200311000-00008; EMONSON DL, 1995, SPACE ENV MED, V66, P260; Escamilla RF, 1942, J CLIN ENDOCRINOL, V2, P65, DOI 10.1210/jcem-2-2-65; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gibney J, 1999, J CLIN ENDOCR METAB, V84, P2596, DOI 10.1210/jc.84.8.2596; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Heilman K.M., 2003, CLIN NEUROPSYCHOLOGY; HILLARY F, 2003, AM J PHYS MED REHABI, V82, P240; Hillier SL, 1997, BRAIN INJURY, V11, P661; JORGENSEN JOL, 1994, EUR J ENDOCRINOL, V130, P224, DOI 10.1530/eje.0.1300224; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Krupp L.B., 2003, FATIGUE, V1st; Krupp LB, 1996, CURR OPIN NEUROL, V9, P456, DOI 10.1097/00019052-199612000-00011; KRUPP LB, 1995, NEUROLOGY, V45, P1956, DOI 10.1212/WNL.45.11.1956; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LARSEN PR, 2003, WILLIAMS TXB ENDOCRI; LEZAK MD, 1978, NEUROPSYCHOLOGICAL A; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Newman CB, 1998, ENDOCRINOLOGIST, V8, P178, DOI 10.1097/00019616-199805000-00009; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Plum F., 1980, DIAGNOSIS STUPOR COM, V3; Rammohan KW, 2002, J NEUROL NEUROSUR PS, V72, P179, DOI 10.1136/jnnp.72.2.179; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Rosenthal M., 1999, REHABILITATION ADULT; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Simpson H, 2002, GROWTH HORM IGF RES, V12, P1, DOI 10.1054/ghir.2001.0263; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Wagner GJ, 2000, J CLIN PSYCHIAT, V61, P436, DOI 10.4088/JCP.v61n0608; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Wesensten NJ, 2002, PSYCHOPHARMACOLOGY, V159, P238, DOI 10.1007/s002130100916	59	11	11	0	0	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142 USA			978-0-262-25135-8	ISS CLIN COGN NEUROP			2005							89	105					17	Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	BPS59	WOS:000279778900008					2021-06-18	
J	Komiyama, M; Yoshimura, M; Honnda, Y; Matsusaka, Y; Yasui, T				Komiyama, M; Yoshimura, M; Honnda, Y; Matsusaka, Y; Yasui, T			Acute basilar artery dissection treated by emergency stenting in a 13-year-old boy	PEDIATRIC NEUROSURGERY			English	Article						basilar artery dissection; brain stem; cerebral infarction; stenting	VERTEBROBASILAR DISSECTION; VERTEBRAL ARTERY; CHILDHOOD; ANEURYSMS; CHILDREN; STROKE; INJURY; FLOW	We report a 13-year-old boy who presented with acute basilar artery occlusion due to traumatic arterial dissection. Because a grave prognosis was expected if left untreated, and the chance of neurological recovery was believed to be unlikely but not zero, given that emergency stenting for the dissection was performed within 6 h of ictus. Recanalization of the basilar artery with stent placement did not change the poor prognosis in this patient because there was extension of dissection into the posterior cerebral arteries. Copyright (c) 2005 S. Karger AG, Basel.	Osaka City Gen Hosp, Dept Neurosurg, Osaka 5340021, Japan	Komiyama, M (corresponding author), Osaka City Gen Hosp, Dept Neurosurg, 2-13-22,Miyakojima Hondohri, Osaka 5340021, Japan.	komiyama@japan-mail.com		komiyama, masaki/0000-0003-0998-6315			AminHanjani S, 1997, ACTA NEUROCHIR, V139, P44, DOI 10.1007/BF01850867; BERGER MS, 1984, J NEUROSURG, V61, P882, DOI 10.3171/jns.1984.61.5.0882; CAPLAN LR, 1988, NEUROLOGY, V38, P868, DOI 10.1212/WNL.38.6.868; Chabrier S, 2000, J CHILD NEUROL, V15, P290, DOI 10.1177/088307380001500504; Chung YS, 2002, NEUROL RES, V24, P129, DOI 10.1179/016164102101199666; deVeber G, 2003, SEMIN THROMB HEMOST, V29, P567; JAMES CA, 1995, AM J NEURORADIOL, V16, P1689; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; KURIHARA S, 2002, CLIN NEUROL, V42, P970; Lotze TE, 2000, J CHILD NEUROL, V15, P694, DOI 10.1177/088307380001501011; MANZ HJ, 1983, J NEUROL, V230, P25, DOI 10.1007/BF00313594; Marietta M, 2002, CLIN APPL THROMB-HEM, V8, P179, DOI 10.1177/107602960200800215; MOSCOW NP, 1973, AM J ROENTGENOL, V119, P597, DOI 10.2214/ajr.119.3.597; Nakatomi H, 1999, ACTA NEUROCHIR, V141, P99, DOI 10.1007/s007010050272; POZZATI E, 1995, NEUROSURGERY, V36, P254, DOI 10.1227/00006123-199502000-00003; Roach, 2000, Curr Treat Options Neurol, V2, P295, DOI 10.1007/s11940-000-0047-5; Schols G, 1999, NEUROPEDIATRICS, V30, P328, DOI 10.1055/s-2007-973514; Willing SJ, 2003, AM J NEURORADIOL, V24, P985	18	11	11	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2005	41	6					318	322		10.1159/000088734			5	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	985GC	WOS:000233363900005	16293951				2021-06-18	
J	Marshall, JC				Marshall, JC			The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation	SHOCK			English	Article; Proceedings Paper	Symposium on the Translational Biology of Shock and Sepsis	JUN 04-06, 2004	Lunenburg, CANADA			G-CSF (Granulocyte Colony Stimulating Factor); sepsis; shock; neutropenia; neutrophils; pre-clinical models	ACUTE LUNG INJURY; TUMOR-NECROSIS-FACTOR; FACTOR G-CSF; PSEUDOMONAS-AERUGINOSA PNEUMONIA; FULMINANT INTRAABDOMINAL SEPSIS; RANDOMIZED CONTROLLED-TRIAL; CANDIDA-ALBICANS INFECTION; TRAUMATIC BRAIN-INJURY; ESCHERICHIA-COLI; FACTOR FILGRASTIM	The cytokine granulocyte colony-stimulating factor (G-CSF) is a potent endogenous trigger for the release of neutrophils from bone marrow stores and for their activation for enhanced antimicrobial activity. G-CSF has been widely evaluated in preclinical models of acute illness, with generally promising though divergent results. A recombinant G-CSF molecule has recently undergone clinical trials to assess its efficacy as an adjuvant therapy in community-acquired and nosocomial pneumonia, however, these studies failed to provide convincing evidence of benefit. We undertook a systematic review of the published literature reporting the effects of modulation of G-CSF in preclinical in vivo models to determine whether evidence of differential efficacy might explain the disappointing results of human studies and point to disease states that might be more likely to benefit from G-CSF therapy. G-CSF has been evaluated in 86 such studies involving a variety of different models. The strongest evidence of benefit was seen in studies involving intraperitoneal challenge with live organisms; benefit was evident whether the agent was given before or after challenge. G-CSF demonstrates anti-inflammatory activity in models of systemic challenge with viable organisms or endotoxin, but only when the agent is given before challenge; evidence of benefit after challenge was minimal. Preclinical models of intrapulmonary challenge only show efficacy when the cytokine is administered before the infectious challenge, and suggested harm in gram-negative pneumonia resulting from challenge with Escherichia coli or Klebsiella. There is little evidence for therapeutic efficacy in noninfectious models of acute illness. We conclude that the most promising populations for evaluation of G-CSF are neutropenic patients with invasive infection and patients with intra-abdominal infection, particularly those with the syndrome of tertiary, or recurrent, peritonitis. Significant variability in the design and reporting of studies of preclinical models of acute illness precludes more sophisticated data synthesis.	Univ Toronto, Toronto Gen Hosp, Dept Surg, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto Gen Hosp, Interdept Div Crit Care, Toronto, ON M5G 2C4, Canada	Marshall, JC (corresponding author), 9 EN 234,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	John.Marshall@uhn.on.ca					ABRAHAM E, 1992, CRIT CARE MED, V20, P1127, DOI 10.1097/00003246-199208000-00011; Agalar F, 1998, J SURG RES, V78, P143, DOI 10.1006/jsre.1998.5386; Anderlini P, 1996, BLOOD, V88, P2819, DOI 10.1182/blood.V88.8.2819.bloodjournal8882819; AOKI Y, 1995, BLOOD, V86, P1420, DOI 10.1182/blood.V86.4.1420.bloodjournal8641420; Attalah HL, 2002, CRIT CARE MED, V30, P2107, DOI 10.1097/00003246-200209000-00026; Avalos BR, 1996, BLOOD, V88, P761, DOI 10.1182/blood.V88.3.761.bloodjournal883761; Azoulay E, 2003, CRIT CARE MED, V31, P157, DOI 10.1097/00003246-200301000-00025; Babalola CP, 2004, J ANTIMICROB CHEMOTH, V53, P1098, DOI 10.1093/jac/dkh237; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Barsig J, 1996, J INFECT DIS, V174, P790, DOI 10.1093/infdis/174.4.790; Basu S, 2000, BLOOD, V95, P3725; Bauhofer A, 2003, SHOCK, V20, P326, DOI 10.1097/01.shk.0000084342.58020.1e; Bauhofer A, 2002, BRIT J SURG, V89, P1457, DOI 10.1046/j.1365-2168.2002.02227.x; Boneberg EM, 2002, INFLAMM RES, V51, P119, DOI 10.1007/PL00000283; Boneberg EM, 2000, BLOOD, V95, P270, DOI 10.1182/blood.V95.1.270; BRADLEY TR, 1966, AUST J EXP BIOL MED, V44, P287, DOI 10.1038/icb.1966.28; Buisman AM, 1996, J INFECT DIS, V174, P417, DOI 10.1093/infdis/174.2.417; CAIRO MS, 1990, BLOOD, V76, P1788; Canturk Z, 1998, ENDOCR RES, V24, P141, DOI 10.1080/07435809809135524; CEBON J, 1994, BRIT J HAEMATOL, V86, P265, DOI 10.1111/j.1365-2141.1994.tb04725.x; CHENG AC, 2004, COCHRANE DB SYST REV, P4400, DOI DOI 10.1002/14651858.CD004400.PUB3; Clark OA, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003039; Dallaire F, 2001, J INFECT DIS, V183, P70, DOI 10.1086/317652; Davis KA, 1999, SURGERY, V126, P305, DOI 10.1067/msy.1999.98742; de Lalla F, 2001, ANTIMICROB AGENTS CH, V45, P1094, DOI 10.1128/AAC.45.4.1094-1098.2001; DEMARSH PL, 1994, IMMUNOPHARMACOLOGY, V27, P199, DOI 10.1016/0162-3109(94)90016-7; Dunne JR, 1996, J SURG RES, V61, P348, DOI 10.1006/jsre.1996.0128; EavesPyles T, 1996, J TRAUMA, V41, P1013, DOI 10.1097/00005373-199612000-00012; EICHACKER PQ, 1994, J APPL PHYSIOL, V77, P2366; FINK MP, 1993, J TRAUMA, V34, P571, DOI 10.1097/00005373-199304000-00015; Freeman BD, 1996, J APPL PHYSIOL, V80, P2066; Freeman BD, 1997, J APPL PHYSIOL, V83, P1467; GORGEN I, 1992, J IMMUNOL, V149, P918; Gough A, 1997, LANCET, V350, P855, DOI 10.1016/S0140-6736(97)04495-4; GOYA T, 1993, CLIN IMMUNOL IMMUNOP, V69, P278, DOI 10.1006/clin.1993.1181; GRAYBILL JR, 1995, EUR J CLIN MICROBIOL, V14, P700, DOI 10.1007/BF01690878; Haberstroh J, 1998, SHOCK, V9, P128, DOI 10.1097/00024382-199802000-00009; HABERSTROH J, 1995, SHOCK, V4, P216, DOI 10.1097/00024382-199509000-00011; HAMOOD M, 1994, MYCOSES, V37, P93, DOI 10.1111/j.1439-0507.1994.tb00783.x; Hanaoka M, 1998, EXP LUNG RES, V24, P15, DOI 10.3109/01902149809046051; Heard SO, 1998, CRIT CARE MED, V26, P748, DOI 10.1097/00003246-199804000-00027; Hebert JC, 1997, J TRAUMA, V43, P875, DOI 10.1097/00005373-199712000-00001; Held TK, 1998, BLOOD, V91, P2525; Hubel K, 2002, J INFECT DIS, V185, P1490, DOI 10.1086/340221; Hustinx W, 1997, EUR J CLIN INVEST, V27, P1044, DOI 10.1046/j.1365-2362.1997.2290787.x; ICHIKAWA Y, 1966, P NATL ACAD SCI USA, V56, P488, DOI 10.1073/pnas.56.2.488; IGUCHI K, 1991, EXP HEMATOL, V19, P352; Ishikawa K, 1998, J TRAUMA, V44, P1047, DOI 10.1097/00005373-199806000-00018; KANAZAWA M, 1992, AM REV RESPIR DIS, V145, P1030, DOI 10.1164/ajrccm/145.5.1030; Karzai W, 1999, AM J RESP CRIT CARE, V159, P1377, DOI 10.1164/ajrccm.159.5.9806082; Kastenbauer T, 2003, DIABETOLOGIA, V46, P27, DOI 10.1007/s00125-002-0998-z; KAWAKAMI M, 1990, BLOOD, V78, P3254; KAYASHIMA S, 1993, IMMUNOLOGY, V80, P471; KING J, 1995, AM J RESP CRIT CARE, V151, P302, DOI 10.1164/ajrccm.151.2.7531097; KOIKE K, 1992, J SURG RES, V52, P656, DOI 10.1016/0022-4804(92)90145-P; KOIZUMI T, 1993, AM REV RESPIR DIS, V148, P132, DOI 10.1164/ajrccm/148.1.132; Kullberg BJ, 1998, J INFECT DIS, V177, P175, DOI 10.1086/513812; Lawlor KE, 2004, P NATL ACAD SCI USA, V101, P11398, DOI 10.1073/pnas.0404328101; LISTER PD, 1993, J INFECT DIS, V168, P922, DOI 10.1093/infdis/168.4.922; Liu FL, 1997, BLOOD, V90, P2522, DOI 10.1182/blood.V90.7.2522.2522_2522_2528; LORENZ W, 1994, SURGERY, V116, P925; Lundblad R, 1996, CRIT CARE MED, V24, P820, DOI 10.1097/00003246-199605000-00016; LUNDBLAD R, 1995, SHOCK, V4, P68, DOI 10.1097/00024382-199507000-00011; Marshall John C, 1998, Sepsis (Boston), V2, P213, DOI 10.1023/A:1009829712638; MATSUMOTO M, 1991, J ANTIMICROB CHEMOTH, V28, P447, DOI 10.1093/jac/28.3.447; Meng ZH, 2000, SHOCK, V14, P41, DOI 10.1097/00024382-200014010-00008; METCALF D, 1983, J CELL PHYSIOL, V116, P198, DOI 10.1002/jcp.1041160211; Metcalf D, 1996, BLOOD, V88, P3755, DOI 10.1182/blood.V88.10.3755.bloodjournal88103755; Molineux G, 2004, CURR PHARM DESIGN, V10, P1235, DOI 10.2174/1381612043452613; Nathens AB, 1998, WORLD J SURG, V22, P158, DOI 10.1007/s002689900364; Nelson S, 1996, CLIN CHEST MED, V17, P319, DOI 10.1016/S0272-5231(05)70317-8; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; Nelson S, 2000, J INFECT DIS, V182, P970, DOI 10.1086/315775; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Nose M, 2001, J RADIAT RES, V42, P191, DOI 10.1269/jrr.42.191; NOVALES JS, 1993, BLOOD, V81, P923; OREILLY M, 1992, J TRAUMA, V33, P679, DOI 10.1097/00005373-199211000-00014; Oz N, 2001, Int J Surg Investig, V2, P347; Pajkrt D, 1997, BLOOD, V90, P1415, DOI 10.1182/blood.V90.4.1415.1415_1415_1424; Patton JH, 1998, J TRAUMA, V44, P750, DOI 10.1097/00005373-199805000-00002; Peter FW, 1999, BURNS, V25, P477, DOI 10.1016/S0305-4179(99)00036-4; Piper RD, 1996, CRIT CARE MED, V24, P2059, DOI 10.1097/00003246-199612000-00021; POLAKWYSS A, 1991, MYCOSES, V34, P109, DOI 10.1111/j.1439-0507.1991.tb00630.x; Pollmacher T, 1996, BLOOD, V87, P900, DOI 10.1182/blood.V87.3.900.bloodjournal873900; Preheim LC, 1996, J INFECT DIS, V174, P225, DOI 10.1093/infdis/174.1.225; QUEZADO Z, 2004, AM J PHYSL INTEGR CO, V281, pR1177; Rao R, 1996, SURGERY, V119, P657, DOI 10.1016/S0039-6060(96)80190-5; Schaefer H, 2004, ANN SURG, V240, P68, DOI 10.1097/01.sla.0000129705.00210.24; Schafer H, 2000, ANN HEMATOL, V79, P143, DOI 10.1007/s002770050570; Schneider C, 2004, ANN SURG, V239, P75, DOI 10.1097/01.sla.0000103062.21049.82; SERUSHAGO BA, 1992, IMMUNOLOGY, V75, P475; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; SHINOMIYA N, 1991, INFECT IMMUN, V59, P4740, DOI 10.1128/IAI.59.12.4740-4743.1991; Shirai R, 1997, CLIN EXP IMMUNOL, V109, P73, DOI 10.1046/j.1365-2249.1997.4211317.x; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; SMITH WS, 1995, BLOOD, V86, P1301, DOI 10.1182/blood.V86.4.1301.bloodjournal8641301; STEINSHAMN S, 1993, J INFECT DIS, V168, P1444, DOI 10.1093/infdis/168.6.1444; Takahashi Y, 1999, ACTA HAEMATOL-BASEL, V101, P124, DOI 10.1159/000040937; TERASHIMA T, 1994, AM J RESP CRIT CARE, V149, P1295, DOI 10.1164/ajrccm.149.5.7513596; Tian SS, 1998, SCIENCE, V281, P257, DOI 10.1126/science.281.5374.257; TODA H, 1993, STEM CELLS, V11, P228, DOI 10.1002/stem.5530110310; Torossian A, 2003, ANESTHESIOLOGY, V99, P1087, DOI 10.1097/00000542-200311000-00014; UCHIDA K, 1992, J MED VET MYCOL, V30, P293; Villa P, 1998, J INFECT DIS, V178, P471, DOI 10.1086/515643; Vollmar B, 1997, J LEUKOCYTE BIOL, V62, P710; WAKIYAMA H, 1993, CLIN EXP IMMUNOL, V92, P218; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Winston DJ, 1999, TRANSPLANTATION, V68, P1298, DOI 10.1097/00007890-199911150-00014; Wolkoff LI, 2002, LUNG, V180, P229, DOI 10.1007/s004080000097; Wunderink RG, 2001, CHEST, V119, P523, DOI 10.1378/chest.119.2.523; Yalcin O, 1997, SURG TODAY, V27, P154, DOI 10.1007/BF02385906; Yonem A, 2001, DIABETES OBES METAB, V3, P332, DOI 10.1046/j.1463-1326.2001.00142.x; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang P, 1997, SHOCK, V7, P193, DOI 10.1097/00024382-199703000-00007; Zhang P, 1998, CRIT CARE MED, V26, P315, DOI 10.1097/00003246-199802000-00035	115	11	11	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock		2005	24			1			120	129		10.1097/01.shk.0000191344.21228.b6			10	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	999XR	WOS:000234425400019	16374383				2021-06-18	
J	McGwin, G; Taylor, AJ; MacLennan, PA; Rue, LW				McGwin, G; Taylor, AJ; MacLennan, PA; Rue, LW			Unusual job activities as a risk factor for occupational injuries	OCCUPATIONAL MEDICINE-OXFORD			English	Article							CASE-CROSSOVER; HAND INJURY	Background Based upon our clinical observation, many job-related injuries occur as a consequence of workers performing a task or engaging in an activity for which they have not been trained. Methods A case-crossover study was used to evaluate unusual job tasks, unusual tools and unusual work locations as triggers for occupational injuries. Data on work activities on the day of the injury and 7 days prior to injury were collected via in-person interview. Results All the 33 subjects enrolled were male, 23 were white and 10 were black, with a mean age of 34.9 years. The most common mechanisms of injury were falls and burns. The most common injuries were fractures and closed head injuries. Unusual job tasks [odds ratio (OR) 27.0, 95% confidence interval (CI) 3.1-235.3] and unusual tools (OR 13.3, 95% CI 1.4-125.4) were associated with the injury. Conclusions Workers should be extra cautious and they should be provided with training for new tasks and new tools.	Univ Alabama, Ctr Injury Sci, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Dept Surg, Div Gen Surg,Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA	McGwin, G (corresponding author), Univ Alabama, Ctr Injury Sci, 120 Kracke Bldg,1922 7th Ave S, Birmingham, AL 35294 USA.	mcgwin@uab.edu					HERTZ RP, 1986, J OCCUP ENVIRON MED, V28, P36, DOI 10.1097/00043764-198601000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Redelmeier DA, 1997, J CLIN EPIDEMIOL, V50, P1281, DOI 10.1016/S0895-4356(97)00196-0; SAARI J, 1981, SCAND J WORK ENV HEA, V7, P97; SOROCK G, 2001, INJ PREV S1, V7, P38; Sorock GS, 2004, OCCUP ENVIRON MED, V61, P305, DOI 10.1136/oem.2002.004028; Sorock GS, 2001, AM J IND MED, V39, P171, DOI 10.1002/1097-0274(200102)39:2<171::AID-AJIM1004>3.3.CO;2-S	7	11	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0962-7480			OCCUP MED-OXFORD	Occup. Med.-Oxf.	JAN	2005	55	1					66	68		10.1093/occmed/kqi020			3	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	899GK	WOS:000227132700013	15699094				2021-06-18	
J	Kim, EH; Kim, TS; Sun, W; Kim, DS; Chung, HS; Kim, DK; Park, SH; Kim, F				Kim, EH; Kim, TS; Sun, W; Kim, DS; Chung, HS; Kim, DK; Park, SH; Kim, F			Differential regulation of metallothionein-I and metallothionein-II mRNA expression in the rat brain following traumatic brain injury	MOLECULES AND CELLS			English	Article						glial cells; metallothioneins; neurons; rat brain; traumatic brain injury	REGIONAL PATTERNS; NEURONAL INJURY; MOUSE; CNS; GENES	In this study, we investigated the expression of metallothionein (MT)-I and MT-II in the rat brain following traumatic brain injury (TBI). In the early stage, significant induction of MT-I and MT-II were observed in various regions including ventricle walls, pia mater, and dentate gyrus. At 12-24 h after TBI, strong induction of MT-I mRNA was observed in cerebral cortical layer II/III, amygdala, and piriform cortex where neurons reside. On the other hand, MT-II appeared to be expressed mainly in glial cells localized in the cerebral cortex and hippocampal formation. Three days after TBI, MTs were observed in the vimentin-positive astrocytes in the penumbra as revealed by double immunohistochemistry. The differences in expression of MT-I and MT-II in different brain regions and cell types (neuron vs. glial cells) suggests that multiple regulatory mechanisms are involved in the control of MT expression following brain injury.	Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea; Natl Inst Hlth, Div Brain Dis, Dept Biomed Sci, Seoul 122701, South Korea; Catholic Univ, Uijongbu St Marys Hosp, Coll Med, Dept Neurosurg, Kyonggi Do 480130, South Korea; Yonsei Univ, Coll Med, Dept Emergency Med, Seoul 120752, South Korea	Kim, F (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea.	kimhyun@korea.ac.kr					Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; CHOUDHURI S, 1995, TOXICOL APPL PHARM, V131, P144, DOI 10.1006/taap.1995.1056; Chung RS, 2003, J NEUROSCI, V23, P3336; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dincer Z, 1999, J COMP PATHOL, V120, P29, DOI 10.1053/jcpa.1998.0254; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Hernandez J, 1998, NEUROCHEM INT, V32, P369, DOI 10.1016/S0197-0186(97)00096-X; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Kim D, 2003, NEUROREPORT, V14, P679, DOI 10.1097/00001756-200304150-00004; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Penkowa M, 1999, J NEUROSCI, V19, P2535; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Soares HD, 1995, J NEUROSCI, V15, P8223; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; YAGLE MK, 1985, MOL CELL BIOL, V5, P291, DOI 10.1128/MCB.5.2.291	20	11	11	1	5	SPRINGER SINGAPORE PTE LTD	SINGAPORE	#04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE	1016-8478			MOL CELLS	Mol. Cells	DEC 31	2004	18	3					326	331					6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	883VA	WOS:000226042600008	15650329				2021-06-18	
J	Heim, C; Schoettker, R; Spahn, DR				Heim, C; Schoettker, R; Spahn, DR			Glasgow coma scale in traumatic brain injury	ANAESTHESIST			German	Article						Glasgow Coma Scale; coma; traumatic brain injury; sum score; pseudoscore; Glasgow Coma Score	SEVERE HEAD-INJURY; PRACTICAL SCALE; SEVERITY SCORE; MOTOR SCORE; MORTALITY; PREDICTION; PROGNOSIS; SYSTEMS; ABILITY; APACHE	Even 30 years after its first publication the Glasgow Coma Scale (GCS) is still used worldwide to describe and assess coma. The GCS consists of three components, the ocular, motor and verbal response to standardized stimulation, and is used as a severity of illness indicator for coma of various origins. The GCS facilitates information transfer and monitoring changes in coma. In addition, it is used as a triage tool in patients with traumatic brain injury. Its prognostic value regarding the outcome after a traumatic brain injury still lacks evidence. One of the main problems is the evaluation of the GCS in sedated, paralysed and/or intubated patients. A multitude of pseudoscores exists but a universal definition has yet to be defined.	CHU Vaudois, Dept Anesthesia, CH-1011 Lausanne, Switzerland	Heim, C (corresponding author), CHU Vaudois, Dept Anesthesia, Rue Bugnon, CH-1011 Lausanne, Switzerland.	Catherine.Heim@hospvd.ch		Schoettker, Patrick/0000-0001-5370-048X			Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Chen LM, 1999, CRIT CARE MED, V27, P1999, DOI 10.1097/00003246-199909000-00046; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; JAGGER J, 1983, LANCET, V2, P97; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; KOZIOL JA, 1990, J NEUROL, V237, P461, DOI 10.1007/BF00314762; Kuhls DA, 2002, J AM COLL SURGEONS, V194, P695, DOI 10.1016/S1072-7515(02)01211-5; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; Lucke JF, 1996, ANN EMERG MED, V28, P408, DOI 10.1016/S0196-0644(96)70006-9; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Nolan JP, 1997, BRIT J ANAESTH, V79, P226; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; ROWLEY G, 1991, LANCET, V337, P535, DOI 10.1016/0140-6736(91)91309-I; SACCO RL, 1990, ARCH NEUROL-CHICAGO, V47, P1181, DOI 10.1001/archneur.1990.00530110035013; SEGATORE M, 1992, HEART LUNG, V21, P548; Senkowski CK, 1999, J AM COLL SURGEONS, V189, P491, DOI 10.1016/S1072-7515(99)00190-8; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1976, BRIT J ANAESTH, V48, P761, DOI 10.1093/bja/48.8.761; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1975, Nurs Times, V71, P972; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P591; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017	39	11	12	0	7	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0003-2417			ANAESTHESIST	Anaesthesist	DEC	2004	53	12					1245	1255		10.1007/s00101-004-0777-y			11	Anesthesiology	Anesthesiology	882ET	WOS:000225922500015	15597166				2021-06-18	
J	Nakamura, T; Miyamoto, O; Auer, RN; Nagao, S; Itano, T				Nakamura, T; Miyamoto, O; Auer, RN; Nagao, S; Itano, T			Delayed precursor cell markers expression in hippocampus following cold-induced cortical injury in mice	JOURNAL OF NEUROTRAUMA			English	Article						3CB2; cold-induced brain injury; mice; migration; nestin; remodeling	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; REACTIVE ASTROCYTES; ADULT-RAT; INTERMEDIATE FILAMENT; SUBVENTRICULAR ZONE	The purpose of this study was to examine the possibility of neuronal remodeling and repair after cold-induced brain injury using immunoassay of nestin and 3CB2 (potential precursor cell markers). Male ddN strain mice were subjected to cold-induced cortical injury. Animals were divided into the following six groups: (1) 1 day after injury, (2) 1 week after injury, (3) 2 weeks after injury, (4) 1 month after injury, (5) sham controls, and (6) normal controls. Western blot analysis (n = 3 in each group) and histological examination (n = 5 in each group) were performed. At 1 day and 1 week after injury, TUNEL-positive cells were observed, while immunoreactivity of nestin and 3CB2 was absent. At 1 month after injury, expression of both nestin and 3CB2 was observed in the ipsilateral hippocampus. Nestin was expressed in GFAP- or 3CB2-positive astrocytes at 1 month after injury, and nestin expression with TUC-4 (immature neuron marker) was present in the hippocampal cell layer. The findings demonstrate delayed nestin expression in both glia and neuron-like cells after brain injury. The present study suggests that the delayed nestin expression in glia and neuron-like cells might be part of the adaptation to injury.	Kagawa Univ, Fac Med, Dept Neurol Surg, Miki, Kagawa 7610793, Japan; Kagawa Univ, Fac Med, Dept Neurobiol, Miki, Kagawa 7610793, Japan; Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; Univ Calgary, Dept Pathol & Lab Med & Clin Neurosci, Calgary, AB T2N 1N4, Canada	Nakamura, T (corresponding author), Kagawa Univ, Fac Med, Dept Neurol Surg, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	neuron@kms.ac.jp	Auer, Roland/G-7164-2011	Auer, Roland/0000-0001-9044-3419; Nakamura, Takehiro/0000-0002-4105-5767			Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Bagum MA, 2001, ACTA MED OKAYAMA, V55, P19; BARRES BA, 1991, J NEUROSCI, V11, P3685; Brook GA, 1999, NEUROREPORT, V10, P1007, DOI 10.1097/00001756-199904060-00021; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chanas-Sacre G, 2000, J NEUROSCI RES, V61, P357, DOI 10.1002/1097-4547(20000815)61:4<357::AID-JNR1>3.0.CO;2-7; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doyle KL, 2001, J COMP NEUROL, V437, P186, DOI 10.1002/cne.1278; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Franklin K. B. J., 1997, MOUSE BRAIN STEREOTA; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kuroda T, 2002, J CHEM NEUROANAT, V24, P137, DOI 10.1016/S0891-0618(02)00042-X; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MASON HA, 2001, J COMP NEUROL, V405, P508; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1998, BRAIN RES, V466, P183; Miyamoto O, 2000, FEMS MICROBIOL LETT, V189, P109, DOI 10.1016/S0378-1097(00)00262-7; Momma S, 2000, CURR OPIN NEUROBIOL, V10, P45, DOI 10.1016/S0959-4388(99)00056-2; Nakamura T, 1999, ACTA NEUROCHIR, V141, P407, DOI 10.1007/s007010050317; Nakamura T, 1999, ICRAN 99: INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN NEUROTRAUMATOLOGY, P187; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parnavelas JG, 2001, NEURON, V31, P881, DOI 10.1016/S0896-6273(01)00437-8; Perry G, 2001, AM J PATHOL, V158, P1, DOI 10.1016/S0002-9440(10)63936-3; Prada FA, 1995, GLIA, V15, P389, DOI 10.1002/glia.440150404; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; Shibuya S, 2003, GLIA, V42, P172, DOI 10.1002/glia.10203; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; SUZUKI M, 1991, ACTA NEUROPATHOL, V82, P93, DOI 10.1007/BF00293950; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Xu RX, 1998, NEUROSURGERY, V43, P107, DOI 10.1097/00006123-199807000-00070; Yang HY, 1997, EXP NEUROL, V146, P199, DOI 10.1006/exnr.1997.6518	43	11	11	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2004	21	12					1747	1755		10.1089/0897715042664902			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	877FY	WOS:000225554400006	15684766				2021-06-18	
J	Orient-Lopez, F; Sevilla-Hernandez, E; Guevara-Espinosa, D; Terre-Boliart, R; Ramon-Rona, S; Bernabeu-Guitart, M				Orient-Lopez, F; Sevilla-Hernandez, E; Guevara-Espinosa, D; Terre-Boliart, R; Ramon-Rona, S; Bernabeu-Guitart, M			Functional outcome at discharge of patients with severe traumatic brain injury admitted to a brain damage unit	REVISTA DE NEUROLOGIA			Spanish	Article						functional independence; post-traumatic amnesia; prognosis; rehabilitation; reintegration; traumatic brain injury	AMANTADINE; REHABILITATION; POSTDISCHARGE; IMPAIRMENTS	Introduction. Severe traumatic brain injuries (TBI) are linked to high morbidity and mortality rates and have important individual and social costs, not only because of the high incidence of deaths they cause but also owing to the large number of individuals who are left with some kind of disability. Aims. The purpose of this study was to analyse the epidemiological, clinical, functional and rehabilitational aspects of patients with severe TBI admitted to a brain damage unit for neurorehabilitation therapy with special emphasis on the functional outcome at discharge. Patients and methods. We carried out a descriptive study of patients suffering from TBI admitted to the Brain Damage Unit of the Institut Guttmann hospital between January 2000 and June 2002. We analysed epidemiological (age, sex, cause of the TBI), clinical (aetiology, initial Glasgow Coma Scale -GCS-, motor deficit, type of injury, duration of post-traumatic amnesia), functional (Glasgow Outcome Scale -GOS-, Level of Cognitive Functioning Scale -LCFS- and Disability Rating Scale -DRS-) variables, in addition to patients' destination on discharge. Results. Of a total of 174 hospitalised patients, 88.52% were cases of serious TBI, 80% of which involved males, with a mean age of 29.72 years (standard deviation: 12.63), and an average of 99.28 days' hospitalisation (standard deviation: 60.72). Road accidents were the chief cause of the TBI (78%). The most frequent neurological injuries were parenchymatous (68.05%), followed by subarachnoid haemorrhages (40.58%). 87.58% of the patients presented TBI-related complications. Functional improvement at discharge was statistically significant (p < 0.001) as regards the GOS, LCFS and DSR scales, and 87.5% of the patients were able to reintegrate into their home life. Conclusions. Despite the severity of the sequelae left by serious TBI, the functional outcome at discharge, associated with the high rate of reintegration into home life, justifies admission of these patients to a brain damage unit for neurorehabilitation therapy.	Hosp Neurorehabil, Inst Guttman, Unidad Dano Cerebral, E-08916 Badalona, Barcelona, Spain; Hosp Morales Meseguer, Serv Rehabil & Med Fis, Murcia, Spain	Orient-Lopez, F (corresponding author), Hosp Neurorehabil, Inst Guttman, Unidad Dano Cerebral, Cami Can Ruti S-N, E-08916 Badalona, Barcelona, Spain.	metges@guttmann.com					Annoni J M, 1992, Disabil Rehabil, V14, P23; *APANEFA, 2002, B INF APANEFA, V3, P4; BORI I, 2002, REHABILITACION, V36, P318; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fuhrer MJ, 1987, REHABILITATION OUTCO, P137; Garcia-Pena M, 2004, REV NEUROLOGIA, V38, P775, DOI 10.33588/rn.3808.2003567; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS3; Junque C, 1999, REV NEUROLOGIA, V28, P423, DOI 10.33588/rn.2804.98420; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Leon-Carrion J, 2001, REV NEUROLOGIA, V33, P377, DOI 10.33588/rn.3304.2000196; LEONCARRION J, 1998, NOTICIAS MED, V3686, P32; LEVIN HS, 1975, J NERV MENT DIS, V11, P675; MALKMUS D, 1974, RANCHO LEVELS COGNIT; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; Mazaux JM, 2002, ACT NEUR S, V79, P49; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MUNOZ CJM, 2002, EVALUACION INTEGRACI; Munoz-Cespedes JM, 2004, REV NEUROLOGIA, V38, P852, DOI 10.33588/rn.3809.2003446; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Novack TA, 2000, BRAIN INJURY, V14, P987; Orient-Lopez F, 2002, REV NEUROLOGIA, V35, P362, DOI 10.33588/rn.3504.2001457; Perea MV, 1999, REV NEUROLOGIA, V29, P1099, DOI 10.33588/rn.2912.99373; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1986, ARCH PHYS MED REHAB, V67, P759, DOI 10.1016/0003-9993(86)90011-0; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SAAD K, 2002, BRAIN INJURY, V16, P537; Suarez JI, 2001, REV NEUROLOGIA, V32, P289, DOI 10.33588/rn.3203.2000518; TEASDALE G, 1974, LANCET, V73, P68; TERRE R, 2002, REHABILITACION, V36, P13; TICO N, 1998, REHABILITACION, V32, P39	41	11	14	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	NOV 16	2004	39	10					901	906		10.33588/rn.3910.2004302			6	Clinical Neurology	Neurosciences & Neurology	874OY	WOS:000225360900001	15573302				2021-06-18	
J	Hu, DZ; Zhou, LF; Zhu, JH				Hu, DZ; Zhou, LF; Zhu, JH			Marrow stromal cells administrated intracisternally to rats after traumatic brain injury migrate into the brain and improve neurological function	CHINESE MEDICAL JOURNAL			English	Article						brain injuries; transplantation; stromal cells; bone marrow; Cisterna magna	ADULT RATS; MOTOR		Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China	Hu, DZ (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.	hudezhi1972@msn.com					Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Bjorklund A, 2000, NAT NEUROSCI, V3, P537; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; FANG JM, 1995, INT J DEV BIOL, V39, P519; Golarai G, 2001, J NEUROSCI, V21, P8523; HEALTON EB, 1982, NEUROLOGY, V32, P776, DOI 10.1212/WNL.32.7.776; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	14	11	11	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	OCT	2004	117	10					1576	1578					3	Medicine, General & Internal	General & Internal Medicine	866QH	WOS:000224787500027	15498388	DOAJ Gold			2021-06-18	
J	Schmitter-Edgecombe, M; Woo, E				Schmitter-Edgecombe, M; Woo, E			Memory self-awareness and memory self-monitoring following severe closed-head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; FRONTAL-LOBE LESIONS; TASK-PERFORMANCE; WORKING-MEMORY; METAMEMORY; ADULTS; ACCURACY; DAMAGE; PREDICTIONS	Objective: To examine the accuracy of memory self-awareness and memory self-monitoring abilities in participants with severe closed-head injury (CHI). Design and methods: A performance-prediction paradigm was used to evaluate meta-memory abilities in 31 participants with severe CHI (>1 year post-injury) and 31 controls. To assess memory self-awareness, before completing story recall, visual reproduction and list learning memory tasks, participants predicted the amount of information they would remember for each task. Memory self-monitoring was evaluated by examining participants' ability to increase the accuracy of their predictions following experience with each memory task. Results: Although participants with CHI exhibited poorer recall than controls, they were equally aware of how differing task demands influence recall. They also successfully modified their predictions following task exposure. Conclusions: Meta-memory was better preserved than actual memory performance. It may be possible to build on meta-memory skills to help patients with CHI more consistently use strategies that aid memory performance.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA	Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Bunnell JK, 1999, NEW ZEAL J PSYCHOL, V28, P23; Cohen J, 1983, APPL MULTIPLE REGRES, P56; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DELIS D, 1987, CALIFORNIA VERBAL LE; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; DEVOLDER PA, 1989, CAN PSYCHOL, V30, P578, DOI 10.1037/h0079822; Fleming JM, 1996, BRAIN INJURY, V10, P1; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Golden J. C., 1978, STROOP COLOR WORD TE; Heaton R., 1981, MANUAL WISCONSIN CAR; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; HERRMANN DJ, 1982, PSYCHOL BULL, V92, P434, DOI 10.1037/0033-2909.92.2.434; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; Hertzog C., 1994, Aging & Cognition, V1, P203, DOI DOI 10.1080/13825589408256577; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Jurado MA, 1998, J CLIN EXP NEUROPSYC, V20, P353, DOI 10.1076/jcen.20.3.353.816; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050120517; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Mattis S, 1988, DEMENTIA RATING SCAL; Nissley HM, 2002, NEUROPSYCHOLOGY, V16, P111, DOI 10.1037//0894-4105.16.1.111; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SCHEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2003, J CLIN EXP NEUROPSYC, V25, P933, DOI 10.1076/jcen.25.7.933.16493; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TEASDALE G, 1974, LANCET, V2, P81; Vilkki J, 1999, NEUROPSYCHOLOGY, V13, P298, DOI 10.1037/0894-4105.13.2.298; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL WECHSL; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328	50	11	11	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2004	18	10					997	1016		10.1080/02699050410001719934			20	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	845LQ	WOS:000223244600004	15370899				2021-06-18	
J	Turner, RJ; Van den Heuvel, C; Vink, R				Turner, RJ; Van den Heuvel, C; Vink, R			Amiloride increases neuronal damage after traumatic brain injury in rats	JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION			English	Article						apoptosis; brain Mg; traumatic brain injury; hemorrhage; Mg treatment; amiloride; Na+/Mg2+ antiport		Objective: It is well known that traumatic brain injury (TBI) decreases brain free magnesium (Mg) concentration, and that administration of Mg salts after TBI restores concentration of Mg in brain and improves functional outcome. In the presence of hemorrhage, administration of Mg salts exacerbates the injury process and worsens outcome. An alternative to administration of Mg salts may be to prevent cellular loss of Mg with use of amiloride, which inhibits the Na+/Mg2+ exchange. Methods: In the present study, male, adult Sprague-Dawley rats were injured using the impact acceleration model of diffuse TBI and administered either 100 mols/kg i.v. amiloride, or an equal volume of 50% DMSO/saline, 30 minutes (min) after injury. Results: Amiloride did not improve functional outcome (motor or cognitive outcome) after TBI relative to vehicle treated controls. Histologically, treatment with amiloride significantly increased hippocampal caspase-3 expression (apoptosis), axonal swellings in the medulla and the degree of dark cell change (cell stress) in the cortex. Phosphorus NMR demonstrated that amiloride did not increase free Mg concentration after injury. Conclusions; Thus, amiloride is ineffective in preventing Mg loss after TBI when administered 30 min after trauma. Moreover, by administering amiloride after the TBI-related Mg decline has already been initiated, it may exacerbate injury by, in part by inhibiting Na+/Mg2+ antiport and preventing entry of Mg back into the cell, and also by inhibiting other Na+ linked transporters.	Univ Adelaide, Dept Pathol, Adelaide, SA, Australia	Vink, R (corresponding author), Univ Adelaide, Dept Pathol, GPO Box 498, Adelaide, SA, Australia.	robert.vink@adetaide.edu.au	AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			ANDREEVA N, 1992, NEUROSCIENCE, V49, P175, DOI 10.1016/0306-4522(92)90085-G; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GUNTHER T, 1985, BIOCHEM BIOPH RES CO, V130, P540, DOI 10.1016/0006-291X(85)90450-4; Gunzel D, 1996, J PHYSIOL-LONDON, V491, P595, DOI 10.1113/jphysiol.1996.sp021242; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	12	11	12	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0731-5724	1541-1087		J AM COLL NUTR	J. Am. Coll. Nutr.	OCT	2004	23	5					534S	537S		10.1080/07315724.2004.10719397			4	Nutrition & Dietetics	Nutrition & Dietetics	863AF	WOS:000224531900018	15466959				2021-06-18	
J	Bedell, EA; DeWitt, DS; Uchida, T; Prough, DS				Bedell, EA; DeWitt, DS; Uchida, T; Prough, DS			Cerebral pressure autoregulation is intact and is not influenced by hypothermia after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral blood flow; fluid percussion injury; hypothermia; laboratory animal models; laser Doppler flowmetry; traumatic brain injury	LASER-DOPPLER FLOWMETRY; SEVERE HEAD-INJURY; BLOOD-FLOW; MODERATE HYPOTHERMIA; CEREBROVASCULAR RESPONSES; CORTICAL IMPACT; L-ARGININE; HYPOPERFUSION; HYPOTENSION; ISCHEMIA	In head-injured patients and experimental traumatic brain injury (TBI), important cerebrovascular abnormalities include decreases in cerebral blood flow (CBF) and impairment of cerebral pressure autoregulation. We evaluated CBF and pressure autoregulation after fluid percussion injury (FPI) and hypothermia in rats with the hypothesis that hypothermia would ameliorate changes in posttraumatic CBF. Male Sprague-Dawley rats, intubated and mechanically ventilated, were prepared for parasaggital FPI (1.8 atm) and laser Doppler CBF flow (LDF) measurement. The abdominal aorta was cannulated for rapid removal and reinfusion of blood. Baseline autoregulatory testing in all groups consisted of LDF measurements at normothermia and a mean arterial pressure (MAP) of 100 mm Hg, followed by randomly ordered changes of MAP to 80, 60, and 40 mm Hg. Animals were then randomized to one of five groups: normothermic control without FPI; normothermia with FPI; hypothermic control (32degreesC) without FPI; hypothermia initiated before FPI; and hypothermia initiated immediately after FPI injury. For each group, a complete, randomly ordered autoregulatory sequence was performed at 30 and 60 min after FPI or sham TBI. In a second study, rats were prepared identically, maintained at normothermic temperatures and autoregulation was tested before and after TBI using a set of randomly ordered levels of hypotension or using progressive reductions in MAP (i.e., 80, 60, 40 mm Hg) with the hypothesis that the technical manner and timing of decreasing of the blood pressure would effect CBF after TBI. Due to high acute mortality, the group in which hypothermia was induced before FPI was excluded from the analysis. At baseline, autoregulation was similar in all groups. There was no change in CBF or autoregulation in the normothermic control group at 30 and 60 min. In the other groups at 30 and 60 min, there was a similar, statistically significant decrease in absolute CBF (i.e., a decrease of 27-57% of baseline values), but pressure autoregulation was intact except at the lowest blood pressure tested at 60 min, where there was a slight improvement in the hypothermic group. Thus, in these experiments, absolute CBF decreased with hypothermia and FPI, while neither hypothermia nor FPI significantly altered autoregulation. In the second study, autoregulatory function was not different before TBI when comparing random and sequential blood pressure changes, but, when comparing the groups after TBI at the 60 mm Hg blood pressure level, CBF was significantly lower in the sequential group than in the random order group. This suggests that the mechanism of creating hypotension, whether random or sequential, significantly affects the measurement of CBF and autoregulation after TBI in rats.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Off Biostat, Galveston, TX 77555 USA	Prough, DS (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	dsprough@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; BLAUTH CI, 1988, J THORAC CARDIOV SUR, V95, P668; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DeWitt D S, 1995, New Horiz, V3, P376; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Irikura K, 1998, J CEREBR BLOOD F MET, V18, P1294, DOI 10.1097/00004647-199812000-00003; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	37	11	11	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1212	1222					11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900010	15453991				2021-06-18	
J	Simpson, G; Long, E				Simpson, G; Long, E			An evaluation of sex education and information resources and their provision to adults with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability process evaluation; sex education; traumatic brain injury		Objectives: To evaluate sex education and information resources developed to address the sexual health concerns of persons with traumatic brain injury (TBI) and the means by which agencies have introduced this clinically sensitive program initiative. Design: A process evaluation methodology was used to assess program reach, participant satisfaction, program component usage, and quality of materials. Subjects: Two samples comprising multidisciplinary rehabilitation and disability staff (n = 37) from 36 brain injury agencies that had been utilizing the resources and 12 people with brain injury, respectively. Settings: A diverse range of rehabilitation and community brain injury agencies. Outcome Measures: Two purpose-designed evaluation protocols for staff and consumers, respectively, and a readability analysis to assess the comprehensibility of program materials (eg, information sheets) for people with TBI. Results: Agencies strongly endorsed their role in addressing consumer sexual health concerns. Agencies generally used a selective rather than a universal approach to sex education, with an average of 10% of consumers within agency caseloads receiving some intervention within the previous 12 months. The 4 issues most frequently addressed in education programs were sexual dysfunction, how to meet people, what is sexuality, and sexual adjustment in the context of established preinjury relationships. Finally, the average reading age needed to comprehend the resources was higher than the recommended levels for communicating health information. Conclusion: The sex education program resources have been positively evaluated by both rehabilitation and community agencies as a means of providing education and information to address the sexual health concerns of people with TBI.	Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW 1871, Australia	Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Sydney, NSW 1871, Australia.	grahame.simpson@swahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; *AUSTR BUR STAT, 2001, CENS BAS COMM PROF S; Balakrishna J, 1998, EUR EAT DISORD REV, V6, P136; Blackerby WF, 1990, J HEAD TRAUMA REHAB, V5, P73; COUGHLIN A, 2003, PERSONAL SEXUAL RELA; CRAFT A, 1992, LIVING LIFE SEX ED P; CRAFT A, 1994, INT J ADOLESCENT MED, V7, P133; CRENSHAW TL, 1985, MED ASPECTS HUMAN SE, V19, P115; CUSHMAN LA, 1988, J REHABIL, V54, P65; DAWSON H, 1999, SEXUALITY ACQUIRED B; DUCHARME S, 1994, INT J ADOLESC MED HL, V7, P174; DUCHARME S, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI DOI 10.1097/00001199-199005020-00007; *ED UN FAM PLANN A, 1990, DOUBL TAB SEX DIS SY; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; FRY E, 1977, J READING, V21, P242; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Griffith ER, 1993, SEXUALITY PERSON TRA; GRIFFITHS D, 1992, STILL SMILING SEXUAL; Gunning R., 1952, TECHNIQUE CLEAR WRIT; HAWE P, 1993, EVALUATING HLTH PROM; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; HORSLEY P, 1990, SEXUALITY RIGHTS CHO; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LAWRENCE P, 1993, DISABILITY HANDICAP, V8, P405, DOI DOI 10.1080/02674649366780381; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; MCDONALD S, 2003, BRAIN IMPAIR, V4, P36, DOI DOI 10.1375/brim.4.1.36.27032; MCLAUGHLIN GH, 1969, J READING, V12, P639; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; MEDLAR TM, 1998, SEX DISABIL, V16, P1; MILLER L, 1994, J COGN REHABIL, V6, P12; Montgomery V, 2002, J TRAUMA, V52, P1121, DOI 10.1097/00005373-200206000-00016; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; POWERS RD, 1958, J EDUC PSYCHOL, V49, P99, DOI 10.1037/h0043254; RICHARDSON D, 1986, SEXUAL THERAPY GUIDE; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; SHAPIRO ES, 1985, APPL RES MENT RETARD, V6, P307, DOI 10.1016/0270-3092(85)90004-9; Simpson G, 2003, BRAIN INJURY, V17, P723, DOI 10.1080/0269905031000110481; Simpson G., 2001, BRAIN IMPAIR, V2, P97, DOI [https://doi.org/10.1375/brim.2.2.97, DOI 10.1375/BRIM.2.2.97]; SIMPSON GK, 2002, P 13 EUR C PHYS MED, P204; SIMPSON GK, 1997, YOU ME GUIDE SEX SEX; SIMPSON GK, 1999, YOU ME ED PROGRAM SE; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TATE RL, 2003, BRAIN INF S, V17, P105; Tepper MS, 1992, SEX DISABIL, V10, P15, DOI DOI 10.1007/BF01102245; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; TORNAS TS, 2003, BRAIN INJURY, V17, P97; *US DEP HHS, 1984, PRET HLTH COMM METH; ZASLER N, 1992, SEXUALITY ISSUES FLO; ZASLER ND, 1995, PHYS MED REHABIL STA, V9, P361; ZILBERGELD B, 1978, MED SEX GUIDE SEXUAL; Zinn W M, 1981, Int Rehabil Med, V3, P18	54	11	11	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					413	428		10.1097/00001199-200409000-00006			16	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300006	15597032				2021-06-18	
J	Laatsch, L; Little, D; Thulborn, K				Laatsch, L; Little, D; Thulborn, K			Changes in fMRI following cognitive rehabilitation in severe traumatic brain injury: A case study	REHABILITATION PSYCHOLOGY			English	Article							TEST-RETEST; ACTIVATION	Objective: To illustrate the relationship between changes in neuropsychological testing and changes in functional magnetic resonance imaging (fMRI) before and after cognitive rehabilitation therapy (CRT). Study Design: Single case study. Setting: Outpatient treatment center. Participant: A woman with history of severe traumatic brain injury (TBI) 16 years before study. Intervention: Individualized CRT using a developmental metacognitive model. Main Outcome Measures: Neuropsychological tests and fMRI imaging performed during an eye movement task and a reading comprehension task. Results: Improvements on some neuropsychological test scores (>1 SD) and changes in the magnitude and distribution of the blood oxygen level dependent (BOLD) response as a function of task performance on both fMRI tasks. Conclusions: Individuals with severe TBI many years postinjury can demonstrate improvements in neuropsychological testing following CRT. Behavioral improvements can be related to changes in brain activity using fMRI.	Univ Illinois, Coll Med, Dept Neurol & Rehabil, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Magnet Resonance Res, Chicago, IL 60612 USA	Laatsch, L (corresponding author), Univ Illinois, Coll Med, Dept Neurol & Rehabil, 912 S Wood St,M-C, Chicago, IL 60612 USA.	llaatsch@uic.edu	Thulborn, Keith Raymond/D-9183-2015	Thulborn, Keith Raymond/0000-0001-6197-4296			BOLGER JF, 1980, CLIN NEUROPSYCHOLOGY, V4, P66; BRACY O, 1985, SOFT TOOLS COGNITIVE; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Christensen C K, 1987, J Diabet Complications, V1, P45, DOI 10.1016/S0891-6632(87)80079-X; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; *EXP SOFTW, 1997, CROSSW MOR; GIANUTSOS R, 1991, Brain Injury, V5, P353, DOI 10.3109/02699059109008108; GIANUTSOS R, 1984, COGNITIVE REHABILITA; GLADSOJO J, 1999, NORMS LETT CATEGORY; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Jastak S, 1984, WIDE RANGE ACHIEVEME; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Kiehl KA, 2003, HUM BRAIN MAPP, V18, P42, DOI 10.1002/hbm.10074; Laatsch L, 2000, NEUROREHABILITATION, V15, P189; LEWIS R, 1995, DIGIIT VIGILANCE TES; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; Luria A. R., 1981, WORKING BRAIN; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MENZEL K, 1995, DEV STANDARDIZATION; Meyers J., 1995, REY COMPLEX FIGURE T; Nybakken GE, 2002, NEURORADIOLOGY, V44, P403, DOI 10.1007/s00234-001-0722-6; Parente R., 1996, RETRAINING COGNITION; Price CJ, 1999, HUM BRAIN MAPP, V8, P102, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<102::AID-HBM6>3.0.CO;2-J; Reitan RM., 1985, HALSTEAD REITAN NEUR; SEYMOUR D, 1983, VISUAL THINKING CARD; STETSON E, 1989, STETSON SPELLING PRO; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; THULBORN KR, 2001, CURRENT PROTOCOLS MR; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 T	33	11	11	0	5	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2004	49	3					262	267		10.1037/0090-5550.49.3.262			6	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	847BX	WOS:000223364900011					2021-06-18	
J	Langeluddecke, PM; Lucas, SK				Langeluddecke, PM; Lucas, SK			Evaluation of two methods for estimating premorbid intelligence on the WAIS-III in a clinical sample	CLINICAL NEUROPSYCHOLOGIST			English	Article							DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; BRAIN-INJURY; R IQ; REGRESSION; ACCURACY; VALIDATION; DECLINE; ABILITY; UTILITY	Two methods of predicting premorbid WAIS-III Full Scale IQ, namely a demographic measure (DP IQ) and the Oklahoma Premorbid Intelligence Estimate-3 (OPIE-3), were assessed in three traumatic brain injury (TBI) groups of varying injury severity and normal controls. On the DP IQ, average scores were in keeping with the general population mean across all groups but range was severely restricted. OPIE-3 IQ scores were not subject to severe range restriction and were comparable with the general population mean in the control and least severely brain injured group. They were significantly lower relative to controls in the severe and extremely severe TBI groups, with differences averaging around 7 and 10 points, respectively. OPIE-3 (Best) proved particularly robust in more severely injured subjects. Effect sizes for the combined TBI sample relative to controls were greatest for OPIE-3 measures that included two non-verbal subtests and were least for that involving vocabulary only. Implications of the findings for clinical practice and further research are discussed.	Westmead Hosp, Dept Psychol Med, Westmead, NSW 2145, Australia	Langeluddecke, PM (corresponding author), Suite 1003,37 Bligh St, Sydney, NSW 2000, Australia.	langeluddecke@bigpond.com					ALEKOUMBIDES A, 1987, INT J CLIN NEUROPSYC, V9, P11; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Basso MR, 2002, CLIN NEUROPSYCHOL, V16, P57, DOI 10.1076/clin.16.1.57.8329; Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P325, DOI 10.1076/1385-4046(200008)14:3;1-P;FT325; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; *PSYCH CORP, 1997, WECHSL AD INT SCAL 3; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SILVERSTEIN AB, 1987, J CLIN PSYCHOL, V43, P493, DOI 10.1002/1097-4679(198709)43:5<493::AID-JCLP2270430511>3.0.CO;2-V; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SWEET JJ, 1990, PSYCHOL ASSESSMENT J, V2, P41; Taylor KI, 1996, J CLIN EXP NEUROPSYC, V18, P883, DOI 10.1080/01688639608408309; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tombaugh TN, 1996, TEST MEMORY MALINGER; Tulsky D., 2003, CLIN INTERPRETATION, P43, DOI 10.1016/B978-012703570-3/50006-7; Tulsky D.S., 2003, CLIN INTERPRETATION; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME	37	11	11	0	5	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2004	18	3					423	432		10.1080/1385404049052422			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	875QP	WOS:000225437100008	15739813				2021-06-18	
J	Tai, PC; Gross, DW				Tai, PC; Gross, DW			Exacerbation of pre-existing epilepsy by mild head injury: a five patient series	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SEIZURES; POPULATION	Objective: While the risk of developing seizures following a mild head injury has been reported and is thought to be low, the effect of mild head injury on patients with a pre-existing seizure disorder has not been reported. We present a series of cases where a strong temporal relationship between mild head injury and worsening of seizure frequency was observed. Methods: Five cases were identified and reviewed in detail. Information was derived from clinic and hospital charts with attention to the degree of injury, pre- and postinjury seizure patterns and frequency. Results: One patient has primary generalized epilepsy and four have localization related epilepsy. Prior to the head injury, three of the patients were seizure free (range: two to 24 years). The patients suffered from mild head injuries with no or transient loss of consciousness and no focal neurological deficits. In all cases, the patients experienced a worsening of seizure control within days of the injury. In one case, the patient's seizure pattern returned to baseline one year after the accident, while in the remaining four cases, the patients continue to have medically refractory seizures. Conclusions: A close temporal relationship between mild head injury and a worsening of seizure control was observed in five patients with epilepsy. Although further study is required, this observation suggests that a head injury that would be considered benign in the general population can have serious consequences such as recurrence of seizures and medical intractability in patients with epilepsy.	Univ Alberta, Walter Mckenzie Ctr, Div Neurol, Edmonton, AB T6G 2B7, Canada	Gross, DW (corresponding author), Univ Alberta, Walter Mckenzie Ctr, Div Neurol, 2E3-19, Edmonton, AB T6G 2B7, Canada.		, DWG/AAF-9259-2020	Gross, Donald/0000-0003-1344-4092			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Clear D, 2000, EPILEPSIA, V41, P243, DOI 10.1111/j.1528-1157.2000.tb00147.x; Haut SR, 2003, EPILEPSY BEHAV, V4, P511, DOI 10.1016/S1525-5050(03)00182-3; Hosokawa C, 1998, J COMPUT ASSIST TOMO, V22, P980, DOI 10.1097/00004728-199811000-00025; MILLER VS, 2000, NEUROLOGY CLIN PRACT, P1683; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x	9	11	11	0	0	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	AUG	2004	31	3					394	397		10.1017/S0317167100003516			4	Clinical Neurology	Neurosciences & Neurology	849OZ	WOS:000223549600019	15376487	Bronze			2021-06-18	
J	Newman, MB; Emerich, DF; Borlongan, CV; Sanberg, CD; Sanberg, PR				Newman, MB; Emerich, DF; Borlongan, CV; Sanberg, CD; Sanberg, PR			Use of human umbilical cord blood (HUCB) cells to repair the damaged brain	CURRENT NEUROVASCULAR RESEARCH			English	Article						human umbilical cord blood cells; neurodegeneration; neural stem cells; cell replacement; traumatic brain injury; spinal cord injury; ALS; transplantation; neural and neuronal phenotypes; immunocytochemistry; stroke; ischemia; middle cerebral artery occlusion (MCAO); and behavior	HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; HIGH-EFFICIENCY RECOVERY; BONE-MARROW; PERIPHERAL-BLOOD; DIFFERENTIATION ABILITY; RETROVIRUS RECEPTOR; REGULATORY FUNCTION; RECOMBINANT HUMAN; INTERFERON-GAMMA	Neurodegenerative diseases as well as acute center nervous system (CNS) injuries remains a problematic and frustrating area of medicine in terms of treatments and cures, which is mostly due to the complex circuitry of the CNS along with our limited knowledge. therapeutically, the last two and a half decades have offered new hope for those suffering from neurodegenerative diseases or in juries with advent of new drug discoveries and Cellular therapies. Cell transplantation is a compelling and potential treatment for certain neurological and neurodegenerative diseases as well as for acute injuries to the spinal cord and brain. The hematopoietic system offers an alternative source of cells that is easily obtainable, abundant, and reliable when compared to cells obtained from fetal or embryonic origins. Human umbilical cord blood (HUCB) cells have been used clinically for over ten years to treat both malignant and non-malignant diseases. With in the last five years these cells have been used pre-clinically in animal models of brain and spinal cord injuries, in which functional recovery have been shown. This paper reviews the advantages, utilization, and progress of HUCB cells in the field of cellular transplantation and repair.	Univ S Florida, Coll Med MDC 78, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Psychol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Pharmacol, Tampa, FL 33612 USA; Saneron CCEL Therapeut Inc, Tampa, FL 33637 USA; Med Coll Georgia, Res & Affiliat Serv Line, Dept Neurol, Inst Mol Med & Genet,Sch Grad Studies, Augusta, GA 30912 USA; Augusta Vet Adm Med Ctr, Augusta, GA 30912 USA	Sanberg, PR (corresponding author), Univ S Florida, Coll Med MDC 78, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL 33612 USA.	psanberg@hsc.usf.edu	Borlongan, Cesar/I-5696-2012	Borlongan, Cesar/0000-0002-2966-9782			BECK R, 1994, IMMUNOL CELL BIOL, V72, P440, DOI 10.1038/icb.1994.65; Bicknese AR, 2002, CELL TRANSPLANT, V11, P261; Broxmeyer H E, 1993, J Hematother, V2, P197, DOI 10.1089/scd.1.1993.2.197; Broxmeyer H E, 1996, Cancer Treat Res, V84, P139; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; Broxmeyer HE, 1997, CLIN EXP IMMUNOL, V107, P45; Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; BROXMEYER HE, 1995, IMMUNOL INVEST, V24, P391, DOI 10.3109/08820139509062787; BROXMEYER HE, 1991, BLOOD CELLS, V17, P313; BROXMEYER HE, 2000, CORD BLOOD CHARACTER; BROXMEYER HE, 1998, CELLULAR CHARACTERIS; Buzanska L, 2003, J NEUROCHEM, V85, P33; Buzanska L, 2002, J CELL SCI, V115, P2131; Cardoso A A, 1993, J Hematother, V2, P275, DOI 10.1089/scd.1.1993.2.275; CARDOSO AA, 1993, P NATL ACAD SCI USA, V90, P8707, DOI 10.1073/pnas.90.18.8707; Cohen I, 1999, INT J COMPUT VISION, V33, P29, DOI 10.1023/A:1008161130332; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P173; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P231; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241; Fallen PR, 2000, CORD BLOOD CHARACTER, P39; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Gluckman E, 1999, Cancer Treat Res, V101, P79; Gluckman E, 1999, BEST PRACT RES CL HA, V12, P279, DOI 10.1053/beha.1999.0023; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Gluckman E, 2001, TRANSFUS CLIN BIOL, V8, P146, DOI 10.1016/S1246-7820(01)00132-X; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Ha Y, 2001, NEUROREPORT, V12, P3523, DOI 10.1097/00001756-200111160-00030; HAN P, 1995, BRIT J HAEMATOL, V89, P733; HOWS JM, 1992, BONE MARROW TRANSPL, V9, P105; *INCFH NAT CTR FAR, 2002, NAT VIT STAT REP; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; KINNIBURGH D, 1993, BONE MARROW TRANSPL, V12, P489; Kosaras B, 2003, EXP NEUROL, V181, P96; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; Lobel DA, 2003, EXP NEUROL, V181, P97; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu L, 1996, CRIT REV ONCOL HEMAT, V22, P61, DOI 10.1016/1040-8428(96)88370-3; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153; Metcalf D., 1984, CLONAL CULTURE HEMOP; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; MIYAWAKI T, 1981, IMMUNOL REV, V57, P61, DOI 10.1111/j.1600-065X.1981.tb00442.x; NAGAOKI T, 1981, J IMMUNOL, V126, P2015; Newman MB, 2003, NEURAL STEM CELLS: DEVELOPMENT AND TRANSPLANTATION, P379; NEWMAN MB, 2003, TIME DEPENDENT FACTO; NONOYAMA S, 1995, J CLIN INVEST, V95, P66, DOI 10.1172/JCI117677; Orlic D, 1999, LEUKEMIA, V13, pS52, DOI 10.1038/sj.leu.2401287; Orlic D, 1996, P NATL ACAD SCI USA, V93, P11097, DOI 10.1073/pnas.93.20.11097; Orlic D, 1999, ANN NY ACAD SCI, V872, P115, DOI 10.1111/j.1749-6632.1999.tb08458.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PEREZCRUZ I, 2000, CORD BLOOD CHARACTER; Potgens AJG, 2001, PLACENTA, V22, P639, DOI 10.1053/plac.2001.0701; Rabian-Herzog C, 1993, J Hematother, V2, P255, DOI 10.1089/scd.1.1993.2.255; Rappold I, 1997, BLOOD, V90, P111; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Rocha V, 2001, BLOOD, V97, P2962, DOI 10.1182/blood.V97.10.2962; Sakabe H, 1998, LEUKEMIA, V12, P728, DOI 10.1038/sj.leu.2401001; Sanberg PR, 2002, NEUROTOX RES, V4, P95, DOI 10.1080/10298420290015917; Sanchez-Ramos JR, 2001, EXP NEUROL, V171, P109, DOI 10.1006/exnr.2001.7748; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Thomson BG, 2000, BLOOD, V96, P2703; TRAYCOFF CM, 1994, EXP HEMATOL, V22, P215; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; UENO Y, 1985, J IMMUNOL, V135, P180; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; WAGNER JE, 1992, BLOOD, V79, P1874; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1; Wenger DA, 2000, MOL GENET METAB, V70, P1, DOI 10.1006/mgme.2000.2990; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; WILSON CB, 1986, J CLIN INVEST, V77, P860, DOI 10.1172/JCI112383; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zigova T, 2002, CELL TRANSPLANT, V11, P265	77	11	12	0	2	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2026	1875-5739		CURR NEUROVASC RES	Curr. Neurovasc. Res.	JUL	2004	1	3					269	281		10.2174/1567202043362261			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	902LD	WOS:000227357700010	16181077				2021-06-18	
J	Opel, DJ; Lundin, DA; Stevenson, KL; Klein, EJ				Opel, DJ; Lundin, DA; Stevenson, KL; Klein, EJ			Glass foreign body in the spinal canal of a child - Case report and review of the literature	PEDIATRIC EMERGENCY CARE			English	Article						foreign bodies; plain radiograph; glass-inflicted laceration	SOFT-TISSUE; PENETRATING INJURIES; BODIES; FRAGMENT; ULTRASONOGRAPHY; LACERATIONS; RADIOGRAPHS; TOMOGRAPHY; DIAGNOSIS; WOUNDS	Retained foreign bodies pose a risk to the patient from the perspective of potential morbidity. We describe a previously healthy 8-year-old boy with head and back trauma from a glass picture frame that fell off the wall. He sustained a closed head injury and a back laceration several centimeters lateral to the spine. A persistent drainage from the back laceration contained glucose and protein levels consistent with cerebral spinal fluid. A foreign body was easily visible on subsequent plain radiograph. The glass foreign body was removed by neurosurgeons after computed tomography and magnetic resonance imaging clarified the exact location of the glass fragment. Physicians should have a low threshold for obtaining plain radiographs in patients with glass foreign bodies and consider that projectiles may rest some distance from the laceration site.	Childrens Hosp & Med Ctr, Seattle, WA 98105 USA; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA 98195 USA	Klein, EJ (corresponding author), Childrens Hosp & Med Ctr, 4800 Sand Point Way NE Mail Stop 5D-1, Seattle, WA 98105 USA.	eileen.klein@seattlechildrens.org					Adornato D C Jr, 1972, Int Surg, V57, P147; *AM COLL EM PHYS, 1999, ANN EMERG MED, V33, P612; ANDERSON MA, 1982, AM J SURG, V144, P63, DOI 10.1016/0002-9610(82)90603-1; AVNER JR, 1992, AM J DIS CHILD, V146, P600, DOI 10.1001/archpedi.1992.02160170080020; BAGHAI P, 1982, NEUROSURGERY, V11, P419, DOI 10.1227/00006123-198209000-00014; BAKER MD, 1990, AM J DIS CHILD, V144, P87, DOI 10.1001/archpedi.1990.02150250097042; BLYME PJH, 1990, ARCH ORTHOP TRAUM SU, V110, P24, DOI 10.1007/BF00431361; BODNE D, 1988, J COMPUT ASSIST TOMO, V12, P608, DOI 10.1097/00004728-198807000-00013; Boyse TD, 2001, RADIOGRAPHICS, V21, P1251, DOI 10.1148/radiographics.21.5.g01se271251; COURTER BJ, 1990, ANN EMERG MED, V19, P997, DOI 10.1016/S0196-0644(05)82562-4; CRIADO E, 1990, SOUTHERN MED J, V83, P332, DOI 10.1097/00007611-199003000-00020; DELACEY G, 1985, BRIT J RADIOL, V58, P27, DOI 10.1259/0007-1285-58-685-27; FELMAN AH, 1969, RADIOLOGY, V92, P1529, DOI 10.1148/92.7.1529; FORDHAM SD, 1976, SOUTHERN MED J, V69, P1484, DOI 10.1097/00007611-197611000-00028; GINSBURG MJ, 1990, ANN EMERG MED, V19, P701, DOI 10.1016/S0196-0644(05)82483-7; Graham DD, 2002, J EMERG MED, V22, P75, DOI 10.1016/S0736-4679(01)00440-1; GRON P, 1986, INJURY, V17, P404, DOI 10.1016/0020-1383(86)90081-1; Heary RF, 1996, ORTHOP CLIN N AM, V27, P69; HUMPHREY G, 1993, INJURY, V24, P493, DOI 10.1016/0020-1383(93)90159-4; JONES FD, 1981, J NEUROSURG, V55, P979, DOI 10.3171/jns.1981.55.6.0979; KEANE JR, 1993, NEUROSURGERY, V33, P274, DOI 10.1227/00006123-199308000-00014; Kulkarni AV, 2000, J EMERG MED, V18, P209, DOI 10.1016/S0736-4679(99)00196-1; Lammers Richard L., 1992, Emergency Medicine Clinics of North America, V10, P767; Lipschitz R, 1967, Paraplegia, V5, P75; MONTANO JB, 1992, ANN EMERG MED, V21, P1360, DOI 10.1016/S0196-0644(05)81902-X; ODRISCOLL SW, 1988, CAN MED ASSOC J, V139, P643; REID I, 1989, IRISH J MED SCI, V158, P280, DOI 10.1007/BF02942071; Silvestro C, 2001, SPINE, V26, P578, DOI 10.1097/00007632-200103010-00025; Steele MT, 1998, AM J EMERG MED, V16, P627, DOI 10.1016/S0735-6757(98)90161-9; Tomaras CR, 1997, NEUROSURGERY, V40, P1291, DOI 10.1097/00006123-199706000-00034; TOPLIFF E, 1931, CMAJ, P836; Yanay O, 2001, PEDIATR EMERG CARE, V17, P354, DOI 10.1097/00006565-200110000-00009	32	11	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUL	2004	20	7					468	472		10.1097/01.pec.0000136894.91647.6f			5	Emergency Medicine; Pediatrics	Emergency Medicine; Pediatrics	838DU	WOS:000222694500013	15232251				2021-06-18	
J	Wood, RL; Rutterford, NA				Wood, RL; Rutterford, NA			Relationships between measured cognitive ability and reported psychosocial activity after bilateral frontal lobe injury: An 18-year follow-up	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; DUAL-TASK PERFORMANCE; HEAD-INJURY; ECOLOGICAL VALIDITY; SIMPLIFIED VERSION; EMPLOYMENT; DEFICITS; WORK; REHABILITATION; BEHAVIOR	This case study illustrates a well-established paradox often seen after serious frontal injury. Some individuals have little or no neurological abnormality, perform well on cognitive tests, and display an apparently "normal" social appearance, yet have serious, if subtle, neurobehavioural disability that prevents reliable and efficient performance in a number of daily activities. In this case study, we report the psychosocial progress of a young man who suffered serious bilateral frontal injury in a road traffic accident at the age of 20 years. He made a good neurological recovery and relatively few cognitive deficits were recorded. His performance on a range of neuropsychological tests, including specialist tests of "frontal function", was mainly in the above average or superior range. In contrast, observations of his functional activities revealed a number of dysexecutive problems that had an adverse impact on his life. Changes in his personality and social behaviour, reflecting a number of "frontal" characteristics, only marginally improved as a result of post-acute neuropsychological rehabilitation. He did not receive long-term professional support but, with the passage of time and continued support from his family, he has married and manages to maintain a basic level of social integration, but not one commensurate with his pre-accident potential. Problems of planning, organisation, initiative, and self-awareness that were not recognised early in his recovery, and are not evident from neuropsychological assessment, remain as major obstacles to full social independence.	Univ Coll Swansea, Dept Psychol, Swansea SA2 8PP, W Glam, Wales	Wood, RL (corresponding author), Univ Coll Swansea, Dept Psychol, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.	r.l.wood@swan.ac.uk					Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A. D., 1986, WORKING MEMORY; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; BUTTERS N, 1972, PERCEPT MOTOR SKILL, V34, P27, DOI 10.2466/pms.1972.34.1.27; Corcoran R, 1997, SCHIZOPHR RES, V24, P319, DOI 10.1016/S0920-9964(96)00117-X; Damasio A. R., 1993, CLIN NEUROPSYCHOLOGY; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Dimitrov M, 1999, NEUROCASE, V5, P345, DOI 10.1080/13554799908411987; Eames P, 2003, NEUROPSYCHOL REHABIL, V13, P241, DOI 10.1080/09602010244000435; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Eslinger PJ, 1999, NEUROCASE, V5, P299, DOI 10.1080/13554799908411983; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Grafman J, 1999, LANCET, V354, P1921, DOI 10.1016/S0140-6736(99)90438-5; Groswasser Z, 1999, NEUROPSYCHOL REHABIL, V9, P493, DOI 10.1080/096020199389545; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Levine B, 1999, NEUROCASE, V5, P263, DOI 10.1080/13554799908402731; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1093/neucas/7.2.123; Manchester D, 2001, BRAIN DAM B, P157; Metzler C, 2000, NEUROPSYCHOLOGIA, V38, P363, DOI 10.1016/S0028-3932(99)00097-4; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Possl O, 2001, BRAIN INJURY, V15, P15; Powell GE, 2001, BRAIN DAM B, P65; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stuss D.T., 1986, FRONTAL LOBES; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Wilson BA, 1996, BEHAV ASSESSMENT DYS; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Wood RL, 2001, NEUROBEHAVIOURAL DIS	46	11	11	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL	2004	14	3					329	350		10.1080/09602010343000255			22	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	829WZ	WOS:000222083400004					2021-06-18	
J	Cunningham, MG; Bolay, H; Scouten, CW; Moore, C; Jacoby, D; Moskowitz, M; Sorensen, JC				Cunningham, MG; Bolay, H; Scouten, CW; Moore, C; Jacoby, D; Moskowitz, M; Sorensen, JC			Preclinical evaluation of a novel intracerebral microinjection instrument permitting electrophysiologically guided delivery of therapeutics	NEUROSURGERY			English	Article						cerebral ischemia; electrophysiology; functional neurosurgery; intracerebral injection; microcannula; neural transplantation; stereotactic surgery	FETAL VENTRAL MESENCEPHALON; TRAUMATIC BRAIN-INJURY; DOPAMINE NEURONS; NEUROTROPHIC FACTOR; STRIATAL REINNERVATION; PARKINSONS-DISEASE; CAUDATE-NUCLEUS; CEREBRAL-CORTEX; GRAFT-SURVIVAL; TRANSPLANTATION	OBJECTIVE: This series of studies was designed to evaluate the function of a new neurosurgical instrument for precision injection of therapeutics within the central nervous system. METHODS: An intracerebral microinjection instrument was designed to 1) allow multiple injections to be placed in three-dimensional space within a target structure from a single proximal brain penetration, 2) incur minimal injury at the site of injection, 3) enable accurate microvolume injections, and 4) permit electrophysiological recording during the injection procedure. Rats received injections of fluorescent microspheres or suspensions of labeled cells to test instrument function and level of induced trauma. A rodent model of stroke was used to test the instrument's ability to record electrocorticograms or somatosensory evoked potentials from normal and damaged tissue. RESULTS: Microliter volumes of fluorescent microspheres; were accurately placed at predetermined sites within the rat striatum. Reactive gliosis was markedly reduced using the intracerebral microinjection instrument when compared with standard cannulas. in a stroke model, electrophysiological recording with the instrument allowed discrimination between viable and nonviable ischemic tissue, and function of pathways or circuits was assessed using evoked potentials. Embryonic stem cells grafted immediately after electrophysiological recordings demonstrated robust long-term survival. CONCLUSION: The intracerebral microinjection instrument enables electrophysiologically guided microinjection of therapeutics to target areas with exquisite accuracy while incurring minimal local trauma and reactive gliosis at the injection site. The instrument also permits minimally invasive, multiple injections to be disseminated in three-dimensional space within the target region from a single proximal penetration of the brain.	McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; Harvard Univ, Sch Med, Lab Neural Reconstruct, Belmont, MA 02178 USA; Gazi Univ, Dept Neurol, Ankara, Turkey; MyNeuroLab Inc, St Louis, MO USA; MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Cambridge, MA USA; Diacrin Inc, Charlestown, MA USA; Massachusetts Gen Hosp, Stroke & Neurovasc Regulatory Lab, Charlestown, MA USA; Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark	Cunningham, MG (corresponding author), McLean Hosp, Dept Psychiat, 115 Mill St,MRC 333, Belmont, MA 02478 USA.	mcunningham@mclean.harvard.edu	Moskowitz, Michael A/D-9916-2011; Bolay, Hayrunnisa/ABG-8829-2020	Bolay, Hayrunnisa/0000-0002-3357-7733; SCOUTEN, CHARLES/0000-0003-2299-3464	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2 R44 NS36869-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS036869] Funding Source: NIH RePORTER		Bolay H, 1998, STROKE, V29, P1988, DOI 10.1161/01.STR.29.9.1988; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Brundin P, 2000, CELL TRANSPLANT, V9, P179, DOI 10.1177/096368970000900205; Costa S, 2001, EUR J PHARMACOL, V412, P45, DOI 10.1016/S0014-2999(00)00933-X; FAWCETT JW, 2001, BRAIN DAMAGE BRAIN R; FINSEN BR, 1990, PROG BRAIN RES, V82, P111; FINSEN BR, 1991, J NEUROIMMUNOL, V32, P159, DOI 10.1016/0165-5728(91)90008-U; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREEMAN T, 1994, NEUROLOGY, V44, pA324; Galpern WR, 1996, EXP NEUROL, V140, P1, DOI 10.1006/exnr.1996.0109; HENDERSON BTH, 1991, ARCH NEUROL-CHICAGO, V48, P822, DOI 10.1001/archneur.1991.00530200062020; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Mendez I, 2000, J NEUROSURG, V92, P493, DOI 10.3171/jns.2000.92.3.0493; Miyazaki H, 1999, NEUROSCIENCE, V89, P643, DOI 10.1016/S0306-4522(98)00592-2; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; NIKKHAH G, 1994, NEUROSCIENCE, V63, P57, DOI 10.1016/0306-4522(94)90007-8; NIKKHAH G, 1994, BRAIN RES, V633, P133, DOI 10.1016/0006-8993(94)91532-6; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Roitberg B, 1999, SURG NEUROL, V52, P13; SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TSUKAHARA T, 1995, NEUROSURGERY, V37, P733, DOI 10.1227/00006123-199510000-00018; Watts C, 2000, CELL TRANSPLANT, V9, P223, DOI 10.1177/096368970000900208; WIDNER H, 1992, NEW ENGL J MED, V327, P1556, DOI 10.1056/NEJM199211263272203; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	36	11	11	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2004	54	6					1497	1507		10.1227/01.NEU.0000125007.03145.00			11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	828IB	WOS:000221965900045	15157308				2021-06-18	
J	Dawes, H; Collett, J; Ramsbottom, R; Howells, K; Sackley, C; Wade, D				Dawes, H; Collett, J; Ramsbottom, R; Howells, K; Sackley, C; Wade, D			Measuring oxygen cost during level walking in individuals with acquired brain injury in the clinical setting	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						oxygen consumption brain injury; test re-test; level walking	ENERGY-EXPENDITURE; CONSUMPTION; VARIABILITY; KNEE	This study examined the test-retest reliability of oxygen cost (ml.kg(-1).min(-1)) during level walking in individuals with acquired brain injury (ABI). Ten individuals with ABI (5 men, 5 women) (Traumatic brain injury, 1, central pontine myelinolysis, 1, stroke 8) and 21 healthy controls (11 men, 10 women). Measurements of gross and net (walking minus resting) oxygen consumption (ml.kg(-1).min(-1)), and oxygen cost (ml.kg(-1).m(-1)) during level walking at self-selected speeds. Measurements were taken on two occasions within one week. Oxygen cost was significantly lower (p < 0.05) in individuals with ABI on the second test versus the first test. Percentage variability in oxygen cost from test to re-test ranged from 14.7 to 17.3% in the control group and from 17.4 to 20.8% in the brain injury group. Clinical populations may demonstrate a significant decrease in oxygen cost between testing occasions. Individuals require at least one period of familiarisation if oxygen cost is used as an outcome measure during level walking in clinical groups. The amount of familiarisation has yet to be investigated in individuals with ABI.	Oxford Brookes Univ, Sch Biol & Mol Sci, Movement Sci Grp, Oxford OX3 ODB, England; Oxford Brookes Univ, Sch Biol & Mol Sci, Exercise Sci Grp, Oxford OX3 ODB, England; Univ Birmingham, Sch Hlth Sci, Birmingham, W Midlands, England; Nuffield Orthopaed Ctr, Oxford Ctr Enablement, Oxford OX3 7LD, England	Dawes, H (corresponding author), Oxford Brookes Univ, Sch Biol & Mol Sci, Movement Sci Grp, Gipsy Lane, Oxford OX3 ODB, England.	hdawes@brookes.ac.uk		Wade, Derick/0000-0002-1188-8442; , Johnny/0000-0003-4138-2589; sackley, catherine/0000-0002-8580-6622; Dawes, Helen/0000-0002-2933-5213			[Anonymous], 1996, BRIT MED J, V313, P1448; ASTRAND I, 1960, ACTA PHYSL SCAND, V49, P61; Baker R, 2001, GAIT POSTURE, V13, P202, DOI 10.1016/S0966-6362(00)00104-1; Bernardi M, 1999, J ELECTROMYOGR KINES, V9, P149, DOI 10.1016/S1050-6411(98)00046-7; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Bowen TR, 1998, J PEDIATR ORTHOPED, V18, P738, DOI 10.1097/00004694-199811000-00008; Boyd R, 1999, DEV MED CHILD NEUROL, V41, P676, DOI 10.1017/S0012162299001395; Corcoran P J, 1970, Arch Phys Med Rehabil, V51, P69; da Cunha IT, 2003, J REHABIL RES DEV, V40, P19, DOI 10.1682/JRRD.2003.01.0019; DAWES H, 2001, THESIS U E LONDON LO, P259; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Hanada E, 2001, ARCH PHYS MED REHAB, V82, P1251, DOI 10.1053/apmr.2001.24902; Inman V.T., 1981, HUMAN WALKING; Kerrigan DC, 2001, J REHABIL RES DEV, V38, pIX; LINNARSSON D, 1989, CLIN PHYSIOL, V9, P1, DOI 10.1111/j.1475-097X.1989.tb00950.x; MATTSSON E, 1990, SCAND J REHABIL MED, V22, P51; MATTSSON E, 1990, SCAND J REHABIL MED, V22, P55; MUNRO B, 1993, CORRELATION STAT MET; RALSTON HJ, 1965, ERGONOMICS S, P53; RIEPER H, 1993, BRIT J NUTR, V69, P29, DOI 10.1079/BJN19930006; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Wergel-Kolmert U, 1999, CLIN PHYSIOL, V19, P161, DOI 10.1046/j.1365-2281.1999.00160.x; Zamparo P., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P348; Zamparo P, 1998, SCAND J MED SCI SPOR, V8, P222	25	11	12	0	2	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	JUN	2004	3	2					76	82					7	Sport Sciences	Sport Sciences	915AV	WOS:000228270900004	24482582	DOAJ Gold			2021-06-18	
J	Valach, L; Selz, B; Signer, S				Valach, L; Selz, B; Signer, S			Length of stay in the rehabilitation center, the admission functional independence measure and the functional independence measure gain	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						length of stay; functional independence measure; decision to discharge	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MEDICAL REHABILITATION; STROKE REHABILITATION; CLASSIFICATION-SYSTEM; DISCHARGE DESTINATION; POSTSTROKE DEPRESSION; RESOURCE UTILIZATION; CASE-MIX; OUTCOMES		Univ Zurich, Rehabil Ctr, Buerger Hosp Solothum, CH-8006 Zurich, Switzerland; Univ Zurich, Fac Philosophy, CH-8006 Zurich, Switzerland	Valach, L (corresponding author), Univ Zurich, Klin Schloessli, CH-8618 Oetwil Am See, Switzerland.	ladislav.valach@schloessli.ch	valach, ladislav k/D-9250-2016	valach, ladislav k/0000-0002-1017-9329			ALEXANDER MP, 1994, STROKE, V25, P128, DOI 10.1161/01.STR.25.1.128; Andrews AW, 2001, NEUROREHAB NEURAL RE, V15, P93, DOI 10.1177/154596830101500202; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DILLER L, 1995, TOP STROKE REHABIL, V2, P44, DOI DOI 10.1080/10749357.1995.11754069; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Eilertsen TB, 1998, MED CARE, V36, P695, DOI 10.1097/00005650-199805000-00009; GALSKI T, 1993, STROKE, V24, P1794, DOI 10.1161/01.STR.24.12.1794; Gillen R, 2001, ARCH PHYS MED REHAB, V82, P1645, DOI 10.1053/apmr.2001.26249; Gillen R, 1999, J Stroke Cerebrovasc Dis, V8, P300, DOI 10.1016/S1052-3057(99)80004-4; Gordon WA, 1997, ARCH PHYS MED REHAB, V78, P658, DOI 10.1016/S0003-9993(97)90433-0; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; HAMILITON BB, 1994, PHYS THER, V74, P494, DOI 10.1093/ptj/74.5.494; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; Hosking SG, 1996, NEUROPSYCHOL REV, V6, P107, DOI 10.1007/BF01874894; Mills TL, 2002, J NATL MED ASSOC, V94, P846; Oczkowski WJ, 1997, ARCH PHYS MED REHAB, V78, P340, DOI 10.1016/S0003-9993(97)90222-7; Reker DM, 1998, ARCH PHYS MED REHAB, V79, P751, DOI 10.1016/S0003-9993(98)90351-3; Ring H, 1997, ARCH PHYS MED REHAB, V78, P630, DOI 10.1016/S0003-9993(97)90429-9; Sandstrom R, 1998, ARCH PHYS MED REHAB, V79, P762, DOI 10.1016/S0003-9993(98)90353-7; Spencer KA, 1997, PSYCHOL BULL, V122, P132; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Stineman MG, 1998, ARCH PHYS MED REHAB, V79, P241, DOI 10.1016/S0003-9993(98)90001-6; Stineman MG, 1997, HEALTH SERV RES, V32, P529; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Unsworth CA, 2001, INT J REHABIL RES, V24, P103; Ween JE, 2000, NEUROREHAB NEURAL RE, V14, P229, DOI 10.1177/154596830001400309; Ween JE, 1996, NEUROLOGY, V47, P659, DOI 10.1212/WNL.47.3.659	30	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	JUN	2004	27	2					135	143		10.1097/01.mrr.0000131577.55940.80			9	Rehabilitation	Rehabilitation	839PH	WOS:000222796500007	15167111				2021-06-18	
J	Xiao-Sheng, H; Xiang, Z; Zhou, F; Luo-An, F; Shuang, W				Xiao-Sheng, H; Xiang, Z; Zhou, F; Luo-An, F; Shuang, W			Calcium overloading in traumatic axonal injury by lateral head rotation: a morphological evidence in rat model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						calcium overloading; traumatic axonal injury; rat	MYELINATED NERVE-FIBERS; EXPERIMENTAL BRAIN-INJURY; ATPASE ACTIVITY; OPTIC-NERVE; LOCALIZATION; PATHOGENESIS; PROTEOLYSIS; MECHANISMS; PATHOLOGY; BREAKDOWN	The study investigated morphologically axonal calcium overloading and its relationship with axonal structural changes. Twelve SD rats were divided into an injury and a sham group. The rat model of traumatic axonal injury (TAI) by lateral head rotation was produced. The oxalate-pyroantimonate technique for calcium localization was used to process the rat's medulla oblongata tissues with thin sections observed electron-microscopically for axonal structure and calcium precipitates on it. The axonal damage in medulla oblongata appeared at 2 h postinjury, gradually became diffuse and severe, and continued to exist at 24 hours. At 2 hours, calcium precipitates were deposited on separated lamellae and axolemma, but were rarely distributed in the axoplasm. At 6 hours, calcium precipitates occurred on separated lamellae and axolemma in much higher density, but on axoplasm in extremely small amounts. Some axons, though lacking structural changes of the myelin sheath, sequestered plenty of calcium deposits on their swollen mitochondria. At 24 hours, damaged axons presented with much more severe lamellae separation and calcium deposits. Axonal calcium overloading developed in rat TAI model using lateral head rotation. This was significantly related to structural damage in the axons. These findings suggest the feasibility of using calcium antagonists in cope the management of human DAI in its very early stage. (C) 2004 Elsevier Ltd. All rights reserved.	Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China	Xiao-Sheng, H (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 W Chang Le Rd, Xian 710032, Shaanxi, Peoples R China.	xiaohe@pub.xaonline.com					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BENNETT M, 1995, IRISH MED J, V88, P59; BLAUSTEIN MP, 1988, TRENDS NEUROSCI, V11, P438, DOI 10.1016/0166-2236(88)90195-6; BORGERS M, 1977, LAB INVEST, V37, P1; BORGERS M, 1981, ACTA HISTOCHEM, P327; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; KAMAKURA K, 1983, J NEUROCHEM, V40, P908, DOI 10.1111/j.1471-4159.1983.tb08072.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; MATA M, 1986, J NEUROBIOL, V17, P449, DOI 10.1002/neu.480170508; MATA M, 1987, HISTOCHEMISTRY, V87, P339, DOI 10.1007/BF00492588; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; MAXWELL WL, 1991, J ANAT, V176, P71; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McIntosh TK, 1997, NEUROSCIENTIST, V3, P169, DOI 10.1177/107385849700300310; OBERC MA, 1977, LAB INVEST, V36, P566; OCHS S, 1990, NEUROSCIENCE, V36, P553, DOI 10.1016/0306-4522(90)90445-A; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SLANZINSKI T, 1994, J NEUROSCI NURS, V26, P151; WADE CR, 1980, J ANAT, V130, P641; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800	34	11	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2004	11	4					402	407		10.1016/j.jocn.2004.01.001			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	818DW	WOS:000221226800014	15080957				2021-06-18	
J	Olvey, SE; Knox, T; Cohn, KA				Olvey, SE; Knox, T; Cohn, KA			The development of a method to measure head acceleration and motion in high-impact crashes	NEUROSURGERY			English	Article						ear accelerometers; head impact analysis; high-velocity traumatic brain injury; measured head accelerations	INJURY	OBJECTIVE: To establish a mechanism to obtain precise measurements of the accelerations of the head in the high-speed racing environment and during crash impacts. The long-term goal is to apply this system to the assessment of head injury in automobile racing drivers and then in participants in other helmeted sports. METHODS: A multidisciplinary team conceptualized, designed, and successfully tested a triaxial accelerometer system capable of measuring head acceleration and motion in high-impact crashes. The system has been implemented successfully in the professional racing environment. RESULTS: Accurate and reproducible data have been obtained from the accelerometer system in tests on manikins and cadavers and in actual racing events. The system has been implemented in two professional racing series in 2003. Information gained from the accelerometer system is currently being entered into a database. Eventually, the data should aid in the development of improved cockpit head protection in racing cars. Improved helmet design not only in motor sports but also in other helmeted sports should benefit from the data collected. These data will also aid the development of improved head injury protection in military aircraft and passenger vehicles. CONCLUSION: Although there has been a significant decrease in the overall rate of injury during the past 25 years, head injury remains a serious safety concern in motor sports and the greatest cause of death. Sports-related head injuries are also of great concern because repeated mild head injury has become an important health issue with potential long-term disability. True human tolerance to brain injury has yet to be established. Our scientific knowledge of brain injury is currently based on results derived from manikin, cadaver, and human volunteer testing, along with animal and computer models. The racing environment represents a venue to ethically measure and evaluate the forces involved in human brain injury.	Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; USAF, Res Lab, Biodynam & Accelerat Branch, Wright Patterson AFB, OH 45433 USA; Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	Olvey, SE (corresponding author), Univ Miami, Sch Med, Dept Neurol Surg, 1095 NW 14th Terrace,D4-6, Miami, FL 33136 USA.	solvey@med.miami.edu					CHENG LY, 1990, VEHICLE CRASHWORTHIN, P141; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; Gennarelli T. A., 1987, HEAD INJURY, P108; HANDMAN D, 2000, SAE 2000 WORLD C DET; KNOX T, 2003, RES TECHN ORG APPL V; Kraus JF, 1993, HEAD INJURY, P1; LEE MC, 1987, P 31 STAPP CAR CRASH; Melvin J. W., 1998, P 42 STAPP CAR CRASH; Mendis K., 1992, THESIS OHIO STATE U; *NAT CTR INJ PREV, 2004, NCIPC; Olvey S.E., 1998, SPORTS NEUROLOGY, P317; PLUCHE R, 1985, HEAD INJURY PREVENTI, P235; RUAN JS, 1994, P 38 STAPP CAR CRASH; SHUGAR TA, 1975, J ENG MECH DIV-ASCE, V101, P223; TRAMMELL TR, 1990, 34 ANN P ASS ADV AUT, P329; Ueno K., 1989, CRASH WORTHINESS OCC, P123	16	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2004	54	3					672	677		10.1227/01.NEU.0000108782.68099.29			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	802FN	WOS:000220149500043	15028143				2021-06-18	
J	Moore, BA; Donders, J; Thompson, EH				Moore, BA; Donders, J; Thompson, EH			Validity of the Children's Category Test-Level 1 after pediatric traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychology; traumatic brain injury; assessment	HEAD-INJURY; STANDARDIZATION SAMPLE; LATENT STRUCTURE	The performance of 38 5-8-year-old children with traumatic brain injury (TBI) on the Children's Category Test-Level 1 (CCT-1; Boll, 1993) was investigated in order to examine the criterion validity of the component subtests. Only subtests III and V varied in a consistent and meaningful manner with levels of injury severity and post-injury psychometric intelligence. In contrast, 21% of the sample performed at chance level on subtest IV, a task that did not demonstrate any criterion validity. It is concluded that when a substantial proportion of the total errors (e.g., greater than or equal to50%) on the CCT-1 pertain to items from subtest IV, interpretation of the composite summary T score may not be valid. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Mary Free Bed Hosp, Grand Rapids, MI 49503 USA; Adler Sch Profess Psychol, Chicago, IL 60601 USA	Donders, J (corresponding author), Mary Free Bed Hosp, 235 Wealthy SE, Grand Rapids, MI 49503 USA.						BOLL T, 1993, CHILDRENS CATEGORY T; Culbertson W. C., 2001, TOWER LONDON DREXEL; DALBY R, 1991, DEV NEUROPSYCHOL, V7, P39; DELIS D, 1994, CALIFORNIA VERBAL LE; Donders J, 1998, CHILD NEUROPSYCHOL, V4, P178; Donders J, 1999, J CLIN EXP NEUROPSYC, V21, P279; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Gutentag SS, 1998, ASSESSMENT, V5, P263, DOI 10.1177/107319119800500306; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Kizilbash A., 2001, PEDIAT REHABILITATIO, V4, P71; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LEVIN HS, 1994, NEUROPSYCHOLOGY, V8, P171, DOI DOI 10.1037/0894-4105.8.2.171; Murphy K.R., 1998, STAT POWER ANAL SIMP; Nesbit-Greene K, 2002, J CLIN EXP NEUROPSYC, V24, P194, DOI 10.1076/jcen.24.2.194.996; Reitan R.M., 1992, NEUROPSYCHOLOGICAL E; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D., 1991, WECHSLER INTELLIGENC; Woodward H, 1998, APPL NEUROPSYCHOL, V5, P113, DOI 10.1207/s15324826an0503_1	21	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2004	19	1					1	9	PII S0887-6177(02)00171-3	10.1016/S0887-6177(02)00171-3			9	Psychology, Clinical; Psychology	Psychology	759MB	WOS:000187740500001	14670375				2021-06-18	
J	Lang, EW; Yip, K; Griffith, J; Lagopoulos, J; Mudaliar, Y; Dorsch, NW				Lang, EW; Yip, K; Griffith, J; Lagopoulos, J; Mudaliar, Y; Dorsch, NW			Hemispheric asymmetry and temporal profiles of cerebral pressure autoregulation in head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Neurosurgical-Society-of-Australasia	JUL, 2002	BROOME, AUSTRALIA	Neurosurg Soc Australasia		dynamic cerebral pressure autoregulation; transcranial Doppler ultrasound; hemisphere asymmetry; temporal profiles	TRAUMATIC BRAIN-INJURY; ARTERIAL-BLOOD-PRESSURE; TRANSCRANIAL DOPPLER; CEREBROVASCULAR AUTOREGULATION; PHASE RELATIONSHIP; FLOW VELOCITY; REACTIVITY; VALIDATION; HEALTHY; HUMANS	A moving correlation index (Mx-ABP) between arterial blood pressure (ABP) and mean middle cerebral artery blood flow velocity (CBFV) can be used to monitor dynamic cerebrovascular autoregulation (CA) after traumatic brain injury (TBI). In this study we examined hemispheric CA asymmetry and temporal CA profiles, their relationship with ABP and CBFV, and their prognostic relevance. Mx-ABP was calculated for each hemisphere in 25 TBI patients second-daily for as long as they were receiving sedation and analgesia. Forty-nine recordings were obtained, between one and six per patient. Four time periods were defined: immediate - postinjury days (PID) 0 and 1; early PID 2 and 3; intermediate - PID 4 and 5, and late - PID 6 and later. GOS was estimated at discharge, GOS 4 and 5 were considered favorable (15 patients) and GOS 1-3 unfavorable outcome (10 patients). A Mx difference >0.2 was classified as hemispheric asymmetry (HA). HA was observed at least once in 12 of the 25 patients (48%) and in 18 of 49 recordings (37%). It was observed during all time periods: 35%, 43%, 25%, 43%, respectively, and was not related to outcome. There was no difference in mean CBFV or ABP between patients with and without HA. HA was not related to interhemispheric CBFV differences. A significant improvement in Mx was seen over time. Hemispheric CA asymmetry is common after traumatic brain injury. It does not bear significant clinical or predictive relevance, and it is unrelated to CBFV or ABP. CA is most profoundly disturbed during the immediate postinjury phase and improves gradually during the ICU course. Further studies are needed to investigate CA during post ICU recovery and rehabilitation. Crown Copyright (C) 2003 Published by Elsevier Ltd. All rights reserved.	Univ Sydney, Westmead Hosp, Dept Neurosurg, Sydney, NSW 2006, Australia; Univ Sydney, Westmead Hosp, Dept Neurol, Sydney, NSW 2006, Australia; Univ Sydney, Westmead Hosp, Dept Intens Care, Sydney, NSW 2006, Australia	Lang, EW (corresponding author), Univ Kiel, Dept Neurosurg, Weimarer Str 8, D-24106 Kiel, Germany.						AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; BULLOCK R, 1996, GUIDELINES MANAGEMEN; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; Heckmann JG, 1999, NEUROL RES, V21, P457, DOI 10.1080/01616412.1999.11740959; JENNETT B, 1975, LANCET, V1, P480; Lang E W, 1994, Neurosurg Clin N Am, V5, P573; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Piechnik SK, 2001, J CEREBR BLOOD F MET, V21, P182, DOI 10.1097/00004647-200102000-00010; Schmidt EA, 2002, ACT NEUR S, V81, P133; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STEINMEIER R, 1999, J NEUROSURG, V90, P427; SYMON L, 1971, EUR NEUROL, V6, P11, DOI 10.1159/000114458; Vavilala MS, 2002, ACTA ANAESTH SCAND, V46, P393, DOI 10.1034/j.1399-6576.2002.460411.x; Wallis SJ, 1996, STROKE, V27, P2287, DOI 10.1161/01.STR.27.12.2287	27	11	11	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2003	10	6					670	673		10.1016/S0967-5868(03)00197-8			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	748AJ	WOS:000186839100005	14592614				2021-06-18	
J	Prigatano, GP; Borgaro, S; Caples, H				Prigatano, GP; Borgaro, S; Caples, H			Non-pharmacological management of psychiatric disturbances after traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							CLOSED HEAD-INJURY; REHABILITATION; BEHAVIOR; DAMAGE	Persons who suffer traumatic brain injury (TBI) often demonstrate a variety of psychiatric and neuropsychiatric disturbances. Some of those disturbances may be managed by non-pharmacological methods. The methods draw heavily on established principles of psychotherapy and behavioral modification. However, the unique problems imposed by neurocognitive deficits must be factored into any form of non-pharmacological intervention with this patient group. A simple model consolidates information about the important ingredients in the non-pharmacological management of psychiatric disturbances in TBI patients.	St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychoil, Div Neurol, Phoenix, AZ 85013 USA	Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychoil, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; AYLLON T, 1968, TOKEN EC; Ben-Yishay Y., 1990, REHABILITATION ADULT, P393; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; CHRISTENSEN AL, 2000, INT HDB NEUROPSYCHOL; Christensen AL, 1994, BRAIN INJURY NEUROPS; Dollard J., 1950, PERSONALITY PSYCHOTH; Ducharme JM, 2000, CLIN PSYCHOL REV, V20, P405, DOI 10.1016/S0272-7358(98)00102-0; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; EAMES P, 1988, J HEAD TRAUMA REHAB, V3, P1; ESSLINGER PJ, 2002, NEUROPSYCHOLOGICAL I; FINN SE, 1996, USING MMPI 2 THERAPE; Frank J. D., 1984, MASTER LECT SERIES, V1, P5; Freud S., 1924, GEN INTRO PSYCHOANAL; GOLDSTEIN FC, 1995, HDB MEMORY DISORDERS, P187; GOLDSTEIN K, 1942, AFTER EFFECTS BRAIN; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Grattan LM, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P266; Guthrie ER, 1939, PSYCHOL REV, V46, P480, DOI 10.1037/h0058583; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; IWATA BA, 1990, J APPL BEHAV ANAL, V23, P11, DOI 10.1901/jaba.1990.23-11; Jehkonen M, 2000, ACTA NEUROL SCAND, V102, P378, DOI 10.1034/j.1600-0404.2000.102006378.x; JUNG CG, 1957, PRACTICE PSYCHOTHERA; KALFF DM, 1980, SANDPLAY PSYCHOTHERA; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Klonoff PS, 1989, J HEAD TRAUMA REHAB, V4, P37; Laatsch L, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P131; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Mateer C. A., 1999, REHABILITATION ADULT, P254; Meyer A, 1904, AM J INSANITY, V60, P373, DOI 10.1176/ajp.60.3.373; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PACE GM, 1993, STAFF DEV CLIN INTER, P105; Pedersen PM, 1996, J NEUROL REHABIL, V10, P243; Pepping M, 2003, NEURO S B C, P313; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; PRIGATANO GP, 2003, OXFORD HDB CLIN NEUR; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; Prigatano GP, 1999, REHABILITATION ADULT, P271; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; Schilder P, 1934, AM J PSYCHIAT, V91, P155, DOI 10.1176/ajp.91.1.155; Sherer M, 2003, NEURO S B C, P39; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHERER M, IN PRESS ARCH PHYSIC; Skinner BF, 1938, BEHAV ORGANISMS; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; Thorndike E., 1932, FUNDAMENTALS LEARNIN; TOLMAN EC, 1949, PSYCHOL REV, V56, P144, DOI 10.1037/h0055304; VONSTEINBUCHEL NV, 1992, NEUROPSYCHOLOGICAL R; WOOD RL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P153; WOOD RL, 1992, NEUROPSYCHOL REHABIL, P51; ZENICUS A, 1989, BRAIN INJURY, V3, P67	56	11	13	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					371	379		10.1080/09540260310001606755			9	Psychiatry	Psychiatry	739UD	WOS:000186364100009	15276958				2021-06-18	
J	Ross, SR; Krukowski, RA; Putnam, SH; Adams, KM				Ross, SR; Krukowski, RA; Putnam, SH; Adams, KM			The memory assessment scales in the detection of incomplete effort in mild head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							ADULT INTELLIGENCE SCALE; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; WMS-R; COGNITIVE IMPAIRMENT; MALINGERING TOMM; RECOGNITION TEST; TESTS; VALIDATION; DEFICITS	Despite differences in the constructs measured, the Memory Assessment Scales (MAS) remain an alternative to the Wechsler Memory Scales (WMS) as a broad-band instrument for assessing multiple aspects of attention and memory. Although a number of studies have examined indices of the WMS as indicators of malingering, few studies have similarly investigated the MAS. In this study, we examined the degree to which the MAS was effective in detecting incomplete effort in a clinical sample of patients referred for neuropsychological evaluation after mild head injury. Included in the sample were 21 financially compensable (FC) participants with alleged mild head injury and 21 participants who were not involved in litigation and suffered more serious head injuries. Examination of the four MAS domain indices indicated that Short-Term Memory was most useful at identifying incomplete effort. We also examined subscales of the MAS. Consistent with previous findings, brief tests such as Verbal and Visual Span had high rates of diagnostic sensitivity and specificity. Although tests based on a forced-choice recognition paradigm (e.g., Immediate and Delayed Visual Recognition) predicted group membership above chance levels, they failed to significantly add to prediction above Verbal and Visual Span subtests.	DePauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Univ Vermont, Burlington, VT USA; Wayne State Univ, Sch Med, Detroit, MI USA; VA Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Ann Arbor, MI 48109 USA	Ross, SR (corresponding author), DePauw Univ, Dept Psychol, Greencastle, IN 46135 USA.	srross@depauw.edu	Krukowski, Rebecca/AAS-4304-2020	Krukowski, Rebecca/0000-0001-9193-2783			Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Fahrmeir L., 1994, MULTIVARIATE STAT MO; Golden CJ, 1999, ARCH CLIN NEUROPSYCH, V14, P265, DOI 10.1016/S0887-6177(98)00017-1; Gontkovsky ST, 2000, PSYCHOL REP, V87, P512, DOI 10.2466/PR0.87.6.512-514; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; HILSABECK RC, 1996, ASSESSMENT, V3, P417; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; Iverson G.L., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401, DOI 10.1177/107319119400100401]; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Menard S. W., 2002, APPL LOGISTIC REGRES; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Rawling P, 1990, NEUROPSYCHOLOGY, V4, P223, DOI 10.1037/0894-4105.4.4.223; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; ROSS SR, IN PRESS J CLIN EXPT; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; VANZOMEREN AH, 1990, HDB CLIN NEUROLOGY, V13, P397; Warrington EK., 1984, RECOGNITION MEMORY T; WILLIAMS MJ, 1991, MEMORY ASSESSMENT SC; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]; ZIELINSKI JJ, 1993, PROF PSYCHOL-RES PR, V24, P353, DOI 10.1037/0735-7028.24.3.353	48	11	11	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					581	591		10.1076/clin.17.4.581.27940			11	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400014	15168922				2021-06-18	
J	Frattali, C; Bayles, K; Beeson, P; Kennedy, MRT; Wambaugh, J; Yorkston, KM				Frattali, C; Bayles, K; Beeson, P; Kennedy, MRT; Wambaugh, J; Yorkston, KM			Development of evidence-based practice guidelines: Committee update	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article								The Academy of Neurologic Communication Disorders and Sciences (ANCDS), by way of the mission, purposes, and activities of its Ad Hoc Practice Guidelines Coordinating Committee and respective Writing Committees, has embarked on a 5-year project to develop a range of evidence-based practice guidelines for specific neurologically impaired patient populations (i.e., dysarthria, dementia, acquired apraxia of speech, developmental apraxia of speech, aphasia, cognitive-communication disorders after traumatic brain injury, and cognitive and communication disorders after right-hemisphere brain damage). The project embraces a philosophy that quality of care is best supported by scientific evidence of treatment efficacy. This article, which details and updates the proceedings from the Committee's presentation at the ANCDS annual educational and scientific meeting in 2002 in Atlanta, Georgia, summarizes the progress to date by the various Writing Committees responsible for developing these evidence-based practice guidelines.	NIH, Dept Rehabil Med, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Univ Arizona, Dept Hearing & Speech Sci, Tucson, AZ USA; Univ Minnesota, Dept Commun, Minneapolis, MN USA; Univ Utah, Salt Lake City, UT USA; Univ Washington, Seattle, WA 98195 USA	Frattali, C (corresponding author), NIH, Dept Rehabil Med, Warren G Magnuson Clin Ctr, Bldg 10,Rm 6S 235,MSC 1604, Bethesda, MD 20892 USA.	carol_frattali@nih.gov					DUFFY JR, 2001, 2 ACAD NEUR COMM DIS; DUFFY JR, IN PRESS J MED SPEEC; FRATTALI C, HDB MED SPEECH LANGU; GOLPER L, 2001, J MED SPEECH-LANG PA, V9, P9; GOLPER LC, 2001, EVIDENCE BASED PRACT; KENNEDY MR, 2002, J MED SPEECH-LANG PA, V10, P9; KENNEDY MRT, 2002, NEUROPHYSIOLOGY NEUR, V12; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Spencer KA, 2003, J MED SPEECH-LANG PA, V11, pXXXIX; SPENCER KA, 2002, PRACTICE GUIDELINES; SPENCER KA, 2002, NEUROPHYSIOLOGY NEUR, V12, P4; Ylvisaker M, 2002, J MED SPEECH-LANG PA, V10, pXXV; Yorkston KM, 2003, J MED SPEECH-LANG PA, V11, P73; Yorkston KM, 2001, J MED SPEECH-LANG PA, V9, P257; YORKSTON KM, 2001, PRACTICE GUIDELINES	15	11	11	0	8	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2003	11	3					IX	XVII					9	Audiology & Speech-Language Pathology; Clinical Neurology	Audiology & Speech-Language Pathology; Neurosciences & Neurology	722PH	WOS:000185384900002					2021-06-18	
J	Philip, S; Armstead, WM				Philip, S; Armstead, WM			Differential role of PTK, ERK and p38 MAPK in superoxide impairment of NMDA cerebrovasodilation	BRAIN RESEARCH			English	Article						cerebral circulation; excitatory amino acid; oxygen free radical; signal transduction	ACTIVATED PROTEIN-KINASE; CEREBRAL ARTERIOLAR DILATION; HYPOXIC-ISCHEMIC IMPAIRMENT; NOC/OFQ-INDUCED IMPAIRMENT; BRAIN-INJURY; NITRIC-OXIDE; INDUCED CONTRACTION; TYROSINE KINASE; PIAL ARTERY; RAT-BRAIN	Previous studies in piglets have shown that the generation of oxygen free radicals (O-2(-)) following traumatic brain injury and hypoxia/ischemia contribute to the reversal of N-methyl-D-aspartate (NMDA)-induced pial artery dilation to vasoconstriction. This study determined the contribution of protein tyrosine kinase (PTK) and mitogen-activated protein (MAPK) activation to impairment of NMDA cerebrovasodilation by O-2(-) in piglets equipped with a closed window. Exposure of the cerebral cortex to a xanthine oxidase O-2(-) generating system (OX) reversed NMDA (10(-8), 10(-6) M) dilation to vasoconstriction but such impairment was partially prevented by the PTK inhibitor, genistein, the MAPK (ERK isoform) inhibitor, U0126, and the MAPK (p38 isoform) inhibitor, SB203580 (9 +/- 1 and 15 +/- 1 vs. - 1 +/- 1 and - 1 +/- 1 vs. 5 +/- 1 and 9 +/- 1 % for sham control, OX and OX in the presence of genistein, respectively). However, the p38 MAPK inhibitor, SB203580, prevented NMDA dilator impairment significantly less than the ERK MAPK inhibitor, U0126. Similar results were obtained for glutamate. These data show that PTK and MAPK activation by the presence of O-2(-) contributes to the impairment of NMDA dilation. Furthermore, these data indicate a differential role for ERK and p38 MAPK activation in impairment of NMDA dilation by O-2(-) in the brain. (C) 2003 Elsevier B.V. All rights reserved.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA	Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu					Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2002, PEDIATR RES, V51, P586, DOI 10.1203/00006450-200205000-00007; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 2001, J NEUROTRAUM, V18, P615, DOI 10.1089/089771501750291855; Armstead WM, 2000, BRAIN RES, V868, P48, DOI 10.1016/S0006-8993(00)02262-9; Armstead WM, 2000, AM J PHYSIOL-HEART C, V279, pH2678; ARMSTEAD WM, 2000, AM J PHYSIOL, pH2188; Bari F, 1998, BRAIN RES, V780, P237, DOI 10.1016/S0006-8993(97)01196-7; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; BECKMAN JS, 1994, ANN NY ACAD SCI, V738, P69; Bolla M, 2002, J VASC RES, V39, P353, DOI 10.1159/000065547; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Busija DW, 1996, AM J PHYSIOL-HEART C, V270, pH1225; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Jagolino AL, 2003, AM J PHYSIOL-HEART C, V284, pH101, DOI 10.1152/ajpheart.00457.2002; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; Kim CJ, 1998, J NEUROSURG, V89, P289, DOI 10.3171/jns.1998.89.2.0289; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; McKeon RJ, 1997, EXP NEUROL, V148, P558, DOI 10.1006/exnr.1997.6698; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; NAMURA S, 1999, P NATL ACAD SCI USA, V98, P11568; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Philip S, 2003, NEUROREPORT, V14, P201, DOI 10.1097/00001756-200302100-00008; ROSS J, IN PRESS AM J PHYSL; Shin HK, 2002, J CEREBR BLOOD F MET, V22, P869, DOI 10.1097/00004647-200207000-00012; Veltkamp R, 1999, STROKE, V30, P148, DOI 10.1161/01.STR.30.1.148; WATSON DB, 1984, J NEUROCHEM, V41, P268; WEI EP, 1985, AM J PHYSIOL, V248, pH157; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781	40	11	11	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 25	2003	979	1-2					98	103		10.1016/S0006-8993(03)02879-8			6	Neurosciences	Neurosciences & Neurology	705LT	WOS:000184397100013	12850576				2021-06-18	
J	Glover, A				Glover, A			An exploration of the extent to which attending Headway enhances quality of life after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article							HEALTH; REHABILITATION	Purpose: This paper explores the perception of quality of life (QOL) of four men following traumatic brain injury (TBI) and the effects of their injury on family, social and working life. Method: It also highlights their on going difficulties 6, 8, 10 and 11 years post injury and that long term support is not available from rehabilitation services often due to the NHS financial restraints. Results: Participants in this study have highlighted: (a) the need for long term support over an unspecified continuum;, (b) the value of peer support; (c) the value of an understanding environment prepared to address individual needs which encourages independence; (d) the need for a social outlet; (e) the benefit of structure and boundaries after rehabilitation; and (f) the need for ongoing information for the survivor and family. Conclusions: Headway, the brain injury association has provided a continuum of care revealing a lengthy process of adjustment towards a new self, a new role and a new life.	Headway Essex, Colchester CO4 5HG, Essex, England	Glover, A (corresponding author), Headway Essex, Headway House,2 Boxted Rd, Colchester CO4 5HG, Essex, England.	AnnabelleGlover.info@headwayessex.org.uk					Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; Bethoux F, 1996, INT J REHABIL RES, V19, P291, DOI 10.1097/00004356-199612000-00001; Bond A E, 1997, Crit Care Nurse, V17, P112; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bowling A, 1997, MEASURING HLTH; *BSRM, 1998, REH BRAIN INJ WORK P, V45; Carlson Hannah Bick, 1993, Brain Injury, V7, P183, DOI 10.3109/02699059309008172; Crisp R., 1993, DISABILITY HANDICAP, V8, P393, DOI [DOI 10.1080/02674649366780371, 10.1080/02674649366780371]; Ehrlich JS., 1985, COGNITIVE REHABILITA, V3, P32; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GARNER R, 1990, ACUTE HEAD INJURY PR; Gosling J, 1999, BRAIN INJURY, V13, P785; *HFBC, 1997, NHS ADV SERV HAS THE; *HIDD DIS, 1996, REP SSI TRAUM BRAIN; Hyland ME, 1997, PSYCHOL HEALTH, V12, P389, DOI 10.1080/08870449708406715; Johnson J, 2001, INT J PSYCHIAT CLIN, V5, P141, DOI 10.1080/136515001300374894; Kendall E, 2000, DISABIL REHABIL, V22, P435, DOI 10.1080/09638280050045901; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; McColl MA, 2000, DISABIL REHABIL, V22, P555, DOI 10.1080/096382800416805; McMillan TM, 2001, NEUROBEHAVIOURAL DIS; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; *NOTT TRENT U PROJ, ASS LONG TERM RES NE; *NTBIS, 1998, CTR HLTH SERV STUD U; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Parr S., 1997, TALKING APHASIA; Pepin M, 2000, BRAIN INJURY, V14, P563; Richie J, 1994, ANAL QUALITATIVE DAT; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; SIMPSON G, INT PERSPECTIVES TRA, P403; Skevington SM, 1997, BRIT J HEALTH PSYCH, V2, P55, DOI 10.1111/j.2044-8287.1997.tb00523.x; Sohlberg MM, 1998, BRAIN INJURY, V12, P333; Stonnington HH, 2000, BRAIN INJURY, V14, P393, DOI 10.1080/026990500120501; TYERMAN A, 1984, INT J REHABILITATION, V7, P373; TYERMAN A, 1997, REHABILITATION PHYSI; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Woodend AK, 1997, INT J REHABIL RES, V20, P71, DOI 10.1097/00004356-199703000-00006	38	11	11	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 8	2003	25	13					750	760		10.1080/0963828021000058503			11	Rehabilitation	Rehabilitation	695YH	WOS:000183857600007	12791560				2021-06-18	
J	LoBello, SC; Underhil, AT; Valentine, PV; Stroud, TP; Bartolucci, AA; Fine, PR				LoBello, SC; Underhil, AT; Valentine, PV; Stroud, TP; Bartolucci, AA; Fine, PR			Social integration and life and family satisfaction in survivors of injury at 5 years postinjury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						CHART; disability; family satisfaction; FSS; injury; life satisfaction; LSI-A; social integration	TRAUMATIC BRAIN-INJURIES; SPINAL-CORD INJURY; HANDICAP; IMPAIRMENT; DISABILITY	This study assessed the relationship of social integration (SI) to life satisfaction and family satisfaction among survivors 5 years after injury. Thirty-four matched pairs of injured patients were interviewed by telephone 60 months after initial discharge from the acute care setting. Respondents were matched according to sex, race, education, injury severity, and employment status before comparing high and low socially integrated persons on measures of family and life satisfaction. High and low SI groups were formed based on the Craig Handicap Assessment and Reporting Technique (CHART) SI Scale. The former consisted of patients scoring 100; the latter consisted of patients scoring 50 or less. Analyses of covariance, with age and injury type as covariates, were used to test for group differences. The high and low SI groups differed on both the life and the family satisfaction measures, with the high SI group reporting greater life and family satisfaction.	Auburn Univ, Montgomery, AL 36117 USA; Univ Alabama Birmingham, Sch Med, Injury Control Res Ctr, Birmingham, AL USA; Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA	LoBello, SC (corresponding author), POB 244023, Montgomery, AL 36124 USA.	lobello@strudel.aum.edu			ODCDC CDC HHS [R49/CCR403641] Funding Source: Medline		ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; AMERIKANER M, 1994, J COUNS DEV, V72, P614, DOI 10.1002/j.1556-6676.1994.tb01691.x; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carruth AK, 1997, NURS RES, V46, P93, DOI 10.1097/00006199-199703000-00006; COLLETTE J, 1984, J GERONTOL, V39, P243, DOI 10.1093/geronj/39.2.243; *COMM INJ SCAL AM, 1985, ABBR INJ SCAL 1985 R; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; KENNEDY GE, 1989, PERCEPT MOTOR SKILL, V68, P129, DOI 10.2466/pms.1989.68.1.129; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; LOHMANN N, 1977, J GERONTOL, V32, P73, DOI 10.1093/geronj/32.1.73; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; NOREAU L, 1995, SPORTS MED, V20, P226, DOI 10.2165/00007256-199520040-00003; OLSON DH, 1982, FAMILY SATISFACTION; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; RAO VN, 1982, INT J AGING HUM DEV, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; VIITANEN M, 1988, SCAND J REHABIL MED, V20, P17; Vogel LC, 1998, ARCH PHYS MED REHAB, V79, P1496, DOI 10.1016/S0003-9993(98)90409-9; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/0013164402062004009; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	26	11	13	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	JUL-AUG	2003	40	4					293	299		10.1682/JRRD.2003.07.0293			7	Rehabilitation	Rehabilitation	712CU	WOS:000184779800002	15074440	Bronze			2021-06-18	
J	Chua, KSG; Kong, KH				Chua, KSG; Kong, KH			Acquired heterotopic ossification in the settings of cerebral anoxia and alternative therapy: two cases	BRAIN INJURY			English	Article								Acquired Heterotopic Ossification (HO) has been well described in the literature as a recognized complication following spinal cord injury, traumatic brain injury and joint arthroplasty. Commonly, large proximal limb joints are affected. The underlying mechanisms for ectopic bone formation remain poorly elucidated. Post-stroke hemiplegia as a cause of neurogenic HO is rare, and no published reports of HO occurring after anoxic brain injury in adults have been documented. This study reports two unusual cases of acquired HO: (1) Polyarticular HO involving the ankle joint in a 24-year-old Chinese female who suffered severe anoxic encephalopathy following near drowning which resulted in persistent vegetative state; and (2) Elbow HO in chronic post-stroke hemiplegia occurring as a complication of alternative therapy following repeated forceful manipulation by a traditional practitioner in a 46 year-old male.	Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore	Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17,Ang Mo Kio Ave 9, Singapore 569766, Singapore.	karen_chua@ttsh.com.sg					BARON M, 1983, J RHEUMATOL, V10, P961; BOHANNON RW, 1987, PHYS THER, V67, P216; Condon F, 1998, J SPINAL DISORD, V11, P448; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Hagan C., 1982, COGNITIVE REHABILITA, P131; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Kimura Masahiko, 1995, No To Hattatsu, V27, P487; MICHELSSON J, 1993, CLIN ORTHOP RELAT R, V176, P265; SHAH S, 1999, CLIN REHABIL, V13, P141; Stover SL, 1986, MANAGEMENT SPINAL CO, P284; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; SUBBARAO JV, 1990, AM J PHYS MED REHAB, V69, P88, DOI 10.1097/00002060-199004000-00008; Taly AB, 2001, NEUROL INDIA, V49, P37	15	11	11	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2003	17	6					535	544		10.1080/0269905021000010104			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	672GG	WOS:000182512400007	12745708				2021-06-18	
J	Petrov, T; Rafols, JA; Alousi, SS; Kupsky, WJ; Johnson, R; Shah, J; Shah, A; Watson, C				Petrov, T; Rafols, JA; Alousi, SS; Kupsky, WJ; Johnson, R; Shah, J; Shah, A; Watson, C			Cellular compartmentalization of phosphorylated eIF2 alpha and neuronal NOS in human temporal lobe epilepsy with hippocampal sclerosis	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						hippocampus; neurons; glia; immunocytochemistry; NADPH-D	BRAIN ISCHEMIA; NADPH-DIAPHORASE; SYNAPTIC REORGANIZATION; FEBRILE CONVULSIONS; MESIAL STRUCTURES; INTERNEURON LOSS; GRADING SYSTEM; IMMUNOREACTIVITY; REPERFUSION; LOCALIZATION	Hippocampal sclerosis (HS) is the most common neuropathologic finding in patients with medically refractory temporal lobe epilepsy (TLE). The mechanisms resulting in neuronal injury and cell loss in HS are incompletely understood, but inhibition of protein synthesis may play a pivotal role in these processes. This study examined the relationships between two molecules known to be involved in reduced protein synthesis in animals subjected to traumatic brain injury. Translational initiation of protein synthesis is inhibited when 2alpha (eIF2alpha) is phosphorylated. Recently, nitric oxide (NO) has been shown to reduce protein synthesis by inducing phosphorylation of eIF2alpha. We performed immunocytochemistry for eIF2alpha(P) and histochemistry (NADPH-D reaction) for nitric oxide synthase (NOS) to determine the distribution of these molecules in hippocampi removed from patients undergoing anterior temporal lobectomy (ATL) for medically intractable TLE due to HS. The greatest number of eIF2alpha(P) positive cells was in the CA1 sector of the hippocampus, followed by the hilus of the dentate gyrus. NADPH-D positive neurons were observed most often in the hilus. Labeling in both instances involved neuronal cell body cytoplasm and varicose processes. Combination of both staining procedures revealed close relationships between differentially labeled neurons within the hilus. The results suggest that NO participates in the phosphorylation of eIF2alpha since we demonstrated that nNOS processes are closely related to eIF2alpha(P) positive cells. This may occur through activation of kinases such as PERK, which was recently revealed. In human, TLE protein synthesis inhibition may occur at the translational level since the eIF2alpha(P) labeling is cytoplasmic. Protein synthesis inhibition may contribute to neuronal cell injury and death in HS. (C) 2003 Elsevier Science B.V All rights reserved.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu		Shah, Aashit/0000-0001-7370-3004	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 39860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Atkins CM, 1999, J NEUROSCI, V19, P7241, DOI 10.1523/JNEUROSCI.19-17-07241.1999; Babb T.L., 1987, SURGICAL TREATMENT E, P511; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Bruton CJ, 1988, NEUROPATHOLOGY TEMPO; CENDES F, 1993, ANN NEUROL, V34, P795, DOI 10.1002/ana.410340607; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Davies KG, 1996, EPILEPSY RES, V24, P119, DOI 10.1016/0920-1211(96)00008-3; de Lanerolle NC, 1998, EUR J NEUROSCI, V10, P1687, DOI 10.1046/j.1460-9568.1998.00171.x; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; DELANEROLLE NC, 1988, EPILEPSIA, V29, P674; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Downen M, 1999, J NEUROPATH EXP NEUR, V58, P12, DOI 10.1097/00005072-199901000-00002; Doyle CA, 1997, NEUROSCIENCE, V76, P387, DOI 10.1016/S0306-4522(96)00297-7; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; FALCONER MA, 1959, BRAIN, V82, P483, DOI 10.1093/brain/82.4.483; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Goldstein EN, 1999, ACTA NEUROPATHOL, V98, P493, DOI 10.1007/s004010051115; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; HOUSER CR, 1990, J NEUROSCI, V10, P267; Jhamandas JH, 1996, NEUROREPORT, V7, P2843, DOI 10.1097/00001756-199611250-00006; JOHANSEN FF, 1987, ACTA NEUROPATHOL, V73, P110, DOI 10.1007/BF00693775; Kim YM, 1998, MOL MED, V4, P179, DOI 10.1007/BF03401915; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; MATHERN GW, 1995, J NEUROSURG, V82, P211, DOI 10.3171/jns.1995.82.2.0211; Mathern GW, 1998, J NEUROPATH EXP NEUR, V57, P615, DOI 10.1097/00005072-199806000-00008; MATHERN GW, 1995, J NEUROSCI, V15, P3990; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; McNaught KSP, 1998, J NEUROCHEM, V70, P1541; Norris PJ, 1996, MOL BRAIN RES, V41, P36, DOI 10.1016/0169-328X(96)00064-2; PETROV T, 1995, NEUROPHARMACOLOGY, V34, P509, DOI 10.1016/0028-3908(95)00002-N; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Rafols J. A., 2001, Society for Neuroscience Abstracts, V27, P568; RAFOLS JA, 1995, ACTA NEUROPATHOL, V90, P17; RAFOLS JA, 1999, J CEREB BLOOD FLO S1, V19, pS511; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; SAGAR HJ, 1987, ANN NEUROL, V22, P334, DOI 10.1002/ana.410220309; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Tasch E, 1999, ANN NEUROL, V45, P568, DOI 10.1002/1531-8249(199905)45:5<568::AID-ANA4>3.0.CO;2-P; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; TRENERRY MR, 1993, EPILEPSY RES, V15, P247, DOI 10.1016/0920-1211(93)90062-C; UNDERWOOD BD, IN PRESS J NEUROTRAU; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Watson C, 1996, J EPILEPSY, V9, P56, DOI 10.1016/0896-6974(95)00060-7; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P1521, DOI 10.1001/archneur.1997.00550240071015; Watson C, 1997, ARCH NEUROL-CHICAGO, V54, P67, DOI 10.1001/archneur.1997.00550130049015; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; WYLER AR, 1992, J EPILEPSY, V5, P220, DOI 10.1016/S0896-6974(05)80120-3; Yasuda H, 2001, EPILEPSIA, V42, P13, DOI 10.1046/j.1528-1157.2001.083032.x	55	11	11	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAY 15	2003	209	1-2					31	39		10.1016/S0022-510X(02)00461-6			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	672VN	WOS:000182543800006	12686399				2021-06-18	
J	Hart, T; Bogner, JA; Whyte, J; Polansky, M				Hart, T; Bogner, JA; Whyte, J; Polansky, M			Attribution of blame in accidental and violence-related traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article; Proceedings Paper	29th Annual Meeting of the International-Neuropsychological-Society	FEB 14-17, 2001	CHICAGO, ILLINOIS	Int Neuropsychol Soc			DISABILITY RATING-SCALE; SPINAL-CORD INJURY; HEAD-INJURY; SELF-BLAME; ADJUSTMENT	Objective: To study reliability and validity of blame attribution following acute moderate to severe traumatic brain injury (TBI) caused by violence versus accident. Study Design: Prospective study with test-retest component, comparing groups with violent versus accidental injuries as determined by self-report and chart review. Participants: Fifty-seven persons in acute rehabilitation for moderate to severe TBI. Measure: Eight-item Blame Attribution Questionnaire. Results: Blame attribution was reliable, even for participants with severe TBI. Violence and accident groups apportioned different amounts of blame to other people; concern with cause of injury and degree of self-blame showed less striking differences. Conclusions: Blame of others, which may increase risk of adverse psychological outcome, is strongest in those with violence-related TBI. Self-blame is not as strongly related to external circumstances and could signal a constructive coping mechanism.	Moss Rehabil Res Inst, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Med Coll Penn & Hahnemann Univ, Sch Publ Hlth, Philadelphia, PA USA	Hart, T (corresponding author), Moss Rehabil Res Inst, 1200 W Tabor Rd, Philadelphia, PA 19141 USA.		Bogner, Jennifer/E-2773-2011	Whyte, John/0000-0002-4381-1474			ATHELSTAN GT, 1979, REHABIL COUNS BULL, V22, P311; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; BULMAN RJ, 1977, J PERS SOC PSYCHOL, V35, P351, DOI 10.1037/0022-3514.35.5.351; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; Hagen C., 1972, LEVELS COGNITIVE FUN; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HEINEMANN AW, 1988, REHABIL PSYCHOL, V33, P195, DOI 10.1037//0090-5550.33.4.195; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REIDY K, 1994, ARCH PHYS MED REHAB, V75, P837, DOI 10.1016/0003-9993(94)90106-6; SCHULZ R, 1985, J PERS SOC PSYCHOL, V48, P1162, DOI 10.1037/0022-3514.48.5.1162; SHOLOMSKAS DE, 1990, J APPL SOC PSYCHOL, V20, P548, DOI 10.1111/j.1559-1816.1990.tb00427.x; VANDENBOUT J, 1988, J CLIN PSYCHOL, V44, P17, DOI 10.1002/1097-4679(198801)44:1<17::AID-JCLP2270440104>3.0.CO;2-J; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774	17	11	11	0	5	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2003	48	2					86	92		10.1037/0090-5550.48.2.86			7	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	674FV	WOS:000182627500003					2021-06-18	
J	Ruttan, LA; Heinrichs, RW				Ruttan, LA; Heinrichs, RW			Depression and neurocognitive functioning in mild traumatic brain injury patients referred for assessment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; MEMORY TEST-PERFORMANCE; NEUROPSYCHOLOGICAL DEFICITS; RECOVERY; SYMPTOMS; IMPACT	The relationship between depression and performance on selected neurocognitive tests was examined in two mild head injury samples (n(1) = 72, n(2) = 50). A series of hierarchical regression analyses showed that scores on depression-related scales of both the MCMI-II (Millon Clinical Multi-Axial Inventory; Millon, 1987) and MMPI-2 (Minnesota Multiphasic Personality Inventory; Hathaway & McKinley, 1989) were largely independent of cognitive performance. Depression may be prevalent in mild injury, but it is unlikely to mediate deficits observed on commonly used measures of problem solving, visual-niotor speed, prose and figural recall.	York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; Toronto Rehabil Inst, Toronto, ON, Canada	Heinrichs, RW (corresponding author), York Univ, Dept Psychol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	walterh@yorku.ca					Acker MB, 1989, NEUROPSYCHOLOGY, V3, P123, DOI 10.1037//0894-4105.3.3.123; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Butcher J. N., 1989, MANUAL RESTANDARDIZE; Christensen LB., 1985, EXPT METHODOLOGY, V3; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1986, J CONSULT CLIN PSYCH, V54, P261, DOI 10.1037/0022-006X.54.2.261; GASS CS, 1990, PSYCHOL ASSESSMENT J, V2, P175, DOI DOI 10.1037//1040-3590.2.2.175; Gronwall D, 1989, MILD HEAD INJURY, P153; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Halstead WC, 1947, BRAIN INTELLIGENCE; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HATHAWAY SR, 1989, MINNESOTA MULTIPHASI, V2; Jennett B, 1989, MILD HEAD INJURY, P22; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MACNIVEN E, 1990, CLIN NEUROPSYCHOL, V4, P305; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLON T, 1987, MANUAL MCMI 2; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R.M., 1993, HALSTEADREITAN NEURO; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; SAPIENZA MM, 1989, THESIS YORK U N YORK; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Sherman EMS, 2000, BRAIN INJURY, V14, P621; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI DOI 10.1080/13854048708520046; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tabachnick B.G., 1989, USING MULTIVARIATE S; Tellier A, 1999, BRAIN INJURY, V13, P463; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; WETZLER S, 1993, J PERS ASSESS, V60, P1, DOI 10.1207/s15327752jpa6001_1	56	11	11	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2003	25	3					407	419		10.1076/jcen.25.3.407.13812			13	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	683GX	WOS:000183141200010	12916653				2021-06-18	
J	Valentin, A; Lang, T; Karnik, R; Ammerer, HP; Ploder, J; Slany, J				Valentin, A; Lang, T; Karnik, R; Ammerer, HP; Ploder, J; Slany, J			Intracranial pressure monitoring and case mix-adjusted mortality in intracranial hemorrhage	CRITICAL CARE MEDICINE			English	Article						intracranial hemorrhage; intracranial pressure; intracranial pressure/diagnosis; outcome assessment; hospital mortality; risk adjustment	TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; CARE; MANAGEMENT; PERFORMANCE; PREDICTION; GUIDELINES; QUALITY; MODELS; SCORE	Objective: Intracranial pressure (ICP) monitoring is frequently used in intensive care treatment of patients with intracranial hemorrhage. Data demonstrating an improved outcome from this intervention are lacking. We analyzed standardized mortality ratios in patients with and without ICP monitoring to determine its efficacy. Design; A nonrandomized study of case records of consecutively admitted intensive care unit (ICU) patients with intracranial hemorrhage. Setting: General and medical ICU of a 900-bed tertiary-care hospital. Patients: A total of 225 patients with intracranial hemorrhage (mainly nontraumatic) admitted consecutively between April 1997 and March 2000. Measurements: Simplified Acute Physiology Score (SAPS) II, diagnosis, age, sex, use of ICP monitoring, and in-hospital mortality rates were collected from the hospital's ICU database. Expected mortality was provided by means of SAPS II. Standardized mortality ratios were calculated and compared in 119 patients with ICP monitoring and 106 patients without ICP monitoring. Main Results: The case mix-adjusted hospital mortality in the group with ICP monitoring was in the expected range (standardized mortality ratio, 1.09 [95% confidence interval (Cl), 0.87-1.31]). Patients without ICP monitoring had a significantly higher standardized mortality ratio than expected (1.26 [95% Cl, 1.06-1.46]). Conclusions: A beneficial effect of ICP monitoring in patients with intracranial hemorrhage may be reflected in an improved standardized mortality ratio.	Univ Vienna, Dept Med 2, A-1010 Vienna, Austria; Univ Vienna, Dept Neurosurg, A-1010 Vienna, Austria; Univ Vienna, KA Rudolfstiftung, A-1010 Vienna, Austria; Univ Vienna, Dept Med Stat, A-1010 Vienna, Austria	Valentin, A (corresponding author), Univ Vienna, Dept Med 2, Garnisongasse 13, A-1010 Vienna, Austria.			Valentin, Andreas/0000-0001-7443-3595			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Chesnut R M, 1995, New Horiz, V3, P581; HOSMER DW, 1995, STAT MED, V14, P2161, DOI 10.1002/sim.4780141909; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lane PL, 2000, CAN J SURG, V43, P442; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Metnitz PGH, 2000, INTENS CARE MED, V26, P1466, DOI 10.1007/s001340000638; Moreno R, 1998, INTENS CARE MED, V24, P40, DOI 10.1007/s001340050513; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825	13	11	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	MAY	2003	31	5					1539	1542		10.1097/01.CCM.0000065270.53951.9E			4	Critical Care Medicine	General & Internal Medicine	680ME	WOS:000182981300037	12771630				2021-06-18	
J	Murakami, M; Kakita, K; Hosokawa, Y				Murakami, M; Kakita, K; Hosokawa, Y			Ruptured traumatic aneurysm after trivial injury mimicking acute spontaneous subdural hematoma - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic aneurysm; acute spontaneous subdural hematoma; middle cerebral artery	CEREBRAL-ARTERIES	A 75-year-old man suffered acute subdural hematoma shortly after trivial head trauma. Thirteen hours after a trivial brow to the occipital region, caused by contact with a mat, he suddenly deteriorated to the level of a Glasgow Coma Scale score of 6. Computed tomography demonstrated an acute subdural hematoma on the left and angiography revealed an aneurysm of the distal middle cerebral artery. An emergent craniotomy disclosed no skull fracture and exposed a thick subdural hematoma with no brain contusions. After evacuation of the hematoma, an aneurysm was found on the distal portion of posterior temporal artery, which was compatible with the angiographical findings. The neck of aneurysm was so fragile that neck clipping could not be successfully performed. Therefore, the aneurysm was extirpated, and the bleeding site coagulated with oxidized cellulose reinforcement. Histological examination of the aneurysm indicated a pseudoaneurysm during the early phase of clot formation. The acute subdural hematoma resulted from rupture of this pseudoaneurysm which was formed shortly after the minor head trauma. Rupture of a pseudoaneurysm caused by trivial trauma might be one of the origins for so-called acute "spontaneous" subdural hematoma.	Kyoto 1st Red Cross Hosp, Dept Neurosurg, Kyoto, Japan; Kyoto 1st Red Cross Hosp, Dept Pathol, Kyoto, Japan	Murakami, M (corresponding author), Kyoto Prefectural Univ Med, Dept Neurosurg, 465 Kajii Cho,Kaaramachi Hirokoji, Kyoto 6028566, Japan.	mamoru@koto.kpu-m.ac.jp					ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GELABERT M, 1989, CLIN NEUROL NEUROSUR, V91, P75, DOI 10.1016/S0303-8467(89)80012-5; GREENBERG MS, 1997, HDB NEUROSURGERY, P853; HESSELBROCK R, 1984, SURG NEUROL, V21, P363, DOI 10.1016/0090-3019(84)90115-0; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; Koc RK, 1997, SURG NEUROL, V47, P9, DOI 10.1016/S0090-3019(96)00150-4; Komiyama M, 2001, NEUROL MED-CHIR, V41, P264, DOI 10.2176/nmc.41.264; Matsuyama T, 1997, SURG NEUROL, V47, P423, DOI 10.1016/S0090-3019(96)00398-9; MCDERMOTT M, 1984, NEUROSURGERY, V14, P13, DOI 10.1227/00006123-198401000-00004; NAKASHIMA H, 1992, Neurological Surgery, V20, P391; OBRIEN PK, 1974, J NEUROSURG, V41, P435, DOI 10.3171/jns.1974.41.4.0435; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; SEDZIMIR CB, 1968, J NEUROSURG, V29, P636, DOI 10.3171/jns.1968.29.6.0636; SERIZAWA T, 1991, Neurological Surgery, V19, P1061; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; TOKORO K, 1988, SURG NEUROL, V29, P159, DOI 10.1016/0090-3019(88)90076-6; Yagi T, 1996, NEUROL SURG TOKYO, V24, P665; YANAI Y, 1985, SURG NEUROL, V23, P417, DOI 10.1016/0090-3019(85)90221-6; YASUI T, 1995, SURG NEUROL, V43, P61, DOI 10.1016/0090-3019(95)80041-E	26	11	11	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAR	2003	43	3					130	133		10.2176/nmc.43.130			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	656ZP	WOS:000181641200011	12699120	Bronze			2021-06-18	
J	Ng, KC; Moochhala, SM; Md, S; Yap, EL; Low, SY; Lu, J				Ng, KC; Moochhala, SM; Md, S; Yap, EL; Low, SY; Lu, J			Preservation of neurological functions by nitric oxide synthase inhibitors following hemorrhagic shock	NEUROPHARMACOLOGY			English	Article						iNOS inhibitor; hemorrhagic shock; MABP; neurological functions; rat	TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; L-CANAVANINE; L-ARGININE; RAT; AMINOGUANIDINE; RESUSCITATION; DAMAGE; CELLS	Excessive production of nitric oxide (NO) as result of inducible nitric oxide synthase (iNOS) induction has been implicated in the pathophysiology of hemorrhagic shock. Our aim was to study the effect of iNOS inhibitors, L-canavanine (50mg/kg) and N-G-nitro- L-arginine methyl (L-NAME, 10mg/kg) and a resuscitation fluid, lactated Ringer's solution (3 time,, amount of blood lost), on survivability and neurological functions in rodents subjected to hemorrhagic shock. rat,, had significantly higher survival rates (75%) compared to L-NAME-treated rats (44%) and lactated Ringer's solution-treated rats (40%), 72 h following hemorrhagic shock. A marked increase in the neurological performance was observed in rats over the three-day period. Histological examinations also showed a reduction of degenerating neurons in rats when compared to L-NAME, lactated Ringer's solution- or un-treated rats. Mean arterial blood pressure (MABP), nitrate/nitrite level, glutamic oxalacetic transaminase (GOT) level, and blood gases were also significantly improved in L-canavanine-treated rats when compared to those of L-NAME-, lactated Ringer's solution- or un-treated rats. In conclusion. rats were able to improve survivability, attenuate organ damage, and improve neurological outcome when compared to other treatment groups. It is therefore suggest that L-canavanine may be beneficial as a potentially useful therapeutic agent in treating neurological deficit as a result of hemorrhagic shock. (C) 2003 Elsevier Science Ltd. All rights reserved.	NUS, Def Sci & Technol Agcy, Med Res Inst Chem Def, Singapore 117579, Singapore; Natl Univ Singapore, Dept Pharmacol, Singapore 117579, Singapore	Lu, J (corresponding author), NUS, Def Sci & Technol Agcy, Med Res Inst Chem Def, 18 Med Dr,01-06,MD2, Singapore 117579, Singapore.			MOOCHHALA, SHABBIR/0000-0003-4521-3192			Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; Cash D, 2001, BRAIN RES, V905, P91, DOI 10.1016/S0006-8993(01)02508-2; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; DALKARA T, 1994, BRAIN PATHOL, V4, P49; DAWSON TM, 1994, J NEUROSCI, V14, P5147; Harbrecht BG, 1997, SHOCK, V8, P415, DOI 10.1097/00024382-199712000-00004; Hua TC, 1999, SHOCK, V11, P51, DOI 10.1097/00024382-199901000-00008; Iadecola C, 1995, AM J PHYSIOL, V268, P286; JANIGRO D, 1994, CIRC RES, V75, P528, DOI 10.1161/01.RES.75.3.528; Kawase M, 1996, BRAIN RES, V738, P319, DOI 10.1016/S0006-8993(96)00924-9; Kilbourn RG, 1997, SHOCK, V7, P235, DOI 10.1097/00024382-199704000-00001; Kline JA, 1999, SHOCK, V12, P454, DOI 10.1097/00024382-199912000-00007; KOBARI M, 1994, BRAIN RES, V667, P255, DOI 10.1016/0006-8993(94)91503-2; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Liaudet L, 1996, CLIN SCI, V90, P369, DOI 10.1042/cs0900369; MONEADA S, 1991, PHARMACOL REV, V43, P109; ROBERT GK, 1997, SHOCK, V4, P235; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SULLIVAN SJ, 1994, BRAIN INJURY, V8, P613, DOI 10.3109/02699059409151014; SZABO C, 1994, SHOCK, V2, P145, DOI 10.1097/00024382-199408000-00011; Szabo C, 1995, New Horiz, V3, P2; UMANS JG, 1992, EUR J PHARMACOL, V210, P343, DOI 10.1016/0014-2999(92)90425-4; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; Zingarelli B, 1997, EUR J PHARMACOL, V338, P55, DOI 10.1016/S0014-2999(97)01325-3	26	11	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908			NEUROPHARMACOLOGY	Neuropharmacology	FEB	2003	44	2					244	252		10.1016/S0028-3908(02)00368-4			9	Neurosciences; Pharmacology & Pharmacy	Neurosciences & Neurology; Pharmacology & Pharmacy	647DL	WOS:000181077100011	12623223				2021-06-18	
J	Kowianski, P; Karwacki, Z; Dziewiatkowski, J; Domaradzka-Pytel, B; Ludkiewicz, B; Wojcik, S; Litwinowicz, B; Narkiewicz, O; Morys, J				Kowianski, P; Karwacki, Z; Dziewiatkowski, J; Domaradzka-Pytel, B; Ludkiewicz, B; Wojcik, S; Litwinowicz, B; Narkiewicz, O; Morys, J			Evolution of microglial and astroglial response during experimental intracerebral haemorrhage in the rat	FOLIA NEUROPATHOLOGICA			English	Article						astrocytes; inflammation; intracerebral haemorrhage; microglia	TUMOR-NECROSIS-FACTOR; CEREBRAL-ARTERY OCCLUSION; EDEMA FORMATION; BRAIN EDEMA; TNF-ALPHA; GLOBAL-ISCHEMIA; BLOOD-FLOW; CELL-DEATH; IN-VITRO; EXPRESSION	Intracerebral haemorrhage is a strong stimulus for both microglial and astroglial activations. There are some important pathophysiological features during haemorrhage that do not occur in ischaemic or traumatic brain injuries, and may influence the dynamics and intensity of glial activation. Studies on the evolution of glial reaction may have practical importance to the introduction of new therapeutic methods for influencing the inflammatory reaction during haemorrhage. Microglial and astroglial responses to experimental intracerebral haematoma were studied in 50 adult rats for 5 minutes after injection of 100 mul autologous arterial blood into the striatum. The survival period varied from 1 to 21 days. Microglial-macrophage lineage cells were immunocytochemically stained with antibodies OX42, OX6 and ED1. The astrocytic population was studied by means of anti-GFAP staining. Changes in cellular morphology and intensity of staining were time-dependent reactions in both microglial and astroglial cells. Strong activation of microglial-macrophage lineage cells revealed with OX6-and OX42-immunoreactivity started during the first postoperative day. The complete pattern of activation for ED1-immunoreactivity was observed from the third postoperative day. At this stage, numerous phagocytic macrophages started to appear in the perihaematoma region. Morphological changes were most intensive during the second postoperative week. The astroglial (anti-GFAP) reaction was observed after the third postoperative day and proceeded less dynamically. The glial reaction gradually stopped but not completely during the period of observation. The early occurrence of glial activation, pattern of morphological changes and characteristic sequence of antigens expression indicate a very intense type of glial reaction. Evolution of glial response to haemorrhage reveals characteristic features. In our opinion, the initial phase of glial activation, comprising 72 hours after the occurrence of haemorrhage, is potentially the most promising period for influencing the extent of glial reaction with therapeutic agents.	Med Acad Gdansk, Dept Anat & Neurobiol, PL-80211 Gdansk, Poland; Med Univ Gdansk, Dept Anaesthesiol & Intens Therapy, Gdansk, Poland	Kowianski, P (corresponding author), Med Acad Gdansk, Dept Anat & Neurobiol, Ul Debiniki 1, PL-80211 Gdansk, Poland.		Wojcik, Slawomir/U-5266-2018; Kowianski, Przemyslaw/W-9953-2018; Janusz Morys, Professor//ABF-9423-2020	Wojcik, Slawomir/0000-0002-9635-2005; Kowianski, Przemyslaw/0000-0001-6257-5780; Janusz Morys, Professor//0000-0002-4048-1721; Ludkiewicz, Beata/0000-0001-7065-6126; Morys, Janusz/0000-0001-5037-4607			Abraham H, 2000, BRAIN RES, V862, P63, DOI 10.1016/S0006-8993(00)02072-2; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Brown RD, 1996, STROKE, V27, P373; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GEHRMANN J, 1992, ACTA NEUROPATHOL, V84, P588; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Hua Y, 2000, J NEUROSURG, V92, P1016, DOI 10.3171/jns.2000.92.6.1016; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Kaplanski G, 1997, J IMMUNOL, V158, P5435; Kaufman HH, 1996, NEUROSURGERY, V2, P2567; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Lambertsen KL, 2002, J CEREBR BLOOD F MET, V22, P785, DOI 10.1097/00004647-200207000-00004; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Mabuchi T, 2000, STROKE, V31, P1735, DOI 10.1161/01.STR.31.7.1735; Masada T, 2001, J NEUROSURG, V95, P680, DOI 10.3171/jns.2001.95.4.0680; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Orzylowska O, 1999, NEUROSCI LETT, V263, P72, DOI 10.1016/S0304-3940(99)00043-9; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Qureshi AI, 2001, NEUROSURGERY, V49, P416, DOI 10.1097/00006123-200108000-00027; Qureshi AI, 2001, CRIT CARE MED, V29, P152, DOI 10.1097/00003246-200101000-00030; Saito K, 1996, NEUROSCI LETT, V206, P149, DOI 10.1016/S0304-3940(96)12460-5; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; WAGA S, 1983, STROKE, V14, P480, DOI 10.1161/01.STR.14.4.480; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xi GH, 2001, STROKE, V32, P162, DOI 10.1161/01.STR.32.1.162; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2	38	11	20	0	4	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1641-4640			FOLIA NEUROPATHOL	Folia Neuropathol.		2003	41	3					123	130					8	Neurosciences; Pathology	Neurosciences & Neurology; Pathology	732HR	WOS:000185935200001	14604292				2021-06-18	
J	Krieger, D; Hansen, K; McDermott, C; Matthews, R; Mitchell, R; Bollegala, N; Bhalerao, S				Krieger, D; Hansen, K; McDermott, C; Matthews, R; Mitchell, R; Bollegala, N; Bhalerao, S			Loxapine versus olanzapine in the treatment of delirium following traumatic brain injury	NEUROREHABILITATION			English	Article						delirium; brain injury; neuroleptic; loxapine; olanzapine	D-2 RECEPTOR OCCUPANCY; SCHIZOPHRENIA; 5-HT2	The use of typical neuroleptics has always been the mainstay of treatment for delirium following traumatic brain injury (TBI). Given the recent application of atypical neuroleptics to various psychiatric conditions formerly treated with typical neuroleptics, one questions whether this new class of drugs is superior to its predecessor in treating delirium post-TBI. We present a case of one patient with TBI-induced delirium where in fact the use of the typical mid-potency neuroleptic, loxapine, appeared to have a better clinical effect over the atypical neuroleptic, olanzapine.	St Michaels Hosp, Med Psychiat Serv, Toronto, ON M5B 1W8, Canada; Univ Alberta, Sch Med, Edmonton, AB, Canada; Univ Toronto, Sch Med, Toronto, ON, Canada	Bhalerao, S (corresponding author), St Michaels Hosp, Med Psychiat Serv, 30 Bond St,17-046 Victoria Wing, Toronto, ON M5B 1W8, Canada.			McDermott, Colleen/0000-0002-9588-6574			[Anonymous], 1994, DIAGN CRIT DSM 4; FENTON M, 2000, COCHRANE LIB, P3; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pB239, DOI 10.1093/gerona/54.6.B239; Kapur S, 1999, AM J PSYCHIAT, V156, P286; Kapur S, 1997, AM J PSYCHIAT, V154, P1525, DOI 10.1176/ajp.154.11.1525; Kapur S, 1998, AM J PSYCHIAT, V155, P921, DOI 10.1176/ajp.155.7.921; Leshner AI, 1999, AM J PSYCHIAT, V156, P1; O'Keeffe ST, 1999, AGE AGEING, V28, P115, DOI 10.1093/ageing/28.2.115; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RUMMANS TA, 1995, MAYO CLIN PROC, V70, P989, DOI 10.4065/70.10.989; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1992, NEUROPSYCHIATRIC ASP; Silver JM., 1994, NEUROPSYCHIATRY TRAU	13	11	12	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2003	18	3					205	208					4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	733ZZ	WOS:000186031900004	14530585				2021-06-18	
J	Labi, MLC; Brentjens, M; Coad, ML; Flynn, WJ; Zielezny, M				Labi, MLC; Brentjens, M; Coad, ML; Flynn, WJ; Zielezny, M			Development of a longitudinal study of complications and functional outcomes after traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; SECONDARY INSULTS; REHABILITATION; PREVENTION; HYPOTENSION; DEPRESSION; ADULTS; DAMAGE; ABUSE; TBI	Primary objective: To create a longitudinal database of patients with moderate and severe traumatic brain injury. Research design: A prospective study design was used to collect data pertaining to demographics, acute and post-acute management, complications, resource utilization and functional outcomes. Methods and procedures: Data were collected on 233 patients with a Glasgow Coma Score of 12 or less, admitted to a Level 1 Trauma Centre within 24 hours of injury and continued through post-hospitalization follow-up. Main outcomes and results: The mean age was 37.7 years, 70% were males, 54% were motor vehicle related accidents, and 21% died. Of the 185 survivors, 23% were discharged directly home from acute hospital care and 74% required inpatient rehabilitation. At hospital discharge, 76% had Rancho Los Amigos Scores of VII or higher; 81% had no or only mild verbal communication deficits and 79% were able to ambulate. Conclusions: The study indicates that while it is difficult to predict functional outcomes for individual survivors of TBI in the early stages of acute care, they are often better than suspected at the time of injury.	SUNY Buffalo, Sch Biol & Med Sci, Buffalo, NY 14260 USA	Labi, MLC (corresponding author), Geisinger Med Ctr, 2 Rehab Lane, Danville, PA 17821 USA.	labi@acsu.buffalo.edu		Coad, Mary Lou/0000-0002-5791-9240	ODCDC CDC HHS [R04/CCR208541] Funding Source: Medline		Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Davis CH, 1997, AM J PHYS MED REHAB, V76, P213, DOI 10.1097/00002060-199705000-00011; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; EISENBERG HM, 1987, HEAD INJURY, P20; Eker C, 2000, BRAIN INJURY, V14, P605; ELOVIC E, 1996, MED REHABILITATION T, P1; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HAGAN C, 1979, REHABILITATION HEAD; Hall KM, 1997, ARCH PHYS MED REHAB, V78, pS5, DOI 10.1016/S0003-9993(97)90149-0; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON MV, 1994, AM J PHYS MED REHAB, V73, P296, DOI 10.1097/00002060-199407000-00014; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kraus Jess F., 1994, P3; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazaux JM, 2001, J REHABIL MED, V33, P99; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MERLI GJ, 1993, ARCH PHYS MED REHAB, V74, P1199; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; *NHIF PROF COUNC S, 1988, WHIT PAP; NIKAS D L, 1987, Critical Care Nursing Quarterly, V10, P19; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIESENBERG D, 1989, JAMA-J AM MED ASSOC, V262, P943, DOI 10.1001/jama.262.7.943; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; THOMSEN IV, 1996, INT TBI C NIAG ON TH; WATANABE TK, 2001, PHYS MED REHABILITAT, V15, P283; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533	68	11	11	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	4					265	278		10.1080/0269905021000038410			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	660MP	WOS:000181837200001	12637180				2021-06-18	
J	Love, JM; Greve, KW; Sherwin, E; Mathias, C				Love, JM; Greve, KW; Sherwin, E; Mathias, C			Comparability of the standard WCST and WCST-64 in traumatic brain injury	APPLIED NEUROPSYCHOLOGY			English	Article						Wisconsin Card Sort-64 (Short Form); Wisconsin Card Sort (Standard form); traumatic brain injury	CARD-SORTING-TEST; TEST-PERFORMANCE; SHORT-FORM; SAMPLE	The aim of this study was to investigate the comparability of the Wisconsin Card Sorting Test short form (WCST-64) to the standard form in a clinical population with documented brain pathology: chronic severe traumatic brain injury (TBI). Participants were 61 patients at least I year after severe TBI living at a large residential rehabilitation facility. The WCST was administered in standard fashion with both the standard and 64-card versions scored. All derived scores with norms were examined. Results indicated that the WCST-64 scores were comparable to the standard version, and assigned impairment levels remained relatively stable. These results suggest the WCST-64 is a valid alternative to the standard version in chronic severe TBI.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Georgia So Univ, Dept Psychol, Statesboro, GA 30460 USA	Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu		Mathias, Charles/0000-0003-1902-673X			*AM PSYCH ASS, 1992, AM PSYCHOL, V47, P1597, DOI DOI 10.1037/0003-066X.47.12.1597; Axelrod B, 1992, CLIN NEUROPSYCHOL, P27; Axelrod BN, 1997, ASSESSMENT, V4, P41, DOI 10.1177/107319119700400105; AXELROD BN, 1993, CLIN NEUROPSYCHOL, V7, P205, DOI 10.1080/13854049308401523; BONDI MW, 1993, NEUROPSYCHOLOGY, V7, P205; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; GREVE KW, 1991, GERONTOLOGY GERIATRI, V11, P57, DOI DOI 10.1300/J021v11n04_05; HAALAND KY, 1987, J GERONTOL, V42, P345, DOI 10.1093/geronj/42.3.345; HART R. P., 1988, CLIN NEUROPSYCHOL, V2, P49, DOI DOI 10.1080/13854048808520085; Heaton R., 1981, MANUAL WISCONSIN CAR; Heaton RK., 1999, WISCONSIN CARD SORTI; HEATON RK, 2000, WCST 64 COMPUTER VER; HEATON SK, 1992, J CLIN EXPT NEUROPSY, V14, P63; Heaton SK, 1993, WISCONSIN CARD SORTI; Jenkins R. L., 1978, ALCOHOL TECHNICAL RE, V7, P76; KIRK RE, 1999, STAT INTRO; Kongs SK, 2000, WISCONSIN CARD SORTI; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Osmon DC, 1996, ARCH CLIN NEUROPSYCH, V11, P541, DOI 10.1016/0887-6177(95)00048-8; Paolo AM, 1996, J CLIN EXP NEUROPSYC, V18, P892, DOI 10.1080/01688639608408310; Purdon SE, 2001, J PSYCHIATR NEUROSCI, V26, P253; Ramage A, 1999, BRAIN LANG, V66, P329, DOI 10.1006/brln.1999.2032; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; SILLANPAA MC, 1993, J CLIN EXP NEUROPSYC, V15, P68; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7	30	11	11	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2003	10	4					246	251		10.1207/s15324826an1004_7			6	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	780NT	WOS:000189388100007	14690806				2021-06-18	
J	Chute, DL				Chute, DL			Neuropsychological technologies in rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						amyotrophic lateral sclerosis; assistive technology; cognitive prosthetics; cognitive rehabilitation; computerized assessment; functional brain imaging; neuropsychology; traumatic brain injury	PSYCHOLOGY; MACINTOSH	Objective: To provide an introduction and a conceptual context for the articles presented in this special edition of the Journal of Head Trauma Rehabilitation on neuropsychological technologies. Summary: Many clinical assessments in neuropsychology are metamorphosing from a psychometric search for a lesion to a functional image of the working brain. Behavioral probes increasingly employ technology to provide more ecologically valid stimuli to elicit diagnostically relevant responses. Intervention strategies include an expanding range of assistive devices and technologically based treatments. The advent of the microprocessor and discipline specific programming have allowed certain aspects of rehabilitation practice to incorporate these new assessment and intervention strategies. For example, the development of neuropsychological technologies has already lead to computer based prosthetics and orthotics, cognitive probes with millisecond accurate links to functional imaging, virtual reality managed ecological assessments, cognitive retraining, assistive devices, and online, and "real-time" database-driven evaluations. Emerging technologies offer the potential for personal, portable, everyday brain imaging and rehabilitation systems. Few psychologists, physiatrists, or allied health professionals are formally trained in technological development. What has emerged thus far is a collection of individual efforts that remain to be integrated into more comprehensive tools for the rehabilitation professions. The selective history of neuropsychological technologies presented here is meant to illustrate past difficulties in the emergence of this sub-specialty and point to new applications and technological integration that may prove fruitful. The convergence of neuroengineering, adaptive assessments, everyday neuroimaging, neuroinformatics, and educational neuroimaging, presage such future developments in neuropsychological technologies.	Drexel Univ, Philadelphia, PA 19104 USA; Med Coll Penn & Hahnemann Univ, Dept Psychol, Philadelphia, PA USA	Chute, DL (corresponding author), Drexel Univ, 3141 Chestnut St, Philadelphia, PA 19104 USA.						BANK B, 1986, BRAIN RES, P390; CHANCE B, 1995, THERAP RES, V16, P107; Chute D. L., 1992, Proceedings of the Johns Hopkins National Search for Computing Applications to Assist Persons with Disabilities (Cat. No.92TH0429-1), P124, DOI 10.1109/CAAPWD.1992.217426; Chute D. L., 1987, ACAD COMP, V2, P40; CHUTE DL, 1993, BEHAV RES METH INSTR, V25, P180, DOI 10.3758/BF03204492; Chute DL, 1996, BEHAV RES METH INSTR, V28, P311, DOI 10.3758/BF03204788; CHUTE DL, 1986, BEHAV RES METH INSTR, V18, P205, DOI 10.3758/BF03201023; CHUTE DL, 1987, BEHAV RES METH INSTR, V19, P2005; CHUTE DL, 2001, INT C TECHN AG; CHUTE DL, 1998, ACTIVITIES HDB TEACH, V4; CHUTE DL, 1995, EXPLORING PSYCHOL DI; Chute DL, 1988, NEUROPSYCHOLOGY, V2, P41, DOI 10.1037//0894-4105.2.1.41; Crook TH, 1988, NEUROPSYCHOLOGY, V2, P1, DOI 10.1037//0894-4105.2.1.1; DANIEL RS, 1972, STUDENTS MANUAL GEN; GUR RC, 1992, ARCH GEN PSYCHIAT, V49, P409; KOFFLER SP, 2001, SLIP TEST NEUROPSYCH; KUTZIK D, 1997, Patent No. 5692215; Lynch WJ, 1988, NEUROPSYCHOLOGY, V2, P111, DOI 10.1037/h0091794; MIHAILIDIS A, 2000, TECHNOLOGY DISABILIT, V13, P23, DOI DOI 10.3233/TAD-2000-13104; MUELLER J, 2000, PSYCHOL EXPT INTERNE; RUFF R, 2001, PRESIDENTIAL ADDRESS; SCHATZ P, 1998, SYLLABUS 98; SCHULTHEISS M, IN PRESS HDB DRIVING; TULSKEY D, 2002, DEV PROGR PSYCHOL IQ; WESTALL RF, 1989, BEHAV RES METH INSTR, V21, P540, DOI 10.3758/BF03202886; ZABEL TA, 2001, DISS ABSTR INT B, V61, P5045	26	11	11	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2002	17	5					369	377		10.1097/00001199-200210000-00001			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	610DD	WOS:000178944700001	12802249				2021-06-18	
J	Frontczak-Baniewicz, M; Walski, M				Frontczak-Baniewicz, M; Walski, M			Non-sprouting angiogenesis in neurohypophysis after traumatic injury of the cerebral cortex. Electron-microscopic studies	NEUROENDOCRINOLOGY LETTERS			English	Article						angiogenesis; cerebral cortex; neurohypophysis; perivascular cells	ENDOTHELIAL GROWTH-FACTOR; WOUND-HEALING ANGIOGENESIS; CELL-PROLIFERATION; NITRIC-OXIDE; FACTOR VEGF; MECHANISMS; EXPRESSION; MICROGLIA; PHENOTYPE; HYPOXIA	OBJECTIVES: Angiogenesis comprises two different mechanisms: endothelial sprouting and intussusceptive microvascular growth. The sprouting process is based on endothelial cell migration, proliferation and tube formation. Intussusceptive microvascular growth divides existing vessel lumens by formation and insertion of endothelial columns into the vessel lumen. The morphological features of microvessels of cerebral cortex and neurohypophysis were evaluated in a model of the cerebral traumatic injury. METHOD: The observations were conducted seven days after induction of cortical trauma. Traumatic injury was induced in the fronto-temporal region of cerebral cortex in general anesthesia with 20mg/kg ketamine hydrochloride. RESULTS: Seven days after traumatic brain injury in sections from cerebral cortex and neurohypophysis we can observe morphological features of angiogenesis. Endothelium of the cerebral cortex possesses high endotheliocytes tightly connected and enveloped by amorphous basement membrane-like material. Transcapillary pillars tightly connected with neighbouring endothelial cells split the newly formed vessels and branching takes place. In neurohypophysis we can observe all stages of non-sprouting angiogenesis: proliferation endothelial cells on the inside mother vessel, splitting newly formed blood vessels by transcapillary pillars directed into the vessel lumen, maturation of endothelium and network formation. CONCLUSION: The mechanical injuries directly induced angiogenesis not only in cerebral cortex, but also in neurohypophysis. Our studies show that mechanism of angiogenesis is not the same as observed previously in neurohypophysis after focal cerebral ischemia (Neuroendocrinology Letters 2001; 22: 87-92). This study indicates that mechanism of angiogenesis can depend on kind of induction.	Polish Acad Sci, Med Res Ctr, Lab Cell Ultrastruct, PL-02106 Warsaw, Poland	Frontczak-Baniewicz, M (corresponding author), Polish Acad Sci, Med Res Ctr, Lab Cell Ultrastruct, Pawinskiego St 5, PL-02106 Warsaw, Poland.	gosia@cmdik.pan.pl					ADAIR TH, 1990, AM J PHYSIOL, V259, pR393; Alexander CM, 1991, CELL BIOL EXTRACELLU, P255; BAR T, 1980, ADV ANAT EMBRYOL CEL, V59, P1, DOI DOI 10.1007/978-3-642-67432-7_1; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Carmeliet P, 2000, NATURE, V408, P43, DOI 10.1038/35040684; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cho CH, 2001, J PHYSIOLOGY-PARIS, V95, P253, DOI 10.1016/S0928-4257(01)00034-1; DAmore PA, 1996, CANCER METAST REV, V15, P205, DOI 10.1007/BF00437473; DAVIES PF, 1995, PHYSIOL REV, V75, P519; FALANGA V, 1993, J DERMATOL SURG ONC, V19, P711, DOI 10.1111/j.1524-4725.1993.tb00414.x; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Frontczak-Baniewicz M, 2001, NEUROENDOCRINOL LETT, V22, P87; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Goke M, 1998, AM J PHYSIOL-GASTR L, V274, pG809, DOI 10.1152/ajpgi.1998.274.5.G809; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Gu WG, 2001, ACTA NEUROPATHOL, V102, P216; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hossmann KA, 2001, ACTA NEUROPATHOL, V101, P101; Ichioka S, 1997, J SURG RES, V72, P29, DOI 10.1006/jsre.1997.5170; KNIGHTON DR, 1981, SURGERY, V90, P262; KNIGHTON DR, 1983, SCIENCE, V221, P1283, DOI 10.1126/science.6612342; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; NEWCOMB PM, 1993, J CELL PHYSIOL, V155, P385, DOI 10.1002/jcp.1041550220; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SCHOR AM, 1992, ANGIOGENESIS KEY PRI, P22; Skalak Thomas C., 1996, Microcirculation (Philadelphia), V3, P143, DOI 10.3109/10739689609148284; Steinbrech DS, 1999, J SURG RES, V84, P127, DOI 10.1006/jsre.1999.5627; Stockhammer G, 2000, NEUROLOGY, V54, P1670, DOI 10.1212/WNL.54.8.1670; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Walski M, 2001, NEUROENDOCRINOL LETT, V22, P19; Walski M, 1999, J BRAIN RES, V39, P455; Ware JA, 1997, NAT MED, V3, P158, DOI 10.1038/nm0297-158	40	11	14	0	2	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X	2354-4716		NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.	OCT-DEC	2002	23	5-6					396	404	PII NEL235602A02				9	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	632ZQ	WOS:000180255100006	12500160				2021-06-18	
J	Stover, JF; Sakowitz, OW; Thomale, UW; Kroppenstedt, SN; Unterberg, AW				Stover, JF; Sakowitz, OW; Thomale, UW; Kroppenstedt, SN; Unterberg, AW			Norepinephrine-induced hyperglycemia does not increase cortical lactate in brain-injured rats	INTENSIVE CARE MEDICINE			English	Article						catecholamines; blood-brain barrier; glucose; microdialysis; traumatic brain injury	CEREBROSPINAL-FLUID GLUTAMATE; TRANSIENT CEREBRAL-ISCHEMIA; NECROSIS-FACTOR-ALPHA; IMPACT INJURY; GLUCOSE-TRANSPORTER; FOREBRAIN ISCHEMIA; CONTUSION VOLUME; PREISCHEMIC HYPERGLYCEMIA; SECONDARY ISCHEMIA; ENERGY-METABOLISM	Objective: Hyperglycemia aggravates ischemic brain damage. Since catecholamines increase hepatic gluconeogenesis, resulting in hyperglycemia, we investigated whether norepinephrine and dopamine elevate arterial blood glucose, thereby increasing pericontusional cortical glucose and lactate concentrations and brain edema in brain-injured rats. Design: Prospective, randomized, controlled animal study. Subjects: Male Sprague Dawley rats. Interventions: Physiological saline solution, norepinephrine, or dopamine were infused intravenously for 90 min beginning 4.5 h after inducing a focal cortical contusion. Blood glucose, lactate, and pericontusional cortical extracellular glucose and lactate were determined before, during and up to 60 min after the infusion period. Thereafter brains were removed to assess hemispheric water content. Measurements and results: Continuous norepinephrine and dopamine infusion significantly increased pericontusional glucose concentrations, being mostly sustained by norepinephrine (NaCl: 1.3 +/- 0.2, dopamine: 2.7 +/- 0.2, norepinephrine: 4.8 +/- 1.1 mM). While arterial blood glucose was only significantly elevated in norepinephrine-treated rats from 8.6 +/- 0.6 to 12.6 +/- 1.6 mM, the extracellular to blood glucose ratio was significantly increased in dopamine- and norepinephrine-treated rats (0.28 +/- 0.01 and 0.38 +/- 0.05 vs. 0.17 +/- 0.01). Plasma and pericontusional lactate remained unchanged, and brain edema was similar in all groups. Conclusions: Norepinephrine and dopamine significantly increased pericontusional glucose concentrations which did not elevate extracellular lactate and aggravate underlying posttraumatic edema formation. In addition to possibly increased facilitated endothelial glucose transport, the elevated extracellular to blood glucose ratio suggests a passive concentration- and pressure- dependent entry via a damaged blood-brain barrier. This might contribute to the observed reversible increase in extracellular glucose.	Humboldt Univ, Dept Neurosurg, Charite, Virchow Med Ctr, Berlin, Germany	Stover, JF (corresponding author), Univ Penn, Dept Neurosurg, 105 C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.						Anderson MS, 2001, AM J PHYSIOL-REG I, V281, pR1545; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Cherian L, 1998, J NEUROTRAUM, V15, P1059, DOI 10.1089/neu.1998.15.1059; Dempsey RJ, 1996, NEUROL RES, V18, P546; DIETRICH WD, 1993, STROKE, V24, P111, DOI 10.1161/01.STR.24.1.111; Duelli R, 2000, BRAIN RES, V858, P338, DOI 10.1016/S0006-8993(00)01942-9; Duelli R, 2001, NEUROSCI LETT, V310, P101, DOI 10.1016/S0304-3940(01)02060-2; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FILIPPONI P, 1982, DIABETES METAB, V8, P313; Garcia-Barrado MJ, 1998, J AUTON PHARMACOL, V18, P287, DOI 10.1046/j.1365-2680.1998.18596.x; Gisselsson L, 1999, J CEREBR BLOOD F MET, V19, P288, DOI 10.1097/00004647-199903000-00007; Guyot LL, 2001, NEUROSURGERY, V48, P385, DOI 10.1097/00006123-200102000-00030; HIROSE H, 1992, ACTA ENDOCRINOL-COP, V127, P279, DOI 10.1530/acta.0.1270279; Huang NC, 1996, EXP BRAIN RES, V109, P33; Kawai N, 1998, ACT NEUR S, V71, P219; KECK FS, 1990, DIABETES RES CLIN PR, V8, P155, DOI 10.1016/0168-8227(90)90026-P; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LANG CH, 1994, AM J PHYSIOL, V266, pE863; Li PA, 1997, BRAIN RES, V753, P133, DOI 10.1016/S0006-8993(97)00005-X; Li PA, 1998, BRAIN RES, V782, P175, DOI 10.1016/S0006-8993(97)01150-5; Li PA, 2000, STROKE, V31, P183, DOI 10.1161/01.STR.31.1.183; Li PA, 1999, FREE RADICAL BIO MED, V27, P1033, DOI 10.1016/S0891-5849(99)00152-5; Li PA, 2001, J CEREBR BLOOD F MET, V21, P568, DOI 10.1097/00004647-200105000-00011; Lin BW, 1998, ACTA NEUROPATHOL, V96, P610, DOI 10.1007/s004010050942; Lin BW, 2000, NEUROSCI LETT, V278, P1, DOI 10.1016/S0304-3940(99)00889-7; Park WS, 2001, BRAIN RES, V901, P102, DOI 10.1016/S0006-8993(01)02295-8; Pellerin L, 1997, GLIA, V21, P74, DOI 10.1002/(SICI)1098-1136(199709)21:1<74::AID-GLIA8>3.0.CO;2-1; PRADO R, 1988, J CEREBR BLOOD F MET, V8, P186, DOI 10.1038/jcbfm.1988.48; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043; Salvi S, 2001, CHEST, V119, P1242, DOI 10.1378/chest.119.4.1242; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; Shimizu Y, 1998, BIOCHEM J, V330, P397, DOI 10.1042/bj3300397; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Stroop R, 1998, ACT NEUR S, V71, P303; Tirone TA, 2001, WORLD J SURG, V25, P461, DOI 10.1007/s002680020338; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; Wei JN, 1997, FREE RADICAL BIO MED, V23, P986, DOI 10.1016/S0891-5849(97)00127-5; YIP PK, 1991, NEUROLOGY, V41, P899, DOI 10.1212/WNL.41.6.899	54	11	11	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	OCT	2002	28	10					1491	1497		10.1007/s00134-002-1431-2			7	Critical Care Medicine	General & Internal Medicine	641PG	WOS:000180753500019	12373476				2021-06-18	
J	Weitzenkamp, DA; Whiteneck, GG; Lammertse, DP				Weitzenkamp, DA; Whiteneck, GG; Lammertse, DP			Predictors of personal care assistance for people with spinal cord injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						activities of daily living; personal health services; rehabilitation; spinal cord injuries	FUNCTIONAL INDEPENDENCE MEASURE; REHABILITATION OUTCOMES; MEDICAL REHABILITATION; DISABILITY MEASURES; ASSESSMENT SCALES; TRAUMATIC BRAIN; HEALTH; VALIDITY; HANDICAP; COSTS	Objective: To assess the predictors of personal care assistance (PCA) use in people with spinal cord injury (SCI). Design: Cross-sectional. Setting: Follow-up of individuals crossing their 1st, 5th, 10th, 15th, 20th, or 25th anniversary of injury who underwent their initial rehabilitation at a Spinal Cord Injury Model Systems center. Participants: A total of 2154 participants (2547 records) who met the inclusion criteria for the National Spinal Cord Injury Database and had valid values for the main outcome measures. Interventions: Not applicable. Main Outcome Measures: Daily hours of paid, unpaid, and occasional PCA services. Results: Differences in an interval version of the motor portion of the FIM(TM) instrument accounted for 26.3% of the variance in total PCA hours, Model Systems differences accounted for 9.3%, and no other predictor accounted for more than 2.1% of the variance. Conclusion: Activities of daily living functioning, as measured by the motor portion of the FIM, was the strongest predictor of PCA use among people with SCI.	Craig Hosp, Res Dept, Englewood, CO 80110 USA	Weitzenkamp, DA (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80110 USA.	davidaw@craighospital.org		Lammertse, Daniel/0000-0003-4590-2481			BERKOWITZ M, 1998, SPINAL CORD INJURY A, P87; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BURNS TJ, 1990, ARCH PHYS MED REHAB, V71, P138; Coll JR, 1998, SPINAL CORD, V36, P275, DOI 10.1038/sj.sc.3100497; Cook RD, 2001, TECHNOMETRICS, V43, P443, DOI 10.1198/00401700152672537; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DEJONG G, 1991, PARAPLEGIA, V29, P373, DOI 10.1038/sc.1991.53; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; FUHRER MJ, 1987, ARCH PHYS MED REHAB, V68, P353; GERHART KA, 1993, ARCH PHYS MED REHAB, V74, P1030, DOI 10.1016/0003-9993(93)90057-H; Go Bette K., 1995, P21; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Graves DE, 1999, ARCH PHYS MED REHAB, V80, P1464, DOI 10.1016/S0003-9993(99)90259-9; GRAVES DE, 1997, J SPINAL CORD MED, V20, P142; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; Hamilton BB, 1999, ARCH PHYS MED REHAB, V80, P385, DOI 10.1016/S0003-9993(99)90274-5; HARVEY C, 1992, PARAPLEGIA, V30, P834, DOI 10.1038/sc.1992.160; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Heinemann AW, 1994, TOP STROKE REHABIL, V1, P1; Hoenig H, 1999, SPINE, V24, P539, DOI 10.1097/00007632-199903150-00007; Holicky R, 1996, Rehabil Nurs, V21, P247; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MattsonPrince J, 1997, SPINAL CORD, V35, P326, DOI 10.1038/sj.sc.3100453; NOSEK MA, 1993, ARCH PHYS MED REHAB, V74, P127; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Shackelford M, 1998, SPINAL CORD, V36, P337, DOI 10.1038/sj.sc.3100510; *STAT U NEW YORK, 1997, GUID UN DAT SET MED; Stover SL, 1999, ARCH PHYS MED REHAB, V80, P1365, DOI 10.1016/S0003-9993(99)90246-0; TATE D, 1994, AM J PHYS MED REHAB, V73, P175, DOI 10.1097/00002060-199406000-00006; TATE DG, 1994, ARCH PHYS MED REHAB, V75, P407, DOI 10.1016/0003-9993(94)90164-3; Whiteneck G, 1999, ARCH PHYS MED REHAB, V80, P1485, DOI 10.1016/S0003-9993(99)90262-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLAN AR, 1978, TECHNOMETRICS, V20, P407, DOI 10.2307/1267640; World Health Organization, 2001, INT CLASS FUNCT DIS; YOUNG MA, 1993, J SPEECH HEAR RES, V36, P644, DOI 10.1044/jshr.3604.644	40	11	11	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2002	83	10					1399	1405		10.1053/apmr.2002.35087			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	600NT	WOS:000178397800013	12370876				2021-06-18	
J	Pointinger, H; Sarahrudi, K; Poeschl, G; Munk, P				Pointinger, H; Sarahrudi, K; Poeschl, G; Munk, P			Electroencephalography in primary diagnosis of mild head trauma	BRAIN INJURY			English	Article							INJURY; EEG	Objective: The aim of this study was to compare the clinical examination and EEG examination regarding their relevance in diagnosing cerebral function changes in early head trauma. Methods: Ninety four male patients who suffered from mild head trauma (GCS 13-15) were assigned into two groups. The first group fulfilled at least one sign of cerebral concussion (amnesia, anisocoria, changes of vigilance or vegetative symptoms such as vomiting), the second group did not. EEG examination was performed in both groups. Results: In the first group, more pathologic EEG records were found. These findings showed a statistical significance (p=0.019). The concussion group showed more focal changes (p=0.283) and specific changes (p=0.317), but they were statistically not significant. Conclusion: EEG can be used for detecting pathologic unspecific alterations with a high accuracy, but is not useful in specifing the findings for an exact diagnosis.	Mil Hosp Vienna, Dept Surg, Vienna, Austria; Mil Hosp Vienna, Dept Anaesthesia & Crit Care Med, Vienna, Austria	Pointinger, H (corresponding author), Maurer Lange Gasse 101, A-1238 Vienna, Austria.						Airoldi L, 1999, J CLIN NEUROPHYSIOL, V16, P456, DOI 10.1097/00004691-199909000-00007; Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; BERNAD PG, 1991, CLIN ELECTROENCEPHAL, V22, P203, DOI 10.1177/155005949102200408; Cheung DS, 1999, EMERG MED CLIN N AM, V17, P9, DOI 10.1016/S0733-8627(05)70044-4; DICHGANS J, 1978, FORTSCHRITTE NEUROLO, V47, P144; DUFFNER F, 1995, ZBL CHIR, V120, P536; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; GROTE EH, 1993, UNFALLCHIRURG, V96, P609; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Kelsch G, 1996, UNFALLCHIRURG, V99, P202; KRUGER J, 1991, NERVENARZT, V62, P226; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; LORENZONI E, 1975, FORTSCHR NEUROL PSYC, V43, P155; LORENZONI E, 1976, J NEUROL, V211, P275, DOI 10.1007/BF00313237; Pfenninger E, 1994, Klin Anasthesiol Intensivther, V46, P229; ROGOZEA R, 1980, ARCH PSYCHIAT NERVEN, V229, P75, DOI 10.1007/BF00343804; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Wocjan J, 1972, Hefte Unfallheilkd, V111, P170	22	11	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					799	805		10.1080/02699050210131911			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800005	12217205				2021-06-18	
J	Rintala, DH; Novy, DM; Garza, HM; Young, ME; High, WM; Chiou-Tan, FY				Rintala, DH; Novy, DM; Garza, HM; Young, ME; High, WM; Chiou-Tan, FY			Psychometric properties of a Spanish-language version of the Community Integration Questionnaire (CIQ)	REHABILITATION PSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; TERM REHABILITATION OUTCOMES; SPINAL-CORD INJURY; QUALITY-OF-LIFE; HEALTH-CARE; DISABILITY; AGREEMENT; HANDICAP; VALIDITY; PAIN	Objective: To develop and test the Psychometric properties of a Spanish version of the Community Integration Questionnaire (CIQ; Willer et al., 1993). Study Design: Descriptive data, comparison of Spanish and English versions, and test-retest comparisons of the Spanish version. Setting: Community in southeastern Texas. Participants: Individuals with spinal cord injury (SCI) or traumatic brain injury (TBI) who speak and read Spanish. Main Measures: CIQ and Craig Handicap Assessment and Reporting Technique. Results: Total score correlations: Spanish-English = .83; test-retest = .85. The internal consistency was .70. The Social Integration subscale was the most problematic. Conclusions: The total score and the Home Integration subscale of the Spanish CIQ have adequate psychometric properties for group research, but further refinement is recommended.	Vet Affairs Ctr Excellence Healthy Aging Disabil, Houston, TX USA; Baylor Coll Med, Houston, TX 77030 USA; Inst Rehabil & Res, Houston, TX USA; Univ Texas, Med Sch, Houston, TX USA; Univ Florida, Gainesville, FL 32611 USA; Harris County Hosp Dist, Houston, TX USA	Rintala, DH (corresponding author), Vet Affairs Ctr Excellence Healthy Aging Disabil, Houston, TX USA.						ABELLOBANFI M, 1994, J RHEUMATOL, V21, P1250; ANUAGA JC, 1991, HISPANIC J BEHAV SCI, V13, P63; Bates MS, 1997, SOC SCI MED, V45, P1433, DOI 10.1016/S0277-9536(97)00068-3; BERKANOVIC E, 1985, SOC SCI MED, V20, P567, DOI 10.1016/0277-9536(85)90395-8; Chapman D. W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI DOI 10.3102/01623737001003071; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; DEJONG G, 1987, REHABILITATION OUTCO, P261; Devivo Michael J., 1995, P289; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; EISENBERG MG, 1991, PARAPLEGIA, V29, P514, DOI 10.1038/sc.1991.74; EZZATI TM, 1995, STAT MED, V14, P571, DOI 10.1002/sim.4780140515; FERKETICH S, 1993, RES NURS HEALTH, V16, P227, DOI 10.1002/nur.4770160310; FUHRER MJ, 1992, ARCH PHYS MED REHAB, V73, P552; FUHRER MJ, 1995, AM J PHYS MED REHAB, V74, P243, DOI 10.1097/00002060-199505000-00013; FUHRER MJ, 1987, REHABILITATION OUTCO, P1; FURINO A, 1991, JAMA-J AM MED ASSOC, V265, P255; GRANGER CV, 1976, ARCH PHYS MED REHAB, V57, P103; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HU DJ, 1986, WESTERN J MED, V144, P490; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; KUSTER AE, 1993, NURS RES, V42, P266; LAMMERTSE DP, 1991, ARCH PHYS MED REHAB, V72, pS309; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEAVITT F, 1994, SPINE, V19, P1048, DOI 10.1097/00007632-199405000-00009; NOSEK MA, 1987, REHABILITATION OUTCO, P71; NOVY DM, 1998, AM TRANSLATOR ASS CH, V27, P25; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; Richardson LD, 1999, MT SINAI J MED, V66, P267; ROBERTS RE, 1989, J NERV MENT DIS, V177, P581, DOI 10.1097/00005053-198910000-00001; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; TRIESCHMANN RB, 1978, PARAPLEGIA, V16, P212, DOI 10.1038/sc.1978.37; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WILLER B, 1993, J HEAD TRAUMA REHAB, V72, P372; World Health Organization, 1980, INT CLASS IMP DIS HA	37	11	11	0	0	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2002	47	2					144	164		10.1037//0090-5550.47.2.144			21	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	550WD	WOS:000175526500002					2021-06-18	
J	Savage, R; Combs, DR; Pinkston, JB; Advokat, C; Gouvier, WD				Savage, R; Combs, DR; Pinkston, JB; Advokat, C; Gouvier, WD			The role of temporal lobe and orbitofrontal cortices in olfactory memory function	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						olfaction; olfactory identification; cerebrovascular accident (CVA); traumatic brain injury (TBI)	DEFICITS; DISEASE; DISCRIMINATION	Differences in verbal and nonverbal olfactory identification and recognition were examined among three groups with brain impairment. A left cerebrovascular accident (LCVA) group, a right CVA (RCVA) group, and a traumatic brain injury (TBI) group were compared with two nonimpaired age-matched comparison groups on olfaction identification and recognition abilities. Odors were presented to the left and right nostrils, which maximized hemispheric differences in olfactory processing. Results showed that persons with LCVA demonstrated the greatest impairment on the verbal identification of odors, while persons with RCVA showed the most impairment on the nonverbal identification of odors. Persons with TBI showed an inconsistent impairment across both verbal and nonverbal odor identification tasks. Odor recognition was impaired in both CVA groups as well. In contrast, persons with TBI performed better on the delayed odor recognition tasks. Results are discussed in relation to hemispheric differences in processing olfactory information. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; Univ Alabama, Birmingham, AL 35294 USA	Gouvier, WD (corresponding author), Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70803 USA.						ANDERSEN R, 1978, NEUROPSYCHOLOGIA, V16, P439, DOI 10.1016/0028-3932(78)90067-2; CERMACK L, 1982, HUMAN MEMORY AMNESIA; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1992, J HEAD TRAUMA REHAB, V7, P42; Eichenbaum H, 1998, ANN NY ACAD SCI, V855, P657, DOI 10.1111/j.1749-6632.1998.tb10642.x; GELLERMAN LW, 1933, J GENET PSYCHOL, V4, P207; GORDON HW, 1969, NEUROPSYCHOLOGIA, V7, P111, DOI 10.1016/0028-3932(69)90009-8; GUYTON AC, 1987, BASIC NEUROSCIENCE A, P325; Iversen S D, 1976, Int Rev Neurobiol, V19, P1, DOI 10.1016/S0074-7742(08)60700-X; JONES BP, 1975, NEUROPSYCHOLOGIA, V13, P173, DOI 10.1016/0028-3932(75)90026-3; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; KIRK RE, 1982, EXPT DESIGN, P101; KOLB B, 1985, FUNDAMENTALS HUMAN N, P475; KOPALA L, 1990, SCHIZOPHRENIA BULL, V16, P255, DOI 10.1093/schbul/16.2.255; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MISHKIN M, 1987, SCI AM, V256, P80, DOI 10.1038/scientificamerican0687-80; MONTEMURRO DG, 1988, HUMAN BRAIN DISSECTI, P62; Nordin S, 1998, ANN NY ACAD SCI, V855, P686, DOI 10.1111/j.1749-6632.1998.tb10646.x; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; RAUSCH R, 1977, CORTEX, V13, P445, DOI 10.1016/S0010-9452(77)80024-5; REZEK DL, 1987, ARCH NEUROL-CHICAGO, V44, P1030, DOI 10.1001/archneur.1987.00520220036012; SMITH PDC, 1992, PHLEBOLOGY, V7, P1; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P51; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; ZATORRE RJ, 1990, PERCEPT PSYCHOPHYS, V47, P526, DOI 10.3758/BF03203105	26	11	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2002	17	4					305	318	PII S0887-6177(01)00114-7	10.1016/S0887-6177(01)00114-7			14	Psychology, Clinical; Psychology	Psychology	556DW	WOS:000175834900001	14589716				2021-06-18	
J	Orihara, Y; Nakasono, I				Orihara, Y; Nakasono, I			Induction of apolipoprotein E after traumatic brain injury in forensic autopsy cases	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						apolipoprotein E; traumatic brain injury; immunohistochemistry; astrocyte; neuron	E EPSILON 4; ALZHEIMERS-DISEASE; E IMMUNOREACTIVITY; NEURONS; HIPPOCAMPUS; HEMORRHAGE; ISCHEMIA; GENOTYPE; APOE	We investigated the dynamics of the induction of apolipoprotein E (apoE) in the human brain after death caused by traumatic brain injury (TBI). A striking difference in apoE immunoreactivity in the traumatised cortical hemisphere compared with the contralateral non-traumatised hemisphere was observed. ApoE was detected within the neurons of the traumatised cortical hemisphere in cases surviving only about 2 h, as well as in those surviving for extended periods. In contrast, no apoE staining within the neurons was seen in the contralateral cortical hemisphere. ApoE staining within astrocytes was faint in both traumatised and contralateral hemispheres of cases surviving only 2 h. However, staining was intense in the traumatised hemispheres in short as well as long surviving cases, even those surviving more than 1 month. ApoE immunoreactivity was also observed in areas adjacent to capillaries and surrounding the neuropil of the injured hemisphere. These observations corroborated the idea of a prolonged induction of apoE within the neurons and also in the extracellular matrix after TBI. Furthermore, the possibility is suggested that the alteration of apoE distribution may contribute to a cerebroprotective mechanism immediately after TBI.	Kagoshima Univ, Fac Med, Dept Legal Med, Kagoshima 8908520, Japan; Nagasaki Univ, Sch Med, Dept Legal Med, Nagasaki 8528523, Japan	Orihara, Y (corresponding author), Kagoshima Univ, Fac Med, Dept Legal Med, Sakuragaoka 8-35-1, Kagoshima 8908520, Japan.	orihara@m3.kufm.kagoshima-u.ac.jp					ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Graham DI, 1999, ACT NEUR S, V73, P89; Greenberg SM, 1996, STROKE, V27, P1333, DOI 10.1161/01.STR.27.8.1333; HALL ED, 1995, EXP NEUROL, V135, P17, DOI 10.1006/exnr.1995.1062; HAN SH, 1994, J NEUROPATH EXP NEUR, V53, P535, DOI 10.1097/00005072-199409000-00013; HAN SH, 1994, EXP NEUROL, V128, P13, DOI 10.1006/exnr.1994.1108; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; Hausmann R, 2001, INT J LEGAL MED, V114, P338, DOI 10.1007/s004140000199; Horsburgh K, 1997, BRAIN RES, V763, P103, DOI 10.1016/S0006-8993(97)00411-3; Horsburgh K, 1996, NEUROPATH APPL NEURO, V22, P342, DOI 10.1111/j.1365-2990.1996.tb01113.x; Horsburgh K, 1996, ALZHEIMER RES, V2, P37; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KIDA E, 1995, BRAIN RES, V674, P341, DOI 10.1016/0006-8993(94)01467-V; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Nicoll JAR, 1996, ANN NEUROL, V39, P682, DOI 10.1002/ana.410390521; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; Quan L, 2001, INT J LEGAL MED, V114, P310, DOI 10.1007/s004140000192; REBECK GW, 1993, NEURON, V11, P575; Seliger G, 1997, NEUROLOGY, V48, P28001; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303	30	11	14	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	APR	2002	116	2					92	98		10.1007/s00414-001-0265-8			7	Medicine, Legal	Legal Medicine	552JU	WOS:000175617700007	12056527				2021-06-18	
J	Satoh, JI; Kuroda, Y				Satoh, JI; Kuroda, Y			Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						cytokines; GAP-43; human neurones; neurotrophic factors; Nogo; Nogo receptor; NTera2	NEURITE GROWTH-INHIBITORS; LINES FOLLOWING INDUCTION; CARCINOMA-CELL-LINE; FUNCTIONAL RECOVERY; GENE-EXPRESSION; PURKINJE-CELLS; ADULT CNS; MYELIN; PROTEIN; EXPOSURE	Nogo is a novel myelin-associated inhibitor of neurite outgrowth which regulates stable neuronal connections during axonal regeneration following injury in the adult mammalian central nervous system (CNS). Because cytokines and neurotrophic factors play a key role in inflammation-related axonal regeneration, we investigated: (i) the constitutive expression of Nogo and the Nogo receptor (NgR) mRNA in human neural cell lines: (ii) Nogo and NgR mRNA levels in the NTera2 human teratocarcinoma cell line during retinoic acid (RA)-induced neuronal differentiation; and (iii) their regulation in NTera2-derived differentiated neurones (NTera2-N) after exposure to a battery of cytokines and growth factors potentially produced by activated glial cells at post-traumatic inflammatory lesions in the CNS. By reverse transcriptase-polymerase chain reaction analysis, the constitutive expression of Nogo-A, the longest isoform of three distinct Nogo transcripts and NgR mRNA was identified in a wide variety of human neural and non-neural cell lines. By Northern blot analysis, the levels of Nogo-A mRNA here elevated markedly in NTera2 cells following RA-induced neuronal differentiation, accompanied by an increased expression of the neurite growth-associated protein GAP-43 mRNA. In contrast, Nogo-A, Nogo-B, NgR and GAP-43 mRNA levels were unaltered in NTera2-N cells by exposure to basic fibroblast growth factor. brain-derived neurotrophic factor, glia-derived neurotrophic factor, tumour necrosis factor-alpha, interleukin-1beta, dibutyryl cyclic AMP or phorbol 12-myristate 13-acetate. These results indicate that both Nogo-A and NgR mRNA are coexpressed in various human cell types, including differentiated neurones, where their expression is unaffected by exposure to a panel of cytokines and neurotrophic factors which might be involved in inflammation-related axonal regeneration in the CNS.	Saga Med Sch, Dept Internal Med, Div Neurol, Saga 8498501, Japan	Satoh, JI (corresponding author), Saga Med Sch, Dept Internal Med, Div Neurol, 5-1-1 Nabeshima, Saga 8498501, Japan.	satoj1@post.saga-med.ac.jp					Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1; Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076; Bregman BS, 1998, CURR OPIN NEUROBIOL, V8, P800, DOI 10.1016/S0959-4388(98)80124-4; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Brosamle C, 2000, J NEUROSCI, V20, P8061; Buffo A, 1997, J NEUROSCI, V17, P8778; Buffo A, 2000, J NEUROSCI, V20, P2275; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GIULIAN D, 1985, SCIENCE, V228, P497, DOI 10.1126/science.3872478; GOODWIN RG, 1996, CYTOKINES CNS, P5; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Houle JD, 1996, RESTOR NEUROL NEUROS, V10, P205, DOI 10.3233/RNN-1996-10403; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Josephson A, 2001, EXP NEUROL, V169, P319, DOI 10.1006/exnr.2001.7659; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; KAPFHAMMER JP, 1994, EUR J NEUROSCI, V6, P403, DOI 10.1111/j.1460-9568.1994.tb00283.x; Kobayashi NR, 1997, J NEUROSCI, V17, P9583; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; LOTAN M, 1994, EXP NEUROL, V126, P284, DOI 10.1006/exnr.1994.1066; Mehler MF, 1997, TRENDS NEUROSCI, V20, P357, DOI 10.1016/S0166-2236(96)01045-4; Morris NJ, 1999, BBA-MOL CELL RES, V1450, P68, DOI 10.1016/S0167-4889(99)00033-6; Olson L, 1997, NAT MED, V3, P1329, DOI 10.1038/nm1297-1329; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Satoh J, 2000, J NEUROSCI METH, V94, P155, DOI 10.1016/S0165-0270(99)00143-0; Satoh J, 1997, NEUROPATHOLOGY, V17, P80, DOI 10.1111/j.1440-1789.1997.tb00018.x; Satoh J, 2000, NEUROPATHOLOGY, V20, P289, DOI 10.1046/j.1440-1789.2000.00349.x; Satoh JI, 1999, NEUROPATH APPL NEURO, V25, P492; Satoh JI, 2001, PARKINSONISM RELAT D, V8, P7, DOI 10.1016/S1353-8020(00)00075-4; Satoh JI, 2001, NEUROPATH APPL NEURO, V27, P95, DOI 10.1046/j.1365-2990.2001.00313.x; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Schwab ME, 1996, PHYSIOL REV, V76, P319; SCHWARTZ M, 1991, BRAIN RES, V545, P334, DOI 10.1016/0006-8993(91)91309-O; SELMAJ KW, 1990, J IMMUNOL, V144, P129; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Tessier-Lavigne M, 2000, SCIENCE, V287, P813, DOI 10.1126/science.287.5454.813; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Z'Graggen WJ, 1998, J NEUROSCI, V18, P4744; Zagrebelsky M, 1998, J NEUROSCI, V18, P7912	50	11	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	APR	2002	28	2					95	106		10.1046/j.1365-2990.2002.00375.x			12	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	545HQ	WOS:000175211700002	11972796				2021-06-18	
J	Segura, T; Jimenez, P; Jerez, P; Garcia, F; Corcoles, V				Segura, T; Jimenez, P; Jerez, P; Garcia, F; Corcoles, V			Prolonged clinical pattern of brain death in patients under barbiturate sedation: usefulness of transcranial Doppler	NEUROLOGIA			Spanish	Article						brain death; transcraneal Doppler; barbiturates at high dosages; severe head injury; intracraneal hypertension; electroencephalography		INTRODUCTION: Throughout the world, is fully accepted that a person is dead when brain death exists. In most situations, neurological criteria permit the diagnosis of brain death, but in some instances, as when high-dose barbiturate therapy has been used, confirmatory testing are required by law. CLINICAL CASE: We report the case of a 17 year-old women who suffered high-dose barbiturate therapy due to post traumatic intracranial hypertension. During the period of the barbiturate infusion and until six days after the suppression of this therapy, neurological exploration and EEG findings seem to confirm brain death, while transcranial Doppler (TCD) study remained normal. CONCLUSIONS: TCD is a fast, simple and accurate confirmatory testing in the determination of brain death and its findings are not affected by high-dose barbiturate therapy. We think that TCD must be present in all hospitals where mechanical ventilation and support of patients are carried out.	Hosp Gen Albacete, Secc Neurol, Albacete 02006, Spain; Hosp Gen Albacete, Sev Med Intens, Albacete 02006, Spain; Hosp Gen Albacete, Serv Neurofisiol, Albacete 02006, Spain	Segura, T (corresponding author), Hosp Gen Albacete, Secc Neurol, Hermanos Falco S-N, Albacete 02006, Spain.	tseguram@meditex.es		Segura, Tomas/0000-0003-3625-0987; Serrano-Heras, Gemma/0000-0001-9368-4832			[Anonymous], 1968, JAMA, V205, P337; [Anonymous], 1990, Neurology, V40, P680; DAVALOS A, 1993, MED CLIN-BARCELONA, V100, P249; GANES T, 1983, J NEUROL NEUROSUR PS, V46, P509, DOI 10.1136/jnnp.46.6.509; Goldfrank LR, 1998, GOLDFRANKS TOXICOLOG; LUNDAR T, 1983, CRIT CARE MED, V11, P559, DOI 10.1097/00003246-198307000-00017; PETTY GW, 1990, NEUROLOGY, V40, P300, DOI 10.1212/WNL.40.2.300; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; ROPPER AH, 1987, NEUROLOGY, V37, P1733, DOI 10.1212/WNL.37.11.1733; Segura T, 1999, Neurologia, V14, P437; THOMPSON AE, 1989, CRIT CARE MED, V17, P194, DOI 10.1097/00003246-198902000-00019; TURCANT A, 1985, ANESTHESIOLOGY, V63, P50, DOI 10.1097/00000542-198507000-00007; YANG KL, 1991, CHEST, V99, P1037, DOI 10.1378/chest.99.4.1037	13	11	12	0	0	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0213-4853	1578-1968		NEUROLOGIA	Neurologia	APR	2002	17	4					219	222					4	Clinical Neurology	Neurosciences & Neurology	544HV	WOS:000175152900007	11940411				2021-06-18	
J	Hadley, MN				Hadley, MN			Occipital condyle fractures	NEUROSURGERY			English	Article							HYPOGLOSSAL NERVE PALSY; COLLET-SICARD SYNDROME; CLOSED-HEAD-INJURY; FORGOTTEN CONDYLE; LIGAMENT INJURY; CT; IMPAIRMENT; DIAGNOSIS; SKULL		Univ Alabama, Div Neurol Surg, Birmingham, AL 35294 USA	Hadley, MN (corresponding author), Univ Alabama, Div Neurol Surg, 516 Med Educ Bldg,1813 6th Ave S, Birmingham, AL 35294 USA.						ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; BELL C, 1817, MIDDLESEX HOSP J, V4, P469; BETTINI N, 1993, SKELETAL RADIOL, V22, P187; Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; Bloom AI, 1996, PEDIATR RADIOL, V26, P786, DOI 10.1007/BF01396202; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BOZBOGA M, 1992, SPINE, V17, P1119, DOI 10.1097/00007632-199209000-00019; BRIDGMAN SA, 1992, SURG NEUROL, V38, P152, DOI 10.1016/0090-3019(92)90094-4; CASTLING B, 1995, BRIT J ORAL MAX SURG, V33, P171, DOI 10.1016/0266-4356(95)90292-9; COTTALORDA J, 1996, J PEDIATR ORTHOPED, V5, P161; Curri D, 1988, J Neurosurg Sci, V32, P157; DEEB Z L, 1988, Journal of Computed Tomography, V12, P261, DOI 10.1016/0149-936X(88)90081-1; Demisch S, 1998, CLIN NEUROL NEUROSUR, V100, P44, DOI 10.1016/S0303-8467(97)00111-X; DESAI SS, 1990, J TRAUMA, V30, P240, DOI 10.1097/00005373-199002000-00023; Emery E, 1995, Eur Spine J, V4, P191, DOI 10.1007/BF00298245; GOLDSTEIN SJ, 1982, SURG NEUROL, V17, P350, DOI 10.1016/0090-3019(82)90308-1; HARDINGSMITH J, 1981, J BONE JOINT SURG AM, V63, P1170, DOI 10.2106/00004623-198163070-00016; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; Ide C, 1998, J NEUROSURG, V88, P773, DOI 10.3171/jns.1998.88.4.0773; JACOBY CG, 1979, AM J ROENTGENOL, V132, P500, DOI 10.2214/ajr.132.3.500-b; JONES DN, 1990, AM J NEURORADIOL, V11, P1181; Lam CH, 1996, CAN J NEUROL SCI, V23, P145, DOI 10.1017/S0317167100038890; Legros B, 2000, J TRAUMA, V48, P342, DOI 10.1097/00005373-200002000-00031; Leone A, 2000, RADIOLOGY, V216, P635, DOI 10.1148/radiology.216.3.r00se23635; LEVENTHAL MR, 1992, ORTHOPEDICS, V15, P944; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; MANN FA, 1994, AM J ROENTGENOL, V163, P193, DOI 10.2214/ajr.163.1.8010212; MARIANI PJ, 1990, ANN EMERG MED, V19, P1447, DOI 10.1016/S0196-0644(05)82618-6; MASSARO F, 1993, INJURY, V24, P419, DOI 10.1016/0020-1383(93)90110-R; MODY BS, 1992, INJURY, V23, P350, DOI 10.1016/0020-1383(92)90194-W; Noble ER, 1996, AM J NEURORADIOL, V17, P507; OLSSON R, 1994, ACTA RADIOL, V35, P90; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; PALEY MD, 1995, BRIT J ORAL MAX SURG, V33, P239, DOI 10.1016/0266-4356(95)90008-X; RAILA FA, 1993, SKELETAL RADIOL, V22, P269; Savolaine E R, 1989, J Orthop Trauma, V3, P71, DOI 10.1097/00005131-198903010-00014; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; STROOBANTS J, 1994, J NEUROSURG, V81, P137, DOI 10.3171/jns.1994.81.1.0137; STROOBANTS J, 1994, J TRAUMA, V36, P440, DOI 10.1097/00005373-199403000-00037; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; VALASKATZIS EP, 1990, S AFR MED J, V77, P47; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025; WASSERBERG J, 1995, NEURORADIOLOGY, V37, P370; WESSELS LS, 1990, S AFR J SURG, V28, P155; YOUNG WF, 1994, NEUROSURGERY, V34, P257, DOI 10.1227/00006123-199402000-00008	47	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2002	50	3		S			S114	S119					6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	527VU	WOS:000174209300027	29272875				2021-06-18	
J	Banks, ME; Ackerman, RJ				Banks, ME; Ackerman, RJ			Head and brain injuries experienced by African American women victims of intimate partner violence	WOMEN & THERAPY			English	Article						blacks; head injury; traumatic brain injury; battered women; rehabilitation; neuropsychology	DOMESTIC VIOLENCE; BATTERED WOMEN; REHABILITATION; MRI	Regardless of ethnicity, traumatic brain injury (TBI) is one of the most serious, prevalent, and often undiagnosed results of intimate partner violence. Greater severity of violence, coupled with inadequate health care, places battered African American women at increased risk for head injuries. Accordingly, we review the symptoms associated with head injuries in battered women, with a focus on the experiences of Black women. A case study is used to illustrate rehabilitation and treatment options. Assessment was conducted using the Ackerman-Banks Neuropsychological Rehabilitation Battery. Neuropsychological assessment is recommended, as well as culturally relevant and multidisciplinary treatment strategies that can empower clients. (C) 2002 by The Haworth Press, Inc. All. rights reserved.	ABackans DCP Inc, Res Div, Akron, OH 44313 USA; ABackans DCP Inc, Res & Dev Div, Akron, OH 44313 USA	Banks, ME (corresponding author), ABackans DCP Inc, Res Div, 1700 W Market St,Dept RD 301, Akron, OH 44313 USA.		Banks, Martha/AAB-2391-2021	Banks, Martha/0000-0002-5367-2076			ACKERMAN RJ, IN PRESS WOMEN THERA; ACKERMAN RJ, 2000, ACKERMAN BANKS NEURO; ASBURY CA, 1994, REHABIL PSYCHOL, V39, P113, DOI 10.1037/h0080314; BANKS ME, 1997, POST ASSAULT TRAUMAT; BANKS ME, 1995, VARIATIONS THEME DIV, P29; Deering C, 2001, PERCEPT MOTOR SKILL, V92, P682; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; Donnelly D.A., 1999, VIOLENCE AGAINST WOM, V5, P710; Grisso JA, 1999, NEW ENGL J MED, V341, P1899, DOI 10.1056/NEJM199912163412506; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Jenkins EJ, 2002, WOMEN THER, V25, P29, DOI 10.1300/J015v25n03_03; JOHNSON LD, 1998, LAW PSYCHOL REV, V22, P271; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; Mahon D, 1989, J Neurosci Nurs, V21, P382; Mahoney P., 2001, SOURCEBOOK VIOLENCE, P143; MALEC JF, 1996, ARCH PHYSICAL MED RE, V77, P149; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McNutt LA, 2000, AM J PREV MED, V19, P264, DOI 10.1016/S0749-3797(00)00233-6; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Muelleman RL, 1996, ANN EMERG MED, V28, P486, DOI 10.1016/S0196-0644(96)70110-5; NABORS NA, IN PRESS WOMEN THERA; ODEN TM, 2001, DISS ABSTR INT, V61; ONEAL J, 1992, HEADLINES, V3, P5; Perciaccante VJ, 1999, J ORAL MAXIL SURG, V57, P760, DOI 10.1016/S0278-2391(99)90808-X; Uswatte G, 1997, REHABIL PSYCHOL, V42, P61, DOI 10.1037/0090-5550.42.1.61; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; WHITE E, 1994, CHAIN CHAIN CHANGE B	29	11	11	0	8	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	0270-3149			WOMEN THER	Women Ther.		2002	25	3-4					133	143		10.1300/J015v25n03_10			11	Psychology, Multidisciplinary; Women's Studies	Psychology; Women's Studies	620YY	WOS:000179562800010					2021-06-18	
J	Shafer, LL; McNulty, JA; Young, MRI				Shafer, LL; McNulty, JA; Young, MRI			Brain activation of monocyte lineage cells: Brain-derived soluble factors differentially regulate BV2 microglia and peripheral macrophage immune functions	NEUROIMMUNOMODULATION			English	Article						phagocytosis; MHC II; ANA 1; organotypic; coculture	CENTRAL-NERVOUS-SYSTEM; TRAUMATIC NEURONAL INJURY; IN-VITRO; UP-REGULATION; ANTIGEN PRESENTATION; INTERFERON-GAMMA; NITRIC-OXIDE; BONE-MARROW; PHAGOCYTOSIS; EXPRESSION	Brain injury and subsequent neurodegeneration are often associated with infiltrating leukocytes and the activation of microglia as well as other infiltrating cells. However, the characteristics of activation are poorly understood. The objective of this study was to further the understanding of brain regulation of microglial activation. We used an organotypic coculture paradigm to assess how brain-derived soluble factors modulate microglia and peripheral macrophage activation through microscopy and flow cytometry techniques. In the presence of brain-derived soluble factors, the BV2 microglia cell line increased MHC II and phagocytic receptor (Fcgamma II/III) expression. The increased expression correlated with a functional increase in phagocytic activity, but did not correlate with an increase in allostimulation ability. Furthermore, this interaction was selective to an interaction between brain-derived soluble factor(s) and BV2 microglia, since it was not observed in the ANA1 macrophage cell line or in primary peritoneal macrophages. The results indicated that brain-derived soluble factor(s) modulate microglial activation in a manner that is distinct from the effects on peripheral macrophages. Moreover, our results suggest that inflammatory events associated with some types of brain injury may be induced by the brain without dependence on infiltrating peripheral macrophages or T lymphocytes.	Hines VA Hosp, Res Serv, Hines, IL 60141 USA; Loyola Univ, Med Ctr, Dept Cell Biol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Neurobiol & Anat, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Otolaryngol, Maywood, IL 60153 USA	Young, MRI (corresponding author), Hines VA Hosp, Res Serv, Bldg 1,Rm A319, Hines, IL 60141 USA.	myoung1@lumc.edu			NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R55-CA78262, R01-CA4500, R21-CA77208-1, R01-CA85266] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R55CA078262, R21CA077208, R01CA085266] Funding Source: NIH RePORTER		Acarin L, 1999, NEUROSCIENCE, V89, P549, DOI 10.1016/S0306-4522(98)00331-5; Acarin L, 1996, J COMP NEUROL, V367, P361; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Aloisi F, 1998, J IMMUNOL, V160, P4671; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Bechmann I, 2000, ANN NY ACAD SCI, V911, P192; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; Beyer M, 2000, GLIA, V31, P262, DOI 10.1002/1098-1136(200009)31:3<262::AID-GLIA70>3.0.CO;2-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brana C, 1999, J NEUROSCI METH, V90, P7, DOI 10.1016/S0165-0270(99)00045-X; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; CASH E, 1993, CELL IMMUNOL, V147, P129, DOI 10.1006/cimm.1993.1053; Chang RCC, 2000, BRAIN RES, V853, P236, DOI 10.1016/S0006-8993(99)02255-6; COX GW, 1989, J NATL CANCER I, V81, P1492, DOI 10.1093/jnci/81.19.1492; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.3.CO;2-0; DAS GD, 1976, VIRCHOWS ARCH B, V20, P287; del Zoppo GJ, 2001, ARCH NEUROL-CHICAGO, V58, P669, DOI 10.1001/archneur.58.4.669; Duport S, 1998, P NATL ACAD SCI USA, V95, P1840, DOI 10.1073/pnas.95.4.1840; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Giulian D, 1996, NEUROCHEM INT, V29, P65, DOI 10.1016/0197-0186(95)00140-9; Greenberg S, 2001, J CELL SCI, V114, P1039; Han YF, 2000, NEUROSCI LETT, V288, P95, DOI 10.1016/S0304-3940(00)01198-8; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Iglesias BM, 1997, J NEUROIMMUNOL, V72, P83, DOI 10.1016/S0165-5728(96)00155-5; Jander S, 1996, GLIA, V18, P255, DOI 10.1002/(SICI)1098-1136(199611)18:3<255::AID-GLIA9>3.0.CO;2-Y; Kant A, 1996, LEUKEMIA RES, V20, P93, DOI 10.1016/0145-2126(95)00126-3; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LASSMANN H, 1991, J NEUROSCI RES, V28, P236, DOI 10.1002/jnr.490280211; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; Matsubara T, 1999, INVEST OPHTH VIS SCI, V40, P3186; MATSUMOTO Y, 1986, J IMMUNOL, V136, P3668; MAUERHOFF T, 1988, J NEUROIMMUNOL, V18, P271, DOI 10.1016/0165-5728(88)90049-5; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MORGENSTERN S, 1965, ANAL BIOCHEM, V13, P149, DOI 10.1016/0003-2697(65)90129-6; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; PAUETTE RL, 1995, MOL IMMUNOL, V32, P841; Perry VH, 1998, J NEUROIMMUNOL, V90, P113; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; RIESKE E, 1989, BRAIN RES, V492, P1, DOI 10.1016/0006-8993(89)90883-4; Sakai M, 2000, BIOCHEM BIOPH RES CO, V278, P79, DOI 10.1006/bbrc.2000.3767; SCHWAB ME, 1990, TRENDS NEUROSCI, V13, P452, DOI 10.1016/0166-2236(90)90098-U; Smith ME, 1998, J NEUROSCI RES, V54, P68, DOI 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F; SMITH ME, 1993, J NEUROSCI RES, V35, P480, DOI 10.1002/jnr.490350504; Sriram S, 1997, NEUROLOGY, V48, P464, DOI 10.1212/WNL.48.2.464; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sugaya K, 1997, NEUROREPORT, V8, P2241, DOI 10.1097/00001756-199707070-00030; Toku K, 1999, J NEUROSCI RES, V57, P855, DOI 10.1002/(SICI)1097-4547(19990915)57:6<855::AID-JNR11>3.0.CO;2-R; Walker WS, 1999, J NEUROIMMUNOL, V94, P127, DOI 10.1016/S0165-5728(98)00237-9; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wilson ME, 2000, BRAIN RES, V873, P235, DOI 10.1016/S0006-8993(00)02479-3; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0; WUCHERPFENNIG KW, 1994, CLIN IMMUNOL IMMUNOP, V72, P293, DOI 10.1006/clin.1994.1145; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029	67	11	12	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2002	10	5					283	294		10.1159/000069972			12	Endocrinology & Metabolism; Immunology; Neurosciences	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	681RR	WOS:000183049600004	12759565				2021-06-18	
J	Gagnon, I; Friedman, D; Swaine, B; Forget, R				Gagnon, I; Friedman, D; Swaine, B; Forget, R			Balance findings in a child before and after a mild head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; mild head injuries	TRAUMATIC BRAIN INJURY; POSTCONCUSSION SYNDROME; POSTURAL CONTROL; PERFORMANCE; CONCUSSION; SEQUELAE	Objective: This case study reviews the preinjury and postinjury balance performance of an 11-year-old child who sustained a mild head injury. Design: A prospective design was used to document balance 5 days before injury and 1, 4, and 12 weeks after injury. Outcome Measures: The assessments used were the balance subtest of the Bruininks-Oseretsky Test of Motor Proficiency, the Pediatric Clinical Test of Sensory Interaction for Balance, and the Postural Stress Test. Results: One week after the trauma, balance deficits were observed in the three tests. The deficits improved 4 weeks after the injury and performance remained stable over the following 2 months for two of the evaluations except for the Postural Stress Test performance, which failed to improve in the 3-month period after trauma. Conclusions: The good recovery of balance skills observed over the first month after injury seems to validate the current activity restrictions imposed on children after a mild head injury. However, the persistence of poor performance in the area of reactions to external perturbations indicates that some deficits may persist beyond what is expected with this population.	McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Phys Therapy, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Pediat & Adolescent Trauma & Neurotrauma Program, Montreal, PQ H3H 1P3, Canada; Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ, Canada	Gagnon, I (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Phys Therapy, 2300 Tupper, Montreal, PQ H3H 1P3, Canada.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BIJUR P, 1988, AM J DIS CHILD, V142, P1307, DOI 10.1001/archpedi.1988.02150120061041; BIJUR PE, 1990, PEDIATRICS, V86, P337; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Bruininks R. H., 1978, BRUININKS OSERETSKY; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CHANDLER JM, 1990, PHYS THER, V70, P410, DOI 10.1093/ptj/70.7.410; CROWE T K, 1990, Physical and Occupational Therapy in Pediatrics, V10, P1; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; LEMMON J, 1995, J COGN REHABIL   SEP, P4; MATHENY AP, 1971, J PEDIATR-US, V79, P122, DOI 10.1016/S0022-3476(71)80071-9; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.0.CO;2-Y; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Swaine BR, 2001, J HEAD TRAUMA REHAB, V16, P292, DOI 10.1097/00001199-200106000-00008; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; The Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; WOLFSON LI, 1986, J AM GERIATR SOC, V34, P845, DOI 10.1111/j.1532-5415.1986.tb07256.x	31	11	11	0	4	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2001	16	6					595	602		10.1097/00001199-200112000-00007			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	501AL	WOS:000172660800007	11732974				2021-06-18	
J	Huisman, TAGM; Hawighorst, H; Benoit, CH; Sorensen, AG				Huisman, TAGM; Hawighorst, H; Benoit, CH; Sorensen, AG			Diffusion weighted magnetic resonance imaging: Ischemic and traumatic injury of the central nervous system	RADIOLOGE			German	Article						diffusion weighted MRI; apparent diffusion coefficient; anisotropic diffusion; anisotropic diffusion; trauma; stroke	RAT SPINAL-CORD; ACUTE STROKE; IN-VIVO; MR; ANISOTROPY	Diffusion weighted magnetic resonance imaging (DWI) represents a recent development that extends imaging from the depiction of the neuroanatomy into the field of functional and physiologic processes. DWI measures a fundamentally different physiologic parameter than conventional MRI. Image contrast is related to differences in the microscopic motion (diffusion) of water molecules within brain tissue rather than a change in total tissue water. Consequently, DWI can reveal pathology where conventional T1- and T2-weighted MR images are negative. DWI has clinically proven its value in the assessment of acute cerebral stroke and trauma by showing cerebral injury early due to ist ability to discriminate between lesions with cytotoxic edema (decreased diffusion) from lesions with vasogenic edema (increased diffusion). Full tensor DWI allows to calculate a variety of functional maps, the most widely used maps include maps of apparent diffusion coefficients and isotropic diffusion. In addition maps of anisotropic diffusion can be calculated which are believed to give information about the integrity and location of fiber tracts. This functional-anatomical information will most probably play an increasingly important role in the early detection of primary and secondary tissue injury from various reasons and could guide and validate current and future neuroprotective treatments.	Massachusetts Gen Hosp, NMR Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Swiss Parapleg Ctr, Inst Radiol, Nottwil, Switzerland	Huisman, TAGM (corresponding author), Massachusetts Gen Hosp, NMR Ctr, Mailingcode 149,2301, Charlestown, MA 02119 USA.						Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; CHIEN D, 1992, AM J NEURORADIOL, V13, P1097; Clark CA, 1999, MAGN RESON MED, V41, P1269, DOI 10.1002/(SICI)1522-2594(199906)41:6<1269::AID-MRM26>3.0.CO;2-2; DOUSSET V, 1997, P AM SOC NEUR TOR; FORD JC, 1994, MAGNET RESON MED, V31, P488, DOI 10.1002/mrm.1910310504; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GEAN AD, 1994, IMAGING HEAD TRAUMA, P217; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Holder CA, 2000, AM J NEURORADIOL, V21, P1799; Inglis BA, 1997, MAGN RESON IMAGING, V15, P441, DOI 10.1016/S0730-725X(96)00242-1; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; MOHR JP, 1995, STROKE, V26, P807, DOI 10.1161/01.STR.26.5.807; NAKADA T, 1994, NEUROREPORT, V5, P2053, DOI 10.1097/00001756-199410270-00016; NOMURA Y, 1994, AM J NEURORADIOL, V15, P231; Provenzale JM, 1999, AM J ROENTGENOL, V173, P1459, DOI 10.2214/ajr.173.6.10584783; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005	18	11	16	0	6	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0033-832X			RADIOLOGE	Radiologe	DEC	2001	41	12					1038	+		10.1007/s001170170003			10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	506HQ	WOS:000172964600003	11793928				2021-06-18	
J	Nariai, T; Suzuki, R; Ohta, Y; Ohno, K; Hirakawa, K				Nariai, T; Suzuki, R; Ohta, Y; Ohno, K; Hirakawa, K			Focal cerebral hyperemia in postconcussive amnesia	JOURNAL OF NEUROTRAUMA			English	Article						amnesia; cerebral blood flow; cerebral concussion; head injury; hyperemia, posttraumatic amnesia; xenon CT	MILD HEAD-INJURY; ENHANCED COMPUTED-TOMOGRAPHY; TRAUMATIC BRAIN INJURY; BLOOD-FLOW; RETROGRADE-AMNESIA; WORKING-MEMORY; CT; HIPPOCAMPUS; ACTIVATION; HUMANS	Transient amnesia caused by minor head injury is commonly encountered in daily neurosurgical practice, but the mechanism of such amnesia has not been extensively studied. We measured the regional cerebral blood flow (rCBF) of patients with postconcussive amnesia with Xe/CT CBF to examine whether a focal disturbance of CBF exists. The Xe/CT CBF study was performed in eight patients with closed head injury without organic cerebral lesion while they were suffering from posttraumatic amnesia (concussion group). The time interval between accident and CBF measurement was less than 2 h in three patients, 5-6 h in two, 8-9 h in two, and 18 in one. The results were compared with those of nine normal volunteers and eight other age-matched patients who recovered without any neurological deficit despite the presence of hemorrhagic regions (mild hemorrhage group). The rCBF of the concussion group was significantly elevated in the bilateral mesial temporal cortex in comparison to the normal group. The rCBF in the mild hemorrhage group was lower than that of normal controls in all regions. The analysis of right-left difference in CBF indicated that there was significant asymmetry (right > left) in the frontal and temporal cortex in the concussion group, but not in the normal and mild hemorrhage group. This Xe/CT CBF study in acute stages of cerebral concussion, in which patients were amnestic, detected focal cerebral hyperemia. Such hyperemia in regions closely related to human memory function may be the result of vasoparalysis or the compensatory activation of memory circuits after denervation injury.	Tokyo Med & Dent Univ, Dept Neurosurg, Tokyo, Japan; Showa Univ, Fujigaoka Hosp, Dept Neurosurg, Yokohama, Kanagawa 227, Japan	Nariai, T (corresponding author), Tokyo Med & Dent Univ, Dept Neurosurg, Tokyo, Japan.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; BARON JC, 1994, BRAIN, V117, P545, DOI 10.1093/brain/117.3.545; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; CAO WH, 1989, NEUROSCI LETT, V107, P135, DOI 10.1016/0304-3940(89)90805-7; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; FALCONER MA, 1971, EPILEPSIA, V12, P13, DOI 10.1111/j.1528-1157.1971.tb03912.x; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GUR D, 1982, SCIENCE, V215, P1267, DOI 10.1126/science.7058347; Jacobs A, 1996, J NUCL MED, V37, P1605; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KALENDER WA, 1991, J COMPUT ASSIST TOMO, V15, P816, DOI 10.1097/00004728-199109000-00017; KAMEYAMA M, 1983, EXP NEUROL, V79, P329, DOI 10.1016/0014-4886(83)90217-0; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRAUS JF, 1996, NEUROTRAUMA, P13; KUSCHINSKY W, 1978, PHYSIOL REV, V58, P656; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MAEHARA T, 1993, ADV NEUROTRAUMA RES, V5, P83; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Masdeu J C, 1994, J Neuroimaging, V4, P177; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MCBEAN DE, 1990, BRAIN RES, V537, P307, DOI 10.1016/0006-8993(90)90374-K; NARIAI T, 1995, AM J NEURORADIOL, V16, P563; Obrist WD, 1998, J CEREBR BLOOD F MET, V18, P1192, DOI 10.1097/00004647-199811000-00005; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; Stein S. C., 1996, NEUROTRAUMA, P31; SUZUKI R, 1986, PROG CT, V8, P139; TOUHO H, 1988, RADIOLOGY, V168, P207, DOI 10.1148/radiology.168.1.3380959; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	47	11	12	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2001	18	12					1323	1332		10.1089/08977150152725623			10	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	504RE	WOS:000172869000003	11780863				2021-06-18	
J	Yakubovich, N; Eldstrom, JR; Mathers, DA				Yakubovich, N; Eldstrom, JR; Mathers, DA			Lipopolysaccharide can activate BK channels of arterial smooth muscle in the absence of iNOS expression	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						vascular smooth muscle cell; Ca2+-activated potassium channel; BK channel; lipopolysaccharide; inducible nitric oxide synthase; iNOS knockout mouse	NITRIC-OXIDE SYNTHASE; INDUCIBLE NO SYNTHASE; DEPENDENT PROTEIN-KINASE; MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; K-CA CHANNELS; RAT AORTA; POTASSIUM CHANNEL; HIGH-CONDUCTANCE; ENDOTOXIC-SHOCK	The role of inducible nitric oxide synthase (iNOS) in the acute activation of large-conductance, Ca2+-dependent K+ channels (BK channels) by Escherichia coli endotoxin (lipopolysaccharide, LPS) was studied in murine vascular smooth muscle cells. Confocal laser scanning microscopy and patch clamp recordings were utilised. Within 2 h of donor rat sacrifice, iNOS-like immunoreactivity Could be detected in cerebrovascular smooth muscle cells (CVSMCs) enzymatically dispersed from rat cerebral arteries. This staining was absent in cells fixed immediately after donor rat sacrifice. LPS as then applied to the cytoplasmic face of inside-out membrane patches excised from rat CVSMCs within 2-4 h of donor rat sacrifice. It was found that LPS (10-100 mug/ml) rapidly and reversibly increased the open probability of BK channels in these patches. This LPS response was not altered in the presence of the non-isoform specific NOS inhibitor N-omega-nitro-L-arginine. LPS responses were then compared in aortic smooth muscle (ASMC) BK channels derived from wild-type and iNOS-knockout (iNOS-KO) mice. LPS activated BK channels in inside-out patches of ASMC membrane derived from both wild-type and iNOS-knockout mice. These Studies establish that LPS can activate BK channels by a mechanism quite independent of the well-established pathway mediated by iNOS in vascular smooth muscle cells. ((C)) 2001 Elsevier Science B.V. All rights reserved.	Univ British Columbia, Dept Physiol, Vancouver, BC V6T 1Z3, Canada	Mathers, DA (corresponding author), Univ British Columbia, Dept Physiol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.						Alonso MJ, 1998, J AUTON PHARMACOL, V18, P105, DOI 10.1046/j.1365-2680.1998.1820105.x; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Briones AM, 1999, BRIT J PHARMACOL, V126, P111, DOI 10.1038/sj.bjp.0702281; Brophy CM, 2000, AM J PHYSIOL-HEART C, V278, pH991; Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279; Chen SJ, 1999, N-S ARCH PHARMACOL, V359, P493, DOI 10.1007/PL00005381; Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643; Chyu KY, 1999, CIRC RES, V85, P1192; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Das R, 1999, BRIT J PHARMACOL, V128, P493, DOI 10.1038/sj.bjp.0702737; Gunnett CA, 1998, AM J PHYSIOL-HEART C, V275, pH416; Hall S, 1996, BIOCHEM BIOPH RES CO, V224, P184, DOI 10.1006/bbrc.1996.1005; Hecker M, 1999, GEN PHARMACOL, V32, P9, DOI 10.1016/S0306-3623(98)00082-2; Hoang L, 1998, BBA-BIOMEMBRANES, V1369, P335, DOI 10.1016/S0005-2736(97)00237-X; Hoang LM, 1998, BRIT J PHARMACOL, V123, P5, DOI 10.1038/sj.bjp.0701570; Horrigan FT, 1999, J GEN PHYSIOL, V114, P277, DOI 10.1085/jgp.114.2.277; Horrigan FT, 1999, J GEN PHYSIOL, V114, P305, DOI 10.1085/jgp.114.2.305; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Ishiwata T, 1997, JPN HEART J, V38, P445; Laporte R, 1997, J VASC RES, V34, P325, DOI 10.1159/000159242; LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Marin J, 1997, PHARMACOL THERAPEUT, V75, P111, DOI 10.1016/S0163-7258(97)00051-X; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Mertineit C, 2000, CAN J PHYSIOL PHARM, V78, P217, DOI 10.1139/cjpp-78-3-217; MIYOSHI H, 1994, J MOL CELL CARDIOL, V26, P1487, DOI 10.1006/jmcc.1994.1167; Morales E, 1996, J PHYSIOL-LONDON, V495, P701, DOI 10.1113/jphysiol.1996.sp021627; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Muller B, 2000, PHYSIOL RES, V49, P19; Nicholson SC, 1999, J SURG RES, V86, P198, DOI 10.1006/jsre.1999.5715; Palacios B, 1996, EUR J PHARMACOL, V296, P75, DOI 10.1016/0014-2999(95)00765-2; REES DD, 1990, BIOCHEM BIOPH RES CO, V173, P541, DOI 10.1016/S0006-291X(05)80068-3; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Schwarz PM, 1999, ARTERIOSCL THROM VAS, V19, P2584, DOI 10.1161/01.ATV.19.11.2584; Segal SS, 1999, AM J PHYSIOL-HEART C, V277, pH1167; Senba E, 1997, NEUROSCI RES, V29, P183, DOI 10.1016/S0168-0102(97)00095-3; Sennequier N, 1996, BIOCHEMISTRY-US, V35, P5883, DOI 10.1021/bi952844e; Sherman TS, 1999, AM J PHYSIOL-LUNG C, V276, pL383, DOI 10.1152/ajplung.1999.276.2.L383; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Snetkov VA, 1996, EXP PHYSIOL, V81, P743, DOI 10.1113/expphysiol.1996.sp003973; Taguchi H, 1996, J PHARMACOL EXP THER, V279, P1514; TANIGUCHI J, 1993, PFLUG ARCH EUR J PHY, V423, P167, DOI 10.1007/BF00374390; Thiemermann C, 1997, GEN PHARMACOL-VASC S, V29, P159, DOI 10.1016/S0306-3623(96)00410-7; Trovati M, 1999, DIABETOLOGIA, V42, P831, DOI 10.1007/s001250051234; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang R, 1997, J BIOL CHEM, V272, P8222, DOI 10.1074/jbc.272.13.8222; WANG Y, 1993, J PHYSIOL-LONDON, V462, P529, DOI 10.1113/jphysiol.1993.sp019567; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854	52	11	12	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736			BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	OCT 1	2001	1514	2					239	252		10.1016/S0005-2736(01)00378-9			14	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	474QG	WOS:000171117900009	11557024				2021-06-18	
J	Jacobs, R; Anderson, V; Harvey, AS				Jacobs, R; Anderson, V; Harvey, AS			Neuropsychological profile of a 9-year-old child with subcortical band heterotopia or 'double cortex'	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							DIFFUSE CORTICAL DYSPLASIA; TRAUMATIC BRAIN INJURY; NEURONAL MIGRATION; MALFORMATIONS; DISORDERS; PROTEIN	Subcortical band heterotopia (SBH) or 'double cortex', is a congenital brain abnormality that results from aberrant migration of neurons during development of the cortex. MRI shows a continuous band of heterotopic grey matter located between the cortex and ventricular walls, separated from them by a thin layer of white matter. The condition is quite rare, found predominantly in females, and is occasionally familial with an X-linked dominant inheritance. Current research has focused on genetic and neurological correlates, with cognitive assessment restricted to a global measure of general intellectual functioning. This paper describes in detail the results of a neuropsychological assessment of a 9-year-old female recently diagnosed with SBH. Predominant features were a significantly reduced speed of processing for visuomotor and oral output and reduced immediate registration of information. This difficulty has functional implications affecting skill acquisition, learning in the classroom, and social interaction.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Dept Psychol, Melbourne, Vic, Australia; Univ Melbourne, Dept Psychol, Parkville, Vic 3052, Australia	Jacobs, R (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.						Allen KM, 1999, EPILEPSY RES, V36, P143, DOI 10.1016/S0920-1211(99)00048-0; Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; ANDERSON V, 1994, ARCH DIS CHILD, V70, P476, DOI 10.1136/adc.70.6.476; ANDERSON V, 1995, NEUROPSYCHOLOGICAL A; BARKOVICH AJ, 1994, ANN NEUROL, V36, P609, DOI 10.1002/ana.410360409; BATTAGLIA GT, 1994, ITAL J NEUROL SCI, V15, P15; BROUWERS P, 1984, J CLIN NEUROPSYCHOL, V6, P325, DOI 10.1080/01688638408401222; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DEVOLDER AG, 1994, PEDIATR NEUROL, V11, P290, DOI 10.1016/0887-8994(94)90003-5; Dobyns WB, 1996, NEUROLOGY, V47, P331, DOI 10.1212/WNL.47.2.331; EVRARD P, 1992, HDB NEUROPSYCHOLOGY, V6, P11; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gioia G.A., 2000, BEHAV RATING INVENTO; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hannan AJ, 1999, J NEUROSCI RES, V55, P650, DOI 10.1002/(SICI)1097-4547(19990301)55:5<650::AID-JNR12>3.0.CO;2-S; HASHIMOTO R, 1993, BRAIN DEV-JPN, V15, P57, DOI 10.1016/0387-7604(93)90007-U; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; IANNETTI P, 1993, ACTA PAEDIATR, V82, P501; JASTAK S, 1994, WIDE RANGE ACHIEVEME; Jozwiak S, 1998, ARCH NEUROL-CHICAGO, V55, P379, DOI 10.1001/archneur.55.3.379; KETONEN L, 1994, J CHILD NEUROL, V9, P384, DOI 10.1177/088307389400900409; KUZNIECKY RI, 1994, EPILIPSIA, V35, P44; Leventer RJ, 1999, NEUROLOGY, V53, P715, DOI 10.1212/WNL.53.4.715; Leventer RJ, 1998, J PAEDIATR CHILD H, V34, P6, DOI 10.1046/j.1440-1754.1998.00143.x; Manly T., 1999, TEST EVERYDAY ATTENT; MIURA K, 1993, BRAIN DEV-JPN, V15, P288, DOI 10.1016/0387-7604(93)90025-4; NORTHAM E, 2001, DEV NEUROPSYCHOLOGY; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; PALMINI A, 1991, NEUROLOGY, V41, P1656, DOI 10.1212/WNL.41.10.1656; PALMINI A, 1993, DEV MED CHILD NEUROL, V35, P331; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford J., 1995, TRAUMATIC BRAIN INJU; REY A, 1941, ARCH PSYCHOL, V28, P240; RICCI S, 1992, ARCH NEUROL-CHICAGO, V49, P61, DOI 10.1001/archneur.1992.00530250065017; ROSS ME, 1997, HUM MOL GENET, V6, P552; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Weschler D., 1992, WESCHLER INTELLIGENC; WOOD S, 1999, J INT NEUROPSYCH SOC, V5, P274; WRENNALL J, 2001, DEV NEUROPSYCHOLOGY	42	11	11	0	2	CAMBRIDGE UNIV PRESS	PORT CHESTER	110 MIDLAND AVE, PORT CHESTER, NY 10573-9863 USA	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	SEP	2001	43	9					628	633		10.1017/S0012162201001141			6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	490MU	WOS:000172056300009	11570633				2021-06-18	
J	Lukas, SE; Kouri, EM; Rhee, C; Madrid, A; Renshaw, PF				Lukas, SE; Kouri, EM; Rhee, C; Madrid, A; Renshaw, PF			Effects of short-term citicoline treatment on acute cocaine intoxication and cardiovascular effects	PSYCHOPHARMACOLOGY			English	Article						cocaine; citicoline; pharmacotherapy; subjective effect; plasma level; human subject	TRAUMATIC BRAIN INJURY; CEREBRAL BLOOD-FLOW; CDP-CHOLINE; PERFUSION; HUMANS; TECHNETIUM-99M-HMPAO; VOLUNTEERS; ABUSERS; MEMORY; USERS	Rationale: The majority of pharmacotherapies proposed for cocaine dependence have been marginally effective and frequently have undesirable side effects. We recently demonstrated that short-term treatment with citicoline decreased self-reported desire to use cocaine in crack cocaine users. Objective: The present study was conducted to assess the safety of citicoline in combination with cocaine by investigating whether cocaine-induced cardiovascular and behavioral effects and cocaine plasma levels are altered by citicoline pretreatment. Methods: Eight healthy male and female volunteers who used cocaine on an occasional basis participated in this randomized, placebo-controlled, three-visit study. During all three visits, subjects received an acute intranasal dose of cocaine (0.9 mg/kg) and were continuously monitored for the ensuing 3.5 h. The first visit involved no pretreatment, and visits 2 and 3 were preceded by a 4-day pretreatment period of either citicoline (1 g/day) or placebo. Results: Citicoline pretreatment did not alter the cardiovascular, physiologic, or subjective effects of acute cocaine. Conclusions: Although citicoline did not block the acute subjective effects of cocaine in a laboratory environment, the combined use of citicoline and a moderate dose of intranasal cocaine presented no added risk of cardiovascular effects. Further study is necessary to determine whether this medication (which is currently used to treat strokes) will be a useful adjunct to treat cocaine dependence.	Harvard Univ, Sch Med, McLean Hosp, Behav Psychopharmacol Res Lab, Belmont, MA 02478 USA; Harvard Univ, Sch Med, McLean Hosp, Brain Imaging Ctr, Belmont, MA 02478 USA	Lukas, SE (corresponding author), Harvard Univ, Sch Med, McLean Hosp, Behav Psychopharmacol Res Lab, 115 Mill St, Belmont, MA 02478 USA.		Renshaw, Perry/O-1384-2018		NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA011098] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA11098, DA0343] Funding Source: Medline		Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; CHIDA N, 1973, TOHOKU J EXP MED, V111, P41, DOI 10.1620/tjem.111.41; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; CONE EJ, 1994, CLIN CHEM, V40, P1299; CORSO E A, 1982, Clinica Terapeutica, V102, P379; DARAS M, 1996, PUBL US DEP HHS, P43; HOLMAN BL, 1991, J NUCL MED, V32, P1206; Kaufman MJ, 1998, JAMA-J AM MED ASSOC, V279, P376, DOI 10.1001/jama.279.5.376; Kaufman MJ, 1998, PSYCHOPHARMACOLOGY, V138, P76, DOI 10.1007/s002130050647; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kosten T R, 1993, NIDA Res Monogr, V135, P48; Kouri EM, 2000, PSYCHOPHARMACOLOGY, V152, P268, DOI 10.1007/s002130000540; LEVIN JM, 1994, J NUCL MED, V35, P1902; LUKAS SE, 1994, PHARMACOL BIOCHEM BE, V48, P715, DOI 10.1016/0091-3057(94)90338-7; Lukas SE, 1996, PSYCHOPHARMACOLOGY, V125, P346, DOI 10.1007/BF02246017; MANSCHRECK TC, 1990, COMPR PSYCHIAT, V31, P369, DOI 10.1016/0010-440X(90)90045-T; MARTINET M, 1979, ARCH INT PHARMACOD T, V239, P52; Martins N, 1997, IEEE T POWER SYST, V12, P245, DOI 10.1109/59.574945; Mathew RJ, 1996, BIOL PSYCHIAT, V40, P609, DOI 10.1016/0006-3223(95)00033-X; MITTENBERG W, 1993, ARCH CLIN NEUROPSYCH, V8, P447; Moriyama M., 1967, GENDAI NO RINSHO, V1, P114; MYKITA S, 1986, J NEUROCHEM, V47, P223; O'Malley S S, 1990, NIDA Res Monogr, V101, P179; OMALLEY S, 1992, AM J DRUG ALCOHOL AB, V18, P131, DOI 10.3109/00952999208992826; Renshaw PF, 1999, PSYCHOPHARMACOLOGY, V142, P132, DOI 10.1007/s002130050871; SALIGAUT C, 1984, CIRC METAB CERVEAU, V2, P33; SECADES JJ, 1995, METHOD FIND EXP CLIN, V17, P1; Spiers PA, 1996, ARCH NEUROL-CHICAGO, V53, P441, DOI 10.1001/archneur.1996.00550050071026; Spiers PA, 1999, J INT NEUROPSYCH SOC, V5, P260, DOI 10.1017/S1355617799533092; STRICKLAND TL, 1993, J NEUROPSYCH CLIN N, V5, P419; TAZAKI Y, 1988, STROKE, V19, P211, DOI 10.1161/01.STR.19.2.211; TUMEH SS, 1990, RADIOLOGY, V176, P821, DOI 10.1148/radiology.176.3.2389042; VOLKOW ND, 1988, BRIT J PSYCHIAT, V152, P641, DOI 10.1192/bjp.152.5.641; Wallace EA, 1996, PSYCHOPHARMACOLOGY, V128, P17, DOI 10.1007/s002130050104; WEISS GB, 1995, LIFE SCI, V56, P637, DOI 10.1016/0024-3205(94)00427-T; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6	36	11	11	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0033-3158			PSYCHOPHARMACOLOGY	Psychopharmacology	SEP	2001	157	2					163	167		10.1007/s002130100824			5	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	476TD	WOS:000171244100006	11594440				2021-06-18	
J	Leon-Carrion, J; Machuca-Murga, F; Murga-Sierra, M; Dominguez-Morales, R				Leon-Carrion, J; Machuca-Murga, F; Murga-Sierra, M; Dominguez-Morales, R			Outcome after an intensive, holistic and multidisciplinar rehabilitation program after traumatic brain injury. Medico-legal values	REVISTA DE NEUROLOGIA			Spanish	Article						brain injury; neuropsychology; rehabilitation		Introduction. This paper was designed to evaluate the integral rehabilitation treatments for patients with traumatic brain injury, data about efficiency of the C.RE.CER.(R) intensive, holistic and multidisciplinar rehabilitation program is given. Patients and methods. The study was done keeping in mind not only the clinical aspects of rehabilitation, but also setting it within the judicial realm in which a great number of brain injury cases are found, mainly when caused by traffic accidents. A sample of 10 severe traumatic brain injury patients was studied, aged between 19 and 39. All the patients were assessed at the beginning and the end of the treatment, using a neuropsychological test battery, meanwhile were treated with the C.RE.CER.(R) intensive, holistic and multidisciplinar rehabilitation program. Results and conclusions. The results show a high efficiency of treatments in the majority of the patients, with reductions of more than 70% in emotional deficits and more than 60% in the global recovery of the patients that carried out the programs. This paper also shows some limitations of the criteria for compensation in Spanish legislation.	Univ Seville, Fac Psicol, E-41009 Seville, Spain; Univ Seville, Fac Med, E-41009 Seville, Spain; Ctr Rehabil Dano Cerebral CRE CER, Seville, Spain		jleon@cica.es	Leon Carrion, Jose/D-5638-2012				BENTON AL, 1963, REVISED VISUAL RETEN; CHRISTENSEN AL, 1997, NEUROPSYCHOLOGICAL R; FORASTERO P, 1992, REHABILITACION, V26, P211; Goodglass H., 1986, EVALUACION AFASIA TR; Leon-Carrion J, 1998, NEUROREHABILITATION, V11, P129, DOI 10.1016/S1053-8135(98)00017-1; LEONCARRION J, 1995, BATERIA NEUROPSICOLO; LEONCARRION J, 1994, DANO CEREBRAL GUIA F; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; LEONCARRION J, 1998, NOTICIOAS MED, P3686; LEONJIMENEZ F, 1998, REV ESP NEUROPSICOL, V1, P99; PERINO C, 1997, NEUROPSYCHOLOGICAL R	11	11	13	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	AUG 16	2001	33	4					377	383		10.33588/rn.3304.2000196			7	Clinical Neurology	Neurosciences & Neurology	478RY	WOS:000171360200016	11588734				2021-06-18	
J	Jacome, DE				Jacome, DE			Blepharoclonus and Arnold-Chiari malformation	ACTA NEUROLOGICA SCANDINAVICA			English	Article						Arnold-Chiari malformation; blepharoclonus; digital dysplasia; dural venous malformation; post-traumatic headache; syrinx	NYSTAGMUS; HEADACHE; BLEPHAROSPASM; HYDROCEPHALUS; MIGRAINE; CLOSURE; REFLEX	Objective - Blepharoclonus (BLC) denotes a large amplitude, involuntary tremors of the orbicularis oculi muscles, observed during gentle closure of the eyelids. BLC may follow major head trauma. Four patients with Arnold-Chiari malformation (ACM) and BLC are described. Materials and methods - The first patient had facial numbness for 5 months; the remaining patients had headaches following minor head or cervical spinal injuries. Brain magnetic resonance imaging (MRI), electroencephalogram (EEG) blink reflexes, mental and facial nerve responses and facial electromyogram (EMG) were performed. Results - All patients exhibited ACM on brain MRI. The first patient had coincidental dural venous malformation, empty-sella turcica and familial digital dysplasia. She exhibited oculopterygoid synkinesis. The last 3 patients had posttraumatic headache; the second and third patients had limited features of Ehlers-Danlos syndrome (EDS). The second patient had cervical spinal fusion and the fourth a cervical syrinx. All the patients had BLC on gentle eyelid closure. Conclusion - BLC is an underdiagnosed neuro-ophthalmological sign of ACM.	Franklin Med Ctr, Dept Med, Greenfield, MA 01301 USA; Dartmouth Hitchcock Med Ctr, Div Neurol, Lebanon, NH 03756 USA	Jacome, DE (corresponding author), 1 Burnham St, Turners Falls, MA 01376 USA.						ARAMIDEH M, 1994, BRAIN, V117, P1457, DOI 10.1093/brain/117.6.1457; BARTON JJS, 1990, ARCH NEUROL-CHICAGO, V47, P357; BEHRMAN S, 1988, MOVEMENT DISORD, V3, P326, DOI 10.1002/mds.870030407; Brodsky MC, 1995, J NEURO-OPHTHALMOL, V15, P236; Carmichael E A, 1925, Br J Ophthalmol, V9, P49, DOI 10.1136/bjo.9.2.49; CIRIGNOTTA F, 1991, EUR NEUROL, V31, P36, DOI 10.1159/000116624; DAROFF RB, 1968, J NEUROL NEUROSUR PS, V31, P362, DOI 10.1136/jnnp.31.4.362; GATTO M, 1990, MOVEMENT DISORD, V5, P310, DOI 10.1002/mds.870050409; GILBERT JN, 1986, NEUROSURGERY, V18, P559, DOI 10.1227/00006123-198605000-00008; Hoban Timothy F., 1997, Neurology, V48, pA401; JACOME DE, 1986, HEADACHE, V26, P515, DOI 10.1111/j.1526-4610.1986.hed2610515.x; Jacome DE, 1997, J NEURO-OPHTHALMOL, V17, P95; Jacome DE, 2000, J NEURO-OPHTHALMOL, V20, P276, DOI 10.1097/00041327-200020040-00016; KASNER SE, 1995, HEADACHE, V35, P557, DOI 10.1111/j.1526-4610.1995.hed3509557.x; KEANE JR, 1978, ANN NEUROL, V3, P243, DOI 10.1002/ana.410030310; KHURANA RK, 1991, HEADACHE, V31, P151, DOI 10.1111/j.1526-4610.1991.hed3103151.x; KIMURA J, 1969, ARCH NEUROL-CHICAGO, V21, P193, DOI 10.1001/archneur.1969.00480140093009; KOSNIK E, 1976, NEUROLOGY, V26, P248, DOI 10.1212/WNL.26.3.248; LARON Z, 1997, HELV PAEDIATR ACTA, V24, P576; LAWDEN MC, 1993, J NEUROL NEUROSUR PS, V56, P708, DOI 10.1136/jnnp.56.6.708; LEWIS JA, 1972, NEUROLOGY, V22, P1145, DOI 10.1212/WNL.22.11.1145; LOEFFLER JD, 1996, ARCH OPHTHALMOL-CHIC, V76, P178; MOSSMAN SS, 1990, ARCH NEUROL-CHICAGO, V47, P357, DOI 10.1001/archneur.1990.00530030139030; MOSTER ML, 1988, ANN NEUROL, V23, P190, DOI 10.1002/ana.410230213; OBESO JA, 1985, NEUROLOGY, V35, P1378, DOI 10.1212/WNL.35.9.1378; PEARCE JMS, 1989, J NEUROL NEUROSUR PS, V52, P907, DOI 10.1136/jnnp.52.7.907; SAFRAN AB, 1983, J CLIN NEURO-OPHTHAL, V3, P133; Thomas P, 1996, NEUROLOGY, V46, P1165, DOI 10.1212/WNL.46.4.1165; TOMITA Y, 1991, BRAIN DEV-JPN, V13, P425, DOI 10.1016/S0387-7604(12)80041-6; VANDENBERGH R, 1992, J NEUROL, V239, P263; VRABEC TR, 1989, ANN NEUROL, V26, P401, DOI 10.1002/ana.410260317; WEINTRAUB MI, 1990, DEV MED CHILD NEUROL, V32, P929; ZAHN JR, 1978, J NEUROL NEUROSUR PS, V41, P617, DOI 10.1136/jnnp.41.7.617	33	11	12	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	2001	104	2					113	117		10.1034/j.1600-0404.2001.104002113.x			5	Clinical Neurology	Neurosciences & Neurology	459WJ	WOS:000170274200012	11493230				2021-06-18	
J	Rao, WLR; Dogan, A; Bowen, KK; Dempsey, RJ				Rao, WLR; Dogan, A; Bowen, KK; Dempsey, RJ			Ornithine decarboxylase knockdown exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						antisense knockdown; cerebral ischemia; infarct; middle cerebral artery occlusion; neuronal damage; ornithine decarboxylase	GLUTAMATE TRANSPORTER GLT-1; TRANSGENIC MICE; MESSENGER-RNA; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; POLYAMINE METABOLISM; ANTISENSE KNOCKDOWN; ENERGY-METABOLISM; TRAUMATIC INJURY; ARTERY OCCLUSION; INFARCT VOLUME	Transient cerebral ischemia leads to increased expression of ornithine decarboxylase (ODC). Contradicting studies attributed neuroprotective and neurotoxic roles to ODC after ischemia. Using antisense oligonucleotides (ODNs), the current study evaluated the functional role of ODC in the process of neuronal damage after transient focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO) in spontaneously hypertensive rats. Transient MCAO significantly increased the ODC immunoreactive protein levels and catalytic activity in the ipsilateral cortex. which were completely pre-vented by the infusion of antisense ODN specific for ODC. Transient MCAO in rats infused with ODC antisense ODN increased the infarct volume, motor deficits, and mortality compared with the sense or random ODN-infused controls. Results of the current study support a neuroprotective or recovery role, or both, for ODC after transient focal ischemia.	Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI 53792 USA; William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	Dempsey, RJ (corresponding author), Univ Wisconsin, Dept Neurol Surg, H4-336 CSC,600 Highland Ave, Madison, WI 53792 USA.		Dogan, Aclan/AAF-8305-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS028000] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS28000, NS31220] Funding Source: Medline		ALHONEN L, 1995, INT J CANCER, V63, P402, DOI 10.1002/ijc.2910630317; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; BOURDIOL F, 1992, BRAIN RES, V596, P183, DOI 10.1016/0006-8993(92)91546-Q; Chan PH, 1998, J NEUROSCI, V18, P8292, DOI 10.1523/jneurosci.18-20-08292.1998; DEMPSEY R J, 1988, Neurological Research, V10, P175; DEMPSEY RJ, 1991, J CEREBR BLOOD F MET, V11, P979, DOI 10.1038/jcbfm.1991.164; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; DIENEL GA, 1985, J NEUROCHEM, V44, P600, DOI 10.1111/j.1471-4159.1985.tb05454.x; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; DOGAN A, 1998, J NEUROSURG, V88; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; Harada J, 1997, BRAIN RES, V753, P251, DOI 10.1016/S0006-8993(97)00011-5; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; Johnson TD, 1998, PROG DRUG RES, V50, P193; Kaasinen K, 2000, EUR J NEUROSCI, V12, P540, DOI 10.1046/j.1460-9568.2000.00940.x; KAUPPINEN RA, 1992, J NEUROCHEM, V58, P831, DOI 10.1111/j.1471-4159.1992.tb09332.x; Keinanen R, 1997, NEUROSCI LETT, V239, P69, DOI 10.1016/S0304-3940(97)00890-2; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUKKARAINEN J, 1995, EUR J NEUROSCI, V7, P1840, DOI 10.1111/j.1460-9568.1995.tb00704.x; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; Lukkarinen JA, 1999, BRAIN RES, V826, P325, DOI 10.1016/S0006-8993(99)01327-X; Lukkarinen JA, 1998, EUR J NEUROSCI, V10, P2046, DOI 10.1046/j.1460-9568.1998.00216.x; Mehrotra PK, 1998, CONTRACEPTION, V57, P55, DOI 10.1016/S0010-7824(97)00208-4; MUSZYNSKI CA, 1993, J CEREBR BLOOD F MET, V13, P1033, DOI 10.1038/jcbfm.1993.131; Nishioka K, 1995, J CELL BIOCHEM, P87; PASCHEN W, 1988, BRAIN RES, V453, P9, DOI 10.1016/0006-8993(88)90138-2; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pussinen R, 1998, SYNAPSE, V28, P288, DOI 10.1002/(SICI)1098-2396(199804)28:4<288::AID-SYN4>3.0.CO;2-5; Rao AM, 2000, J NEUROCHEM, V74, P1106; RAO AM, 1995, J NEUROCHEM, V65, P2639; Rao VLR, 1998, BRAIN RES, V783, P163, DOI 10.1016/S0006-8993(97)01301-2; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Reeben M, 1996, J NEUROSCI RES, V45, P542, DOI 10.1002/(SICI)1097-4547(19960901)45:5<542::AID-JNR4>3.3.CO;2-R; ROHN G, 1992, EXP NEUROL, V117, P210, DOI 10.1016/0014-4886(92)90129-E; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SEILER N, 1984, NEUROCHEM RES, V9, P871, DOI 10.1007/BF00964520; Seiler N, 2000, NEUROCHEM RES, V25, P471, DOI 10.1023/A:1007508008731; Shyng SL, 1996, P NATL ACAD SCI USA, V93, P12014, DOI 10.1073/pnas.93.21.12014; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; WEN L, 1989, J BIOL CHEM, V264, P9016; Zoli M, 1996, MOL BRAIN RES, V38, P122, DOI 10.1016/0169-328X(95)00339-T	51	11	11	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2001	21	8					945	954					10	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	459AQ	WOS:000170228000007	11487730				2021-06-18	
J	Barbiro-Micahely, E; Mayevsky, A				Barbiro-Micahely, E; Mayevsky, A			Multiparametric monitoring of brain under elevated intracranial pressure in a rat model	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cisternal infusion; intracranial hypertension; NADH redox state; rat	LASER-DOPPLER FLOWMETRY; CEREBRAL BLOOD-FLOW; CEREBROSPINAL-FLUID; INTRAOPERATIVE MEASUREMENT; CARBON-MONOXIDE; HEAD-INJURY; AUTOREGULATION; HYPERTENSION; RESPONSES; MICROCIRCULATION	Intracranial hypertension may develop in most patients exposed to traumatic head injury. In many cases, patients enduring elevated intracranial pressure (ICP) will incur morbidity or mortality. Several methods are used in animal models to investigate the influence of ICP elevation on physiological parameters. In this study, we developed a cisterna magna model by adding a mechanism for warming the mock cerebrospinal fluid (CSF) entering the cisterna space to a temperature of 37 degreesC and combined this method for ICP elevation with the multiparametric monitoring system (Multiprobe Assembly [MPA]). Using the MPA, we monitored, for the first time, mitochondrial NADH redox state as well as ionic homeostasis under elevated ICP in a rat model. In addition, we monitored cerebral blood flow (CBF) by laser Doppler flowmetry, ECoG (bipolar electrodes), and surface temperature. Blood pressure was measured in the cannulated femoral artery. The ICP (monitored by Camino probe) was elevated to 50-60 mm Hg for 13-15 min, followed by 2 h of recovery. The results show that CBF was decreased by 90%, while NADH was elevated by 80% as compared to the normoxic levels. Complete depolarization occurred as evidence by the decrease in extracellular Ca2+ and a significant increase in K+. All parameters recovered 10 min after reopening the cannula to the cisterna magna to air pressure. We conclude that ICP elevation through the cisterna magna infusion method, used simultaneously with multiparametric monitoring, supplies reliable information on the brain tissue metabolic state with intracranial hypertension in a rat model.	Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel	Mayevsky, A (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	mayevsa@mail.biu.ac.il					ANDREWS B T, 1988, Neurological Research, V10, P123; ARBIT E, 1989, NEUROSURGERY, V24, P166, DOI 10.1227/00006123-198902000-00003; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; BOTEL C, 1994, J EXP ANIM SCI, V36, P78; BOUMAN HJ, 1979, BRAIN RES BULL, V4, P575, DOI 10.1016/0361-9230(79)90045-5; Bullock MR, 1996, J NEUROTRAUM, V13, P685; DALEY ML, 1995, IEEE T BIO-MED ENG, V42, P420, DOI 10.1109/10.376137; DEARDEN NM, 1984, J NEUROSURG, V60, P123, DOI 10.3171/jns.1984.60.1.0123; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; FASANO VA, 1988, ACTA NEUROCHIR, V95, P40, DOI 10.1007/BF01793081; FITCH W, 1977, J NEUROL NEUROSUR PS, V40, P843, DOI 10.1136/jnnp.40.9.843; FRIEDLI CM, 1982, AM J PHYSIOL, V243, pR462; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247; HAUERBERG J, 1994, J CEREBR BLOOD F MET, V14, P519, DOI 10.1038/jcbfm.1994.64; HUDETZ AG, 1995, AM J PHYSIOL-HEART C, V268, pH2202; INAO S, 1993, NEUROL RES, V15, P264; JOHNSTON IH, 1973, J NEUROL NEUROSUR PS, V36, P161, DOI 10.1136/jnnp.36.2.161; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; MALKINSON TJ, 1985, BRAIN RES BULL, V15, P321, DOI 10.1016/0361-9230(85)90158-3; MARMAROU A, 1993, HEAD INJURY, P203; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MAYEVSKY A, 1984, BRAIN RES REV, V7, P49, DOI 10.1016/0165-0173(84)90029-8; MAYEVSKY A, 1982, SCIENCE, V217, P537, DOI 10.1126/science.7201167; MAYEVSKY A, 1995, J APPL PHYSIOL, V78, P1188; Mayevsky A, 1999, ACT NEUR S, V75, P63; MAYEVSKY A, 1985, AM J PHYSIOL, V248, pR99; Mayevsky A, 1998, NEUROL RES, V20, pS76; MAYEVSKY A, 1991, SPIE P, V1431, P303; Meilin S, 1996, J APPL PHYSIOL, V81, P1078; MORROW BA, 1990, AM J PHYSIOL, V258, pR1170; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; NITTA M, 1990, ACTA NEUROCHIR, V104, P30, DOI 10.1007/BF01842890; Osbakken M, 1996, J Basic Clin Physiol Pharmacol, V7, P97; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; ROSENBLUM BR, 1987, J NEUROSURG, V66, P396, DOI 10.3171/jns.1987.66.3.0396; SHALIT MN, 1974, J NEUROSURG, V40, P594, DOI 10.3171/jns.1974.40.5.0594; SIESJO BK, 1970, ACTA NEUROL SCAND, V46, P187, DOI 10.1111/j.1600-0404.1970.tb05615.x; SIOUTOS PJ, 1996, NEUROTRAUMA, P503; STERN MD, 1977, AM J PHYSIOL, V232, pH441; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841; SUTTON LN, 1987, J NEUROSURG, V67, P381, DOI 10.3171/jns.1987.67.3.0381; Tsai M L, 1988, Chin J Physiol, V31, P113; VINAS FC, 1995, NEUROL RES, V17, P465, DOI 10.1080/01616412.1995.11740365; Wadhwani K.C., 1990, LASER DOPPLER BLOOD, P265; YAMANE K, 1994, SURG NEUROL, V41, P477, DOI 10.1016/0090-3019(94)90011-6	47	11	11	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2001	18	7					711	725		10.1089/089771501750357654			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	457CK	WOS:000170119400007	11497097				2021-06-18	
J	DeFord, SM; Wilson, MS; Gibson, CJ; Baranova, A; Hamm, RJ				DeFord, SM; Wilson, MS; Gibson, CJ; Baranova, A; Hamm, RJ			Nefiracetam improves Morris water maze performance following traumatic brain injury in rats	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						nefiracetam; brain injury; traumatic brain injury; rats; fluid percussion; Morris water maze; cognitive recovery	FOREBRAIN CHOLINE-ACETYLTRANSFERASE; HEAD-INJURY; ANIRACETAM; ACETYLCHOLINE; IMPAIRMENT; GLUTAMATE; CURRENTS; DM-9384; CHANNEL; MEMORY	Nefiracetam, a pyrrolidone derivative, is a nootropic agent that has facilitated cognitive function in a wide variety of animal models of cognitive dysfunction. The purpose of this study was to investigate the efficacy of the chronic postinjury administration of nefiracetam (DM-9384) in improving cognitive performance following central fluid percussion brain injury in rats. Twenty-four hours following surgical preparation, a sham injury or a moderate fluid percussive injury (2.1 arm) was delivered. Nefiracetam was administered chronically (0 or 9 mg/kg, po, for sham animals and 0, 3, or 9 mg/kg for injured animals) on postinjury days 1-15. Cognitive performance was assessed using the Morris water maze (MWM) on postinjury days 11-15. Chronic administration of 3 and 9 mg/kg nefiracetam attenuated MWM deficits produced by central fluid percussive brain injury. Importantly, the MWM performance of the injured animals treated with 9 mg/kg did not significantly differ from uninjured, sham animals. The 9-mg/kg dose of nefiracetam did not have a positive or negative effect on MWM performance of uninjured animals. The results of the present experiment suggest that a nootropic such as nefiracetam may be an appropriate treatment for trauma-induced cognitive dysfunction. (C) 2001 Elsevier Science Inc. All rights reserved.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA	Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Dept Psychol, POB 842018,808 W Franklin St, Richmond, VA 23284 USA.						ABE E, 1994, J NEURAL TRANSM-GEN, V95, P179, DOI 10.1007/BF01271565; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; FUNK KF, 1984, BIOMED BIOCHIM ACTA, V11, P1301; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hiramatsu M, 1997, BEHAV BRAIN RES, V83, P107, DOI 10.1016/S0166-4328(97)86053-6; HIRAMATSU M, 1992, EUR J PHARMACOL, V216, P279, DOI 10.1016/0014-2999(92)90371-A; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARCHI M, 1990, EUR J PHARMACOL, V185, P247, DOI 10.1016/0014-2999(90)90650-U; NABESHIMA T, 1994, EUR J PHARMACOL, V255, P57, DOI 10.1016/0014-2999(94)90082-5; Nabeshima Toshitaka, 1994, Drugs of Today, V30, P357; Nishizaki T, 1998, MOL PHARMACOL, V53, P1; Nomura T, 2000, BRAIN RES, V870, P157, DOI 10.1016/S0006-8993(00)02417-3; Oyaizu M, 1999, BRAIN RES, V822, P72, DOI 10.1016/S0006-8993(99)01077-X; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1997, PHARM BIOCH BEHAV, V57, P1; SAKURAI T, 1989, JPN J PHARMACOL, V50, P47, DOI 10.1254/jjp.50.47; SARTER M, 1991, TRENDS PHARMACOL SCI, V12, P456, DOI 10.1016/0165-6147(91)90636-7; SPIGNOLI G, 1987, PHARMACOL BIOCHEM BE, V27, P491, DOI 10.1016/0091-3057(87)90353-4; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Von Monakow C, 1969, BRAIN BEHAVIOR, P27; YOSHII M, 1994, BRAIN RES, V642, P123, DOI 10.1016/0006-8993(94)90913-X; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	35	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	JUL-AUG	2001	69	3-4					611	616		10.1016/S0091-3057(01)00559-7			6	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	460RP	WOS:000170322600037	11509223				2021-06-18	
J	Alberti, A; Sarchielli, P; Mazzotta, G; Gallai, V				Alberti, A; Sarchielli, P; Mazzotta, G; Gallai, V			Event-related potentials in posttraumatic headache	HEADACHE			English	Article						posttraumatic headache; event-related potentials; cognitive impairment	COGNITIVE EVOKED-POTENTIALS; AXONAL INJURY; P300; DEPRESSION; SYMPTOMS; LATENCY; STRESS; MEMORY	Objectives-To assess impairment of cognitive functions occurring in patients with posttraumatic headache as a consequence of a minor cranial trauma in the absence of organic damage involving the central nervous system. Background.-The term posttraumatic syndrome defines a stereotypic set of symptoms following traumatic brain injury that are subjective and varied. A deficit of cognitive function and impairment of the rapid processes of learning, attention, and short-term memory have frequently been identified. Moreover, headache is the most frequent symptom reported by the patients. Due to the nature of the symptoms, a great limitation in defining the posttraumatic syndrome is represented by the lack of methods and diagnostic tools that allow quantification of the subjective disturbances and evidence of the signs indicative of central nervous system involvement in this pathological condition. Methods.-Twenty-five subjects (16 women, 9 men; mean age, 28 +/- 9 years) were examined between 3 and 6 months after the traumatic event. The P300 event-related potential was recorded by an odd-ball paradigm with an acoustic modality. The patients underwent electroencephalography and brain stem auditory evoked potentials; magnetic resonance imaging was performed to exclude the presence of cerebral lesions. Results.-The mean latency of P300 was increased in both central electrodes (Cz and Pt) in patients with posttraumatic syndrome compared with controls (P < .001); assuming the value of mean +/- 2 SD was the cutoff point between normal and abnormal results, the P300 latency results were altered in 13 patients (52%). In the patient group, a significant correlation was demonstrated between Zung Depression Scale score and P3 and N2 wave latencies (r = 0.54, P < .004; r = 0.56, P < .003) and between Zung Anxiety Scale scores and P3 wave latencies (r = 0.46, P < .02). Conclusions.-These data suggest the usefulness of the P300 event-related potential in evaluating cognitive disturbances in patients affected by posttraumatic syndrome. Alteration of cognitive potential in such patients, even in the absence of lesions detectable by neuroimaging, indicate the functional impairment of specific cerebral areas that can occur after a traumatic event.	Interuniv Ctr Study Headache & Neurotransmitter D, Perugia, Italy	Alberti, A (corresponding author), Univ Perugia, Dept Neurosci, Via E Dal Pozzo 79, I-06126 Perugia, Italy.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Bange F, 1998, EVOKED POTENTIAL, V108, P472, DOI 10.1016/S0168-5597(98)00024-0; BARNAT MR, 1986, HEADACHE, V26, P271, DOI 10.1111/j.1526-4610.1986.hed2606271.x; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BLACKWOOD DHR, 1986, BIOL PSYCHIAT, V21, P557, DOI 10.1016/0006-3223(86)90201-5; Boudarene M, 1998, ENCEPHALE, V24, P557; CALLAWAY E, 1983, PSYCHOPHYSIOLOGY, V20, P359, DOI 10.1111/j.1469-8986.1983.tb00915.x; GALLAI V, 1995, ACTA NEUROL SCAND, V91, P358, DOI 10.1111/j.1600-0404.1995.tb07021.x; Gallai V, 1994, Electromyogr Clin Neurophysiol, V34, P397; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GOODIN DS, 1986, BRAIN, V109, P1103, DOI 10.1093/brain/109.6.1103; Granovsky Y, 1998, EVOKED POTENTIAL, V108, P554, DOI 10.1016/S0168-5597(98)00036-7; HAMMOND EJ, 1987, NEUROLOGY, V37, P346, DOI 10.1212/WNL.37.2.346; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSON R, 1985, PSYCHOPHYSIOLOGY, V22, P497, DOI 10.1111/j.1469-8986.1985.tb01639.x; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MEADOR KJ, 1987, NEUROLOGY, V37, P526, DOI 10.1212/WNL.37.3.526; Miller J. D., 1989, TXB HEAD INJURY, P507; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Packard RC, 1996, HEADACHE Q-CURR TREA, V7, P218; PACKARD RC, 1993, HEADACHE, V33, P365, DOI 10.1111/j.1526-4610.1993.hed3307365.x; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P104, DOI 10.1016/0168-5597(84)90027-3; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHLEGEL S, 1991, ACTA PSYCHIAT SCAND, V83, P438, DOI 10.1111/j.1600-0447.1991.tb05571.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; SPEED WG, 1986, PRACTICING PHYSICIAN, P113; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Vandoolaeghe E, 1998, J AFFECT DISORDERS, V48, P105, DOI 10.1016/S0165-0327(97)00165-1; Zampolini M, 1997, EUR J NEUROL, V4, P246, DOI 10.1111/j.1468-1331.1997.tb00343.x	34	11	22	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2001	41	6					579	585		10.1046/j.1526-4610.2001.041006579.x			7	Clinical Neurology	Neurosciences & Neurology	447TC	WOS:000169587700010	11437894				2021-06-18	
J	Cherner, M; Temkin, NR; Machamer, JE; Dikmen, SS				Cherner, M; Temkin, NR; Machamer, JE; Dikmen, SS			Utility of a composite measure to detect problematic alcohol use in persons with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						alcohol abuse; brain injuries; rehabilitation	SUBSTANCE-ABUSE; HEAD-INJURY; INTOXICATION; SEVERITY; DRINKING; PATTERNS; TRENDS	Objectives: To examine factors complicating the study of alcohol-related effects in traumatic brain injury (TBI) patients and to evaluate a composite measure to categorize such patients according to degree of alcohol-related problems. Design: Inception cohort. Setting: Level I trauma center. Patients: Consecutively hospitalized adult TBI patients (n = 156; 73% men; 87% Caucasian; mean age, 30yr; mean education, 12yr). Selection criteria required objective evidence of brain trauma; minimum survival of 1 month postinjury; age 15 years or older; and English speaking. Main Outcome Measures: An index of problematic drinking based on a measure created by combining blood-alcohol level, quantity-frequency of consumption, and the Short Michigan Alcoholism Screening Test. Preinjury characteristics were obtained through structured interview. Results: Participants with highly problematic drinking showed poorer premorbid psychosocial functioning, including lower educational attainment, greater likelihood of problems with the law, lower perceived social support, and greater prevalence of other substance abuse. Conclusion: The composite index is useful in identifying problematic drinkers among TBI patients. Results have implications for interpreting and planning research on the role of alcohol in TBI outcomes. (C) 2001 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	Dikmen, SS (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	dikmen@u.washington.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS005304] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD033677] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [HS05304] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD33677] Funding Source: Medline		ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; ALTERMAN AI, 1985, INT J NEUROSCI, V26, P75, DOI 10.3109/00207458508985606; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bombardier CH, 1997, REHABIL PSYCHOL, V42, P259; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CHERPITEL CJ, 1994, ALCOHOL CLIN EXP RES, V18, P679, DOI 10.1111/j.1530-0277.1994.tb00930.x; COHEN J, 1975, APPL MULTIPLE REGRES, V21; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Dikmen S. S., 1993, NEUROPSYCHOLOGIA, V7, P296, DOI DOI 10.1037/0894-4105.7.3.296; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Drubach D A, 1993, Md Med J, V42, P989; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P93; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Li GH, 1997, J TRAUMA, V42, P562, DOI 10.1097/00005373-199703000-00032; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; MIDANIK LT, 1994, AM J PUBLIC HEALTH, V84, P1218, DOI 10.2105/AJPH.84.8.1218; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; *US DEP HHS, 1997, 9 SPEC REP US C ALC; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Wilsnack S C, 1995, Recent Dev Alcohol, V12, P29; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955	44	11	12	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2001	82	6					780	786		10.1053/apmr.2001.23263			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	439KK	WOS:000169115900011	11387583				2021-06-18	
J	McCrory, P				McCrory, P			The nature of concussion: a speculative hypothesis	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							MINOR HEAD-INJURY; SPORT		Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia; Univ Melbourne, Inst Brain Res, Parkville, Vic 3052, Australia	McCrory, P (corresponding author), Univ Melbourne, Ctr Sports Med Res & Educ, Parkville, Vic 3052, Australia.		McCrory, Paul/Q-8688-2019				BROWN WJ, 1972, AM J PATHOL, V67, P41; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GOLDBERG E, 1982, CORTEX, V18, P459, DOI 10.1016/S0010-9452(82)80042-7; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 1999, BRIT J SPORT MED, V33, P297; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Povlishock JT, 1996, ACT NEUR S, V66, P81; RHAZES A, 1497, OPERA MEDICA VARIA; Shetter A G, 1979, Adv Neurol, V22, P5	21	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	JUN	2001	35	3					146	147		10.1136/bjsm.35.3.146			2	Sport Sciences	Sport Sciences	440UV	WOS:000169193700006	11375871	Bronze, Green Published			2021-06-18	
J	Wong, PP; Monette, G; Weiner, NI				Wong, PP; Monette, G; Weiner, NI			Mathematical models of cognitive recovery	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; HEAD-INJURY; SEVERITY	Longitudinal psychological test results are used as dependant variables to explore the complex relationship between length of coma, time of testing on the recovery curve, and corresponding cognitive status after traumatic brain injury (TBI). A database containing 319 TBI patients with a broad spectrum of coma duration was used. Statistical analysis of mixed effects modelling was applied to longitudinal WAIS-R (Wechsler Adult Intelligence Scale-Revised) scores to construct two mathematical models (verbal IQ and performance IQ). The models predict the course of recovery (initial cognitive level post-coma, eventual recovery level, and level of cognitive functioning at any point on the recovery curve) when the duration of coma is known. Performance IQ was found to recover at a rate that is almost four times slower than verbal IQ. The results have important clinical rehabilitation implications. This statistical modelling technique also enables the medical researcher to investigate disease progression or recovery using structured assessments, which would normally be part of the routine medical monitoring.	York Univ, Dept Kinesiol & Hlth Sc, Toronto, ON M3J 1P3, Canada	Wong, PP (corresponding author), York Univ, Dept Kinesiol & Hlth Sc, 4700 Keele St, Toronto, ON M3J 1P3, Canada.						ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Annoni J M, 1992, Disabil Rehabil, V14, P23; BATES DM, 1997, MODELLING LONGITUDIN; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Brooks N., 1984, CLOSED HEAD INJURY P; COHADON F, 1991, J NEUROL SCI, V103, P27; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KOSTECKIDILLON T, 1999, YORK U I SOCIAL RES, V14, P3; MILLER JD, 1990, REHABILITATION ADULT, P236; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133; VILKKI J, 1988, J NEUROL NEUROSUR PS, V51, P1452, DOI 10.1136/jnnp.51.11.1452; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wong P P, 1993, Leadersh Health Serv, V2, P25; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003	25	11	11	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2001	15	6					519	530		10.1080/02699050010005995			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600005	11394971				2021-06-18	
J	Ashley, MJ; Persel, CS; Clark, MC				Ashley, MJ; Persel, CS; Clark, MC			Validation of an independent living scale for post-acute rehabilitation applications	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; VALIDITY	The Independent Living Scale (ILS) was developed in a post-acute traumatic brain injury (TBI) rehabilitation facility over a 15-year period to assess three main areas: (1) activities of daily living, (2) behaviour, and (3) initiation. The purpose of this study was to examine the psychometric properties of the ILS, including test-retest stability, construct validity, and statistical fit. Statistical analysis was completed on all weekly scores between the years 1986-1995 (n = 5250). A previous study showed ILS inter-rater reliability to be 0.85 and convergent validity 0.82-0.87. This study demonstrated a test-retest stability of 0.72, the Kaiser-Meyer-Olkin Measure of Sampling Adequacy 0.94 (marvelous), and a Bartlett Test of Sphericity result of 'scale items independent'. The ILS was shown to have good construct validity, inter-rater reliability, internal consistency, instrument stability, and convergent validity.	Ctr Neuro Skills, Bakersfield, CA 93306 USA; Kern Reg Ctr Dev Disabled, Bakersfield, CA USA	Ashley, MJ (corresponding author), Ctr Neuro Skills, 2658 Mt Vernon Ave, Bakersfield, CA 93306 USA.						Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HALL K, 1997, J REHABIL OUTCOMES M, V1, P63; KAUFERT JM, 1983, ARCH PHYS MED REHAB, V64, P260; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Nihira K., 1974, AAMD ADAPTIVE BEHAV; PERSEL CS, 1987, 49 ANN ASS AM AC PHY; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sparrow S., 1984, VINELAND ADAPTIVE BE; *SPSS INC, 1994, SPSS STAT PROGR SOC; TEASDALE G, 1974, LANCET, V2, P81	13	11	11	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2001	15	5					435	442		10.1080/02699050010005896			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	431TW	WOS:000168648700006	11350657				2021-06-18	
J	Kochanek, PM; Hendrich, KS; Robertson, CL; Williams, DS; Melick, JA; Ho, C; Marion, DW; Jackson, EK				Kochanek, PM; Hendrich, KS; Robertson, CL; Williams, DS; Melick, JA; Ho, C; Marion, DW; Jackson, EK			Assessment of the effect of 2-chloroadenosine in normal rat brain using spin-labeled MRI measurement of perfusion	MAGNETIC RESONANCE IN MEDICINE			English	Article						cerebral blood flow; brain; purine; hyperemia; adenosine	CONTROLLED CORTICAL IMPACT; CEREBRAL BLOOD-FLOW; ADENOSINE RECEPTORS; ISCHEMIC BRAIN; ARTERIAL WATER; INJURY	Adenosine analogs such as 2-chloroadenosine are potent cerebrovasodilators. Spin-labeled MRI was used to investigate the spatial distribution, dose-response, and timing of the effect of 2-chloroadenosine on cerebral blood flow (CBF) after intraparenchymal injection into rat brain. Sprague-Dawley rats (N = 10) were injected with 2-chloroadenosine at doses of 0.3, 6.0, or 12 nmoles, or saline vehicle (2-4 muL) CBF was serially quantified in a slice through the injection site in a circular (3.6 mm diameter) region of interest (ROI) around the injection and in ipsilateral hemispheric ROIs at similar to 90 min and similar to 180 min. Marked 3.17- and 3.93-fold increases in CBF (vs, vehicle) were seen in the circular ROI at similar to 90 min and similar to 180 min after 12-nmol injection, respectively. Similarly, 2.92- and 2.78-fold increases in hemispheric CBF were observed at similar to 90 min and similar to 180 min, respectively, after injection of 12 nmoles, Linear dose-response relationships were observed at both times after injection in both ROIs (all P < 0.01), Spin-labeling MRI assessment revealed that parenchymal injection of 2-chloroadenosine produces potent, dose-dependent, and sustained vasodilation over large areas of brain. This treatment and imaging paradigm should facilitate investigation of the effect of CBF promotion in models of traumatic and ischemic brain injury, (C) 2001 Wiley-Liss, Inc.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15260 USA; Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, 3434 5th Ave,Suite 201, Pittsburgh, PA 15260 USA.		Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021; Ho, Chien/O-6112-2016	Kochanek, Patrick M/0000-0002-2627-913X; Ho, Chien/0000-0002-4094-9232; Jackson, Edwin/0000-0002-8101-6009	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R01RR010962, P41RR003631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, R01NS038087, P50NS030318, P01NS030318] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR03631, RR-10962] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30318, NS 38087] Funding Source: Medline		AbdulGhani AS, 1997, EUR J PHARMACOL, V326, P7, DOI 10.1016/S0014-2999(97)00139-8; BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; BRUNS RF, 1986, MOL PHARMACOL, V29, P331; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Coney AM, 1998, J PHYSIOL-LONDON, V509, P507, DOI 10.1111/j.1469-7793.1998.507bn.x; DALY JW, 1981, LIFE SCI, V28, P2083, DOI 10.1016/0024-3205(81)90614-7; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; DORA E, 1984, J CEREBR BLOOD F MET, V4, P447, DOI 10.1038/jcbfm.1984.64; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; KALARIA RN, 1986, J CEREBR BLOOD F MET, V6, P463, DOI 10.1038/jcbfm.1986.80; MILLER LP, 1992, J NEUROTRAUM, V9, pS563; SILVA AC, 1995, MAGNET RESON MED, V33, P209, DOI 10.1002/mrm.1910330210; STRUPP JP, 1996, NEUROIMAGE, V3, P607; VANWYLEN DGL, 1989, J CEREBR BLOOD F MET, V9, P556, DOI 10.1038/jcbfm.1989.79; VONLUBITZ DKJ, 1997, PURINERGIC APPROACHE, P449; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; ZHANG WG, 1995, MAGNET RESON MED, V33, P370, DOI 10.1002/mrm.1910330310; ZHANG WG, 1993, MAGNET RESON MED, V29, P416, DOI 10.1002/mrm.1910290323	22	11	12	0	0	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0740-3194			MAGNET RESON MED	Magn. Reson. Med.	MAY	2001	45	5					924	929		10.1002/mrm.1123			6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	428CR	WOS:000168444000025	11323821				2021-06-18	
J	Komiyama, M; Morikawa, T; Nakajima, H; Yasui, T; Kan, M				Komiyama, M; Morikawa, T; Nakajima, H; Yasui, T; Kan, M			"Early" apoplexy due to traumatic intracranial aneurysm - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						diagnostic angiography; subarachnoid hemorrhage; timing of angiography; traumatic intracranial aneurysm	ANTERIOR CEREBRAL-ARTERY; INTERNAL CAROTID-ARTERY; MASSIVE EPISTAXIS; FALSE ANEURYSM; STAB WOUNDS; HEAD-INJURY; BRAIN; ANGIOGRAPHY; SURGERY; FISTULA	A 76-year-old man presented with a traumatic aneurysm of the left infernal carotid artery which caused repeated subarachnoid hemorrhages within 20 hours of a fall from a height. Early computed tomography (CT) detected no brain abnormalities, but repeat CT found subarachnoid hemorrhage. Internal carotid angiography detected a pseudoaneurysm, which was not treated because of his poor clinical condition. He died of multiple organ failure. Early detection of a traumatic infracranial aneurysm is important for the prevention of aneurysmal rupture, or "delayed" apoplexy. Review of 171 cases with traumatic aneurysms from the literature found that false negative angiography occurred only in three cases on post-trauma day 7 and thereafter. Early diagnostic angiography within a week of the initial trauma is indicated if traumatic aneurysm is suspected to detect early signs of irregularity, spasm, and narrowing of the arterial wall. Repeat angiography is indicated if aneurysmal formation is still highly suspected in spite of negative initial angiography.	Osaka City Gen Hosp, Dept Neurosurg, Miyakojima Ku, Osaka 5340021, Japan; Osaka City Gen Hosp, Emergency & Crit Care Ctr, Miyakojima Ku, Osaka 5340021, Japan	Komiyama, M (corresponding author), Osaka City Gen Hosp, Dept Neurosurg, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.			komiyama, masaki/0000-0003-0998-6315			AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; AMAGASA M, 1986, Neurological Surgery, V14, P1585; ARAKI C, 1965, J NEUROSURG, V23, P64, DOI 10.3171/jns.1965.23.1.0064; Asari S, 1976, No To Shinkei, V28, P793; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; CABEZUDO JM, 1981, J NEUROSURG, V54, P118, DOI 10.3171/jns.1981.54.1.0118; CAPANNA AH, 1984, SURG NEUROL, V22, P263, DOI 10.1016/0090-3019(84)90011-9; COCKRILL HH, 1977, J NEUROSURG, V46, P377, DOI 10.3171/jns.1977.46.3.0377; COSGROVE GR, 1983, J NEUROSURG, V58, P291; COURVILLE C B, 1960, Bull Los Angel Neuro Soc, V25, P48; CRESSMAN MR, 1966, J NEUROSURG, V24, P102, DOI 10.3171/jns.1966.24.1.0102; DITMORE M, 1980, NEUROSURGERY, V6, P293; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; Endo S, 1974, No Shinkei Geka, V2, P329; ENOMOTO H, 1984, NEUROSURGERY, V15, P700, DOI 10.1227/00006123-198411000-00011; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FUJIWARA K, 1976, TRAUMATOLOGY, V7, P377; Funahashi K, 1977, No Shinkei Geka, V5, P619; Funakoshi T, 1976, No Shinkei Geka, V4, P405; GOALD HJ, 1961, J NEUROSURG, V18, P401, DOI 10.3171/jns.1961.18.3.0401; Handa H, 1967, No To Shinkei, V19, P1063; HANDA J, 1970, AMER J ROENTGENOL RA, V109, P127, DOI 10.2214/ajr.109.1.127; HIGAZI I, 1969, J NEUROSURG, V30, P172, DOI 10.3171/jns.1969.30.2.0172; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; IDE Y, 1987, Neurological Surgery, V15, P1353; ITO H, 1975, NO TO SHINKEI, V27, P787; Jackson F E, 1970, J Trauma, V10, P1158, DOI 10.1097/00005373-197012000-00008; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; Kamijo Y, 1968, No To Shinkei, V20, P965; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; KOMIYAMA M, 1991, SURG NEUROL, V36, P126, DOI 10.1016/0090-3019(91)90230-7; KUHN RA, 1964, J NEUROSURG, V21, P92, DOI 10.3171/jns.1964.21.2.0092; Lam CH, 1996, NEUROSURGERY, V39, P1252, DOI 10.1097/00006123-199612000-00041; LAURENT JP, 1981, NEUROSURGERY, V9, P303, DOI 10.1227/00006123-198109000-00015; LIU MY, 1985, NEUROSURGERY, V17, P569, DOI 10.1227/00006123-198510000-00006; Marubayashi T, 1975, No Shinkei Geka, V3, P177; MCCORMICK WF, 1964, J NEUROSURG, V21, P678, DOI 10.3171/jns.1964.21.8.0678; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MENEZES AH, 1974, J NEUROSURG, V40, P544, DOI 10.3171/jns.1974.40.4.0544; Miyahara S, 1977, No Shinkei Geka, V5, P991; MIYAZAKI S, 1981, Neurological Surgery, V9, P531; MOORE D, 1979, SURG NEUROL, V11, P115; NAGASAWA S, 1976, TRAUMATOLOGY, V7, P373; Nakamura T, 1977, No Shinkei Geka, V5, P371; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; NOTERMAN J, 1985, NEUROSURGERY, V17, P807, DOI 10.1097/00006123-198511000-00014; PAILLAS JE, 1964, J NEUROSURG, V21, P667, DOI 10.3171/jns.1964.21.8.0667; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PAULLUS WS, 1979, J NEUROSURG, V51, P707, DOI 10.3171/jns.1979.51.5.0707; PETTY J M, 1969, Journal of Neurosurgery, V30, P741, DOI 10.3171/jns.1969.30.6.0741; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RAHMAT H, 1984, J NEUROSURG, V60, P630, DOI 10.3171/jns.1984.60.3.0630; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; Sakuta Y, 1997, NEUROL SURG TOKYO, V25, P357; SALAR G, 1978, J NEUROSURG, V49, P100, DOI 10.3171/jns.1978.49.1.0100; SALCMAN M, 1985, NEUROSURGERY, V16, P218; Sasaoka Y, 1997, NEUROL SURG TOKYO, V25, P337; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; SEDZIMIR CB, 1968, J NEUROSURG, V29, P636, DOI 10.3171/jns.1968.29.6.0636; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SHALLAT RF, 1981, NEUROSURGERY, V8, P569, DOI 10.1227/00006123-198105000-00010; SHIGEMORI M, 1982, Neurologia Medico-Chirurgica, V22, P241, DOI 10.2176/nmc.22.241; Shima T, 1978, No Shinkei Geka, V6, P1025; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; SMITH KR, 1968, J NEUROSURG, V29, P551, DOI 10.3171/jns.1968.29.5.0551; SPETZLER RF, 1979, NEUROSURGERY, V4, P334, DOI 10.1227/00006123-197904000-00011; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; TANI S, 1982, Neurological Surgery, V10, P423; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; Tokuno Tatsuya, 1994, Neurological Surgery, V22, P1073; Tsubokawa T, 1975, No Shinkei Geka, V3, P663; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; VORIS HC, 1961, J NEUROSURG, V18, P841, DOI 10.3171/jns.1961.18.6.0841; WORTZMAN D, 1980, SURG NEUROL, V13, P329; YAMAURA A, 1978, SURG NEUROL, V10, P327; YOKOTA H, 1983, Neurological Surgery, V11, P521; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	86	11	12	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2001	41	5					264	270		10.2176/nmc.41.264			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	434YA	WOS:000168842400014	11396307	Bronze			2021-06-18	
J	Bigler, ED				Bigler, ED			Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; IMAGING GUIDE; ATROPHY; MEMORY	Three cases are presented in patients all of whom sustained focal left frontal traumatic injury to the brain. Although each case was selected because of a neuroimaging-identified frontal lesion, the point is made that the behavioral significance of such lesions is defined by the neuropsychological examination process, and not the specific size, location, or type of lesion. While neuroimaging information is critical to the comprehensive evaluation of the neurologic patient, neuroimaging findings alone have only limited predictive ability with regard to neurobehavioral syndromes. The key role of information from neuropsychological test data, combined with neuroimaging findings to fully evaluate the neurologic patient, is made. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA	Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 Kimball Tower, Provo, UT 84602 USA.						Ardaman MF, 1996, INT J NEURORADIOL, V2, P296; Ardaman MF, 1996, INT J NEURORADIOL, V2, P374; Bigler E D, 1991, Arch Clin Neuropsychol, V6, P113, DOI 10.1016/0887-6177(91)90028-8; Bigler E. D., 1989, NEUROPSYCHOLOGICAL F; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 1997, NEUROLOGY, V49, P1180, DOI 10.1212/WNL.49.4.1180-a; BIGLER ED, 1981, PROF PSYCHOL, V12, P195, DOI 10.1037/h0078095; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1996, NEUROIMAGING, V1; BIGLER ED, 1996, NEUROIMAGING, V2; BIGLER ED, 1992, PHYSICAL MED REHABIL, V6, P395; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; Finger S., 1994, ORIGINS NEUROSCIENCE; Netter F. H., 1953, CIBA COLLECTION MED, V1; REYNOLDS CR, 1994, NEUROLOGY, V47, P592	15	11	11	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	APR	2001	16	3					227	236		10.1016/S0887-6177(00)00081-0			10	Psychology, Clinical; Psychology	Psychology	424VU	WOS:000168255300004	14590175	Bronze			2021-06-18	
J	Coetzer, R; Stein, DJ; Du Toit, PL				Coetzer, R; Stein, DJ; Du Toit, PL			Executive function in traumatic brain injury and obsessive-compulsive disorder: An overlap?	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						brain injury; executive function; obsessive-compulsive disorder	NEUROPSYCHOLOGY	Thirteen individuals with traumatic brain injury, 13 individuals with obsessive-compulsive disorder (OCD) and 10 normal controls were compared on neuropsychological measures of executive function. Individuals with a traumatic brain injury performed significantly poorer than the other two groups on a test measuring visuo-spatial strategy. Although the traumatic brain injury group made more errors on a test of maze learning and the OCD group less than the control group, this did not reach statistical significance. No support for an overlap in executive dysfunction in traumatic brain injury and OCD was found. It may be that the 'error prevention system' in the brain was influenced in a contrasting way by executive dysfunction in these disorders. This difference may reveal itself clinically in impulsivity/perseveration and slowness, respectively. Further studies were needed to test this hypothesis.	Univ Stellenbosch, Sch Med, MRC, Anxiety Disorders Res Unit, ZA-7600 Stellenbosch, South Africa	Coetzer, R (corresponding author), Colwyn Bay Hosp, Brain Injry Serv, Hesketh Rd, Colwyn Bay LL29 3AS, Wales.		Stein, Dan J/A-1752-2008	Stein, Dan J/0000-0001-7218-7810			ABBRUZZESE M, 1995, BRAIN COGNITION, V27, P202, DOI 10.1006/brcg.1995.1017; ALARCON RD, 1994, J NEUROPSYCH CLIN N, V6, P217; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BAXTER LR, 1994, J CLIN PSYCHIAT, V55, P54; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; Childers MK, 1998, BRAIN INJURY, V12, P613; Coetzer R, 1999, PSYCHIAT CLIN NEUROS, V53, P413, DOI 10.1046/j.1440-1819.1999.00565.x; CORWIN J, 1993, CLIN NEUROPSYCHOL, P4; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P9; COX CS, 1989, OBSESSIVE COMPULSIVE; Deb S, 1999, AM J PSYCHIAT, V156, P374; DIRSON S, 1995, PSYCHOTHER PSYCHOSOM, V63, P22, DOI 10.1159/000288933; *HUM SCI RES COUNC, 1969, S AFR WECHSL AD INT; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; LEZAC MD, 1995, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P206; OTTO MW, 1992, PSYCHIAT CLIN N AM, V15, P825; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SOHLBERG MM, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Tallis F, 1997, BRIT J CLIN PSYCHOL, V36, P3, DOI 10.1111/j.2044-8260.1997.tb01226.x; TAMMINGA CA, 2000, AM J PSYCHIAT, V157, P3; Walsh K. W., 1985, UNDERSTANDING BRAIN; Wilson KD, 1998, PSYCHON B REV, V5, P161, DOI 10.3758/BF03212942	24	11	11	0	5	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1323-1316			PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	APR	2001	55	2					83	87		10.1046/j.1440-1819.2001.00792.x			5	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	429YD	WOS:000168544800001	11285083				2021-06-18	
J	Vanderploeg, RD; Curtiss, G; Schinka, JA; Lanham, RA				Vanderploeg, RD; Curtiss, G; Schinka, JA; Lanham, RA			Material-specific memory in traumatic brain injury: Differential effects during acquisition, recall, and retention	NEUROPSYCHOLOGY			English	Article; Proceedings Paper	106th Annual Convention of the American-Psychological-Association	AUG 14-18, 1998	SAN FRANCISCO, CA	Amer Psychol Assoc			CONFIRMATORY FACTOR-ANALYSIS; TEMPORAL-LOBE; CONSTRUCT-VALIDITY; NONVERBAL MEMORY; COGNITIVE CHANGE; SCALE; LOBECTOMY; EPILEPSY; IMAGERY; IMPAIRMENT	Material-specific memory refers to the ability to learn and recall new episodic information on the basis of the nature of the stimulus material (e.g., verbal vs. nonverbal-visuospatial). Structural equation modeling was used to analyze data from a sample of patients with traumatic brain injury to compare 3 models of memory functioning: material-specific, material-specific plus general, and general (non-material-specific). The models were examined separately for acquisition, delayed free recall, and retention aspects of memory. Results suggest that, at least in a population with traumatic brain injury, the acquisition of new information takes place in a material-specific memory fashion, delayed free recall involves both material-specific and general (non-material-specific) memory components, but retention relies primarily on general (non-material-specific) memory processes.	James A Haley Vet Affairs Med Ctr, Psychol Serv 116B, Tampa, FL USA; Univ S Florida, Dept Psychiat, Tampa, FL 33620 USA; Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; Vet Head Injury Program, Tampa, FL USA; Def & Vet Headad Injury Program, Minneapolis, MN USA; Minneapolis Vet Affairs Med Ctr, Psychol Serv, Minneapolis, MN USA	Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	rodney.vanderploeg@med.va.gov	Schinka, John/A-2619-2009				Anderson J.R., 1973, HUMAN ASSOCIATIVE ME; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Arbuckle J. L., 1997, AMOS USERS GUIDE; Barr WB, 1997, BRAIN COGNITION, V35, P26, DOI 10.1006/brcg.1997.0925; Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.107.2.238; Benton A, 1989, MULTILINGUAL APHASIA; BOLLER F, 1967, NEUROLOGY, V17, P1052; BORNSTEIN RA, 1988, CLIN NEUROPSYCHOL, V2, P107, DOI DOI 10.1080/13854048808520093; Brown J.W., 1989, NEUROPSYCHOLOGY VISU, P203; Browne M.W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; CHELUNE GJ, 1991, NEUROLOGY, V41, P399, DOI 10.1212/WNL.41.3.399; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; De Renzi E, 1967, CORTEX, V3, P194, DOI 10.1016/S0010-9452(67)80012-1; DELANEY RC, 1980, CORTEX, V16, P103, DOI 10.1016/S0010-9452(80)80026-8; Delis DC, 1987, CALIFORNIA VERBAL LE; Denman S.B, 1984, DENMAN NEUROPSYCHOLO; DERENZI E, 1981, CORTEX, V17, P447, DOI 10.1016/S0010-9452(81)80034-2; DERENZI E, 1966, CORTEX, V2, P322; Ehrlichman H, 1983, Brain Cogn, V2, P55, DOI 10.1016/0278-2626(83)90029-5; ELWOOD R W, 1991, Neuropsychology Review, V2, P179, DOI 10.1007/BF01109053; ELWOOD RW, 1993, J CLIN PSYCHOL, V49, P854, DOI 10.1002/1097-4679(199311)49:6<854::AID-JCLP2270490613>3.0.CO;2-F; ELWOOD RW, 1991, CLIN NEUROPSYCHOL, V5, P329; FELER CA, 1992, HDB HEAD TRAUMA ACUT, P19; Gainotti G, 1994, Int J Neurosci, V78, P9; GLANZER M, 1964, AM J PSYCHOL, V77, P621, DOI 10.2307/1420773; GLOSSER G, 1995, NEUROPSYCHOLOGY, V9, P449, DOI 10.1037/0894-4105.9.4.449; Golden C., 1978, STROOP COLOR WORD TE; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Gregg, 1972, COGNITION LEARNING M; HEILBRONNER RL, 1992, CLIN NEUROPSYCHOL, V6, P105; HERMANN BP, 1987, EPILEPSIA, V28, P547, DOI 10.1111/j.1528-1157.1987.tb03687.x; JONESGOTMAN M, 1986, NEUROPSYCHOLOGIA, V24, P193, DOI 10.1016/0028-3932(86)90052-7; Joreskog K.G., 1989, LISREL 7 GUIDE PROGR; Kelloway E. K., 1998, USING LISREL STRUCTU; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LANHAM RA, 1995, J INT NEUROPSYCH SOC, V1, P171; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P239, DOI 10.1080/01688638508401257; LARRABEE GJ, 1985, INT J NEUROSCI, V26, P269, DOI 10.3109/00207458508985624; Lee G.P., 1989, PSYCHOL ASSESSMENT J, V1, DOI [https://doi.org/10.1037/1040-3590.1.3.192, DOI 10.1037/1040-3590.1.3.192]; Long JS., 1993, TESTING STRUCTURAL E, P163; LORING DW, 1991, J CLIN EXP NEUROPSYC, V13, P575, DOI 10.1080/01688639108401072; MALEC JF, 1991, PSYCHOL ASSESSMENT J, V3, P82; Martin A, 1999, HIPPOCAMPUS, V9, P62, DOI 10.1002/(SICI)1098-1063(1999)9:1<62::AID-HIPO7>3.0.CO;2-K; MARTIN RC, 1990, CORTEX, V26, P443, DOI 10.1016/S0010-9452(13)80093-7; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MUNGAS D, 1985, EPILEPSIA, V26, P340, DOI 10.1111/j.1528-1157.1985.tb05660.x; NAUGLE RI, 1993, ARCH CLIN NEUROPSYCH, V8, P381, DOI 10.1016/0887-6177(93)90002-I; NOVELLY RA, 1984, ANN NEUROL, V15, P64, DOI 10.1002/ana.410150112; OJEMANN GA, 1985, J NEUROSURG, V62, P101, DOI 10.3171/jns.1985.62.1.0101; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PAIVIO A, 1969, J EXP PSYCHOL, V80, P279, DOI 10.1037/h0027273; PHILLIPS NA, 1995, J CLIN EXP NEUROPSYC, V17, P713, DOI 10.1080/01688639508405161; *PSYCH CORP, 1997, WAIX 3 WMS 3 TECHN M; PYLYSHYN ZW, 1981, PSYCHOL REV, V88, P16, DOI 10.1037/0033-295X.88.1.16; Randolph C., 1993, NEUROPSYCHOLOGY, V7, P82, DOI [10.1037/0894-4105.7.1.82, DOI 10.1037/0894-4105.7.1.82]; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roid G. H., 1988, CLIN NEUROPSYCHOL, V2, P116, DOI [10.1080/13854048808520094, DOI 10.1080/13854048808520094]; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; SMITH GE, 1992, J CLIN EXP NEUROPSYC, V14, P211, DOI 10.1080/01688639208402824; SMITH ML, 1989, NEUROPSYCHOLOGIA, V27, P71, DOI 10.1016/0028-3932(89)90091-2; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Snow R. E., 1984, ADV PSYCHOL HUMAN IN, P47; Squire L. R., 1983, MEMORY CONSOLIDATION, P185; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; VANDERPLOEG RD, 1997, CLIN NEUROPSYCHOL, V11, P326; Wechsler, 1981, WAIS R MANUAL; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WHITEHOUSE PJ, 1981, BRAIN LANG, V14, P315, DOI 10.1016/0093-934X(81)90083-3; WILLIAMS JM, 1992, MEMORY ASSESSMENT SC; Wilson RS, 1996, NEUROPSYCHOLOGY, V10, P459; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	79	11	11	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	APR	2001	15	2					174	184		10.1037//0894-4105.15.2.174			11	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	471UK	WOS:000170946900003	11324861				2021-06-18	
J	Buytaert, KA; Kline, AE; Montanez, S; Likler, E; Millar, CJ; Hernandez, TD				Buytaert, KA; Kline, AE; Montanez, S; Likler, E; Millar, CJ; Hernandez, TD			The temporal patterns of c-Fos and basic fibroblast growth factor expression following a unilateral anteromedial cortex lesion	BRAIN RESEARCH			English	Article						rat; growth factor; cortical injury; recovery of function; somatosensory asymmetry	MESSENGER-RNA EXPRESSION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; FACTOR BFGF EXPRESSION; TACTILE EXTINCTION; KINDLED SEIZURES; TRANSCRIPTION FACTOR; PRIMARY CULTURES; MOTOR CORTEX; NEURONS	Following a unilateral anteromedial cortex lesion, a critical period of 12 h to 6 days exists during which the recovery process is exquisitely vulnerable to manipulation. Certain anti-convulsant drugs, as well as convulsive seizures impede recovery when administered during, but not after, the critical period. The mechanisms underlying these behavioral phenomena have not been delineated. Thus, the present study was designed to determine potential mechanisms underlying and responsible for the critical period. To this end, we measured the immunoreactivity of two important markers of the post-injury response cascade, c-Fos and bFGF, at designated times after a unilateral anteromedial cortex lesion. These temporal patterns of expression in the perilesional cortex and ipsilateral dorsal striatum were mapped onto functional recovery patterns. Within the critical period, c-Fos was dramatically elevated through 48 h after the lesion. while bFGF peaked later, on day 6. Upregulation of these markers preceded recovery from somatosensory deficits, which was most dramatic after post-operative day 9 and complete by day 23. Early post-lesion expression of c-Fos may contribute to lesion-induced bFGF expression, which through its neurotrophic properties could be responsible for subsequent functional recovery. Gaining a similar understanding of the critical period following human traumatic brain injury could be an important first step toward improved treatment strategies and neurobehavioral outcome. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Colorado, Dept Psychol, Behav Neurosci Program, Boulder, CO 80309 USA	Hernandez, TD (corresponding author), Univ Colorado, Dept Psychol, Behav Neurosci Program, Campus Box 345, Boulder, CO 80309 USA.	terid@psych.colorado.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS030595] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30595] Funding Source: Medline		ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; ANNETT LE, 1992, BRAIN, V115, P825, DOI 10.1093/brain/115.3.825; BARTH TM, 1994, BEHAV NEUROSCI, V108, P818, DOI 10.1037/0735-7044.108.4.818; BARTH TM, 1987, EXP NEUROL, V95, P661, DOI 10.1016/0014-4886(87)90307-4; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; Bury SD, 2000, NEUROPHARMACOLOGY, V39, P743, DOI 10.1016/S0028-3908(99)00272-5; Buytaert K. A., 1998, Society for Neuroscience Abstracts, V24, P737; Cao W, 1998, INVEST OPHTH VIS SCI, V39, P565; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; ENDOH M, 1994, MOL BRAIN RES, V22, P76, DOI 10.1016/0169-328X(94)90034-5; FERHAT L, 1993, J NEUROCHEM, V61, P1105, DOI 10.1111/j.1471-4159.1993.tb03626.x; FINKLESTEIN SP, 1993, STROKE, V24, P1141; FINKLESTEIN SP, 1995, BRAIN ISCHEMIA BASIC, P37; FRAGUNOW M, 1988, EUR J PHARMACOL, V135, P113; FRANK E, 1995, NEUROL RES, V17, P129, DOI 10.1080/01616412.1995.11740300; GINSBERG MD, 1993, ARNMD RES PUBLICATIO, P207; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; HAYNES LW, 1988, MOL NEUROBIOL, V2, P263, DOI 10.1007/BF02935635; HEDREEN JC, 1976, NEUROSCI LETT, V4, P1; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; HERNANDEZ TD, 1995, BRAIN RES, V673, P208, DOI 10.1016/0006-8993(94)01415-E; HERNANDEZ TD, 1989, CEREBROVASC DIS, P327; IWATA A, 1997, J NEUROTRAUM, V4, P201; JONES TA, 1994, J NEUROSCI, V14, P2140; KALSBEEK WD, 1980, J NEUROSURG, V53, P519; KAWAMATA T, 1996, J CEREB BLOOD FLOW M, V16, P543; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; Kline AE, 2000, BRAIN RES, V880, P38, DOI 10.1016/S0006-8993(00)02762-1; KOLB B, 1992, ADV EXP MED BIOL, V325, P169; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Lin TN, 1997, MOL BRAIN RES, V49, P255, DOI 10.1016/S0169-328X(97)00152-6; LIU HM, 1994, J NEUROPATH EXP NEUR, V53, P598, DOI 10.1097/00005072-199411000-00007; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; MCGEER PL, 1977, BRAIN RES, V128, P369, DOI 10.1016/0006-8993(77)91003-4; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; NIETOSAMPEDRO M, 1985, SYNAPTIC PLASTICITY, P407; NOZAKI K, 1993, J CEREBR BLOOD F MET, V13, P221, DOI 10.1038/jcbfm.1993.27; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PETTMANN B, 1986, NEUROSCI LETT, V68, P175, DOI 10.1016/0304-3940(86)90137-0; Ren JM, 1997, EUR J PHARMACOL, V327, P11, DOI 10.1016/S0014-2999(97)89672-0; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; Rowntree S, 1997, EUR J NEUROSCI, V9, P2432, DOI 10.1111/j.1460-9568.1997.tb01660.x; RUZDIJIC S, 1993, BRAIN RES, V601, P230, DOI 10.1016/0006-8993(93)91715-5; Schallert T, 1998, RESTORATIVE NEUROLOGY, P91; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHALLERT T, 1982, PHARMACOL BIOCHEM BE, V16, P455, DOI 10.1016/0091-3057(82)90452-X; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHWARTZ AS, 1979, BRAIN, V102, P669, DOI 10.1093/brain/102.4.669; Shibata F, 1991, GROWTH FACTORS, V4, P277, DOI 10.3109/08977199109043913; SIMPSON CS, 1994, NEUROSCI LETT, V170, P281, DOI 10.1016/0304-3940(94)90338-7; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; To T., 1994, Society for Neuroscience Abstracts, V20, P1048; WALICKE PA, 1988, J NEUROSCI, V8, P2618	58	11	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 9	2001	894	1					121	130		10.1016/S0006-8993(01)01987-4			10	Neurosciences	Neurosciences & Neurology	411VZ	WOS:000167521100014	11245822				2021-06-18	
J	Davis, AE; Gimenez, AM; Therrien, B				Davis, AE; Gimenez, AM; Therrien, B			Effects of entorhinal cortex lesions on sensory integration and spatial learning	NURSING RESEARCH			English	Article						brain injury; entorhinal cortex; sensory integration; spatial learning	HIPPOCAMPAL-FORMATION; BRAIN INJURY; 2 VERSIONS; PERFORMANCE; RAT; REINNERVATION; DENERVATION; SYSTEM; MONKEY; MAZE	Background: The entorhinal cortex provides sensory information to the hippocampus for memory and learning. Damage to the entorhinal cortex is common in patients who experience traumatic brain injury, stroke, and Alzheimer's disease. Entorhinal damage is assumed to interfere with sensory integration; however, substantive knowledge of behavioral patterns is lacking. Objectives: To describe specific behavioral deficits associated with entorhinal cortex injury related to special senses identification, sensory integration, and spatial learning. Method: Adult male rats received bilateral entorhinal cortex damage (n = 19) or sham surgery (n = 11)with a subset randomized to participate in special senses identification, exploration, and sensory integration testing. Spatial learning was examined using a water maze. Results: Lesion and control animals were similar in special senses identification testing. Sensory integration was markedly impaired in lesion animals over 3 days for all integration tasks; however, travel deficit persisted for 4 days. By day 5 sensory integration ability was equal. Lesion animals were significantly impaired across all days of spatial learning for swim time (p = .0001) and directional heading error (p = .03). Control animals exposed to sensory testing demonstrated significantly more efficient learning (p = .005) on swim days 2 and 3 versus control animals not exposed to sensory testing. Conclusions: Early and prolonged behavioral changes are evident following entorhinal cortex damage including sensory integration deficits and persistent spatial learning impairment.	Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; Clin Puerta Hierro, Madrid, Spain	Davis, AE (corresponding author), Univ Michigan, Sch Nursing, 400 N Ingalls, Ann Arbor, MI 48109 USA.						Braak H, 1996, ACTA NEUROL SCAND, V93, P3; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Gennarelli TA, 1997, NEUROSCIENTIST, V3, P73, DOI 10.1177/107385849700300117; *HARC BRAC WORLD, 1966, FUNK WAGN STAND COLL; HEINEMANN U, 1993, HIPPOCAMPUS, V3, P89; HOLDEN JE, 1993, NURS RES, V42, P338; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; LINGENHOHL K, 1991, EXP BRAIN RES, V84, P57; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; Luria AR., 1972, MAN SHATTERED WORLD; NAGAHARA AH, 1995, BEHAV NEUROSCI, V109, P3, DOI 10.1037/0735-7044.109.1.3; OHM TG, 1993, HIPPOCAMPUS, V3, P131; OTTENBACHER K, 1982, AM J OCCUP THER, V36, P571, DOI 10.5014/ajot.36.9.571; Otto T, 1997, NEUROBIOL LEARN MEM, V68, P21, DOI 10.1006/nlme.1997.3778; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; SAUNDERS RC, 1988, J COMP NEUROL, V271, P153, DOI 10.1002/cne.902710202; STEWARD O, 1977, BRAIN RES BULL, V2, P41, DOI 10.1016/0361-9230(77)90023-5; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	21	11	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-6562	1538-9847		NURS RES	Nurs. Res.	MAR-APR	2001	50	2					77	85		10.1097/00006199-200103000-00003			9	Nursing	Nursing	453LU	WOS:000169918000003	11302296				2021-06-18	
J	Williams, PJ; Lane, JR; Turkel, CC; Capparelli, EV; Dziewanowska, Z; Fox, AW				Williams, PJ; Lane, JR; Turkel, CC; Capparelli, EV; Dziewanowska, Z; Fox, AW			Dichloroacetate: Population pharmacokinetics with a pharmacodynamic sequential link model	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article							PYRUVATE-DEHYDROGENASE; SODIUM DICHLOROACETATE; LACTIC-ACIDOSIS; BRAIN INJURY; HEAD-INJURY; CEREBRAL-ISCHEMIA; LACTATE; HUMANS; METABOLITES; ACTIVATION	Dichloroacetate (DCA) is a small molecule that reduces ambient concentrations of lactate in man. It was the purpose of this study to develop pharmacokinetic and pharmacodynamic models for determination of a dose for a pivotal Phase III clinical trial of DCA in patients with traumatic brain injury (TBI). Population pharmacokinetic and pharmacodynamic models were developed for DCA using NONMEM(R) software. The pharmacokinetic data were fit to a physiologic two-compartment model, and the pharmacodynamic data were fit to an indirect physiologic response model. Simulations were employed to evaluate various dosing strategies for consideration in a pivotal Phase III clinical trial of DCA. For the pharmacokinetic model, it was discovered that the clearance of DCA decreased on multiple dosing from 4.82 L/h to 1.07 L/h and that the pharmacokinetics and pharmacodynamics in TBI patients could not be predicted from normal volunteers. Population pharmacokinetic modeling and simulation of the expected effects of several dosing strategies were useful procedures for designing a Phase III trial. Journal of Clinical Pharmacology, 2001;41:259-267 (C) 2001 the American College of Clinical Pharmacology.	Univ Pacific, Sch Pharm, Stockton, CA 95211 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Cypros Pharmaceut Corp, Carlsbad, CA USA; Trials Design LLC, La Jolla, CA USA; EBD Grp Inc, Carlsbad, CA USA	Williams, PJ (corresponding author), Trials Design LLC, POB 1918,Verdi Ct, Stockton, CA 95207 USA.						ABEMAYOR E, 1984, J NEUROCHEM, V42, P38, DOI 10.1111/j.1471-4159.1984.tb09694.x; BARSAN WG, 1987, LIFE SCI, V41, P1065, DOI 10.1016/0024-3205(87)90622-9; BEAL SL, 1989, NONMEM USERS GUIDE 1; Boeckman AJ, 1992, NONMEM USERS GUIDE 4; BREIMER DD, 1977, CLIN PHARMACOKINET, V2, P93, DOI 10.2165/00003088-197702020-00002; CHANG LH, 1992, J CEREBR BLOOD F MET, V12, P1030, DOI 10.1038/jcbfm.1992.140; CHU PI, 1987, THESIS U FLORIDA; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193; DIMLICH RVW, 1989, ANN EMERG MED, V18, P1172, DOI 10.1016/S0196-0644(89)80054-X; EVANS OB, 1983, BIOCHEM PHARMACOL, V31, P1324; Fox AW, 1996, J PHARMACOL EXP THER, V279, P686; Goodman JC, 1996, ACT NEUR S, V67, P37; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P209, DOI 10.1111/j.1399-6576.1971.tb05462.x; Henderson GN, 1997, J CLIN PHARMACOL, V37, P416, DOI 10.1002/j.1552-4604.1997.tb04319.x; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KING LR, 1974, J NEUROSURG, V40, P617, DOI 10.3171/jns.1974.40.5.0617; Kochanek PM, 1997, ACT NEUR S, V70, P109; LUKAS G, 1980, J PHARM SCI, V69, P419, DOI 10.1002/jps.2600690415; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; SEITZ HD, 1977, ACTA NEUROCHIR, V38, P211, DOI 10.1007/BF01401092; STACPOOLE PW, 1992, NEW ENGL J MED, V327, P1564, DOI 10.1056/NEJM199211263272204; Stacpoole PW, 1998, ENVIRON HEALTH PERSP, V106, P989, DOI 10.1289/ehp.98106s4989; TOMSIG JL, 1991, BRAIN RES, V568, P92, DOI 10.1016/0006-8993(91)91383-C; WELLS PG, 1980, DIABETOLOGIA, V19, P109, DOI 10.1007/BF00421855; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; WHITEHOUSE S, 1973, BIOCHEM J, V134, P651, DOI 10.1042/bj1340651	30	11	13	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2700			J CLIN PHARMACOL	J. Clin. Pharmacol.	MAR	2001	41	3					259	267		10.1177/00912700122010078			9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	403MW	WOS:000167047900003	11762553				2021-06-18	
J	Wilson, RF; Dente, C; Tyburski, JG				Wilson, RF; Dente, C; Tyburski, JG			The nutritional management of patients with head injuries	NEUROLOGICAL RESEARCH			English	Article						nutrition; head injuries	TRAUMATIC BRAIN INJURY; GROWTH-FACTOR-I; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ZINC SUPPLEMENTATION; LIPID-PEROXIDATION; ENERGY-EXPENDITURE; CONTROLLED TRIAL; MAGNESIUM; IMMUNE; HYPERALIMENTATION	Severe head injuries tend to be associated with hypermetabolism and hypercatabolism resulting in negative nitrogen balances which may exceed 30 grams day(-1). Enteral feeding should begin as soon as the patient is hemodynamically stable, attempting to reach a non-protein caloric intake of at least 30-35 kcal kg(-1) day(-1) and a protein intake of 2.0-2.5 g kg(-1) day(-1) as soon as possible. With severe head injuries (Glasgow Coma Scale < 8), there is an increased tendency for gastric feeding to regurgitate into the upper airway Keeping the patient upright and checking residuals is import-ant in such patients. Jejunal feedings are less apt to be aspirated. if it is apparent that the gastro-intestinal tract cannot be used to reach the nutritional goals within three days, total parental nutrition is begun within 24-48 h so as to reach these nutrition goals by either one or both routes by the third or fourth day. Blood glucose levels exceeding 150-200 mg dl(-1) tend to increase the severity of the neurologic problems and efforts should be made to prevent hyperglycemia by carefully regulating the glucose and insulin intake. Indirect calormetry to determine the respiratory quotient and resting energy expenditure should be determined twice weekly. To determine N-2 balance, urinary urea nitrogen should be measured in 24-h specimens. These tests should be performed once or twice weekly until it is clear that the nutrition is adequate.	Wayne State Univ, Detroit Receiving Hosp, Dept Surg, Detroit, MI 48201 USA	Wilson, RF (corresponding author), Wayne State Univ, Detroit Receiving Hosp, Dept Surg, 4201 St Antoine,Suite 4V-23, Detroit, MI 48201 USA.						Altmayer T, 1996, ARCH PHYS MED REHAB, V77, P1093, DOI 10.1016/S0003-9993(96)90075-1; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BRAU RH, 1984, NEUROSURGERY, V14, P142, DOI 10.1227/00006123-198402000-00004; BRAUGHLER JM, 1991, CENTRAL NERVOUS SYST, pS1; BUCCI MN, 1988, ACTA NEUROCHIR, V93, P133, DOI 10.1007/BF01402895; Bullock MR, 1996, J NEUROTRAUM, V13, P721; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; CLIFTON CL, 1991, NEUROSURGERY, V8, P10; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; CORTE FD, 1998, CRIT CARE MED, V27, P1419; DALY JM, 1988, ANN SURG, V208, P512, DOI 10.1097/00000658-198810000-00013; DAMELIO LF, 1994, AM SURGEON, V60, P180; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; GORLIN R, 1988, ARCH INTERN MED, V148, P2043, DOI 10.1001/archinte.148.9.2043; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P91; Harbrecht BG, 1998, AM J SURG, V176, P311, DOI 10.1016/S0002-9610(98)00206-2; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; HATTON J, 1993, J NEUROSURG, V78, pA370; Hill D. B., 1992, Journal of the American College of Nutrition, V11, P630; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; KUDSK KA, 1994, ARCH SURG-CHICAGO, V129, P66; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MARIE C, 1991, CEREBROVAS BRAIN MET, V3, P29; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MILLER C H, 1991, Neurological Research, V13, P117; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Ng PCH, 1996, J LAPAROENDOSC SURG, V6, P25, DOI 10.1089/lps.1996.6.25; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; NORTON L, 1970, ARCH SURG-CHICAGO, V101, P200; OTT L, 1991, J NEUROSURG, V74, P738, DOI 10.3171/jns.1991.74.5.0738; OTT LG, 1988, DRUG INTEL CLIN PHAR, V22, P763, DOI 10.1177/106002808802201004; OTT M, 1994, CRIT CARE MED, V22, P393, DOI 10.1097/00003246-199403000-00007; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; RANSEEN JD, 1990, J CLIN EXP NEUROPSYC, V12, P34; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; Roberts P R, 1995, New Horiz, V3, P506; ROBERTS PR, 1993, JPEN J PARENTER EN S, V17, P69; RODRIGUEZ DJ, 1995, J SURG RES, V59, P455, DOI 10.1006/jsre.1995.1191; ROSS LH, 1988, PHARM APPROACH CRITI, V3, P818; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; SPAPEN HD, 1995, CRIT CARE MED, V23, P481, DOI 10.1097/00003246-199503000-00011; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; Twyman D, 1997, CRIT CARE CLIN, V13, P39, DOI 10.1016/S0749-0704(05)70295-5; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; WILLMORE LJ, 1984, EXP NEUROL, V83, P62, DOI 10.1016/0014-4886(84)90046-3; Wilson RF, 1998, J HEAD TRAUMA REHAB, V13, P11, DOI 10.1097/00001199-199802000-00005; WILSON RF, 1980, CRIT CARE MED, V8, P281, DOI 10.1097/00003246-198005000-00002; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; ZALOGA G, 1992, CRIT CARE MED S, V20, pS94; ZHANG Y, 1993, J CEREB BLOOD FLOW M, V13, P578	65	11	11	0	8	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					121	128		10.1179/016164101101198451			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	422DX	WOS:000168104200003	11320590				2021-06-18	
J	Dell'Acqua, R; Stablum, F; Galbiati, S; Spannocchi, G; Cerri, C				Dell'Acqua, R; Stablum, F; Galbiati, S; Spannocchi, G; Cerri, C			Selective effect of closed-head injury on central resource allocation: evidence from dual-task performance	EXPERIMENTAL BRAIN RESEARCH			English	Article						closed-head injury; PRP paradigm; speed of processing	WORKING-MEMORY; ATTENTIONAL PROCESSES; DEFICITS; INTERFERENCE; IMPAIRMENTS; BOTTLENECK; LOCUS	Two dual-task experiments are reported bearing on the issue of slower processing time for severe chronic closed-head injury (CHI) patients compared to matched controls. In the first experiment, a classical psychological refractory period (PRP) paradigm was employed, in which two sequential stimuli, a pure tone and a colored dot, were presented at variable stimulus onset asynchronies (SOAs), each associated with a distinct task. The task on the tone required a speeded vocal response based on pitch, and the task on the colored dot required a speeded manual response based on color. In the second experiment, either one or three masked letters was presented, followed by a pure tone at variable SOAs. The task on the letters required a delayed report of the letters at the end of each trial. The task on the tone required an immediate manual response based on pitch. In both experiments, both CHI patients and matched controls reported an SOA-locked slowing of the speeded response to the second stimulus, a PRP effect. The PRP effect was more substantial for CHI patients than for matched controls, suggesting that a component of the slower processing time for CHI patients was related to a selective increase in temporal demands for central processing of the stimuli.	Univ Ferrara, Dipartimento Sci Umane, I-44100 Ferrara, Italy; Univ Padua, Dipartimento Psicol Sviluppo & Socializzaz, I-35131 Padua, Italy; Osped TRabattoni Ronzoni Seregno, I-20126 Milan, Italy; Univ Milano Bicocca, I-20126 Milan, Italy	Dell'Acqua, R (corresponding author), Univ Ferrara, Dipartimento Sci Umane, 38 Via Savonarola, I-44100 Ferrara, Italy.	dellacqu@psy.unipd.it	Dell'Acqua, Roberto/B-1682-2008; Galbiati, Susanna/AAH-6883-2019; Cerri, Cesare/C-4267-2011	Dell'Acqua, Roberto/0000-0002-3393-1907; Galbiati, Susanna/0000-0001-7209-4251; Stablum, Franca/0000-0003-0123-5090			Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; BROULIK PD, 1993, HORM METAB RES, V25, P219, DOI 10.1055/s-2007-1002080; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; DEJONG R, 1993, J EXP PSYCHOL HUMAN, V19, P965, DOI 10.1037/0096-1523.19.5.965; Dell'Acqua R, 2000, MEM COGNITION, V28, P184, DOI 10.3758/BF03213798; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; HARTMAN A, 1992, CLIN REHABIL, V6, P133; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jolicoeur P, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P309; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MCCANN RS, 1992, J EXP PSYCHOL HUMAN, V18, P471, DOI 10.1037/0096-1523.18.2.471; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Meyer DE, 1997, PSYCHOL REV, V104, P749, DOI 10.1037/0033-295X.104.4.749; Miller E, 1970, Cortex, V6, P121; NAVEHBENJAMIN M, 1984, J VERB LEARN VERB BE, V23, P494, DOI 10.1016/S0022-5371(84)90318-9; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; OGDEN WC, 1980, J EXP PSYCHOL HUMAN, V6, P355, DOI 10.1037/0096-1523.6.2.355; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, NEUROREPORT, V5, P2381, DOI 10.1097/00001756-199411000-00042; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Pashler H.E., 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Pashler HE., 1998, PSYCHOL ATTENTION; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Riese H, 1999, NEUROPSYCHOL REHABIL, V9, P189, DOI 10.1080/713755600; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Schubert T, 1999, J EXP PSYCHOL HUMAN, V25, P408, DOI 10.1037/0096-1523.25.2.408; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SHUM DHK, 1994, J CLIN EXP NEUROPSYC, V16, P547, DOI 10.1080/01688639408402666; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; SPINNLER H, 1987, J NEUROL SCI S, V8; Spreen O., 1998, COMPENDIUM NEUROPSYC; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; STABLUM F, 2000, UNPUB NEUROPSYCHOLOG; Van Selst M, 1997, PROCEEDINGS OF THE NINETEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P787; Van Selst M, 1999, J EXP PSYCHOL HUMAN, V25, P1268, DOI 10.1037/0096-1523.25.5.1268; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VANDERLINDEN M, 1992, COGNITIVE NEUROPSYCH, V9, P301, DOI 10.1080/02643299208252063; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1994, CLIN NEUROPSCYHOLOGY; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0	53	11	12	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	FEB	2001	136	3					364	378		10.1007/s002210000586			15	Neurosciences	Neurosciences & Neurology	403FY	WOS:000167032900009	11243478				2021-06-18	
J	Demery, JA; Hanlon, RE; Bauer, RM				Demery, JA; Hanlon, RE; Bauer, RM			Profound amnesia and confabulation following traumatic brain injury	NEUROCASE			English	Article							ANTERIOR COMMUNICATING ARTERY; EPISODIC MEMORY; ANEURYSM; RETRIEVAL; RUPTURE; DISEASE; LESIONS	Amnesia and confabulation may persist following acute: aneurysmal hemorrhage of the anterior communicating artery, chronic alcoholic Korsakoff's syndrome, and late-stage dementia of the Alzheimer type. However, there is a paucity of information regarding the persistence of these symptoms following traumatic brain injury. We present the case of JL, a 43-year-old male with persistent and severe anterograde amnesia for verbal and visual information with co-occurring provoked confabulation which persists well into the chronic phase of recovery after a severe traumatic brain injury. Neuropsychological testing at 7 weeks post-injury demonstrated severe anterograde amnesia with co-occurring confabulation. Follow-up testing at 9.5 months post-injury showed persistent and severe anterograde amnesia and provoked confabulation despite superior non-verbal intelligence and above average attentional and perceptual abilities. Late computed tomography showed chronic hypodense: regions in the temporal lobes, bilaterally (L > R), and in the region of the left ventrolateral frontal lobe. This case demonstrates that anterograde amnesia and provoked confabulation may persist long after the acute phase of recovery after traumatic brain injury, and also supports previous research which asserts that medial temporal lobe damage must be accompanied by ventral frontal lobe pathology to produce the amnestic-confabulatory syndrome.	Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, Gainesville, FL 32610 USA; Northwestern Univ, Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Demery, JA (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	jdemery@ufl.edu					ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BENTON A L, 1978, Archives of Neurology, V35, P364; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Blair JR., 1989, CLIN NEUROPSYCHOL, V3, P129; Butters N, 1980, ALCOHOLIC KORSAKOFFS; BUTTERS N, 1989, HDB NEUROPSYCHOLOGY, V3; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P263, DOI 10.1001/archneur.1985.04060030081013; DELIS D, 1987, CALIFORNIA VERBAL LE; DELUCA J, 1995, J CLIN EXP NEUROPSYC, V17, P100, DOI 10.1080/13803399508406586; GOLDBERG E, 1985, REMOTE MEMORY BATTER; GRAFFRADFORD NR, 1980, BRAIN, V113, P1; Heaton R., 1993, WISCONSIN CARD SORTI; KAPLAN E, 1983, BOSTON NAMING; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Kertesz A., 1982, W APHASIA BATTERY; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LINDQVIST G, 1966, ACTA PSYCHIAT SCAND, V42, P24, DOI 10.1111/j.1600-0447.1966.tb01913.x; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Partington J., 1949, PSYCHOL SERVICE CTR, V1, P9; PHILLIPS S, 1987, ARCH NEUROL-CHICAGO, V44, P1134, DOI 10.1001/archneur.1987.00520230024008; Raven JC, 1996, PROGR MATRICES PERCE; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SHIMAMURA AP, 1987, J EXP PSYCHOL LEARN, V13, P464, DOI 10.1037/0278-7393.13.3.464; SIGNORET JL, 1985, PRINCIPLES BEHAV NEU; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; VILKKI J, 1985, CORTEX, V21, P431, DOI 10.1016/S0010-9452(85)80007-1; VOLPE BT, 1983, J NEUROL NEUROSUR PS, V46, P704, DOI 10.1136/jnnp.46.8.704; VONCRAMON DY, 1985, BRAIN, V108, P993, DOI 10.1093/brain/108.4.993; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WEINSTEIN EA, 1968, ARCH GEN PSYCHIAT, V18, P348; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	42	11	11	0	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1355-4794			NEUROCASE	Neurocase		2001	7	4					295	301		10.1076/neur.7.4.295.16258			7	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	487LV	WOS:000171877400002	11557825				2021-06-18	
J	Kolakowsky-Hayner, SA; Kreutzer, JS				Kolakowsky-Hayner, SA; Kreutzer, JS			Pre-injury crime, substance abuse, and neurobehavioural functioning after traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; ALCOHOL-USE; PATTERNS; MODEL; URBAN	There is limited information regarding the effects of pre-injury history of arrest or history of substance use on neurobehavioural functioning after brain injury. The current study included 211 patients with traumatic brain injury, who were seen for a follow-up neuropsychological evaluation in an outpatient setting. An effort was made to distinguish between (1) patients with a history of pre-injury arrests and patients without a history of pre-injury arrests, (2) patients classified as substance abusers and non-abusers, and (3) patients with and without a history of pre-injury illicit drug use on the basis of demographic characteristics, injury characteristics, and neurobehavioural functioning. Results indicate significant differences between patients with a history of pre-injury arrests and patients without a history of pre-injury arrests in terms of demographic and injury characteristics. Differences were also noted between persons classified as substance abusers and non-abusers in terms of demographic and injury characteristics, and neurobehavioural functioning. Clinical implications and future research are discussed.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA	Kolakowsky-Hayner, SA (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Med Coll Virginia Campus,Box 980542, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Albonetti CA, 1997, SOC PROBL, V44, P124, DOI 10.1525/sp.1997.44.1.03x0216h; Belenko S, 1998, ISSUES SCI TECHNOL, V15, P53; BLANCHARD C, 1999, SPECTRUM-J STATE GOV, V72, P26; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P642; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; Claus RE, 1999, ADDICT BEHAV, V24, P471, DOI 10.1016/S0306-4603(98)00106-3; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Drubach D A, 1993, Md Med J, V42, P989; *FED BUR INV US DE, 1998, CRIM US 1998 UN CRIM; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Garretsen HFL, 1999, ALCOHOL ALCOHOLISM, V34, P733, DOI 10.1093/alcalc/34.5.733; GROSSMAN LS, 1995, PSYCHIATR SERV, V46, P790; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kermani EJ, 1996, AM J DRUG ALCOHOL AB, V22, P1, DOI 10.3109/00952999609001642; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Kouri EM, 1997, AM J DRUG ALCOHOL AB, V23, P413, DOI 10.3109/00952999709016886; Kreutzer J., 1987, GEN HLTH HIST QUESTI; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Kreutzer JS., 1999, NEUROBEHAVIORAL FUNC; LINDENBAUM GA, 1989, J TRAUMA, V29, P1654, DOI 10.1097/00005373-198912000-00012; Mowbray CT, 1997, AM J DRUG ALCOHOL AB, V23, P309, DOI 10.3109/00952999709040949; *NAT CTR ADD SUBST, 1999, SPECTRUM-J STATE GOV, V72, P8; ORD RA, 1995, J ORAL MAXIL SURG, V53, P514, DOI 10.1016/0278-2391(95)90061-6; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1983, REHABILITATION HEAD; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SEE RT, 1997, ARCH PHYSICAL MED RE, V78, P1254; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010	33	11	11	0	8	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2001	15	1					53	63		10.1080/02699050150209138			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	384UF	WOS:000165963600006	11201315				2021-06-18	
J	Cahill, LM; Murdoch, BE; Theodoros, DG				Cahill, LM; Murdoch, BE; Theodoros, DG			Variability in speech outcome following severe childhood traumatic brain injury: A report of three cases	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article								The aim of the present paper was to demonstrate the variation in the nature and extent of the physiological and perceptual speech impairments that can occur in children following traumatic brain injury (TBI). Three children who presented with different speech profiles following severe TBI were discussed. The four speech subsystems were comprehensively evaluated using physiological measures of respiratory (Respitrace), laryngeal (Laryngograph, Aerophone II), velopharyngeal (accelerometry), and articulatory (lip and tongue pressure transduction systems) function. Perceptual speech evaluations included the Frenchay Dysarthria Assessment, the Assessment of Intelligibility of Dysarthric Speech, and a perceptual analysis of a speech sample. The findings for each case were compared with those of a non-neurologically impaired control group or a control subject matched for age and sex. Although demonstrating similar severity of injury, each subject was found to have a differing profile of speech subsystem deficits, highlighting the need for a full physiological and perceptual assessment of speech production.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia	Cahill, LM (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012	Cahill, Louise/0000-0003-3662-896X			Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; ENDERBY PM, 1983, FRENCHAY DYSARTHRIA; MALKMUS DD, 1989, TOP LANG DISORD, V9, P50, DOI 10.1097/00011363-198903000-00006; Murdoch B. E., 1987, AUSTR J HUMAN COMMUN, V15, P15; Yorkston K.M., 1981, ASSESSMENT INTELLIGI	5	11	11	0	12	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2000	8	4					347	352					6	Audiology & Speech-Language Pathology; Clinical Neurology	Audiology & Speech-Language Pathology; Neurosciences & Neurology	388EU	WOS:000166165100020					2021-06-18	
J	Leathem, JM; Babbage, DR				Leathem, JM; Babbage, DR			Affective disorders after traumatic brain injury: Cautions in the use of the Symptom Checklist-90-R	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive impairment; psychological assessment; psychopathology	BECK-DEPRESSION-INVENTORY; MULTIPLE-SCLEROSIS; SCALE; PREVALENCE; SCL-90-R; IMPACT; TUMOR	Design: The current study compared the Symptom Checklist 90-Revised (SCL-30-R) results from a population of 88 individuals with traumatic brain injury (TBI) to those of a normative group. Setting: Individuals with traumatic brain injury referred to a university-based psychology clinic. Results: Results corroborated those from a smaller study,(1) where a considerable proportion of the elevations found on the subscales was attributed to endorsement of items identified as having a neurological basis. Conclusion: This reinforces the view that the results of neurological groups on clinical measures of emotional distress that have been standardized on physically healthy populations can be distorted because many of the items can be answered from physical and emotional perspectives.	Massey Univ, Sch Psychol, Palmerston North, New Zealand; Mid Cent Hlth, Serv Elderly, Palmerston North, New Zealand	Leathem, JM (corresponding author), Massey Univ, Sch Psychol, Private Bag 11-222, Palmerston North, New Zealand.	J.M.Leathem@massey.ac.nz	Babbage, Duncan/D-8866-2012	Babbage, Duncan/0000-0002-9259-9246			Aikens JE, 1998, INT J PSYCHIAT MED, V28, P265, DOI 10.2190/RJ82-3JKB-YKEM-BNU0; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ATKINS JE, 1999, J BEHAV MED, V27, P142; ATKINS JE, 1999, J BEHAV MED, V2, P122; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Beck A.T., 1987, BECK DEPRESSION INVE; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Broocks A, 1998, AM J PSYCHIAT, V155, P555, DOI 10.1176/ajp.155.4.555; DAHLSTROM WG, 1975, MMPI HDB, V1; Derogatis LR, 1983, SCL 90 R ADM SCORING; DICESARE A, 1990, COGNITIVE REHABILITA, V8, P14; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Kaplan CP, 1998, J HEAD TRAUMA REHAB, V13, P94, DOI 10.1097/00001199-199806000-00009; Kaplan CP, 1998, BRAIN INJURY, V12, P977, DOI 10.1080/026990598122025; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEZAK MD, 1990, J CLIN EXP NEUROPSYC, V12, P50; LEZAK MD, 1985, NEURPSYCHOLOGICAL AS; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Mohr DC, 1997, J BEHAV MED, V20, P407, DOI 10.1023/A:1025573315492; MUELIER SR, 1998, PSYCHOL REP, V63, P483; NELSON LD, 1989, J CONSULT CLIN PSYCH, V1, P266; OHARA C, 1998, COGN REHABIL, V6, P26; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P29; Radnitz CL, 1997, REHABIL PSYCHOL, V42, P93, DOI 10.1037/0090-5550.42.2.93; RUDD MD, 1995, COGNITIVE THER RES, V19, P51; TEASDALE TW, 1997, APPL NEUROPSYCHOL, V2, P116; TEMEN H, 1985, TEST CRITIQUES, V111; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; WOESSNER R, 1986, ASSESSMENT, V3, P291; WOODY SR, 1995, BEHAV RES THER, V33, P607, DOI 10.1016/0005-7967(94)00090-7	33	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2000	15	6					1246	1255		10.1097/00001199-200012000-00005			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	378ZX	WOS:000165617400005	11056406				2021-06-18	
J	Luiselli, JK; Arons, M; Marchese, N; Potoczny-Gray, A; Rossi, E				Luiselli, JK; Arons, M; Marchese, N; Potoczny-Gray, A; Rossi, E			Incidence of law-violating behavior in a community sample of children and adolescents with traumatic brain injury	INTERNATIONAL JOURNAL OF OFFENDER THERAPY AND COMPARATIVE CRIMINOLOGY			English	Article							VIOLENT	A survey was conducted with children and adolescents (N = 69) who had traumatic brain injury (TBI) and attended a community-based program of education and neurorehabilitation to determine the incidence of law-violating behavior subsequent to sustaining trauma. Thirteen categories of offenses were identified: alcohol use, animal cruelty, breaking and entering, indecent exposure, fire setting, paraphilia, physical assault, sexual assault, substance use, theft. truancy, vandalism, and vehicular homicide. Approximately one third of the sample had documented violations, and of this group, 72% had two or more incidents. Of the individuals who committed offenses, 90% were male. There were no differences in the type of TBI between the groups who did and did not have a history of law violations. The forensic concerns presented by children and adolescents with TBI are discussed.	May Inst Inc, Norwood, MA 02062 USA; May Ctr Educ & Neurorehabil, Training & Clin Serv, Randolph, MA 02368 USA; May Ctr Educ & Neurorehabil, Educ Serv, Randolph, MA 02368 USA; May Ctr Educ & Neurorehabil, Social Serv, Randolph, MA 02368 USA; May Ctr Educ & Neurorehabil, Allied Hlth serv, Randolph, MA 02368 USA	Luiselli, JK (corresponding author), May Inst Inc, 220 Norwood Pk S, Norwood, MA 02062 USA.						BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Gerring J P, 1986, Pediatr Rev, V8, P115, DOI 10.1542/pir.8-4-115; LEMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; LINK BG, 1992, AM SOCIOL REV, V57, P275, DOI 10.2307/2096235; LUISELLI JK, 1998, BEHAV INTERVENT, V13, P181; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; MONAHAN J, 1992, AM PSYCHOL, V47, P511, DOI 10.1037/0003-066X.47.4.511; QUINSEY VL, 1998, VIOLENT AFFENDERS AP; RUTTER M, 1977, J CHILD PSYCHOL PSYC, V18, P1, DOI 10.1111/j.1469-7610.1977.tb00413.x; SWANSON J, 1991, HOSPITAL COMMUNITY P, V42, P474; TEASDALE G, 1974, LANCET, V2, P81; WESSELY S, 1991, CRIMINAL BEHAVIOUR M, V1, P193	13	11	11	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0306-624X			INT J OFFENDER THER	Int. J. Offender Ther. Comp. Criminol.	DEC	2000	44	6					647	656		10.1177/0306624X00446002			10	Criminology & Penology; Psychology, Applied	Criminology & Penology; Psychology	416PK	WOS:000167789200002					2021-06-18	
J	Rosenfeld, JV; McDermott, FT; Laidlaw, JD; Cordner, SM; Tremayne, AB				Rosenfeld, JV; McDermott, FT; Laidlaw, JD; Cordner, SM; Tremayne, AB		Consultative Comm Road Traffic	The preventability of death in road traffic fatalities with head injury in Victoria, Australia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						neurotrauma; mortality; traffic accidents; prevention; evaluation studies; injuries	TRAUMA SYSTEM; ORANGE COUNTY; MANAGEMENT; MORTALITY; QUALITY; CARE; REGIONALIZATION; IDENTIFICATION; EXPERIENCE; MORBIDITY	Since 1992 the Consultative Committee on Road Traffic Fatalities in Victoria (CCRTF) has examined the medical management of patients who died following motor vehicle accidents. Three hundred and fifty-five fatalities with head injury occurring between I July, 1992 and 31 December 1997 were assessed by the CCRTF They represented 79% of the total 449 fatalities examined by the Committee. Following examination of the complete medical records and multidisciplinary discussion, the Committee considered 237 (67%) of the 355 neurotrauma deaths to be non-preventable, 105 (30%) potentially preventable and 13 (4%) preventable. The present analysis excludes the non-preventable deaths in order to focus on preventable factors. Problems identified in the 118 patients pre-hospital included: no intubation; prolonged scene time; and no intravenous access; in 139 emergency room attendances: inappropriate reception including delay in arrival of a consultant, no neurosurgical consultation, no CT scan of the head, inadequate blood gases and oxygen monitoring, inadequate fluid resuscitation, delayed respiratory resuscitation and delayed despatch to the operating room; in 111 operating room visits: no ICF monitoring, inadequate fluid administration and inappropriate anaesthetic technique; and in 90 intensive care unit admissions: no ICP monitoring. Overall, 1745 individual problems in the various areas of care were identified, of which 1104 (63%) were judged to have contributed to death. Improved delivery and quality of trauma care could reduce the identified problems in emergency services and clinical management. Basic principles of trauma management remain the most important means of reducing morbidity and death following road trauma. The leadership role of the neurosurgeon in neurotrauma care is emphasised. (C) 2000 Harcourt Publishers Ltd.	Victorian Inst Forens Med, Consultat Comm Rd Traff Fatal, Southbank 3006, Australia; Royal Childrens Hosp, Dept Neurosurg, Parkville, Vic 3052, Australia; Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Surg, Parkville, Vic 3052, Australia; Monash Univ, Alfred Hosp, Dept Surg, Prahran, Vic, Australia; Alfred Hosp, Dept Neurosurg, Prahran, Vic 3181, Australia; Monash Univ, Dept Forens Med, Victorian Inst Forens Med, Southbank, Australia	Rosenfeld, JV (corresponding author), Victorian Inst Forens Med, Consultat Comm Rd Traff Fatal, 57-83 Kavanagh St, Southbank 3006, Australia.		Morley, Peter/G-5280-2017; Rosenfeld, Jeffrey V/B-7249-2011	Morley, Peter/0000-0003-2653-090X; 			*AM ASS AUT MED CO, 1992, ABBR INJ SCAL 1990 R; *AM ASS AUT MED CO, 1985, ABBR INJ SCAL 1985 R; *AM COLL SURG, 1990, RES OPT CAR INJ PAT; ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CALES H, 1985, JAMA-J AM MED ASSOC, V253, P1059; CALES RH, 1984, ANN EMERG MED, V13, P1, DOI 10.1016/S0196-0644(84)80375-3; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; Civil IDS, 1997, AUST NZ J SURG, V67, P587, DOI 10.1111/j.1445-2197.1997.tb04601.x; DAVIS JW, 1992, J TRAUMA, V32, P660, DOI 10.1097/00005373-199205000-00020; DEANE SA, 1988, AUST NZ J SURG, V58, P147, DOI 10.1111/j.1445-2197.1988.tb01025.x; DRAAISMA JMT, 1989, J TRAUMA, V29, P1552; Kelly AM, 1997, AUST NZ J SURG, V67, P591, DOI 10.1111/j.1445-2197.1997.tb04603.x; KREIS DJ, 1986, J TRAUMA, V26, P649, DOI 10.1097/00005373-198607000-00010; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; McDermott FT, 1997, AUST NZ J SURG, V67, P611, DOI 10.1111/j.1445-2197.1997.tb04608.x; McDermott FT, 1996, J TRAUMA, V40, P520, DOI 10.1097/00005373-199604000-00003; McDermott FT, 1997, J TRAUMA, V43, P831, DOI 10.1097/00005373-199711000-00016; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NORUSIS MJ, 1996, STAT DATA ANAL; *QUANT LTD, 1993, QUANT V5D5 US MAN; Rosenfeld JV, 1997, J CLIN NEUROSCI, V4, P287, DOI 10.1016/S0967-5868(97)90095-3; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SELECKI BR, 1986, AUST NZ J SURG, V56, P529, DOI 10.1111/j.1445-2197.1986.tb07095.x; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; *TRANSP ACC COMM I, 1997, TAC ROAD SAF MONTHL; *TRAUM COMM, 1992, EARL MAN SEV TRAUM E; WEST JG, 1983, ARCH SURG-CHICAGO, V118, P740; WILSON DS, 1992, J TRAUMA, V32, P45, DOI 10.1097/00005373-199201000-00010	33	11	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2000	7	6					507	514		10.1054/jocn.1999.0694			8	Clinical Neurology; Neurosciences	Neurosciences & Neurology	384ME	WOS:000165946000007	11029231				2021-06-18	
J	Van den Heuvel, C; Finnie, JW; Blumbergs, PC; Manavis, J; Jones, NR; Reilly, PL; Pereira, RA				Van den Heuvel, C; Finnie, JW; Blumbergs, PC; Manavis, J; Jones, NR; Reilly, PL; Pereira, RA			Upregulation of neuronal amyloid precursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						amyloid precursor protein; head injury model; in-situ hybridization; magnesium sulphate; messenger RNA; northern blot hybridization; sheep	HEAD IMPACT MODEL; HUMAN-ENDOTHELIAL-CELLS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; SECRETED FORMS; AXONAL INJURY; TRANSCRIPTIONAL ACTIVATION; RAT HIPPOCAMPUS; MESSENGER-RNA; UP-REGULATION	The aim of this study was to assess and quantitate topographically the effects of posttraumatic intravenous magnesium sulphate (MgSO4) on neuronal perikaryal APP antigen and messenger RNA (mRNA) expression in sheep brains 2 h after a controlled focal head impact. The percentage brain rea with APP immunoreactive neuronal perikarya was 71, 56, 27.5 and 5.5%, respectively, in MgSO4-treated head-injured animals, head-injured animals without any treatment, MgSO4 treated nonimpacted animals, and nontreated nonimpacted control sheep. Although there was no statistically significant difference in APP immunoreactive neuronal perikarya in the MgSO4-treated Hf group (mean 71%) compared to the HI group without any treatment (mean 56%), northern analysis showed that there was a 2.3- +/- 0.2-fold increase in APP mRNA in the thalamus of treated impacted animals compared to untreated impacted animals (p < 0.005), However, MgSO4 treated nonimpacted control animals also showed a 1.6- +/-0.1-fold increase in APP mRNA compared to untreated nonimpacted controls (p < 0.005), MgSO4 therapy results in upregulation of neuronal APP mRNA and APP expression that is quantitatively greater following a focal head impact.	Inst Med & Vet Sci, Dept Neuropathol, Neuropathol Lab, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Vet Div, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Infect Dis Lab, Adelaide, SA 5000, Australia; Univ Adelaide, Dept Pathol, Adelaide, SA, Australia; Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia	Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Dept Neuropathol, Neuropathol Lab, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.	peter.blumbergs@imvs.sa.gov.au	van den Heuvel, Cameron J./E-1993-2012	van den Heuvel, Cameron J./0000-0001-7264-4655			ARTHUR J, 1993, J GEN VIROL, V74, P1363, DOI 10.1099/0022-1317-74-7-1363; Bourbonniere M, 1997, J NEUROCHEM, V68, P909; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; CIALLELLA JR, 1994, J NEUROSCI RES, V37, P769, DOI 10.1002/jnr.490370611; CLARK AF, 1980, J BIOL CHEM, V255, P6556; DEWJI NN, 1995, MOL BRAIN RES, V33, P245, DOI 10.1016/0169-328X(95)00131-B; Dewji NN, 1996, MOL BRAIN RES, V35, P325, DOI 10.1016/0169-328X(95)00214-D; DONNELLY RJ, 1990, CELL MOL NEUROBIOL, V10, P485, DOI 10.1007/BF00712843; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Furukawa K, 1998, NEUROSCIENCE, V83, P429, DOI 10.1016/S0306-4522(97)00398-9; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GARFINKEL L, 1985, Magnesium, V4, P60; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Griffin WST, 1998, BRAIN PATHOL, V8, P65; GRUBBS RD, 1987, MAGNESIUM, V6, P113; HAJIMOHAMMADREZA I, 1994, BRAIN RES, V640, P25, DOI 10.1016/0006-8993(94)91853-8; HEALTH DL, 1999, J NEUROSURG, V90, P504; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; HOFFMAN DJ, 1994, BRAIN RES, V644, P144, DOI 10.1016/0006-8993(94)90357-3; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; Johnson D, 1997, EDN, V42, P94; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; Lee RKK, 1997, P NATL ACAD SCI USA, V94, P5422, DOI 10.1073/pnas.94.10.5422; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lin L, 1998, NEUROREPORT, V9, P547, DOI 10.1097/00001756-199802160-00030; LOFFLER J, 1992, J NEUROCHEM, V59, P1316, DOI 10.1111/j.1471-4159.1992.tb08443.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; May C, 1998, AUST VET J, V76, P752, DOI 10.1111/j.1751-0813.1998.tb12307.x; MCDONALD JW, 1990, NEUROSCI LETT, V109, P234, DOI 10.1016/0304-3940(90)90569-U; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MCKENZIE JE, 1994, NEUROREPORT, V6, P161, DOI 10.1097/00001756-199412300-00041; Morimoto T, 1998, J NEUROSCI RES, V51, P185, DOI 10.1002/(SICI)1097-4547(19980115)51:2<185::AID-JNR7>3.0.CO;2-9; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OKAMOTO T, 1995, J BIOL CHEM, V270, P4205, DOI 10.1074/jbc.270.9.4205; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Panegyres PK, 1998, J NEUROL SCI, V154, P123, DOI 10.1016/S0022-510X(97)00214-1; Pierce JES, 1996, J NEUROSCI, V16, P1083; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; RICHARDS IS, 1982, AUST VET J, V58, P115, DOI 10.1111/j.1751-0813.1982.tb00606.x; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; SCHUBERT W, 1991, BRAIN RES, V563, P184, DOI 10.1016/0006-8993(91)91532-6; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; SHIGEMATSU K, 1992, BRAIN RES, V593, P117, DOI 10.1016/0006-8993(92)91272-G; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; TERASAKI M, 1985, P NATL ACAD SCI USA, V82, P7324, DOI 10.1073/pnas.82.21.7324; Tominaga K, 1997, NEUROREPORT, V8, P2067, DOI 10.1097/00001756-199705260-00051; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VACANTI FX, 1984, STROKE, V15, P695, DOI 10.1161/01.STR.15.4.695; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WOLF G, 1991, NEUROSCIENCE, V43, P31, DOI 10.1016/0306-4522(91)90413-I; Yang YX, 1998, MOL BRAIN RES, V60, P40, DOI 10.1016/S0169-328X(98)00164-8; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	77	11	11	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2000	17	11					1041	1053		10.1089/neu.2000.17.1041			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	374KY	WOS:000165345400004	11101207				2021-06-18	
J	Shewmon, DA				Shewmon, DA			Coma prognosis in children - Part II: Clinical application	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Neurophysiology-Society	OCT 29-NOV 01, 1999	ST LOUIS, MO	Amer Neurophysiol Soc			SOMATOSENSORY-EVOKED-POTENTIALS; PEDIATRIC HEAD-INJURY; SEVERE BRAIN INJURY; TERM FOLLOW-UP; CARDIOPULMONARY-RESUSCITATION; PERINATAL HYPOXIA; VEGETATIVE STATE; TRAUMATIC COMA; FULL-TERM; EEG		Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Shewmon, DA (corresponding author), Olive View UCLA Med Ctr, Dept Neurol, Div Pediat, 14445 Olive View Dr,N Annex, Sylmar, CA 91342 USA.						ALLMAN FD, 1986, AM J DIS CHILD, V140, P571, DOI 10.1001/archpedi.1986.02140200081033; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; AOKI Y, 1973, NEUROLOGY, V23, P333, DOI 10.1212/WNL.23.4.333; ASHWAL S, 1988, ANN NEUROL, V24, P329; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BOLTE RG, 1988, JAMA-J AM MED ASSOC, V260, P377, DOI 10.1001/jama.260.3.377; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRITT CW, 1981, NEUROLOGY, V31, P393; CARROLL WM, 1979, ELECTROEN CLIN NEURO, V46, P95, DOI 10.1016/0013-4694(79)90054-3; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1205, DOI 10.1056/NEJM198205203062004; CHIAPPA KH, 1982, NEW ENGL J MED, V306, P1140, DOI 10.1056/NEJM198205133061904; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; COLLINS AT, 1980, NEUROLOGY, V30, P1316, DOI 10.1212/WNL.30.12.1316; De Meirleir L J, 1986, Pediatr Neurol, V2, P31, DOI 10.1016/0887-8994(86)90036-6; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; DEMEIRLEIR LJ, 1987, PEDIATR NEUROL, V3, P78, DOI 10.1016/0887-8994(87)90031-2; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; FERBERT A, 1986, ELECTROEN CLIN NEURO, V65, P157, DOI 10.1016/0168-5597(86)90049-3; FRANK LM, 1985, NEUROLOGY, V35, P931, DOI 10.1212/WNL.35.6.931; FRISHER S, 1985, CHILD NERV SYST, V1, P208, DOI 10.1007/BF00270763; GANES T, 1987, ELECTROENCEPHALOGR C, V69, P6; GILLIS J, 1986, CRIT CARE MED, V14, P469, DOI 10.1097/00003246-198605000-00007; GOLDIE WD, 1981, NEUROLOGY, V31, P248, DOI 10.1212/WNL.31.3.248; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; GOODWIN SR, 1993, CRIT CARE MED, V21, P631, DOI 10.1097/00003246-199304000-00027; GRIGGDAMBERGER MM, 1989, PEDIATR NEUROL, V5, P84, DOI 10.1016/0887-8994(89)90032-5; HANSOTIA P, 1981, NEUROLOGY, V31, P83, DOI 10.1212/WNL.31.1.83; HECOX KE, 1981, NEUROLOGY, V31, P1429, DOI 10.1212/WNL.31.11.1429; HOLMES G, 1982, ELECTROEN CLIN NEURO, V53, P60, DOI 10.1016/0013-4694(82)90106-7; HULIHAN JF, 1994, NEUROLOGY, V44, P758, DOI 10.1212/WNL.44.4.758; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JONAS RA, 1990, RFETAL NEONATAL INFA, P983; KARNAZE DS, 1982, NEUROLOGY, V32, P289, DOI 10.1212/WNL.32.3.289; KERN FH, 1995, CRITICAL HEART DIS I, P497; KVITTINGEN TD, 1963, BRIT MED J, P1315; LAVELLE JM, 1993, CRIT CARE MED, V21, P368, DOI 10.1097/00003246-199303000-00013; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEWIS JK, 1983, ANN EMERG MED, V12, P297, DOI 10.1016/S0196-0644(83)80512-5; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MODELL JH, 1980, CAN ANAESTH SOC J, V27, P211, DOI 10.1007/BF03007430; MOLOFSKY WJ, 1982, J NEUROL NEUROSUR PS, V45, P95, DOI 10.1136/jnnp.45.1.95; MONOD N, 1972, ELECTROEN CLIN NEURO, V32, P529, DOI 10.1016/0013-4694(72)90063-6; NATALONI S, 1988, RESUSCITATION, V16, P127, DOI 10.1016/0300-9572(88)90077-9; OCARROLL PW, 1988, JAMA-J AM MED ASSOC, V260, P380, DOI 10.1001/jama.260.3.380; ORLOWSKI JP, 1979, JACEP-J AM COLL EMER, V8, P176, DOI 10.1016/S0361-1124(79)80121-5; ORLOWSKI JP, 1987, PEDIATR CLIN N AM, V34, P75; OROURKE PP, 1986, CRIT CARE MED, V14, P466, DOI 10.1097/00003246-198605000-00006; PAMPIGLI.G, 1968, LANCET, V1, P1261; Pampiglione G, 1978, Ann N Y Acad Sci, V315, P281, DOI 10.1111/j.1749-6632.1978.tb50346.x; PLOUIN P, 1977, REV EEG NEUROPHYSIOL, V7, P410, DOI 10.1016/S0370-4475(77)80027-0; ROSE AL, 1970, PEDIATRICS, V45, P404; SANDERS RA, 1981, J OTOLARYNGOL, V10, P52; SARNAIK AP, 1985, CRIT CARE MED, V13, P224, DOI 10.1097/00003246-198504000-00003; SCHWARZ G, 1988, Klinische Wochenschrift, V66, P48; Shewmon DA, 1999, DEV MED CHILD NEUROL, V41, P364, DOI 10.1017/S0012162299000821; SIEBKE H, 1975, LANCET, V1, P1275; SIMON RP, 1986, ANN NEUROL, V20, P351, DOI 10.1002/ana.410200313; STAUDT F, 1982, NEUROPEDIATRICS, V13, P24, DOI 10.1055/s-2008-1059591; STRICKBINEVANREET P, 1984, AM J DIS CHILD, V138, P492; TAKEUCHI T, 1989, BRAIN DEV-JPN, V11, P115, DOI 10.1016/S0387-7604(89)80079-8; TAKEUCHI T, 1989, BRAIN DEV, V11, P203; TASKER RC, 1988, ARCH DIS CHILD, V63, P895, DOI 10.1136/adc.63.8.895; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; THARP BR, 1989, NEUROPEDIATRICS, V20, P64, DOI 10.1055/s-2008-1071267; THARP BR, 1981, ELECTROEN CLIN NEURO, V51, P219, DOI 10.1016/0013-4694(81)90136-X; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; VONSEGGERN K, 1986, CRIT CARE MED, V14, P275; WATANABE K, 1981, EUR J PEDIATR, V137, P177; WATANABE K, 1980, ELECTROEN CLIN NEURO, V49, P618, DOI 10.1016/0013-4694(80)90402-2; WERNOVSKY G, 1995, MOSS ADAMS HEART DIS, V1, P398; WHITE LE, 1985, ANN NEUROL, V18, P417; YOUNG RSK, 1980, JAMA-J AM MED ASSOC, V244, P1233, DOI 10.1001/jama.244.11.1233	75	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	SEP	2000	17	5					467	472		10.1097/00004691-200009000-00005			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	371MQ	WOS:000165183100005	11085550				2021-06-18	
J	Jang, SH; Shin, SW; Ahn, SH; Cho, IH; Kim, SH				Jang, SH; Shin, SW; Ahn, SH; Cho, IH; Kim, SH			Radiation therapy for heterotopic ossification in a patient with traumatic brain injury	YONSEI MEDICAL JOURNAL			English	Article						heterotopic ossification; radiation therapy; traumatic brain injury	BONE	Radiation therapy has been known to have a prophylactic effect for heterotopic ossification (HO), but until now it has not been known to have a therapeutic effect for established HO. We report a case of established HO compounded with a sudden increase in activity, that was improved with radiation therapy. A patient with traumatic brain injury had HO in both hips and thighs two months after the initial trauma. The existing level of HO activity suddenly increased seven months after the initial trauma, and was accompanied by severe pain that was refractory to indomethacin. We assumed chat the pain was caused by the increased activity of HO on the basis of clinical symptoms and laboratory results. Initially, che patient received radiation therapy to the left lower extremity, with a total dose of 20 Gy in ten tractions. Next, the patient received radiation therapy at the same dosage to the right lower extremity, after which the pain and level of serum alkaline phosphatase significantly decreased. The patient experienced a mild pancytopenia as a side effect of the radiation therapy, but it was not severe enough to stop the radiation therapy, given the patient's suffering from the increased HO activity.	Yeungnam Univ, Coll Med, Dept Rehabil Med, Taegu 705717, South Korea; Yeungnam Univ, Coll Med, Dept Therapeut Radiol & Oncol, Taegu 705717, South Korea; Yeungnam Univ, Coll Med, Dept Nucl Med, Taegu 705717, South Korea; Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea	Jang, SH (corresponding author), Yeungnam Univ, Sch Med, Dept Phys Med & Rehabil, Namku, 317-1 Daemyungdong, Taegu 705717, South Korea.						AYERS DC, 1991, CLIN ORTHOP RELAT R, P87; DJERGAIAN RS, 1996, MED REHABILITATION T, P459; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Hammond FM MJT, 1999, REHABILITATION ADULT, P53; Han Chang Dong, 1997, Yonsei Medical Journal, V38, P96; KEWALRAMANI LS, 1977, AM J PHYS MED REHAB, V56, P99; ORZEL JA, 1985, J NUCL MED, V26, P125; Pittenger D E, 1991, Orthop Rev, V20, P33; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407	12	11	11	0	1	YONSEI UNIV COLLEGE MEDICINE	SEOUL	C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL 120-752, SOUTH KOREA	0513-5796			YONSEI MED J	Yonsei Med. J.	AUG	2000	41	4					536	539		10.3349/ymj.2000.41.4.536			4	Medicine, General & Internal	General & Internal Medicine	351WX	WOS:000089183400018	10992819	Bronze			2021-06-18	
J	Neese, LE; Caroselli, JS; Klaas, P; High, WM; Becker, LJ; Scheibel, RS				Neese, LE; Caroselli, JS; Klaas, P; High, WM; Becker, LJ; Scheibel, RS			Neuropsychological assessment and the Disability Rating Scale (DRS): a concurrent validity study	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; COMMUNITY INTEGRATION; TESTS	Assessment of current level of functioning among clients with traumatic brain injury (TBI) often guides the establishment of realistic outcome goals for post-acute rehabilitation. Further, data generated from neuropsychological testing provide a clinician with a better understanding of a client's pattern of cognitive strengths and weaknesses. The Disability Rating Scale (DRS) is commonly used by TBI rehabilitation facilities to assess a client's general level of functioning in terms of impairment, disability, and handicap. Previous studies have used clients' neuropsychological test results to predict future level of functioning. These studies have shown mixed results regarding the predictive validity of the test findings; however, they usually employ only a limited number of tests for prediction representing a limited number of cognitive domains. Using a concurrent validity design, the present study investigated the bivariate associations between various neuropsychological testing domains (i.e. intellectual, academic, language, visuoperceptual, memory, and executive functioning) and level of functioning as indexed by the DRS. Participants were administered the DRS and the neuropsychological evaluation during the initial part of post-acute rehabilitation. Composite scores were derived for each of the neuropsychological domains. Most participants were categorized as sustaining a severe TBI. The mean age and education of this predominately male sample was 28.84 years (SD = 9.13) and 11.83 years (SD = 1.7), respectively. Results revealed a significant positive relationship between performances in intellectual, executive, academic, and visuoperceptual domains and level of functioning.	Transit Learning Ctr Galveston, Galveston, TX 77550 USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA; TIRR, Brain Injury Res Ctr, Houston, TX USA	Caroselli, JS (corresponding author), Transit Learning Ctr Galveston, 1528 Post Off, Galveston, TX 77550 USA.						Ashley MJ, 1997, BRAIN INJURY, V11, P677; BENTON A, 1978, CONTRIBUTIONS NEUROP; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Benton AL, 1978, MULTILINGUAL APHASIA; Brown L., 1990, TEST NONVERBAL INTEL; COHEN, 1983, APPL MULTIPLE REGRES, P53; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; DELIS D, 1987, CALIFORNIA VERBAL LE; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Heaton R., 1981, MANUAL WISCONSIN CAR; Johnstone B, 1996, BRAIN INJURY, V10, P627, DOI 10.1080/026990596124052; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; MARKWOOD FC, 1989, PEABODY INDIVIDUAL A; Millis S R, 1994, Int J Neurosci, V79, P165; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1986, TRAIL MAKING TEST MA; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wechsler D., 1987, MANUAL WECHSLER MEMO; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilkinson G. S., 1993, WIDE RANGE ACHIEVEME; ZAFONTE RD, 1996, CME ARTICLE, V13, P364	25	11	11	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2000	14	8					719	724					6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	342XT	WOS:000088672000005	10969890				2021-06-18	
J	Chong, ZZ; Feng, YP				Chong, ZZ; Feng, YP			dl-3-n-butylphthalide reduces brain damage in mice with closed head injury	CHINESE MEDICAL JOURNAL			English	Article						dl-3-n-butylphthalide; closed head injury; blood-brain barrier; brain edema; choline acetyltransferase	CHOLINE-ACETYLTRANSFERASE; EDEMA	Objective To investigate the protective effect of dl-3-n-butylphthalide (NBP) as an anti-cerebral ischemic drug on brain damage 24 h after closed head injury in mice. Methods Closed head injury was induced by dropping a 50-g weight from a height of 18 cm on a metal impounder resting on the parietal bone in mice. Results The neurotraumatic model induced impairment of memory function, significant cerebral edema, and disruption of the blood-brain barrier. dl-3-n-butylphthalide (50 mg . kg(-1)) given intraperitoneally 5 minutes and 60 minutes after the onset of closed head injury was found to attenuate the impairment of memory function (P < 0.05), alleviate brain edema in the injured cerebral cortex (P < 0.05), and reduce extravasation of plasma protein bound to Evans blue dye by 63.5% (P < 0.01). NBP was also shown to increase the activity of choline acetyltransferase in the injured cortex to 0.83 +/- 0.21 ng . min(-1) . mg(-1) ( P < 0.01, compared with 0.48 +/- 0.14 ng . min(-1) . mg(-1) of vehicle group). Conclusion NBP provides therapeutic response in experimental closed head injury.	Peking Union Med Coll, Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China	Chong, ZZ (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.						CHONG ZZ, 1998, ACTA PHARMACOL SINIC, V32, P245; Deng W, 1997, Chin Med Sci J, V12, P102; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DEWAR D, 1997, J CEREB BLOOD FLO S1, V17, P527; FENG YP, 1995, ACTA PHARMACOL SINIC, V30, P741; Gorman L. K., 1995, Society for Neuroscience Abstracts, V21, P471; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LIU XG, 1995, ACTA PHARMACOL SINIC, V30, P896; UNTERBERG A, 1986, J NEUROSURG, V64, P269, DOI 10.3171/jns.1986.64.2.0269; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; Yan CH, 1998, CHINESE J PHARM TOXI, V12, P36	13	11	13	0	4	CHINESE MEDICAL ASSOCIATION	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JUL	2000	113	7					613	616					4	Medicine, General & Internal	General & Internal Medicine	342JH	WOS:000088641100010	11776030	DOAJ Gold			2021-06-18	
J	Anderson, GD; Lin, YX; Temkin, NR; Fischer, JH; Winn, HR				Anderson, GD; Lin, YX; Temkin, NR; Fischer, JH; Winn, HR			Incidence of intravenous site reactions in neurotrauma patients receiving valproate or phenytoin	ANNALS OF PHARMACOTHERAPY			English	Article						intravenous therapy; phenytoin; valproate; neurotrauma	POSTTRAUMATIC SEIZURES; FOSPHENYTOIN; PREVENTION; INFUSION	OBJECTIVE: To determine the incidence of intravenous site reactions to phenytoin and valproate in a large population of patients with neurotrauma. DESIGN: Retrospective chart review of two double-blind, randomized clinical trials evaluating the use of antiepileptic drugs to prevent posttraumatic seizures in patients with neurotrauma: phenytoin versus placebo (n = 390), and valproate versus phenytoin with placebo (n = 385). Information collected from the charts included the number, type, and location of intravenous lines and intravenous site events. SETTING: Tertiary care trauma and university teaching hospital. MAIN RESULTS: Intravenous site reactions occurred in 18% and 25% of patients receiving valproate or phenytoin, respectively, with the majority of events (70%) occurring in the first intravenous site. Patients received the neurosurgery study drug (NSSD) by either central or peripheral lines; all intravenous site reactions occurred in peripheral administration sites. When patients who received the drug by central line during the course of therapy were excluded, the estimated incidence of site reactions was 21% and 30% for valproate and phenytoin, respectively (p = 0.056). The time to the first event was shorter with phenytoin compared with valproate (2.0 +/- 1.3 vs. 3.0 +/- 1.9 d; p = 0.009). Fewer adverse events were noted with phenytoin in the phenytoin-without-valproate study than in the phenytoin-with:valproate study, with 4.3% and 8.2% of intravenous site events recorded in patients receiving placebo or phenytoin, respectively. There was no significant difference in the number of intravenous lines per patient used during NSSD drug infusion for phenytoin versus placebo or phenytoin Versus valproate. CONCLUSIONS: Both intravenous phenytoin and valproate resulted in intravenous site reactions, with the loading doses responsible the majority of the events.	Univ Washington, Dept Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; Univ Illinois, Dept Pharm Practice, Chicago, IL USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Box 357630, Seattle, WA 98195 USA.						Boucher BA, 1996, PHARMACOTHERAPY, V16, P638; CARDUCCI B, 1984, ANN EMERG MED, V13, P1027, DOI 10.1016/S0196-0644(84)80063-3; DELACRUZ FG, 1988, CLIN PHARMACY, V7, P219; DONOVAN PJ, 1991, ANN EMERG MED, V20, P139, DOI 10.1016/S0196-0644(05)81211-9; EARNEST MP, 1983, JAMA-J AM MED ASSOC, V249, P762, DOI 10.1001/jama.249.6.762; JAMERSON BD, 1994, PHARMACOTHERAPY, V14, P47, DOI 10.1002/j.1875-9114.1994.tb02788.x; KILARSKI DJ, 1984, NEW ENGL J MED, V311, P1186; SALEM RB, 1981, AM J HOSP PHARM, V38, P354, DOI 10.1093/ajhp/38.3.354; SPENGLER RF, 1988, ARCH INTERN MED, V148, P1329, DOI 10.1001/archinte.148.6.1329; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593	11	11	11	0	0	HARVEY WHITNEY BOOKS CO	CINCINNATI	PO BOX 42696, CINCINNATI, OH 45242 USA	1060-0280			ANN PHARMACOTHER	Ann. Pharmacother.	JUN	2000	34	6					697	702					6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	321GF	WOS:000087447200001	10860128				2021-06-18	
J	Schlund, MW; Pace, G				Schlund, MW; Pace, G			The effects of traumatic brain injury on reporting and responding to causal relations: an investigation of sensitivity to reinforcement contingencies	BRAIN INJURY			English	Article							MOTIVATIONAL DEFICITS; DAMAGE; BEHAVIOR	Impairments in judging and responding to consequences that follow behaviour are often attributed to changes in various cognitive processes. An alternative conceptualization is that impairments may produce a reduction in sensitivity to reinforcement contingencies. The present investigation employed a methodology commonly used in research on judgements of causality to examine the effects of TBI on sensitivity to reinforcement contingencies. Participants were non-injured control subjects and adults with TBI. The experimental task required subjects to press a response key under a series of concurrent response-reinforcer contingencies that periodically delivered money for responding and not responding. Afterwards, subjects provided a judgement about each response-reinforcer contingency by reporting the amount of money earned for responding and for not responding. Results suggest that TBI reduced the sensitivity of judgements and responding under select contingencies. These results lend some support to the view that TBI may reduce sensitivity to reinforcement contingencies. Furthermore, the investigation highlights the potential benefits of employing methods commonly used in human and animal operant research for the study of TBI.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg,Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Bandura A., 1969, PRINCIPLES BEHAV MOD; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; CHATLOSH DL, 1985, LEARN MOTIV, V16, P1, DOI 10.1016/0023-9690(85)90002-5; Damasio A. R., 1993, CLIN NEUROPSYCHOLOGY, V3, P409; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; HAMMOND LJ, 1980, J EXP ANAL BEHAV, V34, P297, DOI 10.1901/jeab.1980.34-297; Heaton R., 1993, WISCONSIN CARD SORTI; Heider, 1958, PSYCHOL INTERPERSONA; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mackintosh NJ, 1974, PSYCHOL ANIMAL LEARN; MAIER SF, 1976, J EXP PSYCHOL GEN, V105, P3, DOI 10.1037/0096-3445.105.1.3; MALKMUS D, 1974, RANCHO LOS AMIGOS SC; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NEWLAND MC, 1994, TOXICOL APPL PHARM, V126, P6, DOI 10.1006/taap.1994.1084; OSCARBERMAN M, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P230; Piaget J., 1974, UNDERSTANDING CAUSAL; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; REED P, 1992, Q J EXP PSYCHOL-B, V44B, P81; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; SCHLUND MW, 2000, IN PRESS BEHAV INTER; Skinner BF, 1938, BEHAV ORGANISMS; *STAT U NEW YORK B, 1993, GUID UN DAT SET MED; Wechsler D, 1985, WECHSLER ADULT INTEL; Williamson D. J. G., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [10.1037/10198-001, DOI 10.1037/10198-001]	28	11	11	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2000	14	6					573	583		10.1080/026990500120475			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	325WN	WOS:000087699600007	10887890				2021-06-18	
J	del Pozo, NO; Ezquerra-Iribarren, JA; Urruticoechea-Sarriegui, I; Quemada-Ubis, JI; Munoz-Cespedes, JM				del Pozo, NO; Ezquerra-Iribarren, JA; Urruticoechea-Sarriegui, I; Quemada-Ubis, JI; Munoz-Cespedes, JM			Training in social skills in patients with acquired brain damage	REVISTA DE NEUROLOGIA			Spanish	Article						brain damage; neuropsychology; neuropsychological rehabilitation; social skills	SEVERE HEAD-INJURY; ADJUSTMENT; INDIVIDUALS; PERSONALITY; SEQUELAE; PROFILE; SUPPORT; STRESS	Introduction. Brain damaged patients have cognitive deficits, behaviour disorders and personality changes which affect socio-familial behaviour. Frequently, these changes generate considerable disturbance between family members and make it very difficult to return to work Objective. We describe a pilot study which led to the development and application of a focal rehabilitation programme aimed at retraining this group in social skills. Patients and methods. The programme was intensive (3 months) and included 6 outpatients (5 men and 1 woman) who took part in programmes of neuropsychological rehabilitation after traumatic or vascular cerebral lesions (X=19.2 months after the lesion occurred). The average age of the patients was 27.2 years and their average IQ 109.2. Individual and group interventions were combined (role-playing, 'make-believe' work, video filming) emphasizing particularly the processes of learning without making mistakes and the extension of achievements to the natural setting (controlled trials). Results and conclusions. We state and describe the relationship between the nature of neuropsychological and psychopathological deficits, and the characteristics of the limitations in social behaviour The patients showed a significant reduction in the level of anxiety and aggressive behaviour and improvement in consciousness of their defects. Some improvement was seen in expressing opinions and emotions and in ability to adapt social conduct to different situations (flexible behaviour), Finally we describe the conclusions drawn as to this treatment for future review and improvement of the programme.	Hosp Aita Menni, Serv Rehabil Dano Cerebral, Mondragon, Guipuzcoa, Spain; Univ Complutense Madrid, Dept Psicol Basica Procesos Cognit, Hosp Beata Maria Ana, Unidad Dano Cerebral, Madrid, Spain				OJEDA, NATALIA/0000-0002-0952-0649			ALONSO J, 1990, AM J PUBLIC HEALTH, V80, P704, DOI 10.2105/AJPH.80.6.704; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BEL MTR, 1995, DANO CEREBRAL TRAUMA, P249; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROTHERTON FA, 1988, ARCH PHYS MED REHAB, V69, P827; CABALLO VE, 1987, 7 JORN MOD COND MADR; FERNANDEZGUINEA S, 1997, MAPFRE MED, V8, P191; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; KWASNICA CM, 1994, ARCH PHYS MED REHAB, V75, P384, DOI 10.1016/0003-9993(94)90159-7; Leathem J, 1996, BRAIN INJURY, V10, P27; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lezak M. D., 1989, ASSESSMENT BEHAV CON, P113; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUNOZCESPEDES JM, 1999, IN PRESS POLIBEA; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; TURKSTRA IS, 1995, BRAIN INJURY, V10, P329; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; URRUTICOECHEASA.I, 1997, NEUROPSIQUIATRIA DAN, P319; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	30	11	14	0	11	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	APR 16	2000	30	8					783	787		10.33588/rn.3008.99650			5	Clinical Neurology	Neurosciences & Neurology	313GW	WOS:000086992800015	10893745				2021-06-18	
J	Freeman, J; Godfrey, H				Freeman, J; Godfrey, H			The validity of the NART-RSPM index in detecting intellectual decline following traumatic brain injury: A controlled study	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							ADULT READING TEST; STANDARD PROGRESSIVE MATRICES; PREMORBID INTELLIGENCE; HEAD-INJURY; VALIDATION; DEMENTIA; HOLD; IQ	The present study replicated Van den Broek and Bradshaw's (1994) study by developing a multiple regression equation to predict Ravens Standard Progressive Matrices (RSPM) scores from participants' National Adult Reading Test (NART) stores and demographic variables. A test of the validity of this procedure was undertaken by applying both the Van den Broek and Bradshaw equation and the present study's equation to a mixed sample of orthopedic control (OC) and closed head injury (CHI) participants. Premorbid RSPM scores were estimated using both equations and then compared to obtained scores. Results indicated that both equations had good predictive accuracy in estimating RSPM scores and were able to detect significantly higher rates of impairment in general intelligence in the CHI participants (24%) compared to the OC sample (7%).	Univ Otago, Dept Psychol, Dunedin, New Zealand	Godfrey, H (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.						Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P275, DOI 10.1111/j.2044-8260.1989.tb01377.x; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P585, DOI 10.1016/0191-8869(89)90043-3; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; ELLEY WB, 1985, NEW ZEAL J EDUC STUD, V20, P115; Garb HN, 1996, PSYCHOL BULL, V120, P140, DOI 10.1037/0033-2909.120.1.140; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HARTLAGE LC, 1982, J CLIN PSYCHOL, V32, P658; IRVING JC, 1977, NEW ZEAL J EDUC STUD, V12, P154; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nelson HE, 1982, NATL ADULT READING T; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P315, DOI 10.1111/j.2044-8260.1987.tb01367.x; OLEARY UM, 1991, J CLIN PSYCHOL, V47, P277, DOI 10.1002/1097-4679(199103)47:2<277::AID-JCLP2270470215>3.0.CO;2-I; ORME JE, 1970, ACTA PSYCHOL, V32, P145, DOI 10.1016/0001-6918(70)90096-X; Raven, 1958, GUIDE USING MILL HIL; Stebbins Glenn T, 1990, Clin Neuropsychol, V4, P64, DOI 10.1080/13854049008401497; VANDENBROEK MD, 1994, BRIT J CLIN PSYCHOL, V33, P509	21	11	11	0	0	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	MAR	2000	39		1				95	103		10.1348/014466500163130			9	Psychology, Clinical	Psychology	296TX	WOS:000086043400010	10789031				2021-06-18	
J	O'Neill, B				O'Neill, B			Head restraints - the neglected countermeasure	ACCIDENT ANALYSIS AND PREVENTION			English	Article; Proceedings Paper	World Congress on Whiplash Associated Disorders	1999	VANCOUVER, CANADA			head restraints; whiplash; neck injuries; occupant protection; motor vehicle crashes		In a rear-end crash, if an occupant's head is unsupported it lags behind as the torso is accelerated forward. This causes the neck to change shape, first taking an s-shape and then bending backward in a 'whiplash' motion. This sudden differential movement of the head and torso can cause 'whiplash' injuries to the neck. This paper reviews methods to minimize the differential head/torso movement and reduce the resulting injuries, focusing on the necessary first step for prevention, which is a head restraint that is behind and close to the back of an occupant's head during the crash. The history of head restraints since the 1950s is reviewed, with particular attention to advanced restraint designs that are proving effective in reducing whiplash injury risk in dynamic tests using a new crash test dummy neck and a new neck injury criterion. (C) 2000 Elsevier Science Ltd. All rights reserved.	Insurance Inst Highway Safety, Arlington, VA USA	O'Neill, B (corresponding author), Insurance Inst Highway Safety, 1005 N Glebe Rd, Arlington, VA USA.						Bostrom O., 1996, P IRCOBI C, P123; CAMERON MH, 1979, EFFECTIVENESS AUSTR; CAMERON MH, 1980, EFFECT AUSTR DESIGN; *COUNC EUR COMM, 1978, OFFICIAL J EUROPEAN, V21, P1; Council of the European Communities, 1996, OFFICIAL J EUROPEAN, V39, P28; CROWE K, 1962, COMMUNICATION   1221; Davidsson J., 1998, P IRCOBI C BIOM IMP, P377; EICHBERGER A, 1998, P INT C BIOM IMP IRC, P321; Farmer CM, 1999, ACCIDENT ANAL PREV, V31, P719, DOI 10.1016/S0001-4575(99)00035-4; GARRETT JW, 1972, SAE TECHNICAL PAPER; KAHANE CJ, 1982, 202 US DEP TRANSP; LUNDELL B, 1998, SAE TECHNICAL PAPER; MCINTIRE RT, 1957, J INT COLL SURG, V228, P54; MCNAB I, 1965, P ANN M AM ASS AUT M, P11; Mertz H.J., 1967, SAE TECHNICAL PAPER; MORRIS CR, 1998, MEASUREMENT EVALUATI; Olsson I, 1990, P INT IRCOBI C BIOM, P269; ONEILL B, 1972, AM J PUBLIC HEALTH, V62, P309; RUEDEMANN AD, 1957, JAMA-J AM MED ASSOC, V164, P1889, DOI 10.1001/jama.1957.62980170001006; SEVERY DM, 1968, SAE TECHNICAL PAPER; SEVRY DM, 1967, P 11 STAPP CAR CRASH, P337; *SOC AUT ENG, 1995, DEV US DEF MEAS VEH, pJ826; States JD, 1972, P 16 STAPP CAR CRASH, P228; Svensson M.Y., 1993, P INT RES COMM BIOM, P189; *UN EC SOC COUNC, 1997, EC COMM EUR STAT AGR, P79; Vann, 1995, MEASUREMENT EVALUATI; WIKLUND K, 1998, SAE TECHNICAL PAPER	27	11	11	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	MAR	2000	32	2					143	150		10.1016/S0001-4575(99)00057-3			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	282GG	WOS:000085209300002	10688470				2021-06-18	
J	Huh, PW; Belayev, L; Zhao, WZ; Clemens, JA; Panetta, JA; Busto, R; Ginsberg, MD				Huh, PW; Belayev, L; Zhao, WZ; Clemens, JA; Panetta, JA; Busto, R; Ginsberg, MD			Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						LY341122; cerebral ischemia, focal; neuroprotection; stroke; oxygen radical; (rat)	CEREBRAL-ARTERY OCCLUSION; INTRALUMINAL SUTURE; REPERFUSION INJURY; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; INFARCT VOLUME; BLOOD-FLOW; MODEL; U-101033E; DEFICITS	LY341122 (2-(3,5-di-t-butyl-4-hydroxyphenyl)-4-(2-(4-methylethylaminomethyl-phenyloxy)ethyl)oxazole) is a potent inhibitor of lipid peroxidation which has been shown to protect against global ischemia and traumatic brain injury in rats. The purpose of this study was to examine the effect of LY341122 on ischemic injury in a highly reproducible model of focal cerebral ischemia in rats. Male Sprague-Dawley rats were anesthetized with halothane and subjected to 120 min of temporary middle cerebral artery occlusion by retrograde insertion of an intraluminal nylon suture coated with poly-L-lysine. The drug (LY341122, n = 19) or vehicle (phosphate-buffered saline (PBS), n = 10) was administered i.v. las a 5 or 10 mg/kg bolus followed by a 5 or 10 mg/kg/h infusion for 20 h, respectively, starting 1 or 2 h after the onset of middle cerebral artery occlusion). Neurological status was evaluated during middle cerebral artery occlusion (60 min) and daily for 3 days thereafter. Three days after ischemia, brains were perfusion-fixed and infarct volumes and brain edema were determined. LY341122 significantly improved the neurological score compared to vehicle at 24, 48 and 72 h after middle cerebral artery occlusion. Treatment with LY341122 significantly reduced total infarct volume in all treated groups compared to vehicle rats. Cortical infarct volume was significantly reduced by LY341122 treatment in the 10 mg/kg (1 h) and LY341122 10 mg/kg (2 h) groups compared to vehicle rats (14.7 +/- 9.5 vs. 106.8 +/- 20.9 mm(3), and 36.9 +/- 20.1 vs. 106.8 +/- 20.9 mm(3), respectively (mean +/- S.E.M.)). Striatal infarct volume was also significantly reduced by treatment with LY341122 in the 10 mg/kg (1 h) group compared to vehicle (23.7 +/- 3.4 vs. 68.2 +/- 6.7 mm(3)). These results demonstrate the neuroprotective efficacy of LY341122 in focal cerebral ischemia. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Miami, Sch Med, Dept Neurol D4 5, Cerebral Vasc Dis Res Ctr, Miami, FL 33101 USA; Lilly Res Labs, Indianapolis, IN 46285 USA	Belayev, L (corresponding author), Univ Miami, Sch Med, Dept Neurol D4 5, Cerebral Vasc Dis Res Ctr, POB 016960, Miami, FL 33101 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 05820] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS005820, P50NS005820] Funding Source: NIH RePORTER		BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 1998, BRAIN RES, V787, P277, DOI 10.1016/S0006-8993(97)01499-6; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CHAN PH, 1993, NEUROREPORT, V5, P293, DOI 10.1097/00001756-199312000-00028; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; CLEMENS JA, 1999, J CEREB BLOOD FLO S1, V19, pS183; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Ginsberg M. D, 1995, NEUROSCIENTIST, P164; Ginsberg MD, 1995, NEUROSCIENTIST, V1, P95; Hall ED, 1997, J PHARMACOL EXP THER, V281, P895; HALL ED, 1994, FREE RADICAL DAMAGE, P217; HALL ED, 1998, CEREBROVASC DIS, P710; KUGE Y, 1995, STROKE, V26, P1655, DOI 10.1161/01.STR.26.9.1655; LAING RJ, 1993, STROKE, V24, P294, DOI 10.1161/01.STR.24.2.294; LIU TH, 1989, AM J PHYSIOL, V256, P589; LIU XH, 1994, BRAIN RES, V644, P257, DOI 10.1016/0006-8993(94)91688-8; MARKGRAF CG, 1994, STROKE, V25, P153, DOI 10.1161/01.STR.25.1.153; MARTZ D, 1990, J CEREBR BLOOD F MET, V10, P352, DOI 10.1038/jcbfm.1990.64; Moore L E, 1994, Adv Pharmacol, V31, P565, DOI 10.1016/S1054-3589(08)60642-0; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; OLIFF HS, 1995, BRAIN RES, V699, P329, DOI 10.1016/0006-8993(95)01045-W; SAKAMOTO A, 1991, BRAIN RES, V554, P186, DOI 10.1016/0006-8993(91)90187-Z; SchmidElsaesser R, 1997, STROKE, V28, P2018, DOI 10.1161/01.STR.28.10.2018; Siegel S., 1956, NONPARAMETRIC STAT B; Soehle M, 1998, STROKE, V29, P1240, DOI 10.1161/01.STR.29.6.1240; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Watson BD, 1998, CELL MOL NEUROBIOL, V18, P581, DOI 10.1023/A:1020209616428; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Zea Longa E. L., 1989, STROKE, V20, P84; Zhao WZ, 1996, STROKE, V27, P1112, DOI 10.1161/01.STR.27.6.1112; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003	36	11	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 11	2000	389	1					79	88		10.1016/S0014-2999(99)00768-2			10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	286YH	WOS:000085476100010	10686299				2021-06-18	
J	Bombardier, CH; Heinemann, AW				Bombardier, CH; Heinemann, AW			The construct validity of the readiness to change questionnaire for persons with TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol problems; brain injury; measurement of readiness to change	TRAUMATIC BRAIN INJURY; DRINKING	Objective: To examine the reliability and validity of the Readiness to Change Questionnaire (RTC) among persons with recent traumatic brain injury. Design: Survey Setting: Inpatient rehabilitation. Participants: One-hundred twenty-six persons with recent TBI. Results: In the first step of the analyses the RTC measure was rescaled and shortened to produce a coherent Linear measure of readiness to change. Subsequent analyses showed that the linear measure fit a three stage model of change and correlated in meaningful ways with independent measures of alcohol problem severity. Conclusions: The RTC measure can be substantially improved by utilizing results obtained from rating scale analysis. The resulting IO-item Linear scale has good internal consistency a theoretically sound factor structure and meaningful correlations with external variables. Measuring readiness to change may be useful for tailoring treatment and predicting outcomes, though mure research is needed in this area.	Northwestern Univ, Sch Med, Rehabil Inst Chicago, Rehabil Serv Evaluat Unit, Chicago, IL USA; Univ Washington, Sch Med, Seattle, WA USA	Bombardier, CH (corresponding author), Harborview Med Ctr, Box 359740,325 9th Ave, Seattle, WA 98104 USA.		Heinemann, Allen W./AAI-2790-2021; Heinemann, Allen W/K-6283-2012	Heinemann, Allen W./0000-0003-2782-7326; Heinemann, Allen W/0000-0003-2782-7326	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR011714-01, R49/CCR512721] Funding Source: Medline		ALLEN JP, 1995, TREATMENT HDB SERIES, V4; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; CHESS SB, 1971, J GEN PSYCHOL, V85, P93, DOI 10.1080/00221309.1971.9920657; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DENT THS, 1995, ALCOHOL ALCOHOLISM, V30, P577; Dijkstra A, 1999, PREV MED, V28, P203, DOI 10.1006/pmed.1998.0407; Dijkstra A, 1998, ADDICT BEHAV, V23, P339, DOI 10.1016/S0306-4603(97)00070-1; Doherty S C, 1998, J Cardiovasc Risk, V5, P147, DOI 10.1097/00043798-199806000-00002; DONOVAN D, 1995, RES SOC ALCOHOLISM S; DONOVAN DM, 1977, J STUD ALCOHOL, V38, P465, DOI 10.15288/jsa.1977.38.465; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; HEATHER N, 1993, 19 U NEW S WAL NAT D; ISENHART CE, 1994, ADDICT BEHAV, V19, P463, DOI 10.1016/0306-4603(94)90002-7; Laforge RG, 1999, PREV MED, V28, P61, DOI 10.1006/pmed.1998.0384; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Miller W, 1995, HDB ALCOHOLISM TREAT; MILLER WR, 1993, J CONSULT CLIN PSYCH, V61, P455, DOI 10.1037/0022-006X.61.3.455; Miller WR, 1987, BRIEF DRINKER PROFIL; Miller WR, 1991, MOTIVATIONAL INTERVI; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; SELZER ML, 1975, J STUD ALCOHOL, V36, P127; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	24	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2000	15	1					696	709		10.1097/00001199-200002000-00008			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	287MX	WOS:000085510800009	10745185				2021-06-18	
J	Grisoni, ER; Pillai, SB; Volsko, TA; Mutabagani, K; Garcia, V; Haley, K				Grisoni, ER; Pillai, SB; Volsko, TA; Mutabagani, K; Garcia, V; Haley, K			Pediatric airbag injuries: The Ohio experience	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	30th Annual Meeting of the American-Pediatric-Surgical-Association	MAY 16-19, 1999	RANCHO MIRAGE, CALIFORNIA	Amer Pediat Surg Assoc		pediatric trauma; airbag injury	CHILDREN; PATTERNS	Background/Purpose: We sought to determine if properly restrained children, less than 13 years of age, placed in the front passenger seat are at greater risk for trauma from airbag deployment than unrestrained children. Methods: The charts of children treated at any of 3 regional pediatric trauma centers in Ohio were reviewed for airbag injuries sustained in motor vehicle crashes between January 1995 and September 1998. injury Severity Scores (ISS) were compared with Mann-Whitney Rank Sum Test and outcome data with Fisher's Exact Tests. Statistical significance was set at P less than or equal to.05. Results: Twenty-seven children aged 1 month to 12 years sustained airbag-related injuries. Sixty-one percent were girls. ISS ranged from 1 to 75 with a mean score (+/-SD) of 10 (14.5). All crashes were at reported speeds of less than 45 mph, and 64% were head-on collisions. No significant differences in the mean ISS (P=.074) occurred between groups. Both groups had similar closed head, ocular and facial injuries, extremity fractures, and number of deaths (P=1.0). Abdominal organ injury was exclusive to the restrained group. Decapitation only occurred among unrestrained children. Conclusion: Our data showed that airbags, with or without proper safety restraints, can lead to mortality or serious morbidity in children. J Pediatr Surg 35:160-763. Copyright (C) 2000 by W.B. Saunders Company.	Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Pediat Surg, Cleveland, OH 44106 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Grisoni, ER (corresponding author), Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Pediat Surg, 11100 Euclid Ave,RBC Room 122, Cleveland, OH 44106 USA.		Volsko, Teresa/AAE-3009-2019	Volsko, Teresa/0000-0001-5111-898X			Giguere JF, 1998, J PEDIATR SURG, V33, P811, DOI 10.1016/S0022-3468(98)90648-0; Graham JD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e3; GRAHM JD, 1997, JAMA-J AM MED ASSOC, V178, P1418; Hollands CM, 1996, J TRAUMA, V41, P920, DOI 10.1097/00005373-199611000-00033; Marshall KW, 1998, AM J NEURORADIOL, V19, P1599; McCaffrey M, 1999, J PEDIATR ORTHOPED, V19, P60, DOI 10.1097/00004694-199901000-00014; Mohamed AA, 1998, POSTGRAD MED J, V74, P455, DOI 10.1136/pgmj.74.874.455; *NAT HIGHW TRAFF S, 1996, QUEST FREQ ASK CHILD; *NAT HIGHW TRAFF S, 1998, FAT ACC REP SYST; 1996, MMWR MORB MORTAL WKL, V45, P1073	10	11	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	FEB	2000	35	2					160	162		10.1016/S0022-3468(00)90002-2			3	Pediatrics; Surgery	Pediatrics; Surgery	280XH	WOS:000085128700003	10693658				2021-06-18	
J	Alexiou, T; Crane, LH; Vink, R				Alexiou, T; Crane, LH; Vink, R			Increased mortality in female rats after severe diffuse traumatic brain injury is significantly attenuated by magnesium administration	NEUROSCIENCE RESEARCH COMMUNICATIONS			English	Article						neurotrauma; brain injury; gender; treatment; hormones	NEUROCHEMICAL SEQUELAE; AXONAL INJURY; NEURONS; RECEPTORS; REDUCTION; BLOCKADE; THERAPY; DEATH; MODEL	Previous studies using focal models of traumatic brain injury have shown that female animals have a higher postinjury mortality than male animals, and that this higher mortality may be due to a worsened magnesium homeostasis in the female animals. The present study examined whether a similar difference in male and female mortality existed following a more diffuse model of traumatic brain injury and whether any mortality could be attenuated by ovariectomy or posttraumatic magnesium administration. Severe impact-acceleration induced diffuse brain trauma resulted in a 20% mortality in male rats as opposed to a 100% mortality in female animals (p< 0.05). This difference was not apparent at less severe injury levels. Administration of 750 mu moles/kg magnesium sulphate intramuscularly at 30 min after severe trauma reduced female mortality to 29% (p< 0.05). Female outcomes were similar in ovariectomised animals suggesting that the protective effects of magnesium were unrelated to cyclic changes in gonadal hormones. We conclude that the higher mortality observed in female animals following brain trauma is dependent on injury severity and that this mortality can be significantly attenuated with posttraumatic administration of magnesium sulphate.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia	Alexiou, T (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		Vink, Robert/J-7351-2012; AM, Robert Vink/S-5616-2019	Vink, Robert/0000-0002-4885-0667; AM, Robert Vink/0000-0002-4885-0667			AGUS ZS, 1991, ANNU REV PHYSIOL, V53, P299, DOI 10.1146/annurev.ph.53.030191.001503; Altura BM, 1998, ALCOHOL, V15, P181, DOI 10.1016/S0741-8329(97)00107-9; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Ciarallo L, 1996, J PEDIATR-US, V129, P809, DOI 10.1016/S0022-3476(96)70023-9; Delivoria-Papadopoulos M, 1998, J PEDIATR-US, V132, pS30, DOI 10.1016/S0022-3476(98)70525-6; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frakes MA, 1997, AM J EMERG MED, V15, P182, DOI 10.1016/S0735-6757(97)90098-X; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; IZUMI Y, 1991, J CEREBR BLOOD F MET, V11, P1025, DOI 10.1038/jcbfm.1991.170; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROTHMAN SM, 1983, SCIENCE, V220, P536, DOI 10.1126/science.6836300; Vink R, 1990, Magnes Res, V3, P163; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	22	11	11	0	2	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0893-6609			NEUROSCI RES COMMUN	Neurosci. Res. Commun.	JAN-FEB	2000	26	1					1	8		10.1002/(SICI)1520-6769(200001/02)26:1<1::AID-NRC1>3.0.CO;2-Q			8	Neurosciences	Neurosciences & Neurology	287QF	WOS:000085516700001					2021-06-18	
J	Biros, MH; Kukielka, D; Sutton, RL; Rockswold, GL; Bergman, TA				Biros, MH; Kukielka, D; Sutton, RL; Rockswold, GL; Bergman, TA			The effects of acute and chronic alcohol ingestion on outcome following multiple episodes of mild traumatic brain injury in rats	ACADEMIC EMERGENCY MEDICINE			English	Article						ethanol; traumatic brain injury; minor head trauma; fluid percussion injury; Morris Water Maze	CHRONIC ETHANOL; WISTAR RATS; INTOXICATION; MODEL; ABUSE	Objective: Recent studies suggest that in some circumstances, alcohol intoxication at the time of severe head injury may be neuroprotective. The objective of this study was to determine the effect of acute and chronic alcohol ingestion on outcome in rodents sustaining multiple episodes of mild traumatic brain injury while intoxicated. Methods: For two weeks before experimentation, adult male Sprague-Dawley rats received intoxicating levels of 95% ethanol (3 g/kg) or normal saline (NS) every other day by orogastric instillation. On the day of experimentation, the animals were randomized to receive alcohol or NS. Two hours later, the animals received either mild (1.2 +/- 0.4 ATA) fluid percussion injury (FPI) or no injury. The injured animals received a total of three episodes of FPI (once every four days). Mean reflex recovery time (RRT) was determined (seconds +/- SEM) immediately after each episode. Mean latency time (seconds +/- SEM) for Morris Water Maze (MWM) performance was assessed at posttrauma days 11-19. Results: The chronic alcohol-exposed (CA) and the non-alcohol-exposed (NA) animals intoxicated when injured had prolonged escape, righting, and corneal RRTs after each FPI compared with the nonintoxicated injured animals and the noninjured shams. However, the CA animals had significantly shorter RRTs when compared with the NA rats. All the injured animals had MWM deficits on testing days 1-6 compared with the noninjured controls. On the last two MWM testing days, the injured NA animals had significantly better MWM performance than the injured CA rats. Conclusions: The injured intoxicated CA animals had a more rapid recovery of reflexes compared with the injured intoxicated NA animals. Despite initial MWM deficits, the injured NA rodents eventually began to learn the MWM. The injured CA rats never learned the maze. Under the conditions of this study, acute alcohol intoxication at the time of multiple episodes of minor head trauma did not provide neuroprotection for NA or CA rodents.	Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; Hennepin Cty Med Ctr, Div Neurosurg, Minneapolis, MN 55415 USA	Biros, MH (corresponding author), Hennepin Cty Med Ctr, Dept Emergency Med, 701 Pk Ave S, Minneapolis, MN 55415 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS30322] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030322] Funding Source: NIH RePORTER		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; Biros MH, 1996, ACAD EMERG MED, V3, P853, DOI 10.1111/j.1553-2712.1996.tb03530.x; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; DACEY RG, 1993, HEAD INJURY, P159; DeCrescito V, 1974, Surg Forum, V25, P438; DILDYMAYFIELD JE, 1991, J NEUROCHEM, V56, P1536, DOI 10.1111/j.1471-4159.1991.tb02048.x; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; GRANT KA, 1990, EUR J PHARMACOL, V176, P289, DOI 10.1016/0014-2999(90)90022-X; Heegaard W, 1997, ACAD EMERG MED, V4, P33, DOI 10.1111/j.1553-2712.1997.tb03640.x; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KOKKA N, 1993, ALCOHOL CLIN EXP RES, V17, P525, DOI 10.1111/j.1530-0277.1993.tb00793.x; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kraus JF, 1993, HEAD INJURY, P1; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1097/00000374-199804000-00018; McQueen J D, 1975, Surg Neurol, V4, P375; MICHAELIS EK, 1978, BIOCHEM PHARMACOL, V27, P1685, DOI 10.1016/0006-2952(78)90179-X; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; NURMI M, 1994, ALCOHOL, V11, P315, DOI 10.1016/0741-8329(94)90098-1; Prasad RM, 1997, J NEUROTRAUM, V14, P919, DOI 10.1089/neu.1997.14.919; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; Ruff R. M., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI DOI 10.1097/00001199-199009000-00006; Schulteis G, 1996, ALCOHOL CLIN EXP RES, V20, P164, DOI 10.1111/j.1530-0277.1996.tb01060.x; SILVERBAGECARLS.G, 1987, J NEUROSURG, V67, P197; SONNE NM, 1992, BRIT J NEUROSURG, V6, P125, DOI 10.3109/02688699209002914; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	32	11	11	0	1	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	NOV	1999	6	11					1088	1097		10.1111/j.1553-2712.1999.tb00109.x			10	Emergency Medicine	Emergency Medicine	255NN	WOS:000083676200004	10569379	Bronze			2021-06-18	
J	Vinjamuri, S; O'Driscoll, K; Maltby, P; McEwan, AJ; Wiebe, LI; Critchley, M				Vinjamuri, S; O'Driscoll, K; Maltby, P; McEwan, AJ; Wiebe, LI; Critchley, M			Identification of hypoxic regions in traumatic brain injury	CLINICAL NUCLEAR MEDICINE			English	Article						hypoxic brain injury; I-123 iodoazomycin arabinoside			Royal Liverpool Hosp, Dept Nucl Med, Liverpool L7 8XP, Merseyside, England; Rathbone Hosp, Brain Injury Rehabil Ctr, Liverpool, Merseyside, England; Univ Alberta, Edmonton, AB, Canada; Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada	Vinjamuri, S (corresponding author), Royal Liverpool Hosp, Dept Nucl Med, Prescot St, Liverpool L7 8XP, Merseyside, England.						NUNN A, 1995, EUR J NUCL MED, V22, P265, DOI 10.1007/BF01081524	1	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0363-9762			CLIN NUCL MED	Clin. Nucl. Med.	NOV	1999	24	11					891	892		10.1097/00003072-199911000-00018			2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	249XC	WOS:000083357600018	10551478				2021-06-18	
J	Banja, J				Banja, J			Patient advocacy at risk: ethical, legal and political dimensions of adverse reimbursement practices in brain injury rehabilitation in the US	BRAIN INJURY			English	Article							MANAGED-CARE; HEALTH-CARE; INSURANCE	This article examines the relationship between the growing challenge of securing reimbursement for delivering traumatic brain injury rehabilitation in the US and the health providers' duty to advocate for the welfare of patients. Following a discussion of live impediments or barriers to reimbursement-namely, the erosion of private insurance, the insurer's refusal to pay, lack of empirical data to justify rehabilitation as 'medically necessary', financial incentives to abbreviate care, and the ERISA pre emption-the article offers a series of recommendations aimed at enhancing patient advocacy. A prominent theme of this article is that health providers cannot forsake their advocacy role and so must be protected from potential penalties imposed by payers for doing so. The degree to which this protection occurs, however, may largely depend on a willingness to agitate for health reform on the state and federal levels.	Emory Univ, Sch Med, Atlanta, GA 30322 USA	Banja, J (corresponding author), Ctr Rehabil Med, 1441 Clifton Rd,NE, Atlanta, GA 30322 USA.	jbanja@emory.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133F980025] Funding Source: Medline		Banja JD, 1997, J HEAD TRAUMA REHAB, V12, P91, DOI 10.1097/00001199-199706000-00010; BEATRICE DF, 1996, STRATEGIC CHOICES CH, P183; Bodenheimer T, 1997, INT J HEALTH SERV, V27, P409, DOI 10.2190/YAGR-4KXN-J50E-B62H; Bontke CF, 1997, J HEAD TRAUMA REHAB, V12, P37, DOI 10.1097/00001199-199702000-00007; Caplan A, 1997, J HEAD TRAUMA REHAB, V12, P29, DOI 10.1097/00001199-199702000-00006; CHESTNUT RM, 1998, NIH CONS DEV C REH P, P73; CHOLLET D, 1996, STRATEGIC CHOICES CH, P33; CLARK J, 1999, COMMERICAL INSURANCE; COPE DN, 1994, J HEAD TRAUMA REHAB, V9, P1, DOI 10.1097/00001199-199409000-00003; DEJONG G, 1996, BNAS MANAGED CARE RE, V2, P138; deLateur BJ, 1997, ARCH PHYS MED REHAB, V78, P237, DOI 10.1016/S0003-9993(97)90026-5; EMANUEL EJ, 1995, JAMA-J AM MED ASSOC, V273, P323, DOI 10.1001/jama.273.4.323; Enthoven AC, 1997, HEALTH AFFAIR, V16, P26, DOI 10.1377/hlthaff.16.6.26; EPSTEIN RA, 1997, MORTAL PERIL OUR IND; Evans RG, 1997, J HEALTH POLIT POLIC, V22, P427, DOI 10.1215/03616878-22-2-427; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; Ginzberg E, 1999, NEW ENGL J MED, V340, P144, DOI 10.1056/NEJM199901143400212; Glazier AK, 1997, AM J LAW MED, V23, P45; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Haas JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199702000-00003; HACKEY RB, 1998, RETHINKING HLTH CARE, P58; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HALL MA, 1992, U PENN LAW REV, V140, P1637, DOI 10.2307/3312428; Iglehart JK, 1999, NEW ENGL J MED, V340, P70, DOI 10.1056/NEJM199901073400122; Iglehart JK, 1999, NEW ENGL J MED, V340, P403, DOI 10.1056/NEJM199902043400525; Iglehart JK, 1997, HEALTH AFFAIR, V16, P36, DOI 10.1377/hlthaff.16.6.36; JOHNSTON MV, 1998, 1998 NIH CONS DEV C; KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910; Kuttner R, 1999, NEW ENGL J MED, V340, P248, DOI 10.1056/NEJM199901213400324; KUTTNER R, 1997, EVERYTHING SALE VIRT, P110; Miller TE, 1998, J LAW MED ETHICS, V26, P89, DOI 10.1111/j.1748-720X.1998.tb01665.x; *NAT CTR POL AN, 1998, PROBL 5 UN; PELLEGRINO ED, 1994, JAMA-J AM MED ASSOC, V271, P1668, DOI 10.1001/jama.271.21.1668; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RODWIN MA, 1995, NEW ENGL J MED, V332, P604, DOI 10.1056/NEJM199503023320913; Sparer MS, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.3.7; The Reforming States Group, 1998, HEALTH AFFAIR, V17, P181; White Joseph, 1995, COMPETING SOLUTIONS; YOUNGBERG BJ, 1996, MANAGED HLTH CARE HD, P608	39	11	11	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT	1999	13	10					745	758		10.1080/026990599121142			14	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	247TV	WOS:000083236800001	10576459				2021-06-18	
J	McCrory, PR				McCrory, PR			You can run but you can't hide: the role of concussion severity scales in sport	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CEREBRAL CONCUSSION; GUIDELINES; INJURIES		Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic 3084, Australia	McCrory, PR (corresponding author), Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med Neurol, Heidelberg, Vic 3084, Australia.		McCrory, Paul/Q-8688-2019				CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; GERSOFF W, 1991, SPORTS MED SCH AGE A; JENNETT B, 1975, LANCET, V1, P480; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; KOLB J, 1989, SPORTS TRAINING MED, V1, P165; KULUND D, 1982, INJURED ATHLETE, P225; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Schneider R., 1973, HEAD NECK INJURIES F; Torg JS., 1991, ATHLETIC INJURIES HE	13	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	OCT	1999	33	5					297	298					2	Sport Sciences	Sport Sciences	242UY	WOS:000082961100005	10522628				2021-06-18	
J	Rowe, LA				Rowe, LA			Case studies in dysphagia after pediatric brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dysphagia; head injury; pediatrics		The course of pediatric traumatic brain injury is not homogeneous because the underlying neuropathology can be so variable. Assessment, intervention, and recovery are examined among five individuals whose neuroradiologic imaging differed grossly on initial and early presentations after head trauma. Knowledge of the neuropathology in an overarching sense can be informative to a clinician's management of different swallowing problems after brain injury.	Childrens Hosp Wisconsin, Dept Speech & Hearing, Milwaukee, WI 53201 USA	Rowe, LA (corresponding author), Childrens Hosp Wisconsin, Dept Speech & Hearing, Mail Stn 785,900 Wisconsin Ave,POB 1997, Milwaukee, WI 53201 USA.						ADAMOVICH BLB, 1990, APHASIA RELATED NEUR; ARVEDSON JC, 1993, PEDIAT SWALLOWING FE; BEHRMAN RE, 1990, ESSENTIALS PEDIAT; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; CHERNEY LR, 1991, CLIN MANAGEMENT COMM; Dodds W J, 1989, Dysphagia, V3, P171, DOI 10.1007/BF02407219; DODDS WJ, 1990, AM J ROENTGENOL, V154, P953, DOI 10.2214/ajr.154.5.2108569; Hagen C, 1981, TOP LANG DIS, V1, P73; LOVE RJ, 1996, NEUROLOGY SPEECH LAN	9	11	11	0	4	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1999	14	5					497	504		10.1097/00001199-199910000-00010			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	245MW	WOS:000083113600010	10653945				2021-06-18	
J	Garri, JI; Perlyn, CA; Johnson, MJ; Mobley, SR; Shatz, DV; Kirton, OC; Thaller, SR				Garri, JI; Perlyn, CA; Johnson, MJ; Mobley, SR; Shatz, DV; Kirton, OC; Thaller, SR			Patterns of maxillofacial injuries in powered watercraft collisions	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							PERSONAL WATERCRAFT	Because of the widespread popularity of water sports, plastic and reconstructive surgeons can expect to manage an increasing number of injuries associated with these activities, particularly those related to powered watercraft vehicles. Although seat belts for motorists and helmets for motorcyclists may be efficacious, such devices currently do not serve a similar role in powered watercraft sports. In this study, a retrospective chart review of 194 consecutive patients who presented to the University of Miami/Jackson Memorial Hospital (Level I trauma center) as a result of powered watercraft collisions is presented. The purpose of this investigation was to assess the incidence, cause, demographics, and available management options for head and neck injuries secondary to powered watercraft. Identified were 194 patients who presented because of watersports-related injuries during the period January 1, 1991, through December 31, 1996. From this group, 81 patients (41.8 percent) sustained injuries directly attributable to powered watercraft collisions, including 41 personal watercraft collisions (50.6 percent), 39 boat collisions (48.1 percent), and 1 airboat collision (1.2 percent). The patient population, as expected, tended to be young and male with an average age of 29 years (range, 8 to 64 years old). Interestingly, 41 of the patients (50.6 percent) who presented to this trauma center as a result of powered watercraft collisions also sustained associated head and neck trauma. Of 74 injuries 24 were facial fractures (32.4 percent), 18 were facial lacerations (24.3 percent), 14 were closed head injuries (18.9 percent), 8 were skull fractures (10.8 percent), 4 were scalp lacerations (5.4 percent), 4 were C-spine fractures (5.4 percent), 1 was an ear laceration (1.4 percent), and 1 was a fatality (1.4 percent). Le Fort fractures were the most commonly identified facial fracture in this series. The number of these injuries seen in hospital emergency rooms will most likely increase in the future as the popularity of water-related recreational activities becomes even more widespread. Based on these findings, it is strongly recommended that future efforts be directed toward the prevention of these injuries through patient education and the eventual development of efficacious and safe protective equipment.	Univ Miami, Sch Med, Jackson Mem Hosp, Dept Otolaryngol,Div Plast Surg, Miami, FL 33101 USA; Univ Miami, Sch Med, Jackson Mem Hosp, Dept Gen Surg,Div Trauma Crit Care, Miami, FL 33101 USA; Univ Miami, Sch Med, Jackson Mem Hosp, Dept Gen Surg,Div Plast & Reconstruct Surg, Miami, FL 33101 USA; Univ Miami, Sch Med, Jackson Mem Hosp, Dept Gen Surg,Div Oral & Maxillofacial Surg, Miami, FL 33101 USA	Garri, JI (corresponding author), Univ Miami, Sch Med, Jackson Mem Hosp, Dept Otolaryngol,Div Plast Surg, POB 016968 R-88, Miami, FL 33101 USA.		Thaller, Seth/AAO-1801-2020				*AM DENT ASS HOUS, 1995, RES 80H; Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; *CAN HOSP INJ REP, INJ ASS PERS POW WAT; GOMEZ GA, 1991, SURG CLIN N AM, V71, P419; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Jeffery R S, 1991, Br J Sports Med, V25, P232; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; *NAT YOUTH SPORTS, 1992, DENT INJ FACT SHEET; PeekAsa C, 1997, ANN EMERG MED, V29, P630, DOI 10.1016/S0196-0644(97)70252-X; Shatz D V, 1997, J Fla Med Assoc, V84, P458; Shatz DV, 1998, J TRAUMA, V44, P198, DOI 10.1097/00005373-199801000-00029; *US DEP TRANSP, 1988, BOAT STAT 1986; VERNBERG D, 1989, JAMA-J AM MED ASSOC, V261, P1883, DOI 10.1001/jama.1989.03420130045021; WOODMANSEY KF, 1997, J AM COLL HLTH, V45, P178	14	11	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052			PLAST RECONSTR SURG	Plast. Reconstr. Surg.	SEP	1999	104	4					922	927		10.1097/00006534-199909040-00005			6	Surgery	Surgery	231HN	WOS:000082302500005	10654729				2021-06-18	
J	Walker, NW; Boling, MS; Cobb, H				Walker, NW; Boling, MS; Cobb, H			Training of school psychologists in neuropsychology and brain injury: Results of a national survey of training programs	CHILD NEUROPSYCHOLOGY			English	Article								School psychologists are in a primary position to meet the unique assessment and intervention needs of students with brain injury, including traumatic brain injury (TBI). Little research has been done, however, to determine the extent to which school psychology training programs are preparing their graduates to work with this population. All school psychology training programs in the United States were surveyed as to their training practices in neuropsychology and brain injury. Results indicate that (a) relatively few programs offer training in neuropsychology/brain injury, (b) the training appears to be limited in nature and content, and (c) there appear to be few program faculty with neuropsychological expertise. It appears that many school psychology training programs may not see this area as an important addition to their curriculum.	James Madison Univ, Sch Psychol, Harrisonburg, VA 22807 USA	Walker, NW (corresponding author), James Madison Univ, Sch Psychol, MSC 7401, Harrisonburg, VA 22807 USA.						BEGALI V, 1992, HEAD INJURY CHILDREN; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; HYND GW, 1981, NEUROPSYCHOLOGICAL A, P379; Lehr E, 1990, PSYCHOL MANAGEMENT T; *NAT ASS SCH PSYCH, 1994, STAND TRAIN FIELD PL; Obrzut J. E., 1981, NEUROPSYCHOLOGICAL A, P237; Savage R. C., 1991, HEAD INJURY FAMILY M, P203; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; *VIRG STAT DEP ED, 1991, NAT SERC PROV STUD T; WALKER NW, 1996, BEST PRACTICES ASSES	11	11	11	1	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	1999	5	2					137	142		10.1076/chin.5.2.137.3168			6	Clinical Neurology	Neurosciences & Neurology	237ME	WOS:000082659500006					2021-06-18	
J	Crowe, SF; Ponsford, J				Crowe, SF; Ponsford, J			The role of imagery in sexual arousal disturbances in the male traumatically brain injured individual	BRAIN INJURY			English	Article								Over 50% of individuals who suffer traumatic brain injury (TBI) demonstrate a decrease in sexual arousal posl-injury. This study investigated the basis of this loss and hypothesized that it occurred as a consequence of the effect of the injury on cognition: specifically, diminution of the ability to form and manipulate sexually arousing imagery. The study compared 14 male participants who identified themselves as having alteration in sexual functioning following traumatic brain injury with a further 14 non-brain injured participants, case matched to them for age and education. All TBI participants were assessed after 2 years following injury, and had had a loss of consciousness of 3 days or greater. The results indicated that the two groups differed in terms of their performance on the Bett's QMI Scale, the Gordon Test of Visual Imagery Control, the Vividness of Sexual Imagery Scale of the Imaginal Processes Inventory, the State Trait Anxiety Inventory, and the Beck Depression Inventory. After correction for the level of depression by analysis of covariance, the TBI participants still featured lower levels of performance on the Sexual Imagery sub-scale of the Imaginary Processes Inventory. The results indicate that sexual arousal disturbances may exist above and beyond the disturbances to affect associated with the psychosocial effects of the TBI.	La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia; Bethesda Hosp, Richmond, Vic, Australia	Crowe, SF (corresponding author), La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3083, Australia.			Crowe, Simon/0000-0002-4407-8542			Beck A.T., 1987, BECK DEPRESSION INVE; BRECHER J, 1977, INT J HEALTH SERV, V7, P89, DOI 10.2190/NBK8-VL8W-ADHV-JKTC; Britton KR, 1998, BRAIN INJURY, V12, P703, DOI 10.1080/026990598122269; DUCHARME S, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI DOI 10.1097/00001199-199005020-00007; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; GARDEN F, 1990, J HEAT TRAUMA REHABI, V5, P53; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; KAUFMAN DM, 1981, CLIN NEUROLOGY PSYCH, P257; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; MEDLAR T, 1990, J HEAD TRAUMA REHAB, V5, P46; MILLER L, 1994, J COGNITIVE REHABILI, V12, P12; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Hara CC, 1991, REHABILITATION BRAIN; Richardson A., 1969, MENTAL IMAGERY; SEAGRAVES RT, 1996, NEUROPSYCHIATRY, P757; SHEEHAN PW, 1967, J CLIN PSYCHOL, V23, P386, DOI 10.1002/1097-4679(196707)23:3<386::AID-JCLP2270230328>3.0.CO;2-S; SMITH D, 1990, ARCH SEX BEHAV, V19, P477, DOI 10.1007/BF02442349; SMITH D, 1987, ARCH SEX BEHAV, V16, P395, DOI 10.1007/BF01541422; Spielberger CD, 1983, STATE TRAIT ANXIETY; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; Zinn W M, 1981, Int Rehabil Med, V3, P18	24	11	12	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1999	13	5					347	354					8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	200LE	WOS:000080541100003	10367145				2021-06-18	
J	Mautes, AEM; Paschen, W; Rohn, G; Nacimiento, AC				Mautes, AEM; Paschen, W; Rohn, G; Nacimiento, AC			Changes in ornithine decarboxylase activity and putrescine concentrations after spinal cord compression injury in the rat	NEUROSCIENCE LETTERS			English	Article						polyamines; spinal cord compression; ornithine decarboxylase; putrescine; rat	REVERSIBLE CEREBRAL-ISCHEMIA; POLYAMINE LEVELS; CELL-DEATH; BRAIN; DEXAMETHASONE; INDUCTION; CALCIUM	Traumatic spinal cord injury results in direct physical damage to structures and the generation of local factors contributing to secondary pathogenesis. In the present study, we investigated changes in polyamine metabolism after spinal cord compression injury in the rat. This is a stress induced metabolic pathway, of which an activation may indicate both, secondary pathogenesis or induction of neuroprotective response. Ornithine decarboxylase (ODC) activity, the rate limiting step of polyamine synthesis, and levels of the diamine putrescine, the product of ornithine decarboxylase reaction, were analyzed in control (non-laminectomized) animals and at 2 and 4 h after laminectomy or compression injury at the L4 segmental level. ODC activity was significantly increased 4 h after laminectomy in L4 and in adjacent L3 and L5 segments and compression to L4 produced a further increase 4 h after injury as compared with the intact control group. Putrescine levels were likewise significantly elevated to the same extend in the laminectomized and injured cord as compared with the intact control group. These findings demonstrate increased ODC and putrescine levels in the laminectomized and traumatized spinal cord and suggest that laminectomy may be an important 'priming event' that contributes to secondary injury after spinal cord compression injury. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Saarland, Sch Med, Neurosurg Res Lab, Homburg, Germany; Max Planck Inst Neurol Res, Dept Expt Neurol, Cologne, Germany	Mautes, AEM (corresponding author), Univ Saarland, Sch Med, Neurosurg Res Lab, Homburg, Germany.						Baskaya MFK, 1996, NEUROSURGERY, V38, P140; CAMPBELL JB, 1974, J NEUROSURG, V40, P726, DOI 10.3171/jns.1974.40.6.0726; DEMEDIUK P, 1987, NEUROCHEM PATHOL, V7, P79, DOI 10.1007/BF02834293; DIENEL GA, 1984, J NEUROCHEM, V42, P1053, DOI 10.1111/j.1471-4159.1984.tb12710.x; GILAD GM, 1991, EXP NEUROL, V111, P349, DOI 10.1016/0014-4886(91)90102-I; GILAD GM, 1994, BRAIN RES, V636, P187, DOI 10.1016/0006-8993(94)91016-2; GONZALEZ S, 1995, J STEROID BIOCHEM, V55, P85, DOI 10.1016/0960-0760(95)00160-2; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HOLTZ A, 1989, SURG NEUROL, V31, P350, DOI 10.1016/0090-3019(89)90066-9; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; MOULINOUX JP, 1989, ANTICANCER RES, V9, P1063; MULLER M, 1991, ACTA NEUROPATHOL, V83, P39; NACIMIENTO AC, 1985, J NEUROSURG, V62, P898, DOI 10.3171/jns.1985.62.6.0898; NACIMIENTO AC, 1986, SURG NEUROL, V25, P9; NISTICO G, 1980, BIOCHEM PHARMACOL, V29, P954, DOI 10.1016/0006-2952(80)90228-2; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PASCHEN W, 1990, J CEREBR BLOOD F MET, V10, P236, DOI 10.1038/jcbfm.1990.40; PASCHEN W, 1988, NEUROCHEM PATHOL, P1; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SHOHAMI E, 1992, EXP NEUROL, V117, P189, DOI 10.1016/0014-4886(92)90126-B; VERMA AK, 1986, ARCH BIOCHEM BIOPHYS, V247, P272, DOI 10.1016/0003-9861(86)90584-9; WELCH WJ, 1992, PHYSIOL REV, V72, P1063	25	11	11	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 2	1999	264	1-3					153	156		10.1016/S0304-3940(99)00197-4			4	Neurosciences	Neurosciences & Neurology	189LR	WOS:000079906900039	10320037				2021-06-18	
J	Toomela, A; Tomberg, T; Orasson, A; Tikk, A; Nomm, M				Toomela, A; Tomberg, T; Orasson, A; Tikk, A; Nomm, M			Paradoxical facilitation of a free recall of nonwords in persons with traumatic brain injury	BRAIN AND COGNITION			English	Article							CLOSED-HEAD-INJURY; WORKING MEMORY; INDIVIDUAL-DIFFERENCES; COGNITIVE SEQUELAE; LIMBIC LESIONS; TERM-MEMORY; MONKEYS; KNOWLEDGE; RECOVERY; BEHAVIOR	Brain damage is usually associated with behavioral deficits. However, there is an increasing amount of evidence that lesions of some brain regions are associated with improvements instead of impairments of certain behaviors. We report the results of a study of free recall performance in subjects with traumatic brain injury. One-fourth of the subjects displayed above-normal performance in recall of nonwords. No such facilitation was found with nine lists of words, (C) 1999 Academic Press.	Tartu State Univ, Dept Psychol, EE-50410 Tartu, Estonia; Tartu State Univ, Dept Neurol & Neurosurg, EE-50410 Tartu, Estonia	Toomela, A (corresponding author), Tartu State Univ, Dept Psychol, 78 Tigi St, EE-50410 Tartu, Estonia.		Toomela, Aaro/H-6033-2018	Toomela, Aaro/0000-0002-8520-9676			BADDELEY A, 1990, HUNAN MNEMORY THEORY; BADDELEY AD, 1995, COGNITIVE NEUROSCIEN; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; Bergman LR, 1995, SLEIPNER STAT PACKAG; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; CRAIK FIM, 1970, J EXP PSYCHOL, V86, P77, DOI 10.1037/h0029799; Hart R. P., 1994, NEUROPSYCHOLOGY, V8, P325, DOI [10.1037/0894-4105.8.3.325, DOI 10.1037/0894-4105.8.3.325]; IRLE E, 1983, BEHAV NEUROSCI, V97, P908, DOI 10.1037/0735-7044.97.6.908; IRLE E, 1987, BRAIN RES REV, V12, P307, DOI 10.1016/0165-0173(87)90003-8; IRLE E, 1990, BRAIN RES BULL, V25, P79, DOI 10.1016/0361-9230(90)90256-Y; IRLE E, 1990, BRAIN RES REV, V15, P181, DOI 10.1016/0165-0173(90)90001-5; IRLE E, 1984, BEHAV NEUROSCI, V98, P884, DOI 10.1037/0735-7044.98.5.884; JENNETT B, 1975, LANCET, V7905, P480; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Labbate L A, 1997, Ann Clin Psychiatry, V9, P27, DOI 10.1023/A:1026278224598; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LUCARIELLO J, 1992, CHILD DEV, V63, P978; LURIA AR, 1974, NEIROPSKHOLOGIYA PAM; MACDONALD MC, 1992, COGNITIVE PSYCHOL, V24, P56, DOI 10.1016/0010-0285(92)90003-K; MARTIN RC, 1992, COGNITIVE NEUROPSYCH, V9, P509, DOI 10.1080/02643299208252070; Meunier M, 1996, J NEUROPHYSIOL, V75, P1190; NELSON K, 1988, HUM DEV, V31, P3, DOI 10.1159/000273198; SELL MA, 1992, J CHILD LANG, V19, P659, DOI 10.1017/S0305000900011612; SPRAGUE JM, 1966, SCIENCE, V153, P1544, DOI 10.1126/science.153.3743.1544; Tabachnick BG, 2013, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V7872, P81; TULVING E, 1964, PSYCHOL REV, V71, P219, DOI 10.1037/h0043186; Tulving E, 1983, ELEMENTS EPISODIC ME; VONEYE A, 1990, INTRO CONFIGURATIONA; Wilson BA, 1997, BRAIN INJURY, V11, P259, DOI 10.1080/026990597123566; ZATORRE RJ, 1983, BRAIN COGNITION, V2, P331, DOI 10.1016/0278-2626(83)90017-9	35	11	11	0	3	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	APR	1999	39	3					187	201		10.1006/brcg.1999.1077			15	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	184UW	WOS:000079633000003	10101040				2021-06-18	
J	Milovanovic, AV; DiMaio, VJM				Milovanovic, AV; DiMaio, VJM			Death due to concussion and alcohol	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						concussion; brain injuries; alcohol; blunt trauma; apnea; death		We encountered 5 deaths following blunt trauma to the face and head in which the injuries were predominantly soft tissue in nature with absence of skull fractures, intracranial bleeding, or detectible injury to the brain. All individuals were intoxicated, with blood ethanol levels ranging from 0.22 to 0.33 g/dl. We feel that in these deaths, ethanol augmentation of the effects of concussive brain injury, with resultant posttraumatic apnea, was the mechanism of death.	Beth Israel Med Ctr, New York, NY 10003 USA	Milovanovic, AV (corresponding author), Beth Israel Med Ctr, 1st Ave & 16th St, New York, NY 10003 USA.						BECKER DP, 1987, ENCY NEUROSCIENCE, V1, P174; Di Maio DJ, 1989, FORENSIC PATHOLOGY; Gennarelli TA, 1993, HEAD INJURY, P137; LEVINE JE, 1979, NEW ENGL J MED, V301, P109; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	7	11	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	1999	20	1					6	9		10.1097/00000433-199903000-00002			4	Medicine, Legal; Pathology	Legal Medicine; Pathology	181QR	WOS:000079453800002	10208327				2021-06-18	
J	Rummans, TA; Lauterbach, EC; Coffey, CE; Royall, DR; Cummings, JL; Salloway, S; Duffy, J; Kaufer, D				Rummans, TA; Lauterbach, EC; Coffey, CE; Royall, DR; Cummings, JL; Salloway, S; Duffy, J; Kaufer, D			Pharmacologic efficacy in neuropsychiatry: A review of placebo-controlled treatment trials - A report of the ANPA committee on research	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							DOUBLE-BLIND TRIAL; MENTALLY-HANDICAPPED PATIENTS; TRAUMATIC BRAIN INJURY; NURSING-HOME PATIENTS; ALZHEIMERS-DISEASE; ANTIDEPRESSANT PHARMACOTHERAPY; DEPRESSED-PATIENTS; DEMENTIA; CITALOPRAM; AGGRESSION	Psychiatric disorders frequently compound the disability and complicate the management of neurologic conditions. These disorders result in increased morbidity for the person afflicted, stress for the caregiver, and financial burden. tis study review the randomized double-blind placebo-controlled pharmacologic treatment trials of psychosis, depression, anxiety, and agitation in neurologic conditions from 1966 to 1998. Ten studies involving psychosis, 13 involving depression, and 20 involving anxiety-agitation meeting the committee's criteria were identified. Relatively few randomized double-blind placebo-controlled pharmacologic treatment trials of psychiatric disorders complicating neurologic disease have been conducted. These trials do not strongly support one specific pharmacologic approach to treatment. Further study of newer psychotropic agents, augmentation strategies, and novel use of other agents may help improve the treatment of psychiatric disorders observed in patients with neurologic disease.		Rummans, TA (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.						ALBERT JM, 1977, CURR THER RES CLIN E, V21, P786; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210; BARNES R, 1982, AM J PSYCHIAT, V139, P1170; BARTON R, 1966, BRIT J PSYCHIAT, V112, P989, DOI 10.1192/bjp.112.491.989; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; BREIER A, 1991, ARCH GEN PSYCHIAT, V48, P239; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; COFFEY E, 1994, TXB GERIATRIC NEUROP; COLERICK EJ, 1986, J AM GERIATR SOC, V34, P493, DOI 10.1111/j.1532-5415.1986.tb04239.x; CRAFT M, 1987, BRIT J PSYCHIAT, V150, P685, DOI 10.1192/bjp.150.5.685; DECUYPER H, 1985, NEUROPSYCHOBIOLOGY, V13, P1, DOI 10.1159/000118153; DEVANAND DP, 1989, ARCH NEUROL-CHICAGO, V46, P854, DOI 10.1001/archneur.1989.00520440036018; FINKEL SI, 1995, INT J GERIATR PSYCH, V10, P129, DOI 10.1002/gps.930100208; FUCHS A, 1993, PHARMACOPSYCHIATRY, V26, P37, DOI 10.1055/s-2007-1014339; GOTESTAM KG, 1981, ACTA PSYCHIAT SCAND, P46; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GREENDYKE RM, 1986, J CLIN PSYCHIAT, V47, P423; HAMILTON LD, 1962, J AM GERIATR SOC, V10, P140, DOI 10.1111/j.1532-5415.1962.tb00266.x; KODJIAN A, 1986, CURR THER RES CLIN E, V40, P694; LAWLOR BA, 1994, INT J GERIATR PSYCH, V9, P55, DOI 10.1002/gps.930090112; LIPSEY JR, 1984, LANCET, V1, P297; LYNCH DM, 1985, BRIT J PSYCHIAT, V146, P525, DOI 10.1192/bjp.146.5.525; NYTH AL, 1990, BRIT J PSYCHIAT, V157, P894, DOI 10.1192/bjp.157.6.894; NYTH AL, 1992, ACTA PSYCHIAT SCAND, V86, P138, DOI 10.1111/j.1600-0447.1992.tb03242.x; OLAFSSON K, 1992, ACTA PSYCHIAT SCAND, V85, P453, DOI 10.1111/j.1600-0447.1992.tb03211.x; OYEWUMI LK, 1981, AM J PSYCHIAT, V138, P110; Petracca G, 1996, J NEUROPSYCH CLIN N, V8, P270; PETRIE WM, 1982, J CLIN PSYCHOPHARM, V2, P122; RADA RT, 1976, J AM GERIATR SOC, V24, P105, DOI 10.1111/j.1532-5415.1976.tb04280.x; Raskind MA, 1997, ARCH NEUROL-CHICAGO, V54, P836, DOI 10.1001/archneur.1997.00550190026010; RATEY J, 1991, J CLIN PSYCHIAT, V52, P159; REDING MJ, 1986, ARCH NEUROL-CHICAGO, P763; REIFLER BV, 1989, AM J PSYCHIAT, V146, P45; ROBERTSON MM, 1985, J AFFECT DISORDERS, V9, P127, DOI 10.1016/0165-0327(85)90091-6; SCHIFFER RB, 1990, AM J PSYCHIAT, V147, P1493; SUGERMAN AA, 1964, AM J PSYCHIAT, V120, P1190, DOI 10.1176/ajp.120.12.1190; TARIOT PN, 1994, J AM GERIATR SOC, V42, P1160, DOI 10.1111/j.1532-5415.1994.tb06982.x; Tariot PN, 1998, AM J PSYCHIAT, V155, P54, DOI 10.1176/ajp.155.1.54; WHITE JC, 1992, J CLIN PSYCHIAT, V53, P153; WOLTERS EC, 1990, NEUROLOGY, V40, P832, DOI 10.1212/WNL.40.5.832; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206; ZIGARELLI G, 1992, AM J MENT RETARD, V97, P57	43	11	11	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	1999	11	2					176	189					14	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	194QE	WOS:000080204400002	10333990				2021-06-18	
J	Bauer, R; Walter, B; Fritz, H; Zwiener, U				Bauer, R; Walter, B; Fritz, H; Zwiener, U			Ontogenetic aspects of traumatic brain edema - facts and suggestions	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain edema; pathogenesis; brain development; blood-brain barrier; traumatic brain edema; edema, brain	PEDIATRIC HEAD-INJURY; CEREBRAL BLOOD-FLOW; NEONATAL RAT-BRAIN; COMA DATA-BANK; DELAYED DEPOLARIZATION; MODERATE HYPOTHERMIA; CORTICAL-NEURONS; CHILDREN; GLUTAMATE; DAMAGE	Diffuse brain swelling (DBS) after severe traumatic brain injury (TBI) occurs more commonly in children than adults. Most of the recent clinical studies suggest that young children are more negatively affected by DBS. Until now studies in young animals in which the pathophysiology of DBS was evaluated remained seldom. However, pathogenetic mechanisms of edema formation after TBI in the immature brain appeared to be different in comparison to adult brains. There are evidences that vasogenic as well as cytotoxic edema components may be responsible for the development of DBS. Besides mechanical disturbance, the blood-brain barrier seems to be strongly endangered by oxidative stress after TBI because regional antioxidative capacity is obviously diminished. In addition, cytotoxic components of DBS may be caused by at least two different mechanisms. First, it was shown that a sustained posttraumatic cerebral hypoperfusion occurs in the immature brain. Moreover, a transient increase of NMDA receptor expression at this period of life may be responsible for an increased threat of intracellular sodium ion accumulation in brain cells. Obviously, brain swelling can be detrimental because it can elevate intracranial pressure, impair CBF, and may represent ongoing secondary brain injury.	Univ Jena, Inst Pathophysiol, D-07740 Jena, Germany; Univ Jena, Dept Anesthesiol & Intens Care, D-07740 Jena, Germany	Bauer, R (corresponding author), Univ Jena, Inst Pathophysiol, D-07740 Jena, Germany.	rbau@mti-n.uni-jena.de					Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BAUER R, PFLUGERS ARCH SR, V435, P89; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CIRIOLO MR, 1991, MECH AGEING DEV, V61, P287, DOI 10.1016/0047-6374(91)90061-4; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, NEUROTRAUMA, P1491; Dijkhuizen RM, 1996, NMR BIOMED, V9, P84, DOI 10.1002/(SICI)1099-1492(199604)9:2<84::AID-NBM401>3.3.CO;2-2; Dobbing J, 1968, Prog Brain Res, V29, P417; DSOUZA SW, 1992, LANCET, V339, P1240, DOI 10.1016/0140-6736(92)91188-E; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Ginsberg MD, 1997, CEREBROVASC DIS, V7, P7, DOI 10.1159/000108237; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JOHNSTON MV, 1998, FETAL NEONATAL PHYSL, P2110; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAIERHAUFF K, 1984, J NEUROSURG, V61, P97, DOI 10.3171/jns.1984.61.1.0097; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A., 1996, NEUROTRAUMA, P413; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MOSHE SL, 1983, DEV BRAIN RES, V7, P81, DOI 10.1016/0165-3806(83)90083-4; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; ORR EL, 1984, J NEUROCHEM, V42, P727, DOI 10.1111/j.1471-4159.1984.tb02743.x; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PATT A, 1988, J CLIN INVEST, V81, P1556, DOI 10.1172/JCI113488; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; SCHILLING L, 1997, KIDNEY INT S59, V51, pS69; SCHULZE C, 1992, DEV BRAIN RES, V69, P85, DOI 10.1016/0165-3806(92)90125-G; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SLATER P, 1993, BRIT J PHARMACOL, V108, P1143, DOI 10.1111/j.1476-5381.1993.tb13518.x; SPERBER EF, 1988, DEV BRAIN RES, V39, P295, DOI 10.1016/0165-3806(88)90033-8; STEWART PA, 1987, DEV BRAIN RES, V32, P271, DOI 10.1016/0165-3806(87)90107-6; Symon L, 1977, Adv Exp Med Biol, V94, P775; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767; UNTERBERG A, 1987, ACTA NEUROPATHOL, V73, P209, DOI 10.1007/BF00686613; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; VERHEUL HB, 1993, BRAIN RES, V618, P203, DOI 10.1016/0006-8993(93)91267-V; Walter B, 1999, EXP TOXICOL PATHOL, V51, P124, DOI 10.1016/S0940-2993(99)80085-2; WALTER B, 1998, PFLUGERS ARCH S, V435, pR238; WARD JD, 1994, PEDIATR NEUROSURG, V20, P183, DOI 10.1159/000120784; Wass CT, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603440-00008; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; Zauner A, 1996, ACT NEUR S, V67, P40	58	11	11	0	2	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					143	150		10.1016/S0940-2993(99)80088-8			8	Pathology; Toxicology	Pathology; Toxicology	177NZ	WOS:000079218000006	10192583				2021-06-18	
J	Hussain, A				Hussain, A			Dislocation of the first metatarsophalangeal joint with fracture of fibular sesamoid - A case report	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								Dorsal dislocations of the first metatarsophalangeal joint are classified by Jahss into two types. In Type 1, the hallux with the intact intersesamoid ligament dislocates dorsally over the metatarsal head. Such cases in the literature have been irreducible by closed manipulation, In Type 2 the hallux is dislocated dorsally with rupture of the intersesamoid ligament, resulting in wide separation of the sesamoids (Type 2A) or a transverse fracture of one or both sesamoids (Type 2B), The importance in classifying these injuries allows one to predict whether closed reduction will be successful as in Type 2, The patient reported had a fracture of the fibular sesamoid in addition to dislocation of the hallux. The clinical findings were consistent with Type 1 injury, including an intact intersesamoid ligament, but the radiographs showed, in addition to the dislocation, that there was a fracture of the fibular sesamoid, Reduction was achieved surgically through a dorsal approach. Although such injuries have been unreported previously, Type 1 injuries may be associated with a fracture of the fibular sesamoid but without rupture of intersesamoid ligament, so the injury reported is classified as Type 1A.	Prince Salman Bin Abdulaziz Hosp, Dept Orthopaed, Riyadh, Saudi Arabia	Hussain, A (corresponding author), 20 Plas Ty Mawr, Penyfai CF31 4NH, Bridgend, Wales.						BROWN TIS, 1980, CLIN ORTHOP RELAT R, P229; GIANNIKAS AC, 1975, J BONE JOINT SURG BR, V57, P384; Jahss M H, 1980, Foot Ankle, V1, P15; KONKEL KF, 1975, J TRAUMA, V15, P733, DOI 10.1097/00005373-197508000-00018; LEWIS AG, 1984, J BONE JOINT SURG AM, V66A, P1120, DOI 10.2106/00004623-198466070-00026; SALAMON PB, 1974, J BONE JOINT SURG AM, VA 56, P1073, DOI 10.2106/00004623-197456050-00022	6	11	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	FEB	1999		359					209	212					4	Orthopedics; Surgery	Orthopedics; Surgery	171BP	WOS:000078842800023	10078145				2021-06-18	
J	Geldmacher, DS; Alhaj, M				Geldmacher, DS; Alhaj, M			Spatial aspects of letter cancellation performance in Arabic readers	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article							TRAUMATIC BRAIN INJURY; TO-DISTRACTOR RATIO; READING HABITS; STIMULUS NUMBER; LINE BISECTION; TASK; ATTENTION; NEGLECT; BIAS	Studies of visuospatial and directed attention that used subjects drawn from cultures with left-to-right reading patterns have suggested a slight performance bias toward left space. This pattern could reflect an intrinsic, organic, bias in spatial processing or the confounding effect of overlearned reading patterns. We studied the spatial distribution of errors on random array letter cancellation tasks obtained from 128 healthy Syrians who were native readers of Arabic. Fifty-eight of the 128 subjects (45.3%) made a total of 91 errors in which they omitted canceling a target. The distribution of errors was not spatially biased. This differs from the error pattern reported for native readers of English on a similar task. The findings, consistent with results of other approaches, suggest that reading patterns influence visuospatial attention, but are not the sole cause of spatial biases observed in readers of Indo-European languages.	Univ Hosp Cleveland, Univ Alzheimer Ctr, Cleveland, OH 44120 USA; Univ Hosp Cleveland, Alzheimer Ctr, Cleveland, OH 44120 USA; Case Western Reserve Univ, Sch Med, Dept Neurol, Cleveland, OH 44120 USA	Geldmacher, DS (corresponding author), Univ Hosp Cleveland, Univ Alzheimer Ctr, 12200 Fairhill Rd, Cleveland, OH 44120 USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG08012] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG008012] Funding Source: NIH RePORTER		BOWERS D, 1976, NEUROPSYCHOLOGIA, V14, P123, DOI 10.1016/0028-3932(76)90013-0; BRAINE LG, 1968, NEUROPSYCHOLOGIA, V6, P73, DOI 10.1016/0028-3932(68)90041-9; CHEDRU F, 1973, Cortex, V9, P94; Chokron S, 1995, COGNITIVE BRAIN RES, V3, P51, DOI 10.1016/0926-6410(95)00018-6; Chokron S, 1997, CORTEX, V33, P47, DOI 10.1016/S0010-9452(97)80004-4; CHOKRON S, 1993, COGNITIVE BRAIN RES, V1, P219, DOI 10.1016/0926-6410(93)90005-P; Dawson DR, 1997, OCCUP THER J RES, V17, P264, DOI 10.1177/153944929701700403; De Renzi E, 1970, Cortex, V6, P191; EVIATAR Z, 1995, BRAIN COGNITION, V29, P137, DOI 10.1006/brcg.1995.1273; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Geldmacher DS, 1996, BRAIN COGNITION, V32, P405, DOI 10.1006/brcg.1996.0073; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; GELDMACHER DS, 1995, NEUROPSY NEUROPSY BE, V8, P259; GELDMACHER DS, 1994, NEUROPSY NEUROPSY BE, V7, P275; HEILMAN KM, 1993, CLIN NEUROPSYCHOLOGY, P279; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; KINSBOURNE M, 1974, NEUROPSYCHOLOGIA, V12, P270; LINCOLN RS, 1956, J APPL PSYCHOL, V40, P105, DOI 10.1037/h0042392; Mesulam M-M, 1985, PRINCIPLES BEHAV NEU, P125; NACHSHON I, 1985, INT J NEUROSCI, V25, P161, DOI 10.3109/00207458508985369; POSNER MI, 1987, TRENDS NEUROSCI, V10, P13, DOI 10.1016/0166-2236(87)90116-0; Schwartz RL, 1997, NEUROLOGY, V48, P234, DOI 10.1212/WNL.48.1.234; VINGIANO W, 1991, INT J NEUROSCI, V58, P63, DOI 10.3109/00207459108987183; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P625	25	11	11	0	1	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1999	97	1-2					29	39		10.3109/00207459908994301			11	Neurosciences	Neurosciences & Neurology	184HK	WOS:000079605200003	10681116				2021-06-18	
J	Lazarus, MD; Guttmann, D; Rich, CE; Keenan, MAE				Lazarus, MD; Guttmann, D; Rich, CE; Keenan, MAE			Heterotopic ossification resection about the elbow	NEUROREHABILITATION			English	Article						heterotopic ossification; surgery for elbow heterotopic ossification; acquired brain injury	TRAUMATIC BRAIN INJURY; SPINAL-CORD INJURY; RISK-FACTORS; BONE	We studied twenty-four patients (twenty-seven elbows) that underwent resection of heterotopic ossification about the elbow. All of the patients had suffered from a traumatic brain injury. In addition, eight of the patients suffered local trauma, either fracture or burn. All patients had surgery performed by one of two surgeons (MAK, MDL). The mean follow-up was 25.9 +/- 2.6 months with a minimum of 12 months. Maximum flexion increased from 80.1 +/- 7.8 degrees preoperative to 111.9 +/- 4.5 degrees postoperative (p = 0.0003). Maximum extension increased from 58.9 +/- 6.2 degrees preoperative to 32.1 +/- 5.3 degrees postoperative (p = 0.0005). Twenty-three of the 27 elbows gained motion, with 4 patients loosing an average of 15.0 +/- 5.8 degrees. Interestingly, in the 17 patients who had ankylosed elbows preoperatively, the average gain in motion was 59.1 +/- 10.6 degrees as compared to a gain of 23.2 +/- 11.0 degrees in the remaining 10 patients (p = 0.03). The time from injury until resection was a significant predictor of outcome, with longer times associated with worse outcome (p = 0.02). Those patients who had continuous passive motion (CPM) after surgery had better motion gain (57.9 +/- 4.3 degrees) than those that did not have CPM (24.1 +/- 7.9 degrees) (p = 0.04). Resection of heterotopic ossification about the elbow is effective in gaining motion in most patients. The surgery can be technically challenging and requires extensive preoperative planning. Patients who have greater loss of motion preoperatively (i.e., ankylosed) have better outcomes than those with less to gain. Continuous passive motion should be considered postoperatively as its use is associated with a better result.	Albert Einstein Med Ctr, Dept Orthopaed Surg WCB4, Philadelphia, PA 19141 USA	Lazarus, MD (corresponding author), Albert Einstein Med Ctr, Dept Orthopaed Surg WCB4, 5501 Old York Rd, Philadelphia, PA 19141 USA.		Keenan, Mary Ann/ABB-1551-2020				ABRAMS RA, 1993, J HAND SURG-AM, V18A, P703, DOI 10.1016/0363-5023(93)90322-T; AYERS DC, 1986, J BONE JOINT SURG AM, V68A, P1423, DOI 10.2106/00004623-198668090-00016; BLANE CE, 1981, SKELETAL RADIOL, V7, P21, DOI 10.1007/BF00347167; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; CONNOR JM, 1983, SOFT TISSUE OSSIFICA; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; FAILLA JM, 1990, CLIN ORTHOP RELAT R, P133; FINERMAN GAM, 1981, METAB BONE DIS RELAT, V4, P337; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P303; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, V263, P58; HAMBLEN D L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P764; HASTINGS H, 1994, HAND CLIN, V10, P417; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; JONES BV, 1980, J BONE JOINT SURG BR, V62, P506; JUHN AMB, 1989, T ORTHOP RES SOC, V42; Keenan MAE, 1996, J HEAD TRAUMA REHAB, V11, P8, DOI 10.1097/00001199-199608000-00004; KIM JH, 1978, RADIOLOGY, V129, P501, DOI 10.1148/129.2.501; KOLESSAR DJ, 1996, MUSCULOSKELETAL CONS, P78; MALONEY WJ, 1991, J BONE JOINT SURG AM, V73A, P191, DOI 10.2106/00004623-199173020-00006; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MCLAREN AC, 1990, J BONE JOINT SURG AM, V72A, P245, DOI 10.2106/00004623-199072020-00012; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; NOLLEN AJG, 1986, ACTA ORTHOP SCAND, V57, P358, DOI 10.3109/17453678608994411; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; Pittenger D E, 1991, Orthop Rev, V20, P33; REIGLER HG, 1976, CLIN ORTHOPAEDICS, V117, P209; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; RITTER MA, 1985, CLIN ORTHOP RELAT R, P217; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; SCHMIDT SA, 1988, J BONE JOINT SURG AM, V70A, P834, DOI 10.2106/00004623-198870060-00005; SOBALLE K, 1988, CLIN ORTHOP RELAT R, P57; SODEMANN B, 1988, CLIN ORTHOP RELAT R, P150; Summerfield SL, 1997, J SHOULDER ELB SURG, V6, P321, DOI 10.1016/S1058-2746(97)90025-2; Testa N N, 1988, Orthop Rev, V17, P965; THOMAS BJ, 1985, J BONE JOINT SURG AM, V67A, P400, DOI 10.2106/00004623-198567030-00008; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215	44	11	11	0	0	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	12	2					145	153					9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	218FF	WOS:000081542000006					2021-06-18	
S	van Rossem, K; Garcia-Martinez, S; De Mulder, G; Van Deuren, B; Engelborghs, K; Van Reempts, J; Borgers, M		Eke, A; Delpy, DT		van Rossem, K; Garcia-Martinez, S; De Mulder, G; Van Deuren, B; Engelborghs, K; Van Reempts, J; Borgers, M			Brain oxygenation after experimental closed head injury - A NIRS study	OXYGEN TRANSPORT TO TISSUE XXI	ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY		English	Article; Proceedings Paper	26th Annual Meeting of the International-Society-on-Oxygen-Transport-to-Tissue (ISOTT 98)	AUG 23-28, 1998	BUDAPEST, HUNGARY	Int Soc Oxygen Transport Tissue, Alliance Pharmaceut, Hemox Therapeut, Radiometer Copenhagen, Berlex Biosic			NEAR-INFRARED SPECTROSCOPY; CEREBRAL OXYGENATION; QUANTIFICATION; RATS		Janssen Res Fdn, Dept Life Sci Neuropathol, B-2340 Beerse, Belgium	van Rossem, K (corresponding author), Janssen Res Fdn, Dept Life Sci Neuropathol, B-2340 Beerse, Belgium.						Barzo P, 1997, ACT NEUR S, V70, P115; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BROWN GC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P273, DOI 10.1016/S0005-2728(05)80109-4; Bullock MR, 1996, J NEUROTRAUM, V13, P705; COOPER CE, 1994, BIOCHEM SOC T, V22, P974, DOI 10.1042/bst0220974; Cope M, 1989, Adv Exp Med Biol, V248, P33; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; ENGELBORGHS K, 1998, IN PRESS J NEUROSURG; Gilbert CL, 1996, WORLD DEV, V24, P1, DOI 10.1016/0305-750X(95)00121-R; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; MACGOVERN GJ, 1984, CIRCULATION S1, V70, P191; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; MATCHER SJ, 1994, PHYS MED BIOL, V39, P1295, DOI 10.1088/0031-9155/39/8/008; Unterberg AW, 1997, ACT NEUR S, V70, P106; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8	19	11	11	0	2	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0065-2598		0-306-46281-8	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		1999	471						209	215					7	Cell Biology; Hematology; Medicine, Research & Experimental; Physiology	Cell Biology; Hematology; Research & Experimental Medicine; Physiology	BP58J	WOS:000085570200025	10659149				2021-06-18	
J	Rao, AM; Hatcher, JF; Baskaya, MK; Dempsey, RJ				Rao, AM; Hatcher, JF; Baskaya, MK; Dempsey, RJ			Simultaneous assay of ornithine decarboxylase and polyamines after central nervous system injury in gerbil and rat	NEUROSCIENCE LETTERS			English	Article						cerebral ischemia; cortex; hippocampus; ornithine decarboxylase; polyamines; putrescine; traumatic brain injury	BLOOD-BRAIN-BARRIER; FOCAL CEREBRAL-ISCHEMIA; TRANSIENT ISCHEMIA; BREAKDOWN; CORTEX; PHASE; EDEMA	Ornithine decarboxylase (ODC) is considered the rate-limiting enzyme in polyamine biosynthesis. An increase in putrescine (a natural polyamine) synthesis after central nervous system (CNS) injury appears to be involved in blood-brain barrier dysfunction, development of vasogenic edema and neuronal death. An improved method is described to determine the ODC activity as well as polyamine levels from the same brain tissue. The polyamine results showed no significant differences from data obtained with the conventional assay. The advantages of this method are to: (1) minimize the number of animals needed for the study, and (2) eliminate any internal inconsistencies resulting from use of two independent groups of animals for ODC and polyamine measurements. Using this method, ODC activities and polyamine levels were measured in cortices and hippocampi from global transient ischemia of gerbils and traumatic brain injury (TBI) of rats. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Univ Wisconsin, Ctr Clin Sci, Dept Neurol Surg, Madison, WI 53792 USA; Vet Adm Hosp, Madison, WI USA; Louisiana State Univ, Med Ctr, Dept Neurosurg, Shreveport, LA 71130 USA	Rao, AM (corresponding author), Univ Wisconsin, Ctr Clin Sci, Dept Neurol Surg, F4-313,600 Highland Ave, Madison, WI 53792 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031220, R01NS028000] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS31220, R01 NS 28000] Funding Source: Medline		Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 1997, BRAIN RES, V744, P302; BAUDRY M, 1994, NEUROSCI LETT, V171, P151, DOI 10.1016/0304-3940(94)90627-0; DEMPSEY RJ, 1991, J CEREBR BLOOD F MET, V11, P979, DOI 10.1038/jcbfm.1991.164; deVera N, 1997, AMINO ACIDS, V12, P1; DIENEL GA, 1985, J NEUROCHEM, V44, P600, DOI 10.1111/j.1471-4159.1985.tb05454.x; Henley CM, 1997, J NEUROCHEM, V69, P259; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KINDY MS, 1994, J CEREBR BLOOD F MET, V14, P1040, DOI 10.1038/jcbfm.1994.136; KOENIG H, 1989, J NEUROCHEM, V52, P101, DOI 10.1111/j.1471-4159.1989.tb10903.x; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; PASCHEN W, 1993, PROG BRAIN RES, V96, P147; Rao AM, 1997, MOL BRAIN RES, V44, P134, DOI 10.1016/S0169-328X(96)00245-8; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; RAO AM, 1995, J NEUROCHEM, V65, P2639; Rao VLR, 1998, BRAIN RES, V783, P163, DOI 10.1016/S0006-8993(97)01301-2; SCHMITZ MP, 1993, NEUROSURGERY, V33, P882; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Zoli M, 1996, MOL BRAIN RES, V38, P122, DOI 10.1016/0169-328X(95)00339-T	22	11	13	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 6	1998	256	2					65	68		10.1016/S0304-3940(98)00780-0			4	Neurosciences	Neurosciences & Neurology	142HQ	WOS:000077195100002	9853704				2021-06-18	
J	Tiersky, LA; Cicerone, KD; Natelson, BH; DeLuca, J				Tiersky, LA; Cicerone, KD; Natelson, BH; DeLuca, J			Neuropsychological functioning in chronic fatigue syndrome and mild traumatic brain injury: A comparison	CLINICAL NEUROPSYCHOLOGIST			English	Article							MINOR HEAD-INJURY; MULTIPLE-SCLEROSIS; CHRONIC PAIN; POSTCONCUSSION SYNDROME; ATTENTION; SYMPTOMS; DEFICITS; MEMORY; DEPRESSION; IMPAIRMENT	Persons with chronic fatigue syndrome (CFS) (n = 30), individuals who had sustained a mild traumatic brain injury with postconcussive symptoms (MTBI) (n = 33), and healthy controls (n = 20), who were age and education-matched, were compared on measures of complex information processing, attention/concentration, memory, and higher-order cognitive processes. MTBI and CFS patients demonstrated a similar deficit in complex information processing and verbal learning. Overall, however, individuals who suffered a MTBI demonstrated a greater degree of impairment than did individuals with CFS and healthy controls. Implications for treatment and future research are discussed.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Chron Fatigue Syndrome Ctr, Newark, NJ USA; JFK Johnson Rehabil Inst, Edison, NJ USA; Rehabil & Educ Corp, Kessler Med Res, W Orange, NJ USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Newark, NJ 07103 USA	Tiersky, LA (corresponding author), Fatigue Res Ctr, 385 Tremont Ave,127A, E Orange, NJ 07018 USA.	ltiersky@nbunj.jvnc.net					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; BOHNEN N, 1992, NEUROSURGERY, V30, P692; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Buchwald D, 1996, RHEUM DIS CLIN N AM, V22, P219, DOI 10.1016/S0889-857X(05)70270-2; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COPE H, 1995, BRIT J PSYCHIAT, V167, P86, DOI 10.1192/bjp.167.1.86; DEFILIPPIS NA, 1993, CATEGORY TEST COMPUT; DeFilippis NA, 1979, BOOKLET CATEGORY TES; Delis DC, 1987, CALIFORNIA VERBAL LE; DELUCA J, 1993, ARCH NEUROL-CHICAGO, V50, P301, DOI 10.1001/archneur.1993.00540030065016; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; EVANS RW, 1992, NEUROL CLIN, V10, P815; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GRAFMAN J, 1993, J NEUROL NEUROSUR PS, V56, P684, DOI 10.1136/jnnp.56.6.684; Grafman J., 1994, CHRONIC FATIGUE SYND, P263; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V81, P403, DOI 10.2466/pms.1995.81.2.403; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1986, J HEAD TRAUMA REHAB, V1, P53, DOI DOI 10.1097/00001199-198606000-00009; HARTLAGE S, 1993, PSYCHOL BULL, V113, P247, DOI 10.1037/0033-2909.113.2.247; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Johnson SK, 1996, PERCEPT MOTOR SKILL, V83, P51, DOI 10.2466/pms.1996.83.1.51; Joyce E, 1996, J NEUROL NEUROSUR PS, V60, P495, DOI 10.1136/jnnp.60.5.495; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Marshall PS, 1996, BIOL PSYCHIAT, V39, P199, DOI 10.1016/0006-3223(95)00131-X; Marshall PS, 1997, PSYCHOSOM MED, V59, P58, DOI 10.1097/00006842-199701000-00008; MATEER CA, 1992, PHYSICAL MED REHABIL, V6, P143; MCDONALD E, 1993, J NEUROL NEUROSUR PS, V56, P812, DOI 10.1136/jnnp.56.7.812; MossMorris R, 1996, J NEUROL NEUROSUR PS, V60, P474, DOI 10.1136/jnnp.60.5.474; PRASHER D, 1990, J NEUROL NEUROSUR PS, V53, P247, DOI 10.1136/jnnp.53.3.247; RASKIN S, 1994, M INT NEUR SOC ANG; RASKIN S, 1993, SOC COGN REH ATL; RAY C, 1993, BRIT J CLIN PSYCHOL, V32, P357, DOI 10.1111/j.2044-8260.1993.tb01068.x; REITAN RM, 1959, J NERV MENT DIS, V129, P257, DOI 10.1097/00005053-195909000-00006; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHEFFERS MK, 1992, NEUROLOGY, V42, P1667, DOI 10.1212/WNL.42.9.1667; SCHLOMAN BF, 1992, HEALTH EDUC RES, V7, P117, DOI 10.1093/her/7.1.117; SMITH A, 1991, POSTVIRAL FATIGUE SY, P179; SMITH AP, 1993, BRIT J PSYCHOL, V84, P411, DOI 10.1111/j.2044-8295.1993.tb02492.x; SOHLBERG M, 1993, MANUAL APT 2; The Mild Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; TIERSKY L, 1997, M AM PSYCH ASS CHIC; Tiersky LA, 1997, J CLIN EXP NEUROPSYC, V19, P560, DOI 10.1080/01688639708403744; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Visser RSH, 1973, MANUAL COMPLEX FIGUR; Wechsler, 1981, WAIS R MANUAL; Wechsler D., 1987, WECHSLER MEMORY SCAL; Weingartner H, 1982, Psychopharmacol Bull, V18, P27	58	11	11	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1998	12	4					503	512		10.1076/clin.12.4.503.7237			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	203GF	WOS:000080699400007					2021-06-18	
J	Glenn, MB				Glenn, MB			Methylphenidate for cognitive and behavioral dysfunction after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article									Spaulding Rehabil Hosp, Outpatient & Community Brain Injury Programs, Boston, MA 02114 USA	Glenn, MB (corresponding author), Spaulding Rehabil Hosp, Outpatient & Community Brain Injury Programs, Boston, MA 02114 USA.						GLENN MB, 1986, J HEAD TRAUMA REHAB, V1, P74; GLENN MB, 1987, J HEAD TRAUMA REHAB, V2, P71; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Laborde A, 1997, J HEAD TRAUMA REHAB, V12, P90, DOI 10.1097/00001199-199708000-00009; MCDOWELL SK, 1996, J HEAD TRAUMA REHAB, V11, P99; MOONEY GF, 1993, ARCH PHYS MED REHAB, V74, P153; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WROBLEWSKI BA, 1992, J CLIN PSYCHIAT, V53, P86; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004	12	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1998	13	5					87	90		10.1097/00001199-199810000-00010			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	175UU	WOS:000079114600010	9753538				2021-06-18	
J	Rise, IR; Risoe, C; Kirkeby, OJ				Rise, IR; Risoe, C; Kirkeby, OJ			Cerebrovascular effects of high intracranial pressure after moderate hemorrhage	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral blood flow; hemorrhage; high intracranial pressure; pig	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; HYDROGEN CLEARANCE; HYPERTENSION; ISCHEMIA	Patients with head injuries often develop increased intracranial pressure after hemorrhage. The authors studied the effect of moderate hemorrhage followed by elevated intracranial pressure on cerebrovascular variables. Cerebral blood flow in la pigs was measured with laser Doppler flowmetry, and cerebral venous blood gases were taken from the sagittal sinus. High intracranial pressure (80% of mean arterial pressure) was induced by infusion of artificial cerebrospinal fluid into the cisterna magna, and blood pressure was reduced by bleeding to a mean of 78% of the prebleeding values in eight pigs. Five pigs served as secondary controls. High intracranial pressure before hemorrhage caused a decrease in cerebral blood flow to 34% of the baseline values, a decrease in sagittal sinus oxygen saturation to 46%, and a decrease in cerebral perfusion pressure to 36%, but did not change cerebrovascular resistance. High intracranial pressure after hemorrhage decreased cerebral blood flow to 14% of baseline values. Sagittal sinus oxygen saturation decreased to 22%, cerebral perfusion pressure decreased to 30%, and the cerebrovascular resistance increased by 355%. The moderate hypotension after hemorrhage caused a considerable enhancement of the effects of high intracranial pressure on cerebral hemodynamics.	Univ Oslo, Ulleval Hosp, Dept Neurosurg, N-0407 Oslo, Norway; Natl Hosp, Inst Surg Res, Oslo, Norway	Kirkeby, OJ (corresponding author), Univ Oslo, Ulleval Hosp, Dept Neurosurg, N-0407 Oslo, Norway.						ALTMAN PL, 1974, BIOL DATA BOOK, V3, P1846; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BENABID AL, 1978, J PHYSIOL-PARIS, V74, P369; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BRICOLO AP, 1981, J NEUROSURG, V55, P397, DOI 10.3171/jns.1981.55.3.0397; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; CHIANG J, 1968, AM J PATHOL, V52, P455; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIETRICH WD, 1984, J NEUROPATH EXP NEUR, V43, P72, DOI 10.1097/00005072-198401000-00006; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P402; FEUSTEL PJ, 1984, J APPL PHYSIOL, V56, P150; FIESCHI C, 1969, EXP BRAIN RES, V7, P111; FISHER EG, 1972, STROKE, V3, P538; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; KATO Y, 1989, ACTA NEUROCHIR, V98, P184, DOI 10.1007/BF01407346; KIRKEBY OJ, 1995, J APPL PHYSIOL, V79, P1479; KOHELER RC, 1983, INTRACRANIAL PREESSU, V5, P880; KONG DL, 1991, CRIT CARE MED, V19, P532, DOI 10.1097/00003246-199104000-00013; KUMMER R V, 1984, Stroke, V15, P108; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LITTLE RA, 1989, J TRAUMA, V29, P903, DOI 10.1097/00005373-198907000-00001; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1991, J NEUROSURG S, V75, P59; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P12, DOI 10.1109/TBME.1980.326686; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P597, DOI 10.1109/TBME.1980.326582; OGILVY CS, 1987, BIOL NEONATE, V52, P327; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PUCHER R, 1991, ACTA NEUROCHIR, V109, P52, DOI 10.1007/BF01405698; REDDY GD, 1974, BIOL NEONATE, V25, P249; SCHALEN W, 1992, ACTA ANAESTH SCAND, V3, P367; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; TOMIDA S, 1989, J CEREBR BLOOD F MET, V9, P79, DOI 10.1038/jcbfm.1989.11; TOMITA M, 1988, J CEREBR BLOOD F MET, V8, P727, DOI 10.1038/jcbfm.1988.120; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; VONLOON J, 1993, J NEUROSURG, V79, P705; WARNER DS, 1992, NEUROSURGERY SCI BAS, P489; Zierski J, 1987, Acta Neurochir Suppl (Wien), V40, P95	43	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	1998	10	4					224	230					7	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	128CJ	WOS:000076387400004	9796606				2021-06-18	
J	Bisiacchi, PS; Sgaramella, TM; Farinello, C				Bisiacchi, PS; Sgaramella, TM; Farinello, C			Planning strategies and control mechanisms: Evidence from closed head injury and aging	BRAIN AND COGNITION			English	Article; Proceedings Paper	TENNET VIII - Theoretical and Experimental Neuropsychology Conference	JUN 16-18, 1997	MONTREAL, CANADA				FRONTAL-LOBE DAMAGE	The ability to plan a sequence of actions in a fictious environment was studied in young adults, CHI patients and elderly. The planning task consisted in completing 10 errands on a map of a hypothetical town where buildings, shops and public offices were shown. Results revealed significant differences across groups. Error analyses revealed the presence of different heuristics at work when planning was performed by young adults, elderly (older than 80 years) and CHI patients. The results are thought to be relevant for detailing a componential analysis of the planning process and control mechanisms.	Univ Padua, Dipartimento Psicol Gen, Padua, Italy; Osped San Bortolo, Vicenza, Italy	Bisiacchi, PS (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.		BISIACCHI, PATRIZIA/B-8976-2008	BISIACCHI, PATRIZIA/0000-0003-2760-8000			COHEN G, 1988, MEMORY REAL WORLD; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1016/S0364-0213(79)80010-5; Norman DA, 1986, CONSCIOUSNESS SELF R; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHALLICE T, 1994, ATTENTION PERFORMANC, V15; Shallice T., 1988, NEUROPSYCHOLOGY MENT; VILKKI J, 1991, CORTEX, V27, P203, DOI 10.1016/S0010-9452(13)80124-4	10	11	11	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	JUN	1998	37	1					113	116					4	Neurosciences; Psychology, Experimental	Neurosciences & Neurology; Psychology	ZZ523	WOS:000074737900053					2021-06-18	
J	Samuel, C; Louis-Dreyfus, A; Couillet, J; Roubeau, B; Bakchine, S; Bussel, B; Azouvi, P				Samuel, C; Louis-Dreyfus, A; Couillet, J; Roubeau, B; Bakchine, S; Bussel, B; Azouvi, P			Dysprosody after severe closed head injury: an acoustic analysis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						dysprosody; head injury; acoustic analysis	SPEECH CHARACTERISTICS; PRACTICAL SCALE; DYSARTHRIA; DYSFUNCTION; DEPRESSION; EXPRESSION; COMA	Objectives-Neurological speech disorders (dysarthria and dysprosody) are known to be frequent sequelae after severe closed head injury. These disorders may dramatically alter communicative intent and accentuate social isolation. The aim was to provide an instrumental evaluation for prosodic production in a group of patients with, severe closed head injury and to determine the correlations between prosodic production and neurobehavioural status. Methods-Fifteen patients, at the subacute stage after severe closed head injury, were studied and compared with 11 controls, matched for age, sex, and duration of education. Each subject was required to read aloud a French sentence "Je m'en vais samedi matin" (I am leaving saturday morning) under six different prosodic intonations (neutral, affirmation, interrogation, happiness, sadness, anger). The recorded sentences were analysed using a sound signal analysis software (Signalyse) allowing the measurement of signal intensity and fundamental frequency. Statistical analyses were carried out using repeated measures analysis of variance (ANOVA). Results-Patients with closed head injury were significantly less able than controls to modulate speech output (pitch and intensity) according to prosodic context. This deficit was particularly pronounced for the intonation feature of anger, question, and statement. No consistent correlations could be found between prosodic production and cognitive or behavioural data. Conclusions-Acoustic analysis of pitch and intensity may show impairments of prosodic production after severe closed head injury, which mag: be useful in rehabilitation planning. This impairment does not seem to reflect the eventual cognitive and behavioural deficits of the patients, but rather a specific disorder of modulation of speech output.	Univ Paris 05, Raymond Poincare Hosp, Dept Neurol Rehabil, Serv Reeduc Neurol, F-92380 Garches, France; Hop Tenon, Serv ORL, F-75970 Paris, France; Hop La Pitie Salpetriere, Federat Neurol, Paris, France	Samuel, C (corresponding author), Univ Paris 05, Raymond Poincare Hosp, Dept Neurol Rehabil, Serv Reeduc Neurol, F-92380 Garches, France.						*AM PSYCH ASS, 1989, LKDIAGN STAT M AN ME; ARONSON AE, 1994, BRAIN INJURY, V8, P663, DOI 10.3109/02699059409151019; CAEKEBEKE JFV, 1991, J NEUROL NEUROSUR PS, V54, P145, DOI 10.1136/jnnp.54.2.145; DANLY M, 1982, BRAIN LANG, V16, P171, DOI 10.1016/0093-934X(82)90082-7; DARBY JK, 1984, J COMMUN DISORD, V17, P75, DOI 10.1016/0021-9924(84)90013-3; DELOCHE G, 1997, TEST DENOMINATION OR; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; HIRD K, 1993, BRAIN LANG, V45, P46, DOI 10.1006/brln.1993.1032; Jennett B, 1981, MANAGEMENT HEAD INJU; KELLER E, 1991, BRIT J DISORD COMMUN, V26, P75; KELLER E, 1992, SIGNALYZE SIGNAL ANA; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MONRADKROHN GH, 1947, BRAIN, V70, P405, DOI 10.1093/brain/70.4.405; MONRADKROHN GH, 1963, PROBLEMS DYNAMIC NEU, P101; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MURPHY D, 1990, J NEUROL NEUROSUR PS, V53, P727, DOI 10.1136/jnnp.53.9.727; NILSONNE A, 1988, ACTA PSYCHIAT SCAND, V77, P253, DOI 10.1111/j.1600-0447.1988.tb05118.x; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; ROSS ED, 1997, BEHAV NEUROLOGY NEUR, P699; Stringer AY, 1996, BRAIN INJURY, V10, P583, DOI 10.1080/026990596124151; TEASDALE G, 1974, LANCET, V2, P81; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; VOGEL M, 1982, FOLIA PHONIATR, V34, P150, DOI 10.1159/000265644; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1983, PHONETICA, V40, P63	32	11	13	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	1998	64	4					482	485		10.1136/jnnp.64.4.482			4	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	ZJ938	WOS:000073268800011	9576539	Green Published, Bronze			2021-06-18	
J	Ahn, MO; Korst, LM; Phelan, JP				Ahn, MO; Korst, LM; Phelan, JP			Normal fetal heart rate pattern in the brain-damaged infant: A failure of intrapartum fetal monitoring?	JOURNAL OF MATERNAL-FETAL INVESTIGATION			English	Article						asphyxia; fetal heart rate; cerebral palsy; intrapartum fetal monitoring; brain-damaged baby	CEREBRAL-PALSY	Objective: To describe the perinatal characteristics of neurologically impaired infants with normal intrapartum fetal heart rate (FHR) patterns. Methods: In a registry of 300 neurologically impaired singleton term infants, a retrospective chart review was undertaken to analyze those patients with a normal intrapartum FHR pattern, i,e. reactive FHR pattern with a normal baseline rate throughout labor, and a subsequent finding of central nervous system impairment. Neonates with an abnormal intrapartum FHR pattern or a traumatic birth were excluded. In addition, the four criteria necessary for intrapartum asphyxia were as follows: arterial pH <7.00, Apgar score less than or equal to 3 for 5 min, neonatal neurologic sequelae, such as seizures, and multiorgan system dysfunction, Infants were then categorized according to the timing of probable fetal injury. Results: Of the 300 infants in the registry, 24 (8%) neonates were identified. Six (25%) of these were considered postdates. Primary antenatal complications included early pregnancy bleeding (3 (13%)), cigarette and/or alcohol use (4 (17%)), and polyhydramnios (2 (8%)). Meconium was found in 12 patients (50%) during labor; of these, two (8%) patients had meconium aspiration syndrome and required extra corporeal membrane oxygenation (ECMO). None of the infants satisfied the four criteria for intrapartum asphyxia. Sixteen (67%) neonates were discharged with their mothers. The remaining eight neonates were admitted to the neonatal intensive care unit, and two (8%) neonatal deaths occurred due to meconium aspiration syndrome and sudden infant death syndrome. The long term neurologic outcome of the 22 survivors ranged from 3 to 14 years and included the following: developmental delay (10 (45%)), seizure disorder (7 (32%)), cerebral palsy (11 (50%)), and mental retardation (4 (17%)). None of these infants appeared to have been injured during labor. The probable timing of neurologic injury appeared to be early pregnancy (13 (54%)) or postnatally (11 (46%)). Conclusions: Infants who are later found to be neurologically impaired can have normal intrapartum FHR patterns during labor. These neurologic injuries seem to occur in early pregnancy or after birth. In the absence of fetal trauma, these findings suggest that a reactive intrapartum FHR pattern is not associated with intrapartum fetal asphyxia.	Cha Womens Hosp, Dept Obstet & Gynecol, Seoul, South Korea; Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; Pomona Valley Hosp, Med Ctr, Dept Maternal Fetal Med, Pomona, CA 91767 USA	Phelan, JP (corresponding author), Suite 200,959 E Walnut St, Pasadena, CA 91106 USA.			Korst, Lisa/0000-0002-0846-7823			*AM COLL OBST GYN, 1992, TECHNICAL B, V163; Cardosi RJ, 1997, J REPROD MED, V42, P251; Korst LM, 1997, PRENAT NEONAT MED, V2, P286; MARDEN PM, J PEDIAT, V164, P357; MENTICOGLOU SM, 1989, OBSTET GYNECOL, V74, P457; *NAT CTR HLTH STAT, 1993, MONTH VIT STAT REP, V41, P28; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; PHELAN JP, 1994, AM J OBSTET GYNECOL, V171, P424, DOI 10.1016/0002-9378(94)90278-X; PHELAN JP, 1994, CLIN PERINATOL, V21, P879; PHELAN JP, 1998, IN PRESS J MATERN FE; SHIELDS JR, 1988, OBSTET GYNECOL, V71, P899; THACKER SB, 1995, OBSTET GYNECOL, V86, P613, DOI 10.1016/0029-7844(95)00232-G; VANDERMOER PE, 1985, OBSTET GYNECOL, V65, P125; VOLPE JJ, 1995, NEUROLOGY NEWBORN, P172; YEH SY, 1982, AM J OBSTET GYNECOL, V143, P496, DOI 10.1016/0002-9378(82)90536-1	15	11	11	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0939-6322			J MATERN-FETAL INVES	J. Matern.-Fetal Invest.	SPR	1998	8	2					58	60					3	Obstetrics & Gynecology	Obstetrics & Gynecology	ZW485	WOS:000074415700002					2021-06-18	
J	Kristof, RA; Clusmann, H; Koehler, W; Fink, KB; Schramm, J				Kristof, RA; Clusmann, H; Koehler, W; Fink, KB; Schramm, J			Treatment of accidental high dose intraventricular mezlocillin application by cerebrospinal fluid exchange	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						intrathecal; mezlocillin; seizures; ventricular drainage complication	METHOTREXATE	An accidental high dose of intraventricular mezlocillin was given during antibiotic treatment for pneumonia in a patient admitted because of severe traumatic brain injury and occlusive hydrocephalus. Because of serial epileptic seizures not responsive to antiepileptic drug treatment, CSF exchange was performed. The CSF was drained through a ventricular catheter, while mock CSF was infused into the lumbar subarachnoid space. The patient soon recovered to her clinical status previous to intraventricular mezlocillin application. Side effects of CSF exchange were not seen. Under continued antiepileptic medication no more seizures occurred. It is concluded that high doses of intraventricular mezlocillin have proconvulsive effects. In this patient CSF exchange was a suitable means of preventing putatively permanent impairment of brain function caused by serial epileptic seizures due to intraventricular mezlocillin application.	Univ Bonn, Neurochirurg Klin, Dept Neurosurg, D-53105 Bonn, Germany; Univ Bonn, Inst Pharmacol & Toxicol, D-53113 Bonn, Germany	Clusmann, H (corresponding author), Univ Bonn, Neurochirurg Klin, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.						ANDRIOLE VT, 1981, HOSP FORMUL, V8, P816; Cadeo G P, 1985, G Ital Chemioter, V32, P303; CHEN MN, 1986, JAP J ANTIBIOT, V34, P1234; FRIEDRICH H, 1980, ACTA NEUROCHIR, V52, P136; GLOOR P, 1977, ELECTROEN CLIN NEURO, V43, P79, DOI 10.1016/0013-4694(77)90198-5; GRONDAHL TO, 1993, J NEUROSURG, V78, P938, DOI 10.3171/jns.1993.78.6.0938; GRUNEBERG RN, 1984, J ANTIMICROB CHEMOTH, V13, P49, DOI 10.1093/jac/13.suppl_C.49; HENKER J, 1982, KINDERARZTL PRAX, V6, P288; HILDEBRANDT R, 1982, J CHROMATOGR, V228, P409, DOI 10.1016/S0378-4347(00)80464-8; JOHNSON HC, 1945, JAMA-J AM MED ASSOC, V127, P217, DOI 10.1001/jama.1945.92860040001007; Kataoka Noriaki, 1994, Hokkaido Journal of Medical Science, V69, P84; Kelsey M C, 1982, Eur J Clin Microbiol, V1, P138, DOI 10.1007/BF02019613; KIMELBERG HK, 1978, J NEUROSURG, V48, P883, DOI 10.3171/jns.1978.48.6.0883; KONOPKA CA, 1982, J ANTIMICROB CHEMOTH, V9, P267, DOI 10.1093/jac/9.suppl_A.267; PARRY MF, 1982, J ANTIMICROB CHEMOTH, V9, P273, DOI 10.1093/jac/9.suppl_A.273; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; SHAPIRO WR, 1975, NEW ENGL J MED, V293, P161, DOI 10.1056/NEJM197507242930402; SIMON C, 1993, ANTIBIOTIKA THERAPIE, P35; SPIEGEL RJ, 1984, NEW ENGL J MED, V311, P386, DOI 10.1056/NEJM198408093110607; YEN J, 1978, J NEUROSURG, V48, P895, DOI 10.3171/jns.1978.48.6.0895	20	11	11	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAR	1998	64	3					379	381		10.1136/jnnp.64.3.379			3	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	ZD117	WOS:000072653100020	9527154	Bronze, Green Published			2021-06-18	
J	O'Dell, MW; Bell, KR; Sandel, ME				O'Dell, MW; Bell, KR; Sandel, ME			Brain injury rehabilitation. 2. Medical rehabilitation of brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							INTRATHECAL BACLOFEN APPLICATION; PLACEBO-CONTROLLED TRIAL; BOTULINUM TOXIN; DOUBLE-BLIND; POSTTRAUMATIC SEIZURES; VENOUS THROMBOEMBOLISM; NONFLUENT APHASIA; SPASTICITY; PHENYTOIN; HYDROCEPHALUS	This self-directed learning module highlights new advances in the area of medical issues in brain injury rehabilitation, with an emphasis on traumatic etiologies. It is part of the chapter on brain injury rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. This article contains information on post-traumatic seizures and hydrocephalus, principles of pharmacologic and spasticity management, dizziness, visual disturbances, and language impairment. New advances covered in this section include more conservative approaches to post-traumatic seizure prophylaxis and the use of botulinum toxin and intrathecal baclofen pumps in the management of spasticity, (C) 1998 by the American Academy of Physical Medicine and Rehabilitation.	Southside Hosp, Bay Shore, NY 11706 USA; Long Isl Jewish Med Ctr, New Hyde Park, NY 11040 USA; Washington Univ, Sch Med, St Louis, MO 63130 USA; Kaiser Fdn Rehabil Ctr, Vallejo, CA 94589 USA	O'Dell, MW (corresponding author), Long Isl Jewish Med Ctr, New Hyde Park, NY 11040 USA.			Bell, Kathleen/0000-0002-0928-2046			ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BodineFowler SC, 1996, MUSCLE NERVE, V19, P497, DOI 10.1002/mus.880190404; Bontke C. F., 1993, J HEAD TRAUMA REHAB, V8, P34; BONTKE CF, 1989, PHYS MED REHABIL STA, V3, P43; BOYESON MG, 1994, J HEAD TRAUMA REHAB, V9, P78, DOI 10.1097/00001199-199409000-00007; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; Cohen A H, 1992, J Am Optom Assoc, V63, P569; COPE DN, 1996, MED REHABILITATION T, P573; COSGROVE JL, 1989, AM J PHYS MED REHAB, V68, P15, DOI 10.1097/00002060-198902000-00005; Dall JT, 1996, BRAIN INJURY, V10, P453; DJERGAIAN RS, 1996, MED REHABILITATION T, P459; Doherty D., 1992, PHYS MED REH CLIN N, V3, P389; Furman JM., 1996, BALANCE DISORDERS CA; Gellman H, 1996, J HEAD TRAUMA REHAB, V11, P23, DOI 10.1097/00001199-199608000-00005; GELLMAN H, 1992, PAIN, V51, P307, DOI 10.1016/0304-3959(92)90214-V; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; Gillham R, 1996, EPILEPSY RES, V24, P47, DOI 10.1016/0920-1211(95)00102-6; GIZZI M, 1995, J HEAD TRAUMA REHAB, V10, P60, DOI 10.1097/00001199-199512000-00009; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; GLENN MB, 1990, PRACTICAL MANAGEMENT, P227; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; GOLDSTEIN LB, 1996, ATLAS CEREBROVASCULA; GUILTERI CT, 1991, NEUROPSYCHIATRY BEHA; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; HERDMAN SJ, 1993, PHYS MED REHABIL STA, V7, P559; JONES RFC, 1994, ACT NEUR S, V61, P79; KATZ RT, 1994, STATE ART REV, V8; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; KOFLER M, 1994, NEUROLOGY, V44, P25, DOI 10.1212/WNL.44.1.25; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; Leach JP, 1997, J NEUROL NEUROSUR PS, V62, P372, DOI 10.1136/jnnp.62.4.372; LONG DF, 1996, MED REHABILITATION T, P333; MANN NR, 1996, MED REHABILITATION T, P479; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MEADOR KJ, 1995, NEUROLOGY, V45, P1494, DOI 10.1212/WNL.45.8.1494; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Middleton JW, 1996, ARCH PHYS MED REHAB, V77, P824, DOI 10.1016/S0003-9993(96)90264-6; MONREAL M, 1992, CHEST, V102, P677, DOI 10.1378/chest.102.3.677; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; Pierson SH, 1996, ARCH PHYS MED REHAB, V77, P717, DOI 10.1016/S0003-9993(96)90015-5; Rifici C, 1994, Funct Neurol, V9, P29; ROGERS FB, 1995, SURG CLIN N AM, V75, P279, DOI 10.1016/S0039-6109(16)46588-6; Sabe L, 1995, NEUROLOGY, V45, P2272, DOI 10.1212/WNL.45.12.2272; Sandel ME, 1996, NEUROREHABILITATION, V6, P9, DOI 10.3233/NRE-1996-6103; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; SHEN JL, 1993, PHYS MED REHABIL STA, V7, P503; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SMALL SL, 1994, STROKE, V25, P1282, DOI 10.1161/01.STR.25.6.1282; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; VANNESTE J, 1992, NEUROLOGY, V42, P54, DOI 10.1212/WNL.42.1.54; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; ZUBER M, 1993, NEUROLOGY, V43, P1715, DOI 10.1212/WNL.43.9.1715	61	11	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1998	79	3		1			S10	S15		10.1016/S0003-9993(98)90114-9			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	ZC421	WOS:000072576300003					2021-06-18	
J	Stevens, H; Van de Wiele, C; Santens, P; Jansen, HML; De Reuck, J; Dierckx, R; Korf, J				Stevens, H; Van de Wiele, C; Santens, P; Jansen, HML; De Reuck, J; Dierckx, R; Korf, J			Cobalt-57 and technetium-99m-HMPAO-labeled leukocytes for visualization of ischemic infarcts	JOURNAL OF NUCLEAR MEDICINE			English	Article						cerebral ischemia; stroke; leukocyte; cobalt-57; SPECT; technetium-99m-HMPAO	POSITRON EMISSION TOMOGRAPHY; MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; PROGRESSIVE MULTIPLE-SCLEROSIS; CALCIUM ACCUMULATION; RAT-BRAIN; STROKE; OCCLUSION; ANTIBODY; NEURONS	Previous studies have shown the usefulness of divalent cobalt isotopes to visualize cerebral damage after stroke, The site of accumulation of cobalt ion is unknown but may be explained by neuronal influx, analogous to that of calcium ion. Additionally, uptake may be due to infiltrating leukocytes or protein-bound cobalt. The aims of this study were to compare Co-57-SPECT with leukocyte SPECT and to compare the SPECT findings with clinical outcome as scored by the Orgogozo scale. Materials: Ten patients with a CT scan positive for middle cerebral artery infarcts were included in the study (7 men, 3 women; mean age 70 yr), Technetium-99m leukocyte and cobalt-SPECT (interval 2-4 days) were made with a double-headed gamma camera, after the injection of 10-15 mCi Tc-99m-HMPAO-labeled leukocytes and 0.4 mCi Co-57, respectively, Scans were performed within 5-30 days after onset of the first symptoms. Regions of interest (ROI) containing the area of infarction in the slices displaying enhanced radioactivity or the middle cerebral artery (MCA) region in four successive slices were defined for calculating enhancement ratios. The (TC)-T-99m leukocyte enhancement ratio (LER) and cobalt enhancement ratio (CER) were defined as the quotient of radioactivity in the ROI and an identical contralateral ROI. The MCA stroke-scale according to Orgogozo was used to assess neurological deficits at the time of scanning and discharge. Results: Cobalt-57 and Tc-99m-HMPAO showed uptake in the infarcted brain area in five patients; the quantitative uptake in the infarcted brain area of the two tracers correlated significantly (p < 0.05). Both the LER and the CER correlated significantly (p < 0.05) with the Orgogozo score at the time of scanning. Only the LER correlated significantly (p < 0.05) with the Orgogozo score at discharge. Conclusion: Uptake of cobalt and leukocytes in the peri-infarct tissue suggests that Co-57 may visualize a component of the inflammatory response. Divalent Co-57 may be convenient to predict clinical prognosis after stroke.	Univ Groningen Hosp, Dept Biol Psychiat, Neuro PET Coordinat, NL-9700 RB Groningen, Netherlands; Univ Hosp Ghent, Dept Nucl Med, Ghent, Belgium; Univ Hosp Ghent, Dept Neurol, Ghent, Belgium	Korf, J (corresponding author), Univ Groningen Hosp, Dept Biol Psychiat, Neuro PET Coordinat, POB 30-001, NL-9700 RB Groningen, Netherlands.		santens, patrick/O-2505-2013	Santens, Patrick/0000-0002-8886-9776			ARAKI T, 1991, ACTA NEUROL SCAND, V83, P244, DOI 10.1111/j.1600-0404.1991.tb04690.x; BOWES MP, 1995, NEUROLOGY, V45, P815, DOI 10.1212/WNL.45.4.815; DIENEL GA, 1984, J NEUROCHEM, V43, P913, DOI 10.1111/j.1471-4159.1984.tb12825.x; Dux E, 1996, ACTA NEUROPATHOL, V92, P264, DOI 10.1007/s004010050517; FASSBENDER K, 1995, STROKE, V26, P1361, DOI 10.1161/01.STR.26.8.1361; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; GRAMSBERGEN JBP, 1994, BRAIN RES, V667, P216, DOI 10.1016/0006-8993(94)91499-0; GRAMSBERGEN JBP, 1988, J NEUROCHEM, V50, P1798, DOI 10.1111/j.1471-4159.1988.tb02481.x; JACOBS A, 1994, J NUCL MED, V35, P942; JANDER S, 1995, J CEREBR BLOOD F MET, V15, P42, DOI 10.1038/jcbfm.1995.5; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; Jansen HML, 1996, J NUCL MED, V37, P2082; JANSEN HML, 1995, J NEUROL SCI, V132, P139, DOI 10.1016/0022-510X(95)00139-S; Jansen HML, 1997, CLIN NEUROL NEUROSUR, V99, P6, DOI 10.1016/S0303-8467(96)00558-6; JANSEN HML, 1994, J NUCL MED, V35, P456; JOOSTEN AAJ, 1995, NUCL MED COMMUN, V16, P703, DOI 10.1097/00006231-199508000-00014; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; LEFER DJ, 1993, CIRCULATION, V88, P1779, DOI 10.1161/01.CIR.88.4.1779; Linde R, 1996, ACT NEUR S, V66, P15; NAGY I, 1993, NEUROSCIENCE, V56, P241, DOI 10.1016/0306-4522(93)90576-2; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; NISHINO H, 1994, BRAIN RES BULL, V35, P51, DOI 10.1016/0361-9230(94)90215-1; ORGOGOZO JM, 1991, CEREBROVASC DIS, V1, P100, DOI 10.1159/000108904; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; SHIROTANI T, 1994, J CEREBR BLOOD F MET, V14, P831, DOI 10.1038/jcbfm.1994.104; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SILVESTRINI M, 1994, STROKE, V25, P1390, DOI 10.1161/01.STR.25.7.1390; Stevens Henk, 1997, P31; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236; WILLIAMS LR, 1992, BRAIN RES, V581, P181, DOI 10.1016/0006-8993(92)90707-G; WISE RJS, 1983, BRAIN, V106, P197, DOI 10.1093/brain/106.1.197; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747	32	11	11	0	0	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505			J NUCL MED	J. Nucl. Med.	MAR	1998	39	3					495	498					4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	ZA974	WOS:000072421600026	9529298				2021-06-18	
J	Wiercisiewski, DR; McDeavitt, JT				Wiercisiewski, DR; McDeavitt, JT			Pulmonary complications in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aspiration; neurogenic pulmonary edema; pulmonary complications; traumatic brain injury; ventilatory failure	HEAD-INJURIES; PERCUTANEOUS TRACHEOSTOMY; EDEMA; DOBUTAMINE	Survivors of traumatic brain injury frequently develop respiratory complications that require specialized knowledge and management skills in both acute and postacute environments. This article discusses the pathophysiology of and treatment options for ventilatory failure, neurogenic pulmonary edema, and aspiration. Management of tracheostomies is also discussed, with particular attention paid to decision making regarding the removal of a tracheal appliance. Long-term tracheal complications are also outlined.	Charlotte Inst Rehabil, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA; Charlotte Inst Rehabil, Brain Injury Rehabil Serv, Charlotte, NC 28203 USA	Wiercisiewski, DR (corresponding author), Charlotte Inst Rehabil, Dept Phys Med & Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						Chen HI, 1995, BIOL SIGNAL, V4, P186; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; COLICE GL, 1985, CLIN CHEST MED, V6, P473; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; Deehan SC, 1996, INTENS CARE MED, V22, P672, DOI 10.1007/BF01709745; ELL SR, 1991, INVEST RADIOL, V26, P499, DOI 10.1097/00004424-199105000-00022; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; KNUDSEN F, 1991, NEUROSURGERY, V29, P269, DOI 10.1227/00006123-199108000-00019; LANZA DC, 1990, LARYNGOSCOPE, V100, P958; LANZA DC, 1990, ANN OTO RHINOL LARYN, V99, P38, DOI 10.1177/000348949009900106; LAW JH, 1993, CHEST, V104, P136, DOI 10.1378/chest.104.1.136; MOORE FA, 1992, J TRAUMA, V33, P435, DOI 10.1097/00005373-199209000-00017; NOWAK P, 1987, AM J OTOLARYNG, V8, P91, DOI 10.1016/S0196-0709(87)80030-3; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; ROSEN P, 1992, EMERGENCY MED CONCEP; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; SCHACHNER A, 1989, CRIT CARE MED, V17, P1052, DOI 10.1097/00003246-198910000-00017; SCHWARZ GR, 1992, PRINCIPLES PRACTICE; SIMON RP, 1993, NEUROL CLIN, V11, P309; Spain DA, 1995, J TRAUMA, V39, P1100, DOI 10.1097/00005373-199512000-00015; Woratyla S P, 1995, Conn Med, V59, P643	22	11	16	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	1998	13	1					28	35		10.1097/00001199-199802000-00006			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YW212	WOS:000071909700006	9565702				2021-06-18	
J	Oliaro, SM; Guskiewicz, KM; Prentice, WE				Oliaro, SM; Guskiewicz, KM; Prentice, WE			Establishment of normative data on cognitive tests for comparison with athletes sustaining mild head injury	JOURNAL OF ATHLETIC TRAINING			English	Article						neuropsychological testing; concussion	NEUROPSYCHOLOGICAL DEFICITS; CONTACT-SPORTS; CONCUSSION; GUIDELINES; SEQUELAE; SYMPTOMS	Objective: To provide normal data for comparison with objective measures of an athlete's cognitive ability after mild head injury (MHI). Subjects: Seventy-two Division 1 college athletes. Design and Setting: Athletes were assessed on three test dates (two days apart) in a sports medicine research laboratory. Measurements: Normative data were collected on four cognitive tests (Hopkins Verbal Learning Test, Stroop Test, Reitan Trail-Making Tests, and Wechsler Digit Span Tests). Results: A repeated-measures analysis of variance revealed significant learning effects on all tests except the Hopkins Verbal Learning Test. A high correlation was noted between the Stroop and the Trail-Making Tests. Conclusions: These normative data can be used as comparisons to provide an objective measure of an athlete's cognitive ability following MHI. By adding this test battery to the athlete's other physical and neurologic tests, the decision to return an athlete to competition after MHI can be made with greater confidence and with less risk of reinjury.	Univ N Carolina, Dept Phys Educ Exercise & Sport Sci, Chapel Hill, NC 27599 USA	Oliaro, SM (corresponding author), Univ N Carolina, Dept Phys Educ Exercise & Sport Sci, Chapel Hill, NC 27599 USA.			Guskiewicz, Kevin/0000-0002-8682-2130			ALVES WM, 1987, CLIN SPORT MED, V6, P211; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BOHNEN N, 1992, NEUROSURGERY, V30, P692; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI 10.1080/13854049108403297.; BREAM T, 1996, ATHL THER TODAY, V1, P7; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DELIS D, 1990, COGNITIVE SCI APPROA, V7; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; INGERSOLL CD, 1993, SPORTS MED, V16, P342, DOI 10.2165/00007256-199316050-00005; JORDAN BD, 1994, P NATA ES ED FDN MIL; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN H, 1994, P NATA RES ED FDN MI; LEZAK MD, 1994, NEUROPSYCHOLOGICAL A; Maroon J C, 1980, Clin Neurosurg, V27, P414; MATARAZZO J, 1980, J CLIN NEUROPSYCHOL, V6, P351; *NAT ATHL TRAIN AS, 1994, P NATA RES ED FDN MI; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Spreen O., 1991, COMPENDIUM NEUROPSYC; Torg JS., 1991, ATHLETIC INJURIES HE; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1	28	11	11	1	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JAN-MAR	1998	33	1					36	40					5	Sport Sciences	Sport Sciences	124PT	WOS:000076191400008	16558482				2021-06-18	
J	Bodjarian, N; Jamali, S; Boisset, N; Tadie, M				Bodjarian, N; Jamali, S; Boisset, N; Tadie, M			Strong expression of GFAP mRNA in rat hippocampus after a closed-head injury	NEUROREPORT			English	Article						astrocytes; axonal damage; closed-head injury; GFAP mRNA; hippocampus; in situ hybridization	TRAUMATIC BRAIN INJURY; DIFFUSE AXONAL INJURY; ACCELERATION; ASTROCYTES; METABOLISM; DAMAGE; MODEL	WE investigated the spatiotemporal GFAP mRNA expression over a period of 11 days following brain injury in rats caused by impact acceleration, which is known to produce diffuse axonal injury (DAI). We observed widespread GFAP mRNA expression throughout the brain, which was more rapid and intense in the hippocampus. This expression was obvious in most animals 2 days after injury and appeared maximal at day 6. Although it decreased by day 11, the level of expression remained high compared with control levels. We noted slight differences in time of onset and the magnitude of the response between hippocampus and white matter structures or cortical areas. The different mechanisms able to trigger this response are discussed in regard to histopathological changes observed in DAI models.	Hop Bicetre, Serv Neurochirurg, Lab Neurochirurg Expt, F-94275 Le Kremlin Bicetre, France; Hop Bicetre, Dept Anesthesiol Reanimat Chirurg, F-94275 Le Kremlin Bicetre, France	Bodjarian, N (corresponding author), Hop Bicetre, Serv Neurochirurg, Lab Neurochirurg Expt, 78 Av Gen Leclerc, F-94275 Le Kremlin Bicetre, France.						BAILLELECROM V, 1995, NEUROREPORT, V7, P355; DIX X, 1996, REST NEUROL NEUROSCI, V9, P231; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KELLEY MS, 1993, INT J DEV NEUROSCI, V11, P105, DOI 10.1016/0736-5748(93)90071-K; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McIntosh TK, 1996, LAB INVEST, V74, P315; MCLELLAN DR, 1989, COMA TRAUMATIQUE, P165; MELDRUM B, 1985, BRIT J ANAESTH, V57, P44, DOI 10.1093/bja/57.1.44; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; MOONEN G, 1990, PROG BRAIN RES, V86, P63; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; NG HK, 1989, ACTA NEUROPATHOL, V78, P438; OCALLAGHAN JP, 1993, ANN NY ACAD SCI, V679, P195, DOI 10.1111/j.1749-6632.1993.tb18299.x; Paxinos G, 1986, RAT BRAIN STEREOTAXI; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; SMITH ME, 1983, BRAIN RES, V264, P241, DOI 10.1016/0006-8993(83)90822-3; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025	26	11	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0959-4965			NEUROREPORT	Neuroreport	DEC 22	1997	8	18					3951	3956		10.1097/00001756-199712220-00020			6	Neurosciences	Neurosciences & Neurology	YN915	WOS:000071221500022	9462472				2021-06-18	
J	Kreutzer, JS; Sander, AM; Fernandez, CC				Kreutzer, JS; Sander, AM; Fernandez, CC			Misperceptions, mishaps, and pitfalls in working with families after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						family therapy; rehabilitation; traumatic brain injury	SEVERE HEAD-INJURY; RELATIVES	Traumatic brain injury often has serious adverse consequences for individual family members and for the family's overall functioning. Rehabilitation environments are often stressful, chaotic, and complicated. Lack of family therapy training, misperceptions, conflicting personal philosophies, and complicated situations challenge professionals' abilities to involve family members as active, effective partners in the rehabilitation process. Presenting case analyses and suggestions for intervention, this article is intended to help clinicians working with family members recognize and avoid common errors in evaluation and intervention.		Kreutzer, JS (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYS MED & REHABIL,MCV BOX 980542,RICHMOND,VA 23298, USA.						Bowen M., 1978, FAMILY THERAPY CLIN; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Carter B., 1989, CHANGING FAMILY LIFE; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; *COMM ACCR REH FAC, 1996, 1996 STAND MED REH; FALICOV CJ, 1988, HDB FAMILY THERAPY T; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GAW A, 1993, ETHNICITY MENTAL ILL; Haley J., 1976, PROBLEM SOLVING THER; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; HOSACK KR, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199504000-00007; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 1990, COMMUNITY INTEGRATIO; LEZAK M, 1978, J CLIN PSYCHIAT, V39, P111; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCNENY R, 1991, NEUROREHABILITATION, V1, P7; MINUCHIN S, 1996, MASTERING FAMILY THE; Minuchin S., 1974, FAMILIES FAMILY THER; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; MUIR CA, 1990, REHABILITATION ADULT; Panting A., 1972, REHABILITATION, V38, P33; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; Shaw L R, 1990, Brain Inj, V4, P87, DOI 10.3109/02699059009026152; WATZLAWICK P, 1974, CHANGE PROBLEM FORMA	36	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1997	12	6					63	73		10.1097/00001199-199712000-00006			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YK459	WOS:A1997YK45900006					2021-06-18	
J	Striem, S; BarJoseph, A; Berkovitch, Y; Biegon, A				Striem, S; BarJoseph, A; Berkovitch, Y; Biegon, A			Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						HU-211; NMDA receptor antagonist; dopamine receptor antagonist; catalepsy; Parkinson's disease	INHIBIT ADENYLATE-CYCLASE; CLOSED-HEAD INJURY; CANNABINOID RECEPTOR; PARKINSONS-DISEASE; BRAIN-DAMAGE; RAT; ISCHEMIA; STRIATUM; NEUROTRANSMITTERS; METHAMPHETAMINE	The interaction of 7-hydroxy-Delta(6)-tetrahydrocannabinol 1,1-dimethylheptyl (Dexanabinol; HU-211), a novel NMDA receptor antagonist, with the dopaminergic system was examined using in vitro and in vivo systems. HU-211 (50 or 100 mu M) inhibited the binding of [H-3]R(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol hydrochloride ([H-3] SCH-23390), a dopamine D-1 receptor antagonist, by 29.7 +/- 1.8% and 52.7 +/- 6.3%, respectively. HU-211 10 mu M, like the dopamine D-1 receptor agonist R(+)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrochloride (SKF-38393), enhanced the conversion of [H-3]adenine to cyclic AMP (cAMP) (51.8 +/- 29.7% and 35.6 +/- 21.5% over control, respectively). The HU-211-induced increase was not inhibited by SCH-23390. HU-211 together with the dopamine D-1 receptor agonist caused a synergistic elevation (314.7 +/- 14.3%). HU-211 reduced the catalepsy induced by dopamine receptor antagonists. At 10 mg/kg, HU-211 significantly (P < 0.001) reduced the catalepsy time induced by D-1, D-2 and non-selective dopamine receptor antagonists. Overall, the results of the present study demonstrate that HU-211 interacts with the dopaminergic system and enhances activity at the dopamine D-1 receptor level. This activity may have implications in diseases involving the dopaminergic system, such as Parkinson's disease. (C) 1997 Elsevier Science B.V.	PHARMOS CORP, IL-76326 REHOVOT, ISRAEL							BALDWIN HA, 1993, BRIT J PHARMACOL, V108, P590, DOI 10.1111/j.1476-5381.1993.tb12847.x; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; BARJOSEPH A, 1995, J CEREB BLOOD FLO S1, V15, pS429; BARJOSEPH A, 1994, ABSTR SOC NEUROSCI, V82, P11; BELAYEV L, 1995, BRAIN RES, V702, P266, DOI 10.1016/0006-8993(95)01127-9; BELAYEV L, 1995, MOL CHEM NEUROPATHOL, V25, P19, DOI 10.1007/BF02815084; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DEVANE WA, 1992, J MED CHEM, V35, P2065, DOI 10.1021/jm00089a018; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DICHIARA G, 1994, TRENDS NEUROSCI, V17, P228, DOI 10.1016/0166-2236(94)90005-1; ESHHAR N, 1989, BRAIN RES, V476, P57, DOI 10.1016/0006-8993(89)91536-9; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; ESHHAR N, 1993, NEUROREPORT, V5, P237, DOI 10.1097/00001756-199312000-00013; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; GANDOLFI O, 1993, PHARMACOL BIOCHEM BE, V44, P683, DOI 10.1016/0091-3057(93)90186-W; HOWLETT AC, 1988, MOL PHARMACOL, V33, P297; HOWLETT AC, 1990, NEUROPHARMACOLOGY, V29, P161, DOI 10.1016/0028-3908(90)90056-W; IVERSEN LL, 1975, SCIENCE, V188, P1084, DOI 10.1126/science.2976; KLOCKGETHER T, 1990, ANN NEUROL, V28, P539, DOI 10.1002/ana.410280411; KOEK W, 1990, J PHARMACOL EXP THER, V253, P1017; LEANDER JD, 1988, BRAIN RES, V448, P115, DOI 10.1016/0006-8993(88)91107-9; LOSCHER W, 1991, NEUROSCI LETT, V128, P191, DOI 10.1016/0304-3940(91)90258-U; LOSCHER W, 1991, J PHARMACOL EXP THER, V256, P432; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MOORE NA, 1993, EUR J PHARMACOL, V237, P1, DOI 10.1016/0014-2999(93)90085-V; MORELLI M, 1992, J PHARMACOL EXP THER, V260, P402; NADLER V, 1993, NEUROSCI LETT, V162, P43, DOI 10.1016/0304-3940(93)90555-Y; NADLER V, 1993, BRAIN RES, V622, P79, DOI 10.1016/0006-8993(93)90804-V; OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3; SALOMON Y, 1991, METHOD ENZYMOL, V195, P22; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SINGH NA, 1992, BRAIN RES, V571, P260, DOI 10.1016/0006-8993(92)90663-T; SONSALLA PK, 1989, SCIENCE, V243, P398, DOI 10.1126/science.2563176; ULAS J, 1994, J NEUROSCI, V14, P6317; VANCALKER D, 1978, J NEUROCHEM, V30, P713; WEIHMULLER FB, 1992, NEUROREPORT, V3, P977, DOI 10.1097/00001756-199211000-00007; ZIV I, 1994, NEUROSCI LETT, V170, P136, DOI 10.1016/0304-3940(94)90258-5	41	11	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	NOV 12	1997	338	3					205	213		10.1016/S0014-2999(97)81923-1			9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	YJ789	WOS:A1997YJ78900001	9424014				2021-06-18	
J	Tremont, G; Hoffman, RG; Scott, JG; Adams, RL; Nadolne, MJ				Tremont, G; Hoffman, RG; Scott, JG; Adams, RL; Nadolne, MJ			Clinical utility of Wechsler Memory Scale - Revised and predicted IQ discrepancies in closed head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								Comparisons between Wechsler Memory Scale-Revised (WMS-R) indexes and Wechsler Adult Intelligence Scale-Revised (WAIS-R) IQ scores have been proposed to identify severity of memory deficits. However, many neurologic conditions reduce both intellectual and memory functioning, and thus, examining differences between these scores may be of little value. Closed head injured subjects who completed the WMS-R were divided into either mild injury (MI, n = 41) or moderate/severe (SI, n = 41) injury groups based on trauma severity indicators and were matched on age and level of education. The Oklahoma Premorbid Intelligence Estimation (OPIE), a regression formula that takes into account demographic variables as well as IQ performance, was calculated for each subject. Discrepancy scores were calculated between predicted IQ scores and WAIS-R IQ and WMS-R indexes. SI head-injured subjects displayed significantly larger discrepancies (19 points) between OPIE scores and Delayed Recall Indexes from the WMS-R than the MI subjects (10 points). Significantly larger percentages of subjects in the SI group displayed significant (>SD) reductions in many of the WMS-R and WAIS-R scores from estimates than subjects in the MI group. Comparing current memory functioning to estimates of premorbid intellectual ability appears to be a sensitive indicator of presence and degree of intellectual and memory dysfunction in head trauma patients. Results also provide evidence that estimates of premorbid intellectual ability can serve as estimates of premorbid memory functioning. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	UNIV OKLAHOMA, CTR HLTH SCI, NORMAN, OK 73019 USA				Nadolne, Marnie/0000-0002-6259-6722			BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; Butters N., 1988, CLIN NEUROPSYCHOL, V2, P133; CROSSEN JR, 1988, CLIN NEUROPSYCHOL, V2, P181; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Mittenberg W., 1991, PSYCHOL ASSESSMENT J, V3, P492; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Wechsler D., 1987, WECHSLER MEMORY SCAL	8	11	11	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	1997	12	8					757	762		10.1016/S0887-6177(97)00049-8			6	Psychology, Clinical; Psychology	Psychology	YH876	WOS:A1997YH87600006	14590652	Bronze			2021-06-18	
J	Ball, JW; Binder, H; Brown, CW; Christensen, JR; Dreier, C; Fendya, DG; Ferketic, MM; Forsman, I; Gregory, JL; Healy, MD; HackettWaters, P; Helfer, B; Herrin, K; Jaimovich, DG; Kaufman, J; Lash, M; Magnuson, DK; Marvin, JA; Patton, P; Presler, B; Rushton, DB; Sacchetti, A; SanAgustin, T; Savage, RC; Sells, CJ; Storgion, SA; Tittle, S; Valvano, J; Warnock, L; Weaver, MD; Weiss, D; Wertz, EM				Ball, JW; Binder, H; Brown, CW; Christensen, JR; Dreier, C; Fendya, DG; Ferketic, MM; Forsman, I; Gregory, JL; Healy, MD; HackettWaters, P; Helfer, B; Herrin, K; Jaimovich, DG; Kaufman, J; Lash, M; Magnuson, DK; Marvin, JA; Patton, P; Presler, B; Rushton, DB; Sacchetti, A; SanAgustin, T; Savage, RC; Sells, CJ; Storgion, SA; Tittle, S; Valvano, J; Warnock, L; Weaver, MD; Weiss, D; Wertz, EM			EMS for children: Recommendations for coordinating care for children with special health care needs	ANNALS OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN INJURY	Study objective: To address the need for coordinated care for children and their families during the acute care phase of their hospitalization. Methods: A multidiscipline task force developed this concept paper through a consensus process. The process was coordinated by the Emergency Medical Services for Children Program (a program of the Health Resources and Services Administration and the National Highway Traffic Safety Administration). The task force included representatives from prehospital care, acute care, rehabilitation, primary care, and education, as well as consumers. This representation provided a broad perspective on the needs of children and their families in the transition from hospital care to home. Conclusion: One designated individual is essential during the acute care phase who can assist the family with gaining information and resources to ensure a successful transition to community services and resources. This article provides a framework for acute care facilities and providers to use in planning services and working with acutely ill and injured children. Several recommendations highlight the need for care coordination to be initiated early in the child's hospitalization. An overview of services and resources (both health and educational) that a child and family may need is also provided. Such services and resources include identifying a care coordinator, working with the family to identify a primary care provider before hospital discharge, and building bridges with community-based health and education services.		Ball, JW (corresponding author), EMSC,NATL RESOURCE CTR,WASHINGTON,DC, USA.						*COMM PED EM MED, 1992, EM MED SERV CHILDR R, P251; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; *INST MED, 1993, EM MED SERV CHILDR, P215; LASH M, 1992, EXCEPTIONAL PARENT; SAVAGE R, 1994, ADOLESC MED STATE AR, V5, P311; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; 1990, AM J DIS CHILD, V144, P627	8	11	11	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	SEP	1997	30	3					274	280					7	Emergency Medicine	Emergency Medicine	XU225	WOS:A1997XU22500005					2021-06-18	
J	Stevens, H; Jansen, HML; DeReuck, J; Lemmerling, M; Strijckmans, K; Goethals, P; Lemahieu, I; DeJong, BM; Willemsen, ATM; Korf, J				Stevens, H; Jansen, HML; DeReuck, J; Lemmerling, M; Strijckmans, K; Goethals, P; Lemahieu, I; DeJong, BM; Willemsen, ATM; Korf, J			Co-55-PET in stroke: relation to bloodflow, oxygen metabolism and gadolinium-MRI	ACTA NEUROLOGICA BELGICA			English	Article; Proceedings Paper	International Symposium on Nuclear Medicine and Clinical Neurology	MAR 07-08, 1997	GHENT, BELGIUM				POSITRON EMISSION TOMOGRAPHY; PROGRESSIVE MULTIPLE-SCLEROSIS; TRAUMATIC BRAIN INJURY; ACUTE ISCHEMIC STROKE; CALCIUM; NEURONS; TISSUE	BACKGROUND: Several studies have shown the feasibility of Co-isotopes (Co-55 and Co-57) in imaging of neuronal damage in stroke, multiple sclerosis, cerebral tumors and trauma. These studies indicate that Co-isotopes allow visualization of brain pathology related to inflammatory processes, reactive gliosis and cell death. Until now, it is not clear if Co-55 accumulation occurs in the core of infarction or in the penumbra. Therefore, in the present study, we compared Co-55-PET with functional parameter such as cerebral bloodflow (rCBF) using (CO2)-O-15, oxygen metabolism (rCMRO(2)) using O-15(2) and cerebral bloodvolume (CBV) using (CO)-O-15 in PET and with the anatomical parameter Gd-MRI. PATIENTS AND METHODS: Seventeen patients (11 male; 6 female) age 43 to 84 (mean 69) with middle cerebral artery (mca) stroke, as proven by CT or MRI, were examined with Co-55-PET (0.5-1.0 mCi (CoCl2)-Co-55), (CO2)-O-15-, O-15(2)- and (CO)-O-15-PET in one session 0-30 days after stroke-onset. Regions of infarction were defined by rCMRO(2) being smaller than 65% or rCBF below 45% of the contralateral value and were subsequently superimposed on the cobalt scan. To compare the Cobalt uptake with the Gd-MRI, a realignment program was used that matches the MRI with the blood-flow images. Clinical status was established using the Orgogozo stroke scale at admission and at discharge (at least 6 weeks after admission) and the Barthel index. RESULTS: Eight patients showed a positive Co-PET scan and were used for further analysis. It appeared that Co accumulates in areas with a diminished oxygen metabolism and with a preserved bloodflow. We found Co-uptake in only a part of the Gd enhanced brain tissue with a tendency to be located peripherally or outside the Gd demarcated brain tissue. CONCLUSION: The results of the present study suggest that Co accumulates into infarcted brain tissue with a rather preserved flow independently of blood-brain barrier breakdown.	UNIV GRONINGEN HOSP,DEPT BIOL PSYCHIAT,NL-9700 RB GRONINGEN,NETHERLANDS; UNIV HOSP,PET CTR,GHENT,BELGIUM; UNIV HOSP,DEPT RADIOL,INST NUCL MED,GHENT,BELGIUM; UNIV HOSP,DEPT NEUROL,INST NUCL MED,GHENT,BELGIUM; STATE UNIV GHENT,DEPT ELECT & INFORMAT SYST,B-9000 GHENT,BELGIUM; UNIV GRONINGEN HOSP,DEPT NEUROL,GRONINGEN,NETHERLANDS; UNIV GRONINGEN HOSP,NATL PET CTR,GRONINGEN,NETHERLANDS			Lemahieu, Ignace/G-8625-2012	Lemahieu, Ignace/0000-0002-0894-9988			BARON JC, 1993, CURR OPIN NEUROL, V6, P900, DOI 10.1097/00019052-199312000-00012; CLEMENTI E, 1994, EUR J IMMUNOL, V24, P1365, DOI 10.1002/eji.1830240619; DEREUCK J, 1993, J NEUROL, V240, P430; DUBINSKY JM, 1993, ANN NY ACAD SCI, V679, P34, DOI 10.1111/j.1749-6632.1993.tb18287.x; FRISTON KJ, 1995, HUM BRAIN MAPP, V0003, P00165, DOI DOI 10.1002/HBM.460030303; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; GRAMSBERGEN JBP, 1988, J NEUROCHEM, V50, P1798, DOI 10.1111/j.1471-4159.1988.tb02481.x; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; HEISS WD, 1994, EUR J NUCL MED, V21, P455; HEISS WD, 1993, STROKE, V24, P1784, DOI 10.1161/01.STR.24.12.1784; HEISS WD, 1993, STROKE S1, V24, P50; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JANSEN HML, 1995, J NEUROL SCI, V132, P139, DOI 10.1016/0022-510X(95)00139-S; Jansen HML, 1997, CLIN NEUROL NEUROSUR, V99, P6, DOI 10.1016/S0303-8467(96)00558-6; JANSEN HML, 1994, J NUCL MED, V35, P456; JOOSTEN AAJ, 1995, NUCL MED COMMUN, V16, P703, DOI 10.1097/00006231-199508000-00014; MARCHAL G, 1993, LANCET, V341, P925, DOI 10.1016/0140-6736(93)91214-7; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; ORGOGOZO JM, 1991, CEREBROVASC DIS, V1, P100, DOI 10.1159/000108904; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; STEVENS H, 1996, CLIN PHARM CEREBRAL, P31; WANG PY, 1993, STROKE, V24, P236, DOI 10.1161/01.STR.24.2.236	23	11	11	0	2	ACTA MEDICA BELGICA	BRUSSELS	AVENUE CIRCULAIRE 138-A, B-1180 BRUSSELS, BELGIUM	0300-9009			ACTA NEUROL BELG	Acta Neurol. Belg.	SEP	1997	97	3					172	177					6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	YH226	WOS:A1997YH22600006	9345588				2021-06-18	
J	Emanuelson, IM; vonWendt, L; Bjure, J; Wiklund, LM; Uvebrant, P				Emanuelson, IM; vonWendt, L; Bjure, J; Wiklund, LM; Uvebrant, P			Computed tomography and single photon emission computed tomography as diagnostic tools in acquired brain injury among children and adolescents	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							CLOSED-HEAD-INJURY; HM-PAO-SPECT; TECHNETIUM-99M-HMPAO SPECT; CT; MILD; COMA; MRI	Twenty children with acquired brain injuries were investigated with GT and SPECT. The findings were related to the clinical outcome judged at discharge following acute care after the injury and at follow-up 5 years later, The abnormalities that were found were classifier? for each lobe on a scale ranging from 0 (normal) to 5 (severe abnormality). The patients were divided into two groups showing mild and severe injury. CT and SPECT revealed similar results in the patients with severe injury, but in the group of mildly injured children the number of affected lobes and scores indicated by SPECT were significantly higher than those indicated by CT. SPECT also differentiated more effectively between the two outcome groups. This supports the hypothesis that SPECT could be used as an instrument to objectivise ruiner sequelae and that SPECT and GT are both useful methods for forecasting outcome.	E HOSP GOTHENBURG,DEPT PAEDIAT 2,GOTHENBURG,SWEDEN; E HOSP GOTHENBURG,DEPT PAEDIAT RADIOL,GOTHENBURG,SWEDEN; E HOSP GOTHENBURG,DEPT CLIN PHYSIOL,GOTHENBURG,SWEDEN	Emanuelson, IM (corresponding author), BRACKE OSTERGARD REG PAEDIAT REHABIL CTR,GOTHENBURG,SWEDEN.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; Gillberg I. C., 1993, EUROPEAN CHILD ADOLE, V2, P50; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; GRAY BG, 1992, J NUCL MED, V33, P52; JACOBS A, 1994, J NUCL MED, V35, P942; JENNETT B, 1975, LANCET, V1, P480; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; UVEBRANT P, 1991, NEUROPEDIATRICS, V22, P3, DOI 10.1055/s-2008-1071407; UVEBRANT P, 1993, RETT SYNDROME CLIN B; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	18	11	11	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	AUG	1997	39	8					502	507					6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	XV650	WOS:A1997XV65000002	9295844				2021-06-18	
J	Zafonte, RD; Watanabe, TK; Mann, NR; Ho, DH				Zafonte, RD; Watanabe, TK; Mann, NR; Ho, DH			Psychogenic polydipsia after traumatic brain injury - A case report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						hyponatremia; drinking; water intoxication; brain injury	PSYCHIATRIC-PATIENTS; CLOZAPINE; HYPONATREMIA	Electrolyte abnormalities are common medical complications of traumatic brain injury (TBI). Hyponatremia is the most common of these disorders. The syndrome of inappropriate antidiuretic hormone and cerebral salt-wasting are the most well know causes of hyponatremia following TBI. In the presence of polydipsia and polyuria, psychogenic polydipsia should be included in the differential diagnosis. It is important to distinguish among these entities because treatment differs to such an extent that improper diagnosis may lead to a worsening of the patient's condition. We present a patient who presented with a new onset of polyuria and polydipsia after sustaining a TBI. Evaluation, including monitoring of fluid intake and output, serum and urine sodium and osmolarity, as well as a fluid deprivation test revealed the cause to be psychogenic polydipsia. The patient's symptoms improved after institution of a behavioral program and fluid restriction. Various models of drinking behavior have been used to identify the site of dysregulation. Dopaminergic, cholinergic, and hippocampal etiologies have been implicated in this abnormality of fluid homeostasis. If disorders of these systems can lead to psychogenic polydipsia, it is reasonable to believe that a person who has sustained a TBI would be at higher risk of developing psychogenic polydipsia.		Zafonte, RD (corresponding author), WAYNE STATE UNIV,DETROIT MED CTR,DEPT PHYS MED & REHABIL,REHABIL INST MICHIGAN,261 MACK AVE,DETROIT,MI 48201, USA.						Batuev A S, 1993, Neurosci Behav Physiol, V23, P35, DOI 10.1007/BF01182636; BELL KR, 1995, NEUROREHABILITATION, V5, P233, DOI 10.3233/NRE-1995-5306; BLUM A, 1983, AM J PSYCHIAT, V140, P915; CAMBIASSO MJ, 1992, BEHAV NEURAL BIOL, V58, P190, DOI 10.1016/0163-1047(92)90454-C; CRAPANZANO KA, 1993, BIOL PSYCHIAT, V34, P889, DOI 10.1016/0006-3223(93)90057-K; DELEON J, 1995, NEUROPSYCHOPHARMACOL, V12, P133; Elovic E, 1996, J HEAD TRAUMA REHAB, V11, P89, DOI 10.1097/00001199-199606000-00013; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; LEADBETTER RA, 1994, J CLIN PSYCHIAT, V55, P110; LEE HS, 1991, J CLIN PSYCHOPHARM, V11, P222, DOI 10.1097/00004714-199106000-00022; Spears NM, 1996, J CLIN PSYCHIAT, V57, P123; UMBRICHT D, 1994, BIOL PSYCHIAT, V36, P709, DOI 10.1016/0006-3223(94)91183-5; VERGHESE C, 1993, NEUROPSYCHOPHARMACOL, V9, P157, DOI 10.1038/npp.1993.54; ZABIK JE, 1992, PHYSIOL BEHAV, V54, P29	14	11	11	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	1997	76	3					246	248		10.1097/00002060-199705000-00018			3	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	XG430	WOS:A1997XG43000015	9207712				2021-06-18	
J	Gurevich, B; Talmor, D; Artru, AA; Katcko, L; Geva, D; Gurman, G; Shapira, Y				Gurevich, B; Talmor, D; Artru, AA; Katcko, L; Geva, D; Gurman, G; Shapira, Y			Brain edema, hemorrhagic necrosis volume, and neurological status with rapid infusion of 0.45% saline or 5% dextrose in 0.9% saline after closed head trauma in rats	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL-ISCHEMIA; HYPERTONIC SALINE; LACTATED RINGERS; CARDIAC-ARREST; HYPERGLYCEMIA; GLUCOSE; INJURY; DAMAGE; MODEL	We previously reported that in rats with closed head trauma (CHT), intravenous (IV) administration of 0.25 mL/g of 5% dextrose solution (D5W) increased blood glucose (G), decreased blood sodium (Na), caused no change in blood osmolality (Osm), increased brain edema (BE), and worsened neurological severity score (NSS) and mortality rate (MR). D5W in 0.9% saline (D5NS) is isonatremic and hyperosmolar with respect to blood and may avoid the problems reported with D5W. The present study compared the effects of 0.25 mL/g of D5NS or 0.45% saline (0.45 S) after CHT in rats. In 11 groups of rats, the three experimental variables were CHT (yes or no), IV fluid (none, D5NS, or 0.45 S), and time of death (4 or 24 h). D5NS or 0.45 S was given IV at 1 h after surgical preparation with or without CHT, and experimental values were determined at 1, 2, 4, and 24 h. D5NS decreased BE at 4 h compared with the untreated group, increased Osm (380 +/- 2 mOsm/kg) and G (1278 +/- 199 mg/dL), decreased Na (131 +/- 2 mEq/L) in blood, and caused no significant change in hemorrhagic necrosis volume (HNV), NSS, or MR. 0.45 S increased MR (50%) at 2 1 h, decreased Osm (270 +/- 5 mOsm/kg) and Na (123 +/- 1 mEq/L) in blood, and caused no significant change in G, BE, HNV, or NSS. We conclude that after CHT in rats, D5NS decreased BE without changing NSS or MR. 0.45 S increased MR and significantly altered blood chemistries.	SOROKA MED CTR,DEPT ANESTHESIOL,DIV ANESTHESIOL,IL-84101 BEER SHEVA,ISRAEL; KAPLAN HOSP,DEPT ANESTHESIOL,BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,FAC HLTH SCI,BEER SHEVA,ISRAEL; UNIV WASHINGTON,SCH MED,DEPT ANESTHESIOL,SEATTLE,WA 98195							ARTRU AA, 1994, ANESTHESIA NEUROSURG, P93; DALECY LG, 1986, SURGERY, V100, P505; DRUMMOND JC, 1989, ANESTHESIOLOGY, V70, P64, DOI 10.1097/00000542-198901000-00014; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; FOXWORTHY JC, 1990, J NEUROSURG ANESTH, V2, P256, DOI 10.1097/00008506-199012000-00002; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LAM AM, 1995, ANESTHETIC MANAGEMEN, P181; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MILHORAT TH, 1994, ANESTHESIA NEUROSURG, P136; NEDERGAARD M, 1987, BRAIN RES, V408, P79, DOI 10.1016/0006-8993(87)90360-X; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; VENABLES GS, 1985, J NEUROL NEUROSUR PS, V48, P663, DOI 10.1136/jnnp.48.7.663; VOLL CL, 1988, ANN NEUROL, V24, P638, DOI 10.1002/ana.410240508; ZASSLOW MA, 1989, STROKE, V20, P519, DOI 10.1161/01.STR.20.4.519; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; ZORNOW MH, 1994, ANESTHESIA NEUROSURG, P247	25	11	11	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0003-2999			ANESTH ANALG	Anesth. Analg.	MAR	1997	84	3					554	559		10.1097/00000539-199703000-00016			6	Anesthesiology	Anesthesiology	WL116	WOS:A1997WL11600016	9052300				2021-06-18	
J	Lubinski, R; Moscato, BS; Willer, BS				Lubinski, R; Moscato, BS; Willer, BS			Prevalence of speaking and hearing disabilities among adults with traumatic brain injury from a national household survey	BRAIN INJURY			English	Article								The purpose of this study is to provide prevalence estimates of the sociodemographic characteristics and extent of speaking and hearing disabilities among a community-based sample of adults (15 years and older) who have survived traumatic brain injury (TBI). This report is based on the Canadian Health and Activity Limitation Survey (1986-87), a national household survey of self-reported disabilities. Results indicate that adults with TBI with speaking or hearing difficulties tend to be male, middle-aged and older, urban dwellers, of relatively low income levels who are limited at work. Over 75% of adults with speaking difficulties report difficulty being understood by people outside their immediate family context. Hearing difficulties rise dramatically from 75% occurring with one communication partner to over 96% occurring with three partners. The mean duration of disabilities is 12.7 years for speaking and 13.5 years for hearing. More than 80% of adults with communicative difficulties have co-occurring disabilities of mobility and agility. Results have specific implications for functional assessment of adults with TBI and service delivery decision-making.		Lubinski, R (corresponding author), SUNY BUFFALO, DEPT COMMUNICAT DISORDERS & SCI, 115 PK HALL, AMHERST, NY 14260 USA.						ADAMS PF, 1992, VITAL HLTH STAT, V10; BERGMAN M, 1987, EAR HEARING, V8, P87, DOI 10.1097/00003446-198704000-00005; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DOLSON D, 1987, SUURVEY METHODOLOGY, V13, P93; FURRIE A, 1987, NATL DATABASE DISABL; GRIFFITHS M, 1979, J LARYNGOL OTOL, V92, P253; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HIRDES J, 1993, AUGMENTATIVE ALTERNA, V9, P1; Kewman D G, 1988, Brain Inj, V2, P131, DOI 10.3109/02699058809150937; MCDOWELL I, 1988, DISABILITY SCORE HLT; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; *NAT CTR HLTH STAT, 1988, VIT HLTH STAT, V10; Rothman K. J., 1986, MODERN EPIDEMIOLOGY; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; *STAT CAN, 1991, SPEC TOP SER HLTH AC, V4; *STAT CAN, 1988, DIS DAT PROGR HLTH A; *STAT CAN, 1989, HLTH ACT LIM SURV HA; THEBERGE A, 1988, WEIGHTING HLTH ACTIV; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; World Health Organization, 1980, INT CLASS IMP DIS HA	20	11	11	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1997	11	2					103	114		10.1080/026990597123692			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	WD430	WOS:A1997WD43000002	9012943				2021-06-18	
S	Banik, NL; Matzelle, D; GanttWilford, G; Hogan, EL		Slikker, W		Banik, NL; Matzelle, D; GanttWilford, G; Hogan, EL			Role of calpain and its inhibitors in tissue degeneration and neuroprotection in spinal cord injury	NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	3rd International Conference on Neuroprotective Agents - Clinical and Experimental Aspects	SEP 09-12, 1996	VARENNA, ITALY	New York Acad Sci, FDA, Natl Ctr Toxicol Res, Arkansas, Dept Vet Affairs Med Ctr, Togus, Maine			TRAUMATIC BRAIN INJURY; MU-CALPAIN; RAT; METHYLPREDNISOLONE; IMMUNOREACTIVITY; DEGRADATION; ACTIVATION; MYELIN			Banik, NL (corresponding author), MED UNIV S CAROLINA, DEPT NEUROL, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-31622] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031622] Funding Source: NIH RePORTER		BALENTINE JD, 1978, LAB INVEST, V39, P254; BALENTINE JD, 1985, TRAUMA CENTRAL NERVO, P285; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; Banik NL, 1996, GWUMC DEPT, P377; BANIK NL, 1980, J NEUROPATH EXP NEUR, V39, P232, DOI 10.1097/00005072-198005000-00002; BANIK NL, 1986, J NEUROL SCI, V73, P245, DOI 10.1016/0022-510X(86)90149-8; BANIK NL, 1996, IN PRESS PRINCIPLES; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRAUGHLER JM, 1984, J NEUROSURG, V61, P290, DOI 10.3171/jns.1984.61.2.0290; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; Chakrabarti AK, 1996, J NEUROSCI RES, V44, P374; CONG JY, 1989, J BIOL CHEM, V264, P10096; DESHPANDE RV, 1995, J NEUROSCI RES, V42, P259, DOI 10.1002/jnr.490420214; DESHPANDE RV, 1995, J BIOL CHEM, V270, P2497, DOI 10.1074/jbc.270.6.2497; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HOGAN EL, 1985, HDB NEUROCHEMISTRY, V10, P285; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KOMATSU K, 1986, EXP NEUROL, V91, P23, DOI 10.1016/0014-4886(86)90022-1; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; LI ZH, 1995, NEUROCHEM INT, V27, P425, DOI 10.1016/0197-0186(95)00024-3; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SAIDO TC, 1994, FASEB J, V8, P814; Shields D. C., 1996, Society for Neuroscience Abstracts, V22, P2137; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; TAMAI M, 1987, J PHARMACOBIO-DYNAM, V10, P678, DOI 10.1248/bpb1978.10.678; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1	31	11	11	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-093-X	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1997	825						120	127		10.1111/j.1749-6632.1997.tb48421.x			8	Multidisciplinary Sciences; Neurosciences; Pharmacology & Pharmacy	Science & Technology - Other Topics; Neurosciences & Neurology; Pharmacology & Pharmacy	BJ99G	WOS:A1997BJ99G00011	9369980				2021-06-18	
J	Callahan, CD; Schopp, L; Johnstone, B				Callahan, CD; Schopp, L; Johnstone, B			Clinical utility of a seven subtest WAIS-R short form in the neuropsychological assessment of traumatic brain injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								Comparison of IQ scores from the standard Wechsler Adult Intelligence Scale-Revised (WAIS-R) and the Ward (1990) seven-subtest short form (WAIS-R/7 SF) was performed on a sample of 459 patients with traumatic brain injury due to head trauma. The results indicate that this short form provides Verbal, Performance, and Full Scale IQ scores that vary little from the complete WAIS-R, at approximately one-half the typical administration time. The seven subtest short form predicted WAIS-R Full Scale IQ within 6 points in 95% of this clinical sample, with Verbal-Performance Ie discrepancies that were highly correlated (r(s) = .85, p < .0001). No differential gender effect in proration of IQs was found. Applications and pitfalls of abbreviated neuropsychological testing batteries are discussed, with utilization of the WAIS-R/7 SF offered as a means to reduce intelligence resting time while maintaining the ability to detect subtle information processing abnormalities with appropriate supplemental tasks. (C) 1997 National Academy of Neuropsychology.	UNIV MISSOURI,COLUMBIA SCH MED,COLUMBIA,MO 65211	Callahan, CD (corresponding author), MEM MED CTR,CTR NEUROMUSCULAR SCI,800 N RUTLEDGE,SPRINGFIELD,IL 62781, USA.			Johnstone, Brick/0000-0001-8845-9649			*BAXT HEALTHC CORP, 1994, M CUST REQ PART GUID; Benedict R. H. B., 1992, PSYCHOL ASSESSMENT, V4, P322, DOI DOI 10.1037//1040-3590.4.3.322; BENTON A, 1992, J CLIN EXP NEUROPSYC, V14, P407, DOI 10.1080/01688639208407616; DOPELT JE, 1956, J CLIN PSYCHOL, V20, P63; FAUST D, 1995, COPING PSYCHIAT PSYC, P916; Franzen M. D., 1989, RELIABILITY VALIDITY; JOHNSTONE B, 1995, PROF PSYCHOL-RES PR, V26, P341, DOI 10.1037/0735-7028.26.4.341; KAUFMAN AS, 1991, J PSYCHOEDUC ASSESS, V9, P4, DOI 10.1177/073428299100900101; KAUFMAN AS, 1977, J CONSULT CLIN PSYCH, V45, P1159, DOI 10.1037/0022-006X.45.6.1159; Kreutzer JS, 1993, J HEAD TRAUMA REHAB, V8, P47; REITAN RM, 1993, B NATL ACAD NEUROPSY, V10, P1; SATTERFIELD WA, 1994, J PSYCHOEDUC ASSESS, V12, P364, DOI 10.1177/073428299401200406; SATZ P, 1962, J CLIN PSYCHOL, V18, P77, DOI 10.1002/1097-4679(196201)18:1<77::AID-JCLP2270180124>3.0.CO;2-R; Schretlen D., 1994, PSYCHOL ASSESSMENT, V6, P188; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; SILVERSTEIN AB, 1977, J CONSULT CLIN PSYCH, V45, P1162, DOI 10.1037/h0078060; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WILLIAMS JM, 1993, B NATL ACAD NEUROPSY, V10, P1	19	11	11	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	2					133	138		10.1016/S0887-6177(96)00029-7			6	Psychology, Clinical; Psychology	Psychology	WV548	WOS:A1997WV54800004	14588424	Bronze			2021-06-18	
J	Johnstone, B; Slaughter, J; Schopp, L; McAllister, JA; Schwake, C; Luebbering, A				Johnstone, B; Slaughter, J; Schopp, L; McAllister, JA; Schwake, C; Luebbering, A			Determining neuropsychological impairment using estimates of premorbid intelligence: Comparing methods based on level of education versus reading scores	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; COGNITIVE DECLINE; NORMATIVE DATA	When inferring brain dysfunction, test scores are typically compared to normative data based on estimates of premorbid intelligence (e.g., by educational level or reading scores). However; these methods are likely to lead to differing results, with important diagnostic and forensic implications. The current study compared estimates of impairment (reported in z-scores) based on educational level versus reading scores in a population,vith traumatic br-ain injury The study included 174 patients (M age = 27.3; M education = 12.3) evaluated as outpatients at a university hospital rehabilitation department. Wilcoxen ranked sign tests indicated that the true methods yielded estimates that were statistically different (p < .0001) for all variables. The education based method yielded greater estimates of impairment than the reading score method for WAIS-R FIQ, Grip Strength, and Finger Tapping, with a pattern of generally consistent impairment across cognitive/motor areas (z-score range = -0.59 to -.97). In contrast, the reading score based method yielded greater estimates of impairment in processing speed (Trails A) and flexibility (Trails B), with a wider range of impairment noted between cognitive and motor domains (z-score range = +0.21 to -2.95). Clinical implications are discussed. (C) 1997 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	UNIV MISSOURI, SCH MED, COLUMBIA, MO 65211 USA				Johnstone, Brick/0000-0001-8845-9649			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Christensen H., 1991, PSYCHOL ASSESS J CON, V3, P147; Crawford J. R., 1992, HDB NEUROPSYCHOLOGIC, P21; DESMOND DW, 1995, ARCH CLIN NEUROPSYCH, V10, P535; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; FROMMAUCH C, 1993, J CLIN NEUROPSYCHOLO, V5, P221; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heaton RK, 1996, J CLIN EXP NEUROPSYC, V18, P449, DOI 10.1080/01688639608409001; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; JASTAK S, 1984, WRAT R WIDE RANGE AC; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; JOHNSTONE B, 1995, NEUROREHABILITATION, V5, P75, DOI 10.3233/NRE-1995-5107; KARAKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147; KREUTZER JS, 1990, COMMUNITY INTEGRATIO, P49; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Paque L, 1995, J Int Neuropsychol Soc, V1, P517; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; REITAIN RM, 1985, HALSTEAD REITAN NEUR; Reitan R, 1986, TRAIL MAKING TEST MA; SEIDENBERG M, 1983, J CONSULT CLIN PSYCH, V51, P406, DOI 10.1037/0022-006X.51.3.406; Spreen O., 1991, COMPENDIUM NEUROPSYC; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889; Wilkinson G, 1993, WRAT3 WIDE RANGE ACH; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	33	11	12	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1997	12	6					591	601		10.1016/S0887-6177(97)00002-4			11	Psychology, Clinical; Psychology	Psychology	XP931	WOS:A1997XP93100008	14590671	Bronze			2021-06-18	
J	Altmayer, T; ODell, MW; Jones, M; Martin, V; Hawkins, HH				Altmayer, T; ODell, MW; Jones, M; Martin, V; Hawkins, HH			Cisapride as a treatment for gastroparesis in traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							RECOVERY; METOCLOPRAMIDE; REHABILITATION; HALOPERIDOL	Gastroparesis is a well-documented finding among patients with severe traumatic brain injuries. The treatment of choice has been metoclopramide, but it is less than ideal given its central dopaminergic blocking activity. Cisapride is a newer prokinetic agent without side effects on the central nervous system and might be a superior treatment. The case of a healthy 22-year-old man who suffered a severe traumatic brain injury and multiple trauma in a motor vehicle accident is reported. The patient required gastrostomy tube placement but developed recurrent aspiration pneumonia once feeding were initiated. Despite receiving metoclopramide, barium studies revealed gastroparesis, a significant decrease in gastric peristalsis, and reflux. A jejunostomy tube was placed to prevent further aspiration. The administration of cisapride was begun, and 2 days later the patient was changed back to G-tube feedings with no evidence of residual aspirates. Repeat barium study showed definite improved in peristalsis. The case of demonstrates the potential usefulness of cisapride in patients with traumatic brain injury. Although further research is necessary, efficacy without central dopamine blockage may make cisapride the treatment of choice for gastroparesis and reflex in traumatic brain injury. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	UNIV CINCINNATI,DEPT PHYS MED & REHABIL,COLL MED,CINCINNATI,OH 45267; UNIV CINCINNATI,DIV GEN INTERNAL MED,COLL MED,CINCINNATI,OH 45267; UNIV CINCINNATI,DEPT RADIOL,COLL MED,CINCINNATI,OH 45267; WASHINGTON UNIV,SCH MED,ST LOUIS,MO							ABELL TL, 1991, DIGEST DIS SCI, V36, P616, DOI 10.1007/BF01297028; BOECKXSTAENS GE, 1990, J PHARMACOL EXP THER, V254, P652; BONFIGLIO R L, 1991, Archives of Physical Medicine and Rehabilitation, V72, P817; BROOKE MM, 1986, ARCH PHYS MED REHAB, V67, P634; BUCCI M N, 1986, Surgical Forum (Chicago), V37, P524; CAMILLERI M, 1989, GASTROENTEROLOGY, V96, P704; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; GOLDSTEIN LB, 1990, STROKE, V21, P179; HAGEN C, 1979, PROFESSIONAL STAFF A, P87; HEYMSFIELD SB, 1979, ANN INTERN MED, V90, P63, DOI 10.7326/0003-4819-90-1-63; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; KAWAGISHI T, 1993, AM J GASTROENTEROL, V88, P933; LONGO WE, 1993, DIS COLON RECTUM, V36, P696, DOI 10.1007/BF02238599; MCCALLUM RW, 1991, AM J GASTROENTEROL, V86, P135; MCHUGH S, 1992, DIGEST DIS SCI, V37, P997, DOI 10.1007/BF01300277; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; PORCH B, 1985, Society for Neuroscience Abstracts, V11, P52; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; RICHARDS RD, 1993, DIGEST DIS SCI, V38, P811, DOI 10.1007/BF01295905; SCHILLER LR, 1992, MANAGEMENT GASTROINT, V31; SUTTON RL, 1987, J HEAD TRAUMA REHAB, V2, P50; WHITLOCK JA, 1994, J HEAD TRAUMA REHABI, V9, P115	24	11	13	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1996	77	10					1093	1094		10.1016/S0003-9993(96)90075-1			2	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	VL132	WOS:A1996VL13200018	8857893				2021-06-18	
J	Luber, SD; Brady, WJ; Brand, A; Young, J; Guertler, AT; Kefer, M				Luber, SD; Brady, WJ; Brand, A; Young, J; Guertler, AT; Kefer, M			Acute hypoglycemia masquerading as head trauma: A report of four cases	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						hypoglycemia; head trauma; closed head injury; diabetes mellitus; masquerade; altered mental status	HYPERGLYCEMIA; HEMIPLEGIA; EMERGENCY; ADMISSION; GLUCAGON; DEXTROSE; ACCIDENT; STROKE; COMA	Hypoglycemia, a commonly encountered metabolic emergency, is most often easily diagnosed and rapidly treated with satisfactory patient outcome, If not recognized and treated promptly, hypoglycemia may cause irreversible central nervous system injury; it rarely results in death, The classic presentation of hypoglycemia, a patient with diabetes mellitus on medical therapy (insulin or oral hypoglycemic agents) who presents with an altered sensorium, is frequently seen in the emergency department (ED), Less often, patients with this metabolic emergency present to the ED in a manner suggestive of a situation other than hypoglycemia, Patients may present with seizure activity or focal neuro logical deficits, leading the physician to treat a primary neurological syndrome and not immediately recognize the primary cause of the problem, Alternatively, patients with hypoglycemia will present to the ED with an altered mental status after a traumatic event, The physician may again assume that the alteration in consciousness has resulted from a head injury and not a metabolic disorder, Four cases are presented in which the medical history of the event (ie, trauma) suggested head injury as an explanation of the presentation when, in fact, hypoglycemia was responsible for the altered sensorium, The diagnosis of hypoglycemia is easily made with the performance of a bedside screening test which can be subsequently confirmed by laboratory blood analysis, It is imperative that emergency physicians consider hypoglycemia in all patients with any mental status abnormality, focal neurological deficit, or seizure activity, even when the findings seem to be explained initially by other etiologies. Copyright (C) 1996 by W.B. Saunders Company	UNIV VIRGINIA,HLTH SCI CTR,DEPT EMERGENCY MED,CHARLOTTESVILLE,VA 22908							BOYLE PJ, 1988, NEW ENGL J MED, V318, P1487, DOI 10.1056/NEJM198806093182302; BRADY W, 1994, AM J EMERG MED, V12, P383, DOI 10.1016/0735-6757(94)90172-4; CLEMENTS R, 1992, PRINCIPLES PRACTICE, P2087; COLLIER A, 1987, DIABETES CARE, V10, P712, DOI 10.2337/diacare.10.6.712; FILKINS JP, 1974, AM J PHYSIOL, V227, P778; FOSTER DW, 1991, HARRISONS PRINCIPLES, P1759; FOSTER JW, 1987, STROKE, V18, P944, DOI 10.1161/01.STR.18.5.944; GALE E, 1980, CLIN ENDOCRINOL META, V9, P461; KHANNA PB, 1987, J AM GERIATR SOC, V35, P477, DOI 10.1111/j.1532-5415.1987.tb04683.x; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; PANT SS, 1966, NEUROLOGY, V166, P837; PATRICK AW, 1990, ARCH EMERG MED, V7, P73; PEDEN N, 1983, ORAL HYPOGLYCAEMIC A, V286, P1564; PLUM F, 1979, DIAGNOSIS STUPOR COM, P221; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; RICH LM, 1990, ARCH INTERN MED, V150, P894, DOI 10.1001/archinte.150.4.894; SELTZER HS, 1972, DIABETES, V21, P955, DOI 10.2337/diab.21.9.955; SHOTLIFF K, 1992, POSTGRAD MED J, V68, P843, DOI 10.1136/pgmj.68.804.843; WALLIS WE, 1985, ANN NEUROL, V18, P510, DOI 10.1002/ana.410180415; WATSON AJS, 1981, IRISH J MED SCI, V150, P301, DOI 10.1007/BF02938260; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; ZEE DS, 1974, ARCH NEUROL-CHICAGO, V30, P403, DOI 10.1001/archneur.1974.00490350061010	24	11	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	OCT	1996	14	6					543	547		10.1016/S0735-6757(96)90094-7			5	Emergency Medicine	Emergency Medicine	VL732	WOS:A1996VL73200001	8857800				2021-06-18	
J	Srinivas, S; Poole, F; Redpath, J; Underhill, TJ				Srinivas, S; Poole, F; Redpath, J; Underhill, TJ			Review of a computer based telephone helpline in an A&E department	JOURNAL OF ACCIDENT & EMERGENCY MEDICINE			English	Article						accident and emergency department; Helpline; telephone advice; computerisation	EMERGENCY; ADVICE; ACCIDENT	Objective-An audit of use of the telephone Helpline in the accident and emergency (A&E) department was conducted to establish the type of call, time, by whom the calls were made, appropriateness of advice given, and whether callers attended or not as advised, and also to obtain feedback from callers as to the degree of satisfaction with the advice given. Methods-AU calls over a four week period were included in the study. The information logged comprised name, age, telephone number, date and time of call, nature of query, advice given, and name of advisor. Callers whose telephone number had been noted were contacted for feedback. Results-There were 300 calls over the four week period, and 150 callers were available for feedback. Most calls were received between 12.00 and 20.00 hours. The majority of callers were parent or self, 52% of calls were for problems concerning adults, and 40% for children; no age was recorded in 8%. Nursing staff answered 90.7% of the calls. Queries were wide ranging but commonly involved open and closed wounds and head injuries, with 29.3% being advised to attend A&E, 32.3% to ring or see their GP, and 38.4% were reassured or given other advice; 4% of callers attended A&E despite being advised otherwise, 97% were judged to have received appropriate advice, and 91.3% of callers were satisfied with the advice given. Conclusion-The Helpline has proved of benefit to the public. It is necessary and important to have protocols for common problems and to document all details carefully. It is also necessary that nursing staff are trained in handling the telephone queries and using the protocols. The use of a PC based system has improved data collection and also allows immediate access to protocols.		Srinivas, S (corresponding author), CONQUEST HOSP,THE RIDGE,ST LEONARDS TN37 7RD,E SUSSEX,ENGLAND.						AUNER JR, 1993, PEDIATR EMERG CARE, V9, P300; *BAEM, 1992, GUID HANDL TEL ENQ A; EVANS RJ, 1993, ARCH EMERG MED, V10, P216; ISAACMAN DJ, 1992, PEDIATRICS, V89, P35; KERNOHAN S M, 1992, Health Bulletin (Edinburgh), V50, P233; Kunkler R, 1994, Nurs Times, V90, P29; MARSH GN, 1987, J ROY COLL GEN PRACT, V37, P301; MOLYNEUX E, 1994, J ACCID EMERG MED, V11, P246; SINGH G, 1991, J ROY SOC MED, V84, P345; VEGLESTON C, 1994, BRIT MED J, V308, P31; VERDILE VP, 1989, ANN EMERG MED, V18, P278, DOI 10.1016/S0196-0644(89)80414-7	11	11	11	0	0	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	1351-0622			J ACCID EMERG MED	J. Accid. Emerg. Med.	SEP	1996	13	5					330	333					4	Emergency Medicine	Emergency Medicine	VM113	WOS:A1996VM11300007	8894858				2021-06-18	
J	Mayer, NH; Esquenazi, A; Wannstedt, G				Mayer, NH; Esquenazi, A; Wannstedt, G			Surgical planning for upper motoneuron dysfunction: The role of motor control evaluation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						motor control; surgical planning; upper motoneuron dysfunction	MANAGEMENT; GAIT	After severe traumatic brain injury, the upper motoneuron syndrome results in a variety of common patterns of movement dysfunction attributable, in part, to imbalance of musculotendinous forces acting across joints. Surgical options for rebalancing these deforming forces may include tendon lengthenings and transfers, muscle releases, neurectomies, and release of joint contracture. This article describes the key role of motor control evaluation in assisting surgical planning and making appropriate selections from among the available options.	TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19122; MOSSREHAB HOSP,GAIT & MOT ANAL LAB,PHILADELPHIA,PA 19141	Mayer, NH (corresponding author), MOSSREHAB HOSP,MOTOR CONTROL ANAL LAB,1200 W TABOR RD,PHILADELPHIA,PA 19141, USA.						ANMUTH CJ, 1994, STATE ART REV PHYS M, V8, P547; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI; BOTTE MJ, 1989, J HAND SURG-AM, V14, P174, DOI 10.1016/0363-5023(89)90002-6; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P34; ESQUENAZI A, 1993, REHABILITATION MED P; Esquenazi A, 1991, PHYS MED REHABIL CLI, V2, P473, DOI [10.1016/S1047-9651(18)30695-8, DOI 10.1016/S1047-9651(18)30695-8]; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; GRIFFITH ER, 1990, REHABILITATION ADULT; Heiden JS, 1979, NEURAL TRAUMA; Hoffer M M, 1979, J Hand Surg Am, V4, P424; HOUSE JH, 1981, J BONE JOINT SURG AM, V63, P216, DOI 10.2106/00004623-198163020-00006; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1987, J BONE JOINT SURG AM, V69A, P1127, DOI 10.2106/00004623-198769080-00003; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P734, DOI 10.1016/S0363-5023(87)80059-X; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P575, DOI 10.1016/S0363-5023(87)80211-3; KEENAN MAE, 1989, J BONE JOINT SURG AM, V71A, P120, DOI 10.2106/00004623-198971010-00018; KEENAN MAE, 1988, ORTHOP REV, V27, P1185; KLEIN RB, 1995, NEUROLOGY S4, V45, P330; LANCE JW, 1980, SPATISCITY DISORDERE; MAYER NH, 1996, MED REHABILITATION T; ORCUTT SA, 1990, J HAND SURG-AM, V13, P940; PEAT M, 1976, ARCH PHYS MED REHAB, V57, P421; WINTER DA, 1984, ARCH PHYS MED REHAB, V65, P393	23	11	11	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					37	56		10.1097/00001199-199608000-00007			20	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600007					2021-06-18	
J	Rosenthal, M				Rosenthal, M			1995 Sheldon Berrol, MD senior lectureship: The ethics and efficacy of traumatic brain injury rehabilitation-myths, measurements, and meaning	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	14th Annual Conference of the Brain-Injury-Association	DEC 05, 1995	SAN DIEGO, CA	Brain Injury Assoc		efficacy; ethics; outcome measurement; traumatic brain injury	CLOSED HEAD-INJURY; EARLY INTERVENTION; BENEFIT	The modern age of brain injury rehabilitation has experienced rapid growth as it has moved from the era of enlightenment to the era of consolidation during the past 2 decades. This growth has been character ized by a proliferation of specialized programs, development of innovative treatment methods, and an expansion of the care continuum. Unfortunately, the scientific foundation for much of commonly accepted practice has not kept pace with these developments. In addition, the field has been subjected to increased scrutiny and regulation as consumer allegations of fraud and abuse have been brought to the forefront of public attention. As practitioners attempt to deliver high-quality care under the new cost-reduction philosophy of managed care, there is a need to systematically develop and utilize outcome measurement systems that evaluate the efficacy of our brain injury rehabilitation programs. Outcome measurement in this rehabilitation must meet the needs of a diverse set of customers. It is critical to fully evaluate the physical, neuropsychological, and psychosocial consequences of traumatic brain injury and determine which treatment methods are most effective in ameliorating these problems and result in optimal long-term outcome. ''Meaningful'' measurement systems will need to address customer satisfaction, long-term outcome, quality of life, and cost-effectiveness.	REHABIL INST MICHIGAN, DETROIT, MI USA	Rosenthal, M (corresponding author), WAYNE STATE UNIV, DEPT PHYS MED & REHABIL, 261 MACK BLVD, DETROIT, MI 48201 USA.						BANJA J, 1993, STAFF DEV CLIN INTER; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; BENYISHAY Y, 1983, REHABILITATION HEAD; BERROL S, 1982, HEAD INJURY REHABILI; Bush Gerald W., 1988, J HEAD TRAUMA REHAB, V3, P73; *COMM ACCR REH FAC, 1985, STAND MAN MED REH; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COPE DN, 1985, SEMIN NEUROL, V5, P212, DOI 10.1055/s-2008-1041518; Eames P, 1985, Int Rehabil Med, V7, P130; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; Hall KM, 1994, ARCH PHYS MED REHABI, V75, pSC; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1983, REHABILITATION HEAD; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Jones M L, 1992, J Insur Med, V24, P186; KERR P, 1992, NY TIMES        0316, P1; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TEASDALE G, 1974, LANCET, V2, P81; THOMAS RL, 1988, TOXIC CONTAMINATION, V3, P1; TREXLER LE, 1982, COGNITIVE REHABILITA	28	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					88	95		10.1097/00001199-199608000-00011			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600011					2021-06-18	
J	Soon, JCC; Kumar, VP; Satkunanartham, K				Soon, JCC; Kumar, VP; Satkunanartham, K			Elbow dislocation with ipsilateral radial shaft fracture - An unusual outcome	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								The authors describe an uncommon injury of the upper limb, namely, dislocation of the elbow with fracture of the ipsilateral radial shaft, in a young man, After closed reduction of the joint, the radial head was found to be subluxated, and when a nonanatomic internal fixation of the radial shaft was undertaken, the radial head became dislocated, Repeat operation with removal of the implants and internal fixation with correction of rotation and angulation at the fracture site and reconstruction of the annular ligament restored normal anatomy.	NATL UNIV SINGAPORE HOSP, DEPT HAND & RECONSTRUCT MICROSURG, SINGAPORE 117548, SINGAPORE; NATL UNIV SINGAPORE HOSP, DEPT ORTHOPAED SURG, SINGAPORE 117548, SINGAPORE			Kumar, V Prem/A-1678-2010				BEACH PM, 1966, AM J SURG, V112, P941; BURGESS RC, 1984, CLIN ORTHOP RELAT R, P192; DELEE JC, 1984, FRACTURES ADULTS, P606; EVANS EM, 1949, J BONE JOINT SURG BR, V31, P578; MEHARA AK, 1993, J TRAUMA, V35, P958, DOI 10.1097/00005373-199312000-00027; SIMPSON JM, 1991, CLIN ORTHOP RELAT R, P205	6	11	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	AUG	1996		329					212	215					4	Orthopedics; Surgery	Orthopedics; Surgery	VC566	WOS:A1996VC56600026	8769454				2021-06-18	
J	Andrews, PJD; Murugavel, S; Deehan, S				Andrews, PJD; Murugavel, S; Deehan, S			Conventional multimodality monitoring and failure to detect ischemic cerebral blood flow	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral blood flow; jugular venous oxygen saturation; head injury; cerebral infarction; cerebral edema; cardiac index	PLATELET-ACTIVATING FACTOR; SEVERE BRAIN INJURY; HEAD-INJURY; RAT-BRAIN; INTERLEUKIN-1; PATIENT; DAMAGE	We report a case of cerebral infarction following traumatic brain injury associated with low cerebral blood flow, but not detected by measurements of jugular venous oxygen saturation, cerebral lactate production, cerebral perfusion pressure, transcranial Doppler ultrasound, or measures of systemic hemodynamics.	WESTERN GEN HOSP,NHS TRUST,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,EDINBURGH,MIDLOTHIAN,SCOTLAND	Andrews, PJD (corresponding author), WESTERN GEN HOSP,NHS TRUST,DEPT ANESTHESIA & INTENS CARE,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.						ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; ANDREWS PJD, 1990, BRIT J ANAESTH, V64, P393; ANDREWS PJD, 1995, IN PRESS CURRENT PRA; [Anonymous], 1992, CRIT CARE MED, V20, P864; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BRAQUET P, 1989, INT ARCH ALLER A IMM, V88, P88, DOI 10.1159/000234755; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1993, NEUROSURGERY, V32, P547; FEUERSTEIN GZ, 1990, STROKE S11, V21, P11190; FISHER M, 1995, INTENS CARE MED, V21, P131; FRERICHS KU, 1990, J NEUROSURG, V73, P223, DOI 10.3171/jns.1990.73.2.0223; GLAUSER FL, 1988, AM REV RESPIR DIS, V138, P458, DOI 10.1164/ajrccm/138.2.458; GOPINATH SP, 1993, J NEUROL TRAUMA S1, V10, pS202; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HIRASHIMA Y, 1994, J NEUROSURG, V80, P31, DOI 10.3171/jns.1994.80.1.0031; JONES PA, 1994, J NEUROSURG ANESTHES, V6, P1; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; MARINI JJ, 1992, AM REV RESPIR DIS, V146, P2, DOI 10.1164/ajrccm/146.1.2; MCCLAIN CJ, 1987, J LAB CLIN MED, V110, P48; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SCHEINBERG P, 1949, J CLIN INVEST, V28, P1163, DOI 10.1172/JCI102150; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; STAHL WM, 1987, CRIT CARE MED, V15, P545, DOI 10.1097/00003246-198706000-00001; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAMASAKI Y, 1992, NEUROSCI LETT, V142, P45, DOI 10.1016/0304-3940(92)90616-F; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	29	11	11	2	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	1996	8	3					220	226		10.1097/00008506-199607000-00006			7	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	UT939	WOS:A1996UT93900006	8803834				2021-06-18	
J	Brzuzy, S; Corrigan, JD				Brzuzy, S; Corrigan, JD			Predictors of living independently after moderate to severe traumatic brain injury: A comparison study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							BLUNT HEAD-INJURY; RELATIVES VIEW	Objective: To identify factors that predict long-term, independent living for adults after traumatic brain injury (TBI). Design: A case-comparison study of unmarried adults who experienced TBI and were either living independently or living with parents. Setting: Cases drawn randomly from a state-wide needs survey of 1,265 Ohioans with brain injuries. Subjects: From a pool of 356 unmarried respondents ages 21 to 49; 32 subjects living alone and 34 living with parents were compared. Primary Measures: Age, time postinjury, education, current and previous income, preinjury living arrangement, history of postinjury living arrangements, current and previous employment, length of loss of consciousness, and functional disabilities. Results: Of those living alone, 98% lived with their parents an average of 3 pears after release from the hospital. Those currently living with parents had lived with them the entire time since being released. Almost 60% of those living with parents were 6 pears or less postinjury versus 30% of those living alone. Of those living with parents, 56% were 30 years old or younger versus 13% of those living alone. Prior living arrangement, current age, time postinjury, education, and current income contributed significantly to discriminant analysis, while length of loss of consciousness and prior employment did not. The contribution of prior income and functional disabilities could not be evaluated due to problems with the self-report format of these variables. Conclusions: Living independently after moderate to severe TBI may be achieved by a complex interaction of prior skills, available resources; current capabilities, and the expectations of both family and individual. The minimal role that severity of injury appeared to play is consistent with the World Health Organization model and suggests that the determinants of independent living may be subject to systematic intervention.	OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH	Brzuzy, S (corresponding author), ARIZONA STATE UNIV,SCH SOCIAL WORK,BOX 871802,TEMPE,AZ 85287, USA.		Corrigan, John D./E-2921-2011				BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; DEJONG G, 1982, ARCH PHYS MED REHAB, V63, P68; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; *OH REH SERV COMM, 1992, OH HEAD INJ PROGR NE; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; World Health Organization, 1980, INT CLASS IMP DIS HA	21	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1996	11	3					74	83		10.1097/00001199-199606000-00011			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UP774	WOS:A1996UP77400011					2021-06-18	
J	Murray, S; Bush, M; Tell, LA				Murray, S; Bush, M; Tell, LA			Medical management of postpartum problems in an Asian elephant (Elephas maximus) cow and calf	JOURNAL OF ZOO AND WILDLIFE MEDICINE			English	Article						passive transfer; retained placenta; Asian elephant; Elephas maximus; immunoglobulin	PROGESTERONE; SECRETION; BEER	An 18-yr-old female Asian elephant (Elephas maximus) gave birth to a 120-kg female calf following 22 mo of gestation. immediately after parturition, the cow became agitated and aggressive towards the calf Before the keepers were able to safely intervene and remove the calf, the cow stepped on the calf's head and right front leg. Within 30 min, the cow calmed down, allowing the calf's safe reintroduction under close keeper supervision and control. The cow had a retained placenta, poor mammary development, and low milk production. The calf's injuries, in combination with the cow's low milk production, impeded the calf's ability to nurse and gain weight. Within 10 days, the calf lost 10% of its weight. Serum protein electrophoresis indicated failure of passive transfer of maternal immunoglobulin. On day 10, the calf received a transfusion of concentrated immunoglobulin extracted and concentrated from the cow's previously banked plasma. On day 13, the calf developed a urinary tract infection, as diagnosed by white blood cells and bacteria in the urine. Following immunoglobulin administration and antibiotic therapy, clinical signs slowly resolved and the calf gained weight. The cow passed the fetal membranes during parturition, but the placenta was retained. Despite prophylactic systemic antibiotics and vaginal flushing, the cow became depressed and developed a leukocytosis and an anemia. A mucopurulent vaginal discharge and ventral edema were noted on day 3, and milk production was minimal. Because decreased milk production has been reported as a common sequel to retained placenta, efforts were focused on removing the placenta. Intermittent oxytocin therapy on days 2-14 did not result in expulsion of the placenta and produced only transient abdominal contractions and minimal increases in milk letdown. On day 15, 10 mg estradiol cypionate was administered i.m. followed by 200 IU oxytocin i.v. An additional 10 IU oxytocin was administered i.v. on day 16. The friable placenta was palpable within the vaginal vault on day 17. The remaining placenta was removed by gentle traction applied by a modified weighted blood pressure cuff. Once the placenta was removed, the cow's clinical problems slowly resolved and the calf continued to gain weight.	UNIV CALIF DAVIS,SCH VET MED,DEPT MED & EPIDEMIOL,DAVIS,CA 95616	Murray, S (corresponding author), NATL ZOOL PK,CONSERVAT RES CTR,1500 REMOUNT RD,FRONT ROYAL,VA 22630, USA.						BROWN JL, 1991, J ZOO WILDLIFE MED, V22, P49; CARLSON HE, 1985, J CLIN ENDOCR METAB, V60, P673, DOI 10.1210/jcem-60-4-673; Colahan P.T., 1991, EQUINE MED SURG; DEUTSCH HF, 1957, AM J PHYSIOL, V191, P271; DUHEM C, 1994, CLIN EXP IMMUNOL, V97, P79; FISCHER GW, 1994, CLIN EXP IMMUNOL, V97, P73; GROSSMAN ER, 1987, JAMA-J AM MED ASSOC, V259, P1016; JEFFCOTT LB, 1972, BIOL REV, V47, P439, DOI 10.1111/j.1469-185X.1972.tb01078.x; LEDERER J, 1980, REV ALCOOL, V26, P215; MCGUIRE TC, 1975, J AM VET MED ASSOC, V166, P71; MCGUIRE TC, 1976, J AM VET MED ASSOC, V169, P713; MENNELLA JA, 1993, DEV PSYCHOBIOL, V26, P459, DOI 10.1002/dev.420260804; MIKOTA SK, 1994, MED MANAGEMEN ELEPHA; OLSEN JH, 1994, J ZOO WILDLIFE MED, V25, P349; ROBERTS SJ, 1971, VET OBSTETRICS GENIT; SAWYER M, 1977, J AM VET MED ASSOC, V171, P1255; SHIDELER RK, 1987, P ANN C AM ASS EQ PR, P763; STICKLE JE, 1992, J ZOO WILDLIFE MED, V23, P245	18	11	11	0	7	AMER ASSOC Z00 VETERINARIANS	MEDIA	6 NORTH PENNELL ROAD, MEDIA, PA 19063	1042-7260			J ZOO WILDLIFE MED	J. Zoo Wildl. Med.	JUN	1996	27	2					255	258					4	Veterinary Sciences	Veterinary Sciences	UZ764	WOS:A1996UZ76400014					2021-06-18	
J	Sokol, DK; Ferguson, CF; Pitcher, GA; Huster, GA; FitzhughBell, K; Luerssen, TG				Sokol, DK; Ferguson, CF; Pitcher, GA; Huster, GA; FitzhughBell, K; Luerssen, TG			Behavioural adjustment and parental stress associated with closed head injury in children	BRAIN INJURY			English	Article							SEQUELAE; RELATIVES	Parental stress and parental perception of children's behavioural problems were determined for 25 caretakers of children with closed head injury. Compared to normative samples a greater proportion of parents in this study were more stressed, and thought that their children were more behaviourally impaired. In contrast to previous studies, injury severity was not related to behavioural impairment. Parental stress was related to perceived behavioural impairment for the brain-injured sample. When compared to low-stressed parents (n = 14), high-stressed parents (n = 11) described their children as more aggressive and with more thought disorders and attention problems. Time since injury, age at injury, number of siblings, and mother's age were not different between the high- and low-stressed groups. Low income and less education were associated with the high stress levels in these parents. Test-retest data showed that, over time, parents perceived their brain-injured children as less behaviourally impaired.	JAMES WHITCOMB RILEY HOSP CHILDREN,DEPT PEDIAT NEUROSURG,INDIANAPOLIS,IN 46202							ABIDIN RR, 1990, MANUAL PARENTING STR; ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CASEY R, 1987, PEDIATRICS, V80, P159; Fletcher J M, 1991, Brain Inj, V5, P337, DOI 10.3109/02699059109008106; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; HINKELDEY NS, 1990, BRAIN INJURY, V4, P114; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; WAALAND PK, 1993, BRAIN INJURY, V8, P135; Ylvisaker M., 1989, MILD MODERATE HEAD I, P203	21	11	11	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1996	10	6					439	451		10.1080/026990596124296			13	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UR327	WOS:A1996UR32700004	8816097				2021-06-18	
J	ChathamShowalter, PE; Dubov, WE; Barr, MC; Rhodes, M; Sun, JM; Wasser, T				ChathamShowalter, PE; Dubov, WE; Barr, MC; Rhodes, M; Sun, JM; Wasser, T			Alcohol level at head injury and subsequent psychotropic treatment during trauma critical care	PSYCHOSOMATICS			English	Article; Proceedings Paper	150th Annual Meeting of the American-Psychiatric-Association	MAY 21-26, 1994	PHILADELPHIA, PA	Amer Psychiat Assoc			BRAIN INJURY; INTOXICATION; ABUSE	Alcohol intoxication at the time of traumatic brain injury (TBI) presents many complications for critical care treatment. This is the first reported data on psychotropic dosages administered to TBI patients in the critical care setting. In this study, the blood alcohol level (BAL)-positive patients (n = 14) tended to be older (P = 0.095), have lower admission Glascow Coma Scores (P = 0.031), and spent more days on respirators (P = 0.125) than the BAL-zero patients (n = 21). The BAL-positive group received more days of narcotics and benzodiazepines with markedly higher average daily doses, not statistically significant. These results are a basis for studying relationships between medication, treatment variables, and outcomes for TBI patients and then developing specific medication guidelines.	LEHIGH VALLEY HOSP,DEPT PSYCHIAT,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT PHYS MED REHABIL,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT PHARM,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT TRAUMA,ALLENTOWN,PA; LEHIGH VALLEY HOSP,DEPT RES,ALLENTOWN,PA							GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HAYES PE, 1993, PHARMACOTHERAPY, P1098; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; *MED EC COMP, 1993, DUR PHYS DESK REF, P1163; PORKORNY AD, 1972, AM J PSYCHIAT, V129, P342; *ROCH LAB, 1993, VERS DAT ROCH LAB; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; WATSON RR, 1986, ALCOHOL CLIN EXP RES, V10, P364, DOI 10.1111/j.1530-0277.1986.tb05108.x	9	11	11	0	2	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0033-3182			PSYCHOSOMATICS	Psychosomatics	MAY-JUN	1996	37	3					285	288		10.1016/S0033-3182(96)71567-0			4	Psychiatry; Psychology	Psychiatry; Psychology	UG788	WOS:A1996UG78800007	8849505				2021-06-18	
J	Harris, JR				Harris, JR			Verbal rehearsal and memory in children with closed head injury: A quantitative and qualitative analysis	JOURNAL OF COMMUNICATION DISORDERS			English	Article							ADOLESCENTS; RECALL	Nine closed head injured (CHI) children (mean age = 11.4 years) with post-onset intervals of seven months to eight years were studied. The CHI children ranged from mild-moderate to severely impaired. Nine normally developing children (mean age = 10.9 years) served as controls. An overt rehearsal free recall task was used. Subjects were instructed to ''think aloud'' following presentation of each item to-be-recalled. Quantitative analyses suggested impaired verbal recall and inefficient, passive rehearsal strategy use in severely injured subjects. Mild-moderate subjects performed similarly to controls and exhibited active rehearsal strategy use. Qualitative analysis revealed differences between CHI subjects and controls' range of rehearsal strategies, monitoring and metamemory. Implications for clinical assessment and intervention with respect to use of rehearsal strategies are discussed.		Harris, JR (corresponding author), OHIO STATE UNIV,DEPT SPEECH & HEARING SCI,110 PRESSEY HALL,1070 CARMACK RD,COLUMBUS,OH 43210, USA.						ARNETT JA, 1986, PSYCHOL REP, V59, P315, DOI 10.2466/pr0.1986.59.1.315; Atkinson R. C, 1968, PSYCHOL LEARNING MOT, P90; Baddeley A. D., 1986, WORKING MEMORY; BATTIG WF, 1969, J EXPT PSYCHOL MON 2, V80; BJORKLUND DF, 1988, J EXP CHILD PSYCHOL, V45, P71, DOI 10.1016/0022-0965(88)90051-3; Entwisle D. R., 1966, WORD ASS YOUNG CHILD; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; FLAVELL JH, 1985, COGNITIVE DEV; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GUTTENTAG RE, 1987, COGNITIVE DEV, V2, P307, DOI 10.1016/S0885-2014(87)80010-2; HARRIS JR, 1993, UNPUB SCHEMATIC ORG; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; Jenkins J. J., 1964, WORD ASS NORMS GRADE; KELLAS G, 1975, J EXP CHILD PSYCHOL, V19, P51, DOI 10.1016/0022-0965(75)90148-4; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MATEER CA, 1992, SEMINARS SPEECH LANG, V13, P239; MCGILLY K, 1989, CHILD DEV, V60, P172, DOI 10.2307/1131083; ORNSTEIN PA, 1977, DEV PSYCHOL, V13, P15, DOI 10.1037/0012-1649.13.1.15; ORNSTEIN PA, 1978, MEMORY ORG STRUCTURE; ORNSTEIN PA, 1975, CHILD DEV, V26, P818; POSNANSKY CJ, 1978, BEHAV RES METH INSTR, V10, P819, DOI 10.3758/BF03205407; Pressley Michael, 1993, Seminars in Speech and Language, V14, P1, DOI 10.1055/s-2008-1064155; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; TEASDALE G, 1974, LANCET, V2, P81; Thorndike EL, 1963, TEACHERS WORD BOOK 3; YLVISAKER M, 1985, HEAD INJURY REHABILI, P311	29	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0021-9924			J COMMUN DISORD	J. Commun. Disord.	MAR-APR	1996	29	2					79	93		10.1016/0021-9924(94)00035-2			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	UF913	WOS:A1996UF91300001	9157177				2021-06-18	
J	Anderson, SI; Wilson, CL; McDowell, IP; Pentland, B; Gray, JM; Robertson, IH				Anderson, SI; Wilson, CL; McDowell, IP; Pentland, B; Gray, JM; Robertson, IH			Late rehabilitation for closed head injury: A follow-up study of patients 1 year from time of discharge	BRAIN INJURY			English	Article							RELATIVES VIEW	Subsequent to the setting up of an outpatient psychological service for head-injured patients, 50 patients were interviewed a year from the time of their discharge from our neurorehabilitation unit. The problems which persisted at this stage are presented and discussed. Some of the difficulties encountered in the evaluation of rehabilitation effects are identified. We conclude that: (1) there is a desperate need in the UK for more long-term support and rehabilitation services for this group of patients and (2) it is essential that such services are carefully monitored and evaluated despite the difficulties involved.	ASTLEY AINSLIE HOSP,EDINBURGH EH9 2HL,MIDLOTHIAN,SCOTLAND; WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH,MIDLOTHIAN,SCOTLAND; NEWCASTLE GEN HOSP,REG NEUROSCI CTR,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND; MRC,APPL PSYCHOL UNIT,CAMBRIDGE,ENGLAND				Robertson, Ian H/0000-0001-8637-561X			AFFLECK JW, 1988, LANCET, V1, P230; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1984, CLOSED HEAD INJURY P, P44; Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROTHERTON FA, 1989, ARCH PHYSICAL MED RE, V69, P827; GOLDBERG DP, 1974, PSYCHOL MED, V6, P565; HENDERSON EJ, 1990, CLIN REHABIL, V4, P167; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1979, NURS MIRROR, V1, P30; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; ODDY M, 1989, CLIN REHABIL, V3, P253; Pentland B, 1990, Int Disabil Stud, V12, P86; PENTLAND B, 1988, BRIT J NEUROSURGERY, V2, P601; ROBERTSON I, 1990, APHASIOLOGY, V4, P381, DOI 10.1080/02687039008249090; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wood R. L., 1987, BRAIN INJURY REHABIL; 1986, J ROYAL COLL PHYSICI, V20, P161; 1982, LANCET, V2, P1034	21	11	11	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					115	124		10.1080/026990596124601			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600005	8696311				2021-06-18	
J	Demaree, HA; Harrison, DW				Demaree, HA; Harrison, DW			Case study: Topographical brain mapping in hostility following mild closed head injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						brain mapping; closed head injury; hostility; QEEG; self-awareness	AMBULATORY BLOOD-PRESSURE; CARDIOVASCULAR REACTIVITY; EMOTIONAL EXPRESSION; ASYMMETRY; LESIONS; MEN	Previous research suggests that right frontal and temporal lobe arousal may inhibit and elicit hostility, respectively. For example, emotional lability (including rage) has resulted from lesion of the bulbar motor nuclei, and neocortical upper motor neurons in particular (Lieberman & Benson, 1977). Ablation of hypothalamic sites has resulted in sham rage (Flynn, Cummings & Tomiyasu, 1988; Sachdev, Smith, Matheson & Last, 1992; Tonkonogy & Geller, 1992) suggesting that these frontal pathways may inhibit hostility. In the present study, a patient with hostility management problems secondary to closed head injury from a motor vehicle accident was evaluated using topographical brain mapping and quantitative electroencephalograph (QEEG) techniques. Comparisons of beta magnitude were performed between frontal and temporal sites at the right and left cerebrums. The results support the contention of an oppositional anterior to posterior mediation of hostility. The present electroencephalagraphic research supports the predominant neuropsychological theory that the right orbital-frontal region inhibits the right amygdaloid bodies, thereby decreasing hostility level (Kolb & Wishaw, 1990).	VIRGINIA POLYTECH INST & STATE UNIV,DEPT PSYCHOL,BLACKSBURG,VA 24061				Demaree, Heath/0000-0001-9655-8882			BROWN JASON W., 1967, BRAIN RES, V5, P1, DOI 10.1016/0006-8993(67)90215-6; BUTTER CM, 1970, J COMP PHYSIOL PSYCH, V72, P132, DOI 10.1037/h0029303; CONTU RC, 1966, J NEUROSURG, V24, P1024; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; DECSI L, 1974, NEUROPHARMACOLOGY, V13, P1153, DOI 10.1016/0028-3908(74)90065-3; DEMAREE HA, 1996, UNPUB PHYSL NEUROPSY; EVERHART E, 1996, UNPUB DELUSIONS SPAC; FLYNN FG, 1989, BEHAV NEUROL, V1, P49; JAMNER LD, 1991, PSYCHOSOM MED, V53, P393, DOI 10.1097/00006842-199107000-00005; KALAT JW, 1992, BIOL PSYCHOL; KOLB B, 1990, HUMAN NEUROPSYCHOLOG; KRYNICKI VE, 1978, J NERV MENT DIS, V166, P59, DOI 10.1097/00005053-197801000-00009; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; LU CL, 1992, BRAIN RES, V581, P123, DOI 10.1016/0006-8993(92)90351-9; MOYER KE, 1987, VIOLENCE AGGRESSION; NAGY J, 1973, NEUROPHARMACOLOGY, V12, P757, DOI 10.1016/0028-3908(73)90016-6; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; SACHDEV P, 1992, AUST NZ J PSYCHIAT, V26, P671, DOI 10.3109/00048679209072105; SACKEIM HA, 1978, SCIENCE, V202, P434, DOI 10.1126/science.705335; SCHNEIDER RH, 1989, PSYCHOSOM MED, V51, P290, DOI 10.1097/00006842-198905000-00004; SIEGMAN AW, 1992, J BEHAV MED, V15, P257, DOI 10.1007/BF00845355; SMITH TW, 1984, MOTIV EMOTION, V15, P232; Starkstein S. E., 1991, FRONTAL LOBE FUNCTIO; TONKONOGY JM, 1992, J NEUROPSYCH CLIN N, V4, P45; WEIDNER G, 1989, PSYCHOSOM MED, V51, P36, DOI 10.1097/00006842-198901000-00004; WITTLING W, 1990, NEUROPSYCHOLOGIA, V28, P457, DOI 10.1016/0028-3932(90)90072-V	26	11	11	0	0	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1996	87	1-2					97	101		10.3109/00207459608990757			5	Neurosciences	Neurosciences & Neurology	VQ435	WOS:A1996VQ43500009	8913823				2021-06-18	
J	Saveland, H; Uski, T; Sjoholm, H; Sonesson, B; Brandt, L				Saveland, H; Uski, T; Sjoholm, H; Sonesson, B; Brandt, L			SPECT with technetium-99m-HMPAO in relation to late cognitive outcome after surgery for ruptured cerebral aneurysms	ACTA NEUROCHIRURGICA			English	Article						aneurysmal subarachnoid haemorrhage; surgery; SPECT; cognitive outcome	CLOSED-HEAD-INJURY; ANTERIOR COMMUNICATING ARTERY; SUBARACHNOID HEMORRHAGE; EARLY OPERATION; BLOOD-FLOW; DEFICITS; IMPAIRMENT; ADJUSTMENT; SEQUELAE; MEMORY	Fifteen patients with a good neurological outcome after aneurysmal SAH and surgery were collected prospectively. Six months after surgery neurological examination and a SPECT study for evaluation of the three dimensional CBF distribution as well as an extensive neuropsychological test were performed. In all patients with pathological SPECT findings the location of the reduced regional CBF correlated with the location of the ruptured aneurysm and/or side of surgical approach. The volume of the brain tissue with reduced rCBF showed a great variety, from 9-112 cm(3) (mean: 33 cm(3)). Similarly, the maximum flow reduction in the affected areas also varied considerably from 17-95% (mean: 39%). In general, the neuropsychological functioning of the patients post SAH was favourable. Seven individuals had a presumably normal neuropsychological appearance with respect to estimates of premorbid levels of functioning. Another four patients were slightly impaired and the remaining four were moderately affected. Only in five cases did the location of SPECT pathology and the site of neuropsychological impairment appear to coincide, whereas this was not the case in the remaining 10 patients. In general, the extent of SPECT pathology did not differ in the three neuropsychological outcome groups (normal, slight and moderate disability).	UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT PSYCHIAT,S-22185 LUND,SWEDEN	Saveland, H (corresponding author), UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN.						BENTON AL, 1974, CLIN EXPT APPLICATIO, P1; BORNSTEIN RA, 1987, NEUROSURGERY, V21, P651, DOI 10.1227/00006123-198711000-00008; CRONHOLM B, 1957, ACTA PSYCH NEUROL, V32, P280, DOI 10.1111/j.1600-0447.1957.tb09467.x; DESANTIS A, 1989, J NEUROL NEUROSUR PS, V52, P1123; DUREMAN I, 1971, MANUAL DS BATTERY, P1; FISHER CM, 1980, NEUROSURGERY, V6, P11; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Graham FK, 1960, PERCEPT MOTOR SKILL, V11, P147, DOI DOI 10.2466/PMS.11.6.147-188; HARDEMARK HG, 1989, ACTA NEUROCHIR, V99, P135, DOI 10.1007/BF01402322; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; HUTTER BO, 1992, ACTA NEUROCHIR, V116, P6, DOI 10.1007/BF01541247; HUTTER BO, 1993, NEUROSURGERY, V33, P999; ICHISE M, 1994, J NUCL MED, V35, P217; Larsson C, 1989, BRIT J NEUROSURG, V3, P549, DOI 10.3109/02688698909002846; LJUNGGREN B, 1985, J NEUROSURG, V62, P673, DOI 10.3171/jns.1985.62.5.0673; LJUNGGREN B, 1983, NEUROSURGERY, V12, P525, DOI 10.1227/00006123-198305000-00008; MAURICEWILLIAMS RS, 1991, J NEUROL NEUROSUR PS, V54, P335, DOI 10.1136/jnnp.54.4.335; MCKENNA P, 1989, NEUROSURGERY, V24, P361, DOI 10.1227/00006123-198903000-00009; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; OGDEN JA, 1993, NEUROSURGERY, V33, P572, DOI 10.1227/00006123-199310000-00004; REITAN RM, 1966, CAN PSYCHOLOG-PSYCHO, VA  7, P368, DOI 10.1037/h0083114; Rey A., 1959, TEST COPIE FIGURE CO; ROMNER B, 1989, NEUROSURGERY, V25, P390, DOI 10.1227/00006123-198909000-00012; ROPER SN, 1991, J NUCL MED, V32, P1684; SAVELAND H, 1992, J NEUROSURG, V76, P729, DOI 10.3171/jns.1992.76.5.0729; SAVELAND H, 1986, J NEUROSURG, V64, P191, DOI 10.3171/jns.1986.64.2.0191; SONESSON B, 1987, NEUROSURGERY, V21, P279, DOI 10.1227/00006123-198709000-00001; STENHOUSE LM, 1991, J NEUROL NEUROSUR PS, V54, P909, DOI 10.1136/jnnp.54.10.909; VILKKI J, 1989, NEUROSURGERY, V25, P166, DOI 10.1227/00006123-198908000-00003; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D., 1945, WECHSLER MEMORY SCAL; WITELSON SF, 1992, NEUROLOGY, V42, P709, DOI 10.1212/WNL.42.4.709	33	11	12	0	2	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1996	138	3					301	307		10.1007/BF01411741			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	UB183	WOS:A1996UB18300014	8861699				2021-06-18	
J	TAYLOR, JS				TAYLOR, JS			NEUROLAW - TOWARDS A NEW MEDICAL JURISPRUDENCE	BRAIN INJURY			English	Article								Traumatic brain injuries and spinal cord injuries occur in a variety of accidents which may become the subject of civil litigation. A new field of medical jurisprudence, called neurolaw, is emerging to join health-care professionals and attorneys in a common quest to employ legal remedies to enhance the quality of life for individuals with neurological injury and their families. Presented here is a review of the underpinnings of this developing area of inquiry.		TAYLOR, JS (corresponding author), TAYLOR HARP & CALLIER,POB 2645,COLUMBUS,GA 31902, USA.						BRAITHWAITE B, 1992, NEW LAW J        JUL, P942; BRAITHWAITE B, 1994, PERSONAL INJURY LAW, V1, P330; BROOKS N, 1982, CLOSED HEAD INJURY P, P123; BUSH DS, 1993, DEFENSE COUNSEL J, V60, P122; COPE DN, 1994, INST RES BN, P201; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; HEILBRONNER RL, 1994, ANAL UNDERSTANDING P, P65; JENNETT B, 1982, CLOSED HEAD INJURY P, P37; KOLPAN KI, 1989, J HEAT TRAUMA REHABI, V4, P95; LITVAK SB, 1993, ARIZONA TRIAL LA DEC, P1; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Mohr James C., 1993, DOCTORS LAW MED JURI, P3; OMENN GS, 1994, ENVIRON HEALTH PERSP, V102, P674, DOI 10.2307/3432196; ROBERTS AC, 1991, LITIGATING HEAD TRAU; ROTHENBERG MA, 1994, EMERGENCY MED MALPRA; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Taylor John G., 1991, INSURANCE SETTLE WIN, P21; TAYLOR JS, 1992, NEUROLAW LETT, V1, P4; TAYLOR JS, 1994, EMERGENCY MED MALPRA, P465; TAYLOR JS, 1994, PERSONAL INJURY LAW, V1, P314; TAYLOR JS, 1992, TRIAL DIPLOMACY J, V15, P65; TAYLOR JS, 1991, LITIGATING HEAD TRAU; TAYLOR JS, 1994, IE MAGAZINE, V2, P12; TAYLOR JS, 1993, J HEAD INJURY, V3, P54; TAYLOR JS, 1991, NEUROLAW LETT, V1, P1; TAYLOR JS, 1993, REV FRANCAISE DOMMAG, V19, P149; TAYLOR JS, 1993, NEUROLAW LETT, V2, P4; TAYLOR JS, 1994, INTEGRATING COMMUNIT, pH17; TAYLOR JS, 1994, VIEWPOINTS, V28, P2; TAYLOR JS, 1994, PERSONAL INJURY LAW, V1, P205; TAYLOR S, 1991, J ANXIETY DISORD, V5, P293, DOI 10.1016/0887-6185(91)90030-W; WEED RO, 1994, REHABILITATION CONSU, pB12; 1993, ACQUIRED BRAIN INJUR; 1993, ORTHOPAEDIC MED TEST; 1992, 3RD ANN SEM HELD NEW; 1994, CODE MED ETHICS CURR; 1994, NATIONAL DIRECTORY H; 1989, QUALIFICATIONS GUIDE; 1995, NEUROLAW COMPREHENSI; NEUROLAW LETT; 1993, NATIONAL DIRECTORY L; 1994, 4TH C STUD TRAUM BRA; 1994, MARTINDALE HUBBELL R	43	11	11	0	5	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1995	9	7					745	751		10.3109/02699059509008230			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	RZ814	WOS:A1995RZ81400007	8680401				2021-06-18	
J	MASANA, Y; YOSHIMINE, T; FUJITA, T; MARUNO, M; KUMURA, E; HAYAKAWA, T				MASANA, Y; YOSHIMINE, T; FUJITA, T; MARUNO, M; KUMURA, E; HAYAKAWA, T			REACTION OF MICROGLIAL CELLS AND MACROPHAGES AFTER CORTICAL INCISION IN RATS - EFFECT OF A SYNTHESIZED FREE-RADICAL SCAVENGER,(+/-)-N,N'-PROPYLENEDINICOTINAMIDE (AVS)	NEUROSCIENCE RESEARCH			English	Article						OXYGEN FREE RADICAL; TRAUMATIC BRAIN INJURY; MICROGLIAL CELL; MACROPHAGE; EDI; (+/-)-N,N'-PROPYLENEDINICOTINAMIDE (AVS)	CENTRAL NERVOUS-SYSTEM; BRAIN MACROPHAGES; ORIGIN; INJURY; ADULT	Reactive microglial cells and macrophages appear after trauma to the brain. To investigate the accumulation patterns of reactive microgial cells and macrophages after cortical incision, these cells were stained immunohistochemically with anti-EDl antibody in the brain sections before and 1, 3, 5, and 7 days after incision. And to ascertain the participation of oxygen free radicals in these cellular reactions, a synthesized free radical scavenger, (+/-)-N,N'-propylenedinicotinamide (AVS) was administered in this model. Rats were administered AVS (300 mg/kg, i.p.) 30 min before, 2.5 h and every 24 h after incision (AVS group), while only saline was administered in the same manner as a control (saline group). In the saline group, both reactive microglial cells and macrophages had already appeared on day 1 post-incision. The former continued to increase in number during the following days, whereas the latter increased in number up to day 3 and thereafter decreased. Both the numbers of reactive microglial cells and macrophages were significantly decreased (P < 0.05) in the AVS group on days 5 and 7. The results suggest the participation of oxygen free radicals in the reaction of microglial cells and macrophages in traumatic brain injury.		MASANA, Y (corresponding author), OSAKA UNIV,SCH MED,DEPT NEUROSURG,2-2 YAMADAOKA,SUITA,OSAKA 565,JAPAN.						Asano T, 1984, Neurol Res, V6, P163; ASANO T, 1984, Neurological Research, V6, P49; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GLENN JA, 1992, J ANAT, V180, P109; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; JORDAN FL, 1988, BRAIN RES REV, V13, P165, DOI 10.1016/0165-0173(88)90019-7; KAUR C, 1987, J ANAT, V154, P215; KOIDE T, 1985, J NEUROCHEM, V44, P85, DOI 10.1111/j.1471-4159.1985.tb07116.x; KOIDE T, 1983, 11TH P S DRUGS ACT S, P121; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; PIANI D, 1994, NEWS PHYSIOL SCI, V9, P80; SCHELPER RL, 1986, J NEUROPATH EXP NEUR, V45, P1, DOI 10.1097/00005072-198601000-00001; SMINIA T, 1987, IMMUNOBIOLOGY, V174, P43, DOI 10.1016/S0171-2985(87)80083-9; STEVENS A, 1993, J NEUROL SCI, V118, P117, DOI 10.1016/0022-510X(93)90100-D; STOLL G, 1989, J NEUROSCI, V9, P2327; THOMAS WE, 1992, BRAIN RES REV, V17, P61; WATANABE T, 1988, J NEUROCHEM, V4, P1145	25	11	11	0	0	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	SEP	1995	23	2					217	221		10.1016/0168-0102(95)00936-N			5	Neurosciences	Neurosciences & Neurology	RX055	WOS:A1995RX05500008	8532218				2021-06-18	
J	NUSHOLTZ, GS; WYLIE, EB; GLASCOE, LG				NUSHOLTZ, GS; WYLIE, EB; GLASCOE, LG			INTERNAL CAVITATION IN SIMPLE HEAD IMPACT MODEL	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		2-DIMENSIONAL COMPUTATIONAL MODEL; CAVITATION; TRAUMATIC BRAIN INJURY		A two-dimensional computational model is used to evaluate the potential for cavitation to occur inside the brain material during head impact. The model represents a simple water-fined 14-cm-diameter, S-cm-deep cylinder, For the purpose of our study, this cylinder represents the skull while the water inside the cylinder represents the brain material. To ensure that the stress predicted by the model is realistic, it has been calibrated against experimental data, When the cylinder is struck by a free-flying mass cavitation is initiated at the boundary opposite impact, Significant vaporous regions may develop at the boundary, while only limited vaporization occurs internally, Higher accelerations, or an additional loading of the domain by a constant acceleration perpendicular to impact, adds to the likelihood and to the severity of internal cavitation, This indicates that preexisting conditions or complex loading conditions of the head during an impact event may affect the cavitation response, Such conditions could be the result of angular velocity, angular accelerations, or head accelerations as a result of neck loading.	UNIV MICHIGAN,DEPT CIVIL & ENVIRONM ENGN,ANN ARBOR,MI 48109	NUSHOLTZ, GS (corresponding author), CHRYSLER MOTOR CORP,800 CHRYSLER DR E,CIMS 483-05-10,AUBURN HILLS,MI 48326, USA.						BENEDICT JV, 1970, BIOMECHANICS HUMAN F; BENJAMIN WYLIE E., 1993, FLUID TRANSIENTS; Hammitt Frederick G., 1970, CAVITATION; HENKE R, 1980, THESIS U MICHIGAN; LUBACK P, 1988, J BIOMECH, V13, P1041; NUSHOLTZ GS, 1984, 28TH P STAPP CAR CRA; NUSHOLTZ GS, 1986, 30TH P STAPP CAR CRA, P237; NUSHOLTZ GS, 1995, AVIAT SPACE ENV MED, V66; NUSHOLTZ GS, 1994, 14TH ESV C MUN; NUSHOLTZ GS, 1987, AVIAT SPACE ENV MED, V88, P9; STALNAKER RL, 1977, 21ST STAPP CAR CRASH, P303; WYLIE EB, 1980, J FLUID ENG-T ASME, V102, P203, DOI 10.1115/1.3240646; WYLIE EB, 1984, J FLUID ENG-T ASME, V106, P227, DOI 10.1115/1.3243107	13	11	11	0	12	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					707	714		10.1089/neu.1995.12.707			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000022	8683622				2021-06-18	
J	Donders, J; Strom, D				Donders, J; Strom, D			Factor and cluster analysis of the intermediate Halstead Category Test	CHILD NEUROPSYCHOLOGY			English	Article							CHILDREN; INJURY; SCALE	The factorial invariance of the six subtests of the Intermediate version of the Halstead Category Test (IHCT), as well as clusters of IHCT subtest patterns, were evaluated in a sample of 87 children with traumatic brain injuries. A two-factor solution was found which partially replicated that found in previous research with children with learning disabilities, supporting the assumption that the IHCT measures multiple underlying constructs in clinical populations. Four clusters were found, with differences between clusters determined to a substantial extent by relative accuracy on subtest III, and to a less substantial extent by relative accuracy on subtests IV and V Clinical and research implications are discussed.	MARY FREE BED HOSP,GRAND RAPIDS,MI 49503							CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DONDERS J, 1993, CLIN NEUROPSYCHOL, V7, P430, DOI 10.1080/13854049308401533; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GEWEKE JF, 1980, J AM STAT ASSOC, V75, P133, DOI 10.2307/2287400; JARVIS PE, 1984, HALSTEAD REITAN TEST; KELLY MD, 1992, ARCH CLIN NEUROPSYCH, V7, P415, DOI 10.1016/0887-6177(92)90154-F; KNIGHTS RM, 1980, REVISED SMOOTHED NOR; Leckliter Ingrid N, 1992, Clin Neuropsychol, V6, P201, DOI 10.1080/13854049208401856; RATTAN AI, 1989, J PSYCHOEDUCATIONAL, V7, P296; Reitan R.M., 1992, NEUROPSYCHOLOGICAL E; Reitan RM., 1985, HALSTEAD REITAN NEUR; Reitan RM, 1979, MANUAL ADM NEUROPSYC; STRANG JD, 1983, J CLIN CHILD PSYCHOL, V12, P33, DOI 10.1080/15374418309533110; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1987, J SCHOOL PSYCHOL, V25, P93, DOI 10.1016/0022-4405(87)90064-1; THINGSTROM DH, 1988, J CLIN PSYCHOL, V44, P799; Wechsler D., 1974, MANUAL WECHSLER INTE; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; 1990, SAS STAT USERS GUIDE	20	11	11	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	APR	1995	1	1					19	25		10.1080/09297049508401339			7	Clinical Neurology	Neurosciences & Neurology	TY623	WOS:A1995TY62300003					2021-06-18	
J	WILLIAMS, J; HAUT, JS				WILLIAMS, J; HAUT, JS			DIFFERENTIAL PERFORMANCES ON THE WRAML IN CHILDREN AND ADOLESCENTS DIAGNOSED WITH EPILEPSY, HEAD-INJURY, AND SUBSTANCE-ABUSE	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							MEMORY	Assessment of memory in children and adolescents has been limited because of the lack of standardized instruments available. The recently released Wide Range Assessment of Memory and Learning (WRAML; Sheslow & Adams, 1990) was used in this exploratory study to examine memory skills in children and adolescents with conditions affecting neuropsychological functioning. Diagnostic categories included epilepsy, traumatic brain injury, and substance abuse, as well as a nonneurological comparison group with psychiatric disturbance. Results indicated that children with epilepsy scored significantly below those with substance abuse or psychiatric disorders on the Verbal Memory Index. Within-group comparisons suggested that all clinical groups had more difficulty with tasks that purportedly measure auditory attentional skills. Children with epilepsy demonstrated greater variability in memory performances, suggesting possible problems with both attention and memory factors. The WRAML appears to be a potentially useful assessment tool in the measurement of memory processes in children, although further research is needed concerning subtest specificity.	W VIRGINIA UNIV,SCH MED,DEPT BEHAV MED & PSYCHIAT,MORGANTOWN,WV 26506	WILLIAMS, J (corresponding author), UNIV ARKANSAS MED SCI HOSP,DEPT PEDIAT,800 MARSHALL ST,LITTLE ROCK,AR 72202, USA.						ADAMS W, 1991, AUG ANN M AM PSYCH A; ALDENKAMP AP, 1990, EPILEPSIA, V31, pS9, DOI 10.1111/j.1528-1157.1990.tb05874.x; BLENNOW G, 1990, EPILEPSIA, V31, pS50, DOI 10.1111/j.1528-1157.1990.tb05871.x; BOLTER JF, 1986, CHILD NEUROPSYCHOL, V2, P59; BURTON DB, 1993, 21ST ANN M INT NEUR; CALLAHAN TSA, 1993, 101ST ANN M AM PSYCH; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; DAM M, 1990, EPILEPSIA, V31, pS26, DOI 10.1111/j.1528-1157.1990.tb05866.x; ELLIOT RW, 1989, HDB CLIN CHILD NEURO, P311; Frey WF, 1994, ADOLESCENT MED, V5, P311; GIOIA GA, 1991, 19TH ANN M INT NEUR; HAUT JS, 1992, 20TH ANN M INT NEUR; HAUT JS, 1992, 12TH ANN M NAT AC NE; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; KASTELEIJNNOLST.DG, 1990, DEV MED CHILD NEUROL, V32, P46; KRULL KR, 1994, 22ND ANN M INT NEUR; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; NOBLE EP, 1987, J SUBST ABUSE TREAT, V4, P145; Osborn RG, 1990, BEHAV DISORDERS, V16, P32; POGGE DL, 1992, J ABNORM CHILD PSYCH, V20, P151, DOI 10.1007/BF00916546; REYNOLDS EH, 1983, EPILEPSIA, V24, pS85, DOI 10.1111/j.1528-1157.1983.tb04651.x; Sheslow D., 1990, WIDE RANGE ASSESSMEN; WASSERMAN JD, 1992, UNDERSTANDING TRAUMA, V7	24	11	11	0	1	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		1995	11	2					201	213		10.1080/87565649509540613			13	Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	RM650	WOS:A1995RM65000003					2021-06-18	
J	SUN, FY; FADEN, AI				SUN, FY; FADEN, AI			HIGH-AFFINITY AND LOW-AFFINITY NMDA RECEPTOR-BINDING SITES IN RAT SPINAL-CORD - EFFECTS OF TRAUMATIC INJURY	BRAIN RESEARCH			English	Article						NMDA RECEPTOR; RECEPTOR-BINDING; [H-3] MK801; SPINAL CORD INJURY; TRAUMA	D-ASPARTATE RECEPTOR; BRAIN INJURY; AMINO-ACIDS; GLUTAMATE; MK-801; <H-3>MK-801; ISCHEMIA	N-methyl-D-aspartate (NMDA) receptor-mediated events hade been implicated in the pathophysiology of posttraumatic spinal. cord injury. In the present study, [H-3]MK801 was used to analyse the changes in NMDA receptor-binding sites in rat spinal cord after impact trauma at T9. In contrast to brain, which showed only a single binding site, spinal cord showed both high-affinity (K-d1 = 0.47 +/- 0.24 nM) and low-affinity (K-d2 = 7.75 +/- 1.82 nM) binding sites with relatively low binding density (B-max1 = 0.11 +/- 0.04 pmol/mg protein and B-max2 = 0.84 +/- 0.11 pmol/mg protein). Time-course studies demonstrated significant decreases in the binding of [H-3]MK801 at the thoracic and lumbar segments at 4 h after spinal cord injury with recovery by 24 h. Scatchard analyses indicate that these changes likely involve bath high- and low-affinity binding sites. The transitory reduction in [H-3]MK801-binding after trauma may reflect downregulation of NMDA receptors as a consequence of posttraumatic glutamate release and may serve to limit excitotoxin-induced injury.	GEORGETOWN UNIV,SCH MED,DEPT NEUROL,WASHINGTON,DC 20007; GEORGETOWN UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20007					NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS27849] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR 306634] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027849] Funding Source: NIH RePORTER		ARAM J, 1986, British Journal of Pharmacology, V89, p778P; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; FADEN AI, 1986, NEUROLOGY, V36, P723, DOI 10.1212/WNL.36.5.723; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1988, J NEUROTRAUM, V5, P27; GILL R, 1988, NEUROSCIENCE, V25, P847, DOI 10.1016/0306-4522(88)90040-1; GONZALEZ DL, 1993, NEUROSCI LETT, V151, P134, DOI 10.1016/0304-3940(93)90004-5; HENLEY JM, 1993, NEUROPHARMACOLOGY, V32, P37, DOI 10.1016/0028-3908(93)90127-O; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; LEACH MJ, 1993, STROKE, V24, P1063, DOI 10.1161/01.STR.24.7.1063; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P25; MELDRUM BS, 1992, BRAIN RES, V59, P1; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; RANSOM RW, 1988, J NEUROCHEM, V51, P830, DOI 10.1111/j.1471-4159.1988.tb01818.x; REYNOLDS IJ, 1991, J NEUROCHEM, V56, P1731, DOI 10.1111/j.1471-4159.1991.tb02074.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHAW PJ, 1991, BRAIN RES, V539, P164, DOI 10.1016/0006-8993(91)90701-V; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; WONG EHF, 1988, J NEUROCHEM, V50, P274, DOI 10.1111/j.1471-4159.1988.tb13260.x; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	28	11	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 12	1994	666	1					88	92		10.1016/0006-8993(94)90285-2			5	Neurosciences	Neurosciences & Neurology	PV595	WOS:A1994PV59500010	7889371				2021-06-18	
J	DALEO, G; BRAMANTI, P; SILVESTRI, R; SALTUARI, L; GERSTENBRAND, F; DIPERRI, R				DALEO, G; BRAMANTI, P; SILVESTRI, R; SALTUARI, L; GERSTENBRAND, F; DIPERRI, R			SLEEP SPINDLES IN THE INITIAL-STAGES OF THE VEGETATIVE STATE	ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						SLEEP; SPINDLES; VEGETATIVE STATE	PROGNOSTIC VALUE; COMA	The aim of this study was to look for the presence of spindling in the different stages of remission of the vegetative state to underline all possible correlations with lesional sites, severity of coma and final outcome. The nocturnal polygraphic recordings from 30 patients were examined: 20 (15M, 5F, mean age 31.7 years, range 16-41) had originally suffered a traumatic brain injury, 10 (4M, 6F, mean age 40.5 years, range 24-48) had hypoxic brain lesions. Evidence of spindling, always reduced in density and duration, was found in 44% of these patients, prevalently in the traumatic patients (53.3% versus 30% of hypoxic patients). No subjects in the full stage 0, 0-1 of the vegetative state (apallic syndrome) presented spindling. No significant correlation was found between spindling and the following parameters: gender, the time between the onset of coma and the polygraphic recording, or the site of the lesion.	UNIV INNSBRUCK, NEUROL CLIN, A-6020 INNSBRUCK, AUSTRIA; UNIV MESSINA, NEUROL CLIN 1, MESSINA, ITALY	DALEO, G (corresponding author), UNIV MESSINA, CTR STUDIO & TRATTAMENTO NEUROL LUNGODEGENTI, CATTEDRA NEUROFISIOPATOL, I-98124 MESSINA, ITALY.						ANGELERI F, 1990, DIENCEPHALON AND SLEEP, P77; CHATRIAN GE, 1963, ELECTROEN CLIN NEURO, V15, P272, DOI 10.1016/0013-4694(63)90096-8; DOSSI RC, 1992, J PHYSIOL-LONDON, V447, P215, DOI 10.1113/jphysiol.1992.sp018999; Gerstenbrand F., 1967, TRAUMATISCHE APALLIS; HANSOTIA P, 1981, NEUROLOGY, V31, P83, DOI 10.1212/WNL.31.1.83; HUGES JR, 1972, CLIN ELECTROENCEPHAL, V3, P86; Rechtschaffen A, 1968, MANUAL STANDARDIZED; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; RUMPL E, 1980, Z EEG EMG, V11, P43; Stockard JJBRG, 1975, HDB CLIN NEUROLOGY, V23, P217	10	11	12	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0392-0461			ITAL J NEUROL SCI	Ital. J. Neurol. Sci.	OCT	1994	15	7					347	351		10.1007/BF02339931			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	PU513	WOS:A1994PU51300003	7698892				2021-06-18	
J	SILVER, JM; YUDOFSKY, SC				SILVER, JM; YUDOFSKY, SC			PSYCHOPHARMACOLOGICAL APPROACHES TO THE PATIENT WITH AFFECTIVE AND PSYCHOTIC FEATURES	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AFFECTIVE DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOSIS; TRAUMATIC BRAIN INJURY	CLOSED HEAD-INJURY; NEUROLEPTIC MALIGNANT SYNDROME; TRAUMATIC BRAIN INJURY; TARDIVE-DYSKINESIA; FOLLOW-UP; PARKINSONS-DISEASE; SOCIAL-ADJUSTMENT; DEPRESSION; FLUOXETINE; SCHIZOPHRENIA	Affective and psychotic disorders may occur after traumatic brain injury. These symptoms may arise from the direct effect of the trauma on the brain, from the side effects or withdrawal from drugs and medications, and from the emotional reaction to the event. Patients with TBI are especially sensitive to the side effects of drugs that act on the central nervous system. When appropriate guidelines are followed, psychopharmacological intervention alleviates these symptoms, enhances rehabilitation, and avoids impairment of arousal and attention.	COLUMBIA UNIV,COLL PHYS & SURG,NEW YORK,NY; BAYLOR COLL MED,DEPT PSYCHIAT & BEHAV SCI,HOUSTON,TX	SILVER, JM (corresponding author), COLUMBIA PRESBYTERIAN MED CTR,NEW YORK,NY 10032, USA.						BAREGGI SR, 1975, EUR NEUROL, V13, P528, DOI 10.1159/000114709; BERMAN KF, 1988, ARCH GEN PSYCHIAT, V45, P616; BESSETTE RF, 1992, PSYCHOSOMATICS, V33, P224, DOI 10.1016/S0033-3182(92)72001-5; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1990, REHABILITATION ADULT; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; DAVIDSON J, 1989, J CLIN PSYCHIAT, V50, P256; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DESMET Y, 1982, J NEUROL NEUROSUR PS, V45, P1161, DOI 10.1136/jnnp.45.12.1161; DUBOIS B, 1990, ANN NEUROL, V28, P117, DOI 10.1002/ana.410280202; DUBOVSKY SL, 1992, AM PSYCHIATRIC PRESS; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GARYFALLOS G, 1988, ACTA PSYCHIAT SCAND, V78, P87, DOI 10.1111/j.1600-0447.1988.tb06305.x; GLAZER WM, 1984, ARCH GEN PSYCHIAT, V41, P623; GRIMSLEY SR, 1991, CLIN PHARMACOL THER, V50, P10, DOI 10.1038/clpt.1991.98; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hillbom E., 1960, ACTA PSYCHIATRICA S, VS142, P1; HSIAO JK, 1987, CONVULSIVE THER, V3, P121; JALIL P, 1992, J NEUROL NEUROSUR PS, V55, P414; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kass F, 1990, J Neuropsychiatry Clin Neurosci, V2, P15; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; LAUTERBACH EC, 1991, J CLIN PSYCHOPHARM, V11, P392, DOI 10.1097/00004714-199112000-00021; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVINE R, 1994, J CLIN PSYCHOPHARM, V14, P145, DOI 10.1097/00004714-199404000-00011; LIEBERMAN JA, 1989, J CLIN PSYCHIAT, V50, P329; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; MICHALS ML, 1993, J CLIN PSYCHOPHARM, V13, P198; MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605; NASRALLAH HA, 1981, PSYCHOSOMATICS, V22, P359; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OJEMANN LM, 1987, NEUROLOGY, V37, P1525, DOI 10.1212/WNL.37.9.1525; OLIVER AP, 1982, ARCH GEN PSYCHIAT, V39, P206; Panzer MJ, 1992, J GERIATR PSYCHIAT, V4, P195; PINDER RM, 1977, DRUGS, V13, P321, DOI 10.2165/00003495-197713050-00001; PORTA M, 1975, EUR NEUROL, V13, P545, DOI 10.1159/000114710; ROBINSON RG, 1994, NEUROPSYCHIATRY TRAU; ROSEBUSH P, 1989, AM J PSYCHIAT, V146, P717; ROSEBUSH PI, 1991, BRIT J PSYCHIAT, V159, P709, DOI 10.1192/bjp.159.5.709; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; ROSS ED, 1987, J NERV MENT DIS, V176, P165; RUTHERFORD WH, 1977, LANCET, V1, P1; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SELIGER G M, 1992, Brain Injury, V6, P267, DOI 10.3109/02699059209029668; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; SILVER JM, 1994, AM PSYCHIATRIC PRESS; Silver JM., 1994, NEUROPSYCHIATRY TRAU; SILVER JM, 1993, 146TH ANN M AM PSYCH; SLOAN R L, 1992, Brain Injury, V6, P315, DOI 10.3109/02699059209034945; Smeltzer D., 1994, NEUROPSYCHIATRY TRAU; SOVNER R, 1991, J CLIN PSYCHOPHARM, V11, P389, DOI 10.1097/00004714-199112000-00018; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VANWOERKOM TCAM, 1977, LANCET, V1, P812; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; VINCENT FM, 1986, NEUROSURGERY, V18, P190, DOI 10.1227/00006123-198602000-00013; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; WOLF B, 1989, COMPR PSYCHIAT, V30, P534, DOI 10.1016/0010-440X(89)90084-9; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009; YASSA R, 1984, PSYCHOSOMATICS, V25, P852, DOI 10.1016/S0033-3182(84)72946-X; YASSA R, 1984, PSYCHOSOMATICS, V25, P135, DOI 10.1016/S0033-3182(84)73083-0; ZIMMER B, 1992, 145TH ANN M AM PSYCH; 1985, AM J PSYCHIAT, V142, P155	71	11	11	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP	1994	9	3					61	77		10.1097/00001199-199409000-00006			17	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	QD376	WOS:A1994QD37600006					2021-06-18	
J	MACNIVEN, E				MACNIVEN, E			INCREASED PREVALENCE OF LEFT-HANDEDNESS IN VICTIMS OF HEAD TRAUMA	BRAIN INJURY			English	Article							INJURY; ABILITY; HAND	Compared to a historical control group, an increased prevalence of left hand preference was found in a population of patients having traumatic brain injuries. The data support the hypothesis that left-handed individuals may be more likely to experience accidents, particularly those involving motor vehicles. There are also implications for prediction of outcome after head trauma.	MCGILL UNIV,MONTREAL H3A 2T5,QUEBEC,CANADA							ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BRYDEN MP, 1982, LATERALITY FUNCTIONA; COOPER PR, 1982, HEAD INJURY, P1; COREN S, 1989, AM J PUBLIC HEALTH, V79, P1040, DOI 10.2105/AJPH.79.8.1040; COREN S, 1991, PSYCHOL BULL, V109, P90, DOI 10.1037/0033-2909.109.1.90; ELLIS SJ, 1988, CORTEX, V24, P157, DOI 10.1016/S0010-9452(88)80025-X; HAY RK, 1967, CAN MED ASSOC J, V97, P1364; HECAEN H, 1979, BEHAV BRAIN SCI, V2, P503, DOI 10.1017/S0140525X00064050; KLONOFF H, 1969, CAN MED ASSOC J, V100, P235; LANSKY LM, 1988, NEUROPSYCHOLOGIA, V26, P564; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MACNIVEN E, 1993, MAY CAN PSYCH ASS AN; MILLER E, 1971, BRIT J PSYCHOL, V62, P111, DOI 10.1111/j.2044-8295.1971.tb02018.x; PARKINSON D, 1985, CAN J SURG, V28, P79; Porac C., 1981, LATERAL PREFERENCES; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; REITAN RM, 1973, NEUROPSYCHOLOGY HDB, P134; SANDERS B, 1982, CORTEX, V18, P79, DOI 10.1016/S0010-9452(82)80020-8; SARNO J E, 1971, Archives of Physical Medicine and Rehabilitation, V52, P73; SATZ P, 1980, NEUROPSYCHOLOGY LEFT, P189; SNOW WG, 1988, CAN J SURG, V31, P191; SPRINGER SP, 1989, RIGHT BRAIN LEFT BRA; STRICH SJ, 1961, LANCET, V2, P443; SUBIRANA A, 1958, BRAIN, V81, P415, DOI 10.1093/brain/81.3.415; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; YEN WM, 1975, BEHAV GENET, V5, P281, DOI 10.1007/BF01066180	26	11	11	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1994	8	5					457	462		10.3109/02699059409150997			6	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	NW122	WOS:A1994NW12200007	7951208				2021-06-18	
J	FISHER, JM; WILLIAMS, AD				FISHER, JM; WILLIAMS, AD			NEUROPSYCHOLOGIC INVESTIGATION OF MILD HEAD-INJURY - ENSURING DIAGNOSTIC-ACCURACY IN THE ASSESSMENT PROCESS	SEMINARS IN NEUROLOGY			English	Article							CONCUSSION; SYMPTOMS; TESTS; SEQUELAE; DEFICITS		PEPPERDINE UNIV,GRAD SCH EDUC & PSYCHOL,IRVINE,CA; UNIV ROCHESTER,SCH MED & DENT,DEPT NEUROL,ROCHESTER,NY 14642							Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ALVES W, 1992, REHABILITATION POSTC, P21; Anastasi A., 1988, PSYCHOL TESTING; Armstrong CL, 1987, NEUROPSYCHOLOGY, V1, P15; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Barth J. T., 1986, J HEAD TRAUMA REHAB, V1, P63; BERROL S, 1992, REHABILITATION POST, P1; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; CICERONE K, 1992, REHABILITATION POST, P129; CRIPE LI, 1989, REHABIL PSYCHOL, V34, P93; DAVIDOFF DA, 1988, COGNITIVE REHABILITA, V6, P8; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Evans R W, 1987, Tex Med, V83, P49; FLORHENRY P, 1983, NEUROPSYCHOLOGY HUMA, P193; GASS C, 1991, J CLIN PSYCHOL, V47, P101; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GREENE RL, 1988, MMPI USE SPECIFIC PO; Gronwall D, 1991, NEUROPSYCHOLOGY, V5, P253, DOI DOI 10.1037/0894-4105.5.4.253; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; HAYES R, 1992, REHABILITATION POST, P9; Heaton R.K., 1991, COMPREHENSIVE NORMS; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KANE R L, 1991, Neuropsychology Review, V2, P281, DOI 10.1007/BF01108849; KAY T, 1992, REHABILITATION POST, P109; KAY T, 1986, MINOR HEAD INJURY IN; KEYSER D, TEST CRITIQUES; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEININGER B, 1992, REHABILITATION POST, P169; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MACCIOCCHI S, 1988, J HEAD TRAUMA REHABI, V3, P1; MCCAFFREY R, 1993, IN PRESS J HEAD TRAU; MCCAFFREY R, UNPUB FORENSIC NEURO; MCMILLAN TM, 1985, J NEUROL NEUROSUR PS, V48, P847, DOI 10.1136/jnnp.48.8.847-b; MIDDELBOE T, 1992, J PERS DISORD, V6, P246, DOI 10.1521/pedi.1992.6.3.246; MITCHELL J, MENTAL MEASUREMENTS; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NEWMAN B, 1992, NEW YORK U MED CTR R, V4, P3; NYLANDER I, 1988, ACTA PAEDIATR SCAND, V77, P475, DOI 10.1111/j.1651-2227.1988.tb10685.x; ONORATO VA, 1987, INT J CLIN NEUROPSYC, V9, P125; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Reitan R.M., 1993, HALSTEADREITAN NEURO; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; Stuss D. T., 1989, CLIN NEUROPSYCHOL, V3, P145, DOI DOI 10.1080/13854048908403287; TRIMBLE MR, 1981, POST TRAUMATIC NEURO; WILKINSON HA, 1991, J NEUROL NEUROSUR PS, V54, P846; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams JM, 1991, MEMORY ASSESSMENT SC; 1985, STANDARDS ED PSYCHOL; 1993, STRUCTURED CLIN ASSE; 1990, STRUCTURED CLIN INTE; 1989, PSYCHIATRIC DIAGNOST	63	11	11	0	0	THIEME MEDICAL PUBL INC	NEW YORK	381 PARK AVE SOUTH, NEW YORK, NY 10016	0271-8235			SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					53	59		10.1055/s-2008-1041059			7	Clinical Neurology	Neurosciences & Neurology	NE151	WOS:A1994NE15100010	8029560				2021-06-18	
J	SCHMOKER, JD; JING, Z; SHACKFORD, SR; PIETROPAOLI, J				SCHMOKER, JD; JING, Z; SHACKFORD, SR; PIETROPAOLI, J			EFFECT OF LESION VOLUME ON CEREBRAL HEMODYNAMICS AFTER FOCAL BRAIN INJURY AND SHOCK	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							SEVERE HEAD-INJURIES; BLOOD-FLOW; INTRACRANIAL-PRESSURE; METABOLISM; EDEMA; FLUID; ICP; CSF	Cerebral blood flow (CBF) varies unpredictably in patients after head injury and hemorrhagic shock. Proper treatment requires knowledge of ischemic versus hyperemic flow. The degree to which the size or severity of the injury may contribute to CBF abnormalities is unknown. We hypothesized that lesion size is a determinant of postinjury CBF. We measured cerebral and systemic variables in a porcine model of focal cryogenic brain injury and hemorrhagic shock over a 5-hour period. Swine were randomized to receive either a large or small lesion followed by hemorrhage. In the small lesion group traumatic brain injury, followed by shock and resuscitation, produced a significant and sustained elevation in bihemispheric regional CBF and cerebral oxygen delivery that was significantly greater than that observed in either the large lesion group or the controls (p < 0.05). There were no significant differences between the experimental groups in volume of hemorrhage, intracranial pressure, cerebral perfusion pressure, arterial oxygen content, or PaCO2. These data suggest that the volume of injured tissue may determine post-resuscitation CBF, and that interventions to reduce cerebral blood volume (i.e., hyperventilation) may not be universally applicable in all head injured patients.	UNIV VERMONT, COLL MED, DEPT SURG, BURLINGTON, VT 05405 USA					NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS ROI NS27061-02] Funding Source: Medline; DS NIH HHS [NINDS P2ONS30324-02] Funding Source: Medline		Barie Philip S., 1992, Journal of Trauma, V33, P148, DOI 10.1097/00005373-199207000-00029; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLASEN RA, 1953, SURG GYNECOL OBSTET, V96, P605; ELLIS EF, 1988, AM J PHYSIOL, V255, pH397; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HERRMANN HD, 1972, EXP NEUROL, V34, P115, DOI 10.1016/0014-4886(72)90192-6; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1991, CENTRAL NERVOUS SYST, pS327; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NELSON SR, 1971, J APPL PHYSIOL, V30, P268; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SCHMOKER JD, 1992, CIRC SHOCK, V37, P13; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHIGENO T, 1982, J NEUROSURG, V57, P99, DOI 10.3171/jns.1982.57.1.0099; WALD S, 1991, Journal of Trauma, V31, P1041, DOI 10.1097/00005373-199107000-00102; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Ward JD, 1989, INTRACRANIAL PRESSUR, P630; YOUNG W, 1980, STROKE, V11, P552, DOI 10.1161/01.STR.11.5.552	32	11	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	1993	35	4					627	636					10	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	MD998	WOS:A1993MD99800020	8411289				2021-06-18	
J	NETZ, J; HOMBERG, V				NETZ, J; HOMBERG, V			INTACT CONDUCTION OF FASTEST CORTICOSPINAL EFFERENTS IS NOT SUFFICIENT FOR NORMAL VOLUNTARY MUSCLE STRENGTH - TRANSCRANIAL MOTOR CORTEX STIMULATION IN PATIENTS WITH TETRAPLEGIA	NEUROSCIENCE LETTERS			English	Article						TRANSCRANIAL MAGNETIC STIMULATION; UPPER MOTOR NEURON; PYRAMIDAL TRACT; EXTRAPYRAMIDAL PATHWAY; TETRAPARESIS; VOLUNTARY MOVEMENT	MULTIPLE-SCLEROSIS; BRAIN IRON; NEURON; ABNORMALITIES	In six patients with chronic severe tetraparesis, caused by closed head injury (3 cases), basilar thrombosis (2 cases) or global hypoxia (1 case), responses of suprathreshold transcranial magnetic stimulation of motor cortex to thenar and abductor hallucis muscles on both sides were studied. Results showed in most patients normal thresholds and latencies (17 out of 24 latencies within normal +/- 2 S.D., 20 thresholds within normal +/- 1 S.D.) and amplitudes of even higher than normal values. Latencies or thresholds did not correlate with severity of pareses and were in marked contrast to the severe pareses of the muscles under investigation. Despite different etiology CT-scans showed diffuse atrophy of cerebral white matter as a common finding. It is concluded that intact descending corticospinal motor pathways are a necessary but not a sufficient condition for voluntary motor function.	HEINRICH HEINE UNIV,CTR NEUROL THERAPY,HOHENSANDWEG 37,W-4000 DUSSELDORF 13,GERMANY							ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; ASANUMA H, 1975, PHYSIOL REV, V55, P143; BERARDELLI A, 1987, J NEUROL NEUROSUR PS, V50, P861, DOI 10.1136/jnnp.50.7.861; BUCY PC, 1964, J NEUROSURG, V21, P385, DOI 10.3171/jns.1964.21.5.0385; BUCY PC, 1966, J NEUROSURG, V25, P1, DOI 10.3171/jns.1966.25.1.0001; COWAN JMA, 1984, LANCET, V2, P304; CRCEVIC N, 1977, APALLIC SYNDROME, P109; DIMITRIJEVIC MR, 1988, NONINVASIVE STIMULAT, P243; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; EYRE JA, 1989, J PHYSIOL-LONDON, V414, pP9; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUNNARELLI TA, 1982, ANN NEUROL, V12, P564; HOMBERG V, 1991, ELECTROEN CLIN NEURO, V81, P377, DOI 10.1016/0168-5597(91)90027-U; INGRAM DA, 1987, J NEUROL NEUROSUR PS, V50, P159, DOI 10.1136/jnnp.50.2.159; INGRAM DA, 1988, J NEUROL NEUROSUR PS, V51, P487, DOI 10.1136/jnnp.51.4.487; MASUR H, 1990, 32 JAHR DTSCH EEG GE; MULLER K, 1992, ELECTROEN CLIN NEURO, V85, P86, DOI 10.1016/0168-5597(92)90073-K; NETZ J, 1989, 23 JAHR DTSCH GES NE; PHILLIPS CG, 1977, MONOGR PHYSL SOC LON, V34, P77; RUTLEDGE JN, 1987, AM J ROENTGENOL, V149, P365, DOI 10.2214/ajr.149.2.365; THOMPSON PD, 1987, J NEUROL SCI, V80, P91, DOI 10.1016/0022-510X(87)90224-3; ULE G, 1977, APALLIC SYNDROME, P104	23	11	11	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	OCT 26	1992	146	1					29	32		10.1016/0304-3940(92)90164-3			4	Neurosciences	Neurosciences & Neurology	JW568	WOS:A1992JW56800008	1475046				2021-06-18	
J	YOSHIDA, K; BURTON, GF; YOUNG, H; ELLIS, EF				YOSHIDA, K; BURTON, GF; YOUNG, H; ELLIS, EF			BRAIN LEVELS OF POLYETHYLENE GLYCOL-CONJUGATED SUPEROXIDE-DISMUTASE FOLLOWING FLUID PERCUSSION BRAIN INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article							CATALASE; EDEMA	Polyethylene glycol-conjugated superoxide dismutase (PEG-SOD) is being explored as an agent to reduce oxygen radical-mediated damage following brain injury. Yet little is known concerning the site of action of IV-administered PEG-SOD or the capacity of this conjugated enzyme to enter the brain. The purpose of this study was to determine the brain content of PEG-SOD in normal and fluid percussion injured rats. The fluid percussion device was attached over the right parietal cortex and a moderate (2.0 atm) intensity injury was produced. PEG-SOD was conjugated with I-125 and given (2000 U/kg, 5-mu-Ci/kg) to rats either 30 min before or 30 min after brain injury. Another group received [I-125]PEG-SOD but was not injured. Plasma and left and right brain hemispheres were counted for [I-125]PEG-SOD. Plasma levels of [I-125]PEG-SOD declined similarly in all three groups during the 90-min period after IV administration. Brain [I-125]PEG-SOD was low in control animals (0.034 U/g wet wt). In animals given PEG-SOD after injury the brain level was elevated sixfold in both the left and right hemispheres, compared to control. In rats given the drug before injury, [I-125]PEG-SOD was 10 times control level in the right hemisphere, which is the side on which the injury device is attached, and 6 times control level in the left hemisphere. We conclude that traumatic brain injury produces an increase in brain PEG-SOD. The exact cellular site of the increased brain PEG-SOD remains to be clarified.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214, P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587, NS27214] Funding Source: Medline		BECKMAN JS, 1988, J BIOL CHEM, V263, P6884; CAPRO JD, 1978, METHOD ENZYMOL, V53, P382; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; HALL ED, 1988, OXYGEN RADICALS TISS, P92; HAUN SE, 1991, STROKE, V22, P655, DOI 10.1161/01.STR.22.5.655; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MEANS ED, 1987, HDB SPINAL CORD, V5, P19; ODLIND B, 1988, PHARMACOL TOXICOL, V62, P95, DOI 10.1111/j.1600-0773.1988.tb01853.x; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185; TURRENS JF, 1984, J CLIN INVEST, V73, P87, DOI 10.1172/JCI111210; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YOSHIDA K, 1992, STROKE, V23, P865, DOI 10.1161/01.STR.23.6.865; ZHANG XM, 1991, STROKE, V22, P489, DOI 10.1161/01.STR.22.4.489	21	11	11	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	SUM	1992	9	2					85	92		10.1089/neu.1992.9.85			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	JL725	WOS:A1992JL72500002	1404439				2021-06-18	
J	DEWEY, CW; BUDSBERG, SC; OLIVER, JE				DEWEY, CW; BUDSBERG, SC; OLIVER, JE			PRINCIPLES OF HEAD TRAUMA MANAGEMENT IN DOGS AND CATS .1.	COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN			English	Article								Injury to the brain in dogs and cats is a medical and sometimes surgical emergency. Of great importance in the treatment of head-injured animals is preservation of vital brain stem structures. Before a thorough assessment of the patient's neurologic status and subsequent therapy for brain injury, the trauma patient must be evaluated for other life-threatening injuries and stabilized, if necessary. Brain trauma can be classified as concussion, contusion, or laceration injuries. Brain hemorrhage and edema occur immediately after the traumatic insult, and secondary inflammatory processes perpetuate brain edema and ischemia. The secondary inflammatory mediators in concert with blood gas aberrations in the brain vasculature contribute to successive elevations of intracranial pressure. Accurate assessment and recording of the patient's neurologic status soon after arrival at the emergency room are important for guiding therapy, monitoring progress or deterioration, and making prognostic decisions.		DEWEY, CW (corresponding author), UNIV GEORGIA,COLL VET MED,DEPT SMALL ANIM MED,ATHENS,GA 30602, USA.							0	11	12	0	8	VETERINARY LEARNING SYSTEMS	TRENTON	425 PHILLIPS BLVD #100, TRENTON, NJ 08618	0193-1903			COMP CONT EDUC PRACT	Compend. Contin. Educ. Pract. Vet.	FEB	1992	14	2					199	&					0	Veterinary Sciences	Veterinary Sciences	HD423	WOS:A1992HD42300006					2021-06-18	
J	Maxwell, WL; Irvine, A; Watt, C; Graham, DI; Adams, JH; Gennarelli, TA				Maxwell, William L.; Irvine, Alyson; Watt, Christine; Graham, David I.; Adams, J. Hume; Gennarelli, Thomas A.			The Microvascular Response to Stretch Injury in the Adult Guinea Pig Visual System	JOURNAL OF NEUROTRAUMA			English	Article								In a variety of brain injury models, both reactive axonal change and microvascular abnormalities occur. Development of a stretch injury model in the guinea pig optic nerve has allowed for the characterization of the early axonal response to injury. In this same model, we have now attempted to characterize those morphologic changes occurring in the visual system microvasculature after injury. Thirty adult guinea pigs were subjected to axonal stretch injury and killed at posttraumatic survival periods ranging from 10 minutes to 14 days. Twenty animals were examined by scanning electron microscopy (SEM) for the detection of posttraumatic changes in the surface morphology of the microvasculature, and 10 animals were processed for transmission electron microscopy (TEM) analysis. Through this approach, increased pit vesicle activity and formation of endothelial microvilli were recognized within 10 minutes of injury. Pit vesicle activity returned to control levels by 2 hours. The formation of endothelial microvilli was widespread, affecting the microvessels in both the stretched and unstretched optic nerves and in the chiasm. The greatest response developed most slowly in the stretched nerve, and it was faster but less marked in the unstretched nerve and chiasm. Microvilli were more numerous in larger vessels. Related astrocytic swelling/lucency was not apparent until 6 hours after injury. The astrocyte response was less marked than that documented after brain injury. The results of this investigation demonstrate a widespread microvascular response to stretch injury of the guinea pig optic nerve. Comparison with the documented responses to traumatic brain injury indicates different rates of response to different types of insult.	[Maxwell, William L.; Irvine, Alyson; Watt, Christine] Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland; [Graham, David I.; Adams, J. Hume] Univ Glasgow, Dept Neuropathol, Glasgow G12 8QQ, Lanark, Scotland; [Gennarelli, Thomas A.] Univ Penn, Div Neurosurg, Philadelphia, PA 19104 USA	Maxwell, WL (corresponding author), Univ Glasgow, Dept Anat, Glasgow G12 8QQ, Lanark, Scotland.				NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-08803-18]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS008803, P50NS008803] Funding Source: NIH RePORTER	This work was supported by NIH grant number NS-08803-18. The authors are grateful to Caroline A. Morris for drawing Figures 1 and 2.	ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; Bradbury MWB, 1979, CONCEPT BLOOD BRAIN; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CANCILLA PA, 1979, LAB INVEST, V40, P74; Cheng CLY, 1988, J NEUROTRAUM, V5, P47, DOI 10.1089/neu.1988.5.47; DAVSON H, 1963, ERGEBN PHYSIOL, V52, P21; Dietrich W D, 1986, Cent Nerv Syst Trauma, V3, P265; DIETRICH WD, 1987, ACTA NEUROPATHOL, V72, P315, DOI 10.1007/BF00687262; DIETRICH WD, 1984, J NEUROPATH EXP NEUR, V43, P72, DOI 10.1097/00005072-198401000-00006; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HILLS CP, 1964, AM J PATHOL, V44, P531; KAWAI K, 1989, ACTA NEUROPATHOL, V78, P449, DOI 10.1007/BF00687705; KAWAI K, 1989, ACTA NEUROPATHOL, V77, P449, DOI 10.1007/BF00687245; LEWIS PD, 1985, SCI BASIS CLIN NEURO, P583; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MAXWELL WL, 1990, J NEUROCYTOL, V19, P235, DOI 10.1007/BF01217301; MORRISON JC, 1989, ARCH OPHTHALMOL-CHIC, V107, P123, DOI 10.1001/archopht.1989.01070010125040; NAG S, 1988, ACTA NEUROPATHOL, V75, P547, DOI 10.1007/BF00686198; NAG S, 1990, ACTA NEUROPATHOL, V80, P7, DOI 10.1007/BF00294215; NAG S, 1986, ACTA NEUROPATHOL, V70, P38, DOI 10.1007/BF00689512; Peters A., 1976, FINE STRUCTURE NERVO; POVLISHOCK J, 1982, HEAD INJURY BASIC CL, P15; POVLISHOCK JT, 1980, ACTA NEUROPATHOL, V51, P203, DOI 10.1007/BF00687387; Povlishock JT, 1985, CENTRAL NERVOUS SYST, P443; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; TROUT JJ, 1986, LAB INVEST, V55, P622; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; ZHANG ET, 1990, J ANAT, V170, P111	32	11	12	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	WIN	1991	8	4					271	279		10.1089/neu.1991.8.271			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	V07UU	WOS:000207286900005	1803035				2021-06-18	
J	HORST, A; RUTTNER, B				HORST, A; RUTTNER, B			ASEPTIC DURAL SINUS AND CEREBRAL VENOUS THROMBOSIS - A CRITICAL-EVALUATION OF 5 CASES	SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT			German	Article							PROTEIN-S DEFICIENCY; CLOSED HEAD-INJURY; ORAL-CONTRACEPTIVES; TOMOGRAPHIC FINDINGS; ARTERIAL THROMBOSIS; MAGNETIC-RESONANCE; MANIFESTATIONS; PREGNANCY; DISEASE; MRI	From 1988 to 1990, we observed five cases of aseptic dural sinus and cerebral venous thrombosis, all in non-smoking women (age 18 to 47 years) receiving low dose oral contraceptives. Treatment consisted of full anticoagulation over 2 to 6 months, over which time the neurologic symptoms disappeared almost completely. Extensive tests of the blood clotting system in 4 patients after 6 to 19 months revealed a reduction of free protein S in 2 patients with a history of contraceptive use over several years, and normal results in 2 patients in which the sinus thrombosis occurred within the first 6 weeks of use of the oral contraceptive. Whether the protein S deficiency was congenital or caused by the oral contraceptive cannot be decided retrospectively. Even modern oral contraceptives seem to lead to an increased incidence of sinus thrombosis. Initial symptoms of sinus thrombosis include headache and somnolence, followed either by focal neurologic deficits (often associated with focal seizures) or by signs of increased intracranial pressure. CT scans show venous infarcts or general brain edema and may specifically show the "empty triangle sign" and "delta sign". The CT scan may also be normal if focal neurologic deficits are absent. MRI is favoured as it can directly show the thrombosed sinus or veins. Differential diagnosis includes arterial stroke, brain tumor, encephalitis or "benign intracranial hypertension", which should only be diagnosed after sinus venous thrombosis has been appropriately ruled out. Recently, full anticoagulation has been recommended as therapy.	UNIV HOSP ZURICH, NEUROCHIRURG KLIN, CH-8091 ZURICH, SWITZERLAND	HORST, A (corresponding author), UNIV HOSP ZURICH, NEUROL KLIN, CH-8091 ZURICH, SWITZERLAND.						ADAMS RD, 1985, PRINCIPLES NEUROLOGY; ATKINSON EA, 1970, LANCET, V1, P914; AVERBACK P, 1978, ANN NEUROL, V3, P81, DOI 10.1002/ana.410030112; BEAUMONT JL, 1976, CLIN EXP IMMUNOL, V24, P455; BEAUMONT V, 1989, PRESSE MED, V18, P1249; BONNAR J, 1987, AM J OBSTET GYNECOL, V157, P1042, DOI 10.1016/S0002-9378(87)80129-1; BOTTIGER LE, 1980, LANCET, V1, P1097; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; BOUSSER MG, 1988, CURR OPIN NEUROL NEU, V1, P69; BUONANNO FS, 1978, J COMPUT ASSIST TOMO, V2, P281, DOI 10.1097/00004728-197807000-00008; BURKHARDT S, 1964, ARCH NEUROL NEUROCHI, V94, P1; DEMAEREL P, 1989, FORTSCHR RONTG NEUEN, V151, P386; DIROCCO C, 1981, ARCH NEUROL-CHICAGO, V38, P431, DOI 10.1001/archneur.1981.00510070065011; DORSTELMANN D, 1981, NERVENARZT, V52, P243; EINHAUPL KM, 1988, THERAPIE VERLAUF NEU, P275; ENGESSER L, 1987, ANN INTERN MED, V106, P677, DOI 10.7326/0003-4819-106-5-677; ESTANOL B, 1979, STROKE, V10, P680, DOI 10.1161/01.STR.10.6.680; FAIRBURN B, 1973, BMJ-BRIT MED J, V2, P647, DOI 10.1136/bmj.2.5867.647; GETTELFINGER DM, 1977, ARCH NEUROL-CHICAGO, V34, P2, DOI 10.1001/archneur.1977.00500130022004; HANLEY DF, 1988, STROKE, V19, P903, DOI 10.1161/01.STR.19.7.903; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; HULCELLE PJ, 1989, NEURORADIOLOGY, V31, P217, DOI 10.1007/BF00344346; KALBAG RM, 1972, HDB CLIN NEUROLOGY, V12, P422; Krayenbuhl H, 1967, CLIN NEUROSURG, V14, P1; LEFKOWITZ D, 1989, HDB CLIN NEUROLOGY 2, V10, P395; LORENTZ IT, 1962, BRIT MED J, P1191; MACCHI PJ, 1986, J COMPUT ASSIST TOMO, V10, P10, DOI 10.1097/00004728-198601000-00002; MALM J, 1988, BRIT J HAEMATOL, V68, P437, DOI 10.1111/j.1365-2141.1988.tb04232.x; MATTLE H, 1990, NEUROLOGY, V40, P813, DOI 10.1212/WNL.40.5.813; MCMURDO SK, 1986, RADIOLOGY, V161, P83, DOI 10.1148/radiology.161.1.3763888; MEADE TW, 1980, BRIT MED J, V280, P1157, DOI 10.1136/bmj.280.6224.1157; PATRONAS NJ, 1981, SURG NEUROL, V15, P11; RAO KCVG, 1981, RADIOLOGY, V140, P391, DOI 10.1148/radiology.140.2.7255715; RAY BS, 1951, ANN SURG, V134, P376, DOI 10.1097/00000658-195113430-00009; SCHAFER HP, 1989, SCHWEIZ MED WSCHR, V119, P489; SCHELL CL, 1988, WESTERN J MED, V149, P304; SIGSBEE B, 1979, NEUROLOGY, V29, P139, DOI 10.1212/WNL.29.2.139; SRINIVASAN K, 1983, ANGIOLOGY, V34, P731, DOI 10.1177/000331978303401107; Stansfield FR, 1942, BMJ-BRIT MED J, V1942, P436, DOI 10.1136/bmj.1.4239.436; STRINGER WL, 1983, NEUROSURGERY, V12, P95; THRON A, 1986, J NEUROL, V233, P283, DOI 10.1007/BF00314160; Towbin A, 1973, STROKE, V4, P419, DOI 10.1161/01.STR.4.3.419; VILLRINGER A, 1989, LANCET, V1, P1086; VILLRINGER A, 1988, STROKE, V19, P135; 1973, NEW ENGL J MED, V288, P871	45	11	11	0	0	E M H SWISS MEDICAL PUBLISHERS LTD	MUTTENZ	FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND	0036-7672			SCHWEIZ MED WSCHR	Schweiz. Med. Wochenschr.	NOV 2	1991	121	44					1601	1611					11	Medicine, General & Internal	General & Internal Medicine	GN067	WOS:A1991GN06700002	1947957				2021-06-18	
J	FOX, MA; FABIAN, TC; CROCE, MA; MANGIANTE, EC; CARSON, JP; KUDSK, KA				FOX, MA; FABIAN, TC; CROCE, MA; MANGIANTE, EC; CARSON, JP; KUDSK, KA			ANATOMY OF THE ACCIDENT SCENE - A PROSPECTIVE-STUDY OF INJURY AND MORTALITY	AMERICAN SURGEON			English	Article							SEAT BELTS	This study of the accident scene focuses on the effects of vehicular deformity and restraint devices on occupant injury. In 500 patients evaluated in a Level I trauma center, seatbelts significantly reduced the likelihood of individuals' requiring the trauma center (P < 0.0001). Seatbelts also significantly reduced the mortality rate of those who were transported to the trauma center (P < 0.04). Dashboard intrusion correlated with pelvic (P < 0.001) and femur (P < 0.03) fractures, closed head injuries (P < 0.001), and intra-abdominal injuries (P < 0.02). Steering wheel deformity correlated with pelvic fractures (P < 0.001) and closed head injuries (P < 0.005). Windshield violation correlated with closed head injuries (P < 0.014) and spinal fractures (P < 0.03). Irreparable vehicles correlated with pelvic (P < 0.0001) and femur fractures (P < 0.01), closed head injuries (P < 0.0001) and intra-abdominal injuries (P < 0.0001). The authors conclude that a careful examination of the accident scene for specific mechanisms of injury can lead to better prehospital care, more rapid and consistent diagnosis of injury, and improved patient outcome. Further prospective studies should accumulate data that will improve prehospital care, alert physicians to possible injury, increase community awareness of injury prevention, and improve vehicle construction.	UNIV TENNESSEE,CTR HLTH SCI,DEPT SURG,956 COURT AVE,ROOM E228,MEMPHIS,TN 38163							HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; MCDERMOTT FT, 1979, BRIT J SURG, V66, P518, DOI 10.1002/bjs.1800660721; NEWMAN RJ, 1986, J TRAUMA, V12, P561; RASTOGI S, 1986, J BONE JOINT SURG, V168, P950; SATO TB, 1987, J TRAUMA, V27, P754, DOI 10.1097/00005373-198707000-00011; 1986, FIELD CATEGORIZATION, P38	6	11	11	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	1776 PEACHTREE RD, NW., SUITE 410N, ATLANTA, GA 30309-2352	0003-1348			AM SURGEON	Am. Surg.	JUN	1991	57	6					394	397					4	Surgery	Surgery	FT463	WOS:A1991FT46300014	2048854				2021-06-18	
J	ARMSTRONG, C				ARMSTRONG, C			EMOTIONAL CHANGES FOLLOWING BRAIN INJURY - PSYCHOLOGICAL AND NEUROLOGICAL COMPONENTS OF DEPRESSION, DENIAL AND ANXIETY	JOURNAL OF REHABILITATION			English	Article							CLOSED HEAD-INJURY; DIFFERENTIAL LATERALIZATION; NEGATIVE EMOTION; REHABILITATION; MOOD; INTERVENTION; BEHAVIOR; STROKE			ARMSTRONG, C (corresponding author), BRYN MAWR REHABIL HOSP, PSYCHOL, 414 PAOLI PIKE, MALVERN, PA 19355 USA.						AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; AHERN GL, 1979, NEUROPSYCHOLOGIA, V17, P693, DOI 10.1016/0028-3932(79)90045-9; ARMSTRONG C, 1987, DEC NAT HEAD INJ F A; ARMSTRONG C, 1985, GUIDELINES BEHAVIORA; Babinski J, 1918, REV NEUROL, V31, P365; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DAVIDSON R, 1983, LATERALITY PSYCHOPAT; DEUTSCH P, 1987, NATIONAL HEAD INJURY; FINSET A, 1989, SCAND J REHABIL MED, V21, P1; FLORHENRY P, 1983, LATERALITY PSYCHOPAT; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; GLOAG D, 1985, BRIT MED J, V290, P913, DOI 10.1136/bmj.290.6472.913; GRIGSBY JP, 1986, INT J CLIN NEUROPSYC, V8, P65; GUR RC, 1983, LATERALITY PSYCHOPAT; HECAEN H, 1956, ARCH NEURO PSYCHIATR, V75, P400, DOI 10.1001/archneurpsyc.1956.02330220064007; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; LEZAK M, 1978, J CLIN PSYCHIATRY, V32; LEZAK M, 1986, NEW YORK NEUROPSYCHO; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; MILLER E, 1980, BEHAV RES THER, V18, P527, DOI 10.1016/0005-7967(80)90045-5; MILLER E, 1984, RECOVERY MANAGEMENT; NATHANSON M, 1952, AMA ARCH NEUROL PSY, V68, P380, DOI 10.1001/archneurpsyc.1952.02320210090010; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PRIGATANO G, J NEUROL NEUROSUR PS, V47, P505; Rimmele C T, 1987, Arch Clin Neuropsychol, V2, P353; ROBINSON R, 1985, PSYCHOSOMATICS, V36, P769; ROBINSON RG, 1987, PSYCHIAT ANN, V17, P731, DOI 10.3928/0048-5713-19871101-06; ROBINSON RG, 1980, ANN NEUROL, V9, P447; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; SCHWARTZ GE, 1979, PSYCHOPHYSIOLOGY, V16, P561, DOI 10.1111/j.1469-8986.1979.tb01521.x; STUSS DT, 1983, LOCALIZATION NEUROPS, P429; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; TUCKER DM, 1981, ARCH GEN PSYCHIAT, V38, P169; TYERMAN A, 1983, HEADWAY INT C ENGLAN; TYPERMAN A, 1984, INT J REHABILITATION, V7, P11; VALENSTEIN E, 1979, CLIN NEUROPSYCHOLOGY; VONKNORRING L, 1983, LATERALITY PSYCHOPAT; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Weinstein E. A., 1955, DENIAL ILLNESS SYMBO	43	11	11	0	5	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	1991	57	2					15	22					8	Rehabilitation	Rehabilitation	FQ142	WOS:A1991FQ14200003					2021-06-18	
J	WEST, M; WEHMAN, P; KREGEL, J; KREUTZER, J; SHERRON, P; ZASLER, N				WEST, M; WEHMAN, P; KREGEL, J; KREUTZER, J; SHERRON, P; ZASLER, N			COSTS OF OPERATING A SUPPORTED WORK PROGRAM FOR TRAUMATICALLY BRAIN-INJURED INDIVIDUALS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						EMPLOYMENT; HANDICAPPED; HEAD INJURIES; REHABILITATION; VOCATIONAL		This paper presents a preliminary analysis of costs associated with a return-to-work program emphasizing a supported employment approach for persons who had sustained severe traumatic brain injuries. This analysis spans almost three years. Results indicated that a mean of 237.8 hours of staff intervention time was required to achieve job stabilization, at a cost of $6896. Ongoing follow-along and support services averaged 1.64 hours per week at a cost of $47.56. Over 68% of total staff time and costs were expanded in job-site training and advocacy efforts. Application of these findings to state-level and agency-level policies should be weighed against individual characteristics and needs of clients, program design, and outcomes which clients achieve as a result of services.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT REHABIL MED, RICHMOND, VA 23298 USA							ANDERSON DW, 1980, J NEUROSURG S, V53; BENYISHAY Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; COHEN J, 1985, J APPLIED REHABILITA, V16, P25; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; HILL M, 1988, VOCATIONAL REHABILIT, P31; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jennett B., 1983, REHABILITATION HEAD, P3; KREGEL J, 1988, AM J MENT RETARD, V93, P200; KREGEL J, 1989, J ASSOC PERS SEVERE, V14, P293; KREGEL J, 1989, SUPPORTED EMPLOYMENT, P115; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; KREUTZER JS, 1988, VOCATIONAL REHABILIT, P291; MANK D, 1986, PATHWAYS EMPLOYMENT, P139; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; MOON MS, 1988, VOCATIONAL REHABILIT, P17; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; STAPLETON MC, 1986, COGNITIVE REHABIL, V4, P34; TRAPHAJAN J, 1988, COMMUNITY REENTRY; Vogenthaler D R, 1987, Brain Inj, V1, P113; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; Wehman P, 1985, J ASSOC PERS SEVERE, V10, P3; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; 1987, FED REGISTER, V52, P30546; 1987, DATA MANAGEMENT SYST	28	11	12	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1991	72	2					127	131					5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	EX239	WOS:A1991EX23900009	1991014				2021-06-18	
J	BROWN, DSO; NELL, V				BROWN, DSO; NELL, V			EPIDEMIOLOGY OF TRAUMATIC BRAIN INJURY IN JOHANNESBURG .1. METHODOLOGICAL ISSUES IN A DEVELOPING-COUNTRY CONTEXT	SOCIAL SCIENCE & MEDICINE			English	Article						EPIDEMIOLOGY; METHODOLOGY; TRAUMATIC BRAIN INJURY; SAMPLING; JOHANNESBURG; DEVELOPING COUNTRY	HEAD-INJURY; CAPE-TOWN; CHILDREN		UNIV S AFRICA,HLTH PSYCHOL UNIT,POB 392,PRETORIA,SOUTH AFRICA							ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; AUSTEN MH, 1987, S AFR MED J, V72, P770; AUSTIN RL, 1983, J CRIM JUST, V11, P93, DOI 10.1016/0047-2352(83)90045-4; AUSTIN RL, 1987, J CRIM JUST, V15, P437, DOI 10.1016/0047-2352(87)90001-8; BOTHA JL, 1988, SOC SCI MED, V26, P851; BROWN DSO, 1990, 904 U S AFR HLTH PSY; DEBEER C, 1984, S AFRICAN DISEASE AP; DEVILLIERS JC, 1984, S AFR MED J, V66, P801; ENGELHART H, 1986, HOSPITAL NURSING YB; GUTHKELCH AN, 1979, ACTA NEUROCHIR S, V1, P120; *INT ROAD FED, 1988, WORLD ROAD STAT; JANSEN CP, 1988, THESIS U S AFRICA PR; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; KOK PC, 1986, BEVOLKINGS HERVERSPR; KUSTNER HGV, 1987, EPIDEMIOLOGICAL COMM, V14, P2; MURRAY GD, 1986, STAT MED, V5, P103, DOI 10.1002/sim.4780050202; PANG D, 1985, HEAD INJURY REHABILI; ROSEINNES AP, 1974, S AFR MED J, V48, P2548; Sanders D, 1985, STRUGGLE HLTH; TEASDALE G, 1974, LANCET, V2, P81; VANDELLEN JR, UNPUB ANN STATISTICS; WHO, 1977, MAN INT STAT CLASS D, V1; *WHO, 1977, MAN INT STAT CLASS D, V2; *WHO, 1986, PROBL MENT HLTH AFR; *WHO, 1986, POP CENS 1985; *WHO, 1984, 698 TECHN REP; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	28	11	11	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0277-9536			SOC SCI MED	Soc. Sci. Med.		1991	33	3					283	287		10.1016/0277-9536(91)90362-G			5	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Public, Environmental & Occupational Health; Biomedical Social Sciences	GA785	WOS:A1991GA78500007	1925692				2021-06-18	
J	CAMPBELL, KB; SUFFIELD, JB; DEACON, DL				CAMPBELL, KB; SUFFIELD, JB; DEACON, DL			ELECTROPHYSIOLOGICAL ASSESSMENT OF COGNITIVE DISORDER IN CLOSED HEAD-INJURED OUTPATIENTS	ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article							EVENT-RELATED POTENTIALS; ATTENTION; P300; PROBABILITY; COMPONENT; SURPRISE; STIMULUS; MEMORY	Severe closed head-injury results in a multitude of long-lasting cognitive deficits. ERPs can effectively complement the more traditional behavioural measures to provide information that is not available through any other means. It is now fairly clear that a late positive wave. P3. associated with contextual updating is attenuated and prolonged in a variety of conditions in the head-injured. It is also possible that measures of selective attention such as the processing negativity may be abnormal in this group. A more definitive statement will, however. have to wait the results of further investigations. A number of investigators have now indicated that cognitive processing is slowed in the head-injured. Again, ERPs have been instrumental in explaining why it is slowed. Decision making time as measured by RT is generally longer than P3 latency. Because P3 latency is delayed in the head-injured. the time required for evaluation of the stimulus (recognition and classification) is slowed in the head-injured. The additional delay in RT must, however. be explained by other processes, most probably a response bias that perhaps emphasizes accuracy at a cost of speed. Such a strategy can be manipulated if the patient is provided with cues about their speed of responding. Finally, ERPs have been instrumental in explaining possible reasons for cognitive slowing. A powerful CNV technique may permit the categorization of the head-injured into at least 2 distinctive groups: those that tend to underprocess information (perhaps as a result of apathy or a lack of motivation) and those that tend to overprocess (perhaps as a result of an inefficient and needless processing of irrelevant information resulting in fatigue). The extent to which the different modes of information processing are related to the site of brain injury and possible personality change remains an issue of speculation.	PARKWOOD HOSP,DEPT NEUROPSYCHOL,LONDON N6C 5J1,ONTARIO,CANADA; UNIV OTTAWA,SCH PSYCHOL,OTTAWA K1N 6N5,ONTARIO,CANADA; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461							ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; Baddeley A. D., 1986, WORKING MEMORY; BARIBEAU J, 1989, 9TH INT C EV REL POT; BROOKS D N, 1975, Cortex, V11, P329; Campbell K., 1986, ELECTROENCEPHALOGR S, V38, P486; Campbell K.S.W., 1985, International Union of Geological Sciences Publication, P117; CAMPBELL KB, 1979, BIOL PSYCHOL, V8, P45, DOI 10.1016/0301-0511(79)90004-8; CURRY SH, 1980, MOTIVATION MOTOR SEN, P507; Deacon-Elliott D L, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P664; DEACONELLIOTT DL, 1988, THESIS U OTTAWA; DEADWYLER SA, 1985, CRIT REV CLIN NEUROB, V2, P335; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Donchin E, 1984, COGNITIVE PSYCHOPHYS; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; FACCO E, 1990, EEG CL NEUR, V41, pCH36; FITZGERALD PG, 1981, CAN J PSYCHOL, V35, P188, DOI 10.1037/h0081154; GOLDEN CJ, 1983, CLIN NEUROPSYCHOLOGY; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSON R, 1985, PSYCHOPHYSIOLOGY, V22, P182, DOI 10.1111/j.1469-8986.1985.tb01584.x; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; Johnson R., 1988, ADV PSYCHOPHYSIOLOGY, V3, P69; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LAPPIN JS, 1978, COGNITIVE THEORY, V3, P179; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; McCallum WC., 1988, HDB ELECTROENCEPHALO, V3, P427; MCCARTHY G, 1978, NEUROPSYCHOLOGIA, V16, P571, DOI 10.1016/0028-3932(78)90085-4; MEYER DE, 1988, PSYCHOL REV, V95, P183, DOI 10.1037/0033-295X.95.2.183; NAATANEN R, 1988, BIOL PSYCHOL, V26, P117, DOI 10.1016/0301-0511(88)90017-8; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Pachella R. G., 1974, HUMAN INFORM PROCESS, P41; PAPANICOLAOU AC, 1987, NEUROBEHAVIORAL RECO; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P191, DOI 10.1016/0013-4694(74)90156-4; POSNER MI, 1987, NEUROBEHAVIORAL RECO, P390; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; Rohrbaugh JW., 1983, TUTORIALS EVENT RELA, P269, DOI [10.1016/S0166-4115(08)62044-0, DOI 10.1016/S0166-4115(08)62044-0]; SCHWENT VL, 1976, ELECTROEN CLIN NEURO, V40, P615, DOI 10.1016/0013-4694(76)90136-X; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; WOOD CC, 1984, BRAIN INFORMATION EV, P681	47	11	11	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0013-4694			ELECTROEN CLIN NEURO	Electroencephalogr. Clin. Neurophysiol.		1990				41			202	215					14	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	HB513	WOS:A1990HB51300022	2289430				2021-06-18	
J	ANDY, OJ				ANDY, OJ			POST CONCUSSION SYNDROME - BRAIN-STEM SEIZURES, A CASE-REPORT	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article										ANDY, OJ (corresponding author), UNIV MISSISSIPPI,MED CTR,DEPT NEUROSURG,2500 N STATE ST,JACKSON,MS 39216, USA.						ANDERSON LS, 1971, J NEUROSURG, V35, P444, DOI 10.3171/jns.1971.35.4.0444; ANDY OJ, 1987, APPL NEUROPHYSIOL, V50, P455; ANDY OJ, 1986, PAVLOVIAN J BIOL SCI, V21, P50; ANDY OJ, 1987, PAVLOVIAN J BIOL SCI, V22, P132; ANDY OJ, 1985, CLIN ELECTROENCEPHAL, V16, P195, DOI 10.1177/155005948501600406; ANDY OJ, 1985, APPL NEUROPHYSIOL, V48, P432; ANDY OJ, 1985, J MISSISSIPPI ACADEM, V30, P111; ANDY OJ, 1985, CLIN ELECTROENCEPHAL, V17, P52; BRITT RH, 1980, NEUROSURGERY, V6, P623, DOI 10.1227/00006123-198006000-00002; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; CROMPTON MR, 1971, LANCET, V1, P669; DENO RL, 1938, J NEUROPHYSIOL, V1, P210; EMMERS R, 1981, PAIN SPIKE INTERVAL; Feldman RS, 1984, FUNDAMENTALS NEUROPS; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hardman J M, 1979, Adv Neurol, V22, P15; HOUK JC, 1988, FASEB J, V2, P97; JANE JA, 1982, HEAD INJURY BASIC CL; KELLER EL, 1980, RETICULAR FORMATION, P227; LEGG NJ, 1978, NEUROTRANSMITTER SYS; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARSONS LC, 1981, NEUROSCI LETT, V24, P199, DOI 10.1016/0304-3940(81)90248-2; PILZ P, 1982, J NEUROL NEUROSUR PS, V45, P422, DOI 10.1136/jnnp.45.5.422; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; SABELLI HC, 1973, CHEM MODULATION BRAI; SCHALTENBRAND G, 1959, INTRO STEREOTAXIS AT; Scheibel ME, 1958, RETICULAR FORMATION, P31; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; TRIMBLE MR, 1984, PSYCHOPHARMACOLOGY L; VALZELLI L, 1973, PSYCHOPHARMACOLOGY; WESTRUM LE, 1980, EPILEPSY WINDOW BRAI, P137	33	11	11	0	2	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	JAN	1989	20	1					24	34		10.1177/155005948902000107			11	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	R7443	WOS:A1989R744300003	2784362				2021-06-18	
J	ALDEN, PB; SVINGEN, BA; DEUTSCHMAN, CS; JOHNSON, SB; KONSTANTINIDES, FN; HOLMAN, RT; CERRA, FB				ALDEN, PB; SVINGEN, BA; DEUTSCHMAN, CS; JOHNSON, SB; KONSTANTINIDES, FN; HOLMAN, RT; CERRA, FB			ESSENTIAL FATTY-ACID STATUS IN ISOLATED CLOSED HEAD-INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article									ST PAUL RAMSEY MED CTR,SURG METAB RES LAB,ST PAUL,MN 55101; UNIV MINNESOTA HOSP & CLIN,DEPT SURG,MINNEAPOLIS,MN 55455; HORMEL INST,AUSTIN,MN; JOHNS HOPKINS MED INST,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD 21205			Deutschman, Clifford/AAN-2742-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL008214, T32HL007311] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL08214, HL07311] Funding Source: Medline; NIADDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [AM34931] Funding Source: Medline		ALDEN PB, 1986, SURGERY, V100, P671; CERRA FB, 1979, J TRAUMA, V19, P621, DOI 10.1097/00005373-197908000-00010; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; HOLMAN RT, 1983, P NATL ACAD SCI-BIOL, V80, P2375, DOI 10.1073/pnas.80.8.2375; Holman RT, 1983, DIETARY FATS HLTH, P247; JELEN S, 1983, JPEN-PARENTER ENTER, V7, P142, DOI 10.1177/0148607183007002142; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; PAULSRUD JR, 1972, AM J CLIN NUTR, V25, P897; SIEGEL JH, 1979, SURGERY, V86, P163; WOLFRAM G, 1983, KLIN WOCHENSCHR, V61, P1181, DOI 10.1007/BF01537429	12	11	11	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1987	27	9					1039	1043		10.1097/00005373-198709000-00014			5	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	K2621	WOS:A1987K262100014	3656466				2021-06-18	
J	LARSSON, C; RONNBERG, J				LARSSON, C; RONNBERG, J			MEMORY DISORDERS AS A FUNCTION OF TRAUMATIC BRAIN INJURY - WORD COMPLETION, RECALL OF WORDS AND ACTIONS	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article										LARSSON, C (corresponding author), UNIV UMEA,DEPT PSYCHOL,S-90247 UMEA,SWEDEN.			Ronnberg, Jerker/0000-0001-7311-9959				0	11	11	0	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1987	19	3					99	104					6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	L1220	WOS:A1987L122000002	3441777				2021-06-18	
J	COSTEFF, H; GROSWASSER, Z; LANDMAN, Y; BRENNER, T				COSTEFF, H; GROSWASSER, Z; LANDMAN, Y; BRENNER, T			SURVIVORS OF SEVERE TRAUMATIC BRAIN INJURY IN CHILDHOOD .2. LATE RESIDUAL DISABILITY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article										COSTEFF, H (corresponding author), LEOWENSTEIN REHAB HOSP,POB 3,IL-43100 RAANANA,ISRAEL.							0	11	12	1	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1985				12			10	15					6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	AWU58	WOS:A1985AWU5800002					2021-06-18	
J	RICHARDSON, JTE				RICHARDSON, JTE			THE EFFECTS OF CLOSED HEAD-INJURY UPON INTRUSIONS AND CONFUSIONS IN FREE-RECALL	CORTEX			English	Article										RICHARDSON, JTE (corresponding author), BRUNEL UNIV,DEPT PSYCHOL,UXBRIDGE UB8 3PH,MIDDX,ENGLAND.			Richardson, John/0000-0002-6267-0603			BADDELEY A, 1977, ATTENTION PERFORMANC, V6; BADDELEY AD, 1975, STUDIES LONG TERM ME; BADDELEY AD, 1974, ADV RES THEORY, V8; BROOKS D N, 1974, Cortex, V10, P224; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; CONKEY RC, 1938, ARCH PSYCHOL, V33, P232; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1976, DIS NERV SYST, V37, P68; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; RICHARDSON JTE, 1979, BRIT J SOC CLIN PSYC, V18, P319, DOI 10.1111/j.2044-8260.1979.tb00342.x; RICHARDSON JTE, 1983, B PSYCHONOMIC SOC, V21, P348; RICHARDSON JTE, 1979, CORTEX, V15, P145, DOI 10.1016/S0010-9452(79)80016-7; RICHARDSON JTE, 1982, PATHOLOGY PSYCHOL CO; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; THOMSEN IV, 1977, SCAND J REHABIL MED, V9, P73; WATKINS MJ, 1974, PSYCHOL BULL, V81, P695, DOI 10.1037/h0036952	24	11	11	0	0	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex		1984	20	3					413	420		10.1016/S0010-9452(84)80009-X			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	TL039	WOS:A1984TL03900009	6488817				2021-06-18	
J	SHAW, NA; CANT, BR				SHAW, NA; CANT, BR			THE EFFECT OF EXPERIMENTAL CONCUSSION ON SOMATOSENSORY EVOKED-POTENTIALS	AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE			English	Article										SHAW, NA (corresponding author), UNIV AUCKLAND,SCH MED,DEPT PHYSIOL,AUCKLAND,NEW ZEALAND.						ANGEL A, 1977, PROG NEUROBIOL, V9, P1, DOI 10.1016/0301-0082(77)90018-1; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DONG WK, 1982, ELECTROEN CLIN NEURO, V53, P143, DOI 10.1016/0013-4694(82)90020-7; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; GRONWALL DMA, 1974, PSYCHOL EFFECTS CONC, P1; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; LETCHER FS, 1973, J NEUROSURG, V39, P167, DOI 10.3171/jns.1973.39.2.0167; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PLUM F, 1980, DIAGNOSIS STUPOR COM, P118; SHAW NA, 1981, ELECTROEN CLIN NEURO, V51, P674, DOI 10.1016/0013-4694(81)90213-3; SYMONDS C, 1962, LANCET, V1, P1; WIEDERHOLT WC, 1977, ELECTROEN CLIN NEURO, V42, P456, DOI 10.1016/0013-4694(77)90209-7	16	11	11	0	2	AUST JRNL EXP BIOL & MED SCI	ADELAIDE SO AUSTRALIA	DEPT MICROBIOLOGY & IMMUNOLOGY UNIV ADELAIDE, ADELAIDE SO AUSTRALIA 5000, AUSTRALIA	0004-945X			AUST J EXP BIOL MED			1984	62	JUN					361	371		10.1038/icb.1984.36			11	Medicine, Research & Experimental	Research & Experimental Medicine	SY423	WOS:A1984SY42300012	6093755				2021-06-18	
J	PARKINSON, D				PARKINSON, D			CONCUSSION	MAYO CLINIC PROCEEDINGS			English	Article									UNIV MANITOBA,WINNIPEG R3T 2N2,MANITOBA,CANADA							BERTRAND C, 1951, CAN MED ASSOC J, V65, P225; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; COURVILLE CB, 1953, COMMOTIO CEREBRI CER; DENKER PG, 1954, NEUROLOGY, V4, P912, DOI 10.1212/WNL.4.12.912; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; FULTON JF, 1943, PHYSIOLOGY NERVOUS S; GRONWALL, 1974, LANCET, V2, P605; HUSSEY HH, 1976, JAMA-J AM MED ASSOC, V236, P485; INCH T, 1951, BOXING BEGINNERS NOV; JENNETT B, COMMUNICATION; KAPLAN HA, 1954, JAMA-J AM MED ASSOC, V156, P1138, DOI 10.1001/jama.1954.02950120012004; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; OMMAYA A K, 1971, International Journal of Neuroscience, V1, P371, DOI 10.3109/00207457109146986; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RICHARDSON JC, 1951, CAN MED ASSOC J, V64, P414; Sherrington C. S., 1947, INTEGRATIVE ACTION N; VORIS HC, 1950, AM J SURG, V80, P707, DOI 10.1016/0002-9610(50)90595-2; 1976, LANCET, V1, P401	18	11	11	0	0	MAYO CLINIC PROCEEDINGS	ROCHESTER	660 SIEBENS BLDG MAYO CLINIC, ROCHESTER, MN 55905	0025-6196			MAYO CLIN PROC	Mayo Clin. Proc.		1977	52	8					492	496					5	Medicine, General & Internal	General & Internal Medicine	DQ768	WOS:A1977DQ76800003	881900				2021-06-18	
J	RABOW, L; TIBBLING, G				RABOW, L; TIBBLING, G			SERUM ACTIVITIES OF HYDROXYBUTYRATE DEHYDROGENASE (HBD) AND ISOENZYMES OF LACTATE-DEHYDROGENASE (LD) AS AN INDEX OF TRAUMATIC BRAIN INJURY	ACTA NEUROCHIRURGICA			English	Article									LINKOPING UNIV,DEPT NEUROSURG,LINKOPING,SWEDEN; LINKOPING UNIV,DEPT CLIN CHEM,LINKOPING,SWEDEN							DAWSON DM, 1969, ANN INTERN MED, V70, P799, DOI 10.7326/0003-4819-70-4-799; DUBACH UC, 1965, DEUT MED WOCHENSCHR, V90, P1429, DOI 10.1055/s-0028-1113351; Freedland R A, 1970, Adv Vet Sci Comp Med, V14, P61; Gurdjian E S, 1972, Clin Neurosurg, V19, P1; JOHANSSON BG, 1972, SCAND J CLIN LAB INV, V29, P7, DOI 10.3109/00365517209102747; KOWALEWSKI SL, 1972, ISOENZYME LACTATDEHY; KOWALEWSKI SL, 1969, THESIS BONN; KVAMME E, 1962, SCAND J CLIN LAB INV, V14, P453, DOI 10.3109/00365516209051262; Lindblom U, 1972, Scand J Rehabil Med, V4, P61; Lindblom U, 1967, Nord Med, V77, P337; PFLEIDERER G, 1961, BIOCHEM Z, V334, P185; Rabow L, 1972, Scand J Rehabil Med, V4, P90; RABOW L, 1975, ACTA NEUROCHIR, V32, P199, DOI 10.1007/BF01405453; RABOW L, 1977, ACTA NEUROCHIR, V36, P61, DOI 10.1007/BF01405987; RABOW L, 1971, ACTA CHIR SCAND, V137, P1240; WILKINSON JH, 1970, ISOENZYMES; WILKINSON JH, 1975, METHODS ENZYMATIC AN; WROBLEWSKI F, 1961, ANN NY ACAD SCI, V94, P912, DOI 10.1111/j.1749-6632.1961.tb35584.x; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; ZONDAG HA, 1967, DETERMINATION DIAGNO	20	11	11	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1977	37	3-4					245	261		10.1007/BF01402129			17	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DL773	WOS:A1977DL77300005	906904				2021-06-18	
J	BLACK, FW				BLACK, FW			COGNITIVE AND MEMORY PERFORMANCE IN SUBJECTS WITH BRAIN-DAMAGE SECONDARY TO PENETRATING MISSILE WOUNDS AND CLOSED HEAD-INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article									FITZSIMONS ARMY MED CTR,DENVER,CO 80240							GOLDSTEIN K, 1948, AFTEREFFECTS BRAIN I; GRAHAM FK, 1960, PERCEPT MOT SKILL S2; KORMAN CD, 1963, J CONSULT PSYCHOL, V27, P303; RUSSELL WR, 1951, J NEUROL NEUROSUR PS, V14, P35, DOI 10.1136/jnnp.14.1.35; SIMPSON CD, 1971, J CLIN PSYCHOL, V27, P204, DOI 10.1002/1097-4679(197104)27:2<204::AID-JCLP2270270214>3.0.CO;2-9	5	11	11	0	0	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1973	29	4					441	442					2	Psychology, Clinical	Psychology	R3598	WOS:A1973R359800012	4766716				2021-06-18	
J	GORDON, E				GORDON, E			SOME CORRELATIONS BETWEEN CLINICAL OUTCOME AND ACID-BASE STATUS OF BLOOD AND CEREBROSPINAL FLUID IN PATIENTS WITH TRAUMATIC BRAIN INJURY	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article																Baldy-Moulmier M, 1969, CEREBRAL BLOOD FLOW, P216; CAMPAN L, 1968, ANN ANESTH FRANC, V9, P4; COTEV S, 1969, ANESTH ANALG, V48, P1; FIESCHI C, 1968, NEUROLOGY, V18, P12; FIESCHI C, 1969, CEREBRAL BLOOD FLOW, P120; FROMAN C, 1968, BRIT J ANAESTH, V40, P354, DOI 10.1093/bja/40.5.354; FROWEIN R A, 1964, Zentralbl Neurochir, V25, P39; FROWEIN R A, 1968, Acta Neurochirurgica, V19, P1, DOI 10.1007/BF01402409; GORDON E, 1970, ACTA ANAESTH SCAND, V14, P97, DOI 10.1111/j.1399-6576.1970.tb00763.x; GORDON E, 1968, ACTA ANAESTH SCAND, V12, P51, DOI 10.1111/j.1399-6576.1968.tb00411.x; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P193, DOI 10.1111/j.1399-6576.1971.tb05461.x; GRUNERT V, 1969, NEURO-CHIR, V15, P275; LASSEN NA, 1961, EXPERIENTIA, V17, P42, DOI 10.1007/BF02157946; LASSEN NA, 1969, CEREBRAL BLOOD FLOW, P278; Lassen NA, 1968, SCAND J CLIN LA S102, pXIII; Lassen NA, 1969, CEREBRAL BLOOD FLOW, P117; PLUM F, 1959, ARCH NEURO PSYCHIATR, V81, P535, DOI 10.1001/archneurpsyc.1959.02340170001001; ROSSANDA M, 1970, ACTA ANAESTH SCAND, V14, P173, DOI 10.1111/j.1399-6576.1970.tb00963.x; STEINBEREITHNER K, 1967, KLIN WOCHENSCHR, V45, P126, DOI 10.1007/BF01725067; WOLLMAN H, 1969, CEREBRAL BLOOD FLOW, P273	20	11	11	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.		1971	15	3					209	&		10.1111/j.1399-6576.1971.tb05462.x			0	Anesthesiology	Anesthesiology	K5975	WOS:A1971K597500006	5120956				2021-06-18	
J	MULLER, R; NAUMANN, B				MULLER, R; NAUMANN, B			EARLY AMBULATION AND PSYCHOTHERAPY FOR TREATMENT OF CLOSED HEAD INJURY	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article																ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; CEDERMARK J, 1942, ACTA CHIR SCANDI S75, V86, P1; DALSGAARDNIELSEN T, 1954, ACTA PSYCH NEUROL, V29, P28, DOI 10.1111/j.1600-0447.1954.tb05661.x; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DENNYBROWN D, 1942, NEW ENGL J MED, V227, P813; FRIEDMAN AP, 1945, J NEUROSURG, V2, P36, DOI 10.3171/jns.1945.2.1.0036; Guttmann E, 1943, Br Med J, V1, P94; Guttmann E, 1943, LANCET, V1, P10; Lewis A. J., 1942, P ROY SOC MED, V35, P607; MCKENZIE KG, 1943, T AM NEUROL A, V69, P103; MULLER R, 1955, Nord Med, V53, P677; Ross WD, 1944, ARCH NEURO PSYCHIATR, V52, P255, DOI 10.1001/archneurpsyc.1944.02290340002001; RUESCH J, 1945, AM J PSYCHIAT, V102, P145, DOI 10.1176/ajp.102.2.145; RUESCH J, 1945, A RES NERV MENT DIS, V24, P507; Russell W Ritchie, 1934, Edinb Med J, V41, P129; Russell WR, 1942, BMJ-BRIT MED J, V1942, P521, DOI 10.1136/bmj.2.4269.521; SHEARBURN EW, 1943, B US ARMY MED DEP, V69, P36; SIMONS DJ, 1946, PSYCHOSOM MED, V8, P227, DOI 10.1097/00006842-194607000-00001; Symonds CP, 1943, LANCET, V1, P7	21	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0096-6754			ARCH NEURO PSYCHIATR			1956	76	DEC					597	607					11	Psychiatry	Psychiatry	WD825	WOS:A1956WD82500004	13371975				2021-06-18	
J	Denny-Brown, D				Denny-Brown, D			Post-concussion syndrome - A critique	ANNALS OF INTERNAL MEDICINE			English	Article									Harvard Univ, Med Sch, Dept Neurol, Cambridge, MA USA; Boston City Hosp, Neurol Unit, Boston, MA USA							[Anonymous], 1942, Proc R Soc Med, V35, P601; Bright R., 1831, REPORTS MED CASES 1, V2; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1942, NEW ENGL J MED, V227, P813; HUTCHINSON J, 1877, ILLUSTRATIONS CLIN S, V1; Lemere F, 1936, ARCH NEURO PSYCHIATR, V35, P990, DOI 10.1001/archneurpsyc.1936.02260050064005; Malone JY, 1942, J AMER MED ASSOC, V119, P861, DOI 10.1001/jama.1942.02830280007002; Penfield W, 1936, ARCH NEURO PSYCHIATR, V36, P75, DOI 10.1001/archneurpsyc.1936.02260070083007; PENFIELD W, 1927, SURG GYNECOL OBSTET, V45, P747; RUSSEL C, 1942, ARCH NEUROL PSYCHIAT, V47, P1030; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Schaller WF, 1939, J AMER MED ASSOC, V113, P1779; SCHILDER P, 1940, INJURIES SKULL BRAIN, pCH12; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1932, LANCET, V1, P820; SYMONDS CP, 1940, INJURIES SKULL BRAIN, pCH4	17	11	11	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP	1943	19	3					427	432		10.7326/0003-4819-19-3-427			6	Medicine, General & Internal	General & Internal Medicine	V07HL	WOS:000200492500003					2021-06-18	
J	Eulion, JF				Eulion, JF			Blast and concussion in the present war	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Yale Univ, Sch Med, Lab Physiol, New Haven, CT USA							ARNOUX, 1915, JOURNAL PARIS   0606; BARCROFT J, 1939, SECTIONAL STEEL SHEL; Bernal JD, 1941, NATURE, V147, P594, DOI 10.1038/147594a0; Bowlby A, 1915, LANCET, V2, P1385; Carver A, 1919, BRAIN, V42, P113, DOI 10.1093/brain/42.2.113; Davis HA, 1941, ARCH SURG-CHICAGO, V43, P1; Dean DM, 1940, LANCET, V2, P224; DEGUTIERREZMAHO.W, 1941, WAR MED, V1, P816; Denny-Brown D, 1940, J PHYSIOL-LONDON, V99, P153, DOI 10.1113/jphysiol.1940.sp003887; Denny-Brown D, 1941, LANCET, V1, P371; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1941, P ROY SOC MED, V34, P685; Eden K., 1941, PROC ROY SOC MED, V34, P685; Falla S T, 1940, Br Med J, V2, P255; FULTON JE, 1940, T STUD COLL PHYS PHI, V8, P157; GITHENS TS, 1919, AM J PHYSIOL, V49, P120; Hadfield G, 1941, BRIT MED J, V1941, P77, DOI 10.1136/bmj.1.4176.77; Hadfield G, 1940, LANCET, V2, P478; Hooker DR, 1924, AM J PHYSIOL, V67, P219; Kretzschmar CH, 1940, LANCET, V1, P832; KROHN PL, 1941, BRIT MED J, V1, P645; Logan DD, 1939, BRIT MED J, V2, P864, DOI 10.1136/bmj.2.4112.864; MARINESCO G, 1918, REV NEUROL, V31, P329; McKibben PS, 1919, AM J PHYSIOL, V48, P331; MITCHELL SW, 1864, GUNSHOT WOUNDS OTHER; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Mott FW, 1916, LANCET, V1, P545; Myers CS, 1940, SHELL SHOCK FRANCE 1; O' Reilly JN, 1941, LANCET, V2, P423; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER CM, 1922, HIST GREAT WAR MED S, V1, P36; Pitres A, 1916, REV NEUROL-FRANCE, V29, P298; RCHWILD E, 1940, MED KLIN, V36, P867; Robb-Smith AHT, 1941, LANCET, V1, P135; ROBBSMITH AHT, 1941, P ROY SOC MED, V34, P639; ROUBINOVITSCH J, 1940, B MED, V54, P65; Rowlands RA, 1941, LANCET, V1, P502; Schaller WF, 1941, ARCH NEURO PSYCHIATR, V45, P1; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Smith H. W., 1944, BMJ-BRIT MED J, V30, P193; Stewart OW, 1941, LANCET, V1, P172; THOMSON GF, 1940, BRIT MED J, V1, P44; von Sarbo A, 1932, SCHWEIZ ARCH NEUROL, V29, P127; WANKE R, 1940, ARCH KLIN CHIR, V200, P189; Zuckerman S, 1940, LANCET, V2, P219; ZUCKERMAN S, 1941, BRIT MED J, V1, P645; Zuckerman S., 1941, P ROY SOC MED, V34, P171	48	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN-JUN	1942	226						1	8					8	Medicine, General & Internal	General & Internal Medicine	V32ZV	WOS:000202230300001					2021-06-18	
